PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Shi, ZX; Shen, TJ; Liu, YL; Huang, YY; Jiao, JW				Shi, Zixiao; Shen, Tianjin; Liu, Yanli; Huang, Yuanyuan; Jiao, Jianwei			Retinoic Acid Receptor gamma (Rarg) and Nuclear Receptor Subfamily 5, Group A, Member 2 (Nr5a2) Promote Conversion of Fibroblasts to Functional Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenovirus; Fibroblast; Neurons; Nuclear Receptors; Retinoid	ADENOVIRAL GENE DELIVERY; PLURIPOTENT STEM-CELLS; MOUSE-BRAIN; EXPRESSION; DIFFERENTIATION; INDUCTION; ALPHA	Background: It is necessary to identify more factors to increase fibroblast to neuron conversion with non-integration adenovirus. Results: Nuclear receptor Rarg and Nr5a2 or agonist greatly enhance the conversion efficiency. Conclusion: Rarg and Nr5a2 both promote transdifferentiation and improve neuronal function. Significance: It would be of potential advantage to obtain safe and functional neurons with high efficiency. Somatic cells can be reprogrammed to neurons and various other cell types with retrovirus or lentivirus. The limitation of this technology is that these genome-integration viruses may increase the risk of gene mutation and cause insertional mutagenesis. We recently found that non-integration adenovirus carrying neuronal transcription factors can induce fibroblasts to neurons. However, the conversion efficiency by the adenovirus is lower than that of the retrovirus or lentivirus. Therefore, it is crucial to identify other factors or chemical compounds to obtain neurons with high efficiency. In this study we show that the combination of Rarg (retinoic acid receptor ) and Nr5a2 (nuclear receptor subfamily 5, group A, member 2; also known as Lrh-1 (liver receptor homologue 1)) rapidly promote the iN cell maturation within 1 week and greatly facilitate the conversion with neuronal purities of approximate to 50% and yields of >130%. They also improve neuronal pattern formation, electrophysiological characteristics, and functional integration in vivo. Moreover, the chemical compound agonists to Rarg and Nr5a2 function effectively as well. This approach may be used for the generation and application of iN cells in regenerative medicine.	[Shi, Zixiao; Liu, Yanli; Huang, Yuanyuan; Jiao, Jianwei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Shi, Zixiao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Shen, Tianjin] Anhui Univ, Sch Life Sci, Hefei 230601, Anhui, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Anhui University	Jiao, JW (corresponding author), Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China.	jwjiao@ioz.ac.cn	Jiao, Jianwei/AAA-7902-2020; Jiao, Jianwei/I-1452-2013	Jiao, Jianwei/0000-0002-7893-0721; Jiao, Jianwei/0000-0002-7893-0721	National Basic Research Program of China [2014CBCB964903]; National Science Foundation of China [31371477]; Strategic Priority Stem Cell Program Grant [XDA01020301]; Hundreds Talent Program	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Stem Cell Program Grant; Hundreds Talent Program	This work was supported by National Basic Research Program of China Grant 2014CBCB964903, National Science Foundation of China Grant 31371477, Strategic Priority Stem Cell Program Grant XDA01020301, and the Hundreds Talent Program.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; BOYLAN JF, 1995, MOL CELL BIOL, V15, P843; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Drager Ursula C, 2006, Sci STKE, V2006, ppe10, DOI 10.1126/stke.3242006pe10; GIANNI M, 1993, BIOCHEM BIOPH RES CO, V196, P252, DOI 10.1006/bbrc.1993.2242; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Goslin K., 1998, CULTURING NERVE CELL, P339; Grgurevic N, 2005, NEUROENDOCRINOL LETT, V26, P541; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Li WL, 2013, CELL RES, V23, P81, DOI 10.1038/cr.2012.182; Lu JF, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-57; Luo T, 2004, BIOL PSYCHIAT, V56, P971, DOI 10.1016/j.biopsych.2004.09.020; Maden M, 2002, NAT REV NEUROSCI, V3, P843, DOI 10.1038/nrn963; McCaffery P, 2006, J NEUROBIOL, V66, P780, DOI 10.1002/neu.20237; Meng FX, 2012, CELL RES, V22, P436, DOI 10.1038/cr.2011.185; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zechel C, 2005, MOL ENDOCRINOL, V19, P1629, DOI 10.1210/me.2004-0540; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201	28	15	15	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6415	6428		10.1074/jbc.M113.515601	http://dx.doi.org/10.1074/jbc.M113.515601			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24459144	Green Published, hybrid			2022-12-25	WOS:000332389400010
J	Brooks, SJ; Nilsson, EK; Jacobsson, JA; Stein, DJ; Fredriksson, R; Lind, L; Schioth, HB				Brooks, Samantha J.; Nilsson, Emil K.; Jacobsson, Josefin A.; Stein, Dan J.; Fredriksson, Robert; Lind, Lars; Schioth, Helgi B.			BDNF Polymorphisms Are Linked to Poorer Working Memory Performance, Reduced Cerebellar and Hippocampal Volumes and Differences in Prefrontal Cortex in a Swedish Elderly Population	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; VOXEL-BASED MORPHOMETRY; VAL66MET POLYMORPHISM; VAL(66)MET POLYMORPHISM; GENE; PLASTICITY; CONNECTIVITY; COGNITION; WOMEN	Background: Brain-derived neurotrophic factor (BDNF) links learning, memory and cognitive decline in elderly, but evidence linking BDNF allele variation, cognition and brain structural differences is lacking. Methods: 367 elderly Swedish men (n = 181) and women (n = 186) from Prospective Investigation of the Vasculature in Uppsala seniors (PIVUS) were genotyped and the BDNF functional rs6265 SNP was further examined in subjects who completed the Trail Making Task (TMT), verbal fluency task, and had a magnetic resonance imaging (MRI) scan. Voxel-based morphometry (VBM) examined brain structure, cognition and links with BDNF. Results: The functional BDNF SNP (rs6265,) predicted better working memory performance on the TMT with positive association of the Met rs6265, and was linked with greater cerebellar, precuneus, left superior frontal gyrus and bilateral hippocampal volume, and reduced brainstem and bilateral posterior cingulate volumes. Conclusions: The functional BDNF polymorphism influences brain volume in regions associated with memory and regulation of sensorimotor control, with the Met rs6265 allele potentially being more beneficial to these functions in the elderly.	[Brooks, Samantha J.; Nilsson, Emil K.; Jacobsson, Josefin A.; Fredriksson, Robert; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Brooks, Samantha J.; Stein, Dan J.] Univ Cape Town, Fac Hlth Sci, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa	Uppsala University; Uppsala University; University of Cape Town	Brooks, SJ (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	samantha.brooks@neuro.uu.se	Nilsson, Emil/D-3662-2014; Stein, Dan/A-1752-2008; Fredriksson, Robert/AAH-3921-2019; Schioth, Helgi/AAQ-7239-2020; Brooks, Samantha/AAJ-2159-2020	Stein, Dan/0000-0001-7218-7810; Fredriksson, Robert/0000-0002-2810-3226; Brooks, Samantha/0000-0002-9146-6257	Swedish Research Council; Swedish Brain research foundation; Gunvor och Josef Aners foundation; Karlssons foundation; LR Akerhams foundation; Tore Nilsons foundation; Novo Nordisk Fonden [NNF13OC0005723] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain research foundation; Gunvor och Josef Aners foundation; Karlssons foundation; LR Akerhams foundation; Tore Nilsons foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The studies were supported by the Swedish Research Council, the Swedish Brain research foundation, Gunvor och Josef Aners foundation, A Karlssons foundation, LR Akerhams foundation, and Tore Nilsons foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Benedict C, 2012, DIABETES CARE, V35, P488, DOI 10.2337/dc11-2075; Bernard JA, 2013, NEUROIMAGE, V83, P103, DOI 10.1016/j.neuroimage.2013.06.042; Brooks SJ, 2012, INT J OBES LOND; Camicioli R, 2009, PARKINSONISM RELAT D, V15, P187, DOI 10.1016/j.parkreldis.2008.05.002; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Ding H, 2012, NEUROSCI LETT, V508, P47, DOI 10.1016/j.neulet.2011.12.016; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Foubert-Samier A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.023; Gajewski PD, 2012, NEUROPSYCHOLOGIA; Getzmann S, 2013, NEUROIMAGE, V64, P290, DOI 10.1016/j.neuroimage.2012.08.079; Gruber O, 2012, EUR ARCH PSY CLIN N, V262, P23, DOI 10.1007/s00406-011-0214-6; Hajcak G, 2009, GENES BRAIN BEHAV, V8, P80, DOI 10.1111/j.1601-183X.2008.00447.x; Hopkins ME, 2012, NEUROSCIENCE, V215, P59, DOI 10.1016/j.neuroscience.2012.04.056; Kambeitz JP, 2012, NEUROSCI BIOBEHAV R, V36, P2165, DOI 10.1016/j.neubiorev.2012.07.002; Khabour OF, 2013, BRAIN RES BULL, V90, P19, DOI 10.1016/j.brainresbull.2012.08.005; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Laing KR, 2012, AGE, V34, P1011, DOI 10.1007/s11357-011-9275-8; Lee MC, 2012, J APPL PHYSIOL, V113, P1260, DOI 10.1152/japplphysiol.00869.2012; Lezak H, 2004, NEUROPSYCHOLOGICAL A; Li SC, 2010, J COGNITIVE NEUROSCI, V22, P2164, DOI 10.1162/jocn.2009.21374; Li W, 2012, HUMAN BRAIN MAPPING; Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da; Long XJ, 2012, ACAD RADIOL, V19, P785, DOI 10.1016/j.acra.2012.03.006; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Marais L, 2009, METAB BRAIN DIS, V24, P587, DOI 10.1007/s11011-009-9157-2; Mattson MP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.005.2010; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Mercader JM, 2007, GENES BRAIN BEHAV, V6, P706, DOI 10.1111/j.1601-183X.2007.00301.x; Nemoto K, 2006, NEUROSCI LETT, V397, P25, DOI 10.1016/j.neulet.2005.11.067; Noble KG, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00307; Noonan MP, 2012, EUR J NEUROSCI, V35, P997, DOI 10.1111/j.1460-9568.2012.08023.x; Nordenskjold R, 2013, NEUROIMAGE, V83, P355, DOI 10.1016/j.neuroimage.2013.06.068; Ofen N, 2012, J NEUROSCI, V32, P10012, DOI 10.1523/JNEUROSCI.1082-11.2012; Patel R, 2012, NEUROREHABILITATION; Radua J, 2013, BRAIN STRUCT FUNCT; Shugart YY, 2009, EUR J HUM GENET, V17, P1050, DOI 10.1038/ejhg.2008.272; Team RC, 2012, R LANG ENV STAT COMP; Wei SM, 2012, J NEUROSCI, V32, P7074, DOI 10.1523/JNEUROSCI.5375-11.2012; Wu LJ, 2010, DIABETES, V59, P3085, DOI 10.2337/db10-0273; Yang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037777	44	35	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e82707	10.1371/journal.pone.0082707	http://dx.doi.org/10.1371/journal.pone.0082707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465375	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000002
J	Sacristan-Reviriego, A; Madrid, M; Cansado, J; Martin, H; Molina, M				Sacristan-Reviriego, Almudena; Madrid, Marisa; Cansado, Jose; Martin, Humberto; Molina, Maria			A Conserved Non-Canonical Docking Mechanism Regulates the Binding of Dual Specificity Phosphatases to Cell Integrity Mitogen-Activated Protein Kinases (MAPKs) in Budding and Fission Yeasts	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; SACCHAROMYCES-CEREVISIAE; TYROSINE PHOSPHATASES; FUSION PROTEINS; PATHWAY; STRESS; MSG5; EXPRESSION; ENCODES; MODULATION	Dual-specificity MAPK phosphatases (MKPs) are essential for the negative regulation of MAPK pathways. Similar to other MAPK-interacting proteins, most MKPs bind MAPKs through specific docking domains known as D-motifs. However, we found that the Saccharomyces cerevisiae MKP Msg5 binds the MAPK Slt2 within the cell wall integrity (CWI) pathway through a distinct motif (IYT). Here, we demonstrate that the IYT motif mediates binding of the Msg5 paralogue Sdp1 to Slt2 as well as of the MKP Pmp1 to its CWI MAPK counterpart Pmk1 in the evolutionarily distant yeast Schizosaccharomyces pombe. As a consequence, removal of the IYT site in Msg5, Sdp1 and Pmp1 reduces MAPK trapping caused by the overexpression of catalytically inactive versions of these phosphatases. Accordingly, an intact IYT site is necessary for inactive Sdp1 to prevent nuclear accumulation of Slt2. We also show that both Ile and Tyr but not Thr are essential for the functionality of the IYT motif. These results provide mechanistic insight into MKP-MAPK interplay and stress the relevance of this conserved non-canonical docking site in the regulation of the CWI pathway in fungi.	[Sacristan-Reviriego, Almudena; Martin, Humberto; Molina, Maria] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain; [Sacristan-Reviriego, Almudena; Martin, Humberto; Molina, Maria] IRYCIS, Madrid, Spain; [Madrid, Marisa; Cansado, Jose] Univ Murcia, Dept Genet & Microbiol, Yeast Physiol Grp, Fac Biol, Murcia, Spain	Complutense University of Madrid; University of Murcia	Martin, H (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain.	humberto@ucm.es	Madrid, Marisa/AAV-2154-2020; Cansado, Jose/ABC-6872-2020; Cansado, Jose/K-5212-2014; Martín, Humberto/Z-3423-2019; Brieva, Humberto Martin/E-9254-2016; Molina, Maria/ABE-7186-2021; Madrid, Marisa/K-7755-2014	Madrid, Marisa/0000-0002-7970-2587; Cansado, Jose/0000-0002-2342-8152; Martín, Humberto/0000-0002-6736-3602; Brieva, Humberto Martin/0000-0002-6736-3602; Molina, Maria/0000-0003-0074-3309; Madrid, Marisa/0000-0002-7970-2587	Ministerio de Ciencia e Innovacion (Spain) [BIO2010-22369-C02-01, BFU2011-22517]; Comunidad Autonoma de Madrid (Spain) [S2011/BMD-2414]; Fundacion Seneca (Region de Murcia, Spain) European Regional Development Fund (ERDF); EU [15280/PI/10]; FPU fellowship from Ministerio de Educacion y Ciencia (Spain)	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad Autonoma de Madrid (Spain)(Comunidad de Madrid); Fundacion Seneca (Region de Murcia, Spain) European Regional Development Fund (ERDF); EU(European Commission); FPU fellowship from Ministerio de Educacion y Ciencia (Spain)(German Research Foundation (DFG))	This work was supported by the Ministerio de Ciencia e Innovacion (Spain) [grant BIO2010-22369-C02-01] and Comunidad Autonoma de Madrid (Spain) [grant S2011/BMD-2414] to M.M. and by Ministerio de Ciencia e Innovacion (Spain) [grant BFU2011-22517] and Fundacion Seneca (Region de Murcia, Spain) European Regional Development Fund (ERDF) co-funding from the EU [grant 15280/PI/10] to J.C. A.S-R is recipient of a FPU fellowship from Ministerio de Educacion y Ciencia (Spain). M. Madrid is a postdoctoral researcher (Juan de la Cierva Program) from Ministerio de Economia y Competitividad (Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bardwell L, 2006, METHODS, V40, P213, DOI 10.1016/j.ymeth.2006.06.008; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Collister M, 2002, FEBS LETT, V527, P186, DOI 10.1016/S0014-5793(02)03220-9; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; Flandez M, 2004, J BIOL CHEM, V279, P11027, DOI 10.1074/jbc.M306412200; Fox GC, 2007, NATURE, V447, P487, DOI 10.1038/nature05804; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hahn JS, 2002, J BIOL CHEM, V277, P21278, DOI 10.1074/jbc.M202557200; Harrison JC, 2004, J BIOL CHEM, V279, P2616, DOI 10.1074/jbc.M306110200; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Jeong DG, 2006, ACTA CRYSTALLOGR D, V62, P582, DOI 10.1107/S0907444906010109; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Madrid M, 2007, MOL BIOL CELL, V18, P4405, DOI 10.1091/mbc.E07-05-0484; Marin MJ, 2009, MOL GENET GENOMICS, V281, P345, DOI 10.1007/s00438-008-0415-5; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Palacios L, 2011, J BIOL CHEM, V286, P42037, DOI 10.1074/jbc.M111.286948; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Rodriguez-Pena JM, 2008, J BIOTECHNOL, V133, P311, DOI 10.1016/j.jbiotec.2007.10.006; SHARROCKS AD, 1994, GENE, V138, P105, DOI 10.1016/0378-1119(94)90789-7; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Tanoue T, 2002, PHARMACOL THERAPEUT, V93, P193, DOI 10.1016/S0163-7258(02)00188-2; Toda T, 1996, MOL CELL BIOL, V16, P6752; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021	38	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85390	10.1371/journal.pone.0085390	http://dx.doi.org/10.1371/journal.pone.0085390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465549	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000330283100040
J	Puig-Domingo, M; Luque, RM; Reverter, JL; Lopez-Sanchez, LM; Gahete, MD; Culler, MD; Diaz-Soto, G; Lomena, F; Squarcia, M; Mate, JL; Mora, M; Fernandez-Cruz, L; Vidal, O; Alastrue, A; Balibrea, J; Halperin, I; Mauricio, D; Castano, JP				Puig-Domingo, Manel; Luque, Raul M.; Reverter, Jordi L.; Lopez-Sanchez, Laura M.; Gahete, Manuel D.; Culler, Michael D.; Diaz-Soto, Gonzalo; Lomena, Francisco; Squarcia, Mattia; Luis Mate, Jose; Mora, Mireia; Fernandez-Cruz, Laureano; Vidal, Oscar; Alastrue, Antonio; Balibrea, Jose; Halperin, Irene; Mauricio, Didac; Castano, Justo P.			The Truncated Isoform of Somatostatin Receptor5 (sst5TMD4) Is Associated with Poorly Differentiated Thyroid Cancer	PLOS ONE			English	Article							SUBTYPE EXPRESSION; MEDICAL-TREATMENT; GENE-EXPRESSION; CARCINOMA; ANALOGS; PROLIFERATION; SCINTIGRAPHY; RATIONALE; THERAPIES; GROWTH	Somatostatin receptors (ssts) are expressed in thyroid cancer cells, but their biological significance is not well understood. The aim of this study was to assess ssts in well differentiated (WDTC) and poorly differentiated thyroid cancer (PDTC) by means of imaging and molecular tools and its relationship with the efficacy of somatostatin analog treatment. Thirty-nine cases of thyroid carcinoma were evaluated (20 PDTC and 19 WDTC). Depreotide scintigraphy and mRNA levels of sst-subtypes, including the truncated variant sst5TMD4, were carried out. Depreotide scans were positive in the recurrent tumor in the neck in 6 of 11 (54%) PDTC, and in those with lung metastases in 5/11 cases (45.4%); sst5TMD4 was present in 18/20 (90%) of PDTC, being the most densely expressed sst-subtype, with a 20-fold increase in relation to sst2. In WDTC, sst2 was the most represented, while sst5TMD4 was not found; sst2 was significantly increased in PDTC in comparison to WDTC. Five depreotide positive PDTC received octreotide for 3-6 months in a pilot study with no changes in the size of the lesions in 3 of them, and a significant increase in the pulmonary and cervical lesions in the other 2. All PDTC patients treated with octreotide showed high expression of sst5TMD4. ROC curve analysis demonstrated that only sst5TMD4 discriminates between PDTC and WDTC. We conclude that sst5TMD4 is overexpressed in PDTC and may be involved in the lack of response to somatostatin analogue treatment.	[Puig-Domingo, Manel; Reverter, Jordi L.; Mauricio, Didac] Univ Autonoma Barcelona, Dept Med, Serv Endocrinol & Nutr, Germans Trias & Pujol Hlth Sci Res Inst & Hosp, Badalona, Spain; [Luque, Raul M.; Lopez-Sanchez, Laura M.; Gahete, Manuel D.; Castano, Justo P.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC,CIBE, Cordoba, Spain; [Culler, Michael D.] IPSEN, Milford, MA USA; [Diaz-Soto, Gonzalo] IEN UVa, Hosp Clin Valladolid, Serv Endocrinol, Valladolid, Spain; [Lomena, Francisco] Hosp Clin Barcelona, Nucl Med Serv, Barcelona, Spain; [Squarcia, Mattia] Hosp Clin Barcelona, Serv Radiol, Barcelona, Spain; [Luis Mate, Jose] Univ Autonoma Barcelona, Dept Pathol, Germans Trias & Pujol Hlth Sci Res Inst & Hosp, Badalona, Spain; [Mora, Mireia; Halperin, Irene] Hosp Clin Barcelona, Serv Endocrinol & Nutr, Barcelona, Spain; [Fernandez-Cruz, Laureano; Vidal, Oscar] Hosp Clin Barcelona, Surg Serv, Barcelona, Spain; [Alastrue, Antonio; Balibrea, Jose] Univ Autonoma Barcelona, Serv Gen Surg, Dept Surg, Germans Trias & Pujol Hlth Sci Res Inst & Hosp, Badalona, Spain; [Balibrea, Jose] Univ Autonoma Barcelona, Serv Gen Surg, Dept Surg, Vall dHebron Res Inst & Hosp, Badalona, Spain	Autonomous University of Barcelona; Universidad de Cordoba; Ipsen; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona	Puig-Domingo, M (corresponding author), Univ Autonoma Barcelona, Dept Med, Serv Endocrinol & Nutr, Germans Trias & Pujol Hlth Sci Res Inst & Hosp, Badalona, Spain.	mpuigd@gmail.com	Balibrea, Jose M/V-5007-2019; López-Sánchez, Laura María/E-3260-2018; SANZ, JOSE LUIS MATE/O-3158-2019; Puig-Domingo, Manel/S-2169-2019; Raul, Luque Huertas/M-6948-2018; Castaño, Justo P/A-7124-2010; Mauricio, Didac/B-7951-2009; Gahete, Manuel D./C-4969-2009; Mora, Mireia/R-6696-2018	Balibrea, Jose M/0000-0002-0764-7179; López-Sánchez, Laura María/0000-0002-0763-1804; SANZ, JOSE LUIS MATE/0000-0002-4829-3426; Puig-Domingo, Manel/0000-0002-6744-7195; Castaño, Justo P/0000-0002-3145-7287; Mauricio, Didac/0000-0002-2868-0250; Gahete, Manuel D./0000-0002-4578-2179; Culler, Michael D./0000-0001-5168-8739; Luque, Raul M./0000-0002-7585-1913; Halperin Rabinovich, Irene/0000-0003-3151-5990; Diaz-Soto, Gonzalo/0000-0001-9743-9412; Mora, Mireia/0000-0002-5887-5016	Novartis; Ipsen; CIBERobn; "Sara Borrell" program [CD11/00276]; "Juan de la Cierva" program [JCI-2009-05675]; Novartis Oncology Spain;  [BIO-0139];  [CTS-5051];  [PI-036-2012];  [BFU2010-19300]; European Foundation for the Study of Diabetes [BI 2014_6_clinical] Funding Source: researchfish	Novartis(Novartis); Ipsen(Ipsen); CIBERobn; "Sara Borrell" program; "Juan de la Cierva" program; Novartis Oncology Spain; ; ; ; ; European Foundation for the Study of Diabetes	M. Puig-Domingo, J.P. Castano, R. M. Luque and I. Halperin have received lectures fees from Novartis and Ipsen. M. Puig-Domingo has received honoraria for participation in Advisory boards from Genzyme. This work has been funded by the following grants: BIO-0139, CTS-5051, PI-036-2012, BFU2010-19300, CIBERobn, (to R. M. Luque and J.P. Castano); "Sara Borrell" program CD11/00276 (to M. D. Gahete) and "Juan de la Cierva" program JCI-2009-05675 (to L. M. Lopez-Sanchez). This work was partially supported by Novartis Oncology Spain (to M. Puig-Domingo and I. Halperin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain KB, 1997, J CLIN ENDOCR METAB, V82, P1857, DOI 10.1210/jcem.82.6.4013; Ambrosini V, 2011, J NUCL MED, V52, p42S, DOI 10.2967/jnumed.110.085753; Antonelli A, 2011, CURR GENOMICS, V12, P626, DOI 10.2174/138920211798120808; Atkinson H, 2013, INT J EXP PATHOL, V94, P226, DOI 10.1111/iep.12024; Benali N, 2000, P NATL ACAD SCI USA, V97, P9180, DOI 10.1073/pnas.130196697; Bousquet C, 2012, J CLIN ENDOCR METAB, V97, P727, DOI 10.1210/jc.2011-2088; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cordoba-Chacon J, 2011, ANN NY ACAD SCI, V1220, P6, DOI 10.1111/j.1749-6632.2011.05985.x; Csaba Z, 2012, J MOL ENDOCRINOL, V48, pR1, DOI 10.1530/JME-11-0121; Duran-Prado M, 2012, ONCOGENE, V31, P2049, DOI 10.1038/onc.2011.389; Duran-Prado M, 2010, J CLIN ENDOCR METAB, V95, P2497, DOI 10.1210/jc.2009-2247; Duran-Prado M, 2009, J CLIN ENDOCR METAB, V94, P2634, DOI 10.1210/jc.2008-2564; Fleseriu M, 2011, PITUITARY, V14, P184, DOI 10.1007/s11102-010-0282-z; Klagge A, 2010, HORM METAB RES, V42, P237, DOI 10.1055/s-0029-1243636; Kohlfuerst S, 2006, THYROID, V16, P1113, DOI 10.1089/thy.2006.16.1113; Leu FP, 2008, MOL CANCER RES, V6, P1029, DOI 10.1158/1541-7786.MCR-07-2073; Margulies DJ, 2010, THYROID, V20, P671, DOI 10.1089/thy.2009.0453; Naraev BG, 2012, ONCOLOGY-BASEL, V83, P117, DOI 10.1159/000339539; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Pazaitou-Panayiotou K, 2012, HORM-INT J ENDOCRINO, V11, P290, DOI 10.14310/horm.2002.1357; Pedroncelli AM, 2010, NEUROENDOCRINOLOGY, V92, P120, DOI 10.1159/000314352; Pisarek H, 2009, THYROID RES, V2, DOI 10.1186/1756-6614-2-1; Reverter Jordi L, 2010, Endocrinol Nutr, V57, P364, DOI 10.1016/j.endonu.2010.06.004; Rodrigues M, 2006, J CLIN ENDOCR METAB, V91, P3997, DOI 10.1210/jc.2006-0825; Schlumberger M, 2012, J ENDOCRINOL INVEST, V35, P40; Schlumberger M, 2012, EUR J ENDOCRINOL, V166, P5, DOI 10.1530/EJE-11-0631; Sideris L, 2012, ONCOLOGIST, V17, P747, DOI 10.1634/theoncologist.2011-0458; Sorensen ES, 2003, EUR J BIOCHEM, V270, P3651, DOI 10.1046/j.1432-1033.2003.03755.x; Susini C, 2006, ANN ONCOL, V17, P1733, DOI 10.1093/annonc/mdl105; Taboada GF, 2007, EUR J ENDOCRINOL, V156, P65, DOI 10.1530/eje.1.02313; Tutuncu Y, 2012, PITUITARY, V15, P398, DOI 10.1007/s11102-011-0335-y; Unger N, 2012, EXP CLIN ENDOCR DIAB, V120, P482, DOI 10.1055/s-0032-1314859; Zatelli MC, 2006, J CLIN ENDOCR METAB, V91, P2218, DOI 10.1210/jc.2006-0334; Zatelli MC, 2001, J CLIN ENDOCR METAB, V86, P2161, DOI 10.1210/jc.86.5.2161	34	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85527	10.1371/journal.pone.0085527	http://dx.doi.org/10.1371/journal.pone.0085527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465589	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500071
J	Allen, SJ; Mott, KR; Matsuura, Y; Moriishi, K; Kousoulas, KG; Ghiasi, H				Allen, Sariah J.; Mott, Kevin R.; Matsuura, Yoshiharu; Moriishi, Kohji; Kousoulas, Konstantin G.; Ghiasi, Homayon			Binding of HSV-1 Glycoprotein K (gK) to Signal Peptide Peptidase (SPP) Is Required for Virus Infectivity	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; INDUCED CELL-FUSION; STROMAL KERATITIS; GAMMA-SECRETASE; CORE PROTEIN; INTRAMEMBRANE PROTEOLYSIS; ASPARTIC PROTEASE; AMINO-TERMINUS	Glycoprotein K (gK) is a virion envelope protein of herpes simplex virus types 1 (HSV-1) and 2 (HSV-2), which plays important roles in virion entry, morphogenesis and egress. Two-hybrid and pull-down assays were utilized to demonstrate that gK and no other HSV-1 genes specifically binds to signal peptide peptidase (SPP), also known as minor histocompatibility antigen H13. SPP dominant negative mutants, shRNA against SPP significantly reduced HSV-1 replication in vitro. SPP also affected lysosomes and ER responses to HSV-1 infection. Thus, in this study we have shown for the first time that gK, despite its role in fusion and egress, is also involved in binding the cytoplasmic protein SPP. These results also suggest that SPP plays an important role in viral replication and possibly virus pathogenesis. This makes SPP unique in that its function appears to be required by the virus as no other protein can compensate its loss in terms of viral replication.	[Allen, Sariah J.; Mott, Kevin R.; Ghiasi, Homayon] Ctr Neurobiol & Vaccine Dev, Dept Surg, Los Angeles, CA USA; [Matsuura, Yoshiharu] Osaka Univ, Dept Mol Virol, Microbial Dis Res Inst, Osaka, Japan; [Moriishi, Kohji] Yamanashi Univ, Fac Med, Dept Microbiol, Yamanashi, Japan; [Kousoulas, Konstantin G.] Louisiana State Univ, Sch Vet Med, Div Biotechnol & Mol Med, Baton Rouge, LA 70803 USA	Osaka University; University of Yamanashi; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Ghiasi, H (corresponding author), Ctr Neurobiol & Vaccine Dev, Dept Surg, Los Angeles, CA USA.	ghiasih@CSHS.org	Moriishi, Kohji/I-4173-2019	Moriishi, Kohji/0000-0002-9542-5188; Allen, Sariah J./0000-0001-8118-2413; KOUSOULAS, KONSTANTIN/0000-0001-7077-9003	National Institutes of Health (NIH) grant [1 RO1 EY13615]; NIH [AI43000]; NGMS [P20 GM103458]; NATIONAL EYE INSTITUTE [R01EY013615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103458] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NGMS; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant 1 RO1 EY13615 to HG. KGK was supported by NIH AI43000 and NGMS P20 GM103458. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2011, J VIROL, V85, P4184, DOI 10.1128/JVI.02290-10; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARRON BA, 1994, OPHTHALMOLOGY, V101, P1871; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Binder P S, 1984, Cornea, V3, P178; Bolhuis A, 1999, J BIOL CHEM, V274, P24585, DOI 10.1074/jbc.274.35.24585; BOND VC, 1984, VIROLOGY, V132, P368, DOI 10.1016/0042-6822(84)90042-4; Branco BC, 2004, BRIT J OPHTHALMOL, V88, P1285, DOI 10.1136/bjo.2003.040162; Burnett HF, 2012, CELL STRESS CHAPERON, V17, P473, DOI 10.1007/s12192-012-0324-8; Chouljenko VN, 2010, J VIROL, V84, P8596, DOI 10.1128/JVI.00298-10; Crawshaw SG, 2004, BIOCHEM J, V384, P9, DOI 10.1042/BJ20041216; David AT, 2008, CURR EYE RES, V33, P455, DOI 10.1080/02713680802130362; Dawson C R, 1984, Clin Dermatol, V2, P56, DOI 10.1016/0738-081X(84)90066-X; DEBROY C, 1985, VIROLOGY, V145, P36, DOI 10.1016/0042-6822(85)90199-0; Dix R.D., 2002, PATHOGENESIS HERPES; Dolan A, 1998, J VIROL, V72, P2010, DOI 10.1128/JVI.72.3.2010-2021.1998; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Foster TP, 2008, J VIROL, V82, P6310, DOI 10.1128/JVI.00147-08; Foster TP, 2003, VIROLOGY, V317, P237, DOI 10.1016/j.virol.2003.07.008; Foster TP, 2003, J VIROL, V77, P499, DOI 10.1128/JVI.77.1.499-510.2003; Foster TP, 1999, J VIROL, V73, P8457, DOI 10.1128/JVI.73.10.8457-8468.1999; Ghiasi H, 1997, INVEST OPHTH VIS SCI, V38, P1213; GHIASI H, 1994, J VIROL, V68, P2347, DOI 10.1128/JVI.68.4.2347-2354.1994; GHIASI H, 1994, J VIROL, V68, P2118, DOI 10.1128/JVI.68.4.2118-2126.1994; GHIASI H, 1995, INVEST OPHTH VIS SCI, V36, P1352; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; Grigorenko AP, 2002, BIOCHEMISTRY-MOSCOW+, V67, P826, DOI 10.1023/A:1016365227942; Heimann M, 2006, J VIROL, V80, P1915, DOI 10.1128/JVI.80.4.1915-1921.2006; HILL TJ, 1987, CURR EYE RES, V6, P1, DOI 10.3109/02713688709020060; HUTCHINSON L, 1995, J VIROL, V69, P5401, DOI 10.1128/JVI.69.9.5401-5413.1995; HUTCHINSON L, 1992, J VIROL, V66, P5603, DOI 10.1128/JVI.66.9.5603-5609.1992; HUTCHINSON L, 1995, J VIROL, V69, P4556, DOI 10.1128/JVI.69.7.4556-4563.1995; Jambunathan N, 2011, J VIROL, V85, P12910, DOI 10.1128/JVI.06268-11; Jayachandra S, 1997, J VIROL, V71, P5012, DOI 10.1128/JVI.71.7.5012-5024.1997; Jing LC, 2012, J CLIN INVEST, V122, P654, DOI 10.1172/JCI60556; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kroeger H, 2012, INVEST OPHTH VIS SCI, V53, P7590, DOI 10.1167/iovs.12-10221; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Li XR, 2009, BIOCHEM BIOPH RES CO, V380, P454, DOI 10.1016/j.bbrc.2009.01.083; Liesegang TJ, 1999, CORNEA, V18, P127, DOI 10.1097/00003226-199903000-00001; Liesegang TJ, 2001, CORNEA, V20, P1, DOI 10.1097/00003226-200101000-00001; LITTLE SP, 1981, VIROLOGY, V112, P686, DOI 10.1016/0042-6822(81)90314-7; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; MCGEOCH DJ, 1991, J GEN VIROL, V72, P3057, DOI 10.1099/0022-1317-72-12-3057; MCGEOCH DJ, 1988, J GEN VIROL, V69, P1531, DOI 10.1099/0022-1317-69-7-1531; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Melancon JM, 2005, J VIROL, V79, P299, DOI 10.1128/JVI.79.1.299-313.2005; Mo CJ, 1997, J BIOL CHEM, V272, P33305, DOI 10.1074/jbc.272.52.33305; Mott KR, 2007, J VIROL, V81, P12962, DOI 10.1128/JVI.01442-07; Mott KR, 2007, INVEST OPHTH VIS SCI, V48, P2185, DOI 10.1167/iovs.06-1276; Mulvey M, 2007, J VIROL, V81, P3377, DOI 10.1128/JVI.02191-06; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; PERNG GC, 1994, J VIROL, V68, P8045, DOI 10.1128/JVI.68.12.8045-8055.1994; POGUEGEILE KL, 1987, VIROLOGY, V157, P67, DOI 10.1016/0042-6822(87)90314-X; RAMASWAMY R, 1992, VIROLOGY, V186, P579, DOI 10.1016/0042-6822(92)90024-J; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Schenk D, 2000, NATURE, V407, P34, DOI 10.1038/35024194; Schrul B, 2010, BIOCHEM J, V427, P523, DOI 10.1042/BJ20091005; St Leger AJ, 2011, J IMMUNOL, V186, P3927, DOI 10.4049/jimmunol.1003735; Streilein JW, 1997, IMMUNOL TODAY, V18, P443, DOI 10.1016/S0167-5699(97)01114-6; Sun HL, 2006, J MUSCLE RES CELL M, V27, P241, DOI 10.1007/s10974-006-9067-4; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; Thomas J, 1997, IMMUNOL RES, V16, P375, DOI 10.1007/BF02786400; Urny J, 2003, GENE EXPR PATTERNS, V3, P685, DOI 10.1016/S1567-133X(03)00094-2; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wilhelmus KR, 1996, BRIT J OPHTHALMOL, V80, P969, DOI 10.1136/bjo.80.11.969; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992	75	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85360	10.1371/journal.pone.0085360	http://dx.doi.org/10.1371/journal.pone.0085360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465545	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500044
J	Barcelo, A; Pierola, J; Esquinas, C; de la Pena, M; Arque, M; Alonso-Fernandez, A; Bauca, JM; Robles, J; Barcelo, B; Barbe, F				Barcelo, Antonia; Pierola, Javier; Esquinas, Cristina; de la Pena, Monica; Arque, Meritxell; Alonso-Fernandez, Alberto; Miquel Bauca, Josep; Robles, Juan; Barcelo, Bernardino; Barbe, Ferran			Relationship between Aldosterone and the Metabolic Syndrome in Patients with Obstructive Sleep Apnea Hypopnea Syndrome: Effect of Continuous Positive Airway Pressure Treatment	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; PLASMA-ALDOSTERONE; INSULIN-RESISTANCE; RISK-FACTORS; HYPERTENSION; OBESITY; SEVERITY; ASSOCIATION	Background: Metabolic syndrome (MS) occurs frequently in patients with obstructive sleep apnea-hypopnea syndrome (OSAHS). We hypothesized that aldosterone levels are elevated in OSAHS and associated with the presence of MS. Methods: We studied 66 patients with OSAHS (33 with MS and 33 without MS) and 35 controls. The occurrence of the MS was analyzed according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) clinical criteria. Measurements of plasma renin activity (PRA), aldosterone, aldosterone: PRA ratio, creatinine, glucose, triglycerides, cholesterol and HDL cholesterol were obtained at baseline and after CPAP treatment. Results: Aldosterone levels were associated with the severity of OSAHS and higher than controls (p = 0.046). Significant differences in aldosterone levels were detected between OSAHS patients with and without MS (p = 0.041). A significant reduction was observed in the aldosterone levels in patients under CPAP treatment (p = 0.012). Conclusion: This study shows that aldosterone levels are elevated in OSAHS in comparison to controls, and that CPAP therapy reduces aldosterone levels. It also shows that aldosterone levels are associated with the presence of metabolic syndrome, suggesting that aldosterone excess might predispose or aggravate the metabolic and cardiovascular complications of OSAHS.	[Barcelo, Antonia; Miquel Bauca, Josep; Robles, Juan; Barcelo, Bernardino] Hosp Univ Son Espases, Serv Anal Clin, Serv Pneumol, Palma De Mallorca, Spain; [de la Pena, Monica; Alonso-Fernandez, Alberto] Hosp Univ Son Espases, Serv Pneumol, Palma De Mallorca, Spain; [Pierola, Javier; Arque, Meritxell] Hosp Univ Son Espases, Unitat Invest, Serv Pneumol, Palma De Mallorca, Spain; [Esquinas, Cristina; Barbe, Ferran] Hosp Arnau de Vilanova Santa Maria, Lleida, Spain; [Pierola, Javier; de la Pena, Monica; Arque, Meritxell; Alonso-Fernandez, Alberto; Barbe, Ferran] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Mallorca, Illes Balears, Spain	Hospital Universitari Son Espases; Hospital Universitari Son Espases; Hospital Universitari Son Espases; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Barcelo, A (corresponding author), Hosp Univ Son Espases, Serv Anal Clin, Serv Pneumol, Palma De Mallorca, Spain.	Antonia.barcelo@ssib.es	Barcelo, Bernardino/H-2806-2017; Pierola Lopetegui, Javier/U-6193-2017; Barbé, Ferran/A-5988-2010	Barcelo, Bernardino/0000-0002-6952-5994; Pierola Lopetegui, Javier/0000-0003-0759-5580; Barbé, Ferran/0000-0002-2340-8928; , Alonso-Fernandez/0000-0002-0802-8871; Bauca, Josep Miquel/0000-0001-8808-6870; Barcelo Bennasar, Antonia/0000-0002-3170-5439	Hospital Universitari Son Espases (Proyectos piloto HUSE)	Hospital Universitari Son Espases (Proyectos piloto HUSE)	This work was supported in part by a grant from the Hospital Universitari Son Espases (Proyectos piloto HUSE-2011. No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acelajado MC, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/837817; Bochud M, 2006, HYPERTENSION, V48, P239, DOI 10.1161/01.HYP.0000231338.41548.fc; Bonsignore Maria Rosaria, 2008, Archives of Physiology and Biochemistry, V114, P255, DOI 10.1080/13813450802307451 ; Briet M, 2011, CURR HYPERTENS REP, V13, P163, DOI 10.1007/s11906-011-0182-2; Cooper R, 1997, J HUM HYPERTENS, V11, P107, DOI 10.1038/sj.jhh.1000391; de Kloet AD, 2010, PHYSIOL BEHAV, V100, P525, DOI 10.1016/j.physbeh.2010.03.018; Dudenbostel T, 2012, J HUM HYPERTENS, V26, P281, DOI 10.1038/jhh.2011.47; EGAN BM, 1994, AM J HYPERTENS, V7, P886, DOI 10.1093/ajh/7.10.886; Fallo F, 2006, J CLIN ENDOCR METAB, V91, P454, DOI 10.1210/jc.2005-1733; Gaddam K, 2010, J HUM HYPERTENS, V24, P532, DOI 10.1038/jhh.2009.96; Giordani I, 2013, ACTA DIABETOL, V50, P639, DOI 10.1007/s00592-013-0487-5; Gonzaga CC, 2010, J CLIN SLEEP MED, V6, P363; Goodfriend TL, 2008, CURR HYPERTENS REP, V10, P222, DOI 10.1007/s11906-008-0042-x; Goodfriend TL, 1999, OBES RES, V7, P355, DOI 10.1002/j.1550-8528.1999.tb00418.x; Goodfriend TL, 1999, PROSTAG LEUKOTR ESS, V60, P401, DOI 10.1016/S0952-3278(99)80020-9; Hall JE, 2003, HYPERTENSION, V41, P625, DOI 10.1161/01.HYP.0000052314.95497.78; Hannemann A, 2011, EUR J ENDOCRINOL, V164, P751, DOI 10.1530/EJE-10-1074; Ingelsson E, 2007, CIRCULATION, V116, P984, DOI 10.1161/CIRCULATIONAHA.107.708537; Kidambi S, 2007, HYPERTENSION, V49, P704, DOI 10.1161/01.HYP.0000253258.36141.c7; Krug AW, 2008, HYPERTENSION, V51, P1252, DOI 10.1161/HYPERTENSIONAHA.107.109439; Lam JCM, 2007, CURR OPIN PULM MED, V13, P484, DOI 10.1097/MCP.0b013e3282efae9c; Lastra-Lastra G, 2009, CLIN ENDOCRINOL, V71, P1, DOI 10.1111/j.1365-2265.2008.03498.x; Levy P, 2009, EUR RESPIR J, V34, P243, DOI 10.1183/09031936.00166808; Marzolla V, 2012, MOL CELL ENDOCRINOL, V350, P281, DOI 10.1016/j.mce.2011.09.011; Pimenta E, 2009, PROG CARDIOVASC DIS, V51, P371, DOI 10.1016/j.pcad.2008.02.004; Pratt-Ubunama MN, 2007, CHEST, V131, P453, DOI 10.1378/chest.06-1442; Saarelainen S, 1996, J SLEEP RES, V5, P181, DOI 10.1046/j.1365-2869.1996.t01-1-00007.x; Sim JJ, 2011, J HYPERTENS, V29, P1553, DOI 10.1097/HJH.0b013e3283492219; Stewart PM, 1999, LANCET, V353, P1341, DOI 10.1016/S0140-6736(98)06102-9; Stiefel P, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/685238; Strazzullo P, 2004, CURR OPIN NEPHROL HY, V13, P325, DOI 10.1097/00041552-200405000-00010; Svatikova A, 2009, SLEEP, V32, P1589, DOI 10.1093/sleep/32.12.1589; Thethi T, 2012, CURR HYPERTENS REP, V14, P160, DOI 10.1007/s11906-012-0245-z; Umemura S, 1997, AM J HYPERTENS, V10, P629, DOI 10.1016/S0895-7061(97)00053-8; Vasan RS, 2004, NEW ENGL J MED, V351, P33, DOI 10.1056/NEJMoa033263; Vaz M, 1997, CIRCULATION, V96, P3423; Yvan-Charvet L, 2011, KIDNEY INT, V79, P162, DOI 10.1038/ki.2010.391	37	30	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84362	10.1371/journal.pone.0084362	http://dx.doi.org/10.1371/journal.pone.0084362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465407	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500016
J	Mosser, JF; Grant, LR; Millar, EV; Weatherholtz, RC; Jackson, DM; Beall, B; Craig, MJ; Reid, R; Santosham, M; O'Brien, KL				Mosser, Jonathan F.; Grant, Lindsay R.; Millar, Eugene V.; Weatherholtz, Robert C.; Jackson, Delois M.; Beall, Bernard; Craig, Mariddie J.; Reid, Raymond; Santosham, Mathuram; O'Brien, Katherine L.			Nasopharyngeal Carriage and Transmission of Streptococcus pneumoniae in American Indian Households after a Decade of Pneumococcal Conjugate Vaccine Use	PLOS ONE			English	Article							CHANGING EPIDEMIOLOGY; HIGH-RISK; SEROTYPE; COLONIZATION; DISEASE; CHILDREN; PARAMETERS; RESPONSES; FAMILIES; NAVAJO	Background: Young children played a major role in pneumococcal nasopharyngeal carriage, acquisition, and transmission in the era before pneumococcal conjugate vaccine (PCV) use. Few studies document pneumococcal household dynamics in the routine-PCV7 era. Methods: We investigated age-specific acquisition, household introduction, carriage clearance, and intra-household transmission in a prospective, longitudinal, observational cohort study of pneumococcal nasopharyngeal carriage in 300 American Indian households comprising 1,072 participants between March 2006 and March 2008. Results: Pneumococcal acquisition rates were 2-6 times higher in children than adults. More household introductions of new pneumococcal strains were attributable to children <9 years than adults >= 17 years (p<0.001), and older children (2-8 years) than younger children (<2 years) (p<0.008). Compared to children <2 years, carriage clearance was more rapid in older children (2-4 years, HRclearance 1.53 [95% CI: 1.22, 1.91]; 5-8 years, HRclearance 1.71 [1.36, 2.15]) and adults (HRclearance 1.75 [1.16, 2.64]). Exposure to serotype-specific carriage in older children (2-8 years) most consistently increased the odds of subsequently acquiring that serotype for other household members. Conclusions: In this community with a high burden of pneumococcal colonization and disease and routine PCV7 use, children (particularly older children 2-8 years) drive intra-household pneumococcal transmission: first, by acquiring, introducing, and harboring pneumococcus within the household, and then by transmitting acquired serotypes more efficiently than household members of other ages.	[Mosser, Jonathan F.; Grant, Lindsay R.; Weatherholtz, Robert C.; Reid, Raymond; Santosham, Mathuram; O'Brien, Katherine L.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Baltimore, MD 21205 USA; [Millar, Eugene V.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Jackson, Delois M.; Beall, Bernard] Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Craig, Mariddie J.] White Mt Apache Tribe, Whiteriver, AZ USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Uniformed Services University of the Health Sciences - USA; Centers for Disease Control & Prevention - USA	Grant, LR (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Baltimore, MD 21205 USA.	lgrant@jhsph.edu; klobrien@jhsph.edu		Mosser, Jonathan/0000-0001-9093-3186; O'Brien, Katherine/0000-0002-0164-4030	PneumoCarr Consortium; Grand Challenges in Global Health initiative; Bill & Melinda Gates Foundation; Foundation for the National Institutes of Health (US); Wellcome Trust; Canadian Institutes of Health Research; Native American Research Centers for Health [U26IHS300013/03]; National Institutes of Health; Indian Health Service; Centers for Disease Control and Prevention National Vaccine Program Office; Thrasher Research Fund	PneumoCarr Consortium; Grand Challenges in Global Health initiative; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Foundation for the National Institutes of Health (US); Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Native American Research Centers for Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indian Health Service(United States Department of Health & Human Services); Centers for Disease Control and Prevention National Vaccine Program Office(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Thrasher Research Fund	This work was supported by the PneumoCarr Consortium funded by the Grand Challenges in Global Health initiative which is supported by the Bill & Melinda Gates Foundation, the Foundation for the National Institutes of Health (US), the Wellcome Trust and the Canadian Institutes of Health Research. This study was additionally supported by The Native American Research Centers for Health [U26IHS300013/03], a joint initiative between the National Institutes of Health and Indian Health Service to reduce Native health disparities and build tribal autonomy in conducting health research. This study was also funded by the Centers for Disease Control and Prevention National Vaccine Program Office and the Thrasher Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auranen K, 2000, J AM STAT ASSOC, V95, P1044, DOI 10.2307/2669741; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Darboe MK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-195; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Granat SM, 2009, J INFECT DIS, V200, P99, DOI 10.1086/599364; Grant LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074906; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Hogberg L, 2007, J CLIN MICROBIOL, V45, P948, DOI 10.1128/JCM.01913-06; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Lacapa R, 2008, CLIN INFECT DIS, V47, P476, DOI 10.1086/590001; Leino T, 2001, PEDIATR INFECT DIS J, V20, P1022, DOI 10.1097/00006454-200111000-00004; Leino T, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-173; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Melegaro A, 2004, EPIDEMIOL INFECT, V132, P433, DOI 10.1017/S0950268804001980; Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076; Melnick N, 2010, J CLIN MICROBIOL, V48, P2311, DOI 10.1128/JCM.00410-10; Mercado E, 2011, J CLIN MICROBIOL, V49, P2080, DOI 10.1128/JCM.00153-11; Millar EV, 2008, CLIN INFECT DIS, V47, P989, DOI 10.1086/591966; Millar EV, 2006, CLIN INFECT DIS, V43, P8, DOI 10.1086/504802; Millar EV, 2010, CLIN INFECT DIS, V51, P1258, DOI 10.1086/657070; Millar EV, 2009, PEDIATR INFECT DIS J, V28, P711, DOI 10.1097/INF.0b013e3181a06303; O'Brien KL, 2007, J INFECT DIS, V196, P1211, DOI 10.1086/521833; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Pinheiro J. C., 1995, J COMPUTATIONAL GRAP, V4, P12, DOI [DOI 10.2307/1390625, 10.1080/10618600.1995.10474663, DOI 10.1080/10618600.1995.10474663]; Pinheiro JC, 2006, J COMPUT GRAPH STAT, V15, P58, DOI 10.1198/106186006X96962; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; Shah SS, 2006, CLIN INFECT DIS, V42, DOI 10.1086/498745; StataCorp, 2011, STAT STAT SOFTW REL, P173; Tigoi CC, 2012, CLIN INFECT DIS, V55, P180, DOI 10.1093/cid/cis371; Weatherholtz R, 2010, CLIN INFECT DIS, V50, P1238, DOI 10.1086/651680; World Health Organization, 2008, EST HIB PNEUM DEATHS	38	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e79578	10.1371/journal.pone.0079578	http://dx.doi.org/10.1371/journal.pone.0079578			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465365	Green Submitted, Green Published, gold			2022-12-25	WOS:000330237000002
J	Jiang, ZG; Mukamal, K; Tapper, E; Robson, SC; Tsugawa, Y				Jiang, Zhenghui Gordon; Mukamal, Kenneth; Tapper, Elliot; Robson, Simon C.; Tsugawa, Yusuke			Low LDL-C and High HDL-C Levels Are Associated with Elevated Serum Transaminases amongst Adults in the United States: A Cross-sectional Study	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ALANINE AMINOTRANSFERASE; FAMILIAL HYPOBETALIPOPROTEINEMIA; METABOLIC SYNDROME; APO-B; ALCOHOL-CONSUMPTION; PREVALENCE; CHOLESTEROL; POPULATION; INDIVIDUALS	Background: Dyslipidemia, typically recognized as high serum triglyceride, high low-density lipoprotein cholesterol (LDL-C) or low high-density lipoprotein cholesterol (HDL-C) levels, are associated with nonalcoholic fatty liver disease (NAFLD). However, low LDL-C levels could result from defects in lipoprotein metabolism or impaired liver synthetic function, and may serve as ab initio markers for unrecognized liver diseases. Whether such relationships exist in the general population has not been investigated. We hypothesized that despite common conception that low LDL-C is desirable, it might be associated with elevated liver enzymes due to metabolic liver diseases. Methods and Findings: We examined the associations between alanine aminotransferase (ALT), aspartate aminotransferase (AST) and major components of serum lipid profiles in a nationally representative sample of 23,073 individuals, who had no chronic viral hepatitis and were not taking lipid-lowering medications, from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2010. ALT and AST exhibited non-linear U-shaped associations with LDL-C and HDL-C, but not with triglyceride. After adjusting for potential confounders, individuals with LDL-C less than 40 and 41-70 mg/dL were associated with 4.2 (95% CI 1.5-11.7, p = 0.007) and 1.6 (95% CI 1.1-2.5, p = 0.03) times higher odds of abnormal liver enzymes respectively, when compared with those with LDL-C values 71-100 mg/dL (reference group). Surprisingly, those with HDL-C levels above 100 mg/dL was associated with 3.2 (95% CI 2.1-5.0, p < 0.001) times higher odds of abnormal liver enzymes, compared with HDL-C values of 61-80 mg/dL. Conclusions: Both low LDL-C and high HDL-C, often viewed as desirable, were associated with significantly higher odds of elevated transaminases in the general U. S. adult population. Our findings underscore an underestimated biological link between lipoprotein metabolism and liver diseases, and raise a potential need for liver evaluation among over 10 million people with particularly low LDL-C or high HDL-C in the United States.	[Jiang, Zhenghui Gordon; Tapper, Elliot; Robson, Simon C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Sch Med,Dept Med, Boston, MA 02215 USA; [Mukamal, Kenneth; Tsugawa, Yusuke] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Sch Med,Dept Med, Boston, MA 02215 USA; [Tsugawa, Yusuke] Harvard Univ, Harvard Univ Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University	Jiang, ZG (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Sch Med,Dept Med, Boston, MA 02215 USA.	zgjiang@bidmc.harvard.edu	Jiang, Z. Gordon/U-5256-2017; Robson, Simon C./AAA-8537-2021; Mukamal, Kenneth/GVR-7978-2022	Jiang, Z. Gordon/0000-0003-0495-9940; Tsugawa, Yusuke/0000-0002-1937-4833	National Institute of Health [P01 HL087203]; Honjo International Scholarship Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087203] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Honjo International Scholarship Foundation(Honjo International Scholarship Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Simon was supported in part by National Institute of Health Grant P01 HL087203. Dr. Yusuke Tsugawa was supported in part by Honjo International Scholarship Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; BROWN MS, 1983, J CLIN INVEST, V72, P743, DOI 10.1172/JCI111044; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Burnett JR, 2003, J BIOL CHEM, V278, P13442, DOI 10.1074/jbc.M300235200; Burnett JR, 2007, J BIOL CHEM; Charlton N, 2002, HEPATOLOGY, V35, P898, DOI 10.1053/jhep.2002.32527; Cicognani C, 1997, ARCH INTERN MED, V157, P792, DOI 10.1001/archinte.157.7.792; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COLLINS JC, 1989, GASTROENTEROLOGY, V97, P766, DOI 10.1016/0016-5085(89)90651-3; Curtin Lester R, 2012, Vital Health Stat 2, P1; Fraser A, 2007, GASTROENTEROLOGY, V133, P1814, DOI 10.1053/j.gastro.2007.08.077; Higuchi N, 2011, EXP THER MED, V2, P1077, DOI 10.3892/etm.2011.328; Ioannou GN, 2006, AM J GASTROENTEROL, V101, P76, DOI 10.1111/j.1572-0241.2005.00341.x; Ioannou GN, 2005, GASTROENTEROLOGY, V128, P627, DOI 10.1053/j.gastro.2004.12.004; Jiang ZG, 2013, J BIOMED RES, V27, P1, DOI 10.7555/JBR.27.20120077; Kelishadi R, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-29; Korn EL, 1999, WILEY SERIES SURVEY; Liangpunsakul S, 2005, AM J MED SCI, V329, P111, DOI 10.1097/00000441-200503000-00001; LINN S, 1993, AM J PUBLIC HEALTH, V83, P811, DOI 10.2105/AJPH.83.6.811; LINTON MF, 1993, J LIPID RES, V34, P521; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013; Mineo C, 2012, CIRC RES, V111, P1079, DOI 10.1161/CIRCRESAHA.111.258673; Mukamal KJ, 2008, CURR ATHEROSCLER REP, V10, P536, DOI 10.1007/s11883-008-0083-2; Park HS, 2005, AM J CLIN NUTR, V82, P1046, DOI 10.1093/ajcn/82.5.1046; Prevention CfDC, NAT HLTH NUTR EX SUR; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Schonfeld G, 2005, CELL MOL LIFE SCI, V62, P1372, DOI 10.1007/s00018-005-4473-0; Schonfeld G, 2003, J LIPID RES, V44, P878, DOI 10.1194/jlr.R300002-JLR200; Schwimmer JB, 2005, PEDIATRICS, V115, pE561, DOI 10.1542/peds.2004-1832; Tanoli T, 2004, J LIPID RES, V45, P941, DOI 10.1194/jlr.M300508-JLR200; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; WETTERAU JR, 1992, SCIENCE, V258, P999; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; WITTE DL, 1988, CLIN CHEM, V34, P1447; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020	40	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85366	10.1371/journal.pone.0085366	http://dx.doi.org/10.1371/journal.pone.0085366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454851	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100075
J	Kelly, RP; Port, JA; Yamahara, KM; Crowder, LB				Kelly, Ryan P.; Port, Jesse A.; Yamahara, Kevan M.; Crowder, Larry B.			Using Environmental DNA to Census Marine Fishes in a Large Mesocosm	PLOS ONE			English	Article							BIODIVERSITY ASSESSMENT; ANIMAL DNA; REGION; ATLANTIC; BARCODE; DIET	The ocean is a soup of its resident species' genetic material, cast off in the forms of metabolic waste, shed skin cells, or damaged tissue. Sampling this environmental DNA (eDNA) is a potentially powerful means of assessing whole biological communities, a significant advance over the manual methods of environmental sampling that have historically dominated marine ecology and related fields. Here, we estimate the vertebrate fauna in a 4.5-million-liter mesocosm aquarium tank at the Monterey Bay Aquarium of known species composition by sequencing the eDNA from its constituent seawater. We find that it is generally possible to detect mitochondrial DNA of bony fishes sufficient to identify organisms to taxonomic family-or genus-level using a 106 bp fragment of the 12S ribosomal gene. Within bony fishes, we observe a low false-negative detection rate, although we did not detect the cartilaginous fishes or sea turtles present with this fragment. We find that the rank abundance of recovered eDNA sequences correlates with the abundance of corresponding species' biomass in the mesocosm, but the data in hand do not allow us to develop a quantitative relationship between biomass and eDNA abundance. Finally, we find a low false-positive rate for detection of exogenous eDNA, and we were able to diagnose non-native species' tissue in the food used to maintain the mesocosm, underscoring the sensitivity of eDNA as a technique for community-level ecological surveys. We conclude that eDNA has substantial potential to become a core tool for environmental monitoring, but that a variety of challenges remain before reliable quantitative assessments of ecological communities in the field become possible.	[Kelly, Ryan P.; Port, Jesse A.; Yamahara, Kevan M.; Crowder, Larry B.] Stanford Univ, Ctr Ocean Solut, Woods Inst Environm, Palo Alto, CA 94304 USA; [Kelly, Ryan P.] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA	Stanford University; University of Washington; University of Washington Seattle	Kelly, RP (corresponding author), Stanford Univ, Ctr Ocean Solut, Woods Inst Environm, Palo Alto, CA 94304 USA.	rpkelly@uw.edu		Kelly, Ryan/0000-0001-5037-2441	David and Lucile Packard Foundation [2013-38473]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was funded by the David and Lucile Packard Foundation #2013-38473. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Rachel I, 2013, Microb Ecol, V66, P735, DOI 10.1007/s00248-013-0266-4; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; BIBER E, 2011, U COLO L REV, V83, P1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deagle BE, 2013, MOL ECOL RESOUR, V13, P620, DOI 10.1111/1755-0998.12103; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dunshea G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005252; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Encalada SE, 1996, MOL ECOL, V5, P473; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Luo AR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-84; Machida RJ, 2012, PLOS ONE, V7; Magurran A.E., 1998, J APPL ECOL, DOI DOI 10.2307/2403731; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; MPA Monitoring Enterprise, 2010, N CENTR COAST MPA MO; Murray DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025776; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x	43	234	256	8	248	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86175	10.1371/journal.pone.0086175	http://dx.doi.org/10.1371/journal.pone.0086175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454960	Green Published, gold			2022-12-25	WOS:000330235100148
J	Lin, LG; Chen, KY; Khalek, WA; Ward, JL; Yang, H; Chabi, B; Wrutniak-Cabello, C; Tong, Q				Lin, Ligen; Chen, Keyun; Khalek, Waed Abdel; Ward, Jack Lee, III; Yang, Henry; Chabi, Beatrice; Wrutniak-Cabello, Chantal; Tong, Qiang			Regulation of Skeletal Muscle Oxidative Capacity and Muscle Mass by SIRT3	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; MYOSIN HEAVY-CHAIN; CALORIC RESTRICTION; TRANSGENIC MICE; SIRT3-MEDIATED DEACETYLATION; MITOCHONDRIAL-FUNCTION; LYSINE ACETYLATION; UBIQUITIN LIGASES; GENE-EXPRESSION	We have previously reported that the expression of mitochondrial deacetylase SIRT3 is high in the slow oxidative muscle and that the expression of muscle SIRT3 level is increased by dietary restriction or exercise training. To explore the function of SIRT3 in skeletal muscle, we report here the establishment of a transgenic mouse model with muscle-specific expression of the murine SIRT3 short isoform (SIRT3M3). Calorimetry study revealed that the transgenic mice had increased energy expenditure and lower respiratory exchange rate (RER), indicating a shift towards lipid oxidation for fuel usage, compared to control mice. The transgenic mice exhibited better exercise performance on treadmills, running 45% further than control animals. Moreover, the transgenic mice displayed higher proportion of slow oxidative muscle fibers, with increased muscle AMPK activation and PPARd expression, both of which are known regulators promoting type I muscle fiber specification. Surprisingly, transgenic expression of SIRT3M3 reduced muscle mass up to 30%, likely through an up-regulation of FOXO1 transcription factor and its downstream atrophy gene MuRF-1. In summary, these results suggest that SIRT3 regulates the formation of oxidative muscle fiber, improves muscle metabolic function, and reduces muscle mass, changes that mimic the effects of caloric restriction.	[Lin, Ligen; Chen, Keyun; Ward, Jack Lee, III; Yang, Henry; Tong, Qiang] Baylor Coll Med, Dept Pediat, USDA ARS Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Khalek, Waed Abdel; Chabi, Beatrice; Wrutniak-Cabello, Chantal] INRA, UMR Dynam Musculaire & Metab 866, F-34060 Montpellier, France; [Tong, Qiang] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Tong, Qiang] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); INRAE; Universite de Montpellier; Baylor College of Medicine; Baylor College of Medicine	Tong, Q (corresponding author), Baylor Coll Med, Dept Pediat, USDA ARS Childrens Nutr Res Ctr, Houston, TX 77030 USA.	qtong@bcm.tmc.edu	Lin, Ligen/ABC-1078-2020; Chabi, Beatrice/AAI-6545-2020	Lin, Ligen/0000-0002-6799-5327; Chabi, Beatrice/0000-0002-5604-5668	American Heart Association [0665162Y]; U.S. Department of Agriculture [6250-51000-055]; Baylor Diabetes Endocrinology Research Center-Pilot & Feasibility Grant [P30 DK079638]; NIH [DK075978]; USDA ARS; PHS [DK 56338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638, P30DK056338, R01DK075978] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Baylor Diabetes Endocrinology Research Center-Pilot & Feasibility Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Heart Association (0665162Y), a U.S. Department of Agriculture (6250-51000-055), Baylor Diabetes Endocrinology Research Center-Pilot & Feasibility Grant (P30 DK079638), and NIH (DK075978) to Q. T. Measurements of energy balance and food intake were performed in the Mouse Metabolic Research Unit at the USDA/ARS Children's Nutrition Research Center, which is supported by funds from the USDA ARS (www.bcm.edu/cnrc/mmru). The services provided by the Molecular Morphology Core Laboratory was sponsored by PHS grant DK 56338. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen BL, 2010, ACTA PHARMACOL SIN, V31, P798, DOI 10.1038/aps.2010.73; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cooper HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004986; COX GA, 1993, NATURE, V364, P725, DOI 10.1038/364725a0; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Dixit M, 2008, CARDIOVASC RES, V77, P160, DOI 10.1093/cvr/cvm017; Donoviel DB, 1996, MOL CELL BIOL, V16, P1649; Dyck DJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE340, DOI 10.1152/ajpendo.1997.272.3.E340; FERNANDES G, 1976, NATURE, V263, P504, DOI 10.1038/263504b0; Furuyama T, 2002, MICROSC RES TECHNIQ, V59, P331, DOI 10.1002/jemt.10213; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; HANSEN BC, 1993, DIABETES, V42, P1809, DOI 10.2337/diabetes.42.12.1809; Hepple RT, 2005, FASEB J, V19, P1320, DOI 10.1096/fj.04-3535fje; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kamei Y, 2003, FEBS LETT, V536, P232, DOI 10.1016/S0014-5793(03)00062-0; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Krawiec BJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1555, DOI 10.1152/ajpendo.00622.2006; Kregel, 2006, RESOURCE BOOK DESIGN; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Law IKM, 2009, PROTEOMICS, V9, P2444, DOI 10.1002/pmic.200800738; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; McKiernan SH, 2011, EXP GERONTOL, V46, P23, DOI 10.1016/j.exger.2010.09.011; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nystrom GJ, 2008, INT J CLIN EXP MED, V1, P50; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; SCHIAFFINO S, 1988, DEV BIOL, V127, P1, DOI 10.1016/0012-1606(88)90183-2; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shabalina IG, 2010, BBA-BIOENERGETICS, V1797, P968, DOI 10.1016/j.bbabio.2010.02.033; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Srere PA., 1969, METHODS ENZYMOLOGY, P3, DOI DOI 10.1016/0076-6879(69)13005-0; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Yang YJ, 2011, GENE, V488, P46, DOI 10.1016/j.gene.2011.07.029; Yang YJ, 2010, J CELL BIOCHEM, V111, P1051, DOI 10.1002/jcb.22795; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	71	37	38	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85636	10.1371/journal.pone.0085636	http://dx.doi.org/10.1371/journal.pone.0085636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454908	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100111
J	Li, L; Wang, JY; Zhang, Z; Wang, YL; Liu, MX; Jiang, H; Chai, RY; Mao, XQ; Qiu, HP; Liu, FQ; Sun, GC				Li, Ling; Wang, Jiaoyu; Zhang, Zhen; Wang, Yanli; Liu, Maoxin; Jiang, Hua; Chai, Rongyao; Mao, Xueqin; Qiu, Haiping; Liu, Fengquan; Sun, Guochang			MoPex19, which Is Essential for Maintenance of Peroxisomal Structure and Woronin Bodies, Is Required for Metabolism and Development in the Rice Blast Fungus	PLOS ONE			English	Article							MEDIATED PLANT INFECTION; MITOCHONDRIAL BETA-OXIDATION; INTEGRAL MEMBRANE-PROTEINS; MAGNAPORTHE-GRISEA; ASPERGILLUS-NIDULANS; PATHOGENIC FUNGUS; FATTY-ACIDS; COLLETOTRICHUM-LAGENARIUM; BIOGENESIS DISORDERS; NEUROSPORA-CRASSA	Peroxisomes are present ubiquitously and make important contributions to cellular metabolism in eukaryotes. They play crucial roles in pathogenicity of plant fungal pathogens. The peroxisomal matrix proteins and peroxisomal membrane proteins (PMPs) are synthesized in the cytosol and imported post-translationally. Although the peroxisomal import machineries are generally conserved, some species-specific features were found in different types of organisms. In phytopathogenic fungi, the pathways of the matrix proteins have been elucidated, while the import machinery of PMPs remains obscure. Here, we report that MoPEX19, an ortholog of ScPEX19, was required for PMPs import and peroxisomal maintenance, and played crucial roles in metabolism and pathogenicity of the rice blast fungus Magnaporthe oryzae. MoPEX19 was expressed in a low level and Mopex19p was distributed in the cytoplasm and newly formed peroxisomes. MoPEX19 deletion led to mislocalization of peroxisomal membrane proteins (PMPs), as well peroxisomal matrix proteins. Peroxisomal structures were totally absent in Delta mopex19 mutants and woronin bodies also vanished. Delta mopex19 exhibited metabolic deficiency typical in peroxisomal disorders and also abnormality in glyoxylate cycle which was undetected in the known mopex mutants. The Delta mopex19 mutants performed multiple disorders in fungal development and pathogenicity-related morphogenesis, and lost completely the pathogenicity on its hosts. These data demonstrate that MoPEX19 plays crucial roles in maintenance of peroxisomal and peroxisome-derived structures and makes more contributions to fungal development and pathogenicity than the known MoPEX genes in the rice blast fungus.	[Li, Ling; Liu, Maoxin; Liu, Fengquan] Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Li, Ling; Wang, Jiaoyu; Zhang, Zhen; Wang, Yanli; Liu, Maoxin; Jiang, Hua; Chai, Rongyao; Mao, Xueqin; Qiu, Haiping; Sun, Guochang] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Plant Protect Microbiol, Hangzhou, Zhejiang, Peoples R China	Nanjing Agricultural University; Zhejiang Academy of Agricultural Sciences	Liu, FQ (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	fqliu@njau.edu.cn; sungc01@sina.com		Li, Ling/0000-0003-4921-0423	National Natural Science Foundation of China [30900933, 31170136, 30970082]; National Basic Research Program (973) from the Ministry of Science and Technology of China [2012CB722504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973) from the Ministry of Science and Technology of China(National Basic Research Program of China)	This work was supported by the grants (No. 30900933 and 31170136 to J.-Y. Wang and 30970082 to G.-C. Sun) from National Natural Science Foundation of China and the National Basic Research Program (973) (No. 2012CB722504) from the Ministry of Science and Technology of China (http://www.nsfc.gov.cn/Portal0/default152.htm) (http://www.973.gov.cn/AreaAppl.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura M, 2006, APPL ENVIRON MICROB, V72, P6345, DOI 10.1128/AEM.00988-06; BEEVERS H, 1982, ANN NY ACAD SCI, V386, P243, DOI 10.1111/j.1749-6632.1982.tb21420.x; Bonekamp NA, 2009, BIOFACTORS, V35, P346, DOI 10.1002/biof.48; Bonnet C, 2006, MOL MICROBIOL, V62, P157, DOI 10.1111/j.1365-2958.2006.05353.x; CRAWFORD MS, 1986, GENETICS, V114, P1111; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; Dodt G, 1996, ANN NY ACAD SCI, V804, P516, DOI 10.1111/j.1749-6632.1996.tb18641.x; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Faust PL, 2005, J INHERIT METAB DIS, V28, P369, DOI 10.1007/s10545-005-7059-y; Fransen M, 2005, J MOL BIOL, V346, P1275, DOI 10.1016/j.jmb.2005.01.013; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Fujihara N, 2010, MOL PLANT MICROBE IN, V23, P436, DOI 10.1094/MPMI-23-4-0436; Girzalsky W, 2010, BIOCH BIOPHYSICA ACT, V1803; Goh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028220; Gotte K, 1998, MOL CELL BIOL, V18, P616; HAMER JE, 1988, SCIENCE, V239, P288, DOI 10.1126/science.239.4837.288; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Holroyd C, 2001, FEBS LETT, V501, P6, DOI 10.1016/S0014-5793(01)02617-5; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Hynes MJ, 2008, GENETICS, V178, P1355, DOI 10.1534/genetics.107.085795; Hynes MJ, 2006, EUKARYOT CELL, V5, P794, DOI 10.1128/EC.5.5.794-805.2006; Idnurm A, 2007, EUKARYOT CELL, V6, P60, DOI 10.1128/EC.00214-06; Jones AB, 2001, MED RES REV, V21, P540, DOI 10.1002/med.1025; Jungwirth H, 2008, FEBS LETT, V582, P2882, DOI 10.1016/j.febslet.2008.07.023; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kim KH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000653; Kimura A, 2001, PLANT CELL, V13, P1945, DOI 10.1105/tpc.13.8.1945; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Lambkin GR, 2001, MOL BIOL CELL, V12, P3353, DOI 10.1091/mbc.12.11.3353; Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; Managadze D, 2007, TRAFFIC, V8, P687, DOI 10.1111/j.1600-0854.2007.00560.x; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Min K, 2012, MOL PLANT MICROBE IN, V25, P1617, DOI 10.1094/MPMI-06-12-0149-R; Money NP, 1996, FUNGAL GENET BIOL, V20, P217, DOI 10.1006/fgbi.1996.0037; NOTTEGHEM JL, 1992, PHYTOPATHOLOGY, V82, P421, DOI 10.1094/Phyto-82-421; Nuttall JM, 2011, CURR OPIN CELL BIOL, V23, P421, DOI 10.1016/j.ceb.2011.05.005; Otzen M, 2004, J BIOL CHEM, V279, P19181, DOI 10.1074/jbc.M314275200; Patkar RN, 2012, MOL MICROBIOL, V86, P1345, DOI 10.1111/mmi.12060; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Ramos-Pamplona M, 2006, MOL MICROBIOL, V61, P61, DOI 10.1111/j.1365-2958.2006.05194.x; Rehling P, 1996, ANN NY ACAD SCI, V804, P34, DOI 10.1111/j.1749-6632.1996.tb18606.x; REISS J, 1971, PROTOPLASMA, V72, P43, DOI 10.1007/BF01281009; Rho HS, 2001, MOL CELLS, V12, P407; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; SCHULZ H, 1991, BIOCHIM BIOPHYS ACTA, V1081, P109, DOI 10.1016/0005-2760(91)90015-A; Shen YQ, 2009, FUNCT INTEGR GENOMIC, V9, P145, DOI 10.1007/s10142-008-0095-6; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; Shibata N, 2004, MOL REPROD DEV, V67, P1, DOI 10.1002/mrd.20009; Sichting M, 2003, MOL BIOL CELL, V14, P810, DOI 10.1091/mbc.E02-08-0539; Snyder WB, 2000, J CELL BIOL, V149, P1171, DOI 10.1083/jcb.149.6.1171; Soundararajan S, 2004, PLANT CELL, V16, P1564, DOI 10.1105/tpc.020677; Sun CB, 2006, PLANT CELL, V18, P3686, DOI 10.1105/tpc.105.037861; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Titorenko VI, 2004, J CELL BIOL, V164, P641, DOI 10.1083/jcb.200312081; Titorenko VI, 2001, TRENDS CELL BIOL, V11, P22, DOI 10.1016/S0962-8924(00)01865-1; Valenciano S, 1996, ARCH MICROBIOL, V166, P336, DOI 10.1007/s002030050392; VALENT B, 1990, PHYTOPATHOLOGY, V80, P33, DOI 10.1094/Phyto-80-33; Wanders RJA, 2005, CLIN GENET, V67, P107, DOI 10.1111/j.1399-0004.2004.00329.x; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016; Wang JY, 2008, J ZHEJIANG UNIV-SC B, V9, P802, DOI 10.1631/jzus.B0860001; Wang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055554; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x	71	31	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85252	10.1371/journal.pone.0085252	http://dx.doi.org/10.1371/journal.pone.0085252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454828	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800030
J	Phillips, CJ; Phillips, CD; Goecks, J; Lessa, EP; Sotero-Caio, CG; Tandler, B; Gannon, MR; Baker, RJ				Phillips, Carleton J.; Phillips, Caleb D.; Goecks, Jeremy; Lessa, Enrique P.; Sotero-Caio, Cibele G.; Tandler, Bernard; Gannon, Michael R.; Baker, Robert J.			Dietary and Flight Energetic Adaptations in a Salivary Gland Transcriptome of an Insectivorous Bat	PLOS ONE			English	Article							ACYLATION-STIMULATING PROTEIN; DNA TRANSPOSON ACTIVITY; CARBOXYL ESTER LIPASE; MYOTIS-LUCIFUGUS; COMPLEMENT COMPONENT-3; INSULIN-RESISTANCE; FAT-ABSORPTION; BROWN BAT; EVOLUTION; MORPHOLOGY	We hypothesized that evolution of salivary gland secretory proteome has been important in adaptation to insectivory, the most common dietary strategy among Chiroptera. A submandibular salivary gland (SMG) transcriptome was sequenced for the little brown bat, Myotis lucifugus. The likely secretory proteome of 23 genes included seven (RETNLB, PSAP, CLU, APOE, LCN2, C3, CEL) related to M. lucifugus insectivorous diet and metabolism. Six of the secretory proteins probably are endocrine, whereas one (CEL) most likely is exocrine. The encoded proteins are associated with lipid hydrolysis, regulation of lipid metabolism, lipid transport, and insulin resistance. They are capable of processing exogenous lipids for flight metabolism while foraging. Salivary carboxyl ester lipase (CEL) is thought to hydrolyze insect lipophorins, which probably are absorbed across the gastric mucosa during feeding. The other six proteins are predicted either to maintain these lipids at high blood concentrations or to facilitate transport and uptake by flight muscles. Expression of these seven genes and coordinated secretion from a single organ is novel to this insectivorous bat, and apparently has evolved through instances of gene duplication, gene recruitment, and nucleotide selection. Four of the recruited genes are single-copy in the Myotis genome, whereas three have undergone duplication(s) with two of these genes exhibiting evolutionary 'bursts' of duplication resulting in multiple paralogs. Evidence for episodic directional selection was found for six of seven genes, reinforcing the conclusion that the recruited genes have important roles in adaptation to insectivory and the metabolic demands of flight. Intragenic frequencies of mobile-element-like sequences differed from frequencies in the whole M. lucifugus genome. Differences among recruited genes imply separate evolutionary trajectories and that adaptation was not a single, coordinated event.	[Phillips, Carleton J.; Phillips, Caleb D.; Sotero-Caio, Cibele G.; Baker, Robert J.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Goecks, Jeremy] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Goecks, Jeremy] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA; [Lessa, Enrique P.] Univ Republica, Dept Ecol & Evoluc, Fac Ciencias, Montevideo, Uruguay; [Tandler, Bernard] Case Western Reserve Univ, Dept Biol Sci, Sch Dent Med, Cleveland, OH 44106 USA; [Gannon, Michael R.] Penn State Univ, Dept Biol, Altoona Coll, Altoona, PA USA	Texas Tech University System; Texas Tech University; Emory University; Emory University; Universidad de la Republica, Uruguay; Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Phillips, CJ (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	carl.phillips@ttu.edu	Lessa, Enrique/D-8894-2011	Lessa, Enrique/0000-0001-9750-4093; Sotero-Caio, Cibele/0000-0002-3112-0000	Texas Biological Database Program; Natural Science Research Laboratory and Genetic Resources Center at The Museum of Texas Tech University	Texas Biological Database Program; Natural Science Research Laboratory and Genetic Resources Center at The Museum of Texas Tech University	Financial and curatorial support was provided by the Texas Biological Database Program and the Natural Science Research Laboratory and Genetic Resources Center at The Museum of Texas Tech University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL KJ, 1992, MAMM GENOME, V2, P32, DOI 10.1007/BF00570438; ALOE L, 1986, P NATL ACAD SCI USA, V83, P6184, DOI 10.1073/pnas.83.16.6184; Altenberg J.S., 1987, P100; Arrese EL, 2001, INSECT BIOCHEM MOLEC, V31, P7, DOI 10.1016/S0965-1748(00)00102-8; AW TY, 1980, J NUTR, V110, P2133, DOI 10.1093/jn/110.11.2133; Bailey R, 1999, MOL CELL ENDOCRINOL, V151, P17, DOI 10.1016/S0303-7207(99)00016-7; BAKER RJ, 1986, P NATL ACAD SCI USA, V83, P8245, DOI 10.1073/pnas.83.21.8245; BAKER RJ, 2006, ATLAS MAMMALIAN CHRO, P378; Baker Robert J., 2003, Occasional Papers Museum of Texas Tech University, V229, P1; Baker RJ, 2012, CAM STUD MORPHOL MOL, P385; BALDO A, 1993, J CLIN INVEST, V92, P1543, DOI 10.1172/JCI116733; Cabej NR, 2010, DEVEL DYNAMICS, V240, P1; Calero M, 1999, BIOCHEM J, V344, P375, DOI 10.1042/0264-6021:3440375; CAPORALE LH, 1980, J BIOL CHEM, V255, P758; CAREY MC, 1983, ANNU REV PHYSIOL, V45, P651, DOI 10.1146/annurev.ph.45.030183.003251; Chapman M John, 2007, Diab Vasc Dis Res, V4 Suppl 3, pS5; CHAPPELL MA, 1990, RESP PHYSIOL, V81, P401, DOI 10.1016/0034-5687(90)90120-N; CHOY LN, 1992, J BIOL CHEM, V267, P12736; Cianflone K, 2004, J LIPID RES, V45, P124, DOI 10.1194/jlr.M300214-JLR200; Cianflone K, 1997, J ENDOCRINOL, V155, P203, DOI 10.1677/joe.0.1550203; DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Delport W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000885; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; DOWNER RGH, 1976, AM ZOOL, V16, P733; Dumont ER, 2012, P ROY SOC B-BIOL SCI, V279, P1797, DOI 10.1098/rspb.2011.2005; Elosua R, 2003, OBES RES, V11, P1502, DOI 10.1038/oby.2003.201; Fayard E, 2003, J BIOL CHEM, V278, P35725, DOI 10.1074/jbc.M302370200; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; FOEHRING RC, 1984, J MAMMAL, V65, P388, DOI 10.2307/1381084; FREEMAN PW, 1979, J MAMMAL, V60, P467, DOI 10.2307/1380088; FREEMAN PW, 1981, J MAMMAL, V62, P166, DOI 10.2307/1380489; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; HAMOSH M, 1989, PEDIATRICS, V83, P86; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; HIRAIWA M, 1992, P NATL ACAD SCI USA, V89, P11254, DOI 10.1073/pnas.89.23.11254; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Isenman L, 1999, AM J PHYSIOL-ENDOC M, V276, pE223, DOI 10.1152/ajpendo.1999.276.2.E223; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jin DZ, 2011, FASEB J, V25, P754, DOI 10.1096/fj.10-165175; KARMEN A, 1963, J LIPID RES, V4, P312; LIN HH, 1991, GENOMICS, V10, P102, DOI 10.1016/0888-7543(91)90490-6; Liu Y, 2012, MOL BIOL EVOL, V29, P1507, DOI 10.1093/molbev/mss013; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MEISLER MH, 1993, CRIT REV ORAL BIOL M, V4, P503, DOI 10.1177/10454411930040033501; Mitra R, 2013, P NATL ACAD SCI USA, V110, P234, DOI 10.1073/pnas.1217548110; Muotri AR, 2007, HUM MOL GENET, V16, pR159, DOI 10.1093/hmg/ddm196; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Ozyildirim AM, 2005, INVEST OPHTH VIS SCI, V46, P1572, DOI 10.1167/iovs.04-1380; Pagan HJT, 2012, GENOME BIOL EVOL, V4, P575, DOI 10.1093/gbe/evs038; Phillips CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057649; Phillips Carleton J., 2000, P247, DOI 10.1017/CBO9780511541872.008; Phillips CJ, 1998, EUR J MORPHOL, V36, P19; Phillips CJ, 1996, CONTRIBUTIONS MAMMAL, P1; Phillips CJ, 1993, BIOL SALIVARY GLANDS, P39; PINKSTAFF CA, 1982, J MORPHOL, V172, P271, DOI 10.1002/jmor.1051720303; Poorkhalkali N, 1998, HISTOCHEM CELL BIOL, V110, P367, DOI 10.1007/s004180050297; POWERS LV, 1991, J COMP PHYSIOL A, V168, P675; Proctor GB, 1998, FRONT ORAL BIOL, V10, P73; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Ratcliffe JM, 2003, ANIM BEHAV, V66, P847, DOI 10.1006/anbe.2003.2297; Ray DA, 2008, GENOME RES, V18, P717, DOI 10.1101/gr.071886.107; Ray DA, 2007, MOL BIOL EVOL, V24, P632, DOI 10.1093/molbev/msl192; Raybould HE, 1998, AM J PHYSIOL-REG I, V274, pR1834, DOI 10.1152/ajpregu.1998.274.6.R1834; Roberts A, 2011, BIOINFORMATICS, V9, DOI 10.1093; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; SAMUELSON LC, 1990, MOL CELL BIOL, V10, P2513, DOI 10.1128/MCB.10.6.2513; SAMUELSON LC, 1988, NUCLEIC ACIDS RES, V16, P8261, DOI 10.1093/nar/16.17.8261; Santana SE, 2011, FUNCTIONAL ECOL, DOI 10.1111; Shamir R, 1996, J CLIN INVEST, V97, P1696, DOI 10.1172/JCI118596; Shen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033197; Soulages JL, 1996, BIOCHEMISTRY-US, V35, P5191, DOI 10.1021/bi952794d; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tandler B, 2006, ANAT REC PART A, V288A, P498, DOI 10.1002/ar.a.20319; Tandler B, 2001, ANAT RECORD, V264, P121, DOI 10.1002/ar.1108; TANDLER B, 1993, MICROSC RES TECHNIQ, V26, P32, DOI 10.1002/jemt.1070260105; Thai CT, 2003, J IMMUNOL, V171, P6565, DOI 10.4049/jimmunol.171.12.6565; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Oostrom AJHHM, 2007, ATHEROSCLEROSIS, V190, P167, DOI 10.1016/j.atherosclerosis.2006.01.009; Verseyden C, 2003, J LIPID RES, V44, P2100, DOI 10.1194/jlr.M300201-JLR200; Voigt CC, 2010, ECOLOGY, V91, P2908, DOI 10.1890/09-2232.1; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Wilson MR, 2000, CLUSTERIN IS SECRETE; Winter Y, 1998, J COMP PHYSIOL B, V168, P105, DOI 10.1007/s003600050126; YACOE ME, 1982, AM J PHYSIOL, V242, pR189, DOI 10.1152/ajpregu.1982.242.3.R189; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yuan WM, 2007, P NATL ACAD SCI USA, V104, P5551, DOI 10.1073/pnas.0700617104; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zwiner J, 1998, EUR J IMMUNOL, V28, P1570	99	10	10	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e83512	10.1371/journal.pone.0083512	http://dx.doi.org/10.1371/journal.pone.0083512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454705	gold, Green Published, Green Submitted			2022-12-25	WOS:000329925800009
J	Zhang, C; Kho, YS; Wang, Z; Chiang, YT; Ng, GKH; Shaw, PC; Wang, YZ; Qi, RZ				Zhang, Chao; Kho, Yik-Shing; Wang, Zhe; Chiang, Yan Ting; Ng, Gary K. H.; Shaw, Pang-Chui; Wang, Yuzhuo; Qi, Robert Z.			Transmembrane and Coiled-Coil Domain Family 1 Is a Novel Protein of the Endoplasmic Reticulum	PLOS ONE			English	Article							MEMBRANE-PROTEINS; CANDIDATE GENES; ER; KINECTIN; CELLS; TRANSLOCATION; DYNAMICS; TUBULES; PHOSPHORYLATION; IDENTIFICATION	The endoplasmic reticulum (ER) is a continuous membrane network in eukaryotic cells comprising the nuclear envelope, the rough ER, and the smooth ER. The ER has multiple critical functions and a characteristic structure. In this study, we identified a new protein of the ER, TMCC1 (transmembrane and coiled-coil domain family 1). The TMCC family consists of at least 3 putative proteins (TMCC1-3) that are conserved from nematode to human. We show that TMCC1 is an ER protein that is expressed in diverse human cell lines. TMCC1 contains 2 adjacent transmembrane domains near the C-terminus, in addition to coiled-coil domains. TMCC1 was targeted to the rough ER through the transmembrane domains, whereas the N-terminal region and C-terminal tail of TMCC1 were found to reside in the cytoplasm. Moreover, the cytosolic region of TMCC1 formed homo-or hetero-dimers or oligomers with other TMCC proteins and interacted with ribosomal proteins. Notably, overexpression of TMCC1 or its transmembrane domains caused defects in ER morphology. Our results suggest roles of TMCC1 in ER organization.	[Zhang, Chao; Kho, Yik-Shing; Wang, Zhe; Chiang, Yan Ting; Ng, Gary K. H.; Qi, Robert Z.] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Zhang, Chao; Kho, Yik-Shing; Wang, Zhe; Chiang, Yan Ting; Ng, Gary K. H.; Qi, Robert Z.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Chiang, Yan Ting; Wang, Yuzhuo] British Columbia Canc Agcy, Dept Expt Therapeut, Vancouver, BC V5Z 4E6, Canada; [Shaw, Pang-Chui] Chinese Univ Hong Kong, Biochem Programme, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Shaw, Pang-Chui] Chinese Univ Hong Kong, Ctr Prot Sci & Crystallog, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; British Columbia Cancer Agency; Chinese University of Hong Kong; Chinese University of Hong Kong	Qi, RZ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	qirz@ust.hk		Zhang, Chao/0000-0002-7174-044X; Wang, Yuzhuo/0000-0002-9749-8591; Qi, Robert Zhong/0000-0001-5596-8172	Research Grants Council of Hong Kong; National Key Basic Research Program of China [2013CB530900]; University Grants Committee of Hong Kong [SEG_HKUST05]; TUYF Charitable Trust; Hong Kong University of Science and Technology	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Key Basic Research Program of China(National Basic Research Program of China); University Grants Committee of Hong Kong; TUYF Charitable Trust; Hong Kong University of Science and Technology	This work was supported by grants from the Research Grants Council (General Research Fund and Theme-based Research Scheme) of Hong Kong, the National Key Basic Research Program (2013CB530900) of China, the University Grants Committee (Area of Excellence Scheme and Special Equipment Grant SEG_HKUST05) of Hong Kong, the TUYF Charitable Trust, and by funds from the Hong Kong University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2007, NEUROSCI LETT, V413, P238, DOI 10.1016/j.neulet.2006.11.064; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Chen XQ, 2010, J PROTEOME RES, V9, P885, DOI 10.1021/pr900784c; Dudek J, 2013, METHODS MOL BIOL, V1033, P285, DOI 10.1007/978-1-62703-487-6_18; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Hong WJ, 1998, J CELL SCI, V111, P2831; Hopkins PCR, 2011, J ALZHEIMERS DIS, V26, P239, DOI 10.3233/JAD-2011-102115; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Ivanova AV, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-91; Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054382; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; McMaster CR, 2001, BIOCHEM CELL BIOL, V79, P681, DOI 10.1139/bcb-79-6-681; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; MICHALIK J, 1981, LIFE SCI, V28, P1371, DOI 10.1016/0024-3205(81)90411-2; Michielse CB, 2006, EUR J HUM GENET, V14, P1306, DOI 10.1038/sj.ejhg.5201706; Murtazina DA, 2011, BIOL REPROD, V85, P315, DOI 10.1095/biolreprod.111.091082; Nagase T, 1998, DNA Res, V5, P277, DOI 10.1093/dnares/5.5.277; Ogawa-Goto K, 2007, MOL BIOL CELL, V18, P3741, DOI 10.1091/mbc.E06-12-1125; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong LL, 2006, J BIOL CHEM, V281, P33621, DOI 10.1074/jbc.M607555200; Ong LL, 2003, J BIOL CHEM, V278, P32115, DOI 10.1074/jbc.M210917200; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; Schwernmers S, 2007, EXP HEMATOL, V35, P1695, DOI 10.1016/j.exphem.2007.07.004; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; SINGER SJ, 1990, ANNU REV CELL BIOL, V6, P247, DOI 10.1146/annurev.cb.06.110190.001335; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; TAKEI K, 1994, NEURON, V12, P327, DOI 10.1016/0896-6273(94)90275-5; Tavassoli S, 2013, EMBO REP, V14, P434, DOI 10.1038/embor.2013.36; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; Ueno T, 2012, NUCLEIC ACIDS RES, V40, P3006, DOI 10.1093/nar/gkr1197; Ueno T, 2010, EXP CELL RES, V316, P329, DOI 10.1016/j.yexcr.2009.11.009; van der Zwaag B, 2005, GENOMICS, V86, P55, DOI 10.1016/j.ygeno.2005.03.007; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Voeltz GK, 2007, NAT REV MOL CELL BIO, V8, P258, DOI 10.1038/nrm2119; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Volkova EG, 2012, BIOL OPEN, V1, P802, DOI 10.1242/bio.20121537; Wanzel M, 2008, NAT CELL BIOL, V10, P1051, DOI 10.1038/ncb1764; Yamamoto A, 1996, J CELL SCI, V109, P1727; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006; ZENGEL JM, 1990, P NATL ACAD SCI USA, V87, P2675, DOI 10.1073/pnas.87.7.2675; Zhang X, 2010, J CELL SCI, V123, P3901, DOI 10.1242/jcs.069153	52	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85206	10.1371/journal.pone.0085206	http://dx.doi.org/10.1371/journal.pone.0085206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454821	Green Published, gold			2022-12-25	WOS:000329925800026
J	Collins, PE; Kiely, PA; Carmody, RJ				Collins, Patricia E.; Kiely, Patrick A.; Carmody, Ruaidhri J.			Inhibition of Transcription by B Cell Leukemia 3 (Bcl-3) Protein Requires Interaction with Nuclear Factor kappa B (NF-kappa B) p50	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine Induction; Inflammation; Mutagenesis; NF-B transcription factor; Ubiquitination	GENE-EXPRESSION; C-REL; RECEPTOR; PHOSPHORYLATION; COACTIVATOR; REPRESSION; REPEAT; KINASE; DOMAIN; ALPHA	Background: Bcl-3 is an essential negative regulator of cytokine expression. Results: A mutation in NF-B p50 that prevents interaction with Bcl-3 abrogates Bcl-3 inhibition of gene expression. Conclusion: The inhibition of cytokine expression by Bcl-3 requires interaction with NF-B p50. Significance: NF-B p50 is the key target of Bcl-3 anti-inflammatory activity. B cell leukemia 3 (Bcl-3) is an essential negative regulator of NF-B during Toll-like receptor and TNF receptor signaling. Bcl-3 also interacts with a number of transcriptional regulators, including homodimers of the NF-B p50 subunit. Deletion of Bcl-3 results in increased NF-B p50 ubiquitination and proteasomal degradation and increased inflammatory gene expression. We employed immobilized peptide array technology to define a region of p50 required for the formation of a Bcl-3p50 homodimer immunosuppressor complex. Our data demonstrate that amino acids 359-361 and 363 of p50 are critical for interaction with Bcl-3 and essential for Bcl-3-mediated inhibition of inflammatory gene expression. Bcl-3 is unable to interact with p50 when these amino acids are mutated, rendering it incapable of inhibiting the transcriptional activity of NF-B. Bcl-3 interaction-defective p50 is hyperubiquitinated and has a significantly reduced half-life relative to wild-type p50. Nfkb1(-/-) cells reconstituted with mutated p50 precursor p105 are hyperresponsive to TNF stimulation relative to wild-type p105, as measured by inflammatory gene expression. Mutant p105 recapitulates a Bcl3(-/-) phenotype. This study demonstrates that interaction with p50 is necessary and sufficient for the anti-inflammatory properties of Bcl-3 and further highlights the importance of p50 homodimer stability in the control of NF-B target gene expression.	[Collins, Patricia E.] Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cork, Ireland; [Kiely, Patrick A.] Univ Limerick, Dept Life Sci, Limerick, Ireland; [Kiely, Patrick A.] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland; [Carmody, Ruaidhri J.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Ctr Immunobiol, Glasgow G12 8TA, Lanark, Scotland	University College Cork; University of Limerick; University of Limerick; University of Glasgow	Carmody, RJ (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland.	ruaidhri.carmody@glasgow.ac.uk	Carmody, Ruaidhri/H-5396-2019	Collins, Patricia/0000-0002-0218-7847	Science Foundation Ireland [08/IN.1/B1843]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland Grant 08/IN.1/B1843.	Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Cheng CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001501; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; COWAN R, 1990, Peptide Research, V3, P75; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hishiki T, 2007, J BIOL CHEM, V282, P28335, DOI 10.1074/jbc.M702656200; Jamaluddin M, 2005, J VIROL, V79, P15302, DOI 10.1128/JVI.79.24.15302-15313.2005; Kabuta T, 2010, BIOCHEM BIOPH RES CO, V394, P697, DOI 10.1016/j.bbrc.2010.03.054; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Kramer A, 1998, METH MOL B, V87, P25; Latimer M, 1998, MOL CELL BIOL, V18, P2640, DOI 10.1128/MCB.18.5.2640; Michel F, 2001, EMBO J, V20, P6180, DOI 10.1093/emboj/20.22.6180; Muhlbauer M, 2008, J BIOL CHEM, V283, P14182, DOI 10.1074/jbc.M709029200; Na SY, 1998, J BIOL CHEM, V273, P30933, DOI 10.1074/jbc.273.47.30933; Na SY, 1999, J BIOL CHEM, V274, P28491, DOI 10.1074/jbc.274.40.28491; Neasta J, 2012, J BIOL CHEM, V287, P322, DOI 10.1074/jbc.M111.272195; Palmer S, 2008, IMMUNOL RES, V42, P210, DOI 10.1007/s12026-008-8075-4; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Southern SL, 2012, ONCOGENE, V31, P2761, DOI 10.1038/onc.2011.452; Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004; Weyrich AS, 1998, P NATL ACAD SCI USA, V95, P5556, DOI 10.1073/pnas.95.10.5556; Yan Q, 2012, P NATL ACAD SCI USA, V109, P14140, DOI 10.1073/pnas.1119842109; Yang J, 2009, MOL CELL BIOL, V29, P4091, DOI 10.1128/MCB.01669-08; Zhao YJ, 2005, BIOCHEM BIOPH RES CO, V335, P865, DOI 10.1016/j.bbrc.2005.07.162	29	42	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7059	7067		10.1074/jbc.M114.551986	http://dx.doi.org/10.1074/jbc.M114.551986			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24459141	hybrid, Green Published			2022-12-25	WOS:000332389400065
J	Prins, PA; Hill, MF; Airey, D; Nwosu, S; Perati, PR; Tavori, H; Linton, MF; Kon, V; Fazio, S; Sampson, UK				Prins, Petra A.; Hill, Michael F.; Airey, David; Nwosu, Sam; Perati, Prudhvidhar R.; Tavori, Hagai; Linton, MacRae F.; Kon, Valentina; Fazio, Sergio; Sampson, Uchechukwu K.			Angiotensin-Induced Abdominal Aortic Aneurysms in Hypercholesterolemic Mice: Role of Serum Cholesterol and Temporal Effects of Exposure	PLOS ONE			English	Article							E-DEFICIENT MICE; OXIDATIVE STRESS; MATRIX METALLOPROTEINASES; INFLAMMATION; CYCLOPHILIN; ATHEROSCLEROSIS; IDENTIFICATION; ATHEROGENESIS; PATHOGENESIS; BIOMARKERS	Objective: Understanding variations in size and pattern of development of angiotensin II (Ang II)-induced abdominal aortic aneurysms (AAA) may inform translational research strategies. Thus, we sought insight into the temporal evolution of AAA in apolipoprotein (apo) E-/- mice. Approach: A cohort of mice underwent a 4-week pump-mediated infusion of saline (n = 23) or 1500 ng/kg/min of Ang II (n = 85) and AAA development was tracked via in vivo ultrasound imaging. We adjusted for hemodynamic covariates in the regression models for AAA occurrence in relation to time. Results: The overall effect of time was statistically significant (p<0.001). Compared to day 7 of AngII infusion, there was no decrease in the log odds of AAA occurrence by day 14 (-0.234, p = 0.65), but compared to day 21 and 28, the log odds decreased by 9.07 (p<0.001) and 2.35 (p = 0.04), respectively. Hemodynamic parameters were not predictive of change in aortic diameter (Delta) (SBP, p = 0.66; DBP, p = 0.66). Mean total cholesterol (TC) was higher among mice with large versus small AAA (601 vs. 422 mg/ml, p<0.0001), and the difference was due to LDL. AngII exposure was associated with 0.43 mm (95% CI, 0.27 to 0.61, p<0.0001) increase in aortic diameter; and a 100 mg/dl increase in mean final cholesterol level was associated with a 12% (95% CI, 5.68 to 18.23, p<0.0001) increase in aortic diameter. Baseline cholesterol was not associated with change in aortic diameter (p = 0.86). Conclusions: These are the first formal estimates of a consistent pattern of Ang II-induced AAA development. The odds of AAA occurrence diminish after the second week of Ang II infusion, and TC is independently associated with AAA size.	[Prins, Petra A.; Hill, Michael F.; Tavori, Hagai; Linton, MacRae F.; Fazio, Sergio; Sampson, Uchechukwu K.] VUMC, Dept Med, Nashville, TN USA; [Airey, David; Nwosu, Sam] VUMC, Dept Biostat, Nashville, TN USA; [Perati, Prudhvidhar R.] NCI Informat Syst Inc, Nashville, TN USA; [Kon, Valentina] VUMC, Dept Pediat, Nashville, TN USA; [Fazio, Sergio; Sampson, Uchechukwu K.] VUMC, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Sampson, Uchechukwu K.] VUMC, Dept Radiol & Radiol Sci, Nashville, TN USA		Sampson, UK (corresponding author), VUMC, Dept Med, Nashville, TN USA.	u.sampson@vanderbilt.edu	Tavori, Hagai/AAS-9079-2021		Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; American College of Cardiology Foundation/General Electric Healthcare Career Development Award in Cardiovascular Imaging Technologies and Targeted Imaging Agents; NIH [HL057986, HL106845]; National Heart, Lung, and Blood Institute [R01 HL089385];  [5R01HL087061-05];  [U24 DK059637]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057986, R01HL106845, R01HL089385, R01HL087061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637] Funding Source: NIH RePORTER	Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; American College of Cardiology Foundation/General Electric Healthcare Career Development Award in Cardiovascular Imaging Technologies and Targeted Imaging Agents; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding support for Dr. Sampson was provided in part by the Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation, the Vanderbilt Clinical and Translational Scholars Award, and the American College of Cardiology Foundation/General Electric Healthcare Career Development Award in Cardiovascular Imaging Technologies and Targeted Imaging Agents. Dr. Fazio was supported in part by NIH grants HL057986 and HL106845. Dr. Hill was supported in part by National Heart, Lung, and Blood Institute grant R01 HL089385. Dr Kon was supported in part by 5R01HL087061-05 The Vanderbilt Mouse Metabolic phenotyping Center (MMPC) is supported in part by grant U24 DK059637. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayabe N, 2006, ATHEROSCLEROSIS, V184, P312, DOI 10.1016/j.atherosclerosis.2005.05.016; Barisione C, 2006, J VASC SURG, V44, P372, DOI 10.1016/j.jvs.2006.04.047; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Cassis LA, 2004, REGUL PEPTIDES, V117, P107, DOI 10.1016/j.regpep.2003.09.008; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Gavrila D, 2005, ARTERIOSCL THROM VAS, V25, P1671, DOI 10.1161/01.ATV.0000172631.50972.0f; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Hellenthal FAMVI, 2009, CARDIOVASC PATHOL, V18, P286, DOI 10.1016/j.carpath.2008.06.014; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P543, DOI 10.1038/nrcardio.2009.102; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P464, DOI 10.1038/nrcardio.2009.80; JEANCLAUDE J, 1994, SURGERY, V116, P472; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Juvonen J, 1997, ARTERIOSCL THROM VAS, V17, P2843, DOI 10.1161/01.ATV.17.11.2843; Liao DF, 2000, J BIOL CHEM, V275, P189, DOI 10.1074/jbc.275.1.189; Martin-McNulty B, 2005, ULTRASOUND MED BIOL, V31, P745, DOI 10.1016/j.ultrasmedbio.2005.02.012; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; NEWMAN KM, 1994, ARTERIOSCLER THROMB, V14, P1315, DOI 10.1161/01.ATV.14.8.1315; Nishimura K, 2003, INT ANGIOL, V22, P229; Prins PA, 2012, CELL PHYSIOL BIOCHEM, V29, P121, DOI 10.1159/000337593; R Development Core Team, 2010, R LANG ENV STAT COMP; Sampson UK, 2011, J ULTRAS MED, V30, P773, DOI 10.7863/jum.2011.30.6.773; Sampson UK, 2010, ARTERIOSCLER THROMB; Satoh K, 2008, CIRCULATION, V117, P3088, DOI 10.1161/CIRCULATIONAHA.107.756106; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Tavori H, 2013, CIRCULATION, V127, P2403, DOI 10.1161/CIRCULATIONAHA.113.001592; Wang YX, 2001, AM J PATHOL, V159, P1455, DOI 10.1016/S0002-9440(10)62532-1; Yoshimura K, 2006, ANN NY ACAD SCI, V1085, P74, DOI 10.1196/annals.1383.031	33	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e84517	10.1371/journal.pone.0084517	http://dx.doi.org/10.1371/journal.pone.0084517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465413	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000004
J	Xiong, LP; He, ZY; Qian, L; Mu, L; Chen, AX; Han, S; Qiu, JW; Fu, XS				Xiong Liping; He Zhongyi; Qian Liang; Mu Lin; Chen Aixi; Han Sheng; Qiu Jianwei; Fu Xisheng			Synthesis, Tribological and Hydrolysis Stability Study of Novel Benzotriazole Borate Derivative	PLOS ONE			English	Article							ANTIWEAR ADDITIVES; PHOSPHORUS; ESTERS; ASH	Benzotriazole and borate derivatives have long been used as multifunctional additives to lubricants. A novel, environmentally friendly additive borate ester (NHB), which contains boron, ethanolamine, and benzotriazole groups in one molecule, was synthesized by a multi-step reaction, and its tribological properties in rapeseed oil (RSO) were investigated by a four-ball tribometer. The hydrolysis stability of the additive was investigated by half-time and open observation methods, and the mechanism of hydrolysis stability was discussed through Gaussian calculation. The novel compound NHB showed excellent performance under extreme pressure, against wearing, and in reducing friction, and its hydrolysis time is more than 1,220 times, which is better than that of triethyl borate. The mass ratio of NHB is bigger than that of the mixed liquid of triethyl borate and ethanolamine. The lone electron of amino N atoms forms a coordination effect with the B atom to compensate for the shortage of electrons in the B atom and to improve the hydrolysis stability of NHB. The surface morphology and the traces of different elements in the tribofilms formed with 1.0 wt.% NHB in were detected with scanning electron microscopy(SEM), energy dispersive X-ray spectroscopy (EDX) and X-ray photoelectron spectroscopy(XPS). The results shown that the additive caused a tribochemical reaction with the steel ball surface during the lubricating process. A mixed boundary lubrication film that contains organic nitrogen and inorganic salts, such as BN, B2O3, FeOx, Fe-O-B, and FeB, was also formed, and the formation of the lubricating film improved the tribological properties of the base oil.	[Xiong Liping; He Zhongyi; Qian Liang; Mu Lin; Chen Aixi] East China Jiaotong Univ, Sch Basic Sci, Nanchang, Jiangxi, Peoples R China; [Han Sheng] Shanghai Inst Technol, Shanghai, Peoples R China; [He Zhongyi; Qiu Jianwei; Fu Xisheng] PetroChina Lanzhou Lubricating Oil R&D Inst, Lanzhou, Peoples R China	East China Jiaotong University; Shanghai Institute of Technology; China National Petroleum Corporation	Xiong, LP (corresponding author), East China Jiaotong Univ, Sch Basic Sci, Nanchang, Jiangxi, Peoples R China.	helijia666@163.com			Chinese Natural Science Foundation [21063007]; Jiangxi Provincial Natural Science Foundation [20122BAB203011]; Jiangxi Education Department Foundation of China [GJJ13358]	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Natural Science Foundation; Jiangxi Education Department Foundation of China	The work reported here was sponsored by Chinese Natural Science Foundation (No: 21063007); Jiangxi Provincial Natural Science Foundation (No: 20122BAB203011); Jiangxi Education Department Foundation of China (Grant No: GJJ13358). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	DIDZIULIS SV, 1995, LANGMUIR, V11, P917, DOI 10.1021/la00003a040; Erdemir A., 2008, NANOLUBRICANTS, P203, DOI DOI 10.1002/9780470987711.CH6; He ZY, 2005, CHINESE SCI BULL, V50, P1174, DOI 10.1360/04wb0103; [胡晓兰 Hu Xiaolan], 2002, 材料导报, V16, P58; Jia ZF, 2011, TRIBOL LETT, V41, P247, DOI 10.1007/s11249-010-9706-1; Jia ZF, 2011, TRIBOL LETT, V41, P425, DOI 10.1007/s11249-010-9728-8; Li JS, 2010, TRIBOL INT, V43, P1048, DOI 10.1016/j.triboint.2009.12.030; Liang P, 2010, P I MECH ENG J-J ENG, V224, P65, DOI 10.1243/13506501JET615; Philippon D, 2011, TRIBOL LETT, V41, P73, DOI 10.1007/s11249-010-9685-2; Shah FU, 2012, TRIBOL LETT, V45, P67, DOI 10.1007/s11249-011-9855-x; Shah FU, 2009, ACS APPL MATER INTER, V1, P2835, DOI 10.1021/am900572y; Spikes H, 2008, LUBR SCI, V20, P103, DOI 10.1002/ls.57; Wang Q, 2011, APPL MECH MATER, V84-85, P499, DOI 10.4028/www.scientific.net/AMM.84-85.499; Wang Y, 2008, P I MECH ENG J-J ENG, V222, P133, DOI 10.1243/13506501JET293; Xue RT, 2011, THESIS OCEAN U CHINA; Yao J. B., 2006, LUBR OIL CHINA, V21, P29; Zhang H, 2008, LUBRI ENG CHINA, V33, P94; Zheng Z, 1998, WEAR, V222, P135, DOI 10.1016/S0043-1648(98)00323-8; Zhou XD, 2007, TRIBOL INT, V40, P863, DOI 10.1016/j.triboint.2006.09.002	19	12	15	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e83501	10.1371/journal.pone.0083501	http://dx.doi.org/10.1371/journal.pone.0083501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465382	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100005
J	Chen, LW; Zhang, JH; Chen, WN				Chen, Liwei; Zhang, Jianhua; Chen, Wei Ning			Engineering the Saccharomyces cerevisiae beta-Oxidation Pathway to Increase Medium Chain Fatty Acid Production as Potential Biofuel	PLOS ONE			English	Article							YEAST YARROWIA-LIPOLYTICA; ACYL-COA THIOESTERASES; CARNITINE ACYLTRANSFERASES; LIPID-ACCUMULATION; METABOLISM; COENZYME; OXIDASES; POLYHYDROXYALKANOATE; MICROORGANISMS; BIOSYNTHESIS	Fatty acid-derived biofuels and biochemicals can be produced in microbes using beta-oxidation pathway engineering. In this study, the beta-oxidation pathway of Saccharomyces cerevisiae was engineered to accumulate a higher ratio of medium chain fatty acids (MCFAs) when cells were grown on fatty acid-rich feedstock. For this purpose, the haploid deletion strain Delta pox1 was obtained, in which the sole acyl-CoA oxidase encoded by POX1 was deleted. Next, the POX2 gene from Yarrowia lipolytica, which encodes an acyl-CoA oxidase with a preference for long chain acyl-CoAs, was expressed in the Delta pox1 strain. The resulting Delta pox1 [pox2+] strain exhibited a growth defect because the beta-oxidation pathway was blocked in peroxisomes. To unblock the beta-oxidation pathway, the gene CROT, which encodes carnitine O-octanoyltransferase, was expressed in the Delta pox1 [pox2+] strain to transport the accumulated medium chain acyl-coAs out of the peroxisomes. The obtained Delta pox1 [pox2+, crot+] strain grew at a normal rate. The effect of these genetic modifications on fatty acid accumulation and profile was investigated when the strains were grown on oleic acids-containing medium. It was determined that the engineered strains Delta pox1 [pox2+] and Delta pox1 [pox2+, crot+] had increased fatty acid accumulation and an increased ratio of MCFAs. Compared to the wild-type (WT) strain, the total fatty acid production of the strains Delta pox1 [pox2+] and Delta pox1 [pox2+, crot+] were increased 29.5% and 15.6%, respectively. The intracellular level of MCFAs in Delta pox1 [pox2+] and Delta pox1 [pox2+, crot+] increased 2.26- and 1.87-fold compared to the WT strain, respectively. In addition, MCFAs in the culture medium increased 3.29-fold and 3.34-fold compared to the WT strain. These results suggested that fatty acids with an increased MCFAs ratio accumulate in the engineered strains with a modified beta-oxidation pathway. Our approach exhibits great potential for transforming low value fatty acid-rich feedstock into high value fatty acid-derived products.	[Chen, Liwei; Zhang, Jianhua; Chen, Wei Ning] Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chen, WN (corresponding author), Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore 639798, Singapore.	WNChen@ntu.edu.sg		, Yang/0000-0002-6620-8897; Chen, Liwei/0000-0002-4165-4102	National Research Foundation, Singapore	National Research Foundation, Singapore(National Research Foundation, Singapore)	National Research Foundation, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardi L, 1999, INT J FOOD MICROBIOL, V47, P133, DOI 10.1016/S0168-1605(98)00203-7; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Dellomonaco C, 2010, APPL ENVIRON MICROB, V76, P5067, DOI 10.1128/AEM.00046-10; DMOCHOWSKA A, 1990, GENE, V88, P247, DOI 10.1016/0378-1119(90)90038-S; FARRELL SO, 1984, J BIOL CHEM, V259, P3089; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Haddouche R, 2010, FEMS YEAST RES, V10, P917, DOI 10.1111/j.1567-1364.2010.00670.x; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Horak T, 2009, J AGR FOOD CHEM, V57, P11081, DOI 10.1021/jf9028305; Hunt MC, 2008, PROG LIPID RES, V47, P405, DOI 10.1016/j.plipres.2008.05.001; Jones JM, 1999, J BIOL CHEM, V274, P9216, DOI 10.1074/jbc.274.14.9216; KOPKA J, 1995, ANAL BIOCHEM, V224, P51, DOI 10.1006/abio.1995.1007; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Lennen RM, 2010, BIOTECHNOL BIOENG, V106, P193, DOI 10.1002/bit.22660; Luo YS, 2002, ARCH BIOCHEM BIOPHYS, V407, P32, DOI 10.1016/S0003-9861(02)00466-6; Mal M, 2009, RAPID COMMUN MASS SP, V23, P487, DOI 10.1002/rcm.3898; Meng X, 2009, RENEW ENERG, V34, P1, DOI 10.1016/j.renene.2008.04.014; Mlickova K, 2004, APPL ENVIRON MICROB, V70, P3918, DOI 10.1128/AEM.70.7.3918-3924.2004; Mlickova K, 2004, J MOL CATAL B-ENZYM, V28, P81, DOI 10.1016/j.molcatb.2004.01.007; MORTENSEN PB, 1992, BIOCHIM BIOPHYS ACTA, V1124, P71, DOI 10.1016/0005-2760(92)90128-I; Poirier Y, 2001, APPL ENVIRON MICROB, V67, P5254, DOI 10.1128/AEM.67.11.5254-5260.2001; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Shockey J, 2011, APPL MICROBIOL BIOT, V92, P1207, DOI 10.1007/s00253-011-3505-y; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Torija MJ, 2003, INT J FOOD MICROBIOL, V85, P127, DOI 10.1016/S0168-1605(02)00506-8; van Roermund CWT, 2003, CELL MOL LIFE SCI, V60, P1838, DOI 10.1007/s00018-003-3076-x; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; Wang HJJ, 1999, J BACTERIOL, V181, P5140, DOI 10.1128/JB.181.17.5140-5148.1999; Wang MX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015441; Westin MAK, 2008, CELL MOL LIFE SCI, V65, P982, DOI 10.1007/s00018-008-7576-6	31	30	33	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84853	10.1371/journal.pone.0084853	http://dx.doi.org/10.1371/journal.pone.0084853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465440	Green Published, gold			2022-12-25	WOS:000330244500019
J	Chen, HY; Cheng, FC; Pan, HC; Hsu, JC; Wang, MF				Chen, Hsuan-Ying; Cheng, Fu-Chou; Pan, Huan-Chuan; Hsu, Jaw-Cheng; Wang, Ming-Fu			Magnesium Enhances Exercise Performance via Increasing Glucose Availability in the Blood, Muscle, and Brain during Exercise	PLOS ONE			English	Article							PROLONGED EXERCISE; IN-VIVO; SUBSTRATE UTILIZATION; SUBMAXIMAL EXERCISE; ENERGY-METABOLISM; SKELETAL-MUSCLE; PLASMA-GLUCOSE; LACTATE; TRANSPORTERS; EXPRESSION	Glucose mobilization and utilization in the periphery and central nervous system are important during exercise and are responsible for exercise efficacy. Magnesium (Mg) is involved in energy production and plays a role in exercise performance. This study aimed to explore the effects of Mg on the dynamic changes in glucose and lactate levels in the muscle, blood and brain of exercising rats using a combination of auto-blood sampling and microdialysis. Sprague-Dawley rats were pretreated with saline or magnesium sulfate (MgSO4, 90 mg/kg, i.p.) 30 min before treadmill exercise (20 m/min for 60 min). Our results indicated that the muscle, blood, and brain glucose levels immediately increased during exercise, and then gradually decreased to near basal levels in the recovery periods of both groups. These glucose levels were significantly enhanced to approximately two-fold (P<0.05) in the Mg group. Lactate levels in the muscle, blood, and brain rapidly and significantly increased in both groups during exercise, and brain lactate levels in the Mg group further elevated (P<0.05) than those in the control group during exercise. Lactate levels significantly decreased after exercise in both groups. In conclusion, Mg enhanced glucose availability in the peripheral and central systems, and increased lactate clearance in the muscle during exercise.	[Chen, Hsuan-Ying; Wang, Ming-Fu] Providence Univ, Dept Food & Nutr, Taichung, Taiwan; [Chen, Hsuan-Ying; Cheng, Fu-Chou] Taichung Vet Gen Hosp, Dept Med Res, Stem Cell Ctr, Taichung, Taiwan; [Cheng, Fu-Chou] Providence Univ, Dept Appl Chem, Taichung 43309, Taiwan; [Pan, Huan-Chuan] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Hsu, Jaw-Cheng] HungKuang Univ, Dept Appl Cosmetol, Taichung, Taiwan; [Hsu, Jaw-Cheng] HungKuang Univ, Grad Inst Cosmet Sci, Taichung, Taiwan	Providence University - Taiwan; Taichung Veterans General Hospital; Providence University - Taiwan; Taichung Veterans General Hospital; Hungkuang University; Hungkuang University	Wang, MF (corresponding author), Providence Univ, Dept Food & Nutr, Taichung, Taiwan.	vc1035@gmail.com			Taichung Veterans General Hospital, Providence University [TCVGH-PU-1008107]; National Science Council, Taiwan, R.O.C. [NSC-100-2113-M-075A-001-MY2]	Taichung Veterans General Hospital, Providence University; National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This study was supported by grants from Taichung Veterans General Hospital, Providence University (TCVGH-PU-1008107), and the National Science Council (NSC-100-2113-M-075A-001-MY2), Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBORG B, 1968, ACTA PHYSIOL SCAND, V74, P238, DOI 10.1111/j.1748-1716.1968.tb04231.x; AHLBORG G, 1972, SCAND J CLIN LAB INV, V29, P397, DOI 10.3109/00365517209080256; Bequet F, 2001, ACTA PHYSIOL SCAND, V173, P223, DOI 10.1046/j.1365-201X.2001.00859.x; Bohl CH, 2002, CRIT REV FOOD SCI, V42, P533, DOI 10.1080/20024091054247; Bonen A, 2001, EUR J APPL PHYSIOL, V86, P6, DOI 10.1007/s004210100516; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Brooks GA, 2002, BIOCHEM SOC T, V30, P258, DOI 10.1042/bst0300258; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; Chen IJ, 2009, INT J SPORT EXERCISE, V1, P75; Chen YJ, 2009, APPL PHYSIOL NUTR ME, V34, P1040, DOI 10.1139/H09-105; Cheng SM, 2007, EUR J APPL PHYSIOL, V99, P695, DOI 10.1007/s00421-006-0374-7; Cheng SM, 2010, EUR J APPL PHYSIOL, V108, P363, DOI 10.1007/s00421-009-1235-y; Choi IY, 2003, J NEUROSCI RES, V72, P25, DOI 10.1002/jnr.10574; Christensen SD, 2009, LAB ANIM-UK, V43, P65, DOI 10.1258/la.2008.007075; Clarkson PM, 1991, J SPORT SCI, V9, P91, DOI 10.1080/02640419108729869; COGGAN AR, 1991, SPORTS MED, V11, P102, DOI 10.2165/00007256-199111020-00003; Coker RH, 2005, SPORTS MED, V35, P575, DOI 10.2165/00007256-200535070-00003; CONSOLAZIO CF, 1963, J NUTR, V79, P407, DOI 10.1093/jn/79.4.407; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; FELIG P, 1982, NEW ENGL J MED, V306, P895, DOI 10.1056/NEJM198204153061503; GINSBERG MD, 1987, NEUROLOGY, V37, P11, DOI 10.1212/WNL.37.1.11; Golf SW, 1998, CARDIOVASC DRUG THER, V12, P197, DOI 10.1023/A:1007708918683; Gotoh M, 1998, BRAIN RES, V780, P74, DOI 10.1016/S0006-8993(97)01131-1; Hashimoto T, 2005, J PHYSIOL-LONDON, V567, P121, DOI 10.1113/jphysiol.2005.087411; Helge JW, 2010, ACTA PHYSIOL, V199, P519, DOI 10.1111/j.1748-1716.2010.02123.x; HERMANSE.L, 1967, ACTA PHYSIOL SCAND, V71, P129, DOI 10.1111/j.1748-1716.1967.tb03719.x; Hocher B, 2009, PHARMACOGENET GENOM, V19, P710, DOI 10.1097/FPC.0b013e328330bc7a; Holmang A, 2002, J APPL PHYSIOL, V92, P982, DOI 10.1152/japplphysiol.01194.2000; Huang CY, 2010, CELL BIOCHEM FUNCT, V28, P313, DOI 10.1002/cbf.1659; Ide K, 1999, J APPL PHYSIOL, V87, P1604, DOI 10.1152/jappl.1999.87.5.1604; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; Kemppainen J, 2005, J PHYSIOL-LONDON, V568, P323, DOI 10.1113/jphysiol.2005.091355; KENNEDY C, 1976, P NATL ACAD SCI USA, V73, P4230, DOI 10.1073/pnas.73.11.4230; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kimura Y, 1996, J NUTR SCI VITAMINOL, V42, P407, DOI 10.3177/jnsv.42.407; Kjaer M, 1998, ADV EXP MED BIOL, V441, P117; KORF J, 1990, INT J BIOCHEM, V22, P1371, DOI 10.1016/0020-711X(90)90225-R; Lukaski HC, 2002, J NUTR, V132, P930, DOI 10.1093/jn/132.5.930; Lukaski HC, 2000, AM J CLIN NUTR, V72, p585S, DOI 10.1093/ajcn/72.2.585S; MacLean DA, 1999, J APPL PHYSIOL, V87, P1483, DOI 10.1152/jappl.1999.87.4.1483; Meeusen R, 1997, ACTA PHYSIOL SCAND, V159, P335, DOI 10.1046/j.1365-201X.1997.00118.x; Mooren FC, 2005, LIFE SCI, V77, P1211, DOI 10.1016/j.lfs.2004.12.040; Murphy E, 2000, CIRC RES, V86, P245, DOI 10.1161/01.RES.86.3.245; NISHIMURA H, 1993, J BIOL CHEM, V268, P8514; PAGES T, 1993, LAB ANIM, V27, P171, DOI 10.1258/002367793780810342; PERNOW B, 1971, J APPL PHYSIOL, V31, P416, DOI 10.1152/jappl.1971.31.3.416; Peters A, 2004, NEUROSCI BIOBEHAV R, V28, P143, DOI 10.1016/j.neubiorev.2004.03.002; Quistorff B, 2008, FASEB J, V22, P3443, DOI 10.1096/fj.08-106104; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; ROLAND PE, 1985, HUM NEUROBIOL, V4, P155; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; SHARP FR, 1975, BRAIN RES, V98, P596, DOI 10.1016/0006-8993(75)90377-7; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; STENDIGLINDBERG G, 1987, J AM COLL NUTR, V6, P35; Stuart CA, 2001, METABOLISM, V50, P771, DOI 10.1053/meta.2001.24202; Toft MF, 2006, LAB ANIM-UK, V40, P261, DOI 10.1258/002367706777611433; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Vannucci SJ, 1998, DEV NEUROSCI-BASEL, V20, P369, DOI 10.1159/000017333; VOLLESTAD NK, 1985, ACTA PHYSIOL SCAND, V125, P395, DOI 10.1111/j.1748-1716.1985.tb07735.x; Zhang WW, 2009, CHINESE MED J-PEKING, V122, P1996, DOI 10.3760/cma.j.issn.0366-6999.2009.17.007; ZHAO YP, 1995, ANAL CHIM ACTA, V316, P403, DOI 10.1016/0003-2670(95)00379-E	61	13	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85486	10.1371/journal.pone.0085486	http://dx.doi.org/10.1371/journal.pone.0085486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465574	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500050
J	Kwasniewska, M; Jegier, A; Kostka, T; Dziankowska-Zaborszczyk, E; Rebowska, E; Kozinska, J; Drygas, W				Kwasniewska, Magdalena; Jegier, Anna; Kostka, Tomasz; Dziankowska-Zaborszczyk, Elzbieta; Rebowska, Ewa; Kozinska, Joanna; Drygas, Wojciech			Long-Term Effect of Different Physical Activity Levels on Subclinical Atherosclerosis in Middle-Aged Men: A 25-Year Prospective Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CORONARY-ARTERY CALCIUM; VASCULAR ENDOTHELIAL FUNCTION; CARDIOVASCULAR RISK-FACTORS; HEART-DISEASE; LEISURE-TIME; CAROTID ATHEROSCLEROSIS; WALL THICKNESS; EXERCISE; PREVENTION	Background: The purpose of the study was to investigate the influence of lifetime physical activity (PA) on selected indices of atherosclerosis in longitudinal observation of middle-aged men. Methods: The subject of the study was a cohort of 101 men (mean age 59,769,0 years), free of cardiovascular symptoms and treatment, participating in follow-up examinations in the years 1985/90-2011/12. Self-report PA was assessed by interviewer-administered Seven-Day PA Recall and Historical PA questionnaire. Subclinical atherosclerosis was measured by assessing the coronary artery calcification (CAC) according to Agatston's method using multi-slice computed tomography; the carotid intima-media thickness (IMT) using high-resolution B-mode ultrasound; and the reactive hyperemia index (RHI) using peripheral arterial tonometry (EndoPAT2000). The participants were initially divided into three groups according to tertiles of exercise-related energy expenditure (EE) in kcal/week at baseline, i.e. <2050 (low-to-moderate; n = 33), 2050-3840 (high; n = 34), >3840 (very high; n = 34). Results: The low-to-moderate, high and very high PA groups were comparable in terms of age and atherosclerosis risk factors at baseline. No linear relationship was found between PA and CAC, IMT and RHI. Men who maintained low-to-moderate (n = 26), high (n = 21) and very high (n = 15) PA level had the mean CAC of 286.1 +/- 361.9, 10.7 +/- 28.9, and 106.1 +/- 278.3 (p<0.001 for low-to moderate vs high; p<0.05 for low-to-moderate vs very high); the mean IMT of 0.751 +/- 0.19 mm, 0,641 +/- 0.26 mm, and 0.750 +/- 0.60 mm (p>0.05); and the mean RHI of 1.69 +/- 0.4, 2.00 +/- 0.4, and 2.13 +/- 0.5 (p for trend = 0.050), respectively. No cases of CAC>400, IMT >= 0.9 and RHI<1.67 were noted only among men with maintained high PA level. At final examination men with high and very high PA had more favorable cardiometabolic profile than men with lower PA. Conclusions: Maintaining regular high PA level through young and middle adulthood may protect against atherosclerosis as measured by CAC, IMT and RHI.	[Kwasniewska, Magdalena; Dziankowska-Zaborszczyk, Elzbieta; Rebowska, Ewa; Kozinska, Joanna; Drygas, Wojciech] Med Univ Lodz, Dept Social & Prevent Med, Lodz, Poland; [Jegier, Anna] Med Univ Lodz, Dept Sports Med, Lodz, Poland; [Kostka, Tomasz] Med Univ Lodz, Dept Geriatr, Lodz, Poland; [Drygas, Wojciech] Inst Cardiol, Dept Cardiovasc Epidemiol & Prevent, Warsaw, Poland	Medical University Lodz; Medical University Lodz; Medical University Lodz; Institute of Cardiology - Poland	Kwasniewska, M (corresponding author), Med Univ Lodz, Dept Social & Prevent Med, Lodz, Poland.	magdalena.kwasniewska@umed.lodz.pl	Drygas, Wojciech/GLR-9863-2022; Kwaśniewska, Magdalena/S-6655-2016	Drygas, Wojciech/0000-0002-4351-6459; Rebowska, Ewa/0000-0002-3620-588X; Kostka, Tomasz/0000-0003-0437-650X; Kwasniewska, Magdalena/0000-0003-4547-5627; Dziankowska-Zaborszczyk, Elzbieta/0000-0001-8423-9606; Jegier, Anna/0000-0003-4737-2226	National Science Centre (Poland) [NN 404 258940]	National Science Centre (Poland)(National Science Centre, Poland)	The study was supported by the scientific grant NN 404 258940 from the National Science Centre (Poland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Bertoni AG, 2009, AM J EPIDEMIOL, V169, P444, DOI 10.1093/aje/kwn350; Bonetti PO, 2004, J AM COLL CARDIOL, V44, P2137, DOI 10.1016/j.jacc.2004.08.062; Clarkson P, 1999, J AM COLL CARDIOL, V33, P1379, DOI 10.1016/S0735-1097(99)00036-4; de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba; Desai MY, 2004, AM J CARDIOL, V94, P729, DOI 10.1016/j.amjcard.2004.06.004; Drygas W, 2000, INT J SPORTS MED, V21, P235, DOI 10.1055/s-2000-309; Drygas W, 2009, PUBLIC HEALTH, V123, P592, DOI 10.1016/j.puhe.2009.08.004; Drygas Wojciech, 2005, Przegl Lek, V62 Suppl 3, P8; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; FOLSOM AR, 1994, STROKE, V25, P66, DOI 10.1161/01.STR.25.1.66; Fox S M 3rd, 1972, Mod Concepts Cardiovasc Dis, V41, P25; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Hamburg NM, 2008, CIRCULATION, V117, P2467, DOI 10.1161/CIRCULATIONAHA.107.748574; Hamer M, 2010, HEART, V96, P380, DOI 10.1136/hrt.2009.183350; Han SH, 2010, ATHEROSCLEROSIS, V209, P197, DOI 10.1016/j.atherosclerosis.2009.08.027; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Janssen I, 2012, INT J EPIDEMIOL, V41, P1132, DOI 10.1093/ije/dys038; Kriska AM, 1997, MED SCI SPORTS EXERC, V29, pS43; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2; Laursen AH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001711; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Luedemann J, 2002, STROKE, V33, P2929, DOI 10.1161/01.STR.0000038422.57919.7F; Moreau KL, 2002, AM J PHYSIOL-HEART C, V283, pH1409, DOI 10.1152/ajpheart.00035.2002; Nordstrom CK, 2003, AM J MED, V115, P19, DOI 10.1016/S0002-9343(03)00242-0; Paffenbarger Jr, 1997, Blood Press Monit, V2, P115; Pahkala K, 2011, CIRCULATION, V124, P1956, DOI 10.1161/CIRCULATIONAHA.111.043851; Popovic M, 2010, AM J MED SCI, V339, P332, DOI 10.1097/MAJ.0b013e3181cefbb9; Rauramaa R, 2004, ANN INTERN MED, V140, P1007, DOI 10.7326/0003-4819-140-12-200406150-00010; Rubinshtein R, 2010, EUR HEART J, V31, P1142, DOI 10.1093/eurheartj/ehq010; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Siscovick DS, 1997, AM J EPIDEMIOL, V145, P977; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Stensland-Bugge E, 2000, STROKE, V31, P574, DOI 10.1161/01.STR.31.3.574; Sung J, 2012, AM J CARDIOL, V109, P839, DOI 10.1016/j.amjcard.2011.11.009; Swain DP, 2006, AM J CARDIOL, V97, P141, DOI 10.1016/j.amjcard.2005.07.130; Tanaka H, 2002, J APPL PHYSIOL, V92, P1458, DOI 10.1152/japplphysiol.00824.2001; Taylor AJ, 2002, MED SCI SPORT EXER, V34, P228, DOI 10.1097/00005768-200202000-00008; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Vanhees L, 2005, EUR J CARDIOV PREV R, V12, P102, DOI 10.1097/00149831-200504000-00004; Wannamethee SG, 2001, SPORTS MED, V31, P101, DOI 10.2165/00007256-200131020-00003; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Williams PT, 2001, MED SCI SPORT EXER, V33, P754, DOI 10.1097/00005768-200105000-00012; Wilund KR, 2008, METABOLISM, V57, P584, DOI 10.1016/j.metabol.2007.11.024	49	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85209	10.1371/journal.pone.0085209	http://dx.doi.org/10.1371/journal.pone.0085209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465505	gold, Green Submitted, Green Published			2022-12-25	WOS:000330240500038
J	Mwafi, N; Beretta, CA; Paolini, A; Carl, M				Mwafi, Nesrin; Beretta, Carlo A.; Paolini, Alessio; Carl, Matthias			Divergent Wnt8a Gene Expression in Teleosts	PLOS ONE			English	Article							ORYZIAS-LATIPES; ZEBRAFISH WNT8; SONIC-HEDGEHOG; MEDAKA; MOUSE; XWNT-8; COMPLEMENTARY; MESODERM; MUTATION; EMBRYO	The analysis of genes in evolutionarily distant but morphologically similar species is of major importance to unravel the changes in genomes over millions of years, which led to gene silencing and functional diversification. We report the analysis of Wnt8a gene expression in the medakafish and provide a detailed comparison to other vertebrates. In all teleosts analyzed there are two paralogous Wnt8a copies. These show largely overlapping expression in the early developing zebrafish embryo, an evolutionarily distant relative of medaka. In contrast to zebrafish, we find that both maternal and zygotic expression of particularly one Wnt8a paralog has diverged in medaka. While Wnt8a1 expression is mostly conserved at early embryonic stages, the expression of Wnt8a2 differs markedly. In addition, both genes are distinctly expressed during organogenesis unlike the zebrafish homologs, which may hint at the emergence of functional diversification of Wnt8a ligands during evolution.	[Mwafi, Nesrin; Beretta, Carlo A.; Paolini, Alessio; Carl, Matthias] Heidelberg Univ, Med Fac Mannheim, Dept Cell & Mol Biol, Mannheim, Germany	Ruprecht Karls University Heidelberg	Carl, M (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Cell & Mol Biol, Mannheim, Germany.	matthias.carl@medma.uni-heidelberg.de		Paolini, Alessio/0000-0001-7002-7303; Carl, Matthias/0000-0002-9936-5813	German Academic Exchange Service [DAAD - 441-kl]; Medical Faculty Mannheim of the University Heidelberg; Biotechnology and Biological Sciences Research Council [BB/C51454X/1] Funding Source: researchfish	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Medical Faculty Mannheim of the University Heidelberg; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by the German Academic Exchange Service (DAAD - 441-kl) to NM and the Medical Faculty Mannheim of the University Heidelberg to CB and MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beretta CA, 2011, GENE EXPR PATTERNS, V11, P277, DOI 10.1016/j.gep.2011.01.004; Bouillet P, 1996, MECH DEVELOP, V58, P141, DOI 10.1016/S0925-4773(96)00569-2; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; Christian JL, 1993, DEV BIOL, V180, P22; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Force A, 1999, GENETICS, V151, P1531; Fujita M, 2006, DEV DYNAM, V235, P734, DOI 10.1002/dvdy.20696; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUME CR, 1993, DEVELOPMENT, V119, P1147; Jaspard B, 2000, MECH DEVELOP, V90, P263, DOI 10.1016/S0925-4773(99)00236-1; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kobayashi D, 2006, DEV GROWTH DIFFER, V48, P283, DOI 10.1111/j.1440-169x.2006.00870.x; Koster R, 1997, DEVELOPMENT, V124, P3147; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Loosli F, 2003, EMBO REP, V4, P894, DOI 10.1038/sj.embor.embor919; Loosli F, 1998, MECH DEVELOP, V74, P159, DOI 10.1016/S0925-4773(98)00055-0; Martin A, 2012, EVOL DEV, V14, P178, DOI 10.1111/j.1525-142X.2012.00534.x; MCDONALD FJ, 1994, DEV GENET, V15, P148, DOI 10.1002/dvg.1020150205; McNabb A, 2012, ZEBRAFISH, V9, P120, DOI 10.1089/zeb.2012.0768; Narayanan A, 2012, DEV DYNAM, V241, P1062, DOI 10.1002/dvdy.23787; Narayanan A, 2011, DEV DYNAM, V240, P898, DOI 10.1002/dvdy.22599; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Ramel MC, 2004, DEV DYNAM, V231, P441, DOI 10.1002/dvdy.20141; Rieden PMJID, 2010, DEV DYNAM, V239, P126, DOI 10.1002/dvdy.22020; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; Tian Q, 1999, DEVELOPMENT, V126, P3371; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Winkler S, 2000, DEVELOPMENT, V127, P1911; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yokoi H, 2003, DEV GROWTH DIFFER, V45, P51, DOI 10.1046/j.1440-169X.2003.00674.x; Yokoi H, 2007, DEV BIOL, V304, P326, DOI 10.1016/j.ydbio.2006.12.043	40	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85303	10.1371/journal.pone.0085303	http://dx.doi.org/10.1371/journal.pone.0085303			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465531	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500041
J	Samuels, BA; Leonardo, ED; Dranovsky, A; Williams, A; Wong, E; Nesbitt, AMI; McCurdy, RD; Hen, R; Alter, M				Samuels, Benjamin A.; Leonardo, E. David; Dranovsky, Alex; Williams, Amanda; Wong, Erik; Nesbitt, Addie May I.; McCurdy, Richard D.; Hen, Rene; Alter, Mark			Global State Measures of the Dentate Gyrus Gene Expression System Predict Antidepressant-Sensitive Behaviors	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; HISTONE DEACETYLASE INHIBITORS; VENTRAL HIPPOCAMPUS; REGULATORY NETWORKS; IMMUNE-RESPONSES; MICROARRAY DATA; DORSAL; FLUOXETINE; BDNF; RECEPTOR	Background: Selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine are the most common form of medication treatment for major depression. However, approximately 50% of depressed patients fail to achieve an effective treatment response. Understanding how gene expression systems respond to treatments may be critical for understanding antidepressant resistance. Methods: We take a novel approach to this problem by demonstrating that the gene expression system of the dentate gyrus responds to fluoxetine (FLX), a commonly used antidepressant medication, in a stereotyped-manner involving changes in the expression levels of thousands of genes. The aggregate behavior of this large-scale systemic response was quantified with principal components analysis (PCA) yielding a single quantitative measure of the global gene expression system state. Results: Quantitative measures of system state were highly correlated with variability in levels of antidepressant-sensitive behaviors in a mouse model of depression treated with fluoxetine. Analysis of dorsal and ventral dentate samples in the same mice indicated that system state co-varied across these regions despite their reported functional differences. Aggregate measures of gene expression system state were very robust and remained unchanged when different microarray data processing algorithms were used and even when completely different sets of gene expression levels were used for their calculation. Conclusions: System state measures provide a robust method to quantify and relate global gene expression system state variability to behavior and treatment. State variability also suggests that the diversity of reported changes in gene expression levels in response to treatments such as fluoxetine may represent different perspectives on unified but noisy global gene expression system state level responses. Studying regulation of gene expression systems at the state level may be useful in guiding new approaches to augmentation of traditional antidepressant treatments.	[Samuels, Benjamin A.; Leonardo, E. David; Dranovsky, Alex; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Samuels, Benjamin A.; Leonardo, E. David; Dranovsky, Alex; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY USA; [Williams, Amanda; Wong, Erik] CNS Discovery, AstraZeneca Pharmaceut, Wilmington, DE USA; [Nesbitt, Addie May I.; McCurdy, Richard D.; Alter, Mark] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA	Columbia University; Columbia University; AstraZeneca; University of Pennsylvania; Pennsylvania Medicine	Hen, R (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	rh95@columbia.edu; markalter1968@gmail.com	Leonardo, Eduardo/AAH-1525-2020; Dranovsky, Alex/P-4357-2018	Leonardo, Eduardo/0000-0001-7426-0217; Dranovsky, Alex/0000-0001-7896-3243	NIMH [1K08MH080228-04, 1K01MH098188-01, 1R01MH091427, 1K08MH076083]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091844, K01MH098188, R01MH091427, K08MH080228, R37MH068542, T32MH014654, K08MH076083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043688] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	MA is funded by 1K08MH080228-04 from NIMH. BS is funded by 1K01MH098188-01 from NIMH. EDL is funded by 1R01MH091427 and was previously funded from 1K08MH076083 from NIMH at the time of participation in this study. RH receives compensation as a consultant for Lundbeck and Roche. Lundbeck and Roche had no role in the study. AW and EW were full-time employees of Astra Zeneca at the time of their participation in this study. Astra Zeneca paid for the microarrays but had no role in the study design, analysis, or writing of the manuscript.	Akimova T, 2012, BLOOD, V119, P2443, DOI 10.1182/blood-2011-10-292003; Alme Maria Nordheim, 2007, Neural Plast, V2007, P26496, DOI 10.1155/2007/26496; Alter MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061324; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100; Alter O, 2006, P NATL ACAD SCI USA, V103, P11828, DOI 10.1073/pnas.0604756103; Bannerman DM, 1999, BEHAV NEUROSCI, V113, P1170, DOI 10.1037/0735-7044.113.6.1170; Bergkvist A, 2010, METHODS, V50, P323, DOI 10.1016/j.ymeth.2010.01.009; Bock M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035077; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Branchi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062226; Branchi I, 2010, PSYCHONEUROENDOCRINO, V35, P743, DOI 10.1016/j.psyneuen.2009.10.016; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Diaz SL, 2012, MOL PSYCHIATR, V17, P154, DOI 10.1038/mp.2011.159; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Felice D, 2012, NEUROPHARMACOLOGY, V63, P1380, DOI 10.1016/j.neuropharm.2012.06.066; Gandal MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041215; Hodes GE, 2010, NEUROSCI LETT, V484, P12, DOI 10.1016/j.neulet.2010.07.084; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Karagiannis TC, 2006, ONCOGENE, V25, P3885, DOI 10.1038/sj.onc.1209417; Karagiannis Tom C, 2004, Hell J Nucl Med, V7, P184; Kim DH, 2007, EXP NEUROL, V204, P748, DOI 10.1016/j.expneurol.2007.01.008; Klebanov L, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-9; Klebanov L, 2007, NAT BIOTECHNOL, V25, P24, DOI 10.1038/nbt0107-25; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lim WK, 2007, BIOINFORMATICS, V23, pI282, DOI 10.1093/bioinformatics/btm201; McHugh SB, 2008, BEHAV NEUROSCI, V122, P1, DOI 10.1037/0735-7044.122.1.1; McHugh SB, 2011, EUR J NEUROSCI, V33, P322, DOI 10.1111/j.1460-9568.2010.07497.x; Molteni R, 2006, INT J NEUROPSYCHOPH, V9, P307, DOI 10.1017/S1461145705005766; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Peixoto L, 2012, NEUROPSYCHOPHARMACOL; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Ponnapalli SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028072; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; Rogers JL, 2006, NEUROBIOL LEARN MEM; Royce SG, 2012, ANN CLIN LAB SCI, V42, P338; Royce SG, 2012, J ASTHMA, V49, P121, DOI 10.3109/02770903.2011.648298; Samuels BA, 2011, NEUROPHARMACOLOGY, V61, P408, DOI 10.1016/j.neuropharm.2011.02.017; Schmidt EF, 2012, CELL, V149, P1152, DOI 10.1016/j.cell.2012.03.038; Tanaka KF, 2012, PHILOS T R SOC B, V367, P2395, DOI 10.1098/rstb.2012.0038; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Vinet J, 2004, NEUROPHARMACOLOGY, V47, P1062, DOI 10.1016/j.neuropharm.2004.07.035; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wall MichaelE., 2003, SINGULAR VALUE DECOM; Wang JW, 2008, BIOL PSYCHIAT, V63, P640, DOI 10.1016/j.biopsych.2008.01.008; Wiech NL, 2009, CURR TOP MED CHEM, V9, P257, DOI 10.2174/156802609788085241; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	54	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85136	10.1371/journal.pone.0085136	http://dx.doi.org/10.1371/journal.pone.0085136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465494	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000026
J	Greene, MW; Burrington, CM; Lynch, DT; Davenport, SK; Johnson, AK; Horsman, MJ; Chowdhry, S; Zhang, J; Sparks, JD; Tirrell, PC				Greene, Michael W.; Burrington, Christine M.; Lynch, Darin T.; Davenport, Samantha K.; Johnson, Andrew K.; Horsman, Melissa J.; Chowdhry, Saleem; Zhang, Jian; Sparks, Janet D.; Tirrell, Paul C.			Lipid Metabolism, Oxidative Stress and Cell Death Are Regulated by PKC Delta in a Dietary Model of Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							PROTEIN-KINASE-C; FATTY LIVER-DISEASE; INDUCED INSULIN-RESISTANCE; MICE; MECHANISMS; STEATOSIS; INFLAMMATION; FIBROSIS; PROGRESSION; DEFICIENCY	Steatosis, oxidative stress, and apoptosis underlie the development of nonalcoholic steatohepatitis (NASH). Protein kinase C delta (PKCd) has been implicated in fatty liver disease and is activated in the methionine and choline-deficient (MCD) diet model of NASH, yet its pathophysiological importance towards steatohepatitis progression is uncertain. We therefore addressed the role of PKCd in the development of steatosis, inflammation, oxidative stress, apoptosis, and fibrosis in an animal model of NASH. We fed PKCd 2/2 mice and wildtype littermates a control or MCD diet. PKCd 2/2 primary hepatocytes were used to evaluate the direct effects of fatty acids on hepatocyte lipid metabolism gene expression. A reduction in hepatic steatosis and triglyceride levels were observed between wildtype and PKCd 2/2 mice fed the MCD diet. The hepatic expression of key regulators of beta-oxidation and plasma triglyceride metabolism was significantly reduced in PKCd 2/2 mice and changes in serum triglyceride were blocked in PKCd 2/2 mice. MCD diet-induced hepatic oxidative stress and hepatocyte apoptosis were reduced in PKCd 2/2 mice. MCD diet-induced NADPH oxidase activity and p47 phox membrane translocation were blunted and blocked, respectively, in PKCd 2/2 mice. Expression of pro-apoptotic genes and caspase 3 and 9 cleavage in the liver of MCD diet fed PKCd 2/2 mice were blunted and blocked, respectively. Surprisingly, no differences in MCD diet-induced fibrosis or pro-fibrotic gene expression were observed in 8 week MCD diet fed PKCd 2/2 mice. Our results suggest that PKCd plays a role in key pathological features of fatty liver disease but not ultimately in fibrosis in the MCD diet model of NASH.	[Greene, Michael W.] Auburn Univ, Boshell Diabet & Metab Dis Res Program, Auburn, AL 36849 USA; [Greene, Michael W.; Zhang, Jian] Auburn Univ, Coll Human Sci, Auburn, AL 36849 USA; [Greene, Michael W.; Burrington, Christine M.; Lynch, Darin T.; Johnson, Andrew K.; Horsman, Melissa J.] Bassett Healthcare Network, Bassett Res Inst, Bassett Med Ctr, Cooperstown, NY USA; [Davenport, Samantha K.] Bassett Healthcare Network, Dept Pathol, Bassett Med Ctr, Cooperstown, NY USA; [Chowdhry, Saleem; Tirrell, Paul C.] Bassett Healthcare Network, Dept Internal Med, Bassett Med Ctr, Cooperstown, NY USA; [Sparks, Janet D.] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; University of Rochester	Greene, MW (corresponding author), Auburn Univ, Boshell Diabet & Metab Dis Res Program, Auburn, AL 36849 USA.	mwgreene@auburn.edu	Greene, Michael/L-6174-2019; Chowdhry, Saleem/AAS-7396-2020	Sparks, Janet/0000-0002-0072-766X; Greene, Michael/0000-0002-6443-8269; Horsman, Melissa/0000-0001-5660-5242	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Anstee QM, 2010, J HEPATOL, V53, P542, DOI 10.1016/j.jhep.2010.03.016; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bezy O, 2011, J CLIN INVEST, V121, P2504, DOI 10.1172/JCI46045; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Bokoch GM, 2009, ANTIOXID REDOX SIGN, V11, P2429, DOI [10.1089/ars.2009.2590, 10.1089/ARS.2009.2590]; Charatcharoenwitthaya P, 2012, DIGEST DIS SCI, V57, P1925, DOI 10.1007/s10620-012-2098-3; Chou WH, 2004, J CLIN INVEST, V114, P49, DOI 10.1172/JC1200421655; Csak T, 2011, AM J PHYSIOL-GASTR L, V300, pG433, DOI 10.1152/ajpgi.00163.2009; Das K, 2010, HEPATOLOGY, V51, P1593, DOI 10.1002/hep.23567; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dixon LJ, 2012, LAB INVEST, V92, P713, DOI 10.1038/labinvest.2012.45; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Feldstein A, 2004, AM J GASTROENTEROL, V99, P1718, DOI 10.1111/j.1572-0241.2004.40573.x; Frangioudakis G, 2009, DIABETOLOGIA, V52, P2616, DOI 10.1007/s00125-009-1543-0; Greene MW, 2010, J BIOL CHEM, V285, P42115, DOI 10.1074/jbc.M110.168575; Greene MW, 2010, CELL SIGNAL, V22, P274, DOI 10.1016/j.cellsig.2009.09.029; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981; Kassel KM, 2010, LAB INVEST, V90, P1794, DOI 10.1038/labinvest.2010.143; Kirsch R, 2003, J GASTROEN HEPATOL, V18, P1272, DOI 10.1046/j.1440-1746.2003.03198.x; Koek GH, 2011, CLIN CHIM ACTA, V412, P1297, DOI 10.1016/j.cca.2011.04.013; Kokorovic A, 2011, GASTROENTEROLOGY, V141, P1720, DOI 10.1053/j.gastro.2011.06.042; Lee GS, 2007, J LIPID RES, V48, P1885, DOI 10.1194/jlr.M700181-JLR200; Lee JS, 2009, CYTOKINE, V48, P186, DOI 10.1016/j.cyto.2009.07.008; Lee SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055979; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Lomonaco R, 2012, HEPATOLOGY, V55, P1389, DOI 10.1002/hep.25539; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH937, DOI 10.1152/ajpheart.00877.2003; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Niture SK, 2009, J CELL SCI, V122, P4452, DOI 10.1242/jcs.058537; Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014; PICKENS MK, 2009, J LIPID RES; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Rombouts K, 2010, DIGEST DIS, V28, P229, DOI 10.1159/000282094; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Tomita K, 2008, HEPATOLOGY, V48, P458, DOI 10.1002/hep.22365; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Witek RP, 2009, HEPATOLOGY, V50, P1421, DOI 10.1002/hep.23167; Yoshida K, 2007, CELL SIGNAL, V19, P892, DOI 10.1016/j.cellsig.2007.01.027; Younossi ZM, 2012, MEDICINE, V91, P319, DOI 10.1097/MD.0b013e3182779d49	48	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85848	10.1371/journal.pone.0085848	http://dx.doi.org/10.1371/journal.pone.0085848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454937	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100136
J	Liu, AP; Yang, Y; Liu, L; Meng, ZF; Li, LZ; Qiu, C; Xu, JQ; Zhang, XY				Liu, Aiping; Yang, Yu; Liu, Lu; Meng, Zhefeng; Li, Liangzhu; Qiu, Chao; Xu, Jianqing; Zhang, Xiaoyan			Differential Compartmentalization of HIV-Targeting Immune Cells in Inner and Outer Foreskin Tissue	PLOS ONE			English	Article							MALE CIRCUMCISION; LANGERHANS CELLS; INTEGRIN ALPHA(4)BETA(7); T-CELLS; INFECTION; TRANSMISSION; MEN; EXPRESSION; PREVENTION; UGANDA	Ex vivo foreskin models have demonstrated that inner foreskin is more susceptible to HIV-1 infection than outer foreskin. In the present study we characterized the compartition of HIV-1 target cells and quantified these cells in the epidermis and dermis of inner and outer foreskins using immunohistochemistry and flow cytometry. Our data showed that the epidermis of the inner foreskin was more enriched with CD4(+) T cells and Langerhans cells (LCs), with the co-expression of CCR5 and alpha 4b7 receptors, than the outer foreskin. Interestingly, the vast majority of CD4(+) T cells and LCs expressed CCR5, but not CXCR4, indicating that the inner foreskin might capture and transmit R5-tropic HIV strains more efficiently. In addition, lymphoid aggregates, composed of T cells, macrophages and dendritic cells (DCs) in the dermis, were closer to the epithelial surface in the inner foreskin than in the outer foreskin. As dendritic cells are able to capture and pass HIV particles to susceptible target cells, HIV may be able to more efficiently infect the inner foreskin by hijacking the augmented immune communication pathways in this tissue. After the inoculation of HIV-1 particles in a foreskin explant culture model, the level of p24 antigen in the supernatant from the inner foreskin was slightly higher than that from the outer foreskin, although this difference was not significant. The present study is the first to employ both CCR5 and a4b7 to identify HIV target cells in the foreskin. Our data demonstrated that the inner foreskin was more enriched with HIV target immune cells than the outer foreskin, and this tissue was structured for efficient communication among immune cells that may promote HIV transmission and replication. In addition, our data suggests the R5-tropism of HIV sexual transmission is likely shaped through the inherent receptor composition on HIV target cells in the mucosa.	[Xu, Jianqing] Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Xu, JQ (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	jianqingxu2008@gmail.com; zhangxy066@gmail.com	Qiu, Chao/M-6702-2014	Qiu, Chao/0000-0001-9401-5219; meng, zhefeng/0000-0001-9396-0673	973 Program [2012CB519001]; NSFC [81171553, 812111038]; Fundamental Research Funds for the Central Universities [10FX111]; Chinese National Grand Program on Key Infectious Disease Control and Prevention [2012ZX10001-007-008, 2013ZX10001006]	973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chinese National Grand Program on Key Infectious Disease Control and Prevention	This work was supported by 973 Program (2012CB519001), NSFC (81171553; 812111038), Fundamental Research Funds for the Central Universities (10FX111) and Chinese National Grand Program on Key Infectious Disease Control and Prevention (2012ZX10001-007-008; 2013ZX10001006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D, 2011, AM J REPROD IMMUNOL; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2010, AIDS, V24, P737, DOI 10.1097/QAD.0b013e32833616e0; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Bohler T, 1999, EUR J PEDIATR, V158, P638, DOI 10.1007/s004310051167; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; CHARM SE, 1992, VOX SANG, V62, P12, DOI 10.1111/j.1423-0410.1992.tb01160.x; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; de Jong MAWP, 2010, METHODS MOL BIOL, V595, P55, DOI 10.1007/978-1-60761-421-0_4; Dinh MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041271; Dinh MH, 2010, AIDS, V24, P899, DOI 10.1097/QAD.0b013e3283367779; Donoval BA, 2006, AM J CLIN PATHOL, V125, P386, DOI 10.1309/JVHQVDJDYKM58EPH; Fahrbach KM, 2010, MUCOSAL IMMUNOL, V3, P410, DOI 10.1038/mi.2010.18; Fischetti L, 2009, AIDS, V23, P319, DOI 10.1097/QAD.0b013e328321b778; Ganor Y, 2010, MUCOSAL IMMUNOL, V3, P506, DOI 10.1038/mi.2010.32; Ganor Yonatan, 2011, Am J Reprod Immunol, V65, P284, DOI 10.1111/j.1600-0897.2010.00933.x; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Grivel JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S6; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hirbod T, 2010, AM J PATHOL, V176, P2798, DOI 10.2353/ajpath.2010.090926; HUSSAIN LA, 1995, IMMUNOLOGY, V85, P475; Kigozi G, 2009, AIDS, V23, P2209, DOI 10.1097/QAD.0b013e328330eda8; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Lynch GW, 2003, EXP DERMATOL, V12, P700, DOI 10.1034/j.1600-0625.2003.00078.x; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; McKinnon LR, 2011, J IMMUNOL, V187, P6032, DOI 10.4049/jimmunol.1101836; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; MILLER CJ, 1992, LAB INVEST, V67, P628; Nie JH, 2010, JAIDS-J ACQ IMM DEF, V53, P440, DOI 10.1097/QAI.0b013e3181cb8300; Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2; Prodger JL, 2012, MUCOSAL IMMUNOL, V5, P121, DOI 10.1038/mi.2011.56; Qin Q, 2009, INT UROL NEPHROL, V41, P747, DOI 10.1007/s11255-008-9521-x; Siegfried N, 2005, LANCET INFECT DIS, V5, P165, DOI 10.1016/S1473-3099(05)01309-5; Szabo R, 2000, BRIT MED J, V320, P1592, DOI 10.1136/bmj.320.7249.1592; Uthman OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009628; Wang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027207; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Zhou ZC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002100	41	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85176	10.1371/journal.pone.0085176	http://dx.doi.org/10.1371/journal.pone.0085176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454812	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100059
J	Lux, RL; Sower, CT; Allen, N; Etheridge, SP; Tristani-Firouzi, M; Saarel, EV				Lux, Robert L.; Sower, Christopher Todd; Allen, Nancy; Etheridge, Susan P.; Tristani-Firouzi, Martin; Saarel, Elizabeth V.			The Application of Root Mean Square Electrocardiography (RMS ECG) for the Detection of Acquired and Congenital Long QT Syndrome	PLOS ONE			English	Article							POTASSIUM CHANNEL; REPOLARIZATION; DISPERSION; HERG; INTERVALS; HEART	Background: Precise measurement of the QT interval is often hampered by difficulty determining the end of the low amplitude T wave. Root mean square electrocardiography (RMS ECG) provides a novel alternative measure of ventricular repolarization. Experimental data have shown that the interval between the RMS ECG QRS and T wave peaks (RTPK) closely reflects the mean ventricular action potential duration while the RMS T wave width (TW) tracks the dispersion of repolarization timing. Here, we tested the precision of RMS ECG to assess ventricular repolarization in humans in the setting of drug-induced and congenital Long QT Syndrome (LQTS). Methods: RMS ECG signals were derived from high-resolution 24 hour Holter monitor recordings from 68 subjects after receiving placebo and moxifloxacin and from standard 12 lead ECGs obtained in 97 subjects with LQTS and 97 age-and sex-matched controls. RTPK, QT(RMS) and RMS TW intervals were automatically measured using custom software and compared to traditional QT measures using lead II. Results: All measures of repolarization were prolonged during moxifloxacin administration and in LQTS subjects, but the variance of RMS intervals was significantly smaller than traditional lead II measurements. TW was prolonged during moxifloxacin and in subjects with LQT-2, but not LQT-1 or LQT-3. Conclusion: These data validate the application of RMS ECG for the detection of drug-induced and congenital LQTS. RMS ECG measurements are more precise than the current standard of care lead II measurements.	[Lux, Robert L.; Sower, Christopher Todd; Allen, Nancy; Tristani-Firouzi, Martin] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA; [Etheridge, Susan P.; Tristani-Firouzi, Martin; Saarel, Elizabeth V.] Univ Utah, Div Pediat Cardiol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Tristani-Firouzi, M (corresponding author), Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA.	mfirouzi@cvrti.utah.edu			Nora Eccles Treadwell Foundation	Nora Eccles Treadwell Foundation	This work was supported by the Nora Eccles Treadwell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoum NW, 2010, PACE, V33, P1198, DOI 10.1111/j.1540-8159.2010.02788.x; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Couderc JP, 2011, ANN NONINVAS ELECTRO, V16, P13, DOI 10.1111/j.1542-474X.2010.00402.x; Couderc JP, 2010, IEEE ENG MED BIO, P6252, DOI 10.1109/IEMBS.2010.5628067; Darpo B, 2011, CARDIOL J, V18, P401; Fuller MS, 2000, J ELECTROCARDIOL, V33, P171, DOI 10.1016/S0022-0736(00)80073-4; Fuller MS, 2000, CIRCULATION, V102, P685, DOI 10.1161/01.CIR.102.6.685; HAWS CW, 1990, CIRCULATION, V81, P281, DOI 10.1161/01.CIR.81.1.281; Holzgrefe Jr HH, 2011, J CLIN PHARM; Kang JS, 2001, MOL PHARMACOL, V59, P122, DOI 10.1124/mol.59.1.122; Lux RL, 1999, J ELECTROCARDIOL, V32, P153, DOI 10.1016/S0022-0736(99)90073-0; Lux RL, 2006, J ELECTROCARDIOL, V39, pS161, DOI 10.1016/j.jelectrocard.2006.05.020; Malik M, 2002, HEART, V87, P220, DOI 10.1136/heart.87.3.220; Malik M, 2009, ANN NONINVAS ELECTRO, V14, P242, DOI 10.1111/j.1542-474X.2009.00304.x; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Segerson NM, 2008, HEART RHYTHM, V5, P208, DOI 10.1016/j.hrthm.2007.10.006; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285	17	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85689	10.1371/journal.pone.0085689	http://dx.doi.org/10.1371/journal.pone.0085689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454918	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100120
J	Guest, J; Grant, R; Mori, TA; Croft, KD				Guest, Jade; Grant, Ross; Mori, Trevor A.; Croft, Kevin D.			Changes in Oxidative Damage, Inflammation and [NAD(H)] with Age in Cerebrospinal Fluid	PLOS ONE			English	Article							NICOTINAMIDE-ADENINE-DINUCLEOTIDE; ALCOHOL INTAKE; COGNITIVE FUNCTION; CELL-DEATH; BRAIN; STRESS; POLY(ADP-RIBOSE); ALZHEIMERS; DNA; DEPLETION	An extensive body of evidence indicates that oxidative stress and inflammation play a central role in the degenerative changes of systemic tissues in aging. However a comparatively limited amount of data is available to verify whether these processes also contribute to normal aging within the brain. High levels of oxidative damage results in key cellular changes including a reduction in available nicotinamide adenine dinucleotide (NAD(+)), an essential molecule required for a number of vital cellular processes including DNA repair, immune signaling and epigenetic processing. In this study we quantified changes in [NAD(H)] and markers of inflammation and oxidative damage (F2-isoprostanes, 8-OHdG, total antioxidant capacity) in the cerebrospinal fluid (CSF) of healthy humans across a wide age range (24-91 years). CSF was collected from consenting patients who required a spinal tap for the administration of anesthetic. CSF of participants aged >45 years was found to contain increased levels of lipid peroxidation (F2-isoprostanes) (p = 0.04) and inflammation (IL-6) (p = 0.00) and decreased levels of both total antioxidant capacity (p = 0.00) and NAD(H) (p = 0.05), compared to their younger counterparts. A positive association was also observed between plasma [NAD(H)] and CSF NAD(H) levels (p = 0.03). Further analysis of the data identified a relationship between alcohol intake and CSF [NAD(H)] and markers of inflammation. The CSF of participants who consumed >1 standard drink of alcohol per day contained lower levels of NAD(H) compared to those who consumed no alcohol (p<0.05). An increase in CSF IL-6 was observed in participants who reported drinking >0-1 (p<0.05) and >1 (p<0.05) standard alcoholic drinks per day compared to those who did not drink alcohol. Taken together these data suggest a progressive age associated increase in oxidative damage, inflammation and reduced [NAD(H)] in the brain which may be exacerbated by alcohol intake.	[Guest, Jade] Sydney Adventist Hosp, Australasian Res Inst, Sydney, NSW, Australia; [Guest, Jade; Grant, Ross] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Fac Med, Sydney, NSW, Australia; [Grant, Ross] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Mori, Trevor A.; Croft, Kevin D.] Univ Western Australia, Sch Med & Pharmacol, Royal Perth Hosp Unit, Perth, WA 6009, Australia	Sydney Adventist Hospital; University of New South Wales Sydney; University of Sydney; Royal Perth Hospital; University of Western Australia	Grant, R (corresponding author), Univ New S Wales, Dept Pharmacol, Sch Med Sci, Fac Med, Sydney, NSW, Australia.	ross.grant@unsw.edu.au	Mori, Trevor/H-5485-2014; Grant, Ross/H-1805-2015	Mori, Trevor/0000-0002-5264-9229; Croft, Kevin/0000-0003-1596-4913	BUPA Health Foundation [219]	BUPA Health Foundation	This study was supported by a grant (#219) from the BUPA Health Foundation www.bupa.com.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agartz I, 1999, ARCH GEN PSYCHIAT, V56, P356, DOI 10.1001/archpsyc.56.4.356; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Annunziato L, 2003, TOXICOL LETT, V139, P125, DOI 10.1016/S0378-4274(02)00427-7; Athilingam Ponrathi, 2013, Congest Heart Fail, V19, P92, DOI 10.1111/chf.12007; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Cakatay U, 2001, EXP GERONTOL, V36, P221, DOI 10.1016/S0531-5565(00)00197-2; CARSON DA, 1986, EXP CELL RES, V164, P273, DOI 10.1016/0014-4827(86)90028-5; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DEGUCHI T, 1968, BIOCHIM BIOPHYS ACTA, V158, P382, DOI 10.1016/0304-4165(68)90292-4; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Ding JZ, 2004, STROKE, V35, P16, DOI 10.1161/01.STR.0000105929.88691.8E; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Espeland MA, 2005, AM J EPIDEMIOL, V161, P228, DOI 10.1093/aje/kwi043; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Fernandez-Lizarbe S, 2008, MOL IMMUNOL, V45, P2007, DOI 10.1016/j.molimm.2007.10.025; Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013; Grant R, 2010, INT J TRYPTOPHAN RES, V3, P151; Grant RS, 1998, J NEUROCHEM, V70, P1759; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Haorah J, 2005, J LEUKOCYTE BIOL, V78, P1223, DOI 10.1189/jlb.0605340; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harper C, 1998, J NEUROPATH EXP NEUR, V57, P101, DOI 10.1097/00005072-199802000-00001; Ji C, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/216450; Kesse-Guyot E, 2012, J NUTR, V142, P76, DOI 10.3945/jn.111.144428; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Luchsinger JA, 2004, J AM GERIATR SOC, V52, P540, DOI 10.1111/j.1532-5415.2004.52159.x; Martinez E, 2013, J ALZHEIMERS DIS, V36, P129, DOI 10.3233/JAD-130215; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MCELFRESH KC, 1983, BIOCHEM GENET, V21, P365, DOI 10.1007/BF00499145; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; Minana R, 2000, J NEUROCHEM, V75, P954, DOI 10.1046/j.1471-4159.2000.0750954.x; MOGHAL S, 1994, NEUROEPIDEMIOLOGY, V13, P175, DOI 10.1159/000110376; Mori TA, 1999, ANAL BIOCHEM, V268, P117, DOI 10.1006/abio.1998.3037; Njie EG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.008; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; OGURA K, 1994, NEUROREPORT, V5, P1224, DOI 10.1097/00001756-199406020-00016; Pamplona R, 2011, AM J PHYSIOL-REG I, V301, pR843, DOI 10.1152/ajpregu.00034.2011; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Ramanathan R, 1996, J CELL BIOL, V133, P381, DOI 10.1083/jcb.133.2.381; Reddy VD, 2013, MOL CELL BIOCHEM, V375, P39, DOI 10.1007/s11010-012-1526-1; Rex A, 2002, PHARMACOL TOXICOL, V90, P220, DOI 10.1034/j.1600-0773.2002.900409.x; REYES E, 1993, ALCOHOL CLIN EXP RES, V17, P877, DOI 10.1111/j.1530-0277.1993.tb00857.x; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Rubio M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023690; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Sattarova EA, 2013, BBA-GEN SUBJECTS, V1830, P3542, DOI 10.1016/j.bbagen.2013.01.027; Schenck JF, 2004, NMR BIOMED, V17, P433, DOI 10.1002/nbm.922; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sheng JG, 1998, ACTA NEUROPATHOL, V95, P229, DOI 10.1007/s004010050792; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Solomon A, 2009, DEMENT GERIATR COGN, V28, P75, DOI 10.1159/000231980; Streit WJ, 2004, GLIA, V45, P208, DOI 10.1002/glia.10319; SZARKOWSKA L, 1965, ACTA BIOCHIM POL, V12, P179; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Verbaten MN, 2009, HUM PSYCHOPHARM CLIN, V24, P199, DOI 10.1002/hup.1022; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; WONG EV, 1995, TRENDS NEUROSCI, V18, P168, DOI 10.1016/0166-2236(95)93896-6; Zhao X, 2013, J MED CHEM, V56, P963, DOI 10.1021/jm301431y	71	39	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85335	10.1371/journal.pone.0085335	http://dx.doi.org/10.1371/journal.pone.0085335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454842	gold, Green Published			2022-12-25	WOS:000329925800037
J	Pesciotta, EN; Sriswasdi, S; Tang, HY; Speicher, DW; Mason, PJ; Bessler, M				Pesciotta, Esther N.; Sriswasdi, Sira; Tang, Hsin-Yao; Speicher, David W.; Mason, Philip J.; Bessler, Monica			Dysferlin and Other Non-Red Cell Proteins Accumulate in the Red Cell Membrane of Diamond-Blackfan Anemia Patients	PLOS ONE			English	Article							ERYTHROID FAILURE; S19 DEFICIENCY; EXPRESSION; GENE; ERYTHROPOIESIS; PROTEOME; MYOPATHY; MUTATION; MODEL	Diamond Blackfan Anemia (DBA) is a congenital anemia usually caused by diverse mutations in ribosomal proteins. Although the genetics of DBA are well characterized, the mechanisms that lead to macrocytic anemia remain unclear. We systematically analyzed the proteomes of red blood cell membranes from multiple DBA patients to determine whether abnormalities in protein translation or erythropoiesis contribute to the observed macrocytosis or alterations in the mature red blood cell membrane. In depth proteome analysis of red cell membranes enabled highly reproducible identification and quantitative comparisons of 1100 or more proteins. These comparisons revealed clear differences between red cell membrane proteomes in DBA patients and healthy controls that were consistent across DBA patients with different ribosomal gene mutations. Proteins exhibiting changes in abundance included those known to be increased in DBA such as fetal hemoglobin and a number of proteins not normally found in mature red cell membranes, including proteins involved in the major histocompatibility complex class I pathway. Most striking was the presence of dysferlin in the red blood cell membranes of DBA patients but absent in healthy controls. Immunoblot validation using red cell membranes isolated from additional DBA patients and healthy controls confirmed a distinct membrane protein signature specific to patients with DBA.	[Pesciotta, Esther N.; Mason, Philip J.; Bessler, Monica] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Sriswasdi, Sira; Tang, Hsin-Yao; Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Sriswasdi, Sira; Tang, Hsin-Yao; Speicher, David W.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Sriswasdi, Sira; Speicher, David W.] Univ Penn, Genom & Computat Biol Grad Grp, Philadelphia, PA 19104 USA; [Bessler, Monica] Univ Penn, Dept Internal Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; The Wistar Institute; The Wistar Institute; University of Pennsylvania; University of Pennsylvania	Bessler, M (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA.	besslerm@email.chop.edu		Tang, Hsin-Yao/0000-0003-1838-018X	National Institutes of Health [RO1-DK084188, HL038794]; National Institutes of Health (National Cancer Institute) [CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084188, T32DK007780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (http://grants1.nih.gov) grants RO1-DK084188 (to MB), HL038794 (to DWS), and CA010815 (National Cancer Institute core grant to the Wistar Institute (http://www.cancer.gov/researchandfunding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegretti AP, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/725684; ALTER BP, 1979, EXP HEMATOL, V7, P200; An HJ, 2009, CELL BIOCHEM FUNCT, V27, P289, DOI 10.1002/cbf.1571; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Ball S, 2011, HEMATOL-AM SOC HEMAT, P487, DOI 10.1182/asheducation-2011.1.487; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Beer LA, 2011, J PROTEOME RES, V10, P1126, DOI 10.1021/pr1008866; BOTTO M, 1990, BRIT J HAEMATOL, V75, P106, DOI 10.1111/j.1365-2141.1990.tb02624.x; Burton NM, 2011, BIOCHEM CELL BIOL, V89, P200, DOI [10.1139/o10-154, 10.1139/O10-154]; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; de Morree A, 2013, J BIOL CHEM; De Palma A, 2010, J CHROMATOGR A, V1217, P5328, DOI 10.1016/j.chroma.2010.06.045; Devlin EE, 2010, BLOOD, V116, P2826, DOI 10.1182/blood-2010-03-275776; EVERETT ET, 1990, HUM IMMUNOL, V29, P14, DOI 10.1016/0198-8859(90)90065-W; Franco RS, 2013, AM J HEMATOL, V88, P44, DOI 10.1002/ajh.23344; Gazda HT, 2006, STEM CELLS, V24, P2034, DOI 10.1634/stemcells.2005-0554; GILES CM, 1987, CLIN EXP IMMUNOL, V69, P368; HOFFMAN JF, 1958, J GEN PHYSIOL, V42, P9, DOI 10.1085/jgp.42.1.9; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Jaako P, 2011, BLOOD, V118, P6087, DOI 10.1182/blood-2011-08-371963; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Moniz H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.88; MORTON JA, 1977, VOX SANG, V32, P26, DOI 10.1111/j.1423-0410.1977.tb00600.x; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; NATHAN DG, 1978, J CLIN INVEST, V61, P489, DOI 10.1172/JCI108960; Neubert H, 2008, J PROTEOME RES, V7, P2270, DOI 10.1021/pr700705u; Ohene-Abuakwa Y, 2005, BLOOD, V105, P838, DOI 10.1182/blood-2004-03-1016; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Paweletz CP, 2010, J PROTEOME RES, V9, P1392, DOI 10.1021/pr900925d; PERDAHL EB, 1994, BLOOD, V83, P645; Pesciotta EN, 2012, J PROTEOMICS; SHARMA R, 1991, BIOCHEM MED METAB B, V46, P33, DOI 10.1016/0885-4505(91)90048-P; Sieff CA, 2010, BRIT J HAEMATOL, V148, P611, DOI 10.1111/j.1365-2141.2009.07993.x; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; van Gestel RA, 2010, J PROTEOMICS, V73, P456, DOI 10.1016/j.jprot.2009.08.010; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Vlachos A, 2013, EUR J HUM GENET, V21, DOI 10.1038/ejhg.2013.34; Weiss MJ, 2012, J CLIN INVEST, V122, P2346, DOI 10.1172/JCI63989; Xu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027884; YURCHENCO PD, 1982, J BIOL CHEM, V257, P9102	42	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85504	10.1371/journal.pone.0085504	http://dx.doi.org/10.1371/journal.pone.0085504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454878	Green Published, Green Submitted, gold			2022-12-25	WOS:000329925800048
J	Collier, JL; Fitzgerald, SP; Hice, LA; Frisk, MG; McElroy, AE				Collier, Jackie L.; Fitzgerald, Sean P.; Hice, Lyndie A.; Frisk, Michael G.; McElroy, Anne E.			A New PCR-Based Method Shows That Blue Crabs (Callinectes sapidus (Rathbun)) Consume Winter Flounder (Pseudopleuronectes americanus (Walbaum))	PLOS ONE			English	Article							SAND SHRIMP; STOMACH CONTENTS; FEEDING-HABITS; GUT CONTENTS; PREDATION; MORTALITY; DNA; ESTUARY; SIZE; IDENTIFICATION	Winter flounder (Pseudopleuronectes americanus) once supported robust commercial and recreational fisheries in the New York (USA) region, but since the 1990s populations have been in decline. Available data show that settlement of young-of-the-year winter flounder has not declined as sharply as adult abundance, suggesting that juveniles are experiencing higher mortality following settlement. The recent increase of blue crab (Callinectes sapidus) abundance in the New York region raises the possibility that new sources of predation may be contributing to juvenile winter flounder mortality. To investigate this possibility we developed and validated a method to specifically detect winter flounder mitochondrial control region DNA sequences in the gut contents of blue crabs. A survey of 55 crabs collected from Shinnecock Bay (along the south shore of Long Island, New York) in July, August, and September of 2011 showed that 12 of 42 blue crabs (28.6%) from which PCR-amplifiable DNA was recovered had consumed winter flounder in the wild, empirically supporting the trophic link between these species that has been widely speculated to exist. This technique overcomes difficulties with visual identification of the often unrecognizable gut contents of decapod crustaceans, and modifications of this approach offer valuable tools to more broadly address their feeding habits on a wide variety of species.	[Collier, Jackie L.; Fitzgerald, Sean P.; Hice, Lyndie A.; Frisk, Michael G.; McElroy, Anne E.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Collier, JL (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	jackie.collier@stonybrook.edu		Collier, Jackie/0000-0001-8774-5715	Saltonstall Kennedy Program of the National Marine Fisheries Service of NOAA [NA101NMF4270202]; Stony Brook University's Undergraduate Research and Creative Activities program; Laurie Landau and Jim Foundation; Marilyn Simons Foundation	Saltonstall Kennedy Program of the National Marine Fisheries Service of NOAA; Stony Brook University's Undergraduate Research and Creative Activities program; Laurie Landau and Jim Foundation; Marilyn Simons Foundation	This project was funded by the Saltonstall Kennedy Program of the National Marine Fisheries Service of NOAA (http://www.nmfs.noaa.gov/mb/financial_services/skhome.htm) in grant NA101NMF4270202 to M. Frisk, M. Fast and A. McElroy. S. Fitzgerald was partially supported by Stony Brook University's Undergraduate Research and Creative Activities program (http://www.stonybrook.edu/ureca/). The Shinnecock Bay Restoration Program received major funding from the Laurie Landau and Jim and Marilyn Simons Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaina A, 2010, J EXP MAR BIOL ECOL, V391, P178, DOI 10.1016/j.jembe.2010.06.029; Asahida T, 1997, J EXP MAR BIOL ECOL, V217, P153, DOI 10.1016/S0022-0981(97)00039-7; ASMFC (Atlantic States Marine Fisheries Commission), 2006, ATLANTIC STATES MARI, V15, P4; Bauer LJ, 2010, ESTUAR COAST, V33, P678, DOI 10.1007/s12237-009-9237-x; Bauer LJ, 2010, ESTUAR COAST, V33, P668, DOI 10.1007/s12237-010-9277-2; Briggs PT, 1998, J SHELLFISH RES, V17, P487; Colton AR, 2011, EVALUATION SYNCHRONI; Countway PD, 2005, J EUKARYOT MICROBIOL, V52, P95, DOI 10.1111/j.1550-7408.2005.05202006.x; CT DEEP, 2011, STUD MAR RECR FISH C; DeLong AK, 2001, CAN J FISH AQUAT SCI, V58, P2233, DOI 10.1139/cjfas-58-11-2233; Fairchild EA, 2000, J SEA RES, V44, P81, DOI 10.1016/S1385-1101(00)00037-X; FITZ HC, 1991, MAR ECOL PROG SER, V76, P249, DOI 10.3354/meps076249; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hines A.H., 2010, BIOL MANAGEMENT EXPL, P109, DOI DOI 10.4027/BMECPCC.2010.22; HINES AH, 1990, MAR ECOL PROG SER, V67, P105, DOI 10.3354/meps067105; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; LAUGHLIN RA, 1982, B MAR SCI, V32, P807; LEE WJ, 1995, J MOL EVOL, V41, P54; McGaw IJ, 2000, J EXP BIOL, V203, P359; Meise CJ, 2003, ESTUARIES, V26, P731, DOI 10.1007/BF02711984; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; NEFSC, 2011, 1102 NEFSC; Nuttal MA, 2010, HIST RECOUNT GREAT S; Nuttall MA, 2011, ECOL MODEL, V222, P3335, DOI 10.1016/j.ecolmodel.2011.07.004; O'Leary SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066126; PAUL RKG, 1981, MAR ECOL PROG SER, V6, P91, DOI 10.3354/meps006091; REICHERT MJM, 1991, NETH J SEA RES, V27, P375, DOI 10.1016/0077-7579(91)90040-8; ROPES JW, 1989, FISH B-NOAA, V87, P197; RYER CH, 1987, ESTUARIES, V10, P136, DOI 10.2307/1352178; Saitoh K, 2003, FISHERIES SCI, V69, P473, DOI 10.1046/j.1444-2906.2003.00647.x; Sheppard SK, 2005, MOL ECOL, V14, P4461, DOI 10.1111/j.1365-294X.2005.02742.x; Socrates J.B., 2006, STUDY STRIPED BASS M; Stehlik LL, 2004, FISH B-NOAA, V102, P693; Sudo H, 2008, FISH RES, V89, P49, DOI 10.1016/j.fishres.2007.08.012; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Taylor DL, 2005, J EXP MAR BIOL ECOL, V324, P112, DOI 10.1016/j.jembe.2005.04.014; Taylor DL, 2005, CAN J FISH AQUAT SCI, V62, P1611, DOI [10.1139/f05-047, 10.1139/F05-047]; Taylor DL, 2004, J EXP MAR BIOL ECOL, V301, P55, DOI 10.1016/j.jembe.2003.09.013; VANDERVEER HW, 1987, MAR ECOL PROG SER, V35, P203, DOI 10.3354/meps035203; WILCOX JR, 1974, BIOL BULL, V146, P424, DOI 10.2307/1540416; WITTING DA, 1993, FISH B-NOAA, V91, P577; Yencho MA, 2009, ABUNDANCE MORTALITY	42	16	16	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85101	10.1371/journal.pone.0085101	http://dx.doi.org/10.1371/journal.pone.0085101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454797	gold, Green Published, Green Submitted			2022-12-25	WOS:000329922500041
J	Lecina-Diaz, J; Alvarez, A; Retana, J				Lecina-Diaz, Judit; Alvarez, Albert; Retana, Javier			Extreme Fire Severity Patterns in Topographic, Convective and Wind-Driven Historical Wildfires of Mediterranean Pine Forests	PLOS ONE			English	Article							NORMALIZED BURN RATIO; FUEL TYPES; HALEPENSIS FORESTS; CLIMATE; VEGETATION; REGENERATION; LANDSCAPE; BEHAVIOR; CLASSIFICATION; INTENSITY	Crown fires associated with extreme fire severity are extremely difficult to control. We have assessed fire severity using differenced Normalized Burn Ratio (dNBR) from Landsat imagery in 15 historical wildfires of Pinus halepensis Mill. We have considered a wide range of innovative topographic, fuel and fire behavior variables with the purposes of (1) determining the variables that influence fire severity patterns among fires (considering the 15 wildfires together) and (2) ascertaining whether different variables affect extreme fire severity within the three fire types (topographic, convective and wind-driven fires). The among-fires analysis showed that fires in less arid climates and with steeper slopes had more extreme severity. In less arid conditions there was more crown fuel accumulation and closer forest structures, promoting high vertical and horizontal fuel continuity and extreme fire severity. The analyses carried out for each fire separately (within fires) showed more extreme fire severity in areas in northern aspects, with steeper slopes, with high crown biomass and in climates with more water availability. In northern aspects solar radiation was lower and fuels had less water limitation to growth which, combined with steeper slopes, produced more extreme severity. In topographic fires there was more extreme severity in northern aspects with steeper slopes and in areas with more water availability and high crown biomass; in convection-dominated fires there was also more extreme fire severity in northern aspects with high biomass; while in wind-driven fires there was only a slight interaction between biomass and water availability. This latter pattern could be related to the fact that wind-driven fires spread with high wind speed, which could have minimized the effect of other variables. In the future, and as a consequence of climate change, new zones with high crown biomass accumulated in non-common drought areas will be available to burn as extreme severity wildfires.	[Lecina-Diaz, Judit; Alvarez, Albert; Retana, Javier] CREAF, Cerdanyola Del Valles, Catalonia, Spain; [Retana, Javier] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Cerdanyola Del Valles, Catalonia, Spain	Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona	Lecina-Diaz, J (corresponding author), CREAF, Cerdanyola Del Valles, Catalonia, Spain.	j.lecina@creaf.uab.es	Retana, Javier/L-1214-2014	Retana, Javier/0000-0002-7505-9467; Lecina-Diaz, Judit/0000-0002-6867-5886; Alvarez Nebot, Albert/0000-0002-7592-9944	project MONTES CONSOLIDER [CSD-2008-00040]	project MONTES CONSOLIDER	This study has been partially funded by the project MONTES CONSOLIDER CSD-2008-00040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Omary A, 2011, NEW FOREST, V42, P285, DOI 10.1007/s11056-011-9251-2; Aldersley A, 2011, SCI TOTAL ENVIRON, V409, P3472, DOI 10.1016/j.scitotenv.2011.05.032; Alexander JD, 2006, INT J WILDLAND FIRE, V15, P237, DOI 10.1071/WF05053; Alrababah MA, 2006, INT J REMOTE SENS, V27, P2703, DOI 10.1080/01431160500522700; Alvarez A, 2013, FOREST SCI, V59, P139, DOI 10.5849/forsci.10-140; Alvarez A, 2012, FOREST ECOL MANAG, V270, P282, DOI 10.1016/j.foreco.2011.01.039; Alvarez A, 2012, EUR J FOREST RES, V131, P463, DOI 10.1007/s10342-011-0520-6; [Anonymous], 2006, RMRSGTR164CD USDA FO; BESSIE WC, 1995, ECOLOGY, V76, P747, DOI 10.2307/1939341; Bradstock RA, 2010, LANDSCAPE ECOL, V25, P607, DOI 10.1007/s10980-009-9443-8; Broncano MJ, 2004, INT J WILDLAND FIRE, V13, P209, DOI 10.1071/WF03036; Capel J.J., 2000, CLIMA PENINSULA IBER; Castellnou M, 2009, P 5 C FOR ESP AV SPA; Castellnou M, 2010, EUR FOR I RES REP, V23, P121; Chafer CJ, 2004, INT J WILDLAND FIRE, V13, P227, DOI 10.1071/WF03041; Chung Joo-Sang, 2002, [Journal of Korean Society of Forest Science, 한국산림과학회지], V91, P34; Costa P., 2011, PREVENTION LARGE WIL; Covington WW, 2000, NATURE, V408, P135; Cruz MG, 2004, FOREST SCI, V50, P640; Cruz MG, 2003, INT J WILDLAND FIRE, V12, P39, DOI 10.1071/WF02024; de la Cueva AV, 2006, INT J WILDLAND FIRE, V15, P397, DOI 10.1071/WF05071; Dimitrakopoulos AP, 2001, FIRE TECHNOL, V37, P143, DOI 10.1023/A:1011641601076; Escuin S, 2008, INT J REMOTE SENS, V29, P1053, DOI 10.1080/01431160701281072; Fule PZ, 2002, FOREST ECOL MANAG, V170, P19, DOI 10.1016/S0378-1127(01)00759-9; Garcia-Martin A, 2008, IEEE J-STARS, V1, P254, DOI 10.1109/JSTARS.2008.2011623; Gong X, 2008, J ARID ENVIRON, V72, P483, DOI 10.1016/j.jaridenv.2007.07.001; Graham R.T., 2004, SCI BASIS CHANGING F; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Holden ZA, 2009, FOREST ECOL MANAG, V258, P2399, DOI 10.1016/j.foreco.2009.08.017; Ireland KB, 2012, LANDSCAPE ECOL, V27, P983, DOI 10.1007/s10980-012-9753-0; Kane VR, 2013, FOREST ECOL MANAG, V287, P17, DOI 10.1016/j.foreco.2012.08.044; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Kulakowski D, 2007, ECOLOGY, V88, P759, DOI 10.1890/06-0124; Lee B, 2008, J FOREST RES-JPN, V13, P197, DOI 10.1007/s10310-008-0072-x; Lee SW, 2009, FOREST ECOL MANAG, V258, P1594, DOI 10.1016/j.foreco.2009.07.017; Lentile LB, 2006, INT J WILDLAND FIRE, V15, P557, DOI 10.1071/WF05096; Lentile LB, 2006, INT J WILDLAND FIRE, V15, P319, DOI 10.1071/WF05097; Martinson EJ, 2008, INT J WILDLAND FIRE, V17, P415, DOI 10.1071/WF06067; McArthur AG, 1968, 9 COMM FOR C; MCSC, 2005, MAP COB SOL CAT; Miller JD, 2012, ECOL APPL, V22, P184, DOI 10.1890/10-2108.1; Miller JD, 2007, REMOTE SENS ENVIRON, V109, P66, DOI 10.1016/j.rse.2006.12.006; Mitsopoulos ID, 2007, ANN FOREST SCI, V64, P287, DOI 10.1051/forest:2007006; Moriondo M, 2006, CLIM RES, V31, P85, DOI 10.3354/cr031085; Ninyerola M, 2000, INT J CLIMATOL, V20, P1823, DOI 10.1002/1097-0088(20001130)20:14<1823::AID-JOC566>3.0.CO;2-B; Ninyerola M, 2005, ATLAS CLIMATICO PENI; Oliveras I, 2009, INT J WILDLAND FIRE, V18, P755, DOI 10.1071/WF08070; PALA V, 1995, PHOTOGRAMM ENG REM S, V61, P935; Pausas J., 1999, REMOTE SENSING LARGE, P3, DOI [10.1007/978-3-642-60164-4, DOI 10.1007/978-3-642-60164-4, 10.1007/978-3-642-60164-4_2, DOI 10.1007/978-3-642-60164-4_2]; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pausas JC, 2008, INT J WILDLAND FIRE, V17, P713, DOI 10.1071/WF07151; Pflugmacher D, 2012, REMOTE SENS ENVIRON, V122, P146, DOI 10.1016/j.rse.2011.09.025; PONS X, 1994, REMOTE SENS ENVIRON, V48, P191, DOI 10.1016/0034-4257(94)90141-4; PONS X., 2000, MIRAMON SISTEMA INFO; PONS X, 1996, 7 C GEOGR CUANT SIST; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raz-Yaseef N, 2010, AGR FOREST METEOROL, V150, P454, DOI 10.1016/j.agrformet.2010.01.010; Retana J, 2002, ECOSCIENCE, V9, P89, DOI 10.1080/11956860.2002.11682694; Rodrigo A, 2004, ECOLOGY, V85, P716, DOI 10.1890/02-0492; Rothermel R.C., 1972, MATH MODEL PREDICTIN; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Schulz JJ, 2010, APPL GEOGR, V30, P436, DOI 10.1016/j.apgeog.2009.12.003; Schwind B, 2010, PNWGTR802 USDA FOR S; Scott JH, 2001, RMRS29 USDA FOR SERV; Silva J. S., 2010, INTEGRATED FIRE MANA; Soverel NO, 2011, INT J WILDLAND FIRE, V20, P518, DOI 10.1071/WF10081; Stocks BJ, 2004, CAN J FOREST RES, V34, P1543, DOI [10.1139/x04-905, 10.1139/X04-905]; Stow D, 2007, GISCI REMOTE SENS, V44, P1, DOI 10.2747/1548-1603.44.1.1; Taylor SW, 2004, CAN J FOREST RES, V34, P1561, DOI 10.1139/X04-116; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Turner MG, 1999, INT J WILDLAND FIRE, V9, P21, DOI 10.1071/WF99003; TURNER MG, 1994, LANDSCAPE ECOL, V9, P59, DOI 10.1007/BF00135079; Van Wagner C, 1985, EQUATIONS FORTRAN PR, P1; Velez R., 2000, DEFENSA INCENDIOS FO; Vicente-Serrano SM, 2010, AGR FOREST METEOROL, V150, P614, DOI 10.1016/j.agrformet.2010.02.002; Villanueva J. A., 2005, TERCER INVENTARIO FO; Wagner C. E. van, 1977, Canadian Journal of Forest Research, V7, P23, DOI 10.1139/x77-004; WEATHERSPOON CP, 1995, FOREST SCI, V41, P430; Werth PA, 2011, PNW854 USDA FOR SERV	81	52	52	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85127	10.1371/journal.pone.0085127	http://dx.doi.org/10.1371/journal.pone.0085127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465492	gold, Green Published			2022-12-25	WOS:000330283100023
J	Schabrun, SM; van den Hoorn, W; Moorcroft, A; Greenland, C; Hodges, PW				Schabrun, Siobhan M.; van den Hoorn, Wolbert; Moorcroft, Alison; Greenland, Cameron; Hodges, Paul W.			Texting and Walking: Strategies for Postural Control and Implications for Safety	PLOS ONE			English	Article							OLDER-ADULTS; EXECUTIVE CONTROL; GAIT; FALLS; PELVIS; STABILITY; HEAD; COORDINATION; TALKING; BALANCE	There are concerns about the safety of texting while walking. Although evidence of negative effects of mobile phone use on gait is scarce, cognitive distraction, altered mechanical demands, and the reduced visual field associated with texting are likely to have an impact. In 26 healthy individuals we examined the effect of mobile phone use on gait. Individuals walked at a comfortable pace in a straight line over a distance of similar to 8.5 m while; 1) walking without the use of a phone, 2) reading text on a mobile phone, or 3) typing text on a mobile phone. Gait performance was evaluated using a three-dimensional movement analysis system. In comparison with normal waking, when participants read or wrote text messages they walked with: greater absolute lateral foot position from one stride to the next; slower speed; greater rotation range of motion (ROM) of the head with respect to global space; the head held in a flexed position; more in-phase motion of the thorax and head in all planes, less motion between thorax and head (neck ROM); and more tightly organized coordination in lateral flexion and rotation directions. While writing text, participants walked slower, deviated more from a straight line and used less neck ROM than reading text. Although the arms and head moved with the thorax to reduce relative motion of the phone and facilitate reading and texting, movement of the head in global space increased and this could negatively impact the balance system. Texting, and to a lesser extent reading, modify gait performance. Texting or reading on a mobile phone may pose an additional risk to safety for pedestrians navigating obstacles or crossing the road.	[Schabrun, Siobhan M.] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; NHMRC, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Schabrun, SM (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	s.schabrun@uq.edu.au	van den Hoorn, Wolbert/F-6894-2010; Hodges, Paul W/B-6578-2008	van den Hoorn, Wolbert/0000-0002-9658-2388; Hodges, Paul W/0000-0002-1206-9107; Greenland, Cameron/0000-0001-9206-616X; Schabrun, Siobhan/0000-0002-9083-3107	National Health and Medical Research Council of Australia [ID1002190, ID631612, ID631717]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	SM Schabrun is supported by a Clinical Research fellowship (ID631612) and PW Hodges by a Senior Principal Research fellowship (ID1002190) both from the National Health and Medical Research Council of Australia. Funding for the study was provided by the National Health and Medical Research Council of Australia (ID631717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberici E, 2011, AUSTR BROADCASTING C; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; Bruijn SM, 2008, GAIT POSTURE, V27, P455, DOI 10.1016/j.gaitpost.2007.05.017; Bruijn SM, 2010, J EXP BIOL, V213, P3945, DOI 10.1242/jeb.045112; Cole MH, 2010, MOVEMENT DISORD, V25, P2369, DOI 10.1002/mds.23292; Demura S, 2009, EUR J SPORT SCI, V9, P303, DOI 10.1080/17461390902853069; Drews FA, 2009, HUM FACTORS, V51, P762, DOI 10.1177/0018720809353319; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; Herman T, 2010, J GERONTOL A-BIOL, V65, P1086, DOI 10.1093/gerona/glq077; Hosking SG, 2009, HUM FACTORS, V51, P582, DOI 10.1177/0018720809341575; Lamberg EM, 2012, GAIT POSTURE, V35, P688, DOI 10.1016/j.gaitpost.2011.12.005; Lamoth CJC, 2002, GAIT POSTURE, V16, P101, DOI 10.1016/S0966-6362(01)00146-1; Latt MD, 2008, EXP BRAIN RES, V184, P201, DOI 10.1007/s00221-007-1094-x; Menz HB, 2003, J GERONTOL A-BIOL, V58, P446, DOI 10.1093/gerona/58.5.M446; Newcombe A, 2012, AM BROADCASTING CORP; Nymark JR, 2005, J REHABIL RES DEV, V42, P523, DOI 10.1682/JRRD.2004.05.0059; Pijnappels M, 2001, GAIT POSTURE, V14, P11, DOI 10.1016/S0966-6362(01)00110-2; Pijnappels M, 2010, EXP BRAIN RES, V201, P689, DOI 10.1007/s00221-009-2088-7; Richtel M, 2010, NY TIMES, pA1; Rubinstein JS, 2001, J EXP PSYCHOL HUMAN, V27, P763, DOI 10.1037//0096-1523.27.4.763; Schwebel DC, 2012, ACCIDENT ANAL PREV, V45, P266, DOI 10.1016/j.aap.2011.07.011; Segev-Jacubovski O, 2011, EXPERT REV NEUROTHER, V11, P1057, DOI [10.1586/ern.11.69, 10.1586/ERN.11.69]; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; St George RJ, 2011, J PHYSIOL-LONDON, V589, P807, DOI 10.1113/jphysiol.2010.197665; Watson JM, 2010, PSYCHON B REV, V17, P479, DOI 10.3758/PBR.17.4.479; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yizhar Z, 2009, INT J REHABIL RES, V32, P115, DOI 10.1097/MRR.0b013e32830d3675; Yogev-Seligmann G, 2012, MOVEMENT DISORD, V27, P765, DOI 10.1002/mds.24963	28	94	95	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84312	10.1371/journal.pone.0084312	http://dx.doi.org/10.1371/journal.pone.0084312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465402	Green Published, gold			2022-12-25	WOS:000330283100011
J	Petrie, JR; Shrestha, P; Belide, S; Kennedy, Y; Lester, G; Liu, Q; Divi, UK; Mulder, RJ; Mansour, MP; Nichols, PD; Singh, SP				Petrie, James R.; Shrestha, Pushkar; Belide, Srinivas; Kennedy, Yoko; Lester, Geraldine; Liu, Qing; Divi, Uday K.; Mulder, Roger J.; Mansour, Maged P.; Nichols, Peter D.; Singh, Surinder P.			Metabolic Engineering Camelina sativa with Fish Oil-Like Levels of DHA	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LONG-CHAIN; TRANSGENIC PLANTS; BIOSYNTHESIS; OMEGA-3; OMEGA-3-FATTY-ACIDS; ARABIDOPSIS; OILSEEDS	Background: Omega-3 long-chain (>= C20) polyunsaturated fatty acids (omega 3 LC-PUFA) such as eicosapentaenoic acid (EPA) and docosapentaenoic acid (DHA) are critical for human health and development. Numerous studies have indicated that deficiencies in these fatty acids can increase the risk or severity of cardiovascular, inflammatory and other diseases or disorders. EPA and DHA are predominantly sourced from marine fish although the primary producers are microalgae. Much work has been done to engineer a sustainable land-based source of EPA and DHA to reduce pressure on fish stocks in meeting future demand, with previous studies describing the production of fish oil-like levels of DHA in the model plant species, Arabidopsis thaliana. Principal Findings: In this study we describe the production of fish oil-like levels (>12%) of DHA in the oilseed crop species Camelina sativa achieving a high omega 3/omega 6 ratio. The construct previously transformed in Arabidopsis as well as two modified construct versions designed to increase DHA production were used. DHA was found to be stable to at least the T-5 generation and the EPA and DHA were found to be predominantly at the sn-1,3 positions of triacylglycerols. Transgenic and parental lines did not have different germination or seedling establishment rates. Conclusions: DHA can be produced at fish oil-like levels in industrially-relevant oilseed crop species using multi-gene construct designs which are stable over multiple generations. This study has implications for the future of sustainable EPA and DHA production from land-based sources.	[Petrie, James R.; Shrestha, Pushkar; Belide, Srinivas; Kennedy, Yoko; Lester, Geraldine; Liu, Qing; Divi, Uday K.; Singh, Surinder P.] CSIRO Food Futures Natl Res Flagship, Canberra, ACT, Australia; [Mansour, Maged P.; Nichols, Peter D.] CSIRO Food Futures Natl Res Flagship, Hobart, Tas, Australia; [Mulder, Roger J.] CSIRO Mat Sci & Engn, Clayton, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Singh, SP (corresponding author), CSIRO Food Futures Natl Res Flagship, Canberra, ACT, Australia.	surinder.singh@csiro.au	Nichols, Peter D/C-5128-2011; singh, surinder/C-9528-2009; Divi, Uday/P-2581-2017; Shrestha, Pushkar/A-2728-2010; Liu, Qing/A-1395-2010; Divi, Uday K/H-8010-2012; Belide, Srinivas/H-5649-2012; Mulder, Roger J/F-4607-2011	singh, surinder/0000-0003-4488-8147; Divi, Uday/0000-0003-0905-7567; Shrestha, Pushkar/0000-0001-9642-6636; Liu, Qing/0000-0001-6617-6859; Mulder, Roger J/0000-0002-8740-802X; Belide, Srinivas/0000-0001-9536-8200	CSIRO Food Futures Flagship; Nuseed Pty Ltd; Australian Grains Research and Development Corporation	CSIRO Food Futures Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Nuseed Pty Ltd; Australian Grains Research and Development Corporation(Grains R&D Corp)	This research was funded by CSIRO Food Futures Flagship, Nuseed Pty Ltd and the Australian Grains Research and Development Corporation. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The authors were granted permission to publish the manuscript by the funders.	Abbadi A, 2004, PLANT CELL, V16, P2734, DOI 10.1105/tpc.104.026070; AURSAND M, 1995, J AM OIL CHEM SOC, V72, P293, DOI 10.1007/BF02541085; Brenna JT, 2009, PROSTAG LEUKOTR ESS, V80, P85, DOI 10.1016/j.plefa.2009.01.004; BREYNE P, 1992, MOL GEN GENET, V235, P389, DOI 10.1007/BF00279385; Cheng BF, 2010, TRANSGENIC RES, V19, P221, DOI 10.1007/s11248-009-9302-z; Liu XJ, 2012, IN VITRO CELL DEV-PL, V48, P462, DOI 10.1007/s11627-012-9459-7; Petrie JR, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr011; Petrie JR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035214, 10.1371/journal.pone.0049165]; Petrie JR, 2012, TRANSGENIC RES, V21, P139, DOI 10.1007/s11248-011-9517-7; Putnam D.H., 1993, NEW CROPS; Qi BX, 2004, NAT BIOTECHNOL, V22, P739, DOI 10.1038/nbt972; Robert SS, 2005, FUNCT PLANT BIOL, V32, P473, DOI 10.1071/FP05084; Ruiz-Lopez N, 2013, METAB ENG, V17, P30, DOI 10.1016/j.ymben.2013.03.001; Ruiz-Lopez N, 2012, TRANSGENIC RES, V21, P1233, DOI 10.1007/s11248-012-9596-0; Ruiz-Lopez N, 2012, J EXP BOT, V63, P2397, DOI 10.1093/jxb/err454; Standal IB, 2009, J AM OIL CHEM SOC, V86, P401, DOI 10.1007/s11746-009-1370-y; Turchini GM, 2012, CRIT REV FOOD SCI, V52, P795, DOI 10.1080/10408398.2010.509553; Vanhercke T, 2013, FEBS LETT, V587, P364, DOI 10.1016/j.febslet.2012.12.018; Vollmann J, 2007, IND CROP PROD, V26, P270, DOI 10.1016/j.indcrop.2007.03.017; Wu GH, 2005, NAT BIOTECHNOL, V23, P1013, DOI 10.1038/nbt1107; Zar JH., 2010, BIOSTAT ANAL; Zubr J, 1997, IND CROP PROD, V6, P113, DOI 10.1016/S0926-6690(96)00203-8	22	106	124	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85061	10.1371/journal.pone.0085061	http://dx.doi.org/10.1371/journal.pone.0085061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465476	Green Published, gold			2022-12-25	WOS:000330244500032
J	Zhang, Y; Wei, C; Zhang, PF; Li, X; Liu, T; Pu, Y; Li, YS; Cao, ZB; Cao, HG; Liu, Y; Zhang, XR; Zhang, YH				Zhang, Yu; Wei, Chao; Zhang, Pengfei; Li, Xia; Liu, Tong; Pu, Yong; Li, Yunsheng; Cao, Zubing; Cao, Hongguo; Liu, Ya; Zhang, Xiaorong; Zhang, Yunhai			Efficient Reprogramming of Naive-Like Induced Pluripotent Stem Cells from Porcine Adipose-Derived Stem Cells with a Feeder-Independent and Serum-Free System	PLOS ONE			English	Article							GENERATION; ADULT; INDUCTION; DERIVATION; CULTURE; EPIBLAST; 5-HYDROXYMETHYLCYTOSINE; TISSUES; LAYER; LINES	Induced pluripotent stem cells (iPSCs) are somatic cells reprogrammed by ectopic expression of transcription factors or small molecule treatment, which resemble embryonic stem cells (ESCs). They hold great promise for improving the generation of genetically modified large animals. However, few porcine iPSCs (piPSCs) lines obtained currently can support development of cloned embryos. Here, we generated iPSCs from porcine adipose-derived stem cells (pADSCs), using drug-inducible expression of defined human factors (Oct4, Sox2, c-Myc and Klf4). Reprogramming of iPSCs from pADSCs was more efficient than from fibroblasts, regardless of using feeder-independent or feeder-dependent manners. By addition of Lif-2i medium containing mouse Lif, CHIR99021 and PD0325901 (Lif-2i), naive-like piPSCs were obtained under feeder-independent and serum-free conditions. These successfully reprogrammed piPSCs were characterized by short cell cycle intervals, alkaline phosphatase (AP) staining, expression of Oct4, Sox2, Nanog, SSEA3 and SSEA4, and normal karyotypes. The resemblance of piPSCs to naive ESCs was confirmed by their packed dome morphology, growth after single-cell dissociation, Lif-dependency, up-regulation of Stella and Eras, low expression levels of TRA-1-60, TRA-1-81 and MHC I and activation of both X chromosomes. Full reprogramming of naive-like piPSCs was evaluated by the significant up-regulation of Lin28, Esrrb, Utf1 and Dppa5, differentiating into cell types of all three germ layers in vitro and in vivo. Furthermore, nuclear transfer embryos from naive-like piPSCs could develop to blastocysts with improved quality. Thus, we provided an efficient protocol for generating naive-like piPSCs from pADSCs in a feeder-independent and serum-free system with controlled regulation of exogenous genes, which may facilitate optimization of culture media and the production of transgenic pigs.	[Zhang, Yu; Wei, Chao; Zhang, Pengfei; Li, Xia; Liu, Tong; Pu, Yong; Li, Yunsheng; Cao, Zubing; Cao, Hongguo; Liu, Ya; Zhang, Xiaorong; Zhang, Yunhai] Anhui Agr Univ, Anhui Prov Lab Local Livestock & Poultry Genet Re, Dept Anim Sci, Coll Anim Sci & Technol, Hefei, Anhui, Peoples R China	Anhui Agricultural University	Zhang, XR (corresponding author), Anhui Agr Univ, Anhui Prov Lab Local Livestock & Poultry Genet Re, Dept Anim Sci, Coll Anim Sci & Technol, Hefei, Anhui, Peoples R China.	zxr@ahau.edu.cn; yunhaizhang@ahau.edu.cn	Zhang, Yu/M-4249-2017; liu, ya/AAI-1890-2020; Zhang, Yunhai/O-4453-2014; Pu, Yong/T-8450-2019	Zhang, Yu/0000-0002-5592-111X; Zhang, Yunhai/0000-0001-9721-5910; 	National Basic Research Program [2009CB941004]; National Natural Science Foundation of China [31272442, 31372309]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program (2009CB941004), National Natural Science Foundation of China (31272442, 31372309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, REGEN MED, V6, P141, DOI 10.2217/rme.11.11; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Arrigoni E, 2009, CELL TISSUE RES, V338, P401, DOI 10.1007/s00441-009-0883-x; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Cheng D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051778; Cooper GM, 2011, PLAST RECONSTR SURG, V127, P88, DOI 10.1097/PRS.0b013e3181fad311; De Sousa PA, 2006, REPRODUCTION, V132, P681, DOI 10.1530/rep.1.01080; Dhodapkar KM, 2010, P NATL ACAD SCI USA, V107, P8718, DOI 10.1073/pnas.0915086107; Ding Q, 2013, PHARM RES-DORDR, V30, P60, DOI 10.1007/s11095-012-0849-7; Ellerstrom C, 2006, STEM CELLS, V24, P2170, DOI 10.1634/stemcells.2006-0130; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fan NN, 2013, CELL RES, V23, P162, DOI 10.1038/cr.2012.176; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gu Q, 2012, PROTEIN CELL, V3, P71, DOI 10.1007/s13238-012-2007-8; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Haffner MC, 2011, ONCOTARGET, V2, P627; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Havasi P, 2013, MOL BIOL REP, V40, P3023, DOI 10.1007/s11033-012-2376-3; Hirai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039022; Jahn KA, 2011, J PHARM SCI-US, V100, P3751, DOI 10.1002/jps.22418; Jang M, 2013, BIOMATERIALS, V34, P3571, DOI 10.1016/j.biomaterials.2013.01.073; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Li YY, 2011, CELL RES, V21, P1148, DOI 10.1038/cr.2011.97; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Liu L, 2012, BIOTECHNOL LETT, V34, P1951, DOI 10.1007/s10529-012-0973-9; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Manton KJ, 2010, STEM CELLS DEV, V19, P1297, DOI 10.1089/scd.2009.0504; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Mohr F, 2011, EXP HEMATOL, V39, P272, DOI 10.1016/j.exphem.2010.12.004; Montserrat N, 2012, CELL TRANSPLANT, V21, P815, DOI 10.3727/096368911X601019; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park JK, 2013, PLOS ONE, P8; Paul A, 2011, CELL BIOCH BIOPHYS; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Riebeling C, 2011, TOXICOL IN VITRO, V25, P914, DOI 10.1016/j.tiv.2011.02.013; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049079; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rubin Bent, 2008, Cancer Immun, V8, P14; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Simon L, 2009, STEM CELLS, V27, P1666, DOI 10.1002/stem.93; Singh AM, 2012, CELL CYCLE, V11, P2991, DOI 10.4161/cc.21110; Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106; Sugiyama H, 2008, J TISSUE ENG REGEN M, V2, P445, DOI 10.1002/term.111; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Taha MF, 2010, TISSUE CELL, V42, P211, DOI 10.1016/j.tice.2010.04.003; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tat PA, 2010, CELL TRANSPLANT, V19, P525, DOI 10.3727/096368910X491374; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tey SK, 2012, AUTOPHAGY, V8, P1839, DOI 10.4161/auto.21860; van Oosten AL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1822; Wang QH, 2012, PROTEIN CELL, V3, P51, DOI 10.1007/s13238-012-2002-0; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Williams KJ, 2011, METHODS MOL BIOL, V702, P77, DOI 10.1007/978-1-61737-960-4_7; Wu H, 2011, CELL CYCLE, V10, P2428, DOI 10.4161/cc.10.15.16930; Wu T, 2011, STEM CELLS, V29, P755, DOI 10.1002/stem.617; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Xie LQ, 2013, CHINESE MED J-PEKING, V126, P1138, DOI 10.3760/cma.j.issn.0366-6999.20122755; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869	80	14	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85089	10.1371/journal.pone.0085089	http://dx.doi.org/10.1371/journal.pone.0085089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465482	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500031
J	Calderon-Perez, B; Xoconostle-Cazares, B; Lira-Carmona, R; Hernandez-Rivas, R; Ortega-Lopez, J; Ruiz-Medrano, R				Calderon-Perez, Berenice; Xoconostle-Cazares, Beatriz; Lira-Carmona, Rosalia; Hernandez-Rivas, Rosaura; Ortega-Lopez, Jaime; Ruiz-Medrano, Roberto			The Plasmodium falciparum Translationally Controlled Tumor Protein (TCTP) Is Incorporated More Efficiently into B Cells than Its Human Homologue	PLOS ONE			English	Article							HISTAMINE-RELEASING-FACTOR; MOLECULAR-IDENTIFICATION; MALARIA; GROWTH; SECRETION; EXCHANGE	Plasmodium falciparum secretes a homologue of the translationally controlled tumor protein (TCTP) into serum of infected individuals, although its role in pathogenesis or virulence is unknown. To determine the effect of P. falciparum TCTP on B cells as compared to human TCTP, fluorescently labeled proteins were incubated on primary cultures of mouse splenic B cells and analyzed by flow cytometry and confocal microscopy. Our results indicate that both recombinant proteins are incorporated into B cells, but differ significantly in their rate and percentage of incorporation, being significantly higher for P. falciparum TCTP. Furthermore, P. falciparum TCTP showed a lower B cell proliferative effect than human TCTP, suggesting a mechanism through which the former could interfere in the host's immune response.	[Calderon-Perez, Berenice; Xoconostle-Cazares, Beatriz; Ortega-Lopez, Jaime; Ruiz-Medrano, Roberto] Dept Biotechnol & Bioengn CINVESTAV IPN, Mexico City, DF, Mexico; [Lira-Carmona, Rosalia] CMN Siglo XXI IMSS, Unidad Invest Med Enfermedades Infecciosas & Para, Mexico City, DF, Mexico; [Hernandez-Rivas, Rosaura] CINVESTAV IPN, Dept Mol Biomed, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Ruiz-Medrano, R (corresponding author), Dept Biotechnol & Bioengn CINVESTAV IPN, Mexico City, DF, Mexico.	rmedrano@cinvestav.mx	Ortega-Lopez, Jaime/A-1364-2008	Ortega-Lopez, Jaime/0000-0001-9136-9994; Lira, Rosalia/0000-0002-6812-9471	CONACyT Mexico [50769, 105985]; CONACyT doctoral fellowship; ICyT-DF	CONACyT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT doctoral fellowship; ICyT-DF	This work was supported by CONACyT Mexico grants Nos. 50769 to RR-M and 105985 to BX-C. BC-P was supported by a CONACyT doctoral fellowship and an ICyT-DF grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Asito AS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-362; Bheekha-Escura R, 2000, BLOOD, V96, P2191; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Brioudes F, 2010, P NATL ACAD SCI USA, V107, P16384, DOI 10.1073/pnas.1007926107; Dong XC, 2009, J BIOL CHEM, V284, P23754, DOI 10.1074/jbc.M109.012823; Eichhorn T, 2013, BIOCHEM PHARMACOL, V85, P38, DOI 10.1016/j.bcp.2012.10.006; Gnanasekar M, 2002, MOL BIOCHEM PARASIT, V121, P107, DOI 10.1016/S0166-6851(02)00027-0; Hinojosa-Moya J, 2008, J MOL EVOL, V66, P472, DOI 10.1007/s00239-008-9099-z; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Kang HS, 2001, J IMMUNOL, V166, P6545, DOI 10.4049/jimmunol.166.11.6545; Kim M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006464; Kim M, 2011, BIOMATERIALS, V32, P222, DOI 10.1016/j.biomaterials.2010.08.077; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MacDonald SM, 2001, P NATL ACAD SCI USA, V98, P10829, DOI 10.1073/pnas.201191498; Nagano-Ito M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/204960; Nunes MC, 2007, MOL MICROBIOL, V63, P391, DOI 10.1111/j.1365-2958.2006.05521.x; Pelleau S, 2012, INFECT IMMUN, V80, P2963, DOI 10.1128/IAI.00072-12; R Core Team, 2012, R LANG ENV STAT COMP; Rehmann H, 2008, FEBS LETT, V582, P3005, DOI 10.1016/j.febslet.2008.07.057; Scholzen A, 2013, TRENDS PARASITOL, V29, P252, DOI 10.1016/j.pt.2013.03.002; Schroeder JT, 1997, J IMMUNOL, V159, P447; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Yoneda K, 2004, AM J PHYSIOL-LUNG C, V286, pL174, DOI 10.1152/ajplung.00118.2003	25	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85514	10.1371/journal.pone.0085514	http://dx.doi.org/10.1371/journal.pone.0085514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465583	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000040
J	Dodo, K; Chono, H; Saito, N; Tanaka, Y; Tahara, K; Nukaya, I; Mineno, J				Dodo, Katsuyuki; Chono, Hideto; Saito, Naoki; Tanaka, Yoshinori; Tahara, Kenichi; Nukaya, Ikuei; Mineno, Junichi			An Efficient Large-Scale Retroviral Transduction Method Involving Preloading the Vector into a RetroNectin-Coated Bag with Low-Temperature Shaking	PLOS ONE			English	Article							HUMAN T-LYMPHOCYTES; GENE-TRANSFER; LEUKEMIA-VIRUS; TARGET-CELLS; HELPER-FREE; HIGH-TITER; FIBRONECTIN; THERAPY; CONSTRUCTION; OPTIMIZATION	In retroviral vector-mediated gene transfer, transduction efficiency can be hampered by inhibitory molecules derived from the culture fluid of virus producer cell lines. To remove these inhibitory molecules to enable better gene transduction, we had previously developed a transduction method using a fibronectin fragment-coated vessel (i.e., the RetroNectin-bound virus transduction method). In the present study, we developed a method that combined RetroNectin-bound virus transduction with low-temperature shaking and applied this method in manufacturing autologous retroviral-engineered T cells for adoptive transfer gene therapy in a large-scale closed system. Retroviral vector was preloaded into a RetroNectin-coated bag and incubated at 4 degrees C for 16 h on a reciprocating shaker at 50 rounds per minute. After the supernatant was removed, activated T cells were added to the bag. The bag transduction method has the advantage of increasing transduction efficiency, as simply flipping over the bag during gene transduction facilitates more efficient utilization of the retroviral vector adsorbed on the top and bottom surfaces of the bag. Finally, we performed validation runs of endoribonuclease MazF-modified CD4(+) T cell manufacturing for HIV-1 gene therapy and T cell receptor-modified T cell manufacturing for MAGE-A4 antigen-expressing cancer gene therapy and achieved over 200-fold (>= 10(10)) and 100-fold (>= 5x10(9)) expansion, respectively. In conclusion, we demonstrated that the large-scale closed transduction system is highly efficient for retroviral vector-based T cell manufacturing for adoptive transfer gene therapy, and this technology is expected to be amenable to automation and improve current clinical gene therapy protocols.	[Dodo, Katsuyuki; Chono, Hideto; Saito, Naoki; Tanaka, Yoshinori; Tahara, Kenichi; Nukaya, Ikuei; Mineno, Junichi] Takara Bio Inc Seta, Ctr Cell & Gene Therapy, Otsu, Shiga, Japan		Chono, H (corresponding author), Takara Bio Inc Seta, Ctr Cell & Gene Therapy, Otsu, Shiga, Japan.	chonoh@takara-bio.co.jp						Andreadis ST, 1997, J VIROL, V71, P7541, DOI 10.1128/JVI.71.10.7541-7548.1997; BOWERMAN B, 1989, GENE DEV, V3, P469, DOI 10.1101/gad.3.4.469; Bowles NE, 1996, HUM GENE THER, V7, P1735, DOI 10.1089/hum.1996.7.14-1735; Brentjens RJ, 2012, HEMATOL-AM SOC HEMAT, P143, DOI 10.1182/asheducation-2012.1.143; Chono H, 2001, J BIOCHEM, V130, P331, DOI 10.1093/oxfordjournals.jbchem.a002990; Chono H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023585; Chono H, 2011, HUM GENE THER, V22, P35, DOI 10.1089/hum.2010.001; Chono H, 2011, J BIOCHEM, V149, P285, DOI 10.1093/jb/mvq135; Chuck AS, 1996, HUM GENE THER, V7, P743, DOI 10.1089/hum.1996.7.6-743; Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9; Dardalhon V, 1999, HUM GENE THER, V10, P5, DOI 10.1089/10430349950019147; Davis JL, 1997, HUM GENE THER, V8, P1459, DOI 10.1089/hum.1997.8.12-1459; Forestell SP, 1995, GENE THER, V2, P723; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; Hoxie JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007179; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; June C, 2012, NAT BIOTECHNOL, V30, P611, DOI 10.1038/nbt.2305; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kildebeck E, 2012, CURR OPIN PEDIATR, V24, P731, DOI 10.1097/MOP.0b013e328359e480; KIMIZUKA F, 1991, J BIOCHEM-TOKYO, V110, P284, DOI 10.1093/oxfordjournals.jbchem.a123572; Lamers CHJ, 2008, CYTOTHERAPY, V10, P406, DOI 10.1080/14653240801982961; LeDoux JM, 1996, J VIROL, V70, P6468, DOI 10.1128/JVI.70.9.6468-6473.1996; Lee JT, 2004, GENE THER, V11, P94, DOI 10.1038/sj.gt.3302138; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Maier DA, 2013, HUM GENE THER, V24, P245, DOI 10.1089/hum.2012.172; MARKOWITZ D, 1988, VIROLOGY, V167, P400, DOI 10.1016/S0042-6822(88)90101-8; MILLER AD, 1991, J VIROL, V65, P2220, DOI 10.1128/JVI.65.5.2220-2224.1991; Moritz T, 1996, BLOOD, V88, P855, DOI 10.1182/blood.V88.3.855.bloodjournal883855; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Okamoto M, 2013, HUM GENE THER METHOD, V24, P94, DOI 10.1089/hgtb.2012.131; Okamoto S, 2009, CANCER RES, V69, P9003, DOI 10.1158/0008-5472.CAN-09-1450; OLAH Z, 1994, J BIOL CHEM, V269, P25426; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pollok KE, 1998, J VIROL, V72, P4882, DOI 10.1128/JVI.72.6.4882-4892.1998; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Quintas-Cardama A, 2007, HUM GENE THER, V18, P1253, DOI 10.1089/hum.2007.088; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; Seppen J, 1997, BIOTECHNIQUES, V23, P788, DOI 10.2144/97235bm04; Tebas P, 2013, BLOOD, V121, P1524, DOI 10.1182/blood-2012-07-447250; Tonks A, 2005, BIOTECHNOL PROGR, V21, P953, DOI 10.1021/bp0500314; Wilen CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002020; Yang SL, 1999, HUM GENE THER, V10, P123, DOI 10.1089/10430349950019255; YODER MC, 1995, EXP HEMATOL, V23, P961; Yu S, 2008, CANCER GENE THER, V15, P508, DOI 10.1038/cgt.2008.21; Zhou P, 2001, HUM GENE THER, V12, P1843, DOI 10.1089/104303401753153901	48	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86275	10.1371/journal.pone.0086275	http://dx.doi.org/10.1371/journal.pone.0086275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454964	Green Submitted, gold, Green Published			2022-12-25	WOS:000330235100150
J	Greenhill, SD; Chamberlain, SEL; Lench, A; Massey, PV; Yuill, KH; Woodhall, GL; Jones, RSG				Greenhill, Stuart David; Chamberlain, Sophie Elizabeth Lyn; Lench, Alex; Massey, Peter Vernon; Yuill, Kathryn Heather; Woodhall, Gavin Lawrence; Jones, Roland Spencer Gwynne			Background Synaptic Activity in Rat Entorhinal Cortex Shows a Progressively Greater Dominance of Inhibition over Excitation from Deep to Superficial Layers	PLOS ONE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; TEMPORAL-LOBE EPILEPSY; PARVALBUMIN-IMMUNOREACTIVE NEURONS; MEMBRANE-POTENTIAL FLUCTUATIONS; COMPLEX PARTIAL SEIZURES; AMINO-ACID RECEPTORS; IN-VITRO; GAMMA-OSCILLATIONS; EPILEPTIFORM DISCHARGES; DIFFERENTIAL ELECTRORESPONSIVENESS	The entorhinal cortex (EC) controls hippocampal input and output, playing major roles in memory and spatial navigation. Different layers of the EC subserve different functions and a number of studies have compared properties of neurones across layers. We have studied synaptic inhibition and excitation in EC neurones, and we have previously compared spontaneous synaptic release of glutamate and GABA using patch clamp recordings of synaptic currents in principal neurones of layers II (L2) and V (L5). Here, we add comparative studies in layer III (L3). Such studies essentially look at neuronal activity from a presynaptic viewpoint. To correlate this with the postsynaptic consequences of spontaneous transmitter release, we have determined global postsynaptic conductances mediated by the two transmitters, using a method to estimate conductances from membrane potential fluctuations. We have previously presented some of this data for L3 and now extend to L2 and L5. Inhibition dominates excitation in all layers but the ratio follows a clear rank order (highest to lowest) of L2 > L3 > L5. The variance of the background conductances was markedly higher for excitation and inhibition in L2 compared to L3 or L5. We also show that induction of synchronized network epileptiform activity by blockade of GABA inhibition reveals a relative reluctance of L2 to participate in such activity. This was associated with maintenance of a dominant background inhibition in L2, whereas in L3 and L5 the absolute level of inhibition fell below that of excitation, coincident with the appearance of synchronized discharges. Further experiments identified potential roles for competition for bicuculline by ambient GABA at the GABA(A) receptor, and strychnine-sensitive glycine receptors in residual inhibition in L2. We discuss our results in terms of control of excitability in neuronal subpopulations of EC neurones and what these may suggest for their functional roles.	[Greenhill, Stuart David; Chamberlain, Sophie Elizabeth Lyn; Lench, Alex; Massey, Peter Vernon; Jones, Roland Spencer Gwynne] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Woodhall, Gavin Lawrence] Aston Univ, Sch Life & Hlth Sci, Aston Brain Ctr, Birmingham B4 7ET, W Midlands, England; [Yuill, Kathryn Heather] Univ Plymouth, Sch Biomed & Healthcare Sci, Peninsula Sch Med, Plymouth PL4 8AA, Devon, England; [Yuill, Kathryn Heather] Univ Plymouth, Sch Biomed & Healthcare Sci, Peninsula Sch Dent, Plymouth PL4 8AA, Devon, England	University of Bath; Aston University; University of Plymouth; University of Plymouth	Jones, RSG (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Claverton Down, Bath BA2 7AY, Avon, England.	r.s.g.jones@bath.ac.uk	Greenhill, Stuart D./N-9412-2019; Jones, Roland/K-1539-2016	Jones, Roland/0000-0002-3072-7505; woodhall, gavin/0000-0003-1281-9008; Greenhill, Stuart/0000-0002-5038-5258	NC3Rs [G1000059]; University of Bath; BBSRC; Medical Research Council [1096590] Funding Source: researchfish	NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); University of Bath; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Peter Massey is supported by the NC3Rs (Grant Number G1000059; http://www.nc3rs.org.uk/). Alex Lench is an MRC student. Stuart Greenhill received a studentship from the University of Bath. Sophie Chamberlain received a studentship from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Arellano JL, 2002, CEREB CORTEX, V12, P617, DOI 10.1093/cercor/12.6.617; Avoli M, 1996, J NEUROSCI, V16, P3912; Bailey SJ, 2004, NEUROPHARMACOLOGY, V46, P31, DOI 10.1016/j.neuropharm.2003.07.001; BEAR J, 1993, EPILEPSY RES, V14, P183, DOI 10.1016/0920-1211(93)90043-7; Bernasconi N, 2005, NEUROLOGY, V65, P223, DOI 10.1212/01.wnl.0000169066.46912.fa; Berretta N, 1996, J NEUROPHYSIOL, V76, P1089, DOI 10.1152/jn.1996.76.2.1089; Breustedt J, 2004, EUR J NEUROSCI, V19, P1987, DOI 10.1111/j.1460-9568.2004.03266.x; Buchheim K, 2002, EXP NEUROL, V175, P76, DOI 10.1006/exnr.2002.7893; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Cunningham MO, 2006, P NATL ACAD SCI USA, V103, P5597, DOI 10.1073/pnas.0600604103; Cunningham MO, 2006, J NEUROSCI, V26, P2767, DOI 10.1523/JNEUROSCI.5054-05.2006; Cunningham MO, 2004, J PHYSIOL-LONDON, V559, P347, DOI 10.1113/jphysiol.2004.068973; Cunningham MO, 2004, P NATL ACAD SCI USA, V101, P7152, DOI 10.1073/pnas.0402060101; Cunningham MO, 2003, J NEUROSCI, V23, P9761; D'Arcangelo G, 2001, NEUROBIOL DIS, V8, P993, DOI 10.1006/nbdi.2001.0445; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Destexhe A, 2010, FRONT CELL NEUROSCI, V4, P1; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Dickson CT, 2000, ANN NY ACAD SCI, V911, P127; DU F, 1993, EPILEPSY RES, V16, P223, DOI 10.1016/0920-1211(93)90083-J; Eichenbaum H, 2001, NAT NEUROSCI, V4, P1057, DOI 10.1038/nn1101-1057; Erchova I, 2004, J PHYSIOL-LONDON, V560, P89, DOI 10.1113/jphysiol.2004.069930; Fujimaru Y, 1996, NEUROSCI RES, V24, P329, DOI 10.1016/0168-0102(95)01008-4; GOLDRING S, 1992, J NEUROSURG, V77, P185, DOI 10.3171/jns.1992.77.2.0185; Greenhill SD, 2007, NEUROSCIENCE, V147, P884, DOI 10.1016/j.neuroscience.2007.05.016; Greenhill SD, 2010, NEUROSCIENCE, V167, P456, DOI 10.1016/j.neuroscience.2010.02.021; Greenhill SD, 2012, NEUROPHARMACOLOGY, V62, P807, DOI 10.1016/j.neuropharm.2011.09.006; Hamam BN, 2000, J COMP NEUROL, V418, P457; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; Iijima T, 1996, SCIENCE, V272, P1176, DOI 10.1126/science.272.5265.1176; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; JONES RSG, 1994, HIPPOCAMPUS, V4, P335, DOI 10.1002/hipo.450040317; JONES RSG, 1990, EXP BRAIN RES, V80, P310; JONES RSG, 1990, NEUROSCIENCE, V34, P657, DOI 10.1016/0306-4522(90)90172-Z; JONES RSG, 1988, BRAIN RES, V457, P113, DOI 10.1016/0006-8993(88)90062-5; JONES RSG, 1988, J NEUROPHYSIOL, V59, P1476, DOI 10.1152/jn.1988.59.5.1476; Jones RSG, 2005, J PHYSIOL-LONDON, V562, P107, DOI 10.1113/jphysiol.2004.076133; Jones RSG, 1993, NEUROSCI LETT, V149, P5; KLINK R, 1993, J NEUROPHYSIOL, V70, P144, DOI 10.1152/jn.1993.70.1.144; KOHLER C, 1982, J COMP NEUROL, V210, P136, DOI 10.1002/cne.902100204; KOHLER C, 1983, ANAT EMBRYOL, V167, P151, DOI 10.1007/BF00298508; Kohler C, 1985, ANAT EMBRYOL, V173, P335; Lopantsev V, 1996, NEUROSCI LETT, V210, P5, DOI 10.1016/0304-3940(96)12656-2; LOTHMAN EW, 1990, EPILEPSY RES, V6, P110, DOI 10.1016/0920-1211(90)90085-A; LOTSTRA F, 1987, NEUROSCI LETT, V80, P191, DOI 10.1016/0304-3940(87)90652-5; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; Miettinen M, 1997, J COMP NEUROL, V378, P363; Miettinen M, 1996, BRAIN RES, V706, P113, DOI 10.1016/0006-8993(95)01203-6; Mikkonen M, 1997, J COMP NEUROL, V388, P64; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; RAFIQ A, 1993, J NEUROPHYSIOL, V70, P1962, DOI 10.1152/jn.1993.70.5.1962; ROGERS JH, 1992, BRAIN RES, V587, P147, DOI 10.1016/0006-8993(92)91439-L; Rudolph M, 2004, J PHYSIOL-PARIS, V98, P452, DOI 10.1016/j.jphysparis.2005.09.015; Rudolph M, 2004, J NEUROPHYSIOL, V91, P2884, DOI 10.1152/jn.01223.2003; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; RUTECKI PA, 1989, J NEUROSURG, V70, P667, DOI 10.3171/jns.1989.70.5.0667; Schmitz D, 1998, NEUROSCIENCE, V85, P999, DOI 10.1016/S0306-4522(98)00113-4; Shu YS, 2003, J NEUROSCI, V23, P10388; Siegel AN, 1990, EPILEPSY RES, V63, P56; SPENCER SS, 1994, EPILEPSIA, V35, P721, DOI 10.1111/j.1528-1157.1994.tb02502.x; Sperling MR, 1996, JAMA-J AM MED ASSOC, V276, P470, DOI 10.1001/jama.276.6.470; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stacey WC, 2001, J NEUROPHYSIOL, V86, P1104, DOI 10.1152/jn.2001.86.3.1104; Traub RD, 2005, J PHYSIOL-LONDON, V562, P3, DOI 10.1113/jphysiol.2004.074641; Traub RD, 2003, P NATL ACAD SCI USA, V100, P11047, DOI 10.1073/pnas.1934854100; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; WALTHER H, 1986, NEUROSCI LETT, V69, P156, DOI 10.1016/0304-3940(86)90595-1; Weissinger F, 2000, NEUROBIOL DIS, V7, P286, DOI 10.1006/nbdi.2000.0298; Wennberg R, 2002, EPILEPSIA, V43, P716, DOI 10.1046/j.1528-1157.2002.31101.x; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003; Woodhall GL, 2005, HIPPOCAMPUS, V15, P232, DOI 10.1002/hipo.20047; Wouterlood FG, 2000, HIPPOCAMPUS, V10, P77, DOI 10.1002/(SICI)1098-1063(2000)10:1<77::AID-HIPO8>3.3.CO;2-G; Wouterlood FG, 2000, J COMP NEUROL, V425, P177, DOI 10.1002/1096-9861(20000918)425:2<177::AID-CNE2>3.0.CO;2-G; WOUTERLOOD FG, 1995, J NEUROCYTOL, V24, P135, DOI 10.1007/BF01181556	79	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85125	10.1371/journal.pone.0085125	http://dx.doi.org/10.1371/journal.pone.0085125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454801	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100055
J	Qureshi, NK; Yin, SH; Boyle-Vavra, S				Qureshi, Nadia K.; Yin, Shaohui; Boyle-Vavra, Susan			The Role of the Staphylococcal VraTSR Regulatory System on Vancomycin Resistance and vanA Operon Expression in Vancomycin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							CELL-WALL; GLYCOPEPTIDE RESISTANCE; METHICILLIN RESISTANCE; ANTIBIOTIC-RESISTANCE; CLINICAL STRAINS; VRASR; SUSCEPTIBILITY; ACTIVATION; PLASMID	Vancomycin is often the preferred treatment for invasive methicillin-resistant Staphylococcus aureus (MRSA) infection. With the increase in incidence of MRSA infections, the use of vancomycin has increased and, as feared, isolates of vancomycin-resistant Staphylococcus aureus (VRSA) have emerged. VRSA isolates have acquired the entercoccal vanA operon contained on transposon (Tn) 1546 residing on a conjugal plasmid. VraTSR is a vancomycin and beta-lactam-inducible three-component regulatory system encoded on the S. aureus chromosome that modulates the cell-wall stress response to cell-wall acting antibiotics. Mutation in vraTSR has shown to increase susceptibility to beta-lactams and vancomycin in clinical VISA strains and in recombinant strain COLVA-200 which expresses a plasmid borne vanA operon. To date, the role of VraTSR in vanA operon expression in VRSA has not been demonstrated. In this study, the vraTSR operon was deleted from the first clinical VRSA strain (VRS1) by transduction with phage harvested from a USA300 vraTSR operon deletion strain. The absence of the vraTSR operon and presence of the vanA operon were confirmed in the transductant (VRS1 Delta vra) by PCR. Broth MIC determinations, demonstrated that the vancomycin MIC of VRS1 Delta vra (64 mg/ml) decreased by 16-fold compared with VRS1 (1024 mg/ml). The effect of the vraTSR operon deletion on expression of the van gene cluster (vanA, vanX and vanR) was examined by quantitative RT-PCR using relative quantification. A 2-5-fold decreased expression of the vanA operon genes occured in strain VRS1 Delta vra at stationary growth phase compared with the parent strain, VRS1. Both vancomycin resistance and vancomycin-induced expression of vanA and vanR were restored by complementation with a plasmid harboring the vraTSR operon. These findings demonstrate that expression in S. aureus of the horizontally acquired enterococcal vanA gene cluster is enhanced by the staphylococcal three-component cell wall stress regulatory system VraTSR, that is present in all S. aureus strains.	[Qureshi, Nadia K.; Yin, Shaohui; Boyle-Vavra, Susan] Univ Chicago, Dept Pediat, Infect Dis Sect, Chicago, IL 60637 USA	University of Chicago	Boyle-Vavra, S (corresponding author), Univ Chicago, Dept Pediat, Infect Dis Sect, Chicago, IL 60637 USA.	sboyleva@uchicago.edu		Qureshi, Nadia/0000-0003-2629-4986	National Center for Research Resources [UL1RR02499]; Grant Health Care Foundation; National Institutes of Health [NIAID R56 AI04048]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Grant Health Care Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Nadia K. Qureshi was supported by the National Center for Research Resources (grant number UL1RR024999). Susan Boyle-Vavra was supported by the Grant Health Care Foundation and the National Institutes of Health (NIAID R56 AI04048). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum PC, 2007, INT J ANTIMICROB AG, V30, P398, DOI 10.1016/j.ijantimicag.2007.07.011; Arthur M, 1997, J BACTERIOL, V179, P97, DOI 10.1128/jb.179.1.97-106.1997; Arthur M, 2001, ANTIMICROB AGENTS CH, V45, P375, DOI 10.1128/AAC.45.2.375-381.2001; Berger-Bachi B, 1998, DRUG RESIST UPDATE, V1, P325, DOI 10.1016/S1368-7646(98)80048-4; Boyle-Vavra S, 2001, J ANTIMICROB CHEMOTH, V48, P617, DOI 10.1093/jac/48.5.617; Boyle-Vavra S, 2001, ANTIMICROB AGENTS CH, V45, P280, DOI 10.1128/AAC.45.1.280-287.2001; Boyle-Vavra S, 2006, FEMS MICROBIOL LETT, V262, P163, DOI 10.1111/j.1574-6968.2006.00384.x; Boyle-Vavra S, 2013, ANTIMICROB AGENTS CH, V57, P83, DOI 10.1128/AAC.01651-12; Bozdogan B, 2004, ANTIMICROB AGENTS CH, V48, P4762, DOI 10.1128/AAC.48.12.4762-4765.2004; BRISSONNOEL A, 1990, ANTIMICROB AGENTS CH, V34, P924, DOI 10.1128/AAC.34.5.924; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Clinical and Laboratory Standards Institute (CLSI), 2006, METH DIL ANT SUSC TE; COHEN S, 1973, J BACTERIOL, V116, P803, DOI 10.1128/JB.116.2.803-811.1973; Cui LZ, 2000, ANTIMICROB AGENTS CH, V44, P2276, DOI 10.1128/AAC.44.9.2276-2285.2000; Depardieu F, 2003, MOL MICROBIOL, V50, P1069, DOI 10.1046/j.1365-2958.2003.03771.x; Gardete S, 2006, ANTIMICROB AGENTS CH, V50, P3424, DOI 10.1128/AAC.00356-06; Gardete S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002505; Hanaki H, 1998, J ANTIMICROB CHEMOTH, V42, P199, DOI 10.1093/jac/42.2.199; HANDWERGER S, 1992, J BACTERIOL, V174, P5982, DOI 10.1128/jb.174.18.5982-5984.1992; Jo DS, 2011, ANTIMICROB AGENTS CH, V55, P2818, DOI 10.1128/AAC.01704-10; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kos VN, 2012, MBIO, V3, DOI 10.1128/mBio.00112-12; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livermore DM, 2000, INT J ANTIMICROB AG, V16, pS3; McCallum N, 2011, ANTIMICROB AGENTS CH, V55, P1391, DOI 10.1128/AAC.01213-10; Mehta S, 2012, ANTIMICROB AGENTS CH, V56, P92, DOI 10.1128/AAC.00432-10; Perichon B, 2006, ANTIMICROB AGENTS CH, V50, P3622, DOI 10.1128/AAC.00410-06; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Yin SH, 2006, ANTIMICROB AGENTS CH, V50, P336, DOI 10.1128/AAC.50.1.336-343.2006	33	20	22	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85873	10.1371/journal.pone.0085873	http://dx.doi.org/10.1371/journal.pone.0085873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454941	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100138
J	Caldas, GFR; Oliveira, ARD; Araujo, AV; Quixabeira, DCA; Silva-Neto, JD; Costa-Silva, JH; de Menezes, IRA; Ferreira, F; Leite, ACL; da Costa, JGM; Wanderley, AG				Rocha Caldas, Germana Freire; da Silva Oliveira, Alisson Rodrigo; Araujo, Alice Valenca; Alves Quixabeira, Dafne Carolina; Silva-Neto, Jacinto da Costa; Costa-Silva, Joao Henrique; Alencar de Menezes, Irwin Rose; Ferreira, Fabiano; Lima Leite, Ana Cristina; Martins da Costa, Jose Galberto; Wanderley, Almir Goncalves			Gastroprotective and Ulcer Healing Effects of Essential Oil of Hyptis martiusii Benth. (Lamiaceae)	PLOS ONE			English	Article							NEUTROPHIL INFILTRATION; ANTIOXIDANT CAPACITY; GASTRIC-ULCER; NITRIC-OXIDE; PLANTS; RATS; PROSTAGLANDINS; SULFHYDRYLS; EXTRACT; FOOD	Hyptis martiusii Benth. is an aromatic plant found in abundance in northeastern Brazil that is used in ethnomedicine to treat gastric disorders. The aim of this study was to elucidate the mechanisms of action involved in the gastroprotection of the essential oil of Hyptis martiusii (EOHM) and to evaluate its healing capacity. Wistar rats were exposed to different protocols and subsequently were treated with 1% Tween-80 aqueous solution (negative control), pantoprazole, carbenoxolone, N-acetylcysteine (depending on the specificity of each model) or EOHM. The antisecretory activity (basal or stimulated) was determined using the pyloric ligature method. The gastroprotective action of nitric oxide and sulphydryl groups (-SH groups), as well as the quantification of adherent mucus and the levels of malondialdehyde and -SH groups in gastric mucosa, were evaluated using ethanol-induced gastric ulcer model. The healing ability was evaluated using the acetic acidinduced gastric ulcer model and histological and immunohistochemical analysis (HE, PAS and PCNA). EOHM (400 mg/ kg) reduced the volume and acidity of gastric secretion stimulated by histamine and pentagastrin. The gastroprotective effect of EOHM involves the participation of endogenous sulfhydryl groups. EOHM increased mucus production (54.8%), reduced levels of MDA (72.5%) and prevented the depletion of -SH groups (73.8%) in the gastric mucosa. The treatment with EOHM reduced in 70.3% the gastric lesion area, promoting significant regeneration of the gastric mucosa, as confirmed by histological analysis and analysis of proliferating cell nuclear antigen. The results show that gastroprotective effect of EOHM is mediated by cytoprotective and antioxidant mechanisms and by their antisecretory activity, and suggest that the essential oil of Hyptis martiusii is a promising candidate for the treatment of gastric ulcers.	[Rocha Caldas, Germana Freire; Lima Leite, Ana Cristina; Wanderley, Almir Goncalves] Univ Fed Pernambuco, Dept Pharmaceut Sci, Recife, PE, Brazil; [da Silva Oliveira, Alisson Rodrigo; Araujo, Alice Valenca; Ferreira, Fabiano; Wanderley, Almir Goncalves] Univ Fed Pernambuco, Dept Physiol & Pharmacol, Recife, PE, Brazil; [Alves Quixabeira, Dafne Carolina; Silva-Neto, Jacinto da Costa] Univ Fed Pernambuco, Dept Histol & Embryol, Recife, PE, Brazil; [Costa-Silva, Joao Henrique] Univ Fed Pernambuco, Dept Phys Educ & Sport Sci, Vitoria De Santo Antao, PE, Brazil; [Alencar de Menezes, Irwin Rose; Martins da Costa, Jose Galberto] Reg Univ Cariri, Dept Biol Chem, Crato, Ceara, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Regional do Cariri	Wanderley, AG (corresponding author), Univ Fed Pernambuco, Dept Pharmaceut Sci, Recife, PE, Brazil.	almirgw@globo.com	Costa, Jose Galberto/L-6022-2016; WANDERLEY, ALMIR GONÇALVES/T-3087-2019; Silva Neto, Jacinto da Costa/R-5602-2017; Costa-Silva, João Henrique/D-1372-2014; de Menezes, Irwin Rose Alencar/A-6777-2012; Araújo, Alice V/S-2346-2018; Costa, Jose Galberto Martins/AFP-6381-2022; CALDAS, GERMANA/O-7180-2014; Lima Leite, Ana/C-5430-2013	Costa, Jose Galberto/0000-0002-0730-7246; WANDERLEY, ALMIR GONÇALVES/0000-0001-5193-1153; Silva Neto, Jacinto da Costa/0000-0003-4418-801X; Costa-Silva, João Henrique/0000-0002-9794-1418; de Menezes, Irwin Rose Alencar/0000-0003-1065-9581; Costa, Jose Galberto Martins/0000-0003-4268-663X; CALDAS, GERMANA/0000-0002-7655-2974; Quixabeira, Dafne/0000-0003-2614-3942; Lima Leite, Ana/0000-0002-9346-2292	CNPq [483470/2009-0, 305256/2009-2]; GFRC [554207/2010-9]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); GFRC	CNPq (projects no.: 483470/2009-0 and 305256/2009-2) Grants doctoral scholarship from GFRC (process no.: 554207/2010-9) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2004, IDENTIFICATION ESSEN, V3rd ed.; Agra MD, 2008, REV BRAS FARMACOGN, V18, P472, DOI 10.1590/S0102-695X2008000300023; Allen A, 2005, AM J PHYSIOL-CELL PH, V288, pC1, DOI 10.1152/ajpcell.00102.2004; Amakura Y, 2002, FOOD CHEM, V77, P47, DOI 10.1016/S0308-8146(01)00321-1; Arrieta J, 2003, PLANTA MED, V69, P905, DOI 10.1055/s-2003-45098; Avila JR, 1996, INFLAMM RES, V45, P83, DOI 10.1007/BF02265120; Araujo ECD, 2006, Z NATURFORSCH C, V61, P177; Cherubini A, 2005, FREE RADICAL BIO MED, V39, P841, DOI 10.1016/j.freeradbiomed.2005.06.025; Chow DKL, 2009, BEST PRACT RES CL GA, V23, P3, DOI 10.1016/j.bpg.2008.11.010; Corne S.J., 1974, J PHYSL, V242, P116; Costa J. G. M., 2005, REV BRAS FARMACOGN, V15, P304, DOI DOI 10.1590/S0102-695X2005000400008; Costa-Lotufo LV, 2004, PHARMAZIE, V59, P78; Coutinho HDM, 2008, REV BRAS FARMACOGN, V18, P670, DOI 10.1590/S0102-695X2008000500005; Kobayashi T, 2001, PHARMACOL RES, V43, P23, DOI 10.1006/phrs.2000.0748; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Diniz LRL, 2013, J ETHNOPHARMACOL, V149, P694, DOI 10.1016/j.jep.2013.07.026; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Matsuda H, 1999, LIFE SCI, V65, pPL27, DOI 10.1016/S0024-3205(99)00241-6; McNeil M, 2011, NAT PROD COMMUN, V6, P1775; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ojeda-Sana AM, 2013, FOOD CONTROL, V31, P189, DOI 10.1016/j.foodcont.2012.09.022; Okabe S, 2005, BIOL PHARM BULL, V28, P1321, DOI 10.1248/bpb.28.1321; Park S, 2004, DIGEST DIS SCI, V49, P384, DOI 10.1023/B:DDAS.0000020490.34220.6d; Sobrinho TJSP, 2011, AFR J PHARM PHARMACO, V5, P2310, DOI 10.5897/AJPP11.608; Rebelo MM, 2009, REV BRAS FARMACOGN, V19, P230, DOI 10.1590/S0102-695X2009000200009; ROBERT A, 1979, GASTROENTEROLOGY, V77, P433; Caldas GFR, 2011, J ETHNOPHARMACOL, V137, P886, DOI 10.1016/j.jep.2011.07.005; Rozza AL, 2013, FUND CLIN PHARMACOL, V27, P51, DOI 10.1111/j.1472-8206.2012.01067.x; Samonina G.E., 2004, Pathophysiology, V11, P1, DOI 10.1016/j.pathophys.2003.10.008; Santos AKL, 2010, PHARMACOGN MAG, V6, P335, DOI 10.4103/0973-1296.71789; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; SHAY H, 1945, GASTROENTEROLOGY, V5, P43; TAKAGI K, 1969, JPN J PHARMACOL, V19, P418, DOI 10.1254/jjp.19.418; Takayama C, 2011, J ETHNOPHARMACOL, V135, P147, DOI 10.1016/j.jep.2011.03.002; Wang L, 2008, CAN J PHYSIOL PHARM, V86, P97, DOI [10.1139/Y08-003, 10.1139/y08-003]; Yanishlieva NV, 1999, FOOD CHEM, V64, P59, DOI 10.1016/S0308-8146(98)00086-7	36	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84400	10.1371/journal.pone.0084400	http://dx.doi.org/10.1371/journal.pone.0084400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454726	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100022
J	Shuryak, I; Bryan, RA; Nosanchuk, JD; Dadachova, E				Shuryak, Igor; Bryan, Ruth A.; Nosanchuk, Joshua D.; Dadachova, Ekaterina			Mathematical Modeling Predicts Enhanced Growth of X-Ray Irradiated Pigmented Fungi	PLOS ONE			English	Article							IONIZING-RADIATION; GAMMA-RADIATION; MELANIN; MICROFUNGI	Ionizing radiation is known for its cytotoxic and mutagenic properties. However, recent evidence suggests that chronic sublethal irradiation stimulates the growth of melanin-pigmented (melanized) fungi, supporting the hypothesis that interactions between melanin and ionizing photons generate energy useful for fungal growth, and/or regulate growth-promoting genes. There are no quantitative models of how fungal proliferation is affected by ionizing photon energy, dose rate, and presence versus absence of melanin on the same genetic background. Here we present such a model, which we test using experimental data on melanin-modulated radiation-induced proliferation enhancement in the fungus Cryptococcus neoformans, exposed to two different peak energies (150 and 320 kVp) over a wide range of X-ray dose rates. Our analysis demonstrates that radiation-induced proliferation enhancement in C. neoformans behaves as a binary "on/off'' phenomenon, which is triggered by dose rates <0.002 mGy/h, and stays in the "on'' position. A competing dose rate-dependent growth inhibition becomes apparent at dose rates <5000 mGy/h. Proliferation enhancement of irradiated cells compared with unirradiated controls occurs at both X-ray peak energies, but its magnitude is modulated by X-ray peak energy and cell melanization. At dose rates <5000 mGy/h, both melanized and non-melanized cells exposed to 150 kVp Xrays, and non-melanized cells exposed to 320 kVp X-rays, all exhibit the same proliferation enhancement: on average, chronic irradiation stimulates each founder cell to produce 100 (95% CI: 83, 116) extra descendants over 48 hours. Interactions between melanin and 320 kVp X-rays result in a significant (2-tailed p-value = 4.8x10(-5)) additional increase in the number of radiation-induced descendants per founder cell: by 55 (95% CI: 29, 81). These results show that both melanin-dependent and melanin-independent mechanisms are involved in radiation-induced fungal growth enhancement, and implicate direct and/or indirect interactions of melanin with high energy ionizing photons as an important pro-proliferative factor.	[Shuryak, Igor] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA; [Bryan, Ruth A.; Dadachova, Ekaterina] Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA; [Nosanchuk, Joshua D.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Nosanchuk, Joshua D.; Dadachova, Ekaterina] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Columbia University; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Shuryak, I (corresponding author), Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA.	is144@columbia.edu	Dadachova, Ekaterina/I-7838-2013; Nosanchuk, Joshua/AAS-7801-2021		NIAID [U19-AI67773]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported through NIAID grant U19-AI67773. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryan R, 2011, FUNGAL BIOL-UK, V115, P945, DOI 10.1016/j.funbio.2011.04.003; Dadachova E, 2008, PIGM CELL MELANOMA R, V21, P192, DOI 10.1111/j.1755-148X.2007.00430.x; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Dadachova E, 2008, CURR OPIN MICROBIOL, V11, P525, DOI 10.1016/j.mib.2008.09.013; Dighton J, 2008, FEMS MICROBIOL LETT, V281, P109, DOI 10.1111/j.1574-6968.2008.01076.x; DURRELL LW, 1960, MYCOLOGIA, V52, P636, DOI 10.2307/3756096; GOCHENAU.SE, 1974, ECOLOGY, V55, P1004, DOI 10.2307/1940351; Myers R., 1990, CLASSICAL MODERN REG; National Research Council, 2006, HLTH RISKS EXPOSURE, P311; Robertson KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048674; Rosas AL, 2000, J IMMUNOL METHODS, V244, P69, DOI 10.1016/S0022-1759(00)00255-6; Tibshirani R., 1993, INTRO BOOTSTRAP, DOI 10.1007/978-1-4899-4541-9; Tugay T, 2006, MYCOLOGIA, V98, P521, DOI 10.3852/mycologia.98.4.521; Tugay TI, 2011, HEALTH PHYS, V101, P375, DOI 10.1097/HP.0b013e3181f56bf8; Turick CE, 2011, BIOELECTROCHEMISTRY, V82, P69, DOI 10.1016/j.bioelechem.2011.04.009; Zaragoza O, 2011, ANTIMICROB AGENTS CH, V55, P1563, DOI 10.1128/AAC.01631-10; Zhdanova NN, 2004, MYCOL RES, V108, P1089, DOI 10.1017/S0953756204000966; ZHDANOVA NN, 1995, MYCOL RES, V98, P789	18	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85561	10.1371/journal.pone.0085561	http://dx.doi.org/10.1371/journal.pone.0085561			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454887	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100098
J	Yang, XJ; Cui, W; Yu, SC; Xu, C; Chen, GL; Gu, A; Li, TT; Cui, YH; Zhang, X; Bian, XW				Yang, Xiaojun; Cui, Wei; Yu, Shicang; Xu, Chuan; Chen, Guilai; Gu, Ai; Li, Tingting; Cui, Youhong; Zhang, Xia; Bian, Xiuwu			A Synthetic dl-Nordihydroguaiaretic acid (Nordy), Inhibits Angiogenesis, Invasion and Proliferation of Glioma Stem Cells within a Zebrafish Xenotransplantation Model	PLOS ONE			English	Article							PHASE-II; LIPOXYGENASE INHIBITOR; MALIGNANT GLIOMA; ARACHIDONIC-ACID; IN-VIVO; CANCER; VATALANIB; AXITINIB; RECEPTOR; DIFFERENTIATION	The zebrafish (Danio rerio) and their transparent embryos represent a promising model system in cancer research. Compared with other vertebrate model systems, we had previously shown that the zebrafish model provides many advantages over mouse or chicken models to study tumor invasion, angiogenesis, and tumorigenesis. In this study, we systematically investigated the biological features of glioma stem cells (GSCs) in a zebrafish model, such as tumor angiogenesis, invasion, and proliferation. We demonstrated that several verified anti-angiogenic agents inhibited angiogenesis that was induced by xenografted-GSCs. We next evaluated the effects of a synthetic dl-nordihydroguaiaretic acid compound (dl-NDGA or "Nordy''), which revealed anti-tumor activity against human GSCs in vitro by establishing parameters through studying its ability to suppress angiogenesis, tumor invasion, and proliferation. Furthermore, our results indicated that Nordy might inhibit GSCs invasion and proliferation through regulation of the arachidonate 5-lipoxygenase (Alox-5) pathway. Moreover, the combination of Nordy and a VEGF inhibitor exhibited an enhanced ability to suppress angiogenesis that was induced by GSCs. By contrast, even following treatment with 50 mM Nordy, there was no discernible effect on zebrafish embryonic development. Together, these results suggested efficacy and safety of using Nordy in vivo, and further demonstrated that this model should be suitable for studying GSCs and anti-GSC drug evaluation.	[Yang, Xiaojun; Cui, Wei; Yu, Shicang; Xu, Chuan; Chen, Guilai; Gu, Ai; Li, Tingting; Cui, Youhong; Zhang, Xia; Bian, Xiuwu] Third Mil Med Univ, Southwest Hosp, Minist Educ China, Key Lab Tumor Immunopathol, Chongqing, Peoples R China; [Yang, Xiaojun; Cui, Wei; Yu, Shicang; Xu, Chuan; Chen, Guilai; Gu, Ai; Li, Tingting; Cui, Youhong; Zhang, Xia; Bian, Xiuwu] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Yang, Xiaojun; Cui, Wei; Yu, Shicang; Xu, Chuan; Chen, Guilai; Gu, Ai; Li, Tingting; Cui, Youhong; Zhang, Xia; Bian, Xiuwu] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China	Army Medical University; Ministry of Education, China; Army Medical University; Army Medical University	Yang, XJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Minist Educ China, Key Lab Tumor Immunopathol, Chongqing, Peoples R China.	xiaojunyang.cn@gmail.com; bianxiuwu@263.net	Bian, Xiu-Wu/D-4736-2017; Zhang, Xia/B-8152-2008	Bian, Xiu-Wu/0000-0003-4383-0197; Zhang, Xia/0000-0002-9040-1486	National Basic Research Program of China (973 Program) [2010CB529403]; National Natural Science Fundation of China [81101632, 81272598]; Liaoning Science and Technology Program [201225109]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Science and Technology Program	This work was supported by grants from the National Basic Research Program of China (973 Program, Grant No. 2010CB529403), The National Natural Science Fundation of China (Grant No. 81101632 and 81272598), and Liaoning Science and Technology Program (No. 201225109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JM, 2009, ZEBRAFISH, V6, P329, DOI 10.1089/zeb.2009.0626; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bian XW, 2008, PROTEOMICS, V8, P484, DOI 10.1002/pmic.200700054; Chang NW, 2013, J NUTR BIOCHEM, V24, P274, DOI 10.1016/j.jnutbio.2012.06.005; Chen JH, 2006, BIOCHEM BIOPH RES CO, V342, P1368, DOI 10.1016/j.bbrc.2006.02.113; Chen JH, 2007, J NEURO-ONCOL, V84, P223, DOI 10.1007/s11060-007-9369-4; Cohen EEW, 2008, J CLIN ONCOL, V26, P4708, DOI 10.1200/JCO.2007.15.9566; Furstenberger G, 2006, INT J CANCER, V119, P2247, DOI 10.1002/ijc.22153; Geiger GA, 2008, CANCER RES, V68, P3396, DOI 10.1158/0008-5472.CAN-07-6396; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; Hyde CAC, 2009, INT IMMUNOPHARMACOL, V9, P701, DOI 10.1016/j.intimp.2009.02.003; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Paesler J, 2010, CLIN CANCER RES, V16, P3390, DOI 10.1158/1078-0432.CCR-10-0232; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Ping YF, 2007, J NEURO-ONCOL, V84, P21, DOI 10.1007/s11060-007-9349-8; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rixe O, 2007, LANCET ONCOL, V8, P975, DOI 10.1016/S1470-2045(07)70285-1; Schiller JH, 2009, J CLIN ONCOL, V27, P3836, DOI 10.1200/JCO.2008.20.8355; Scott EN, 2007, EXPERT OPIN INV DRUG, V16, P367, DOI 10.1517/13543784.16.3.367; Sobrero AF, 2011, J CLIN ONCOL, V29, P1938, DOI 10.1200/JCO.2010.33.2429; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Visted T, 2003, FRONT BIOSCI-LANDMRK, V8, pE289, DOI 10.2741/1026; Wang B, 2011, STEM CELL REV REP, V7, P458, DOI 10.1007/s12015-010-9175-9; Yang XJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061801, 10.1371/journal.pone.0062181]; Yang XJ, 2013, INT IMMUNOPHARMACOL, V15, P191, DOI 10.1016/j.intimp.2012.12.002; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010	35	73	76	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85759	10.1371/journal.pone.0085759	http://dx.doi.org/10.1371/journal.pone.0085759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454929	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100131
J	Srivastava, SK; Huang, XQ; Brar, HK; Fakhoury, AM; Bluhm, BH; Bhattacharyya, MK				Srivastava, Subodh K.; Huang, Xiaoqiu; Brar, Hargeet K.; Fakhoury, Ahmad M.; Bluhm, Burton H.; Bhattacharyya, Madan K.			The Genome Sequence of the Fungal Pathogen Fusarium virguliforme That Cause Sudden Death Syndrome in Soybean	PLOS ONE			English	Article							MAGNAPORTHE-GRISEA; DNA; ALIGNMENT; DATABASE; TOXIN; EXPRESSION; TUCUMANIAE; REVEALS; BLAST; RICE	Fusarium virguliforme causes sudden death syndrome (SDS) of soybean, a disease of serious concern throughout most of the soybean producing regions of the world. Despite the global importance, little is known about the pathogenesis mechanisms of F. virguliforme. Thus, we applied Next-Generation DNA Sequencing to reveal the draft F. virguliforme genome sequence and identified putative pathogenicity genes to facilitate discovering the mechanisms used by the pathogen to cause this disease. Methodology/Principal Findings: We have generated the draft genome sequence of F. virguliforme by conducting whole-genome shotgun sequencing on a 454 GS-FLX Titanium sequencer. Initially, single-end reads of a 400-bp shotgun library were assembled using the PCAP program. Paired end sequences from 3 and 20 Kb DNA fragments and approximately 100 Kb inserts of 1,400 BAC clones were used to generate the assembled genome. The assembled genome sequence was 51 Mb. The N50 scaffold number was 11 with an N50 Scaffold length of 1,263 Kb. The AUGUSTUS gene prediction program predicted 14,845 putative genes, which were annotated with Pfam and GO databases. Gene distributions were uniform in all but one of the major scaffolds. Phylogenic analyses revealed that F. virguliforme was closely related to the pea pathogen, Nectria haematococca. Of the 14,845 F. virguliforme genes, 11,043 were conserved among five Fusarium species: F. virguliforme, F. graminearum, F. verticillioides, F. oxysporum and N. haematococca; and 1,332 F. virguliforme-specific genes, which may include pathogenicity genes. Additionally, searches for candidate F. virguliforme pathogenicity genes using gene sequences of the pathogen-host interaction database identified 358 genes. Conclusions: The F. virguliforme genome sequence and putative pathogenicity genes presented here will facilitate identification of pathogenicity mechanisms involved in SDS development. Together, these resources will expedite our efforts towards discovering pathogenicity mechanisms in F. virguliforme. This will ultimately lead to improvement of SDS resistance in soybean.	[Srivastava, Subodh K.; Brar, Hargeet K.; Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Huang, Xiaoqiu] Iowa State Univ, Dept Comp Sci, Ames, IA USA; [Fakhoury, Ahmad M.] So Illinois Univ, Dept Plant Soil Sci & Agr Syst, Carbondale, IL 62901 USA; [Bluhm, Burton H.] Univ Arkansas, Dept Plant Pathol, Fayetteville, AR 72701 USA	Iowa State University; Iowa State University; Southern Illinois University System; Southern Illinois University; University of Arkansas System; University of Arkansas Fayetteville	Bhattacharyya, MK (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	mbhattac@iastate.edu			Soybean Research Development Council & Iowa Soybean Association	Soybean Research Development Council & Iowa Soybean Association	The authors are thankful to Soybean Research Development Council & Iowa Soybean Association for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki T, 2003, MYCOLOGIA, V95, P660, DOI 10.2307/3761942; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Brar HK, 2012, MOL PLANT MICROBE IN, V25, P817, DOI 10.1094/MPMI-12-11-0317; Brar HK, 2011, MOL PLANT MICROBE IN, V24, P1179, DOI 10.1094/MPMI-12-10-0285; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Covert SF, 2007, FUNGAL GENET BIOL, V44, P799, DOI 10.1016/j.fgb.2006.12.009; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Huang XQ, 2004, BIOINFORMATICS, V20, P2529, DOI 10.1093/bioinformatics/bth279; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; Innocenti A, 2010, BIOORGAN MED CHEM, V18, P1034, DOI 10.1016/j.bmc.2009.12.058; Ji J, 2006, PLANT BIOLOGY, V8, P597, DOI 10.1055/s-2006-924175; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li S, 2009, J PLANT PATHOL, V91, P77; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Mar JC, 2011, BIOINFORMATICS, V27, P1094, DOI 10.1093/bioinformatics/btr074; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; MUTO A, 1987, P NATL ACAD SCI USA, V84, P166, DOI 10.1073/pnas.84.1.166; Osoegawa K, 2007, GENOMICS, V89, P291, DOI 10.1016/j.ygeno.2006.10.002; Pal K, 2007, STUD MYCOL, P19, DOI 10.3114/sim.2007.59.03; Pudake RN, 2013, CURR GENET, V59, P107, DOI 10.1007/s00294-013-0392-z; Rep M, 2010, CURR OPIN PLANT BIOL, V13, P420, DOI 10.1016/j.pbi.2010.04.004; RUPE JC, 1989, PLANT DIS, V73, P581, DOI 10.1094/PD-73-0581; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Winnenburg R, 2008, NUCLEIC ACIDS RES, V36, pD572, DOI 10.1093/nar/gkm858; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Wrather JA, 2006, J NEMATOL, V38, P173	45	38	39	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e81832	10.1371/journal.pone.0081832	http://dx.doi.org/10.1371/journal.pone.0081832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454689	gold, Green Published, Green Submitted			2022-12-25	WOS:000329925800005
J	Gai, XH; Lu, ZT; Tu, KS; Liang, ZY; Zheng, X				Gai, Xiaohong; Lu, Zhongtang; Tu, Kangsheng; Liang, Zheyong; Zheng, Xin			Caveolin-1 Is Up-Regulated by GLI1 and Contributes to GLI1-Driven EMT in Hepatocellular Carcinoma	PLOS ONE			English	Article							POOR-PROGNOSIS; EXPRESSION; METASTASIS; CANCER; OVEREXPRESSION; ADENOCARCINOMA; PROSTATE; SURVIVAL; INVASION; GROWTH	Caveolin-1 (Cav-1) has been recently identified to be over-expressed in hepatocellular carcinoma (HCC) and promote HCC cell motility and invasion ability via inducing epithelial-mesenchymal transition (EMT). However, the mechanism of aberrant overexpression of Cav-1 remains vague. Here, we observed that Cav-1 expression was positively associated with GLI1 expression in HCC tissues. Forced expression of GLI1 up-regulated Cav-1 in Huh7 cells, while knockdown of GLI1 decreased expression of Cav-1 in SNU449 cells. Additionally, silencing Cav-1 abolished GLI1-induced EMT of Huh7 cells. The correlation between GLI1 and Cav-1 was confirmed in tumor specimens from HCC patients and Cav-1 was found to be associated with poor prognosis after hepatic resection. The relationship between protein expression of GLI1 and Cav-1 was also established in HCC xenografts of nude mice. These results suggest that GLI1 may be attributed to Cav-1 up-regulation which plays an important role in GLI1-driven EMT phenotype in HCC.	[Gai, Xiaohong; Lu, Zhongtang; Tu, Kangsheng; Liang, Zheyong; Zheng, Xin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Zheng, X (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Shaanxi, Peoples R China.	xin.zheng.xjtu@gmail.com	Tu, Kangsheng/N-1544-2019; ZHENG, XIN/H-2342-2016; Zheng, Xin/AAX-4333-2021	Tu, Kangsheng/0000-0002-0032-1459; ZHENG, XIN/0000-0002-6328-0834; 	Research Fund for the doctoral Program of High Education of China from Ministry of Education [20120201120090]	Research Fund for the doctoral Program of High Education of China from Ministry of Education	This study was supported by Research Fund for the doctoral Program of High Education of China from Ministry of Education (No. 20120201120090 to Xin Zheng). The URL of Research Fund for the doctoral Program of High Education of China from Ministry of Education is http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/2013/02/1354173488080563.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred MA, 2003, CANCER RES, V63, P2864; Bender FC, 2000, CANCER RES, V60, P5870; Cokakli M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-65; Collin G, 2007, MOL CELL BIOL, V27, P7631, DOI 10.1128/MCB.00543-07; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Fong A, 2003, AM J CLIN PATHOL, V120, P93, DOI 10.1309/292NHAYNWAVREJ37; Hatanaka M, 1998, BIOCHEM BIOPH RES CO, V253, P382, DOI 10.1006/bbrc.1998.9744; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Joo HJ, 2004, BJU INT, V93, P291, DOI 10.1111/j.1464-410X.2004.04604.x; Kato K, 2002, CANCER, V94, P929, DOI 10.1002/cncr.10329.abs; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Razani B, 2000, BIOCHEMISTRY-US, V39, P13916, DOI 10.1021/bi001489b; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sato M, 2012, RESPIROLOGY, V17, P1048, DOI 10.1111/j.1440-1843.2012.02173.x; Tahir SA, 2001, CANCER RES, V61, P3882; Tang Y, 2012, MED ONCOL, V29, P977, DOI 10.1007/s12032-011-9900-5; Tse EYT, 2012, J PATHOL, V226, P645, DOI 10.1002/path.3957; Wiechen K, 2001, AM J PATHOL, V158, P833, DOI 10.1016/S0002-9440(10)64031-X; Wikman H, 2002, ONCOGENE, V21, P5804, DOI 10.1038/sj.onc.1205726; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Yang G, 1998, CLIN CANCER RES, V4, P1873; Yang JD, 2011, CLIN GASTROENTEROL H, V9, P617, DOI 10.1016/j.cgh.2011.03.027; Yang SF, 2010, PATHOLOGY, V42, P438, DOI 10.3109/00313025.2010.494293; Zhang ZB, 2009, PATHOL ONCOL RES, V15, P495, DOI 10.1007/s12253-008-9144-7; Zheng X, 2013, ONCOL REP, V29, P1811, DOI 10.3892/or.2013.2341; Zheng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049581; Zheng X, 2010, MOL MED REP, V3, P965, DOI 10.3892/mmr.2010.375	30	31	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84551	10.1371/journal.pone.0084551	http://dx.doi.org/10.1371/journal.pone.0084551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454730	gold, Green Submitted, Green Published			2022-12-25	WOS:000329922500012
J	Trebbien, R; Chriel, M; Struve, T; Hjulsager, CK; Larsen, G; Larsen, LE				Trebbien, Ramona; Chriel, Mariann; Struve, Tina; Hjulsager, Charlotte Kristiane; Larsen, Gitte; Larsen, Lars Erik			Wildlife Reservoirs of Canine Distemper Virus Resulted in a Major Outbreak in Danish Farmed Mink (Neovison vison)	PLOS ONE			English	Article							TRANSPLACENTAL TRANSMISSION; RED FOXES; HEMAGGLUTININ; PREVALENCE; ANTIBODIES; CARNIVORES; PARVOVIRUS; INFECTION; EMERGENCE; STRAINS	A major outbreak of canine distemper virus (CDV) in Danish farmed mink (Neovison vison) started in the late summer period of 2012. At the same time, a high number of diseased and dead wildlife species such as foxes, raccoon dogs, and ferrets were observed. To track the origin of the outbreak virus full-length sequencing of the receptor binding surface protein hemagglutinin (H) was performed on 26 CDV's collected from mink and 10 CDV's collected from wildlife species. Subsequent phylogenetic analyses showed that the virus circulating in the mink farms and wildlife were highly identical with an identity at the nucleotide level of 99.45% to 100%. The sequences could be grouped by single nucleotide polymorphisms according to geographical distribution of mink farms and wildlife. The signaling lymphocytic activation molecule (SLAM) receptor binding region in most viruses from both mink and wildlife contained G at position 530 and Y at position 549; however, three mink viruses had an Y549H substitution. The outbreak viruses clustered phylogenetically in the European lineage and were highly identical to wildlife viruses from Germany and Hungary (99.29% - 99.62%). The study furthermore revealed that fleas (Ceratophyllus sciurorum) contained CDV and that vertical transmission of CDV occurred in a wild ferret. The study provides evidence that wildlife species, such as foxes, play an important role in the transmission of CDV to farmed mink and that the virus may be maintained in the wild animal reservoir between outbreaks.	[Trebbien, Ramona; Chriel, Mariann; Hjulsager, Charlotte Kristiane; Larsen, Gitte; Larsen, Lars Erik] Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark; [Struve, Tina] Kopenhagen Diagnost, Glostrup, Denmark	Technical University of Denmark	Larsen, LE (corresponding author), Tech Univ Denmark, Natl Vet Inst, Frederiksberg C, Denmark.	lael@vet.dtu.dk	Larsen, Lars E/G-3827-2015	Larsen, Lars E/0000-0003-0730-5555; Trebbien, Ramona/0000-0003-2352-5726	Kopenhagen Fur	Kopenhagen Fur	The project was supported financial by Kopenhagen Fur www.kopenhagenfur.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL MJG, 1995, VET MICROBIOL, V44, P187, DOI 10.1016/0378-1135(95)00011-X; Bolt G, 1997, J GEN VIROL, V78, P367, DOI 10.1099/0022-1317-78-2-367; Calderon MG, 2007, VET MICROBIOL, V125, P341, DOI 10.1016/j.vetmic.2007.05.020; Cha SY, 2012, COMP IMMUNOL MICROB, V35, P497, DOI 10.1016/j.cimid.2012.04.006; Damien BC, 2002, J WILDLIFE DIS, V38, P856, DOI 10.7589/0090-3558-38.4.856; Denzin N, 2013, VET MICROBIOL, V162, P214, DOI 10.1016/j.vetmic.2012.08.031; Frolich K, 2000, VET MICROBIOL, V74, P283, DOI 10.1016/S0378-1135(00)00192-9; Guo L, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-109; Kameo Y, 2012, VET MICROBIOL, V154, P222, DOI 10.1016/j.vetmic.2011.07.006; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; KRAKOWKA S, 1974, AM J VET RES, V35, P1251; KRAKOWKA S, 1977, AM J VET RES, V38, P919; Martella V, 2006, VET MICROBIOL, V116, P301, DOI 10.1016/j.vetmic.2006.04.019; Martella V, 2011, VACCINE, V29, P1222, DOI 10.1016/j.vaccine.2010.12.001; McCarthy AJ, 2007, P ROY SOC B-BIOL SCI, V274, P3165, DOI 10.1098/rspb.2007.0884; Nikolin VM, 2012, VET MICROBIOL, V156, P45, DOI 10.1016/j.vetmic.2011.10.009; Perpinan D, 2008, VET REC, V163, P248; Pomeroy LW, 2008, J MOL EVOL, V66, P98, DOI 10.1007/s00239-007-9040-x; Santos N, 2009, J WILDLIFE DIS, V45, P221, DOI 10.7589/0090-3558-45.1.221; Sekulin K, 2011, VET J, V187, P399, DOI 10.1016/j.tvjl.2009.12.029; Sobrino R, 2008, VET MICROBIOL, V126, P251, DOI 10.1016/j.vetmic.2007.06.014; Tan B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-520; van de Bildt MWG, 2002, EMERG INFECT DIS, V8, P211; von Messling V, 2001, J VIROL, V75, P6418, DOI 10.1128/JVI.75.14.6418-6427.2001; Woma TY, 2010, VET MICROBIOL, V143, P126, DOI 10.1016/j.vetmic.2009.11.013; Zhao JJ, 2010, VET MICROBIOL, V140, P34, DOI 10.1016/j.vetmic.2009.07.010	26	38	39	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85598	10.1371/journal.pone.0085598	http://dx.doi.org/10.1371/journal.pone.0085598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454897	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500057
J	Cebotaru, V; Cebotaru, L; Kim, H; Chiaravalli, M; Boletta, A; Qian, F; Guggino, WB				Cebotaru, Valeriu; Cebotaru, Liudmila; Kim, Hyunho; Chiaravalli, Marco; Boletta, Alessandra; Qian, Feng; Guggino, William B.			Polycystin-1 Negatively Regulates Polycystin-2 Expression via the Aggresome/Autophagosome Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channels; Physiology; Protein Degradation; Protein Processing; Trafficking	KIDNEY-DISEASE; LIVER-DISEASE; CELL-PROLIFERATION; GENE-PRODUCT; PKD1; PROTEIN; DEGRADATION; MUTATIONS; DOMAIN; MATURATION	Background: PC1 and PC2 function as a complex, but their interrelations are not completely understood. Results: Expression of PC1 accelerates degradation of PC2. Conclusion: PC1 negatively regulates PC2 expression, presumptively by enhancing degradation via the aggresome/autophagosome pathway. Significance: Understanding how PC1 regulates PC2 within a critical range may help elucidate the pathogenesis of cyst formation. Mutations of the PKD1 and PKD2 genes, encoding polycystin-1 (PC1) and polycystin-2 (PC2), respectively, lead to autosomal dominant polycystic kidney disease. Interestingly, up-regulation or down-regulation of PKD1 or PKD2 leads to polycystic kidney disease in animal models, but their interrelations are not completely understood. We show here that full-length PC1 that interacts with PC2 via a C-terminal coiled-coil domain regulates PC2 expression in vivo and in vitro by down-regulating PC2 expression in a dose-dependent manner. Expression of the pathogenic mutant R4227X, which lacks the C-terminal coiled-coil domain, failed to down-regulate PC2 expression, suggesting that PC1-PC2 interaction is necessary for PC2 regulation. The proteasome and autophagy are two pathways that control protein degradation. Proteins that are not degraded by proteasomes precipitate in the cytoplasm and are transported via histone deacetylase 6 (HDAC6) toward the aggresomes. We found that HDAC6 binds to PC2 and that expression of full-length PC1 accelerates the transport of the HDAC6-PC2 complex toward aggresomes, whereas expression of the R4227X mutant fails to do so. Aggresomes are engulfed by autophagosomes, which then fuse with the lysosome for degradation; this process is also known as autophagy. We have now shown that PC1 overexpression leads to increased degradation of PC2 via autophagy. Interestingly, PC1 does not activate autophagy generally. Thus, we have now uncovered a new pathway suggesting that when PC1 is expressed, PC2 that is not bound to PC1 is directed to aggresomes and subsequently degraded via autophagy, a control mechanism that may play a role in autosomal dominant polycystic kidney disease pathogenesis.	[Cebotaru, Valeriu] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; [Cebotaru, Liudmila] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Kim, Hyunho; Qian, Feng] Univ Maryland, Dept Med, Div Nephrol, Baltimore, MD 21201 USA; [Chiaravalli, Marco; Boletta, Alessandra] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Guggino, WB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Wood Basic Sci Bldg 214A,725 N Wolfe St, Baltimore, MD 21205 USA.	wguggino@jhmi.edu		chiaravalli, marco/0000-0003-0369-1989	National Institutes of Health [R01 DK 32753, DK062199, P30 DK090868]; National Kidney Foundation of Maryland Professional Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062199, R01DK032753, P30DK090868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation of Maryland Professional Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK 32753 (to W. G.), DK062199 (to F. Q.), and P30 DK090868 (to the Baltimore Polycystic Kidney Disease Research and Clinical Core Center). This work was also supported by a National Kidney Foundation of Maryland Professional Development Award (to V. C.).	Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Chauvet V, 2002, AM J PATHOL, V160, P973, DOI 10.1016/S0002-9440(10)64919-X; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Dallavalle S, 2012, BIOCHEM PHARMACOL, V84, P756, DOI 10.1016/j.bcp.2012.06.014; Drenth JPH, 2003, NAT GENET, V33, P345, DOI 10.1038/ng1104; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Gao HY, 2010, HUM MOL GENET, V19, P16, DOI 10.1093/hmg/ddp463; Geng L, 1996, J CLIN INVEST, V98, P2674, DOI 10.1172/JCI119090; Grimm DH, 2006, J BIOL CHEM, V281, P137, DOI 10.1074/jbc.M507845200; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Lantinga-van Leeuwen IS, 2004, HUM MOL GENET, V13, P3069, DOI 10.1093/hmg/ddh336; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Li AR, 2003, AM J HUM GENET, V72, P691, DOI 10.1086/368295; Liang GQ, 2008, HUM MOL GENET, V17, P3254, DOI 10.1093/hmg/ddn221; Liang GQ, 2008, HUM MOL GENET, V17, P1109, DOI 10.1093/hmg/ddm383; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; McConkey DJ, 2012, ADV CANCER RES, V116, P131, DOI 10.1016/B978-0-12-394387-3.00004-5; Merrick D, 2012, DEV CELL, V22, P197, DOI 10.1016/j.devcel.2011.10.028; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Nims N, 2003, BIOCHEMISTRY-US, V42, P13035, DOI 10.1021/bi035074c; Ong ACM, 1999, KIDNEY INT, V56, P1324, DOI 10.1046/j.1523-1755.1999.00659.x; Park EY, 2009, J BIOL CHEM, V284, P7214, DOI 10.1074/jbc.M805890200; Patel V, 2012, J AM SOC NEPHROL, V23, P1941, DOI 10.1681/ASN.2012030321; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Ramasubbu K, 1998, J AM SOC NEPHROL, V9, P937; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Simms-Waldrip T, 2008, MOL GENET METAB, V94, P283, DOI 10.1016/j.ymgme.2008.03.012; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Wu WKK, 2010, DRUG RESIST UPDATE, V13, P87, DOI 10.1016/j.drup.2010.04.003; Xiong R, 2013, CHEM-BIOL INTERACT, V204, P116, DOI 10.1016/j.cbi.2013.04.016; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	42	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6404	6414		10.1074/jbc.M113.501205	http://dx.doi.org/10.1074/jbc.M113.501205			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24459142	hybrid, Green Published			2022-12-25	WOS:000332389400009
J	Chen, L; Schrementi, ME; Ranzer, MJ; Wilgus, TA; DiPietro, LA				Chen, Lin; Schrementi, Megan E.; Ranzer, Matthew J.; Wilgus, Traci A.; DiPietro, Luisa A.			Blockade of Mast Cell Activation Reduces Cutaneous Scar Formation	PLOS ONE			English	Article							WOUND CONTRACTION; GROWTH-FACTOR; I COLLAGEN; SKIN; TRYPTASE; MICE; FIBROBLASTS; EXPRESSION; INJURY; MYOFIBROBLASTS	Damage to the skin initiates a cascade of well-orchestrated events that ultimately leads to repair of the wound. The inflammatory response is key to wound healing both through preventing infection and stimulating proliferation and remodeling of the skin. Mast cells within the tissue are one of the first immune cells to respond to trauma, and upon activation they release pro-inflammatory molecules to initiate recruitment of leukocytes and promote a vascular response in the tissue. Additionally, mast cells stimulate collagen synthesis by dermal fibroblasts, suggesting they may also influence scar formation. To examine the contribution of mast cells in tissue repair, we determined the effects the mast cell inhibitor, disodium cromoglycate (DSCG), on several parameters of dermal repair including, inflammation, re-epithelialization, collagen fiber organization, collagen ultrastructure, scar width and wound breaking strength. Mice treated with DSCG had significantly reduced levels of the inflammatory cytokines IL-1 alpha, IL-1 beta, and CXCL1. Although DSCG treatment reduced the production of inflammatory mediators, the rate of re-epithelialization was not affected. Compared to control, inhibition of mast cell activity caused a significant decrease in scar width along with accelerated collagen re-organization. Despite the reduced scar width, DSCG treatment did not affect the breaking strength of the healed tissue. Tryptase beta 1 exclusively produced by mast cells was found to increase significantly in the course of wound healing. However, DSCG treatment did not change its level in the wounds. These results indicate that blockade of mast cell activation reduces scar formation and inflammation without further weakening the healed wound.	[Chen, Lin; Schrementi, Megan E.; Ranzer, Matthew J.; Wilgus, Traci A.; DiPietro, Luisa A.] Univ Illinois, Ctr Wound Healing & Tissue Regenerat, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	DiPietro, LA (corresponding author), Univ Illinois, Ctr Wound Healing & Tissue Regenerat, Chicago, IL 60607 USA.	Ldipiet@uic.edu			NIH [R01-GM55238, R01-GM50875, P20-GM078426, 5T32AA013527]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055238, R01GM050875, P20GM078426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013527] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This publication was supported by NIH Grants R01-GM55238 (LAD), R01-GM50875 (LAD), P20-GM078426 (LAD), and 5T32AA013527 (MJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1998, CLIN EXP ALLERGY, V28, P1509; Artuc M, 1999, EXP DERMATOL, V8, P1, DOI 10.1111/j.1600-0625.1999.tb00342.x; Boesiger J, 1998, J EXP MED, V188, P1135, DOI 10.1084/jem.188.6.1135; Cairns JA, 1997, J CLIN INVEST, V99, P1313, DOI 10.1172/JCI119290; Chen L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-471; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Egozi EI, 2003, WOUND REPAIR REGEN, V11, P46, DOI 10.1046/j.1524-475X.2003.11108.x; Ferreira AM, 2006, J INVEST DERMATOL, V126, P1900, DOI 10.1038/sj.jid.5700302; Gailit J, 2001, J INVEST DERMATOL, V117, P1113, DOI 10.1046/j.1523-1747.2001.15211.x; Gallant-Behm CL, 2008, WOUND REPAIR REGEN, V16, P226, DOI 10.1111/j.1524-475X.2008.00363.x; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; Gamelli RL, 2003, METH MOLEC MED, V78, P37; GEISSLER EN, 1983, EXP HEMATOL, V11, P461; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Gruber BL, 1997, J IMMUNOL, V158, P2310; Huttunen M, 2000, EXP DERMATOL, V9, P258, DOI 10.1034/j.1600-0625.2000.009004258.x; IOFFREDA MD, 1993, J INVEST DERMATOL, V101, P150, DOI 10.1111/1523-1747.ep12363632; KLEIN LM, 1989, P NATL ACAD SCI USA, V86, P8972, DOI 10.1073/pnas.86.22.8972; Kolaczkowska E, 2001, J LEUKOCYTE BIOL, V69, P33; Mak K, 2009, J DERMATOL SCI, V56, P168, DOI 10.1016/j.jdermsci.2009.09.005; MAZUREK N, 1980, NATURE, V286, P722, DOI 10.1038/286722a0; MAZUREK N, 1980, FEBS LETT, V111, P194, DOI 10.1016/0014-5793(80)80791-5; Nagarsenker MS, 2003, INT J PHARMACEUT, V251, P49, DOI 10.1016/S0378-5173(02)00583-5; PERSINGER MA, 1983, BRIT J DERMATOL, V108, P179, DOI 10.1111/j.1365-2133.1983.tb00060.x; QU ZH, 1995, AM J PATHOL, V147, P564; Shiota N, 2010, INT ARCH ALLERGY IMM, V151, P80, DOI 10.1159/000232573; Steinhoff M, 1999, EXP DERMATOL, V8, P282; Szabo A, 1997, SHOCK, V8, P284, DOI 10.1097/00024382-199710000-00008; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; TRABUCCHI E, 1988, INT J TISSUE REACT, V10, P367; Tsai M, 2002, INT J HEMATOL, V75, P345, DOI 10.1007/BF02982122; VIDAL BD, 1988, ACTA HISTOCHEM, V83, P189; WEBER S, 1995, INT J DERMATOL, V34, P1, DOI 10.1111/j.1365-4362.1995.tb04366.x; Welker P, 2001, ARCH DERMATOL RES, V293, P249, DOI 10.1007/s004030100225; Weller K, 2006, FASEB J, V20, P2366, DOI 10.1096/fj.06-5837fje; Wilgus TA, 2003, WOUND REPAIR REGEN, V11, P25, DOI 10.1046/j.1524-475X.2003.11106.x; Wulff BC, 2012, J INVEST DERMATOL, V132, P458, DOI 10.1038/jid.2011.324	38	53	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85226	10.1371/journal.pone.0085226	http://dx.doi.org/10.1371/journal.pone.0085226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465509	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100027
J	Chow, WZ; Takebe, Y; Syafina, NE; Prakasa, MS; Chan, KG; Al-Darraji, HAA; Koh, C; Kamarulzaman, A; Tee, KK				Chow, Wei Zhen; Takebe, Yutaka; Syafina, Nur Ezreen; Prakasa, Malarvelli Soorya; Chan, Kok Gan; Al-Darraji, Haider Abdulrazzaq Abed; Koh, Clayton; Kamarulzaman, Adeeba; Tee, Kok Keng			A Newly Emerging HIV-1 Recombinant Lineage (CRF58_01B) Disseminating among People Who Inject Drugs in Malaysia	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; KUALA-LUMPUR; MOLECULAR EPIDEMIOLOGY; RISK POPULATIONS; FORM CRF33-01B; IDENTIFICATION; SEROCONVERTERS; SEQUENCE; SUBTYPES	The HIV epidemic is primarily characterised by the circulation of HIV-1 group M (main) comprising of 11 subtypes and sub-subtypes (A1, A2, B-D, F1, F2, G, H, J, and K) and to date 55 circulating recombinant forms (CRFs). In Southeast Asia, active inter-subtype recombination involving three main circulating genotypes-subtype B (including subtype B', the Thai variant of subtype B), CRF01_AE, and CRF33_01B-have contributed to the emergence of novel unique recombinant forms. In the present study, we conducted the molecular epidemiological surveillance of HIV-1 gag-RT genes among 258 people who inject drugs (PWIDs) in Kuala Lumpur, Malaysia, between 2009 and 2011 whereby a novel CRF candidate was recently identified. The near full-length genome sequences obtained from six epidemiologically unlinked individuals showed identical mosaic structures consisting of subtype B' and CRF01_AE, with six unique recombination breakpoints in the gag-RT, pol, and env regions. Among the high-risk population of PWIDs in Malaysia, which was predominantly infected by CRF33_01B (>70%), CRF58_01B circulated at a low but significant prevalence (2.3%, 6/258). Interestingly, the CRF58_01B shared two unique recombination breakpoints with other established CRFs in the region: CRF33_01B, CRF48_01B, and CRF53_01B in the gag gene, and CRF15_01B (from Thailand) in the env gene. Extended Bayesian Markov chain Monte Carlo sampling analysis showed that CRF58_01B and other recently discovered CRFs were most likely to have originated in Malaysia, and that the recent spread of recombinant lineages in the country had little influence from neighbouring countries. The isolation, genetic characterization, and evolutionary features of CRF58_01B among PWIDs in Malaysia signify the increasingly complex HIV-1 diversity in Southeast Asia that may hold an implication on disease treatment, control, and prevention.	[Chow, Wei Zhen; Takebe, Yutaka; Syafina, Nur Ezreen; Prakasa, Malarvelli Soorya; Al-Darraji, Haider Abdulrazzaq Abed; Koh, Clayton; Kamarulzaman, Adeeba; Tee, Kok Keng] Univ Malaya, Dept Med, Ctr Excellence Res AIDS CERiA, Fac Med, Kuala Lumpur, Malaysia; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan; [Chan, Kok Gan] Univ Malaya, Inst Biol Sci, Div Genet & Mol Biol, Fac Sci, Kuala Lumpur, Malaysia	Universiti Malaya; National Institute of Infectious Diseases (NIID); Universiti Malaya	Tee, KK (corresponding author), Univ Malaya, Dept Med, Ctr Excellence Res AIDS CERiA, Fac Med, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	Chan, Kok Gan/B-8347-2010; KAMARULZAMAN, ADEEBA/B-5216-2010; Tee, Kok Keng/A-8148-2008; Chow, Wei Zhen/L-8228-2013	Chan, Kok Gan/0000-0002-1883-1115; Tee, Kok Keng/0000-0002-7923-5448; 	Ministry of Higher Education, Malaysia [E-000001-20001, H-500001-00-A000011-000001, H-500001-00-A000012-000001]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This work was supported in part by grants from the Ministry of Higher Education, Malaysia: High Impact Research E-000001-20001 to AK, and High Impact Research H-500001-00-A000011-000001 and H-500001-00-A000012-000001 to KKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2007, J VIROL, V81, P8543, DOI 10.1128/JVI.00463-07; [Anonymous], 2012, GLOB REP UNAIDS REP; Beyrer C, 1998, AIDS RES HUM RETROV, V14, P1687, DOI 10.1089/aid.1998.14.1687; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Brown TM, 1996, AIDS RES HUM RETROV, V12, P1655, DOI 10.1089/aid.1996.12.1655; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Chow WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062560; Chow WZ, 2012, J VIROL, V86, P11398, DOI 10.1128/JVI.01932-12; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Lee CC, 2009, HIV MED, V10, P370, DOI 10.1111/j.1468-1293.2009.00698.x; Li Y, 2010, JAIDS-J ACQ IMM DEF, V54, P129, DOI 10.1097/QAI.0b013e3181d82ce5; Liu YJ, 2012, AIDS RES HUM RETROV, V28, P1357, DOI 10.1089/aid.2011.0376; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Ministry of Health, 2012, GLOB AIDS RESP COUNT; Ng KT, 2012, J VIROL, V86, P11405, DOI 10.1128/JVI.01949-12; Ng OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015738; Ong LY, 2014, J MED VIROL, V86, P38, DOI 10.1002/jmv.23772; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; SahBandar IN, 2011, AIDS RES HUM RETROV, V27, P97, DOI 10.1089/aid.2010.0163; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Saraswathy T. S., 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P283; Schierup MH, 2000, GENETICS, V156, P879; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tee KK, 2005, AIDS RES HUM RETROV, V21, P1046, DOI 10.1089/aid.2005.21.1046; Tee KK, 2005, AIDS, V19, P119, DOI 10.1097/00002030-200501280-00003; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Tee KK, 2006, JAIDS-J ACQ IMM DEF, V43, P523; Tovanabutra S, 2001, AIDS, V15, P1063, DOI 10.1097/00002030-200105250-00018; Tovanabutra S, 2003, AIDS RES HUM RETROV, V19, P561, DOI 10.1089/088922203322230923; Wang B, 2007, VIROLOGY, V367, P288, DOI 10.1016/j.virol.2007.05.033; WENIGER BG, 1994, AIDS, V8, pS13; Weniger BG, 1996, NEW ENGL J MED, V335, P343, DOI 10.1056/NEJM199608013350510	35	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85250	10.1371/journal.pone.0085250	http://dx.doi.org/10.1371/journal.pone.0085250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465513	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100029
J	Lazarus, D; Barron, J; Renaudie, J; Diver, P; Turke, A				Lazarus, David; Barron, John; Renaudie, Johan; Diver, Patrick; Tuerke, Andreas			Cenozoic Planktonic Marine Diatom Diversity and Correlation to Climate Change	PLOS ONE			English	Article							MACROEVOLUTIONARY CHANGE; FOSSIL RECORD; OCEAN; EVOLUTION; PACIFIC; SILICA; IMPACT; CYCLE; PHYTOPLANKTON; FORAMINIFERA	Marine planktonic diatoms export carbon to the deep ocean, playing a key role in the global carbon cycle. Although commonly thought to have diversified over the Cenozoic as global oceans cooled, only two conflicting quantitative reconstructions exist, both from the Neptune deep-sea microfossil occurrences database. Total diversity shows Cenozoic increase but is sample size biased; conventional subsampling shows little net change. We calculate diversity from a separately compiled new diatom species range catalog, and recalculate Neptune subsampled-in-bin diversity using new methods to correct for increasing Cenozoic geographic endemism and decreasing Cenozoic evenness. We find coherent, substantial Cenozoic diversification in both datasets. Many living cold water species, including species important for export productivity, originate only in the latest Miocene or younger. We make a first quantitative comparison of diatom diversity to the global Cenozoic benthic delta O-18 (climate) and carbon cycle records (delta C-13, and 20-0 Ma pCO(2)). Warmer climates are strongly correlated with lower diatom diversity (raw: rho=.92, p<.001; detrended, r=.6, p=.01). Diatoms were 20% less diverse in the early late Miocene, when temperatures and pCO(2) were only moderately higher than today. Diversity is strongly correlated to both delta C-13 and pCO(2) over the last 15 my (for both: r>.9, detrended r>.6, all p<.001), but only weakly over the earlier Cenozoic, suggesting increasingly strong linkage of diatom and climate evolution in the Neogene. Our results suggest that many living marine planktonic diatom species may be at risk of extinction in future warm oceans, with an unknown but potentially substantial negative impact on the ocean biologic pump and oceanic carbon sequestration. We cannot however extrapolate our my-scale correlations with generic climate proxies to anthropogenic time-scales of warming without additional species-specific information on proximate ecologic controls.	[Lazarus, David; Renaudie, Johan; Tuerke, Andreas] Museum Naturkunde, Berlin, Germany; [Barron, John] US Geol Survey, Menlo Pk, CA 94025 USA; [Diver, Patrick] Divdat Consulting, Wesley, AR USA; [Tuerke, Andreas] Univ Bremen, Dept Geosci, D-28359 Bremen, Germany	Leibniz Institut fur Evolutions und Biodiversitatsforschung; United States Department of the Interior; United States Geological Survey; University of Bremen	Lazarus, D (corresponding author), Museum Naturkunde, Berlin, Germany.	david.lazarus@mfn-berlin.de	Renaudie, Johan/D-9077-2012	Renaudie, Johan/0000-0002-9107-1984; Barron, John/0000-0002-9309-1145	German Federal Research Agency [DFG LA1191/8]; Center for Ecological and Evolutionary Synthesis (CEES), Oslo	German Federal Research Agency; Center for Ecological and Evolutionary Synthesis (CEES), Oslo	German Federal Research Agency grant DFG LA1191/8; database porting partial support by Center for Ecological and Evolutionary Synthesis (CEES), Oslo. Both grants to senior author (DBL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2010, PALEONTOLOGICAL SOC, V16, P55, DOI [10.1017/S1089332600001819, DOI 10.1017/S1089332600001819]; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Aze T, 2011, BIOL REV, DOI [10.1111/j.1469-185X.2011.00178.x, DOI 10.1111/J.1469-185X.2011.00178.X:]; BALDAUF JG, 1990, NATO ADV SCI I C-MAT, V308, P575; Barron J.A., 1995, SILICEOUS MICROFOSSI, V8, P107, DOI DOI 10.1017/S2475263000001446; Barron JA, 2003, DIATOM RES, V18, P203; BARRON JA, 1989, LIFE SCI R, V44, P341; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Beerling DJ, 2012, J ECOL, V100, P31, DOI 10.1111/j.1365-2745.2011.01905.x; Beerling DJ, 2011, NAT GEOSCI, V4, P418, DOI 10.1038/ngeo1186; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Berger WH, 2007, DEEP-SEA RES PT II, V54, P2399, DOI 10.1016/j.dsr2.2007.07.024; Berggren WA, 1995, GEOCHRONOLOGY TIME S, V54, P129, DOI DOI 10.2110/PEC.95.04.0129; Bopp L, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023653; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Bown PR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P481; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014130; Bradshaw CD, 2012, CLIM PAST, V8, P715, DOI DOI 10.5194/CPD-8-715-2012; BURCKLE LH, 1982, NATURE, V299, P435, DOI 10.1038/299435a0; Butzin M., 2011, PALEOCEANOGRAPHY, V26, P1; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Cermeno P, 2008, P NATL ACAD SCI USA, V105, P20344, DOI 10.1073/pnas.0811302106; Cervato C, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000805; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Cortese G, 2004, EARTH PLANET SC LETT, V224, P509, DOI 10.1016/j.epsl.2004.05.035; Dornelas M, 2012, P ROYAL SOC B, V280, P1; Dowsett HJ, 2012, NAT CLIM CHANGE, V2, P365, DOI [10.1038/NCLIMATE1455, 10.1038/nclimate1455]; Egan KE, 2013, EARTH PLANET SC LETT, V375, P34, DOI 10.1016/j.epsl.2013.04.030; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Falkowski PG, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P429; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Fils D, 2009, COMPUT GEOSCI-UK, V35, P774, DOI 10.1016/j.cageo.2008.02.035; Finkel ZV, 2007, P NATL ACAD SCI USA, V104, P20416, DOI 10.1073/pnas.0709381104; Goldner A., 2013, CLIMATE DISCUSSIONS, V9, P3489; Gradstein FM, 2004, GEOLOGIC TIME SCALE; Halpern Benjamin S., 2012, P285; Hannisdal B, 2011, GEOL SOC SPEC PUBL, V358, P19, DOI 10.1144/SP358.3; Hannisdal B, 2011, SCIENCE, V334, P1121, DOI 10.1126/science.1210695; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Hays GC, 2005, TRENDS ECOL EVOL, V20, P337, DOI 10.1016/j.tree.2005.03.004; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Huber M, 2011, CLIM PAST DISCUSS, V7, P241, DOI DOI 10.5194/CPD-7-241-2011; IPCC Core Writing Team, 2007, CLIM CHANG 2007 SYNT; Kamikuri S, 2009, PALAEOGEOGR PALAEOCL, V280, P469, DOI 10.1016/j.palaeo.2009.06.034; Katz ME, 2005, MAR GEOL, V217, P323, DOI 10.1016/j.margeo.2004.08.005; Kennett J., 1982, MARINE GEOLOGY; Kidder DL, 2005, PALAIOS, V20, P198, DOI 10.2110/palo.2003.p03-108; Kump LR, 1999, CHEM GEOL, V161, P181, DOI 10.1016/S0009-2541(99)00086-8; LaRiviere JP, 2012, NATURE, V486, P97, DOI 10.1038/nature11200; LAZARUS D, 1994, MATH GEOL, V26, P817, DOI 10.1007/BF02083119; Lazarus D, 2011, GEOB ENV SIL BIOM, P20; Lazarus D, 2006, SCI DRILL, V3, P46, DOI 10.5194/sd-3-46-2006; Lazarus D, 2012, PALEOBIOLOGY, V38, P144, DOI 10.1666/10067.1; Lazarus DB, 2011, GEOL SOC SPEC PUBL, V358, P141, DOI 10.1144/SP358.10; Lazarus DB, 2009, P NATL ACAD SCI USA, V106, P9333, DOI 10.1073/pnas.0812979106; Lazarus DB, 1995, REVISED CHRONOLOGY N; Lear CH, 2003, EARTH PLANET SC LETT, V208, P69, DOI 10.1016/S0012-821X(02)01156-1; Lear CH, 2003, EARTH PLANET SC LETT, V210, P425, DOI [10.1016/S0012-821X(03)00164-X, 10.1016/S0012-821X(03)-00164-X]; Lefebvre V, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002345; LEINEN M, 1979, GEOL SOC AM B 2, V90, P1310; Levy R, 2012, GLOBAL PLANET CHANGE, V80-81, P61, DOI 10.1016/j.gloplacha.2011.10.002; Lloyd GT, 2012, PALEOBIOLOGY, V38, P569, DOI 10.1666/11041.1; Lloyd GT, 2011, GEOL SOC SPEC PUBL, V358, P167, DOI 10.1144/SP358.11; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Lunt DJ, 2012, EARTH PLANET SC LETT, V321, P128, DOI 10.1016/j.epsl.2011.12.042; Marshall CR, 2010, SCIENCE, V329, P1156, DOI 10.1126/science.1194924; Marx FG, 2010, SCIENCE, V327, P993, DOI 10.1126/science.1185581; Mayhew PJ, 2012, P NATL ACAD SCI USA, V109, P15141, DOI 10.1073/pnas.1200844109; Micheels A, 2007, PALAEOGEOGR PALAEOCL, V253, P251, DOI 10.1016/j.palaeo.2007.03.042; Micheels A, 2011, PALAEOGEOGR PALAEOCL, V304, P337, DOI 10.1016/j.palaeo.2010.09.021; Muttoni G, 2007, PALAEOGEOGR PALAEOCL, V253, P348, DOI 10.1016/j.palaeo.2007.06.008; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nisancioglu KH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000767; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Rabosky DL, 2009, NATURE, V457, P183, DOI 10.1038/nature07435; Ragueneau O, 2000, GLOBAL PLANET CHANGE, V26, P317, DOI 10.1016/S0921-8181(00)00052-7; RAYMO ME, 1994, PALEOCEANOGRAPHY, V9, P399, DOI 10.1029/94PA00289; Renaudie J, 2013, PALEOBIOLOGY, V39, P491, DOI 10.1666/12016; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Sanderson BM, 2011, ENVIRON RES LETT, V6, P1; Scherer R.P., 2007, POND SCUM CARBON SIN, V13, P61; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; SPENCERCERVATO C, 1994, PALEOCEANOGRAPHY, V9, P739, DOI 10.1029/94PA01456; SPENCERCERVATO C, 1999, PALAEONTOLOGICA ELEC, V2; STANLEY SM, 1988, PALEOBIOLOGY, V14, P235, DOI 10.1017/S0094837300011970; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; van de Wal RSW, 2011, CLIM PAST, V7, P1459, DOI 10.5194/cp-7-1459-2011; Wei KY, 1986, PALEOCEANOGRAPHY, V1, P67, DOI 10.1029/PA001i001p00067; Willenbring JK, 2010, NATURE, V465, P211, DOI 10.1038/nature09044; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	95	75	78	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84857	10.1371/journal.pone.0084857	http://dx.doi.org/10.1371/journal.pone.0084857			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465441	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100013
J	De Boer, AA; Monk, JM; Robinson, LE				De Boer, Anna A.; Monk, Jennifer M.; Robinson, Lindsay E.			Docosahexaenoic Acid Decreases Pro-Inflammatory Mediators in an In Vitro Murine Adipocyte Macrophage Co-Culture Model	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; ADIPOSE-TISSUE INFLAMMATION; POLYUNSATURATED FATTY-ACIDS; TNF-ALPHA EXPRESSION; PPAR-GAMMA; INSULIN ACTION; MESSENGER-RNA; ADIPONECTIN; CELLS; DIET	Paracrine interactions between adipocytes and macrophages contribute to chronic inflammation in obese adipose tissue. Dietary strategies to mitigate such inflammation include long-chain polyunsaturated fatty acids, docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids, which act through PPAR gamma-dependent and independent pathways. We utilized an in vitro co-culture model designed to mimic the ratio of macrophages: adipocytes in obese adipose tissue, whereby murine 3T3-L1 adipocytes were cultured with RAW 264.7 macrophages in direct contact, or separated by a trans-well membrane (contact-independent mechanism), with 125 mu M of albumin-complexed DHA, EPA, palmitic acid (PA), or albumin alone (control). Thus, we studied the effect of physical cell contact versus the presence of soluble factors, with or without a PPAR gamma antagonist (T0070907) in order to elucidate putative mechanisms. After 12 hr, DHA was the most anti-inflammatory, decreasing MCP1 and IL-6 secretion in the contact system (-57%, -63%, respectively, p <= 0.05)with similar effects in the trans-well system. The trans-well system allowed for isolation of cell types for inflammatory mediator analysis. DHA decreased mRNA expression (p<0.05) of Mcp1 (-7.1 fold) and increased expression of the negative regulator, Mcp1-IP (+1.5 fold). In macrophages, DHA decreased mRNA expression of pro-inflammatory M1 polarization markers (p <= 0.05), Nos2 (iNOS; -7 fold), Tnf alpha (-4.2 fold) and Nf kappa b (-2.3 fold), while increasing anti-inflammatory Tgf beta 1 (+1.7 fold). Interestingly, the PPAR gamma antagonist co-administered with DHA or EPA in co-culture reduced (p <= 0.05) adiponectin cellular protein, without modulating other cytokines (protein or mRNA). Overall, our findings suggest that DHA may lessen the degree of MCP1 and IL-6 secreted from adipocytes, and may reduce the degree of M1 polarization of macrophages recruited to adipose tissue, thereby decreasing the intensity of pro-inflammatory cross-talk between adipocytes and macrophages in obese adipose tissue.	[De Boer, Anna A.; Monk, Jennifer M.; Robinson, Lindsay E.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Robinson, LE (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	lrobinso@uoguelph.ca			Natural Science and Engineering Research Council of Canada [400536]; CBS PhD award from the College of Biological Sciences, University of Guelph	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); CBS PhD award from the College of Biological Sciences, University of Guelph	This study was funded by the Natural Science and Engineering Research Council of Canada (LER; 400536). AAD was supported by the CBS PhD award from the College of Biological Sciences, University of Guelph. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; Bradley RL, 2008, OBESITY, V16, P938, DOI 10.1038/oby.2008.39; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Chen CW, 2003, J IMMUNOL, V171, P979, DOI 10.4049/jimmunol.171.2.979; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Greene M. E., 1995, Gene Expression, V4, P281; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Hsueh HW, 2011, J NUTR, V141, P1260, DOI 10.3945/jn.110.132571; Kadegowda AKG, 2009, J DAIRY SCI, V92, P4276, DOI 10.3168/jds.2008-1932; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lolmede K, 2011, DIABETES METAB, V37, P283, DOI 10.1016/j.diabet.2011.03.002; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Martin H, 2010, MUTAT RES-FUND MOL M, V690, P57, DOI 10.1016/j.mrfmmm.2009.09.009; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oliver E, 2012, J NUTR BIOCHEM, V23, P1192, DOI 10.1016/j.jnutbio.2011.06.014; Oster RT, 2010, APPL PHYSIOL NUTR ME, V35, P783, DOI 10.1139/H10-076; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Scheele C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039657; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Surmi BK, 2008, FUTURE LIPIDOL, V3, P545, DOI 10.2217/17460875.3.5.545; Takahashi K, 2008, AM J PHYSIOL-ENDOC M, V294, pE898, DOI 10.1152/ajpendo.00131.2007; Thieringer R, 2000, J IMMUNOL, V164, P1046, DOI 10.4049/jimmunol.164.2.1046; Tishinsky JM, 2011, OBESITY, V19, P262, DOI 10.1038/oby.2010.186; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Turk H. F., 2012, PROSTAGLANDINS LEUKO, V88, P43; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Wilson SAF, 2013, INT J OBESITY, V37, P350, DOI 10.1038/ijo.2012.50; Xie LL, 2010, CLIN VACCINE IMMUNOL, V17, P651, DOI 10.1128/CVI.00494-09	46	46	47	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85037	10.1371/journal.pone.0085037	http://dx.doi.org/10.1371/journal.pone.0085037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465472	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500029
J	Fernandez-Ponce, C; Dominguez-Villar, M; Aguado, E; Garcia-Cozar, F				Fernandez-Ponce, Cecilia; Dominguez-Villar, Margarita; Aguado, Enrique; Garcia-Cozar, Francisco			CD4+Primary T Cells Expressing HCV-Core Protein Upregulate Foxp3 and IL-10, Suppressing CD4 and CD8 T Cells	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; BLOOD MONONUCLEAR-CELLS; CELLULAR IMMUNE-RESPONSES; IN-VITRO PROLIFERATION; PERIPHERAL-BLOOD; INFECTED PATIENTS; PD-1 EXPRESSION; VIRAL CLEARANCE; HELPER-CELLS; LYMPHOCYTES	Adaptive T cell responses are critical for controlling HCV infection. While there is clinical evidence of a relevant role for regulatory T cells in chronic HCV-infected patients, based on their increased number and function; mechanisms underlying such a phenomena are still poorly understood. Accumulating evidence suggests that proteins from Hepatitis C virus can suppress host immune responses. We and others have shown that HCV is present in CD4+ lymphocytes from chronically infected patients and that HCV-core protein induces a state of unresponsiveness in the CD4+ tumor cell line Jurkat. Here we show that CD4+ primary T cells lentivirally transduced with HCV-core, not only acquire an anergic phenotype but also inhibit IL-2 production and proliferation of bystander CD4+ or CD8+ T cells in response to anti-CD3 plus anti-CD28 stimulation. Core-transduced CD4+ T cells show a phenotype characterized by an increased basal secretion of the regulatory cytokine IL-10, a decreased IFN-gamma production upon stimulation, as well as expression of regulatory T cell markers, CTLA-4, and Foxp3. A significant induction of CD4+CD25+CD127(low)PD-1(high)TIM-3(high) regulatory T cells with an exhausted phenotype was also observed. Moreover, CCR7 expression decreased in HCV-core expressing CD4+ T cells explaining their sequestration in inflamed tissues such as the infected liver. This work provides a new perspective on de novo generation of regulatory CD4+ T cells in the periphery, induced by the expression of a single viral protein.	[Garcia-Cozar, Francisco] Univ Cadiz, Dept Biomed Biotechnol & Publ Hlth Immunol, Cadiz, Spain; Puerto Real Univ Hosp, Res Unit, Sch Med, Cadiz, Spain	Universidad de Cadiz; Universidad de Cadiz; Hospital Universitario Puerto Real	Garcia-Cozar, F (corresponding author), Univ Cadiz, Dept Biomed Biotechnol & Publ Hlth Immunol, Cadiz, Spain.	curro.garcia@uca.es	Garcia-Cozar, Francisco/A-6212-2013; Ponce, Cecilia Matilde Fernández/L-4752-2014; Aguado, Enrique/L-4908-2014	Garcia-Cozar, Francisco/0000-0003-3720-259X; Ponce, Cecilia Matilde Fernández/0000-0002-0027-1703; Aguado, Enrique/0000-0002-7232-2661; Dominguez-Villar, Margarita/0000-0002-9719-0028	Ministerio de Ciencia e Innovacion (Spain) [SAF2009-09449]; Consejeria de Salud, Junta de Andalucia [PI-0007/2007]; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia [P08-CTS-04348]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia(Junta de Andalucia)	This work was supported by grants (SAF2009-09449) from the Ministerio de Ciencia e Innovacion (Spain), PI-0007/2007 from Consejeria de Salud, Junta de Andalucia, and P08-CTS-04348 from Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia to FGC. MDV was a graduate fellow of the FIS program (Ministerio de Salud, Spain) and CFP is a graduate fellow of the Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Aberle JH, 2006, J CLIN VIROL, V36, P24, DOI 10.1016/j.jcv.2005.12.010; Alatrakchi N, 2007, J VIROL, V81, P5882, DOI 10.1128/JVI.02202-06; Andris F, 2004, J IMMUNOL, V173, P3201, DOI 10.4049/jimmunol.173.5.3201; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Bergqvist A, 2001, J VIROL, V75, P772, DOI 10.1128/JVI.75.2.772-781.2001; Billerbeck E, 2009, J GEN VIROL, V90, P1692, DOI 10.1099/vir.0.009837-0; Blackard JT, 2005, J INFECT DIS, V192, P258, DOI 10.1086/430949; Boettler T, 2005, J VIROL, V79, P7860, DOI 10.1128/JVI.79.12.7860-7867.2005; Bolacchi F, 2006, CLIN EXP IMMUNOL, V144, P188, DOI 10.1111/j.1365-2249.2006.03048.x; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Campbell DJ, 2007, NAT REV IMMUNOL, V7, P305, DOI 10.1038/nri2061; Carabaich A, 2005, J MED VIROL, V76, P55, DOI 10.1002/jmv.20322; Castello G, 2010, CLIN IMMUNOL, V134, P237, DOI 10.1016/j.clim.2009.10.007; Castillo I, 2005, GUT, V54, P682, DOI 10.1136/gut.2004.057281; CHEN A, 1994, J IMMUNOL, V153, P1430; Claassen MAA, 2011, J VIROL, V85, P5323, DOI 10.1128/JVI.02551-10; Claassen MAA, 2010, J HEPATOL, V52, P315, DOI 10.1016/j.jhep.2009.12.013; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Dehesa-Violante M, 2007, ARCH MED RES, V38, P606, DOI 10.1016/j.arcmed.2007.03.001; Dominguez-Villar M, 2007, J LEUKOCYTE BIOL, V82, P1301, DOI 10.1189/jlb.0507335; Dominguez-Villar M, 2012, SCAND J IMMUNOL, V75, P54, DOI 10.1111/j.1365-3083.2011.02624.x; Dominguez-Villar M, 2012, CLIN SCI, V123, P15, DOI 10.1042/CS20110631; Doumba PP, 2013, CELL MOL LIFE SCI; Ebinuma H, 2008, J VIROL, V82, P5043, DOI 10.1128/JVI.01548-07; Eckels DD, 1999, HUM IMMUNOL, V60, P187, DOI 10.1016/S0198-8859(98)00111-6; El-Awady MK, 2005, WORLD J GASTROENTERO, V11, P5203; Engelhardt JJ, 2006, J IMMUNOL, V177, P1052, DOI 10.4049/jimmunol.177.2.1052; Falcon V, 2005, BIOCHEM BIOPH RES CO, V329, P1320, DOI 10.1016/j.bbrc.2005.02.107; Falcon V, 2003, BIOCHEM BIOPH RES CO, V310, P54, DOI 10.1016/j.bbrc.2003.08.118; Ferri S, 2011, DIGEST LIVER DIS, V43, P807, DOI 10.1016/j.dld.2011.04.020; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Freeman AJ, 2001, IMMUNOL CELL BIOL, V79, P515, DOI 10.1046/j.1440-1711.2001.01036.x; Fu S, 2004, AM J TRANSPLANT, V4, P65, DOI 10.1046/j.1600-6143.2003.00293.x; Fuller MJ, 2013, P NATL ACAD SCI USA, V110, P15001, DOI 10.1073/pnas.1312772110; Gavin MA, 2007, NATURE; Golden-Mason L, 2006, HEPATOLOGY, V44, P1098, DOI 10.1002/hep.21365; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Goutagny N, 2003, J INFECT DIS, V187, P1951, DOI 10.1086/375350; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Gremion C, 2005, REV MED VIROL, V15, P235, DOI 10.1002/rmv.466; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Hall CHT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012154; Hayashi RJ, 1998, J IMMUNOL, V160, P33; Hiroishi K, 2008, J GASTROEN HEPATOL, V23, P1473, DOI 10.1111/j.1440-1746.2008.05475.x; Huang CT, 2003, J IMMUNOL, V170, P3945, DOI 10.4049/jimmunol.170.8.3945; Irshad M, 2006, MED PRIN PRACT, V15, P405, DOI 10.1159/000095485; Ji XJ, 2013, EUR J IMMUNOL, V43, P458, DOI 10.1002/eji.201242768; Kakumu S, 1997, CLIN EXP IMMUNOL, V108, P138, DOI 10.1046/j.1365-2249.1997.d01-987.x; Kaplan DE, 2008, J HEPATOL, V48, P903, DOI 10.1016/j.jhep.2008.01.030; Kared H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003422; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Kondo Y, 2006, VIROLOGY; Kondo Y, 2011, J GASTROENTEROL, V46, P232, DOI 10.1007/s00535-010-0297-2; Koziel MJ, 2005, CLIN INFECT DIS, V41, pS25, DOI 10.1086/429492; Koziel MJ, 1999, SEMIN LIVER DIS, V19, P157, DOI 10.1055/s-2007-1007107; Krishnadas DK, 2010, VACCINE, V28, P2104, DOI 10.1016/j.vaccine.2009.12.037; Lange C, 2011, BRAIN BEHAV IMMUN, V25, P120, DOI 10.1016/j.bbi.2010.09.004; Langhans B, 2010, CLIN SCI, V119, P97, DOI 10.1042/CS20090661; Laskus T, 1998, J INFECT DIS, V178, P1189, DOI 10.1086/515682; Laskus T, 2007, J INFECT DIS, V195, P124, DOI 10.1086/509897; Lauer GM, 2006, CLIN INFECT DIS, V42, P953, DOI 10.1086/500944; Lee S, 2010, CLIN EXP IMMUNOL, V161, P118, DOI 10.1111/j.1365-2249.2010.04141.x; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li S, 2007, IMMUNOL CELL BIOL, V85, P197, DOI 10.1038/sj.icb.7100020; MacDonald AJ, 2002, J INFECT DIS, V185, P720, DOI 10.1086/339340; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Maillard P, 2001, J VIROL, V75, P8240, DOI 10.1128/JVI.75.17.8240-8250.2001; Manigold T, 2007, LANCET INFECT DIS, V7, P804, DOI 10.1016/S1473-3099(07)70289-X; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Melen K, 2004, J MED VIROL, V73, P536, DOI 10.1002/jmv.20123; Menning A, 2007, EUR J IMMUNOL, V37, P1575, DOI 10.1002/eji.200737201; Moorman JP, 2012, J IMMUNOL, V189, P755, DOI 10.4049/jimmunol.1200162; Muhanna N, 2008, HEPATOLOGY, V48, P963, DOI 10.1002/hep.22413; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Pal S, 2006, GASTROENTEROLOGY, V130, P1107, DOI 10.1053/j.gastro.2005.12.039; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pham TNQ, 2004, J VIROL, V78, P5867, DOI 10.1128/JVI.78.11.5867-5874.2004; Pham TN, 2008, WORLD J GASTROENTERO, V14, P2789, DOI 10.3748/wjg.14.2789; Piazzolla G, 2000, J CLIN IMMUNOL, V20, P54, DOI 10.1023/A:1006694627907; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Quiroga JA, 2006, J VIROL, V80, P10972, DOI 10.1128/JVI.00852-06; Radkowski M, 2002, J VIROL, V76, P600, DOI 10.1128/JVI.76.2.600-608.2002; Radziewicz H, 2008, J VIROL, V82, P9808, DOI 10.1128/JVI.01075-08; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Radziewicz H, 2009, J CLIN INVEST, V119, P450, DOI 10.1172/JCI38661; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rehermann B, 2007, SEMIN LIVER DIS, V27, P152, DOI 10.1055/s-2007-979468; Rushbrook SM, 2007, EXPERT OPIN BIOL TH, V7, P1689, DOI 10.1517/14712598.7.11.1689; Rushbrook SM, 2005, J VIROL, V79, P7852, DOI 10.1128/JVI.79.12.7852-7859.2005; Rustgi VK, 2007, J GASTROENTEROL, V42, P513, DOI 10.1007/s00535-007-2064-6; Safadi R, 2004, GASTROENTEROLOGY, V127, P870, DOI 10.1053/j.gastro.2004.04.062; Sakthivel P, 2012, REV RECENT CLIN TRIA, V7, P10, DOI 10.2174/157488712799363262; Semmo N, 2005, HEPATOLOGY, V41, P1019, DOI 10.1002/hep.20669; Serti E, 2011, CELL MOL LIFE SCI, V68, P505, DOI 10.1007/s00018-010-0466-8; Shen T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-279; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Soguero C, 2002, J VIROL, V76, P9345, DOI 10.1128/JVI.76.18.9345-9354.2002; Spangenberg HC, 2005, HEPATOLOGY, V42, P828, DOI 10.1002/hep.20856; Sturm N, 2010, J HEPATOL, V53, P25, DOI 10.1016/j.jhep.2010.02.024; Sugimoto K, 2003, HEPATOLOGY, V38, P1437, DOI 10.1016/j.hep.2003.09.026; Sundstrom S, 2005, J VIROL, V79, P2230, DOI 10.1128/JVI.79.4.2230-2239.2005; Tellinghuisen TL, 2002, CURR OPIN MICROBIOL, V5, P419, DOI 10.1016/S1369-5274(02)00341-7; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Tsai SL, 1997, HEPATOLOGY, V25, P449; Tseng CTK, 2002, J EXP MED, V195, P43, DOI 10.1084/jem.20011145; Tsitoura P, 2007, FEBS LETT, V581, P4049, DOI 10.1016/j.febslet.2007.07.032; Ulsenheimer A, 2003, HEPATOLOGY, V37, P1189, DOI 10.1053/jhep.2003.50194; Venken K, 2007, J IMMUNOL METHODS, V322, P1, DOI 10.1016/j.jim.2007.01.025; Ward SM, 2007, J HEPATOL, V47, P316, DOI 10.1016/j.jhep.2007.03.023; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Woitas RP, 1997, J IMMUNOL, V159, P1012; Yao ZQ, 2003, VIROLOGY, V314, P271, DOI 10.1016/S0042-6822(03)00419-7; Zhao BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077008; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zignego AL, 2007, DIGEST LIVER DIS, V39, P2, DOI 10.1016/j.dld.2006.06.008; zur Wiesch JS, 2005, J IMMUNOL, V175, P3603, DOI 10.4049/jimmunol.175.6.3603	124	17	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85191	10.1371/journal.pone.0085191	http://dx.doi.org/10.1371/journal.pone.0085191			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465502	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500037
J	Lin, ZH; Zhang, C; Zhang, MF; Xu, DQ; Fang, YF; Zhou, Z; Chen, XL; Qin, N; Zhang, XW				Lin, Zhaohu; Zhang, Chao; Zhang, Meifang; Xu, Danqing; Fang, Yanfen; Zhou, Zheng; Chen, Xiaolong; Qin, Ning; Zhang, Xiongwen			Targeting Cadherin-17 Inactivates Ras/Raf/MEK/ERK Signaling and Inhibits Cell Proliferation in Gastric Cancer	PLOS ONE			English	Article							LIVER-INTESTINE-CADHERIN; LI-CADHERIN; HEPATOCELLULAR-CARCINOMA; DIAGNOSTIC MARKER; TUMOR-GROWTH; EXPRESSION; METASTASIS; PATHWAY; ADENOCARCINOMAS; INVASIVENESS	Cadherin-17 (CDH17), one member of 7D-cadherin superfamily, was overexpressed in gastric cancer (GC) and was associated with poor survival, tumor recurrence, metastasis, and advanced tumor stage. So far the cellular function and signaling mechanism of CDH17 in GC remains unclear. In this study, we showed that over 66% of GC cell lines (20/30) were CDH17 positive. Tissue microarray (TMA) assay showed that 73.6% Chinese GC tissues (159/216) were CDH17 positive, while 37% respective adjacent normal tissues were CDH17 positive. Knockdown of CDH17 inhibited cell proliferation, migration, adhesion and colony formation, and also induced a cell cycle arrest and apoptosis in AGS human GC cells. On the other side, overexpression of CDH17 facilitated MGC-803 GC tumor growth in nude mice. Antibody array and Western blotting assay demonstrated that knockdown of CDH17 in AGS cells down-regulated integrin beta series proteins, further inactivated the Ras/Raf/MEK/ERK pathway and led to p53 and p21 accumulation, which resulted in proliferation inhibition, cell-cycle arrest and apoptosis induction. Collectively, our data firstly demonstrate the capacity of CDH17 to regulate the activity of Ras/Raf/MEK/ERK pathway for cell proliferation in GC, and suggest that CDH17 can serve as an attractive therapeutic target for future research.	[Lin, Zhaohu; Zhang, Chao; Zhang, Meifang; Xu, Danqing; Zhou, Zheng; Chen, Xiaolong; Qin, Ning; Zhang, Xiongwen] Roche Pharma Res & Early Dev China, Dept Discovery Technol, Shanghai, Peoples R China; [Fang, Yanfen; Zhang, Xiongwen] E China Normal Univ, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Shanghai 200062, Peoples R China	East China Normal University	Zhang, XW (corresponding author), Roche Pharma Res & Early Dev China, Dept Discovery Technol, Shanghai, Peoples R China.	xwzhang@sat.ecnu.edu.cn						Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bartolome R. A., 2013, ONCOGENE; Dong WG, 2008, DIGEST DIS SCI, V53, P1811, DOI 10.1007/s10620-007-0080-2; Dulic V, 1998, MOL CELL BIOL, V18, P546, DOI 10.1128/MCB.18.1.546; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Ge J, 2008, CLIN ONCOL-UK, V20, P275, DOI 10.1016/j.clon.2008.01.013; Grotzinger C, 2001, GUT, V49, P73, DOI 10.1136/gut.49.1.73; Hartgrink HH, 2009, GASTRIC CANCER, V12, P3, DOI 10.1007/s10120-009-0501-3; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; Hippo Y, 2002, CANCER RES, V62, P233; Ito R, 2005, VIRCHOWS ARCH, V447, P717, DOI 10.1007/s00428-005-0015-2; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Ko S, 2004, BIOCHEM BIOPH RES CO, V319, P562, DOI 10.1016/j.bbrc.2004.04.197; Lee HJ, 2010, GASTROENTEROLOGY, V139, P213, DOI 10.1053/j.gastro.2010.04.008; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; Liu QS, 2010, CANCER SCI, V101, P1807, DOI 10.1111/j.1349-7006.2010.01600.x; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Park JH, 2011, HISTOPATHOLOGY, V58, P316, DOI 10.1111/j.1365-2559.2011.03746.x; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Su MC, 2008, MODERN PATHOL, V21, P1379, DOI 10.1038/modpathol.2008.107; Takamura M, 2003, CANCER SCI, V94, P425, DOI 10.1111/j.1349-7006.2003.tb01459.x; Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Wang J, 2013, CANCER BIOL THER, V14, P262, DOI 10.4161/cbt.23299; Wang XQ, 2005, CLIN CANCER RES, V11, P483; Wong BW, 2003, BIOCHEM BIOPH RES CO, V311, P618, DOI 10.1016/j.bbrc.2003.10.032; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Xu Y, 2012, WORLD J GASTROENTERO, V18, P3129, DOI 10.3748/wjg.v18.i24.3129; Yee KL, 2008, IET SYST BIOL, V2, P8, DOI 10.1049/iet-syb:20060058; Zhang J, 2011, MED ONCOL, V28, P494, DOI 10.1007/s12032-010-9489-0	31	27	37	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85296	10.1371/journal.pone.0085296	http://dx.doi.org/10.1371/journal.pone.0085296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465527	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500039
J	Retschnig, G; Williams, GR; Mehmann, MM; Yanez, O; de Miranda, JR; Neumann, P				Retschnig, Gina; Williams, Geoffrey R.; Mehmann, Marion M.; Yanez, Orlando; de Miranda, Joachim R.; Neumann, Peter			Sex-Specific Differences in Pathogen Susceptibility in Honey Bees (Apis mellifera)	PLOS ONE			English	Article							PAENIBACILLUS-LARVAE-LARVAE; WING VIRUS-INFECTION; DRONE BROOD CELLS; NOSEMA-CERANAE; VARROA-JACOBSONI; AMERICAN FOULBROOD; IMMUNE-RESPONSE; PARALYSIS VIRUS; COLONIES; PCR	Sex-related differences in susceptibility to pathogens are a common phenomenon in animals. In the eusocial Hymenoptera the two female castes, workers and queens, are diploid and males are haploid. The haploid susceptibility hypothesis predicts that haploid males are more susceptible to pathogen infections compared to females. Here we test this hypothesis using adult male (drone) and female (worker) honey bees (Apis mellifera), inoculated with the gut endoparasite Nosema ceranae and/or black queen cell virus (BQCV). These pathogens were chosen due to previously reported synergistic interactions between Nosema apis and BQCV. Our data do not support synergistic interactions between N. ceranae and BQCV and also suggest that BQCV has limited effect on both drone and worker health, regardless of the infection level. However, the data clearly show that, despite lower levels of N. ceranae spores in drones than in workers, Nosema-infected drones had both a higher mortality and a lower body mass than non-infected drones, across all treatment groups, while the mortality and body mass of worker bees were largely unaffected by N. ceranae infection, suggesting that drones are more susceptible to this pathogen than workers. In conclusion, the data reveal considerable sex-specific differences in pathogen susceptibility in honey bees and highlight the importance of ultimate measures for determining susceptibility, such as mortality and body quality, rather than mere infection levels.	[Retschnig, Gina; Williams, Geoffrey R.; Mehmann, Marion M.; Yanez, Orlando; Neumann, Peter] Res Stn Agroscope Liebefeld Posieux ALP HARAS, Swiss Bee Res Ctr, Bern, Switzerland; [Retschnig, Gina; Williams, Geoffrey R.; Yanez, Orlando; Neumann, Peter] Univ Bern, Inst Bee Hlth, Vetsuisse Fac, Bern, Switzerland; [Williams, Geoffrey R.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [de Miranda, Joachim R.] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Neumann, Peter] Univ Pretoria, Dept Zool & Entomol, Social Insect Res Grp, ZA-0002 Pretoria, South Africa	Swiss Federal Research Station Agroscope; University of Bern; Dalhousie University; Swedish University of Agricultural Sciences; University of Pretoria	Retschnig, G (corresponding author), Res Stn Agroscope Liebefeld Posieux ALP HARAS, Swiss Bee Res Ctr, Bern, Switzerland.	gina.retschnig@gmail.com	Williams, Geoffrey/C-9637-2015; Yanez, Orlando/AAQ-8347-2020; Yanez, Orlando/I-2428-2016; Neumann, Peter/C-9964-2015	Williams, Geoffrey/0000-0002-0093-1126; Yanez, Orlando/0000-0001-8493-2726; Yanez, Orlando/0000-0001-8493-2726; Neumann, Peter/0000-0001-5163-5215; Retschnig, Gina/0000-0001-6249-9853; Rodrigues de Miranda, Joachim/0000-0002-0335-0386	European Union [244956]; BEEDOC (BEes in Europe and the Decline Of Colonies); Vinetum, Swiss National Science and Ricola foundations	European Union(European Commission); BEEDOC (BEes in Europe and the Decline Of Colonies); Vinetum, Swiss National Science and Ricola foundations	The research has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. (244956 CPFP), BEEDOC (BEes in Europe and the Decline Of Colonies), as well as the Vinetum, Swiss National Science and Ricola foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2001, ANIM BEHAV, V62, P417, DOI 10.1006/anbe.2001.1786; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Anderson D., 1993, Australasian Beekeeper, V94, P292; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; Azzami K, 2012, ARCH VIROL, V157, P689, DOI 10.1007/s00705-012-1223-0; BAILEY L, 1983, ANN APPL BIOL, V103, P13, DOI 10.1111/j.1744-7348.1983.tb02735.x; BAILEY L, 1977, J GEN VIROL, V37, P175, DOI 10.1099/0022-1317-37-1-175; Bailey L., 1972, Journal apic Res, V11, P171; Bailey L, 1991, HONEYBEE PATHOLOGY; BOOT WJ, 1995, APIDOLOGIE, V26, P109, DOI 10.1051/apido:19950204; Brodsgaard CJ, 2000, APIDOLOGIE, V31, P543, DOI 10.1051/apido:2000145; Burgher-MacLellan KL, 2010, CAN ENTOMOL, V142, P271, DOI 10.4039/n10-010; CAMAZINE S, 1986, ANN ENTOMOL SOC AM, V79, P801, DOI 10.1093/aesa/79.5.801; Cantwell G. E., 1970, AM BEE J, V110, P222; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Costa C, 2011, J INVERTEBR PATHOL, V108, P224, DOI 10.1016/j.jip.2011.08.012; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; Crailsheim K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.05; DEMIRANDA JR, 2013, J APICULT RES, V52, DOI DOI 10.3896/IBRA.1.52.4.22; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Duay Pedro, 2002, Genetics and Molecular Research, V1, P227; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Evans Jay D., 2006, BMC Ecology, V6, P4, DOI 10.1186/1472-6785-6-4; Evans JD, 2005, J APICULT RES, V44, P168; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Fries I, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.14; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; FUCHS S, 1990, APIDOLOGIE, V21, P193, DOI 10.1051/apido:19900304; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; Gauthier L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016217; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; GROSSMAN C, 1989, J STEROID BIOCHEM, V34, P241, DOI 10.1016/0022-4731(89)90088-5; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Hrassnigg N, 2005, APIDOLOGIE, V36, P255, DOI 10.1051/apido:2005015; Huang Q, 2012, J INVERTEBR PATHOL, V109, P297, DOI 10.1016/j.jip.2012.01.004; Human H, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.10; KELLNER N, 1978, VLAAMS DIERGEN TIJDS, V47, P252; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koeniger G, 2005, APIDOLOGIE, V36, P143, DOI 10.1051/apido:2005017; Koeniger N, 2005, APIDOLOGIE, V36, P211, DOI 10.1051/apido:2005011; Kurtz J, 2000, DEV COMP IMMUNOL, V24, P1, DOI 10.1016/S0145-305X(99)00057-9; Locke B, 2012, APPL ENVIRON MICROB, V78, P227, DOI 10.1128/AEM.06094-11; LOCKE SJ, 1993, PHYSIOL ENTOMOL, V18, P144, DOI 10.1111/j.1365-3032.1993.tb00461.x; Martin SJ, 2013, ENV MICROBIOL REP, V5, P506, DOI 10.1111/1758-2229.12052; Mayack C, 2010, J INSECT PHYSIOL, V56, P1572, DOI 10.1016/j.jinsphys.2010.05.016; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Morton A, 2013, J INVERTEBR PATHOL, V112, P203, DOI 10.1016/j.jip.2012.11.012; Neumann P, 2000, INSECT SOC, V47, P271, DOI 10.1007/PL00001714; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; O'Donnell S, 2004, P ROY SOC B-BIOL SCI, V271, P979, DOI 10.1098/rspb.2004.2685; OERTEL E., 1953, ANN ENT SOC AMER, V46, P596; Otteni M, 2004, APIACTA, V39, P91; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Poulin R, 2007, EVOLUTIONARY ECOLOGY, P188; Rhodes JW, 2011, APIDOLOGIE, V42, P29, DOI 10.1051/apido/2010026; Ribiere M, 2008, VIROLOGY HONEY BEE, P29; RINDERER TE, 1969, J INVERTEBR PATHOL, V13, P81, DOI 10.1016/0022-2011(69)90241-9; Roff Derek A., 1992; Roman A, 2010, J APIC SCI, V54, P25; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Ruiz-Gonzalez MX, 2006, BEHAV ECOL SOCIOBIOL, V60, P501, DOI 10.1007/s00265-006-0192-2; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Siede R, 2003, BERL MUNCH TIERARZTL, V116, P130; Soroker V, 2011, APIDOLOGIE, V42, P192, DOI 10.1051/apido/2010047; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Traver BE, 2012, J INVERTEBR PATHOL, V109, P187, DOI 10.1016/j.jip.2011.11.001; Traver BE, 2011, J INVERTEBR PATHOL, V107, P234, DOI 10.1016/j.jip.2011.05.016; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; VERBEKE M, 1984, AM BEE J, V124, P468; Williams GR, 2008, J INVERTEBR PATHOL, V97, P189, DOI 10.1016/j.jip.2007.08.005; Williams GR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.04; Wilson EO, 1971, INSECT SOC, P548; Winston M.L., 1991, BIOL HONEY BEE; Yue C, 2006, J INVERTEBR PATHOL, V92, P105, DOI 10.1016/j.jip.2006.03.001; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI 10.1016/S0020-7519(96)80001-4	90	41	41	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85261	10.1371/journal.pone.0085261	http://dx.doi.org/10.1371/journal.pone.0085261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465518	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000330237000028
J	Ishtiaq, M; Campos-Melo, D; Volkening, K; Strong, MJ				Ishtiaq, Muhammad; Campos-Melo, Danae; Volkening, Kathryn; Strong, Michael J.			Analysis of Novel NEFL mRNA Targeting microRNAs in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; SELECTIVE LOSS; WEB SERVER; CELL FATE; EXPRESSION; PROTEIN; MIRNA; GENE; PREDICTION; TDP-43	Amyotrophic lateral sclerosis (ALS) is a fatal disease characterized by progressive motor neuron degeneration and neurofilament aggregate formation. Spinal motor neurons in ALS also show a selective suppression in the levels of low molecular weight neurofilament (NEFL) mRNA. We have been interested in investigating the role of microRNAs (miRNAs) in NEFL transcript stability. MiRNAs are small, 20-25 nucleotide, non-coding RNAs that act as post-transcriptional gene regulators by targeting the 3' untranslated region (3'UTR) of mRNA resulting in mRNA decay or translational silencing. In this study, we characterized putative novel miRNAs from a small RNA library derived from control and sporadic ALS (sALS) spinal cords. We detected 80 putative novel miRNAs, 24 of which have miRNA response elements (MREs) within the NEFL mRNA 3'UTR. From this group, we determined by real-time PCR that 10 miRNAs were differentially expressed in sALS compared to controls. Functional analysis by reporter gene assay and relative quantitative RT-PCR showed that two novel miRNAs, miR-b1336 and miR-b2403, were downregulated in ALS spinal cord and that both stabilize NEFL mRNA. We confirmed the direct effect of these latter miRNAs using anit-miR-b1336 and anti-miR-b2403. These results demonstrate that the expression of two miRNAs (miRNAs miR-b1336 and miR-b2403) whose effect is to stabilize NEFL mRNA are down regulated in ALS, the net effect of which is predicted to contribute directly to the loss of NEFL steady state mRNA which is pathognomic of spinal motor neurons in ALS.	[Ishtiaq, Muhammad; Campos-Melo, Danae; Volkening, Kathryn; Strong, Michael J.] Univ Western Ontario, Robarts Res Inst, Mol Med Res Grp, London, ON, Canada; [Volkening, Kathryn; Strong, Michael J.] Univ Western Ontario, Dept Clin Neurol Sci, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Strong, MJ (corresponding author), Univ Western Ontario, Robarts Res Inst, Mol Med Res Grp, London, ON, Canada.	Michael.Strong@schulich.uwo.ca	Strong, Michael/AAU-5699-2020; Strong, Michael J/H-9689-2012; Ishtiaq, Muhammad/GSN-4278-2022	Strong, Michael/0000-0003-1988-6262; 	ALS Society of Canada; Canadian Institutes of Health Research (CIHR)	ALS Society of Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Research was funded by the ALS Society of Canada (Senior Scientist Bridge Funding) and the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; BERGERON C, 1994, J NEUROPATH EXP NEUR, V53, P221, DOI 10.1097/00005072-199405000-00002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhattacharyya SN, 2007, CELL, V128, P1027, DOI 10.1016/j.cell.2007.02.033; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Buchan JR, 2007, SCIENCE, V318, P1877, DOI 10.1126/science.1152623; Campos-Melo D, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-26; Cerutti H, 2011, EUKARYOT CELL, V10, P1164, DOI 10.1128/EC.05106-11; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Crippa S, 2012, CURR PHARM DESIGN, V18, P1718, DOI 10.2174/138161212799859620; De Felice B, 2012, GENE, V508, P35, DOI 10.1016/j.gene.2012.07.058; Droppelmann CA, 2013, NEUROBIOL AGING, V34, P248, DOI 10.1016/j.neurobiolaging.2012.06.021; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Eulalio A, 2012, RNA BIOL, V9, P742, DOI 10.4161/rna.20018; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fowler A, 2011, EUR J CANCER, V47, P953, DOI 10.1016/j.ejca.2010.11.026; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ge WW, 2007, MOL CELL NEUROSCI, V34, P80, DOI 10.1016/j.mcn.2006.10.001; Ge WW, 2005, J BIOL CHEM, V280, P118, DOI 10.1074/jbc.M405065200; Ge WW, 2003, J BIOL CHEM, V278, P26558, DOI 10.1074/jbc.M302886200; Ghosh T, 2008, NUCLEIC ACIDS RES, V36, P6318, DOI 10.1093/nar/gkn624; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Iwasaki S, 2009, FLY, V3, P204; KONDO A, 1986, JPN J PSYCHIAT NEUR, V40, P677; Kucherenko MM, 2012, EMBO J, V31, P4511, DOI 10.1038/emboj.2012.298; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee S, 2013, ADV EXP MED BIOL, V768, P97, DOI 10.1007/978-1-4614-5107-5_7; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Menzies FM, 2002, J NEUROCHEM, V82, P1118, DOI 10.1046/j.1471-4159.2002.01045.x; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; O'Carroll Donal, 2013, Neuropsychopharmacology, V38, P39, DOI 10.1038/npp.2012.87; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Ritchie W, 2008, BIOINFORMATICS, V24, P1394, DOI 10.1093/bioinformatics/btn137; Saraiya AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055672; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Sonntag KC, 2010, BRAIN RES, V1338, P48, DOI 10.1016/j.brainres.2010.03.106; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Strong MJ, 2010, J NEUROL SCI, V288, P1, DOI 10.1016/j.jns.2009.09.029; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; Tyagi S, 2008, BIOCHEM BIOPH RES CO, V372, P831, DOI 10.1016/j.bbrc.2008.05.134; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Volkening K, 2010, AMYOTROPH LATERAL SC, V11, P97, DOI 10.3109/17482960902995584; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wong NKY, 2000, J NEUROPATH EXP NEUR, V59, P972, DOI 10.1093/jnen/59.11.972; Zeller John L, 2007, JAMA, V298, P248, DOI 10.1001/jama.298.2.248; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	57	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85653	10.1371/journal.pone.0085653	http://dx.doi.org/10.1371/journal.pone.0085653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454911	Green Submitted, gold, Green Published			2022-12-25	WOS:000330235100114
J	Liu, SQ; Miriyala, S; Keaton, MA; Jordan, CT; Wiedl, C; St Clair, DK; Moscow, JA				Liu, Shuqian; Miriyala, Sumitra; Keaton, Mignon A.; Jordan, Craig T.; Wiedl, Christina; St Clair, Daret K.; Moscow, Jeffrey A.			Metabolic Effects of Acute Thiamine Depletion Are Reversed by Rapamycin in Breast and Leukemia Cells	PLOS ONE			English	Article							ENZYME; IDENTIFICATION; INHIBITORS	Thiamine-dependent enzymes (TDEs) control metabolic pathways that are frequently altered in cancer and therefore present cancer-relevant targets. We have previously shown that the recombinant enzyme thiaminase cleaves and depletes intracellular thiamine, has growth inhibitory activity against leukemia and breast cancer cell lines, and that its growth inhibitory effects were reversed in leukemia cell lines by rapamycin. Now, we first show further evidence of thiaminase therapeutic potential by demonstrating its activity against breast and leukemia xenografts, and against a primary leukemia xenograft. We therefore further explored the metabolic effects of thiaminase in combination with rapamycin in leukemia and breast cell lines. Thiaminase decreased oxygen consumption rate and increased extracellular acidification rate, consistent with the inhibitory effect of acute thiamine depletion on the activity of the TDEs pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes; these effects were reversed by rapamycin. Metabolomic studies demonstrated intracellular thiamine depletion and the presence of the thiazole cleavage product in thiaminase-treated cells, providing validation of the experimental procedures. Accumulation of ribose and ribulose in both cell lines support the thiaminase-mediated suppression of the TDE transketolase. Interestingly, thiaminase suppression of another TDE, branched chain amino ketoacid dehydrogenase (BCKDH), showed very different patterns in the two cell lines: in RS4 leukemia cells it led to an increase in BCKDH substrates, and in MCF-7 breast cancer cells it led to a decrease in BCKDH products. Immunoblot analyses showed corresponding differences in expression of BCKDH pathway enzymes, and partial protection of thiaminase growth inhibition by gabapentin indicated that BCKDH inhibition may be a mechanism of thiaminase-mediated toxicity. Surprisingly, most of thiaminase-mediated metabolomic effects were also reversed by rapamycin. Thus, these studies demonstrate that acute intracellular thiamine depletion by recombinant thiaminase results in metabolic changes in thiamine-dependent metabolism, and demonstrate a previously unrecognized role of mTOR signaling in the regulation of thiamine-dependent metabolism.	[Liu, Shuqian; Moscow, Jeffrey A.] Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY 40536 USA; [Miriyala, Sumitra; St Clair, Daret K.] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY USA; [Keaton, Mignon A.] Metabolon Inc, Durham, NC USA; [Jordan, Craig T.] Univ Colorado, Div Hematol Hematol Malignancies & Stem Cell Tran, Denver, CO 80202 USA; [Wiedl, Christina] Virginia Commonwealth Univ, Dept Pediat, Richmond, VA USA	University of Kentucky; University of Kentucky; Metabolon; University of Colorado System; University of Colorado Denver; Virginia Commonwealth University	Moscow, JA (corresponding author), Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY 40536 USA.	jmoscow@uky.edu	jordan, craig/D-7666-2014	jordan, craig/0000-0003-0869-3465; Miriyala, Sumitra/0000-0001-7158-9295	DanceBlue, an effort of the University of Kentucky student community	DanceBlue, an effort of the University of Kentucky student community	The authors thank the Research Communication Office of the Markey Cancer Center at the University of Kentucky for editorial and graphics assistance. This work was supported by DanceBlue, an effort of the University of Kentucky student community to support pediatric oncology care and research.	Casteels M, 2007, BIOCHEM SOC T, V35, P876, DOI 10.1042/BST0350876; Costello CA, 1996, J BIOL CHEM, V271, P3445, DOI 10.1074/jbc.271.7.3445; Daily A, 2013, INT J VITAM IN PRESS; Daily A, 2011, MOL CANCER THER, V10, P1563, DOI 10.1158/1535-7163.MCT-11-0003; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Hassane DC, 2010, BLOOD, V116, P5983, DOI 10.1182/blood-2010-04-278044; Hutson SM, 1998, J NEUROCHEM, V71, P863; Le Huerou Y, 2008, BIOORG MED CHEM LETT, V18, P505, DOI 10.1016/j.bmcl.2007.11.100; Liu SQ, 2012, J PHARMACOL EXP THER, V341, P775, DOI 10.1124/jpet.112.191817; Liu SQ, 2010, CANCER CHEMOTH PHARM, V66, P171, DOI 10.1007/s00280-009-1148-9; Liu SQ, 2004, MOL CANCER RES, V2, P477; Liu SQ, 2003, MOL CANCER RES, V1, P665; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Santra S, 2008, EXPERT OPIN PHARMACO, V9, P1229, DOI 10.1517/146565608D2042343; Thomas AA, 2008, BIOORG MED CHEM LETT, V18, P2206, DOI 10.1016/j.bmcl.2007.11.101; Zastre JA, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-16	17	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85702	10.1371/journal.pone.0085702	http://dx.doi.org/10.1371/journal.pone.0085702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454921	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100123
J	Loebel, M; Strohschein, K; Giannini, C; Koelsch, U; Bauer, S; Doebis, C; Thomas, S; Unterwalder, N; von Baehr, V; Reinke, P; Knops, M; Hanitsch, LG; Meisel, C; Volk, HD; Scheibenbogen, C				Loebel, Madlen; Strohschein, Kristin; Giannini, Carolin; Koelsch, Uwe; Bauer, Sandra; Doebis, Cornelia; Thomas, Sybill; Unterwalder, Nadine; von Baehr, Volker; Reinke, Petra; Knops, Michael; Hanitsch, Leif G.; Meisel, Christian; Volk, Hans-Dieter; Scheibenbogen, Carmen			Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; IGM SERUM ANTIBODIES; GENE-PRODUCTS P52; HUMAN HERPESVIRUS-6; IMMUNOLOGICAL ABNORMALITIES; HHV-6 REACTIVATION; UNIQUELY PRESENT; CROSS-REACT; INFECTION; REPLICATION	Epstein-Barr virus (EBV) has long been discussed as a possible cause or trigger of Chronic Fatigue Syndrome (CFS). In a subset of patients the disease starts with infectious mononucleosis and both enhanced and diminished EBV-specific antibody titers have been reported. In this study, we comprehensively analyzed the EBV-specific memory B-and T-cell response in patients with CFS. While we observed no difference in viral capsid antigen (VCA)-IgG antibodies, EBV nuclear antigen (EBNA)-IgG titers were low or absent in 10% of CFS patients. Remarkably, when analyzing the EBV-specific memory B-cell reservoir in vitro a diminished or absent number of EBNA-1- and VCA-antibody secreting cells was found in up to 76% of patients. Moreover, the ex vivo EBV-induced secretion of TNF-alpha and IFN-gamma was significantly lower in patients. Multicolor flow cytometry revealed that the frequencies of EBNA-1-specific triple TNF-alpha/IFN-gamma/IL-2 producing CD4(+) and CD8(+) T-cell subsets were significantly diminished whereas no difference could be detected for HCMV-specific T-cell responses. When comparing EBV load in blood immune cells, we found more frequently EBER-DNA but not BZLF-1 RNA in CFS patients compared to healthy controls suggesting more frequent latent replication. Taken together, our findings give evidence for a deficient EBV-specific B-and T-cell memory response in CFS patients and suggest an impaired ability to control early steps of EBV reactivation. In addition the diminished EBV response might be suitable to develop diagnostic marker in CFS.	[Loebel, Madlen; Strohschein, Kristin; Giannini, Carolin; Bauer, Sandra; Thomas, Sybill; Knops, Michael; Hanitsch, Leif G.; Meisel, Christian; Volk, Hans-Dieter; Scheibenbogen, Carmen] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Strohschein, Kristin] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Koelsch, Uwe; Unterwalder, Nadine; Meisel, Christian] Charite, Dept Immunol, Lab Berlin GmbH, D-13353 Berlin, Germany; [Doebis, Cornelia; von Baehr, Volker] Inst Med Diagnost, Berlin, Germany; [Reinke, Petra; Volk, Hans-Dieter; Scheibenbogen, Carmen] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Reinke, Petra] Charite, Dept Nephrol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Loebel, M (corresponding author), Charite, Inst Med Immunol, Campus Virchow, D-13353 Berlin, Germany.	Madlen.loebel@charite.de	volk, hans-dieter/AAV-8053-2021	volk, hans-dieter/0000-0002-7743-6668; Hanitsch, Leif G./0000-0002-8181-0093; Reinke, Petra/0000-0003-0771-4375; Scheibenbogen, Carmen/0000-0002-8554-9638; Meisel, Christian/0000-0003-0222-991X	Fatigatio e.V. Bundesverband Chronisches Erschopfungssyndrom; "Europaischen Fonds fur regionale Entwicklung (EFRE)" of the European Union	Fatigatio e.V. Bundesverband Chronisches Erschopfungssyndrom; "Europaischen Fonds fur regionale Entwicklung (EFRE)" of the European Union	This work was supported by a grant from the "Fatigatio e.V. Bundesverband Chronisches Erschopfungssyndrom" and the "Europaischen Fonds fur regionale Entwicklung (EFRE)" of the European Union grant "Investition in Ihre Zukunft''. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablashi DV, 2000, J CLIN VIROL, V16, P179, DOI 10.1016/S1386-6532(99)00079-7; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Altmann M, 2006, P NATL ACAD SCI USA, V103, P14188, DOI 10.1073/pnas.0605985103; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Bansal AS, 2012, BRAIN BEHAV IMMUN, V26, P24, DOI 10.1016/j.bbi.2011.06.016; Beqaj SH, 2008, J CLIN PATHOL, V61, P623, DOI 10.1136/jcp.2007.050633; Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; Brenu EW, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-81; Broderick G, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-191; Broderick G, 2010, BRAIN BEHAV IMMUN, V24, P1209, DOI 10.1016/j.bbi.2010.04.012; Burbelo PD, 2012, AM J TRANSL RES, V4, P443; Cameron B, 2010, J MED VIROL, V82, P1684, DOI 10.1002/jmv.21873; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Chang CM, 2012, CANCER-AM CANCER SOC, V118, P5929, DOI 10.1002/cncr.27612; Chapenko S, 2006, J CLIN VIROL, V37, pS47, DOI 10.1016/S1386-6532(06)70011-7; Chapenko S, 2012, ADV VIROL, V2012, DOI 10.1155/2012/205085; Christley Y, 2012, J EVAL CLIN PRACT, V18, P25, DOI 10.1111/j.1365-2753.2010.01512.x; Cohen JI, 1999, CURR OPIN IMMUNOL, V11, P365, DOI 10.1016/S0952-7915(99)80062-4; Colmenares M, 2002, INFECT IMMUN, V70, P6597, DOI 10.1128/IAI.70.12.6597-6605.2002; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Curriu M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-68; Devanur LD, 2006, J CLIN VIROL, V37, P139, DOI 10.1016/j.jcv.2006.08.013; Draborg AH, 2012, SCAND J RHEUMATOL, V41, P280, DOI 10.3109/03009742.2012.665944; Dreyfus DH, 2011, AUTOIMMUN REV, V11, P88, DOI 10.1016/j.autrev.2011.08.005; El-Far Mohamed, 2008, Curr HIV/AIDS Rep, V5, P13, DOI 10.1007/s11904-008-0003-7; Fletcher MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010817; Fremont M, 2009, IN VIVO, V23, P209; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gabibov AG, 2011, FASEB J, V25, P4211, DOI 10.1096/fj.11-190769; Glaser R, 2005, BRAIN BEHAV IMMUN, V19, P91, DOI 10.1016/j.bbi.2004.09.001; GREENSPAN JS, 1985, NEW ENGL J MED, V313, P1564, DOI 10.1056/NEJM198512193132502; Guerreiro M, 2010, EUR J IMMUNOL, V40, P1566, DOI 10.1002/eji.200940000; HENLE W, 1987, P NATL ACAD SCI USA, V84, P570, DOI 10.1073/pnas.84.2.570; Hohn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015632; Iwakiri D, 2010, ADV CANCER RES, V107, P119, DOI 10.1016/S0065-230X(10)07004-1; Jason LA, 2002, BIOL PSYCHOL, V59, P15, DOI 10.1016/S0301-0511(01)00120-X; Jason LA, 2000, J CLIN PSYCHOL, V56, P1497, DOI 10.1002/1097-4679(200012)56:12<1497::AID-2>3.0.CO;2-Z; Jilek S, 2008, BRAIN, V131, P1712, DOI 10.1093/brain/awn108; JOSEPHS SF, 1991, LANCET, V337, P1346, DOI 10.1016/0140-6736(91)93018-5; KAWAI K, 1992, INTERNAL MED, V31, P313, DOI 10.2169/internalmedicine.31.313; Klatt NR, 2011, BLOOD, V118, P5803, DOI 10.1182/blood-2011-07-365874; Klein G, 2010, BIOCHEM BIOPH RES CO, V396, P67, DOI 10.1016/j.bbrc.2010.02.146; KLIMAS NG, 1990, J CLIN MICROBIOL, V28, P1403, DOI 10.1128/JCM.28.6.1403-1410.1990; Komaroff AL, 2011, SEMIN NEUROL, V31, P325, DOI 10.1055/s-0031-1287654; Krueger GRF, 2001, IN VIVO, V15, P461; Larsen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002328; Lerner AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047891; Lerner AM, 2004, IN VIVO, V18, P101; Lerner AM, 2002, IN VIVO, V16, P153; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; Ling PD, 2003, CLIN INFECT DIS, V37, P1244, DOI 10.1086/378808; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lunemann JD, 2008, J EXP MED, V205, P1763, DOI 10.1084/jem.20072397; Maher KJ, 2005, CLIN EXP IMMUNOL, V142, P505, DOI 10.1111/j.1365-2249.2005.02935.x; MANIAN FA, 1994, CLIN INFECT DIS, V19, P448, DOI 10.1093/clinids/19.3.448; McClain MT, 2005, NAT MED, V11, P85, DOI 10.1038/nm1167; MILLER G, 1985, NEW ENGL J MED, V312, P750, DOI 10.1056/NEJM198503213121204; Niller HH, 2008, AUTOIMMUNITY, V41, P298, DOI 10.1080/08916930802024772; Niller HH, 2011, ADV EXP MED BIOL, V711, P82; NILSSON K, 1971, INT J CANCER, V8, P443, DOI 10.1002/ijc.2910080312; Ortega-Hernandez OD, 2009, ANN NY ACAD SCI, V1173, P600, DOI 10.1111/j.1749-6632.2009.04799.x; Patarca R, 2001, ANN NY ACAD SCI, V933, P185; PATNAIK M, 1995, J INFECT DIS, V172, P1364, DOI 10.1093/infdis/172.5.1364; Piriou E, 2005, BLOOD, V106, P3166, DOI 10.1182/blood-2005-01-0432; Piriou ER, 2005, EUR J IMMUNOL, V35, P796, DOI 10.1002/eji.200425792; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Rezk SA, 2007, HUM PATHOL, V38, P1293, DOI 10.1016/j.humpath.2007.05.020; Rodrigue-Gervais IG, 2010, J IMMUNOL, V184, P3134, DOI 10.4049/jimmunol.0902522; Sairenji T, 1995, INTERVIROLOGY, V38, P269, DOI 10.1159/000150450; SCHLUEDERBERG A, 1992, ANN INTERN MED, V117, P325, DOI 10.7326/0003-4819-117-4-325; SECCHIERO P, 1995, J CLIN MICROBIOL, V33, P2124, DOI 10.1128/JCM.33.8.2124-2130.1995; Shepherd C, 2002, BRIT MED J, V324, P914, DOI 10.1136/bmj.324.7342.914; Simmons G, 2011, SCIENCE, V334, P814, DOI 10.1126/science.1213841; SIXBEY JW, 1984, NEW ENGL J MED, V310, P1225, DOI 10.1056/NEJM198405103101905; Skowera A, 2004, CLIN EXP IMMUNOL, V135, P294, DOI 10.1111/j.1365-2249.2004.02354.x; Soto Norberto E, 2000, Herpes, V7, P46; STRAUS SE, 1993, J CLIN IMMUNOL, V13, P30, DOI 10.1007/BF00920633; Tanaka Yoshihide, 2012, Nihon Rinsho, V70, P880; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; van Baarle D, 2008, J INFECT DIS, V198, P1353, DOI 10.1086/592170; van Kuppeveld FJM, 2012, LANCET, V379, pE27, DOI 10.1016/S0140-6736(11)60899-4; Wallace HL, 1999, CLIN DIAGN LAB IMMUN, V6, P216, DOI 10.1128/CDLI.6.2.216-223.1999; WHELTON CL, 1992, J RHEUMATOL, V19, P939; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806	84	53	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85387	10.1371/journal.pone.0085387	http://dx.doi.org/10.1371/journal.pone.0085387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454857	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100078
J	Nir, O; Gruber, DF; Shemesh, E; Glasser, E; Tchernov, D				Nir, Orit; Gruber, David F.; Shemesh, Eli; Glasser, Eliezra; Tchernov, Dan			Seasonal Mesophotic Coral Bleaching of Stylophora pistillata in the Northern Red Sea	PLOS ONE			English	Article							SYMBIOTIC ALGAE; REEF CORALS; LIGHT; EVOLUTION; DENSITIES	Coral bleaching occurs when environmental stress induces breakdown of the coral-algae symbiosis and the host initiates algae expulsion. Two types of coral bleaching had been thoroughly discussed in the scientific literature; the first is primarily associated with mass coral bleaching events; the second is a seasonal loss of algae and/or pigments. Here, we describe a phenomenon that has been witnessed for repeated summers in the mesophotic zone (40-63 m) in the northern Red Sea: seasonal bleaching and recovery of several hermatypic coral species. In this study, we followed the recurring bleaching process of the common coral Stylophora pistillata. Bleaching occurred from April to September with a 66% decline in chlorophyll a concentration, while recovery began in October. Using aquarium and transplantation experiments, we explored environmental factors such as temperature, photon flux density and heterotrophic food availability. Our experiments and observations did not yield one single factor, alone, responsible for the seasonal bleaching. The dinoflagellate symbionts (of the genus Symbiodinium) in shallow (5 m) Stylophora pistillata were found to have a net photosynthetic rate of 56.98-92.19 mu mol O-2 cm(-2) day(-1). However, those from mesophotic depth (60 m) during months when they are not bleached are net consumers of oxygen having a net photosynthetic rate between -12.86 -(-10.24) mu mol O-2 cm(-2) day(-1). But during months when these mesophotic corals are partially-bleached, they yielded higher net production, between -2.83-0.76 mu mol O-2 cm(-2) day(-1). This study opens research questions as to why mesophotic zooxanthellae are more successfully meeting the corals metabolic requirements when Chl a concentration decreases by over 60% during summer and early fall.	[Nir, Orit; Shemesh, Eli; Glasser, Eliezra; Tchernov, Dan] Univ Haifa, Dept Marine Biol, Leon H Charney Sch Marine Sci, IL-31999 Haifa, Israel; [Gruber, David F.] CUNY Bernard M Baruch Coll, Dept Nat Sci, New York, NY 10010 USA; [Gruber, David F.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA	University of Haifa; City University of New York (CUNY) System; Baruch College (CUNY); American Museum of Natural History (AMNH)	Nir, O (corresponding author), Univ Haifa, Dept Marine Biol, Leon H Charney Sch Marine Sci, IL-31999 Haifa, Israel.	oritnir.eco@gmail.com	Tchernov, Dan/AAE-2545-2021	Tchernov, Dan/0000-0003-1135-8270	Israeli Science Foundation [981/05]; United States National Science Foundation [0920572]	Israeli Science Foundation(Israel Science Foundation); United States National Science Foundation(National Science Foundation (NSF))	Funding provided by Israeli Science Foundation Grant No. 981/05 to DT and United States National Science Foundation grant No. 0920572 to DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Borell EM, 2008, OECOLOGIA, V157, P593, DOI 10.1007/s00442-008-1102-2; Brown BE, 1999, MAR ECOL PROG SER, V191, P53, DOI 10.3354/meps191053; Cunning R, 2013, NAT CLIM CHANGE, V3, P259, DOI [10.1038/NCLIMATE1711, 10.1038/nclimate1711]; Dimond JL, 2011, LIMNOL OCEANOGR, V56, P2233, DOI 10.4319/lo.2011.56.6.2233; Dishon G, 2012, INT J REMOTE SENS, V33, P2683, DOI 10.1080/01431161.2011.619209; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Douglas AE, 1998, HEREDITY, V81, P599, DOI 10.1038/sj.hdy.6884550; Einbinder S, 2009, MAR ECOL PROG SER, V381, P167, DOI 10.3354/meps07908; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GHIOLD J, 1990, Caribbean Journal of Science, V26, P52; GLYNN PW, 1991, TRENDS ECOL EVOL, V6, P175, DOI 10.1016/0169-5347(91)90208-F; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Kvitt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028665; LaJeunesse TC, 2007, CORAL REEFS, V26, P265, DOI 10.1007/s00338-006-0189-3; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; McWilliams JP, 2005, ECOLOGY, V86, P2055, DOI 10.1890/04-1657; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; Nir O, 2011, CORAL REEFS, V30, P1089, DOI 10.1007/s00338-011-0801-z; PEARSE VB, 1971, BIOL BULL, V141, P350, DOI 10.2307/1540123; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Sunagawa S, 2008, CIENC MAR, V34, P113, DOI 10.7773/cm.v34i2.1230; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Tchernov D, 2012, TRENDS ECOL EVOL, V27, P194, DOI 10.1016/j.tree.2011.11.002; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V263, P211, DOI 10.1016/S0022-0981(01)00309-4; Veal CJ, 2010, CORAL REEFS, V29, P893, DOI 10.1007/s00338-010-0647-9; Wagner D, 2011, P ROY SOC B-BIOL SCI, V278, P1323, DOI 10.1098/rspb.2010.1681; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Wooldridge SA, 2010, BIOESSAYS, V32, P615, DOI 10.1002/bies.200900182	35	34	36	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84968	10.1371/journal.pone.0084968	http://dx.doi.org/10.1371/journal.pone.0084968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454772	Green Published, gold			2022-12-25	WOS:000330235100045
J	Borg, C; Georgiadis, JR; Renken, RJ; Spoelstra, SK; Schultz, WW; de Jong, PJ				Borg, Charmaine; Georgiadis, Janniko R.; Renken, Remco J.; Spoelstra, Symen K.; Schultz, Willibrord Weijmar; de Jong, Peter J.			Brain Processing of Visual Stimuli Representing Sexual Penetration versus Core and Animal-Reminder Disgust in Women with Lifelong Vaginismus	PLOS ONE			English	Article							CONTAMINATION SENSITIVITY; AROUSAL; RESPONSES; FEAR; EXPOSURE; PICTURES; EMOTION; PHOBIA; SPIDER; FMRI	It has been proposed that disgust evolved to protect humans from contamination. Through eliciting the overwhelming urge to withdraw from the disgusting stimuli, it would facilitate avoidance of contact with pathogens. The physical proximity implied in sexual intercourse provides ample opportunity for contamination and may thus set the stage for eliciting pathogen disgust. Building on this, it has been argued that the involuntary muscle contraction characteristic of vaginismus (i.e., inability to have vaginal penetration) may be elicited by the prospect of penetration by potential contaminants. To further investigate this disgust-based interpretation of vaginismus (in DSM-5 classified as a Genito-Pelvic Pain/Penetration Disorder, GPPPD) we used functional magnetic resonance imaging (fMRI) to examine if women with vaginismus (n = 21) show relatively strong convergence in their brain responses towards sexual penetration- and disgust-related pictures compared to sexually asymptomatic women (n = 21) and women suffering from vulvar pain (dyspareunia/also classified as GPPPD in the DSM-5, n = 21). At the subjective level, both clinical groups rated penetration stimuli as more disgusting than asymptomatic women. However, the brain responses to penetration stimuli did not differ between groups. In addition, there was considerable conjoint brain activity in response to penetration and disgust pictures, which yield for both animal-reminder (e. g., mutilation) and core (e. g., rotten food) disgust domains. However, this overlap in brain activation was similar for all groups. A possible explanation for the lack of vaginismus-specific brain responses lies in the alleged female ambiguity (procreation/pleasure vs. contamination/disgust) toward penetration: generally in women a (default) disgust response tendency may prevail in the absence of sexual readiness. Accordingly, a critical next step would be to examine the processing of penetration stimuli following the induction of sexual arousal.	[Borg, Charmaine; de Jong, Peter J.] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands; [Georgiadis, Janniko R.] Univ Groningen, Univ Med Ctr Groningen, Sect Anat, Dept Neurosci, Groningen, Netherlands; [Renken, Remco J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Neuroimaging Ctr BCN NiC, Groningen, Netherlands; [Spoelstra, Symen K.; Schultz, Willibrord Weijmar] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Borg, C (corresponding author), Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands.	C.borg@med.umcg.nl	de Jong, Peter/ABB-1750-2020; de Jong, Peter/E-9095-2014	de Jong, Peter/0000-0002-3512-3663; de Jong, Peter/0000-0002-3512-3663; Borg, Charmaine/0000-0002-0122-1118; Renken, Remco Jan/0000-0002-7777-9484	Malta Government Scholarship Scheme [MGSS_PHD_2008-12]	Malta Government Scholarship Scheme	This work was supported by the Malta Government Scholarship Scheme Grant Number MGSS_PHD_2008-12, which partially funds the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Basson R, 2004, J PSYCHOSOMATIC OBST, V34, P221; Basson R, 2007, LANCET, V369, P409, DOI 10.1016/S0140-6736(07)60197-4; Bianchi KN, 2012, J ANXIETY DISORD, V26, P753, DOI 10.1016/j.janxdis.2012.06.004; Binik YM, 2010, ARCH SEX BEHAV, V39, P278, DOI 10.1007/s10508-009-9560-0; Borg C, 2014, SOC COGN AFFECT NEUR, V9, P158, DOI 10.1093/scan/nss117; Borg C, 2013, SOC COGN AFFECT NEUR, V8, P351, DOI 10.1093/scan/nss006; Borg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044111; Borg C, 2010, J SEX MED, V7, P2149, DOI 10.1111/j.1743-6109.2010.01800.x; Brauer M, 2007, EUR J PAIN, V11, P788, DOI 10.1016/j.ejpain.2006.12.006; Cherner RA, 2013, J SEX MED, V10, P1291, DOI 10.1111/jsm.12102; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; de Jong PJ, 2013, J SEX RES, V50, P247, DOI 10.1080/00224499.2012.746280; de Jong PJ, 2010, INT J COGN THER, V3, P23, DOI 10.1521/ijct.2010.3.1.23; de Jong PJ, 2009, ARCH SEX BEHAV, V38, P244, DOI 10.1007/s10508-007-9240-x; de Jong PJ, 2002, J ANXIETY DISORD, V16, P51, DOI 10.1016/S0887-6185(01)00089-5; de Jong PJ, 1998, PERS INDIV DIFFER, V24, P153, DOI 10.1016/S0191-8869(97)00178-5; Engelhard IM, 2011, J ANXIETY DISORD, V25, P58, DOI 10.1016/j.janxdis.2010.08.003; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Georgiadis JR, 2012, PROG NEUROBIOL, V98, P49, DOI 10.1016/j.pneurobio.2012.05.004; Goldstein A, 2009, PROVOKED VESTIBULODY, P43; Huijding J, 2011, J SEX MED, V8, P806, DOI 10.1111/j.1743-6109.2010.02083.x; Karama S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022343; Lang PJ, 1999, A4 U FLOR CTR RES PS, DOI DOI 10.1016/J.BIOPSYCH.2010.04.020; Leiblum SR, 2000, PRINCIPLES AND PRACTICE OF SEX THERAPY, THIRD EDITION, P181; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Olatunji BO, 2007, BEHAV RES THER, V45, P263, DOI 10.1016/j.brat.2006.03.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phillips ML, 1998, BRIT J PSYCHIAT, V172, P373, DOI 10.1192/bjp.172.5.373; ROZIN P, 1995, J RES PERS, V29, P318, DOI 10.1006/jrpe.1995.1019; Sarlo M, 2005, NEUROSCI LETT, V382, P330; Schienle A, 2006, NEUROSCI LETT, V393, P2347; Smith KS, 2009, BEHAV BRAIN RES, V196, P155, DOI 10.1016/j.bbr.2008.09.038; Stark R, 2005, BIOL PSYCHOL, V70, P19, DOI 10.1016/j.biopsycho.2004.11.014; Stevenson RJ, 2011, ARCH SEX BEHAV, V40, P79, DOI 10.1007/s10508-009-9529-z; ter Kuile MM, 2009, J CONSULT CLIN PSYCH, V77, P149, DOI 10.1037/a0014273; Tybur JM, 2013, PSYCHOL REV, V120, P65, DOI 10.1037/a0030778; van der Velde J, 2001, INT UROGYNECOL J PEL, V12, P328, DOI 10.1007/s001920170035; van Overveld M, 2013, J SEX MED, V10, P396, DOI 10.1111/j.1743-6109.2012.02979.x; van Overveld WJM, 2009, BIOL PSYCHOL, V80, P149, DOI 10.1016/j.biopsycho.2008.08.002; Verwoerd J, 2013, BEHAV RES THER, V51, P122, DOI 10.1016/j.brat.2012.11.005; Walter M, 2008, NEUROIMAGE, V40, P1482, DOI 10.1016/j.neuroimage.2008.01.040; Wright P, 2004, NEUROREPORT, V15, P2347, DOI 10.1097/00001756-200410250-00009; Yartz AR, 2002, BIOL PSYCHOL, V59, P55, DOI 10.1016/S0301-0511(01)00121-1; Young LJ, 2002, BIOL PSYCHIAT, V51, P18, DOI 10.1016/S0006-3223(01)01268-9	46	20	21	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84882	10.1371/journal.pone.0084882	http://dx.doi.org/10.1371/journal.pone.0084882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465445	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100016
J	Dancik, GM; Theodorescu, D				Dancik, Garrett M.; Theodorescu, Dan			Robust Prognostic Gene Expression Signatures in Bladder Cancer and Lung Adenocarcinoma Depend on Cell Cycle Related Genes	PLOS ONE			English	Article							PREDICT SURVIVAL; PROGRESSION; CARCINOMA; PROFILES; MODULES; HEAD; TOOL	Few prognostic biomarkers are approved for clinical use primarily because their initial performance cannot be repeated in independent datasets. We posited that robust biomarkers could be obtained by identifying deregulated biological processes shared among tumor types having a common etiology. We performed a gene set enrichment analysis in 20 publicly available gene expression datasets comprising 1968 patients having one of the three most common tobacco-related cancers (lung, bladder, head and neck) and identified cell cycle related genes as the most consistently prognostic class of biomarkers in bladder (BL) and lung adenocarcinoma (LUAD). We also found the prognostic value of 13 of 14 published BL and LUAD signatures were dependent on cell cycle related genes, supporting the importance of cell cycle related biomarkers for prognosis. Interestingly, no prognostic gene classes were identified in squamous cell lung carcinoma or head and neck squamous cell carcinoma. Next, a specific 31 gene cell cycle proliferation (CCP) signature, previously derived in prostate tumors was evaluated and found predictive of outcome in BL and LUAD cohorts in univariate and multivariate analyses. Specifically, CCP score significantly enhanced the predictive ability of multivariate models based on standard clinical variables for progression in BL patients and survival in LUAD patients in multiple cohorts. We then generated random CCP signatures of various sizes and found sets of 10-15 genes had robust performance in these BL and LUAD cohorts, a finding that was confirmed in an independent cohort. Our work characterizes the importance of cell cycle related genes in prognostic signatures for BL and LUAD patients and identifies a specific signature likely to survive additional validation.	[Dancik, Garrett M.] Eastern Connecticut State Univ, Math & Comp Sci Dept, Willimantic, CT 06226 USA; [Theodorescu, Dan] Univ Colorado, Dept Surg, Aurora, CO 80045 USA; [Theodorescu, Dan] Univ Colorado, Dept Pharmacol, Aurora, CO USA; [Theodorescu, Dan] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA	Connecticut State University System; Eastern Connecticut State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Theodorescu, D (corresponding author), Univ Colorado, Dept Surg, Aurora, CO 80045 USA.	dan.theodorescu@ucdenver.edu		Dancik, Garrett/0000-0002-1391-8641	National Institutes of Health [CA075115, CA104106]; NATIONAL CANCER INSTITUTE [R01CA075115, P01CA104106, R29CA075115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by National Institutes of Health grants CA075115 and CA104106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Colo AEL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-33; Cooperberg MR, 2011, CANCER-AM CANCER SOC, V117, P5039, DOI 10.1002/cncr.26169; Cuzick J, 2012, BRIT J CANCER, V106, P1095, DOI 10.1038/bjc.2012.39; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Diamandis EP, 2010, J NATL CANCER I, V102, P1462, DOI 10.1093/jnci/djq306; Dyrskjot L, 2007, CLIN CANCER RES, V13, P3545, DOI 10.1158/1078-0432.CCR-06-2940; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071462; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kenfield SA, 2011, JAMA-J AM MED ASSOC, V305, P2548, DOI 10.1001/jama.2011.879; Lauss M, 2010, CLIN CANCER RES, V16, P4421, DOI 10.1158/1078-0432.CCR-10-0606; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; MAMELLE G, 1994, AM J SURG, V168, P494, DOI 10.1016/S0002-9610(05)80109-6; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Mosley JD, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-11; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967	25	21	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85249	10.1371/journal.pone.0085249	http://dx.doi.org/10.1371/journal.pone.0085249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465512	gold, Green Submitted, Green Published			2022-12-25	WOS:000330283100028
J	Elliott, KH; Davis, M; Elliott, JE				Elliott, Kyle H.; Davis, Mikaela; Elliott, John E.			Equations for Lipid Normalization of Carbon Stable Isotope Ratios in Aquatic Bird Eggs	PLOS ONE			English	Article							FISH-TISSUES; EXTRACTION; DELTA-C-13; SEABIRDS; MERCURY; CONTAMINANTS; PREY; ACCUMULATION; CONSEQUENCES; REPRODUCTION	Stable isotope ratios are biogeochemical tracers that can be used to determine the source of nutrients and contaminants in avian eggs. However, the interpretation of stable carbon ratios in lipid-rich eggs is complicated because C-13 is depleted in lipids. Variation in C-13 abundance can therefore be obscured by variation in percent lipids. Past attempts to establish an algebraic equation to correct carbon isotope ratios for lipid content in eggs have been unsuccessful, possibly because they relied partly on data from coastal or migratory species that may obtain egg lipids from different habitats than egg protein. We measured carbon, nitrogen and sulphur stable isotope ratios in 175 eggs from eight species of aquatic birds. Carbon, nitrogen and sulphur isotopes were enriched in lipid-extracted egg samples compared with non extracted egg samples. A logarithmic equation using the C:N ratio and carbon isotope ratio from the non extracted egg tissue calculated 90% of the lipid-extracted carbon isotope ratios within +/- 0.5 parts per thousand. Calculating separate equations for eggs laid by species in different habitats (pelagic, offshore and terrestrial-influenced) improved the fit. A logarithmic equation, rather than a linear equation as often used for muscle, was necessary to accurately correct for lipid content because the relatively high lipid content of eggs compared with muscle meant that a linear relationship did not accurately approximate the relationship between percent lipids and the C: N ratio. Because lipid extraction alters sulphur and nitrogen isotope ratios (and cannot be corrected algebraically), we suggest that isotopic measurement on bulk tissue followed by algebraic lipid normalization of carbon stable isotope ratio is often a good solution for homogenated eggs, at least when it is not possible to complete separate chemical analyses for each isotope.	[Elliott, Kyle H.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Davis, Mikaela] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Elliott, John E.] Environm Canada, Sci & Technol Branch, Delta, BC, Canada	University of Manitoba; Simon Fraser University; Environment & Climate Change Canada	Elliott, KH (corresponding author), Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada.	urialomvia@gmail.com	Elliott, Kyle/S-9185-2019	Elliott, Kyle/0000-0001-5304-3993; Chiaradia, Andre/0000-0002-6178-4211	NSERC Vanier scholarship; ACUNS Garfield Weston Foundation Northern Studies Award; Jennifer Robinson Memorial Award (Arctic Institute of North America); Environment Canada's Chemical Management Plan	NSERC Vanier scholarship; ACUNS Garfield Weston Foundation Northern Studies Award; Jennifer Robinson Memorial Award (Arctic Institute of North America); Environment Canada's Chemical Management Plan	KHE received financial support via an NSERC Vanier scholarship, ACUNS Garfield Weston Foundation Northern Studies Award and Jennifer Robinson Memorial Award (Arctic Institute of North America). M. Davis and J. Elliott were funded by Environment Canada's Chemical Management Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bodin N, 2007, J EXP MAR BIOL ECOL, V341, P168, DOI 10.1016/j.jembe.2006.09.008; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Braune BM, 2011, ENVIRON POLLUT, V159, P2891, DOI 10.1016/j.envpol.2011.04.036; Braune BM, 2005, SCI TOTAL ENVIRON, V346, P156, DOI 10.1016/j.scitotenv.2004.12.017; Chiaradia A, 2012, AUSTRAL ECOL, V37, P610, DOI 10.1111/j.1442-9993.2011.02323.x; Choy ES, 2010, SCI TOTAL ENVIRON, V408, P1858, DOI 10.1016/j.scitotenv.2010.01.014; Crosse JD, 2012, ENVIRON POLLUT, V161, P93, DOI 10.1016/j.envpol.2011.10.003; Day RD, 2012, ENVIRON POLLUT, V166, P226, DOI 10.1016/j.envpol.2012.03.004; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; Ehrich D, 2011, METHODS ECOL EVOL, V2, P66, DOI 10.1111/j.2041-210X.2010.00047.x; Elliott J.E., 1992, P181; Elliott JE, 2005, ENVIRON TOXICOL CHEM, V24, P3099, DOI 10.1897/04-474R.1; Elliott JE, 2005, ARCH ENVIRON CON TOX, V49, P89, DOI 10.1007/s00244-004-0180-3; Elliott JE, 1984, ENV SPECIMEN BANKING, P45; Elliott JE, 2007, ECOL APPL, V17, P1223, DOI 10.1890/06-1213; Elliott JE, 2013, SCIENCE, V340, P556, DOI 10.1126/science.1235197; Elliott JE, 2012, ENVIRON SCI TECHNOL, V46, P9681, DOI 10.1021/es301539b; Elliott KH, 2010, BEHAV ECOL, V21, P1024, DOI 10.1093/beheco/arq076; Elliott KH, 2009, SCI TOTAL ENVIRON, V407, P3867, DOI 10.1016/j.scitotenv.2009.02.027; Guigueno MF, 2012, ENVIRON INT, V40, P24, DOI 10.1016/j.envint.2011.11.004; Hebert CE, 2008, ECOLOGY, V89, P891, DOI 10.1890/07-1603.1; Hobson KA, 2005, J WILDLIFE MANAGE, V69, P1221, DOI 10.2193/0022-541X(2005)069[1221:TNATRI]2.0.CO;2; Hobson KA, 2010, J AVIAN BIOL, V41, P565, DOI 10.1111/j.1600-048X.2010.04980.x; Holmstrom KE, 2005, ENVIRON SCI TECHNOL, V39, P80, DOI 10.1021/es049257d; Hussey NE, 2012, J EXP MAR BIOL ECOL, V434, P7, DOI 10.1016/j.jembe.2012.07.012; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Ito M, 2012, ORNITHOL SCI, V11, P113, DOI 10.2326/osj.11.113; Jacobs SR, 2009, J AVIAN BIOL, V40, P327, DOI 10.1111/j.1600-048X.2008.04625.x; Jardine TD, 2006, ENVIRON SCI TECHNOL, V40, P7501, DOI 10.1021/es061263h; JO N, 1997, OIKOS, V78, P57, DOI DOI 10.2307/3545800); Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; Lesage V, 2010, MAR ECOL PROG SER, V419, P249, DOI 10.3354/meps08825; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; Logan JM, 2008, RAPID COMMUN MASS SP, V22, P1081, DOI 10.1002/rcm.3471; Mallory ML, 2012, MAR POLLUT BULL, V64, P1475, DOI 10.1016/j.marpolbul.2012.05.012; Mintenbeck K, 2008, J FISH BIOL, V72, P815, DOI 10.1111/j.1095-8649.2007.01754.x; Morrissey CA, 2010, ENVIRON POLLUT, V158, P447, DOI 10.1016/j.envpol.2009.08.040; Oppel S, 2010, AUK, V127, P72, DOI 10.1525/auk.2009.09153; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Ricca MA, 2007, CAN J ZOOL, V85, P40, DOI 10.1139/Z06-187; Roth JD, 2003, J ANIM ECOL, V72, P668, DOI 10.1046/j.1365-2656.2003.00739.x; Schlechtriem C, 2003, ISOT ENVIRON HEALT S, V39, P135, DOI 10.1080/1025601031000113565; Sharp CM, 2009, CONDOR, V111, P361, DOI 10.1525/cond.2009.090011; Sotiropoulos MA, 2004, ECOL FRESHW FISH, V13, P155, DOI 10.1111/j.1600-0633.2004.00056.x; Sweeting CJ, 2004, RAPID COMMUN MASS SP, V18, P2587, DOI 10.1002/rcm.1661; Sweeting CJ, 2006, RAPID COMMUN MASS SP, V20, P595, DOI 10.1002/rcm.2347; Tarroux A, 2010, METHODS ECOL EVOL, V1, P231, DOI 10.1111/j.2041-210X.2010.00033.x; Thomas VG, 1989, P INT ORN C, VXIX, P353; Vander Pol SS, 2004, ENVIRON SCI TECHNOL, V38, P1305, DOI 10.1021/es034987r; Vo ATE, 2011, P NATL ACAD SCI USA, V108, P7466, DOI 10.1073/pnas.1013865108; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x; Yohannes E, 2010, J AVIAN BIOL, V41, P580, DOI 10.1111/j.1600-048X.2010.04965.x	54	37	38	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e83597	10.1371/journal.pone.0083597	http://dx.doi.org/10.1371/journal.pone.0083597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465384	gold, Green Submitted, Green Published			2022-12-25	WOS:000330283100006
J	Hrbek, T; da Silva, VMF; Dutra, N; Gravena, W; Martin, AR; Farias, IP				Hrbek, Tomas; Ferreira da Silva, Vera Maria; Dutra, Nicole; Gravena, Waleska; Martin, Anthony R.; Farias, Izeni Pires			A New Species of River Dolphin from Brazil or: How Little Do We Know Our Biodiversity	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; MICROSATELLITE LOCI; BAYESIAN-INFERENCE; INIA-GEOFFRENSIS; POPULATION; EVOLUTION; DNA; PHYLOGENY; PHYLOGEOGRAPHY; PROBABILITIES	True river dolphins are some of the rarest and most endangered of all vertebrates. They comprise relict evolutionary lineages of high taxonomic distinctness and conservation value, but are afforded little protection. We report the discovery of a new species of a river dolphin from the Araguaia River basin of Brazil, the first such discovery in nearly 100 years. The species is diagnosable by a series of molecular and morphological characters and diverged from its Amazonian sister taxon 2.08 million years ago. The estimated time of divergence corresponds to the separation of the Araguaia-Tocantins basin from the Amazon basin. This discovery highlights the immensity of the deficit in our knowledge of Neotropical biodiversity, as well as vulnerability of biodiversity to anthropogenic actions in an increasingly threatened landscape. We anticipate that this study will provide an impetus for the taxonomic and conservation reanalysis of other taxa shared between the Araguaia and Amazon aquatic ecosystems, as well as stimulate historical biogeographical analyses of the two basins.	[Hrbek, Tomas; Dutra, Nicole; Gravena, Waleska; Farias, Izeni Pires] Fed Univ Amazonas UFAM, Inst Biol Sci, Dept Biol, Lab Evolut & Anim Genet LEGAL, Manaus, Amazonas, Brazil; [Ferreira da Silva, Vera Maria] Natl Res Inst Amazon INPA, LMA, Manaus, Amazonas, Brazil; [Martin, Anthony R.] Univ Dundee, Ctr Remote Environm, Dundee, Scotland	Universidade Federal de Amazonas; Institute Nacional de Pesquisas da Amazonia; University of Dundee	Hrbek, T (corresponding author), Fed Univ Amazonas UFAM, Inst Biol Sci, Dept Biol, Lab Evolut & Anim Genet LEGAL, Manaus, Amazonas, Brazil.	hrbek@evoamazon.net	Hrbek, Tomas/J-6988-2012; Gravena, Waleska/AAJ-2875-2020; Farias, Izeni Pires/J-3069-2014	Hrbek, Tomas/0000-0003-3239-7068; Gravena, Waleska/0000-0002-1102-971X; Farias, Izeni Pires/0000-0002-1416-4351	CNPq/CT [Amazonia-575603/2008-9]; CNPq/FAPEAM [SISBIOTA-563348/2010-0]; Scott Neotropical Fund; Society for Marine Mammalogy; Bolsa de Pesquisa scholarship from CNPq; CAPES fellowship; CNPq fellowship;  [CNPq-483408/2009-3];  [482253/2012-6]	CNPq/CT; CNPq/FAPEAM; Scott Neotropical Fund; Society for Marine Mammalogy; Bolsa de Pesquisa scholarship from CNPq(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ; 	Financial support for fieldwork and laboratory analyses was provided by grants CNPq-483408/2009-3 and 482253/2012-6, CNPq/CT Amazonia-575603/2008-9 and CNPq/FAPEAM SISBIOTA-563348/2010-0 to IPF, and the Scott Neotropical Fund and the Society for Marine Mammalogy to WG. TH and IPF were supported by a Bolsa de Pesquisa scholarship from CNPq during the study, ND by a CAPES fellowship and WG by a CNPq fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Araujo CC, 2010, DISTRIBUICAO ESTIMAT; Araujo CC, 2010, 14 REUN TRAB ESP MAM, P1; Araujo CC, 2012, AQUAT MAMM, V38, P435, DOI 10.1578/AM.38.4.2012.435; Banguera-Hinestroza E, 2002, J HERED, V93, P312, DOI 10.1093/jhered/93.5.312; BARNES LG, 1985, MAR MAMMAL SCI, V1, P149, DOI 10.1111/j.1748-7692.1985.tb00003.x; BAUM DA, 1995, SYST BOT, V20, P560, DOI 10.2307/2419810; BERGGREN WA, 1992, EOCENE OLIGOCENE CLI, P29; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Caldwell M, 2002, MOL ECOL NOTES, V2, P393, DOI 10.1046/j.1471-8286.2002.00270.x; CARROLL RL, 1988, VERTEBRATE PALEONTOL; Cassens I, 2000, P NATL ACAD SCI USA, V97, P11343, DOI 10.1073/pnas.97.21.11343; Castoe TA, 2004, SYST BIOL, V53, P448, DOI 10.1080/10635150490445797; Cracraft J., 1983, Current Ornithology, V1, P159; da Silva V. M. F., 2000, BIOL CONSERVATION FR, P121; da Silva VMF., 1994, ASPECTS BIOL AMAZONI; Da Silva VMF, 2009, ENCY MARINE MAMMALS, P18; DAVIS JI, 1992, SYST BIOL, V41, P421, DOI 10.2307/2992584; De Muizon C, 1983, CR HEBD ACAD SCI, V296, P625; Drummond AJ, 2012, GENEIOUS V5 6 3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EDWARDS AWF, 1963, ANN HUM GENET, V27, P104; Espurt N, 2007, GEOLOGY, V35, P515, DOI 10.1130/G23237A.1; Espurt N, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P89; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fordyce Ewan, 2001, P169; Gesai C, 2010, EIA SANTA ISABEL ENV; Gibbard PL, 2010, J QUATERNARY SCI, V25, P96, DOI 10.1002/jqs.1338; Goulding M, 2003, SMITHSONIAN ATLAS AM; Gravena W, 2009, MOL ECOL RESOUR, V9, P600, DOI 10.1111/j.1755-0998.2008.02458.x; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; HOLM S, 1979, SCAND J STAT, V6, P65; Hubert N, 2007, MOL ECOL, V16, P2115, DOI 10.1111/j.1365-294X.2007.03267.x; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Latrubesse EM, 2009, GEOMORPHOLOGY, V113, P239, DOI 10.1016/j.geomorph.2009.03.014; Mayr E., 1942, SYSTEMATICS ORIGIN S; Mchedlidze GA, 1970, NEKOTORYE OBSHIE CHE; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; PAITHANKAR KR, 1991, NUCLEIC ACIDS RES, V19, P1346, DOI 10.1093/nar/19.6.1346; Pericchi LR, 2005, HANDB STAT, V25, P115, DOI 10.1016/S0169-7161(05)25004-6; Pilleri G, 1977, INVESTIGATIONS CETAC, P11; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/BF02338839; Reeves RR, 2006, CONSERV BIOL, V20, P626, DOI 10.1111/j.1523-1739.2006.00472.x; Renno JF, 2006, MOL PHYLOGENET EVOL, V41, P503, DOI 10.1016/j.ympev.2006.05.029; Rice D. W., 1998, SOC MARINE MAMMALOGY, V4; Rosel PE, 2005, MOL ECOL NOTES, V5, P830, DOI 10.1111/j.1471-8286.2005.01078.x; ROSEN D E, 1979, Bulletin of the American Museum of Natural History, V162, P267; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rossetti DF, 2007, CATENA, V70, P253, DOI 10.1016/j.catena.2006.08.009; Ruiz-Garcia M, 2008, POPULATION GENETICS, P177; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TEMPLETON AR, 2006, POPULATION GENETICS; Thioulouse J, 1997, STAT COMPUT, V7, P75, DOI 10.1023/A:1018513530268; Trujillo F, 2010, ACTION PLAN S AM RIV, P167; Turvey S., 2008, WITNESS EXTINCTION W; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Vilstrup JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-65; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Xiong Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-20	74	88	104	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e83623	10.1371/journal.pone.0083623	http://dx.doi.org/10.1371/journal.pone.0083623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465386	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100007
J	Feng, ZM; Zhou, XL; Wu, F; Yao, K; Kong, XF; Li, TJ; Blachier, F; Yin, YL				Feng, Zemeng; Zhou, Xiaoli; Wu, Fei; Yao, Kang; Kong, Xiangfeng; Li, Tiejun; Blachier, Francois; Yin, Yulong			Both Dietary Supplementation with Monosodium L-Glutamate and Fat Modify Circulating and Tissue Amino Acid Pools in Growing Pigs, but with Little Interactive Effect	PLOS ONE			English	Article							GROWTH-PERFORMANCE; RENAL METABOLISM; GUT MICROBIOTA; PROTEIN; LEUCINE; AMMONIA; PLASMA; MUSCLE; KIDNEY; CARBOHYDRATE	Background: The Chinese population has undergone rapid transition to a high-fat diet. Furthermore, monosodium L-glutamate (MSG) is widely used as a daily food additive in China. Little information is available on the effects of oral MSG and dietary fat supplementation on the amino acid balance in tissues. The present study aimed to determine the effects of both dietary fat and MSG on amino acid metabolism in growing pigs, and to assess any possible interactions between these two nutrients. Methods and Results: Four iso-nitrogenous and iso-caloric diets (basal diet, high fat diet, basal diet with 3% MSG and high fat diet with 3% MSG) were provided to growing pigs. The dietary supplementation with fat and MSG used alone and in combination were found to modify circulating and tissue amino acid pools in growing pigs. Both dietary fat and MSG modified the expression of gene related to amino acid transport in jejunum. Conclusions: Both dietary fat and MSG clearly influenced amino acid content in tissues but in different ways. Both dietary fat and MSG enhance the absorption of amino acids in jejunum. However, there was little interaction between the effects of dietary fat and MSG.	[Feng, Zemeng; Wu, Fei; Yao, Kang; Kong, Xiangfeng; Li, Tiejun; Yin, Yulong] Chinese Acad Sci, Hunan Engn & Res Ctr Anim & Poultry Sci, Res Ctr Hlth Breeding Livestock & Poultry,Key Lab, Inst Subtrop Agr,Minist Agr,Sci Observat & Expt S, Changsha, Hunan, Peoples R China; [Zhou, Xiaoli] Guiyang Univ, Coll Food & Pharm Engn, Guiyang, Guizhou, Peoples R China; [Blachier, Francois] Paris Inst Technol Life Food & Environm Sci, Paris, France	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Ministry of Agriculture & Rural Affairs; Guiyang University	Yin, YL (corresponding author), Chinese Acad Sci, Hunan Engn & Res Ctr Anim & Poultry Sci, Res Ctr Hlth Breeding Livestock & Poultry,Key Lab, Inst Subtrop Agr,Minist Agr,Sci Observat & Expt S, Changsha, Hunan, Peoples R China.	yinyulong@isa.ac.cn			Major Program for International Cooperation of the National Natural Science Foundation of China [31110103909]; Funds of the Chinese Academy of Sciences for Key Topics in Innovation Engineering [KZCX2-EW-412]; Funds of Institute of Subtropical Agriculture, the Chinese Academy of Sciences for field cutting- edge [Y151012100]	Major Program for International Cooperation of the National Natural Science Foundation of China; Funds of the Chinese Academy of Sciences for Key Topics in Innovation Engineering(Chinese Academy of Sciences); Funds of Institute of Subtropical Agriculture, the Chinese Academy of Sciences for field cutting- edge	This work was supported by the Major Program for International Cooperation of the National Natural Science Foundation of China (Grant No. 31110103909), Funds of the Chinese Academy of Sciences for Key Topics in Innovation Engineering (Grant No. KZCX2-EW-412) and Funds of Institute of Subtropical Agriculture, the Chinese Academy of Sciences for field cutting- edge (Grant No. Y151012100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauchart-Thevret C, 2013, J NUTR, V143, P563, DOI 10.3945/jn.112.167783; Blachier F, 1999, DIGESTION, V60, P349, DOI 10.1159/000007682; Blachier F, 2009, AM J CLIN NUTR, V90, p814S, DOI 10.3945/ajcn.2009.27462S; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Boutry C, 2011, AM J PHYSIOL-GASTR L, V300, pG137, DOI 10.1152/ajpgi.00299.2010; BUSE MG, 1975, J CLIN INVEST, V56, P1250, DOI 10.1172/JCI108201; CHUA B, 1979, J BIOL CHEM, V254, P8358; Cui ZH, 2012, BRIT J NUTR, V108, P1292, DOI 10.1017/S0007114511006891; Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005; Farombi EO, 2006, HUM EXP TOXICOL, V25, P251, DOI 10.1191/0960327106ht621oa; Friedman AN, 2004, AM J KIDNEY DIS, V44, P950, DOI 10.1053/j.ajkd.2004.08.020; Garlick PJ, 2005, J NUTR, V135, p1553S, DOI 10.1093/jn/135.6.1553S; Go G, 2012, AMINO ACIDS, V43, P1713, DOI 10.1007/s00726-012-1255-5; Graham TE, 1998, MED SCI SPORT EXER, V30, P34, DOI 10.1097/00005768-199801000-00006; HARRIS CI, 1979, P NUTR SOC, V38, pA11; Janeczko MJ, 2007, J NUTR, V137, P2384, DOI 10.1093/jn/137.11.2384; Jinap S, 2010, APPETITE, V55, P1, DOI 10.1016/j.appet.2010.05.002; KING AJ, 1993, J AM SOC NEPHROL, V3, P1723; Kong XF, 2007, LIVEST SCI, V108, P272, DOI 10.1016/j.livsci.2007.01.079; Kopple JD, 2007, J NUTR, V137, p1586S, DOI 10.1093/jn/137.6.1586S; MELLINKOFF SM, 1965, AM J CLIN NUTR, V16, P232, DOI 10.1093/ajcn/16.2.232; Mong MC, 2011, EUR J PHARMACOL, V653, P82, DOI 10.1016/j.ejphar.2010.12.001; Nakashima K, 2005, BIOCHEM BIOPH RES CO, V336, P660, DOI 10.1016/j.bbrc.2005.08.138; Noguchi Y, 2006, AM J CLIN NUTR, V83, p513S; Novak EM, 2012, AM J PHYSIOL-GASTR L, V302, pG250, DOI 10.1152/ajpgi.00189.2011; Oda H, 2006, J NUTR, V136, p1666S, DOI 10.1093/jn/136.6.1666S; OWEN EE, 1963, J CLIN INVEST, V42, P263, DOI 10.1172/JCI104713; Paddon-Jones D, 2004, AM J PHYSIOL-ENDOC M, V286, pE321, DOI 10.1152/ajpendo.00368.2003; Popkin BM, 2002, PUBLIC HEALTH NUTR, V5, P205, DOI 10.1079/PHN2001295; Reeds PJ, 2000, J NUTR, V130, p978S, DOI 10.1093/jn/130.4.978S; Rezaei R, 2013, AMINO ACIDS, V44, P911, DOI 10.1007/s00726-012-1420-x; Schmid RD, 2002, TASCHENATLAS BIOTECH; Tan B, 2012, AMINO ACIDS, V43, P2481, DOI 10.1007/s00726-012-1328-5; Tessari P, 2000, Curr Opin Clin Nutr Metab Care, V3, P51, DOI 10.1097/00075197-200001000-00009; TIZIANELLO A, 1980, J CLIN INVEST, V65, P1162, DOI 10.1172/JCI109771; Turnbaugh PJ, 2012, NATURE, V487, P47, DOI 10.1038/487047a; van de Poll MCG, 2004, AM J CLIN NUTR, V79, P185; van der Laan JW, 2010, J PHARMACOL TOX MET, V62, P184, DOI 10.1016/j.vascn.2010.05.005; VAZQUEZ JA, 1985, J CLIN INVEST, V76, P737, DOI 10.1172/JCI112029; Wright Jacqueline D, 2010, NCHS Data Brief, P1; YOUNG GA, 1982, KIDNEY INT, V21, P492, DOI 10.1038/ki.1982.51; Zai H, 2009, AM J CLIN NUTR, V89, P431, DOI 10.3945/ajcn.2008.26180	42	22	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84533	10.1371/journal.pone.0084533	http://dx.doi.org/10.1371/journal.pone.0084533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465415	gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500007
J	Kar, PK; Murmu, S; Saha, S; Tandon, V; Acharya, K				Kar, Pradip Kumar; Murmu, Sanatan; Saha, Saswati; Tandon, Veena; Acharya, Krishnendu			Anthelmintic Efficacy of Gold Nanoparticles Derived from a Phytopathogenic Fungus, Nigrospora oryzae	PLOS ONE			English	Article							ROOT-TUBER EXTRACT; IN-VITRO; SILVER NANOPARTICLES; HAEMONCHUS-CONTORTUS; FASCIOLA-HEPATICA; FLEMINGIA VESTITA; ACID-PHOSPHATASE; ESSENTIAL OIL; PLANT; BIOSYNTHESIS	Exploring a green chemistry approach, this study brings to the fore, the anthelmintic efficacy of gold nanoparticles, highlighting the plausible usage of myconanotechnology. Gold nanoparticles of similar to 6 to similar to 18 nm diameter were synthesized by treating the mycelia-free culture filtrate of the phytopathogenic fungus with gold chloride. Their size and morphology were confirmed by UV-Vis spectroscopy, DLS data, AFM and TEM images. The XRD studies reveal a crystalline nature of the nanoparticles, which are in cubic phase. The FTIR spectroscopic studies before and after the formation of nanoparticles show the presence of possible functional groups responsible for the bio-reduction and capping of the synthesized gold nanoparticles. The latter were tested as vermifugal agents against a model cestode Raillietina sp., an intestinal parasite of domestic fowl. Further, ultrastructural and biochemical parameters were used to corroborate the efficacy study.	[Kar, Pradip Kumar; Murmu, Sanatan] Jhargram Raj Coll, Parasitol Lab, Post Grad Dept Zool, West Midnapore, W Bengal, India; [Saha, Saswati; Acharya, Krishnendu] Univ Calcutta, Dept Bot, Mol & Appl Mycol & Plant Pathol Lab, Kolkata, W Bengal, India; [Tandon, Veena] NE Hill Univ, Parasitol Lab, Shillong 793014, Meghalaya, India	University of Calcutta; North Eastern Hill University	Kar, PK (corresponding author), Jhargram Raj Coll, Parasitol Lab, Post Grad Dept Zool, West Midnapore, W Bengal, India.	karpradip@gmail.com; krish_paper@yahoo.com	Acharya, Krishnendu/G-2317-2012	Acharya, Krishnendu/0000-0003-1193-1823; Tandon, Veena/0000-0003-4315-2082; MURMU, SANATAN/0000-0001-7697-9604				Acharya K, 2009, ADV BIOTECHNOL, P204; Alawa CBI, 2003, VET PARASITOL, V113, P73, DOI 10.1016/S0304-4017(03)00040-2; ANDERSON HR, 1995, INT J PARASITOL, V25, P319, DOI 10.1016/0020-7519(94)00105-W; Bajaj S, 1998, INDIAN J MED RES, V108, P104; BHAKUNI DS, 1988, INDIAN J EXP BIOL, V26, P883; Biftu D, 2004, ETHIOP VET J, V8, P57; Bunitian HC, 1970, HDB NEUROCHEMISTRY; Chen PC, 2008, NANOTECHNOL SCI APPL, V1, P45; CHHABRA SC, 1990, J ETHNOPHARMACOL, V29, P295, DOI 10.1016/0378-8741(90)90041-Q; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; DEY S, 1989, J MICROSC-OXFORD, V156, P259, DOI 10.1111/j.1365-2818.1989.tb02925.x; Fetterer RH, 2000, J PARASITOL, V86, P1, DOI 10.1645/0022-3395(2000)086[0001:COAPAP]2.0.CO;2; Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016; Hillyer JF, 2001, J PHARM SCI, V90, P1927, DOI 10.1002/jps.1143; Hordegen P, 2006, J ETHNOPHARMACOL, V108, P85, DOI 10.1016/j.jep.2006.04.013; Kamei H, 1998, CANCER BIOTHER RADIO, V13, P403, DOI 10.1089/cbr.1998.13.403; Kaplan C, 1957, J BIOL CHEM, VIII; Kar P. K., 2004, Journal of Parasitic Diseases, V28, P45; KAUSHIK RK, 1981, INDIAN J ANIM SCI, V51, P869; Ketzis JK, 2002, SMALL RUMINANT RES, V44, P193, DOI 10.1016/S0921-4488(02)00047-0; Khunkitti W, 2000, J HELMINTHOL, V74, P241, DOI 10.1017/S0022149X00000342; Kumar D., 1995, Indian Journal of Pharmacology, V27, P161; Kwak Kee-Hoon, 1996, Korean Journal of Parasitology, V34, P69, DOI 10.3347/kjp.1996.34.1.69; LEON P, 1989, VET PARASITOL, V30, P297, DOI 10.1016/0304-4017(89)90099-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luechinger NA, 2010, CHEM MATER, V22, P155, DOI 10.1021/cm902527n; Mohamed AM, 2005, MEM I OSWALDO CRUZ, V100, P205, DOI 10.1590/S0074-02762005000200016; Mohanpuria P, 2008, J NANOPART RES, V10, P507, DOI 10.1007/s11051-007-9275-x; Molgaard P, 2001, J ETHNOPHARMACOL, V74, P257, DOI 10.1016/S0378-8741(00)00377-9; Mukherjee Priyabrata, 2007, Journal of Nanobiotechnology, V5, P4, DOI 10.1186/1477-3155-5-4; Mulvaney P, 1996, LANGMUIR, V12, P788, DOI 10.1021/la9502711; Pal Papri, 1998, Parasitology International, V47, P233, DOI 10.1016/S1383-5769(98)00025-7; PAPPAS PW, 1988, J CELL BIOCHEM, V37, P395, DOI 10.1002/jcb.240370407; PARVEEN N, 1991, Fitoterapia, V62, P163; PERRETT S, 1995, PHYTOTHER RES, V9, P401, DOI 10.1002/ptr.2650090603; Perry Lily M., 1980, MED PLANTS E SE ASIA; Pessoa LM, 2002, VET PARASITOL, V109, P59, DOI 10.1016/S0304-4017(02)00253-4; Plummer D. T., 1988, INTRO PRACTICAL BIOC; Richards DG, 2002, INT J NEUROSCI, V112, P31, DOI 10.1080/00207450212018; ROBINSON RD, 1990, W INDIAN MED J, V39, P213; Roy B, 1996, PARASITOL RES, V82, P248, DOI 10.1007/s004360050104; Roy B, 2008, PHARMACOGN MAG, V4, P20; Roy B, 2008, MICROSC RES TECHNIQ, V71, P810, DOI 10.1002/jemt.20623; Saha S, 2010, DIG J NANOMATER BIOS, V5, P887; Saha S, 2011, DIG J NANOMATER BIOS, V6, P1519; Sarkar J, 2011, MICRO NANO LETT, V6, P599, DOI 10.1049/mnl.2011.0227; Sarkar J, 2013, MATER LETT, V92, P313, DOI 10.1016/j.matlet.2012.10.130; Sarkar J, 2012, BIOPROC BIOSYST ENG, V35, P637, DOI 10.1007/s00449-011-0646-4; Sarkar J, 2011, DIG J NANOMATER BIOS, V6, P563; Shilaskar DV, 1989, INDIAN J INDIGENOUS, V6, P49; Sperling RA, 2008, CHEM SOC REV, V37, P1896, DOI 10.1039/b712170a; Tandon V., 2004, Journal of Parasitic Diseases, V28, P37; Tandon V, 1997, PARASITOL RES, V83, P492, DOI 10.1007/s004360050286; Tangpu Temgenmogla V., 2006, Indian Journal of Pharmacology, V38, P29; Temjenmongla T., 2005, AFR J TRADIT COMPLEM, V2, P129, DOI [10.4314/ajtcam.v2i2.31111, DOI 10.4314/AJTCAM.V2I2.31111]; TERADA M, 1982, Folia Pharmacologica Japonica, V79, P93, DOI 10.1254/fpj.79.93; Tikariha S, 2012, INT J PHARM SCI RES, V3, P1603, DOI 10.13040/IJPSR.0975-8232.3(6).1603-15; Verma VC, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9743-6; Yadav AK, 2006, PHARM ONLINE, V3, P90	59	37	39	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84693	10.1371/journal.pone.0084693	http://dx.doi.org/10.1371/journal.pone.0084693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465424	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500011
J	Di Sabatino, D; Lorusso, A; Di Francesco, CE; Gentile, L; Di Pirro, V; Bellacicco, AL; Giovannini, A; Di Francesco, G; Marruchella, G; Marsilio, F; Savini, G				Di Sabatino, Daria; Lorusso, Alessio; Di Francesco, Cristina E.; Gentile, Leonardo; Di Pirro, Vincenza; Bellacicco, Anna Lucia; Giovannini, Armando; Di Francesco, Gabriella; Marruchella, Giuseppe; Marsilio, Fulvio; Savini, Giovanni			Arctic Lineage-Canine Distemper Virus as a Cause of Death in Apennine Wolves (Canis lupus) in Italy	PLOS ONE			English	Article							MORBILLIVIRUS INFECTIONS; GENETIC-CHARACTERIZATION; HEMAGGLUTININ GENES; VACCINATED DOGS; RED FOXES; CDV; PCR; EMERGENCE; STRAINS; DISEASE	Canine distemper virus (CDV) infection is a primary threat affecting a wide number of carnivore species, including wild animals. In January 2013, two carcasses of Apennine wolves (Canis lupus) were collected in Ortona dei Marsi (L'Aquila province, Italy) by the local Veterinary Services. CDV was immediately identified either by RT-PCR or immunohistochemistry in lung and central nervous tissue samples. At the same time, severe clinical signs consistent with CDV infection were identified and taped (Videos S1-S3) from three wolves rescued in the areas surrounding the National Parks of the Abruzzi region by the Veterinary Services. The samples collected from these symptomatic animals also turned out CDV positive by RT-PCR. So far, 30 carcasses of wolves were screened and CDV was detected in 20 of them. The sequencing of the haemagglutinin gene and subsequent phylogenetic analysis demonstrated that the identified virus belonged to the CDV Arctic lineage. Strains belonging to this lineage are known to circulate in Italy and in Eastern Europe amongst domestic dogs. To the best of our knowledge this is the first report of CDV Arctic lineage epidemics in the wild population in Europe.	[Di Sabatino, Daria; Lorusso, Alessio; Bellacicco, Anna Lucia; Giovannini, Armando; Di Francesco, Gabriella; Marruchella, Giuseppe; Savini, Giovanni] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, Italy; [Di Francesco, Cristina E.; Marsilio, Fulvio] Fac Vet Med Teramo, Infect Dis Unit, Teramo, Italy; [Gentile, Leonardo; Di Pirro, Vincenza] Natl Pk Abruzzi Lazio & Molise, Vet Serv, Pescasseroli, AQ, Italy	IZS Dell'abruzzo E Del Molise Giuseppe Caporale	Lorusso, A (corresponding author), Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, Italy.	a.lorusso@izs.it	Di Francesco, Gabriella/D-8396-2016; Di Francesco, Cristina/AAE-8997-2019; Giovannini, Armando/B-9828-2013; Di Sabatino, Daria/I-2868-2016; Marsilio, Fulvio/AAS-3924-2020; Savini, Giovanni/AAT-7897-2020; Lorusso, Alessio/A-7311-2016; Savini, Giovanni/D-8416-2016	Di Francesco, Gabriella/0000-0001-5002-9969; Giovannini, Armando/0000-0001-5006-5564; Di Sabatino, Daria/0000-0003-0348-3709; Savini, Giovanni/0000-0001-7933-7367; Lorusso, Alessio/0000-0001-6156-8212; Savini, Giovanni/0000-0001-7933-7367; DI FRANCESCO, Cristina Esmeralda/0000-0002-0896-4539; MARSILIO, FULVIO/0000-0001-9552-1199	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	Funding was provided by the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altobello Giuseppe, 1921, FAUNA ABRUZZO MOLISE; Appel M.J.G., 1987, VIRUS INFECT CARNIVO, P133; Barrett T, 1999, VET MICROBIOL, V69, P3, DOI 10.1016/S0378-1135(99)00080-2; BLIXENKRONEMOLLER M, 1992, ARCH VIROL, V123, P279, DOI 10.1007/BF01317264; Calderon MG, 2007, VET MICROBIOL, V125, P341, DOI 10.1016/j.vetmic.2007.05.020; Daoust PY, 2009, J WILDLIFE DIS, V45, P611, DOI 10.7589/0090-3558-45.3.611; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; Demeter Z, 2007, VET MICROBIOL, V122, P258, DOI 10.1016/j.vetmic.2007.02.001; Di Francesco CE, 2012, J VET DIAGN INVEST, V24, P107, DOI 10.1177/1040638711425700; Di Guardo G, 2005, J VET MED A, V52, P88, DOI 10.1111/j.1439-0442.2005.00693.x; Di Guardo G, 2013, RES VET SCI, V94, P132, DOI 10.1016/j.rvsc.2012.07.030; Frisk AL, 1999, J CLIN MICROBIOL, V37, P3634, DOI 10.1128/JCM.37.11.3634-3643.1999; Gervasi V, 2012, BIOL CONSERV, V152, P10, DOI 10.1016/j.biocon.2012.04.005; Iwatsuki K, 2000, VET MICROBIOL, V71, P281, DOI 10.1016/S0378-1135(99)00172-8; Kapil S, 2011, VET CLIN N AM-SMALL, V41, P1069, DOI 10.1016/j.cvsm.2011.08.005; Kennedy S, 1998, J COMP PATHOL, V119, P201, DOI 10.1016/S0021-9975(98)80045-5; Marsilio F., 1999, Veterinaria (Cremona), V13, P39; Marsilio F, 1997, J WILDLIFE DIS, V33, P304, DOI 10.7589/0090-3558-33.2.304; Martella V, 2006, VET MICROBIOL, V116, P301, DOI 10.1016/j.vetmic.2006.04.019; Martella V, 2002, MOL CELL PROBE, V16, P77, DOI 10.1006/mcpr.2001.0387; Martella V, 2008, VET CLIN N AM-SMALL, V38, P787, DOI 10.1016/j.cvsm.2008.02.007; Martella V, 2007, VET MICROBIOL, V122, P32, DOI 10.1016/j.vetmic.2007.01.005; Martella V, 2010, EMERG INFECT DIS, V16, P2007, DOI 10.3201/eid1612.100579; McCarthy AJ, 2007, P ROY SOC B-BIOL SCI, V274, P3165, DOI 10.1098/rspb.2007.0884; Meli ML, 2010, VET MICROBIOL, V146, P132, DOI 10.1016/j.vetmic.2010.04.024; Mochizuki M, 1999, J CLIN MICROBIOL, V37, P2936, DOI 10.1128/JCM.37.9.2936-2942.1999; Monne I, 2011, VET MICROBIOL, V150, P63, DOI 10.1016/j.vetmic.2011.01.009; Murray DL, 1999, ANIM CONSERV, V2, P241, DOI 10.1111/j.1469-1795.1999.tb00070.x; Ohishi K, 2010, COMP IMMUNOL MICROB, V33, P227, DOI 10.1016/j.cimid.2008.10.003; Osterhaus A, 2001, PHILOS T ROY SOC B, V356, P791, DOI 10.1098/rstb.2001.0856; Pavlacik L, 2007, VET MED-CZECH, V52, P69, DOI 10.17221/2057-VETMED; RANDI E, 1994, HEREDITY, V73, P480, DOI 10.1038/hdy.1994.146; Sekulin K, 2011, VET J, V187, P399, DOI 10.1016/j.tvjl.2009.12.029; Simon-Martinez J, 2008, VET J, V175, P423, DOI 10.1016/j.tvjl.2007.01.015; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; van de Bildt MWG, 1999, VET MICROBIOL, V69, P19, DOI 10.1016/S0378-1135(99)00082-6; von Messling V, 2001, J VIROL, V75, P6418, DOI 10.1128/JVI.75.14.6418-6427.2001; Woma TY, 2010, VET MICROBIOL, V143, P126, DOI 10.1016/j.vetmic.2009.11.013; Zhao JJ, 2010, VET MICROBIOL, V140, P34, DOI 10.1016/j.vetmic.2009.07.010	41	41	41	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e82356	10.1371/journal.pone.0082356	http://dx.doi.org/10.1371/journal.pone.0082356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465373	gold, Green Submitted, Green Published			2022-12-25	WOS:000330240500003
J	Fan, AR; Wu, XF; Wu, HJ; Li, L; Huang, R; Zhu, YY; Qiu, Y; Fu, J; Ren, J; Zhu, CG				Fan, Angran; Wu, Xiaofeng; Wu, Huijuan; Li, Long; Huang, Rui; Zhu, Yueyong; Qiu, Yan; Fu, Jin; Ren, Jie; Zhu, Chenggang			Atheroprotective Effect of Oleoylethanolamide (OEA) Targeting Oxidized LDL	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; MUSCLE-CELL PROLIFERATION; CORONARY-HEART-DISEASE; TYPE-2 DIABETES-MELLITUS; LOW-DENSITY-LIPOPROTEIN; PPAR-GAMMA ACTIVATORS; BODY-WEIGHT; METABOLIC SYNDROME; NUCLEAR RECEPTORS; SMALL-INTESTINE	Dietary fat-derived lipid oleoylethanolamide (OEA) has shown to modulate lipid metabolism through a peroxisome proliferator-activated receptor-alpha (PPAR-alpha)-mediated mechanism. In our study, we further demonstrated that OEA, as an atheroprotective agent, modulated the atherosclerotic plaques development. In vitro studies showed that OEA antagonized oxidized LDL (ox-LDL)-induced vascular endothelial cell proliferation and vascular smooth muscle cell migration, and suppressed lipopolysaccharide (LPS)-induced LDL modification and inflammation. In vivo studies, atherosclerosis animals were established using balloon-aortic denudation (BAD) rats and ApoE(-/-) mice fed with high-caloric diet (HCD) for 17 or 14 weeks respectively, and atherosclerotic plaques were evaluated by oil red staining. The administration of OEA (5 mg/kg/day, intraperitoneal injection, i.p.) prevented or attenuated the formation of atherosclerotic plaques in HCD-BAD rats or HCD-ApoE(-/-) mice. Gene expression analysis of vessel tissues from these animals showed that OEA induced the mRNA expressions of PPAR-alpha and downregulated the expression of M-CFS, an atherosclerotic marker, and genes involved in oxidation and inflammation, including iNOS, COX-2, TNF-alpha and IL-6. Collectively, our results suggested that OEA exerted a pharmacological effect on modulating atherosclerotic plaque formation through the inhibition of LDL modification in vascular system and therefore be a potential candidate for anti-atherosclerosis drug.	[Fan, Angran; Wu, Xiaofeng; Wu, Huijuan; Li, Long; Huang, Rui; Qiu, Yan; Fu, Jin; Ren, Jie] Xiamen Univ, Dept Med Sci, Coll Med, Xiamen, Fujian, Peoples R China; [Zhu, Yueyong] Fujian Med Univ, Affiliated Hosp 1, Div Liver Dis, Fuzhou, Fujian, Peoples R China; [Zhu, Chenggang] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Xiamen University; Fujian Medical University; Fudan University	Ren, J (corresponding author), Xiamen Univ, Dept Med Sci, Coll Med, Xiamen, Fujian, Peoples R China.	renjie_7912@xmu.edu.cn; chenggang.zhu@gmail.com			Fundamental Research Fund for China Universities [2011121059]; National Natural Science Foundation of China [91129722]; Xiamen Science and Technology Program, China [3502Z20113010]	Fundamental Research Fund for China Universities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xiamen Science and Technology Program, China	This work was supported by the Fundamental Research Fund for China Universities (To JF, No. 2011121059); National Natural Science Foundation of China (To JF, 91129722) and Xiamen Science and Technology Program (To QY, 3502Z20113010), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astarita G, 2006, J PHARMACOL EXP THER, V318, P563, DOI 10.1124/jpet.106.105221; Babaev VR, 2007, CIRCULATION, V116, P1404, DOI 10.1161/CIRCULATIONAHA.106.684704; Belfort R, 2010, J CLIN ENDOCR METAB, V95, P829, DOI 10.1210/jc.2009-1487; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Bocher Virginie, 2002, Journal de la Societe de Biologie, V196, P47; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Chinetti-Gbaguidi G, 2005, CURR OPIN PHARMACOL, V5, P177, DOI 10.1016/j.coph.2004.11.004; Duval C, 2002, TRENDS MOL MED, V8, P422, DOI 10.1016/S1471-4914(02)02385-7; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Gizard F, 2005, J CLIN INVEST, V115, P3228, DOI 10.1172/JCI22756; Gizard F, 2008, CIRC RES, V103, P1155, DOI 10.1161/CIRCRESAHA.108.186205; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; Keating GM, 2007, DRUGS, V67, P121, DOI 10.2165/00003495-200767010-00013; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Kooistra T, 2006, ARTERIOSCL THROM VAS, V26, P2322, DOI 10.1161/01.ATV.0000238348.05028.14; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Madej A, 1998, INT J CLIN PHARM TH, V36, P345; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Marx N, 2004, CIRC RES, V94, P1168, DOI 10.1161/01.RES.0000127122.22685.0A; Marx N, 2002, CIRC RES, V90, P703, DOI 10.1161/01.RES.0000014225.20727.8F; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Suardiaz M, 2007, PAIN, V133, P99, DOI 10.1016/j.pain.2007.03.008; Thabuis C, 2008, LIPIDS, V43, P887, DOI 10.1007/s11745-008-3217-y; Wagner JD, 2010, J PHARMACOL EXP THER, V333, P844, DOI 10.1124/jpet.110.166736; Yang YK, 2007, AM J PHYSIOL-REG I, V292, pR235, DOI 10.1152/ajpregu.00270.2006; Zahradka P, 2006, J PHARMACOL EXP THER, V317, P651, DOI 10.1124/jpet.105.096271; Zahradka P, 2003, MOL CELL BIOCHEM, V246, P105, DOI 10.1023/A:1023424500160	47	39	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85337	10.1371/journal.pone.0085337	http://dx.doi.org/10.1371/journal.pone.0085337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465540	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500043
J	Molina, L; Udaondo, Z; Duque, E; Fernandez, M; Molina-Santiago, C; Roca, A; Porcel, M; de la Torre, J; Segura, A; Plesiat, P; Jeannot, K; Ramos, JL				Molina, Lazaro; Udaondo, Zulema; Duque, Estrella; Fernandez, Matilde; Molina-Santiago, Carlos; Roca, Amalia; Porcel, Mario; de la Torre, Jesus; Segura, Ana; Plesiat, Patrick; Jeannot, Katy; Ramos, Juan-Luis			Antibiotic Resistance Determinants in a Pseudomonas putida Strain Isolated from a Hospital	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; HEMOLYTIC-UREMIC SYNDROME; ESCHERICHIA-COLI; QUINOLONE RESISTANCE; REGULATORY SYSTEM; SEQUENCE-ANALYSIS; ACTIVE EFFLUX; GENE; IDENTIFICATION; PLASMID	Environmental microbes harbor an enormous pool of antibiotic and biocide resistance genes that can impact the resistance profiles of animal and human pathogens via horizontal gene transfer. Pseudomonas putida strains are ubiquitous in soil and water but have been seldom isolated from humans. We have established a collection of P. putida strains isolated from inpatients in different hospitals in France. One of the isolated strains (HB3267) kills insects and is resistant to the majority of the antibiotics used in laboratories and hospitals, including aminoglycosides, beta-lactams, cationic peptides, chromoprotein enediyne antibiotics, dihydrofolate reductase inhibitors, fluoroquinolones and quinolones, glycopeptide antibiotics, macrolides, polyketides and sulfonamides. Similar to other P. putida clinical isolates the strain was sensitive to amikacin. To shed light on the broad pattern of antibiotic resistance, which is rarely found in clinical isolates of this species, the genome of this strain was sequenced and analysed. The study revealed that the determinants of multiple resistance are both chromosomally-borne as well as located on the pPC9 plasmid. Further analysis indicated that pPC9 has recruited antibiotic and biocide resistance genes from environmental microorganisms as well as from opportunistic and true human pathogens. The pPC9 plasmid is not self-transmissible, but can be mobilized by other bacterial plasmids making it capable of spreading antibiotic resistant determinants to new hosts.	[Molina, Lazaro] Univ Huelva, Lab Invest & Control Agroalimentario, Huelva, Spain; [Molina, Lazaro; Udaondo, Zulema; Duque, Estrella; Molina-Santiago, Carlos; Porcel, Mario; de la Torre, Jesus; Segura, Ana; Ramos, Juan-Luis] CSIC, Estn Expt Zaidin, Granada, Spain; [Molina, Lazaro] Univ Huelva, Ctr Invest Quim Sostenible, Huelva, Spain; [Fernandez, Matilde; Roca, Amalia] Bioiliberis Res & Dev, Peligros Granada, Spain; [Plesiat, Patrick; Jeannot, Katy] Ctr Hosp Reg Univ Hop Jean Minjoz, Besancon, France	Universidad de Huelva; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Universidad de Huelva; Universite de Franche-Comte; CHU Besancon	Ramos, JL (corresponding author), CSIC, Estn Expt Zaidin, Granada, Spain.	juanluis.ramos@eez.csic.es	Hernandez, Amalia Roca/AAD-3048-2019; Udaondo, Zulema/ABI-7810-2020; Fernandez, Matilde/F-5980-2013; Molina, Carlos/AAS-5053-2020; Segura, Ana/F-9811-2016; Molina, Lazaro/K-9645-2014; Roca, Amalia/AAB-9240-2021	Hernandez, Amalia Roca/0000-0003-2332-3112; Fernandez, Matilde/0000-0002-7064-670X; Molina, Carlos/0000-0002-1131-8917; Segura, Ana/0000-0001-7985-5658; Molina, Lazaro/0000-0002-8483-9203; Udaondo, Zulema/0000-0003-3445-6842; Jeannot, katy/0000-0002-4634-8550; Porcel, Mario/0000-0002-8445-5621; De la Torre Zuniga, Jesus/0000-0001-8111-6299; Duque, Estrella/0000-0002-4857-8974; Ramos, Juan L./0000-0002-8731-7435; Fernandez, Matilde/0000-0002-5832-5161	ERANET [BIO2008-04419-E, BIO2010-17227]	ERANET	Funds were recieved from ERANET BIO2008-04419-E and BIO2010-17227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Molina-Henares MA, 2010, ENVIRON MICROBIOL, V12, P1468, DOI 10.1111/j.1462-2920.2010.02166.x; Aranda-Olmedo I, 2002, NUCLEIC ACIDS RES, V30, P1826, DOI 10.1093/nar/30.8.1826; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Bramucci M, 2006, APPL MICROBIOL BIOT, V71, P67, DOI 10.1007/s00253-005-0119-2; Ceri H, 2001, METHOD ENZYMOL, V337, P377, DOI 10.1016/S0076-6879(01)37026-X; Dahshan H, 2011, VET RES COMMUN, V35, P55, DOI 10.1007/s11259-010-9448-4; Pescaretti MD, 2011, MICROBIOL-SGM, V157, P2515, DOI 10.1099/mic.0.050088-0; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Docquier JD, 2003, ANTIMICROB AGENTS CH, V47, P1522, DOI 10.1128/AAC.47.5.1522-1528.2003; Dogan NM, 2011, ENVIRON SCI TECHNOL, V45, P2278, DOI 10.1021/es102095t; Duque E, 2012, ENV MICROBI IN PRESS; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P4012, DOI 10.1128/AAC.48.10.4012-4015.2004; Espinosa-Urgel Manuel, 2002, Microbiology (Reading), V148, P341, DOI 10.1099/00221287-148-2-341; Fernandez M, 2012, ANTIMICROB AGENTS CH, V56, P1001, DOI 10.1128/AAC.05398-11; Fernandez M, 2009, MICROB BIOTECHNOL, V2, P287, DOI 10.1111/j.1751-7915.2009.00085.x; Frapolli M, 2007, ENVIRON MICROBIOL, V9, P1939, DOI 10.1111/j.1462-2920.2007.01310.x; Godoy P, 2010, MICROB BIOTECHNOL, V3, P691, DOI 10.1111/j.1751-7915.2010.00189.x; GOLDMAN RA, 1983, BIOCHEMISTRY-US, V22, P359, DOI 10.1021/bi00271a020; GRAEVENITZ AV, 1971, YALE J BIOL MED, V44, P265; Hainrichson M, 2007, ANTIMICROB AGENTS CH, V51, P774, DOI 10.1128/AAC.01034-06; Han HS, 2004, J MICROBIOL, V42, P365; HEDGES RW, 1985, ANTIMICROB AGENTS CH, V27, P479, DOI 10.1128/AAC.27.4.479; Hernandez A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00022; Horii T, 2005, J ANTIMICROB CHEMOTH, V56, P643, DOI 10.1093/jac/dki254; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Kamath R, 2004, ENVIRON SCI TECHNOL, V38, P1740, DOI 10.1021/es0306258; Kent M., 2000, ADV BIOL, P46; Khan NH, 2008, APPL ENVIRON MICROB, V74, P6194, DOI 10.1128/AEM.02322-07; Kumita W, 2009, J INFECT CHEMOTHER, V15, P6, DOI 10.1007/s10156-008-0661-9; Levy SB, 2002, J APPL MICROBIOL, V92, p65S, DOI 10.1046/j.1365-2672.92.5s1.4.x; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; LOISEAUMAROLLEAU ML, 1977, PATHOL BIOL, V25, P637; Marcelletti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027297; MCMURRY L, 1980, P NATL ACAD SCI-BIOL, V77, P3974, DOI 10.1073/pnas.77.7.3974; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Mendes RE, 2007, ANTIMICROB AGENTS CH, V51, P2611, DOI 10.1128/AAC.00838-06; Mine T, 1998, J BIOCHEM-TOKYO, V124, P187, DOI 10.1093/oxfordjournals.jbchem.a022078; Molina L, 2011, ENVIRON MICROBIOL, V13, P2315, DOI 10.1111/j.1462-2920.2011.02492.x; Moskowitz SM, 2012, ANTIMICROB AGENTS CH, V56, P1019, DOI 10.1128/AAC.05829-11; Muller C, 2011, ANTIMICROB AGENTS CH, V55, P1211, DOI 10.1128/AAC.01252-10; Parameswaran GI, 2009, DRUG AGING, V26, P985, DOI 10.2165/11315700-000000000-00000; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P891, DOI 10.1128/AAC.44.4.891-897.2000; RADSTROM P, 1988, ANTIMICROB AGENTS CH, V32, P1684, DOI 10.1128/AAC.32.11.1684; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rodriguez-Herva JJ, 2007, ENVIRON MICROBIOL, V9, P1550, DOI 10.1111/j.1462-2920.2007.01276.x; Rojas A, 2001, J BACTERIOL, V183, P3967, DOI 10.1128/JB.183.13.3967-3973.2001; Rolston KVI, 2005, DIAGN MICR INFEC DIS, V51, P215, DOI 10.1016/j.diagmicrobio.2004.11.002; Saha Rumpa, 2010, J Indian Med Assoc, V108, P344; Santos C, 2010, CLIN MICROBIOL INFEC, V16, P1558, DOI 10.1111/j.1469-0691.2010.03165.x; SCHMIDT FRJ, 1988, MOL MICROBIOL, V2, P709, DOI 10.1111/j.1365-2958.1988.tb00081.x; Steinmann J, 2011, EUROSURVEILLANCE, V16, P13; Struble JM, 2006, ANTIMICROB AGENTS CH, V50, P2506, DOI 10.1128/AAC.01640-05; Tang HZ, 2011, J BACTERIOL, V193, P6789, DOI 10.1128/JB.06201-11; Trevino M, 2010, J MED MICROBIOL, V59, P853, DOI 10.1099/jmm.0.018036-0; VAARA M, 1993, ANTIMICROB AGENTS CH, V37, P354, DOI 10.1128/AAC.37.2.354; Vaziri F, 2011, CLINICS, V66, P1519, DOI 10.1590/S1807-59322011000900002; Wang SN, 2007, MICROBIOL-SGM, V153, P1556, DOI 10.1099/mic.0.2006/005223-0; Wei Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029276; WILLIAMS PA, 1974, J BACTERIOL, V120, P416, DOI 10.1128/JB.120.1.416-423.1974; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; Yomoda S, 2003, J CLIN MICROBIOL, V41, P4246, DOI 10.1128/JCM.41.9.4246-4251.2003; Yoshino Y, 2011, J INFECT CHEMOTHER, V17, P278, DOI 10.1007/s10156-010-0114-0; Zhao HB, 2005, MICROBIOL RES, V160, P307, DOI 10.1016/j.micres.2005.02.004	68	55	55	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e81604	10.1371/journal.pone.0081604	http://dx.doi.org/10.1371/journal.pone.0081604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465371	Green Submitted, gold, Green Published			2022-12-25	WOS:000330237000004
J	Wang, J; Guo, XY; Lui, M; Chu, PJ; Yoo, J; Chang, M; Yen, Y				Wang, James; Guo, Xiaoyu; Lui, Monica; Chu, Pei-Ju; Yoo, Jennifer; Chang, Megan; Yen, Yun			Identification of a Distinct Small Cell Population from Human Bone Marrow Reveals Its Multipotency In Vivo and In Vitro	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SPORE-LIKE CELLS; ADIPOSE-TISSUE; STROMAL CELLS; SELF-RENEWAL; DIFFERENTIATION; PLURIPOTENCY; NANOG; TRANSPLANTATION; RECEPTORS	Small stem cells, such as spore-like cells, blastomere-like stem cells (BLSCs), and very-small embryonic-like stem cells (VSELs) have been described in recent studies, although their multipotency in human tissues has not yet been confirmed. Here, we report the discovery of adult multipotent stem cells derived from human bone marrow, which we call StemBios (SB) cells. These isolated SB cells are smaller than 6 im and are DAPI+ and Lgr5+ (Leucine-Rich Repeat Containing G Protein-Coupled Receptor 5). Because Lgr5 has been characterized as a stem cell marker in the intestine, we hypothesized that SB cells may have a similar function. In vivo cell tracking assays confirmed that SB cells give rise to three types of cells, and in vitro studies demonstrated that SB cells cultured in proprietary media are able to grow to 6-25 im in size. Once the SB cells have attached to the wells, they differentiate into different cell lineages upon exposure to specific differentiation media. We are the first to demonstrate that stem cells smaller than 6 im can differentiate both in vivo and in vitro. In the future, we hope that SB cells will be used therapeutically to cure degenerative diseases.	[Wang, James; Guo, Xiaoyu; Lui, Monica; Chu, Pei-Ju; Yoo, Jennifer; Chang, Megan] StemBios Technol Inc, Monterey Pk, CA USA		Wang, J (corresponding author), StemBios Technol Inc, Monterey Pk, CA USA.	jwang@stembios.com; yyen@stembios.com	Yen, Yun/H-9591-2016		TriMax SBT LLC of Los Angeles, a venture investment company	TriMax SBT LLC of Los Angeles, a venture investment company	This study was funded by TriMax SBT LLC of Los Angeles, a venture investment company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Bongso A, 2008, J CELL BIOCHEM, V105, P1352, DOI 10.1002/jcb.21957; Borlongan CV, 2011, PROG NEUROBIOL, V95, P213, DOI 10.1016/j.pneurobio.2011.08.005; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Danova-Alt R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034899; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Frankel MS, 2000, SCIENCE, V287, P1397, DOI 10.1126/science.287.5457.1397; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Havens AM, 2013, STEM CELLS DEV, V22, P622, DOI 10.1089/scd.2012.0327; He QL, 2007, STEM CELLS, V25, P69, DOI 10.1634/stemcells.2006-0335; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Iglesias-Bartolome R, 2011, CURR OPIN CELL BIOL, V23, P716, DOI 10.1016/j.ceb.2011.08.002; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kassmer SH, 2013, MOL REPROD DEV; Katoh Y, 2006, INT J MOL MED, V18, P1019; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Madden DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028530; Mannon PJ, 2011, EXPERT OPIN BIOL TH, V11, P1249, DOI 10.1517/14712598.2011.602967; Mazzini L, 2012, CYTOTHERAPY, V14, P56, DOI 10.3109/14653249.2011.613929; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyanishi M, 2013, STEM CELL REP, V1, P198, DOI 10.1016/j.stemcr.2013.07.001; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Ratajczak MZ, 2008, EXP HEMATOL, V36, P742, DOI 10.1016/j.exphem.2008.03.010; Ratajczak MZ, 2011, DIFFERENTIATION, V81, P153, DOI 10.1016/j.diff.2011.01.006; Sakata N, 2011, WORLD J GASTROENTERO, V17, P5150, DOI 10.3748/wjg.v17.i47.5150; Shin DM, 2012, STEM CELLS DEV, V21, P1639, DOI 10.1089/scd.2011.0389; Shmilovici A, 2007, MED HYPOTHESES, V68, P767, DOI 10.1016/j.mehy.2006.08.044; Slupsky JR, 1997, BRIT J HAEMATOL, V96, P275, DOI 10.1046/j.1365-2141.1997.d01-2011.x; Stout CL, 2007, AM SURGEON, V73, P1106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Talens-Visconti R, 2006, WORLD J GASTROENTERO, V12, P5834, DOI 10.3748/wjg.v12.i36.5834; Tetta C, 2011, ORGANOGENESIS, V7, P105, DOI 10.4161/org.7.2.15782; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Vacanti MP, 2001, J CELL BIOCHEM, V80, P455, DOI 10.1002/1097-4644(20010301)80:3<455::AID-JCB180>3.0.CO;2-Z; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; Wang J, 2013, US Patent, Patent No. [12391,581 50045-004001, 12391581]; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Yamanaka Shinya, 2006, Tanpakushitsu Kakusan Koso, V51, P2346; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	55	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85112	10.1371/journal.pone.0085112	http://dx.doi.org/10.1371/journal.pone.0085112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465489	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000025
J	Hu, KD; Wang, Q; Hu, LY; Gao, SP; Wu, J; Li, YH; Zheng, JL; Han, Y; Liu, YS; Zhang, H				Hu, Kang-Di; Wang, Qian; Hu, Lan-Ying; Gao, Shuai-Ping; Wu, Jun; Li, Yan-Hong; Zheng, Ji-Lian; Han, Yi; Liu, Yong-Sheng; Zhang, Hua			Hydrogen Sulfide Prolongs Postharvest Storage of Fresh-Cut Pears (Pyrus pyrifolia) by Alleviation of Oxidative Damage and Inhibition of Fungal Growth	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; SHORT-TERM EXPOSURE; NITRIC-OXIDE; ANTIOXIDANT ACTIVITY; POLYPHENOL OXIDASE; STRAWBERRY FRUIT; GENE-EXPRESSION; SALICYLIC-ACID; ASCORBIC-ACID; APPLE SLICES	Hydrogen sulfide (H2S) has proved to be a multifunctional signaling molecule in plants and animals. Here, we investigated the role of H2S in the decay of fresh-cut pears (Pyrus pyrifolia). H2S gas released by sodium hydrosulfide (NaHS) prolonged the shelf life of fresh-cut pear slices in a dose-dependent manner. Moreover, H2S maintained higher levels of reducing sugar and soluble protein in pear slices. H2S significantly reduced the accumulation of hydrogen peroxide (H2O2), superoxide radicals (center dot O-2(-)) and malondialdehyde (MDA). Further investigation showed that H2S fumigation up-regulated the activities of antioxidant enzymes ascorbate peroxidase (APX), catalase (CAT), and guaiacol peroxidase (POD), while it down-regulated those of lipoxygenase (LOX), phenylalanine ammonia lyase (PAL) and polyphenol oxidase (PPO). Furthermore, H2S fumigation effectively inhibited the growth of two fungal pathogens of pear, Aspergillus niger and Penicillium expansum, suggesting that H2S can be developed as an effective fungicide for postharvest storage. The present study implies that H2S is involved in prolonging postharvest storage of pears by acting as an antioxidant and fungicide.	[Hu, Kang-Di; Wang, Qian; Hu, Lan-Ying; Gao, Shuai-Ping; Li, Yan-Hong; Zheng, Ji-Lian; Han, Yi; Liu, Yong-Sheng; Zhang, Hua] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Anhui, Peoples R China; [Wu, Jun] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China	Hefei University of Technology; Nanjing Agricultural University	Zhang, H (corresponding author), Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Anhui, Peoples R China.	hzhanglab@gmail.com	li, yan/GTI-4638-2022; Han, Yi/AAS-8007-2021; Han, Yi/GQP-5513-2022; Han, Yi/AAV-8691-2021	Han, Yi/0000-0002-4424-1485; Han, Yi/0000-0002-4424-1485	National Natural Science Foundation of China [31271803, 31301820, 31300133]; Scientific Research Foundation for Returned Overseas Chinese Scholars (SRF for ROCS, SEM); Natural Science Foundations of Anhui Province [11040606M85]; Anhui Provincial Education Department [2012AJZR0028, ZD200910]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Returned Overseas Chinese Scholars (SRF for ROCS, SEM)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundations of Anhui Province; Anhui Provincial Education Department	This work was financially supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm, project number 31271803, 31301820, 31300133), the Scientific Research Foundation for Returned Overseas Chinese Scholars (SRF for ROCS, SEM), the Natural Science Foundations of Anhui Province (11040606M85), and the Anhui Provincial Education Department (2012AJZR0028, ZD200910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo E, 2010, POSTHARVEST BIOL TEC, V57, P52, DOI 10.1016/j.postharvbio.2010.03.001; Alvarez C, 2012, PLANT CELL, V24, P4621, DOI 10.1105/tpc.112.105403; Ayala-Zavala JF, 2004, LEBENSM-WISS TECHNOL, V37, P687, DOI 10.1016/j.lwt.2004.03.002; BEAUDOINEAGAN LD, 1985, PLANT PHYSIOL, V78, P438, DOI 10.1104/pp.78.3.438; BENJAMIN ND, 1973, J FOOD SCI, V38, P799, DOI 10.1111/j.1365-2621.1973.tb02079.x; Bloem E, 2004, J EXP BOT, V55, P2305, DOI 10.1093/jxb/erh236; Bonghi C, 1999, POSTHARVEST BIOL TEC, V16, P213, DOI 10.1016/S0925-5214(99)00028-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng GP, 2009, J AGR FOOD CHEM, V57, P5799, DOI 10.1021/jf901173n; Ding ZS, 2007, PHYSIOL PLANTARUM, V130, P112, DOI 10.1111/j.1399-3054.2007.00893.x; Duan XW, 2007, J HORTIC SCI BIOTECH, V82, P467, DOI 10.1080/14620316.2007.11512260; Flores FB, 2008, EUR FOOD RES TECHNOL, V227, P1599, DOI 10.1007/s00217-008-0884-0; Fonseca S, 2004, PLANT SCI, V167, P457, DOI 10.1016/j.plantsci.2004.03.033; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; Garcia-Limones C, 2002, PHYSIOL MOL PLANT P, V61, P325, DOI 10.1006/pmpp.2003.0445; Garcia-Mata C, 2010, NEW PHYTOL, V188, P977, DOI 10.1111/j.1469-8137.2010.03465.x; Gupta SM, 2006, POSTHARVEST BIOL TEC, V42, P16, DOI 10.1016/j.postharvbio.2006.05.002; Haneklaus S, 2007, MINERAL ELEMENTS PLA; Hernandez-Munoz P, 2008, FOOD CHEM, V110, P428, DOI 10.1016/j.foodchem.2008.02.020; Hodges DM, 2008, POSTHARVEST BIOL TEC, V48, P155, DOI 10.1016/j.postharvbio.2007.10.016; Hu LY, 2012, J AGR FOOD CHEM, V60, P8684, DOI 10.1021/jf300728h; Jimenez A, 2002, PLANTA, V214, P751, DOI 10.1007/s004250100667; Lana MM, 2006, FOOD CHEM, V97, P203, DOI 10.1016/j.foodchem.2005.03.037; Lazar EE, 2008, LETT APPL MICROBIOL, V46, P688, DOI 10.1111/j.1472-765X.2008.02373.x; Lisjak M, 2013, PLANT CELL ENVIRON, V36, P1607, DOI 10.1111/pce.12073; MARSH R. W., 1929, JOUR POMOLOGY & HORT SCI, V7, P237; Mhamdi A, 2010, PLANT PHYSIOL, V153, P1144, DOI 10.1104/pp.110.153767; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mishra BB, 2013, FOOD CHEM, V139, P105, DOI 10.1016/j.foodchem.2013.01.074; Nguyen TBT, 2003, POSTHARVEST BIOL TEC, V30, P187, DOI 10.1016/S0925-5214(03)00103-0; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Oms-Oliu G, 2008, POSTHARVEST BIOL TEC, V50, P87, DOI 10.1016/j.postharvbio.2008.03.005; Oms-Oliu G, 2008, FOOD CHEM, V106, P1085, DOI 10.1016/j.foodchem.2007.07.040; Papenbrock J, 2007, PLANT BIOLOGY, V9, P582, DOI 10.1055/s-2007-965424; Pristijono P, 2006, POSTHARVEST BIOL TEC, V42, P256, DOI 10.1016/j.postharvbio.2006.07.006; Raseetha S, 2013, FOOD CHEM, V138, P1360, DOI 10.1016/j.foodchem.2012.09.126; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; Reyes LF, 2007, FOOD CHEM, V101, P1254, DOI 10.1016/j.foodchem.2006.03.032; Riemenschneider A, 2005, PLANT PHYSIOL BIOCH, V43, P473, DOI 10.1016/j.plaphy.2005.04.001; SIMPSON RJ, 1976, J BIOL CHEM, V251, P1936; Singh R, 2008, FOOD CHEM, V111, P951, DOI 10.1016/j.foodchem.2008.05.011; SURREY K, 1964, PLANT PHYSIOL, V39, P65, DOI 10.1104/pp.39.1.65; Vicente AR, 2006, POSTHARVEST BIOL TEC, V40, P116, DOI 10.1016/j.postharvbio.2005.12.012; Villalobos-Acuna M, 2008, POSTHARVEST BIOL TEC, V49, P187, DOI 10.1016/j.postharvbio.2008.03.003; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Zhang H, 2008, J INTEGR PLANT BIOL, V50, P1518, DOI 10.1111/j.1744-7909.2008.00769.x; Zhang H, 2011, POSTHARVEST BIOL TEC, V60, P251, DOI 10.1016/j.postharvbio.2011.01.006; Zhang H, 2009, J INTEGR PLANT BIOL, V51, P1086, DOI 10.1111/j.1744-7909.2009.00885.x; Zheng XD, 2007, POSTHARVEST BIOL TEC, V45, P221, DOI 10.1016/j.postharvbio.2007.03.001; Zhu LQ, 2009, FOOD CHEM, V114, P174, DOI 10.1016/j.foodchem.2008.09.036; Zhu SH, 2007, FOOD CHEM, V100, P1517, DOI 10.1016/j.foodchem.2005.12.022	52	54	63	6	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85524	10.1371/journal.pone.0085524	http://dx.doi.org/10.1371/journal.pone.0085524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454881	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100095
J	Kelaher, BP; Coleman, MA; Broad, A; Rees, MJ; Jordan, A; Davis, AR				Kelaher, Brendan P.; Coleman, Melinda A.; Broad, Allison; Rees, Matthew J.; Jordan, Alan; Davis, Andrew R.			Changes in Fish Assemblages following the Establishment of a Network of No-Take Marine Reserves and Partially-Protected Areas	PLOS ONE			English	Article							CONSERVATION BENEFITS; REEF; POPULATIONS; ENFORCEMENT; COMMUNITIES; CONNECTIVITY; RECRUITMENT; MANAGEMENT; FISHERIES; RESPONSES	Networks of no-take marine reserves and partially-protected areas (with limited fishing) are being increasingly promoted as a means of conserving biodiversity. We examined changes in fish assemblages across a network of marine reserves and two different types of partially-protected areas within a marine park over the first 5 years of its establishment. We used Baited Remote Underwater Video (BRUV) to quantify fish communities on rocky reefs at 20-40 m depth between 2008-2011. Each year, we sampled 12 sites in 6 no-take marine reserves and 12 sites in two types of partially-protected areas with contrasting levels of protection (n = 4 BRUV stations per site). Fish abundances were 38% greater across the network of marine reserves compared to the partially-protected areas, although not all individual reserves performed equally. Compliance actions were positively associated with marine reserve responses, while reserve size had no apparent relationship with reserve performance after 5 years. The richness and abundance of fishes did not consistently differ between the two types of partially-protected areas. There was, therefore, no evidence that the more regulated partially-protected areas had additional conservation benefits for reef fish assemblages. Overall, our results demonstrate conservation benefits to fish assemblages from a newly established network of temperate marine reserves. They also show that ecological monitoring can contribute to adaptive management of newly established marine reserve networks, but the extent of this contribution is limited by the rate of change in marine communities in response to protection.	[Kelaher, Brendan P.; Coleman, Melinda A.; Jordan, Alan] New South Wales Fisheries, Dept Primary Ind, Coffs Harbour, NSW 2450, Australia; [Kelaher, Brendan P.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Kelaher, Brendan P.] So Cross Univ, Ctr Coastal Biogeochem Res, Sch Environm Sci & Engn, Coffs Harbour, NSW, Australia; [Broad, Allison; Rees, Matthew J.; Davis, Andrew R.] Univ Wollongong, Sch Biol Sci, Inst Conservat Biol & Environm Management, Wollongong, NSW 2522, Australia	NSW Department of Primary Industries; Southern Cross University; Southern Cross University; University of Wollongong	Kelaher, BP (corresponding author), New South Wales Fisheries, Dept Primary Ind, POB 4321, Coffs Harbour, NSW 2450, Australia.	brendan.kelaher@scu.edu.au	Davis, Andy/H-3607-2011; Rees, Matthew J/I-9177-2012; Broad, Allison/AAY-5852-2021; Coleman, Melinda A/R-5563-2016; Kelaher, Brendan/P-3647-2017	Davis, Andy/0000-0002-8146-7424; Broad, Allison/0000-0002-1402-6098; Coleman, Melinda A/0000-0003-2623-633X; Kelaher, Brendan/0000-0002-7505-4412; Rees, Matthew/0000-0002-2472-6215	NSW Government	NSW Government	The study was funded by the NSW Government. Independent university-based scientists and NSW Fisheries scientists were responsible for the data collection and analysis, decision to publish, and preparation of the manuscript.	Alvarez-Romero JG, 2011, ANNU REV ECOL EVOL S, V42, P381, DOI 10.1146/annurev-ecolsys-102209-144702; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], SOL ISL MAR PARK ZON; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Banks SA, 2010, MAR POLICY, V34, P197, DOI 10.1016/j.marpol.2009.06.006; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; Botsford LW, 2005, B MAR SCI, V76, P245; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Burfeind DD, 2013, BIOL INVASIONS, V15, P17, DOI 10.1007/s10530-012-0265-2; Byers JE, 2007, ECOL APPL, V17, P1851, DOI 10.1890/07-0067.1; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Coleman MA, 2013, BIOL CONSERV, V167, P257, DOI 10.1016/j.biocon.2013.08.033; Coleman MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020168; Coleman MA, 2011, J ECOL, V99, P1026, DOI 10.1111/j.1365-2745.2011.01822.x; Coleman MA, 2009, MAR ECOL PROG SER, V381, P63, DOI 10.3354/meps07977; Colton MA, 2010, MAR ECOL PROG SER, V400, P19, DOI 10.3354/meps08377; Crain CM, 2009, ANN NY ACAD SCI, V1162, P39, DOI 10.1111/j.1749-6632.2009.04496.x; Curley BG, 2013, REV FISH BIOL FISHER; Davis BC, 2005, ENFORCING US MARINE; Denny CM, 2004, BIOL CONSERV, V116, P119, DOI 10.1016/S0006-3207(03)00183-6; Edgar GJ, 2012, ENVIRON CONSERV, V39, P271, DOI 10.1017/S0376892912000185; Edgar GJ, 2009, ECOL APPL, V19, P1967, DOI 10.1890/09-0610.1; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gladstone W, 2012, J EXP MAR BIOL ECOL, V429, P28, DOI 10.1016/j.jembe.2012.06.013; GRAY CA, 1994, AUST J MAR FRESH RES, V45, P665; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hastings A, 2006, P NATL ACAD SCI USA, V103, P6067, DOI 10.1073/pnas.0506651103; Hastings A, 2003, ECOL APPL, V13, pS65; Jordan A, 2010, NSW DEP ENV CLIMATE; Kelaher BP, 2003, OECOLOGIA, V135, P431, DOI 10.1007/s00442-003-1196-5; Klages J, 2014, ENVIRON BIOL FISH, V97, P215, DOI 10.1007/s10641-013-0138-2; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lowry M, 2012, J EXP MAR BIOL ECOL, V416, P243, DOI 10.1016/j.jembe.2012.01.013; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; Malcolm HA, 2010, AQUAT CONSERV, V20, P83, DOI 10.1002/aqc.1055; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Moffitt EA, 2009, ECOL APPL, V19, P1835, DOI 10.1890/08-1101.1; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Mosqueira I, 2000, ANIM CONSERV, V3, P321, DOI 10.1017/S1367943000001049; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Olds AD, 2012, CONSERV LETT, V5, P56, DOI 10.1111/j.1755-263X.2011.00204.x; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Read AD, 2011, J ENVIRON MANAGE, V92, P2558, DOI 10.1016/j.jenvman.2011.05.022; Read AD, 2010, OCEAN COAST MANAGE, V53, P636, DOI 10.1016/j.ocecoaman.2010.08.003; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roberts Callum M., 2005, P265; Roberts CM, 2003, ECOL APPL, V13, pS199; Rowling K, 2010, STATUS FISHERIES RES; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Shears NT, 2003, MAR ECOL PROG SER, V246, P1, DOI 10.3354/meps246001; Steffe AS, 2005, ASSESSMENT CHANGES; Stoms DM, 2005, FRONT ECOL ENVIRON, V3, P429, DOI 10.1890/1540-9295(2005)003[0429:ICRPMT]2.0.CO;2; Tuya FC, 2000, ICES J MAR SCI, V57, P1218, DOI 10.1006/jmsc.2000.0808; UNDERWOOD AJ, 1993, AUST J ECOL, V18, P99, DOI 10.1111/j.1442-9993.1993.tb00437.x; Wraith J, 2013, MAR ECOL PROG SER, V477, P189, DOI 10.3354/meps10137	63	47	49	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85825	10.1371/journal.pone.0085825	http://dx.doi.org/10.1371/journal.pone.0085825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454934	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100135
J	Lee, CG; McCarthy, S; Gruidl, M; Timme, C; Yeatman, TJ				Lee, Chang Gong; McCarthy, Susan; Gruidl, Mike; Timme, Cindy; Yeatman, Timothy J.			MicroRNA-147 Induces a Mesenchymal-To-Epithelial Transition (MET) and Reverses EGFR Inhibitor Resistance	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LUNG-CANCER; E-CADHERIN; MIR-200 FAMILY; GEFITINIB RESISTANCE; TARGETED THERAPY; REPRESSORS ZEB1; EMT; PATHWAY; PROGRESSION	Background: The epithelial-mesenchymal transition (EMT) is a key developmental program that is often activated during cancer progression and may promote resistance to therapy. An analysis of patients (n = 71) profiled with both gene expression and a global microRNA assessment (similar to 415 miRs) identified miR-147 as highly anti-correlated with an EMT gene expression signature score and postulated to reverse EMT (MET). Methods and Findings: miR-147 was transfected into colon cancer cells (HCT116, SW480) as well as lung cancer cells (A-549). The cells were assessed for morphological changes, and evaluated for effects on invasion, motility, and the expression of key EMT markers. Resistance to chemotherapy was evaluated by treating cells with gefitinib, an EGFR inhibitor. The downstream genes regulated by miR-147 were assayed using the Affymetrix GeneChip U133 Plus2.0 platform. miR-147 was identified to: 1. cause MET primarily by increasing the expression of CDH1 and decreasing that of ZEB1; 2. inhibit the invasion and motility of cells; 3. cause G1 arrest by up-regulating p27 and down-regulating cyclin D1. miR-147 also dramatically reversed the native drug resistance of the colon cancer cell line HCT116 to gefitinib. miR-147 significantly repressed Akt phosphorylation, and knockdown of Akt with siRNA induced MET. The morphologic effects of miR-147 on cells appear to be attenuated by TGF-B1, promoting a plastic and reversible transition between MET and EMT. Conclusion: miR-147 induced cancer cells to undergo MET and induced cell cycle arrest, suggesting a potential tumor suppressor role. miR-147 strikingly increased the sensitivity to EGFR inhibitor, gefitinib in cell with native resistance. We conclude that miR-147 might have therapeutic potential given its ability to inhibit proliferation, induce MET, as well as reverse drug sensitivity.	[Lee, Chang Gong; Yeatman, Timothy J.] Gibbs Canc Ctr & Res Inst, Spartanburg, SC 29303 USA; [McCarthy, Susan; Gruidl, Mike; Timme, Cindy] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Yeatman, TJ (corresponding author), Gibbs Canc Ctr & Res Inst, Spartanburg, SC 29303 USA.	jharvey@gibbscc.org			 [1U01CA157960-01A1]; NATIONAL CANCER INSTITUTE [U01CA157960] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grant 1U01CA157960-01A1, www.cancer.gov http://report.nih.gov/award/index.cfm?ot=&fy=2012&state=FL&ic=N-CI&fm=&orgid=3736101&distr=&rfa=&pid=6418154#tab5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri RR, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-143; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birnbaum Ariel, 2005, Curr Treat Options Oncol, V6, P75, DOI 10.1007/s11864-005-0015-0; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bullock MD, 2012, BIOL CELL, V104, P3, DOI 10.1111/boc.201100115; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Glickman MS, 2012, CELL, V148, P1089, DOI 10.1016/j.cell.2012.02.015; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Harazono Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062757; Jain A, 2005, P NATL ACAD SCI USA, V102, P11858, DOI 10.1073/pnas.0502113102; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Koizumi F, 2004, INT J CANCER, V108, P464, DOI 10.1002/ijc.11539; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kosaka T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/165214; Kwon TK, 1997, BIOCHEM BIOPH RES CO, V238, P534, DOI 10.1006/bbrc.1997.7335; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Li J, 2000, WORLD J GASTROENTERO, V6, P513; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Maseki S, 2012, BRIT J CANCER, V106, P1196, DOI 10.1038/bjc.2012.24; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Rho JK, 2009, LUNG CANCER, V63, P219, DOI 10.1016/j.lungcan.2008.05.017; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Semb H, 1998, AM J HUM GENET, V63, P1588, DOI 10.1086/302173; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomson S, 2008, CLIN EXP METASTAS, V25, P843, DOI 10.1007/s10585-008-9200-4; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; UMBAS R, 1994, CANCER RES, V54, P3929; Wang XT, 1997, ONCOGENE, V15, P2991, DOI 10.1038/sj.onc.1201450; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xia H, 2012, CANCER GENE THER, V19, P723, DOI 10.1038/cgt.2012.58; Xia W, 2010, MOL CELL BIOCHEM, V344, P261, DOI 10.1007/s11010-010-0550-2; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107	43	76	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84597	10.1371/journal.pone.0084597	http://dx.doi.org/10.1371/journal.pone.0084597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454732	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100026
J	Untawale, S; Odegaard, AO; Koh, WP; Jin, AZ; Yuan, JM; Anderson, KE				Untawale, Seema; Odegaard, Andrew O.; Koh, Woon-Puay; Jin, Ai Zhen; Yuan, Jian-Min; Anderson, Kristin E.			Body Mass Index and Risk of Pancreatic Cancer in a Chinese Population	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SMOKING STATUS; OLDER CHINESE; OBESITY; SINGAPORE; HEALTH; DIETARY; WEIGHT; COHORT; METAANALYSIS	Few studies have examined the association between body mass index (BMI: kg/m(2)) and pancreatic cancer risk in Asian populations. We examined this relationship in 51,251 Chinese men and women aged 45-74 who enrolled between 1993 and 1998 in the population based, prospective Singapore Chinese Health Study. Data were collected through in-person interviews. By December 31, 2011, 194 cohort participants had developed pancreatic cancer. A Cox proportional hazards model was used to estimate hazard ratios (HR) and their 95% confidence intervals (95% CI). We hypothesized the association between BMI and pancreatic cancer risk may vary by smoking status (ever v. never) and there was evidence for this as the interaction between BMI and smoking status was significant (p = 0.018). Among ever smokers, being classified as underweight (BMI < 18.5 kg/m(2)), was associated with a significantly elevated risk of pancreatic cancer relative to smokers with a BMI of 21.5-24.4 kg/m(2) (HR = 1.99, 95% CI = 1.03-3.84). This association was strengthened after exclusion of the first three years of follow-up time. Among never smokers, there was no association between BMI and pancreatic cancer risk. However, after excluding pancreatic cancer cases and person-years in the first three years of follow-up, never smokers with a BMI >= 27.5 kg/m(2) showed a suggestive increased risk of pancreatic cancer relative to never smokers with a BMI of 21.5-24.4 kg/m(2) (HR = 1.75, 95% CI = 0.93-3.3). In conclusion, Singaporean Chinese who were underweight with a history of smoking had an increased risk of developing pancreatic cancer, whereas there was no significant association between BMI and pancreatic cancer in never smokers.	[Untawale, Seema; Odegaard, Andrew O.; Anderson, Kristin E.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Koh, Woon-Puay] Duke NUS Grad Med Sch Singapore, Singapore, Singapore; [Jin, Ai Zhen] Hlth Promot Board, Natl Registry Dis Off, Singapore, Singapore; [Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA USA; [Untawale, Seema] Tacoma Pierce Cty Hlth Dept, Tacoma, WA USA; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Anderson, Kristin E.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Minnesota System; University of Minnesota Twin Cities	Odegaard, AO (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	odeg0025@umn.edu		Yuan, Jian-Min/0000-0002-4620-3108	NIH, USA [NCI RO1 CA055069, R35 CA053890, R01 CA080205, R01 CA098497, R01 CA144034]; NATIONAL CANCER INSTITUTE [R01CA144034, R01CA080205, R35CA053890, R01CA055069, R01CA098497] Funding Source: NIH RePORTER	NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by 'NIH, USA (NCI RO1 CA055069, R35 CA053890, R01 CA080205, R01 CA098497 and R01 CA144034).' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Anderson LN, 2009, CANCER CAUSE CONTROL, V20, P825, DOI 10.1007/s10552-009-9303-5; Arslan AA, 2010, ARCH INTERN MED, V170, P791, DOI 10.1001/archinternmed.2010.63; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berrington de Gonzalez A, 2003, NEW ENGL J MED, V348, P1625; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; CONOVER CA, 1992, J CLIN ENDOCR METAB, V74, P1355, DOI 10.1210/jc.74.6.1355; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Durazo-Arvizu RA, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.86; Edwards B. K., 2013, CANCER; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; Hart AR, 2008, CLIN GASTROENTEROL H, V6, P275, DOI 10.1016/j.cgh.2007.12.041; Hu FB, 2008, OBESITY EPIDEMIOLOGY, V1; Iodice S, 2008, LANGENBECK ARCH SURG, V393, P535, DOI 10.1007/s00423-007-0266-2; Jee SH, 2008, INT J CANCER, V123, P1892, DOI 10.1002/ijc.23719; Jiao L, 2010, CANCER CAUSE CONTROL, V21, P1305, DOI 10.1007/s10552-010-9558-x; KLESGES RC, 1991, J CONSULT CLIN PSYCH, V59, P899, DOI 10.1037/0022-006X.59.6.899; Koh WP, 2005, J NUTR, V135, P2473, DOI 10.1093/jn/135.10.2473; Kuczmarski RJ, 1997, OBES RES, V5, P542, DOI 10.1002/j.1550-8528.1997.tb00575.x; Larsson SC, 2005, BRIT J CANCER, V93, P1310, DOI 10.1038/sj.bjc.6602868; Larsson SC, 2007, INT J CANCER, V120, P1993, DOI 10.1002/ijc.22535; Lin Y, 2013, EUROPEAN J CANC PREV, V22, P244; Lin YS, 2007, INT J CANCER, V120, P2665, DOI 10.1002/ijc.22614; Lu XH, 2006, WORLD J GASTROENTERO, V12, P2229, DOI 10.3748/wjg.v12.i4.2229; Luo J, 2008, BRIT J CANCER, V99, P527, DOI 10.1038/sj.bjc.6604487; Luo JH, 2007, CANCER CAUSE CONTROL, V18, P603, DOI 10.1007/s10552-007-9002-z; Ma J, 2000, AM J CLIN NUTR, V71, P774, DOI 10.1093/ajcn/71.3.774; Manson JE, 2007, J WOMENS HEALTH, V16, P168, DOI 10.1089/jwh.2006.0080; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; Nothlings U, 2007, CANCER CAUSE CONTROL, V18, P165, DOI 10.1007/s10552-006-0100-0; Odegaard AO, 2011, DIABETES CARE, V34, P880, DOI 10.2337/dc10-2350; Olusi SO, 2002, INT J OBESITY, V26, P1159, DOI 10.1038/sj.ijo.0802066; Parkin D, 2002, CANC INCIDENCE 5 CON, VVIII, P155; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patel AV, 2005, CANCER EPIDEM BIOMAR, V14, P459, DOI 10.1158/1055-9965.EPI-04-0583; PERKINS KA, 1989, NEW ENGL J MED, V320, P898, DOI 10.1056/NEJM198904063201404; Samanic C, 2004, CANCER CAUSE CONTROL, V15, P35, DOI 10.1023/B:CACO.0000016573.79453.ba; Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9; Seow A, 1998, CANCER EPIDEM BIOMAR, V7, P135; Seow A, 1998, CANCER EPIDEM BIOMAR, V7, P775; Stevens RJ, 2009, INT J CANCER, V124, P2400, DOI 10.1002/ijc.24196; Stolzenberg-Solomon RZ, 2008, AM J EPIDEMIOL, V167, P586, DOI 10.1093/aje/kwm361; Stolzenberg-Solomon RZ, 2002, CANCER CAUSE CONTROL, V13, P417, DOI 10.1023/A:1015729615148; Stolzenberg-Solomon RZ, 2002, AM J EPIDEMIOL, V155, P783, DOI 10.1093/aje/155.9.783; Tsong WH, 2007, BRIT J CANCER, V96, P821, DOI 10.1038/sj.bjc.6603623; Wada K, 2005, INT J OBESITY, V29, P1093, DOI 10.1038/sj.ijo.0803012; Wang MY, 1998, CANCER RES, V58, P38; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	50	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85149	10.1371/journal.pone.0085149	http://dx.doi.org/10.1371/journal.pone.0085149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454807	Green Published, gold			2022-12-25	WOS:000330235100057
J	Zhang, FQ; Liu, CX; Xu, Y; Qi, GY; Yuan, GZ; Cheng, ZH; Wang, JD; Wang, GQ; Wang, ZQ; Zhu, W; Zhou, ZH; Zhao, XF; Tian, L; Jin, CH; Yuan, JM; Zhang, GF; Chen, YG; Wang, LF; Lu, TL; Yan, H; Ruan, YY; Yue, WH; Zhang, D				Zhang, Fuquan; Liu, Chenxing; Xu, Yong; Qi, Guoyang; Yuan, Guozhen; Cheng, Zaohuo; Wang, Jidong; Wang, Guoqiang; Wang, Zhiqiang; Zhu, Wei; Zhou, Zhenhe; Zhao, Xingfu; Tian, Lin; Jin, Chunhui; Yuan, Janmin; Zhang, Guofu; Chen, Yaguang; Wang, Lifang; Lu, Tianlan; Yan, Hao; Ruan, Yanyan; Yue, Weihua; Zhang, Dai			A Two-Stage Association Study Suggests BRAP as a Susceptibility Gene for Schizophrenia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PROTEIN; RISK; DISEASE; SNPS; POLYMORPHISMS; VISUALIZATION; NEUROBIOLOGY; CHINESE; SAMPLE	Schizophrenia (SZ) is a neurodevelopmental disorder in which altered immune function typically plays an important role in mediating the effect of environmental insults and regulation of inflammation. The breast cancer suppressor protein associated protein (BRAP) is suggested to exert vital effects in neurodevelopment by modulating the mitogen-activated protein kinase cascade and inflammation signaling. To explore the possible role of BRAP in SZ, we conducted a two-stage study to examine the association of BRAP polymorphisms with SZ in the Han Chinese population. In stage one, we screened SNPs in BRAP from our GWAS data, which detected three associated SNPs, with rs3782886 being the most significant one (P = 2.31E-6, OR = 0.67). In stage two, we validated these three SNPs in an independently collected population including 1957 patients and 1509 controls, supporting the association of rs3782886 with SZ (P = 1.43E-6, OR = 0.73). Furthermore, cis-eQTL analysis indicates that rs3782886 genotypes are associated with mRNA levels of aldehyde dehydrogenase 2 family (ALDH2) (P = 0.0039) and myosin regulatory light chain 2 (MYL2) (P < 1.0E-4). Our data suggest that the BRAP gene may confer vulnerability for SZ in Han Chinese population, adding further evidence for the involvement of developmental and/or neuroinflammatory cascades in the illness.	[Zhang, Fuquan; Qi, Guoyang; Yuan, Guozhen; Cheng, Zaohuo; Wang, Jidong; Wang, Guoqiang; Wang, Zhiqiang; Zhu, Wei; Zhou, Zhenhe; Zhao, Xingfu; Tian, Lin; Jin, Chunhui; Yuan, Janmin; Zhang, Guofu] Nanjing Med Univ, Wuxi Mental Hlth Ctr, Wuxi, Jiangsu, Peoples R China; [Zhang, Fuquan; Liu, Chenxing; Chen, Yaguang; Wang, Lifang; Lu, Tianlan; Yan, Hao; Ruan, Yanyan; Yue, Weihua; Zhang, Dai] Peking Univ, Key Lab Mental Hlth, Minist Hlth, Inst Mental Hlth,Hosp 6, Beijing 100871, Peoples R China; [Xu, Yong] Shanxi Med Univ, Dept Psychiat, Hosp 1, Taiyuan, Peoples R China; [Zhang, Dai] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Zhang, Dai] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China	Nanjing Medical University; Peking University; Shanxi Medical University; Peking University	Yue, WH (corresponding author), Peking Univ, Key Lab Mental Hlth, Minist Hlth, Inst Mental Hlth,Hosp 6, Beijing 100871, Peoples R China.	dyue@bjmu.edu.cn; daizhang@bjmu.edu.cn	Yan, Hao/U-1330-2017	Yan, Hao/0000-0003-0376-9037; Zhang, Fuquan/0000-0003-3204-8191	National High-Tech Research and Development Program of China [2009AA022702]; National Natural Science Foundation of China [81000578, 81071087, 81071088]; Science Fund for Creative Research Groups of the National Natural Science Foundation of China [81221002]; National Basic Research Program of China [2011CB707805]; International Science & Technology Cooperation Program of China [2010DFB30820]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); International Science & Technology Cooperation Program of China	This work was supported by research grants from the National High-Tech Research and Development Program of China (2009AA022702), the National Natural Science Foundation of China (81000578, 81071087 and 81071088), Science Fund for Creative Research Groups of the National Natural Science Foundation of China (81221002), the National Basic Research Program of China (2011CB707805), and the International Science & Technology Cooperation Program of China (2010DFB30820). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada M, 2004, MOL CELL BIOL, V24, P8236, DOI 10.1128/MCB.24.18.8236-8243.2004; Avery CL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002322; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Chen CC, 1999, AM J HUM GENET, V65, P795, DOI 10.1086/302540; Demirhan O, 2006, Genetika, V42, P985; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Hinohara K, 2009, J HUM GENET, V54, P642, DOI 10.1038/jhg.2009.87; Kneeland RE, 2013, PROG NEURO-PSYCHOPH, V42, P35, DOI 10.1016/j.pnpbp.2012.02.001; Lanctot AA, 2013, DEV CELL, V25, P241, DOI 10.1016/j.devcel.2013.04.006; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Lee SA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S20; Lee SY, 2012, PROG NEURO-PSYCHOPH, V38, P247, DOI 10.1016/j.pnpbp.2012.04.005; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Liao YC, 2011, MOL MED, V17, P1065, DOI 10.2119/molmed.2011.00043; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Mehler MF, 1997, TRENDS NEUROSCI, V20, P357, DOI 10.1016/S0166-2236(96)01045-4; Messias EL, 2007, PSYCHIAT CLIN N AM, V30, P323, DOI 10.1016/j.psc.2007.04.007; Meyer U, 2013, PROG NEURO-PSYCHOPH, V42, P20, DOI 10.1016/j.pnpbp.2011.11.003; MURRAY RM, 1987, BRIT MED J, V295, P681, DOI 10.1136/bmj.295.6600.681; Owen MJ, 2011, BRIT J PSYCHIAT, V198, P173, DOI 10.1192/bjp.bp.110.084384; Ozaki K, 2009, NAT GENET, V41, P329, DOI 10.1038/ng.326; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reif A, 2006, MOL PSYCHIATR, V11, P286, DOI 10.1038/sj.mp.4001779; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Takashima O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058911; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Thaiparambil JT, 2012, MOL CELL BIOL, V32, P3203, DOI 10.1128/MCB.00418-12; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Verrall L, 2010, MOL PSYCHIATR, V15, P122, DOI 10.1038/mp.2009.99; WADGAONKAR R, 1993, CELL MOL BIOL RES, V39, P13; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Weterman MAJ, 2013, BRAIN, V136, P282, DOI 10.1093/brain/aws293; Wood SJ, 2009, ANN ACAD MED SINGAP, V38, P396; Wu LJ, 2013, DIABETES VASC DIS RE, V10, P202, DOI 10.1177/1479164112455535; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yang XL, 2013, AM J CLIN NUTR, V97, P545, DOI 10.3945/ajcn.112.046482; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zhang YM, 2011, PHARMACOL THERAPEUT, V132, P86, DOI 10.1016/j.pharmthera.2011.05.008	44	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86037	10.1371/journal.pone.0086037	http://dx.doi.org/10.1371/journal.pone.0086037			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454952	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100144
J	Ju, L; Zhang, GL; Zhang, X; Jia, ZY; Gao, XJ; Jiang, Y; Yan, CL; Duerksen-Hughes, PJ; Chen, FF; Li, HJ; Zhu, XQ; Yang, J				Ju, Li; Zhang, Guanglin; Zhang, Xing; Jia, Zhenyu; Gao, Xiangjing; Jiang, Ying; Yan, Chunlan; Duerksen-Hughes, Penelope J.; Chen, Fanqing Frank; Li, Hongjuan; Zhu, Xinqiang; Yang, Jun			Proteomic Analysis of Cellular Response Induced by Multi-Walled Carbon Nanotubes Exposure in A549 Cells	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; DNA-DAMAGE; IN-VITRO; INTRATRACHEAL INSTILLATION; INFLAMMATORY RESPONSE; ACTIN CYTOSKELETON; OXIDATIVE STRESS; EPITHELIAL-CELLS; IMMUNE FUNCTION; HEAT-SHOCK	The wide application of multi-walled carbon nanotubes (MWCNT) has raised serious concerns about their safety on human health and the environment. However, the potential harmful effects of MWCNT remain unclear and contradictory. To clarify the potentially toxic effects of MWCNT and to elucidate the associated underlying mechanisms, the effects of MWCNT on human lung adenocarcinoma A549 cells were examined at both the cellular and the protein level. Cytotoxicity and genotoxicity were examined, followed by a proteomic analysis (2-DE coupled with LC-MS/MS) of the cellular response to MWCNT. Our results demonstrate that MWCNT induces cytotoxicity in A549 cells only at relatively high concentrations and longer exposure time. Within a relatively low dosage range (30 mg/ml) and short time period (24 h), MWCNT treatment does not induce significant cytotoxicity, cell cycle changes, apoptosis, or DNA damage. However, at these low doses and times, MWCNT treatment causes significant changes in protein expression. A total of 106 proteins show altered expression at various time points and dosages, and of these, 52 proteins were further identified by MS. Identified proteins are involved in several cellular processes including proliferation, stress, and cellular skeleton organization. In particular, MWCNT treatment causes increases in actin expression. This increase has the potential to contribute to increased migration capacity and may be mediated by reactive oxygen species (ROS).	[Ju, Li; Zhang, Guanglin; Gao, Xiangjing; Jiang, Ying; Yan, Chunlan; Yang, Jun] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Diag & Therapy,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Ju, Li; Zhang, Guanglin; Gao, Xiangjing; Jiang, Ying; Yan, Chunlan; Zhu, Xinqiang] Zhejiang Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou 310003, Zhejiang, Peoples R China; [Ju, Li; Zhang, Xing; Jia, Zhenyu] Zhejiang Acad Med Sci, Hangzhou, Zhejiang, Peoples R China; [Duerksen-Hughes, Penelope J.] Loma Linda Univ, Div Biochem, Dept Basic Sci, Sch Med, Loma Linda, CA USA; [Chen, Fanqing Frank] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Li, Hongjuan] Hangzhou Normal Univ, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China; [Yang, Jun] Zhejiang Agr & Forestry Univ, Coll Biotechnol, Hangzhou, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Zhejiang Academy of Medical Sciences; Loma Linda University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Hangzhou Normal University; Zhejiang A&F University	Zhu, XQ (corresponding author), Zhejiang Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou 310003, Zhejiang, Peoples R China.	zhuxq@zju.edu.cn; gastate@zju.edu.cn		Duerksen-Hughes, Penelope/0000-0002-0998-2157	National Natural Science Foundation of China [81172692, 81202241, 81373036, 81302398]; Provincial Natural Science Foundation [LY12H26006]; Zhejiang Provincial Department of Science and Technology [2013C14016]; Zhejiang Medical Support Plan in Discipline Construction [11ZC02]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation; Zhejiang Provincial Department of Science and Technology; Zhejiang Medical Support Plan in Discipline Construction; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	This work was supported by grants from the National Natural Science Foundation of China (No. 81172692, 81202241, 81373036 and 81302398; http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list); Zhejiang Provincial Natural Science Foundation (No. LY12H26006; http://www.zjnsf.gov.cn/); Zhejiang Provincial Department of Science and Technology (No. 2013C14016; http://www.zjkjt.gov.cn); and Zhejiang Medical Support Plan in Discipline Construction (11ZC02; http://www.zjwst.gov.cn/). JY is a recipient of the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents (http://www.zjwst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butcher EC, 2004, NAT BIOTECHNOL, V22, P1253, DOI 10.1038/nbt1017; Chandel N, 2013, AM J PHYSIOL-RENAL, V304, pF1347, DOI 10.1152/ajprenal.00717.2012; Ding LH, 2005, NANO LETT, V5, P2448, DOI 10.1021/nl051748o; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; Elgrabli D, 2008, TOXICOLOGY, V253, P131, DOI 10.1016/j.tox.2008.09.004; ENDO M, 1988, CHEMTECH, V18, P568; Ermakov AV, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/649747; Ghosh M, 2011, J HAZARD MATER, V197, P327, DOI 10.1016/j.jhazmat.2011.09.090; Gladwin KM, 2013, ADV HEALTHC MATER, V2, P728, DOI 10.1002/adhm.201200233; GOTLIEB AI, 1990, TOXICOL PATHOL, V18, P603; Guo YY, 2011, MUTAT RES-GEN TOX EN, V721, P184, DOI 10.1016/j.mrgentox.2011.01.014; Hamilton RF, 2007, NANOTOXICOLOGY, V1, P104, DOI 10.1080/17435390600926939; Haniu H, 2010, TOXICOL APPL PHARM, V242, P256, DOI 10.1016/j.taap.2009.10.015; He L, 2006, ANAL CHIM ACTA, V556, P1, DOI 10.1016/j.aca.2005.08.042; Hsieh HL, 2013, MOL NEUROBIOL; Hurd TR, 2012, TRENDS CELL BIOL, V22, P107, DOI 10.1016/j.tcb.2011.11.002; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Inoue K, 2009, TOXICOL APPL PHARM, V237, P306, DOI 10.1016/j.taap.2009.04.003; Ju L, 2013, MUTAT RES-GEN TOX EN, V753, P54, DOI 10.1016/j.mrgentox.2013.01.006; Kateb B, 2007, NEUROIMAGE, V37, pS9, DOI 10.1016/j.neuroimage.2007.03.078; Kermanizadeh A, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-28; Kim JS, 2012, TOXICOL SCI, V128, P439, DOI 10.1093/toxsci/kfs161; Leal MF, 2012, WORLD J GASTROENTERO, V18, P1531, DOI 10.3748/wjg.v18.i13.1531; Lee JSY, 2003, HISTOL HISTOPATHOL, V18, P879, DOI 10.14670/HH-18.879; Liu D, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-361; Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988; McShan D, 2012, TOXICOL IND HEALTH; MEHLEN P, 1993, EUR J BIOCHEM, V215, P277, DOI 10.1111/j.1432-1033.1993.tb18032.x; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053633; Mercer RR, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-21; Mercer RR, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-28; Mezencev R, 2013, ANTI-CANCER DRUG, V24, P504, DOI 10.1097/CAD.0b013e32836009d7; Mitchell LA, 2009, NAT NANOTECHNOL, V4, P451, DOI [10.1038/nnano.2009.151, 10.1038/NNANO.2009.151]; Monteiro-Riviere NA, 2005, TOXICOL LETT, V155, P377, DOI 10.1016/j.toxlet.2004.11.004; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V53, P1123, DOI 10.1016/j.freeradbiomed.2012.05.036; Muller J, 2008, CARCINOGENESIS, V29, P427, DOI 10.1093/carcin/bgm243; Muller J, 2009, TOXICOL SCI, V110, P442, DOI 10.1093/toxsci/kfp100; Murr LE, 2004, J NANOPART RES, V6, P241, DOI 10.1023/B:NANO.0000034651.91325.40; Ni JX, 2013, FREE RADICAL BIO MED, V61, P26, DOI 10.1016/j.freeradbiomed.2013.03.012; Nygaard UC, 2009, TOXICOL SCI, V109, P113, DOI 10.1093/toxsci/kfp057; Pacurari M, 2012, J TOXICOL ENV HEAL A, V75, P112, DOI [10.1080/15287394.2011.615110, 10.1080/15287394.2012.625549]; Park EJ, 2009, TOXICOLOGY, V259, P113, DOI 10.1016/j.tox.2009.02.009; Patel H, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-22; Patlolla A, 2010, ETHNIC DIS, V20; Polla BS, 1996, P NATL ACAD SCI USA, V93, P6458, DOI 10.1073/pnas.93.13.6458; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Pulskamp K, 2007, TOXICOL LETT, V168, P58, DOI 10.1016/j.toxlet.2006.11.001; Qian Y, 2010, J TOXICOL ENV HEAL A, V73, P819, DOI 10.1080/15287391003689317; Raffa V, 2010, NANOSCALE RES LETT, V5, P257, DOI 10.1007/s11671-009-9463-y; Ravichandran P, 2010, APOPTOSIS, V15, P1507, DOI 10.1007/s10495-010-0532-6; Reddy ARN, 2010, TOXICOLOGY, V272, P11, DOI 10.1016/j.tox.2010.03.017; Ryman-Rasmussen JP, 2009, AM J RESP CELL MOL, V40, P349, DOI 10.1165/rcmb.2008-0276OC; SHASBY DM, 1982, CIRC RES, V51, P657, DOI 10.1161/01.RES.51.5.657; Shen Zhen-zhou, 2010, Clinical Oncology and Cancer Research, V7, P7, DOI 10.1007/s11805-010-0007-0; Shibata A, 2013, BIOCHEM BIOPH RES CO, V433, P317, DOI 10.1016/j.bbrc.2013.02.100; Sneh A, 2013, BREAST CANCER RES TR, V138, P727, DOI 10.1007/s10549-013-2491-4; Takagi A, 2008, J TOXICOL SCI, V33, P105, DOI 10.2131/jts.33.105; Tian FR, 2013, EUR J PHARM BIOPHARM, V84, P412, DOI 10.1016/j.ejpb.2013.03.008; Tretyakov YD, 2009, RUSS CHEM REV+, V78, P801, DOI 10.1070/RC2009v078n09ABEH004029; Ursini CL, 2012, TOXICOL IN VITRO, V26, P831, DOI 10.1016/j.tiv.2012.05.001; Vankoningsloo S, 2010, NANOTOXICOLOGY, V4, P84, DOI 10.3109/17435390903428869; Veetil JV, 2009, BIOTECHNOL PROGR, V25, P709, DOI 10.1002/btpr.165; Walker VG, 2009, TOXICOL APPL PHARM, V236, P319, DOI 10.1016/j.taap.2009.02.018; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048247; Wang JY, 2011, TOXICOL IN VITRO, V25, P242, DOI 10.1016/j.tiv.2010.11.010; Witzmann FA, 2006, NANOMED-NANOTECHNOL, V2, P158, DOI 10.1016/j.nano.2006.07.005; Wu D, 2012, NEUROSCI LETT, V507, P72, DOI 10.1016/j.neulet.2011.11.056; Yamashita K, 2010, INFLAMMATION, V33, P276, DOI 10.1007/s10753-010-9182-7; Ye SF, 2009, BIOCHEM BIOPH RES CO, V379, P643, DOI 10.1016/j.bbrc.2008.12.137; Yuan JF, 2012, TOXICOL SCI, V126, P149, DOI 10.1093/toxsci/kfr332; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879; Zhang GL, 2012, MUTAT RES-GEN TOX EN, V746, P66, DOI 10.1016/j.mrgentox.2012.03.004; Zhou CX, 2006, MUTAT RES-GEN TOX EN, V604, P8, DOI 10.1016/j.mrgentox.2005.12.004; Zhu L, 2013, PLANT CELL, V25, P851, DOI 10.1105/tpc.113.110528	76	34	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e84974	10.1371/journal.pone.0084974	http://dx.doi.org/10.1371/journal.pone.0084974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454774	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800019
J	Desai, AJ; Roberts, DJ; Richards, GO; Skerry, TM				Desai, Aditya J.; Roberts, David J.; Richards, Gareth O.; Skerry, Timothy M.			Role of Receptor Activity Modifying Protein 1 in Function of the Calcium Sensing Receptor in the Human TT Thyroid Carcinoma Cell Line	PLOS ONE			English	Article							EXTRACELLULAR CA2+-SENSING RECEPTOR; CALCITONIN-RECEPTOR; INTRACELLULAR CALCIUM; LIGAND SPECIFICITY; CA2+; CATION; TRAFFICKING; KINASE; FRET; ADRENOMEDULLIN	The Calcium Sensing Receptor (CaSR) plays a role in calcium homeostasis by sensing minute changes in serum Ca2+ and modulating secretion of calciotropic hormones. It has been shown in transfected cells that accessory proteins known as Receptor Activity Modifying Proteins (RAMPs), specifically RAMPs 1 and 3, are required for cell-surface trafficking of the CaSR. These effects have only been demonstrated in transfected cells, so their physiological relevance is unclear. Here we explored CaSR/RAMP interactions in detail, and showed that in thyroid human carcinoma cells, RAMP1 is required for trafficking of the CaSR. Furthermore, we show that normal RAMP1 function is required for intracellular responses to ligands. Specifically, to confirm earlier studies with tagged constructs, and to provide the additional benefit of quantitative stoichiometric analysis, we used fluorescence resonance energy transfer to show equal abilities of RAMP1 and 3 to chaperone CaSR to the cell surface, though RAMP3 interacted more efficiently with the receptor. Furthermore, a higher fraction of RAMP3 than RAMP1 was observed in CaSR-complexes on the cell-surface, suggesting different ratios of RAMPs to CaSR. In order to determine relevance of these findings in an endogenous expression system we assessed the effect of RAMP1 siRNA knock-down in medullary thyroid carcinoma TT cells, (which express RAMP1, but not RAMP3 constitutively) and measured a significant 50% attenuation of signalling in response to CaSR ligands Cinacalcet and neomycin. Blockade of RAMP1 using specific antibodies induced a concentration-dependent reduction in CaSR-mediated signalling in response to Cinacalcet in TT cells, suggesting a novel functional role for RAMP1 in regulation of CaSR signalling in addition to its known role in receptor trafficking. These data provide evidence that RAMPs traffic the CaSR as higher-level oligomers and play a role in CaSR signalling even after cell surface localisation has occurred.	[Desai, Aditya J.; Roberts, David J.; Richards, Gareth O.; Skerry, Timothy M.] Univ Sheffield, Mellanby Ctr Bone Res, Dept Human Metab, Sheffield, S Yorkshire, England	University of Sheffield	Skerry, TM (corresponding author), Univ Sheffield, Mellanby Ctr Bone Res, Dept Human Metab, Sheffield, S Yorkshire, England.	t.skerry@sheffield.ac.uk		Richards, Gareth Owain/0000-0001-7984-6882; Skerry, Timothy/0000-0003-1319-5575	BBRSC [117120]; BBSRC; Prostate Cancer UK [PA12-12] Funding Source: researchfish	BBRSC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Prostate Cancer UK	Support for DJR provided by BBRSC Industrial Partnership Award 117120 PI TMS, and support for AJD provided by BBSRC Dorothy Hodgkin Studentship PI TMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Curto E, 2010, J BIOL CHEM, V285, P23316, DOI 10.1074/jbc.M110.122184; Arthur JM, 1997, AM J PHYSIOL-RENAL, V273, pF129, DOI 10.1152/ajprenal.1997.273.1.F129; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bogazzi F, 2011, J ENDOCRINOL INVEST, V34, pE200, DOI 10.3275/7228; Bomberger JM, 2005, J BIOL CHEM, V280, P23926, DOI 10.1074/jbc.M501751200; Bomberger JM, 2005, J BIOL CHEM, V280, P9297, DOI 10.1074/jbc.M413786200; Bonner K, 2010, J ALLERGY CLIN IMMUN, V126, P1277, DOI 10.1016/j.jaci.2010.08.013; Bouschet T, 2005, J CELL SCI, V118, P4709, DOI 10.1242/jcs.02598; Bouschet T, 2012, ADV EXP MED BIOL, V744, P39, DOI 10.1007/978-1-4614-2364-5_4; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Bu L, 2008, PROTEINS, V71, P215, DOI 10.1002/prot.21685; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; COLE DEC, 1990, J CRAN GENET DEV BIO, V10, P205; Corbetta S, 2002, J CLIN ENDOCR METAB, V87, P2201, DOI 10.1210/jc.87.5.2201; DeLapp NW, 1999, J PHARMACOL EXP THER, V289, P946; Faurskov B, 2002, PFLUG ARCH EUR J PHY, V445, P40, DOI 10.1007/s00424-002-0912-z; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; GARRETT JE, 1995, ENDOCRINOLOGY, V136, P5202, DOI 10.1210/en.136.11.5202; Gerbino A, 2005, J CELL BIOL, V171, P303, DOI 10.1083/jcb.200507054; Hachet-Haas M, 2006, MICROSC RES TECHNIQ, V69, P941, DOI 10.1002/jemt.20376; Hammerland LG, 1999, MOL PHARMACOL, V55, P642; Handlogten ME, 2000, AM J PHYSIOL-RENAL, V279, pF1083, DOI 10.1152/ajprenal.2000.279.6.F1083; Harikumar KG, 2009, BIOCHEMISTRY-US, V48, P11773, DOI 10.1021/bi901326k; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hsu YJ, 2010, NEPHROL DIAL TRANSPL, V25, P1428, DOI 10.1093/ndt/gfp645; Huang CF, 2004, AM J PHYSIOL-CELL PH, V286, pC22, DOI 10.1152/ajpcell.00229.2003; Huang Y, 2009, BIOCHEMISTRY-US, V48, P388, DOI 10.1021/bi8014604; Kawase T, 2003, EUR J PHARMACOL, V470, P125, DOI 10.1016/S0014-2999(03)01763-1; Keleg S, 2007, INT J CANCER, V121, P21, DOI 10.1002/ijc.22596; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; Kraenzlin ME, 2011, NAT REV ENDOCRINOL, V7, P647, DOI 10.1038/nrendo.2011.108; Kumar GN, 2004, DRUG METAB DISPOS, V32, P1491, DOI 10.1124/dmd.104.000604; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Mamillapalli R, 2008, J BIOL CHEM, V283, P24435, DOI 10.1074/jbc.M801738200; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Muff R, 1999, ENDOCRINOLOGY, V140, P2924, DOI 10.1210/en.140.6.2924; Nemeth EF, 2001, J PHARMACOL EXP THER, V299, P323; Nemeth EF, 2004, J PHARMACOL EXP THER, V308, P627, DOI 10.1124/jpet.103.057273; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; Quinn SJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1315, DOI 10.1152/ajpcell.1997.273.4.C1315; Ray K, 2002, J BIOL CHEM, V277, P18908, DOI 10.1074/jbc.M202113200; Ward DT, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015623.73739.B8	45	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85237	10.1371/journal.pone.0085237	http://dx.doi.org/10.1371/journal.pone.0085237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454825	gold, Green Published, Green Accepted			2022-12-25	WOS:000329922500050
J	Huang, A; Zhao, HC; Quan, YJ; Jin, RS; Feng, B; Zheng, MH				Huang, Ao; Zhao, Hongchao; Quan, Yingjun; Jin, Runsen; Feng, Bo; Zheng, Minhua			E2A Predicts Prognosis of Colorectal Cancer Patients and Regulates Cancer Cell Growth by Targeting miR-320a	PLOS ONE			English	Article							TRANSCRIPTION FACTOR E2A; CONFERS RESISTANCE; CYCLE PROGRESSION; LIVER METASTASIS; GENE E2A; EXPRESSION; PROTEINS; PROLIFERATION; E47; PROMOTES	Background and objective: Transcriptional factor E2A is crucial for the normal development and differentiation of B and T lymphocytes. Dysregulation of E2A leads to leukemia and tumorigenesis of some solid tumors. The expression and clinical significance of E2A as well as its role in colorectal cancer (CRC) are still unknown. This study aims to assess E2A expression in CRC tissues, evaluate its prognosis value, and investigate its role in colon cancer cell growth. Methods: E2A expression in CRC tissues and normal mucosa was detected by immunohistochemical staining; Kaplan-Meier survival curve and Cox regression model were used to evaluate the prognostic value of E2A. Lentivirus was used to construct E2A stably knocked-down cells. MTT assay was employed to detect cell proliferation change; cell cycle was analyzed by flow cytometry; and chromatin immunoprecipitation (ChIP) assay was used to validate the predicted binding target of E2A. Results: Expression of E2A was lower in CRC tissues than normal mucosa; low E2A expression correlated with advanced TNM stage and larger tumor size, and predicted poor prognosis of CRC patients. E2A knockdown resulted in increased cell proliferation rate and cell cycle acceleration. ChIP assay showed miR-320a was a direct target of E2A and upregulation of miR-320a in E2A downregulated cells could reverse cell proliferation and cell cycle changes caused by E2A deficiency. Conclusions: E2A is an independent prognostic factor for CRC patients and targets miR-320a to regulate cell proliferation of colon cancer cells.	[Huang, Ao; Zhao, Hongchao; Quan, Yingjun; Jin, Runsen; Feng, Bo; Zheng, Minhua] Shanghai Jiao Tong Univ, Dept Surg, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Huang, Ao; Zhao, Hongchao; Quan, Yingjun; Jin, Runsen; Feng, Bo; Zheng, Minhua] Shanghai Inst Digest Surg, Shanghai, Peoples R China; [Huang, Ao; Zhao, Hongchao; Quan, Yingjun; Jin, Runsen; Feng, Bo; Zheng, Minhua] Shanghai Minimally Invas Surg Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zheng, MH (corresponding author), Shanghai Jiao Tong Univ, Dept Surg, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China.	strongao123@163.com			National Natural Science Foundation of China (NSFC) [30873000]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was financially supported by National Natural Science Foundation of China (NSFC, 30873000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrysik Z, 2013, CELL REP, V3, P1346, DOI 10.1016/j.celrep.2013.04.014; Aspland SE, 2001, ONCOGENE, V20, P5708, DOI 10.1038/sj.onc.1204592; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Dong TT, 2011, ANN SURG ONCOL, V18, P1797, DOI 10.1245/s10434-011-1561-2; Engel I, 1999, P NATL ACAD SCI USA, V96, P996, DOI 10.1073/pnas.96.3.996; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Feng Biao, 2012, ISRN Endocrinol, V2012, P549875, DOI 10.5402/2012/549875; Herblot S, 2002, MOL CELL BIOL, V22, P886, DOI 10.1128/MCB.22.3.886-900.2002; Hsieh IS, 2013, CARCINOGENESIS, V34, P530, DOI 10.1093/carcin/bgs371; Hwang-Verslues WW, 2011, ONCOGENE, V30, P2463, DOI 10.1038/onc.2010.618; Kardava L, 2011, INT IMMUNOL, V23, P375, DOI 10.1093/intimm/dxr027; Knosel T, 2004, NEOPLASIA, V6, P23, DOI 10.1016/s1476-5586(04)80050-2; LeBrun DP, 2003, FRONT BIOSCI, V8, pS206, DOI 10.2741/1030; Lietz A, 2007, BRIT J HAEMATOL, V137, P342, DOI 10.1111/j.1365-2141.2007.06583.x; Liu TY, 2010, MODERN PATHOL, V23, P1507, DOI 10.1038/modpathol.2010.139; Mao Z, 2013, PLOS ONE, DOI [10.1371/journal.pone.0068206, DOI 10.1371/J0URNAL.P0NE.0068206]; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Mo ML, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-29; Park ST, 1999, J EXP MED, V189, P501, DOI 10.1084/jem.189.3.501; Patel D, 2012, BIOCHEM BIOPH RES CO, V422, P146, DOI 10.1016/j.bbrc.2012.04.126; PEVERALI FA, 1994, EMBO J, V13, P4291, DOI 10.1002/j.1460-2075.1994.tb06749.x; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schwartz R, 2006, P NATL ACAD SCI USA, V103, P9976, DOI 10.1073/pnas.0603728103; Seidel MG, 2001, ONCOGENE, V20, P5718, DOI 10.1038/sj.onc.1204591; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Slattery C, 2006, FEBS LETT, V580, P4021, DOI 10.1016/j.febslet.2006.06.039; Slyper M, 2012, CANCER RES, V72, P5613, DOI 10.1158/0008-5472.CAN-12-0119; Steininger A, 2011, J EXP MED, V208, P1585, DOI 10.1084/jem.20101785; Sun JY, 2012, BIOCHEM BIOPH RES CO, V420, P787, DOI 10.1016/j.bbrc.2012.03.075; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wilson JW, 2001, CANCER RES, V61, P8803; Wojciechowski J, 2007, J IMMUNOL, V178, P5717, DOI 10.4049/jimmunol.178.9.5717; Yang Q, 2008, J IMMUNOL, V181, P5885, DOI 10.4049/jimmunol.181.9.5885; Yang Q, 2011, BLOOD, V117, P3529, DOI 10.1182/blood-2010-07-297689; Zhang YJ, 2012, ONCOL REP, V27, P685, DOI 10.3892/or.2011.1561; Zhao F, 2001, MOL CELL BIOL, V21, P6346, DOI 10.1128/MCB.21.18.6346-6357.2001; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; ZHUANG Y, 1992, P NATL ACAD SCI USA, V89, P12132, DOI 10.1073/pnas.89.24.12132	44	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85201	10.1371/journal.pone.0085201	http://dx.doi.org/10.1371/journal.pone.0085201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454819	Green Submitted, Green Published, gold			2022-12-25	WOS:000329922500047
J	Janotova, T; Jalovecka, M; Auerova, M; Svecova, I; Bruzlova, P; Maierova, V; Kumzakova, Z; Cunatova, S; Vlckova, Z; Caisova, V; Rozsypalova, P; Lukacova, K; Vacova, N; Wachtlova, M; Salat, J; Lieskovska, J; Kopecky, J; Zenka, J				Janotova, Tereza; Jalovecka, Marie; Auerova, Marie; Svecova, Ivana; Bruzlova, Pavlina; Maierova, Veronika; Kumzakova, Zuzana; Cunatova, Stepanka; Vlckova, Zuzana; Caisova, Veronika; Rozsypalova, Petra; Lukacova, Katarina; Vacova, Nikol; Wachtlova, Marketa; Salat, Jiri; Lieskovska, Jaroslava; Kopecky, Jan; Zenka, Jan			The Use of Anchored Agonists of Phagocytic Receptors for Cancer Immunotherapy: B16-F10 Murine Melanoma Model	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; INNATE IMMUNE; EXPRESSION; LIPOPOLYSACCHARIDE; GROWTH; MACROPHAGES; CELLS; BETA; ACTIVATION; REGRESSION	The application of the phagocytic receptor agonists in cancer immunotherapy was studied. Agonists (laminarin, molecules with terminal mannose, N-Formyl-methioninyl-leucyl-phenylalanine) were firmly anchored to the tumor cell surface. When particular agonists of phagocytic receptors were used together with LPS (Toll-like receptor agonist), high synergy causing tumour shrinkage and a temporary or permanent disappearance was observed. Methods of anchoring phagocytic receptor agonists (charge interactions, anchoring based on hydrophobic chains, covalent bonds) and various regimes of phagocytic agonist/LPS mixture applications were tested to achieve maximum therapeutic effect. Combinations of mannan/LPS and fMLF/LPS (hydrophobic anchors) in appropriate (pulse) regimes resulted in an 80% and 60% recovery for mice, respectively. We propose that substantial synergy between agonists of phagocytic and Toll-like receptors (TLR) is based on two events. The TLR ligand induces early and massive inflammatory infiltration of tumors. The effect of this cell infiltrate is directed towards tumor cells, bearing agonists of phagocytic receptors on their surface. The result of these processes was effective killing of tumor cells. This novel approach represents exploitation of innate immunity mechanisms for treating cancer.	[Janotova, Tereza; Jalovecka, Marie; Auerova, Marie; Svecova, Ivana; Bruzlova, Pavlina; Maierova, Veronika; Kumzakova, Zuzana; Cunatova, Stepanka; Vlckova, Zuzana; Caisova, Veronika; Rozsypalova, Petra; Vacova, Nikol; Wachtlova, Marketa; Lieskovska, Jaroslava; Kopecky, Jan; Zenka, Jan] Univ South Bohemia, Fac Sci, Dept Med Biol, Ceske Budejovice, Czech Republic; [Lukacova, Katarina] Reg Hosp, Dept Pathol, Ceske Budejovice, Czech Republic; [Salat, Jiri] Vet Res Inst, Dept Virol, CS-62132 Brno, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Veterinary Research Institute	Zenka, J (corresponding author), Univ South Bohemia, Fac Sci, Dept Med Biol, Ceske Budejovice, Czech Republic.	jzenka@gmail.com	Lieskovska, Jaroslava/G-9309-2014; JaloveckÃ, MaruÅka/AAU-5086-2020; Jalovecka, Marie/R-3549-2018; Kopecky, Jan/G-9347-2014; Salát, Jiří/F-6295-2019	JaloveckÃ, MaruÅka/0000-0003-4681-116X; Jalovecka, Marie/0000-0003-4681-116X; Salát, Jiří/0000-0002-9915-8953; Lieskovska, Jaroslava/0000-0001-6626-4912	European Social Fund [CZ.1.07/2.2.00/15.0361]; Czech State Budget; company POLAK CZ s.r.o.	European Social Fund(European Social Fund (ESF)); Czech State Budget; company POLAK CZ s.r.o.	This work was supported by the project no. CZ.1.07/2.2.00/15.0361 funded by European Social Fund and Czech State Budget. Further it was supported by the company POLAK CZ s.r.o. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2009, IMMUNOTHERAPY-UK, V1, P949, DOI [10.2217/imt.09.70, 10.2217/IMT.09.70]; Algarra I, 1997, INT J CLIN LAB RES, V27, P95, DOI 10.1007/BF02912442; Blanks MJ, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-26; Chan GCF, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-25; Chicoine MR, 2001, NEUROSURGERY, V48, P607, DOI 10.1097/00006123-200103000-00032; CHRISTIAANSEN JE, 1984, J IMMUNOL METHODS, V74, P229, DOI 10.1016/0022-1759(84)90290-4; Cui Z, 2003, P NATL ACAD SCI USA, V100, P6682, DOI 10.1073/pnas.1031601100; deVries TJ, 1997, CANCER RES, V57, P3223; Dufton N, 2010, PHARMACOL THERAPEUT, V127, P175, DOI 10.1016/j.pharmthera.2010.04.010; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Frasnelli ME, 2005, ARTHRITIS RES THER, V7, pR370, DOI 10.1186/ar1494; Goodridge HS, 2012, TRAFFIC, V13, P1062, DOI 10.1111/j.1600-0854.2012.01382.x; Guha M, 2012, NAT REV DRUG DISCOV, V11, P503, DOI 10.1038/nrd3775; Hamai A, 2010, TISSUE ANTIGENS, V75, P1, DOI 10.1111/j.1399-0039.2009.01401.x; Hayakawa Y, 2006, ADV CANCER RES, V95, P293, DOI 10.1016/S0065-230X(06)95008-8; Hicks AM, 2006, P NATL ACAD SCI USA, V103, P7753, DOI 10.1073/pnas.0602382103; Jager E, 1996, INT J CANCER, V66, P470, DOI 10.1002/(SICI)1097-0215(19960516)66:4<470::AID-IJC10>3.0.CO;2-C; Jinushi M, 2012, ONCOIMMUNOLOGY, V1, P189, DOI 10.4161/onci.1.2.18495; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kato K, 2004, BIOTECHNOL PROGR, V20, P897, DOI 10.1021/bp0342093; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Kingeter LM, 2012, CELL MOL IMMUNOL, V9, P105, DOI 10.1038/cmi.2011.58; Langers I, 2012, BIOL-TARGETS THER, V6, P73, DOI 10.2147/BTT.S23976; Le YY, 2002, INT IMMUNOPHARMACOL, V2, P1, DOI 10.1016/S1567-5769(01)00150-3; Li J, 2009, WORLD J GASTROENTERO, V15, P2602, DOI 10.3748/wjg.15.2602; Mandal P, 2005, J IMMUNOL, V175, P6085, DOI 10.4049/jimmunol.175.9.6085; Mariani CL, 2007, J NEURO-ONCOL, V85, P231, DOI 10.1007/s11060-007-9415-2; Marquez M, 2004, ANTICANCER RES, V24, P1347; Napper CE, 2001, J BIOL CHEM, V276, P14759, DOI 10.1074/jbc.M100425200; Rhee SH, 2008, GASTROENTEROLOGY, V135, P518, DOI 10.1053/j.gastro.2008.04.022; Riedl S, 2011, BBA-BIOMEMBRANES, V1808, P2638, DOI 10.1016/j.bbamem.2011.07.026; SHEPHERD VL, 1990, J IMMUNOL, V145, P1530; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Tripathi P, 2006, CANCER INVEST, V24, P178, DOI 10.1080/07357900500524579; Tsoni SV, 2008, ANN NY ACAD SCI, V1143, P45, DOI 10.1196/annals.1443.019; Underhill DM, 2004, MICROBES INFECT, V6, P1368, DOI 10.1016/j.micinf.2004.08.016; Vetvicka V, 2011, WORLD J CLIN ONCOL, V2, P115, DOI 10.5306/wjco.v2.i2.115; Warren HS, 2010, J INFECT DIS, V201, P223, DOI 10.1086/649557; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Willment JA, 2003, J IMMUNOL, V171, P4569, DOI 10.4049/jimmunol.171.9.4569; Wrzesinski SH, 2007, CLIN CANCER RES, V13, P5262, DOI 10.1158/1078-0432.CCR-07-1157	41	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85222	10.1371/journal.pone.0085222	http://dx.doi.org/10.1371/journal.pone.0085222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454822	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500048
J	van Twillert, I; van Gaans-van den Brink, JAM; Poelen, MCM; Helm, K; Kuipers, B; Schipper, M; Boog, CJP; Verheij, TJM; Versteegh, FGA; van Els, CACM				van Twillert, Inonge; van Gaans-van den Brink, Jacqueline A. M.; Poelen, Martien C. M.; Helm, Kina; Kuipers, Betsy; Schipper, Maarten; Boog, Claire J. P.; Verheij, Theo J. M.; Versteegh, Florens G. A.; van Els, Cecile A. C. M.			Age Related Differences in Dynamics of Specific Memory B Cell Populations after Clinical Pertussis Infection	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; IMMUNE-RESPONSES; SERUM ANTIBODIES; IGG ANTIBODIES; FILAMENTOUS HEMAGGLUTININ; BOOSTER VACCINATION; REFERENCE VALUES; GENOMIC CONTENT; DISEASE BURDEN; PERTACTIN	For a better understanding of the maintenance of immune mechanisms to Bordetella pertussis (Bp) in relation to age, we investigated the dynamic range of specific B cell responses in various age-groups at different time points after a laboratory confirmed pertussis infection. Blood samples were obtained in a Dutch cross sectional observational study from symptomatic pertussis cases. Lymphocyte subpopulations were phenotyped by flowcytometry before and after culture. Memory B (B-mem) cells were differentiated into IgG antibody secreting cells (ASC) by polyclonal stimulation and detected by an ELISPOT assay specific for pertussis antigens pertussis toxin (Ptx), filamentous haemagglutinin (FHA) and pertactin (Prn). Bp antigen specific IgG concentrations in plasma were determined using multiplex technology. The majority of subjects having experienced a clinical pertussis episode demonstrated high levels of both Bp specific IgG and B-mem cell levels within the first 6 weeks after diagnosis. Significantly lower levels were observed thereafter. Waning of cellular and humoral immunity to maintenance levels occurred within 9 months after antigen encounter. Age was found to determine the maximum but not base-line frequencies of B-mem cell populations; higher levels of B-mem cells specific for Ptx and FHA were reached in adults and (pre-) elderly compared to under-fours and schoolchildren in the first 6 weeks after Bp exposure, whereas not in later phases. This age effect was less obvious for specific IgG levels. Nonetheless, subjects' levels of specific B-mem cells and specific IgG were weakly correlated. This is the first study to show that both age and closeness to last Bp encounter impacts the size of Bp specific B-mem cell and plasma IgG levels.	[van Twillert, Inonge; van Gaans-van den Brink, Jacqueline A. M.; Poelen, Martien C. M.; Helm, Kina; Kuipers, Betsy; van Els, Cecile A. C. M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Immunol Infect Dis & Vaccines, Bilthoven, Netherlands; [Schipper, Maarten] Natl Inst Publ Hlth & Environm RIVM, Dept Stat Math Modelling & Data Logist, Bilthoven, Netherlands; [Boog, Claire J. P.] InTraVacc, Bilthoven, Netherlands; [Verheij, Theo J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Versteegh, Florens G. A.] Groene Hart Ziekenhuis, Dept Pediat, Gouda, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	van Els, CACM (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Immunol Infect Dis & Vaccines, Bilthoven, Netherlands.	Cecile.van.Els@rivm.nl		Versteegh, Florens G.A./0000-0003-4773-5592	European Commission [201502]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the European Commission under the grant agreement #201502 (ChildINNOVAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2011, CLIN VACCINE IMMUNOL, V18, P844, DOI 10.1128/CVI.00562-10; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; [Anonymous], 1988, Lancet, V1, P955; Barkoff AM, 2012, CLIN VACCINE IMMUNOL, V19, P1703, DOI 10.1128/CVI.00367-12; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bouchez V, 2009, VACCINE, V27, P6034, DOI 10.1016/j.vaccine.2009.07.074; Buisman AM, 2009, VACCINE, V28, P179, DOI 10.1016/j.vaccine.2009.09.102; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; Colonna-Romano G, 2006, REJUV RES, V9, P149, DOI 10.1089/rej.2006.9.149; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Dalby T, 2010, J MED MICROBIOL, V59, P1029, DOI 10.1099/jmm.0.020826-0; de Greeff SC, 2008, PEDIATR INFECT DIS J, V27, P218, DOI 10.1097/INF.0b013e318161a2b9; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Frasca D, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-14; Gaayeb L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048684; Hallander HO, 2009, APMIS, V117, P797, DOI 10.1111/j.1600-0463.2009.02530.x; Hegerle N, 2012, CLIN MICROBIOL INFEC, V18, pE340, DOI 10.1111/j.1469-0691.2012.03925.x; Hendrikx LH, 2011, VACCINE, V30, P51, DOI 10.1016/j.vaccine.2011.10.048; Hendrikx LH, 2011, VACCINE, V29, P5725, DOI 10.1016/j.vaccine.2011.05.094; Hendrikx LH, 2011, VACCINE, V29, P1431, DOI 10.1016/j.vaccine.2010.12.033; Hendrikx LH, 2009, VACCINE, V27, P6530, DOI 10.1016/j.vaccine.2009.08.052; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Hijnen M, 2005, PROTEIN EXPRES PURIF, V41, P106, DOI 10.1016/j.pep.2005.01.014; Hviid A, 2006, EXPERT REV VACCINES, V5, P641, DOI 10.1586/14760584.5.5.641; ISACSON J, 1995, PEDIATR INFECT DIS J, V14, P517, DOI 10.1097/00006454-199506000-00009; ISACSON J, 1995, SCAND J INFECT DIS, V27, P273, DOI 10.3109/00365549509019021; Jahnmatz M, 2013, J IMMUNOL METHODS, V391, P50, DOI 10.1016/j.jim.2013.02.009; JENKINSON D, 1988, BRIT MED J, V296, P612, DOI 10.1136/bmj.296.6622.612; Kallonen T, 2011, INFECT GENET EVOL, V11, P2034, DOI 10.1016/j.meegid.2011.09.012; Kaur K, 2007, BLOOD, V110, P2948, DOI 10.1182/blood-2007-01-069245; Khurana S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002920; King AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-64; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; LAMBERT HJ, 1965, PUBLIC HEALTH REP, V80, P365, DOI 10.2307/4592424; Leef M, 2000, J EXP MED, V191, P1841, DOI 10.1084/jem.191.11.1841; Luijkx TA, 2008, CLIN VACCINE IMMUNOL, V15, P1598, DOI 10.1128/CVI.00192-08; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; McGuiness CB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-32; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; Ndungu FM, 2013, EUR J IMMUNOL; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Otsuka N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031985; Pichichero ME, 2009, PEDIATRICS, V124, P1633, DOI 10.1542/peds.2008-3645; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Preziosi MP, 2003, CLIN INFECT DIS, V37, P772, DOI 10.1086/377270; Queenan AM, 2013, NEW ENGL J MED, V368, P583, DOI 10.1056/NEJMc1209369; Rashid H, 2012, CURR OPIN INFECT DIS, V25, P243, DOI 10.1097/QCO.0b013e328352f727; Rosado MM, 2011, EUR J IMMUNOL, V41, P1800, DOI 10.1002/eji.201041187; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; Salmaso S, 1998, VACCINE, V16, P1270, DOI 10.1016/S0264-410X(98)00040-1; Schure RM, 2013, CLIN VACCINE IMMUNOL; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Slifka M K, 1998, Dev Biol Stand, V95, P105; Storsaeter J, 2003, VACCINE, V21, P3542, DOI 10.1016/S0264-410X(03)00407-9; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531; Taranger J, 2000, J INFECT DIS, V181, P1010, DOI 10.1086/315318; Taranger J, 2001, CLIN INFECT DIS, V33, P1004, DOI 10.1086/322639; TOMODA T, 1991, J INFECT DIS, V163, P559, DOI 10.1093/infdis/163.3.559; van Boven M, 2005, P ROY SOC B-BIOL SCI, V272, P1617, DOI 10.1098/rspb.2005.3108; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; van Gent R, 2009, CLIN IMMUNOL, V133, P95, DOI 10.1016/j.clim.2009.05.020; Versteegh FGA, 2005, EPIDEMIOL INFECT, V133, P737, DOI 10.1017/S0950268805003833; Versteegh FGA, 2002, ACTA PAEDIATR, V91, P95, DOI 10.1080/080352502753458030; Vincent JM, 2000, CLIN INFECT DIS, V30, P534, DOI 10.1086/313707; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Yoshida T, 2010, IMMUNOL REV, V237, P117, DOI 10.1111/j.1600-065X.2010.00938.x	73	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85227	10.1371/journal.pone.0085227	http://dx.doi.org/10.1371/journal.pone.0085227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454823	Green Submitted, Green Published, gold			2022-12-25	WOS:000329922500049
J	Han, HY; Xu, DW; Liu, C; Claesson, HE; Bjorkholm, M; Sjoberg, J				Han, Hongya; Xu, Dawei; Liu, Cheng; Claesson, Hans-Erik; Bjorkholm, Magnus; Sjoberg, Jan			Interleukin-4-Mediated 15-Lipoxygenase-1 Trans-Activation Requires UTX Recruitment and H3K27me3 Demethylation at the Promoter in A549 Cells	PLOS ONE			English	Article							CLASSICAL HODGKIN LYMPHOMA; COLORECTAL-CANCER; MONOCYTE 15-LIPOXYGENASE; EPITHELIAL-CELLS; GENE-EXPRESSION; DENDRITIC CELLS; METHYLATION; INDUCTION; POLYCOMB; APOPTOSIS	Arachidonate 15-lipoxygenase-1 (ALOX15) oxygenates polyunsaturated fatty acids and bio-membranes, generating multiple lipid signalling mediators involved in inflammation. Several lines of evidence indicate that ALOX15 activation in the respiratory tract contributes to asthma progression. Recent experimental data reveals that histone modification at the promoter plays a critical role in ALOX15 gene transcription. In the present study, we examined the status of histone H3 trimethyl-lysine 27 (H3K27me3) at the ALOX15 promoter by chromatin immunoprecipitation assay in human lung epithelial carcinoma A549 cells incubated with or without interleukin (IL)-4. We identified demethylation of H3K27me3 at the ALOX15 promoter after IL-4 treatment. Furthermore, we found that the H3K27me2/3-specific demethylase, ubiquitously transcribed tetratricopeptide repeat, X chromosome (UTX), mediates the H3K27me3 demethylation during ALOX15 transcriptional activation. When UTX expression was knocked down using siRNA, IL-4-mediated H3K27me3 demethylation and ALOX15 induction were significantly attenuated. The critical role of UTX in ALOX15 expression was confirmed in human monocytes and the Hodgkin lymphoma (HL) cell line L1236, but was in these cells not related to H3K27me3-demethylase activity. These results demonstrate that UTX is implicated in IL-4 mediated transcriptional activation of the ALOX15 gene.	[Han, Hongya; Xu, Dawei; Claesson, Hans-Erik; Bjorkholm, Magnus; Sjoberg, Jan] Karolinska Univ Hosp Solna, Div Hematol, Dept Med, Stockholm, Sweden; [Han, Hongya; Xu, Dawei; Claesson, Hans-Erik; Bjorkholm, Magnus; Sjoberg, Jan] Karolinska Inst, Stockholm, Sweden; [Liu, Cheng] Shandong Univ, Dept Urol, Qilu Hosp, Jinan 250100, Peoples R China	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Shandong University	Han, HY (corresponding author), Karolinska Univ Hosp Solna, Div Hematol, Dept Med, Stockholm, Sweden.	Ya.Han@ki.se		Claesson, Hans-Erik/0000-0002-1960-6542; Xu, Dawei/0000-0003-3141-4524	Swedish Cancer Society; Stockholm County Council; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This study was supported by grants from the Swedish Cancer Society and the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; Bhattacharjee A, 2010, J IMMUNOL, V185, P5211, DOI 10.4049/jimmunol.1000514; Brinckmann R, 1996, BIOCHEM J, V318, P305, DOI 10.1042/bj3180305; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chu H. W., 2002, Clinical and Experimental Allergy, V32, P1558, DOI 10.1046/j.1365-2222.2002.01477.x; Claesson HE, 2008, FEBS J, V275, P4222, DOI 10.1111/j.1742-4658.2008.06570.x; Claesson HE, 2009, PROSTAG OTH LIPID M, V89, P120, DOI 10.1016/j.prostaglandins.2008.12.003; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Hennig R, 2007, NEOPLASIA, V9, P917, DOI 10.1593/neo.07565; Heslin MJ, 2005, ANN SURG, V241, P941, DOI 10.1097/01.sla.0000164177.95620.c1; Hsi LC, 2004, CANCER RES, V64, P8778, DOI 10.1158/0008-5472.CAN-04-1867; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Kelavkar U, 1998, MOL BIOL REP, V25, P173, DOI 10.1023/A:1006813009006; Kelavkar UP, 2001, CARCINOGENESIS, V22, P1765, DOI 10.1093/carcin/22.11.1765; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kuperman DA, 2005, J ALLERGY CLIN IMMUN, V116, P305, DOI 10.1016/j.jaci.2005.03.024; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Liu C, 2004, EXP CELL RES, V297, P61, DOI 10.1016/j.yexcr.2004.02.014; Liu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052703; Liu C, 2012, EXP CELL RES, V318, P169, DOI 10.1016/j.yexcr.2011.10.017; Mahmoudi T, 2001, ONCOGENE, V20, P3055, DOI 10.1038/sj.onc.1204330; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; NASSAR GM, 1994, J BIOL CHEM, V269, P27631; Nixon JB, 2004, PROSTAG LEUKOTR ESS, V70, P7, DOI 10.1016/j.plefa.2003.06.001; Onodera A, 2010, J EXP MED, V207, P2493, DOI 10.1084/jem.20100760; Roy B, 1998, J BIOL CHEM, V273, P32023, DOI 10.1074/jbc.273.48.32023; Satoh Takeshi, 2013, Methods Mol Biol, V960, P401, DOI 10.1007/978-1-62703-218-6_30; Schewe T, 2002, BIOL CHEM, V383, P365, DOI 10.1515/BC.2002.041; Shi LJ, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-59; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Shureiqi I, 1999, CARCINOGENESIS, V20, P1985, DOI 10.1093/carcin/20.10.1985; Shureiqi I, 2001, CANCER RES, V61, P4879; Skinnider BF, 2002, LEUKEMIA LYMPHOMA, V43, P1203, DOI 10.1080/10428190290026259; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Xu DW, 1998, BRIT J HAEMATOL, V102, P1367, DOI 10.1046/j.1365-2141.1998.00969.x; Zhang CL, 2005, J INVEST DERMATOL, V125, P1045, DOI 10.1111/j.0022-202X.2005.23925.x; Zhao JM, 2009, AM J RESP CRIT CARE, V179, P782, DOI 10.1164/rccm.200811-1744OC; Zuo XS, 2008, J BIOL CHEM, V283, P31341, DOI 10.1074/jbc.M803729200	43	13	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85085	10.1371/journal.pone.0085085	http://dx.doi.org/10.1371/journal.pone.0085085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465480	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500030
J	Li, CM; Meng, S; Yang, XH; Wang, J; Hu, JN				Li, Chuanming; Meng, Shan; Yang, Xinhua; Wang, Jian; Hu, Jiani			The Value of T2*in Differentiating Metastatic from Benign Axillary Lymph Nodes in Patients with Breast Cancer - A Preliminary In Vivo Study	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; SENTINEL NODE; RECURRENCE; BIOPSY; WOMEN; DISSECTION; ULTRASONOGRAPHY; SURVIVAL; TRIAL	Background: Accurate detection and determination of axillary lymph node metastasis are crucial for the clinical management of patients with breast cancer. Noninvasive imaging methods including ultrasound (US), computed tomography (CT), or conventional magnetic resonance imaging (MRI) are not yet accurate enough. The purpose of this study was to investigate the value of in vivo T2* in differentiating metastatic from benign axillary lymph nodes in patients with breast cancer. Methodology/Principal Findings: In this institutional review board approved study, 35 women with breast cancer underwent multi-echo T2* weighted imaging (T2* WI) of the axillary area on a 3.0 T clinical magnetic resonance (MR) imaging system. T2* values of pathologically proven benign and metastatic axillary lymph nodes were calculated and compared. Receiver operating characteristics (ROC) analysis was conducted to evaluate the diagnostic ability. The areas under the ROC curve (AUCs) and the confidence intervals (CIs) were assessed. In total, 56 metastatic and 65 benign axillary lymph nodes were identified in this study. For metastatic lymph nodes, the average T2* value (55.96 +/- 11.87 ms) was significantly longer than that of the benign lymph nodes (26.00 +/- 5.51 ms, P<0.05). The AUC of T2* in differentiating benign from metastatic lymph nodes was 0.993. The cut-off value of 37.5 milliseconds (ms) gave a sensitivity of 94.6%, a specificity of 98.5%, a positive predictive value of 98.17 and a negative predictive value 95.54. Conclusions: In vivo T2* can differentiate benign from metastatic axillary lymph nodes in patients with breast cancer. The high sensitivity and specificity as well as the easiness suggest its high potential for use in clinical practice.	[Li, Chuanming; Meng, Shan; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Yang, Xinhua] Third Mil Med Univ, Southwest Hosp, Dept Breast Surg, Chongqing, Peoples R China; [Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA	Army Medical University; Army Medical University; Wayne State University	Wang, J (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China.	wangjian_1964@sohu.com; jiani_hu@sohu.com						Atahan IL, 2008, ACTA ONCOL, V47, P232, DOI 10.1080/02841860701678761; Bahri S, 2008, ANN ONCOL, V19, P822, DOI 10.1093/annonc/mdn043; Beenken SW, 2003, ANN SURG, V237, P732, DOI 10.1097/00000658-200305000-00016; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; Cooper KL, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15040; DOOMS GC, 1984, RADIOLOGY, V153, P719, DOI 10.1148/radiology.153.3.6093190; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Harada T, 2007, EUR J RADIOL, V63, P401, DOI 10.1016/j.ejrad.2007.02.010; He N, 2012, EUR J RADIOL, V81, P2602, DOI 10.1016/j.ejrad.2012.03.019; Heusner TA, 2010, EUR J NUCL MED MOL I, V37, P1077, DOI 10.1007/s00259-010-1399-z; Hildebrandt MG, 2011, DAN MED BULL, V58; IVENS D, 1992, BRIT J CANCER, V66, P136, DOI 10.1038/bjc.1992.230; Korteweg MA, 2011, RADIOLOGY, V261, P127, DOI 10.1148/radiol.11103535; Kvistad KA, 2000, EUR RADIOL, V10, P1464, DOI 10.1007/s003300000370; Kwee TC, 2010, EUR J RADIOL, V75, P215, DOI 10.1016/j.ejrad.2009.03.026; Le Bouedec G, 2008, PRESSE MED, V37, P1685, DOI 10.1016/j.lpm.2007.10.020; Lim SW, 2011, ACAD RADIOL, V18, P504, DOI 10.1016/j.acra.2010.10.017; Luciani A, 2009, EUR J RADIOL, V69, P59, DOI 10.1016/j.ejrad.2008.07.040; Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158; Martin RCG, 2005, ANN SURG, V241, P1005, DOI 10.1097/01.sla.0000165200.32722.02; McLaughlin SA, 2008, J CLIN ONCOL, V26, P5213, DOI 10.1200/JCO.2008.16.3725; Mortellaro VE, 2009, J MAGN RESON IMAGING, V30, P309, DOI 10.1002/jmri.21802; Murray AD, 2002, BRIT J RADIOL, V75, P220, DOI 10.1259/bjr.75.891.750220; Scaranelo AM, 2012, RADIOLOGY, V262, P425, DOI 10.1148/radiol.11110639; Strnad P, 2005, Ceska Gynekol, V70, P291; Tolaney SM, 2007, BREAST, V16, pS45, DOI 10.1016/j.breast.2007.07.005; Ueda S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-165; VASSALLO P, 1993, INVEST RADIOL, V28, P698, DOI 10.1097/00004424-199308000-00009; Zuo CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049337	29	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e84038	10.1371/journal.pone.0084038	http://dx.doi.org/10.1371/journal.pone.0084038			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454715	Green Published, gold, Green Submitted			2022-12-25	WOS:000330236000005
J	Carrette, T; Straehler-Pohl, I; Seymour, J				Carrette, Teresa; Straehler-Pohl, Ilka; Seymour, Jamie			Early Life History of Alatina cf. moseri Populations from Australia and Hawaii with Implications for Taxonomy (Cubozoa: Carybdeida, Alatinidae)	PLOS ONE			English	Article							TRIPEDALIA-CYSTOPHORA CUBOZOA; MARSUPIALIS LINNAEUS; SIVICKISI CNIDARIA; JELLYFISH; SCYPHOZOA; BEHAVIOR; CYCLE; METAMORPHOSIS; CUBOPOLYP; POLYP	The early life stages of the cubomedusa Alatina cf. moseri from Osprey Reef (North Queensland, Australia) and Waikiki (Oahu, Hawaii) were studied using laboratory-based culturing conditions. Spawning populations from both regions were observed with reliable periodicity allowing polyp cultures from these locations to be collected and established under laboratory conditions. The polyps of this species were successfully reared from spawning adults. Polyps of Alatina cf. moseri were cultured at temperatures of 23-28 degrees C, developed up to 19 tentacles and reached up to 1.70 mm in height. The balloonshaped hypostomes possessed 4 well-defined lips. The polyps increased their numbers by means of formation of either sedentary polyp buds or creeping-polyp buds, which attached after 2-3 days. Metamorphosis occurred at temperatures of 25-28 degrees C. Development of polyps and medusae were achieved for the first time within the genus Alatina and allowed comparisons of early life history between these and other species of the Carybdeida families. The metamorphosis and young medusa of this genus showed characters that differed distinctly from those noted for other Carybdeida species, but are very similar to the one described from Puerto Rico by Arneson and Cutress in 1976 for Alatina sp. (named by them Carybdea alata). Based on this evidence, the discrepancies in original specimen descriptions and the previous genetic comparisons, we support the suggestion that the two previously described species of Alatina from Australia and Hawaii (Alatina mordens and Alatina moseri) appear to represent artificial taxonomic units and may in fact be the same as the original Carybdea alata species named from Puerto Rico. Further taxonomic studies are desperately needed in order to clarify the various species and description discrepancies that exist within this newly proposed genus.	[Carrette, Teresa] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Straehler-Pohl, Ilka] Univ Hamburg, Museum & Inst Zool, Bioctr Grindel, Hamburg, Germany; [Seymour, Jamie] Queensland Trop Hlth Alliance, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Qld, Australia; [Seymour, Jamie] James Cook Univ, Cairns, Qld, Australia	James Cook University; University of Hamburg; James Cook University	Carrette, T (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia.	Teresa.Carrette@my.jcu.edu.au		Straehler-Pohl, Ilka/0000-0001-5831-4967	Lions Foundation of Australia; Queensland Emergency Medical Research Foundation, Brisbane, Queensland	Lions Foundation of Australia; Queensland Emergency Medical Research Foundation, Brisbane, Queensland	The Lions Foundation of Australia provided a grant that partially supported this research. J.S. acknowledges the financial support of the Queensland Emergency Medical Research Foundation, Brisbane, Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneson A, 1976, THESIS U PUERTO RICO; Arneson A. C., 1976, COELENTERATE ECOLOGY, P227, DOI [10.1007/978-1-4757-9724-4_24, DOI 10.1007/978-1-4757-9724-4_24]; Bentlage B, 2012, THESIS U KANSAS; Bentlage B, 2012, J NAT HIST, V46, P2595, DOI 10.1080/00222933.2012.717645; Bentlage B, 2010, P ROY SOC B-BIOL SCI, V277, P493, DOI 10.1098/rspb.2009.1707; BERGER EW, 1900, MEM BIOL LAB J HOPKI, V4, P1; Berger EW, 1900, MEMOIRS BIOL LAB J H, V4, P1; BREWER RH, 1976, BIOL BULL-US, V150, P183, DOI 10.2307/1540467; BREWER RH, 1978, ESTUARIES, V1, P120, DOI 10.2307/1351601; CALDER DR, 1982, BIOL BULL, V162, P149, DOI 10.2307/1540810; CALDER DR, 1973, MAR BIOL, V21, P109, DOI 10.1007/BF00354606; Carrette TJ, 2012, DIVING HYPERB MED, V42, P214; CHAPMAN DM, 1978, HELGOLAND WISS MEER, V31, P128, DOI 10.1007/BF02296994; Conant FS, 1897, NOTES CUBOMEDUSAE, P132; CONANT FS, 1898, MEM BIOL LAB J HOPKI, V4, P1; Courtney R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069369; Cutress C. E., 1973, P ASS ISLAND MARINE, V9, P25; Edwards A, 2010, CORAL REEF TARGETED, Vii, P166; Fischer AB, 2004, HYDROBIOLOGIA, V530, P331, DOI 10.1007/s10750-004-2658-4; Fuentes V, 2011, MAR BIOL, V158, P2247, DOI 10.1007/s00227-011-1730-7; Gershwin L., 2005, Memoirs of the Queensland Museum, V51, P501; GOLZ R, 1993, PROTOPLASMA, V173, P13, DOI 10.1007/BF01378858; Haacke W, 1887, JENAISCHE Z NATURWIS, V20, P588; Haeckel E., 1880, DENKSCHRIFTEN MED NA, V2, P361, DOI DOI 10.5962/BHL.TITLE.46856; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P171, DOI 10.1007/BF00026459; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P181, DOI 10.1007/BF00026460; HOLST S, 2006, J MAR BIOL ASSOC UK, V151, P863; Holst S, 2007, MAR BIOL, V151, P1695, DOI 10.1007/s00227-006-0594-8; Kawahara M, 2006, MAR ECOL PROG SER, V307, P161, DOI 10.3354/meps307161; LASKAMEHNERT G, 1985, HELGOLANDER MEERESUN, V39, P129, DOI 10.1007/BF01997447; Lesson R-P, 1843, ACALEPHES; Lewis C, 2005, MAR BIOL, V147, P477, DOI 10.1007/s00227-005-1602-0; Lewis Cheryl, 2008, Publications of the Seto Marine Biological Laboratory, V40, P1; Mayer A. G., 1900, B MUS COMP ZOOL HARV, V37, P1; Mehnert G, 1984, THESIS RHEINESCHEN F; Okada Y. K., 1927, Bulletin Biologique de la France et de la Belgique, V61, P241; Omori M, 2010, MAR BIOL RES, V7, P3, DOI 10.1080/17451001003642317; Pitt KA, 2000, MAR BIOL, V136, P269, DOI 10.1007/s002270050685; Reynaud AAM, 1830, CARYBDEE MEDUSE AILE; Schiariti A, 2008, MAR BIOL, V156, P1, DOI 10.1007/s00227-008-1050-8; SPANGENBERG D B, 1968, Oceanography and Marine Biology an Annual Review, V6, P231; Stangl K, 2002, VIE MILIEU, V52, P131; Stangl K, 1997, THESIS U WIEN; STIASNY G., 1926, ZOOL MEDEDEEL, V9, P239; Straehler-Pohl I, 2005, MAR BIOL, V147, P1271, DOI 10.1007/s00227-005-0031-4; Straehler-Pohl I., 2001, VERWANDTSCHAFT DREIE; Straehler-Pohl I, 2009, THESIS U HAMBURG; Straehler-Pohl I, 2011, ZOOTAXA, P36; Straehler-Pohl I, 2011, ZOOTAXA, P1; Straehler-Pohl Ilka, 2011, Midoriishi, V22, P8; Studebaker JP, 1972, THESIS U PUERTO RICO; Thomas C S, 2001, Hawaii Med J, V60, P205; Thomas C S, 2001, Hawaii Med J, V60, P100; Toshino Sho, 2013, Plankton & Benthos Research, V8, P1; Uchida T., 1970, Publs Seto mar. biol. Lab., V17, P289; Werner B., 1973, Publications Seto Mar Biol Lab, V20, P35; WERNER B, 1973, MAR BIOL, V18, P212, DOI 10.1007/BF00367987; WERNER B, 1975, HELGOLAND WISS MEER, V27, P461, DOI 10.1007/BF01611150; WERNER B, 1983, HELGOLANDER MEERESUN, V36, P257, DOI 10.1007/BF01983630; WERNER B, 1976, EXPERIENTIA, V32, P1047, DOI 10.1007/BF01933964; WERNER B, 1971, NATURE, V232, P582, DOI 10.1038/232582a0; Werner B., 1976, Umschau, V76, P80; Werner B, 1993, LEHBUCH SPEZIELLEN Z, P11; Yamaguchi M., 1980, P11; Yamaguchi M., 1982, Aquabiology (Tokyo), V4, P248; Yoshimoto CM, 2002, T ROY SOC TROP MED H, V96, P300, DOI 10.1016/S0035-9203(02)90105-7	66	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84377	10.1371/journal.pone.0084377	http://dx.doi.org/10.1371/journal.pone.0084377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454725	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000330235100021
J	Schauer, C; Thompson, C; Brune, A				Schauer, Christine; Thompson, Claire; Brune, Andreas			Pyrotag Sequencing of the Gut Microbiota of the Cockroach Shelfordella lateralis Reveals a Highly Dynamic Core but Only Limited Effects of Diet on Community Structure	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; AMERICAN COCKROACH; PERIPLANETA-AMERICANA; BACTERIAL COMMUNITY; GERMAN-COCKROACH; REPRODUCTION; TERMITES; HINDGUT; FOOD; ENVIRONMENT	Although blattid cockroaches and termites share a common ancestor, their diets are distinctly different. While termites consume a highly specialized diet of lignocellulose, cockroaches are omnivorous and opportunistic feeders. The role of the termite gut microbiota has been studied intensively, but little is known about the cockroach gut microbiota and its function in digestion and nutrition, particularly the adaptation to different diets. Our analyses of the bacterial gut microbiota of the blattid cockroach Shelfordella lateralis combining terminal restriction fragment length polymorphism of their 16S rRNA genes with physiological parameters (microbial metabolites, hydrogen and methane emission) indicated substantial variation between individuals but failed to identify any diet-related response. Subsequent deep-sequencing of the 16S rRNA genes of the colonic gut microbiota of S. lateralis fed either a high-or a low-fiber diet confirmed the absence of bacterial taxa that responded to diet. Instead, we found a small number of abundant phylotypes that were consistently present in all samples and made up half of the community in both diet groups. They varied strongly in abundance between individual samples at the genus but not at the family level. The remaining phylotypes were inconsistently present among replicate batches. Our findings suggest that S. lateralis harbors a highly dynamic core gut microbiota that is maintained even after fundamental dietary shifts, and that any dietary effects on the gut community are likely to be masked by strong individual variations.	[Schauer, Christine; Thompson, Claire; Brune, Andreas] Max Planck Inst Terr Microbiol, Dept Biogeochem, D-35043 Marburg, Germany; [Schauer, Christine; Thompson, Claire; Brune, Andreas] Univ Marburg, LOEWE Ctr Synthet Microbiol, SYNMIKRO, Marburg, Germany; [Thompson, Claire] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	Max Planck Society; Philipps University Marburg; University of Sydney	Brune, A (corresponding author), Max Planck Inst Terr Microbiol, Dept Biogeochem, D-35043 Marburg, Germany.	brune@mpi-marburg.mpg.de	Brune, Andreas/C-6944-2011	Brune, Andreas/0000-0002-2667-4391; allnutt, theo/0000-0002-1347-3777	LOEWE program of the State of Hesse (Center for Synthetic Microbiology); Max Planck Society; Alexander von Humboldt Foundation	LOEWE program of the State of Hesse (Center for Synthetic Microbiology); Max Planck Society(Max Planck SocietyFoundation CELLEX); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported within the LOEWE program of the State of Hesse (Center for Synthetic Microbiology) and by the Max Planck Society. CLT received a postdoctoral fellowship of the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett ELB, 2009, P ROY SOC B-BIOL SCI, V276, P3257, DOI 10.1098/rspb.2009.0725; Bignell D.E., 1981, P57; BIGNELL DE, 1977, CAN J ZOOL, V55, P579, DOI 10.1139/z77-073; BIGNELL DE, 1977, CAN J ZOOL, V55, P1100, DOI 10.1139/z77-142; BIGNELL DE, 1977, J INVERTEBR PATHOL, V29, P338, DOI 10.1016/S0022-2011(77)80040-2; BRACKE JW, 1978, ANTIMICROB AGENTS CH, V13, P115, DOI 10.1128/AAC.13.1.115; Brune A, 2007, NATURE, V450, P487, DOI 10.1038/450487a; Brune A, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P439, DOI 10.1007/978-90-481-3977-4_16; COCHRAN DG, 1979, ANN ENTOMOL SOC AM, V72, P197, DOI 10.1093/aesa/72.2.197; COOPER RA, 1992, ENTOMOL EXP APPL, V63, P123, DOI 10.1007/BF00343572; Curtis TP, 2004, CURR OPIN MICROBIOL, V7, P221, DOI 10.1016/j.mib.2004.04.010; Dasch GA, 1984, BERGEYS MANUAL SYSTE, V1, P811; DURBIN EJ, 1985, ENTOMOL EXP APPL, V37, P77, DOI 10.1007/BF00366811; Egert M, 2003, APPL ENVIRON MICROB, V69, P6659, DOI 10.1128/AEM.69.11.6659-6668.2003; HAMILTON RL, 1990, ENTOMOL EXP APPL, V55, P23, DOI 10.1007/BF00188224; He SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061126; Hongoh Y, 2010, MICROBIOL MONOGR, V19, P55, DOI 10.1007/978-3-642-13615-3_5; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Ikeda-Ohtsubo W, 2007, MICROBIOL-SGM, V153, P3458, DOI 10.1099/mic.0.2007/009217-0; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; KANE MD, 1991, APPL ENVIRON MICROB, V57, P2628, DOI 10.1128/AEM.57.9.2628-2634.1991; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; KUNKEL JG, 1966, J INSECT PHYSIOL, V12, P227, DOI 10.1016/0022-1910(66)90137-5; Lo N, 2003, MOL BIOL EVOL, V20, P907, DOI 10.1093/molbev/msg097; Nalepa CA, 2001, INSECT SOC, V48, P194, DOI 10.1007/PL00001767; Noda S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-158; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Pedron T, 2012, MBIO, V3, DOI 10.1128/mBio.00116-12; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; R Core Team, 2021, R LANG ENV STAT COMP; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; Sabree ZL, 2012, APPL ENVIRON MICROB, V78, P204, DOI 10.1128/AEM.06540-11; Schauer C, 2012, APPL ENVIRON MICROB, V78, P2758, DOI 10.1128/AEM.07788-11; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt-Wagner D, 2003, APPL ENVIRON MICROB, V69, P6018, DOI 10.1128/AEM.69.10.6018-6024.2003; Simpson JM, 1999, J MICROBIOL METH, V36, P167, DOI 10.1016/S0167-7012(99)00029-9; Thompson CL, 2008, ISME J, V2, P739, DOI 10.1038/ismej.2008.29; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WILLIS ER, 1957, J ECON ENTOMOL, V50, P438, DOI 10.1093/jee/50.4.438; Yin YS, 2010, ISME J, V4, P367, DOI 10.1038/ismej.2009.128; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854; Zurek L, 1996, J INSECT PHYSIOL, V42, P743, DOI 10.1016/0022-1910(96)00028-5; Zurek L, 1998, J INSECT PHYSIOL, V44, P645, DOI 10.1016/S0022-1910(98)00024-9	46	51	52	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85861	10.1371/journal.pone.0085861	http://dx.doi.org/10.1371/journal.pone.0085861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454939	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100137
J	Witzmann, F; Schwarz-Wings, D; Hampe, O; Fritsch, G; Asbach, P				Witzmann, Florian; Schwarz-Wings, Daniela; Hampe, Oliver; Fritsch, Guido; Asbach, Patrick			Evidence of Spondyloarthropathy in the Spine of a Phytosaur (Reptilia: Archosauriformes) from the Late Triassic of Halberstadt, Germany	PLOS ONE			English	Article							OSSEOUS PATHOLOGY; CROCODILIANS	Pathologies in the skeleton of phytosaurs, extinct archosauriform reptiles restricted to the Late Triassic, have only been rarely described. The only known postcranial pathologies of a phytosaur are two pairs of fused vertebrae of "Angistorhinopsis ruetimeyeri'' from Halberstadt, Germany, as initially described by the paleontologist Friedrich von Huene. These pathologic vertebrae are redescribed in more detail in this study in the light of modern paleopathologic methods. Four different pathologic observations can be made in the vertebral column of this individual: 1) fusion of two thoracic vertebral bodies by new bone formation within the synovial membrane and articular capsule of the intervertebral joint; 2) fusion and conspicuous antero-posterior shortening of last presacral and first sacral vertebral bodies; 3) destruction and erosion of the anterior articular surface of the last presacral vertebra; and 4) a smooth depression on the ventral surface of the fused last presacral and first sacral vertebral bodies. Observations 1-3 can most plausibly and parsimoniously be attributed to one disease: spondyloarthropathy, an aseptic inflammatory process in which affected vertebrae show typical types of reactive new bone formation and erosion of subchondral bone. The kind of vertebral shortening present in the fused lumbosacral vertebrae suggests that the phytosaur acquired this disease in its early life. Observation 4, the smooth ventral depression in the fused lumbosacral vertebrae, is most probably not connected to the spondyloarthropathy, and can be regarded as a separate abnormality. It remains of uncertain origin, but may be the result of pressure, perhaps caused by a benign mass such as an aneurysm or cyst of unknown type. Reports of spondyloarthropathy in Paleozoic and Mesozoic reptiles are still exceptional, and our report of spondyloarthropathy in fossil material from Halberstadt is the first unequivocal occurrence of this disease in a Triassic tetrapod and in a phytosaur.	[Witzmann, Florian; Schwarz-Wings, Daniela; Hampe, Oliver] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Berlin, Germany; [Fritsch, Guido] Forschungsverbund Berlin eV, Leibniz Inst Zoo & Wildtierforsch IZW, Berlin, Germany; [Asbach, Patrick] Charite, Inst Radiol, D-13353 Berlin, Germany	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Leibniz Institut fur Zoo und Wildtierforschung; Technical University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Witzmann, F (corresponding author), Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Berlin, Germany.	florian.witzmann@mfn-berlin.de		Schwarz, Daniela/0000-0003-4017-8914; Asbach, Patrick/0000-0002-6885-3283	Museum fur Naturkunde, Leibniz Institute for Research on Evolution and Biodiversity, Berlin; Deutsche Forschungsgemeinschaft (DFG) [SCHW 1452/2-1, HA 1776/13-1]	Museum fur Naturkunde, Leibniz Institute for Research on Evolution and Biodiversity, Berlin; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding is provided by the Museum fur Naturkunde, Leibniz Institute for Research on Evolution and Biodiversity, Berlin, and by the Deutsche Forschungsgemeinschaft (DFG) to DSW (SCHW 1452/2-1) and OH (HA 1776/13-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O., 1922, Palaeontologische Zeitschrift Berlin, V5, P26; Adler CP, 2005, DIAGNOSTIK MAKROSKOP; Anonymous, 2006, Bulletin of the New Mexico Museum of Natural History and Science, P1; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P133; Benton MJ, 2004, DINOSAURIA, 2ND EDITION, P7; Bruggeman BJ, 2012, DEV DYNAM, V241, P675, DOI 10.1002/dvdy.23750; Brusatte SL, 2010, J SYST PALAEONTOL, V8, P3, DOI 10.1080/14772010903537732; Butler RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034094; CAMP CHARLES L., 1930, MEM UNIV CALIFORNIA, V10, P1; Case C. E., 1932, Contributions from the Museum of Paleontology University of Michigan, V4, P57; Castriota-Scanderbeg A, 2005, ABNORMAL SKELETAL PH; CHATTERJEE S, 1978, Palaeontology (Oxford), V21, P83; Cisneros JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013425; Dawes B, 1930, PHILOS T R SOC LON B, V218, P115, DOI 10.1098/rstb.1930.0004; Eysel P, 1997, BAKTERIELLE INFEKTIO, P52; Gower DJ, 2001, NATURWISSENSCHAFTEN, V88, P119, DOI 10.1007/s001140100206; Gozzi E, 2003, RIV ITAL PALEONTOL S, V109, P475, DOI 10.13130/2039-4942/5518; GREGORY J T, 1969, Palaeontologische Zeitschrift, V43, P37; GREGORY JOSEPH T., 1962, AMER MUS NOVITATES, V2095, P1; Hoffstetter R., 1969, P201; Huene F.von., 1921, Jahrbuch der Preussischen Geologischen Landes-Anstalt, V42, P59; Hungerbuhler A, 2002, PALAEONTOLOGY, V45, P377, DOI 10.1111/1475-4983.00242; Hunt A.P., 1989, P349; Hurlburt Grant R., 2003, Bulletin of the New Mexico Museum of Natural History and Science, V24, P105; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Jaeger G.F., 1828, FOSSILEN REPTILIEN W; Jaekel O., 1914, Palaeontologische Zeitschrift Berlin, V1, P155; Lautenschlager S, 2011, PALAEONTOL Z, V85, P357, DOI 10.1007/s12542-011-0105-1; Leivseth G, 2005, CLIN BIOMECH, V20, P669, DOI 10.1016/j.clinbiomech.2005.04.006; Lucas S.G., 2012, NEW MEX MUS NAT HIST, V55, P1; McGregor J. H., 1906, MEMOIRS AM MUSEUM NA, V9, P27; Moodie R. L., 1917, ANN MED HIST, V1917, P374; Moodie RL, 1923, ANTIQUITY DIS; Moodie RL, 1918, SCI MON, V7, P265; Moore R. I., 1922, Science New York, V56, P417; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Resnick D., 1988, DIAGNOSIS BONE JOINT; Rothschild B, 2002, LANCET, V360, P1454, DOI 10.1016/S0140-6736(02)11471-1; Rothschild BM, ANAT HISTOL EMBRYOL; Rothschild B, 2010, J HERPETOL, V44, P13, DOI 10.1670/08-243.1; Rothschild B, 2009, APPL HERPETOL, V6, P47, DOI 10.1163/157075409X413842; Rothschild Bruce M., 2012, P1, DOI 10.1007/978-1-4614-0824-6_1; Rothschild BM, 2005, CURR RHEUMATOL REV, V1, P57, DOI 10.2174/1573397052954145; Salisbury SW, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P85; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P1; Stocker MR, 2013, GEOL SOC SPEC PUBL, V379, P91, DOI 10.1144/SP379.5; Stocker MR, 2012, J VERTEBR PALEONTOL, V32, P573, DOI 10.1080/02724634.2012.649815; Tsuihiji T, 2004, J VERTEBR PALEONTOL, V24, P165, DOI 10.1671/A1129-12; Vega CS, 2014, VERTEBR PALEOBIOL PA, P151, DOI 10.1007/978-94-007-6841-3_9; von Huene F, 1913, B AM MUS NAT HIST, V32, P275; von Huene F, 1911, GEOLOGISCHE PALAONTO, V10, P67, DOI DOI 10.1086/621900; VONWETTSTEIN O, 1937, HDB ZOOLOGIE, P236; Westphal F., 1976, HDB PALAOHERPETOLOGI, V13, P99; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson J, 2011, TLS-TIMES LIT SUPPL, P6; WINCHESTER L, 1977, J ZOOL, V181, P495	56	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85511	10.1371/journal.pone.0085511	http://dx.doi.org/10.1371/journal.pone.0085511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454880	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100094
J	Bingle, LEH; Constantinidou, C; Shaw, RK; Islam, MS; Patel, M; Snyder, LAS; Lee, DJ; Penn, CW; Busby, SJW; Pallen, MJ				Bingle, Lewis E. H.; Constantinidou, Chrystala; Shaw, Robert K.; Islam, Md. Shahidul; Patel, Mala; Snyder, Lori A. S.; Lee, David J.; Penn, Charles W.; Busby, Stephen J. W.; Pallen, Mark J.			Microarray Analysis of the Ler Regulon in Enteropathogenic and Enterohaemorrhagic Escherichia coli Strains	PLOS ONE			English	Article							ENTEROCYTE EFFACEMENT; H-NS; CONTROLS EXPRESSION; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; PATHOGENICITY ISLAND; SUBVERSIVE ELEMENTS; PROTEIN SECRETION; REGULATORY REGION; EPITHELIAL-CELLS	The type III protein secretion system is an important pathogenicity factor of enteropathogenic and enterohaemorrhagic Escherichia coli pathotypes. The genes encoding this apparatus are located on a pathogenicity island (the locus of enterocyte effacement) and are transcriptionally activated by the master regulator Ler. In each pathotype Ler is also known to regulate genes located elsewhere on the chromosome, but the full extent of the Ler regulon is unclear, especially for enteropathogenic E. coli. The Ler regulon was defined for two strains of E. coli: E2348/69 (enteropathogenic) and EDL933 (enterohaemorrhagic) in mid and late log phases of growth by DNA microarray analysis of the transcriptomes of wild-type and ler mutant versions of each strain. In both strains the Ler regulon is focused on the locus of enterocyte effacement - all major transcriptional units of which are activated by Ler, with the sole exception of the LEE1 operon during mid-log phase growth in E2348/69. However, the Ler regulon does extend more widely and also includes unlinked pathogenicity genes: in E2348/69 more than 50 genes outside of this locus were regulated, including a number of known or potential pathogenicity determinants; in EDL933 only 4 extra-LEE genes, again including known pathogenicity factors, were activated. In E2348/69, where the Ler regulon is clearly growth phase dependent, a number of genes including the plasmid-encoded regulator operon perABC, were found to be negatively regulated by Ler. Negative regulation by Ler of PerC, itself a positive regulator of the ler promoter, suggests a negative feedback loop involving these proteins.	[Bingle, Lewis E. H.; Constantinidou, Chrystala; Shaw, Robert K.; Islam, Md. Shahidul; Patel, Mala; Snyder, Lori A. S.; Lee, David J.; Penn, Charles W.; Busby, Stephen J. W.; Pallen, Mark J.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Pallen, MJ (corresponding author), Univ Warwick, Div Microbiol & Infect, Coventry CV4 7AL, W Midlands, England.	m.pallen@warwick.ac.uk	Bingle, Lewis E.H./A-7591-2012; Busby, Stephen/C-2712-2015	Bingle, Lewis E.H./0000-0001-5168-5167; Pallen, Mark/0000-0003-1807-3657; Snyder, Lori/0000-0003-3172-3984; Lee, David/0000-0003-2395-351X; Busby, Stephen/0000-0003-2148-1758; Islam, Md Shahidul/0000-0003-4712-4046	BBSRC; BBSRC [BB/E020860/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C516701/1, BB/E020860/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a grant from the BBSRC (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2008, DNA RES, V15, P25, DOI 10.1093/dnares/dsm033; Abu-Ali GS, 2010, MICROBIOL-SGM, V156, P408, DOI 10.1099/mic.0.033126-0; Barba J, 2005, J BACTERIOL, V187, P7918, DOI 10.1128/JB.187.23.7918-7930.2005; Berdichevsky T, 2005, J BACTERIOL, V187, P349, DOI 10.1128/JB.187.1.349-357.2005; Bergholz TM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-97; Bishop RE, 2005, J ENDOTOXIN RES, V11, P174, DOI 10.1179/096805105X35242; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; Bustamante VH, 2011, MOL MICROBIOL, V82, P398, DOI 10.1111/j.1365-2958.2011.07819.x; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0; Cordeiro TN, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002380; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Garcia-Angulo VA, 2008, J BACTERIOL, V190, P2388, DOI 10.1128/JB.01602-07; Garmendia J, 2005, FEMS MICROBIOL LETT, V247, P137, DOI 10.1016/j.femsle.2005.04.035; GOMEZDUARTE OG, 1995, INFECT IMMUN, V63, P1767; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Ho TD, 2008, INFECT IMMUN, V76, P1858, DOI 10.1128/IAI.01688-07; Hommais F, 2001, MOL MICROBIOL, V40, P20, DOI 10.1046/j.1365-2958.2001.02358.x; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Islam MS, 2011, MOL MICROBIOL, V79, P468, DOI 10.1111/j.1365-2958.2010.07460.x; Islam MS, 2011, THESIS U BIRMINGHAM; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; KEENLEYSIDE WJ, 1992, J BACTERIOL, V174, P8, DOI 10.1128/jb.174.1.8-16.1992; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; Lathem WW, 2004, J EXP MED, V199, P1077, DOI 10.1084/jem.20030255; Lee DJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-252; Leverton LQ, 2005, INFECT IMMUN, V73, P1034, DOI 10.1128/IAI.73.2.1034-1043.2005; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Mellies JL, 2011, MICROBIOL-SGM, V157, P1123, DOI 10.1099/mic.0.046094-0; Mellies JL, 2008, MICROBIOL-SGM, V154, P3624, DOI 10.1099/mic.0.2008/023382-0; Mellies JL, 2006, INFECT IMMUN, V74, P64, DOI 10.1128/IAI.74.1.64-72.2006; Mellies JL, 2001, INFECT IMMUN, V69, P315, DOI 10.1128/IAI.69.1.315-324.2001; Mellies JL, 1999, MOL MICROBIOL, V33, P296, DOI 10.1046/j.1365-2958.1999.01473.x; Mildiner-Earley S, 2006, INFECT IMMUN, V74, P4361, DOI 10.1128/IAI.00154-06; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Porter ME, 2005, J BACTERIOL, V187, P458, DOI 10.1128/JB.187.2.458-472.2005; Roe AJ, 2007, MICROBIOL-SGM, V153, P1350, DOI 10.1099/mic.0.2006/003707-0; Russell RM, 2007, J BACTERIOL, V189, P5387, DOI 10.1128/JB.00553-07; Salinger N, 2009, APPL ENVIRON MICROB, V75, P275, DOI 10.1128/AEM.01734-08; Sharma VK, 2004, J BACTERIOL, V186, P7290, DOI 10.1128/JB.186.21.7290-7301.2004; Spears KJ, 2006, FEMS MICROBIOL LETT, V255, P187, DOI 10.1111/j.1574-6968.2006.00119.x; Sperandio V, 2002, INFECT IMMUN, V70, P3085, DOI 10.1128/IAI.70.6.3085-3093.2002; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Tobe T, 1996, MOL MICROBIOL, V21, P963, DOI 10.1046/j.1365-2958.1996.531415.x; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Torres AG, 2007, J BACTERIOL, V189, P5916, DOI 10.1128/JB.00245-07; Tree JJ, 2009, TRENDS MICROBIOL, V17, P361, DOI 10.1016/j.tim.2009.06.001; Umanski T, 2002, MICROBIOL-SGM, V148, P2735, DOI 10.1099/00221287-148-9-2735; Vanaja SK, 2010, APPL ENVIRON MICROB, V76, P60, DOI 10.1128/AEM.01666-09; Vidal JE, 2006, INFECT IMMUN, V74, P2293, DOI 10.1128/IAI.74.4.2293-2303.2006; Wade JT, 2000, MOL MICROBIOL, V36, P223, DOI 10.1046/j.1365-2958.2000.01850.x; Wieler LH, 1997, FEMS MICROBIOL LETT, V156, P49, DOI 10.1016/S0378-1097(97)00403-5; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Xicohtencatl-Cortes J, 2010, J BIOL CHEM, V285, P32336, DOI 10.1074/jbc.M110.162248	60	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e80160	10.1371/journal.pone.0080160	http://dx.doi.org/10.1371/journal.pone.0080160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454682	Green Published, Green Accepted, gold			2022-12-25	WOS:000329925800003
J	Bordean, DM; Nica, DV; Harmanescu, M; Banatean-Dunea, I; Gergen, II				Bordean, Despina-Maria; Nica, Dragos V.; Harmanescu, Monica; Banatean-Dunea, Ionut; Gergen, Iosif I.			Soil Manganese Enrichment from Industrial Inputs: A Gastropod Perspective	PLOS ONE			English	Article							SNAIL HELIX-ASPERSA; METAL TRANSFER; GARDEN SNAIL; LAND SNAILS; HEAVY-METAL; TOXICITY; CADMIUM; GROWTH; LEAD; BIOAVAILABILITY	Manganese is one of the most abundant metal in natural environments and serves as an essential microelement for all living systems. However, the enrichment of soil with manganese resulting from industrial inputs may threaten terrestrial ecosystems. Several studies have demonstrated harmful effects of manganese exposure by cutaneous contact and/or by soil ingestion to a wide range of soil invertebrates. The link between soil manganese and land snails has never been made although these invertebrates routinely come in contact with the upper soil horizons through cutaneous contact, egg-laying, and feeding activities in soil. Therefore, we have investigated the direct transfer of manganese from soils to snails and assessed its toxicity at background concentrations in the soil. Juvenile Cantareus aspersus snails were caged under semi-field conditions and exposed first, for a period of 30 days, to a series of soil manganese concentrations, and then, for a second period of 30 days, to soils with higher manganese concentrations. Manganese levels were measured in the snail hepatopancreas, foot, and shell. The snail survival and shell growth were used to assess the lethal and sublethal effects of manganese exposure. The transfer of manganese from soil to snails occurred independently of food ingestion, but had no consistent effect on either the snail survival or shell growth. The hepatopancreas was the best biomarker of manganese exposure, whereas the shell did not serve as a long-term sink for this metal. The kinetics of manganese retention in the hepatopancreas of snails previously exposed to manganese-spiked soils was significantly influenced by a new exposure event. The results of this study reveal the importance of land snails for manganese cycling in terrestrial biotopes and suggest that the direct transfer from soils to snails should be considered when precisely assessing the impact of anthropogenic Mn releases on soil ecosystems.	[Bordean, Despina-Maria; Gergen, Iosif I.] Banats Univ Agr Sci & Vet Med Timisoara, Fac Food Proc Technol, Timisoara, Romania; [Nica, Dragos V.; Banatean-Dunea, Ionut] Banats Univ Agr Sci & Vet Med Timisoara, Fac Anim Sci & Biotechnol, Timisoara, Romania; [Harmanescu, Monica] Banats Univ Agr Sci & Vet Med Timisoara, Fac Agr, Timisoara, Romania	Banat University of Agricultural Sciences & Veterinary Medicine; Banat University of Agricultural Sciences & Veterinary Medicine; Banat University of Agricultural Sciences & Veterinary Medicine	Nica, DV (corresponding author), Banats Univ Agr Sci & Vet Med Timisoara, Fac Anim Sci & Biotechnol, Timisoara, Romania.	nicadragos@gmail.com	Harmanescu, Monica/AAQ-4906-2020; Bordean, Despina Maria/N-8613-2014; Gergen, Iosif I/O-3321-2014	Bordean, Despina Maria/0000-0002-1647-7992; Gergen, Iosif I/0000-0002-8144-1961	project Post-doctoral School Of Agriculture And Veterinary Medicine" [POSDRU/89/1.5/S/62371]; European Social Fund through the Sectorial Operational Programme for the Human Resources Development	project Post-doctoral School Of Agriculture And Veterinary Medicine"; European Social Fund through the Sectorial Operational Programme for the Human Resources Development	The present work was funded by the project "Post-doctoral School Of Agriculture And Veterinary Medicine POSDRU/89/1.5/S/62371'', co-financed by the European Social Fund through the Sectorial Operational Programme for the Human Resources Development 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway B.J., 2012, HEAVY METALS SOILS T, V22; ATSDR (Agency for Toxic Substances and Disease Registry), 2008, TOX PROF MA IN PRESS; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P293, DOI 10.1081/CLT-100102427; BEEBY A, 1989, ARCH ENVIRON CON TOX, V18, P623, DOI 10.1007/BF01055031; BERGER B, 1995, ENVIRON TOXICOL CHEM, V14, P781, DOI 10.1002/etc.5620140507; Bradley MD, 1996, BCPC SYMP SER, P353; Bura M, 2004, CRESTEREA MELCILOR A; CICAD, 2004, 63 CICAD WHO; Coeurdassier M, 2002, ECOTOX ENVIRON SAFE, V53, P425, DOI 10.1016/S0147-6513(02)00004-0; COPPOLINO ML, 2009, THESIS SO ILLINOIS U; DALLINGER R, 1993, SETAC SP P, P245; Dallinger R., 2001, P489, DOI 10.1079/9780851993188.0489; De Grisse A., 1996, Mededelingen Faculteit Landbouwkundige en Toegepaste Biologische Wetenschappen Universiteit Gent, V61, P129; Dahm KCD, 2006, COMP BIOCHEM PHYS C, V143, P316, DOI 10.1016/j.cbpc.2006.03.005; De Vaufleury A, 2006, ENVIRON TOXICOL CHEM, V25, P797, DOI 10.1897/04-560R.1; DECALVENTI IB, 1965, ANN NY ACAD SCI, V118, P1015; Elmslie LJ, 1998, J MOLLUS STUD, V64, P400, DOI 10.1093/mollus/64.3.400; GOMOT A, 1989, J MOLLUS STUD, V55, P1, DOI 10.1093/mollus/55.1.1-a; Gomot-De Vaufleury A, 2002, ENVIRON TOXICOL CHEM, V21, P820, DOI [10.1897/1551-5028(2002)021<0820:MFTAOC>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;0820:MFTAOC&gt;2.0.CO;2]; Gomot-De Vaufleury A, 2000, ENVIRON SCI TECHNOL, V34, P1865, DOI 10.1021/es9907212; HARTENSTEIN R, 1981, J ENVIRON QUAL, V10, P372, DOI 10.2134/jeq1981.00472425001000030026x; Heller J., 2001, P413, DOI 10.1079/9780851993188.0413; Itziou A, 2011, ARCH ENVIRON CON TOX, V60, P697, DOI 10.1007/s00244-010-9583-5; Kerney M.P., 1979, FIELD GUIDE LAND SNA; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Kuperman RG, 2004, ECOTOX ENVIRON SAFE, V57, P48, DOI 10.1016/j.ecoenv.2003.08.010; Laskowski R, 1996, ENVIRON POLLUT, V91, P289, DOI 10.1016/0269-7491(95)00070-4; Law NA, 1999, ADV INORG CHEM, V46, P305; Locher R, 2000, INVERTEBR REPROD DEV, V38, P53, DOI 10.1080/07924259.2000.9652436; Mensink PJ, 2011, J MOLLUS STUD, V77, P241, DOI 10.1093/mollus/eyr011; Menta C, 2001, ENVIRON POLLUT, V115, P205, DOI 10.1016/S0269-7491(01)00110-5; Millaleo R, 2010, J SOIL SCI PLANT NUT, V10, P476, DOI 10.4067/S0718-95162010000200008; Mourier B, 2011, CHEMOSPHERE, V85, P1057, DOI 10.1016/j.chemosphere.2011.07.035; Nica DV, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-145; Nica DV, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-55; Pauget B, 2012, SCI TOTAL ENVIRON, V431, P413, DOI 10.1016/j.scitotenv.2012.05.048; Pauget B, 2011, J HAZARD MATER, V192, P1804, DOI 10.1016/j.jhazmat.2011.07.016; Pihan F, 2000, ECOTOX ENVIRON SAFE, V46, P137, DOI 10.1006/eesa.1999.1891; Pinsino A, 2012, ENV CONTAMINATION, P17, DOI DOI 10.5772/31438; Post JE, 1999, P NATL ACAD SCI USA, V96, P3447, DOI 10.1073/pnas.96.7.3447; Rabitsch WB, 1996, B ENVIRON CONTAM TOX, V56, P734, DOI 10.1007/s001289900108; Regoli F, 2006, ENVIRON HEALTH PERSP, V114, P63, DOI 10.1289/ehp.8397; Salway J., 2012, MED BIOCH GLANCE; Singh A, 2012, B MATER SCI, V35, P1031, DOI 10.1007/s12034-012-0384-5; SPEEG KV, 1968, AM J PHYSIOL, V214, P1392; Tatara CP, 1998, AQUAT TOXICOL, V42, P255, DOI 10.1016/S0166-445X(97)00104-5; TAYLOR MG, 1988, PROC R SOC SER B-BIO, V234, P463, DOI 10.1098/rspb.1988.0059; WHO, 2004, WHOSDEWSH0304104REV1; WILLIAMSON P, 1980, OECOLOGIA, V44, P213, DOI 10.1007/BF00572682	49	10	10	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85384	10.1371/journal.pone.0085384	http://dx.doi.org/10.1371/journal.pone.0085384			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454856	Green Submitted, Green Published, gold			2022-12-25	WOS:000329925800044
J	Jung, K; Molinari, J; Kalko, EKV				Jung, Kirsten; Molinari, Jesus; Kalko, Elisabeth K. V.			Driving Factors for the Evolution of Species-Specific Echolocation Call Design in New World Free-Tailed Bats (Molossidae)	PLOS ONE			English	Article							AERIAL-HAWKING; MOLECULAR PHYLOGENY; INSECTIVOROUS BATS; EMBALLONURID BATS; SIGNAL-DESIGN; MORPHOLOGY; BEHAVIOR; VARIABILITY; CHIROPTERA; WINGBEAT	Phylogeny, ecology, and sensorial constraints are thought to be the most important factors influencing echolocation call design in bats. The Molossidae is a diverse bat family with a majority of species restricted to tropical and subtropical regions. Most molossids are specialized to forage for insects in open space, and thus share similar navigational challenges. We use an unprecedented dataset on the echolocation calls of 8 genera and 18 species of New World molossids to explore how habitat, phylogenetic relatedness, body mass, and prey perception contribute to echolocation call design. Our results confirm that, with the exception of the genus Molossops, echolocation calls of these bats show a typical design for open space foraging. Two lines of evidence point to echolocation call structure of molossids reflecting phylogenetic relatedness. First, such structure is significantly more similar within than among genera. Second, except for allometric scaling, such structure is nearly the same in congeneric species. Despite contrasting body masses, 12 of 18 species call within a relatively narrow frequency range of 20 to 35 kHz, a finding that we explain by using a modeling approach whose results suggest this frequency range to be an adaptation optimizing prey perception in open space. To conclude, we argue that the high variability in echolocation call design of molossids is an advanced evolutionary trait allowing the flexible adjustment of echolocation systems to various sensorial challenges, while conserving sender identity for social communication. Unraveling evolutionary drivers for echolocation call design in bats has so far been hampered by the lack of adequate model organisms sharing a phylogenetic origin and facing similar sensorial challenges. We thus believe that knowledge of the echolocation call diversity of New World molossid bats may prove to be landmark to understand the evolution and functionality of species-specific signal design in bats.	[Jung, Kirsten; Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Molinari, Jesus] Univ Los Andes, Fac Ciencias, Dept Biol, Merida 5101, Venezuela; [Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama	Ulm University; University of Los Andes Venezuela; Smithsonian Institution; Smithsonian Tropical Research Institute	Jung, K (corresponding author), Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany.	kirsten.jung@uni-ulm.de	caputo, carlo/N-3747-2014	Molinari, Jesus/0000-0002-9393-5483	German Academic Exchange Program (DAAD); DFG Schwerpunktprogramm; International Foundation for Science (Sweden) [B/2637]	German Academic Exchange Program (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); DFG Schwerpunktprogramm(German Research Foundation (DFG)); International Foundation for Science (Sweden)(International Foundation for Science)	This work has partly been funded by the German Academic Exchange Program (DAAD) with a PhD-scholarship to K. Jung. Field work of E. Kalko was financed by the DFG Schwerpunktprogramm "Mechanismen der Aufrechterhaltung tropischer Diversitat". Field work by J. Molinari in Venezuela was partly funded by project B/2637 of the International Foundation for Science (Sweden). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE HDJN, 1987, J ANIM ECOL, V56, P763, DOI 10.2307/4947; Ammerman LK, 2012, J MAMMAL, V93, P12, DOI 10.1644/11-MAMM-A-103.1; Barquez RM, 2013, MAMMALIA, V77, P119, DOI 10.1515/mammalia-2012-0053; Bogdanowicz W, 1999, J ZOOL, V247, P381, DOI 10.1111/j.1469-7998.1999.tb01001.x; Dangles O, 2009, Q REV BIOL, V84, P51, DOI 10.1086/596463; Dechmann DKN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009012; Denzinger A., 2004, ECHOLOCATION BATS DO, P311; Denzinger A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00164; Freeman P.W., 1981, FIELDIANA ZOOL CHICA, V7, P1, DOI DOI 10.5962/BHL.TITLE.3128; Gillam EH, 2007, CAN J ZOOL, V85, P795, DOI 10.1139/Z07-060; Gillam EH, 2007, ANIM BEHAV, V74, P277, DOI 10.1016/j.anbehav.2006.12.006; Gillam EH, 2009, BEHAV ECOL SOCIOBIOL, V64, P69, DOI 10.1007/s00265-009-0819-1; Guillen-Servent A, 2007, BEHAV ECOL SOCIOBIOL, V61, P1599, DOI 10.1007/s00265-007-0392-4; HELLER KG, 1989, OECOLOGIA, V80, P178, DOI 10.1007/BF00380148; Holderied MW, 2008, INTEGR COMP BIOL, V48, P74, DOI 10.1093/icb/icn035; Holderied MW, 2005, J EXP BIOL, V208, P1321, DOI 10.1242/jeb.01528; Holderied MW, 2003, P ROY SOC B-BIOL SCI, V270, P2293, DOI 10.1098/rspb.2003.2487; Jakobsen L, 2013, NATURE, V493, P93, DOI 10.1038/nature11664; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jones G, 1999, J EXP BIOL, V202, P3359; JONES G, 1994, FUNCT ECOL, V8, P450, DOI 10.2307/2390068; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Jung K, 2007, J ZOOL, V272, P125, DOI 10.1111/j.1469-7998.2006.00250.x; Kalko EKV, 2008, INTEGR COMP BIOL, V48, P60, DOI 10.1093/icb/icn030; Kingston T, 2004, NATURE, V429, P654, DOI 10.1038/nature02487; Kingston T, 2003, J MAMMAL, V84, P205, DOI 10.1644/1545-1542(2003)084<0205:AOECIS>2.0.CO;2; Knornschild M, 2012, P ROY SOC B-BIOL SCI, V279, P4827, DOI 10.1098/rspb.2012.1995; Lim BK, 2008, J MAMM EVOL, V15, P79, DOI 10.1007/s10914-007-9068-0; Macswiney G. M. C., 2006, REV MEXICANA MASTOZO, V10, P102; Mohl B., 1988, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, P435; Mora EC, 2004, J COMP PHYSIOL A, V190, P561, DOI 10.1007/s00359-004-0519-2; Mora EC, 2011, ACTA CHIROPTEROL, V13, P179, DOI 10.3161/150811011X578723; NEUWEILER G, 1984, NATURWISSENSCHAFTEN, V71, P446, DOI 10.1007/BF00455897; NEUWEILER G, 1989, TRENDS ECOL EVOL, V4, P160, DOI 10.1016/0169-5347(89)90120-1; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Peters SL, 2002, J MAMMAL, V83, P1097, DOI 10.1644/1545-1542(2002)083<1097:SODFBC>2.0.CO;2; PYE JD, 1979, ENDEAVOUR, V3, P57, DOI 10.1016/0160-9327(79)90067-X; Ruczynski I, 2007, J EXP BIOL, V210, P3607, DOI 10.1242/jeb.009837; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; Safi K, 2010, EVOL ECOL, V24, P703, DOI 10.1007/s10682-009-9326-0; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Schuchmann M, 2010, AM NAT, V176, P72, DOI 10.1086/652993; Simmons NB, 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Sparks DW, 2003, SOUTHWEST NAT, V48, P132, DOI 10.1894/0038-4909(2003)048<0132:FHONMA>2.0.CO;2; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Ubernickel K, 2013, ETHOLOGY, V119, P66, DOI 10.1111/eth.12038; Ulanovsky N, 2004, P ROY SOC B-BIOL SCI, V271, P1467, DOI 10.1098/rspb.2004.2750; Voigt CC, 2012, J COMP PHYSIOL B, V182, P415, DOI 10.1007/s00360-011-0627-6; Voigt-Heucke SL, 2010, ANIM BEHAV, V80, P59, DOI 10.1016/j.anbehav.2010.03.025; WILKINS K T, 1989, Mammalian Species, P1, DOI 10.2307/3504148; Yovel Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000400	54	69	81	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85279	10.1371/journal.pone.0085279	http://dx.doi.org/10.1371/journal.pone.0085279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454833	Green Published, Green Submitted, gold			2022-12-25	WOS:000329925800033
J	Terletzky, P; Ramsey, RD				Terletzky, Pat; Ramsey, Robert Douglas			A Semi-Automated Single Day Image Differencing Technique to Identify Animals in Aerial Imagery	PLOS ONE			English	Article							OBSERVER VARIABILITY; SIGHTABILITY MODEL; COUNTS; ABUNDANCE; PHOTOGRAPHS; ACCURACY; WALRUSES; SVALBARD; SEALS; PUPS	Our research presents a proof-of-concept that explores a new and innovative method to identify large animals in aerial imagery with single day image differencing. We acquired two aerial images of eight fenced pastures and conducted a principal component analysis of each image. We then subtracted the first principal component of the two pasture images followed by heuristic thresholding to generate polygons. The number of polygons represented the number of potential cattle (Bos taurus) and horses (Equus caballus) in the pasture. The process was considered semi-automated because we were not able to automate the identification of spatial or spectral thresholding values. Imagery was acquired concurrently with ground counts of animal numbers. Across the eight pastures, 82% of the animals were correctly identified, mean percent commission was 53%, and mean percent omission was 18%. The high commission error was due to small mis-alignments generated from image-to-image registration, misidentified shadows, and grouping behavior of animals. The high probability of correctly identifying animals suggests short time interval image differencing could provide a new technique to enumerate wild ungulates occupying grassland ecosystems, especially in isolated or difficult to access areas. To our knowledge, this was the first attempt to use standard change detection techniques to identify and enumerate large ungulates.	[Terletzky, Pat; Ramsey, Robert Douglas] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Terletzky, P (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	pat.terletzky@usu.edu			Ecology Center at Utah State University; Remote Sensing and GIS laboratory at Utah State University; Utah Division of Wildlife Resources	Ecology Center at Utah State University; Remote Sensing and GIS laboratory at Utah State University; Utah Division of Wildlife Resources	The research was funded by the Ecology Center and the Remote Sensing and GIS laboratory at Utah State University and the Utah Division of Wildlife Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agarwal C, 2002, NE297 USDA NE RES ST; Anderson CR, 1996, WILDLIFE SOC B, V24, P247; BAYLISS P, 1989, J APPL ECOL, V26, P925, DOI 10.2307/2403702; Bernatas S, 2004, WILDLIFE SOC B, V32, P638, DOI 10.2193/0091-7648(2004)032[0638:SMFCBS]2.0.CO;2; Brockett BH, 2002, S AFR J WILDL RES, V32, P121; Cai B, 1999, P 17 BIENN WORKSH CO, P231; CHAVEZ PS, 1989, PHOTOGRAMM ENG REM S, V55, P339; Coudray N, 2010, PATTERN RECOGN LETT, V31, P1010, DOI 10.1016/j.patrec.2009.12.025; Couturier S., 1994, P 6 N AM CAR WORKSH, V1994, P283; DEYOUNG CA, 1985, WILDLIFE SOC B, V13, P146; Easson G, 2010, REMOTE SENS-BASEL, V2, P1331, DOI 10.3390/rs2051331; Endsley M.R, 1996, HUM FAC TRANSP, V20, P163; ERWIN RM, 1982, J FIELD ORNITHOL, V53, P159; Fleming PJS, 2008, WILDLIFE RES, V35, P258, DOI 10.1071/WR07081; Freddy DJ, 2004, WILDLIFE SOC B, V32, P916, DOI 10.2193/0091-7648(2004)032[0916:HMMDAT]2.0.CO;2; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; GILMER DS, 1988, WILDLIFE SOC B, V16, P204; HARRIS MP, 1977, BRIT BIRDS, V70, P200; Heide-Jorgensen MP, 2004, MAR MAMMAL SCI, V20, P246, DOI 10.1111/j.1748-7692.2004.tb01154.x; Hess S. C., 2002, THESIS MONTANA STATE; HIBY AR, 1988, PHOTOGRAMM REC, V12, P589; Huang CQ, 2002, REMOTE SENS ENVIRON, V80, P203, DOI [10.1016/S0034-4257(01)00298-X, 10.1016/S0034-4257(02)00068-8]; Jachmann H, 2002, J APPL ECOL, V39, P841, DOI 10.1046/j.1365-2664.2002.00752.x; Jensen J. R., 2005, INTRO DIGITAL IMAGE; Koski W. R., 2010, Journal of Cetacean Research and Management, V11, P89; Krafft BA, 2006, MAR MAMMAL SCI, V22, P394, DOI 10.1111/j.1748-7692.2006.00035.x; Laliberte AS, 2003, WILDLIFE SOC B, V31, P362; Laube P, 2005, INT J GEOGR INF SCI, V19, P639, DOI 10.1080/13658810500105572; Linklater WL, 2002, WILDLIFE RES, V29, P221, DOI 10.1071/WR01063; Lowry MS, 1999, MAR MAMMAL SCI, V15, P143, DOI 10.1111/j.1748-7692.1999.tb00786.x; Lu D, 2004, INT J REMOTE SENS, V25, P2365, DOI 10.1080/0143116031000139863; Lu D, 2005, INT J REMOTE SENS, V26, P101, DOI 10.1080/01431160410001720748; Lubow BC, 2009, J WILDLIFE MANAGE, V73, P1420, DOI 10.2193/2008-538; Lydersen C, 2008, ARCTIC, V61, P119; Martinez B, 2009, REMOTE SENS ENVIRON, V113, P1823, DOI 10.1016/j.rse.2009.04.016; Medina-Carnicer R, 2010, PATTERN RECOGN, V43, P1224, DOI 10.1016/j.patcog.2009.10.019; Moller A.L., 2008, UTAH CLIMATE; NEALE CMU, 1994, REMOTE SENS ENVIRON, V49, P187, DOI 10.1016/0034-4257(94)90014-0; Patil R., 2004, 2004 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS) (IEEE Cat. No.04CH37566), P1323; Rivest LP, 1998, BIOMETRICS, V54, P865, DOI 10.2307/2533841; Rosin PL, 2005, INT J REMOTE SENS, V26, P1075, DOI 10.1080/01431160512331330481; Russ J. C., 2006, IMAGE PROCESSING HDB; Russell J, 1994, 6 N AM CAR WORKSH PR, P319; SINCLAIR A R E, 1973, East African Wildlife Journal, V11, P93; Skelsey C, 2004, PHOTOGRAMM ENG REM S, V70, P341, DOI 10.14358/PERS.70.3.341; Snyder GM, 2001, MAR MAMMAL SCI, V17, P136, DOI 10.1111/j.1748-7692.2001.tb00984.x; Song DZ, 2010, IEEE T IMAGE PROCESS, V19, P2321, DOI 10.1109/TIP.2010.2048151; Stow D, 2002, ANAL MULTITEMPORAL R, V2, P59; Terletzky P., 2013, THESIS UTAH STATE U; TRIVEDI MM, 1982, PHOTOGRAMM ENG REM S, V48, P1879; Udevitz MS, 2005, MAR MAMMAL SCI, V21, P108, DOI 10.1111/j.1748-7692.2005.tb01211.x; Walter V, 2011, ISPRS J PHOTOGRAMM, V66, P519, DOI 10.1016/j.isprsjprs.2011.02.010; Williams B. K., 2002, ANAL MANAGEMENT ANIM; WOLFE ML, 1989, J WILDLIFE MANAGE, V53, P593, DOI 10.2307/3809181; WYATT CL, 1985, PHOTOGRAMM ENG REM S, V51, P245; Young Robert F., 1999, Journal of Cetacean Research and Management, V1, P279	57	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85239	10.1371/journal.pone.0085239	http://dx.doi.org/10.1371/journal.pone.0085239			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454827	Green Published, Green Submitted, gold			2022-12-25	WOS:000329925800029
J	Fulton, EA; Smith, ADM; Smith, DC; Johnson, P				Fulton, Elizabeth A.; Smith, Anthony D. M.; Smith, David C.; Johnson, Penelope			An Integrated Approach Is Needed for Ecosystem Based Fisheries Management: Insights from Ecosystem-Level Management Strategy Evaluation	PLOS ONE			English	Article							MANAGING FISHERIES; STOCK ASSESSMENT; CATCH SHARES; MARINE; LESSONS; CONSEQUENCES; BENEFITS; BEHAVIOR; IMPACT; FISH	An ecosystem approach is widely seen as a desirable goal for fisheries management but there is little consensus on what strategies or measures are needed to achieve it. Management strategy evaluation (MSE) is a tool that has been widely used to develop and test single species fisheries management strategies and is now being extended to support ecosystem based fisheries management (EBFM). We describe the application of MSE to investigate alternative strategies for achieving EBFM goals for a complex multispecies fishery in southeastern Australia. The study was undertaken as part of a stakeholder driven process to review and improve the ecological, economic and social performance of the fishery. An integrated management strategy, involving combinations of measures including quotas, gear controls and spatial management, performed best against a wide range of objectives and this strategy was subsequently adopted in the fishery, leading to marked improvements in performance. Although particular to one fishery, the conclusion that an integrated package of measures outperforms single focus measures we argue is likely to apply widely in fisheries that aim to achieve EBFM goals.	[Fulton, Elizabeth A.; Smith, Anthony D. M.; Smith, David C.] Commonwealth Sci & Ind Res Org, Wealth Oceans Flagship, Hobart, Tas, Australia; [Johnson, Penelope] Australian Bur Stat, Rural Environm & Agr Stat Branch, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Fulton, EA (corresponding author), Commonwealth Sci & Ind Res Org, Wealth Oceans Flagship, Hobart, Tas, Australia.	beth.fulton@csiro.au	Fulton, Beth/AAJ-1398-2021; Fulton, Beth/A-2871-2008	Fulton, Beth/0000-0002-5904-7917; Fulton, Beth/0000-0002-5904-7917	Fisheries Research and Development Corporation (FRDC); CSIRO	Fisheries Research and Development Corporation (FRDC)(Fisheries R&D Corp); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was funded by the Fisheries Research and Development Corporation (FRDC) and CSIRO on behalf of the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Branch T, 2008, FISH FISH, V9, P1, DOI DOI 10.1111/J.1467-2979.2007.00266.X; Branch TA, 2006, CAN J FISH AQUAT SCI, V63, P1647, DOI 10.1139/F06-072; Brown K, 2008, ECOL ECON, V37, P417; CATON A, 2004, FISHERY STATUS REPOR; Charles A. T., 2001, SUSTAINABLE FISHERY; Chu C, 2009, FISH FISH, V10, P217, DOI 10.1111/j.1467-2979.2008.00313.x; Constable A, 2001, CCAMLR SCI, V8, P37; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; Dinmore TA, 2003, ICES J MAR SCI, V60, P371, DOI 10.1016/S1054-3139(03)00010-9; DIXON JA, 1993, OCEANUS, V36, P35; Essington TE, 2012, CONSERV LETT, V5, P186, DOI 10.1111/j.1755-263X.2012.00226.x; Fulton E. A., 2005, ECOLOGICAL INDICATOR; Fulton EA, 2007, ALTERNATIVE MANAGEME; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Fulton EA, 2011, FISH FISH, V12, P2, DOI 10.1111/j.1467-2979.2010.00371.x; Garcia SM, 2012, SCIENCE, V335, P1045, DOI 10.1126/science.1214594; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Grafton RQ, 2008, MAR POLICY, V32, P630, DOI 10.1016/j.marpol.2007.11.003; Grafton RQ, 2006, CAN J FISH AQUAT SCI, V63, P699, DOI 10.1139/f05-247; Grafton RQ, 2005, EEN0505 AUSTR NAT U; Hilborn R, 2007, AMBIO, V36, P296, DOI 10.1579/0044-7447(2007)36[296:MTSBLF]2.0.CO;2; Hilborn R, 2007, MAR POLICY, V31, P153, DOI 10.1016/j.marpol.2006.05.014; Kaiser MJ, 2005, CAN J FISH AQUAT SCI, V62, P1194, DOI 10.1139/F05-056; Le Quesne WJF, 2009, ICES J MAR SCI, V66, P132, DOI 10.1093/icesjms/fsn201; Maurstad A, 2000, HUM ORGAN, V59, P37, DOI 10.17730/humo.59.1.q0242m112x223862; McLeod K., 2009, ECOSYSTEM BASED MANA; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; *PEW OC COMM, 2003, AM LIV OC CHART COUR; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Polacheck T, 2008, 023 CSIRO MAR ATM; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Rice J, 2011, FISH FISH, V12, P209, DOI 10.1111/j.1467-2979.2011.00416.x; Roberts CM, 1997, TRENDS ECOL EVOL, V12, P35, DOI 10.1016/S0169-5347(96)20109-0; Rudd MA, 2002, COAST MANAGE, V30, P133, DOI 10.1080/089207502753504670; Sainsbury K, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P343, DOI 10.1079/9780851996332.0343; Smith A., 2004, ALTERNATIVE MANAGEME; Smith ADM, 2007, ICES J MAR SCI, V64, P633, DOI 10.1093/icesjms/fsm041; Smith ADM, 1999, ICES J MAR SCI, V56, P967, DOI 10.1006/jmsc.1999.0540; Smith ADM, 2001, MAR FRESHWATER RES, V52, P353, DOI 10.1071/MF01029; Smith ADM, 2008, FISH RES, V94, P373, DOI 10.1016/j.fishres.2008.06.006; Walters C, 1996, REV FISH BIOL FISHER, V6, P125; Ward T, 2002, POLICY PROPOSALS OPE, P80; Weninger Q, 2000, CAN J ECON, V33, P394, DOI 10.1111/0008-4085.00021; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	46	182	182	5	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84242	10.1371/journal.pone.0084242	http://dx.doi.org/10.1371/journal.pone.0084242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454722	Green Submitted, Green Published, gold			2022-12-25	WOS:000329922500008
J	Suckling, DM; Sforza, RFH				Suckling, David Maxwell; Sforza, Rene Francois Henri			What Magnitude Are Observed Non-Target Impacts from Weed Biocontrol?	PLOS ONE			English	Article							CLASSICAL BIOLOGICAL-CONTROL; CACTOBLASTIS-CACTORUM LEPIDOPTERA; FIELD HOST-RANGE; INVASIVE ALIEN PLANTS; GORSE POD MOTH; NEW-ZEALAND; TRICHOSIROCALUS-HORRIDUS; RISK-ASSESSMENT; COLEOPTERA; INSECTS	A systematic review focused by plant on non-target impacts from agents deliberately introduced for the biological control of weeds found significant non-target impacts to be rare. The magnitude of direct impact of 43 biocontrol agents on 140 non-target plants was retrospectively categorized using a risk management framework for ecological impacts of invasive species (minimal, minor, moderate, major, massive). The vast majority of agents introduced for classical biological control of weeds (>99% of 512 agents released) have had no known significant adverse effects on non-target plants thus far; major effects suppressing non-target plant populations could be expected to be detectable. Most direct non-target impacts on plants (91.6%) were categorized as minimal or minor in magnitude with no known adverse long-term impact on non-target plant populations, but a few cacti and thistles are affected at moderate (n = 3), major (n = 7) to massive (n = 1) scale. The largest direct impacts are from two agents (Cactoblastis cactorum on native cacti and Rhinocyllus conicus on native thistles), but these introductions would not be permitted today as more balanced attitudes exist to plant biodiversity, driven by both society and the scientific community. Our analysis shows (as far as is known), weed biological control agents have a biosafety track record of >99% of cases avoiding significant non-target impacts on plant populations. Some impacts could have been overlooked, but this seems unlikely to change the basic distribution of very limited adverse effects. Fewer nontarget impacts can be expected in future because of improved science and incorporation of wider values. Failure to use biological control represents a significant opportunity cost from the certainty of ongoing adverse impacts from invasive weeds. It is recommended that a simple five-step scale be used to better communicate the risk of consequences from both action (classical biological control) and no action (ongoing impacts from invasive weeds).	[Suckling, David Maxwell] New Zealand Inst Plant & Food Res Ltd, Biosecur Grp, Christchurch, New Zealand; [Suckling, David Maxwell] Better Border Biosecur, Christchurch, New Zealand; [Sforza, Rene Francois Henri] USDA ARS, European Biol Control Lab, Montferrier Sur Lez, France	New Zealand Institute for Plant & Food Research Ltd	Suckling, DM (corresponding author), New Zealand Inst Plant & Food Res Ltd, Biosecur Grp, Christchurch, New Zealand.	Max.Suckling@plantandfood.co.nz	Suckling, David M/F-7005-2010; Suckling, David Maxwell/M-7730-2019	Suckling, David M/0000-0001-7216-9348; Suckling, David Maxwell/0000-0001-7216-9348; sforza, Rene/0000-0002-1737-2033	New Zealand Ministry of Business, Innovation and Employment [CO2X0501]; Organisation for Economic Cooperation and Development (Cooperative Research Programme: Biological Resource Management for Sustainable Agricultural Systems) at the European Biological Control Laboratory (USDA ARS), Montpellier	New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Organisation for Economic Cooperation and Development (Cooperative Research Programme: Biological Resource Management for Sustainable Agricultural Systems) at the European Biological Control Laboratory (USDA ARS), Montpellier	This project was partially funded by the New Zealand Ministry of Business, Innovation and Employment (CO2X0501 Better Border Biosecurity, www.b3nz.org), and completed during a fellowship to DMS supported by the Organisation for Economic Cooperation and Development (Cooperative Research Programme: Biological Resource Management for Sustainable Agricultural Systems) at the European Biological Control Laboratory (USDA ARS), Montpellier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres L. A., 1985, Proceedings of the VI International Symposium on Biological Control of Weeds., P235; APHIS, 2012, TECHN ADV GROUP BIOL; Barton J, 2004, BIOL CONTROL, V31, P99, DOI 10.1016/j.biocontrol.2004.04.008; Bourdot GW, 2007, NEW ZEAL J AGR RES, V50, P139, DOI 10.1080/00288230709510288; Briese DT, 2004, AUST J ENTOMOL, V43, P304, DOI 10.1111/j.1326-6756.2004.00442.x; Callaway RM, 1999, ECOLOGY, V80, P1196, DOI 10.1890/0012-9658(1999)080[1196:BCHMIC]2.0.CO;2; CAMPBELL CL, 1991, ENVIRON ENTOMOL, V20, P303, DOI 10.1093/ee/20.1.303; Clewley GD, 2012, J APPL ECOL, V49, P1287, DOI 10.1111/j.1365-2664.2012.02209.x; Corcket E, 2013, INTERACTIONS INSECTS, P443; Coulson JR, 2000, 110 YEARS BIOL CONTR; CRC, 2001, COOP RES CTR CRC WEE, P27; Cronk Q.C.B., 1995, PLANT INVADERS, V79, P313, DOI DOI 10.1023/A:1017152906274; De Clerck-Floate Rosemarie, 2011, P291; Denslow JS, 2005, BIOL CONTROL, V35, P307, DOI 10.1016/j.biocontrol.2005.02.008; DODD ALAN P., 1940; Dodge G, 2005, APPENDICES COLONIZAT; EPA, 2012, BIOL CONTR AG APPR U; EPA, 2011, DEC MAK TECHN GUID I; Ferguson CM, 2007, BCANZ BIOL CONTROL A; Fowler S. V., 2010, 17th Australasian weeds conference. New frontiers in New Zealand: together we can beat the weeds. Christchurch, New Zealand, 26-30 September, 2010, P211; Fowler SV, 2006, ECOL STU AN, V186, P355; Fowler SV, 2012, J APPL ECOL, V49, P307, DOI 10.1111/j.1365-2664.2011.02106.x; Fowler SV, 2000, AUSTRAL ECOL, V25, P553, DOI 10.1046/j.1442-9993.2000.01075.x; Gaskin JF, 2011, BIOL CONTROL, V58, P1, DOI 10.1016/j.biocontrol.2011.03.015; Gassmann A, 2001, EVALUATING INDIRECT ECOLOGICAL EFFECTS OF BIOLOGICAL CONTROL, P147, DOI 10.1079/9780851994536.0147; Gerard P. J., 2006, New Zealand Plant Protection, V59, P285; GREATHEAD D. J., 1968, PANS (C), V14, P167; Groenteman R, 2011, BIOL CONTROL, V57, P50, DOI 10.1016/j.biocontrol.2011.01.005; Habeck DH, 1990, 333 FLOR DEP AGR CON; Havens K, 2012, BIOL CONSERV, V155, P202, DOI 10.1016/j.biocon.2012.06.010; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.ecolsys.21.1.243; JAYANTH KP, 1993, B ENTOMOL RES, V83, P595, DOI 10.1017/S0007485300040013; Jezorek HA, 2010, ENVIRON ENTOMOL, V39, P1884, DOI 10.1603/EN10022; Johnson DM, 1998, FLA ENTOMOL, V81, P12, DOI 10.2307/3495992; Julien M. H., 1998, BIOL CONTROL WEEDS W; Julien M, 2012, BIOLOGICAL CONTROL OF WEEDS IN AUSTRALIA, P518; Klein H, 2011, AFR ENTOMOL, V19, P515, DOI 10.4001/003.019.0214; Lawton J. H., 1990, FRI Bulletin, P3; Le Bourgeois T, 2011, P 13 INT S BIOC WEED; Louda SM, 2003, CONSERV BIOL, V17, P73, DOI 10.1046/j.1523-1739.2003.02020.x; Louda SM, 2005, BIOL CONTROL, V35, P253, DOI 10.1016/j.biocontrol.2005.07.022; Louda SM, 1997, SCIENCE, V277, P1088, DOI 10.1126/science.277.5329.1088; Mantyla E, 2011, OECOLOGIA, V165, P143, DOI 10.1007/s00442-010-1774-2; McCullough DG, 2006, BIOL INVASIONS, V8, P611, DOI 10.1007/s10530-005-1798-4; McFadyen R. E. C., 2012, Pakistan Journal of Weed Science Research, V18, P333; McFadyen REC, 1998, ANNU REV ENTOMOL, V43, P369, DOI 10.1146/annurev.ento.43.1.369; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Nordblum T, 2001, COOPERATIVE RES CTR, P35; Page AR, 2006, TECHNICAL SERIES CRC, V10; Palmer WA, 2010, BIOL CONTROL, V52, P271, DOI 10.1016/j.biocontrol.2009.07.011; Palmer W. A., 2004, Weed management: balancing people, planet, profit. 14th Australian Weeds Conference, Wagga Wagga, New South Wales, Australia, 6-9 September 2004: papers and proceedings, P341; Paraiso O, 2011, FLA ENTOMOL, V94, P81, DOI 10.1653/024.094.0111; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Paxton EH, 2011, CONDOR, V113, P255, DOI 10.1525/cond.2011.090226; Paynter Q, 2008, BIOL CONTROL, V46, P453, DOI 10.1016/j.biocontrol.2008.05.004; Paynter QE, 2004, N Z PLANT PROTECT-SE, P102, DOI 10.30843/nzpp.2004.57.6979; Paynter Q, 2008, BIOL CONTROL, V44, P248, DOI 10.1016/j.biocontrol.2007.08.003; Pearson DE, 2003, TRENDS ECOL EVOL, V18, P456, DOI 10.1016/S0169-5347(03)00188-5; Pearson DE, 2008, ECOL APPL, V18, P1489, DOI 10.1890/07-1789.1; Pemberton RW, 2007, BIOL CONTROL, V41, P272, DOI 10.1016/j.biocontrol.2007.02.002; Pemberton RW, 2000, OECOLOGIA, V125, P489, DOI 10.1007/s004420000477; PEMBERTON RW, 1990, ENTOMOPHAGA, V35, P71, DOI 10.1007/BF02374303; PIMENTEL D, 1992, BIOSCIENCE, V42, P750, DOI 10.2307/1311994; Pratt PD, 2009, BIOL CONTROL, V49, P146, DOI 10.1016/j.biocontrol.2009.01.014; Shaw RH, 2011, WEED RES, V51, P552, DOI 10.1111/j.1365-3180.2011.00880.x; SHEPPARD AW, 2003, BIOCONTROL NEWS INFO, V24, P91; Simberloff D, 1996, ECOLOGY, V77, P1965, DOI 10.2307/2265693; Simberloff D, 2012, BIOCONTROL, V57, P263, DOI 10.1007/s10526-011-9392-4; Sogge MK, 2008, RESTOR ECOL, V16, P146, DOI 10.1111/j.1526-100X.2008.00357.x; Stephens AEA, 2007, AUST J ENTOMOL, V46, P152, DOI 10.1111/j.1440-6055.2007.00571.x; Suckling DM, 2013, BIOL CONTROL, V66, P27, DOI 10.1016/j.biocontrol.2013.02.009; Suckling DM, 2013, AGR ENTOMOL EARLY VI, DOI [10.1111/afe.12028, DOI 10.1111/AFE.12028]; Takahashi M, 2009, ENVIRON ENTOMOL, V38, P731, DOI 10.1603/022.038.0325; Tryon H, 1910, QUEENSLAND AGR J, V25, P188; TURNER CE, 1987, ENVIRON ENTOMOL, V16, P111, DOI 10.1093/ee/16.1.111; Van Lenteren JC, 2003, BIOCONTROL, V48, P3, DOI 10.1023/A:1021262931608; van Wilgen BW, 2004, S AFR J SCI, V100, P113; Waipara N. W., 2009, New Zealand Plant Protection, V62, P41; WAPSHERE AJ, 1974, ANN APPL BIOL, V77, P201, DOI 10.1111/j.1744-7348.1974.tb06886.x; Wiggins GJ, 2009, BIOCONTROL SCI TECHN, V19, P993, DOI 10.1080/09583150903191343; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Willis AJ, 2003, CRC AUST WEED MANAGE, P35; Willis AJ, 1998, AUST J BOT, V46, P707, DOI 10.1071/BT97025; Withers Toni M., 2008, New Zealand Entomologist, V31, P67; Zimmermann H. G., 2000, Diversity and Distributions, V6, P259, DOI 10.1046/j.1472-4642.2000.00088.x; Zimmermann HG, 2004, CACTOBLASTIS CACTORU	86	89	90	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84847	10.1371/journal.pone.0084847	http://dx.doi.org/10.1371/journal.pone.0084847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454755	Green Published, gold			2022-12-25	WOS:000329922500023
J	Wang, XW; Han, XP; Wang, BH				Wang, Xiang-Wen; Han, Xiao-Pu; Wang, Bing-Hong			Correlations and Scaling Laws in Human Mobility	PLOS ONE			English	Article							MODEL	Background: In recent years, several path-breaking findings on human mobility patterns point out a novel issue which is of important theoretical significance and great application prospects. The empirical analysis of the data which can reflect the real-world human mobility provides the basic cognition and verification of the theoretical models and predictive results on human mobility. One of the most noticeable findings in previous studies on human mobility is the wide-spread scaling anomalies, e. g. the power-law-like displacement distributions. Understanding the origin of these scaling anomalies is of central importance to this issue and therefore is the focus of our discussion. Methodology/Principal Findings: In this paper, we empirically analyze the real-world human movements which are based on GPS records, and observe rich scaling properties in the temporal-spatial patterns as well as an abnormal transition in the speed-displacement patterns together with an evidence to the real-world traffic jams. In addition, we notice that the displacements at the population level show a significant positive correlation, indicating a cascading-like nature in human movements. Furthermore, our analysis at the individual level finds that the displacement distributions of users with stronger correlations usually are closer to the power law, suggesting a correlation between the positive correlation of the displacement series and the form of an individual's displacement distribution. Conclusions/Significance: These empirical findings make connections between the two basic properties of human mobility, the scaling anomalies on displacement distributions and the positive correlations on displacement series, implying the cascading-like dynamics which is exhibited by the positive correlations would cause the emergence of scaling properties on human mobility patterns. Our findings would inspire further researches on mechanisms and predictions of human mobility.	[Wang, Xiang-Wen; Han, Xiao-Pu] Hangzhou Normal Univ, Alibaba Res Ctr Complex Sci, Hangzhou, Zhejiang, Peoples R China; [Wang, Xiang-Wen] Virginia Polytech Inst & State Univ, Dept Phys, Blacksburg, VA 24061 USA; [Wang, Xiang-Wen; Wang, Bing-Hong] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China; [Wang, Bing-Hong] Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou, Peoples R China; [Wang, Bing-Hong] Shanghai Univ Sci & Technol, Res Ctr Complex Syst Sci, Shanghai 201800, Peoples R China	Hangzhou Normal University; Virginia Polytechnic Institute & State University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Wenzhou University; University of Shanghai for Science & Technology	Han, XP (corresponding author), Hangzhou Normal Univ, Alibaba Res Ctr Complex Sci, Hangzhou, Zhejiang, Peoples R China.	xp@hznu.edu.cn	Wang, Xiangwen/AAR-6326-2021; Han, Xiao-Pu/E-8401-2010	Wang, Xiangwen/0000-0002-4755-4639	National Natural Science Foundation of China [11205040, 11105024, 70971089, 10635040]; Zhejiang Provincial Natural Science Foundation of China [LY12A05003]; start-up foundation and Pandeng project of Hangzhou Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); start-up foundation and Pandeng project of Hangzhou Normal University	This work was supported by the National Natural Science Foundation of China Grants Nos. 11205040, 11105024, 70971089 and 10635040. XPH acknowledges the Zhejiang Provincial Natural Science Foundation of China (Grant No. LY12A05003), the start-up foundation and Pandeng project of Hangzhou Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan D, 2011, NAT PHYS, V7, P581, DOI 10.1038/NPHYS1944; Bazzani A, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/05/P05001; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Clements M., ARXIV11065213; Feder J, 1988, FRACTALS PHYS SOLIDS; Gallotti R, 2013, INT J MOD PHYS C, V24, DOI 10.1142/S0129183113920010; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Han XP, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036117; Horner MW., 2001, J TRANSP GEOGR, V9, P255, DOI DOI 10.1016/S0966-6923(01)00019-9; Jia T, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/11/P11024; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Lee K, 2009, IEEE INFOCOM SER, P855, DOI 10.1109/INFCOM.2009.5061995; Liang X, 2012, PHYSICA A, V391, P2135, DOI 10.1016/j.physa.2011.11.035; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Ni SJ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016111; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Petrovskii S, 2011, P NATL ACAD SCI USA, V108, P8704, DOI 10.1073/pnas.1015208108; Rhee I., 2008, IEEE INFOCOM, V9, P630; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Rybski D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00560; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; Scellato S, 2011, P 17 ACM SIGKDD INT, P1046, DOI DOI 10.1145/2020408.2020575; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Song CM, 2010, SCIENCE, V327, P1018, DOI 10.1126/science.1177170; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Veneziano D, ARXIV11013719; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021197; Yan XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02678; Yan XY, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/12/120506; Yu Z., 2010, IEEE DATA ENG B, V33, P32; Zheng Y., 2009, P 18 INT C WORLD WID, P791, DOI DOI 10.1145/1526709.1526816; Zheng Y, 2008, PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING (UBICOMP 2008), P312, DOI 10.1145/1409635.1409677	37	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84954	10.1371/journal.pone.0084954	http://dx.doi.org/10.1371/journal.pone.0084954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454769	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500027
J	Kwon, SK; Kim, HB; Song, JJ; Cho, CG; Park, SW; Choi, JS; Ryu, J; Oh, SH; Lee, JH				Kwon, Seong Keun; Kim, Hee-Bok; Song, Jae-Jun; Cho, Chang Gun; Park, Seok-Won; Choi, Jong-Sun; Ryu, Junsun; Oh, Se Heang; Lee, Jin Ho			Vocal Fold Augmentation with Injectable Polycaprolactone Microspheres/Pluronic F127 Hydrogel: Long-Term In Vivo Study for the Treatment of Glottal Insufficiency	PLOS ONE			English	Article							INJECTION LARYNGOPLASTY; INTRAPERITONEAL BARRIER; COLLAGEN INJECTION; CELL CARRIER; PREVENTION; PARALYSIS; SCAFFOLDS; VIBRATION; ADHESION; COMPLICATIONS	There is increasing demand for reconstruction of glottal insufficiency. Several injection materials have been examined for this purpose, but all had limitations, such as poor long-term durability, migration from the injection site, inflammation, granuloma formation, and interference with vocal fold vibration due to viscoelastic mismatch. Here, we developed a novel injection material, consisting of polycaprolactone (PCL) microspheres, which exhibits better viscoelasticity than conventional materials, and Pluronic F127 carrier, which decreases the migration of the injection materials. The material was injected into rabbits with glottal insufficiency and compared with the FDA-approved injection material, calcium hydroxylapatite (CaHA). Endoscopic and histological examinations indicated that PCL/Pluronic F127 remained at the injection site with no inflammatory response or granuloma formation, whereas CaHA leaked out and migrated from the injection site. Therefore, vocal fold augmentation was almost completely retained during the 12-month follow-up period in this study. Moreover, induced phonation and high-speed recording of vocal fold vibration showed decreased vocal fold gap area in the PCL/Pluronic F127 group. Our newly developed injection material, PCL/Pluronic F127, permits efficient augmentation of paralyzed vocal fold without complications, a concept that can be applied clinically, as demonstrated by the successful long-term follow-up.	[Kwon, Seong Keun] Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul 110744, South Korea; [Kwon, Seong Keun] Canc Res Inst, Seoul, South Korea; [Kwon, Seong Keun] Seoul Natl Univ, Med Res Ctr, Seoul, South Korea; [Kim, Hee-Bok; Song, Jae-Jun; Cho, Chang Gun; Park, Seok-Won] Dongguk Univ, Ilsan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Goyang, South Korea; [Choi, Jong-Sun] Dongguk Univ, Ilsan Hosp, Dept Pathol, Goyang, South Korea; [Ryu, Junsun] Natl Canc Ctr, Head & Neck Oncol Clin, Goyang, South Korea; [Oh, Se Heang] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; [Oh, Se Heang] Dankook Univ, WCU Res Ctr, Cheonan, South Korea; [Lee, Jin Ho] Hannam Univ, Dept Adv Mat, Taejon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Dongguk University; NHIS Ilsan Hospital; Dongguk University; NHIS Ilsan Hospital; National Cancer Center - Korea (NCC); Dankook University; Dankook University; Hannam University	Kwon, SK (corresponding author), Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul 110744, South Korea.	otolarynx@snuh.org		Ryu, Junsun/0000-0002-6730-6755	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [NRF-2011-0014024]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2011-0014024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TD, 2004, J VOICE, V18, P392, DOI 10.1016/j.jvoice.2002.04.001; BENNINGER MS, 1994, OTOLARYNG HEAD NECK, V111, P497; BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033; BLESS DM, 1987, EAR NOSE THROAT J, V66, P48; Bruening W, 1911, VERH DTSCH LARYNG, V18, P23; Carroll TL, 2011, LARYNGOSCOPE, V121, P313, DOI 10.1002/lary.21258; Chheda NN, 2008, LARYNGOSCOPE, V118, P2260, DOI 10.1097/MLG.0b013e318184e6ee; Chodara AM, 2012, LARYNGOSCOPE, V122, P58, DOI 10.1002/lary.22324; Courey MS, 2004, OTOLARYNG CLIN N AM, V37, P121, DOI 10.1016/j.otc.2003.12.002; DeFatta RA, 2012, J VOICE, V26, P614, DOI 10.1016/j.jvoice.2011.08.005; Deliyski DD, 2008, FOLIA PHONIATR LOGO, V60, P33, DOI 10.1159/000111802; Deliyski DD, 2010, CURR OPIN OTOLARYNGO, V18, P147, DOI 10.1097/MOO.0b013e3283395dd4; Dursun G, 2008, AM J OTOLARYNG, V29, P7, DOI 10.1016/j.amjoto.2006.12.001; Eshraghi S, 2010, ACTA BIOMATER, V6, P2467, DOI 10.1016/j.actbio.2010.02.002; FORD CN, 1995, LARYNGOSCOPE, V105, P944, DOI 10.1288/00005537-199509000-00014; Havas TE, 2003, ANZ J SURG, V73, P938, DOI 10.1046/j.1445-2197.2003.02824.x; HIRANO M, 1995, ACTA OTO-LARYNGOL, V115, P553, DOI 10.3109/00016489509139366; Katori Y, 2013, CLIN ANAT, V26, P204, DOI 10.1002/ca.22088; Kimura M, 2010, ANN OTO RHINOL LARYN, V119, P359, DOI 10.1177/000348941011900601; Kwon SK, 2013, LARYNGOSCOPE, V123, P1694, DOI 10.1002/lary.23879; Kwon TK, 2010, LARYNGOSCOPE, V120, P326, DOI 10.1002/lary.20749; LEACH RE, 1990, AM J OBSTET GYNECOL, V162, P1317, DOI 10.1016/0002-9378(90)90044-8; Lim JY, 2008, EUR ARCH OTO-RHINO-L, V265, P321, DOI 10.1007/s00405-007-0458-y; Lim SM, 2009, J BIOMED MATER RES B, V90B, P521, DOI 10.1002/jbm.b.31313; Liu GJ, 2011, OPT EXPRESS, V19, P11880, DOI 10.1364/OE.19.011880; Mallur PS, 2010, CLIN EXP OTORHINOLAR, V3, P177, DOI 10.3342/ceo.2010.3.4.177; Mau T, 2012, LARYNGOSCOPE, V122, P2005, DOI 10.1002/lary.23451; Mergell P, 2000, J ACOUST SOC AM, V108, P2996, DOI 10.1121/1.1314398; MIKUS JL, 1995, LARYNGOSCOPE, V105, P17, DOI 10.1288/00005537-199501000-00007; Oh SH, 2005, J BIOMED MATER RES A, V72A, P306, DOI 10.1002/jbm.a.30239; Patel R, 2008, ANN OTO RHINOL LARYN, V117, P413, DOI 10.1177/000348940811700603; Rana RS, 2011, RADIOL CLIN N AM, V49, P165, DOI 10.1016/j.rcl.2010.07.013; REICH AR, 1978, J SPEECH HEAR DISORD, V43, P496, DOI 10.1044/jshd.4304.496; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Rihkanen H, 2004, EUR ARCH OTO-RHINO-L, V261, P177, DOI 10.1007/s00405-003-0642-7; Rontal E, 2003, J VOICE, V17, P434, DOI 10.1067/S0892-1997(03)00020-1; Rosen CA, 2007, OTOLARYNG HEAD NECK, V136, P198, DOI 10.1016/j.otohns.2006.07.014; Schwarz R, 2006, IEEE T BIO-MED ENG, V53, P1099, DOI 10.1109/TBME.2006.873396; Senuma Y, 2000, BIOMATERIALS, V21, P1135, DOI 10.1016/S0142-9612(99)00276-8; Shaw HS, 2008, J VOICE, V22, P23, DOI 10.1016/j.jvoice.2006.08.006; STEINLEITNER A, 1991, OBSTET GYNECOL, V77, P48; STEINLEITNER A, 1992, FERTIL STERIL, V57, P305; Suckow MA BD, 2002, BIOL DIS RABBITS, P329; Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019; Wittenberg T, 2000, J VOICE, V14, P422, DOI 10.1016/S0892-1997(00)80087-9; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645; 권택균, 2006, [Korean Journal of Otorhinolaryngology Head and Neck Surgery, 대한이비인후과학회지 두경부외과학], V49, P768	47	15	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85512	10.1371/journal.pone.0085512	http://dx.doi.org/10.1371/journal.pone.0085512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465582	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100044
J	Cobo, T; Jacobsson, B; Kacerovsky, M; Hougaard, DM; Skogstrand, K; Gratacos, E; Palacio, M				Cobo, Teresa; Jacobsson, Bo; Kacerovsky, Marian; Hougaard, David M.; Skogstrand, Kristin; Gratacos, Eduard; Palacio, Montse			Systemic and Local Inflammatory Response in Women with Preterm Prelabor Rupture of Membranes	PLOS ONE			English	Article							MICROBIAL INVASION; AMNIOTIC-FLUID; INTRAAMNIOTIC INFLAMMATION; CLINICAL-SIGNIFICANCE; SWEDISH POPULATION; CYTOKINE RESPONSE; PREMATURE RUPTURE; LABOR; IDENTIFICATION; INFECTION	Objective: To evaluate the inflammatory pattern in maternal circulation, amniotic cavity, cervix and vagina from women with preterm prelabor rupture of membranes (PPROM) considering the occurrence of microbial invasion of the amniotic cavity (MIAC). Methodology: A prospective study was performed in 58 women with PPROM before 34+0 weeks of gestational age. Twenty-six proteins were analyzed by a multiple immunoassay in samples of amniotic fluid, serum, cervix and vagina. Association of an inflammatory response in the invasive and non-invasive samples with MIAC was investigated. Results: The rate of MIAC was 36.2% (21/58). Both amniotic fluid IL-6 and cervical C-reactive protein (CRP) showed to be independent predictors of MIAC. A cut-off level of cervical CRP >= 1836 pg/mL showed a detection rate of 75%, false positive rate of 19% and positive and negative predictive values to predict MIAC of 67% and 87%, respectively. There were no independent biomarkers of MIAC either in the serum or vaginal compartment. Conclusion: A cervical inflammatory response mediated by CRP was observed in PPROM women with MIAC. Evaluation of serum or vaginal samples did not add valuable information regarding the outcome evaluated.	[Cobo, Teresa; Gratacos, Eduard; Palacio, Montse] Univ Barcelona, Maternal Fetal Med Dept, ICGON, Hosp Clin, Barcelona, Spain; [Cobo, Teresa; Gratacos, Eduard; Palacio, Montse] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Fetal & Perinatal Med Res Grp, Barcelona, Spain; [Cobo, Teresa; Gratacos, Eduard; Palacio, Montse] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Jacobsson, Bo] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden; [Jacobsson, Bo] Inst Publ Hlth, Oslo, Norway; [Kacerovsky, Marian] Univ Hosp Hradec Kralove, Dept Obstet & Gynecol, Hradec Kralove, Czech Republic; [Hougaard, David M.; Skogstrand, Kristin] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Sahlgrenska University Hospital; University Hospital Hradec Kralove; Statens Serum Institut	Cobo, T (corresponding author), Univ Barcelona, Maternal Fetal Med Dept, ICGON, Hosp Clin, Barcelona, Spain.	tcobo@clinic.ub.es	Gratacos, Eduard/AAR-4939-2020; Kacerovsky, Marian/ABE-3437-2020; Hougaard, David/AAD-6368-2019; Jacobsson, Bo/O-8007-2014; Kacerovsky, Marian/A-7586-2011; Cobo, Teresa/K-2770-2017	Gratacos, Eduard/0000-0002-7405-7224; Jacobsson, Bo/0000-0001-5079-2374; Skogstrand, Kristin/0000-0002-0026-3711; Kacerovsky, Marian/0000-0001-9858-7900; Cobo, Teresa/0000-0003-3130-1829; Palacio, Montse/0000-0002-5869-4629	Instituto de Salud Carlos III in Spain [CM09/00213]; Spanish government [FIS PI10/01308]	Instituto de Salud Carlos III in Spain(Instituto de Salud Carlos III); Spanish government(Spanish GovernmentEuropean Commission)	This work was supported by a Rio Hortega grant from Instituto de Salud Carlos III in Spain (CM09/00213) and grants from Spanish government (FIS PI10/01308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins-Obstetrics, 2007, OBSTET GYNECOL, V109, P1007, DOI DOI 10.1097/01.AOG.0000263888.69178.1F; Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018; Buhimschi CS, 2007, PEDIATR RES, V61, P318, DOI 10.1203/01.pdr.0000252439.48564.37; Buhimschi IA, 2005, BJOG-INT J OBSTET GY, V112, P173, DOI 10.1111/j.1471-0528.2004.00340.x; Cobo T, 2013, ACTA OBSTET GYN SCAN, V92, P61, DOI 10.1111/aogs.12028; Cobo T, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.050; Cobo T, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.036; GIBBS RS, 1982, J INFECT DIS, V145, P1, DOI 10.1093/infdis/145.1.1; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Hitti J, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.037; Holst RM, 2011, BJOG-INT J OBSTET GY, V118, P240, DOI 10.1111/j.1471-0528.2010.02765.x; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P423, DOI 10.1034/j.1600-0412.2003.00157.x; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P120, DOI 10.1080/j.1600-0412.2003.00047.x; Jun JK, 2000, AM J OBSTET GYNECOL, V183, P868, DOI 10.1067/mob.2000.109034; Rizzo G, 1996, AM J OBSTET GYNECOL, V175, P812, DOI 10.1016/S0002-9378(96)80004-4; Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680	17	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85277	10.1371/journal.pone.0085277	http://dx.doi.org/10.1371/journal.pone.0085277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465522	Green Published, gold			2022-12-25	WOS:000330244500048
J	Cristaldo, PF; DeSouza, O; Krasulova, J; Jirosova, A; Kutalova, K; Lima, ER; Sobotnik, J; Sillam-Dusses, D				Cristaldo, Paulo Fellipe; DeSouza, Og; Krasulova, Jana; Jirosova, Anna; Kutalova, Katerina; Lima, Eraldo Rodrigues; Sobotnik, Jan; Sillam-Dusses, David			Mutual Use of Trail-Following Chemical Cues by a Termite Host and Its Inquiline	PLOS ONE			English	Article							CONSTRICTOTERMES-CYPHERGASTER TERMITIDAE; NORTHEASTERN BRAZIL; SOCIAL PARASITISM; ISOPTERA; NASUTITERMITINAE; PHEROMONE; RHINOTERMITIDAE; IDENTIFICATION; USURPATION; EVOLUTION	Termite nests are often secondarily inhabited by other termite species (= inquilines) that cohabit with the host. To understand this association, we studied the trail-following behaviour in two Neotropical species, Constrictotermes cyphergaster (Termitidae: Nasutitermitinae) and its obligatory inquiline, Inquilinitermes microcerus (Termitidae: Termitinae). Using behavioural experiments and chemical analyses, we determined that the trail-following pheromone of C. cyphergaster is made of neocembrene and (3Z, 6Z, 8E)-dodeca-3,6,8-trien-1-ol. Although no specific compound was identified in I. microcerus, workers were able to follow the above compounds in behavioural bioassays. Interestingly, in choice tests, C. cyphergaster prefers conspecific over heterospecific trails while I. microcerus shows the converse behaviour. In no-choice tests with whole body extracts, C. cyphergaster showed no preference for, while I. microcerus clearly avoided heterospecific trails. This seems to agree with the hypothesis that trail-following pheromones may shape the cohabitation of C. cyphergaster and I. microcerus and reinforce the idea that their cohabitation is based on conflict-avoiding strategies.	[Cristaldo, Paulo Fellipe; DeSouza, Og; Lima, Eraldo Rodrigues] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Cristaldo, Paulo Fellipe; Krasulova, Jana; Jirosova, Anna; Kutalova, Katerina; Sobotnik, Jan] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Krasulova, Jana; Kutalova, Katerina] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Sobotnik, Jan] Czech Univ Life Sci, Fac Forestry & Wood Sci, Prague, Czech Republic; [Sillam-Dusses, David] Inst Rech Dev, Unite Mixte Rech Biogeochim & Ecol Milieux Contin, Bondy, France; [Sillam-Dusses, David] Univ Paris 13, Sorbonne Paris Cite, Equipe Accueil 4443, Lab Ethol Expt & Comparee, F-93430 Villetaneuse, France	Universidade Federal de Vicosa; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague; Czech University of Life Sciences Prague; Institut de Recherche pour le Developpement (IRD); Universite Paris 13	Krasulova, J (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic.	krasulova@uochb.cas.cz	Lima, Eraldo R/B-6675-2008; Krasulova, Jana/G-8107-2014; DeSouza, Og/A-7140-2008; Jirosova, Anna/G-5697-2014; Sillam-Dussès, David/AAI-5942-2021; Lima, Eraldo R/S-9585-2018; Cristaldo, Paulo/A-1247-2013	Lima, Eraldo R/0000-0003-4446-5435; DeSouza, Og/0000-0002-7108-0242; Jirosova, Anna/0000-0002-5054-5821; Cristaldo, Paulo/0000-0003-4939-0487; Sobotnik, Jan/0000-0002-8581-637X; Sillam-Dusses, David/0000-0001-5027-8703	Brazilian National Council for Research (CNPq) [140085/2010-6, 302486/2010-0, PQ-2, 200271/2010]; Coordination for the Improvement of Higher Education Personnel (CAPES) [PDSE 9669/11-6]; Minas Gerais State Foundation for Research Support (FAPEMIG) [CRA-APQ-02124-09, CRA-APQ-01519-11, BPV-00055-11]; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic [RVO: 61388963]; Internal Grant Agency of Faculty of Forestry and Wood Sciences (Specific research of the Czech University of Life Sciences) [20134359]	Brazilian National Council for Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Minas Gerais State Foundation for Research Support (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Internal Grant Agency of Faculty of Forestry and Wood Sciences (Specific research of the Czech University of Life Sciences)	The Brazilian National Council for Research (CNPq) provided financial support to the following coauthors: PFC (doctoral grant 140085/2010-6), ODS (fellowship 302486/2010-0, PQ-2 and grant 200271/2010). The Coordination for the Improvement of Higher Education Personnel (CAPES) supported PFC (PDSE 9669/11-6). The Minas Gerais State Foundation for Research Support (FAPEMIG) funded significant parts of field and lab work through grants CRA-APQ-02124-09, CRA-APQ-01519-11, and BPV-00055-11. This research was also supported by the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic (RVO: 61388963). JS thanks to project 20134359 of Internal Grant Agency of Faculty of Forestry and Wood Sciences (Specific research of the Czech University of Life Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T., 1987, P125; Bordereau C, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P279, DOI 10.1007/978-90-481-3977-4_11; Bourguignon T, 2011, ECOL ENTOMOL, V36, P261, DOI 10.1111/j.1365-2311.2011.01265.x; Buschinger A, 2009, MYRMECOL NEWS, V12, P219; Crawley MJ., 2007, R BOOK; Cristaldo PF, 2012, INSECT SOC, V59, P541, DOI 10.1007/s00040-012-0249-3; da Cunha HF, 2003, SOCIOBIOLOGY, V42, P761; Moura FMD, 2006, SOCIOBIOLOGY, V48, P21; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Dejean A, 1996, OECOLOGIA, V106, P57, DOI 10.1007/BF00334407; Engel MS, 2009, AM MUS NOVIT, P1, DOI 10.1206/651.1; Fiegna F, 2003, P ROY SOC B-BIOL SCI, V270, P1527, DOI 10.1098/rspb.2003.2387; Florencio DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066535; Grasse P.P., 1986, TERMITOLOGIA, VI; Grasse PP, 1951, ANN PSYCHOL, V50, P273; Hanus R, 2012, CHEM SENSES, V37, P55, DOI 10.1093/chemse/bjr065; HARRIS RN, 1995, ANIM BEHAV, V50, P1309, DOI 10.1016/0003-3472(95)80046-8; Hines HM, 2010, INSECT SOC, V57, P379, DOI 10.1007/s00040-010-0094-1; HOWARD RW, 1980, ANN ENTOMOL SOC AM, V73, P36, DOI 10.1093/aesa/73.1.36; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Jones Clara B., 2005, Mastozool. neotrop., V12, P19; Kilner RM, 2011, BIOL REV, V86, P836, DOI 10.1111/j.1469-185X.2010.00173.x; Kistner D.H., 1979, P339; Kotoklo EA, 2010, SOCIOBIOLOGY, V55, P579; Kronland WJ, 2007, WILSON J ORNITHOL, V119, P486, DOI 10.1676/05-139.1; Legendre F, 2008, MOL PHYLOGENET EVOL, V48, P615, DOI 10.1016/j.ympev.2008.04.017; LEONARDO AMC, 1990, INT J INSECT MORPHOL, V19, P61, DOI 10.1016/0020-7322(90)90030-S; Lo N, 2004, INSECT SOC, V51, P365, DOI 10.1007/s00040-004-0759-8; Mathews A. G. A., 1977, STUDIES TERMITES MAT; Menzel F, 2010, ECOL ENTOMOL, V35, P495, DOI 10.1111/j.1365-2311.2010.01206.x; Moura FMS, 2006, INSECT SOC, V53, P472, DOI 10.1007/s00040-005-0899-0; Noirot C., 1970, P73; Ollerton J, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P411; Ortolani I, 2008, ETHOLOGY, V114, P782, DOI 10.1111/j.1439-0310.2008.01525.x; Pasteels Jacques M., 1998, P193; R Development Core Team, 2012, R LANG ENV STAT COMP; REDFORD KH, 1984, OECOLOGIA, V65, P145, DOI 10.1007/BF00384477; Rupf T, 2008, NATURWISSENSCHAFTEN, V95, P811, DOI 10.1007/s00114-008-0387-7; Shellman-Reeve Janet S., 1997, P52; Sillam-Dusses D, 2005, CHEMOECOLOGY, V15, P1, DOI 10.1007/s00049-005-0285-9; Sillam-Dusses D, 2007, J CHEM ECOL, V33, P1960, DOI 10.1007/s10886-007-9363-5; Sillam-Dusses D, 2010, BIOCHEM RES TRENDS, P39; Sillam-Dusses D, 2010, BIOL J LINN SOC, V99, P20, DOI 10.1111/j.1095-8312.2009.01348.x; Sillam-Dusses D, 2009, CHEMOECOLOGY, V19, P103, DOI 10.1007/s00049-009-0017-7; Sillam-Dusses D, 2009, J INSECT PHYSIOL, V55, P751, DOI 10.1016/j.jinsphys.2009.04.007; Sobotnik J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015761; Souto L, 2000, SOCIOBIOLOGY, V35, P367; STUART AM, 1961, NATURE, V189, P419, DOI 10.1038/189419a0; Traniello JFA, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P141; Tsuneoka Y, 2008, J ETHOL, V26, P243, DOI 10.1007/s10164-007-0055-y; Vasconcellos A, 2007, NEOTROP ENTOMOL, V36, P693, DOI 10.1590/S1519-566X2007000500009; Wilson E.O., 1975, P1	53	32	33	3	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85315	10.1371/journal.pone.0085315	http://dx.doi.org/10.1371/journal.pone.0085315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465533	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500053
J	Fischer, V; Bardet, N; Guiomar, M; Godefroit, P				Fischer, Valentin; Bardet, Nathalie; Guiomar, Myette; Godefroit, Pascal			High Diversity in Cretaceous Ichthyosaurs from Europe Prior to Their Extinction	PLOS ONE			English	Article							JURASSIC MARINE REPTILES; DE-HAUTE-PROVENCE; NEUQUEN BASIN; PLATYPTERYGIUS-AUSTRALIS; LITHOGRAPHIC LIMESTONES; FRANCE; RECORD; GENUS; OPHTHALMOSAURIDAE; REDESCRIPTION	Background: Ichthyosaurs are reptiles that inhabited the marine realm during most of the Mesozoic. Their Cretaceous representatives have traditionally been considered as the last survivors of a group declining since the Jurassic. Recently, however, an unexpected diversity has been described in Upper Jurassic-Lower Cretaceous deposits, but is widely spread across time and space, giving small clues on the adaptive potential and ecosystem control of the last ichthyosaurs. The famous but little studied English Gault Formation and 'greensands' deposits (the Upper Greensand Formation and the Cambridge Greensand Member of the Lower Chalk Formation) offer an unprecedented opportunity to investigate this topic, containing thousands of ichthyosaur remains spanning the Early-Late Cretaceous boundary. Methodology/Principal Findings: To assess the diversity of the ichthyosaur assemblage from these sedimentary bodies, we recognized morphotypes within each type of bones. We grouped these morphotypes together, when possible, by using articulated specimens from the same formations and from new localities in the Vocontian Basin (France); a revised taxonomic scheme is proposed. We recognize the following taxa in the 'greensands': the platypterygiines 'Platypterygius' sp. and Sisteronia seeleyi gen. et sp. nov., indeterminate ophthalmosaurines and the rare incertae sedis Cetarthrosaurus walkeri. The taxonomic diversity of late Albian ichthyosaurs now matches that of older, well-known intervals such as the Toarcian or the Tithonian. Contrasting tooth shapes and wear patterns suggest that these ichthyosaurs colonized three distinct feeding guilds, despite the presence of numerous plesiosaur taxa. Conclusion/Significance: Western Europe was a diversity hot-spot for ichthyosaurs a few million years prior to their final extinction. By contrast, the low diversity in Australia and U.S.A. suggests strong geographical disparities in the diversity pattern of Albian-early Cenomanian ichthyosaurs. This provides a whole new context to investigate the extinction of these successful marine reptiles, at the end of the Cenomanian.	[Fischer, Valentin] Univ Liege, Dept Geol, Liege, Belgium; [Fischer, Valentin; Godefroit, Pascal] Royal Belgian Inst Nat Sci, Brussels, Belgium; [Bardet, Nathalie] Museum Natl Hist Nat, CNRS, UMR 7207, Dept Hist Terre, Paris, France; [Guiomar, Myette] Reserve Nat Geol Haute Provence, Digne Les Bains, France	University of Liege; Royal Belgian Institute of Natural Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Fischer, V (corresponding author), Univ Liege, Dept Geol, Liege, Belgium.	v.fischer@ulg.ac.be	BARDET, Nathalie/N-8670-2019; Bardet, Nathalie/I-3805-2015	Fischer, Valentin/0000-0002-8808-6747; Bardet, Nathalie/0000-0001-7881-7107	national research fund of Belgium	national research fund of Belgium	VF is an aspirant of the F.R.S.-FNRS. This a PhD thesis grant from the national research fund of Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACCARIE H, 1995, CR ACAD SCI II, V320, P327; Adams T.L., 2011, PALAEONTOL ELECTRON, V14; Amedro F, 2008, CARNETS GEOL, V02, P5; Amedro F, 2008, NOTEBOOKS GEOLOGY ME; Andrews CW., 1910, DESCRIPTIVE CATALOGU; APPLEBY R. M., 1961, PROC ZOOL SOC LONDON, V137, P333; APPLEBY R. M., 1956, PROC ZOOL SOC LONDON, V126, P403; Araujo Ricardo, 2008, Irish Journal of Earth Sciences, V26, P17; Arkhangelsky M.S., 2000, PALEONTOL J, V34, P549; Arkhangelsky M.S., 2001, PALEONTOL J+, V35, P521; Arkhangelsky MS, 1997, PALEONTOL ZH, P87; Arkhangelsky MS., 1998, PALEONTOLOGICAL J, V32, P192; Arkhangelsky MS., 2001, PALEONTOL J, V35, P629; Bardet N, 2000, J PALEONTOL, V74, P503, DOI 10.1666/0022-3360(2000)074<0503:ANIFTU>2.0.CO;2; BARDET N, 1990, GEOBIOS-LYON, V23, P169, DOI 10.1016/S0016-6995(06)80049-5; BARDET N, 1992, TERRA NOVA, V4, P649, DOI 10.1111/j.1365-3121.1992.tb00614.x; Bardet N, 1989, MEMOIRES SOC ACAD BO, V6; Bardet Nathalie, 1995, Palaeovertebrata (Montpellier), V24, P177; Bardet Nathalie, 1994, Historical Biology, V7, P313; Barrett PM, 2002, CRETACEOUS RES, V23, P231, DOI 10.1006/cres.2002.0312; Baur G., 1887, American Naturalist, Vxxi, P837; Benson RBJ, 2011, GEOL SOC SPEC PUBL, V358, P191, DOI 10.1144/SP358.13; Benson RBJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031838; Benson RBJ, 2011, PALAEONTOLOGY, V54, P547, DOI 10.1111/j.1475-4983.2011.01044.x; Billon-Bruyat JP, 2005, PALAEOGEOGR PALAEOCL, V216, P359, DOI 10.1016/j.palaeo.2004.11.011; Blain H-A, 2003, ECHOS FALAISES, V7, P35; BLAINVILLE H. D. dE, 1835, NOUV ANN MUS HIST NA, V4, P233; Breheret J.-G., 1997, PUBL SOC GEOL NORD, V25, P614; Breton G, 2011, GEODIVERSITAS, V33, P279, DOI 10.5252/g2011n2a5; Broili Ferdinand, 1907, Palaeontographica Stuttgart, V54; Buchy Marie-Céline, 2009, Bol. Soc. Geol. Mex, V61, P233; Buchy MC, 2010, J PALEONTOL, V84, P149; Buffetaut Eric, 1994, Geobios Memoire Special (Villeurbanne), V16, P259; Butler RJ, 2012, EVOLUTION, V66, P147, DOI 10.1111/j.1558-5646.2011.01415.x; Butler RJ, 2009, PALEOBIOLOGY, V35, P432, DOI 10.1666/0094-8373-35.3.432; Carter A. M., 1846, REPORTS BRIT ASS ADV, V15, P60; Carter J, 1846, LONDON GEOLOGICAL J, V1; Cookson I. C., 1964, Palaeontology, V1, P37; Delair J.B., 1972, Wiltshire Archaeol Nat Hist Mag (Nat Hist), V67, P12; Delair JB, 1960, P DORSET NATURAL HIS, V81, P59; Druckenmiller PS, 2010, CAN J EARTH SCI, V47, P1037, DOI 10.1139/E10-028; Efimov, 1999, PALEONTOL J, V33, P174; Efimov V.M., 1999, Paleontologicheskii Zhurnal, V1, P92; Efimov V.M., 1997, PALEONTOL J+, V31, P422; Efimov VM, 1998, PALEONTOL ZH, P82; Ensom PC, 2009, CRETACEOUS RES, V30, P699, DOI 10.1016/j.cretres.2008.12.005; Fernandez M, 2005, J VERTEBR PALEONTOL, V25, P583, DOI 10.1671/0272-4634(2005)025[0583:ROPHVH]2.0.CO;2; Fernandez M, 2007, J PALEONTOL, V81, P368, DOI 10.1666/0022-3360(2007)81[368:RAPPOC]2.0.CO;2; Fernandez Marta, 2007, P271; Fernandez MS, 2012, GEOBIOS-LYON, V45, P535, DOI 10.1016/j.geobios.2012.02.001; Fernandez MS, 1997, J PALEONTOL, V71, P479, DOI 10.1017/S0022336000039494; Fischer V, 2011, CRETACEOUS RES, V32, P155, DOI 10.1016/j.cretres.2010.11.005; Fischer V, J VERTEBRATE PALEONT; Fischer V, 2013, ORIGIN BIODIVERSITY; Fischer V, GEOLOGICAL IN PRESS; Fischer V, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0021; Fischer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029234; Fischer V, 2011, J VERTEBR PALEONTOL, V31, P1010, DOI 10.1080/02724634.2011.595464; Fischer V, 2012, ACTA PALAEONTOL POL, V57, P123, DOI 10.4202/app.2011.0007; Fischer V, 2011, NEUES JAHRB GEOL P-A, V261, P111, DOI 10.1127/0077-7749/2011/0155; Fv Huene, 1922, ICHTHYOSAURIER LIAS; Gasparini Z, 2005, GEOL SOC SPEC PUBL, V252, P279, DOI 10.1144/GSL.SP.2005.252.01.14; GASPARINI Z, 1988, Ameghiniana, V25, P3; Gasparini Z, 1995, 2 INT S LITH LIM LEI, P81; Godefroit P, 1996, B SOC BELG GEOL, V104, P67; Godefroit Pascal, 1993, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V63, P25; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Herrle JO, 2003, CRETACEOUS RES, V24, P1, DOI 10.1016/S0195-6671(03)00023-5; Hopson, 2005, BRIT GEOLOGICAL SURV; Hopson P.M., 2008, BRIT GEOLOGICAL SURV; JOHNSON R, 1977, CAN J EARTH SCI, V14, P1916, DOI 10.1139/e77-162; Juignet P., 1974, STRATOTYPE CENOMANIE, P810; Kear BP, 2005, ZOOL J LINN SOC-LOND, V145, P583, DOI 10.1111/j.1096-3642.2005.00199.x; Kear BP, 2003, P ROY SOC B-BIOL SCI, V270, pS206, DOI 10.1098/rsbl.2003.0050; Kear BP, 2001, ALCHERINGA, V25, P387, DOI 10.1080/03115510108619228; Kear BP, 2003, CRETACEOUS RES, V24, P277, DOI 10.1016/S0195-6671(03)00046-6; Kear BP, 2013, GEOLOGICAL IN PRESS; Kennedy WJ, 2000, CRETACEOUS RES, V21, P591, DOI 10.1006/cres.2000.0223; Kiprijanoff W., 1881, MEMOIRES ACAD IMPERI, V28, P1; Kirton A.M., 1983, REV BRIT UPPER JURAS; Kolb C, 2009, PALAEONTOGR ABT A, V288, P151; Kuhn O., 1946, Ber naturf Ges Ramburg, V29, P69; Kuhnt Wolfgang, 2007, Carnets de Geologie, P1; Lehmann J, 2009, CRETACEOUS RES, V30, P895, DOI 10.1016/j.cretres.2009.02.002; Lingham-Soliar T, 2003, NEUES JAHRB GEOL P-A, V228, P421; Lydekker R., 1888, GEOLOGICAL MAGAZINE, V5, P309, DOI DOI 10.1017/S0016756800181968; Lydekker R, 1889, CATALOGUE FOSSIL REP; Maisch Michael W., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V209, P47; Maisch Michael W., 2001, Geologica et Palaeontologica, V35, P145; Maisch Michael W., 2008, Palaeodiversity, P227; Maisch Michael W., 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V298, P1; Mannion PD, 2011, BIOL REV, V86, P157, DOI 10.1111/j.1469-185X.2010.00139.x; Mannion PD, 2011, PALAEOGEOGR PALAEOCL, V299, P529, DOI 10.1016/j.palaeo.2010.12.003; Martill DM, 2012, CRETACEOUS RES, V34, P1, DOI 10.1016/j.cretres.2011.09.003; Martin JE, 2012, PALAEONTOLOGY, V55, P995, DOI 10.1111/j.1475-4983.2012.01159.x; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Massare Judy A., 1997, P401, DOI 10.1016/B978-012155210-7/50021-1; Maxwell EE, 2006, PALAEONTOLOGY, V49, P1043, DOI 10.1111/j.1475-4983.2006.00589.x; Maxwell EE, 2006, CAN J EARTH SCI, V43, P1291, DOI 10.1139/E06-029; Maxwell EE, 2012, J PALEONTOL, V86, P105, DOI 10.1666/11-038.1; Maxwell EE, 2011, PALAEONTOL Z, V85, P457, DOI 10.1007/s12542-011-0106-0; Maxwell EE, 2011, J MORPHOL, V272, P129, DOI 10.1002/jmor.10898; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P1059, DOI 10.1080/02724634.2010.483546; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P403, DOI 10.1080/02724631003617944; McGowan C, 1997, J VERTEBR PALEONTOL, V17, P428, DOI 10.1080/02724634.1997.10010986; McGowan C., 1974, Life Sci Contr R Ont Mus, VNo. 100, P1; MCGOWAN C, 1989, PALAEONTOLOGY, V32, P409; MCGOWAN C, 1972, Contributions to Geology University of Wyoming, V11, P9; McGowan C, 1996, CAN J EARTH SCI, V33, P1011, DOI 10.1139/e96-077; McGowan C., 1974, Life Sci Contr R Ont Mus, VNo. 97, P1; McGowan C., 1991, DINOSAURS SPITFIRES; McGowan C., 1973, B BRIT MUS NAT HIST, V24, P1; McGowan C., 2003, ICHTHYOPTERYGIA; Nace RL, 1941, AM J SCI, V239, P908, DOI 10.2475/ajs.239.12.908; Nace RL, 1939, AM J SCI, V237, P673, DOI 10.2475/ajs.237.9.673; Ogg J.G., 2008, CONCISE GEOLOGIC TIM; Owen HG, 2012, P GEOLOGIST ASSOC, V123, P742, DOI 10.1016/j.pgeola.2012.06.006; Owen R, 1851, MONOGRAPH FOSSIL REP; Paramo ME., 1997, REV INGEOMINAS, V6, P1; Pardo-Perez Judith, 2012, Palaeobiodiversity and Palaeoenvironments, V92, P287, DOI 10.1007/s12549-012-0074-8; Robaszynskii F, 2008, B SOC GEOL FR, V179, P245, DOI 10.2113/gssgfbull.179.3.245; Ross MR, 2009, J VERTEBR PALEONTOL, V29, P409, DOI 10.1671/039.029.0212; Sander P. Martin, 2000, Palaeontologische Zeitschrift, V74, P1; Sauvage HE, 1882, MEMOIRES SOC GEOLOGI, V2, P21; Scheyer TM, 2011, SWISS J GEOSCI, V104, pS147, DOI 10.1007/s00015-011-0076-y; Schubert BW, 2005, ACTA PALAEONTOL POL, V50, P93; Scott Robert W., 2009, Carnets de Geologie, P1; Seeley, 1873, Q J GEOLOGICAL SOC, V29, P505; SEELEY H. G., 1869, INDEX FOSSIL REMAINS; Seeley HG, 1876, Q J GEOL SOC LOND, V32, P433, DOI DOI 10.1144/GSL.JGS.1876.032.01-04.48; Sirotti Achille, 2002, Bollettino della Societa Paleontologica Italiana, V41, P237; Smith AS, 2007, ANATOMY SYSTEMATICS; Spalletti LA, 1999, REV GEOL CHILE, V26, P109; TAYLOR MA, 1986, P DORSET NAT HIST AR, V107, P121; Thewissen JGM, 2011, PALEOBIOLOGY, V37, P655; Travassac F, 2004, STRATIGRAPHIE SEDIME; Unwin David M., 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P189; Vincent P, 2008, PLESIOSAURIA REPTILI; Vincent P, 2013, ACTA PALAEONTOL POL, V58, P471, DOI 10.4202/app.2011.0113; Vincent P, 2012, J VERTEBR PALEONTOL, V32, P1049, DOI 10.1080/02724634.2012.686467; Von Huene F, 1927, CENTRALBLATT MINER B, V1, P22; WADE M, 1984, LETHAIA, V17, P99, DOI 10.1111/j.1502-3931.1984.tb01713.x; WADE M, 1990, Memoirs of the Queensland Museum, V28, P115; Wilpshaar M, 1997, CRETACEOUS RES, V18, P457, DOI 10.1006/cres.1997.0062; Woods MA, 2008, P GEOLOGIST ASSOC, V119, P229, DOI 10.1016/S0016-7878(08)80303-3; Young MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044985; Zammit M, 2011, AUSTR CRETACEOUS ICH; Zammit M, 2012, GEOSCIENCES, V2, P11, DOI 10.3390/geosciences2020011; Zammit M, 2010, J VERTEBR PALEONTOL, V30, P1726, DOI 10.1080/02724634.2010.521930; Zammit M, 2010, ALCHERINGA, V34, P281, DOI 10.1080/03115511003663939	150	50	53	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84709	10.1371/journal.pone.0084709	http://dx.doi.org/10.1371/journal.pone.0084709			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465427	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500013
J	Li, XC; Chen, SP; Xie, WW; Vogel, I; Choy, KW; Chen, F; Christensen, R; Zhang, CL; Ge, HJ; Jiang, HJ; Yu, C; Huang, F; Wang, W; Jiang, H; Zhang, XQ				Li, Xuchao; Chen, Shengpei; Xie, Weiwei; Vogel, Ida; Choy, Kwong Wai; Chen, Fang; Christensen, Rikke; Zhang, Chunlei; Ge, Huijuan; Jiang, Haojun; Yu, Chang; Huang, Fang; Wang, Wei; Jiang, Hui; Zhang, Xiuqing			PSCC: Sensitive and Reliable Population-Scale Copy Number Variation Detection Method Based on Low Coverage Sequencing	PLOS ONE			English	Article							ARRAY-CGH; VARIANTS; GENOME; IDENTIFICATION; AMPLIFICATION; ALGORITHM; CANCER; SEQ	Background: Copy number variations (CNVs) represent an important type of genetic variation that deeply impact phenotypic polymorphisms and human diseases. The advent of high-throughput sequencing technologies provides an opportunity to revolutionize the discovery of CNVs and to explore their relationship with diseases. However, most of the existing methods depend on sequencing depth and show instability with low sequence coverage. In this study, using low coverage whole-genome sequencing (LCS) we have developed an effective population-scale CNV calling (PSCC) method. Methodology/Principal Findings: In our novel method, two-step correction was used to remove biases caused by local GC content and complex genomic characteristics. We chose a binary segmentation method to locate CNV segments and designed combined statistics tests to ensure the stable performance of the false positive control. The simulation data showed that our PSCC method could achieve 99.7%/100% and 98.6%/100% sensitivity and specificity for over 300 kb CNV calling in the condition of LCS (similar to 2x) and ultra LCS (similar to 0.2x), respectively. Finally, we applied this novel method to analyze 34 clinical samples with an average of 2xLCS. In the final results, all the 31 pathogenic CNVs identified by aCGH were successfully detected. In addition, the performance comparison revealed that our method had significant advantages over existing methods using ultra LCS. Conclusions/Significance: Our study showed that PSCC can sensitively and reliably detect CNVs using low coverage or even ultra-low coverage data through population-scale sequencing.	[Li, Xuchao; Chen, Shengpei; Xie, Weiwei; Chen, Fang; Zhang, Chunlei; Ge, Huijuan; Jiang, Haojun; Yu, Chang; Wang, Wei; Jiang, Hui; Zhang, Xiuqing] BGI Shenzhen, Shenzhen, Peoples R China; [Vogel, Ida; Christensen, Rikke] Aarhus Univ Hosp, Dept Clin Genet, DK-8000 Aarhus, Denmark; [Choy, Kwong Wai] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China; [Chen, Shengpei; Jiang, Haojun] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China; [Huang, Fang] Guangzhou Childrens Social Welf Home, Guangzhou, Guangdong, Peoples R China; [Wang, Wei] Clin Lab BGI Hlth, Shenzhen, Peoples R China; [Zhang, Xiuqing] BGI Shenzhen, Guangdong Enterprise Key Lab Human Dis Genom, Shenzhen, Peoples R China	Beijing Genomics Institute (BGI); Aarhus University; Chinese University of Hong Kong; Southeast University - China; Beijing Genomics Institute (BGI)	Jiang, H (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	jianghui@genomics.org.cn; zhangxq@genomics.org.cn	Choy, Richard/AAW-8230-2020; Vogel, Ida/AAD-1087-2019; Yu, Chang/AAE-8538-2019	Choy, Richard/0000-0002-3616-6200; Vogel, Ida/0000-0002-1125-0393; 	Key Laboratory Project in Shenzhen [CXB200903110066A, CXB201108250096A]	Key Laboratory Project in Shenzhen	This study was funded by Key Laboratory Project in Shenzhen (CXB200903110066A and CXB201108250096A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Ballantyne KN, 2007, ANAL BIOCHEM, V368, P222, DOI 10.1016/j.ab.2007.05.017; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Dalca AV, 2010, BRIEF BIOINFORM, V11, P3, DOI 10.1093/bib/bbp058; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hormansdorfer C, 2009, ULTRASOUND OBST GYN, V33, P147, DOI 10.1002/uog.6250; Ivakhno S, 2010, BIOINFORMATICS, V26, P3051, DOI 10.1093/bioinformatics/btq587; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kim TM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-432; Klopocki E, 2011, AM J HUM GENET, V88, P70, DOI 10.1016/j.ajhg.2010.11.006; Kusenda M, 2008, CYTOGENET GENOME RES, V123, P36, DOI 10.1159/000184690; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Magi A, 2012, BIOINFORMATICS, V28, P470, DOI 10.1093/bioinformatics/btr707; Magi A, 2010, BIOSTATISTICS, V11, P265, DOI 10.1093/biostatistics/kxp051; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Miller CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016327; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ptacek T, 2008, CYTOGENET GENOME RES, V123, P142, DOI 10.1159/000184701; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Shen YP, 2009, J GENET GENOMICS, V36, P257, DOI 10.1016/S1673-8527(08)60113-7; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Takahashi N, 2008, CYTOGENET GENOME RES, V123, P224, DOI 10.1159/000184712; Wald A, 1940, ANN MATH STAT, V11, P147, DOI 10.1214/aoms/1177731909; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	32	19	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85096	10.1371/journal.pone.0085096	http://dx.doi.org/10.1371/journal.pone.0085096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465483	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500035
J	Raymond, PA; Colvin, SM; Jabeen, Z; Nagashima, M; Barthel, LK; Hadidjojo, J; Popova, L; Pejaver, VR; Lubensky, DK				Raymond, Pamela A.; Colvin, Steven M.; Jabeen, Zahera; Nagashima, Mikiko; Barthel, Linda K.; Hadidjojo, Jeremy; Popova, Lilia; Pejaver, Vivek R.; Lubensky, David K.			Patterning the Cone Mosaic Array in Zebrafish Retina Requires Specification of Ultraviolet-Sensitive Cones	PLOS ONE			English	Article							LIVE CELL EXTRUSION; T-BOX GENES; PHOTORECEPTOR DEVELOPMENT; VISUAL PIGMENTS; TRANSGENIC ZEBRAFISH; EMBRYONIC ZEBRAFISH; TEMPORAL EXPRESSION; MAMMALIAN RETINA; GOLDFISH RETINA; TELEOST RETINA	Cone photoreceptors in teleost fish are organized in precise, crystalline arrays in the epithelial plane of the retina. In zebrafish, four distinct morphological/spectral cone types occupy specific, invariant positions within a regular lattice. The cone lattice is aligned orthogonal and parallel to circumference of the retinal hemisphere: it emerges as cones generated in a germinal zone at the retinal periphery are incorporated as single-cell columns into the cone lattice. Genetic disruption of the transcription factor Tbx2b eliminates most of the cone subtype maximally sensitive to ultraviolet (UV) wavelengths and also perturbs the long-range organization of the cone lattice. In the tbx2b mutant, the other three cone types (red, green, and blue cones) are specified in the correct proportion, differentiate normally, and acquire normal, planar polarized adhesive interactions mediated by Crumbs 2a and Crumbs 2b. Quantitative image analysis of cell adjacency revealed that the cones in the tbx2b mutant primarily have two nearest neighbors and align in single-cell-wide column fragments that are separated by rod photoreceptors. Some UV cones differentiate at the dorsal retinal margin in the tbx2b mutant, although they are severely dysmorphic and are eventually eliminated. Incorporating loss of UV cones during formation of cone columns at the margin into our previously published mathematical model of zebrafish cone mosaic formation (which uses bidirectional interactions between planar cell polarity proteins and anisotropic mechanical stresses in the plane of the retinal epithelium to generate regular columns of cones parallel to the margin) reproduces many features of the pattern disruptions seen in the tbx2b mutant.	[Raymond, Pamela A.; Colvin, Steven M.; Nagashima, Mikiko; Barthel, Linda K.; Popova, Lilia; Pejaver, Vivek R.] Univ Michigan, Coll Literature Sci & Arts, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Jabeen, Zahera; Hadidjojo, Jeremy; Lubensky, David K.] Univ Michigan, Dept Phys, Coll Literature Sci & Arts, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Raymond, PA (corresponding author), Univ Michigan, Coll Literature Sci & Arts, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	praymond@umich.edu; dkluben@umich.edu		Lubensky, David/0000-0002-4619-116X; Raymond, Pamela/0000-0003-1083-5530; Jabeen, Zahera/0000-0001-7813-3493	NSF IOS [0952873]; NATIONAL EYE INSTITUTE [P30EY007003, R01EY015509] Funding Source: NIH RePORTER; Direct For Biological Sciences [0952873] Funding Source: National Science Foundation	NSF IOS(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF IOS 0952873. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R, 2008, BRAIN RES, V1192, P134, DOI 10.1016/j.brainres.2007.03.044; Albalat R, 2010, GENE EXPR PATTERNS, V10, P24, DOI 10.1016/j.gep.2009.11.003; Allison WT, 2010, J COMP NEUROL, V518, P4182, DOI 10.1002/cne.22447; Allison WT, 2003, J COMP NEUROL, V461, P294, DOI 10.1002/cne.10682; Alvarez-Delfin K, 2009, P NATL ACAD SCI USA, V106, P2023, DOI 10.1073/pnas.0809439106; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Behesti H, 2009, DEV BIOL, V333, P360, DOI 10.1016/j.ydbio.2009.06.026; BERGER ER, 1967, J ULTRA MOL STRUCT R, V17, P220, DOI 10.1016/S0022-5320(67)80044-3; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Chinen A, 2003, GENETICS, V163, P663; Dowling J. E., 1987, RETINA APPROACHABLE; Eisenhoffer GT, 2013, TRENDS CELL BIOL, V23, P185, DOI 10.1016/j.tcb.2012.11.006; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; ENGSTROM KJELL, 1963, ACTA ZOOL, V44, P179; Fadool JM, 2003, DEV BIOL, V258, P277, DOI 10.1016/S0012-1606(03)00125-8; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fong SH, 2005, DEVELOPMENT, V132, P3587, DOI 10.1242/dev.01933; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Gosens I, 2008, EXP EYE RES, V86, P713, DOI 10.1016/j.exer.2008.02.005; Gross JM, 2005, P NATL ACAD SCI USA, V102, P4371, DOI 10.1073/pnas.0501061102; Gu YP, 2012, CURR OPIN CELL BIOL, V24, P865, DOI 10.1016/j.ceb.2012.09.003; Hamaoka T, 2002, GENESIS, V34, P215, DOI 10.1002/gene.10155; Hitchcock P, 2004, PROG RETIN EYE RES, V23, P183, DOI 10.1016/j.preteyeres.2004.01.001; Hitchcock PF, 2004, ZEBRAFISH, V1, P257, DOI 10.1089/zeb.2004.1.257; KLJAVIN IJ, 1987, J COMP NEUROL, V260, P461, DOI 10.1002/cne.902600311; KUNZ YW, 1983, CELL TISSUE RES, V230, P469, DOI 10.1007/BF00216193; KUNZ YW, 1994, VISION RES, V34, P1375, DOI 10.1016/0042-6989(94)90136-8; LARISON KD, 1990, DEVELOPMENT, V109, P567; LYALL AH, 1957, Q J MICROSC SCI, V98, P189; Marinari E, 2012, NATURE, V484, P542, DOI 10.1038/nature10984; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; NAWROCKI L, 1985, VISION RES, V25, P1569, DOI 10.1016/0042-6989(85)90127-0; Pocha SM, 2013, CURR BIOL, V23, pR289, DOI 10.1016/j.cub.2013.03.001; Prabhudesai SN, 2005, DEV BIOL, V287, P157, DOI 10.1016/j.ydbio.2005.08.045; Ramsey M, 2013, J COMP NEUROL, V521, P1803, DOI 10.1002/cne.23260; RAYMOND PA, 1993, NEURON, V10, P1161, DOI 10.1016/0896-6273(93)90064-X; Raymond PA, 2004, INT J DEV BIOL, V48, P935, DOI 10.1387/ijdb.041873pr; RAYMOND PA, 1985, TRENDS NEUROSCI, V8, P12; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; RAYMOND PA, 1985, J COMP NEUROL, V236, P90, DOI 10.1002/cne.902360108; Renninger SL, 2011, EUR J NEUROSCI, V33, P658, DOI 10.1111/j.1460-9568.2010.07574.x; Ruvinsky I, 2000, DEV GENES EVOL, V210, P82, DOI 10.1007/s004270050014; Salbreux G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002618; Schmitt EA, 1996, J COMP NEUROL, V371, P222, DOI 10.1002/(SICI)1096-9861(19960722)371:2<222::AID-CNE3>3.0.CO;2-4; Snelson CD, 2008, DEVELOPMENT, V135, P1693, DOI 10.1242/dev.016576; Stenkamp DL, 2007, INT REV CYTOL, V259, P173, DOI 10.1016/S0074-7696(06)59005-9; Stenkamp DL, 2011, PROG RETIN EYE RES, V30, P395, DOI 10.1016/j.preteyeres.2011.06.004; Stenkamp DL, 2002, MOL VIS, V8, P280; Stenkamp DL, 1997, J COMP NEUROL, V382, P272, DOI 10.1002/(SICI)1096-9861(19970602)382:2<272::AID-CNE10>3.0.CO;2-U; Stenkamp DL, 1996, INVEST OPHTH VIS SCI, V37, P363; Suzuki SC, 2013, P NATL ACAD SCI USA, V110, P15109, DOI 10.1073/pnas.1303551110; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thompson BJ, 2013, NAT REV MOL CELL BIO, V14, P307, DOI 10.1038/nrm3568; Wallace VA, 1999, EXP EYE RES, V69, P617, DOI 10.1006/exer.1999.0741; Wei XY, 2006, EXP EYE RES, V83, P31, DOI 10.1016/j.exer.2005.10.030; Westerfield M, 1990, ZEBRAFISH BOOK GUIDE; WILLIAMS DS, 1990, J COMP NEUROL, V295, P155, DOI 10.1002/cne.902950113; Zou J, 2012, DEV CELL, V22, P1261, DOI 10.1016/j.devcel.2012.03.007; Zou J, 2010, INVEST OPHTH VIS SCI, V51, P1738, DOI 10.1167/iovs.09-4520	61	32	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85325	10.1371/journal.pone.0085325	http://dx.doi.org/10.1371/journal.pone.0085325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465536	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500054
J	Douidah, L; De Zutter, L; Van Nieuwerburgh, F; Deforce, D; Ingmer, H; Vandenberg, O; Van den Abeele, AM; Houf, K				Douidah, Laid; De Zutter, Lieven; Van Nieuwerburgh, Filip; Deforce, Dieter; Ingmer, Hanne; Vandenberg, Olivier; Van den Abeele, Anne-Marie; Houf, Kurt			Presence and Analysis of Plasmids in Human and Animal Associated Arcobacter Species	PLOS ONE			English	Article							BUTZLERI BACTEREMIA; IV SECRETION; IDENTIFICATION; CAMPYLOBACTER; PATIENT; DNA; HELICOBACTER; RESISTANCE; DIVERSITY; SEQUENCE	In this study, we report the screening of four Arcobacter species for the presence of small and large plasmids. Plasmids were present in 9.9% of the 273 examined strains. One Arcobacter cryaerophilus and four Arcobacter butzleri plasmids were selected for further sequencing. The size of three small plasmids isolated from A. butzleri and the one from A. cryaerophilus strains ranged between 4.8 and 5.1 kb, and the size of the large plasmid, isolated from A. butzleri, was 27.4 kbp. The G+C content of all plasmids ranged between 25.4% and 26.2%. A total of 95% of the large plasmid sequence represents coding information, which contrasts to the 20 to 30% for the small plasmids. Some of the open reading frames showed a high homology to putative conserved domains found in other related organisms, such as replication, mobilization and genes involved in type IV secretion system. The large plasmid carried 35 coding sequences, including seven genes in a contiguous region of 11.6 kbp that encodes an orthologous type IV secretion system found in the Wolinella succinogenes genome, Helicobacter pylori and Campylobacter jejuni plasmids, which makes this plasmid interesting for further exploration.	[Douidah, Laid; De Zutter, Lieven; Houf, Kurt] Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth & Food Safety, Merelbeke, Belgium; [Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Ingmer, Hanne] Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Frederiksberg, Denmark; [Vandenberg, Olivier] Brussels Publ Hosp Network, Natl Reference Ctr Campylobacter, Iris Lab, Dept Microbiol, Brussels, Belgium; [Van den Abeele, Anne-Marie] Sint Lucas Hosp, Microbiol Lab, Ghent, Belgium	Ghent University; Ghent University; University of Copenhagen; Ghent University	Houf, K (corresponding author), Univ Ghent, Fac Vet Med, Dept Vet Publ Hlth & Food Safety, Merelbeke, Belgium.	Kurt.houf@UGent.be	Van Nieuwerburgh, Filip/H-9697-2015; Deforce, Dieter LD/J-4725-2013; Houf, Kurt/AAC-4027-2019	Van Nieuwerburgh, Filip/0000-0001-8815-5485; Deforce, Dieter LD/0000-0002-0635-661X; Houf, Kurt/0000-0002-0909-7756; Ingmer, Hanne/0000-0002-8350-5631				Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bacon DJ, 2002, INFECT IMMUN, V70, P6242, DOI 10.1128/IAI.70.11.6242-6250.2002; Batchelor RA, 2004, MICROBIOL-SGM, V150, P3507, DOI 10.1099/mic.0.27112-0; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; De Smet S, 2011, APPL ENVIRON MICROB, V77, P1732, DOI 10.1128/AEM.02409-10; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Douidah L, 2010, J MICROBIOL METH, V80, P281, DOI 10.1016/j.mimet.2010.01.009; Harrass B, 1998, J VET MED B, V45, P87, DOI 10.1111/j.1439-0450.1998.tb00770.x; Houf K, 2005, INT J SYST EVOL MICR, V55, P713, DOI 10.1099/ijs.0.63103-0; Houf K, 2002, APPL ENVIRON MICROB, V68, P2172, DOI 10.1128/AEM.68.5.2172-2178.2002; Houf K, 2001, INT J FOOD MICROBIOL, V71, P189, DOI 10.1016/S0168-1605(01)00605-5; Houf K, 2002, J FOOD PROTECT, V65, P1233, DOI 10.4315/0362-028X-65.8.1233; Houf K, 2007, J MICROBIOL METH, V68, P408, DOI 10.1016/j.mimet.2006.09.020; Hsueh PR, 1997, J CLIN MICROBIOL, V35, P489, DOI 10.1128/JCM.35.2.489-491.1997; International Commission on Microbiological Specifications for Foods (ICMSF), 2002, MICR FOODS MICR TEST; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Lau SKP, 2002, J CLIN PATHOL-MOL PA, V55, P182, DOI 10.1136/mp.55.3.182; Miller WG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001358; ON SLW, 1995, J INFECTION, V31, P225, DOI 10.1016/S0163-4453(95)80031-X; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Ricci JCD, 2000, CRIT REV BIOTECHNOL, V20, P79, DOI 10.1080/07388550008984167; Schroder G, 2002, J BACTERIOL, V184, P2767, DOI 10.1128/JB.184.10.2767-2779.2002; Snyder L, 1997, MOL GENETICS BACTERI, P265; STEPHENS KM, 1995, J BACTERIOL, V177, P27, DOI 10.1002/path.1711770106; Sun YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019267; Tagliabue L, 2010, MICROBIOL-SGM, V156, P2901, DOI 10.1099/mic.0.041350-0; Thomas CM, 2000, MOL MICROBIOL, V37, P485, DOI 10.1046/j.1365-2958.2000.02006.x; Toh H, 2011, J BACTERIOL, V193, P6411, DOI 10.1128/JB.06084-11; TREVORS JT, 1985, FEMS MICROBIOL LETT, V32, P39, DOI 10.1016/0378-1097(85)90025-4; Van Driessche E, 2004, RES MICROBIOL, V155, P662, DOI 10.1016/j.resmic.2004.04.011; Van Driessche E, 2003, FEMS MICROBIOL LETT, V229, P243, DOI 10.1016/S0378-1097(03)00840-1; VANDAMME P, 1991, INT J SYST BACTERIOL, V41, P88, DOI 10.1099/00207713-41-1-88; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863, DOI 10.3201/eid1010.040241; Wilson DL, 2003, MICROBIOL-SGM, V149, P3603, DOI 10.1099/mic.0.26531-0; Woo PCY, 2001, DIAGN MICR INFEC DIS, V40, P125, DOI 10.1016/S0732-8893(01)00261-9; Wybo I, 2004, J CLIN MICROBIOL, V42, P1851, DOI 10.1128/JCM.42.4.1851-1852.2004; Yan JJ, 2000, J FORMOS MED ASSOC, V99, P166	38	19	20	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85487	10.1371/journal.pone.0085487	http://dx.doi.org/10.1371/journal.pone.0085487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465575	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500051
J	Schmidt, M; Neuner, B; Kindler, A; Scholtz, K; Eckardt, R; Neuhaus, P; Spies, C				Schmidt, Maren; Neuner, Bruno; Kindler, Andrea; Scholtz, Kathrin; Eckardt, Rahel; Neuhaus, Peter; Spies, Claudia			Prediction of Long-Term Mortality by Preoperative Health-Related Quality-of-Life in Elderly Onco-Surgical Patients	PLOS ONE			English	Article							EORTC QLQ-C30; COGNITIVE FUNCTION; PROGNOSTIC-SIGNIFICANCE; EUROPEAN-ORGANIZATION; CANCER-PATIENTS; SURVIVAL; SURGERY; CHEMOTHERAPY; COMPLICATIONS; DYSFUNCTION	Objective: Aim of this study was to evaluate the association between preoperative health-related quality of life (HRQoL) and mortality in a cohort of elderly patients (>65 years) with gastrointestinal, gynecological and genitourinary carcinomas. Design: Prospective cohort pilot study. Setting: Tertiary university hospital in Germany. Patients: Between June 2008 and July 2010 and after ethical committee approval and written informed consent, 126 patients scheduled for onco-surgery were included. Prior to surgery as well as 3 and 12 months postoperatively all participants completed the EORTC-QLQ-C30 questionnaire (measuring self-reported health-related quality of life). Additionally, demographic and clinical data including the Mini Mental State Examination (MMSE) were collected. Surgery and anesthesia were conducted according to the standard operating procedures. Primary endpoint was the cumulative mortality rate over 12 months after one year. Changes in Quality of life were considered as secondary outcome. Results: Mortality after one year was 28%. In univariable and multivariable logistic regression analysis baseline HRQoL self-reported cognitive function (OR per point: 0.98; CI 95% 0.96-0.99; p = 0.024) and higher symptom burden for appetite loss (per point: OR 1.02; CI 95% 1.00-1.03; p = 0.014) were predictive for long-term mortality. Additionally the MMSE as an objective measure of cognitive impairment (per point: OR 0.69; CI 95% 0.51-0.96; p = 0.026) as well as severity of surgery (OR 0.31; CI 95% 0.11-0.93; p = 0.036) were predictive for long-term mortality. Global health status 12 months after surgery was comparable to the baseline levels in survivors despite moderate impairments in other domains. Conclusion: This study showed that objective and self-reported cognitive functioning together with appetite loss were prognostic for mortality in elderly cancer patients. In addition, impaired cognitive dysfunction and severity of surgery were predictive for one-year mortality whereas in this selected population scheduled for surgery age, gender, cancer site and metastases were not.	[Schmidt, Maren; Neuner, Bruno; Kindler, Andrea; Scholtz, Kathrin; Spies, Claudia] Charite, Dept Anesthesiol & Intens Care Med, D-13353 Berlin, Germany; [Schmidt, Maren; Neuner, Bruno; Kindler, Andrea; Scholtz, Kathrin; Spies, Claudia] Charite, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Eckardt, Rahel] Charite, Charite Res Grp Geriatr, D-13353 Berlin, Germany; [Neuhaus, Peter] Charite, Dept Gen Visceral & Transplantat Surg, Charite Campus Virchow, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Spies, C (corresponding author), Charite, Dept Anesthesiol & Intens Care Med, Campus Charite Mitte, D-13353 Berlin, Germany.	claudia.spies@charite.de	Spies, Claudia/AAJ-5412-2020	Spies, Claudia/0000-0002-1062-0495; Schmidt, Maren/0000-0002-7821-9577				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; ADDINGTONHALL J, 1995, PALLIATIVE MED, V9, P295, DOI 10.1177/026921639500900404; Amemiya T, 2007, ANN SURG, V246, P222, DOI 10.1097/SLA.0b013e3180caa3fb; Benyamini Y, 2003, PSYCHO-ONCOLOGY, V12, P161, DOI 10.1002/pon.637; Blazeby JM, 2005, BRIT J SURG, V92, P1502, DOI 10.1002/bjs.5175; Bowling A, 2002, AGING MENT HEALTH, V6, P355, DOI 10.1080/1360786021000006983; Braun DP, 2013, PANCREAS, V42, P254, DOI 10.1097/MPA.0b013e31825b9f56; Camilleri-Brennan J, 2001, BRIT J SURG, V88, P1617, DOI 10.1046/j.0007-1323.2001.01933.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coates A, 1997, EUR J CANCER, V33, P1025, DOI 10.1016/S0959-8049(97)00049-X; COPELAND GP, 1991, BRIT J SURG, V78, P356; Correa DD, 2012, GYNECOL ONCOL, V124, P404, DOI 10.1016/j.ygyno.2011.11.005; de Graeff A, 2001, EUR J CANCER, V37, P332, DOI 10.1016/S0959-8049(00)00385-3; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Efficace F, 2009, EUR J HAEMATOL, V82, P484, DOI 10.1111/j.1600-0609.2009.01254.x; Fayers P.M., 2001, EORTC QLQ C30 SCORIN, V3rd; Fitzsimmons D, 2009, EUR J CANCER, V45, P19, DOI 10.1016/j.ejca.2008.07.036; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ford ME, 2001, QUAL LIFE RES, V10, P533, DOI 10.1023/A:1013003014340; Gotay CC, 2008, J CLIN ONCOL, V26, P1355, DOI 10.1200/JCO.2007.13.3439; Hestad K, 1998, CLINICAL GEROPSYCHOLOGY, P259, DOI 10.1037/10295-022; Higginson I, 1993, Qual Health Care, V2, P112, DOI 10.1136/qshc.2.2.112; HISLOP TG, 1987, J CHRON DIS, V40, P729; Hjermstad MJ, 1998, EUR J CANCER, V34, P1381, DOI 10.1016/S0959-8049(98)00136-1; Iconomou G, 2004, CANCER-AM CANCER SOC, V101, P404, DOI 10.1002/cncr.20385; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Iwasa H, 2013, INT J GERIATR PSYCH, V28, P841, DOI 10.1002/gps.3890; Johnson C, 2010, EUR J CANCER, V46, P2242, DOI 10.1016/j.ejca.2010.04.014; Kaatsch P, 2012, HAUFIGKEITEN TRENDS, V8; KATZ S, 1987, J CHRON DIS, V40, P459, DOI 10.1016/0021-9681(87)90001-4; Lichtman SM, 2007, J CLIN ONCOL, V25, P1821, DOI 10.1200/JCO.2007.10.6567; Mastracci TM, 2006, DIS COLON RECTUM, V49, P1878, DOI 10.1007/s10350-006-0725-9; Minisini AM, 2008, CRIT REV ONCOL HEMAT, V67, P71, DOI 10.1016/j.critrevonc.2008.02.004; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Montazeri A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-102; Neuman HB, 2013, CANCER-AM CANCER SOC, V119, P639, DOI 10.1002/cncr.27765; O'Connell JB, 2004, ANN SURG ONCOL, V11, P962, DOI 10.1245/ASO.2004.03.052; Oates JE, 2007, ARCH OTOLARYNGOL, V133, P533, DOI 10.1001/archotol.133.6.533; Oberaigner W, 2012, ACTA ONCOL, V51, P441, DOI 10.3109/0284186X.2011.653437; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Osoba D, 2007, SUPPORT CARE CANCER, V15, P353, DOI 10.1007/s00520-006-0187-6; Park S, 2013, ANN ONCOL, V24, P1630, DOI 10.1093/annonc/mds649; PERRY EK, 1980, AGE AGEING, V9, P1, DOI 10.1093/ageing/9.1.1; Quinten C, 2009, LANCET ONCOL, V10, P865, DOI 10.1016/S1470-2045(09)70200-1; Repetto L, 2001, CRIT REV ONCOL HEMAT, V37, P147, DOI 10.1016/S1040-8428(00)00104-9; Robb C, 2010, CRIT REV ONCOL HEMAT, V74, P218, DOI 10.1016/j.critrevonc.2009.07.002; Robinson TN, 2012, J AM COLL SURGEONS, V215, P12, DOI 10.1016/j.jamcollsurg.2012.02.007; Schonberg MA, 2010, J CLIN ONCOL, V28, P2038, DOI 10.1200/JCO.2009.25.9796; Schwarz R, 2001, EUR J CANCER, V37, P1345, DOI 10.1016/S0959-8049(00)00447-0; Semple C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009441.pub2; Soubeyran P, 2012, J CLIN ONCOL, V30, P1829, DOI 10.1200/JCO.2011.35.7442; Spies C., 2013, SOPS AN STHESIOLOGIE; Story DA, 2008, CURR OPIN ANESTHESIO, V21, P375, DOI 10.1097/ACO.0b013e3282f889f8; van Heijl M, 2010, ANN SURG ONCOL, V17, P23, DOI 10.1245/s10434-009-0731-y; Vardy J, 2007, CRIT REV ONCOL HEMAT, V63, P183, DOI 10.1016/j.critrevonc.2007.06.001; Yancik R, 2005, CANCER J, V11, P437, DOI 10.1097/00130404-200511000-00002; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	58	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85456	10.1371/journal.pone.0085456	http://dx.doi.org/10.1371/journal.pone.0085456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297FH	24465568	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500049
J	Weiss, EM; Schulter, G; Fink, A; Reiser, EM; Mittenecker, E; Niederstatter, H; Nagl, S; Parson, W; Papousek, I				Weiss, Elisabeth M.; Schulter, Guenter; Fink, Andreas; Reiser, Eva M.; Mittenecker, Erich; Niederstaetter, Harald; Nagl, Simone; Parson, Walther; Papousek, Ilona			Influences of COMT and 5-HTTLPR Polymorphisms on Cognitive Flexibility in Healthy Women: Inhibition of Prepotent Responses and Memory Updating	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; CARD SORTING TEST; SEROTONIN TRANSPORTER POLYMORPHISM; ACUTE TRYPTOPHAN DEPLETION; RANDOM NUMBER GENERATION; WORKING-MEMORY; GENETIC-VARIATION; SCHIZOPHRENIC-PATIENTS; PARKINSONS-DISEASE; PREFRONTAL CORTEX	Understanding genetic factors that affect monoamine neurotransmitters flux in prefrontal cortex may help to further specify the complex neurobiological processes that underlie cognitive function and dysfunction in health and illness. The current study examined the associations between the polymorphisms of dopaminergic ( COMT Met158Val) and serotoninergic (5-HTTLPR) genes and the sequential pattern of responses in a motor random generation task providing well-established indexes for executive functioning in a large sample of 255 healthy women. Participants homozygous for the Met allele of the COMT polymorphism showed impaired inhibition of prepotent responses, whereas individuals homozygous for the s-allele of the 5-HTTLPR showed a restricted ability to update information in working memory. Taken together the results indicate differentiated influences of dopaminergic and serotonergic genes on important and definite executive sub-processes related to cognitive flexibility.	[Weiss, Elisabeth M.; Schulter, Guenter; Fink, Andreas; Reiser, Eva M.; Mittenecker, Erich; Papousek, Ilona] Graz Univ, Dept Psychol, Biol Psychol Unit, Graz, Austria; [Niederstaetter, Harald; Nagl, Simone; Parson, Walther] Med Univ Innsbruck, Inst Legal Med, A-6020 Innsbruck, Austria	University of Graz; Medical University of Innsbruck	Weiss, EM (corresponding author), Graz Univ, Dept Psychol, Biol Psychol Unit, Graz, Austria.	e.weiss@uni-graz.at	Parson, Walther/AAD-6845-2020; VARRECCHIA, TIWANA/AAJ-8712-2021; Papousek, Ilona/H-3043-2019	Papousek, Ilona/0000-0002-6620-0318; Parson, Walther/0000-0002-5692-2392; Fink, Andreas/0000-0001-7316-3140; Weiss, Elisabeth/0000-0003-1296-3448				Anderson DE, 2012, J COGNITIVE NEUROSCI, V24, P1069, DOI 10.1162/jocn_a_00207; Avons SE, 2003, PSYCHIAT RES, V120, P145, DOI 10.1016/S0165-1781(03)00174-4; AXMACHER I, 1970, ARZNEI-FORSCHUNG, V20, P919; Baddeley A., 2007, WORKING MEMORY THOUG; BADDELEY AD, 1966, Q J EXP PSYCHOL, V18, P119, DOI 10.1080/14640746608400019; Barnett JH, 2007, MOL PSYCHIATR, V12, P502, DOI 10.1038/sj.mp.4001973; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Bilder RM, 2002, BIOL PSYCHIAT, V52, P701, DOI 10.1016/S0006-3223(02)01416-6; Booij L, 2003, MOL PSYCHIATR, V8, P951, DOI 10.1038/sj.mp.4001423; Borg J, 2009, INT J NEUROPSYCHOPH, V12, P783, DOI 10.1017/S1461145708009759; Brown RG, 1998, NEUROPSYCHOLOGIA, V36, P1355, DOI 10.1016/S0028-3932(98)00015-3; Bruder GE, 2005, BIOL PSYCHIAT, V58, P901, DOI 10.1016/j.biopsych.2005.05.010; Brummett BH, 2008, BEHAV GENET, V38, P476, DOI 10.1007/s10519-008-9219-y; Canli T, 2005, P NATL ACAD SCI USA, V102, P12224, DOI 10.1073/pnas.0503880102; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Clarke HF, 2004, SCIENCE, V304, P878, DOI 10.1126/science.1094987; Colzato LS, 2010, NEUROPSYCHOLOGIA, V48, P2764, DOI 10.1016/j.neuropsychologia.2010.04.023; Crisan LG, 2009, SOC COGN AFFECT NEUR, V4, P399, DOI 10.1093/scan/nsp019; DeYoung CG, 2012, DEV PSYCHOPATHOL, V24, P1307, DOI 10.1017/S0954579412000727; Diaz-Asper CM, 2008, BIOL PSYCHIAT, V63, P72, DOI 10.1016/j.biopsych.2007.03.031; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Enge S, 2011, NEUROPSYCHOLOGIA, V49, P3776, DOI 10.1016/j.neuropsychologia.2011.09.038; EVANS FJ, 1978, B PSYCHONOMIC SOC, V12, P35; Fallgatter AJ, 1999, INT J NEUROPSYCHOP, V2, P115, DOI 10.1017/S1461145799001455; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Gonzalez-Burgos I, 2012, NEUROSCI RES, V73, P321, DOI 10.1016/j.neures.2012.05.003; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; GUTTMANN G, 1966, Z EXP ANGEW PSYCHOL, V13, P19; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Harrison PJ, 2008, NEUROPSYCHOPHARMACOL, V33, P3037, DOI 10.1038/sj.npp.1301543; HERZOG GR, 1989, Z EXP ANGEW PSYCHOL, V36, P199; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62; Izquierdo A, 2007, P NATL ACAD SCI USA, V104, P14128, DOI 10.1073/pnas.0706583104; Jacobs E, 2011, J NEUROSCI, V31, P5286, DOI 10.1523/JNEUROSCI.6394-10.2011; Joober R, 2002, ARCH GEN PSYCHIAT, V59, P662, DOI 10.1001/archpsyc.59.7.662; Kane MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048975; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; KRUG R, 1994, PSYCHONEUROENDOCRINO, V19, P21, DOI 10.1016/0306-4530(94)90056-6; KUHL J, 1974, PSYCHOL RES-PSYCH FO, V37, P143, DOI 10.1007/BF00308418; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lamar M, 2009, NEUROBIOL AGING, V30, P1135, DOI 10.1016/j.neurobiolaging.2007.09.013; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; Luciana M, 1998, CEREB CORTEX, V8, P218, DOI 10.1093/cercor/8.3.218; Ludewig K, 2003, PSYCHIAT RES, V119, P293, DOI 10.1016/S0165-1781(03)00103-3; LYON M, 1994, SCHIZOPHR RES, V13, P45, DOI 10.1016/0920-9964(94)90059-0; Madsen K, 2011, PSYCHOPHARMACOLOGY, V213, P573, DOI 10.1007/s00213-010-1926-4; Marini S, 2011, ARCH GERONTOL GERIAT, V52, pE71, DOI 10.1016/j.archger.2010.06.006; Mazei MS, 2002, BRAIN RES, V936, P58, DOI 10.1016/S0006-8993(02)02542-8; Mittenecker E, 1960, Z EXPT ANGEWANDTE PS, V7, P392; Mittenecker E, 1958, Z EXPT ANGEWANDTE PS, V5, P45; Mittenecker E, 1953, Z EXPT ANGEWANDTE PS, V1, P5; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morrens M, 2006, EUR NEUROPSYCHOPHARM, V16, pS392, DOI 10.1016/S0924-977X(06)70480-1; Morrens M, 2008, PSYCHIAT RES, V161, P121, DOI 10.1016/j.psychres.2008.01.017; Morrens M, 2006, SCHIZOPHR RES, V84, P397, DOI 10.1016/j.schres.2006.01.024; Murphy FC, 2002, PSYCHOPHARMACOLOGY, V163, P42, DOI 10.1007/s00213-002-1128-9; Naudon L, 2007, PSYCHOPHARMACOLOGY, V191, P353, DOI 10.1007/s00213-006-0660-4; Nolan KA, 2004, AM J PSYCHIAT, V161, P359, DOI 10.1176/appi.ajp.161.2.359; O'Hara R, 2007, MOL PSYCHIATR, V12, P544, DOI 10.1038/sj.mp.4001978; Oberacher H, 2006, ANAL BIOANAL CHEM, V386, P83, DOI 10.1007/s00216-006-0589-9; Pacheco J, 2012, NEUROPSYCHOLOGIA, V50, P2257, DOI 10.1016/j.neuropsychologia.2012.05.030; Paulus MP, 1999, SCHIZOPHR RES, V35, P69, DOI 10.1016/S0920-9964(98)00108-X; Paulus MP, 1999, BIOL PSYCHIAT, V46, P662, DOI 10.1016/S0006-3223(99)00086-4; Perras B, 2001, PSYCHONEUROENDOCRINO, V26, P1, DOI 10.1016/S0306-4530(00)00031-7; Price JS, 2013, BEHAV BRAIN RES, V242, P158, DOI 10.1016/j.bbr.2012.11.013; Puig MV, 2011, MOL NEUROBIOL, V44, P449, DOI 10.1007/s12035-011-8214-0; Reja V, 2010, METHODS, V50, pS10, DOI 10.1016/j.ymeth.2010.02.006; REMSCHMIDT H, 1970, FORTSCHR NEUROL P I, V38, P524; Roiser JP, 2007, INT J NEUROPSYCHOPH, V10, P449, DOI 10.1017/S146114570600705X; Rosa A, 2004, AM J PSYCHIAT, V161, P1110, DOI 10.1176/appi.ajp.161.6.1110; Rosa EC, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-53; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Rybakowski JK, 2006, PSYCHIAT RES, V143, P13, DOI 10.1016/j.psychres.2005.10.008; Rybakowski JK, 2005, J NEURAL TRANSM, V112, P1575, DOI 10.1007/s00702-005-0292-6; Schmitt JAJ, 2000, J PSYCHOPHARMACOL, V14, P21, DOI 10.1177/026988110001400102; Schmuck P, 1996, DIAGNOSTICA, V42, P47; Schulter G, 1987, PERSPEKTIVEN PSYCHOL, P77; Schulter G, 2010, BEHAV RES METHODS, V42, P333, DOI 10.3758/BRM.42.1.333; SCHWIBBE MH, 1985, Z KLIN PSYCHOL-FORSC, V14, P130; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Stoffers D, 2007, BRAIN, V130, P1847, DOI 10.1093/brain/awm034; Stoffers D, 2001, NEUROLOGY, V57, P2111, DOI 10.1212/WNL.57.11.2111; Stottenberg SF, 2010, NEUROPHARMACOLOGY, V58, P423, DOI 10.1016/j.neuropharm.2009.09.010; Strobel A, 2007, J COGNITIVE NEUROSCI, V19, P1923, DOI 10.1162/jocn.2007.19.12.1923; Towse JN, 1998, BRIT J PSYCHOL, V89, P77, DOI 10.1111/j.2044-8295.1998.tb02674.x; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Walderhaug E, 2002, PSYCHOPHARMACOLOGY, V164, P385, DOI 10.1007/s00213-002-1238-4	92	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85506	10.1371/journal.pone.0085506	http://dx.doi.org/10.1371/journal.pone.0085506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465579	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500053
J	Baranski, M; Gopikrishna, G; Robinson, NA; Katneni, VK; Shekhar, MS; Shanmugakarthik, J; Jothivel, S; Gopal, C; Ravichandran, P; Kent, M; Arnyasi, M; Ponniah, AG				Baranski, Matthew; Gopikrishna, Gopalapillay; Robinson, Nicholas A.; Katneni, Vinaya Kumar; Shekhar, Mudagandur S.; Shanmugakarthik, Jayakani; Jothivel, Sarangapani; Gopal, Chavali; Ravichandran, Pitchaiyappan; Kent, Matthew; Arnyasi, Mariann; Ponniah, Alphis G.			The Development of a High Density Linkage Map for Black Tiger Shrimp (Penaeus monodon) Based on cSNPs	PLOS ONE			English	Article							PACIFIC WHITE SHRIMP; POLYMORPHIC MICROSATELLITE MARKERS; INFECTIOUS PANCREATIC NECROSIS; EXPRESSED SEQUENCE TAGS; SALMO-SALAR REVEALS; SYNDROME VIRUS WSSV; KURUMA PRAWN; LITOPENAEUS-VANNAMEI; GENE-EXPRESSION; GENOME	Transcriptome sequencing using Illumina RNA-seq was performed on populations of black tiger shrimp from India. Samples were collected from (i) four landing centres around the east coastline (EC) of India, (ii) survivors of a severe WSSV infection during pond culture (SUR) and (iii) the Andaman Islands (AI) in the Bay of Bengal. Equal quantities of purified total RNA from homogenates of hepatopancreas, muscle, nervous tissue, intestinal tract, heart, gonad, gills, pleopod and lymphoid organs were combined to create AI, EC and SUR pools for RNA sequencing. De novo transcriptome assembly resulted in 136,223 contigs (minimum size 100 base pairs, bp) with a total length 61 Mb, an average length of 446 bp and an average coverage of 163 x across all pools. Approximately 16% of contigs were annotated with BLAST hit information and gene ontology annotations. A total of 473,620 putative SNPs/indels were identified. An Illumina iSelect genotyping array containing 6,000 SNPs was developed and used to genotype 1024 offspring belonging to seven full-sibling families. A total of 3959 SNPs were mapped to 44 linkage groups. The linkage groups consisted of between 16-129 and 13-130 markers, of length between 139-10.8 and 109.1-10.5 cM and with intervals averaging between 1.2 and 0.9 cM for the female and male maps respectively. The female map was 28% longer than the male map (4060 and 2917 cM respectively) with a 1.6 higher recombination rate observed for female compared to male meioses. This approach has substantially increased expressed sequence and DNA marker resources for tiger shrimp and is a useful resource for QTL mapping and association studies for evolutionarily and commercially important traits.	[Baranski, Matthew; Robinson, Nicholas A.] Nofima, As, Norway; [Gopikrishna, Gopalapillay; Katneni, Vinaya Kumar; Shekhar, Mudagandur S.; Shanmugakarthik, Jayakani; Jothivel, Sarangapani; Gopal, Chavali; Ravichandran, Pitchaiyappan; Ponniah, Alphis G.] Cent Inst Brackishwater Aquaculture, Madras, Tamil Nadu, India; [Robinson, Nicholas A.] Flinders Univ S Australia, Bedford Pk, SA 5042, Australia; [Kent, Matthew; Arnyasi, Mariann] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet CIGENE, As, Norway	Nofima; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute Brackishwater Aquaculture; Flinders University South Australia; Norwegian University of Life Sciences	Baranski, M (corresponding author), Nofima, As, Norway.	matthew.baranski@nofima.no	Robinson, Nicholas/H-2745-2017; Ponniah, A.G./AAI-5665-2020; Katneni, Vinaya/AGU-4127-2022; Robinson, Nicholas/P-2672-2019; Baranski, Matthew/I-7839-2018	Robinson, Nicholas/0000-0003-1724-2551; Baranski, Matthew/0000-0002-9138-071X	Norwegian Research Council; Department of Biotechnology of India; Indian Council of Agricultural Research of India [183833]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Department of Biotechnology of India; Indian Council of Agricultural Research of India	The authors are thankful to the Norwegian Research Council, Department of Biotechnology of India and Indian Council of Agricultural Research of India for funding this project (project 183833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andriantahina F, 2013, MAR BIOTECHNOL, V15, P399, DOI 10.1007/s10126-013-9500-9; Cartwright DA, 2007, GENETICS, V176, P2521, DOI 10.1534/genetics.106.063982; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Ciobanu DC, 2010, ANIM GENET, V41, P39, DOI 10.1111/j.1365-2052.2009.01961.x; de Freitas PD, 2007, GENET MOL BIOL, V30, P1194, DOI 10.1590/S1415-47572007000600027; Du ZQ, 2010, ANIM GENET, V41, P286, DOI 10.1111/j.1365-2052.2009.02002.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fishman L, 2001, GENETICS, V159, P1701; Food and Agriculture Organisation of the United Nations, 2010, STAT WORLD FISH AQ; Galindo J, 2010, J EVOLUTION BIOL, V23, P2004, DOI 10.1111/j.1420-9101.2010.02071.x; Gitterle T, 2005, AQUACULTURE, V246, P139, DOI 10.1016/j.aquaculture.2005.02.011; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hayes BJ, 2013, TRENDS GENET, V29, P206, DOI 10.1016/j.tig.2012.11.009; Hayes BJ, 2010, AQUAC RES, V41, pe872, DOI 10.1111/j.1365-2109.2010.02611.x; Houston RD, 2008, GENETICS, V178, P1109, DOI 10.1534/genetics.107.082974; Huang PY, 2008, FISH SHELLFISH IMMUN, V25, P250, DOI 10.1016/j.fsi.2008.06.002; Huang SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-242; Ibarra AM, 2007, AQUACULTURE, V268, P23, DOI 10.1016/j.aquaculture.2007.04.028; Jeswin J, 2013, AQUACULTURE, V380, P84, DOI 10.1016/j.aquaculture.2012.12.004; Lehnert SA, 1999, MAR BIOTECHNOL, V1, P465, DOI 10.1007/PL00011803; Leu JH, 2011, MAR BIOTECHNOL, V13, P608, DOI 10.1007/s10126-010-9286-y; Li YT, 2003, AQUACULTURE, V219, P143, DOI 10.1016/S0044-8486(02)00355-1; Li YT, 2006, AQUACULTURE, V258, P198, DOI 10.1016/j.aquaculture.2006.04.027; Li ZX, 2006, AQUACULTURE, V261, P463, DOI 10.1016/j.aquaculture.2006.07.002; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; Lyons RE, 2007, MAR BIOTECHNOL, V9, P712, DOI 10.1007/s10126-007-9022-4; Maneeruttanarungroj C, 2006, ANIM GENET, V37, P363, DOI 10.1111/j.1365-2052.2006.01493.x; Meuwissen THE, 2001, GENETICS, V157, P1819; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moen T, 2004, ANIM GENET, V35, P81, DOI 10.1111/j.1365-2052.2004.01097.x; Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368; Nielsen CB, 2010, NAT METHODS, V7, pS5, DOI [10.1038/NMETH.1422, 10.1038/nmeth.1422]; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Pan YW, 2004, MOL ECOL NOTES, V4, P345, DOI 10.1111/j.1471-8286.2004.00692.x; Perez F, 2004, AQUACULTURE, V242, P105, DOI 10.1016/j.aquaculture.2004.09.002; Qi HG, 2009, AQUAC RES, V40, P1661, DOI 10.1111/j.1365-2109.2009.02269.x; Robinson N, 2012, MAR BIOTECHNOL, V14, P620, DOI 10.1007/s10126-012-9433-8; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Staelens J, 2008, GENETICS, V179, P917, DOI 10.1534/genetics.107.080150; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Sun ZN, 2008, HYDROBIOLOGIA, V596, P133, DOI 10.1007/s10750-007-9063-8; Tassanakajon A, 1998, MOL MAR BIOL BIOTECH, V7, P55; Tassanakajon A, 2006, GENE, V384, P104, DOI 10.1016/j.gene.2006.07.012; Tian Y, 2008, CHINESE SCI BULL, V53, P1205, DOI 10.1007/s11434-008-0170-3; Tong J, 2002, AQUACULTURE, V208, P69, DOI 10.1016/S0044-8486(01)00706-2; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Whan VA, 2000, ANIM GENET, V31, P143; Whankaew S, 2008, MOL ECOL RESOUR, V8, P1494, DOI 10.1111/j.1755-0998.2008.02290.x; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Wilson K, 2000, MOL BIOL EVOL, V17, P863, DOI 10.1093/oxfordjournals.molbev.a026366; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0; Woram RA, 2004, GENOME, V47, P304, DOI [10.1139/G03-127, 10.1139/g03-127]; Wuthisuthimethavee S, 2003, AQUACULTURE, V224, P39, DOI 10.1016/S0044-8486(03)00222-9; Xu Z, 1999, ANIM GENET, V30, P150, DOI 10.1046/j.1365-2052.1999.00458.x; You E, 2009, PLANT AN GEN 17 C SA; You EM, 2010, ANIM GENET, V41, P365, DOI 10.1111/j.1365-2052.2009.02014.x; Zhang LS, 2007, GENETICA, V131, P37, DOI 10.1007/s10709-006-9111-8	59	52	55	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85413	10.1371/journal.pone.0085413	http://dx.doi.org/10.1371/journal.pone.0085413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465553	Green Published, gold, Green Accepted			2022-12-25	WOS:000330237000032
J	Guaraldi, P; Poda, R; Calandra-Buonaura, G; Solieri, L; Sambati, L; Gallassi, R; Cortelli, P				Guaraldi, Pietro; Poda, Roberto; Calandra-Buonaura, Giovanna; Solieri, Laura; Sambati, Luisa; Gallassi, Roberto; Cortelli, Pietro			Cognitive Function in Peripheral Autonomic Disorders	PLOS ONE			English	Article							ORTHOSTATIC HYPOTENSION; FAILURE; DEFINITION	Objective: aims of the current study were 1) to evaluate global cognitive function in patients with autonomic failure (AF) of peripheral origin and 2) to investigate the effect of a documented fall in blood pressure (BP) fulfilling the criteria for orthostatic hypotension (OH) on cognitive performances. Methods: we assessed 12 consecutive patients (10 males, 68 +/- 7 years old) with pure AF (PAF) or autoimmune autonomic neuropathy (AAN) and 12 age-and gender-matched controls. All patients had no clinical signs of central nervous system involvement and normal brain CT/MRI scan. Cognitive function was assessed on two consecutive days in 3 conditions: on day 1, while sitting, by means of a comprehensive battery of neuropsychological tests; on day 2, while tilted (HUT) and during supine rest (supine) in a randomized manner. BP and heart rate (HR) were continuously recorded non-invasively for the whole duration of the examination. Results: patients with PAF or AAN displayed a preserved global cognitive function while sitting. However, compared to supine assessment, during HUT patients scored significantly worse during the Trail Making Test A and B, Barrage test, Analogies test, Immediate Visual Memory, Span Forward and Span Backward test. Pathological scores, with regard to Italian normative range values, were observed only during HUT in the Barrage test and in the Analogies test in 3 and 6 patients respectively. On the contrary, in healthy controls, results to neuropsychological tests were not significantly different, during HUT compared to supine rest. Conclusions: these data demonstrate that patients with PAF and AAN present a normal sitting global cognitive evaluation. However, their executive functions worsen significantly during the orthostatic challenge, possibly because of transient frontal lobes hypoperfusion.	[Guaraldi, Pietro; Poda, Roberto; Calandra-Buonaura, Giovanna; Solieri, Laura; Sambati, Luisa; Gallassi, Roberto; Cortelli, Pietro] IRCCS, Inst Neurol Sci Bologna, Bologna, Italy; [Guaraldi, Pietro; Poda, Roberto; Calandra-Buonaura, Giovanna; Solieri, Laura; Sambati, Luisa; Gallassi, Roberto; Cortelli, Pietro] Univ Bologna, Dept Biomed & Neuromotor Sci, Alma Mater Studiorum, Bologna, Italy	IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna	Guaraldi, P (corresponding author), IRCCS, Inst Neurol Sci Bologna, Bologna, Italy.	pietro.guaraldi@unibo.it	Cortelli, Pietro/K-6063-2016; Buonaura, Giovanna Calandra/K-5281-2016; Guaraldi, Pietro/K-4558-2018; Poda, Roberto/AAB-9576-2020	Buonaura, Giovanna Calandra/0000-0002-9447-3532; Poda, Roberto/0000-0003-4055-6989; Cortelli, Pietro/0000-0002-3633-8818; , Luisa Sambati/0000-0002-5939-7933; Guaraldi, Pietro/0000-0003-0597-603X	RFO University of Bologna	RFO University of Bologna	Supported by by RFO 2012 University of Bologna. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elmstahl S, 1997, DEMENT GERIATR COGN, V8, P180, DOI 10.1159/000106629; Fanciulli A, 2013, EUR J NEUROL, V20, P231, DOI 10.1111/j.1468-1331.2012.03819.x; Fukuoka S, 1996, J NUCL MED, V37, P1824; GALLASSI R, 1986, ACTA PSYCHIAT SCAND, V74, P62, DOI 10.1111/j.1600-0447.1986.tb06228.x; Gallassi R, 2010, NEUROL SCI, V31, P327, DOI 10.1007/s10072-010-0224-6; Garland Emily M, 2013, Handb Clin Neurol, V117, P243, DOI 10.1016/B978-0-444-53491-0.00020-1; Gibbons CH, 2012, ARCH NEUROL-CHICAGO, V69, P461, DOI 10.1001/archneurol.2011.2372; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Heims HC, 2006, CLIN AUTON RES, V16, P113, DOI 10.1007/s10286-006-0318-7; Kim JS, 2012, NEUROLOGY, V79, P1323, DOI 10.1212/WNL.0b013e31826c1acd; Klein CM, 2003, ANN NEUROL, V53, P752, DOI 10.1002/ana.10556; Mathias CJ, 1999, AUTONOMIC FAILURE TX, V4, P169; Monaco M, 2013, NEUROL SCI, V34, P749, DOI 10.1007/s10072-012-1130-x; Novak V, 2010, NAT REV CARDIOL, V7, P686, DOI 10.1038/nrcardio.2010.161; Poda R, 2012, NEUROL SCI, V33, P469, DOI 10.1007/s10072-011-0746-6; Rose KM, 2010, NEUROEPIDEMIOLOGY, V34, P1, DOI 10.1159/000255459; Schatz IJ, 1996, NEUROLOGY, V46, P1470, DOI 10.1212/wnl.46.5.1470	17	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85020	10.1371/journal.pone.0085020	http://dx.doi.org/10.1371/journal.pone.0085020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465471	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000021
J	Scerbo, P; Markov, GV; Vivien, C; Kodjabachian, L; Demeneix, B; Coen, L; Girardot, F				Scerbo, Pierluigi; Markov, Gabriel V.; Vivien, Celine; Kodjabachian, Laurent; Demeneix, Barbara; Coen, Laurent; Girardot, Fabrice			On the Origin and Evolutionary History of NANOG	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; POU DOMAIN; PLURIPOTENCY; OCT4; GENE; SPECIFICATION; VERTEBRATES; ORTHOLOGS; ROLES; TRAIT	Though pluripotency is well characterized in mammals, many questions remain to be resolved regarding its evolutionary history. A necessary prerequisite for addressing this issue is to determine the phylogenetic distributions and orthology relationships of the transcription factor families sustaining or modulating this property. In mammals, the NANOG homeodomain transcription factor is one of the core players in the pluripotency network. However, its evolutionary history has not been thoroughly studied, hindering the interpretation of comparative studies. To date, the NANOG family was thought to be monogenic, with numerous pseudogenes described in mammals, including a tandem duplicate in Hominidae. By examining a wide-array of craniate genomes, we provide evidence that the NANOG family arose at the latest in the most recent common ancestor of osteichthyans and that NANOG genes are frequently found as tandem duplicates in sarcopterygians and as a single gene in actinopterygians. Their phylogenetic distribution is thus reminiscent of that recently shown for Class V POU paralogues, another key family of pluripotency-controlling factors. However, while a single ancestral duplication has been reported for the Class V POU family, we suggest that multiple independent duplication events took place during evolution of the NANOG family. These multiple duplications could have contributed to create a layer of complexity in the control of cell competence and pluripotency, which could explain the discrepancies relative to the functional evolution of this important gene family. Further, our analysis does not support the hypothesis that loss of NANOG and emergence of the preformation mode of primordial germ cell specification are causally linked. Our study therefore argues for the need of further functional comparisons between NANOG paralogues, notably regarding the novel duplicates identified in sauropsids and non-eutherian mammals.	[Scerbo, Pierluigi; Markov, Gabriel V.; Vivien, Celine; Demeneix, Barbara; Coen, Laurent; Girardot, Fabrice] Museum Natl Hist Nat, CNRS, Dept Regulat Dev & Diversite Mol, Paris, France; [Scerbo, Pierluigi; Kodjabachian, Laurent] Aix Marseille Univ, Inst Biol Dev Marseille, CNRS, Marseille, France; [Markov, Gabriel V.] Univ Lyon, Inst Genom Fonct Lyon, Ecole Normale Super Lyon, CNRS, Lyon, France; [Markov, Gabriel V.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany; [Vivien, Celine] WatchFrog SA, Evry, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Max Planck Society	Girardot, F (corresponding author), Museum Natl Hist Nat, CNRS, Dept Regulat Dev & Diversite Mol, Paris, France.	girardot@mnhn.fr	Girardot, Fabrice/B-7587-2012; Vivien, Celine/AAJ-8066-2020; Markov, Gabriel V./Y-5043-2019	Girardot, Fabrice/0000-0002-0916-877X; Markov, Gabriel V./0000-0002-8566-7482; Scerbo, Pierluigi/0000-0002-3360-4367; Kodjabachian, Laurent/0000-0002-4000-612X	Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale [FDT20100920225, FDT20110922932]; Watchfrog S.A. (CIFRE Convention) [216/2011]; European Union [LSHM-CT-2005-018652 CRESCENDO, FP7-PEOPLE-2013-ITN DEVCOM]; Ministere de L'Ecologie et du Developpement Durable [2009 nu0007065]; l'Agence Nationale de la Recherche	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Watchfrog S.A. (CIFRE Convention); European Union(European Commission); Ministere de L'Ecologie et du Developpement Durable; l'Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Ministere de l'Enseignement Superieur et de la Recherche (PhD fellowships to PS and GVM); by Fondation pour la Recherche Medicale (PhD fellowships grant FDT20100920225 and FDT20110922932 to GVM and PS, respectively); by Watchfrog S.A. (CIFRE Convention 216/2011 Ph.D. fellowship to C. V.); by European Union (contracts LSHM-CT-2005-018652 CRESCENDO and FP7-PEOPLE-2013-ITN DEVCOM); by Ministere de L'Ecologie et du Developpement Durable (Programme National de Recherche sur les Perturbateurs Endocriniens contract 2009 nu0007065) and by l'Agence Nationale de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2007, MOL BIOL EVOL, V24, P1219, DOI 10.1093/molbev/msm042; Booth HAF, 2004, GENOMICS, V84, P229, DOI 10.1016/j.ygeno.2004.02.014; Borrull A, 2012, J CANCER RES CLIN, V138, P1145, DOI 10.1007/s00432-012-1186-2; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Camp E, 2009, STEM CELLS, V27, P2081, DOI 10.1002/stem.133; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Dixon JE, 2010, DEVELOPMENT, V137, P2973, DOI 10.1242/dev.049262; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fairbanks DJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-12; FELSENSTEIN J, 1978, SYST ZOOL, V27, P27, DOI 10.2307/2412810; Force A, 1999, GENETICS, V151, P1531; Frankenberg S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-56; Frankenberg S, 2013, DEVELOPMENT, V140, P965, DOI 10.1242/dev.091629; Frankenberg S, 2010, DEV BIOL, V337, P162, DOI 10.1016/j.ydbio.2009.10.017; Gharib WH, 2011, BRIEF BIOINFORM, V12, P436, DOI 10.1093/bib/bbr031; Gogarten JP, 1999, CURR OPIN GENET DEV, V9, P630, DOI 10.1016/S0959-437X(99)00029-5; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Johnson AD, 2003, PHILOS T ROY SOC B, V358, P1371, DOI 10.1098/rstb.2003.1331; Johnson AD, 2011, REPRODUCTION, V141, P291, DOI 10.1530/REP-10-0474; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Niwa H, 2008, EVOL DEV, V10, P671, DOI 10.1111/j.1525-142X.2008.00280.x; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Onichtchouk D, 2012, GENESIS, V50, P75, DOI 10.1002/dvg.20800; Onichtchouk D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.9; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Robertson M, 2006, MAMM GENOME, V17, P732, DOI 10.1007/s00335-005-0131-y; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Saunders A, 2013, STEM CELLS; Scerbo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036855; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Schuff M, 2012, STEM CELLS DEV, V21, P1225, DOI 10.1089/scd.2011.0285; Sommer RJ, 2008, BIOESSAYS, V30, P653, DOI 10.1002/bies.20776; TAKEDA H, 1994, GENE DEV, V8, P45, DOI 10.1101/gad.8.1.45; Tapia N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2229; Teshima KM, 2004, GENETICS, V166, P1553, DOI 10.1534/genetics.166.3.1553; Theunissen TW, 2011, DEVELOPMENT, V138, P4853, DOI 10.1242/dev.068775; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vinogradov AE, 1998, CYTOMETRY, V31, P100, DOI 10.1002/(SICI)1097-0320(19980201)31:2<100::AID-CYTO5>3.0.CO;2-Q; Sanchez-Sanchez AV, 2010, STEM CELLS, V28, P1457, DOI 10.1002/stem.469; Xu C, 2012, DEV CELL, V22, P625, DOI 10.1016/j.devcel.2012.01.003; Yang Y, 2004, ANIM GENET, V35, P411, DOI 10.1111/j.1365-2052.2004.01173.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x; Zhou Y, 2013, J MOL CELL BIOL	49	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85104	10.1371/journal.pone.0085104	http://dx.doi.org/10.1371/journal.pone.0085104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465486	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000024
J	Bai, X; Lee, JY; Kim, TI; Dai, F; Lee, TJ; Hong, SJ				Bai, Xuelian; Lee, Ji-Yun; Kim, Tae Im; Dai, Fuhong; Lee, Tae-Jin; Hong, Sung-Jong			Molecular Cloning and Characterization of Growth Factor Receptor Bound-Protein in Clonorchis sinensis	PLOS ONE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; GRB2 ADAPTER PROTEIN; SH3 DOMAINS; SIGNAL-TRANSDUCTION; INSULIN-RECEPTOR; GENE-EXPRESSION; TYROSINE KINASE; RAS; SOS; DYNAMIN	Background: Clonorchis sinensis causes clonorchiasis, a potentially serious disease. Growth factor receptor-bound protein 2 (Grb2) is a cytosolic protein conserved among animals and plays roles in cellular functions such as meiosis, organogenesis and energy metabolism. In the present study, we report first molecular characters of growth factor receptor bound-protein (CsGrb2) from C. sinensis as counter part of Grb2 from animals and its possible functions in development and organogenesis of C. sinensis. Methodology/Principal Findings: A CsGrb2 cDNA clone retrieved from the C. sinensis transcriptome encoded a polypeptide with a SH3-SH2-SH3 structure. Recombinant CsGrb2 was bacterially produced and purified to homogeneity. Native CsGrb2 with estimated molecular weight was identified from C. sinensis adult extract by western blotting using a mouse immune serum to recombinant CsGrb2. CsGrb2 transcripts was more abundant in the metacercariae than in the adults. Immunohistochemical staining showed that CsGrb2 was localized to the suckers, mesenchymal tissues, sperms in seminal receptacle and ovary in the adults, and abundantly expressed in most organs of the metacercariae. Recombinant CsGrb2 was evaluated to be little useful as a serodiagnostic reagent for C. sinesis human infections. Conclusion: Grb2 protein found in C. sinensis was conserved among animals and suggested to play a role in the organogenesis, energy metabolism and mitotic spermatogenesis of C. sinensis. These findings from C. sinensis provide wider understanding on diverse function of Grb2 in lower animals such as platyhelminths.	[Bai, Xuelian; Lee, Ji-Yun; Kim, Tae Im; Dai, Fuhong; Hong, Sung-Jong] Chung Ang Univ, Coll Med, Dept Med Environm Biol, Seoul 156756, South Korea; [Lee, Tae-Jin] Chung Ang Univ, Coll Med, Dept Pathol, Seoul 156756, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital	Hong, SJ (corresponding author), Chung Ang Univ, Coll Med, Dept Med Environm Biol, Seoul 156756, South Korea.	hongsj@cau.ac.kr		Lee, Ji-Yun/0000-0002-4053-6577	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A080681]	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A080681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARSAGI D, 1993, CELL, V74, P83, DOI 10.1016/0092-8674(93)90296-3; BONINI JA, 1995, AM J PHYSIOL-ENDOC M, V269, pE759, DOI 10.1152/ajpendo.1995.269.4.E759; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Cailliau K, 2001, CELL SIGNAL, V13, P51, DOI 10.1016/S0898-6568(00)00138-8; CHARDIN P, 1995, FEBS LETT, V369, P47, DOI 10.1016/0014-5793(95)00578-W; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; CUSSAC D, 1994, EMBO J, V13, P4011, DOI 10.1002/j.1460-2075.1994.tb06717.x; Denkinger DJ, 2000, BBA-GENE STRUCT EXPR, V1491, P253, DOI 10.1016/S0167-4781(00)00008-7; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Kaburagi Y, 1997, J BIOL CHEM, V272, P25839, DOI 10.1074/jbc.272.41.25839; Kim TI, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001414; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kondo A, 2008, J BIOL CHEM, V283, P1428, DOI 10.1074/jbc.M704999200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; MAIGNAN S, 1995, SCIENCE, V268, P291, DOI 10.1126/science.7716522; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; MATUOKA K, 1993, EMBO J, V12, P3467, DOI 10.1002/j.1460-2075.1993.tb06021.x; MATUOKA K, 1992, P NATL ACAD SCI USA, V89, P9015, DOI 10.1073/pnas.89.19.9015; Mur C, 2002, DIABETES, V51, P743, DOI 10.2337/diabetes.51.3.743; Nema V, 2013, BIOINFORMATION, V9, P796, DOI 10.6026/97320630009796; Oligino L, 1997, J BIOL CHEM, V272, P29046, DOI 10.1074/jbc.272.46.29046; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; Paez-Espinosa V, 2001, ENDOCRINE, V14, P295, DOI 10.1385/ENDO:14:3:295; Pan Z, 2008, MOL CELL BIOCHEM, V307, P121, DOI 10.1007/s11010-007-9591-6; SCAIFE R, 1994, EMBO J, V13, P2574, DOI 10.1002/j.1460-2075.1994.tb06547.x; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; SUEN KL, 1993, MOL CELL BIOL, V13, P5500, DOI 10.1128/MCB.13.9.5500; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vidal M, 1998, J BIOL CHEM, V273, P5343, DOI 10.1074/jbc.273.9.5343; Vidal M, 1999, J MOL BIOL, V290, P717, DOI 10.1006/jmbi.1999.2899; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711; Yoo WG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001208; Yoo WG, 2009, PARASITOL RES, V104, P321, DOI 10.1007/s00436-008-1195-x; Yoon SY, 2002, J CELL BIOCHEM, V84, P150, DOI 10.1002/jcb.1275; Yu GZ, 2009, J CANCER RES CLIN, V135, P1331, DOI 10.1007/s00432-009-0574-8; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	44	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85577	10.1371/journal.pone.0085577	http://dx.doi.org/10.1371/journal.pone.0085577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454892	Green Published, gold, Green Submitted			2022-12-25	WOS:000330236000013
J	Li, MH; Holmes, V; Zhou, Y; Ni, HP; Sanzari, JK; Kennedy, AR; Weissman, D				Li, Minghong; Holmes, Veronica; Zhou, Yu; Ni, Houping; Sanzari, Jenine K.; Kennedy, Ann R.; Weissman, Drew			Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections	PLOS ONE			English	Article							SOLAR PARTICLE EVENTS; SPACE-FLIGHT; IMMUNE-SYSTEM; DNA-PKCS; ANTIORTHOSTATIC SUSPENSION; SPACEFLIGHT CONDITIONS; UNLOADING MODEL; RESPONSES; MICE; ASTRONAUTS	A major risk of extended space travel is the combined effects of weightlessness and radiation exposure on the immune system. In this study, we used the hindlimb suspension model of microgravity that includes the other space stressors, situational and confinement stress and alterations in food intake, and solar particle event (SPE)-like radiation to measure the combined effects on the ability to control bacterial infections. A massive increase in morbidity and decrease in the ability to control bacterial growth was observed using 2 different types of bacteria delivered by systemic and pulmonary routes in 3 different strains of mice. These data suggest that an astronaut exposed to a strong SPE during extended space travel is at increased risk for the development of infections that could potentially be severe and interfere with mission success and astronaut health.	[Li, Minghong; Holmes, Veronica; Zhou, Yu; Ni, Houping; Weissman, Drew] Univ Penn, Dept Med, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Sanzari, Jenine K.; Kennedy, Ann R.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Weissman, D (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA.	dreww@mail.med.upenn.edu			National Space Biomedical Research Institute (NSBRI) through NASA NCC [9-58]	National Space Biomedical Research Institute (NSBRI) through NASA NCC	This work was supported by a grant from the National Space Biomedical Research Institute (NSBRI) through NASA NCC 9-58. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aponte VM, 2006, LIFE SCI, V79, P1317, DOI 10.1016/j.lfs.2006.04.007; ARMSTRONG JW, 1993, J APPL PHYSIOL, V75, P2734, DOI 10.1152/jappl.1993.75.6.2734; Aviles H, 2005, NEUROIMMUNOMODULAT, V12, P173, DOI 10.1159/000084850; Aviles H, 2003, J APPL PHYSIOL, V95, P491, DOI 10.1152/japplphysiol.00259.2003; Aviles H, 2003, J APPL PHYSIOL, V95, P73, DOI 10.1152/japplphysiol.00968.2002; Baillie SE, 2012, CHEM COMMUN, V48, P1985, DOI 10.1039/c2cc16959b; Belay T, 2002, J ALLERGY CLIN IMMUN, V110, P262, DOI 10.1067/mai.2002.126459; Cena H, 2003, EUR J NUTR, V42, P99, DOI 10.1007/s00394-003-0392-8; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; CHOI KH, 1994, J ANTIMICROB CHEMOTH, V33, P1233, DOI 10.1093/jac/33.6.1233; Clegg W, 2013, DALTON T, V42, P2512, DOI 10.1039/c2dt32176a; Crucian B., 2009, RISK CREW ADVERSE HL; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Drake B., 2009, NASASP2009566 JOHNS; Fabre KM, 2011, RADIAT RES, V175, P493, DOI 10.1667/RR2431.1; Fischer JC, 2011, TRANSFUSION, V51, P1431, DOI 10.1111/j.1537-2995.2010.02998.x; FLEMING SD, 1990, AVIAT SPACE ENVIR MD, V61, P327; Flowers CR, 2013, J CLIN ONCOL, V31, P794, DOI 10.1200/JCO.2012.45.8661; Fu YP, 2003, CANCER RES, V63, P2440; Gridley DS, 2008, IN VIVO, V22, P159; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hu LH, 2009, J CHROMATOGR A, V1216, P5377, DOI 10.1016/j.chroma.2009.05.030; Hu SW, 2009, HEALTH PHYS, V96, P465, DOI 10.1097/01.HP.0000339020.92837.61; Kahler SW, 2012, ASTROPHYS J, P1; Kantemiris I, 2011, MED PHYS, V38, P6585, DOI 10.1118/1.3662911; Kim MHY, 2009, HEALTH PHYS, V97, P68, DOI 10.1097/01.HP.0000346799.65001.9c; Kita M, 2004, J GRAVIT PHYSL, V11, pP67; LANE HW, 1994, AM J CLIN NUTR, V60, p801S, DOI 10.1093/ajcn/60.5.801S; Lee EH, 2005, AVIAT SPACE ENVIR MD, V76, P536; Levine DS, 1998, AVIAT SPACE ENVIR MD, V69, P172; Maks CJ, 2011, RADIAT RES, V176, P170, DOI 10.1667/RR2413.1; MEEHAN R, 1993, J LEUKOCYTE BIOL, V54, P236, DOI 10.1002/jlb.54.3.236; Mehta SK, 2000, J INFECT DIS, V182, P1761, DOI 10.1086/317624; Mehta SK, 2004, J MED VIROL, V72, P174, DOI 10.1002/jmv.10555; Mermel LA, 2013, CLIN INFECT DIS, V56, P123, DOI 10.1093/cid/cis861; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Mori N, 2001, ONCOGENE, V20, P3609, DOI 10.1038/sj.onc.1204497; NASH PV, 1991, EXP CELL RES, V195, P353, DOI 10.1016/0014-4827(91)90384-7; Ohmori Sachiko, 1997, Environmental Medicine (Nagoya), V41, P9; Okayasu R, 2000, CANCER RES, V60, P4342; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Pierson DL, 2005, BRAIN BEHAV IMMUN, V19, P235, DOI 10.1016/j.bbi.2004.08.001; Romero-Weaver AL, 2013, RAD RES; Romero-Weaver AL, 2013, ASTROBIOLOG IN PRESS; Romero-Weaver Ana L, 2012, Int J Biomed Sci, V8, P7; Sastry KJ, 2001, IN VITRO CELL DEV-AN, V37, P203; Setlow RB, 2003, EMBO REP, V4, P1013, DOI 10.1038/sj.embor.7400016; Shearer WT, 2005, J ALLERGY CLIN IMMUN, V115, P1297, DOI 10.1016/j.jaci.2005.03.003; Sonnenfeld G, 2003, ADV SPACE RES-SERIES, V32, P1473, DOI 10.1016/S0273-1177(03)90383-8; Sonnenfeld G, 2002, NUTRITION, V18, P899, DOI 10.1016/S0899-9007(02)00903-6; STEFFEN JM, 1986, AVIAT SPACE ENVIR MD, V57, P162; Stowe RP, 2001, AVIAT SPACE ENVIR MD, V72, P884; Townsend L. W., 2006, INFORM NEEDED MAKE R; Townsend LW, 2005, RADIAT PROT DOSIM, V115, P44, DOI 10.1093/rpd/nci141; Uri JJ, 2005, ACTA ASTRONAUT, V56, P883, DOI 10.1016/j.actaastro.2005.01.014; Walker C, 2006, J P ROBINSON; Wang KX, 2007, P NATL ACAD SCI USA, V104, P14777, DOI 10.1073/pnas.0703236104; Wei LX, 2003, CELL RES, V13, P465, DOI 10.1038/sj.cr.7290189; Wimalawansa SM, 1999, ENDOCRINE, V10, P253, DOI 10.1007/BF02738624	60	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85665	10.1371/journal.pone.0085665	http://dx.doi.org/10.1371/journal.pone.0085665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454913	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100116
J	Tachinardi, P; Bicudo, JEW; Oda, GA; Valentinuzzi, VS				Tachinardi, Patricia; Wilken Bicudo, Jose Eduardo; Oda, Gisele Akemi; Sandra Valentinuzzi, Veronica			Rhythmic 24 h Variation of Core Body Temperature and Locomotor Activity in a Subterranean Rodent (Ctenomys aff. knighti), the Tuco-Tuco	PLOS ONE			English	Article							WHEEL-RUNNING ACTIVITY; CIRCADIAN-RHYTHMS; DIURNAL RHYTHMS; METABOLIC-RATE; ENERGETICS; THERMOREGULATION; ENTRAINMENT; AMPLITUDE; TALARUM; ACCESS	The tuco-tuco Ctenomys aff. knighti is a subterranean rodent which inhabits a semi-arid area in Northwestern Argentina. Although they live in underground burrows where environmental cycles are attenuated, they display robust, 24 h locomotor activity rhythms that are synchronized by light/dark cycles, both in laboratory and field conditions. The underground environment also poses energetic challenges (e. g. high-energy demands of digging, hypoxia, high humidity, low food availability) that have motivated thermoregulation studies in several subterranean rodent species. By using chronobiological protocols, the present work aims to contribute towards these studies by exploring day-night variations of thermoregulatory functions in tuco-tucos, starting with body temperature and its temporal relationship to locomotor activity. Animals showed daily, 24 h body temperature rhythms that persisted even in constant darkness and temperature, synchronizing to a daily light/dark cycle, with highest values occurring during darkness hours. The range of oscillation of body temperature was slightly lower than those reported for similar-sized and dark-active rodents. Most rhythmic parameters, such as period and phase, did not change upon removal of the running wheel. Body temperature and locomotor activity rhythms were robustly associated in time. The former persisted even after removal of the acute effects of intense activity on body temperature by a statistical method. Finally, regression gradients between body temperature and activity were higher in the beginning of the night, suggesting day-night variation in thermal conductance and heat production. Consideration of these day-night variations in thermoregulatory processes is beneficial for further studies on thermoregulation and energetics of subterranean rodents.	[Tachinardi, Patricia; Wilken Bicudo, Jose Eduardo; Oda, Gisele Akemi] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil; [Sandra Valentinuzzi, Veronica] Ctr Reg Invest Cient & Transferencia Tecnol La Ri, La Rioja, Argentina	Universidade de Sao Paulo	Oda, GA (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil.	gaoda@ib.usp.br; vvalentinuzzi@crilar-conicet.gob.ar	oda, gisele a/F-4283-2012	oda, gisele a/0000-0001-7776-5368	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2011/1979]; CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas; Brazilian Agency FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2008/55035-5, 2010/50222-1, 2012/15767-2]; FAPESP [2008/58687-3, 2010/03565-0]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [130127/2010-08];  [PIP-11420090100252]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Brazilian Agency FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica, grant PICT 2011/1979, and by CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas; http://www.conicet.gov.ar/), grant PIP-11420090100252, from Argentina. Also by the Brazilian Agency FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; www.fapesp.br) grant # 2008/55035-5, 2010/50222-1 and 2012/15767-2. PT received two fellowships from FAPESP 2008/58687-3 and 2010/03565-0 as well as from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; www.cnpq.br) (130127/2010-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arends A., 2002, COMP BIOCH PHYSL A, V131, P105; ASCHOFF J, 1973, J COMP PHYSIOL PSYCH, V85, P20, DOI 10.1037/h0034849; Aschoff J., 1982, COMPANION ANIMAL PHY, P173; Aschoff Jurgen, 1972, ADV CLIMATIC PHYSL, P334; Begall S., 2007, SUBTERRANEAN RODENTS; Blanchong JA, 1999, J BIOL RHYTHM, V14, P364, DOI 10.1177/074873099129000777; Buffenstein R, 2000, LIFE UNDERGROUND, P62; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Burda H, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P21, DOI 10.1007/978-3-540-69276-8_3; BUSCH C, 1989, COMP BIOCHEM PHYS A, V93, P345, DOI 10.1016/0300-9629(89)90048-0; Busch C, 2000, LIFE UNDERGROUND, P183; Chan YL, 2006, PLOS GENET, V2, P451, DOI 10.1371/journal.pgen.0020059; Cook JA, 1998, EVOLUTION, V52, P1521, DOI 10.1111/j.1558-5646.1998.tb02035.x; DECASTRO JM, 1978, PHYSIOL BEHAV, V21, P883, DOI 10.1016/0031-9384(78)90160-9; Decoursey PJ, 1998, PHYSIOL BEHAV, V65, P457, DOI 10.1016/S0031-9384(98)00187-5; EDGAR DM, 1991, J BIOL RHYTHM, V6, P185, DOI 10.1177/074873049100600301; Flores DEFL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068243; Goldman BD, 1997, J BIOL RHYTHM, V12, P348, DOI 10.1177/074873049701200407; GOLOMBEK DA, 1993, PHYSIOL BEHAV, V53, P1049, DOI 10.1016/0031-9384(93)90358-M; Gordon CJ, 1997, J THERM BIOL, V22, P59, DOI 10.1016/S0306-4565(96)00035-6; Harri M, 1999, LAB ANIM SCI, V49, P401; HONMA K, 1978, JPN J PHYSIOL, V28, P159; Kas MJH, 1999, J NEUROSCI, V19, P328, DOI 10.1523/JNEUROSCI.19-01-00328.1999; Lacey EA, 1998, J MAMMAL, V79, P986, DOI 10.2307/1383106; Lacey EA, 2000, LIFE UNDERGROUND BIO; LOVEGROVE BG, 1994, AUST J ZOOL, V42, P65, DOI 10.1071/ZO9940065; Lovegrove BG, 1996, PHYSIOL BEHAV, V60, P991; LOVEGROVE BG, 1991, J THERM BIOL, V16, P185, DOI 10.1016/0306-4565(91)90025-W; Luna F, 2002, CAN J ZOOL, V80, P2144, DOI 10.1139/Z02-201; Luna F, 2007, COMP BIOCHEM PHYS A, V146, P559, DOI 10.1016/j.cbpa.2005.12.025; Luna F, 2009, PHYSIOL BIOCHEM ZOOL, V82, P226, DOI 10.1086/597526; MATHER JG, 1981, MAMMAL REV, V11, P41, DOI 10.1111/j.1365-2907.1981.tb00246.x; MCNAB BK, 1966, ECOLOGY, V47, P712, DOI 10.2307/1934259; Moore-Ede M., 1984, CLOCKS TIME US PHYSL; NEVO E, 1979, ANNU REV ECOL SYST, V10, P269, DOI 10.1146/annurev.es.10.110179.001413; Perissinotti PP, 2009, COMP BIOCHEM PHYS A, V154, P298, DOI 10.1016/j.cbpa.2009.05.013; R Development Core Team, 2010, R LANG ENV STAT COMP; REEBS SG, 1989, J BIOL RHYTHM, V4, P39, DOI 10.1177/074873048900400103; Refinetti R, 1997, BIOL RHYTHM RES, V28, P19, DOI 10.1076/brhm.28.3.5.19.13127; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Refinetti R, 1999, J THERM BIOL, V24, P477, DOI 10.1016/S0306-4565(99)00077-7; Refinetti R, 2010, FRONT BIOSCI-LANDMRK, V15, P564, DOI 10.2741/3634; Riccio AP, 2000, PHYSIOL BEHAV, V71, P15, DOI 10.1016/S0031-9384(00)00280-8; Valentinuzzi VS, 2009, CHRONOBIOL INT, V26, P14, DOI 10.1080/07420520802686331; Schleich CE, 2010, J COMP NEUROL, V518, P4001, DOI 10.1002/cne.22440; Sedlacek F, 2007, SUBTERRANEAN RODENTS, P21; Sherwin CM, 1998, ANIM BEHAV, V56, P11, DOI 10.1006/anbe.1998.0836; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Tachinardi P, 2012, THESIS U SAO PAULO; Tomotani BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037918; VASSALLO AI, 1994, J MAMMAL, V75, P725, DOI 10.2307/1382522; Weinert D, 1998, PHYSIOL BEHAV, V63, P837, DOI 10.1016/S0031-9384(97)00546-5	54	18	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85674	10.1371/journal.pone.0085674	http://dx.doi.org/10.1371/journal.pone.0085674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454916	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100118
J	Nishimura, M; Satoh, M; Nishimura, S; Kakinuma, S; Sato, K; Sawai, S; Tsuchida, S; Kazama, T; Matsushita, K; Kado, S; Kodera, Y; Nomura, F				Nishimura, Motoi; Satoh, Mamoru; Nishimura, Satomi; Kakinuma, Shoko; Sato, Kenichi; Sawai, Setsu; Tsuchida, Sachio; Kazama, Takeshi; Matsushita, Kazuyuki; Kado, Sayaka; Kodera, Yoshio; Nomura, Fumio			Human Apolipoprotein E Resequencing by Proteomic Analysis and Its Application to Serotyping	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; ALZHEIMERS-DISEASE; E ISOFORMS; PROTEINS; PLASMA; SERUM	Background: Apolipoprotein E (ApoE) typing is considered important because of the association between ApoE and Alzheimer's disease and familial dyslipidemia and is currently performed by genetic testing (APOE genotyping). ApoE levels in plasma and serum are clinically determined by immunoassay. Methods: Combining an ApoE immunoassay reagent with proteomic analysis using an Orbitrap mass spectrometer, we attempted to resequence ApoE from trace amounts of serum for typing (serotyping). Most (24 of 33) ApoE mutant proteins registered to date with Online Mendelian Inheritance in Man, such as ApoE2 and ApoE4, involve lysine and arginine mutations. Digestion of mutant ApoE with trypsin will thus result in fragments that differ substantially from wild-type ApoE3 in terms of mass, making serotyping ideally suited to mass spectrometry analysis. Results: The mean coverage of the amino acid sequence of full-length ApoE was 91.6% in the protein resequence. Residues 112 and 158 (which are mutated in ApoE2 and ApoE4) were covered in all samples, and the protein sequences were used for serotyping. Serotypes including all heterozygous combinations (ApoE2/E3, E2/E4, E3/E4) corresponded exactly to the APOE genotyping results in each of the subjects. Conclusion: Our novel ApoE serotyping method with protein resequencing requires no synthesis of stable isotope-labeled peptides or genome analysis. The method can use residual blood from samples collected for routine clinical tests, thus enabling retrospective studies with preserved body fluids. The test could be applied to samples from subjects whose DNA is unavailable. In future studies, we hope to demonstrate the capability of our method to detect rare ApoE mutations.	[Nishimura, Motoi; Satoh, Mamoru; Nishimura, Satomi; Kakinuma, Shoko; Sawai, Setsu; Tsuchida, Sachio; Matsushita, Kazuyuki; Nomura, Fumio] Chiba Univ, Dept Mol Diag, Grad Sch Med, Chiba, Japan; [Nishimura, Motoi; Sato, Kenichi; Sawai, Setsu; Kazama, Takeshi; Matsushita, Kazuyuki; Nomura, Fumio] Chiba Univ Hosp, Div Lab Med & Clin Genet, Chiba, Japan; [Nishimura, Motoi; Satoh, Mamoru; Matsushita, Kazuyuki; Kodera, Yoshio; Nomura, Fumio] Chiba Univ Hosp, Clin Prote Res Ctr, Chiba, Japan; [Kado, Sayaka] Chiba Univ, Ctr Chem Anal, Chiba 260, Japan; [Kodera, Yoshio] Kitasato Univ, Lab Biomol Dynam, Dept Phys, Sch Sci, Sagamihara, Kanagawa 228, Japan	Chiba University; Chiba University; Chiba University; Chiba University; Kitasato University	Nishimura, M (corresponding author), Chiba Univ, Dept Mol Diag, Grad Sch Med, Chiba, Japan.	ZXA03460@nifty.ne.jp	Matsushita, Kazuyuki/AAJ-5380-2020	Matsushita, Kazuyuki/0000-0001-6742-0761	JSPS KAKENHI [13059483]; Grants-in-Aid for Scientific Research [25670266] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Our work is supported by JSPS KAKENHI (Grant-in-Aid for Young Scientists (B)) Grant Number 13059483). The funder has no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ait-Ghezala G, 2008, CYTOKINE, V44, P283, DOI 10.1016/j.cyto.2008.08.013; Chen KH, 2011, J ALZHEIMERS DIS, V26, P755, DOI 10.3233/JAD-2011-110002; Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n; Gupta VB, 2011, NEUROLOGY, V76, P1091, DOI 10.1212/WNL.0b013e318211c352; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luis CA, 2009, AGING NEUROPSYCHOL C, V16, P203, DOI 10.1080/13825580802411766; Oikawa S, 1997, J AM SOC NEPHROL, V8, P820; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Satoh M, 2005, PROTEOMICS, V5, P1113, DOI 10.1002/pmic.200401117; Uchida Y, 2000, J CLIN LAB ANAL, V14, P260, DOI 10.1002/1098-2825(20001212)14:6<260::AID-JCLA2>3.0.CO;2-I; Wang MY, 2012, ANAL CHEM, V84, P8340, DOI 10.1021/ac3018873; Wildsmith KR, 2009, ANAL BIOCHEM, V395, P116, DOI 10.1016/j.ab.2009.07.049	13	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85356	10.1371/journal.pone.0085356	http://dx.doi.org/10.1371/journal.pone.0085356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454848	Green Published, Green Submitted, gold			2022-12-25	WOS:000329925800041
J	Gulia, KK; Patel, N; Radhakrishnan, A; Kumar, VM				Gulia, Kamalesh K.; Patel, Niraj; Radhakrishnan, Arathi; Kumar, Velayudhan Mohan			Reduction in Ultrasonic Vocalizations in Pups Born to Rapid Eye Movement Sleep Restricted Mothers in Rat Model	PLOS ONE			English	Article							ANXIETY-RELATED BEHAVIOR; PRENATAL STRESS; ANIMAL-MODELS; INFANT RATS; PREGNANCY; DEPRIVATION; RISK; CONSEQUENCES; PATTERNS; GROWTH	The effects of rapid eye movement sleep restriction (REMSR) in rats during late pregnancy were studied on the ultrasonic vocalizations (USVs) made by the pups. USVs are distress calls inaudible to human ears. Rapid eye movement (REM) sleep was restricted in one group of pregnant rats for 22 hours, starting from gestational day 14 to 20, using standard single platform method. The USVs of male pups were recorded after a brief isolation from their mother for two minutes on alternate post-natal days, from day one till weaning. The USVs were recorded using microphones and were analysed qualitatively and quantitatively using SASPro software. Control pups produced maximum vocalization on post-natal days 9 to 11. In comparison, the pups born to REMSR mothers showed not only a reduction in vocalization but also a delay in peak call making days. The experimental group showed variations in the types and characteristics of call types, and alteration in temporal profile. The blunting of distress call making response in these pups indicates that maternal sleep plays a role in regulating the neural development involved in vocalizations and possibly in shaping the emotional behaviour in neonates. It is suggested that the reduced ultrasonic vocalizations can be utilized as a reliable early marker for affective state in rat pups. Such impaired vocalization responses could provide an important lead in understanding mother-child bonding for an optimal cognitive development during post-partum life. This is the first report showing a potential link between maternal REM sleep deprivation and the vocalization in neonates and infants.	[Gulia, Kamalesh K.; Patel, Niraj; Radhakrishnan, Arathi; Kumar, Velayudhan Mohan] Sree Chitra Tirunal Inst Med Sci & Technol, Comprehens Ctr Sleep Disorders, Sleep Res Lab, Trivandrum, Kerala, India	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST)	Gulia, KK (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Comprehens Ctr Sleep Disorders, Sleep Res Lab, Trivandrum, Kerala, India.	kkguliak@hotmail.com	Gulia, Kamalesh/AAC-2011-2022	Gulia, Kamalesh/0000-0002-2253-2644; Kumar, Velayudhan Mohan/0000-0002-8477-6679	Department of Science and Technology, India [SR/WOS-A/LS-59/2008, SR/CSI/110/2012]	Department of Science and Technology, India(Department of Science & Technology (India))	The study was supported by the Research Grant from Department of Science and Technology, India (SR/WOS-A/LS-59/2008 & SR/CSI/110/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIN JT, 1972, ANIM BEHAV, V20, P175, DOI 10.1016/S0003-3472(72)80189-1; Blumberg MS, 2001, PSYCHOL REV, V108, P83, DOI 10.1037//0033-295X.108.1.83; Branchi I, 2001, BEHAV BRAIN RES, V125, P49, DOI 10.1016/S0166-4328(01)00277-7; Braw Y, 2008, BEHAV BRAIN RES, V193, P94, DOI 10.1016/j.bbr.2008.04.026; Brudzynski SM, 1999, DEV PSYCHOBIOL, V34, P195, DOI 10.1002/(SICI)1098-2302(199904)34:3<195::AID-DEV4>3.0.CO;2-S; Brunelli SA, 2001, DEV PSYCHOBIOL, V38, P221, DOI 10.1002/dev.1016; BRUNELLI SA, 1994, J COMP PSYCHOL, V108, P298, DOI 10.1037/0735-7036.108.3.298; Chang JJ, 2010, SLEEP MED REV, V14, P107, DOI 10.1016/j.smrv.2009.05.001; D'Amato FR, 2005, BEHAV GENET, V35, P103, DOI 10.1007/s10519-004-0860-9; DRIVER HS, 1992, SLEEP, V15, P449, DOI 10.1093/sleep/15.5.449; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Gale CR, 2004, BRAIN, V127, P321, DOI 10.1093/brain/awh034; Gale CR, 2004, BRIT J PSYCHIAT, V184, P28, DOI 10.1192/bjp.184.1.28; Groenink Lucianne, 2008, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0518s43; Hedman C, 2002, SLEEP MED, V3, P37, DOI 10.1016/S1389-9457(01)00130-7; HERTZ G, 1992, SLEEP, V15, P246, DOI 10.1093/sleep/15.3.246; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Kimura M, 1996, AM J PHYSIOL-REG I, V271, pR1063, DOI 10.1152/ajpregu.1996.271.4.R1063; Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961; LaGasse LL, 2005, MENT RETARD DEV D R, V11, P83, DOI 10.1002/mrdd.20050; Micheli K, 2011, EPIDEMIOLOGY, V22, P738, DOI 10.1097/EDE.0b013e31822546fd; Morgan KN, 1999, DEV PSYCHOBIOL, V34, P205, DOI 10.1002/(SICI)1098-2302(199904)34:3<205::AID-DEV5>3.0.CO;2-V; Naito H, 2000, EXP ANIM TOKYO, V49, P289, DOI 10.1538/expanim.49.289; Nishina H, 1996, NEUROSCI LETT, V203, P5, DOI 10.1016/0304-3940(95)12249-4; NOIROT E, 1972, DEV PSYCHOBIOL, V5, P371, DOI 10.1002/dev.420050410; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; O'Neil MF, 2003, HUM PSYCHOPHARM CLIN, V18, P239, DOI 10.1002/hup.496; OKON EE, 1972, J ZOOL, V68, P139; Okun ML, 2009, OBSTET GYNECOL SURV, V64, P273, DOI 10.1097/OGX.0b013e318195160e; Pertsov SS, 2012, B EXP BIOL MED+, V153, P805, DOI 10.1007/s10517-012-1831-4; Pires GN, 2010, MED HYPOTHESES, V75, P578, DOI 10.1016/j.mehy.2010.07.036; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Ratcliff R, 2009, PSYCHON B REV, V16, P742, DOI 10.3758/PBR.16.4.742; RYCHLIK L, 1990, J ETHOL, V8, P69, DOI 10.1007/BF02350276; Scattoni ML, 2008, BEHAV BRAIN RES, V187, P371, DOI 10.1016/j.bbr.2007.09.034; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schwarting RKW, 2012, BRAZ J MED BIOL RES, V45, P337, DOI 10.1590/S0100-879X2012007500038; Shair HN, 2003, DEV PSYCHOBIOL, V42, P206, DOI 10.1002/dev.10087; Soltis J, 2004, BEHAV BRAIN SCI, V27, P443, DOI 10.1017/S0140525X0400010X; Tonkiss J, 2003, DEV PSYCHOBIOL, V43, P90, DOI 10.1002/dev.10124; VERMA S, 1989, INDIAN J EXP BIOL, V27, P892; Walker MP, 2008, SLEEP MED, V9, pS29, DOI 10.1016/S1389-9457(08)70014-5; Wilson DL, 2011, AUST NZ J OBSTET GYN, V51, P38, DOI 10.1111/j.1479-828X.2010.01252.x; Wohr M, 2008, BEHAV NEUROSCI, V122, P310, DOI 10.1037/0735-7044.122.2.310; Zeskind Philip Sanford, 2011, Front Psychiatry, V2, P56, DOI 10.3389/fpsyt.2011.00056	46	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84948	10.1371/journal.pone.0084948	http://dx.doi.org/10.1371/journal.pone.0084948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454768	Green Submitted, gold, Green Published			2022-12-25	WOS:000329922500026
J	Kovacev, J; Wu, K; Spratt, DE; Chong, RA; Lee, C; Nayak, J; Shaw, GS; Pan, ZQ				Kovacev, Jordan; Wu, Kenneth; Spratt, Donald E.; Chong, Robert A.; Lee, Chan; Nayak, Jaladhi; Shaw, Gary S.; Pan, Zhen-Qiang			A SnapShot of Ubiquitin Chain Elongation LYSINE 48-TETRA-UBIQUITIN SLOWS DOWN UBIQUITINATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Catenin; E3 Ubiquitin Ligase; Enzymes; Post Translational Modification; Protein Degradation; Ubiquitination; Cdc34; E2 Conjugating Enzyme; SCF; UbcH5c	RING E3 LIGASE; CULLIN; SCF; NEDD8; COMPLEX; TETRAUBIQUITIN; CONFORMATION; RECRUITMENT; INHIBITION; ACTIVATION	Background: Polyubiquitin chains are signaling polypeptides altering the fate of substrates. Results: A Lys-48-ubiquitin chain of a length greater than four, but not its Lys-63 linkage counterparts, slowed the rate of additional ubiquitin conjugation. Conclusion: The ubiquitin chain length and linkage may impact kinetic rates of chain elongation. Significance: Our findings suggest a self-restraining mechanism that limits Lys-48-polyubiquitination. We have explored the mechanisms of polyubiquitin chain assembly with reconstituted ubiquitination of IB and -catenin by the Skp1-cullin 1-TrCP F-box protein (SCFTrCP) E3 ubiquitin (Ub) ligase complex. Competition experiments revealed that SCFTrCP formed a complex with IB and that the Nedd8 modified E3-substrate platform engaged in dynamic interactions with the Cdc34 E2 Ub conjugating enzyme for chain elongation. Using elongation intermediates containing -catenin linked with Ub chains of defined length, it was observed that a Lys-48-Ub chain of a length greater than four, but not its Lys-63 linkage counterparts, slowed the rate of additional Ub conjugation. Thus, the Ub chain length and linkage impact kinetic rates of chain elongation. Given that Lys-48-tetra-Ub is packed into compact conformations due to extensive intrachain interactions between Ub subunits, this topology may limit the accessibility of SCFTrCP/Cdc34 to the distal Ub Lys-48 and result in slowed elongation.	[Kovacev, Jordan; Wu, Kenneth; Chong, Robert A.; Lee, Chan; Nayak, Jaladhi; Pan, Zhen-Qiang] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Spratt, Donald E.; Shaw, Gary S.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada; [Pan, Zhen-Qiang] Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou 221002, Jiangsu, Peoples R China	Icahn School of Medicine at Mount Sinai; Western University (University of Western Ontario); Xuzhou Medical University	Pan, ZQ (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, One Gustave L Levy Pl, New York, NY 10029 USA.	zhen-qiang.pan@mssm.edu	Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625; Lee, Chan/0000-0002-5512-8146; Spratt, Donald/0000-0002-0699-155X	National Institutes of Health (Public Health Service) [GM61051, CA095634]; Canadian Institutes of Health Research [MOP-14606]; National Institutes of Health Fellowship [1F30DK095572-01]; NATIONAL CANCER INSTITUTE [R01CA095634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK095572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061051] Funding Source: NIH RePORTER	National Institutes of Health (Public Health Service)(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM61051 and CA095634 (Public Health Service; to Z.-Q.P.). This work was also supported by Canadian Institutes of Health Research Grant MOP-14606 (to G.S.S.).; Supported by National Institutes of Health Fellowship 1F30DK095572-01.	Choi YS, 2010, J BIOL CHEM, V285, P17754, DOI 10.1074/jbc.M109.090621; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2012, MOL CELL, V47, P371, DOI 10.1016/j.molcel.2012.05.044; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Gazdoiu S, 2007, MOL CELL BIOL, V27, P7041, DOI 10.1128/MCB.00812-07; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirano T, 2011, J BIOL CHEM, V286, P37496, DOI 10.1074/jbc.M111.256354; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Lai MY, 2012, BBA-MOL CELL RES, V1823, P2046, DOI 10.1016/j.bbamcr.2012.04.003; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Phillips CL, 2001, ACTA CRYSTALLOGR D, V57, P341, DOI 10.1107/S090744490001800X; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Safadi SS, 2007, BIOCHEMISTRY-US, V46, P14162, DOI 10.1021/bi7016969; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Skaar JR, 2009, CELL, V137, DOI 10.1016/j.cell.2009.05.039; Spratt DE, 2012, J BIOL CHEM, V287, P17374, DOI 10.1074/jbc.M112.353748; Spratt DE, 2011, J MOL BIOL, V407, P425, DOI 10.1016/j.jmb.2011.01.047; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Tron AE, 2012, MOL CELL, V46, P67, DOI 10.1016/j.molcel.2012.02.005; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Wu SD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2636; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Ye Y, 2012, NATURE, V492, P266, DOI 10.1038/nature11722; Zemla A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2628; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	39	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7068	7081		10.1074/jbc.M113.530576	http://dx.doi.org/10.1074/jbc.M113.530576			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24464578	Green Published, hybrid			2022-12-25	WOS:000332389400066
J	Guo, HF; Qu, YF; Liu, XD; Zhong, WF; Fang, JC				Guo, Huifang; Qu, Yufeng; Liu, Xiangdong; Zhong, Wanfang; Fang, Jichao			Female-Biased Symbionts and Tomato Yellow Leaf Curl Virus Infections in Bemisia tabaci	PLOS ONE			English	Article							SECONDARY SYMBIONTS; ENDOSYMBIONTS; APHIDS; TRANSMISSION; WHITEFLIES; DIVERSITY; LOCALIZATION; ALEYRODIDAE; ACQUISITION; RICKETTSIA	The female-biased infection of facultative symbionts has been found in Bemisia tabaci; however, whether there are any differences in tomato yellow leaf curl virus (TYLCV) and obligate symbiont infection rates between females and males is unknown. Determining whether such differences exist would be very important for understanding the spread of the plant virus and of the symbionts. We compared both symbiont infection types, including obligate and facultative symbionts, and the rates of TYLCV infection in both sexes in five field populations from Jiangsu Province, China. The obligate symbiont Portiera aleyrodidarum was not found in every whitefly tested. In all tested populations, more females than males were found to harbor P. aleyrodidarum; and more females than males also harbored Hamiltonella defense, the most common facultative symbiont as well as Cardinium. In addition to female-biased symbiont infections, there were also female-biased TYLCV infections, and the infection frequencies of this plant virus in females were higher than those in males. Taken together, these results suggested that both the female-biased symbiont infections and female-biased TYLCV infections promoted the rapid spread of TYLCV in China.	[Guo, Huifang; Qu, Yufeng; Zhong, Wanfang; Fang, Jichao] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China; [Liu, Xiangdong] Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Nanjing Agricultural University	Guo, HF (corresponding author), Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China.	guohfjaas@163.com			Key Technology R&D Program of Jiangsu province, China [BE2010342]; Independent Innovation Fund of Agricultural Science and Technology in Jiangsu province [cx(11)2016]	Key Technology R&D Program of Jiangsu province, China; Independent Innovation Fund of Agricultural Science and Technology in Jiangsu province	This research was supported by grants from the Key Technology R&D Program of Jiangsu province, China (BE2010342) and the Independent Innovation Fund of Agricultural Science and Technology in Jiangsu province (cx(11)2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Byrne FJ, 1996, BIOCHEM GENET, V34, P93, DOI 10.1007/BF02396243; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Ghanim M, 2000, J VIROL, V74, P4738, DOI 10.1128/JVI.74.10.4738-4745.2000; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Li ZX, 2007, CURR MICROBIOL, V54, P467, DOI 10.1007/s00284-007-0011-7; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; Muniyappa V, 2000, ARCH VIROL, V145, P1583, DOI 10.1007/s007050070078; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Pan Huipeng, 2012, Commun Integr Biol, V5, P337, DOI 10.4161/cib.20398; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Su Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep01367; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Thao ML, 2003, CURR MICROBIOL, V47, P46, DOI 10.1007/s00284-002-3953-9; Thao MLL, 2004, CURR MICROBIOL, V48, P140, DOI 10.1007/s00284-003-4157-7; Thierry M, 2011, MOL ECOL, V20, P2172, DOI 10.1111/j.1365-294X.2011.05087.x; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	35	16	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84538	10.1371/journal.pone.0084538	http://dx.doi.org/10.1371/journal.pone.0084538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465416	gold, Green Submitted, Green Published			2022-12-25	WOS:000330283100012
J	Qasim, M; Khan, ZH; Khan, WA; Shah, IA				Qasim, Muhammad; Khan, Zafar Hayat; Khan, Waqar Ahmad; Shah, Inayat Ali			MHD Boundary Layer Slip Flow and Heat Transfer of Ferrofluid along a Stretching Cylinder with Prescribed Heat Flux	PLOS ONE			English	Article							STAGNATION-POINT FLOW; GROUP TRANSFORMATION; NANOFLUID; SHEET	This study investigates the magnetohydrodynamic (MHD) flow of ferrofluid along a stretching cylinder. The velocity slip and prescribed surface heat flux boundary conditions are employed on the cylinder surface. Water as conventional base fluid containing nanoparticles of magnetite (Fe3O4) is used. Comparison between magnetic (Fe3O4) and non-magnetic (Al2O3) nanoparticles is also made. The governing non-linear partial differential equations are reduced to non-linear ordinary differential equations and then solved numerically using shooting method. Present results are compared with the available data in the limiting cases. The present results are found to be in an excellent agreement. It is observed that with an increase in the magnetic field strength, the percent difference in the heat transfer rate of magnetic nanoparticles with Al2O3 decreases. Surface shear stress and the heat transfer rate at the surface increase as the curvature parameter increases, i.e curvature helps to enhance the heat transfer.	[Qasim, Muhammad] COMSATS Inst Informat Technol, Dept Math, Islamabad, Pakistan; [Khan, Zafar Hayat] Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China; [Khan, Waqar Ahmad] Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan; [Shah, Inayat Ali] Islamia Coll Peshawar CU, Dept Math, Khyber Pakhtunkhwa, Pakistan	COMSATS University Islamabad (CUI); Peking University; National University of Sciences & Technology - Pakistan	Qasim, M (corresponding author), COMSATS Inst Informat Technol, Dept Math, Pk Rd, Islamabad, Pakistan.	mq_qau@yahoo.com	Khan, Waqar/H-3886-2013; QASIM, MUHAMMAD/D-5593-2011; Khan, Zafar Hayat/D-5542-2013	Khan, Waqar/0000-0002-8328-850X; QASIM, MUHAMMAD/0000-0001-6516-9809; Khan, Zafar Hayat/0000-0001-9412-2727				Abdel-Salam, 2011, MIDDLE E J SCI RES, V8, P764; Abdul-Kahar R, 2011, COMPUT FLUIDS, V52, P15, DOI 10.1016/j.compfluid.2011.08.003; Ashorynejad HR, 2013, HEAT MASS TRANSFER, V49, P427, DOI 10.1007/s00231-012-1087-6; Bachok N., 2010, MALAYS J MATH SCI, V4, P159; Choi S.U.S., 1995, ASME, V66, P99, DOI DOI 10.1115/1.1532008; Hamad MAA, 2012, COMMUN NONLINEAR SCI, V17, P132, DOI 10.1016/j.cnsns.2011.02.024; Hamad MAA, 2011, INT COMMUN HEAT MASS, V38, P487, DOI 10.1016/j.icheatmasstransfer.2010.12.042; Hamad MAA, 2011, TRANSPORT POROUS MED, V87, P25, DOI 10.1007/s11242-010-9683-8; Ishak A., 2009, EUR J SCI RES, V36, P22; Kandasamy R, 2011, NUCL ENG DES, V241, P2053, DOI 10.1016/j.nucengdes.2011.04.011; Khan W, 2013, APPL NANOSCI, V1, P1; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Makinde OD, 2013, INT J HEAT MASS TRAN, V62, P526, DOI 10.1016/j.ijheatmasstransfer.2013.03.049; Mukhopadhay S, 2013, INT J APPL MATH MECH, V9, P62; Mukhopadhyay S, 2013, AIN SHAMS ENG J, V4, P317, DOI 10.1016/j.asej.2012.07.003; Nadeem S, 2013, APPL NANOSCIENCE, P1; Ozerinc S, 2010, MICROFLUID NANOFLUID, V8, P145, DOI 10.1007/s10404-009-0524-4; Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0; Rosmila AB, 2012, APPL MATH MECH-ENGL, V33, P593, DOI 10.1007/s10483-012-1573-9; Yacob NA, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-314	20	80	80	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e83930	10.1371/journal.pone.0083930	http://dx.doi.org/10.1371/journal.pone.0083930			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465388	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100009
J	Benzekry, S; Gandolfi, A; Hahnfeldt, P				Benzekry, Sebastien; Gandolfi, Alberto; Hahnfeldt, Philip			Global Dormancy of Metastases Due to Systemic Inhibition of Angiogenesis	PLOS ONE			English	Article							PRIMARY TUMOR; BREAST-CANCER; SIZE DISTRIBUTION; GROWTH; MODEL; MECHANISMS; RESECTION; ANGIOSTATIN; SUPPRESSION; PREVALENCE	Autopsy studies of adults dying of non-cancer causes have shown that virtually all of us possess occult, cancerous lesions. This suggests that, for most individuals, cancer will become dormant and not progress, while only in some will it become symptomatic disease. Meanwhile, it was recently shown in animal models that a tumor can produce both stimulators and inhibitors of its own blood supply. To explain the autopsy findings in light of the preclinical research data, we propose a mathematical model of cancer development at the organism scale describing a growing population of metastases, which, together with the primary tumor, can exert a progressively greater level of systemic angiogenesis-inhibitory influence that eventually overcomes local angiogenesis stimulation to suppress the growth of all lesions. As a departure from modeling efforts to date, we look not just at signaling from and effects on the primary tumor, but integrate over this increasingly negative global signaling from all sources to track the development of total tumor burden. This in silico study of the dynamics of the tumor/metastasis system identifies ranges of parameter values where mutual angio-inhibitory interactions within a population of tumor lesions could yield global dormancy, i.e., an organism-level homeostatic steady state in total tumor burden. Given that mortality arises most often from metastatic disease rather than growth of the primary per se, this finding may have important therapeutic implications.	[Benzekry, Sebastien; Hahnfeldt, Philip] Tufts Univ, Sch Med, Ctr Canc Syst Biol, GRI, Boston, MA 02111 USA; [Benzekry, Sebastien] Inst Math Bordeaux, Inria Team MC2, Bordeaux, France; [Gandolfi, Alberto] Ist Anal Sistemi & Informat Antonio Ruberti, Rome, Italy	Tufts University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR)	Hahnfeldt, P (corresponding author), Tufts Univ, Sch Med, Ctr Canc Syst Biol, GRI, Boston, MA 02111 USA.	philip.hahnfeldt@tufts.edu	Benzekry, Sébastien/AAG-5164-2020	Benzekry, Sébastien/0000-0002-3749-8637	National Cancer Institute [U54CA149233]; NATIONAL CANCER INSTITUTE [U54CA149233] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute under Award Number U54CA149233 (to L. Hlatky). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Albini A, 2012, NAT REV CLIN ONCOL, P1; Almog N, 2006, FASEB J, V20, P947, DOI 10.1096/fj.05-3946fje; Almog N, 2010, CANCER LETT, V294, P139, DOI 10.1016/j.canlet.2010.03.004; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; AUGUST DA, 1985, CANCER-AM CANCER SOC, V55, P1490, DOI 10.1002/1097-0142(19850401)55:7<1490::AID-CNCR2820550712>3.0.CO;2-N; Barbolosi D, 2009, MATH BIOSCI, V218, P1, DOI 10.1016/j.mbs.2008.11.008; Benzekry S, 2012, MATH MODEL NAT PHENO, V7, P306, DOI 10.1051/mmnp/20127114; BENZEKRY S, 2011, J EVOL EQU, V11, P187; Benzekry S, 2012, J BIOL DYNAM, V6, P19, DOI 10.1080/17513758.2011.568071; Benzekry S, 2012, ESAIM-MATH MODEL NUM, V46, P207, DOI 10.1051/m2an/2011041; Bethge A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035689; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; Brackstone M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1677; Chen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017933; Chiarella P, 2012, CANCER LETT, V324, P133, DOI 10.1016/j.canlet.2012.05.021; d'Onofrio A, 2004, MATH BIOSCI, V191, P159, DOI 10.1016/j.mbs.2004.06.003; Devys A, 2009, DISCRETE CONT DYN-B, V12, P731, DOI 10.3934/dcdsb.2009.12.731; DEWYS WD, 1972, CANCER RES, V32, P374; Ehrlich P, 1905, BERLINER KLIN WOCHEN, V42, P871; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FISHER B, 1983, CANCER RES, V43, P1488; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; FOLKMAN J, 1995, MOL MED, V1, P120, DOI 10.1007/BF03401559; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; GORELIK E, 1983, CANCER RES, V43, P138; GUNDUZ N, 1979, CANCER RES, V39, P3861; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hahnfeldt P, 1999, CANCER RES, V59, P4770; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanin L, 2013, ADV EXP MED BIOL, V734, P261, DOI 10.1007/978-1-4614-1445-2_12; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Huang XJ, 2002, CANCER RES, V62, P5727; Iwata K, 2000, J THEOR BIOL, V203, P177, DOI 10.1006/jtbi.2000.1075; Levine HA, 2001, B MATH BIOL, V63, P801, DOI 10.1006/bulm.2001.0240; Li TS, 2001, EUR J CANCER, V37, P2283, DOI 10.1016/S0959-8049(01)00281-7; LIOTTA LA, 1976, BIOMETRICS, V32, P535, DOI 10.2307/2529743; NIELSEN M, 1987, BRIT J CANCER, V56, P814, DOI 10.1038/bjc.1987.296; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Ossowski L, 2010, PIGM CELL MELANOMA R, V23, P41, DOI 10.1111/j.1755-148X.2009.00647.x; Peeters CFJM, 2008, ANN SURG ONCOL, V15, P3308, DOI 10.1245/s10434-008-0029-5; Peeters CFJM, 2006, INT J CANCER, V119, P1249, DOI 10.1002/ijc.21928; PREHN RT, 1993, CANCER RES, V53, P3266; Retsky MW, 2008, APMIS, V116, P730, DOI 10.1111/j.1600-0463.2008.00990.x; Retsky Michael, 2010, Cancers (Basel), V2, P305, DOI 10.3390/cancers2020305; Retsky MW, 1997, BREAST CANCER RES TR, V45, P193, DOI 10.1023/A:1005849301420; Rofstad EK, 2001, J INVEST DERMATOL, V117, P1042, DOI 10.1046/j.0022-202x.2001.01552.x; Sanchez-Chapado M, 2003, PROSTATE, V54, P238, DOI 10.1002/pros.10177; Sckell A, 1998, CANCER RES, V58, P5866; SUGARBAKER EV, 1971, ANN SURG, V174, P161, DOI 10.1097/00000658-197108000-00001; Tait CR, 2004, J PATHOL, V203, P515, DOI 10.1002/path.1544; Venderbosch S, 2011, ANN SURG ONCOL, V18, P3252, DOI 10.1245/s10434-011-1951-5; Volpert OV, 1998, P NATL ACAD SCI USA, V95, P6343, DOI 10.1073/pnas.95.11.6343; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Willis L, 2010, CANCER RES, V70, P4310, DOI 10.1158/0008-5472.CAN-09-3144	58	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84249	10.1371/journal.pone.0084249	http://dx.doi.org/10.1371/journal.pone.0084249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465399	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500002
J	Bitsikas, V; Riento, K; Howe, JD; Barry, NP; Nichols, BJ				Bitsikas, Vassilis; Riento, Kirsi; Howe, Jonathan D.; Barry, Nicholas P.; Nichols, Benjamin J.			The Role of Flotillins in Regulating A beta Production, Investigated Using Flotillin 1-/-, Flotillin 2-/- Double Knockout Mice	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; TRANSGENIC MICE; MEMBRANE MICRODOMAINS; TRAFFICKING; ENDOCYTOSIS; REGGIE-1/FLOTILLIN-2; CYTOSKELETON; REGGIE/FLOTILLIN; ACCUMULATION	Flotillin 1 and flotillin 2 associate in the plasma membrane to form microdomains that have roles in cell signaling, regulation of cell-cell contacts, membrane-cytoskeletal interactions, and endocytosis. They are thought to be involved in the trafficking and hence processing of the Amyloid Precursor Protein, APP. In this study we set out to obtain in vivo confirmation of a link between flotillins and cleavage of APP to release amyloidogenic A beta peptide, and to generate tools that would allow us to ask whether flotillins are functionally redundant. We used a mouse model for A beta-dependent cerebral amyloidosis, APPPS1 mice, combined with deletion of either flotillin 1 singly, or flotillin 1 and flotillin 2 together. There was a small but significant reduction in A beta levels, and the Abundance of congo-red stained plaques, in brains of 12 week old mice lacking flotillin 1. A similar reduction in A beta levels was observed in the flotillin 1-/-, flotillin 2-/-double knockouts. We did not observe large effects on the clustering or endocytosis of APP in flotillin 1-/-mouse embryonic fibroblasts. We conclude that flotillins are likely to play some role in APP trafficking or processing, but the relevant cellular mechanisms require more investigation. The availability of flotillin 1-/-, flotillin 2-/-mice, which have no overt phenotypes, will facilitate research into flotillin function in vivo.	[Bitsikas, Vassilis; Riento, Kirsi; Howe, Jonathan D.; Barry, Nicholas P.; Nichols, Benjamin J.] MRC, Mol Biol Lab, Cambridge, England	MRC Laboratory Molecular Biology	Nichols, BJ (corresponding author), MRC, Mol Biol Lab, Cambridge, England.	ben@mrc-lmb.cam.ac.uk		Bitsikas, Vassilis/0000-0002-1731-9910	Medical Research Council, UK; MRC [MC_U105178778] Funding Source: UKRI; Medical Research Council [MC_U105178778] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affentranger S, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-28; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Chen TY, 2006, BIOCHEM BIOPH RES CO, V342, P266, DOI 10.1016/j.bbrc.2006.01.156; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Girardot N, 2003, NEUROPATH APPL NEURO, V29, P451, DOI 10.1046/j.1365-2990.2003.00479.x; Guillaume E, 2013, J CELL SCI; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jensen M, 2000, MOL MED, V6, P291, DOI 10.1007/BF03401938; Koo EH, 1996, J CELL SCI, V109, P991; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Langhorst MF, 2007, FEBS LETT, V581, P4697, DOI 10.1016/j.febslet.2007.08.074; Langui D, 2004, AM J PATHOL, V165, P1465, DOI 10.1016/S0002-9440(10)63405-0; Ludwig A, 2010, J CELL BIOL, V191, P771, DOI 10.1083/jcb.201005140; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Okabayashi S, 2010, NEUROREPORT, V21, P606, DOI 10.1097/WNR.0b013e3283383467; Otto GP, 2011, J CELL SCI, V124, P3933, DOI 10.1242/jcs.092015; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Rajendrana L, 2007, NEURODEGENER DIS, V4, P164, DOI 10.1159/000101841; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Rossy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005403; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Stuermer CAO, 2011, J NEUROCHEM, V116, P708, DOI 10.1111/j.1471-4159.2010.07007.x; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200	34	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85217	10.1371/journal.pone.0085217	http://dx.doi.org/10.1371/journal.pone.0085217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465508	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500044
J	Ditlev, SB; Florea, R; Nielsen, MA; Theander, TG; Magez, S; Boeuf, P; Salanti, A				Ditlev, Sisse B.; Florea, Raluca; Nielsen, Morten A.; Theander, Thor G.; Magez, Stefan; Boeuf, Philippe; Salanti, Ali			Utilizing Nanobody Technology to Target Non-Immunodominant Domains of VAR2CSA	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; PREGNANCY-ASSOCIATED MALARIA; FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; INHIBITORY ANTIBODIES; MEMBRANE PROTEIN-1; EPITOPES; ADHESION; IMMUNOGLOBULINS; IDENTIFICATION	Placental malaria is a major health problem for both pregnant women and their fetuses in malaria endemic regions. It is triggered by the accumulation of Plasmodium falciparum-infected erythrocytes (IE) in the intervillous spaces of the placenta and is associated with foetal growth restriction and maternal anemia. IE accumulation is supported by the binding of the parasite-expressed protein VAR2CSA to placental chondroitin sulfate A (CSA). Defining specific CSA-binding epitopes of VAR2CSA, against which to target the immune response, is essential for the development of a vaccine aimed at blocking IE adhesion. However, the development of a VAR2CSA adhesion-blocking vaccine remains challenging due to (i) the large size of VAR2CSA and (ii) the extensive immune selection for polymorphisms and thereby non-neutralizing B-cell epitopes. Camelid heavy-chain-only antibodies (HcAbs) are known to target epitopes that are less immunogenic to classical IgG and, due to their small size and protruding antigen-binding loop, able to reach and recognize cryptic, conformational epitopes which are inaccessible to conventional antibodies. The variable heavy chain (VHH) domain is the antigen-binding site of camelid HcAbs, the so called Nanobody, which represents the smallest known (15 kDa) intact, native antigen-binding fragment. In this study, we have used the Nanobody technology, an approach new to malaria research, to generate small and functional antibody fragments recognizing unique epitopes broadly distributed on VAR2CSA.	[Ditlev, Sisse B.; Nielsen, Morten A.; Theander, Thor G.; Salanti, Ali] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Ditlev, Sisse B.; Nielsen, Morten A.; Theander, Thor G.; Salanti, Ali] Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Florea, Raluca; Magez, Stefan] Vrije Univ Brussel, Cellular & Mol Immunol Res Unit, Brussels, Belgium; [Florea, Raluca; Magez, Stefan] VIB, Dept Biol Struct, Brussels, Belgium; [Boeuf, Philippe] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia; [Boeuf, Philippe] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia	University of Copenhagen; Rigshospitalet; University of Copenhagen; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); University of Melbourne; Royal Melbourne Hospital	Ditlev, SB (corresponding author), Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	sditlev@sund.ku.dk	Magez, Stefan/D-9497-2014; Magez, Stefan/AAC-5682-2021; Theander, Thor/F-6714-2015	Magez, Stefan/0000-0003-3760-7968; Magez, Stefan/0000-0003-3760-7968; Theander, Thor/0000-0002-3509-7514; Boeuf, Philippe/0000-0002-5851-3373; Nielsen, Morten Agertoug/0000-0003-2668-4992; Salanti, Ali/0000-0003-2207-5575; Ditlev, Sisse Bolm/0000-0003-4417-9711	Danish Research Council for Development Research (RUF); IWT (Agentschap voor Innovatie door Wetenschap en Technologie) Belgium; Danish National Advanced Technology Foundation; Proof of Concept Foundation DTU; Novo Nordisk Fonden [1015627]; Australian NHMRC [1003384]	Danish Research Council for Development Research (RUF); IWT (Agentschap voor Innovatie door Wetenschap en Technologie) Belgium; Danish National Advanced Technology Foundation; Proof of Concept Foundation DTU; Novo Nordisk Fonden(Novo Nordisk Foundation); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	SBD is supported by a PhD studentship from the Danish Research Council for Development Research (RUF). RF is supported by IWT (Agentschap voor Innovatie door Wetenschap en Technologie) Belgium. This study received funding from Danish National Advanced Technology Foundation and Proof of Concept Foundation DTU. The project also was supported by Novo Nordisk Fonden, Project number: 1015627 and also supported by a Project grant from the Australian NHMRC to Philippe Boeuf Grant # 1003384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Avril M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-36; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Barfod L, 2010, J IMMUNOL, V185, P7553, DOI 10.4049/jimmunol.1002390; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Boeuf P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003153; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; De Genst EJ, 2010, J MOL BIOL, V402, P326, DOI 10.1016/j.jmb.2010.07.001; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Fernandez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012558; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Fried M, 2013, INFECT IMMUN, V81, P487, DOI 10.1128/IAI.01106-12; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Magistrado PA, 2011, VACCINE, V29, P437, DOI 10.1016/j.vaccine.2010.10.080; Minaeian S, 2012, J MICROBIOL BIOTECHN, V22, P721, DOI 10.4014/jmb.1112.12001; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Nielsen MA, 2007, EXP PARASITOL, V117, P1, DOI 10.1016/j.exppara.2007.03.002; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Obiakor H, 2013, CLIN VACCINE IMMUNOL, V20, P433, DOI 10.1128/CVI.00638-12; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Srivastava A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020270; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Stijlemans B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002072; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Tutterrow YL, 2012, INFECT IMMUN, V80, P1479, DOI 10.1128/IAI.00071-12; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7	37	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84981	10.1371/journal.pone.0084981	http://dx.doi.org/10.1371/journal.pone.0084981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465459	Green Submitted, gold, Green Published			2022-12-25	WOS:000330244500024
J	Secatto, A; Soares, EM; Locachevic, GA; Assis, PA; Paula-Silva, FWG; Serezani, CH; de Medeiros, AI; Faccioli, LH				Secatto, Adriana; Soares, Elyara Maria; Locachevic, Gisele Aparecida; Assis, Patricia Aparecida; Garcia Paula-Silva, Francisco Wanderlei; Serezani, Carlos Henrique; de Medeiros, Alexandra Ivo; Faccioli, Lucia Helena			The Leukotriene B-4/BLT1 Axis Is a Key Determinant in Susceptibility and Resistance to Histoplasmosis	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; HOST CONTROL; B-4; PHAGOCYTOSIS; CAPSULATUM; MICE; MEDIATORS; INFECTION; PLAY; INHIBITION	The bioactive lipid mediator leukotriene B-4 (LTB4) greatly enhances phagocyte antimicrobial functions against a myriad of pathogens. In murine histoplasmosis, inhibition of the LT-generating enzyme 5-lypoxigenase (5-LO) increases the susceptibility of the host to infection. In this study, we investigated whether murine resistance or susceptibility to Histoplasma capsulatum infection is associated with leukotriene production and an enhancement of in vivo and/or in vitro antimicrobial effector function. We show that susceptible C57BL/6 mice exhibit a higher fungal burden in the lung and spleen, increased mortality, lower expression levels of 5-LO and leukotriene B-4 receptor 1 (BLT1) and decreased LTB4 production compared to the resistant 129/Sv mice. Moreover, we demonstrate that endogenous and exogenous LTs are required for the optimal phagocytosis of H. capsulatum by macrophages from both murine strains, although C57BL/6 macrophages are more sensitive to the effects of LTB4 than 129/Sv macrophages. Therefore, our results provide novel evidence that LTB4 production and BLT1 signaling are required for a histoplasmosis-resistant phenotype.	[Secatto, Adriana; Soares, Elyara Maria; Locachevic, Gisele Aparecida; Assis, Patricia Aparecida; Garcia Paula-Silva, Francisco Wanderlei; Faccioli, Lucia Helena] Univ Sao Paulo, Dept Anal Clin Toxicol & Bromatol, Fac Ciencias Farmaceut Ribeirao Preto, Sao Paulo, Brazil; [Garcia Paula-Silva, Francisco Wanderlei] Univ Sao Paulo, Dept Odontopediat, Fac Odontol Ribeirao Preto, Sao Paulo, Brazil; [Serezani, Carlos Henrique] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [de Medeiros, Alexandra Ivo] Univ Estadual Paulista, Dept Ciencias Biol, Fac Ciencias Farmaceut, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Indiana University System; Indiana University Bloomington; Universidade Estadual Paulista	de Medeiros, AI (corresponding author), Univ Estadual Paulista, Dept Ciencias Biol, Fac Ciencias Farmaceut, Sao Paulo, Brazil.	medeirosai@fcfar.unesp.br; faccioli@fcfrp.usp.br	Faccioli, Lúcia Helena/AGH-5297-2022; de Paula e Silva, Francisco Wanderley Garcia Garcia/D-1712-2012; Lucia, Faccioli/G-8976-2015; Assis, Patricia/AAW-8642-2021; Medeiros, Alexandra I. AIM/J-6103-2012; serezani, C. Henrique/H-1675-2013	Faccioli, Lúcia Helena/0000-0002-4999-8305; de Paula e Silva, Francisco Wanderley Garcia Garcia/0000-0001-8559-532X; Lucia, Faccioli/0000-0002-4999-8305; Medeiros, Alexandra I. AIM/0000-0001-6048-3647; serezani, C. Henrique/0000-0002-5363-415X	Fundacao de Amparo a Pesquisas do Estado de Sao Paulo (FAPESP, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) [302097/2010-4]; National Institutes of Health (NIH) [HL103777-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL103777] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisas do Estado de Sao Paulo (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Fundacao de Amparo a Pesquisas do Estado de Sao Paulo (FAPESP, Brazil), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico 302097/2010-4 (CNPq, Brazil) and National Institutes of Health (NIH) HL103777-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailie MB, 1996, J IMMUNOL, V157, P5221; Campos MRM, 2009, MOL IMMUNOL, V46, P1204, DOI 10.1016/j.molimm.2008.11.024; Chen NN, 2001, J NEUROIMMUNOL, V120, P94, DOI 10.1016/S0165-5728(01)00415-5; Deepe GS, 2006, J INFECT DIS, V194, P855, DOI 10.1086/506946; Deepe GS, 2000, MED MYCOL, V38, P87, DOI 10.1080/744118735; Deepe GS, 2000, CURR OPIN MICROBIOL, V3, P359, DOI 10.1016/S1369-5274(00)00104-1; FACCIOLI LH, 1991, IMMUNOLOGY, V73, P222; Flamand L, 2007, J IMMUNOL, V178, P8036, DOI 10.4049/jimmunol.178.12.8036; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Funk CD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002040; Calich VLG, 2008, MYCOPATHOLOGIA, V165, P223, DOI 10.1007/s11046-007-9048-1; Heninger E, 2006, J IMMUNOL, V177, P3303, DOI 10.4049/jimmunol.177.5.3303; Lee SP, 2009, J IMMUNOL, V182, P530, DOI 10.4049/jimmunol.182.1.530; Lynch KR, 1999, NATURE, V399, P789; Machado ER, 2005, J IMMUNOL, V175, P3892, DOI 10.4049/jimmunol.175.6.3892; Mancuso P, 1998, INFECT IMMUN, V66, P5140, DOI 10.1128/IAI.66.11.5140-5146.1998; Medeiros AI, 2004, INFECT IMMUN, V72, P1637, DOI 10.1128/IAI.72.3.1637-1644.2004; Medeiros AI, 1999, BRIT J PHARMACOL, V128, P1529, DOI 10.1038/sj.bjp.0702912; Medeiros AI, 2008, J IMMUNOL, V181, P8544, DOI 10.4049/jimmunol.181.12.8544; Morato-Marques M, 2011, J BIOL CHEM, V286, P28902, DOI 10.1074/jbc.M111.235309; Newman SL, 2005, METH MOLEC MED, V118, P181; Okamoto F, 2010, J BIOL CHEM, V285, P41113, DOI 10.1074/jbc.M110.175497; Peres CM, 2007, MICROBES INFECT, V9, P483, DOI 10.1016/j.micinf.2007.01.006; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Pina A, 2008, J LEUKOCYTE BIOL, V83, P1088, DOI 10.1189/jlb.1107738; Pina A, 2006, J LEUKOCYTE BIOL, V79, P1202, DOI 10.1189/jlb.0106052; Sa-Nunes A, 2007, MICROBES INFECT, V9, P1393, DOI 10.1016/j.micinf.2006.10.007; SAMUELSSON B, 1983, ADV PROSTAG THROMB L, V11, P1; Secatto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031701; Serezani CH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002448; Serezani CH, 2006, J IMMUNOL, V177, P3201, DOI 10.4049/jimmunol.177.5.3201; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; Serezani CHC, 2005, BLOOD, V106, P1067, DOI 10.1182/blood-2004-08-3323; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Talvani A, 2002, INFECT IMMUN, V70, P4247, DOI 10.1128/IAI.70.8.4247-4253.2002; Wan Kong-Sang, 2007, Acta Paediatrica Taiwanica, V48, P299; WUHSIEH B, 1989, INFECT IMMUN, V57, P3788, DOI 10.1128/IAI.57.12.3788-3792.1989; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; ZHOU P, 1995, J IMMUNOL, V155, P785	39	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85083	10.1371/journal.pone.0085083	http://dx.doi.org/10.1371/journal.pone.0085083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465479	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500034
J	Tiruvannamalai-Annamalai, R; Armant, DR; Matthew, HWT				Tiruvannamalai-Annamalai, Ramkumar; Armant, David Randall; Matthew, Howard W. T.			A Glycosaminoglycan Based, Modular Tissue Scaffold System for Rapid Assembly of Perfusable, High Cell Density, Engineered Tissues	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; VASCULAR ENDOTHELIAL-CELLS; HUMAN SKIN EQUIVALENT; ARTICULAR CHONDROCYTES; HEPARAN-SULFATE; BLOOD-VESSEL; IN-VITRO; ANGIOGENESIS; HEPATOCYTES	The limited ability to vascularize and perfuse thick, cell-laden tissue constructs has hindered efforts to engineer complex tissues and organs, including liver, heart and kidney. The emerging field of modular tissue engineering aims to address this limitation by fabricating constructs from the bottom up, with the objective of recreating native tissue architecture and promoting extensive vascularization. In this paper, we report the elements of a simple yet efficient method for fabricating vascularized tissue constructs by fusing biodegradable microcapsules with tunable interior environments. Parenchymal cells of various types, (i.e. trophoblasts, vascular smooth muscle cells, hepatocytes) were suspended in glycosaminoglycan (GAG) solutions (4%/1.5% chondroitin sulfate/carboxymethyl cellulose, or 1.5 wt% hyaluronan) and encapsulated by forming chitosan-GAG polyelectrolyte complex membranes around droplets of the cell suspension. The interior capsule environment could be further tuned by blending collagen with or suspending microcarriers in the GAG solution These capsule modules were seeded externally with vascular endothelial cells (VEC), and subsequently fused into tissue constructs possessing VEC-lined, inter-capsule channels. The microcapsules supported high density growth achieving clinically significant cell densities. Fusion of the endothelialized, capsules generated three dimensional constructs with an embedded network of interconnected channels that enabled long-term perfusion culture of the construct. A prototype, engineered liver tissue, formed by fusion of hepatocyte-containing capsules exhibited urea synthesis rates and albumin synthesis rates comparable to standard collagen sandwich hepatocyte cultures. The capsule based, modular approach described here has the potential to allow rapid assembly of tissue constructs with clinically significant cell densities, uniform cell distribution, and endothelialized, perfusable channels.	[Tiruvannamalai-Annamalai, Ramkumar; Matthew, Howard W. T.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA; [Armant, David Randall] Wayne State Univ, Dept Obstet, Detroit, MI USA; [Armant, David Randall] Wayne State Univ, Dept Gynecol, Detroit, MI USA; [Armant, David Randall] NICHHD, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA; [Matthew, Howard W. T.] Wayne State Univ, Dept Chem Engn & Mat Sci, Detroit, MI USA	Wayne State University; Wayne State University; Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University	Matthew, HWT (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.	hmatthew@wayne.edu	Annamalai, Ramkumar T./Q-7043-2019	Annamalai, Ramkumar T./0000-0002-9880-3973; Matthew, Howard/0000-0001-6033-9258; Armant, D. Randall/0000-0001-5904-9325	DRICTR award from Wayne State University; National Science Foundation [CBET-1067323]; National Institutes of Health [HD067629]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD071408] Funding Source: NIH RePORTER; Directorate For Engineering [1067323] Funding Source: National Science Foundation	DRICTR award from Wayne State University; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding for these studies was provided by a DRICTR award from Wayne State University, and grant awards from the National Science Foundation (CBET-1067323) and the National Institutes of Health (HD067629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkadopoulos N, 1998, HEPATOLOGY, V28, P1365, DOI 10.1002/hep.510280527; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bian L, 2011, TISSUE ENG PT A, V17, P1137, DOI [10.1089/ten.tea.2010.0531, 10.1089/ten.TEA.2010.0531]; Bilir BM, 2000, LIVER TRANSPLANT, V6, P32, DOI 10.1016/S1527-6465(00)80030-1; Black AF, 1999, CELL BIOL TOXICOL, V15, P81, DOI 10.1023/A:1007541713398; Butcher JT, 2004, J HEART VALVE DIS, V13, P478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chang Q, 2011, BRAZ J MED BIOL RES, V44, P303, DOI 10.1590/S0100-879X2011007500026; Chang SC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/457971; Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039; Christen T, 1999, CIRC RES, V85, P99; Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7; CROOKS CA, 1990, J BIOMED MATER RES, V24, P1241, DOI 10.1002/jbm.820240908; Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; Fedorovich NE, 2011, TISSUE ENG PT A, V17, P2113, DOI [10.1089/ten.TEA.2011.0019, 10.1089/ten.tea.2011.0019]; Ferretti A, 2003, LIFE SCI, V73, P1985, DOI 10.1016/S0024-3205(03)00541-1; Fillinger MF, 1997, J SURG RES, V67, P169, DOI 10.1006/jsre.1996.4978; Fujita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052272; Fuster MM, 2010, PROG MOL BIOL TRANSL, V93, P179, DOI 10.1016/S1877-1173(10)93009-3; Gaetani R, 2012, BIOMATERIALS, V33, P1782, DOI 10.1016/j.biomaterials.2011.11.003; Gaffney J, 2010, MOL BIOSYST, V6, P437, DOI 10.1039/b910552m; Gallagher SR, 2001, QUANTITATION DNA RNA; Govers R, 2002, BIOCHEM J, V361, P193, DOI 10.1042/0264-6021:3610193; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045; Hammouche S, 2012, CURR STEM CELL RES T, V7, P134, DOI 10.2174/157488812799219018; Jain M, 1996, J CLIN INVEST, V97, P596, DOI 10.1172/JCI118455; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jones E, 2011, INJURY, V42, P562, DOI 10.1016/j.injury.2011.03.030; Kasuya J, 2011, TISSUE ENG PT A, V17, P361, DOI 10.1089/ten.TEA.2010.0033; Kim K, 2012, BIOMATERIALS, V33, P1406, DOI 10.1016/j.biomaterials.2011.10.084; Kobayashi N, 2000, TRANSPLANTATION, V69, P202, DOI 10.1097/00007890-200001270-00002; L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; LaPorta TF, 2012, ORTHOP CLIN N AM, V43, P245, DOI 10.1016/j.ocl.2012.02.002; Lavender MD, 2005, BIOMATERIALS, V26, P4642, DOI 10.1016/j.biomaterials.2004.11.045; Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018; Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381; Leung BM, 2010, TISSUE ENG PT A, V16, P3207, DOI [10.1089/ten.tea.2009.0746, 10.1089/ten.TEA.2009.0746]; Lin SV, 2002, METHODS TISSUE ENG, P815; Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]; Mathieu C, 2013, OSTEOARTHR CARTILAGE, V21, P849, DOI 10.1016/j.joca.2013.03.012; MATTHEW HW, 1993, BIOTECHNOL PROGR, V9, P510, DOI 10.1021/bp00023a010; Matthew HW, 1991, ASAIO T, V37, pM328; Matthew HWT, 1996, BIOTECHNOL BIOENG, V51, P100, DOI 10.1002/(SICI)1097-0290(19960705)51:1<100::AID-BIT12>3.0.CO;2-U; MATTHEW HWT, 1993, J PEDIATR SURG, V28, P1423, DOI 10.1016/0022-3468(93)90424-J; Meretoja VV, 2013, BIOMATERIALS, V34, P4266, DOI 10.1016/j.biomaterials.2013.02.064; Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7; Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007; Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029; Norrby K, 2006, APMIS, V114, P79, DOI 10.1111/j.1600-0463.2006.apm_235.x; Paquet C, 2010, ANN NY ACAD SCI, V1197, P166, DOI 10.1111/j.1749-6632.2009.05373.x; Parekkadan B, 2007, BIOCHEM BIOPH RES CO, V363, P247, DOI 10.1016/j.bbrc.2007.05.150; Scheppke L, 2012, BLOOD, V119, P2149, DOI 10.1182/blood-2011-04-348706; SEGLEN PO, 1979, J TOXICOL ENV HEALTH, V5, P551, DOI 10.1080/15287397909529766; Selwyn AP, 2003, AM J CARDIOL, V91, p3H, DOI 10.1016/S0002-9149(03)00428-4; Steiner D, 2012, J ORTHOP RES, V30, P1682, DOI 10.1002/jor.22130; Stringer SE, 2006, BIOCHEM SOC T, V34, P451, DOI 10.1042/BST0340451; Sun HC, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-41; Surapaneni S, 1997, ASAIO J, V43, pM848; Tao J, 2009, CELLS TISSUES ORGANS, V190, P185, DOI 10.1159/000218139; Uygun BE, 2009, TISSUE ENG PT A, V15, P3499, DOI [10.1089/ten.tea.2008.0405, 10.1089/ten.TEA.2008.0405]; van der Meer AD, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/823148; VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270; Vinatier C, 2009, CURR STEM CELL RES T, V4, P318, DOI 10.2174/157488809789649205; WEST DC, 1989, CIBA F SYMP, V143, P187; WYBENGA DR, 1971, CLIN CHEM, V17, P891; Yagi H, 2009, TISSUE ENG PT A, V15, P3377, DOI [10.1089/ten.tea.2008.0681, 10.1089/ten.TEA.2008.0681]; Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038; Zhao X, 2012, ANN PLAS SURG, V69, P91, DOI 10.1097/SAP.0b013e3182583eb9	72	45	47	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84287	10.1371/journal.pone.0084287	http://dx.doi.org/10.1371/journal.pone.0084287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465401	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500014
J	Herzen, J; Willner, MS; Fingerle, AA; Noel, PB; Kohler, T; Drecoll, E; Rummeny, EJ; Pfeiffer, F				Herzen, Julia; Willner, Marian S.; Fingerle, Alexander A.; Noel, Peter B.; Koehler, Thomas; Drecoll, Enken; Rummeny, Ernst J.; Pfeiffer, Franz			Imaging Liver Lesions Using Grating-Based Phase-Contrast Computed Tomography with Bi-Lateral Filter Post-Processing	PLOS ONE			English	Article							INCIDENTAL FINDINGS; HIGH-RESOLUTION; INTERFEROMETRY; SONOGRAPHY; FREQUENCY; MR	X-ray phase-contrast imaging shows improved soft-tissue contrast compared to standard absorption-based X-ray imaging. Especially the grating-based method seems to be one promising candidate for clinical implementation due to its extendibility to standard laboratory X-ray sources. Therefore the purpose of our study was to evaluate the potential of grating-based phase-contrast computed tomography in combination with a novel bi-lateral denoising method for imaging of focal liver lesions in an ex vivo feasibility study. Our study shows that grating-based phase-contrast CT ( PCCT) significantly increases the soft-tissue contrast in the ex vivo liver specimens. Combining the information of both signals - absorption and phase-contrast - the bi-lateral filtering leads to an improvement of lesion detectability and higher contrast-to-noise ratios. The normal and the pathological tissue can be clearly delineated and even internal structures of the pathological tissue can be visualized, being invisible in the absorption-based CT alone. Histopathology confirmed the presence of the corresponding findings in the analyzed tissue. The results give strong evidence for a sufficiently high contrast for different liver lesions using non-contrast-enhanced PCCT. Thus, ex vivo imaging of liver lesions is possible with a polychromatic X-ray source and at a spatial resolution of similar to 100 mu m. The post-processing with the novel bi-lateral denoising method improves the image quality by combining the information from the absorption and the phase-contrast images.	[Herzen, Julia] Helmholtz Zentrum Geesthacht, Inst Mat Sci, Geesthacht, Germany; [Herzen, Julia; Willner, Marian S.; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, Garching, Germany; [Herzen, Julia; Willner, Marian S.; Pfeiffer, Franz] Tech Univ Munich, Inst Med Engn, Garching, Germany; [Fingerle, Alexander A.; Noel, Peter B.; Rummeny, Ernst J.] Tech Univ Munich, Dept Radiol, D-80290 Munich, Germany; [Koehler, Thomas] Philips Technol GmbH, Innovat Technol, Res Labs, Hamburg, Germany; [Drecoll, Enken] Tech Univ Munich, Inst Pathol, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Technical University of Munich; Technical University of Munich; Technical University of Munich; Philips; Philips Research; Technical University of Munich	Herzen, J (corresponding author), Helmholtz Zentrum Geesthacht, Inst Mat Sci, Geesthacht, Germany.	julia.herzen@hzg.de	Herzen, Julia/B-2368-2015	Herzen, Julia/0000-0002-9456-1591; Noel, Peter/0000-0002-9671-6171	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP); DFG Gottfried Wilhelm Leibniz program; European Research Council (ERC) [StG 240142]; Karlsruhe Nano Micro Facility (KNMF), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)); Karlsruhe Nano Micro Facility (KNMF), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	The Authors JH, MSW and FP acknowledge financial support through the DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP), the DFG Gottfried Wilhelm Leibniz program and the European Research Council (ERC, FP7, StG 240142). This work was carried out with the support of the Karlsruhe Nano Micro Facility (KNMF, www.kit.edu/knmf), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bech M, 2009, J SYNCHROTRON RADIAT, V16, P43, DOI 10.1107/S090904950803464X; Beckmann F, 1999, BIOPHYS J, V76, P98, DOI 10.1016/S0006-3495(99)77181-X; Berland LL, 2010, J AM COLL RADIOL, V7, P754, DOI 10.1016/j.jacr.2010.06.013; Bevins N, 2012, MED PHYS, V39, P424, DOI 10.1118/1.3672163; BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; Cochran ST, 2001, AJR AM J ROENTGENOLO, V176; David C, 2007, MICROELECTRON ENG, V84, P1172, DOI 10.1016/j.mee.2007.01.151; DAVIS TJ, 1995, PHYS REV LETT, V74, P3173, DOI 10.1103/PhysRevLett.74.3173; Dilmanian FA, 2000, PHYS MED BIOL, V45, P933, DOI 10.1088/0031-9155/45/4/309; Donath T, 2010, INVEST RADIOL, V45, P445, DOI 10.1097/RLI.0b013e3181e21866; Eiber M, 2012, EUR J RADIOL, V81, P683, DOI 10.1016/j.ejrad.2011.01.072; Ghetti C, 2008, MED PHYS, V35, P456, DOI 10.1118/1.2828185; Holzapfel K, 2012, ABDOM IMAGING, V37, P74, DOI 10.1007/s00261-011-9758-1; Jensen TH, 2010, PHYS MED BIOL, V55, P3317, DOI 10.1088/0031-9155/55/12/004; Koehler T, 2012, AIP CONF PROC, V1466, P78, DOI 10.1063/1.4742272; Kohler T, 2011, MED PHYS, V38, pS106, DOI 10.1118/1.3532396; Lanitis S, 2012, AM SURGEON, V78, P366; Momose A, 2005, JPN J APPL PHYS 1, V44, P6355, DOI 10.1143/JJAP.44.6355; Momose A, 2006, JPN J APPL PHYS 1, V45, P5254, DOI 10.1143/JJAP.45.5254; Noel PB, 2013, Z MED PHYS; Oudkerk M, 2002, RADIOLOGY, V223, P517, DOI 10.1148/radiol.2232010318; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Raupach R, 2012, MED PHYS, V39, P4761, DOI 10.1118/1.4736529; Revol V, 2011, NUCL INSTRUM METH A, V648, pS302, DOI 10.1016/j.nima.2010.11.040; Reznikova E, 2008, MICROSYST TECHNOL, V14, P1683, DOI 10.1007/s00542-007-0507-x; Sahani DV, 2004, NURSING STANDARD OFF, V10, P55; Schulz G, 2010, J R SOC INTERFACE, V7, P1665, DOI 10.1098/rsif.2010.0281; Seitz K, 2011, ULTRASCHALL MED, V32, P598, DOI 10.1055/s-0031-1281858; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Sztrokay A, 2012, EUROPEAN RADIOLOGY, P1; Thomsen HS, 2010, RADIOLOGY, V256, P672, DOI 10.1148/radiol.100566; van der Molen AJ, 2004, EUR RADIOL, V14, P902, DOI 10.1007/s00330-004-2238-z; Volk M, 2001, ACTA RADIOL, V42, P172, DOI 10.1034/j.1600-0455.2001.042002172.x; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Willner M, 2013, OPT EXPRESS, V21, P4155, DOI 10.1364/OE.21.004155; Zanette I, 2012, P NATL ACAD SCI USA, V109, P10199, DOI 10.1073/pnas.1117861109; Zanette I, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3559849; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109	39	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e83369	10.1371/journal.pone.0083369	http://dx.doi.org/10.1371/journal.pone.0083369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465378	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000007
J	Davison, JM; Yee, M; Krill-Burger, JM; Lyons-Weiler, MA; Kelly, LA; Sciulli, CM; Nason, KS; Luketich, JD; Michalopoulos, GK; LaFramboise, WA				Davison, Jon M.; Yee, Melissa; Krill-Burger, J. Michael; Lyons-Weiler, Maureen A.; Kelly, Lori A.; Sciulli, Christin M.; Nason, Katie S.; Luketich, James D.; Michalopoulos, George K.; LaFramboise, William A.			The Degree of Segmental Aneuploidy Measured by Total Copy Number Abnormalities Predicts Survival and Recurrence in Superficial Gastroesophageal Adenocarcinoma	PLOS ONE			English	Article							LONG-TERM SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; CHROMOSOMAL INSTABILITY; DNA-PLOIDY; BARRETTS-ESOPHAGUS; CANCER; ABERRATIONS; EVENT; GENE; OVEREXPRESSION	Background: Prognostic biomarkers are needed for superficial gastroesophageal adenocarcinoma (EAC) to predict clinical outcomes and select therapy. Although recurrent mutations have been characterized in EAC, little is known about their clinical and prognostic significance. Aneuploidy is predictive of clinical outcome in many malignancies but has not been evaluated in superficial EAC. Methods: We quantified copy number changes in 41 superficial EAC using Affymetrix SNP 6.0 arrays. We identified recurrent chromosomal gains and losses and calculated the total copy number abnormality (CNA) count for each tumor as a measure of aneuploidy. We correlated CNA count with overall survival and time to first recurrence in univariate and multivariate analyses. Results: Recurrent segmental gains and losses involved multiple genes, including: HER2, EGFR, MET, CDK6, KRAS (recurrent gains); and FHIT, WWOX, CDKN2A/B, SMAD4, RUNX1 (recurrent losses). There was a 40-fold variation in CNA count across all cases. Tumors with the lowest and highest quartile CNA count had significantly better overall survival (p = 0.032) and time to first recurrence (p = 0.010) compared to those with intermediate CNA counts. These associations persisted when controlling for other prognostic variables. Significance: SNP arrays facilitate the assessment of recurrent chromosomal gain and loss and allow high resolution, quantitative assessment of segmental aneuploidy (total CNA count). The non-monotonic association of segmental aneuploidy with survival has been described in other tumors. The degree of aneuploidy is a promising prognostic biomarker in a potentially curable form of EAC.	[Davison, Jon M.; Krill-Burger, J. Michael; Lyons-Weiler, Maureen A.; Kelly, Lori A.; Sciulli, Christin M.; Michalopoulos, George K.; LaFramboise, William A.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Yee, Melissa] Univ Pittsburgh, Sch Med, Dept Internal Med, Pittsburgh, PA USA; [Nason, Katie S.; Luketich, James D.] Univ Pittsburgh, Sch Med, Dept Cardiothorac Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Davison, JM (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	davisonjm@upmc.edu	luketich, james/AAY-6230-2020		National Cancer Institute Cancer Center [P30 CA47904]; NATIONAL CANCER INSTITUTE [K07CA151613, P30CA047904] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Cancer Center Support Grant P30 CA47904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2012, NAT GENET, V44, P20, DOI 10.1038/ng.1035; Araujo SEA, 2007, DIS COLON RECTUM, V50, P1800, DOI 10.1007/s10350-007-9013-6; Bang YJ, 2010, LANCET, V376, P1302; Baumbusch LO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054356; Bayraktar S, 2012, BREAST CANCER RES TR, V135, P355, DOI 10.1007/s10549-012-2158-6; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Cahill DP, 1999, TRENDS BIOCHEM SCI, V24, pM57, DOI 10.1016/S0968-0004(99)01466-8; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chang NS, 2007, TRENDS MOL MED, V13, P12, DOI 10.1016/j.molmed.2006.11.006; Choma D, 2001, BRIT J CANCER, V85, P14, DOI 10.1054/bjoc.2001.1892; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Fu BJ, 2008, CANCER BIOL THER, V7, P1593, DOI 10.4161/cbt.7.10.6565; Gaidzik VI, 2011, J CLIN ONCOL, V29, P1364, DOI 10.1200/JCO.2010.30.7926; Goh XY, 2011, GUT, V60, P1317, DOI 10.1136/gut.2010.234179; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gu JA, 2010, CANCER PREV RES, V3, P1176, DOI 10.1158/1940-6207.CAPR-09-0265; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirsch D, 2013, CANCER RES, V73, P1454, DOI 10.1158/0008-5472.CAN-12-0928; Jacobsen CM, 2002, DEV BIOL, V241, P34, DOI 10.1006/dbio.2001.0424; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TM, 2013, GENOME RES, V23, P217, DOI 10.1101/gr.140301.112; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Lai LA, 2010, MOL CANCER RES, V8, P1084, DOI 10.1158/1541-7786.MCR-09-0529; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Li Shuangwei, 2012, Front Med, V6, P275, DOI 10.1007/s11684-012-0216-4; Lin L, 2012, P NATL ACAD SCI USA, V109, P4251, DOI 10.1073/pnas.1011989109; Marx AH, 2010, HISTOPATHOLOGY, V57, P418, DOI 10.1111/j.1365-2559.2010.03643.x; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; MenkePluymers MBE, 1995, HEPATO-GASTROENTEROL, V42, P786; NAKAMURA T, 1994, CANCER-AM CANCER SOC, V73, P1785, DOI 10.1002/1097-0142(19940401)73:7<1785::AID-CNCR2820730703>3.0.CO;2-0; Nancarrow DJ, 2008, CANCER RES, V68, P4163, DOI 10.1158/0008-5472.CAN-07-6710; Ng G, 2006, J MOL DIAGN, V8, P449, DOI 10.2353/jmoldx.2006.060033; Ong CA, 2013, J CLIN ONCOL; Pech O, 2011, ANN SURG, V254, P67, DOI 10.1097/SLA.0b013e31821d4bf6; Pohl H, 2010, CANCER EPIDEM BIOMAR, V19, P1468, DOI 10.1158/1055-9965.EPI-10-0012; Prasad GA, 2009, GASTROENTEROLOGY, V137, P815, DOI 10.1053/j.gastro.2009.05.059; Radu OM, 2012, AM J CLIN PATHOL, V137, P583, DOI 10.1309/AJCPXQVS6YGHPDCY; Reid BJ, 2011, CANCER BIOMARK, V9, P307, DOI 10.3233/CBM-2011-0162; Rice TW, 2010, CANCER-AM CANCER SOC, V116, P3763, DOI 10.1002/cncr.25146; Rice TW, 2001, J THORAC CARDIOV SUR, V122, P1077, DOI 10.1067/mtc.2001.113749; Roylance R, 2011, CANCER EPIDEM BIOMAR, V20, P2183, DOI 10.1158/1055-9965.EPI-11-0343; Saldiyar JC, 2010, J CELL BIOCHEM, V109, P858, DOI 10.1002/jcb.22481; Sarbia M, 1996, J CANCER RES CLIN, V122, P186, DOI 10.1007/BF01366961; Schweigert M, 2013, NAT REV GASTROENTERO; Schweighofer CD, 2013, J MOL DIAGN, V15, P196, DOI 10.1016/j.jmoldx.2012.09.006; Stein HJ, 2005, ANN SURG, V242, P566, DOI 10.1097/01.sla.0000184211.75970.85; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Theisen J, 2007, Adv Surg, V41, P229, DOI 10.1016/j.yasu.2007.05.016; Thompson ER, 2005, HUM MUTAT, V26, P384, DOI 10.1002/humu.20220; Tuefferd M, 2008, GENE CHROMOSOME CANC, V47, P957, DOI 10.1002/gcc.20599	57	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e79079	10.1371/journal.pone.0079079	http://dx.doi.org/10.1371/journal.pone.0079079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454681	Green Accepted, Green Published, gold			2022-12-25	WOS:000330236000003
J	Hu, ZS; Murakami, T; Suzuki, K; Tamura, H; Kuwahara-Arai, K; Iba, T; Nagaoka, I				Hu, Zhongshuang; Murakami, Taisuke; Suzuki, Kaori; Tamura, Hiroshi; Kuwahara-Arai, Kyoko; Iba, Toshiaki; Nagaoka, Isao			Antimicrobial Cathelicidin Peptide LL-37 Inhibits the LPS/ATP-Induced Pyroptosis of Macrophages by Dual Mechanism	PLOS ONE			English	Article							P2X(7) RECEPTOR; CELL-DEATH; PROINFLAMMATORY CYTOKINES; MAMMALIAN DEFENSINS; P2X7 RECEPTOR; SEPSIS; ATP; LPS; APOPTOSIS; SUPPRESSES	Pyroptosis is a caspase-1 dependent cell death, associated with proinflammatory cytokine production, and is considered to play a crucial role in sepsis. Pyroptosis is induced by the two distinct stimuli, microbial PAMPs (pathogen associated molecular patterns) and endogenous DAMPs (damage associated molecular patterns). Importantly, cathelicidin-related AMPs (antimicrobial peptides) have a role in innate immune defense. Notably, human cathelicidin LL-37 exhibits the protective effect on the septic animal models. Thus, in this study, to elucidate the mechanism for the protective action of LL-37 on sepsis, we utilized LPS (lipopolysaccharide) and ATP (adenosine triphosphate) as a PAMP and a DAMP, respectively, and examined the effect of LL-37 on the LPS/ATP-induced pyroptosis of macrophage-like J774 cells. The data indicated that the stimulation of J774 cells with LPS and ATP induces the features of pyroptosis, including the expression of IL-1 beta mRNA and protein, activation of caspase-1, inflammasome formation and cell death. Moreover, LL-37 inhibits the LPS/ATP-induced IL-1 beta expression, caspase-1 activation, inflammasome formation, as well as cell death. Notably, LL-37 suppressed the LPS binding to target cells and ATP-induced/P2X(7)-mediated caspase-1 activation. Together these observations suggest that LL-37 potently inhibits the LPS/ATP-induced pyroptosis by both neutralizing the action of LPS and inhibiting the response of P2X(7) to ATP. Thus, the present finding may provide a novel insight into the modulation of sepsis utilizing LL-37 with a dual action on the LPS binding and P2X(7) activation.	[Hu, Zhongshuang; Murakami, Taisuke; Suzuki, Kaori; Tamura, Hiroshi; Nagaoka, Isao] Juntendo Univ, Grad Sch Med, Dept Host Def & Biochem Res, Tokyo, Japan; [Kuwahara-Arai, Kyoko] Juntendo Univ, Grad Sch Med, Dept Bacteriol, Tokyo, Japan; [Iba, Toshiaki] Juntendo Univ, Grad Sch Med, Dept Emergency & Disaster Med, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University	Nagaoka, I (corresponding author), Juntendo Univ, Grad Sch Med, Dept Host Def & Biochem Res, Tokyo, Japan.	nagaokai@juntendo.ac.jp	Iba, Toshiaki/H-5314-2013; Iba, Toshiaki/AAP-7141-2021	Iba, Toshiaki/0000-0002-0255-4088; Iba, Toshiaki/0000-0002-0255-4088; Tamura, Hiroshi/0000-0003-0077-1801	Japan Society for the Promotion of Science [23590519]; Ministry of Education, Culture, Sports, Science and Technology, Japan [S1201013]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid (Grant number 23590519; http://www.jsps.go.jp/j-grantsinaid/index.html) for Scientific Research from Japan Society for the Promotion of Science, and a Grants-in-Aid (Grant number S1201013; http://www.mext.go.jp/a_menu/koutou/shinkou/07021403/002/002/1218299.htm) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2011, JAMA-J AM MED ASSOC, V306, P2614, DOI 10.1001/jama.2011.1853; Arulkumaran N, 2011, EXPERT OPIN INV DRUG, V20, P897, DOI 10.1517/13543784.2011.578068; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; da Silva F, 2009, APOPTOSIS, V14, P509, DOI 10.1007/s10495-009-0320-3; Dinarello CA, 2002, AM J RESP CRIT CARE, V166, P1156, DOI 10.1164/rccm.2208006; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Fukumoto K, 2005, PEDIATR SURG INT, V21, P20, DOI 10.1007/s00383-004-1256-x; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Kahlenberg JM, 2013, J IMMUNOL, V190, P1217, DOI 10.4049/jimmunol.1202388; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Matsuda A, 2012, J NIPPON MED SCH, V79, P4, DOI 10.1272/jnms.79.4; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Moore SF, 2009, J IMMUNOL, V183, P3302, DOI 10.4049/jimmunol.0900394; Murakami T, 2009, INT IMMUNOL, V21, P905, DOI 10.1093/intimm/dxp057; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Nagaoka I, 2002, CLIN DIAGN LAB IMMUN, V9, P972, DOI 10.1128/CDLI.9.5.972-982.2002; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Netea MG, 2003, TRENDS IMMUNOL, V24, P254, DOI 10.1016/S1471-4906(03)00079-6; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; O'Brien JM, 2007, AM J MED, V120, P1012, DOI 10.1016/j.amjmed.2007.01.035; Pinsky MR, 2004, AM J MED SCI, V328, P220, DOI 10.1097/00000441-200410000-00005; Pochet S, 2006, MOL PHARMACOL, V69, P2037, DOI 10.1124/mol.105.021444; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Seil M, 2010, BBA-BIOMEMBRANES, V1798, P569, DOI 10.1016/j.bbamem.2009.11.002; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Sperlagh B, 1998, NEUROCHEM INT, V33, P209, DOI 10.1016/S0197-0186(98)00025-4; Suzuki K, 2011, INT IMMUNOL, V23, P185, DOI 10.1093/intimm/dxq471; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tomasinsig L, 2008, J BIOL CHEM, V283, P30471, DOI 10.1074/jbc.M802185200; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Wesche DE, 2005, J LEUKOCYTE BIOL, V78, P325, DOI 10.1189/jlb.0105017; Wewers MD, 2009, PURINERG SIGNAL, V5, P189, DOI 10.1007/s11302-009-9131-9; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang D, 2001, J LEUKOCYTE BIOL, V69, P691	58	56	64	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85765	10.1371/journal.pone.0085765	http://dx.doi.org/10.1371/journal.pone.0085765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454930	Green Published, Green Submitted, gold			2022-12-25	WOS:000330236000015
J	Kodavali, PK; Dudkiewicz, M; Pikula, S; Pawlowski, K				Kodavali, Praveen Kumar; Dudkiewicz, Malgorzata; Pikula, Slawomir; Pawlowski, Krzysztof			Bioinformatics Analysis of Bacterial Annexins - Putative Ancestral Relatives of Eukaryotic Annexins	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; PROTEIN HOMOLOGY DETECTION; MEMBRANE-BINDING PROTEINS; HORIZONTAL GENE-TRANSFER; SP-NOV.; PREDICTION; ALIGNMENT; CALCIUM; EVOLUTION; DATABASE	Annexins are Ca2+-binding, membrane-interacting proteins, widespread among eukaryotes, consisting usually of four structurally similar repeated domains. It is accepted that vertebrate annexins derive from a double genome duplication event. It has been postulated that a single domain annexin, if found, might represent a molecule related to the hypothetical ancestral annexin. The recent discovery of a single-domain annexin in a bacterium, Cytophaga hutchinsonii, apparently confirmed this hypothesis. Here, we present a more complex picture. Using remote sequence similarity detection tools, a survey of bacterial genomes was performed in search of annexin-like proteins. In total, we identified about thirty annexin homologues, including single-domain and multi-domain annexins, in seventeen bacterial species. The thorough search yielded, besides the known annexin homologue from C. hutchinsonii, homologues from the Bacteroidetes/Chlorobi phylum, from Gemmatimonadetes, from beta-and delta-Proteobacteria, and from Actinobacteria. The sequences of bacterial annexins exhibited remote but statistically significant similarity to sequence profiles built of the eukaryotic ones. Some bacterial annexins are equipped with additional, different domains, for example those characteristic for toxins. The variation in bacterial annexin sequences, much wider than that observed in eukaryotes, and different domain architectures suggest that annexins found in bacteria may actually descend from an ancestral bacterial annexin, from which eukaryotic annexins also originate. The hypothesis of an ancient origin of bacterial annexins has to be reconciled with the fact that remarkably few bacterial strains possess annexin genes compared to the thousands of known bacterial genomes and with the patchy, anomalous phylogenetic distribution of bacterial annexins. Thus, a massive annexin gene loss in several bacterial lineages or very divergent evolution would appear a likely explanation. Alternative evolutionary scenarios, involving horizontal gene transfer between bacteria and protozoan eukaryotes, in either direction, appear much less likely. Altogether, current evidence does not allow unequivocal judgement as to the origin of bacterial annexins.	[Kodavali, Praveen Kumar; Pikula, Slawomir] Polish Acad Sci, Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland; [Dudkiewicz, Malgorzata; Pawlowski, Krzysztof] Warsaw Univ Life Sci, Fac Agr & Biol, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Warsaw University of Life Sciences	Pawlowski, K (corresponding author), Warsaw Univ Life Sci, Fac Agr & Biol, Warsaw, Poland.	krzysztof_pawlowski@sggw.pll	Pawłowski, Krzysztof/C-2949-2013; Dudkiewicz, Małgorzata/AAG-4553-2020	Pawłowski, Krzysztof/0000-0002-5367-0935; Pikula, Slawomir/0000-0003-4640-3094; Dudkiewicz, Malgorzata/0000-0003-4432-2530	NODPERCEPTION contract from European Community's Marie Curie Research Training Network Program [MRTN-CT-2006-035546]; Nencki Institute of Experimental Biology, Warsaw, Poland; EC NODPERCEPTION contract [ESR7]	NODPERCEPTION contract from European Community's Marie Curie Research Training Network Program; Nencki Institute of Experimental Biology, Warsaw, Poland; EC NODPERCEPTION contract	This work was supported by the NODPERCEPTION contract (MRTN-CT-2006-035546) from the European Community's Marie Curie Research Training Network Program and by the Nencki Institute of Experimental Biology, Warsaw, Poland. PKK acknowledges a fellowship from the EC NODPERCEPTION contract No ESR7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bandorowicz-Pikula J, 2012, MOL MEMBR BIOL, V29, P229, DOI 10.3109/09687688.2012.693210; BARTON GJ, 1991, EUR J BIOCHEM, V198, P749, DOI 10.1111/j.1432-1033.1991.tb16076.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Cantacessi C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02893; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cerda-Costa N, 2011, MOL MICROBIOL, V79, P119, DOI 10.1111/j.1365-2958.2010.07434.x; CLARK GB, 1995, PLANT PHYSIOL, V109, P1133, DOI 10.1104/pp.109.4.1133; Clark GB, 2012, NEW PHYTOL, V196, P695, DOI 10.1111/j.1469-8137.2012.04308.x; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dana CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031643; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Du ZJ, 2011, J BACTERIOL, V193, P4557, DOI 10.1128/JB.05513-11; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrer L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-493; Filippini M, 2012, J BACTERIOL, V194, P4445, DOI 10.1128/JB.00869-12; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Grieve Adam G, 2012, Int J Cell Biol, V2012, P852430, DOI 10.1155/2012/852430; Hall T, 2012, BIOEDIT; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Hofmann A, 2000, BIOCHEMISTRY-US, V39, P7712, DOI 10.1021/bi992359+; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hotopp JCD, 2011, TRENDS GENET, V27, P157, DOI 10.1016/j.tig.2011.01.005; Huang RJ, 2011, VIRULENCE, V2, P435, DOI 10.4161/viru.2.5.16140; HUBER R, 1990, EMBO J, V9, P3867, DOI 10.1002/j.1460-2075.1990.tb07605.x; Huntley S, 2012, J BACTERIOL, V194, P3012, DOI 10.1128/JB.00397-12; Ivanova N, 2010, STAND GENOMIC SCI, V2, P96, DOI 10.4056/sigs.69.1277; Jaroszewski L, 2011, NUCLEIC ACIDS RES, V39, pW38, DOI 10.1093/nar/gkr441; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Kumar S, 2012, J BACTERIOL, V194, P3746, DOI 10.1128/JB.00649-12; Lail K, 2010, STAND GENOMIC SCI, V2, P176, DOI 10.4056/sigs.741334; Lang E, 2009, INT J SYST EVOL MICR, V59, P2122, DOI 10.1099/ijs.0.003566-0; Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x; LEADBETTER ER, 1979, ARCH MICROBIOL, V122, P9, DOI 10.1007/BF00408040; Lee HS, 2011, J BACTERIOL, V193, P4031, DOI 10.1128/JB.05241-11; Lenart A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062272; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin BK, 2012, INT J SYST EVOL MICR, V62, P869, DOI 10.1099/ijs.0.027136-0; Liu HQ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-276; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; McDaniel LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043506; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Morgan RO, 2006, BBA-MOL CELL RES, V1763, P1238, DOI 10.1016/j.bbamcr.2006.09.028; MORGAN RO, 1995, MOL BIOL EVOL, V12, P967; Morgan RO, 2004, BBA-MOL CELL RES, V1742, P133, DOI 10.1016/j.bbamcr.2004.09.010; Morgan RO, 1997, J MOL EVOL, V44, P178, DOI 10.1007/PL00006134; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Nakagawa Y, 2002, J GEN APPL MICROBIOL, V48, P155, DOI 10.2323/jgam.48.155; Nakayama H, 2012, MOL BIOL CELL, V23, P1964, DOI 10.1091/mbc.E11-08-0683; Nikoh N, 2008, GENOME RES, V18, P272, DOI 10.1101/gr.7144908; Nupur, 2012, INT J SYST EVOL MICR, V62, P2213, DOI 10.1099/ijs.0.036608-0; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147; Pawlowski K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-590; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Podell S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-419; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; Schoenfeld TW, 2013, MOL BIOL EVOL, V30, P1653, DOI 10.1093/molbev/mst078; Smith J, 2007, BACTERIALLY MEDIATED; SMITH PD, 1994, TRENDS GENET, V10, P241, DOI 10.1016/0168-9525(94)90171-6; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Steczkiewicz K, 2012, NUCLEIC ACIDS RES, V40, P7016, DOI 10.1093/nar/gks382; SWAIRJO MA, 1994, ANNU REV BIOPH BIOM, V23, P193, DOI 10.1146/annurev.bb.23.060194.001205; Talukdar T, 2009, ACTA BIOCHIM POL, V56, P199; Teles FR, 2012, J PERIODONTAL RES, V47, P95, DOI 10.1111/j.1600-0765.2011.01409.x; Tice H, 2010, STAND GENOMIC SCI, V2, P168, DOI 10.4056/sigs.721316; Vikram S, 2012, J BACTERIOL, V194, P3543, DOI 10.1128/JB.00532-12; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xie G, 2007, APPL ENVIRON MICROB, V73, P3536, DOI 10.1128/AEM.00225-07; Yajima S, 2004, BIOCHEM BIOPH RES CO, V322, P966, DOI 10.1016/j.bbrc.2004.07.206; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhang H, 2003, INT J SYST EVOL MICR, V53, P1155, DOI 10.1099/ijs.0.02520-0	89	8	8	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85428	10.1371/journal.pone.0085428	http://dx.doi.org/10.1371/journal.pone.0085428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454864	gold, Green Published, Green Submitted			2022-12-25	WOS:000330236000009
J	Karczewski, KJ; Fernald, GH; Martin, AR; Snyder, M; Tatonetti, NP; Dudley, JT				Karczewski, Konrad J.; Fernald, Guy Haskin; Martin, Alicia R.; Snyder, Michael; Tatonetti, Nicholas P.; Dudley, Joel T.			STORMSeq: An Open-Source, User-Friendly Pipeline for Processing Personal Genomics Data in the Cloud	PLOS ONE			English	Article								The increasing public availability of personal complete genome sequencing data has ushered in an era of democratized genomics. However, read mapping and variant calling software is constantly improving and individuals with personal genomic data may prefer to customize and update their variant calls. Here, we describe STORMSeq (Scalable Tools for Open-Source Read Mapping), a graphical interface cloud computing solution that does not require a parallel computing environment or extensive technical experience. This customizable and modular system performs read mapping, read cleaning, and variant calling and annotation. At present, STORMSeq costs approximately $2 and 5-10 hours to process a full exome sequence and $30 and 3-8 days to process a whole genome sequence. We provide this open-access and open-source resource as a user-friendly interface in Amazon EC2.	[Karczewski, Konrad J.; Fernald, Guy Haskin; Martin, Alicia R.] Stanford Univ, Sch Med, Biomed Informat Training Program, Stanford, CA 94305 USA; [Karczewski, Konrad J.; Fernald, Guy Haskin; Martin, Alicia R.; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Tatonetti, Nicholas P.] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Dudley, Joel T.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Stanford University; Stanford University; Columbia University; Icahn School of Medicine at Mount Sinai	Karczewski, KJ (corresponding author), Stanford Univ, Sch Med, Biomed Informat Training Program, Stanford, CA 94305 USA.	konradjkarczewski@gmail.com; joel.dudley@mssm.edu	; Karczewski, Jakub/L-7326-2018	Karczewski, Konrad/0000-0003-2878-4671; Tatonetti, Nicholas/0000-0002-2700-2597; Snyder, Michael/0000-0003-0784-7987; Martin, Alicia/0000-0003-0241-3522; Karczewski, Jakub/0000-0001-9322-7842	National Science Foundation (NSF); National Institutes of Health (NIH) [LM007033, GM007790]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	KJK is funded by the National Science Foundation (NSF) Graduate Research Fellowship. KJK and GHF are funded by National Institutes of Health (NIH) Training Grant LM007033. ARM is funded by NIH Training Grant GM007790. MS is funded by grants from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Faster and More Accurate Sequence Alignment with SNAP, 2011, FASTER MORE ACCURAT; Fischer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041948; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Karczewski KJ, 2012, BIOCOMPUT-PAC SYM, P339; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Li H., 2013, ARXIV13033997 Q BIO; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Yin TF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r77	11	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84860	10.1371/journal.pone.0084860	http://dx.doi.org/10.1371/journal.pone.0084860			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454756	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100037
J	Kellner, AWA; Pinheiro, AEP; Campos, DA				Kellner, Alexander W. A.; Pinheiro, Andre E. P.; Campos, Diogenes A.			A New Sebecid from the Paleogene of Brazil and the Crocodyliform Radiation after the K-Pg Boundary	PLOS ONE			English	Article							SNOUTED DYROSAURID CROCODYLIFORMES; PALEOCENE; MESOEUCROCODYLIA; BASIN; OSTEOLOGY	A new crocodyliform, Sahitisuchus fluminensis gen. et sp. nov., is described based on a complete skull, lower jaw and anterior cervical vertebrae collected in the Sao Jose de Itaborai Basin of Rio de Janeiro, Brazil. The specimen is one of the best preserved crocodyliforms from Paleocene deposits recovered so far and represents a sebecosuchian, one of the few clades that survived the Cretaceous-Paleogene biotic crisis. The new taxon is found in the same deposit as an alligatoroid, a group that experienced large diversification in the Paleogene. The sebecosuchian record suggests that after the Cretaceous-Paleogene biotic crisis, the less specialized members of this clade characterized by a higher number of teeth compared to the baurusuchid sebecosuchians survived, some having terrestrial habits while others developed a semi-aquatic life style (e.g., Lorosuchus). Starting in the Eocene, sebecid sebecosuchians became specialized with a more accentuated oreinirostry as observed in Sebecus and in Langstonia, but not showing the typical reduced dentition developed by the Cretaceous baurusuchid sebecosuchians. The basal position of Barinasuchus arveloi, a high-snouted Miocene sebecid, indicates the occurrence of an independent lineage sometime after the K-Pg biotic crisis that developed accentuated oreinirostry, suggesting a more complex history of the post-K-Pg crocodyliform radiation.	[Kellner, Alexander W. A.] Univ Fed Rio de Janeiro, Lab Sistemat & Tafon Vertebrados Fosseis, Dept Geol & Paleontol, Museu Nacl, Rio De Janeiro, Brazil; [Pinheiro, Andre E. P.] Univ Fed Rio de Janeiro, Dept Geol, Lab Macrofosseis, Rio De Janeiro, Brazil; [Campos, Diogenes A.] Co Pesquisa Recursos Minerais, Serv Geol Brasil, Museu Ciencias Terra, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Kellner, AWA (corresponding author), Univ Fed Rio de Janeiro, Lab Sistemat & Tafon Vertebrados Fosseis, Dept Geol & Paleontol, Museu Nacl, Rio De Janeiro, Brazil.	kellner@mn.ufrj.br	Kellner, Alexander W/H-1023-2015; Kellner, Alexander/ABE-9591-2020	Kellner, Alexander W/0000-0001-7174-9447; Kellner, Alexander/0000-0001-7174-9447	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/102.779/2008, E-26/111.273/2010]; Conselho Nacional de DesenvolvimentoCientifico e Tecnologico (CNPq) [307276/2009-0]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de DesenvolvimentoCientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	AWAK acknowledges the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ nos. E-26/102.779/2008 and E-26/111.273/2010) and the Conselho Nacional de DesenvolvimentoCientifico e Tecnologico (CNPq no. 307276/2009-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa JA, 2008, P ROY SOC B-BIOL SCI, V275, P1385, DOI 10.1098/rspb.2008.0110; BARTELS WS, 1984, J PALEONTOL, V58, P1347; Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; Bergqvist LP, 2011, REV BRAS PALEONTOLOG, V14, P75, DOI 10.4072/rbp.2011.1.08; Bergqvist LP, 2005, BASICA SAO JOSE ITAB, P1; Bona P, 2011, J MORPHOL, P1, DOI 10.1002/jmor.10894; Bona P, 2007, AMEGHINIANA, V44, P435; Brochu CA, 2004, J VERTEBR PALEONTOL, V24, P857, DOI 10.1671/0272-4634(2004)024[0857:APATSO]2.0.CO;2; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Brochu CA, 2001, AM ZOOL, V41, P564, DOI 10.1668/0003-1569(2001)041[0564:CSISAT]2.0.CO;2; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Brochu CA, 2011, ZOOL J LINN SOC-LOND, V163, pS228, DOI 10.1111/j.1096-3642.2011.00716.x; BUFFETAUT E, 1975, CR ACAD SCI D NAT, V280, P2741; BUFFETAUT E, 1990, TECTONOPHYSICS, V171, P337, DOI 10.1016/0040-1951(90)90108-K; Buffetaut Eric, 1991, Revista Tecnica de Yacimientos Petroliferos Fiscales Bolivianos, V12, P545; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Campos DA, 2011, AN ACAD BRAS CIENC, V83, P317, DOI 10.1590/S0001-37652011000100020; Carvalho ID, 2004, GONDWANA RES, V7, P975, DOI 10.1016/S1342-937X(05)71079-0; Carvalho ID, 2007, ZOOTAXA, P35; Chiasson R. B., 1962, LAB ANATOMY ALLIGATO, P1; Colbert Edwin Harris, 1946, BULL AMER MUS NAT HIST, V87, P217; De Muizon Christian, 1993, Annales de Paleontologie, V79, P233; Gasparini Z., 1991, Journal of Vertebrate Paleontology, V11, P316; Gasparini Zulma, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P159; Gasparini Zulma, 1993, Historical Biology, V7, P1; Gelfo JN, 2009, PALAEONTOLOGY, V52, P251, DOI 10.1111/j.1475-4983.2008.00835.x; Goloboff P.A., 2008, TNT TREE ANAL USING; Hecht MK, 1983, KONSTRUKTIONSMORPHOL, V152, P657; Hekkala E, 2011, MOL ECOL, V20, P4199, DOI 10.1111/j.1365-294X.2011.05245.x; Iordansky N.N., 1973, P201; Iordansky Nikolai N., 2000, Russian Journal of Herpetology, V7, P41; Jouve S, 2005, PALAEONTOLOGY, V48, P359, DOI 10.1111/j.1475-4983.2005.00442.x; Jouve S, 2008, PALAEONTOLOGY, V51, P281, DOI 10.1111/j.1475-4983.2007.00747.x; KELLNER AWA, 1987, AN ACAD BRAS CIENC, V59, P219; Kellner AWA, 1999, EPISODES, V22, P238; Klein Victor De Carvalho, 2002, Arquivos do Museu Nacional Rio de Janeiro, V60, P245; Langston W, 1997, VERTEBRATE PALEONTOL; LANGSTON W JR, 1975, Fieldiana Geology, V33, P291; Larsson HCE, 2007, ZOOL J LINN SOC-LOND, V149, P533, DOI 10.1111/j.1096-3642.2007.00271.x; Larsson HCE, 2000, NEUES JAHRB GEOL P-A, V217, P131, DOI 10.1127/njgpa/217/2000/131; Marshall L.G., 1985, Topics in Geobiology, V4, P49; Marshall LG, 1997, J S AM EARTH SCI, V10, P49, DOI 10.1016/S0895-9811(97)00005-9; Medeiros R. A., 1999, ACTA GEOLOGICA LEOPO, V22, P3; Montefeltro FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021916; Paolillo A., 2007, PALEOBIOLOGIA NEOTRO, V3, P1; Paula Couto de C., 1952, AM MUS NOVIT, V1559; Paula-Couto C, 1953, NOTAS PRELIMINARES E, V75, P1; Piacentini Pinheiro Andre Eduardo, 2008, Revista Brasileira de Paleontologia, V11, P37; Pinheiro AEP, 2012, HIST BIOL, P1, DOI [10.1080/08912963.2012.705838, DOI 10.1080/08912963.2012.705838)]; Pol D, 2012, J VERTEBR PALEONTOL, V32, P328, DOI 10.1080/02724634.2012.646833; Pol D, 2011, ZOOL J LINN SOC-LOND, V163, pS7, DOI 10.1111/j.1096-3642.2011.00714.x; Powell JE, 2011, EOCENE VERTEBRATES N, P49; Price LI, 1946, B 2 C PANAMERICANO E, V3, P149; Rage Jean-Claude, 1998, Palaeovertebrata (Montpellier), V27, P109; Riccomini C, 2004, GEOLOGIA CONTINENTE, P393; Riff D, 2011, ZOOL J LINN SOC-LOND, V163, pS37, DOI 10.1111/j.1096-3642.2011.00713.x; Rodrigues-Francisco BH, 1985, DNPM SERIE GEOLOGIA, V2, P651; Simpson G. G., 1937, American Museum Novitates, P1; Whetstone K.N., 1983, OCCASIONAL PAPERS MU, V106, P1, DOI DOI 10.1017/CBO9781107415324.004	60	31	31	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e81386	10.1371/journal.pone.0081386	http://dx.doi.org/10.1371/journal.pone.0081386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454686	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100002
J	Kim, S; Kim, JY; Lee, DC; Lee, HS; Lee, JW; Jeon, JY				Kim, Sue; Kim, Ji-Young; Lee, Duk-Chul; Lee, Hye-Sun; Lee, Ji-Won; Jeon, Justin Y.			Combined Impact of Cardiorespiratory Fitness and Visceral Adiposity on Metabolic Syndrome in Overweight and Obese Adults in Korea	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE MORTALITY; HOMEOSTASIS MODEL ASSESSMENT; TYPE-2 DIABETIC-PATIENTS; BODY-FAT DISTRIBUTION; HEART-RATE RECOVERY; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; ALL-CAUSE; OXYGEN-UPTAKE; RISK-FACTORS	Background: Obesity, especially visceral obesity, is known to be an important correlate for cardiovascular disease and increased mortality. On the other hand, high cardiorespiratory fitness is suggested to be an effective contributor for reducing this risk. This study was conducted to determine the combined impact of cardiorespiratory fitness and visceral adiposity, otherwise known as fitness and fatness, on metabolic syndrome in overweight and obese adults. Methods: A total of 232 overweight and obese individuals were grouped into four subtypes according to their fitness level. This was measured by recovery heart rate from a step test in addition to visceral adiposity defined as the visceral adipose tissue area to subcutaneous adipose tissue area ratio (VAT/SAT ratio). Associations of fitness and visceral fatness were analyzed in comparison with the prevalence of metabolic syndrome. Results: The high visceral fat and low fitness group had the highest prevalence of metabolic syndrome [Odds Ratio (OR) 5.02; 95% Confidence Interval (CI) 1.85-13.61] compared with the reference group, which was the low visceral adiposity and high fitness group, after adjustments for confounding factors. Viscerally lean but unfit subjects were associated with a higher prevalence of metabolic syndrome than more viscerally obese but fit subjects (OR 3.42; 95% CI 1.27-9.19, and OR 2.70; 95% CI 1.01-7.25, respectively). Conclusions: Our study shows that visceral obesity and fitness levels are cumulatively associated with a higher prevalence of metabolic syndrome in healthy overweight and obese adults. This suggests that cardiorespiratory fitness is a significant modifier in the relation of visceral adiposity to adverse metabolic outcomes in overweight and obese individuals.	[Kim, Sue; Lee, Duk-Chul; Lee, Ji-Won] Yonsei Univ, Coll Med, Severance Hosp, Dept Family Med, Seoul, South Korea; [Kim, Ji-Young; Jeon, Justin Y.] Yonsei Univ, Dept Sport & Leisure Studies, Seoul 120749, South Korea; [Lee, Hye-Sun] Yonsei Univ, Coll Med, Dept Res Affairs, Biostat Collaborat Units, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System	Lee, JW (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Family Med, Seoul, South Korea.	indi5645@yuhs.ac; jjeon@yonsei.ac.kr	; Lee, Hye Sun/J-2154-2015	LEE, JI WON/0000-0002-2666-4249; Lee, Duk Chul/0000-0001-9166-1813; Lee, Hye Sun/0000-0001-6328-6948; Jeon, Justin/0000-0001-7978-4271	Biomedical Technology Development Research Program through the National Research Foundation of Korea(NRF); Ministry of Science, ICT and Future Planning [NRF-2013M3A9B6046413]	Biomedical Technology Development Research Program through the National Research Foundation of Korea(NRF)(National Research Foundation of Korea); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the Biomedical Technology Development Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2013M3A9B6046413). The funders had no role in study design, data collection and anlalysis, decision to publish, or preparation of the manuscript.	Arsenault BJ, 2007, ARCH INTERN MED, V167, P1518, DOI 10.1001/archinte.167.14.1518; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bjorntorp P, 1997, NUTRITION, V13, P795, DOI 10.1016/S0899-9007(97)00191-3; Clark JE, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-19; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1; Goel K, 2011, AM HEART J, V161, P590, DOI 10.1016/j.ahj.2010.12.012; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Horowitz JF, 2000, AM J CLIN NUTR, V72, p558S, DOI 10.1093/ajcn/72.2.558S; HOUMARD JA, 1993, AM J PHYSIOL, V264, pE896, DOI 10.1152/ajpendo.1993.264.6.E896; Izquierdo M, 2009, EUR J APPL PHYSIOL, V107, P397, DOI 10.1007/s00421-009-1139-x; Jekal Yoonsuk, 2010, Korean Diabetes J, V34, P182, DOI 10.4093/kdj.2010.34.3.182; Jones TE, 2009, OBESITY, V17, P1189, DOI 10.1038/oby.2009.11; Kaess BM, 2012, DIABETOLOGIA, V55, P2622, DOI 10.1007/s00125-012-2639-5; Katzmarzyk PT, 2004, ARCH INTERN MED, V164, P1092, DOI 10.1001/archinte.164.10.1092; Kelley DE, 1999, MED SCI SPORT EXER, V31, pS619, DOI 10.1097/00005768-199911001-00021; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422; LaMonte MJ, 2005, CIRCULATION, V112, P505, DOI 10.1161/CIRCULATIONAHA.104.503805; Lee CD, 1999, AM J CLIN NUTR, V69, P373; Lee DC, 2011, CIRCULATION, V124, P2483, DOI 10.1161/CIRCULATIONAHA.111.038422; Lee JW, 2007, CLIN ENDOCRINOL, V66, P572, DOI 10.1111/j.1365-2265.2007.02780.x; Lentner C, 1982, GEIGY SCI TABLES; Liu JK, 2010, J CLIN ENDOCR METAB, V95, P5419, DOI 10.1210/jc.2010-1378; Mathieu P, 2009, HYPERTENSION, V53, P577, DOI 10.1161/HYPERTENSIONAHA.108.110320; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McArdle WD, 2000, ESSENTIALS EXERCISE; McAuley PA, 2012, J OBES, V2012, DOI 10.1155/2012/951582; McAuley PA, 2009, AM J HYPERTENS, V22, P1062, DOI 10.1038/ajh.2009.122; Miyazaki Y, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-44; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Morshedi-Meibodi A, 2002, AM J CARDIOL, V90, P848, DOI 10.1016/S0002-9149(02)02706-6; Nannipieri M, 2007, INT J OBESITY, V31, P1843, DOI 10.1038/sj.ijo.0803676; Nilsson G, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.06.025; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Rheaume C, 2011, J CLIN ENDOCR METAB, V96, P1462, DOI 10.1210/jc.2010-2432; Santo AS, 2003, RES Q EXERCISE SPORT, V74, P110, DOI 10.1080/02701367.2003.10609070; Shishehbor MH, 2006, JAMA-J AM MED ASSOC, V295, P784, DOI 10.1001/jama.295.7.784; SICONOLFI SF, 1985, AM J EPIDEMIOL, V121, P382, DOI 10.1093/oxfordjournals.aje.a114010; Sieverdes JC, 2010, BRIT J SPORT MED, V44, P238, DOI 10.1136/bjsm.2009.062117; Steele RM, 2008, J APPL PHYSIOL, V105, P342, DOI 10.1152/japplphysiol.00072.2008; Stevens J, 2004, INT J OBESITY, V28, P1463, DOI 10.1038/sj.ijo.0802770; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; WENER J, 1953, CAN MED ASSOC J, V68, P368; Yokoyama H, 2004, J CLIN ENDOCR METAB, V89, P1481, DOI 10.1210/jc.2003-031374	48	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85742	10.1371/journal.pone.0085742	http://dx.doi.org/10.1371/journal.pone.0085742			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454926	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100128
J	Takehana, Y; Yamada, A; Tamori, M; Motokawa, T				Takehana, Yasuhiro; Yamada, Akira; Tamori, Masaki; Motokawa, Tatsuo			Softenin, a Novel Protein That Softens the Connective Tissue of Sea Cucumbers through Inhibiting Interaction between Collagen Fibrils	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; STICHOPUS-JAPONICUS; IONIC ENVIRONMENT; STIFFEST STATE; BODY-WALL; CATCH; STIFFNESS; DERMIS; MORPHOLOGY; VISCOSITY	The dermis in the holothurian body wall is a typical catch connective tissue or mutable collagenous tissue that shows rapid changes in stiffness. Some chemical factors that change the stiffness of the tissue were found in previous studies, but the molecular mechanisms of the changes are not yet fully understood. Detection of factors that change the stiffness by working directly on the extracellular matrix was vital to clarify the mechanisms of the change. We isolated from the body wall of the sea cucumber Stichopus chloronotus a novel protein, softenin, that softened the body-wall dermis. The apparent molecular mass was 20 kDa. The N-terminal sequence of 17 amino acids had low homology to that of known proteins. We performed sequential chemical and physical dissections of the dermis and tested the effects of softenin on each dissection stage by dynamic mechanical tests. Softenin softened Triton-treated dermis whose cells had been disrupted by detergent. The Triton-treated dermis was subjected to repetitive freeze-and-thawing to make Triton-Freeze-Thaw (TFT) dermis that was softer than the Triton-treated dermis, implying that some force-bearing structure had been disrupted by this treatment. TFT dermis was stiffened by tensilin, a stiffening protein of sea cucumbers. Softenin softened the tensilin-stiffened TFT dermis while it had no effect on the TFT dermis without tensilin treatment. We isolated collagen from the dermis. When tensilin was applied to the suspending solution of collagen fibrils, they made a large compact aggregate that was dissolved by the application of softenin or by repetitive freeze-and-thawing. These results strongly suggested that softenin decreased dermal stiffness through inhibiting cross-bridge formation between collagen fibrils; the formation was augmented by tensilin and the bridges were broken by the freeze-thaw treatment. Softenin is thus the first softener of catch connective tissue shown to work on the cross-bridges between extracellular materials.	[Takehana, Yasuhiro; Tamori, Masaki; Motokawa, Tatsuo] Tokyo Inst Technol, Dept Biol Sci, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan; [Yamada, Akira] Natl Inst Informat & Commun Technol, Adv ICT Res Inst, Kobe, Hyogo, Japan	Tokyo Institute of Technology; National Institute of Information & Communications Technology (NICT) - Japan	Takehana, Y (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan.	takehana.y.aa@m.titech.ac.jp			JSPS KAKENHI [21570075, 23570092]; Grants-in-Aid for Scientific Research [21570075] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 21570075 to T. M. and 23570092 to M. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birenheide R, 1998, BIOL BULL-US, V194, P253, DOI 10.2307/1543095; HAYASHI Y, 1986, J EXP BIOL, V125, P71; HILL RB, 1976, J INVERTEBR PATHOL, V28, P131, DOI 10.1016/0022-2011(76)90079-3; Inoue M, 1999, P ROY SOC B-BIOL SCI, V266, P993, DOI 10.1098/rspb.1999.0735; JUNQUEIRA LCU, 1980, REV CAN BIOL EXPTL, V39, P157; Koob TJ, 1999, J EXP BIOL, V202, P2291; MATSUMURA T, 1974, CONNECT TISSUE RES, V2, P117, DOI 10.3109/03008207409152097; MOTOKAWA T, 1994, COMP BIOCHEM PHYS B, V109, P613, DOI 10.1016/0305-0491(94)90124-4; Motokawa T., 1988, P39; Motokawa T, 2003, BIOL BULL-US, V205, P261, DOI 10.2307/1543290; MOTOKAWA T, 1984, BIOL REV, V59, P255, DOI 10.1111/j.1469-185X.1984.tb00409.x; MOTOKAWA T, 1981, COMP BIOCHEM PHYS C, V70, P41, DOI 10.1016/0306-4492(81)90076-9; MOTOKAWA T, 1982, J EXP BIOL, V99, P29; Quinn KP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004205; Ribeiro AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049016; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHIBAYAMA R, 1994, ZOOL SCI, V11, P511; Slatter DA, 2012, PEPTIDES, V36, P86, DOI 10.1016/j.peptides.2012.04.013; SMITH GN, 1973, BIOL BULL-US, V144, P421, DOI 10.2307/1540018; Szulgit G, 2007, BIOESSAYS, V29, P645, DOI 10.1002/bies.20597; Tamori M, 2006, J EXP BIOL, V209, P1594, DOI 10.1242/jeb.02178; Thurmond FA, 1996, J EXP BIOL, V199, P1817; Thurmond FA, 1997, CONNECT TISSUE RES, V36, P211, DOI 10.3109/03008209709160221; Tipper JR, 2002, MATRIX BIOL, V21, P625, DOI 10.1016/S0945-053X(02)00090-2; TROTTER JA, 1994, CELL TISSUE RES, V275, P451, DOI 10.1007/BF00318814; TROTTER JA, 1989, CELL TISSUE RES, V258, P527; Wilkie IC, 2005, PROG MOLEC, V39, P221; Wilkie IC, 2002, J EXP BIOL, V205, P159; Wu HL, 2013, PROCESS BIOCHEM, V48, P871, DOI 10.1016/j.procbio.2013.04.011; Yamada A, 2010, J EXP BIOL, V213, P3416, DOI 10.1242/jeb.044149	30	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85644	10.1371/journal.pone.0085644	http://dx.doi.org/10.1371/journal.pone.0085644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454910	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100113
J	Terragni, R; Gardini, AC; Sabattini, S; Bettini, G; Amadori, D; Talamonti, C; Vignoli, M; Capelli, L; Saunders, JH; Ricci, M; Ulivi, P				Terragni, Rossella; Gardini, Andrea Casadei; Sabattini, Silvia; Bettini, Giuliano; Amadori, Dino; Talamonti, Chiara; Vignoli, Massimo; Capelli, Laura; Saunders, Jimmy H.; Ricci, Marianna; Ulivi, Paola			EGFR, HER-2 and KRAS in Canine Gastric Epithelial Tumors: A Potential Human Model?	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; IN-SITU HYBRIDIZATION; CELL LUNG-CANCER; COLORECTAL-CANCER; CARCINOMA; EXPRESSION; ADENOCARCINOMA; DOG; CETUXIMAB; IMMUNOHISTOCHEMISTRY	Epidermal growth factor receptor (EGFR or HER-1) and its analog c-erbB-2 (HER-2) are protein tyrosine kinases correlated with prognosis and response to therapy in a variety of human cancers. KRAS mediates the transduction of signals between EGFR and the nucleus, and its mutation has been identified as a predictor of resistance to anti-EGFR drugs. In human oncology, the importance of the EGFR/HER-2/KRAS signalling pathway in gastric cancer is well established, and HER-2 testing is required before initiating therapy. Conversely, this pathway has never been investigated in canine gastric tumours. A total of 19 canine gastric epithelial neoplasms (5 adenomas and 14 carcinomas) were retrospectively evaluated for EGFR/HER-2 immunohistochemical expression and KRAS mutational status. Five (35.7%) carcinomas were classified as intestinal-type and 9 (64.3%) as diffuse-type. EGFR was overexpressed (>= 1+) in 8 (42.1%) cases and HER-2 (3+) in 11 (57.9%) cases, regardless of tumour location or biological behaviour. The percentage of EGFR-positive tumours was significantly higher in the intestinal-type (80%) than in the diffuse-type (11.1%, p = 0.023). KRAS gene was wild type in 18 cases, whereas one mucinous carcinoma harboured a point mutation at codon 12 (G12R). EGFR and HER-2 may be promising prognostic and therapeutic targets in canine gastric epithelial neoplasms. The potential presence of KRAS mutation should be taken into account as a possible mechanism of drug resistance. Further studies are necessary to evaluate the role of dog as a model for human gastric cancer.	[Terragni, Rossella] Vet Oncol Ctr, Sasso Marconi, Italy; [Terragni, Rossella; Saunders, Jimmy H.; Ricci, Marianna; Ulivi, Paola] Univ Ghent, Fac Vet Med, B-9000 Ghent, Belgium; [Gardini, Andrea Casadei; Amadori, Dino; Capelli, Laura] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy; [Sabattini, Silvia; Bettini, Giuliano; Talamonti, Chiara] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Vignoli, Massimo] Petcare Vet Assoc, Marzabotto, Italy	Ghent University; IRCCS Meldola (IRST); University of Bologna	Gardini, AC (corresponding author), Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy.	casadeigardini@gmail.com	Vignoli, Massimo/R-5134-2019; Bettini, Giuliano/L-5907-2016; Gardini, Andrea/AAA-6985-2022; Capelli, Laura/AAB-9682-2019; Gardini, Andrea Casadei/F-1830-2016; gardini, Andrea Casadei/L-4859-2019; Sabattini, Silvia/AAN-3233-2020	Vignoli, Massimo/0000-0002-4981-4051; Gardini, Andrea Casadei/0000-0001-6289-7202; gardini, Andrea Casadei/0000-0001-6289-7202; Sabattini, Silvia/0000-0001-7005-2736; Ulivi, Paola/0000-0002-4334-9662; Bettini, Giuliano/0000-0003-1857-7329				Bang YJ, 2010, LANCET, V376, P1302; Bergkvist GT, 2011, VET COMP ONCOL, V9, P81, DOI 10.1111/j.1476-5829.2010.00237.x; Buskens CJ, 2006, J SURG RES, V135, P337, DOI 10.1016/j.jss.2006.04.023; Chen HC, 2011, TUMOR BIOL, V32, P367, DOI 10.1007/s13277-010-0129-2; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; de las Mulas JM, 2003, BREAST CANCER RES TR, V80, P363, DOI 10.1023/A:1024929730165; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; FONDA D, 1989, J SMALL ANIM PRACT, V30, P353, DOI 10.1111/j.1748-5827.1989.tb01579.x; Gama A, 2009, RES VET SCI, V87, P432, DOI 10.1016/j.rvsc.2009.04.016; Grabsch H, 2010, CELL ONCOL, V32, P57, DOI 10.3233/CLO-2009-0497; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Head K. W., 2003, WHO INT HISTOLOGICAL, VX; Hicks DG, 2011, APPL IMMUNOHISTO M M, V19, P1506, DOI 10.1097/PAI.0b013e31822c3a0f; Higgins RJ, 2010, J NEURO-ONCOL, V98, P49, DOI 10.1007/s11060-009-0072-5; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Hsu WL, 2009, VET J, V180, P116, DOI 10.1016/j.tvjl.2007.10.013; Jimeno A, 2009, J CLIN ONCOL, V27, P1130, DOI 10.1200/JCO.2008.19.8168; KRAEGEL SA, 1992, CANCER RES, V52, P4724; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee HR, 1996, ONCOLOGY-BASEL, V53, P192; Lee S, 2011, HISTOPATHOLOGY, V59, P832, DOI 10.1111/j.1365-2559.2011.04017.x; Liu C, 2005, PATHOLOGIC BASIS DIS, P804; Lorenzen S, 2011, CURR OPIN ONCOL, V23, P396, DOI 10.1097/CCO.0b013e3283469567; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Okines AFC, 2010, EUR J CANCER, V46, P1949, DOI 10.1016/j.ejca.2010.05.003; PATNAIK AK, 1978, VET PATHOL, V15, P600, DOI 10.1177/030098587801500503; Pinto C, 2009, BRIT J CANCER, V101, P1261, DOI 10.1038/sj.bjc.6605319; Ressel L, 2013, RES VET SCI, V94, P299, DOI 10.1016/j.rvsc.2012.09.016; Rowinsky EK, 2004, ANNU REV MED, V55, P433, DOI 10.1146/annurev.med.55.091902.104433; Sabattini S, 2012, VET COMP ON IN PRESS; Sassi F, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-5; SAUTTER JH, 1975, J AM VET MED ASSOC, V166, P691; SCANZIANI E, 1991, J SMALL ANIM PRACT, V32, P465, DOI 10.1111/j.1748-5827.1991.tb00991.x; Shiomitsu K, 2009, VET COMP ONCOL, V7, P106, DOI 10.1111/j.1476-5829.2009.00178.x; Singer J, 2012, MOL IMMUNOL, V50, P200, DOI 10.1016/j.molimm.2012.01.002; SULLIVAN M, 1987, VET REC, V120, P79, DOI 10.1136/vr.120.4.79; Swann HM, 2002, J AM ANIM HOSP ASSOC, V38, P157, DOI 10.5326/0380157; Takehana T, 2003, CLIN GASTROENTEROL H, V1, P438, DOI 10.1016/S1542-3565(03)00219-2; TOKUNAGA A, 1995, CANCER, V75, P1418, DOI 10.1002/1097-0142(19950315)75:6+<1418::AID-CNCR2820751505>3.0.CO;2-Y; Wang JF, 2013, CANCER BIOMARK, V13, P89, DOI 10.3233/CBM-130334; Wang YK, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-14; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Withrow S.J., 2007, SMALL ANIMAL CLIN ON, P480	43	29	30	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85388	10.1371/journal.pone.0085388	http://dx.doi.org/10.1371/journal.pone.0085388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454858	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100079
J	Knapp, RT; Wong, MJH; Kollmannsberger, LK; Gassen, NC; Kretzschmar, A; Zschocke, J; Hafner, K; Young, JC; Rein, T				Knapp, Regina T.; Wong, Michael J. H.; Kollmannsberger, Lorenz K.; Gassen, Nils C.; Kretzschmar, Anja; Zschocke, Juergen; Hafner, Kathrin; Young, Jason C.; Rein, Theo			Hsp70 Cochaperones HspBP1 and BAG-1M Differentially Regulate Steroid Hormone Receptor Function	PLOS ONE			English	Article							ENHANCES ANDROGEN RECEPTOR; NUCLEOTIDE EXCHANGE FACTOR; GLUCOCORTICOID-RECEPTOR; MOLECULAR CHAPERONES; NEGATIVE REGULATOR; ATP HYDROLYSIS; CO-CHAPERONE; PROTEIN; COMPLEX; BINDING	Hsp70 binding protein 1 (HspBP1) and Bcl2-associated athanogene 1 (BAG-1), the functional orthologous nucleotide exchange factors of the heat shock protein 70 kilodalton (Hsc70/Hsp70) chaperones, catalyze the release of ADP from Hsp70 while inducing different conformational changes of the ATPase domain of Hsp70. An appropriate exchange rate of ADP/ATP is crucial for chaperone-dependent protein folding processes. Among Hsp70 client proteins are steroid receptors such as the glucocorticoid receptor (GR), the mineralocorticoid receptor (MR), and the androgen receptor (AR). BAG-1 diversely affects steroid receptor activity, while to date the influence of HspBP1 on steroid receptor function is mostly unknown. Here, we compared the influence of HspBP1 and BAG-1M on Hsp70-mediated steroid receptor folding complexes and steroid receptor activity. Coimmunoprecipitation studies indicated preferential binding of Hsp40 and the steroid receptors to BAG-1M as compared to HspBP1. Furthermore, Hsp70 binding to the ligand-binding domain of GR was reduced in the presence of HspBP1 but not in the presence of BAG-1M as shown by pull-down assays. Reporter gene experiments revealed an inhibitory effect on GR, MR, and AR at a wide range of HspBP1 protein levels and at hormone concentrations at or approaching saturation. BAG-1M exhibited a transition from stimulatory effects at low BAG-1M levels to inhibitory effects at higher BAG-1M levels. Overall, BAG-1M and HspBP1 had differential impacts on the dynamic composition of steroid receptor folding complexes and on receptor function with important implications for steroid receptor physiology.	[Knapp, Regina T.; Kollmannsberger, Lorenz K.; Gassen, Nils C.; Kretzschmar, Anja; Zschocke, Juergen; Hafner, Kathrin; Rein, Theo] Max Planck Inst Psychiat, Chaperone Res Grp, Munich, Germany; [Wong, Michael J. H.; Young, Jason C.] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ, Canada	Max Planck Society; McGill University	Rein, T (corresponding author), Max Planck Inst Psychiat, Chaperone Res Grp, Munich, Germany.	theorein@mpipsykl.mpg.de	Gassen, Nils/AAZ-2504-2021	Rein, Theo/0000-0003-2850-4289	Canadian Institutes of Health Research; Canada Research Chair in Molecular Chaperones	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Molecular Chaperones	J.C.Y. is supported by the Canadian Institutes of Health Research, and a Canada Research Chair in Molecular Chaperones, Tier II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel A, 2002, MOL ENDOCRINOL, V16, P1352; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Alberti S, 2003, CELL STRESS CHAPERON, V8, P225, DOI 10.1379/1466-1268(2003)008<0225:BNEFOH>2.0.CO;2; Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871; Cutress RI, 2003, ONCOGENE, V22, P4973, DOI 10.1038/sj.onc.1206688; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Froesch BA, 1998, J BIOL CHEM, V273, P11660, DOI 10.1074/jbc.273.19.11660; Gassler CS, 2001, J BIOL CHEM, V276, P32538, DOI 10.1074/jbc.M105328200; Gebauer M, 1998, MOL CELL BIOL, V18, P6238, DOI 10.1128/MCB.18.11.6238; Gowda NKC, 2013, P NATL ACAD SCI USA, V110, P5975, DOI 10.1073/pnas.1216778110; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hernandez MP, 2002, J BIOL CHEM, V277, P11873, DOI 10.1074/jbc.M111445200; HOHFELD J, 1995, CELL, V83, P589; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Hong W, 2008, J MOL BIOL, V384, P22, DOI 10.1016/j.jmb.2008.09.010; Hong W, 2009, FEBS LETT, V583, P2451, DOI 10.1016/j.febslet.2009.07.010; Kanelakis KC, 2000, BIOCHEMISTRY-US, V39, P14314, DOI 10.1021/bi001671c; Knapp RT, 2012, BIOCHEM J, V441, P297, DOI 10.1042/BJ20111456; Knee DA, 2001, J BIOL CHEM, V276, P12718, DOI 10.1074/jbc.M010841200; Kullmann M, 1998, J BIOL CHEM, V273, P14620, DOI 10.1074/jbc.273.23.14620; Laenger A, 2009, FEBS LETT, V583, P1493, DOI 10.1016/j.febslet.2009.03.072; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Luders J, 2000, J BIOL CHEM, V275, P14817, DOI 10.1074/jbc.275.20.14817; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Maeng SH, 2008, P NATL ACAD SCI USA, V105, P8766, DOI 10.1073/pnas.0803736105; Oh WK, 2003, MOL CELLS, V16, P84; Pratt W B, 1996, EXS, V77, P79; Raynes DA, 2003, TUMOR BIOL, V24, P281, DOI 10.1159/000076459; Raynes DA, 1998, J BIOL CHEM, V273, P32883, DOI 10.1074/jbc.273.49.32883; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Russell R, 1999, BIOCHEMISTRY-US, V38, P4165, DOI 10.1021/bi9824036; Schmidt U, 2003, J BIOL CHEM, V278, P4926, DOI 10.1074/jbc.M212000200; Schneikert J, 1999, J CELL BIOL, V146, P929, DOI 10.1083/jcb.146.5.929; Schulke JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011717; Shatkina L, 2003, MOL CELL BIOL, V23, P7189, DOI 10.1128/MCB.23.20.7189-7197.2003; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; SMITH DF, 1993, MOL ENDOCRINOL, V7, P1418, DOI 10.1210/me.7.11.1418; Sondermann H, 2002, J BIOL CHEM, V277, P33220, DOI 10.1074/jbc.M204624200; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Tanimura S, 2007, J BIOL CHEM, V282, P35430, DOI 10.1074/jbc.M707547200; Townsend PA, 2005, INT J BIOCHEM CELL B, V37, P251, DOI 10.1016/j.biocel.2004.03.016; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Yang XL, 1998, ONCOGENE, V17, P981, DOI 10.1038/sj.onc.1202032; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Zheng HC, 2010, HUM PATHOL, V41, P724, DOI 10.1016/j.humpath.2009.10.017; Zhou R, 2005, J NEUROSCI, V25, P4493, DOI 10.1523/JNEUROSCI.4530-04.2005	51	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85415	10.1371/journal.pone.0085415	http://dx.doi.org/10.1371/journal.pone.0085415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454860	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800045
J	Lippert, J; Halfter, H; Heidbreder, A; Rohr, D; Gess, B; Boentert, M; Osada, N; Young, P				Lippert, Julian; Halfter, Hartmut; Heidbreder, Anna; Roehr, Dominik; Gess, Burkhard; Boentert, Mathias; Osada, Nani; Young, Peter			Altered Dynamics in the Circadian Oscillation of Clock Genes in Dermal Fibroblasts of Patients Suffering from Idiopathic Hypersomnia	PLOS ONE			English	Article							BIPOLAR-I-DISORDER; SCHIZOAFFECTIVE DISORDER; SUPRACHIASMATIC NUCLEUS; INDIVIDUAL FIBROBLASTS; BODY-TEMPERATURE; SLEEP DISORDERS; RHYTHMS; TIME; ASSOCIATION; EXPRESSION	From single cell organisms to the most complex life forms, the 24-hour circadian rhythm is important for numerous aspects of physiology and behavior such as daily periodic fluctuations in body temperature and sleep-wake cycles. Influenced by environmental cues - mainly by light input -, the central pacemaker in the thalamic suprachiasmatic nuclei (SCN) controls and regulates the internal clock mechanisms which are present in peripheral tissues. In order to correlate modifications in the molecular mechanisms of circadian rhythm with the pathophysiology of idiopathic hypersomnia, this study aimed to investigate the dynamics of the expression of circadian clock genes in dermal fibroblasts of idiopathic hypersomniacs (IH) in comparison to those of healthy controls (HC). Ten clinically and polysomnographically proven IH patients were recruited from the department of sleep medicine of the University Hospital of Muenster. Clinical diagnosis was done by two consecutive polysomnographies (PSG) and Multiple Sleep Latency Test (MSLT). Fourteen clinical healthy volunteers served as control group. Dermal fibroblasts were obtained via punch biopsy and grown in cell culture. The expression of circadian clock genes was investigated by semiquantitative Reverse Transcriptase-PCR qRT-PCR analysis, confirming periodical oscillation of expression of the core circadian clock genes BMAL1, PER1/2 and CRY1/2. The amplitude of the rhythmically expressed BMAL1, PER1 and PER2 was significantly dampened in dermal fibroblasts of IH compared to HC over two circadian periods whereas the overall expression of only the key transcriptional factor BMAL1 was significantly reduced in IH. Our study suggests for the first time an aberrant dynamics in the circadian clock in IH. These findings may serve to better understand some clinical features of the pathophysiology in sleep - wake rhythms in IH.	[Lippert, Julian; Halfter, Hartmut; Heidbreder, Anna; Roehr, Dominik; Gess, Burkhard; Boentert, Mathias; Young, Peter] Univ Hosp Muenster, Dept Neurol Sleepmed & Neuromuscular Dis, Munster, Germany; [Osada, Nani] Inst Med Informat, Munster, Germany	University of Munster	Young, P (corresponding author), Univ Hosp Muenster, Dept Neurol Sleepmed & Neuromuscular Dis, Albert Schweitzer Campus 1, Munster, Germany.	Peter.Young@ukmuenster.de		Heidbreder, Anna/0000-0002-9552-7619				Achermann P, 2004, AVIAT SPACE ENVIR MD, V75, pA37; Akashi M, 2010, P NATL ACAD SCI USA, V107, P15643, DOI 10.1073/pnas.1003878107; American Academy of Sleep Medicine, 2005, DIAGN COD MAN; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Bellet MM, 2013, PROCNATLACADSCIUSA; Billiard M, 2001, Sleep Med Rev, V5, P349, DOI 10.1053/smrv.2001.0168; Billiard M., 2003, SLEEP PHYSL INVESTIG, P333; BINGHAM C, 1982, CHRONOBIOLOGIA, V9, P397; Brown S, 2005, AM POETRY REV, V34, P3; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Brown SA, 2012, DEV CELL, V22, P477, DOI 10.1016/j.devcel.2012.02.007; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Coelho FMS, 2011, J CLIN NEUROPHYSIOL, V28, P412, DOI 10.1097/WNP.0b013e31822734a3; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Dauvilliers Yves, 2005, Dialogues Clin Neurosci, V7, P347; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Etain B, 2011, EUR NEUROPSYCHOPHARM, V21, pS676, DOI 10.1016/j.euroneuro.2011.07.007; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fernandez JR, 2009, PHILOS T R SOC A, V367, P431, DOI 10.1098/rsta.2008.0231; Harvey AG, 2008, AM J PSYCHIAT, V165, P820, DOI 10.1176/appi.ajp.2008.08010098; Harvey AG, 2006, DEV PSYCHOPATHOL, V18, P1147, DOI 10.1017/S095457940606055X; Herzog ED, 2003, J NEUROPHYSIOL, V90, P763, DOI 10.1152/jn.00129.2003; Hida A, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-7; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; Mansour HA, 2005, CHRONOBIOL INT, V22, P571, DOI 10.1081/CBI-200062413; Mansour HA, 2006, GENES BRAIN BEHAV, V5, P150, DOI 10.1111/j.1601-183X.2005.00147.x; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; Masri S, 2013, NAT REV NEUROSCI, V14, P69, DOI 10.1038/nrn3393; Mignot E, 1997, SLEEP, V20, P1012; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Moller-Levet CS, 2013, PROCNATLACADSCIUSA; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Nevsimalova S, 2000, Suppl Clin Neurophysiol, V53, P366, DOI 10.1016/S1567-424X(09)70183-7; Pagani L, 2011, P NATL ACAD SCI USA, V108, P7218, DOI 10.1073/pnas.1008882108; Pagani L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013376; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Raizen DM, 2011, CHEST, V139, P446, DOI 10.1378/chest.10-1313; Reid KJ, 2009, SEMIN NEUROL, V29, P393, DOI 10.1055/s-0029-1237120; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Schirmacher A, 2011, BIOL RHYTHM RES, V42, P407, DOI 10.1080/09291016.2010.525382; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Teclemariam-Mesbah R, 1999, J COMP NEUROL, V406, P171, DOI 10.1002/(SICI)1096-9861(19990405)406:2<171::AID-CNE3>3.0.CO;2-U; Terman M, 2005, CNS SPECTRUMS, V10, P647, DOI 10.1017/S1092852900019611; van Oosterhout F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039693; Vernet C, 2009, SLEEP, V32, P753, DOI 10.1093/sleep/32.6.753; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yang S, 2009, MOL PSYCHIATR, V14, P143, DOI 10.1038/mp.2008.10; Young MW, 2000, TRENDS BIOCHEM SCI, V25, P601, DOI 10.1016/S0968-0004(00)01695-9	63	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85255	10.1371/journal.pone.0085255	http://dx.doi.org/10.1371/journal.pone.0085255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454829	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800031
J	Mirkovic-Hosle, M; Forstemann, K				Mirkovic-Hoesle, Milijana; Foerstemann, Klaus			Transposon Defense by Endo-siRNAs, piRNAs and Somatic pilRNAs in Drosophila: Contributions of Loqs-PD and R2D2	PLOS ONE			English	Article							RNA PATHWAY; DISTINCT ROLES; PIWI; EXPRESSION; CHROMATIN; MICRORNAS; INTERACTS; COMPONENT; HOMOLOG; DICER-2	Transposable elements are a serious threat for genome integrity and their control via small RNA mediated silencing pathways is an ancient strategy. The fruit fly Drosophila melanogaster has two silencing activities that target transposons: endogenous siRNAs (esiRNAs or endo-siRNAs) and Piwi-interacting small RNAs (piRNAs). The biogenesis of endo-siRNAs involves the Dicer-2 co-factors Loqs-PD, which acts predominantly during processing of dsRNA by Dcr-2, and R2D2, which primarily helps to direct siRNAs into the RNA interference effector Ago2. Nonetheless, loss of either protein is not sufficient to produce a phenotype comparable with a dcr-2 mutation. We provide further deep sequencing evidence supporting the notion that R2D2 and Loqs-PD have partially overlapping function. Certain transposons display a preference for either dsRBD-protein during production or loading; this appeared to correlate neither with overall abundance, classification of the transposon or a specific site of genomic origin. The endo-siRNA biogenesis pathway in germline operates according to the same principles as the existing model for the soma, and its impairment does not significantly affect piRNAs. Expanding the analysis, we confirmed the occurrence of somatic piRNA-like RNAs (pilRNAs) that show a ping-pong signature. We detected expression of the Piwi-family protein mRNAs only barely above background, indicating that the somatic pilRNAs may arise from a small sub-population of somatic cells that express a functional piRNA pathway.	[Foerstemann, Klaus] Univ Munich, Gene Ctr, Munich, Germany; Univ Munich, Dept Biochem, Munich, Germany	University of Munich; University of Munich	Forstemann, K (corresponding author), Univ Munich, Gene Ctr, Munich, Germany.	Foerstemann@lmb.uni-muenchen.de			DFG [FO360-2]; DFG collaborative research center [SFB646]; Fonds der Chemischen Industrie	DFG(German Research Foundation (DFG)); DFG collaborative research center(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by a DFG grant to KF (FO360-2) and the DFG collaborative research center, SFB646. MMH was the recipient of a PhD fellowship awarded by the "Fonds der Chemischen Industrie''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Cichocki F, 2010, J IMMUNOL, V185, P2009, DOI 10.4049/jimmunol.1000855; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Gerbasi VR, 2011, P NATL ACAD SCI USA, V108, P3204, DOI 10.1073/pnas.1009781108; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hartig JV, 2011, NUCLEIC ACIDS RES, V39, P3836, DOI 10.1093/nar/gkq1324; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Karthik A, 2008, PAK J PHARM SCI, V21, P421; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Klenov MS, 2011, P NATL ACAD SCI USA, V108, P18760, DOI 10.1073/pnas.1106676108; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Thomas A, 2013, GENE DEV, V27, P390, DOI 10.1101/gad.209841.112; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735; Matranga C, 2007, CURR BIOL, V17, pR789, DOI 10.1016/j.cub.2007.07.014; Miyoshi K, 2010, RNA; Nishida KM, 2013, MOL CELL, V49, P680, DOI 10.1016/j.molcel.2012.12.024; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2010, MOL CELL BIOL; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Perrat PN, 2013, SCIENCE, V340, P91, DOI 10.1126/science.1231965; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; SCHUPBACH T, 1991, GENETICS, V129, P1119; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Smulders-Srinivasan TK, 2003, GENETICS, V165, P1971; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Zhou R, 2009, RNA, V15, P1886, DOI 10.1261/rna.1611309	51	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84994	10.1371/journal.pone.0084994	http://dx.doi.org/10.1371/journal.pone.0084994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454776	gold, Green Submitted, Green Published			2022-12-25	WOS:000329922500030
J	Ricankova, VP; Robovsky, J; Riegert, J				Ricankova, Vera Pavelkova; Robovsky, Jan; Riegert, Jan			Ecological Structure of Recent and Last Glacial Mammalian Faunas in Northern Eurasia: The Case of Altai-Sayan Refugium	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PLANT-COMMUNITIES; FOREST-STEPPE; VEGETATION; EUROPE; POLLEN; PATTERNS; CLIMATE; SIBERIA; ORIGIN	Pleistocene mammalian communities display unique features which differ from present-day faunas. The paleocommunities were characterized by the extraordinarily large body size of herbivores and predators and by their unique structure consisting of species now inhabiting geographically and ecologically distinct natural zones. These features were probably the result of the unique environmental conditions of ice age ecosystems. To analyze the ecological structure of Last Glacial and Recent mammal communities we classified the species into biome and trophic-size categories, using Principal Component analysis. We found a marked similarity in ecological structure between Recent eastern Altai-Sayan mammalian assemblages and comparable Pleistocene faunas. The composition of Last Glacial and Recent eastern Altai-Sayan assemblages were characterized by the occurrence of large herbivore and predator species associated with steppe, desert and alpine biomes. These three modern biomes harbor most of the surviving Pleistocene mammals. None of the analyzed Palearctic Last Glacial faunas showed affinity to the temperate forest, taiga, or tundra biome. The Eastern part of the Altai-Sayan region could be considered a refugium of the Last Glacial-like mammalian assemblages. Glacial fauna seems to persist up to present in those areas where the forest belt does not separate alpine vegetation from the steppes and deserts.	[Ricankova, Vera Pavelkova; Robovsky, Jan; Riegert, Jan] Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice	Ricankova, VP (corresponding author), Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic.	ricankova@seznam.cz	Riegert, Jan/D-9070-2016; Robovsky, Jan/AAL-3362-2020; Riegert, Jan/AAQ-5136-2021	Riegert, Jan/0000-0003-4195-1278; Robovsky, Jan/0000-0001-8720-9314; Riegert, Jan/0000-0003-4195-1278; Ricankova, Vera/0000-0002-6475-4894	Czech Ministry of Education [MSM 6007665801]; Czech Science Foundation [P504/11/0454]	Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	The study was supported by Czech Ministry of Education (MSM 6007665801) http://www.msmt.cz/index.php?lang = 2 and Czech Science Foundation (# P504/11/0454) http://www.gacr.cz/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanian A.K., 2005, PALEONTOL J+, V39, P645; Alberdi Maria Teresa, 1998, Geologija (Vilnius), V25, P8; Allen JRM, 2010, QUATERNARY SCI REV, V29, P19; Blinnikov MS, 2011, QUATERNARY SCI REV, V30, P2906, DOI 10.1016/j.quascirev.2011.07.002; Boeskorov GG, 2006, QUATERN INT, V142, P119, DOI 10.1016/j.quaint.2005.03.009; Brugal JP, 2007, QUATERNAIRE, V18, P129; Duff A, 2004, MAMMALS WORLD CHECKL; Dulamsuren C, 2005, APPL VEG SCI, V8, P149, DOI 10.1111/j.1654-109X.2005.tb00640.x; Faith JT, 2011, QUATERNARY SCI REV, V30, P13; Frenzel B, 1992, ATLAS PALEOCLIMATES; Guthrie R.D., 1984, P259; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Guthrie RD, 2001, QUATERNARY SCI REV, V20, P549; HIBBARD CW, 1949, GEOL SOC AM BULL, V60, P1417, DOI 10.1130/0016-7606(1949)60[1417:PVPINA]2.0.CO;2; Hoffmann MH, 2011, J MOLLUS STUD, V77, P76, DOI 10.1093/mollus/eyq039; Hoffmann MH, 2001, PHYTOCOENOLOGIA, V31, P401; HORACEK I, 1988, Rozpravy Ceskoslovenske Akademie Ved Rada Matematickych a Prirodnich Ved, V98, P1; Horsak M, 2010, J BIOGEOGR, V37, P1450, DOI 10.1111/j.1365-2699.2010.02280.x; Huntley B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061963; Jankovska V., 2002, ACTA PALAEOBOT, V42, P29; Jankovska V, 2008, PRESLIA, V80, P307; Kunes P, 2008, J BIOGEOGR, V35, P2223, DOI 10.1111/j.1365-2699.2008.01974.x; KurtUn B., 1968, PLEISTOCENE MAMMALS; Le Fur S, 2011, PALAEOGEOGR PALAEOCL, V305, P295, DOI 10.1016/j.palaeo.2011.03.011; Louys J, 2011, GLOBAL ECOL BIOGEOGR, V20, P717, DOI 10.1111/j.1466-8238.2010.00643.x; Markova AK, 2009, QUATERN INT, V201, P53, DOI 10.1016/j.quaint.2008.05.020; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; Meloro C, 2012, PALAIOS, V27, P90, DOI 10.2110/palo.2011.p11-048r; Mendoza M, 2005, EVOL ECOL RES, V7, P505; Mendoza M, 2004, J THEOR BIOL, V230, P203, DOI 10.1016/j.jtbi.2004.05.002; Musil R., 1999, ACTA MUSEI MORAVIAE, V64, P161; Pelankova B, 2009, REV PALAEOBOT PALYNO, V157, P253, DOI 10.1016/j.revpalbo.2009.05.005; Potapkina AF., 1979, MAMMALS ALTAI SAYAN; Rodriguez J, 2006, J BIOGEOGR, V33, P291, DOI 10.1111/j.1365-2699.2005.01397.x; Rodriguez J, 2006, PALAEOGEOGR PALAEOCL, V239, P355, DOI 10.1016/j.palaeo.2006.02.001; Rodriguez JS, 2004, PALAEOGEOGR PALAEOCL, V207, P1, DOI 10.1016/j.palaeo.2003.12.016; Romer AS, 1933, AM ABORIGINES THEIR, P47; Shackleton N.J., 1969, P ROY SOC LOND B BIO, V174, P135, DOI DOI 10.1098/RSPB.1969.0085; Simakova AN, 2006, QUATERN INT, V149, P110, DOI 10.1016/j.quaint.2005.11.024; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; Smidt S, 2002, HYDROBIOLOGIA, V468, P95, DOI 10.1023/A:1015237411606; Smith R.L., 1986, ELEMENTS ECOLOGY; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2008, QUATERNARY SCI REV, V27, P2499, DOI 10.1016/j.quascirev.2008.08.003; Tarasov PE, 1999, EARTH PLANET SC LETT, V171, P635, DOI 10.1016/S0012-821X(99)00171-5; Tarasov PE, 2000, J BIOGEOGR, V27, P609, DOI 10.1046/j.1365-2699.2000.00429.x; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Van Kolfschoten Thijs, 1995, Acta Zoologica Cracoviensia, V38, P73; VERESHCHAGIN NK, 1991, ANN ZOOL FENN, V28, P253; Wells AG, 2012, APPL VEG SCI, V15, P560, DOI 10.1111/j.1654-109X.2012.01193.x; WILLIAMS DF, 1988, PALAEOGEOGR PALAEOCL, V64, P221, DOI 10.1016/0031-0182(88)90008-9; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119; Willis KJ, 2004, QUATERNARY SCI REV, V53, P203; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wilson JS, 2010, PROG PHYS GEOG, V34, P419, DOI 10.1177/0309133310363991; ZIMOV SA, 1995, AM NAT, V146, P765, DOI 10.1086/285824	57	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85056	10.1371/journal.pone.0085056	http://dx.doi.org/10.1371/journal.pone.0085056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454791	Green Published, gold			2022-12-25	WOS:000329922500038
J	Al-Qahtani, AA; Al-Anazi, MR; Abdo, AA; Sanai, FM; Al-Hamoudi, W; Alswat, KA; Al-Ashgar, HI; Khalaf, NZ; Eldali, AM; Viswan, NA; Al-Ahdal, MN				Al-Qahtani, Ahmed A.; Al-Anazi, Mashael R.; Abdo, Ayman A.; Sanai, Faisal M.; Al-Hamoudi, Waleed; Alswat, Khalid A.; Al-Ashgar, Hamad I.; Khalaf, Nisreen Z.; Eldali, Abdelmoneim M.; Viswan, Nisha A.; Al-Ahdal, Mohammed N.			Association between HLA Variations and Chronic Hepatitis B Virus Infection in Saudi Arabian Patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HEPATOCELLULAR-CARCINOMA; CLEARANCE; ALLELES; LOCUS; SUSCEPTIBILITY; EXPRESSION; VARIANTS; HLA-DPA1; DISEASES	Hepatitis B virus (HBV) infection is a leading cause of liver diseases including cirrhosis and hepatocellular carcinoma. Human leukocyte antigens (HLAs) play an important role in the regulation of immune response against infectious organisms, including HBV. Recently, several genome-wide association (GWAS) studies have shown that genetic variations in HLA genes influence disease progression in HBV infection. The aim of this study was to investigate the role of HLA genetic polymorphisms and their possible role in HBV infection in Saudi Arabian patients. Variations in HLA genes were screened in 1672 subjects who were divided according to their clinical status into six categories as follows; clearance group, inactive carriers, active carriers, cirrhosis, hepatocellular carcinoma (HCC) patients and uninfected healthy controls. Three single nucleotide polymorphisms (SNPs) belonged to HLA-DQ region (rs2856718, rs7453920 and rs9275572) and two SNPs belonged to HLA-DP (rs3077 and rs9277535) were studied. The SNPs were genotyped by PCR-based DNA sequencing (rs2856718) and allele specific TaqMan genotyping assays (rs3077, rs7453920, rs9277535 and rs9275572). The results showed that rs2856718, rs3077, rs9277535 and rs9275572 were associated with HBV infection (p = 0.0003, OR = 1.351, CI = 1.147-1.591; p = 0.041, OR = 1.20, CI = 1.007-1.43; p = 0.045, OR = 1.198, CI = 1.004-1.43 and p = 0.0018, OR = 0.776, CI = 0.662-0.910, respectively). However, allele frequency of rs2856718, rs7453920 and rs9275572 were found more in chronically infected patients when compared to clearance group infection (p = 0.0001, OR = 1.462, CI = 1.204-1.776; p = 0.0178, OR = 1.267, CI = 1.042-1.540 and p = 0.010, OR = 0.776, CI = 0.639-0.942, respectively). No association was found when polymorphisms in HLA genes were compared in active carriers versus cirrhosis/HCC patients. In conclusion, these results suggest that variations in HLA genes could affect susceptibility to and clearance of HBV infection in Saudi Arabian patients.	[Al-Qahtani, Ahmed A.; Al-Anazi, Mashael R.; Khalaf, Nisreen Z.; Viswan, Nisha A.; Al-Ahdal, Mohammed N.] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia; [Abdo, Ayman A.; Al-Hamoudi, Waleed; Alswat, Khalid A.] King Saud Univ, Coll Med, Dept Med, Gastroenterol Sect, Riyadh 11461, Saudi Arabia; [Sanai, Faisal M.] King Abdul Aziz Med City, Hepatobiliary Sci & Liver Transplantat, Riyadh, Saudi Arabia; [Al-Ashgar, Hamad I.] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh 11211, Saudi Arabia; [Eldali, Abdelmoneim M.] King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh 11211, Saudi Arabia; [Al-Qahtani, Ahmed A.; Abdo, Ayman A.; Sanai, Faisal M.; Al-Hamoudi, Waleed; Alswat, Khalid A.] King Saud Univ, Liver Dis Res Ctr, Riyadh, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Saud University; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Saud University	Al-Qahtani, AA (corresponding author), King Faisal Specialist Hosp & Res Ctr, Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia.	aqahtani@kfshrc.edu.sa		Alswat, Khalid/0000-0002-3521-8523; Al-Ahdal, Mohammed/0000-0002-8707-1594	King Abdulaziz City for Science and Technology, Saudi Arabia [ARP-27-18]	King Abdulaziz City for Science and Technology, Saudi Arabia	This study was supported in part by a grant from King Abdulaziz City for Science and Technology, Saudi Arabia [GRANT # ARP-27-18]. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo AA, 2006, ANN SAUDI MED, V26, P261, DOI 10.5144/0256-4947.2006.261; Accolla RS, 2001, TRENDS IMMUNOL, V22, P560, DOI 10.1016/S1471-4906(01)02003-8; Ahn SH, 2000, HEPATOLOGY, V31, P1371, DOI 10.1053/jhep.2000.7988; An P, 2011, J INFECT DIS, V203, P943, DOI 10.1093/infdis/jiq154; Araujo NM, 2011, INFECT GENET EVOL, V11, P1199, DOI 10.1016/j.meegid.2011.04.017; Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Jiang YG, 2003, WORLD J GASTROENTERO, V9, P2221; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Katsuyama Y, 1998, HUM HERED, V48, P126, DOI 10.1159/000022793; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Lau KC, 2011, CLIN CHIM ACTA, V412, P952, DOI 10.1016/j.cca.2011.01.030; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024221; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Lu Liang-ping, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P427; Marsh SGE, 2005, TISSUE ANTIGENS, V65, P301, DOI 10.1111/j.1399-0039.2005.00379.x; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039175; O'Brien TR, 2011, GENES IMMUN, V12, P428, DOI 10.1038/gene.2011.11; PURCELL RH, 1993, GASTROENTEROLOGY, V104, P955, DOI 10.1016/0016-5085(93)90261-A; Thio CL, 1999, J INFECT DIS, V179, P1004, DOI 10.1086/314684; Thio CL, 2003, J VIROL, V77, P12083, DOI 10.1128/JVI.77.22.12083-12087.2003; Thomas R, 2012, J VIROL, V86, P6979, DOI 10.1128/JVI.00406-12; Tseng TC, 2011, ANTIVIR THER, V16, P629, DOI 10.3851/IMP1841; Vermehren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032605; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Wu YF, 2004, J MED VIROL, V72, P17, DOI 10.1002/jmv.10557; Yan ZH, 2012, INFECT GENET EVOL, V12, P1222, DOI 10.1016/j.meegid.2012.03.026	30	48	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e80445	10.1371/journal.pone.0080445	http://dx.doi.org/10.1371/journal.pone.0080445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465366	Green Submitted, gold, Green Published			2022-12-25	WOS:000330283100001
J	Pischke, S; Gisa, A; Suneetha, PV; Wiegand, SB; Taubert, R; Schlue, J; Wursthorn, K; Bantel, H; Raupach, R; Bremer, B; Zacher, BJ; Schmidt, RE; Manns, MP; Rifai, K; Witte, T; Wedemeyer, H				Pischke, Sven; Gisa, Anett; Suneetha, Pothakamuri Venkata; Wiegand, Steffen Bjoern; Taubert, Richard; Schlue, Jerome; Wursthorn, Karsten; Bantel, Heike; Raupach, Regina; Bremer, Birgit; Zacher, Behrend Johann; Schmidt, Reinhold Ernst; Manns, Michael Peter; Rifai, Kinan; Witte, Torsten; Wedemeyer, Heiner			Increased HEV Seroprevalence in Patients with Autoimmune Hepatitis	PLOS ONE			English	Article							E VIRUS-INFECTION; TRANSPLANT RECIPIENTS; LIVER-DISEASE; ANTIBODIES	Background: Hepatitis E virus (HEV) infection takes a clinically silent, self-limited course in the far majority of cases. Chronic hepatitis E has been reported in some cohorts of immunocompromised individuals. The role of HEV infections in patients with autoimmune hepatitis (AIH) is unknown. Methods: 969 individuals were tested for anti-HEV antibodies (MP-diagnostics) including 208 patients with AIH, 537 healthy controls, 114 patients with another autoimmune disease, rheumatoid arthritis (RA), and 109 patients with chronic HCV- or HBV-infection (HBV/HCV). Patients with AIH, RA and HBV/HCV were tested for HEV RNA. HEV-specific proliferative T cell responses were investigated using CFSE staining and in vitro stimulation of PBMC with overlapping HEV peptides. Results: HEV-antibodies tested more frequently positive in patients with AIH (n = 16; 7.7%) than in healthy controls (n = 11; 2.0%; p = 0.0002), patients with RA (n = 4; 3.5%; p = 0.13) or patients with HBV/HCV infection (n = 2; 2.8%; p = 0.03). HEV-specific T cell responses could be detected in all anti-HEV-positive AIH patients. One AIH patient receiving immunosuppression with cyclosporin and prednisolone and elevated ALT levels had acute hepatitis E but HEV viremia resolved after reducing immunosuppressive medication. None of the RA or HBV/HCV patients tested HEV RNA positive. Conclusions: Patients with autoimmune hepatitis but not RA or HBV/HCV patients are more likely to test anti-HEV positive. HEV infection should been ruled out before the diagnosis of AIH is made. Testing for HEV RNA is also recommended in AIH patients not responding to immunosuppressive therapy.	[Pischke, Sven; Gisa, Anett; Suneetha, Pothakamuri Venkata; Wiegand, Steffen Bjoern; Taubert, Richard; Wursthorn, Karsten; Bantel, Heike; Raupach, Regina; Bremer, Birgit; Zacher, Behrend Johann; Manns, Michael Peter; Rifai, Kinan; Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Schlue, Jerome] Hannover Med Sch, Inst Pathol, Hannover, Germany; [Witte, Torsten] Hannover Med Sch, Dept Clin Immunol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Wedemeyer, H (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	Wedemeyer.Heiner@mh-hannover.de	Witte, Torsten/B-5783-2016		German Federal Ministry of Education and Research [01EO0802]; Robert Koch Institute on hepatitis E [1362-1097];  [KFO 250 TP 03]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Robert Koch Institute on hepatitis E; 	This work was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO0802), a grant from the Robert Koch Institute on hepatitis E to Sven Pischke and Heiner Wedemeyer (reference number 1362-1097), and by a grant to Torsten Witte and Reinhold E. Schmidt: KFO 250 TP 03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; [Anonymous], HEPATOLOGY; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746; Goens S. Denise, 2004, Animal Health Research Reviews, V5, P145, DOI 10.1079/AHR200495; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kammer AR, 1999, J EXP MED, V190, P169, DOI 10.1084/jem.190.2.169; LeCann P, 1997, SCAND J GASTROENTERO, V32, P387, DOI 10.3109/00365529709007689; Manns MP, 1997, J VIRAL HEPATITIS, V4, P7, DOI 10.1111/j.1365-2893.1997.tb00154.x; MANNS MP, 1993, INTERVIROLOGY, V35, P108, DOI 10.1159/000150301; Manns MP, 2001, GASTROENTEROLOGY, V120, P1502, DOI 10.1053/gast.2001.24227; Pischke S, 2012, AM J TRANSPLANT, V12, P3128, DOI 10.1111/j.1600-6143.2012.04200.x; Pischke S, 2010, J VIRAL HEPATITIS, V17, P598, DOI 10.1111/j.1365-2893.2009.01219.x; Pischke S, 2010, LIVER TRANSPLANT, V16, P74, DOI 10.1002/lt.21958; Said B, 2009, EMERG INFECT DIS, V15, P1738, DOI 10.3201/eid1511.091094; Suneetha PV, 2012, HEPATOLOGY, V55, P695, DOI 10.1002/hep.24738; Suneetha PV, 2009, J IMMUNOL METHODS, V342, P33, DOI 10.1016/j.jim.2008.11.020; SYLVAN SPE, 1995, JAMA-J AM MED ASSOC, V273, P377, DOI 10.1001/jama.1995.03520290029022; Tei S, 2004, J MED VIROL, V74, P67, DOI 10.1002/jmv.20147; Usui R, 2004, INFECTION, V32, P57, DOI 10.1007/s15010-004-3078-0; Vento S, 2004, AUTOIMMUN REV, V3, P61, DOI 10.1016/S1568-9972(03)00053-3; Vieira CL, 2013, WORLD J HEPATOL, V5, P152, DOI 10.4254/wjh.v5.i3.152; Wedemeyer H, 2013, SEMIN LIVER DIS, V33, P71, DOI 10.1055/s-0033-1338118; Wedemeyer H, 2012, GASTROENTEROLOGY, V142, P1388, DOI 10.1053/j.gastro.2012.02.014; Wenzel JJ, 2013, J INFECT DIS, V207, P497, DOI 10.1093/infdis/jis688	27	52	56	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85330	10.1371/journal.pone.0085330	http://dx.doi.org/10.1371/journal.pone.0085330			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465537	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500055
J	Unzu, C; Melero, I; Morales-Kastresana, A; Sampedro, A; Serrano-Mendioroz, I; Azpilikueta, A; Ochoa, MC; Dubrot, J; Martinez-Anso, E; Fontanellas, A				Unzu, Carmen; Melero, Ignacio; Morales-Kastresana, Aizea; Sampedro, Ana; Serrano-Mendioroz, Irantzu; Azpilikueta, Arantza; Carmen Ochoa, Maria; Dubrot, Juan; Martinez-Anso, Eduardo; Fontanellas, Antonio			Innate Functions of Immunoglobulin M Lessen Liver Gene Transfer with Helper-Dependent Adenovirus	PLOS ONE			English	Article							KUPFFER CELLS LEADS; IMMUNE-RESPONSE; COMPLEMENT ACTIVATION; TRANSGENE EXPRESSION; NATURAL ANTIBODIES; VECTORS; IGM; TRANSDUCTION; DEPLETION; DELIVERY	The immune system poses obstacles to viral vectors, even in the first administration to preimmunized hosts. We have observed that the livers of B cell-deficient mice were more effectively transduced by a helper-dependent adenovirus serotype-5 (HDA) vector than those of WT mice. This effect was T-cell independent as shown in athymic mice. Passive transfer of the serum from adenovirus-naive WT to Rag1KO mice resulted in a reduction in gene transfer that was traced to IgM purified from serum of adenovirus-naive mice. To ascribe the gene transfer inhibition activity to either adenoviral antigen-specific or antigen-unspecific functions of IgM, we used a monoclonal IgM antibody of unrelated specificity. Both the polyclonal and the irrelevant monoclonal IgM inhibited gene transfer by the HDA vector to either cultured hepatocellular carcinoma cells or to the liver of mice in vivo. Adsorption of polyclonal or monoclonal IgMs to viral capsids was revealed by ELISAs on adenovirus-coated plates. These observations indicate the existence of an inborn IgM mechanism deployed against a prevalent virus to reduce early post-infection viremia. In conclusion, innate IgM binding to adenovirus serotype-5 capsids restrains gene-transfer and offers a mechanism to be targeted for optimization of vector dosage in gene therapy with HDA vectors.	[Unzu, Carmen; Melero, Ignacio; Morales-Kastresana, Aizea; Sampedro, Ana; Serrano-Mendioroz, Irantzu; Azpilikueta, Arantza; Carmen Ochoa, Maria; Martinez-Anso, Eduardo; Fontanellas, Antonio] Univ Navarra, Ctr Appl Med Res CIMA, Gene Therapy & Hepatol Area, E-31080 Pamplona, Spain; [Dubrot, Juan] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland	University of Navarra; University of Geneva	Fontanellas, A (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Gene Therapy & Hepatol Area, E-31080 Pamplona, Spain.	afontanellas@unav.es	Unzu, Carmen/ABC-2904-2021; Fontanellas, Antonio/AAD-8073-2022; Unzu, Carmen/M-1026-2019; Melero, Ignacio/T-7600-2019; Ochoa, Maria C./K-4508-2017; Azpilicueta, Arantza/K-2701-2017; Dubrot, Juan/ABI-1676-2020	Unzu, Carmen/0000-0002-1582-7196; Fontanellas, Antonio/0000-0001-9279-7990; Melero, Ignacio/0000-0002-1360-348X; Ochoa, Maria C./0000-0001-9920-2144; Azpilicueta, Arantza/0000-0001-8511-6050; Dubrot, Juan/0000-0002-8093-2208	UTE project of Centro de Investigacion Medica Aplicada; University of Navarra; Spanish Fondo de Investigacion Sanitaria [PS09/02639]; Spanish Fundacion Mutua Madrilena de Investigacion Medica [AP66712009]	UTE project of Centro de Investigacion Medica Aplicada; University of Navarra; Spanish Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Spanish Fundacion Mutua Madrilena de Investigacion Medica	This work was supported in part by grants from UTE project of Centro de Investigacion Medica Aplicada, University of Navarra, Spanish Fondo de Investigacion Sanitaria (PS09/02639) and Spanish Fundacion Mutua Madrilena de Investigacion Medica (AP66712009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahi YS, 2011, CURR GENE THER, V11, P307; Appledorn DM, 2008, GENE THER, V15, P1606, DOI 10.1038/gt.2008.114; Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Brunetti-Pierri N, 2005, MOL THER, V12, P99, DOI 10.1016/j.ymthe.2005.03.001; Brunetti-Pierri N, 2007, MOL THER, V15, P732, DOI 10.1038/sj.mt.6300102; Brunetti-Pierri N, 2012, MOL THER, V20, P1863, DOI 10.1038/mt.2012.143; Brunetti-Pierri N, 2011, HUM MOL GENET, V20, pR7, DOI 10.1093/hmg/ddr143; CAPEL PJA, 1980, J IMMUNOL METHODS, V36, P77, DOI 10.1016/0022-1759(80)90096-4; Casali P, 1996, CURR TOP MICROBIOL, V210, P167; Cerreto M, 2012, CURR GENE THER, V12, P48, DOI 10.2174/156652312799789280; Cerullo V, 2007, MOL THER, V15, P378, DOI 10.1038/sj.mt.6300031; Crettaz J, 2008, J GENE MED, V10, P1092, DOI 10.1002/jgm.1236; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Dimmock D, 2011, HUM GENE THER, V22, P483, DOI 10.1089/hum.2010.167; Elkon K, 2008, NAT CLIN PRACT RHEUM, V4, P491, DOI 10.1038/ncprheum0895; Fontanellas A, 2010, MOL THER, V18, P754, DOI 10.1038/mt.2009.312; Gau CL, 2009, MOL THER, V17, P1155, DOI 10.1038/mt.2009.65; Haegel-Kronenberger H, 2004, GENE THER, V11, P241, DOI 10.1038/sj.gt.3302152; HEYMAN B, 1988, J EXP MED, V167, P1999, DOI 10.1084/jem.167.6.1999; Higgins R, 2010, THER APHER DIAL, V14, P392, DOI 10.1111/j.1744-9987.2010.00821.x; Kaveri SV, 2012, J IMMUNOL, V188, P939, DOI 10.4049/jimmunol.1102107; Khare R, 2013, J VIROL, V87, P3678, DOI 10.1128/JVI.01392-12; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; MARTINEZANSO E, 1994, HEPATOLOGY, V19, P1400, DOI 10.1002/hep.1840190613; Muruve DA, 2004, J VIROL, V78, P5966, DOI 10.1128/JVI.78.11.5966-5972.2004; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; Paneda A, 2009, HUM GENE THER, V20, P908, DOI 10.1089/hum.2009.031; Piccolo P, 2013, MOL THER, V21, P767, DOI 10.1038/mt.2012.287; Racine R, 2009, IMMUNOL LETT, V125, P79, DOI 10.1016/j.imlet.2009.06.003; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Schiedner G, 2003, MOL THER, V7, P35, DOI 10.1016/S1525-0016(02)00017-5; Seregin SS, 2009, MOL THER, V17, P685, DOI 10.1038/mt.2008.297; Smith JG, 2008, J VIROL, V82, P6492, DOI 10.1128/JVI.00557-08; Snoeys J, 2006, MOL THER, V13, P98, DOI 10.1016/j.ymthe.2005.06.477; Sokoloff AV, 2001, MOL THER, V3, P821, DOI 10.1006/mthe.2001.0340; Tao NJ, 2001, MOL THER, V3, P28, DOI 10.1006/mthe.2000.0227; Thaci B, 2011, ONCOTARGET, V2, P113; Tian J, 2009, J VIROL, V83, P5648, DOI 10.1128/JVI.00082-09; Unzu C, 2013, HUM MOL GENET; Varnavski AN, 2002, J VIROL, V76, P5711, DOI 10.1128/JVI.76.11.5711-5719.2002; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Xu ZL, 2013, NAT MED, V19, P452, DOI 10.1038/nm.3107; Xu ZL, 2008, J VIROL, V82, P11705, DOI 10.1128/JVI.01320-08; Yamaguchi T, 2007, HUM GENE THER, V18, P753, DOI 10.1089/hum.2007.016; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06; Zong S, 2011, J GENE MED, V13, P670, DOI 10.1002/jgm.1627	46	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85432	10.1371/journal.pone.0085432	http://dx.doi.org/10.1371/journal.pone.0085432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465560	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500065
J	Wanless, AG; Lin, Y; Weiss, EL				Wanless, Antony G.; Lin, Yuan; Weiss, Eric L.			Cell Morphogenesis Proteins Are Translationally Controlled through UTRs by the Ndr/LATS Target Ssd1	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE W303-1A; GREEN FLUORESCENT PROTEIN; RNA-BINDING PROTEIN; MESSENGER-RNA; GENETIC INTERACTIONS; MITOTIC EXIT; YEAST CBK1; KINASE; WALL; LOCALIZATION	Eukaryotic cells control their growth and morphogenesis to maintain integrity and viability. Free-living cells are further challenged by their direct interaction with the environment and in many cases maintain a resilient cell wall to stay alive under widely varying conditions. For these organisms, stringent and highly localized control of the cell wall's remodeling and expansion is crucial for cell growth and reproduction. In the budding yeast Saccharomyces cerevisiae the RNA binding protein Ssd1 helps control cell wall remodeling by repressing translation of proteins involved in wall expansion. Ssd1 is itself negatively regulated by the highly conserved Ndr/LATS protein kinase Cbk1. We sought to identify mRNA regions that confer Ssd1-mediated translational control. After validating a GFP reporter system as a readout of Ssd1 activity we found that 3' untranslated regions of the known Ssd1 targets CTS1, SIM1 and UTH1 are sufficient for Cbk1-regulated translational control. The 5' untranslated region of UTH1 also facilitated Ssd1-mediated translational control in a heterologous context. The CTS1 and SIM1 3' untranslated regions confer Ssd1 binding, and the SIM1 3' untranslated region improves Ssd1 immunoprecipitation of the endogenous SIM1 transcript. However, SIM1's 3' untranslated region is not essential for Ssd1-regulated control of the message's translation. We propose that Ssd1 regulates translation of its target message primarily through UTRs and the SIM1 message through multiple potential points of interaction, permitting fine translational control in various contexts.	[Wanless, Antony G.; Lin, Yuan; Weiss, Eric L.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Weiss, EL (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	elweiss@northwestern.edu			National Institutes of Health - National Institue of General Medical Sciences (NIGMS) [R01 GM084223]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084223] Funding Source: NIH RePORTER	National Institutes of Health - National Institue of General Medical Sciences (NIGMS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health - National Institue of General Medical Sciences (NIGMS). The relevant grant number is R01 GM084223. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avrahami-Moyal L, 2012, FEMS YEAST RES, V12, P521, DOI 10.1111/j.1567-1364.2012.00803.x; Avrahami-Moyal L, 2012, FEMS YEAST RES, V12, P447, DOI 10.1111/j.1567-1364.2012.00795.x; Bernstein DS, 2002, METHODS, V26, P123, DOI 10.1016/S1046-2023(02)00015-4; Bidlingmaier S, 2001, MOL CELL BIOL, V21, P2449, DOI 10.1128/MCB.21.7.2449-2462.2001; Blethrow Justin, 2004, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1811s66; Chan CS, 2005, PLOS COMPUT BIOL, V1, P564, DOI 10.1371/journal.pcbi.0010069; Chritton JJ, 2011, J BIOL CHEM, V286, P33268, DOI 10.1074/jbc.M111.264572; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Du LL, 2002, MOL BIOL CELL, V13, P503, DOI 10.1091/mbc.01-07-0365; Evans DRH, 1997, GENETICS, V145, P227; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Hasegawa Y, 2008, RNA, V14, P2333, DOI 10.1261/rna.1016508; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Ibeas JI, 2001, PLANT J, V25, P271, DOI 10.1046/j.1365-313x.2001.00967.x; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Jansen JM, 2006, J CELL BIOL, V175, P755, DOI 10.1083/jcb.200604107; Jansen JM, 2009, CURR BIOL, V19, P2114, DOI 10.1016/j.cub.2009.10.071; Jorgensen P, 2002, GENETICS, V162, P1091; Kaeberlein M, 2004, GENETICS, V166, P1661, DOI 10.1534/genetics.166.4.1661; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Kurischko C, 2011, MOL MICROBIOL, V81, P831, DOI 10.1111/j.1365-2958.2011.07731.x; Kurischko C, 2011, J CELL BIOL, V192, P583, DOI 10.1083/jcb.201011061; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; LEVINE TD, 1993, MOL CELL BIOL, V13, P3494, DOI 10.1128/MCB.13.6.3494; Li LH, 2009, MOL BIOL CELL, V20, P3851, DOI 10.1091/mbc.E09-04-0347; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; Moriya H, 1999, YEAST, V15, P481, DOI 10.1002/(SICI)1097-0061(199904)15:6<481::AID-YEA391>3.0.CO;2-M; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Natarajan A, 1998, J BIOTECHNOL, V62, P29, DOI 10.1016/S0168-1656(98)00040-6; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; Ohyama Y, 2010, GENES CELLS, V15, P1169, DOI 10.1111/j.1365-2443.2010.01452.x; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Racki WJ, 2000, EMBO J, V19, P4524, DOI 10.1093/emboj/19.17.4524; Richardson R, 2012, MOL GENET GENOMICS, V287, P711, DOI 10.1007/s00438-012-0709-5; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Uesono Y, 1997, J BIOL CHEM, V272, P16103, DOI 10.1074/jbc.272.26.16103; Vincent K, 2003, GENETICS, V164, P895; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Weiss EL, 2000, NAT CELL BIOL, V2, P677, DOI 10.1038/35036300; Weiss EL, 2012, GENETICS, V192, P1165, DOI 10.1534/genetics.112.145516; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106	47	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85212	10.1371/journal.pone.0085212	http://dx.doi.org/10.1371/journal.pone.0085212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465507	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500043
J	Zhang, HH; Zhang, XQ; Xue, QS; Yan-Luo; Huang, JL; Zhang, S; Shao, HJ; Lu, H; Wang, WY; Yu, BW				Zhang, Hong-Hai; Zhang, Xiao-Qin; Xue, Qing-Sheng; Yan-Luo; Huang, Jin-Lu; Zhang, Su; Shao, Hai-Jun; Lu, Han; Wang, Wen-Yuan; Yu, Bu-Wei			The BDNF/TrkB Signaling Pathway Is Involved in Heat Hyperalgesia Mediated by Cdk5 in Rats	PLOS ONE			English	Article							INFLAMMATORY PAIN HYPERSENSITIVITY; PERIPHERAL-NERVE INJURY; DORSAL-HORN NEURONS; NEUROTROPHIC FACTOR; SPINAL-CORD; NEUROTRANSMITTER RELEASE; HIPPOCAMPAL-NEURONS; THERMAL NOCICEPTION; PERSISTENT PAIN; BDNF	Background: Cyclin-dependent kinase 5 (Cdk5) has been shown to play an important role in mediating inflammation-induced heat hyperalgesia. However, the underlying mechanism remains unclear. The aim of this study was to determine whether roscovitine, an inhibitor of Cdk5, could reverse the heat hyperalgesia induced by peripheral injection of complete Freund's adjuvant (CFA) via the brain-derived neurotrophic factor (BDNF)-tyrosine kinase B (TrkB) signaling pathway in the dorsal horn of the spinal cord in rats. Results: Heat hyperalgesia induced by peripheral injection of CFA was significantly reversed by roscovitine, TrkB-IgG, and the TrkB inhibitor K252a, respectively. Furthermore, BDNF was significantly increased from 0.5 h to 24 h after CFA injection in the spinal cord dorsal horn. Intrathecal adminstration of the Cdk5 inhibitor roscovitine had no obvious effects on BDNF levels. Increased TrkB protein level was significantly reversed by roscovitine between 0.5 h and 6 h after CFA injection. Cdk5 and TrkB co-immunoprecipitation results suggested Cdk5 mediates the heat hyperalgesia induced by CFA injection by binding with TrkB, and the binding between Cdk5 and TrkB was markedly blocked by intrathecal adminstration of roscovitine. Conclusion: Our data suggested that the BDNF-TrkB signaling pathway was involved in CFA-induced heat hyperalgesia mediated by Cdk5. Roscovitine reversed the heat hyperalgesia induced by peripheral injection of CFA by blocking BDNF/TrkB signaling pathway, suggesting that severing the close crosstalk between Cdk5 and the BDNF/TrkB signaling cascade may present a potential target for anti-inflammatory pain.	[Zhang, Hong-Hai; Zhang, Xiao-Qin; Xue, Qing-Sheng; Yan-Luo; Zhang, Su; Shao, Hai-Jun; Lu, Han; Wang, Wen-Yuan; Yu, Bu-Wei] Shanghai JiaoTong Univ Sch Med, Dept Anesthesiol, Ruijin Hosp, Shanghai, Peoples R China; [Zhang, Hong-Hai] Nan Jing Med Univ, Hang Zhou Peoples Hosp 1, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China; [Huang, Jin-Lu] Shanghai JiaoTong Univ Sch Med, Dept Pharm, Affiliated Hosp 6, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yu, BW (corresponding author), Shanghai JiaoTong Univ Sch Med, Dept Anesthesiol, Ruijin Hosp, Shanghai, Peoples R China.	yubuwei_ruijin@163.com			National Natural Science Foundation, Beijing, P.R. China [81102513, 81072703]	National Natural Science Foundation, Beijing, P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation, Beijing, P. R. China, grant No. 81102513 to Dr. Han Lu and grant No. 81072703 to Dr. Buwei Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charlton E, 1995, Pain, V63, P277, DOI 10.1016/0304-3959(95)90040-3; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Garraway SM, 2003, EUR J NEUROSCI, V18, P2467, DOI 10.1046/j.1460-9568.2003.02982.x; Groth R, 2002, PAIN, V100, P171, DOI 10.1016/S0304-3959(02)00264-6; Guo W, 2006, J NEUROSCI, V26, P126, DOI 10.1523/JNEUROSCI.3686-05.2006; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Huang Y, 2012, EXP NEUROL, V233, P791, DOI 10.1016/j.expneurol.2011.11.043; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; Kerr BJ, 1999, J NEUROSCI, V19, P5138; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Lever IJ, 2001, J NEUROSCI, V21, P4469, DOI 10.1523/JNEUROSCI.21-12-04469.2001; Lin YT, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-126; Malcangio M, 1997, J NEUROSCI, V17, P8459; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Obata K, 2006, NEUROSCI RES, V55, P1, DOI 10.1016/j.neures.2006.01.005; Pareek TK, 2007, P NATL ACAD SCI USA, V104, P660, DOI 10.1073/pnas.0609916104; Pareek TK, 2006, CELL CYCLE, V5, P585, DOI 10.4161/cc.5.6.2578; Pareek TK, 2006, P NATL ACAD SCI USA, V103, P791, DOI 10.1073/pnas.0510405103; Ren K, 2007, MOL NEUROBIOL, V35, P224, DOI 10.1007/s12035-007-0028-8; Sandow SL, 2000, IMMUNOL CELL BIOL, V78, P430, DOI 10.1046/j.1440-1711.2000.00924.x; Santi S, 2006, EMBO J, V25, P4372, DOI 10.1038/sj.emboj.7601303; Shu XQ, 1999, PAIN, V80, P463, DOI 10.1016/S0304-3959(99)00042-1; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Utreras E, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-49; Wang XD, 2009, J NEUROSCI, V29, P5508, DOI 10.1523/JNEUROSCI.4288-08.2009; Xing BM, 2012, J NEUROSCI, V32, P14709, DOI 10.1523/JNEUROSCI.1634-12.2012; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yang YR, 2007, PAIN, V127, P109, DOI 10.1016/j.pain.2006.08.008; Zhang BS, 2003, PAIN, V106, P187, DOI 10.1016/j.pain.2003.08.003; Zhang HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046666; Zhang R, 2012, PHARMACOL BIOCHEM BE, V102, P139, DOI 10.1016/j.pbb.2012.03.025; Zhang W, 2008, NEUROSCIENCE, V152, P502, DOI 10.1016/j.neuroscience.2007.12.037; Zhao L, 2009, J CELL SCI, V122, P3123, DOI 10.1242/jcs.047712	38	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85536	10.1371/journal.pone.0085536	http://dx.doi.org/10.1371/journal.pone.0085536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465591	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500072
J	Hessel, J; Heldrich, J; Fuller, J; Staudt, MR; Radisch, S; Hollmann, C; Harvey, BG; Kaner, RJ; Salit, J; Yee-Levin, J; Sridhar, S; Pillai, S; Hilton, H; Wolff, G; Bitter, H; Visvanathan, S; Fine, J; Stevenson, CS; Crystal, RG; Tilley, AE				Hessel, Justina; Heldrich, Jonna; Fuller, Jennifer; Staudt, Michelle R.; Radisch, Sharon; Hollmann, Charleen; Harvey, Ben-Gary; Kaner, Robert J.; Salit, Jacqueline; Yee-Levin, Jenny; Sridhar, Sriram; Pillai, Sreekumar; Hilton, Holly; Wolff, Gerhard; Bitter, Hans; Visvanathan, Sudha; Fine, Jay; Stevenson, Christopher S.; Crystal, Ronald G.; Tilley, Ann E.			Intraflagellar Transport Gene Expression Associated with Short Cilia in Smoking and COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ORGANELLE SIZE REGULATION; FLAGELLAR LENGTH CONTROL; SMALL AIRWAY EPITHELIUM; BRONCHIAL EPITHELIUM; CIGARETTE-SMOKING; MUCOCILIARY CLEARANCE; PROTEIN; ABNORMALITIES; SMOKERS	Smoking and COPD are associated with decreased mucociliary clearance, and healthy smokers have shorter cilia in the large airway than nonsmokers. We hypothesized that changes in cilia length are consistent throughout the airway, and we further hypothesized that smokers with COPD have shorter cilia than healthy smokers. Because intraflagellar transport (IFT) is the process by which cilia of normal length are produced and maintained, and alterations in IFT lead to short cilia in model organisms, we also hypothesized that smoking induces changes in the expression of IFT-related genes in the airway epithelium of smokers and smokers with COPD. To assess these hypotheses, airway epithelium was obtained via bronchoscopic brushing. Cilia length was assessed by measuring 100 cilia (10 cilia on each of 10 cells) per subject and Affymetrix microarrays were used to evaluate IFT gene expression in nonsmokers and healthy smokers in 2 independent data sets from large and small airway as well as in COPD smokers in a data set from the small airway. In the large and small airway epithelium, cilia were significantly shorter in healthy smokers than nonsmokers, and significantly shorter in COPD smokers than in both healthy smokers and nonsmokers. The gene expression data confirmed that a set of 8 IFT genes were down-regulated in smokers in both data sets; however, no differences were seen in COPD smokers compared to healthy smokers. These results support the concept that loss of cilia length contributes to defective mucociliary clearance in COPD, and that smoking-induced changes in expression of IFT genes may be one mechanism of abnormally short cilia in smokers. Strategies to normalize cilia length may be an important avenue for novel COPD therapies.	[Hessel, Justina; Harvey, Ben-Gary; Kaner, Robert J.; Yee-Levin, Jenny; Crystal, Ronald G.; Tilley, Ann E.] Weill Cornell Med Coll, Div Pulm & Crit Care Med, New York, NY 10065 USA; [Heldrich, Jonna; Fuller, Jennifer; Staudt, Michelle R.; Radisch, Sharon; Hollmann, Charleen; Salit, Jacqueline; Crystal, Ronald G.; Tilley, Ann E.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Sridhar, Sriram; Pillai, Sreekumar; Hilton, Holly; Wolff, Gerhard; Bitter, Hans; Visvanathan, Sudha; Fine, Jay; Stevenson, Christopher S.] Hoffmann La Roche Inc, Nutley, NJ 07110 USA	Cornell University; Cornell University; Roche Holding	Tilley, AE (corresponding author), Weill Cornell Med Coll, Div Pulm & Crit Care Med, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu		Wolff MD|PhD, Gerhard/0000-0002-4458-0700; Staudt, Michelle/0000-0002-3364-0894	Hoffmann-La Roche, Inc, Nutley, NJ [1R01HL107882, P20 HL113443, 1 K23 HL103837, UL1- RR024996, UL1- RR024143, P50 HL084936]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996, UL1RR024143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107882, K23HL103837, P50HL084936, P20HL113443] Funding Source: NIH RePORTER	Hoffmann-La Roche, Inc, Nutley, NJ(Hoffmann-La Roche); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported, in part, by 1R01HL107882; P20 HL113443; 1 K23 HL103837; UL1- RR024996; UL1- RR024143; P50 HL084936; Hoffmann-La Roche, Inc, Nutley, NJ; and JP Smith Clinical Scholar (B.G Harvey and R. Kaner). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERBACH O, 1979, NEW ENGL J MED, V300, P381, DOI 10.1056/NEJM197902223000801; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; BALLENGER JJ, 1960, NEW ENGL J MED, V263, P832, DOI 10.1056/NEJM196010272631704; Barr JT, 2000, CLIN THER, V22, P1121, DOI 10.1016/S0149-2918(00)80089-2; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Brazelton WJ, 2001, CURR BIOL, V11, P1591, DOI 10.1016/S0960-9822(01)00485-7; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Brown JM, 2003, MOL BIOL CELL, V14, P3192, DOI 10.1091/mbc.e03-03-0166; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; CHANG SC, 1957, CANCER-AM CANCER SOC, V10, P1246, DOI 10.1002/1097-0142(195711/12)10:6<1246::AID-CNCR2820100623>3.0.CO;2-Z; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fan ZC, 2010, MOL BIOL CELL, V21, P2696, DOI 10.1091/mbc.E10-03-0191; Fowler VM, 2006, CURR BIOL, V16, pR18, DOI 10.1016/j.cub.2005.12.003; FOX B, 1983, EUR J RESPIR DIS, V64, P11; FOX B, 1981, CHEST, V80, P796, DOI 10.1378/chest.80.6.796; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Gower Adam C, 2011, Proc Am Thorac Soc, V8, P173, DOI 10.1513/pats.201011-066MS; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Houtmeyers E, 1999, EUR RESPIR J, V13, P1177, DOI 10.1034/j.1399-3003.1999.13e39.x; Hubner RH, 2009, MOL MED, V15, P203, DOI 10.2119/molmed.2008.00130; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Leopold PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008157; Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; NORRANDER JM, 1995, DEVELOPMENT, V121, P1615; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pierrou S, 2007, AM J RESP CRIT CARE, V175, P577, DOI 10.1164/rccm.200607-931OC; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Rajagopalan V, 2009, MOL BIOL CELL, V20, P708, DOI 10.1091/mbc.E08-07-0746; Rosenbaum J, 2003, CURR BIOL, V13, pR506, DOI 10.1016/S0960-9822(03)00440-8; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; SERAFINI SM, 1977, B EUR PHYSIOPATH RES, V13, P551; Tamashiro E, 2009, AM J RHINOL ALLERGY, V23, P117, DOI 10.2500/ajra.2009.23.3280; Tilley AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022798; Tsao CC, 2008, MOL BIOL CELL, V19, P1450, DOI 10.1091/mbc.E07-05-0403; Veleri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034389; VERRA F, 1995, AM J RESP CRIT CARE, V151, P630; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; WAGENKNECHT T, 1975, BIOPOLYMERS, V14, P2297, DOI 10.1002/bip.1975.360141106; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Wemmer KA, 2007, INT REV CYTOL, V260, P175, DOI 10.1016/S0074-7696(06)60004-1	47	50	51	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85453	10.1371/journal.pone.0085453	http://dx.doi.org/10.1371/journal.pone.0085453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465567	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500048
J	Laine, J; Lumio, J; Toikkanen, S; Virtanen, MJ; Uotila, T; Korpela, M; Kujansuu, E; Kuusi, M				Laine, Janne; Lumio, Jukka; Toikkanen, Salla; Virtanen, Mikko J.; Uotila, Terhi; Korpela, Markku; Kujansuu, Eila; Kuusi, Markku			The Duration of Gastrointestinal and Joint Symptoms after a Large Waterborne Outbreak of Gastroenteritis in Finland in 2007-A Questionnaire-Based 15-Month Follow-Up Study	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; CONTAMINATED DRINKING-WATER; REACTIVE ARTHRITIS; BACTERIAL DYSENTERY; RISK; HYPERTENSION; POPULATION; PROGNOSIS	An extensive drinking water-associated gastroenteritis outbreak took place in the town of Nokia in Southern Finland in 2007. 53% of the exposed came down with gastroenteritis and 7% had arthritis-like symptoms (joint swelling, redness, warmth or pain in movement) according to a population-based questionnaire study at 8 weeks after the incident. Campylobacter and norovirus were the main pathogens. A follow-up questionnaire study was carried out 15 months after the outbreak to evaluate the duration of gastrointestinal and joint symptoms. 323 residents of the original contaminated area were included. The response rate was 53%. Participants were inquired about having gastroenteritis during the outbreak and the duration of symptoms. Of those with gastroenteritis, 43% reported loose stools and abdominal pain or distension after the acute disease. The prevalence of symptoms declined promptly during the first 3 months but at 15 months, 11% reported continuing symptoms. 32% of the respondents with gastroenteritis reported subsequent arthritis-like symptoms. The disappearance of arthritis-like symptoms was more gradual and they levelled off only after 5 months. 19% showed symptoms at 15 months. Prolonged gastrointestinal symptoms correlated to prolonged arthritis-like symptoms. High proportion of respondents continued to have arthritis-like symptoms at 15 months after the epidemic. The gastrointestinal symptoms, instead, had declined to a low level.	[Laine, Janne; Uotila, Terhi; Korpela, Markku] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Laine, Janne; Toikkanen, Salla; Virtanen, Mikko J.; Kuusi, Markku] Natl Inst Hlth & Welf, Epidemiol Surveillance & Response Unit, Helsinki, Finland; [Lumio, Jukka; Korpela, Markku] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kujansuu, Eila] Nokia Hlth Ctr, Nokia, Finland	Tampere University; Tampere University Hospital; Finland National Institute for Health & Welfare; Tampere University; Nokia Corporation	Laine, J (corresponding author), Tampere Univ Hosp, Dept Internal Med, Tampere, Finland.	janne.laine@pshp.fi		Uotila, Terhi/0000-0002-4625-3922	Competitive Research Funding of the Tampere University Hospital [9E129, 9M124]	Competitive Research Funding of the Tampere University Hospital	This study was financially supported by the Competitive Research Funding of the Tampere University Hospital (Grants 9E129 and 9M124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clark WF, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6020; DuPont AW, 2008, CLIN INFECT DIS, V46, P594, DOI 10.1086/526774; Garg AX, 2008, RHEUMATOLOGY, V47, P200, DOI 10.1093/rheumatology/kem339; Garg AX, 2005, CAN MED ASSOC J, V173, P261, DOI 10.1503/cmaj.050581; Halvorson HA, 2006, AM J GASTROENTEROL, V101, P1894, DOI 10.1111/j.1572-0241.2006.00654.x; Hillila MT, 2004, ALIMENT PHARM THERAP, V20, P339, DOI 10.1111/j.1365-2036.2004.02034.x; Laine J, 2011, EPIDEMIOL INFECT, P1; Laine J, 2012, RHEUMATOLOGY, V51, P513, DOI 10.1093/rheumatology/ker320; Leirisalo-Repo M, 2005, SCAND J RHEUMATOL, V34, P251, DOI 10.1080/03009740500202540; Lovell RM, 2012, CLIN GASTROENTEROL H; Marshall JK, 2007, CLIN GASTROENTEROL H, V5, P457, DOI 10.1016/j.cgh.2006.11.025; Marshall JK, 2006, GASTROENTEROLOGY, V131, P445, DOI 10.1053/j.gastro.2006.05.053; Marshall JK, 2010, GUT, V59, P605, DOI 10.1136/gut.2009.202234; Marshall JK, 2009, KIDNEY INT, V75, pS42, DOI 10.1038/ki.2008.618; Maunula L, 2009, FOOD ENVIRON VIROL, V1, P31, DOI 10.1007/s12560-008-9004-3; Moist LM, 2009, KIDNEY INT, V75, pS47, DOI 10.1038/ki.2008.620; Morris D, 2012, CURR RHEUMATOL REP, V14, P390, DOI 10.1007/s11926-012-0280-4; Nielsen H, 2012, SCAND J IMMUNOL, V75, P449, DOI 10.1111/j.1365-3083.2012.02678.x; Porter CK, 2012, CLIN INFECT DIS, V55, P915, DOI 10.1093/cid/cis576; Rasanen S, 2010, EPIDEMIOL INFECT, V138, P1227, DOI 10.1017/S0950268809991671; Rimhanen-Finne R, 2010, SCAND J INFECT DIS, V42, P613, DOI 10.3109/00365541003774608; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; Uotila T, 2011, SCAND J RHEUMATOL, V40, P358, DOI 10.3109/03009742.2011.562533; Uotila TM, 2013, CLIN RHEUMATOL	24	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85457	10.1371/journal.pone.0085457	http://dx.doi.org/10.1371/journal.pone.0085457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465569	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000036
J	Padberg, I; Peter, E; Gonzalez-Maldonado, S; Witt, H; Mueller, M; Weis, T; Bethan, B; Liebenberg, V; Wiemer, J; Katus, HA; Rein, D; Schatz, P				Padberg, Inken; Peter, Erik; Gonzalez-Maldonado, Sandra; Witt, Henning; Mueller, Matthias; Weis, Tanja; Bethan, Bianca; Liebenberg, Volker; Wiemer, Jan; Katus, Hugo A.; Rein, Dietrich; Schatz, Philipp			A New Metabolomic Signature in Type-2 Diabetes Mellitus and Its Pathophysiology	PLOS ONE			English	Article							OXALATE; INSULIN; RISK	Objective: The objective of the current study was to find a metabolic signature associated with the early manifestations of type-2 diabetes mellitus. Research Design and Method: Modern metabolic profiling technology (MxP (TM) Broad Profiling) was applied to find early alterations in the plasma metabolome of type-2 diabetic patients. The results were validated in an independent study. Eicosanoid and single inon monitoring analysis (MxP (TM) Eicosanoid and MxP (TM) SIM analysis) were performed in subsets of samples. Results: A metabolic signature including significantly increased levels of glyoxylate as a potential novel marker for early detection of type-2 diabetes mellitus was identified in an initial study (Study1). The signature was significantly altered in fasted diabetic and pre-diabetic subjects and in non-fasted subjects up to three years prior to the diagnosis of type-2 diabetes; most alterations were also consistently found in an independent patient group (Study 2). In Study 2 diabetic and most control subjects suffered from heart failure. In Study 1 a subgroup of diabetic subjects, with a history of use of antihypertensive medication further showed a more pronounced increase of glyoxylate levels, compared to a non-diabetic control group when tested in a hyperglycemic state. In the context of a prior history of anti-hypertensive medication, alterations in hexosamine and eicosanoid levels were also found. Conclusion: A metabolic signature including glyoxylate was associated with type-2 diabetes mellitus, independent of the fasting status and of occurrence of another major disease. The same signature was also found to be associated with prediabetic subjects. Glyoxylate levels further showed a specifically strong increase in a subgroup of diabetic subjects. It could represent a new marker for the detection of medical subgroups of diabetic subjects.	[Padberg, Inken; Peter, Erik; Gonzalez-Maldonado, Sandra; Witt, Henning; Bethan, Bianca; Liebenberg, Volker; Wiemer, Jan; Rein, Dietrich; Schatz, Philipp] Metan Hlth GmbH, Berlin, Germany; [Padberg, Inken; Peter, Erik; Gonzalez-Maldonado, Sandra; Witt, Henning; Bethan, Bianca; Liebenberg, Volker; Wiemer, Jan; Rein, Dietrich; Schatz, Philipp] Metan GmbH, Biomarker Program, Berlin, Germany; [Mueller, Matthias; Weis, Tanja; Katus, Hugo A.] Univ Heidelberg Hosp, Dept Internal Med 3, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Padberg, I (corresponding author), Metan Hlth GmbH, Berlin, Germany.	inken.padberg@metanomics.de; philipp.schatz@metanomics-health.de	Rein, Dietrich/AAN-3694-2020; Cerviño, Alejandro/L-5853-2014; Liebenberg, Volker/AAY-7687-2021	Rein, Dietrich/0000-0003-0076-1865; Cerviño, Alejandro/0000-0001-8014-3279; Padberg, Inken/0000-0002-3656-5682; Liebenberg, Volker/0000-0003-1936-1247	National Genome Research Network (NGFN); German Ministry of Education and Research (BMBF) [FKZ01GR0813, 01GR0812]; Bayrische Forschungsstiftung [AZ 773-707]	National Genome Research Network (NGFN); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Bayrische Forschungsstiftung	Study II was supported by the National Genome Research Network (NGFN-transfer/http://www.ngfn.de/) and funding was provided by the German Ministry of Education and Research (BMBF) under the funding ID FKZ01GR0813 (University of Heidelberg) and 01GR0812 (metanomics GmbH, Berlin). Sample collection of study I was co-funded by the "Bayrische Forschungsstiftung" (http://www.forschungsstiftung.de/grant number: AZ 773-707). These funders had no role in sample collection, study design, data analysis, decision to publish, and preparation of the manuscript.	Adedayo A, 2012, SLEEP BREATH, V16; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; BARNGROVER DA, 1981, BIOCHEM BIOPH RES CO, V102, P75, DOI 10.1016/0006-291X(81)91490-X; Begum N, 2002, DIABETES, V51, P2256, DOI 10.2337/diabetes.51.7.2256; Brownlee M, 2005, DIABETES; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Caplin B, 2012, ARTERIOSCLEROSIS THR; Dungan KM, 2006, DIABETES CARE, V29, P1214, DOI 10.2337/dc06-1910; Faure P, 2008, EUR RESPIR J, V31, P1046, DOI 10.1183/09031936.00062707; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Holmes RP, 1998, J UROLOGY, V160, P1617, DOI 10.1016/S0022-5347(01)62363-2; Issad T, 2010, DIABETES METAB, V36, P423, DOI 10.1016/j.diabet.2010.09.001; Kim DH, 2011, BMB REP, V44, P415, DOI 10.5483/BMBRep.2011.44.6.415; Knight J, 2010, HORM METAB RES, V42, P868, DOI 10.1055/s-0030-1265145; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Nayak AU, 2013, DIABETES CARE; Rodionov RN, 2010, J BIOL CHEM, V285, P5385, DOI 10.1074/jbc.M109.091280; Sathiyapriya V, 2007, ARCH MED RES, V38, P822, DOI 10.1016/j.arcmed.2007.05.008; SCHROR K, 1990, J CARDIOVASC PHARM, V15, pS60, DOI 10.1097/00005344-199015061-00012; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; VANPRAAG D, 1986, PROSTAG LEUKOTR ESS, V24, P227, DOI 10.1016/0262-1746(86)90130-7; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43	24	63	66	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85082	10.1371/journal.pone.0085082	http://dx.doi.org/10.1371/journal.pone.0085082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465478	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000022
J	Anderson, AE; Hure, AJ; Forder, PM; Powers, J; Kay-Lambkin, FJ; Loxton, DJ				Anderson, Amy E.; Hure, Alexis J.; Forder, Peta M.; Powers, Jennifer; Kay-Lambkin, Frances J.; Loxton, Deborah J.			Risky Drinking Patterns Are Being Continued into Pregnancy: A Prospective Cohort Study	PLOS ONE			English	Article							PRENATAL ALCOHOL EXPOSURE; BINGE DRINKING; WOMEN CHANGE; CONSUMPTION; INTELLIGENCE; BEHAVIORS; AUSTRALIA	Background: Risky patterns of alcohol use prior to pregnancy increase the risk of alcohol-exposed pregnancies and subsequent adverse outcomes. It is important to understand how consumption changes once women become pregnant. Objective: The aim of this study was to describe the characteristics of women that partake in risky drinking patterns before pregnancy and to examine how these patterns change once they become pregnant. Methods: A sample of 1577 women from the 1973-78 cohort of the Australian Longitudinal Study on Women's Health were included if they first reported being pregnant in 2000, 2003, 2006, 2009 and reported risky drinking patterns prior to that pregnancy. Multinomial logistic regression was used to determine which risky drinking patterns were most likely to continue into pregnancy. Results: When reporting risky drinking patterns prior to pregnancy only 6% of women reported weekly drinking only, whereas 46% reported binge drinking only and 48% reported both. Women in both binge categories were more likely to have experienced financial stress, not been partnered, smoked, used drugs, been nulliparous, experienced a violent relationship, and were less educated. Most women (46%) continued these risky drinking patterns into pregnancy, with 40% reducing these behaviors, and 14% completely ceasing alcohol consumption. Once pregnant, women who binged only prior to pregnancy were more likely to continue (55%) rather than reduce drinking (29%). Of the combined drinking group 61% continued to binge and 47% continued weekly drinking. Compared with the combined drinking group, binge only drinkers prior to pregnancy were less likely to reduce rather than continue their drinking once pregnant (OR = 0.37, 95% CI = 0.29, 0.47). Conclusions: Over a third of women continued risky drinking into pregnancy, especially binge drinking, suggesting a need to address alcohol consumption prior to pregnancy.	[Anderson, Amy E.; Hure, Alexis J.; Forder, Peta M.; Powers, Jennifer; Loxton, Deborah J.] Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Gender Hlth & Ageing, Callaghan, NSW 2308, Australia; [Kay-Lambkin, Frances J.] Univ Newcastle, Prior Res Ctr Translat Neurosci & Mental Hlth, Callaghan, NSW 2308, Australia; [Kay-Lambkin, Frances J.] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Randwick, NSW, Australia	University of Newcastle; University of Newcastle; University of New South Wales Sydney	Anderson, AE (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Gender Hlth & Ageing, Callaghan, NSW 2308, Australia.	Amy.Anderson@newcastle.edu.au		Kay-Lambkin, Frances/0000-0002-4252-5572; Hure, Alexis/0000-0003-2225-0986	Department of Health and Ageing [G0189875]	Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The Australian Longitudinal Study on Women's Health was funded by the Department of Health and Ageing (G0189875), http://www.health.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvik A, 2006, ACTA OBSTET GYN SCAN, V85, P1292, DOI 10.1080/00016340600589958; Anderson AE, 2013, BJOG-INT J OBSTET GY, V120, P1366, DOI 10.1111/1471-0528.12356; Anderson AE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-777; Brown WJ, 1998, WOMEN HEALTH, V28, P23; Brown WJBL, 1996, J WOMENS HEALTH, V5, P467, DOI DOI 10.1089/JWH.1996.5.467; Burns E, 2010, ADDICTION, V105, P601, DOI 10.1111/j.1360-0443.2009.02842.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Carson G, 2010, J OBSTET GYNAECOL CA, V32, pS1, DOI 10.1016/S1701-2163(16)34633-3; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P529; Courtney KE, 2009, PSYCHOL BULL, V135, P142, DOI 10.1037/a0014414; Crozier SR, 2009, PAEDIATR PERINAT EP, V23, P446, DOI 10.1111/j.1365-3016.2009.01036.x; de Chazeron I, 2008, ALCOHOL CLIN EXP RES, V32, P868, DOI 10.1111/j.1530-0277.2008.00646.x; Ethen M, 2009, MATERN CHILD HLTH J, V13, P274, DOI 10.1007/s10995-008-0328-2; Feldman HS, 2011, AM J MED GENET A, V155A, P2949, DOI 10.1002/ajmg.a.34276; Floyd RL, 2007, AM J PREV MED, V32, P1, DOI 10.1016/j.amepre.2006.08.028; France K, 2010, SUBST USE MISUSE, V45, P1474, DOI 10.3109/10826081003682172; Gray R, 2006, REV FETAL EFFECTS PR; Harris M., 2009, GUIDELINES PREVENTIV; Henderson J, 2007, BJOG-INT J OBSTET GY, V114, P243, DOI 10.1111/j.1471-0528.2006.01163.x; Ingersoll KS, 2013, J SUBST ABUSE TREAT, V44, P407, DOI 10.1016/j.jsat.2012.10.001; Kesmodel US, 2012, BJOG-INT J OBSTET GY, V119, P1180, DOI 10.1111/j.1471-0528.2012.03393.x; Kesmodel US, 2012, BJOG-INT J OBSTET GY, V119, P1222, DOI 10.1111/j.1471-0528.2012.03395.x; Kuehn D, 2012, ALCOHOL CLIN EXP RES, V36, P1811, DOI 10.1111/j.1530-0277.2012.01794.x; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Lewis SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049407; Livingston M., 2012, PERCEPTIONS LOW RISK; Marie Stopes International, 2008, REAL CHOIC WOM CONTR; McDonald SD, 2005, ADDICT BEHAV, V30, P853, DOI 10.1016/j.addbeh.2004.08.016; McNamara TK, 2005, AM J OBSTET GYNECOL, V193, P1981, DOI 10.1016/j.ajog.2005.04.053; *NAT HLTH MED RES, 1992, IS THER SAF LEV DAIL; National Health and Medical Research Council, 2009, AUSTR GUID RED HLTH; National Health and Medical Research Council Commonwealth of Australia, 2001, AUSTR ALC GUID HLTH; O'Leary CM, 2012, DRUG ALCOHOL REV, V31, P170, DOI 10.1111/j.1465-3362.2011.00331.x; O'Leary CM, 2010, ADDICTION, V105, P74, DOI 10.1111/j.1360-0443.2009.02756.x; Peadon E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-510; Powers JR, 2013, MATERN CHILD HLTH J, V17, P76, DOI 10.1007/s10995-012-0949-3; Riley EP, 2004, AM J MED GENET C, V127C, P35, DOI 10.1002/ajmg.c.30014; Sayal K, 2009, PEDIATRICS, V123, pE289, DOI 10.1542/peds.2008-1861; Sheehan M, 2001, SUBST USE MISUSE, V36, P347, DOI 10.1081/JA-100102630; Skagerstrom J, 2011, J WOMENS HEALTH, V20, P901, DOI 10.1089/jwh.2010.2216; Sokol RJ, 2003, JAMA-J AM MED ASSOC, V290, P2996, DOI 10.1001/jama.290.22.2996; Strandberg-Larsen K, 2008, OBSTET GYNECOL, V111, P602, DOI 10.1097/AOG.0b013e3181661431; Strandberg-Larsen K, 2009, EPIDEMIOLOGY, V20, P884, DOI 10.1097/EDE.0b013e3181bbd46c; Thanh NX, 2010, J POPUL THER CLIN PH, V17, pE302; The Danish National Board of Health, 2010, HLTH HAB DUR PREGN; The Information Centre Lifestyles Statistics, 2007, STAT ALC ENGL 2007, P2007; Tough S, 2006, CLIN MED RES, V4, P97, DOI 10.3121/cmr.4.2.97; Whitworth M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007536.pub2	49	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86171	10.1371/journal.pone.0086171	http://dx.doi.org/10.1371/journal.pone.0086171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454959	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100147
J	Araoka, T; Mae, S; Kurose, Y; Uesugi, M; Ohta, A; Yamanaka, S; Osafune, K				Araoka, Toshikazu; Mae, Shin-ichi; Kurose, Yuko; Uesugi, Motonari; Ohta, Akira; Yamanaka, Shinya; Osafune, Kenji			Efficient and Rapid Induction of Human iPSCs/ESCs into Nephrogenic Intermediate Mesoderm Using Small Molecule-Based Differentiation Methods	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; RETINOIC ACID; MOUSE; KIDNEY; POPULATION; ODD-SKIPPED-RELATED-1; IDENTIFICATION; SPECIFICATION; ESTABLISHMENT; MAINTENANCE	The first step in developing regenerative medicine approaches to treat renal diseases using pluripotent stem cells must be the generation of intermediate mesoderm (IM), an embryonic germ layer that gives rise to kidneys. In order to achieve this goal, establishing an efficient, stable and low-cost method for differentiating IM cells using small molecules is required. In this study, we identified two retinoids, AM580 and TTNPB, as potent IM inducers by high-throughput chemical screening, and established rapid (five days) and efficient (80% induction rate) IM differentiation from human iPSCs using only two small molecules: a Wnt pathway activator, CHIR99021, combined with either AM580 or TTNPB. The resulting human IM cells showed the ability to differentiate into multiple cell types that constitute adult kidneys, and to form renal tubule-like structures. These small molecule differentiation methods can bypass the mesendoderm step, directly inducing IM cells by activating Wnt, retinoic acid (RA), and bone morphogenetic protein (BMP) pathways. Such methods are powerful tools for studying kidney development and may potentially provide cell sources to generate renal lineage cells for regenerative therapy.	[Araoka, Toshikazu; Mae, Shin-ichi; Kurose, Yuko; Ohta, Akira; Yamanaka, Shinya; Osafune, Kenji] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Uesugi, Motonari] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Uesugi, Motonari] Kyoto Univ, Inst Chem Res, Kyoto 606, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	Kyoto University; Kyoto University; Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Osafune, K (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan.	osafu@cira.kyoto-u.ac.jp	Uesugi, Motonari/AAM-9777-2020		Leading Project of MEXT; Uehara Memorial Foundation; Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; Japan Science and Technology Agency (JST) through PRESTO; JST Yamanaka iPS Cell Special Project; research grant "Projects for Technological Development, Research Center Network for Realization of Regenerative Medicine"; JSPS	Leading Project of MEXT; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST) through PRESTO; JST Yamanaka iPS Cell Special Project(Japan Science & Technology Agency (JST)); research grant "Projects for Technological Development, Research Center Network for Realization of Regenerative Medicine"; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by research grants from the Leading Project of MEXT, the Uehara Memorial Foundation and the Takeda Science Foundation, by the Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" and Grant-in-Aid for Young Scientists (B) to KO, and by Japan Science and Technology Agency (JST) through PRESTO to KO, JST Yamanaka iPS Cell Special Project to AO, SY and KO, and its research grant "Projects for Technological Development, Research Center Network for Realization of Regenerative Medicine". SM was supported by a fellowship from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchelder CA, 2009, DIFFERENTIATION, V78, P45, DOI 10.1016/j.diff.2009.05.001; BERNARD BA, 1992, BIOCHEM BIOPH RES CO, V186, P977, DOI 10.1016/0006-291X(92)90842-9; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Brennan HC, 1999, DEVELOPMENT, V126, P5847; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Germain P, 2004, EMBO REP, V5, P877, DOI 10.1038/sj.embor.7400235; HOGAN BLM, 1992, NATURE, V359, P237, DOI 10.1038/359237a0; James RG, 2005, DEV BIOL, V288, P113, DOI 10.1016/j.ydbio.2005.09.025; James RG, 2006, DEVELOPMENT, V133, P2995, DOI 10.1242/dev.02442; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kim MJ, 2000, J INVEST DERMATOL, V114, P349, DOI 10.1046/j.1523-1747.2000.00868.x; Kinder SJ, 2001, DEVELOPMENT, V128, P3623; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Lyu J, 2011, CELL RES, V21, P911, DOI 10.1038/cr.2011.47; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mascrez B, 1998, DEVELOPMENT, V125, P4691; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MORIYA N, 1993, DEV GROWTH DIFFER, V35, P123; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishikawa M, 2012, BIOCHEM BIOPH RES CO, V417, P897, DOI 10.1016/j.bbrc.2011.12.071; Obara-Ishihara T, 1999, DEVELOPMENT, V126, P1103; Oeda S, 2013, INT J DEV BIOL, V57, P383, DOI 10.1387/ijdb.130058ma; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Osafune K, 2002, DEV GROWTH DIFFER, V44, P161; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Ren XH, 2010, ACTA BIOCH BIOPH SIN, V42, P464, DOI 10.1093/abbs/gmq046; Saxen L., 1987, ORGANOGENESIS KIDNEY; Song B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046453; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Unbekandt M, 2010, KIDNEY INT, V77, P407, DOI 10.1038/ki.2009.482; Wang QR, 2005, DEV BIOL, V288, P582, DOI 10.1016/j.ydbio.2005.09.024; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wu X, 2004, J AM CHEM SOC, V126, P1590, DOI 10.1021/ja038950i; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	52	75	81	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84881	10.1371/journal.pone.0084881	http://dx.doi.org/10.1371/journal.pone.0084881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454758	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100038
J	Duriez, O; Kato, A; Tromp, C; Dell'Omo, G; Vyssotski, AL; Sarrazin, F; Ropert-Coudert, Y				Duriez, Olivier; Kato, Akiko; Tromp, Clara; Dell'Omo, Giacomo; Vyssotski, Alexei L.; Sarrazin, Francois; Ropert-Coudert, Yan			How Cheap Is Soaring Flight in Raptors? A Preliminary Investigation in Freely-Flying Vultures	PLOS ONE			English	Article							DOUBLY LABELED WATER; DAILY ENERGY-EXPENDITURE; WHITE-BACKED VULTURE; HEART-RATE; GYPS-FULVUS; OXYGEN-CONSUMPTION; BODY ACCELERATION; HARNESS DESIGN; METABOLIC-RATE; BEHAVIOR	Measuring the costs of soaring, gliding and flapping flight in raptors is challenging, but essential for understanding their ecology. Among raptors, vultures are scavengers that have evolved highly efficient soaring-gliding flight techniques to minimize energy costs to find unpredictable food resources. Using electrocardiogram, GPS and accelerometer bio-loggers, we report the heart rate (HR) of captive griffon vultures (Gyps fulvus and G. himalayensis) trained for freely-flying. HR increased three-fold at take-off (characterized by prolonged flapping flight) and landing (>300 beats-per-minute, (bpm)) compared to baseline levels (80-100 bpm). However, within 10 minutes after the initial flapping phase, HR in soaring/gliding flight dropped to values similar to baseline levels, i.e. slightly lower than theoretically expected. However, the extremely rapid decrease in HR was unexpected, when compared with other marine gliders, such as albatrosses. Weather conditions influenced flight performance and HR was noticeably higher during cloudy compared to sunny conditions when prolonged soaring flight is made easier by thermal ascending air currents. Soaring as a cheap locomotory mode is a crucial adaptation for vultures who spend so long on the wing for wide-ranging movements to find food.	[Duriez, Olivier; Tromp, Clara] Univ Montpellier 2, Ctr Ecol Fonct & Evolut, UMR5175, Montpellier, France; [Duriez, Olivier; Sarrazin, Francois] Univ Paris 06, UMR7204, CERSP, Museum Natl Hist Nat, Paris, France; [Kato, Akiko; Tromp, Clara; Ropert-Coudert, Yan] Univ Strasbourg, IPHC, Strasbourg, France; [Kato, Akiko; Ropert-Coudert, Yan] CNRS, UMR7178, Strasbourg, France; [Dell'Omo, Giacomo] Ornis Ital, Rome, Italy; [Vyssotski, Alexei L.] Univ Zurich, Inst Neuroinformat, ETH Zurich, Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Duriez, O (corresponding author), Univ Montpellier 2, Ctr Ecol Fonct & Evolut, UMR5175, Montpellier, France.	olivier.duriez@cefe.cnrs.fr	Sarrazin, François/AAB-4227-2019; Sarrazin, Francois/B-7593-2013; Kato, Akiko/W-2447-2019; Duriez, Olivier/R-4772-2016	Sarrazin, François/0000-0001-5901-4819; Sarrazin, Francois/0000-0001-5901-4819; Duriez, Olivier/0000-0003-1868-9750; Vyssotski, Alexei/0000-0002-9021-1471; Dell'Omo, Giacomo/0000-0002-9601-9675; Kato, Akiko/0000-0002-8947-3634	French Agency ANR [ANR-07-BLAN-0201]	French Agency ANR(French National Research Agency (ANR))	Project funded by the French Agency ANR grant noANR-07-BLAN-0201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahat O, 1995, THESIS TEL AVIV U TE; Bevan RM, 1995, PHILOS T R SOC B, V350, P119, DOI 10.1098/rstb.1995.0146; BEVAN RM, 1994, J EXP BIOL, V193, P119; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; Bose M, 2007, IBIS, V149, P490, DOI 10.1111/j.1474-919X.2007.00674.x; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Duriez O, 2012, BIRD STUDY, V59, P193, DOI 10.1080/00063657.2012.658640; ELLINGTON CP, 1991, J EXP BIOL, V160, P71; Elliott KH, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0919; Ely CR, 1999, CONDOR, V101, P390, DOI 10.2307/1370002; Gillies JA, 2011, J AVIAN BIOL, V42, P377, DOI 10.1111/j.1600-048X.2011.05105.x; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; Halsey LG, 2009, J FIELD ORNITHOL, V80, P171, DOI 10.1111/j.1557-9263.2009.00219.x; Johnson JA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-65; KANWISHER JW, 1978, AUK, V95, P288; Lanzone MJ, 2012, BIOL LETTERS, V8, P710, DOI 10.1098/rsbl.2012.0359; Mallory Mark L., 2008, Marine Ornithology, V36, P183; Mandel JT, 2008, P NATL ACAD SCI USA, V105, P19102, DOI 10.1073/pnas.0801789105; MASMAN D, 1988, ARDEA, V76, P64; Monsarrat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053077; Mundy P., 1992, VULTURES AFRICA; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; NOLET BA, 1992, PHYSIOL ZOOL, V65, P1188, DOI 10.1086/physzool.65.6.30158275; Norberg Ulla M., 1996, P199; Pelletier D, 2008, P ROY SOC B-BIOL SCI, V275, P2117, DOI 10.1098/rspb.2008.0422; Pennycuick CJ, 2008, THEOR ECOL SER, P1; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; PENNYCUICK CJ, 1971, J EXP BIOL, V55, P39; Pennycuik Colin J., 2002, Avian Science, V2, P1; Prinzinger R, 2002, J ORNITHOL, V143, P456, DOI 10.1046/j.1439-0361.2002.02039.x; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Ropert-Coudert Y, 2004, IBIS, V146, P281, DOI 10.1111/j.1474-919x.2003.00250.x; Ropert-Coudert Y, 2006, MAR ECOL PROG SER, V328, P275, DOI 10.3354/meps328275; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; Sachs G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041449; Sakamoto KQ, 2013, J EXP BIOL, V216, P3175, DOI 10.1242/jeb.079905; Sapir N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013956; Shamoun-Baranes J, 2003, CONDOR, V105, P208, DOI 10.1650/0010-5422(2003)105[0208:DUOTCB]2.0.CO;2; Shannon HD, 2002, CONDOR, V104, P679, DOI 10.1650/0010-5422(2002)104[0679:AWPSFT]2.0.CO;2; Shepard ELC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027375; Speakman J.R., 1997, DOUBLY LABELLED WATE; Spiegel O, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-5; TUCKER VA, 1988, J EXP BIOL, V140, P325; Vyssotski AL, 2009, CURR BIOL, V19, P1159, DOI 10.1016/j.cub.2009.05.070; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 2005, P ROY SOC B-BIOL SCI, V272, P53, DOI 10.1098/rspb.2004.2918; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Wilbur SR., 1983, VULTURE BIOL MANAGEM; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Xirouchakis SM, 2009, WILDLIFE BIOL, V15, P37, DOI 10.2981/07-090	55	88	91	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84887	10.1371/journal.pone.0084887	http://dx.doi.org/10.1371/journal.pone.0084887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454760	Green Published, Green Accepted, gold			2022-12-25	WOS:000330235100039
J	Wong, KS; Snider, JD; Graham, C; Greenblatt, JF; Emili, A; Babu, M; Houry, WA				Wong, Keith S.; Snider, Jamie D.; Graham, Chris; Greenblatt, Jack F.; Emili, Andrew; Babu, Mohan; Houry, Walid A.			The MoxR ATPase RavA and Its Cofactor ViaA Interact with the NADH:Ubiquinone Oxidoreductase I in Escherichia coli	PLOS ONE			English	Article							INDUCIBLE LYSINE DECARBOXYLASE; PERIPLASMIC NITRATE REDUCTASE; NITRIC-OXIDE REDUCTASE; RESPIRATORY COMPLEX I; AAA PLUS ATPASE; BACTERICIDAL ANTIBIOTICS; PARACOCCUS-DENITRIFICANS; DIHYDRORHODAMINE 123; MUTATIONAL ANALYSIS; HYDROGEN-PEROXIDE	MoxR ATPases are widespread throughout bacteria and archaea. The experimental evidence to date suggests that these proteins have chaperone-like roles in facilitating the maturation of dedicated protein complexes that are functionally diverse. In Escherichia coli, the MoxR ATPase RavA and its putative cofactor ViaA are found to exist in early stationary-phase cells at 37 degrees C at low levels of about 350 and 90 molecules per cell, respectively. Both proteins are predominantly localized to the cytoplasm, but ViaA was also unexpectedly found to localize to the cell membrane. Whole genome microarrays and synthetic lethality studies both indicated that RavA-ViaA are genetically linked to Fe-S cluster assembly and specific respiratory pathways. Systematic analysis of mutant strains of ravA and viaA indicated that RavA-ViaA sensitizes cells to sublethal concentrations of aminoglycosides. Furthermore, this effect was dependent on RavA's ATPase activity, and on the presence of specific subunits of NADH: ubiquinone oxidoreductase I (Nuo Complex, or Complex I). Importantly, both RavA and ViaA were found to physically interact with specific Nuo subunits. We propose that RavA-ViaA facilitate the maturation of the Nuo complex.	[Wong, Keith S.; Snider, Jamie D.; Houry, Walid A.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Graham, Chris; Babu, Mohan] Univ Regina, Dept Biochem, Res & Innovat Ctr, Regina, SK S4S 0A2, Canada; [Greenblatt, Jack F.; Emili, Andrew] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada	University of Toronto; University of Regina; University of Toronto	Houry, WA (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	walid.houry@utoronto.ca	Mohan, Babu P./I-7362-2019		Canadian Institutes of Health Research (CIHR) [TGF-53910]; University of Toronto; Natural Sciences and Engineering Research Council of Canada [DG-20234]; CIHR [MOP-82852, MOP-130374]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of Toronto(University of Toronto); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); CIHR(Canadian Institutes of Health Research (CIHR))	KSW is the recipient of a fellowship from the Canadian Institutes of Health Research (CIHR) Strategic Training Program in Protein Folding and Interaction Dynamics: Principles and Diseases (TGF-53910) and a Doctoral Completion Award from the University of Toronto. This work was supported in part by grants from the Natural Sciences and Engineering Research Council of Canada to MB (DG-20234) and from CIHR to JFG and AE (MOP-82852) and to WAH (MOP-130374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Arai H, 1999, FEMS MICROBIOL LETT, V170, P19, DOI 10.1111/j.1574-6968.1999.tb13350.x; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Babu M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002377; Babu Mohan, 2009, Methods Mol Biol, V564, P373, DOI 10.1007/978-1-60761-157-8_22; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Baharoglu Z, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003421; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bartnikas TB, 1997, J BACTERIOL, V179, P3534, DOI 10.1128/jb.179.11.3534-3540.1997; Brondijk THC, 2004, BIOCHEM J, V379, P47, DOI 10.1042/BJ20031115; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Crow JP, 1997, NITRIC OXIDE-BIOL CH, V1, P145, DOI 10.1006/niox.1996.0113; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; DeBoer APN, 1996, EUR J BIOCHEM, V242, P592, DOI 10.1111/j.1432-1033.1996.0592r.x; Dieppedale J, 2013, MOL CELL PROTEOMICS, V12, P2278, DOI 10.1074/mcp.M112.024794; Dieppedale J, 2011, INFECT IMMUN, V79, P1428, DOI 10.1128/IAI.01012-10; Efremov RG, 2011, CURR OPIN STRUC BIOL, V21, P532, DOI 10.1016/j.sbi.2011.07.002; El Bakkouri M, 2010, P NATL ACAD SCI USA, V107, P22499, DOI 10.1073/pnas.1009092107; Erhardt H, 2012, BBA-BIOENERGETICS, V1817, P863, DOI 10.1016/j.bbabio.2011.10.008; Ezraty B, 2013, SCIENCE, V340, P1583, DOI 10.1126/science.1238328; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fritsche E, 1999, J MOL BIOL, V288, P989, DOI 10.1006/jmbi.1999.2719; Gautier V, 2012, J MOL BIOL, V421, P662, DOI 10.1016/j.jmb.2012.01.047; Girgis HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005629; Goltermann L, 2013, J BIOL CHEM, V288, P10483, DOI 10.1074/jbc.M112.420380; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Goswami M, 2007, ANTIMICROB AGENTS CH, V51, P1119, DOI 10.1128/AAC.00779-06; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; HENDERSON LM, 1993, EUR J BIOCHEM, V217, P973, DOI 10.1111/j.1432-1033.1993.tb18328.x; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jain V, 2006, J MICROBIOL, V44, P1; JUNGST A, 1992, FEBS LETT, V314, P308, DOI 10.1016/0014-5793(92)81495-8; Kachlany SC, 2000, J BACTERIOL, V182, P6169, DOI 10.1128/JB.182.21.6169-6176.2000; Kanjee U, 2011, EMBO J, V30, P931, DOI 10.1038/emboj.2011.5; Katerov V, 2000, CURR MICROBIOL, V40, P149, DOI 10.1007/s002849910031; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x; Lee JE, 2000, RES MICROBIOL, V151, P605; LEMIRE BD, 1986, METHOD ENZYMOL, V126, P377; Ling JQ, 2012, MOL CELL, V48, P713, DOI 10.1016/j.molcel.2012.10.001; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Magrane M, 2011, DATABASE J BIOL DATA, V2011; MENON NK, 1991, J BACTERIOL, V173, P4851, DOI 10.1128/jb.173.15.4851-4861.1991; PARK SJ, 1995, J BACTERIOL, V177, P6255, DOI 10.1128/jb.177.21.6255-6262.1995; Park YK, 1996, MOL MICROBIOL, V20, P605, DOI 10.1046/j.1365-2958.1996.5441070.x; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pelzmann A, 2009, J BIOL CHEM, V284, P9578, DOI 10.1074/jbc.M805354200; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Scheele U, 2011, J VIROL, V85, P4812, DOI 10.1128/JVI.00072-11; Schneider D, 2008, BBA-BIOENERGETICS, V1777, P735, DOI 10.1016/j.bbabio.2008.03.003; Snider J, 2006, J BIOL CHEM, V281, P1532, DOI 10.1074/jbc.M511172200; Snider J, 2006, J STRUCT BIOL, V156, P200, DOI 10.1016/j.jsb.2006.02.009; STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18; Stevens JM, 2011, FEBS J, V278, P4170, DOI 10.1111/j.1742-4658.2011.08376.x; Stewart V, 2002, J BACTERIOL, V184, P1314, DOI 10.1128/JB.184.5.1314-1323.2002; Tanapongpipat S, 1998, BIOCHEM J, V334, P355, DOI 10.1042/bj3340355; Todorovic S, 2008, J BIOL INORG CHEM, V13, P765, DOI 10.1007/s00775-008-0362-y; Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x; Toyama H, 1998, FEMS MICROBIOL LETT, V166, P1; Tran QH, 1997, EUR J BIOCHEM, V244, P155, DOI 10.1111/j.1432-1033.1997.00155.x; Tseng CP, 2001, J BACTERIOL, V183, P461, DOI 10.1128/JB.183.2.461-467.2001; Vanderlinde EM, 2011, J BACTERIOL; VANSPANNING RJM, 1991, J BACTERIOL, V173, P6948, DOI 10.1128/jb.173.21.6948-6961.1991; Volbeda A, 2012, P NATL ACAD SCI USA, V109, P5305, DOI 10.1073/pnas.1119806109; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Willows RD, 2003, NAT PROD REP, V20, P327, DOI 10.1039/b110549n; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; Wong KS, 2012, J STRUCT BIOL, V179, P211, DOI 10.1016/j.jsb.2012.03.010; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X	81	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85529	10.1371/journal.pone.0085529	http://dx.doi.org/10.1371/journal.pone.0085529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454883	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100096
J	Gerber, S; Chadoeuf, J; Gugerli, F; Lascoux, M; Buiteveld, J; Cottrell, J; Dounavi, A; Fineschi, S; Forrest, LL; Fogelqvist, J; Goicoechea, PG; Jensen, JS; Salvini, D; Vendramin, GG; Kremer, A				Gerber, Sophie; Chadoeuf, Joel; Gugerli, Felix; Lascoux, Martin; Buiteveld, Joukje; Cottrell, Joan; Dounavi, Aikaterini; Fineschi, Silvia; Forrest, Laura L.; Fogelqvist, Johan; Goicoechea, Pablo G.; Jensen, Jan Svejgaard; Salvini, Daniela; Vendramin, Giovanni G.; Kremer, Antoine			High Rates of Gene Flow by Pollen and Seed in Oak Populations across Europe	PLOS ONE			English	Article							TORMINALIS L. CRANTZ; QUERCUS-PETRAEA; PATERNITY ANALYSIS; BUR OAK; REPRODUCTIVE SUCCESS; PARENTAGE ANALYSIS; DISPERSAL KERNEL; WILDSERVICE TREE; FOREST TREES; PATTERNS	Gene flow is a key factor in the evolution of species, influencing effective population size, hybridisation and local adaptation. We analysed local gene flow in eight stands of white oak (mostly Quercus petraea and Q. robur, but also Q. pubescens and Q. faginea) distributed across Europe. Adult trees within a given area in each stand were exhaustively sampled (range [239, 754], mean 423), mapped, and acorns were collected ([17,147], 51) from several mother trees ([3,47], 23). Seedlings ([65,387], 178) were harvested and geo-referenced in six of the eight stands. Genetic information was obtained from screening distinct molecular markers spread across the genome, genotyping each tree, acorn or seedling. All samples were thus genotyped at 5-8 nuclear microsatellite loci. Fathers/parents were assigned to acorns and seedlings using likelihood methods. Mating success of male and female parents, pollen and seed dispersal curves, and also hybridisation rates were estimated in each stand and compared on a continental scale. On average, the percentage of the wind-borne pollen from outside the stand was 60%, with large variation among stands (21-88%). Mean seed immigration into the stand was 40%, a high value for oaks that are generally considered to have limited seed dispersal. However, this estimate varied greatly among stands (20-66%). Gene flow was mostly intraspecific, with large variation, as some trees and stands showed particularly high rates of hybridisation. Our results show that mating success was unevenly distributed among trees. The high levels of gene flow suggest that geographically remote oak stands are unlikely to be genetically isolated, questioning the static definition of gene reserves and seed stands.	[Gerber, Sophie; Kremer, Antoine] INRA, UMR1202, BIOGECO, Cestas, France; [Gerber, Sophie; Kremer, Antoine] Univ Bordeaux, BIOGECO, UMR1202, Talence, France; [Chadoeuf, Joel] INRA, UR 1052, F-84143 Montfavet, France; [Gugerli, Felix; Dounavi, Aikaterini] WSL Swiss Fed Res Inst, Birmensdorf, Switzerland; [Lascoux, Martin; Fogelqvist, Johan] Uppsala Univ, Dept Ecol & Genet, Sci Life Lab, EBC, Uppsala, Sweden; [Buiteveld, Joukje] Wageningen UR, Alterra, Wageningen, Netherlands; [Cottrell, Joan; Forrest, Laura L.] Forest Res, No Res Stn, Roslin, Midlothian, Scotland; [Fineschi, Silvia; Salvini, Daniela] CNR, Inst Plant Protect, Florence, Italy; [Goicoechea, Pablo G.] NEIKER Tecnalia, Vitoria, Spain; [Jensen, Jan Svejgaard; Salvini, Daniela] Univ Copenhagen, Copenhagen, Denmark; [Vendramin, Giovanni G.] CNR, Inst Biosci & Bioresources, Florence, Italy	INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Uppsala University; Wageningen University & Research; Consiglio Nazionale delle Ricerche (CNR); University of Copenhagen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR)	Gerber, S (corresponding author), INRA, UMR1202, BIOGECO, Cestas, France.	sophie.gerber@pierroton.inra.fr	Gugerli, Felix/C-9369-2009; Gugerli, Felix/U-7195-2019; Vendramin, Giovanni G/K-9731-2014; Goicoechea, Pablo González/O-8276-2015; Fineschi, Silvia/ABF-9775-2020; Kremer, Antoine/G-2272-2018	Gugerli, Felix/0000-0003-3878-1845; Gugerli, Felix/0000-0003-3878-1845; Vendramin, Giovanni G/0000-0001-9921-7872; Goicoechea, Pablo González/0000-0002-5558-1098; buiteveld, joukje/0000-0003-1892-6760; Forrest, Laura/0000-0002-0235-9506; FINESCHI, SILVIA/0000-0002-3583-6073; Kremer, Antoine/0000-0002-3372-3235; Lascoux, Martin/0000-0003-1699-9042; Dounavi, Aikaterini/0000-0002-4738-6698	European Project "Fairoak" ("Synthetic maps of gene diversity and provenance performance for utilisation and conservation of oak genetic resources in Europe", European Commission Directorate General VI Agriculture) [FAIR PL95-0297]; European Union Project "Oakflow" ("Intra- & interspecific gene flow in oaks as mechanisms promoting genetic diversity and adaptive potential") [QLK5-2000-00960]; Swiss State Secretariat for Education and Research (SER) [99.0838]; Copenhagen University	European Project "Fairoak" ("Synthetic maps of gene diversity and provenance performance for utilisation and conservation of oak genetic resources in Europe", European Commission Directorate General VI Agriculture); European Union Project "Oakflow" ("Intra- & interspecific gene flow in oaks as mechanisms promoting genetic diversity and adaptive potential"); Swiss State Secretariat for Education and Research (SER); Copenhagen University	The work was funded by the European Project "Fairoak" ("Synthetic maps of gene diversity and provenance performance for utilisation and conservation of oak genetic resources in Europe", European Commission Directorate General VI Agriculture, contract FAIR PL95-0297), and the European Union Project "Oakflow" ("Intra- & interspecific gene flow in oaks as mechanisms promoting genetic diversity and adaptive potential", QLK5-2000-00960). The Swiss State Secretariat for Education and Research (SER, 99.0838) financially supported FG and AD. DS received a PhD grant from Copenhagen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich PR, 1998, SCIENCE, V281, P103, DOI 10.1126/science.281.5373.103; Austerlitz F, 2007, HEREDITY, V99, P193, DOI 10.1038/sj.hdy.6800983; Austerlitz F, 2004, MOL ECOL, V13, P937, DOI 10.1111/j.1365-294X.2004.02100.x; Bacilieri R, 1996, ANN SCI FOREST, V53, P79, DOI 10.1051/forest:19960106; Bittencourt JVM, 2007, HEREDITY, V99, P580, DOI 10.1038/sj.hdy.6801019; BOSSEMA I, 1979, BEHAVIOUR, V70, P1, DOI 10.1163/156853979X00016; Burczyk J, 2006, GENETICS, V173, P363, DOI 10.1534/genetics.105.046805; Burczyk J, 2002, MOL ECOL, V11, P2379, DOI 10.1046/j.1365-294X.2002.01603.x; Buschbom J, 2011, J HERED, V102, P464, DOI 10.1093/jhered/esr023; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chybicki IJ, 2010, MOL ECOL, V19, P2137, DOI 10.1111/j.1365-294X.2010.04632.x; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; CONNELL J H, 1971, P298; Craft KJ, 2010, AM J BOT, V97, P1999, DOI 10.3732/ajb.0900390; Curtu AL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-284; Curtu AL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-218; Diggle PJ, 1983, STAT ANAL SPATIAL PO; DOW BD, 1995, THEOR APPL GENET, V91, P137, DOI 10.1007/BF00220870; Dow BD, 1998, J HERED, V89, P62, DOI 10.1093/jhered/89.1.62; Dow BD, 1996, MOL ECOL, V5, P615, DOI 10.1111/j.1365-294X.1996.tb00357.x; Dupouey JL., 1993, ANN SCI FOREST, V50, p35S, DOI [10.1051/forest:19930702, DOI 10.1051/FOREST:19930702]; Efron B., 1994, INTRO BOOTSTRAP; Garcia C, 2005, MOL ECOL, V14, P1821, DOI 10.1111/j.1365-294X.2005.02542.x; Gerber S, 2003, MOL ECOL NOTES, V3, P479, DOI 10.1046/j.1471-8286.2003.00439.x; Gerber S, 2000, MOL ECOL, V9, P1037, DOI 10.1046/j.1365-294x.2000.00961.x; Gonzalez-Rodriguez A, 2004, MOL ECOL, V13, P3467, DOI 10.1111/j.1365-294X.2004.02344.x; Goto S, 2006, MOL ECOL, V15, P2985, DOI 10.1111/j.1365-294X.2006.02976.x; Grivet D, 2005, MOL ECOL, V14, P3585, DOI 10.1111/j.1365-294X.2005.02680.x; Gugerli F, 2007, ANN BOT-LONDON, V99, P713, DOI 10.1093/aob/mcm006; Hanewinkel M, 2013, NAT CLIM CHANGE, V3, P203, DOI [10.1038/NCLIMATE1687, 10.1038/nclimate1687]; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Jamieson A, 1997, ANIM GENET, V28, P397, DOI 10.1111/j.1365-2052.1997.00186.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kamm U, 2009, HEREDITY, V103, P476, DOI 10.1038/hdy.2009.70; Kampfer S, 1998, HEREDITAS, V129, P183, DOI 10.1111/j.1601-5223.1998.00183.x; Karl SA, 2008, MOL ECOL, V17, P3973, DOI 10.1111/j.1365-294X.2008.03902.x; Klein EK, 2008, MOL ECOL, V17, P3323, DOI 10.1111/j.1365-294X.2008.03809.x; Kollmann J, 1996, VEGETATIO, V125, P193, DOI 10.1007/BF00044651; Koskela J, 2013, BIOL CONSERV, V157, P39, DOI 10.1016/j.biocon.2012.07.023; Kremer A, 2002, ANN FOR SCI, V59, P777, DOI 10.1051/forest:2002065; Leonarduzzi C, 2012, IFOREST, V5, P18, DOI 10.3832/ifor0606-009; Lepais O, 2009, MOL ECOL, V18, P2228, DOI 10.1111/j.1365-294X.2009.04137.x; Lepais O, 2008, THESIS U BORDEAUX 1; Lepais O, 2011, EVOLUTION, V65, P156, DOI 10.1111/j.1558-5646.2010.01101.x; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MEAGHER TR, 1991, AM NAT, V137, P738, DOI 10.1086/285191; Moran EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036492; Moran EV, 2012, ECOLOGY, V93, P1082, DOI 10.1890/11-1428.1; Moran EV, 2011, MOL ECOL, V20, P1248, DOI 10.1111/j.1365-294X.2011.05019.x; Nakanishi A, 2005, MOL ECOL, V14, P4469, DOI 10.1111/j.1365-294X.2005.02736.x; Nakanishi A, 2004, SILVAE GENET, V53, P258, DOI 10.1515/sg-2004-0048; Neophytou C, 2011, EUR J FOREST RES, V130, P623, DOI 10.1007/s10342-010-0454-4; Niggemann M, 2012, J ECOL, V100, P264, DOI 10.1111/j.1365-2745.2011.01854.x; Oddou-Muratorio S, 2005, MOL ECOL, V14, P4441, DOI 10.1111/j.1365-294X.2005.02720.x; Pakkad G, 2008, FOREST ECOL MANAG, V255, P3819, DOI 10.1016/j.foreco.2008.03.017; Petit RJ, 2004, NEW PHYTOL, V161, P151, DOI 10.1046/j.1469-8137.2003.00944.x; Robledo-Arnuncio JJ, 2007, MOL ECOL, V16, P5098, DOI 10.1111/j.1365-294X.2007.03427.x; Rodriguez-Munoz R, 2010, SCIENCE, V328, P1269, DOI 10.1126/science.1188102; Saintagne C, 2004, HEREDITY, V92, P20, DOI 10.1038/sj.hdy.6800358; Salvini D, 2009, PLANT BIOLOGY, V11, P758, DOI 10.1111/j.1438-8677.2008.00158.x; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Shea K, 2007, SCIENCE, V315, P1231, DOI 10.1126/science.1136096; Steinitz O, 2011, MOL ECOL, V20, P4152, DOI 10.1111/j.1365-294X.2011.05203.x; Steinkellner H, 1997, PLANT MOL BIOL, V33, P1093, DOI 10.1023/A:1005736722794; Streiff R, 1999, MOL ECOL, V8, P831, DOI 10.1046/j.1365-294X.1999.00637.x; Streiff R, 1998, GENET SEL EVOL, V30, pS137, DOI 10.1051/gse:19980708; Tufto J, 1997, THEOR POPUL BIOL, V52, P16, DOI 10.1006/tpbi.1997.1306; Valbuena-Carabana M, 2007, MOL ECOL, V16, P1207, DOI 10.1111/j.1365-294X.2007.03231.x; YAZDANI R, 1985, FOREST SCI, V31, P430	69	67	67	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85130	10.1371/journal.pone.0085130	http://dx.doi.org/10.1371/journal.pone.0085130			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454802	Green Submitted, Green Published, gold			2022-12-25	WOS:000329922500043
J	Zuber, Z; Rozdzynska-Swiatkowska, A; Jurecka, A; Tylki-Szymanska, A				Zuber, Zbigniew; Rozdzynska-Swiatkowska, Agnieszka; Jurecka, Agnieszka; Tylki-Szymanska, Anna			The Effect of Recombinant Human Iduronate-2-Sulfatase (Idursulfase) on Growth in Young Patients with Mucopolysaccharidosis Type II	PLOS ONE			English	Article							REFERENCES; CHILDREN; DISEASE; HEIGHT	Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is an X-linked, recessive, lysosomal storage disorder caused by deficiency of iduronate-2-sulfatase. Early bone involvement leads to decreased growth velocity and short stature in nearly all patients. Our analysis aimed to investigate the effects of enzyme replacement therapy (ERT) with idursulfase (Elaprase) on growth in young patients with mucopolysaccharidosis type II. Analysis of longitudinal anthropometric data of MPS II patients (group 1, n = 13) who started ERT before 6 years of age (range from 3 months to 6 years, mean 3.6 years, median 4 years) was performed and then compared with retrospective analysis of data for MPS II patients naive to ERT (group 2, n = 50). Patients in group 1 received intravenous idursulfase at a standard dose of 0.58 mg/kg weekly for 52-288 weeks. The course of average growth curve for group 1 was very similar to growth pattern in group 2. The average value of body height in subsequent years in group 1 was a little greater than in group 2, however, the difference was not statistically significant. In studied patients with MPS II, idursulfase did not appear to alter the growth patterns.	[Zuber, Zbigniew] S Louis Reg Childrens Hosp, Dept Pediat, Krakow, Poland; [Rozdzynska-Swiatkowska, Agnieszka] Childrens Mem Hlth Inst, Anthropol Lab, Warsaw, Poland; [Jurecka, Agnieszka] Univ Gdansk, Dept Mol Biol, PL-80952 Gdansk, Poland; [Jurecka, Agnieszka] Childrens Mem Hlth Inst, Dept Med Genet, Warsaw, Poland; [Tylki-Szymanska, Anna] Childrens Mem Hlth Inst, Dept Pediat Nutr & Metab Dis, Warsaw, Poland	Children's Memorial Health Institute; Fahrenheit Universities; University of Gdansk; Children's Memorial Health Institute; Children's Memorial Health Institute	Jurecka, A (corresponding author), Univ Gdansk, Dept Mol Biol, PL-80952 Gdansk, Poland.	ajurecka@gmail.com		Rozdzynska-Swiatkowska, Agnieszka/0000-0001-6936-5989; Zuber, Zbigniew/0000-0001-9581-0601; Tylki-Szymanska, Anna/0000-0002-8935-1768				Baehner F, 2005, J INHERIT METAB DIS, V28, P1011, DOI 10.1007/s10545-005-0112-z; Bonthuis M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042506; Burrow TA, 2007, CURR OPIN PEDIATR, V19, P628, DOI 10.1097/MOP.0b013e3282f161f2; Cieslik J, 1994, DZIECKO POZNANSKIE 9; Hinek A, 2000, AM J PATHOL, V156, P925, DOI 10.1016/S0002-9440(10)64961-9; Jones SA, 2013, MOL GENET METAB, V109, P41, DOI 10.1016/j.ymgme.2013.03.001; Juliusson PB, 2011, ARCH DIS CHILD, V96, P916, DOI 10.1136/adc.2009.166157; Kulaga Z, 2013, EUR J PEDIATR, V172, P753, DOI 10.1007/s00431-013-1954-2; Muenzer J, 2011, GENET MED, V13, P102, DOI 10.1097/GIM.0b013e318206786f; Muenzer J, 2011, GENET MED, V13, P95, DOI 10.1097/GIM.0b013e3181fea459; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Rosario AS, 2011, ANN HUM BIOL, V38, P121, DOI 10.3109/03014460.2010.521193; Rozdzynska A, 2011, ACTA PAEDIATR, V100, P456, DOI 10.1111/j.1651-2227.2010.02060.x; Saari A, 2011, ANN MED, V43, P235, DOI 10.3109/07853890.2010.515603; Scarpa M, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-72; Schulze-Frenking G, 2011, J INHERIT METAB DIS, V34, P203, DOI 10.1007/s10545-010-9215-2; Schwartz IVD, 2007, ACTA PAEDIATR, V96, P63, DOI 10.1111/j.1651-2227.2007.00212.x; Simonaro CM, 2008, AM J PATHOL, V172, P112, DOI 10.2353/ajpath.2008.070564	19	12	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85074	10.1371/journal.pone.0085074	http://dx.doi.org/10.1371/journal.pone.0085074			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454794	gold, Green Submitted, Green Published			2022-12-25	WOS:000329922500039
J	Yamagata, Y; Nishino, K; Takaki, E; Sato, S; Maekawa, R; Nakai, A; Sugino, N				Yamagata, Yoshiaki; Nishino, Koichiro; Takaki, Eiichi; Sato, Shun; Maekawa, Ryo; Nakai, Akira; Sugino, Norihiro			Genome-Wide DNA Methylation Profiling in Cultured Eutopic and Ectopic Endometrial Stromal Cells	PLOS ONE			English	Article							STEROIDOGENIC-FACTOR-I; ABERRANT EXPRESSION; GENE-EXPRESSION; PROMOTER METHYLATION; AROMATASE GENE; HYPERMETHYLATION; ISLAND; PROGESTERONE; ESTROGEN	The objective of this study was to characterize the genome-wide DNA methylation profiles of isolated endometrial stromal cells obtained from eutopic endometria with (euESCa) and without endometriosis (euESCb) and ovarian endometrial cysts (choESC). Three samples were analyzed in each group. The infinium methylation array identified more hypermethylated and hypomethylated CpGs in choESC than in euESCa, and only a few genes were methylated differently in euESCa and euESCb. A functional analysis revealed that signal transduction, developmental processes, immunity, etc. were different in choESC and euESCa. A clustering analysis and a principal component analysis performed based on the methylation levels segregated choESC from euESC, while euESCa and euESCb were identical. A transcriptome analysis was then conducted and the results were compared with those of the DNA methylation analysis. Interestingly, the hierarchical clustering and principal component analyses showed that choESC were segregated from euESCa and euESCb in the DNA methylation analysis, while no segregation was recognized in the transcriptome analysis. The mRNA expression levels of the epigenetic modification enzymes, including DNA methyltransferases, obtained from the specimens were not significantly different between the groups. Some of the differentially methylated and/or expressed genes (NR5A1, STAR, STRA6 and HSD17B2), which are related with steroidogenesis, were validated by independent methods in a larger number of samples. Our findings indicate that different DNA methylation profiles exist in ectopic ESC, highlighting the benefits of genome wide DNA methylation analyses over transcriptome analyses in clarifying the development and characterization of endometriosis.	[Yamagata, Yoshiaki; Sato, Shun; Maekawa, Ryo; Sugino, Norihiro] Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Ube, Yamaguchi 755, Japan; [Nishino, Koichiro] Miyazaki Univ, Fac Agr, Lab Vet Biochem & Mol Biol, Miyazaki 88921, Japan; [Takaki, Eiichi; Nakai, Akira] Yamaguchi Univ, Grad Sch Med, Dept Biochem & Mol Biol, Ube, Yamaguchi 755, Japan	Yamaguchi University; University of Miyazaki; Yamaguchi University	Yamagata, Y (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Ube, Yamaguchi 755, Japan.	yymgt@yamaguchi-u.ac.jp	Maekawa, Ryo/AAR-4233-2020	Maekawa, Ryo/0000-0003-0923-376X	Ministry of Education, Science and Culture, Japan [21592099, 22591825, 23659781, 23791846, 23890140]; Yamaguchi University School of Medicine; Grants-in-Aid for Scientific Research [25462560] Funding Source: KAKEN	Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamaguchi University School of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid 21592099, 22591825, 23659781, 23791846 and 23890140 for Scientific Research from the Ministry of Education, Science and Culture, Japan and the New Frontier Project, Yamaguchi University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attar E, 2009, J CLIN ENDOCR METAB, V94, P623, DOI 10.1210/jc.2008-1180; Borghese B, 2008, MOL ENDOCRINOL, V22, P2557, DOI 10.1210/me.2008-0322; Borghese B, 2010, MOL ENDOCRINOL, V24, P1872, DOI 10.1210/me.2010-0160; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Dimitrakopoulos L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-486; Eyster KM, 2007, FERTIL STERIL, V88, P1505, DOI 10.1016/j.fertnstert.2007.01.056; Gentilini D, 2010, FERTIL STERIL, V93, P706, DOI 10.1016/j.fertnstert.2008.10.014; Harada T, 2004, HUM REPROD UPDATE, V10, P29, DOI 10.1093/humupd/dmh007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iwabe T, 2000, J CLIN ENDOCR METAB, V85, P824, DOI 10.1210/jc.85.2.824; Izawa M, 2008, FERTIL STERIL, V89, P1390, DOI 10.1016/j.fertnstert.2007.03.078; Izawa M, 2011, FERTIL STERIL, V95, P33, DOI 10.1016/j.fertnstert.2010.06.024; Lucki NC, 2012, MOL ENDOCRINOL, V26, P228, DOI 10.1210/me.2011-1150; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Pavone ME, 2011, HUM REPROD, V26, P2157, DOI 10.1093/humrep/der172; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Sugino N, 2000, MOL HUM REPROD, V6, P178, DOI 10.1093/molehr/6.2.178; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Wu Y, 2005, AM J OBSTET GYNECOL, V193, P371, DOI 10.1016/j.ajog.2005.01.034; Wu Y, 2007, REPROD SCI, V14, P374, DOI 10.1177/1933719107302913; Wu Y, 2007, FERTIL STERIL, V87, P24, DOI 10.1016/j.fertnstert.2006.05.077; Wu Y, 2006, EPIGENETICS-US, V1, P106, DOI 10.4161/epi.1.2.2766; Xue Q, 2007, BIOL REPROD, V77, P681, DOI 10.1095/biolreprod.107.061804; Xue Q, 2007, J CLIN ENDOCR METAB, V92, P3261, DOI 10.1210/jc.2007-0494; Xue Q, 2011, REPROD SCI, V18, P1080, DOI 10.1177/1933719111404614; Yamagata Y, 2009, HUM REPROD, V24, P1126, DOI 10.1093/humrep/dep015	27	48	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e83612	10.1371/journal.pone.0083612	http://dx.doi.org/10.1371/journal.pone.0083612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465385	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000003
J	Edgar, LT; Underwood, CJ; Guilkey, JE; Hoying, JB; Weiss, JA				Edgar, Lowell T.; Underwood, Clayton J.; Guilkey, James E.; Hoying, James B.; Weiss, Jeffrey A.			Extracellular Matrix Density Regulates the Rate of Neovessel Growth and Branching in Sprouting Angiogenesis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-VITRO ANGIOGENESIS; MECHANICAL-PROPERTIES; CAPILLARY MORPHOGENESIS; MICROVESSEL FRAGMENTS; ENDOTHELIAL-CELLS; COLLAGEN; ORIENTATION; MAINTENANCE; INVOLVEMENT	Angiogenesis is regulated by the local microenvironment, including the mechanical interactions between neovessel sprouts and the extracellular matrix (ECM). However, the mechanisms controlling the relationship of mechanical and biophysical properties of the ECM to neovessel growth during sprouting angiogenesis are just beginning to be understood. In this research, we characterized the relationship between matrix density and microvascular topology in an in vitro 3D organ culture model of sprouting angiogenesis. We used these results to design and calibrate a computational growth model to demonstrate how changes in individual neovessel behavior produce the changes in vascular topology that were observed experimentally. Vascularized gels with higher collagen densities produced neovasculatures with shorter vessel lengths, less branch points, and reduced network interconnectivity. The computational model was able to predict these experimental results by scaling the rates of neovessel growth and branching according to local matrix density. As a final demonstration of utility of the modeling framework, we used our growth model to predict several scenarios of practical interest that could not be investigated experimentally using the organ culture model. Increasing the density of the ECM significantly reduced angiogenesis and network formation within a 3D organ culture model of angiogenesis. Increasing the density of the matrix increases the stiffness of the ECM, changing how neovessels are able to deform and remodel their surroundings. The computational framework outlined in this study was capable of predicting this observed experimental behavior by adjusting neovessel growth rate and branching probability according to local ECM density, demonstrating that altering the stiffness of the ECM via increasing matrix density affects neovessel behavior, thereby regulated vascular topology during angiogenesis.	[Edgar, Lowell T.; Underwood, Clayton J.; Weiss, Jeffrey A.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Edgar, Lowell T.; Weiss, Jeffrey A.] Univ Utah, Sci Comp & Imaging Inst, Salt Lake City, UT USA; [Underwood, Clayton J.] WL Gore & Assoc Inc, Med Prod Div, Flagstaff, AZ USA; [Guilkey, James E.] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA; [Hoying, James B.] Univ Louisville, Cardiovasc Innovat Inst, Div Cardiovasc Therapeut, Louisville, KY 40292 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Louisville	Weiss, JA (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.	jeff.weiss@utah.edu	Edgar, Lowell Taylor/L-3428-2019	Edgar, Lowell/0000-0002-8586-1605	National Institutes of Health [NIH R01HL077683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077683] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding from the National Institutes of Health (NIH R01HL077683) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x; Chang CC, 2006, CELL TRANSPLANT, V15, P533, DOI 10.3727/000000006783981693; Chang CC, 2010, TISSUE ENG PT A, V16, P795, DOI [10.1089/ten.tea.2009.0370, 10.1089/ten.TEA.2009.0370]; Chang CC, 2012, ARTERIOSCL THROM VAS, V32, P5, DOI 10.1161/ATVBAHA.111.238725; Edgar LT, 2013, COMPUT METHOD BIOMEC, V16, P790, DOI 10.1080/10255842.2012.662678; FISHER C, 1994, DEV BIOL, V162, P499, DOI 10.1006/dbio.1994.1104; Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774; Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; Haas TL, 1998, J BIOL CHEM, V273, P3604, DOI 10.1074/jbc.273.6.3604; Hoying JB, 1996, IN VITRO CELL DEV-AN, V32, P409; Huot J, 1998, J CELL BIOL, V143, P1361, DOI 10.1083/jcb.143.5.1361; Hur SS, 2009, CELL MOL BIOENG, V2, P425, DOI 10.1007/s12195-009-0082-6; Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5; Kirkpatrick ND, 2007, AM J PHYSIOL-HEART C, V292, pH3198, DOI 10.1152/ajpheart.01234.2006; Kniazeva E, 2011, TISSUE ENG PT A, V17, P905, DOI [10.1089/ten.tea.2010.0275, 10.1089/ten.TEA.2010.0275]; Kniazeva E, 2009, AM J PHYSIOL-CELL PH, V297, pC179, DOI 10.1152/ajpcell.00018.2009; Korff T, 1999, J CELL SCI, V112, P3249; Krishnan L, 2004, TISSUE ENG, V10, P241, DOI 10.1089/107632704322791880; Krishnan L, 2008, CARDIOVASC RES, V78, P324, DOI 10.1093/cvr/cvn055; Krishnan L, 2007, AM J PHYSIOL-HEART C, V293, pH3650, DOI 10.1152/ajpheart.00772.2007; Liu Y, 2006, BIOMACROMOLECULES, V7, P1819, DOI 10.1021/bm060160o; Lopez JI, 2008, ONCOGENE, V27, P6981, DOI 10.1038/onc.2008.348; NICOSIA RF, 1990, LAB INVEST, V63, P115; NICOSIA RF, 1990, IN VITRO CELL DEV B, V26, P119; Nunes SS, 2010, MICROCIRCULATION, V17, P557, DOI 10.1111/j.1549-8719.2010.00052.x; Nunes SS, 2010, MICROVASC RES, V79, P10, DOI 10.1016/j.mvr.2009.10.001; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; Peirce S, 2008, MICROCIRCULATION, V15, P739, DOI 10.1080/10739680802220331; Rao RR, 2012, ANGIOGENESIS, V15, P253, DOI 10.1007/s10456-012-9257-1; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Richter SJ, 2012, QUAL ENG, V14, P375; Rivilis I, 2002, AM J PHYSIOL-HEART C, V283, pH1430, DOI 10.1152/ajpheart.00082.2002; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Shepherd BR, 2004, ARTERIOSCL THROM VAS, V24, P898, DOI 10.1161/01.ATV.0000124103.86943.1e; Shiu Yan-Ting, 2005, Critical Reviews in Biomedical Engineering, V33, P431, DOI 10.1615/CritRevBiomedEng.v33.i5.10; Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035; Tranqui L, 2000, CR ACAD SCI III-VIE, V323, P31, DOI 10.1016/S0764-4469(00)00110-4; Underwood CJ, P ASME SUMM BIOENG C; Vailhe B, 1997, IN VITRO CELL DEV-AN, V33, P763; Vernon RB, 1996, J CELL BIOCHEM, V60, P185, DOI 10.1002/(SICI)1097-4644(19960201)60:2<185::AID-JCB3>3.0.CO;2-T; Vernon RB, 1999, MICROVASC RES, V57, P118, DOI 10.1006/mvre.1998.2122; WOOD GC, 1960, BIOCHEM J, V75, P588, DOI 10.1042/bj0750588; Yamamura N, 2007, TISSUE ENG, V13, P1443, DOI 10.1089/ten.2006.0333; Yang MT, 2011, INTEGR BIOL-UK, V3, P663, DOI 10.1039/c0ib00156b	48	90	91	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85178	10.1371/journal.pone.0085178	http://dx.doi.org/10.1371/journal.pone.0085178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465500	gold, Green Submitted, Green Published			2022-12-25	WOS:000330283100024
J	Park, J; Yamaura, T; Kawamoto, J; Kurihara, T; Sato, SB				Park, Jungha; Yamaura, Takayuki; Kawamoto, Jun; Kurihara, Tatsuo; Sato, Satoshi B.			Reciprocal Modulation of Surface Expression of Annexin A2 in a Human Umbilical Vein Endothelial Cell-Derived Cell Line by Eicosapentaenoic Acid and Docosahexaenoic Acid	PLOS ONE			English	Article							N-3 FATTY-ACIDS; CARDIOVASCULAR HEALTH; CAVEOLAE; PLASMIN; INFLAMMATION; MECHANISM; RECEPTOR; DISEASE; CULTURE; SERUM	Background: Annexin A2 (ANXA2), a member of the annexin family of cytosolic Ca2+-binding proteins, plays a pivotal role in vascular biology. Small amounts of this protein and S100A10 protein are exposed on the surface of endothelial cells (ECs). They control fibrinolysis by recruiting tissue-type and urokinase-type plasminogen activators from the plasma. Nutritional studies indicate that two major long-chain polyunsaturated fatty acids (PUFAs), i.e., eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), provide benefits for EC functions. The effects of EPA and DHA on the plasminogen/plasmin system have not been characterized. Methodology/Principal Findings: Proteomic analysis of a cultured human umbilical vein EC-derived cell line, HUV-EC-C, showed that cell-associated ANXA2 decreased with EPA treatment and increased with DHA. A small fraction of ANXA2 was bound to the cell surface, which was also affected by these PUFAs following the same trends. Cell surface expression was negatively regulated by protein kinase C (PKC) alpha-mediated Ser-phosphorylation, which was up-and down-regulated by EPA and DHA, respectively. These PUFAs differentially affected a small fraction of caveolae/rafts-associated ANXA2. In addition to chymotrypsin-like activity in the serum, newly activated plasmin cleaved the ANXA2 on the cell surface at distinct sites in the N-terminal sequence. ANXA2 also bound to membranes released in the medium, which was similarly processed by these proteases. Both the PUFAs did not directly affect the release. Conclusion/Significance: These results suggest that EPA and DHA reciprocally control cell surface location of ANXA2. Moreover, cleavage of this protein by plasmin likely resulted in autodigestion of the platform for formation of this protease. In conjunction with termination of the proteolysis by rapid inactivation of plasmin by alpha-2-antiplasmin and other polypeptide inhibitors, this feedback mechanism may emphasize the benefits of these PUFA in regulation of the initiation of fibrinolysis on the surface of ECs.	[Park, Jungha; Sato, Satoshi B.] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Kyoto, Japan; [Yamaura, Takayuki; Kawamoto, Jun; Kurihara, Tatsuo] Kyoto Univ, Inst Chem Res, Uji, Kyoto, Japan	Kyoto University; Kyoto University	Sato, SB (corresponding author), Kyoto Univ, Res Ctr Low Temp & Mat Sci, Kyoto, Japan.	sbsato@ltm.kyoto-u.ac.jp		Kawamoto, Jun/0000-0002-5025-5613				Adkins Y, 2010, J NUTR BIOCHEM, V21, P781, DOI 10.1016/j.jnutbio.2009.12.004; Balakumar P, 2012, FREE RADICAL BIO MED, V53, P271, DOI 10.1016/j.freeradbiomed.2012.05.005; Bannenberg G, 2010, BBA-MOL CELL BIOL L, V1801, P1260, DOI 10.1016/j.bbalip.2010.08.002; Breslow JL, 2006, AM J CLIN NUTR, V83, p1477S, DOI 10.1093/ajcn/83.6.1477S; Bruneel A, 2003, PROTEOMICS, V3, P714, DOI 10.1002/pmic.200300409; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; CEDERHOLMWILLIAMS SA, 1981, J CLIN PATHOL, V34, P979, DOI 10.1136/jcp.34.9.979; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Cockrell E, 2008, LUPUS, V17, P943, DOI 10.1177/0961203308095329; COLLINS T, 1993, LAB INVEST, V68, P499; Cottin SC, 2011, P NUTR SOC, V70, P215, DOI 10.1017/S0029665111000061; Deckelbaum RJ, 2012, J NUTR, V142, p587S, DOI 10.3945/jn.111.148080; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Deryugina EI, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/564259; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Flood EC, 2011, VASC PHARMACOL, V54, P59, DOI 10.1016/j.vph.2011.03.003; GITLIN D, 1969, J CLIN INVEST, V48, P1433, DOI 10.1172/JCI106109; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Gu Y, 2009, REPROD SCI, V16, P905, DOI 10.1177/1933719109337333; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; He KL, 2011, J BIOL CHEM, V286, P15428, DOI 10.1074/jbc.M110.185058; Hedhli N, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/406273; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; HOSHI H, 1984, P NATL ACAD SCI-BIOL, V81, P6413, DOI 10.1073/pnas.81.20.6413; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Kelley DS, 2012, P NUTR SOC, V71, P1; Knipe L, 2010, BLOOD, V116, P2183, DOI 10.1182/blood-2010-03-276170; Lacroix R, 2007, BLOOD, V110, P2432, DOI 10.1182/blood-2007-02-069997; Laumonnier Y, 2006, BLOOD, V107, P3342, DOI 10.1182/blood-2005-07-2840; Leung C, 2011, BIOCHEM BIOPH RES CO, V415, P263, DOI 10.1016/j.bbrc.2011.10.031; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; LOSKUTOFF DJ, 1978, J CELL PHYSIOL, V96, P361, DOI 10.1002/jcp.1040960312; Madureira PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050591; Madureira PA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/353687; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Massaro M, 2008, PROSTAG LEUKOTR ESS, V79, P109, DOI 10.1016/j.plefa.2008.09.009; Matesanz N, 2010, INVEST OPHTH VIS SCI, V51, P6815, DOI 10.1167/iovs.10-5339; Monea S, 2002, J CELL PHYSIOL, V192, P160, DOI 10.1002/jcp.10126; Mozaffarian D, 2012, J NUTR, V142, p614S, DOI 10.3945/jn.111.149633; Mozaffarian D, 2011, ANN INTERN MED, V155, P160, DOI 10.7326/0003-4819-155-3-201108020-00006; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; Nassoy P, 2012, TRENDS CELL BIOL, V22, P381, DOI 10.1016/j.tcb.2012.04.007; Park J, 2012, EXTREMOPHILES, V16, P227, DOI 10.1007/s00792-011-0422-z; Ramadeen A, 2012, CIRC-ARRHYTHMIA ELEC, V5, P978, DOI 10.1161/CIRCEP.112.971515; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Sato SB, 2013, BBA-MOL CELL BIOL L, V1831, P306, DOI 10.1016/j.bbalip.2012.10.004; Sharma M, 2010, EXP MOL PATHOL, V88, P278, DOI 10.1016/j.yexmp.2010.01.001; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Sun Q, 2008, AM J CLIN NUTR, V88, P216, DOI 10.1093/ajcn/88.1.216; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2; Tunica DG, 2009, PROTEOMICS, V9, P4991, DOI 10.1002/pmic.200900065; Valapala M, 2011, J BIOL CHEM, V286, P30911, DOI 10.1074/jbc.M111.271155; Virtanen JK, 2009, CIRCULATION, V120, P2315, DOI 10.1161/CIRCULATIONAHA.109.852657; Wang JL, 2004, BBA-GEN SUBJECTS, V1673, P75, DOI 10.1016/j.bbagen.2004.03.013; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308; Zoeller JJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-7	66	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85045	10.1371/journal.pone.0085045	http://dx.doi.org/10.1371/journal.pone.0085045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465474	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500031
J	Pozzi, L; Dorocic, IP; Wang, XM; Carlen, M; Meletis, K				Pozzi, Laura; Dorocic, Iskra Pollak; Wang, Xinming; Carlen, Marie; Meletis, Konstantinos			Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; FAST-SPIKING INTERNEURONS; MILD STRESS MODEL; PREFRONTAL CORTEX; GLUTAMATERGIC SYSTEM; ANIMAL-MODEL; KETAMINE; BLOCKADE; THERAPEUTICS; OSCILLATIONS	The underlying circuit imbalance in major depression remains unknown and current therapies remain inadequate for a large group of patients. Discovery of the rapid antidepressant effects of ketamine - an NMDA receptor (NMDAR) antagonist - has linked the glutamatergic system to depression. Interestingly, dysfunction in the inhibitory GABAergic system has also been proposed to underlie depression and deficits linked to GABAergic neurons have been found with human imaging and in post-mortem material from depressed patients. Parvalbumin-expressing (PV) GABAergic interneurons regulate local circuit function through perisomatic inhibition and their activity is NMDAR-dependent, providing a possible link between NMDAR and the inhibitory system in the antidepressant effect of ketamine. We have therefore investigated the role of the NMDAR-dependent activity of PV interneurons for the development of depression-like behavior as well as for the response to rapid antidepressant effects of NMDAR antagonists. We used mutant mice lacking NMDA neurotransmission specifically in PV neurons (PV-Cre+/NR1f/f) and analyzed depression-like behavior and anhedonia. To study the acute and sustained effects of a single NMDAR antagonist administration, we established a behavioral paradigm of repeated exposure to forced swimming test (FST). We did not observe altered behavioral responses in the repeated FST or in a sucrose preference test in mutant mice. In addition, the behavioral response to administration of NMDAR antagonists was not significantly altered in mutant PV-Cre+/NR1f/f mice. Our results show that NMDA-dependent neurotransmission in PV neurons is not necessary to regulate depression-like behaviors, and in addition that NMDARs on PV neurons are not a direct target for the NMDAR-induced antidepressant effects of ketamine and MK801.	[Pozzi, Laura; Dorocic, Iskra Pollak; Wang, Xinming; Carlen, Marie; Meletis, Konstantinos] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet	Meletis, K (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	dinos.meletis@ki.se	Carlen, Marie Carlen/C-9112-2014; Pozzi, Laura/F-8687-2011; Meletis, Konstantinos/ABE-6777-2020	Carlen, Marie Carlen/0000-0003-1658-1631; Pozzi, Laura/0000-0001-7662-2904; Meletis, Konstantinos/0000-0001-5665-4781	Swedish Research Council (VR Medicin); Swedish Brain Foundation (Hjarnfonden); Marie Curie Reintegration grant; Strategic Neuroscience programme at Karolinska Institutet; NARSAD Young Investigator Awards; Ake Wiberg Stiftelse; O.E. och Edla Johanssons Stiftelse	Swedish Research Council (VR Medicin)(Swedish Research Council); Swedish Brain Foundation (Hjarnfonden); Marie Curie Reintegration grant(European Commission); Strategic Neuroscience programme at Karolinska Institutet; NARSAD Young Investigator Awards(NARSAD); Ake Wiberg Stiftelse; O.E. och Edla Johanssons Stiftelse	This study was supported by grants from the Swedish Research Council (VR Medicin), the Swedish Brain Foundation (Hjarnfonden), a Marie Curie Reintegration grant (KM), the Strategic Neuroscience programme at Karolinska Institutet, NARSAD Young Investigator Awards (to MC and KM), Ake Wiberg Stiftelse, and O.E. och Edla Johanssons Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Burgdorf J, 2013, NEUROPSYCHOPHARMACOL, V38, P729, DOI 10.1038/npp.2012.246; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; Gabbay V, 2012, ARCH GEN PSYCHIAT, V69, P139, DOI 10.1001/archgenpsychiatry.2011.131; Goforth HW, 2007, J ECT, V23, P23, DOI 10.1097/01.yct.0000263257.44539.23; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; JONES RSG, 1993, NEUROSCI LETT, V149, P35, DOI 10.1016/0304-3940(93)90341-H; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Kugaya A, 2005, CNS SPECTRUMS, V10, P808, DOI 10.1017/S1092852900010403; LAYER RT, 1995, PHARMACOL BIOCHEM BE, V52, P621, DOI 10.1016/0091-3057(95)00155-P; Levinson AJ, 2010, BIOL PSYCHIAT, V67, P458, DOI 10.1016/j.biopsych.2009.09.025; Lewis DA, 2006, ARCH NEUROL-CHICAGO, V63, P1372, DOI 10.1001/archneur.63.10.1372; Ma XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056053; Machado-Vieira R, 2009, CURR PHARM DESIGN, V15, P1595, DOI 10.2174/138161209788168010; Marona-Lewicka, 1997, Stress, V2, P91; Mathews DC, 2012, DRUGS, V72, P1313, DOI 10.2165/11633130-000000000-00000; Mohler H, 2012, NEUROPHARMACOLOGY, V62, P42, DOI 10.1016/j.neuropharm.2011.08.040; Mohler H, 2011, NEUROPHARMACOLOGY, V60, P1042, DOI 10.1016/j.neuropharm.2010.10.020; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Moghaddam B, 2012, SCHIZOPHRENIA BULL, V38, P942, DOI 10.1093/schbul/sbs075; Murrough JW, 2013, BIOL PSYCHIAT, V74, P250, DOI 10.1016/j.biopsych.2012.06.022; MUSCAT R, 1992, BIOL PSYCHIAT, V31, P937, DOI 10.1016/0006-3223(92)90119-K; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nowak K, 2012, ACTA NEUROBIOL EXP, V72, P207; PAPP M, 1994, EUR J PHARMACOL, V263, P1, DOI 10.1016/0014-2999(94)90516-9; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Quirk MC, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.013.2009; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; Sanacora G, 2002, AM J PSYCHIAT, V159, P663, DOI 10.1176/appi.ajp.159.4.663; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; Sibille E, 2011, INT J NEUROPSYCHOPH, V14, P721, DOI 10.1017/S1461145710001616; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; TRULLAS R, 1990, EUR J PHARMACOL, V185, P1, DOI 10.1016/0014-2999(90)90204-J; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Vardigan JD, 2010, PHARMACOL BIOCHEM BE, V95, P223, DOI 10.1016/j.pbb.2010.01.010; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhou ZQ, 2012, MED HYPOTHESES, V79, P85, DOI 10.1016/j.mehy.2012.04.007	49	46	48	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e83879	10.1371/journal.pone.0083879	http://dx.doi.org/10.1371/journal.pone.0083879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454710	Green Submitted, Green Published, gold			2022-12-25	WOS:000330236000004
J	Ge, SW; Hertel, B; Susnik, N; Rong, S; Dittrich, AM; Schmitt, R; Haller, H; von Vietinghoff, S				Ge, Shuwang; Hertel, Barbara; Susnik, Nathan; Rong, Song; Dittrich, Anna M.; Schmitt, Roland; Haller, Hermann; von Vietinghoff, Sibylle			Interleukin 17 Receptor A Modulates Monocyte Subsets and Macrophage Generation In Vivo	PLOS ONE			English	Article							DENDRITIC CELLS; BONE-MARROW; T-CELLS; CHRONIC INFLAMMATION; INFECTION; FIBROSIS; ACCUMULATION; SUPPRESSES; PATHOGENS; ANTIBODY	Interleukin (IL)-17A signaling via Interleukin 17 receptor A (Il17ra) contributes to the inflammatory host response by inducing recruitment of innate immune cells, but also plays a role in homeostatic neutrophilic granulocyte regulation. Monocytes, the other main innate immune cell, have a longer life span and can pursue multiple differentiation pathways towards tissue macrophages. Monocytes are divided into two subpopulations by expression of the Ly6C/Gr1 surface marker in mice. We here investigated the role of Il17ra in monocyte homeostasis and macrophage generation. In Il17ra(-/-) and in mixed bone marrow chimeric wt/Il17ra(-/-) mice, the concentrations of circulating Il17ra(-/-) Gr1(low) monocytes were significantly decreased compared to wt cells. Pulmonary, splenic and resident peritoneal Il17ra(-/-) macrophages were significantly fewer than of wt origin. Bone marrow progenitor and monocyte numbers were equal, but the proportion of Il17ra(-/-) Gr1(low) monocytes was already decreased at bone marrow level. After monocyte depletion, initial Gr1(high) and Gr1(low) monocyte regeneration of Il17ra(-/-) and wt cells was very similar. However, Il17ra(-/-) Gr1(low) counts were not sustained. After labeling with either fluorescent beads or BrdU, Il17ra(-/-) Gr1(high) monocyte transition to Gr1(low) cells was not detectable unlike wt cells. Monocyte recruitment in acute peritonitis, which is known to be largely due to Gr1(high) cell migration, was unaffected in an identical environment. Unilateral ureteral obstruction induces a less acute inflammatory and fibrotic kidney injury. Compared to wt cells in the same environment, Il17ra(-/-) macrophage accumulation in the kidney was decreased. In the absence of Il17ra on all myeloid cells, renal fibrosis was significantly attenuated. Our data show that Il17ra modulates Gr1(low) monocyte counts and suggest defective Gr1(high) to Gr1(low) monocyte transition as an underlying mechanism. Lack of Il17ra altered homeostatic tissue macrophage formation and diminished renal inflammation and fibrosis. Il17ra appears to be a novel modulator of monocyte phenotype and possible therapeutic target in renal fibrosis.	[Ge, Shuwang; Hertel, Barbara; Susnik, Nathan; Rong, Song; Schmitt, Roland; Haller, Hermann; von Vietinghoff, Sibylle] Hannover Med Sch, Dept Med, Hannover, Germany; [Dittrich, Anna M.] Hannover Med Sch, Dept Pediat, Hannover, Germany; [Ge, Shuwang] Huazhong Univ, Tongji Hosp, Dept Nephrol, Wuhan, Peoples R China	Hannover Medical School; Hannover Medical School; Huazhong University of Science & Technology	von Vietinghoff, S (corresponding author), Hannover Med Sch, Dept Med, Hannover, Germany.	vonVietinghoff.Sibylle@mh-hannover.de	Dittrich, Anna Maria/M-5640-2013; Dittrich, Anna/GRY-6738-2022; Schmitt, Roland/AAP-4609-2021	/0000-0001-9985-1515; Schmitt, Roland/0000-0003-4415-8355	National Science Foundation of China [81200531]; Deutsche Forschungsgemeinschaft [VI 508/4-1]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Shuwang Ge was supported by National Science Foundation of China (No. 81200531) and Sibylle von Vietinghoff by Deutsche Forschungsgemeinschaft (www.dfg.de) Grant VI 508/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barin JG, 2011, EUR J IMMUNOL; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Koltsova EK, 2012, J CLIN INVEST, V122, P3114, DOI 10.1172/JCI61758; Le Meur Y, 2002, J LEUKOCYTE BIOL, V72, P530; Lim AKH, 2009, DIABETOLOGIA, V52, P1669, DOI 10.1007/s00125-009-1399-3; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049; Menke J, 2009, J AM SOC NEPHROL, V20, P2581, DOI 10.1681/ASN.2009050499; Miah SMS, 2011, J IMMUNOL, V186, P2959, DOI 10.4049/jimmunol.1000112; Nelson PJ, 2012, J AM SOC NEPHROL, V23, P194, DOI 10.1681/ASN.2011070680; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Peng YF, 2009, J IMMUNOL, V182, P2777, DOI 10.4049/jimmunol.0803172; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sorensen I, 2011, KIDNEY INT, V80, P1035, DOI 10.1038/ki.2011.214; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; von Vietinghoff S, 2011, J AM COLL CARDIOL, V57, P2194, DOI 10.1016/j.jacc.2010.12.030; von Vietinghoff S, 2010, KIDNEY INT, V78, P79, DOI 10.1038/ki.2010.84; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; Xu S, 2010, J IMMUNOL, V185, P5879, DOI 10.4049/jimmunol.1001763; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	39	71	71	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85461	10.1371/journal.pone.0085461	http://dx.doi.org/10.1371/journal.pone.0085461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454873	Green Submitted, gold, Green Published			2022-12-25	WOS:000330235100090
J	Gunnerbeck, A; Bonamy, AKE; Wikstrom, AK; Granath, F; Wickstrom, R; Cnattingius, S				Gunnerbeck, Anna; Bonamy, Anna-Karin Edstedt; Wikstrom, Anna-Karin; Granath, Fredrik; Wickstrom, Ronny; Cnattingius, Sven			Maternal Snuff Use and Smoking and the Risk of Oral Cleft Malformations - A Population-Based Cohort Study	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; ALPHA-GENE VARIANTS; CIGARETTE-SMOKING; OROFACIAL CLEFTS; BIRTH-DEFECTS; N-NITROSAMINES; MOIST SNUFF; PREGNANCY; NICOTINE; EXPOSURE	Objective: To determine if maternal use of snuff (containing high levels of nicotine, low levels of nitrosamines and no combustion products) is associated with an increased risk of oral cleft malformations in the infant and whether cessation of snuff use or smoking before the antenatal booking influences the risk. Method: A population-based cohort study was conducted on all live born infants, recorded in the Swedish Medical Birth Register from 1999 through 2009 (n = 1 086 213). Risks of oral clefts were evaluated by multivariate logistic regression analyses (using adjusted odds ratios, with 95% confidence intervals [CI]). Results: Among 975 866 infants that had information on maternal tobacco use, 1761 cases of oral clefts were diagnosed. More than 50% of the mothers who used snuff or smoked three months prior pregnancy stopped using before the antenatal booking. Almost 8% of the mothers were smoking at the antenatal booking and 1,1% of the mothers used snuff. Compared with infants of non-tobacco users, the adjusted odds ratios (95% CI) of any oral cleft for infants of mothers who continued to use snuff or to smoke were 1.48 [1.00-2.21] and 1.19 [1.01-1.41], respectively. In contrast, in infants of mothers who stopped using snuff or stopped smoking before the antenatal booking, the corresponding risks were not increased (adjusted odds ratios [95% CI] were 0.71 [0.44-1.14] and 0.88 [0.73-1.05], respectively). Conclusion: Maternal snuff use or smoking in early pregnancy is associated with an increased risk of oral clefts. Infants of mothers who stopped using snuff or stopped smoking before the antenatal booking had no increased risk of oral cleft malformations. Oral snuff or other sources of nicotine should not be recommended as an alternative for smoke-cessation during pregnancy.	[Gunnerbeck, Anna; Bonamy, Anna-Karin Edstedt; Wickstrom, Ronny] Karolinska Univ, Hosp Solna, Dept Womens & Childrens Hlth, Karolinska Inst,Neonatal Res Unit, Stockholm, Sweden; [Bonamy, Anna-Karin Edstedt; Wikstrom, Anna-Karin; Granath, Fredrik; Cnattingius, Sven] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Wikstrom, Anna-Karin] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University	Gunnerbeck, A (corresponding author), Karolinska Univ, Hosp Solna, Dept Womens & Childrens Hlth, Karolinska Inst,Neonatal Res Unit, Stockholm, Sweden.	anna.gunnerbeck@ki.se	Gunnerbeck, Anna/AGR-8400-2022; Bonamy, Anna-Karin E/B-7106-2012	Gunnerbeck, Anna/0000-0003-1808-1091; Bonamy, Anna-Karin E/0000-0003-4552-9912	Swedish Council for Working Life and Social Research [2009-1619, 2010-0643]; Karolinska Institutet; Stockholm County Council	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council)	The study was supported by grants from the Swedish Council for Working Life and Social Research (2009-1619 and 2010-0643) and by grants from Karolinska Institutet and Stockholm County Council. The sponsor of the study had no role in the study design, data collection, data analyses, decision to publish or preparation of the manuscript. The authors have no financial relationships relevant to this article to disclose.	Baroni T, 2010, J CELL PHYSIOL, V222, P748, DOI 10.1002/jcp.22006; Benowitz N L, 1997, Adv Dent Res, V11, P336; Brender JD, 2004, EPIDEMIOLOGY, V15, P330, DOI 10.1097/01.ede.0000121381.79831.7b; Brender JD, 2011, AM J EPIDEMIOL, V174, P1286, DOI 10.1093/aje/kwr254; Christensen K, 1999, AM J EPIDEMIOL, V149, P248; Chung KC, 2000, PLAST RECONSTR SURG, V105, P485, DOI 10.1097/00006534-200002000-00001; CNATTINGIUS S, 1988, BMJ-BRIT MED J, V297, P258, DOI 10.1136/bmj.297.6643.258; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Coleman T, 2012, NEW ENGL J MED, V366, P808, DOI 10.1056/NEJMoa1109582; Croen LA, 2001, AM J EPIDEMIOL, V153, P325, DOI 10.1093/aje/153.4.325; Dempsey DA, 2001, DRUG SAFETY, V24, P277, DOI 10.2165/00002018-200124040-00005; ERICSON A, 1979, AM J OBSTET GYNECOL, V135, P348, DOI 10.1016/0002-9378(79)90703-8; Foulds J, 2003, TOB CONTROL, V12, P349, DOI 10.1136/tc.12.4.349; Gartner CE, 2007, LANCET, V369, P2010, DOI 10.1016/S0140-6736(07)60677-1; George L, 2006, ACTA OBSTET GYN SCAN, V85, P1331, DOI 10.1080/00016340600935433; Gunnerbeck A, 2011, PEDIATRICS, V128, P503, DOI 10.1542/peds.2010-3811; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Hafstrom A, 2005, RESP PHYSIOL NEUROBI, V149, P325, DOI 10.1016/j.resp.2005.05.004; HOLM H, 1992, PSYCHOPHARMACOLOGY, V108, P507, DOI 10.1007/BF02247429; Huber JC, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-34; Kallen K, 1997, CLEFT PALATE-CRAN J, V34, P11, DOI 10.1597/1545-1569_1997_034_0011_msaoc_2.3.co_2; Kang P, 2003, Orthod Craniofac Res, V6, P129, DOI 10.1034/j.1600-0544.2003.02236.x; KHOURY MJ, 1987, AM J PUBLIC HEALTH, V77, P623, DOI 10.2105/AJPH.77.5.623; KHOURY MJ, 1989, AM J DIS CHILD, V143, P333, DOI 10.1001/archpedi.1989.02150150091023; Lambe M, 2007, LANCET, V370, P1206, DOI 10.1016/S0140-6736(07)61531-1; Lammer EJ, 2005, EPIDEMIOLOGY, V16, P698, DOI 10.1097/01.ede.0000172136.26733.4b; Lindmark G, 1991, Acta Obstet Gynecol Scand, V70, P105, DOI 10.3109/00016349109006190; Little J, 2004, B WORLD HEALTH ORGAN, V82, P213; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Meyer KA, 2004, EPIDEMIOLOGY, V15, P671, DOI 10.1097/01.ede.0000142148.51230.60; Morales-Suarez-Varela MM, 2006, OBSTET GYNECOL, V107, P51, DOI 10.1097/01.AOG.0000194079.66834.d5; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Munger RG, 1996, TERATOLOGY, V54, P27, DOI 10.1002/(SICI)1096-9926(199607)54:1<27::AID-TERA4>3.0.CO;2-0; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Osterdahl BG, 2004, J AGR FOOD CHEM, V52, P5085, DOI 10.1021/jf049931a; Richter P, 2008, NICOTINE TOB RES, V10, P1645, DOI 10.1080/14622200802412937; Robert E, 1996, J CRAN GENET DEV BIO, V16, P234; Saad A Y, 1990, Biol Struct Morphog, V3, P31; Shaw GM, 1996, AM J HUM GENET, V58, P551; Shaw GM, 1999, J PEDIATR-US, V134, P298, DOI 10.1016/S0022-3476(99)70453-1; Slotkin TA, 1998, J PHARMACOL EXP THER, V285, P931; Stepanov I, 2012, TOB CONTROL, V21, P44, DOI 10.1136/tc.2010.042192; Wehby GL, 2010, ORAL DIS, V16, P11, DOI 10.1111/j.1601-0825.2009.01587.x; WERLER MM, 1990, AM J EPIDEMIOL, V132, P926, DOI 10.1093/oxfordjournals.aje.a115735; Wikstrom AK, 2010, BJOG-INT J OBSTET GY, V117, P1005, DOI 10.1111/j.1471-0528.2010.02575.x; Wikstrom AK, 2010, EPIDEMIOLOGY, V21, P772, DOI 10.1097/EDE.0b013e3181f20d7e; Wyszynski DF, 1997, CLEFT PALATE-CRAN J, V34, P206, DOI 10.1597/1545-1569(1997)034<0206:MCSAOC>2.3.CO;2; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zeiger JS, 2005, CLEFT PALATE-CRAN J, V42, P58, DOI 10.1597/02-128.1; Zhao ZY, 2005, BIRTH DEFECTS RES B, V74, P383, DOI 10.1002/bdrb.20052	50	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84715	10.1371/journal.pone.0084715	http://dx.doi.org/10.1371/journal.pone.0084715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454740	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100030
J	Lehmann, A; Schonwiesner, M				Lehmann, Alexandre; Schoenwiesner, Marc			Selective Attention Modulates Human Auditory Brainstem Responses: Relative Contributions of Frequency and Spatial Cues	PLOS ONE			English	Article							COCHLEAR NUCLEUS; SPEECH; CORTEX; OSCILLATIONS; PROJECTIONS; MECHANISMS; THALAMUS	Selective attention is the mechanism that allows focusing one's attention on a particular stimulus while filtering out a range of other stimuli, for instance, on a single conversation in a noisy room. Attending to one sound source rather than another changes activity in the human auditory cortex, but it is unclear whether attention to different acoustic features, such as voice pitch and speaker location, modulates subcortical activity. Studies using a dichotic listening paradigm indicated that auditory brainstem processing may be modulated by the direction of attention. We investigated whether endogenous selective attention to one of two speech signals affects amplitude and phase locking in auditory brainstem responses when the signals were either discriminable by frequency content alone, or by frequency content and spatial location. Frequency-following responses to the speech sounds were significantly modulated in both conditions. The modulation was specific to the task-relevant frequency band. The effect was stronger when both frequency and spatial information were available. Patterns of response were variable between participants, and were correlated with psychophysical discriminability of the stimuli, suggesting that the modulation was biologically relevant. Our results demonstrate that auditory brainstem responses are susceptible to efferent modulation related to behavioral goals. Furthermore they suggest that mechanisms of selective attention actively shape activity at early subcortical processing stages according to task relevance and based on frequency and spatial cues.	[Lehmann, Alexandre; Schoenwiesner, Marc] Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada; [Lehmann, Alexandre; Schoenwiesner, Marc] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Lehmann, Alexandre; Schoenwiesner, Marc] CRBLM, Montreal, PQ, Canada; [Schoenwiesner, Marc] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University	Schonwiesner, M (corresponding author), Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada.	marc.schoenwiesner@umontreal.ca		Schonwiesner, Marc/0000-0002-2023-1207	Natural Sciences and Engineering Research Council of Canada (NSERC) [365345]; Department of Foreign Affairs and International Trade Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Foreign Affairs and International Trade Canada	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserc-crsng.gc.ca) grant, #365345, to MS and a post-doctoral research grant from the Department of Foreign Affairs and International Trade Canada to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; Brandao ML, 2001, PHYSIOL BEHAV, V72, P365, DOI 10.1016/S0031-9384(00)00418-2; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chandrasekaran B, 2009, NEURON, V64, P311, DOI 10.1016/j.neuron.2009.10.006; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; CONNOLLY JF, 1989, PSYCHOPHYSIOLOGY, V26, P292, DOI 10.1111/j.1469-8986.1989.tb01920.x; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DIAMOND IT, 1969, BRAIN RES, V15, P305, DOI 10.1016/0006-8993(69)90160-7; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; GALBRAITH GC, 1995, INT J PSYCHOPHYSIOL, V19, P203, DOI 10.1016/0167-8760(95)00008-G; Galbraith GC, 1998, NEUROREPORT, V9, P1889, DOI 10.1097/00001756-199806010-00041; Galbraith GC, 2003, NEUROREPORT, V14, P735, DOI 10.1097/00001756-200304150-00015; GALBRAITH GC, 1993, BIOL PSYCHOL, V37, P3, DOI 10.1016/0301-0511(93)90024-3; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Hairston WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055215; HERNANDEZPEON R, 1956, SCIENCE, V123, P331, DOI 10.1126/science.123.3191.331; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533; Hood LJ, 1998, CLIN APPL AUDITORY B, V1st; Hugdahl K, 2003, ASYMMETRICAL BRAIN, P441; Kawahara H., 2001, P MAVEBA, P13; Krizman J, 2012, P NATL ACAD SCI USA, V109, P7877, DOI 10.1073/pnas.1201575109; Muller N, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.001.2009; Mulders WHAM, 2000, HEARING RES, V144, P65, DOI 10.1016/S0378-5955(00)00046-0; OATMAN LC, 1980, ELECTROEN CLIN NEURO, V49, P314, DOI 10.1016/0013-4694(80)90225-4; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; PICTON TW, 1971, SCIENCE, V173, P351, DOI 10.1126/science.173.3994.351; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rinne T, 2008, J NEUROPHYSIOL, V100, P3323, DOI 10.1152/jn.90607.2008; Skoe E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013645; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Strait DL, 2012, BRAIN LANG, V123, P191, DOI 10.1016/j.bandl.2012.09.001; Tzounopoulos T, 2009, NEURON, V62, P463, DOI 10.1016/j.neuron.2009.05.002; Varela Francisco J., 1993, INSCRIPTION CORPOREL, V1st; VILLA AEP, 1991, EXP BRAIN RES, V86, P506, DOI 10.1007/BF00230524; Weedman DL, 1996, J COMP NEUROL, V371, P311; Winer JA, 1998, J COMP NEUROL, V400, P147; Woldorff M, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P146; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; WOLDORFF MG, 1991, ELECTROEN CLIN NEURO, V79, P170, DOI 10.1016/0013-4694(91)90136-R; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Woods DL, 2001, J EXP PSYCHOL HUMAN, V27, P65, DOI 10.1037/0096-1523.27.1.65; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904	45	58	60	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85442	10.1371/journal.pone.0085442	http://dx.doi.org/10.1371/journal.pone.0085442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454869	gold, Green Submitted, Green Published			2022-12-25	WOS:000330235100087
J	Lopez-De-Andres, A; Jimenez-Garcia, R; Hernandez-Barrera, V; Jimenez-Trujillo, I; Gallardo-Pino, C; de Miguel, AG; Carrasco-Garrido, P				Lopez-de-Andres, Ana; Jimenez-Garcia, Rodrigo; Hernandez-Barrera, Valentin; Jimenez-Trujillo, Isabel; Gallardo-Pino, Carmen; Gil de Miguel, Angel; Carrasco-Garrido, Pilar			National Trends over One Decade in Hospitalization for Acute Myocardial Infarction among Spanish Adults with Type 2 Diabetes: Cumulative Incidence, Outcomes and Use of Percutaneous Coronary Intervention	PLOS ONE			English	Article							SEX DISPARITIES; RISK-FACTORS; FOLLOW-UP; MORTALITY; MELLITUS; DISEASE; PEOPLE; WOMEN; HEART; SURVIVAL	Background: This study aims to describe trends in the rate of acute myocardial infarction (AMI) and use of percutaneous coronary interventions (PCI) in patients with and without type 2 diabetes in Spain, 2001-2010. Methods: We selected all patients with a discharge of AMI using national hospital discharge data. Discharges were grouped by diabetes status: type 2 diabetes and no diabetes. In both groups PCIs were identified. The cumulative incidence of discharges attributed to AMI were calculated overall and stratified by diabetes status and year. We calculated length of stay and in-hospital mortality (IHM). Use of PCI was calculated stratified by diabetes status. Multivariate analysis was adjusted by age, sex, year and comorbidity. Results: From 2001 to 2010, 513,517 discharges with AMI were identified (30.3% with type 2 diabetes). The cumulative incidence of discharges due to AMI in diabetics patients increased (56.3 in 2001 to 71 cases per 100,000 in 2004), then decreased to 61.9 in 2010. Diabetic patients had significantly higher IHM (OR, 1.14; 95% CI, 1.05-1.17). The proportion of diabetic patients that underwent PCI increased from 11.9% in 2001 to 41.6% in 2010. Adjusted incidence of discharge in patients with diabetes who underwent PCI increased significantly (IRR, 3.49; 95% CI, 3.30-3.69). The IHM among diabetics patients who underwent a PCI did not change significantly over time. Conclusions: AMI hospitalization rates increased initially but declining slowly. From 2001 to 2010 the proportion of diabetic patients who undergo a PCI increased almost four-fold. Older age and more comorbidity may explain why IHM did not improve after a PCI.	[Lopez-de-Andres, Ana; Jimenez-Garcia, Rodrigo; Hernandez-Barrera, Valentin; Jimenez-Trujillo, Isabel; Gallardo-Pino, Carmen; Gil de Miguel, Angel; Carrasco-Garrido, Pilar] Rey Juan Carlos Univ, Prevent Med & Publ Hlth Dept, Madrid, Spain	Universidad Rey Juan Carlos	Lopez-De-Andres, A (corresponding author), Rey Juan Carlos Univ, Prevent Med & Publ Hlth Dept, Madrid, Spain.	ana.lopez@urjc.es	Jimenez-Garcia, Rodrigo/D-4953-2019; Jimenez-Trujillo, Isabel/AAP-7746-2021; Lopez-de-Andres, Ana/D-4498-2019; Lopez-de-Andres, Ana/AAD-8703-2019	Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Jimenez-Trujillo, Isabel/0000-0002-9394-6799; Lopez-de-Andres, Ana/0000-0001-5551-5181; Lopez-de-Andres, Ana/0000-0001-5551-5181; Hernandez-Barrera, Valentin/0000-0001-5790-1959; GIL DE MIGUEL, ANGEL/0000-0003-1295-7101	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III) [PI10/00360]	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III)	This study forms part of research funded by the FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, grant no. PI10/00360, Instituto de Salud Carlos III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2010, REV ENDOCR METAB DIS, V11, P75, DOI 10.1007/s11154-010-9135-3; Blondal M, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-96; Booth GL, 2006, DIABETES CARE, V29, P32, DOI 10.2337/diacare.29.1.32; Bottle A, 2009, DIABETOLOGIA, V52, P74, DOI 10.1007/s00125-008-1170-1; Champney KP, 2007, AM HEART J, V153, P970, DOI 10.1016/j.ahj.2007.03.036; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Degano IR, 2013, REV ESP CARDIOL, V66, P472, DOI [10.1016/j.recesp.2013.01.019, 10.1016/j.rec.2013.01.018]; Ferrara A, 2008, DIABETES CARE, V31, P69, DOI 10.2337/dc07-1244; Flaherty JD, 2005, JAMA-J AM MED ASSOC, V293, P1501, DOI 10.1001/jama.293.12.1501; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gore MO, 2012, CIRC-CARDIOVASC QUAL, V5, P791, DOI 10.1161/CIRCOUTCOMES.112.965491; Gouni-Berthold I, 2008, DIABETES CARE, V31, P1389, DOI 10.2337/dc08-0194; Hirakawa Y, 2007, DIABETES RES CLIN PR, V75, P59, DOI 10.1016/j.diabres.2006.04.011; Instituto Nacional de Estadistica (INE), 2010, POP EST; Instituto Nacional de Gestion Sanitaria Ministerio de Sanidad y Consumo, 2001, CONJ MIN BAS DAT; Trujillo IJ, 2010, DIABETES METAB, V36, P29, DOI 10.1016/j.diabet.2009.06.007; Jimenez-Garcia R, 2009, J DIABETES COMPLICAT, V23, P394, DOI 10.1016/j.jdiacomp.2008.06.002; Leong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075256; Lopez-de-Andres A, 2013, DIABETES RES CLIN PR, V99, P300, DOI 10.1016/j.diabres.2012.12.011; Lopez-de-Andres A, 2011, DIABETES CARE, V34, P1570, DOI 10.2337/dc11-0077; Luscher TF, 2003, CIRCULATION, V108, P1655, DOI 10.1161/01.CIR.0000089189.70578.E2; Maier B, 2006, J INVEST MED, V54, P143, DOI 10.2310/6650.2006.05056; Ministry of Health Social Services and Equality, CONJ MIN BAS DAT; Norhammar A, 2008, HEART, V94, P1565, DOI 10.1136/hrt.2007.135038; Ouhoummane N, 2010, CAN J CARDIOL, V26, P523, DOI 10.1016/S0828-282X(10)70465-7; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Rana JS, 2010, DIABETES CARE, V33, P1976, DOI 10.2337/dc10-0247; Ribera A, 2008, REV ESP CARDIOL, V61, P843, DOI 10.1016/S1885-5857(08)60232-7; Roche Madonna M, 2013, Diabetes Care, V36, P2582, DOI 10.2337/dc12-1272; Ruiz-Ramos Miguel, 2006, Gac Sanit, V20 Suppl 1, P15, DOI 10.1157/13086022; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Singh M, 2013, MAYO CLIN PROC, V88, P22, DOI 10.1016/j.mayocp.2012.09.014; Svensson AM, 2007, INT J CARDIOL, V119, P319, DOI 10.1016/j.ijcard.2006.07.156; Thomsen Reimar Wernich, 2012, Clin Epidemiol, V4, P43, DOI 10.2147/CLEP.S30083; Vaccaro O, 2004, ARCH INTERN MED, V164, P1438, DOI 10.1001/archinte.164.13.1438; Vamos EP, 2012, DIABETES CARE, V35, P265, DOI 10.2337/dc11-1682; Whiteley L, 2005, DIABETES CARE, V28, P1588, DOI 10.2337/diacare.28.7.1588	37	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85697	10.1371/journal.pone.0085697	http://dx.doi.org/10.1371/journal.pone.0085697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454920	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100122
J	Richards, ZT; Hobbs, JPA				Richards, Zoe T.; Hobbs, Jean-Paul A.			Predicting Coral Species Richness: The Effect of Input Variables, Diversity and Scale	PLOS ONE			English	Article							HIGHER-TAXON RICHNESS; FUNCTIONAL REDUNDANCY; CLIMATE-CHANGE; BIODIVERSITY; SURROGATE; REEF; DECLINE; IMPACT; RESILIENCE; PATTERNS	Coral reefs are facing a biodiversity crisis due to increasing human impacts, consequently, one third of reef-building corals have an elevated risk of extinction. Logistic challenges prevent broad-scale species-level monitoring of hard corals; hence it has become critical that effective proxy indicators of species richness are established. This study tests how accurately three potential proxy indicators (generic richness on belt transects, generic richness on point-intercept transects and percent live hard coral cover on point-intercept transects) predict coral species richness at three different locations and two analytical scales. Generic richness (measured on a belt transect) was found to be the most effective predictor variable, with significant positive linear relationships across locations and scales. Percent live hard coral cover consistently performed poorly as an indicator of coral species richness. This study advances the practical framework for optimizing coral reef monitoring programs and empirically demonstrates that generic richness offers an effective way to predict coral species richness with a moderate level of precision. While the accuracy of species richness estimates will decrease in communities dominated by species-rich genera (e.g. Acropora), generic richness provides a useful measure of phylogenetic diversity and incorporating this metric into monitoring programs will increase the likelihood that changes in coral species diversity can be detected.	[Richards, Zoe T.] Western Australian Museum, Dept Aquat Zool, Welshpool, WA, Australia; [Hobbs, Jean-Paul A.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Hobbs, Jean-Paul A.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia	Western Australian Museum; University of Western Australia; University of Western Australia	Richards, ZT (corresponding author), Western Australian Museum, Dept Aquat Zool, Welshpool, WA, Australia.	zoe.richards@museum.wa.gov.au	Hobbs, Jean-Paul/I-8743-2012	Hobbs, Jean-Paul/0000-0003-0331-354X	Australian Museum Foundation; NOAA; Australian Department of Environment, Arts and Heritage	Australian Museum Foundation; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Australian Department of Environment, Arts and Heritage(Australian Government)	Funding was provided by the Australian Museum Foundation (http://australianmuseum.net.au/The-Australian-Museum-Foundation); The NOAA coral reef conservation programme (http://coastalmanagement.noaa.gov/programs/coral.html); and by the Australian Department of Environment, Arts and Heritage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Araujo MB, 2001, ECOGRAPHY, V24, P103, DOI 10.1034/j.1600-0587.2001.240112.x; Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Balmford A, 1996, P ROY SOC B-BIOL SCI, V263, P1571, DOI 10.1098/rspb.1996.0230; Balmford A, 1996, P ROY SOC B-BIOL SCI, V263, P1267, DOI 10.1098/rspb.1996.0186; Balmford A, 2000, BIOL CONSERV, V93, P209, DOI 10.1016/S0006-3207(99)00140-8; Balmford A, 2005, PHILOS T ROY SOC B, V360, P221, DOI 10.1098/rstb.2004.1599; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Bracken MES, 2012, ECOL LETT, V15, P461, DOI 10.1111/j.1461-0248.2012.01758.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Eakin CM, 2010, OCEANOGRAPHY, V23, P118, DOI 10.5670/oceanog.2010.10; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Favreau JM, 2006, BIODIVERS CONSERV, V15, P3949, DOI 10.1007/s10531-005-2631-1; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hendriks IE, 2006, SCIENCE, V312, P1715, DOI 10.1126/science.1128548; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUMPHRIES CJ, 1995, ANNU REV ECOL SYST, V26, P93, DOI 10.1146/annurev.es.26.110195.000521; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Knowlton Nancy, 2010, P65, DOI 10.1002/9781444325508.ch4; Lewandowski AS, 2010, CONSERV BIOL, V24, P1367, DOI 10.1111/j.1523-1739.2010.01513.x; Lovell S, 2007, BIOL CONSERV, V139, P113, DOI 10.1016/j.biocon.2007.06.008; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Magierowski RH, 2006, ECOL APPL, V16, P2264, DOI 10.1890/1051-0761(2006)016[2264:ROSOBI]2.0.CO;2; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Niemela J, 2000, ANN ZOOL FENN, V37, P307; Pressey RL, 2004, CONSERV BIOL, V18, P1677, DOI 10.1111/j.1523-1739.2004.00434.x; R Core Team, 2021, R LANG ENV STAT COMP; Richards ZT, 2013, DIVERS DISTRIB, V19, P884, DOI 10.1111/ddi.12032; Richards ZT, 2013, CORAL REEFS, V32, P287, DOI 10.1007/s00338-012-0963-3; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Roy K, 1996, PHILOS T R SOC B, V351, P1605, DOI 10.1098/rstb.1996.0144; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Vanderklift MA, 1998, BIOL CONSERV, V86, P307, DOI 10.1016/S0006-3207(98)00036-6; Vellend M, 2008, J APPL ECOL, V45, P161, DOI 10.1111/j.1365-2664.2007.01413.x; Veron JEN, 1995, CORALS SPACE TIME BI, p[48, 156]; Villasenor JL, 2005, CONSERV BIOL, V19, P232, DOI 10.1111/j.1523-1739.2005.00264.x; Wilkinson C., 2004, STATUS CORAL REEFS W; WILLIAMS PH, 1994, BIOL CONSERV, V67, P211, DOI 10.1016/0006-3207(94)90612-2	60	12	12	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83965	10.1371/journal.pone.0083965	http://dx.doi.org/10.1371/journal.pone.0083965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454712	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100014
J	Wang, JZ; Garcia-Bailo, B; Nielsen, DE; El-Sohemy, A				Wang, Jingzhou; Garcia-Bailo, Bibiana; Nielsen, Daiva E.; El-Sohemy, Ahmed			ABO Genotype, 'Blood-Type' Diet and Cardiometabolic Risk Factors	PLOS ONE			English	Article							LOW-CARBOHYDRATE DIETS; LOW-FAT DIETS; FOOD-CONSUMPTION; CLINICAL-TRIALS; WEIGHT-LOSS; METAANALYSIS; PATTERNS; DISEASE; CANCER; ADULTS	Background: The 'Blood-Type' diet advises individuals to eat according to their ABO blood group to improve their health and decrease risk of chronic diseases such as cardiovascular disease. However, the association between blood type-based dietary patterns and health outcomes has not been examined. The objective of this study was to determine the association between 'blood-type' diets and biomarkers of cardiometabolic health and whether an individual's ABO genotype modifies any associations. Methods: Subjects (n = 1,455) were participants of the Toronto Nutrigenomics and Health study. Dietary intake was assessed using a one-month, 196-item food frequency questionnaire and a diet score was calculated to determine relative adherence to each of the four 'Blood-Type' diets. ABO blood group was determined by genotyping rs8176719 and rs8176746 in the ABO gene. ANCOVA, with age, sex, ethnicity, and energy intake as covariates, was used to compare cardiometabolic biomarkers across tertiles of each 'Blood-Type' diet score. Results: Adherence to the Type-A diet was associated with lower BMI, waist circumference, blood pressure, serum cholesterol, triglycerides, insulin, HOMA-IR and HOMA-Beta (P<0.05). Adherence to the Type-AB diet was also associated with lower levels of these biomarkers (P<0.05), except for BMI and waist circumference. Adherence to the Type-O diet was associated with lower triglycerides (P<0.0001). Matching the 'Blood-Type' diets with the corresponding blood group did not change the effect size of any of these associations. No significant association was found for the Type-B diet. Conclusions: Adherence to certain 'Blood-Type' diets is associated with favorable effects on some cardiometabolic risk factors, but these associations were independent of an individual's ABO genotype, so the findings do not support the 'Blood-Type' diet hypothesis.	[Wang, Jingzhou; Garcia-Bailo, Bibiana; Nielsen, Daiva E.; El-Sohemy, Ahmed] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada	University of Toronto	El-Sohemy, A (corresponding author), Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada.	a.el.sohemy@utoronto.ca	Nielsen, Daiva/AAT-5028-2020; Nielsen, Daiva/ACI-1414-2022	Nielsen, Daiva/0000-0002-4265-5748; Wang, Jingzhou/0000-0001-8142-2202; El-Sohemy, Ahmed/0000-0002-8877-6414	Advanced Foods and Materials Network [305352]; Ontario Graduate Scholarship	Advanced Foods and Materials Network; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by grant 305352 from the Advanced Foods and Materials Network (to AE-S). JW is a recipient of an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; Cahill L, 2009, AM J EPIDEMIOL, V170, P464, DOI 10.1093/aje/kwp156; Calafell F, 2008, HUM GENET, V124, P123, DOI 10.1007/s00439-008-0530-8; Craig WJ, 2009, AM J CLIN NUTR, V89, pS1627, DOI 10.3945/ajcn.2009.26736N; Cusack L, 2013, AM J CLIN NUTR, V98, P99, DOI 10.3945/ajcn.113.058693; D'Adamo P, 2012, EAT RIGHT YOUR TYPE; d'Adamo PJ, 1996, EAT RIGHT 4 YOUR TYP; Fung TT, 2004, STROKE, V35, P2014, DOI 10.1161/01.STR.0000135762.89154.92; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Garcia-Bailo B, 2012, AM J CLIN NUTR, V95, P352, DOI 10.3945/ajcn.111.022657; Gates MA, 2011, INT J CANCER, V128, P482, DOI 10.1002/ijc.25339; Ghazarian H, 2011, ACTA HISTOCHEM, V113, P236, DOI 10.1016/j.acthis.2010.02.004; GLASS RI, 1985, AM J EPIDEMIOL, V121, P791, DOI 10.1093/oxfordjournals.aje.a114050; Hu T, 2012, AM J EPIDEMIOL, V176, pS44, DOI 10.1093/aje/kws264; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Liese AD, 2011, CIRCULATION, V123, P1410, DOI 10.1161/CIRCULATIONAHA.110.955922; Mourant AE., 1976, DISTRIBUTION HUMAN B; NACHBAR MS, 1980, AM J CLIN NUTR, V33, P2338, DOI 10.1093/ajcn/33.11.2338; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Patterson E, 2013, J NUTR, V143, P74, DOI 10.3945/jn.112.166330; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Saitou N, 1997, MOL BIOL EVOL, V14, P399, DOI 10.1093/oxfordjournals.molbev.a025776; Santos FL, 2012, OBES REV, V13, P1048, DOI 10.1111/j.1467-789X.2012.01021.x; Steffen LM, 2005, AM J CLIN NUTR, V82, P1169, DOI 10.1093/ajcn/82.6.1169; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; van Dam RM, 2003, AM J CLIN NUTR, V77, P1156, DOI 10.1093/ajcn/77.5.1156; Wolpin BM, 2010, CANCER RES, V70, P1015, DOI 10.1158/0008-5472.CAN-09-2993; Wu O, 2008, J THROMB HAEMOST, V6, P62; Xie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011972; Yamamoto F, 2012, TRANSFUS MED REV, V26, P103, DOI 10.1016/j.tmrv.2011.08.002	34	14	14	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84749	10.1371/journal.pone.0084749	http://dx.doi.org/10.1371/journal.pone.0084749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454746	Green Submitted, gold, Green Published			2022-12-25	WOS:000330235100033
J	Zhu, X; Yuan, M; Shakeel, M; Zhang, YJ; Wang, SL; Wang, X; Zhan, S; Kang, TH; Li, JH				Zhu, Xun; Yuan, Miao; Shakeel, Muhammad; Zhang, Youjun; Wang, Shaoli; Wang, Xin; Zhan, Sha; Kang, Tinghao; Li, Jianhong			Selection and Evaluation of Reference Genes for Expression Analysis Using qRT-PCR in the Beet Armyworm Spodoptera exigua (Hubner) (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							TIME RT-PCR; MESSENGER-RNA LEVELS; REAL-TIME; QUANTITATIVE PCR; DROSOPHILA-MELANOGASTER; HOUSEKEEPING GENES; BETA-ACTIN; INTERNAL CONTROL; VALIDATION; PROTEIN	Quantitative real-time PCR (qRT-PCR) is a reliable and reproducible technique for measuring and evaluating changes in gene expression. The most common method for analyzing qRT-PCR data is to normalize mRNA levels of target genes to internal reference genes. Evaluating and selecting stable reference genes on a case-by-case basis is critical. The present study aimed to facilitate gene expression studies by identifying the most suitable reference genes for normalization of mRNA expression in qRT-PCR analysis of the beet armyworm Spodoptera exigua (Lepidoptera: Noctuidae). For this purpose, three software tools (geNorm, NormFinder and BestKeeper) were used to investigate 10 candidate reference genes in nine developmental stages and five different tissues (epidermis, head, midgut, fat body and hemolymph) in three larval physiological stages (molting, feeding and wandering stages) of, S. exigua. With the exception of 18S ribosomal RNA (18S), all other candidate genes evaluated, beta-actin1(ACT1), beta-actin2 (ACT2), elongation factor1(EF1), elongation factor 2 (EF2), Glyceralde hyde-3-phosphate dehydrogenase (GAPDH), ribosomal protein L10 (L10), ribosomal protein L17A (L17A), superoxide dismutase (SOD), alpha-tubulin (TUB), proved to be acceptable reference genes. However, their suitability partly differed between physiological stages and different tissues. L10, EF2 and L17A ranked highest in all tissue sample sets. SOD, ACT2, GAPDH, EF1 and ACT1 were stably expressed in all developmental stage sample sets; ACT2, ACT1 and L10 for larvae sample sets; GAPDH, ACT1 and ACT2 for pupae and adults; SOD and L17A for males; and EF2 and SOD for females. The expression stability of genes varied in different conditions. The findings provided here demonstrated, with a few exceptions, the suitability of most of the 10 reference genes tested in tissues and life developmental stages. Overall, this study emphasizes the importance of validating reference genes for qRT-PCR analysis in S. exigua.	[Zhu, Xun; Yuan, Miao; Shakeel, Muhammad; Wang, Xin; Zhan, Sha; Kang, Tinghao; Li, Jianhong] Huazhong Agr Univ, Coll Plant Sci & Technol, Lab Pesticide, Wuhan, Peoples R China; [Zhu, Xun; Zhang, Youjun; Wang, Shaoli] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Li, JH (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Lab Pesticide, Wuhan, Peoples R China.	jianhl@mail.hzau.edu.cn	Zhang, Youjun/AAY-7948-2020; Shakeel, Muhammad/B-5096-2019	Zhang, Youjun/0000-0003-3508-6695; Shakeel, Muhammad/0000-0002-8515-0053	National Natural Science Foundation of China [31201544]; Hubei Province Science & Technology Department of China [2011BFA018]; Beijing Natural Science Foundation of China [6102021]; Independent Innovation Foundation of Huazhong Agricultural University [2011PY123]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province Science & Technology Department of China; Beijing Natural Science Foundation of China(Beijing Natural Science Foundation); Independent Innovation Foundation of Huazhong Agricultural University	This research was supported by the National Natural Science Foundation of China (No. 31201544), Hubei Province Science & Technology Department of China (No. 2011BFA018), Beijing Natural Science Foundation of China (6102021), and Independent Innovation Foundation of Huazhong Agricultural University (No. 2011PY123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arbeitman MN, 2004, DEVELOPMENT, V131, P2007, DOI 10.1242/dev.01077; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Carmo ACV, 2012, ANTIVIR RES, V94, P126, DOI 10.1016/j.antiviral.2011.12.010; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Choi JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042462; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; de Boer ME, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-54; Deng JY, 2004, J CHEM ECOL, V30, P2037, DOI 10.1023/B:JOEC.0000045593.62422.73; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fernandez AP, 2004, DEV BIOL, V276, P352, DOI 10.1016/j.ydbio.2004.08.040; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Frost P, 2003, VET PARASITOL, V118, P169, DOI 10.1016/j.vetpar.2003.09.020; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hernandez CS, 2005, APPL ENVIRON MICROB, V71, P5627, DOI 10.1128/AEM.71.9.5627-5629.2005; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jiang Xinfu, 1999, Acta Entomologica Sinica, V42, P270; Lee S, 2011, J INSECT PHYSIOL, V57, P356, DOI 10.1016/j.jinsphys.2010.12.003; Li AQ, 2009, BBA-PROTEINS PROTEOM, V1794, P663, DOI 10.1016/j.bbapap.2008.11.025; Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762; Majerowicz D, 2011, INSECT MOL BIOL, V20, P713, DOI 10.1111/j.1365-2583.2011.01101.x; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Maroniche GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-308; McGraw LA, 2004, CURR BIOL, V14, P1509, DOI 10.1016/j.cub.2004.08.028; Mosallanejad H, 2008, ARCH INSECT BIOCHEM, V67, P36, DOI 10.1002/arch.20220; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Provenano M, 2007, ADV EXP MED BIOL, V593, P66; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rocha CS, 2008, VIROLOGY, V380, P165, DOI 10.1016/j.virol.2008.08.005; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Smagghe G, 2003, PEST MANAG SCI, V59, P1203, DOI 10.1002/ps.756; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; Spanier KI, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-50; Swevers L, 2008, INSECT BIOCHEM MOLEC, V38, P825, DOI 10.1016/j.ibmb.2008.06.001; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Zhang C, 2010, J INSECT PHYSIOL, V56, P788, DOI 10.1016/j.jinsphys.2010.02.001; Zhang DW, 2012, ARCH INSECT BIOCHEM, V79, P220, DOI 10.1002/arch.21018	58	108	113	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84730	10.1371/journal.pone.0084730	http://dx.doi.org/10.1371/journal.pone.0084730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454743	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100031
J	Njomo, DW; Mukoko, DA; Nyamongo, NK; Karanja, J				Njomo, Doris W.; Mukoko, Dunstan A.; Nyamongo, Nipher K.; Karanja, Joan			Increasing Coverage in Mass Drug Administration for Lymphatic Filariasis Elimination in an Urban Setting: a Study of Malindi Town, Kenya	PLOS ONE			English	Article							DIETHYLCARBAMAZINE; PROGRAM; ALBENDAZOLE; IVERMECTIN; INFECTION; INDIA	Introduction: Implementation of Mass Drug Administration (MDA) in urban settings is an obstacle to Lymphatic Filariasis (LF) elimination. No urban-specific guidelines on MDA in urban areas exist. Malindi district urban area had received 4 MDA rounds by the time the current study was implemented. Programme data showed average treatment coverage of 28.4% (2011 MDA), far below recommended minimum of 65-80%. Methods: To identify, design and test strategies for increased treatment coverage in urban areas, a quasi-experimental study was conducted in Malindi urban area. Three sub-locations with lowest treatment coverage in 2011 MDA were purposively selected. In the pre-test phase, 947 household heads sampled using systematic random method were interviewed for quantitative data. For qualitative data, 12 Focus Group Discussions (FGDs) with single sex adult and youth male and female groups and 3 with community drug distributors (CDDs) were conducted. Forty in-depth interviews with opinion leaders and self-administered questionnaires with District Public Health officers purposively selected were carried out. The quantitative data were analyzed using SPSS version 16 and statistical significance assessed by x(2) test. The qualitative data were analyzed manually according to study's themes. Results and Discussion: The identified strategies were implemented prior to and during 2012 MDA in two sub-locations (experimental) while in the third (control), usual MDA strategies were applied. In the post-test phase, 2012 MDA coverage in experimental and control sub-locations was comparatively assessed for effect of the newly designed strategies on urban MDA. Results indicated improved treatment coverage in experimental sub-locations, 77.1% in Shella and 66.0% in Barani. Central (control) sub-location also attained high coverage, 70.4% indicating average treatment coverage of 71%. Conclusion: The identified strategies contributed to increased treatment coverage in experimental sites and should be applied in urban areas. Due to closeness of sites, spillover effects may have contributed to increased coverage in the control site.	[Njomo, Doris W.; Nyamongo, Nipher K.] Kenya Med Res Inst KEMRI, Eastern & Southern Africa Ctr Int Parasite Contro, Nairobi, Kenya; [Mukoko, Dunstan A.] Minist Hlth, Div Vector Borne & Neglected Trop Dis, Nairobi, Kenya; [Karanja, Joan] Minist Hlth, Malindi Dist Hosp, Malindi, Kenya	Kenya Medical Research Institute	Njomo, DW (corresponding author), Kenya Med Res Inst KEMRI, Eastern & Southern Africa Ctr Int Parasite Contro, Nairobi, Kenya.	dnjomo@kemri.org		Karanja, Mary Joan/0000-0001-9521-5773	Neglected Tropical Diseases (NTDs) Support Centre at the Task Force for Global Health (Atlanta, GA, USA); Bill & Melinda Gates Foundation [OPP43922]	Neglected Tropical Diseases (NTDs) Support Centre at the Task Force for Global Health (Atlanta, GA, USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study received support from the Neglected Tropical Diseases (NTDs) Support Centre at the Task Force for Global Health (Atlanta, GA, USA) with funding from the Bill & Melinda Gates Foundation grant #: OPP43922. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarillo MLE, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-14; [Anonymous], 1993, MMWR Recomm Rep, V42, P1; [Anonymous], 2004, Wkly Epidemiol Rec, V79, P417; [Anonymous], 2009, KEN POP HOUS CENS HI, P1; Aswathy S, 2009, ANN TROP MED PARASIT, V103, P617, DOI 10.1179/000349809X12459740922255; Babu B, 2004, TROP MED INT HEALTH, V9, P702, DOI 10.1111/j.1365-3156.2004.01247.x; Bockarie MJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1686; Carter A., 2010, FACTORS CONTRIBUTE L; Ichimori K, 2011, BOL MED HOSP INFANT, V68, P146; Ismail MM, 1998, T ROY SOC TROP MED H, V92, P94, DOI 10.1016/S0035-9203(98)90972-5; KHAN M E, 1991, World Health Statistics Quarterly, V44, P145; Kyelem D, 2008, AM J TROP MED HYG, V79, P480; Lammie P, 2007, B WORLD HEALTH ORGAN, V85, P545, DOI 10.2471/BLT.06.034108; Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646; MOULIAPELAT JP, 1995, TROP MED PARASITOL, V46, P9; Muralidhar MK, 2013, J PUB HLTH MED RES, V1, P1; Nandha B, 2007, Filaria J, V6, P7, DOI 10.1186/1475-2883-6-7; Njenga SM, 2008, T ROY SOC TROP MED H, V102, P1017, DOI 10.1016/j.trstmh.2008.04.039; Njomo D. W., 2012, Southern African Journal of Epidemiology & Infection, V27, P66; Njomo DW, 2012, ANN TROP MED PUBLIC, V5, P103, DOI 10.4103/1755-6783.95962; Njomo DW, 2012, AFRICAN J HLTH SCI, V20, P42; Ottesen EA, 2000, TROP MED INT HEALTH, V5, P591, DOI 10.1046/j.1365-3156.2000.00620.x; OTTESEN EA, 1995, PARASITOL TODAY, V11, P129, DOI 10.1016/0169-4758(95)80128-6; Plaisier AP, 1998, METHOD INFORM MED, V37, P97; Ranganath Ts, 2012, Indian J Community Med, V37, P219, DOI 10.4103/0970-0218.103468; Stolk WA, 2003, J INFECT DIS, V188, P1371, DOI 10.1086/378354; WEERASOORIYA MV, 2007, FILARIA J, V6, P6; WHO, 2000, OP GUID RAP MAPP BAN; World Health Organization, 2008, Weekly Epidemiological Record, V83, P333; World Health Organization, 2004, TRAIN MOD DRUG DISTR; Yirga D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-48	31	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e83413	10.1371/journal.pone.0083413	http://dx.doi.org/10.1371/journal.pone.0083413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454703	gold, Green Published, Green Submitted			2022-12-25	WOS:000329925800008
J	Pan, H; Shen, KZ; Wang, XP; Meng, HZ; Wang, CJ; Jin, BY				Pan, Hao; Shen, Kezhen; Wang, Xueping; Meng, Hongzhou; Wang, Chaojun; Jin, Baiye			Protective Effect of Metalloporphyrins against Cisplatin-Induced Kidney Injury in Mice	PLOS ONE			English	Article							PEROXYNITRITE DECOMPOSITION CATALYST; MANGANESE-SUPEROXIDE-DISMUTASE; NRF2/HO-1 SIGNALING PATHWAY; INDUCED RENAL INJURY; NITRIC-OXIDE; INDUCED NEPHROTOXICITY; IN-VIVO; HEME OXYGENASE-1; OXIDATIVE/NITROSATIVE STRESS; NITROSATIVE STRESS	Oxidative and nitrative stress is a well-known phenomenon in cisplatin-induced nephrotoxicity. The purpose of this work is to study the role of two metalloporphyrins (FeTMPyP and MnTBAP), water soluble complexes, in cisplatin-induced renal damage and their ability to scavenge peroxynitrite. In cisplatin-induced nephropathy study in mice, renal nitrative stress was evident by the increase in protein nitration. Cisplatin-induced nephrotoxicity was also evident by the histological damage from the loss of the proximal tubular brush border, blebbing of apical membranes, tubular epithelial cell detachment from the basement membrane, or intra-luminal aggregation of cells and proteins and by the increase in blood urea nitrogen and serum creatinine. Cisplatin-induced apoptosis and cell death as shown by Caspase 3 assessments, TUNEL staining and DNA fragmentation Cisplatin-induced nitrative stress, apoptosis and nephrotoxicity were attenuated by both metalloporphyrins. Heme oxygenase (HO-1) also plays a critical role in metalloporphyrin-mediated protection of cisplatin-induced nephrotoxicity. It is evident that nitrative stress plays a critical role in cisplatin-induced nephrotoxicity in mice. Our data suggest that peroxynitrite is involved, at least in part, in cisplatin-induced nephrotoxicity and protein nitration and cisplatin-induced nephrotoxicity can be prevented with the use of metalloporphyrins.	[Pan, Hao; Wang, Xueping; Meng, Hongzhou; Wang, Chaojun; Jin, Baiye] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China; [Shen, Kezhen] Minist Publ Hlth, Key Lab Combined Multiorgan Transplantat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Jin, BY (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China.	jinbaiye1964@aliyun.com		Pan, Hao/0000-0001-9925-0752	National Natural Science Foundation of China [81000302]; Science and Technology Department of Zhejiang Province [2013C37053, 2009C14015]; Zhejiang medical and health science and technology plan project [2012RCA022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Zhejiang Province; Zhejiang medical and health science and technology plan project	This work was supported by grants from the National Natural Science Foundation of China (no. 81000302), the Science and Technology Department of Zhejiang Province (no. 2013C37053, 2009C14015), and the Zhejiang medical and health science and technology plan project(2012RCA022. The funders had no role in study design, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2010, J PHARMACOL EXP THER, V335, P2, DOI 10.1124/jpet.110.170084; APPLEGATE LA, 1991, CANCER RES, V51, P974; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Aulak KS, 2001, P NATL ACAD SCI USA, V98, P12056, DOI 10.1073/pnas.221269198; Baliga R, 1998, KIDNEY INT, V53, P394, DOI 10.1046/j.1523-1755.1998.00767.x; Batinic-Haberle I, 2009, FREE RADICAL BIO MED, V46, P192, DOI 10.1016/j.freeradbiomed.2008.09.042; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BOOGAARD PJ, 1990, CONTRIB NEPHROL, V83, P208; Broeders N, 2002, KIDNEY INT, V61, P354, DOI 10.1046/j.1523-1755.2002.00129.x; Brozovic A, 2010, CRIT REV TOXICOL, V40, P347, DOI 10.3109/10408441003601836; Cassina AM, 2000, J BIOL CHEM, V275, P21409, DOI 10.1074/jbc.M909978199; Chirino YI, 2008, TOXICOLOGY, V245, P18, DOI 10.1016/j.tox.2007.12.007; Chirino Yolanda I., 2004, BMC Pharmacology, V4, P20, DOI 10.1186/1471-2210-4-20; Choi BM, 2008, J MED FOOD, V11, P230, DOI 10.1089/jmf.2007.591; Crow J P, 1995, Curr Top Microbiol Immunol, V196, P57; Davis CA, 2001, J AM SOC NEPHROL, V12, P2683, DOI 10.1681/ASN.V12122683; Dhar A, 2006, PHARMACOL RES, V54, P311, DOI 10.1016/j.phrs.2006.06.009; Dillioglugil MO, 2005, UROL INT, V75, P340, DOI 10.1159/000089171; Domitrovic R, 2013, TOXICOLOGY; Domitrovic R, 2013, FOOD CHEM TOXICOL, V62, P397, DOI 10.1016/j.fct.2013.09.003; Guerrero-Beltran CE, 2012, J NUTR BIOCHEM, V23, P494, DOI 10.1016/j.jnutbio.2011.02.004; Estevez AG, 1998, J NEUROSCI, V18, P923; Fram Robert J., 1992, Current Opinion in Oncology, V4, P1073, DOI 10.1097/00001622-199212000-00012; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hartmann JT, 2003, EXPERT OPIN PHARMACO, V4, P889, DOI 10.1517/14656566.4.6.889; Hortelano S, 1999, FASEB J, V13, P2311, DOI 10.1096/fasebj.13.15.2311; Kadikoylu G, 2004, HUM EXP TOXICOL, V23, P29, DOI 10.1191/0960327104ht413oa; Kang JHL, 2001, J TOXICOL ENV HEAL A, V64, P291, DOI 10.1080/152873901316981295; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kim MG, 2010, J KOREAN MED SCI, V25, P557, DOI 10.3346/jkms.2010.25.4.557; Kumar P, 2013, ENVIRON TOXICOL PHAR, V36, P883, DOI 10.1016/j.etap.2013.08.004; Lee S, 2006, NEPHROL DIAL TRANSPL, V21, P2096, DOI 10.1093/ndt/gfl194; Levrand S, 2006, FREE RADICAL BIO MED, V41, P886, DOI 10.1016/j.freeradbiomed.2006.04.034; Li PKT, 2013, NAT REV NEPHROL, V9, P133, DOI 10.1038/nrneph.2013.20; Liaudet L, 2013, CURR VASC PHARMACOL, V11, P196; Liu DX, 2005, J NEUROTRAUM, V22, P1123, DOI 10.1089/neu.2005.22.1123; Loukili N, 2011, CARDIOVASC RES, V89, P586, DOI 10.1093/cvr/cvq373; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Mukhopadhyay P, 2011, FREE RADICAL BIO MED, V51, P1774, DOI 10.1016/j.freeradbiomed.2011.08.006; Mukhopadhyay P, 2010, BRIT J PHARMACOL, V160, P657, DOI 10.1111/j.1476-5381.2010.00769.x; Mukhopadhyay P, 2010, FREE RADICAL BIO MED, V48, P457, DOI 10.1016/j.freeradbiomed.2009.11.022; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Nangle MR, 2004, EUR J PHARMACOL, V502, P143, DOI 10.1016/j.ejphar.2004.08.033; Ozkaya O, 2010, RENAL FAILURE, V32, P368, DOI 10.3109/08860221003611729; Pacher P, 2006, CURR OPIN PHARMACOL, V6, P136, DOI 10.1016/j.coph.2006.01.001; Pacher P, 2005, TRENDS PHARMACOL SCI, V26, P302, DOI 10.1016/j.tips.2005.04.003; Pacher P, 2005, CURR MED CHEM, V12, P267, DOI 10.2174/0929867053363207; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pan H, 2009, J PHARMACOL EXP THER, V328, P708, DOI 10.1124/jpet.108.147181; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; RADI R, 1991, J BIOL CHEM, V266, P4244; Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Saba H, 2007, FREE RADICAL BIO MED, V42, P1571, DOI 10.1016/j.freeradbiomed.2007.02.016; Sahin K, 2010, FOOD CHEM TOXICOL, V48, P2670, DOI 10.1016/j.fct.2010.06.038; Sahin K, 2010, LIFE SCI, V87, P240, DOI 10.1016/j.lfs.2010.06.014; Salvemini D, 1999, BRIT J PHARMACOL, V127, P685, DOI 10.1038/sj.bjp.0702604; Shiraishi F, 2000, AM J PHYSIOL-RENAL, V278, pF726, DOI 10.1152/ajprenal.2000.278.5.F726; Srivastava RC, 1996, BIOMETALS, V9, P139; Szabo C, 1996, FEBS LETT, V381, P82, DOI 10.1016/0014-5793(96)00087-7; Trujillo M, 2002, ARCH BIOCHEM BIOPHYS, V397, P91, DOI 10.1006/abbi.2001.2619; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080; Zingarelli B, 1997, BRIT J PHARMACOL, V120, P259, DOI 10.1038/sj.bjp.0700872	65	36	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e86057	10.1371/journal.pone.0086057	http://dx.doi.org/10.1371/journal.pone.0086057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454954	Green Submitted, Green Published, gold			2022-12-25	WOS:000329925800055
J	Eckerle, I; Ehlen, L; Kallies, R; Wollny, R; Corman, VM; Cottontail, VM; Tschapka, M; Oppong, S; Drosten, C; Muller, MA				Eckerle, Isabella; Ehlen, Lukas; Kallies, Rene; Wollny, Robert; Corman, Victor M.; Cottontail, Veronika M.; Tschapka, Marco; Oppong, Samuel; Drosten, Christian; Mueller, Marcel A.			Bat Airway Epithelial Cells: A Novel Tool for the Study of Zoonotic Viruses	PLOS ONE			English	Article							SEROLOGICAL EVIDENCE; INFECTION; CORONAVIRUSES; RABIES; HANTAVIRUS; STRAINS; FAMILY; AGENT; HOSTS	Bats have been increasingly recognized as reservoir of important zoonotic viruses. However, until now many attempts to isolate bat-borne viruses in cell culture have been unsuccessful. Further, experimental studies on reservoir host species have been limited by the difficulty of rearing these species. The epithelium of the respiratory tract plays a central role during airborne transmission, as it is the first tissue encountered by viral particles. Although several cell lines from bats were established recently, no well-characterized, selectively cultured airway epithelial cells were available so far. Here, primary cells and immortalized cell lines from bats of the two important suborders Yangochiroptera and Yinpterochiroptera, Carollia perspicillata (Seba's short-tailed bat) and Eidolon helvum (Straw-colored fruit bat), were successfully cultured under standardized conditions from both fresh and frozen organ specimens by cell outgrowth of organ explants and by the use of serum-free primary cell culture medium. Cells were immortalized to generate permanent cell lines. Cells were characterized for their epithelial properties such as expression of cytokeratin and tight junctions proteins and permissiveness for viral infection with Rift-Valley fever virus and vesicular stomatitis virus Indiana. These cells can serve as suitable models for the study of bat-borne viruses and complement cell culture models for virus infection in human airway epithelial cells.	[Eckerle, Isabella; Ehlen, Lukas; Kallies, Rene; Wollny, Robert; Corman, Victor M.; Drosten, Christian; Mueller, Marcel A.] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Cottontail, Veronika M.; Tschapka, Marco] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Tschapka, Marco] Smithsonian Trop Res Inst, Balboa, Panama; [Oppong, Samuel] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana	University of Bonn; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute; Kwame Nkrumah University Science & Technology	Eckerle, I (corresponding author), Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany.	eckerle@virology-bonn.de	Müller, Marcel A./O-2425-2019; Corman, Victor M/K-1319-2019; Kallies, René/ACK-2998-2022	Müller, Marcel A./0000-0003-2242-5117; Corman, Victor M/0000-0002-3605-0136; Kallies, Rene/0000-0002-9195-0276; Eckerle, Isabella/0000-0002-4850-7172	German Research Foundation (DFG) [DR 772/3- 1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The study was supported by the German Research Foundation (DFG grant DR 772/3- 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-26; Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; Anthony SJ, 2013, J GEN VIROL, V94, P1028, DOI 10.1099/vir.0.049759-0; Baillie GJ, 2004, J VIROL, V78, P5784, DOI 10.1128/JVI.78.11.5784-5798.2004; Baker KS, 2013, VIROLOGY, V441, P95, DOI 10.1016/j.virol.2013.03.014; Baker KS, 2013, J VIROL, V87, P1348, DOI 10.1128/JVI.01202-12; Barr JA, 2012, J GEN VIROL, V93, P2590, DOI 10.1099/vir.0.045385-0; Biesold SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028131; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Canuti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029140; Carrington CVF, 2008, EMERG INFECT DIS, V14, P1890, DOI 10.3201/eid1412.080642; Corman VM, 2013, J GEN VIROL, V94, P1984, DOI 10.1099/vir.0.054841-0; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; de Almeida MF, 2011, REV SOC BRAS MED TRO, V44, P140, DOI 10.1590/S0037-86822011005000011; de Mattos CA, 2000, J WILDLIFE DIS, V36, P231, DOI 10.7589/0090-3558-36.2.231; de Thoisy B, 2009, VECTOR-BORNE ZOONOT, V9, P157, DOI 10.1089/vbz.2007.0280; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Escutenaire S, 2001, VIRUS RES, V74, P1, DOI 10.1016/S0168-1702(00)00224-0; Fagrouch Z, 2012, J GEN VIROL, V93, P2652, DOI 10.1099/vir.0.044149-0; Fernandez Z, 2003, J MED ENTOMOL, V40, P522, DOI 10.1603/0022-2585-40.4.522; Gonzalez J. P., 2008, HUMAN HLTH FORESTS G, P161; Goris K, 2009, J VIROL, V83, P1962, DOI 10.1128/JVI.01271-08; Hayman DTS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011978; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Heaton PR, 1997, J CLIN MICROBIOL, V35, P2762, DOI 10.1128/JCM.35.11.2762-2766.1997; Huynh J, 2012, J VIROL, V86, P12816, DOI 10.1128/JVI.00906-12; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; KEMP GE, 1988, B SOC PATHOL EXOT, V81, P40; KEMP GE, 1972, AM J TROP MED HYG, V21, P356, DOI 10.4269/ajtmh.1972.21.356; Kuhl A, 2011, J INFECT DIS, V204, pS840, DOI 10.1093/infdis/jir306; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; Peel AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030346; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; PRICE JL, 1978, AM J TROP MED HYG, V27, P162, DOI 10.4269/ajtmh.1978.27.162; PRICE JL, 1978, AM J TROP MED HYG, V27, P153, DOI 10.4269/ajtmh.1978.27.153; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Punyadarsaniya D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028429; Razafindratsimandresy R, 2009, J GEN VIROL, V90, P44, DOI 10.1099/vir.0.006825-0; Reusken CBEM, 2010, VECTOR-BORNE ZOONOT, V10, P785, DOI 10.1089/vbz.2009.0173; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; Stormer M, 2009, INT J MED MICROBIOL, V299, P291, DOI 10.1016/j.ijmm.2008.08.002; Sulkin S E, 1974, Monogr Virol, V8, P1; TESH RB, 1970, AM J EPIDEMIOL, V91, P216, DOI 10.1093/oxfordjournals.aje.a121130; Weiss S, 2012, EMERG INFECT DIS, V18, P159, DOI 10.3201/eid1801.111026; Wise J, 2002, CULTURE EPITHELIAL C, P391; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; You Yingjian, 2013, Methods Mol Biol, V945, P123, DOI 10.1007/978-1-62703-125-7_9; Zhang HJ, 2012, J VIROL, V86, P8014, DOI 10.1128/JVI.00723-12	58	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84679	10.1371/journal.pone.0084679	http://dx.doi.org/10.1371/journal.pone.0084679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454736	Green Published, gold, Green Submitted			2022-12-25	WOS:000329922500014
J	Wilke, SA; Raam, T; Antonios, JK; Bushong, EA; Koo, EH; Ellisman, MH; Ghosh, A				Wilke, Scott A.; Raam, Tara; Antonios, Joseph K.; Bushong, Eric A.; Koo, Edward H.; Ellisman, Mark H.; Ghosh, Anirvan			Specific Disruption of Hippocampal Mossy Fiber Synapses in a Mouse Model of Familial Alzheimer's Disease	PLOS ONE			English	Article							PATTERN SEPARATION; DENDRITIC SPINES; AMYLOID PLAQUES; TRANSGENIC MICE; NMDA RECEPTORS; A-BETA; CA3; AMPA; INHIBITION; EXPRESSION	The earliest stages of Alzheimer's disease (AD) are characterized by deficits in memory and cognition indicating hippocampal pathology. While it is now recognized that synapse dysfunction precedes the hallmark pathological findings of AD, it is unclear if specific hippocampal synapses are particularly vulnerable. Since the mossy fiber (MF) synapse between dentate gyrus (DG) and CA3 regions underlies critical functions disrupted in AD, we utilized serial block-face electron microscopy (SBEM) to analyze MF microcircuitry in a mouse model of familial Alzheimer's disease (FAD). FAD mutant MF terminal complexes were severely disrupted compared to control - they were smaller, contacted fewer postsynaptic spines and had greater numbers of presynaptic filopodial processes. Multi-headed CA3 dendritic spines in the FAD mutant condition were reduced in complexity and had significantly smaller sites of synaptic contact. Significantly, there was no change in the volume of classical dendritic spines at neighboring inputs to CA3 neurons suggesting input-specific defects in the early course of AD related pathology. These data indicate a specific vulnerability of the DG-CA3 network in AD pathogenesis and demonstrate the utility of SBEM to assess circuit specific alterations in mouse models of human disease.	[Wilke, Scott A.; Raam, Tara; Antonios, Joseph K.; Ghosh, Anirvan] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Bushong, Eric A.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Ghosh, Anirvan] F Hoffmann La Roche & Co Ltd, pRED, Neurosci Discovery & Translat Area, Basel, Switzerland	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Roche Holding	Ghosh, A (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	anirvan.ghosh@roche.com		Raam, Tara/0000-0003-2963-8588; Antonios, Joseph/0000-0003-2704-4743	NCRR [5P41RR004050]; NIH [NS064124]; Gatsby Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064124] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NCRR grant 5P41RR004050 to M. H. E., NIH Grant NS064124 to A. G. and a research grant from the Gatsby Charitable Trust to A. G. NCRR URL: http://www.nih.gov/about/almanac/organization/NCRR.htm; NIH URL: http://www.nih.gov/; Gatsby Charitable Trust URL: http://www.gatsby.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsady L, 1998, J NEUROSCI, V18, P3386; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Bischofberger J, 2006, PFLUG ARCH EUR J PHY, V453, P361, DOI 10.1007/s00424-006-0093-2; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Deipolyi AR, 2007, NEUROLOGY, V69, P986, DOI 10.1212/01.wnl.0000271376.19515.c6; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; HENDERSON VW, 1989, ARCH NEUROL-CHICAGO, V46, P391, DOI 10.1001/archneur.1989.00520400045018; Henze DA, 2002, J NEUROPHYSIOL, V87, P15, DOI 10.1152/jn.00394.2001; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jheng SS, 2009, BEHAV BRAIN RES, V200, P42, DOI 10.1016/j.bbr.2008.12.029; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kharazia VN, 1999, J COMP NEUROL, V412, P292, DOI 10.1002/(SICI)1096-9861(19990920)412:2<292::AID-CNE8>3.0.CO;2-G; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2007, LEARN MEMORY, V14, P745, DOI 10.1101/lm.703907; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mueller SG, 2011, NEUROIMAGE, V56, P851, DOI 10.1016/j.neuroimage.2011.03.028; Mueller SG, 2010, HUM BRAIN MAPP, V31, P1339, DOI 10.1002/hbm.20934; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Palmer A, 2011, BIOCHEM SOC T, V39, P902, DOI 10.1042/BST0390902; Rollenhagen A, 2007, J NEUROSCI, V27, P10434, DOI 10.1523/JNEUROSCI.1946-07.2007; Rolls ET, 2010, BEHAV BRAIN RES, V215, P180, DOI 10.1016/j.bbr.2010.03.027; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Wilke SA, 2013, J NEUROSCI, V33, P507, DOI 10.1523/JNEUROSCI.1600-12.2013; Yassa MA, 2011, HIPPOCAMPUS, V21, P968, DOI 10.1002/hipo.20808; Yassa MA, 2010, NEUROIMAGE, V51, P1242, DOI 10.1016/j.neuroimage.2010.03.040	49	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84349	10.1371/journal.pone.0084349	http://dx.doi.org/10.1371/journal.pone.0084349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454724	gold, Green Published, Green Submitted			2022-12-25	WOS:000329922500010
J	Veldwijk, MR; Zhang, B; Wenz, F; Herskind, C				Veldwijk, Marlon R.; Zhang, Bo; Wenz, Frederik; Herskind, Carsten			The Biological Effect of Large Single Doses: A Possible Role for Non-Targeted Effects in Cell Inactivation	PLOS ONE			English	Article							NORMAL HUMAN FIBROBLASTS; LINEAR-QUADRATIC MODEL; BYSTANDER RESPONSES; GLIOMA-CELLS; INTRAOPERATIVE RADIOTHERAPY; RADIATION-THERAPY; CYTOKINE RELEASE; RADIOSURGERY; CANCER; FRACTION	Background and Purpose: Novel radiotherapy techniques increasingly use very large dose fractions. It has been argued that the biological effect of large dose fractions may differ from that of conventional fraction sizes. The purpose was to study the biological effect of large single doses. Material and Methods: Clonogenic cell survival of MCF7 and MDA-MB-231 cells was determined after direct X-ray irradiation, irradiation of feeder cells, or transfer of conditioned medium (CM). Cell-cycle distributions and the apoptotic sub-G1 fraction were measured by flow cytometry. Cytokines in CM were quantified by a cytokine antibody array. gamma H2AX foci were detected by immunofluorescence microscopy. Results: The surviving fraction of MCF7 cells irradiated in vitro with 12 Gy showed an 8.5-fold decrease (95% c.i.: 4.4-16.3; P<0.0001) when the density of irradiated cells was increased from 10 to 50x10(3) cells per flask. Part of this effect was due to a dose-dependent transferrable factor as shown in CM experiments in the dose range 5-15 Gy. While no effect on apoptosis and cell cycle distribution was observed, and no differentially expressed cytokine could be identified, the transferable factor induced prolonged expression of gamma H2AX DNA repair foci at 1-12 h. Conclusions: A dose-dependent non-targeted effect on clonogenic cell survival was found in the dose range 5-15 Gy. The dependence of SF on cell numbers at high doses would represent a "cohort effect" in vivo. These results support the hypothesis that non-targeted effects may contribute to the efficacy of very large dose fractions in radiotherapy.	[Veldwijk, Marlon R.; Zhang, Bo; Wenz, Frederik; Herskind, Carsten] Heidelberg Univ, Med Fac Mannheim, Dept Radiat Oncol, Univ Med Mannheim, Mannheim, Germany	Ruprecht Karls University Heidelberg	Herskind, C (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Radiat Oncol, Univ Med Mannheim, Mannheim, Germany.	Carsten.Herskind@medma.uni-heidelberg.de	Herskind, Carsten/J-2457-2019	Herskind, Carsten/0000-0001-6554-5907	Shanghai Mai-Ge Medical Technology Co. (Shanghai, China)	Shanghai Mai-Ge Medical Technology Co. (Shanghai, China)	BZ was supported by a fellowship from Shanghai Mai-Ge Medical Technology Co. (www.luluyang.ezhaobiao.com; Yanan Rd, 700 room 1102, 200001, Shanghai, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blyth BJ, 2011, RADIAT RES, V176, P139, DOI 10.1667/RR2548.1; Brenner DJ, 2008, SEMIN RADIAT ONCOL, V18, P234, DOI 10.1016/j.semradonc.2008.04.004; Buonanno M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021540; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Burdak-Rothkamm S, 2008, CANCER RES, V68, P7059, DOI 10.1158/0008-5472.CAN-08-0545; Facoetti A, 2009, INT J RADIAT BIOL, V85, P690, DOI 10.1080/09553000903020016; Flickinger JC, 2003, TECHNOL CANCER RES T, V2, P87, DOI 10.1177/153303460300200203; Garcia LM, 2007, INT J RADIAT ONCOL, V67, P587, DOI 10.1016/j.ijrobp.2006.10.017; Gerashchenko BI, 2003, CYTOM PART A, V54A, P1, DOI 10.1002/cyto.a.10049; Gomez-Millan J, 2012, RADIOTHER ONCOL, V102, P450, DOI 10.1016/j.radonc.2011.11.002; Gow MD, 2008, PHYS MED BIOL, V53, P119, DOI 10.1088/0031-9155/53/1/008; Gow MD, 2010, RADIAT RES, V173, P769, DOI 10.1667/RR1895.1; Hei TK, 2008, J PHARM PHARMACOL, V60, P943, DOI 10.1211/jpp.60.8.0001; Herskind C, 2009, INT J RADIAT ONCOL, V74, P976, DOI 10.1016/j.ijrobp.2009.02.042; Hof H, 2007, CANCER-AM CANCER SOC, V110, P148, DOI 10.1002/cncr.22763; Iyer R, 2000, CANCER RES, V60, P1290; Kirkpatrick JP, 2008, SEMIN RADIAT ONCOL, V18, P240, DOI 10.1016/j.semradonc.2008.04.005; Kondziolka D, 2012, PROG NEUROL SURG, V25, P115, DOI 10.1159/000331184; Liu Q, 2013, INT J RADIAT ONCOL, V85, P1127, DOI 10.1016/j.ijrobp.2012.08.005; Liu ZF, 2006, RADIAT RES, V166, P19, DOI 10.1667/RR3580.1; Maier P, 2006, RADIAT RES, V166, P463, DOI 10.1667/RR0550.1; Mariotti LG, 2012, INT J RADIAT BIOL, V88, P751, DOI 10.3109/09553002.2012.703365; McMahon SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054526; Morton G, 2011, RADIOTHER ONCOL, V100, P463, DOI 10.1016/j.radonc.2011.08.022; Mothersill C, 2001, RADIAT RES, V155, P759, DOI 10.1667/0033-7587(2001)155[0759:RIBEPH]2.0.CO;2; Mothersill Carmel, 2012, Frontiers in Genetics, V3, P74, DOI 10.3389/fgene.2012.00074; Nagasawa H, 2003, INT J RADIAT BIOL, V79, P35, DOI 10.1080/0955300021000019230; Pomp J, 1996, RADIOTHER ONCOL, V40, P121, DOI 10.1016/0167-8140(96)01767-7; Shao C, 2008, ONCOGENE, V27, P434, DOI 10.1038/sj.onc.1210653; Shareef MM, 2007, CANCER RES, V67, P11811, DOI 10.1158/0008-5472.CAN-07-0722; Timmerman RD, 2007, J CLIN ONCOL, V25, P947, DOI 10.1200/JCO.2006.09.7469; Tomita M, 2010, RADIAT RES, V173, P380, DOI 10.1667/RR1995.1; Trainor C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043326; Truman JP, 2010, PLOS ONE, V5, DOI [10.1371/annotation/6e222ad5-b175-4a00-9d04-4d120568a897, 10.1371/journal.pone.0012310]; Vaidya JS, 2010, LANCET, V376, P91, DOI 10.1016/S0140-6736(10)60837-9; Veronesi U, 2010, BREAST CANCER RES TR, V124, P141, DOI 10.1007/s10549-010-1115-5; Yang HY, 2005, ONCOGENE, V24, P2096, DOI 10.1038/sj.onc.1208439; Zhou HN, 2008, CANCER RES, V68, P2233, DOI 10.1158/0008-5472.CAN-07-5278	38	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84991	10.1371/journal.pone.0084991	http://dx.doi.org/10.1371/journal.pone.0084991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465461	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100018
J	Francis, JH; Abramson, DH; Gobin, YP; Marr, BP; Dunkel, IJ; Riedel, ER; Brodie, SE				Francis, Jasmine H.; Abramson, David H.; Gobin, Y. Pierre; Marr, Brian P.; Dunkel, Ira J.; Riedel, Elyn R.; Brodie, Scott E.			Electroretinogram Monitoring of Dose-Dependent Toxicity after Ophthalmic Artery Chemosurgery in Retinoblastoma Eyes: Six Year Review	PLOS ONE			English	Article							TRANSGENIC MURINE RETINOBLASTOMA; INTRAOCULAR RETINOBLASTOMA; INTRAARTERIAL CHEMOTHERAPY; SUBCONJUNCTIVAL CARBOPLATIN; RETINAL FUNCTION; PHARMACOKINETIC ANALYSIS; PRECLINICAL MODELS; FIBRIN SEALANT; INJECTION; TOPOTECAN	Purpose: To report electroretinogram responses of retinoblastoma children under anesthesia before and after treatment with chemotherapeutic drugs (melphalan, topotecan, carboplatin) delivery by ophthalmic artery chemosurgery (OAC). Methods: A cohort study of 81 patients with retinoblastoma treated with OAC. All patients treated with OAC at our center through May 2012 for whom the requisite ERG data were available are included in the analysis. This study recorded the ERG 30 Hz flicker amplitude response changes from baseline, at 3 and 12 months following OAC treatment completion. Both univariate and multivariate linear regression models were evaluated, with generalized estimating equations to correct for correlations within patients. Independent numerical variables included maximum doses and cumulative doses of melphalan, topotecan and carboplatin. Results: By univariate analysis, both melphalan and topotecan appear to be associated with changes in ERG amplitude at both 3 and 12 months; but for the most part, these changes are minimal and likely clinically insignificant. By multivariate analysis, maximum and cumulative melphalan have a modest, temporary effect on the ERG amplitude change, which is apparent at 3 months but no longer evident at 12 months after completing treatment. By multivariate analysis, topotecan and carboplatin do not appear to adversely effect the change in ERG response. Conclusion: Melphalan has the strongest, and carboplatin the weakest association with reduction in ERG response amplitudes; but for the most part, these changes are minimal and likely clinically insignificant. These conclusions apply only over the dose ranges used here, and should be applied with caution.	[Francis, Jasmine H.; Abramson, David H.; Marr, Brian P.; Brodie, Scott E.] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, New York, NY 10021 USA; [Abramson, David H.; Marr, Brian P.] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Gobin, Y. Pierre] Weill Cornell Med Coll, Dept Neurosurg Neurol, Serv Intervent Neuroradiol, New York, NY USA; [Gobin, Y. Pierre] Weill Cornell Med Coll, Dept Radiol, Serv Intervent Neuroradiol, New York, NY USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, New York, NY USA; [Dunkel, Ira J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Dunkel, Ira J.] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Riedel, Elyn R.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Brodie, Scott E.] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai	Brodie, SE (corresponding author), Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, 1275 York Ave, New York, NY 10021 USA.	scott.brodie@mssm.edu		Francis, Jasmine/0000-0002-7637-3108; Brodie, Scott/0000-0002-3303-4552; Dunkel, Ira/0000-0001-8091-6067	Fund for Ophthalmic Knowledge, The New York Community Trust; Research to Prevent Blindness; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Fund for Ophthalmic Knowledge, The New York Community Trust; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by The Fund for Ophthalmic Knowledge, The New York Community Trust, and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034120; Abramson DH, 2011, ARCH OPHTHALMOL-CHIC, V129, P1492, DOI 10.1001/archophthalmol.2011.354; Abramson DH, 1999, OPHTHALMOLOGY, V106, P1947, DOI 10.1016/S0161-6420(99)90406-2; Bianciotto C, 2012, OPHTHALMOLOGY, V119, P843, DOI 10.1016/j.ophtha.2011.09.040; Brodie SE, 2012, BRIT J OPHTHALMOL, V96, P877, DOI 10.1136/bjophthalmol-2011-301248; Brodie SE, 2009, DOC OPHTHALMOL, V119, P13, DOI 10.1007/s10633-008-9164-3; Buitrago E, 2013, EXP EYE RES, V108, P103, DOI 10.1016/j.exer.2013.01.002; Friedrich S, 1997, CURR EYE RES, V16, P663, DOI 10.1076/ceyr.16.7.663.5061; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; Harbour JW, 1996, INVEST OPHTH VIS SCI, V37, P1892; INOMATA M, 1987, JPN J CANCER RES, V78, P858; Kirath H, 2007, J AAPOS, V11, P404, DOI 10.1016/j.jaapos.2006.11.005; Lee TC, 2003, OPHTHALMOLOGY, V110, P1989, DOI 10.1016/S0161-6420(03)00669-9; Liu CY, 2013, DOC OPHTHALMOL; Mallipatna AC, 2011, ARCH OPHTHALMOL-CHIC, V129, P738, DOI 10.1001/archophthalmol.2011.130; Marr B, 2010, MIDDLE EAST AFR J OP, V17, P207, DOI 10.4103/0974-9233.65492; Muen WJ, 2012, OPHTHALMOLOGY, V119, P611, DOI 10.1016/j.ophtha.2011.08.045; Mulvihill A, 2003, ARCH OPHTHALMOL-CHIC, V121, P1120, DOI 10.1001/archopht.121.8.1120; Munier FL, 2012, BR J OPHTHALMOL, DOI [10.1136/bjophthalmol-2011-301450, DOI 10.1136/BJ0PHTHALM0L-2011-301450]; Munier FL, 2011, RETINA-J RET VIT DIS, V31, P566, DOI 10.1097/IAE.0b013e318203c101; Nemeth KM, 2011, CANCER-AM CANCER SOC, V117, P421, DOI 10.1002/cncr.25574; Palioura S, 2012, PEDIATR BLOOD CANCER, V59, P859, DOI 10.1002/pbc.24170; Pardue MT, 2004, RETINA-J RET VIT DIS, V24, P776, DOI 10.1097/00006982-200410000-00015; Peterson EC, 2011, J NEUROSURG, V114, P1603, DOI 10.3171/2011.1.JNS10466; Schaiquevich P, 2012, INVEST OPHTH VIS SCI, V53, P4205, DOI 10.1167/iovs.12-9501; Schaiquevich P, 2012, RETINA-J RET VIT DIS, V32, P387, DOI 10.1097/IAE.0b013e31821e9f8a; Schmack I, 2006, AM J OPHTHALMOL, V142, P310, DOI 10.1016/j.ajo.2006.02.044; Shields CL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1407, DOI 10.1001/archophthalmol.2011.151; Shields CL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1399, DOI 10.1001/archophthalmol.2011.150; Suzuki S, 2011, OPHTHALMOLOGY, V118, P2081, DOI 10.1016/j.ophtha.2011.03.013; Tse BC, 2013, JAMA OPHTHALMOL, P1, DOI [10.1001/jamaophthal-mol.2013.2065, DOI 10.1001/JAMA0PHTHAL-M0L.2013.2065]; Ueda Mitsuyuki, 1994, Nippon Ganka Gakkai Zasshi, V98, P352; Ueda Mitsuyuki, 1995, Nippon Ganka Gakkai Zasshi, V99, P1230; Vajzovic LM, 2011, CLIN OPHTHALMOL, V5, P171, DOI 10.2147/OPTH.S12665; Van Quill KR, 2005, OPHTHALMOLOGY, V112, P1151, DOI 10.1016/j.ophtha.2004.11.060; Venturi C, 2013, ACTA OPHTHALMOL, V91, P335, DOI 10.1111/j.1755-3768.2011.02296.x; Wilson MW, 2011, ARCH OPHTHALMOL-CHIC, V129, P1458, DOI 10.1001/archophthalmol.2011.330; ZLIOBA A, 1988, ANN OPHTHALMOL, V20, P71	38	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84247	10.1371/journal.pone.0084247	http://dx.doi.org/10.1371/journal.pone.0084247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465398	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500012
J	Ma, K; Malhotra, P; Soni, V; Hedroug, O; Annaba, F; Dudeja, A; Shen, S; Turner, JR; Khramtsova, EA; Saksena, S; Dudeja, PK; Gill, RK; Alrefai, WA				Ma, Ke; Malhotra, Pooja; Soni, Vinay; Hedroug, Omar; Annaba, Fadi; Dudeja, Amish; Shen, Le; Turner, Jerrold R.; Khramtsova, Ekaterina A.; Saksena, Seema; Dudeja, Pradeep K.; Gill, Ravinder K.; Alrefai, Waddah A.			Overactivation of Intestinal SREBP2 in Mice Increases Serum Cholesterol	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-2; FATTY-ACID SYNTHESIS; LIPID HOMEOSTASIS; TRANSGENIC MICE; STEROL; GUT; LIVER; GENE; METABOLISM; NPC1L1	Sterol Response Element Binding Protein 2 (SREBP2) transcription factor is a master regulator of cholesterol homeostasis. Treatment with statins, inhibitors of cholesterol synthesis, activates intestinal SREBP2, which may hinder their cholesterol-lowering effects. Overactivation of SREBP2 in mouse liver was shown to have no effect on plasma cholesterol. However, the influence of activating intestinal SREBP2 on plasma cholesterol is not known. We have generated a novel transgenic mouse model with intestine specific overexpression of active SREBP2 (ISR2) driven by villin promoter. ISR2 mice showed overexpression of active SREBP2 specifically in the intestine. Microarray analysis of jejunal RNA from ISR2 mice showed a significant increase in genes involved in fatty acid and cholesterol synthesis. Cholesterol and triglyceride (TG) in jejunum and liver (mg/g protein) were significantly increased in ISR2 vs wild type mice. Serum Cholesterol was significantly increased in VLDL and LDL fractions whereas the level of serum triglycerides was decreased in ISR2 vs wild type mice. In conclusion, activation of intestinal SREBP2 alone seems to be sufficient to increase plasma cholesterol, highlighting the essential role of intestine in maintaining cholesterol homeostasis in the body.	[Alrefai, Waddah A.] Jesse Brown VA Med Ctr, Chicago, IL 60612 USA; [Ma, Ke; Malhotra, Pooja; Soni, Vinay; Hedroug, Omar; Annaba, Fadi; Dudeja, Amish; Saksena, Seema; Dudeja, Pradeep K.; Gill, Ravinder K.; Alrefai, Waddah A.] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL USA; [Shen, Le] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Turner, Jerrold R.; Khramtsova, Ekaterina A.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Chicago	Alrefai, WA (corresponding author), Jesse Brown VA Med Ctr, Chicago, IL 60612 USA.	walrefai@uic.edu	Turner, Jerrold/H-1502-2019	Gill, Ravinder/0000-0002-5337-2567	Department of Veterans Affairs; NIDDK [DK54016, DK81858, DK92441, DK96258, DK96245, DK71596]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK067887, R01DK081858, R56DK094954, R01DK054016, R01DK071596, R01DK092441, R56DK071596, R03DK096258, R21DK096254, R24DK099803] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000152] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	These studies were supported by the Department of Veterans Affairs (WAA, PKD) and the following NIDDK grants: DK54016, DK81858, DK92441 (PKD), DK96258 (RKG), DK96245 (SS), and DK71596 (WAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; Alrefai WA, 2007, AM J PHYSIOL-GASTR L, V292, pG369, DOI 10.1152/ajpgi.00306.2006; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Engelking LJ, 2012, J LIPID RES, V53, P1359, DOI 10.1194/jlr.M027599; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Gahete MD, 2011, ENDOCRINOLOGY, V152, P4825, DOI 10.1210/en.2011-1447; Goedeke L, 2012, CELL MOL LIFE SCI, V69, P915, DOI 10.1007/s00018-011-0857-5; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Im SS, 2009, MOL CELL BIOL, V29, P4864, DOI 10.1128/MCB.00553-09; Ishikawa M, 2008, J LIPID RES, V49, P2524, DOI 10.1194/jlr.M800238-JLR200; Iwayanagi Y, 2008, PHARM RES, V25, P1134, DOI 10.1007/s11095-007-9496-9; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Jeon TI, 2011, BIOCHEM J, V438, P33, DOI 10.1042/BJ20110009; Jeon TI, 2012, TRENDS ENDOCRINOL ME; Levy E, 2013, ATHEROSCLEROSIS, V227, P297, DOI 10.1016/j.atherosclerosis.2013.01.023; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Morton NM, 2005, DIABETES, V54, P3371, DOI 10.2337/diabetes.54.12.3371; Pramfalk C, 2010, J LIPID RES, V51, P1354, DOI [10.1194/jlr.M900274-JLR200, 10.1194/jlr.M900274]; Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Tremblay AJ, 2011, J LIPID RES, V52, P558, DOI 10.1194/jlr.M011080; van der Wulp MY, 2013, MOL CELL ENDOCRINOL	28	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84221	10.1371/journal.pone.0084221	http://dx.doi.org/10.1371/journal.pone.0084221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465397	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500011
J	Morreale, M; Marchione, P; Giacomini, P; Pontecorvo, S; Marianetti, M; Vento, C; Tinelli, E; Francia, A				Morreale, Manuela; Marchione, Pasquale; Giacomini, Patrizia; Pontecorvo, Simona; Marianetti, Massimo; Vento, Claudio; Tinelli, Emanuele; Francia, Ada			Neurological Involvement in Primary Sjogren Syndrome: A Focus on Central Nervous System	PLOS ONE			English	Article							NEUROPSYCHIATRIC DYSFUNCTION; MANIFESTATIONS; ALEXITHYMIA; DIAGNOSIS; VALIDITY; SCALE	Objectives: Sjogren syndrome is an autoimmune disease involving mainly salivary and lacrimal glands. Beyond widely described PNS involvement, high variable prevalence of CNS manifestations ranging from 2.5 and 60% of all pSS patients has been reported, without specific syndrome definition. The aim of this cohort study was to evaluate the prevalence of CNS signs and symptoms in pSS patients and to identify possible biomarkers of CNS damage. Methods: 120 patients with pSS diagnosis according to the 2002 American-European Consensus Group criteria were enrolled after exclusion of secondary causes. All patients underwent to a wide neurological, neuropsychological, psychiatric, neuroradiological and ultrasonographic evaluation. Results: Central and peripheral nervous system involvement was observed in 81 patients with a prevalence of 67.5%. The prevalence of CNS involvement was significantly higher than PNS disease (p 0.001). 68 patients (84%) shown non-focal CNS symptoms and 64 (79%) focal CNS deficits with headache as the most common feature (46.9%), followed by cognitive (44.4%) and mood disorders (38.3%). Particularly, we observed a high prevalence of migraine without aura, subcortical frontal executive functions and verbal memory impairment and apathy/alexythimia. MR spectroscopy revealed a reduction of NAA levels or NAA/Cr ratio decrease in subcortical frontal and basal ganglia white matter, while ultrasonography showed an impairment of microvasculature response. At multivariate analysis, headache, cognitive disorders and psychiatric symptoms was significantly associated to serological markers (anti-SSA), MRS and ultrasonographic features. Conclusions: The higher prevalence of MWO-mimic headache, cognitive dys-esecutive syndrome and mood disorders observed in this series confirmed previous evidences of a higher diffused CNS compromission rather than focal involvement such as SM-like clinical course or NMO-like syndrome. The association with immunological biomarkers, metabolic cerebral dysfunction and microvascular damage suggests a possible endothelial dysfunction of the cerebral microcirculation or a potential inflammation-mediated shift of the neurovascular coupling.	[Morreale, Manuela; Pontecorvo, Simona; Francia, Ada] Univ Roma La Sapienza, Dept Neurol & Psychiat, Ctr Neuroimmunol, I-00185 Rome, Italy; [Morreale, Manuela; Marchione, Pasquale; Giacomini, Patrizia; Vento, Claudio] Univ Roma La Sapienza, Neurosonol Unit, Dept Med & Surg Sci & Biotechnol, Neurol Sect, I-00185 Rome, Italy; [Marchione, Pasquale; Tinelli, Emanuele] Inst Neurosci, Dept Clin Neurosci, Neurol Ctr Latium, Rome, Italy; [Giacomini, Patrizia; Marianetti, Massimo] Univ Roma La Sapienza, Neuropsychol Outpatients Serv, Dept Med & Surg Sci & Biotechnol, Neurol Sect, I-00185 Rome, Italy; [Tinelli, Emanuele] Univ Roma La Sapienza, Dept Neurol & Psychiat, Neuroradiol Unit, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Morreale, M (corresponding author), Univ Roma La Sapienza, Dept Neurol & Psychiat, Ctr Neuroimmunol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	manuelamorreale@yahoo.it	Tinelli, Emanuele/AAH-9176-2021; tinelli, emanuele/GSO-0025-2022	Tinelli, Emanuele/0000-0002-3007-4022; tinelli, emanuele/0000-0002-3007-4022; Francia, Ada/0000-0002-9550-9082; Marianetti, Massimo/0000-0002-1402-3831; Pontecorvo, Simona/0000-0002-4256-2568	no profit association SCAN-Onlus	no profit association SCAN-Onlus	This study has been supported by no profit association SCAN-Onlus. The supporters had no role in study design, data collection and statistical analysis. No funding has been received.	ALEXANDER GE, 1981, NEUROLOGY, V31, P1391, DOI 10.1212/WNL.31.11.1391; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDONOPOULOS AP, 1990, BRIT J RHEUMATOL, V29, P21; Belin C, 1999, ANN MED INTERNE, V150, P598; Belleville S, 1998, MEM COGNITION, V26, P572, DOI 10.3758/BF03201163; Birnbaum J, 2010, NEUROLOGIST, V16, P287, DOI 10.1097/NRL.0b013e3181ebe59f; Bressi C, 1996, J PSYCHOSOM RES, V41, P551, DOI 10.1016/S0022-3999(96)00228-0; Carlesimo G. A., 1995, Archivio di Psicologia Neurologia e Psichiatria, V56, P471; Castellino G, 2008, AUTOIMMUN REV, V7, P297, DOI 10.1016/j.autrev.2007.11.022; Colombo L., 2002, G ITAL PSICOL, V3, P613, DOI DOI 10.1421/1256; de Seze J, 2001, NEUROLOGY, V57, P1359, DOI 10.1212/WNL.57.8.1359; Delalande S, 2004, MEDICINE, V83, P280, DOI 10.1097/01.md.0000141099.53742.16; ESCUDERO D, 1995, ANN MED INTERNE, V146, P239; FABER RJ, 1992, J CONSUM RES, V19, P459, DOI 10.1086/209315; FANCELLO GS, 2006, TORRE LONDRA TEST VA; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Harboe E, 2009, ANN RHEUM DIS, V68, P1541, DOI 10.1136/ard.2008.098301; Harboe E, 2009, BRAIN BEHAV IMMUN, V23, P1104, DOI 10.1016/j.bbi.2009.06.151; Harms L, 2012, Z RHEUMATOL, V71, P564, DOI 10.1007/s00393-012-0958-z; Kassan SS, 2004, ARCH INTERN MED, V164, P1275, DOI 10.1001/archinte.164.12.1275; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Lafitte C, 2001, J NEUROL, V248, P577, DOI 10.1007/s004150170135; Le Guern V, 2010, ANN RHEUM DIS, V69, P132, DOI 10.1136/ard.2008.090811; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; MALINOW KL, 1985, ANN INTERN MED, V103, P344, DOI 10.7326/0003-4819-103-3-344; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Martinez S, 2010, ACTA NEUROL SCAND, V122, P182, DOI 10.1111/j.1600-0404.2009.01293.x; Massara A, 2010, RHEUMATOLOGY, V49, P1540, DOI 10.1093/rheumatology/keq111; MAUCH E, 1994, ACTA NEUROL SCAND, V89, P31; Mavragani CP, 2010, AUTOIMMUN REV, V9, pA305, DOI 10.1016/j.autrev.2009.11.004; Meyers J. E., 1995, REY COMPLEX FIGURE T; Nichelli P., 2002, NUOVA RIV NEUROLOGIA, V12, P37; Pavlakis PP, 2011, J NEUROL NEUROSUR PS, V82, P798, DOI 10.1136/jnnp.2010.222109; Peri Y, 2012, BEST PRACT RES CL RH, V26, P105, DOI 10.1016/j.berh.2012.01.012; Rabadi MH, 2010, J NEUROL NEUROSUR PS, V81, P213, DOI 10.1136/jnnp.2009.183913; Reitan RM, 1992, TRAIL MAKING TEST MA; Rey A., 1958, MEMORISATION SERIE 1; Segal B, 2008, RHEUM DIS CLIN N AM, V34, P885, DOI 10.1016/j.rdc.2008.08.001; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Skopouli FN, 2000, SEMIN ARTHRITIS RHEU, V29, P296, DOI 10.1016/S0049-0172(00)80016-5; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Vadacca M, 2008, REUMATISMO, V60, P50, DOI 10.4081/reumatismo.2008.50; van Leeuwen N, 2012, CLIN EXP RHEUMATOL, V30, P492; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	48	62	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84605	10.1371/journal.pone.0084605	http://dx.doi.org/10.1371/journal.pone.0084605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465419	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500019
J	Bouret, Y; Argentina, M; Counillon, L				Bouret, Yann; Argentina, Mederic; Counillon, Laurent			Capturing Intracellular pH Dynamics by Coupling Its Molecular Mechanisms within a Fully Tractable Mathematical Model	PLOS ONE			English	Article							CARBON-DIOXIDE HYDRATION; NA+/H+ EXCHANGER; NA/K PUMP; KINETICS; LACTATE; NHE-1; AE2; DISSOCIATION; GENERATION; TRANSPORT	We describe the construction of a fully tractable mathematical model for intracellular pH. This work is based on coupling the kinetic equations depicting the molecular mechanisms for pumps, transporters and chemical reactions, which determine this parameter in eukaryotic cells. Thus, our system also calculates the membrane potential and the cytosolic ionic composition. Such a model required the development of a novel algebraic method that couples differential equations for slow relaxation processes to steady-state equations for fast chemical reactions. Compared to classical heuristic approaches based on fitted curves and ad hoc constants, this yields significant improvements. This model is mathematically self-consistent and allows for the first time to establish analytical solutions for steady-state pH and a reduced differential equation for pH regulation. Because of its modular structure, it can integrate any additional mechanism that will directly or indirectly affect pH. In addition, it provides mathematical clarifications for widely observed biological phenomena such as overshooting in regulatory loops. Finally, instead of including a limited set of experimental results to fit our model, we show examples of numerical calculations that are extremely consistent with the wide body of intracellular pH experimental measurements gathered by different groups in many different cellular systems.	[Bouret, Yann] Univ Nice Sophia Antipolis, CNRS, LPMC, UMR 7336, F-06189 Nice, France; [Argentina, Mederic] Univ Nice Sophia Antipolis, CNRS, INLN, UMR 7335, Valbonne, France; [Argentina, Mederic] Minist Enseignement Super & Rech Sci, IUF, Paris, France; [Counillon, Laurent] Univ Nice Sophia Antipolis, CNRS, LP2M, FRE 3472, F-06189 Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Counillon, L (corresponding author), Univ Nice Sophia Antipolis, CNRS, LP2M, FRE 3472, F-06189 Nice, France.	laurent.counillon@unice.fr	Argentina, Mederic/AAR-8153-2021; Argentina, Mederic/AAQ-9236-2021; Argentina, Mederic/I-8741-2014	Argentina, Mederic/0000-0002-8926-7398; Argentina, Mederic/0000-0002-8926-7398	University of Nice-Sophia Antipolis; CNRS Bio Maths Info PEPS; INSERM "Physique-Cancer'' Program (H+ Cancer)	University of Nice-Sophia Antipolis; CNRS Bio Maths Info PEPS; INSERM "Physique-Cancer'' Program (H+ Cancer)	This work was supported by the University of Nice-Sophia Antipolis, the CNRS Bio Maths Info PEPS 2012 and the INSERM "Physique-Cancer'' Program (H+ Cancer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boron WF, 2004, ADV PHYSIOL EDUC, V28, P128; Brett CL, 2006, FEBS LETT, V580, P717, DOI 10.1016/j.febslet.2005.12.103; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Cavet ME, 1999, AM J PHYSL CELL PHYS, V277; Cha CY, 2009, BIOPHYS J, V97, P2674, DOI 10.1016/j.bpj.2009.08.053; Despa S, 2003, BIOPHYS J, V84, P4157, DOI 10.1016/S0006-3495(03)75140-6; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Eckhaus, 1979, ASYMPTOTIC ANAL SING; EIGEN M, 1958, PROC R SOC LON SER-A, V247, P505, DOI 10.1098/rspa.1958.0208; Falkenberg CV, 2010, BIOPHYS J, V98, P1476, DOI 10.1016/j.bpj.2009.11.045; GADSBY DC, 1989, J GEN PHYSIOL, V94, P511, DOI 10.1085/jgp.94.3.511; Haragus M, 2011, UNIVERSITEXT, P1, DOI 10.1007/978-0-85729-112-7; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; JOHNSON KS, 1982, LIMNOL OCEANOGR, V27, P849, DOI 10.4319/lo.1982.27.5.0849; Juel C, 1999, J PHYSIOL-LONDON, V517, P633, DOI 10.1111/j.1469-7793.1999.0633s.x; KHALIFAH RG, 1972, P NATL ACAD SCI USA, V69, P172, DOI 10.1073/pnas.69.1.172; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; Lacroix J, 2008, BIOCHEMISTRY-US, V47, P13674, DOI 10.1021/bi801368n; Marcinek DJ, 2010, J APPL PHYSIOL, V108, P1479, DOI 10.1152/japplphysiol.01189.2009; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Pattillo RE, 2005, J APPL PHYSIOL, V99, P822, DOI 10.1152/japplphysiol.00235.2005; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SARDET C, 1990, SCIENCE, V247, P723, DOI 10.1126/science.2154036; SCHWIENING CJ, 1992, J PHYSIOL-LONDON, V447, P693, DOI 10.1113/jphysiol.1992.sp019024; Sekler I, 1996, CELL, V86, P929, DOI 10.1016/S0092-8674(00)80168-3; Swietach P, 2005, BIOPHYS J, V88, P3018, DOI 10.1529/biophysj.104.051391; ten Hove M, 2003, MOL CELL BIOCHEM, V250, P47, DOI 10.1023/A:1024985931797; Touret N, 2003, EUR J PHARMACOL, V459, P151, DOI 10.1016/S0014-2999(02)02824-8; Webb SD, 1999, J THEOR BIOL, V196, P237, DOI 10.1006/jtbi.1998.0836; WU P, 1993, BIOTECHNOL PROGR, V9, P374, DOI 10.1021/bp00022a004; Yabuuchi H, 1998, PHARMACEUT RES, V15, P411, DOI 10.1023/A:1011920213991; Zaniboni M, 2003, AM J PHYSL HEART CIR, V285; Zhang Y, 1996, J BIOL CHEM, V271, P5741, DOI 10.1074/jbc.271.10.5741	33	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85449	10.1371/journal.pone.0085449	http://dx.doi.org/10.1371/journal.pone.0085449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465564	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000035
J	Grafton, KT; Moir, LM; Black, JL; Hansbro, NG; Hansbro, PM; Burgess, JK; Oliver, BG				Grafton, Karryn T.; Moir, Lyn M.; Black, Judith L.; Hansbro, Nicole G.; Hansbro, Philip M.; Burgess, Janette K.; Oliver, Brian G.			LF-15 & T7, Synthetic Peptides Derived from Tumstatin, Attenuate Aspects of Airway Remodelling in a Murine Model of Chronic OVA-Induced Allergic Airway Disease	PLOS ONE			English	Article							ASTHMA; ANGIOGENESIS; INFLAMMATION; HYPERRESPONSIVENESS; IDENTIFICATION; SITE; MICE	Background: Tumstatin is a segment of the collagen-IV protein that is markedly reduced in the airways of asthmatics. Tumstatin can play an important role in the development of airway remodelling associated with asthma due to its anti-angiogenic properties. This study assessed the anti-angiogenic properties of smaller peptides derived from tumstatin, which contain the interface tumstatin uses to interact with the alpha V beta 3 integrin. Methods: Primary human lung endothelial cells were exposed to the LF-15, T3 and T7 tumstatin-derived peptides and assessed for cell viability and tube formation in vitro. The impact of the anti-angiogenic properties on airways hyperresponsiveness (AHR) was then examined using a murine model of chronic OVA-induced allergic airways disease. Results: The LF-15 and T7 peptides significantly reduced endothelial cell viability and attenuated tube formation in vitro. Mice exposed to OVA+ LF-15 or OVA+ T7 also had reduced total lung vascularity and AHR was attenuated compared to mice exposed to OVA alone. T3 peptides reduced cell viability but had no effect on any other parameters. Conclusion: The LF-15 and T7 peptides may be appropriate candidates for use as novel pharmacotherapies due to their small size and anti-angiogenic properties observed in vitro and in vivo.	[Grafton, Karryn T.; Moir, Lyn M.; Black, Judith L.; Burgess, Janette K.; Oliver, Brian G.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Grafton, Karryn T.; Moir, Lyn M.; Black, Judith L.; Burgess, Janette K.; Oliver, Brian G.] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Hansbro, Nicole G.; Hansbro, Philip M.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia; [Hansbro, Nicole G.; Hansbro, Philip M.] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Oliver, BG (corresponding author), Woolcock Inst Med Res, Sydney, NSW, Australia.	brianol@usyd.edu.au	Oliver, Brian/E-7939-2010; Burgess, Janette K/A-3597-2010; Burgess, Janette/M-7117-2019; Hansbro, Phil/G-7486-2013	Oliver, Brian/0000-0002-7122-9262; Hansbro, Phil/0000-0002-4741-3035; Burgess, Janette/0000-0001-9868-9966	Cooperative Research Centre for Asthma and Airways	Cooperative Research Centre for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funding provided by Cooperative Research Centre for Asthma and Airways. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asosingh K, 2007, J IMMUNOL, V178, P6482, DOI 10.4049/jimmunol.178.10.6482; Burgess JK, 2010, AM J RESP CRIT CARE, V181, P106, DOI 10.1164/rccm.200904-0631OC; Eikesdal HP, 2008, P NATL ACAD SCI USA, V105, P15040, DOI 10.1073/pnas.0807055105; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Herbert C, 2008, CLIN EXP ALLERGY, V38, P847, DOI 10.1111/j.1365-2222.2008.02950.x; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Kumar RK, 2008, CURR DRUG TARGETS, V9, P485, DOI 10.2174/138945008784533561; Laube BL, 2001, CHEST, V120, p99S, DOI 10.1378/chest.120.3_suppl.99S; Lee SY, 2006, J ALLERGY CLIN IMMUN, V117, P597, DOI 10.1016/j.jaci.2005.11.008; Li X, 1997, AM J RESP CRIT CARE, V156, P229, DOI 10.1164/ajrccm.156.1.9607066; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; Shifren A, 2012, J ALLERGY, V2012, P1, DOI DOI 10.1155/2012/316049; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Zan JH, 2012, MOL SIMULAT, V38, P498, DOI 10.1080/08927022.2011.649428	15	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85655	10.1371/journal.pone.0085655	http://dx.doi.org/10.1371/journal.pone.0085655			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454912	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100115
J	Ni, J; Zhu, ZX; Wang, GH; Shen, YX; Zhang, YY; Wu, P				Ni, Jun; Zhu, Zhenxing; Wang, Gaohang; Shen, Yanxia; Zhang, Yanyan; Wu, Ping			Intragenic Suppressor of Osiaa23 Revealed a Conserved Tryptophan Residue Crucial for Protein-Protein Interactions	PLOS ONE			English	Article							AUXIN-RESPONSE-FACTOR; RICE ORYZA-SATIVA; LATERAL ROOT-FORMATION; AUX/IAA PROTEINS; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; GENE FAMILY; GROWTH; EXPRESSION; RECEPTOR	The Auxin/Indole-3-Acetic Acid (Aux/IAA) and Auxin Response Factor (ARF) are two important families that play key roles in auxin signal transduction. Both of the families contain a similar carboxyl-terminal domain (Domain III/IV) that facilitates interactions between these two families. In spite of the importance of protein-protein interactions among these transcription factors, the mechanisms involved in these interactions are largely unknown. In this study, we isolated six intragenic suppressors of an auxin insensitive mutant, Osiaa23. Among these suppressors, Osiaa23-R5 successfully rescued all the defects of the mutant. Sequence analysis revealed that an amino acid substitution occurred in the Tryptophan (W) residue in Domain IV of Osiaa23. Yeast two-hybrid experiments showed that the mutation in Domain IV prevents the protein-protein interactions between Osiaa23 and OsARFs. Phylogenetic analysis revealed that the W residue is conserved in both OsIAAs and OsARFs. Next, we performed site-specific amino acid substitutions within Domain IV of OsARFs, and the conserved W in Domain IV was exchanged by Serine (S). The mutated OsARF(WS)s can be released from the inhibition of Osiaa23 and maintain the transcriptional activities. Expression of OsARF(WS) s in Osiaa23 mutant rescued different defects of the mutant. Our results suggest a previously unknown importance of Domain IV in both families and provide an indirect way to investigate functions of OsARFs.	[Ni, Jun; Shen, Yanxia; Zhang, Yanyan] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Ni, Jun; Zhu, Zhenxing; Wu, Ping] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Zhenxing; Wang, Gaohang] Liaoning Acad Agr Sci, Agr Crops Mol Improving Lab, Shenyang, Peoples R China	Hangzhou Normal University; Zhejiang University	Ni, J (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	nijun@hznu.edu.cn			Zhejiang Provincial Natural Science Foundation of China [LQ13C020005]; Qianjiang talents project of Science Technology Department of Zhejiang Province [2012R10059]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Qianjiang talents project of Science Technology Department of Zhejiang Province	This work was funded by Zhejiang Provincial Natural Science Foundation of China under Grant No. LQ13C020005, and Qianjiang talents project of Science Technology Department of Zhejiang Province (2012R10059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia KA, 2009, CURR ISSUES MOL BIOL, V11, pI29, DOI 10.21775/cimb.011.i29; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Chen SY, 2003, PLANT J, V36, P105, DOI 10.1046/j.1365-313X.2003.01860.x; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Goetz M, 2006, PLANT CELL, V18, P1873, DOI 10.1105/tpc.105.037192; Guilfoyle TJ, 2012, PLANT SCI, V190, P82, DOI 10.1016/j.plantsci.2012.04.003; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hardtke CS, 2004, DEVELOPMENT, V131, P1089, DOI 10.1242/dev.00925; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Inukai Y, 2005, PLANT CELL, V17, P1387, DOI 10.1105/tpc.105.030981; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Kitomi Y, 2012, PLANT SCI, V190, P116, DOI 10.1016/j.plantsci.2012.04.005; Li H, 2004, DEV CELL, V7, P193, DOI 10.1016/j.devcel.2004.07.002; Li JS, 2006, PLANT PHYSIOL, V140, P899, DOI 10.1104/pp.105.070987; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Liu H, 2012, FUNCT PLANT BIOL, V39, P736, DOI 10.1071/FP12106; Liu HJ, 2005, PLANT J, V43, P47, DOI 10.1111/j.1365-313X.2005.02434.x; Nagpal P, 2000, PLANT PHYSIOL, V123, P563, DOI 10.1104/pp.123.2.563; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Ni J, 2011, PLANT J, V68, P433, DOI 10.1111/j.1365-313X.2011.04698.x; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Ouellet F, 2001, PLANT CELL, V13, P829, DOI 10.1105/tpc.13.4.829; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; Qi YH, 2012, NEW PHYTOL, V193, P109, DOI 10.1111/j.1469-8137.2011.03910.x; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Sato Y, 2001, GENES GENET SYST, V76, P373, DOI 10.1266/ggs.76.373; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Sessions A, 1997, DEVELOPMENT, V124, P4481; Shen CJ, 2013, PLANT CELL ENVIRON, V36, P607, DOI 10.1111/pce.12001; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tromas A, 2010, CR BIOL, V333, P297, DOI 10.1016/j.crvi.2010.01.005; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Waller F, 2002, PLANT MOL BIOL, V50, P415, DOI 10.1023/A:1019818110761; Wang DK, 2007, GENE, V394, P13, DOI 10.1016/j.gene.2007.01.006; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wilmoth JC, 2005, PLANT J, V43, P118, DOI 10.1111/j.1365-313X.2005.02432.x; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Worley CK, 2000, PLANT J, V21, P553, DOI 10.1046/j.1365-313x.2000.00703.x; Zhu ZX, 2012, MOL PLANT, V5, P154, DOI 10.1093/mp/ssr074	49	14	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85358	10.1371/journal.pone.0085358	http://dx.doi.org/10.1371/journal.pone.0085358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454849	Green Submitted, gold, Green Published			2022-12-25	WOS:000330235100073
J	Xiao, FX; Zimpelmann, J; Agaybi, S; Gurley, SB; Puente, L; Burns, KD				Xiao, Fengxia; Zimpelmann, Joseph; Agaybi, Samih; Gurley, Susan B.; Puente, Lawrence; Burns, Kevin D.			Characterization of Angiotensin-Converting Enzyme 2 Ectodomain Shedding from Mouse Proximal Tubular Cells	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME-2 ACE2; KIDNEY-DISEASE; DIABETIC MICE; URINARY ACE2; EXPRESSION; CARBOXYPEPTIDASE	Angiotensin-converting enzyme 2 (ACE2) is highly expressed in the kidney proximal tubule, where it cleaves angiotensin (Ang) II to Ang-(1-7). Urinary ACE2 levels increase in diabetes, suggesting that ACE2 may be shed from tubular cells. The aim of this study was to determine if ACE2 is shed from proximal tubular cells, to characterize ACE2 fragments, and to study pathways for shedding. Studies involved primary cultures of mouse proximal tubular cells, with ACE2 activity measured using a synthetic substrate, and analysis of ACE2 fragments by immunoblots and mass spectrometry. The culture media from mouse proximal tubular cells demonstrated a time-dependent increase in ACE2 activity, suggesting constitutive ACE2 shedding. ACE2 was detected in media as two bands at similar to 90 kDa and similar to 70 kDa on immunoblots. By contrast, full-length ACE2 appeared at similar to 100 kDa in cell lysates or mouse kidney cortex. Mass spectrometry of the two deglycosylated fragments identified peptides matching mouse ACE2 at positions 18-706 and 18-577, respectively. The C-terminus of the 18-706 peptide fragment contained a non-tryptic site, suggesting that Met(706) is a candidate ACE2 cleavage site. Incubation of cells in high D-glucose (25 mM) (and to a lesser extent Ang II) for 48-72 h increased ACE2 activity in the media (p<0.001), an effect blocked by inhibition of a disintegrin and metalloproteinase (ADAM) 17. High D-glucose increased ADAM17 activity in cell lysates (p<0.05). These data indicate that two glycosylated ACE2 fragments are constitutively shed from mouse proximal tubular cells. ACE2 shedding is stimulated by high D-glucose, at least partly via an ADAM17-mediated pathway. The results suggest that proximal tubular shedding of ACE2 may increase in diabetes, which could enhance degradation of Ang II in the tubular lumen, and increase levels of Ang-(1-7).	[Xiao, Fengxia; Zimpelmann, Joseph; Agaybi, Samih; Burns, Kevin D.] Univ Ottawa, Ottawa Hosp Res Inst, Kidney Res Ctr, Div Nephrol,Dept Med, Ottawa, ON, Canada; [Gurley, Susan B.] Duke Univ, Med Ctr, Dept Med, Div Nephrol, Durham, NC 27710 USA; [Puente, Lawrence] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; Duke University; University of Ottawa; Ottawa Hospital Research Institute	Burns, KD (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Kidney Res Ctr, Div Nephrol,Dept Med, Ottawa, ON, Canada.	kburns@ottawahospital.on.ca			Canadian Institutes of Health Research [MOP110929]; The Kidney Foundation of Canada [KFOC100005]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); The Kidney Foundation of Canada	The sources of funding that have supported the work include: Canadian Institutes of Health Research: grant number: MOP110929; http://www.cihr-irsc.gc.ca/; and The Kidney Foundation of Canada: grant number: KFOC100005; http://www.kidney.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Chodavarapu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062833; Dilauro M, 2010, AM J PHYSIOL-RENAL, V298, pF1523, DOI 10.1152/ajprenal.00426.2009; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Fan HZ, 2003, J BIOL CHEM, V278, P18617, DOI 10.1074/jbc.M300331200; Freour T, 2009, INT J MOL MED, V23, P41, DOI 10.3892/ijmm_00000099; Iwata M, 2009, AM J PHYSIOL-CELL PH, V297, pC1318, DOI 10.1152/ajpcell.00036.2009; Jia HP, 2009, AM J PHYSIOL-LUNG C, V297, pL84, DOI 10.1152/ajplung.00071.2009; Kassiri Z, 2009, J AM SOC NEPHROL, V20, P1223, DOI 10.1681/ASN.2008050492; Lai ZW, 2011, BIOCHEMISTRY-US, V50, P5182, DOI 10.1021/bi200525y; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Li NJ, 2005, AM J PHYSIOL-RENAL, V288, pF353, DOI 10.1152/ajprenal.00144.2004; Maluf-Meiken LC, 2012, INT J HYPERTENS, V2012, P58170; Mizuiri S, 2011, NEPHROLOGY, V16, P567, DOI 10.1111/j.1440-1797.2011.01467.x; Nadarajah R, 2012, KIDNEY INT, V82, P292, DOI 10.1038/ki.2012.83; Oudit GY, 2006, AM J PATHOL, V168, P1808, DOI 10.2353/ajpath.2006.051091; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Park SE, 2013, EUR J ENDOCRINOL, V168, P203, DOI 10.1530/EJE-12-0782; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Reich HN, 2008, KIDNEY INT, V74, P1610, DOI 10.1038/ki.2008.497; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; VINAY P, 1981, AM J PHYSIOL, V241, pF403, DOI 10.1152/ajprenal.1981.241.4.F403; Warner FJ, 2005, J BIOL CHEM, V280, P39353, DOI 10.1074/jbc.M508914200; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Wysocki J, 2013, AM J PHYSIOL-RENAL, V305, pF600, DOI 10.1152/ajprenal.00600.2012; Xiao FX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037649; Ye MH, 2004, HYPERTENSION, V43, P1120, DOI 10.1161/01.HYP.0000126192.27644.76; Ye MH, 2006, J AM SOC NEPHROL, V17, P3067, DOI 10.1681/ASN.2006050423; Ye MH, 2012, HYPERTENSION, V60, P730, DOI 10.1161/HYPERTENSIONAHA.112.198622	30	46	46	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85958	10.1371/journal.pone.0085958	http://dx.doi.org/10.1371/journal.pone.0085958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454948	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100141
J	Zhang, LL; Li, D; Xu, R; Zheng, SC; He, HW; Wan, J; Feng, QL				Zhang, Lili; Li, Ding; Xu, Rui; Zheng, Sichun; He, Hongwu; Wan, Jian; Feng, Qili			Structural and Functional Analyses of a Sterol Carrier Protein in Spodoptera litura	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; AEDES-AEGYPTI; FATTY-ACID; 2/3-OXOACYL-COA THIOLASE; LIPID-BINDING; GENE; INHIBITORS; RESOLUTION; EXPRESSION; IDENTIFICATION	Backgrounds: In insects, cholesterol is one of the membrane components in cells and a precursor of ecdysteroid biosynthesis. Because insects lack two key enzymes, squalene synthase and lanosterol synthase, in the cholesterol biosynthesis pathway, they cannot autonomously synthesize cholesterol de novo from simple compounds and therefore have to obtain sterols from their diet. Sterol carrier protein (SCP) is a cholesterol-binding protein responsible for cholesterol absorption and transport. Results: In this study, a model of the three-dimensional structure of SlSCPx-2 in Spodoptera litura, a destructive polyphagous agricultural pest insect in tropical and subtropical areas, was constructed. Docking of sterol and fatty acid ligands to SlSCPx2 and ANS fluorescent replacement assay showed that SlSCPx-2 was able to bind with relatively high affinities to cholesterol, stearic acid, linoleic acid, stigmasterol, oleic acid, palmitic acid and arachidonate, implying that SlSCPx may play an important role in absorption and transport of these cholesterol and fatty acids from host plants. Site-directed mutation assay of SlSCPx-2 suggests that amino acid residues F53, W66, F89, F110, I115, T128 and Q131 are critical for the ligandbinding activity of the SlSCPx-2 protein. Virtual ligand screening resulted in identification of several lead compounds which are potential inhibitors of SlSCPx-2. Bioassay for inhibitory effect of five selected compounds showed that AH-487/ 41731687, AG-664/14117324, AG-205/36813059 and AG-205/07775053 inhibited the growth of S. litura larvae. Conclusions: Compounds AH-487/41731687, AG-664/14117324, AG-205/36813059 and AG-205/07775053 selected based on structural modeling showed binding affinity to SlSCPx-2 protein and inhibitory effect on the growth of S. litura larvae.	[Zhang, Lili; Xu, Rui; Zheng, Sichun] S China Normal Univ, Sch Life Sci, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China; [Li, Ding; He, Hongwu; Wan, Jian; Feng, Qili] Cent China Normal Univ, Coll Chem, Minist Educ, Key Lab Pesticide & Chem Biol CCNU, Wuhan, Peoples R China	South China Normal University; Central China Normal University	Wan, J (corresponding author), Cent China Normal Univ, Coll Chem, Minist Educ, Key Lab Pesticide & Chem Biol CCNU, Wuhan, Peoples R China.	jianwan@mail.ccnu.edu.cn; qlfeng@scnu.edu.cn		Li, Ding/0000-0003-3130-6099	Chinese National Natural Science Foundation [31071688]; National Basic Research Program of China [2010CB126100]; Scientific Research Foundation of Graduate School of South China Normal University [2012kyjj124]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Scientific Research Foundation of Graduate School of South China Normal University	This research was supported by the Chinese National Natural Science Foundation (31071688), the National Basic Research Program of China (2010CB126100) and the Scientific Research Foundation of Graduate School of South China Normal University (2012kyjj124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEYDON P, 1987, ARCH INSECT BIOCHEM, V5, P139, DOI 10.1002/arch.940050208; Blitzer EJ, 2005, INSECT MOL BIOL, V14, P301, DOI 10.1111/j.1365-2583.2005.00560.x; Choinowski T, 2000, BIOCHEMISTRY-US, V39, P1897, DOI 10.1021/bi992742e; Chuang S, 2008, J MED CHEM, V51, P3755, DOI 10.1021/jm701192w; Du X, 2012, J INSECT PHYSIOL, V58, P1413, DOI 10.1016/j.jinsphys.2012.08.005; Dyer DH, 2008, J LIPID RES, V49, P644, DOI 10.1194/jlr.M700460-JLR200; Dyer DH, 2009, MOL CELL BIOCHEM, V326, P67, DOI 10.1007/s11010-008-0007-z; Dyer DH, 2003, J BIOL CHEM, V278, P39085, DOI 10.1074/jbc.M306214200; Edqvist J, 2004, J BIOL CHEM, V279, P53544, DOI 10.1074/jbc.M405099200; Elam C, 2011, EUR J MED CHEM, V46, P1512, DOI 10.1016/j.ejmech.2011.01.069; Frolov A, 1997, LIPIDS, V32, P1201, DOI 10.1007/s11745-997-0154-5; Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Goroncy Alexander K., 2010, Journal of Structural and Functional Genomics, V11, P247, DOI 10.1007/s10969-010-9096-5; GRIENEISEN ML, 1994, INSECT BIOCHEM MOLEC, V24, P115, DOI 10.1016/0965-1748(94)90078-7; Guo XR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-102; Haapalainen AM, 2001, J MOL BIOL, V313, P1127, DOI 10.1006/jmbi.2001.5084; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Kane CD, 1996, ANAL BIOCHEM, V233, P197, DOI 10.1006/abio.1996.0028; Kim Min-Sik, 2010, BMC Physiology, V10, P9, DOI 10.1186/1472-6793-10-9; Kim MS, 2005, J LIPID RES, V46, P650, DOI 10.1194/jlr.M400389-JLR200; Krebs KC, 2003, INSECT MOL BIOL, V12, P51, DOI 10.1046/j.1365-2583.2003.00386.x; Lascombe MB, 2002, ACTA CRYSTALLOGR D, V58, P1442, DOI 10.1107/S0907444902011745; Li D, 2012, J CHEM INF MODEL, V52, P1833, DOI 10.1021/ci300163v; Radek JT, 2010, BIOCHEMISTRY-US, V49, P7532, DOI 10.1021/bi902026v; Schroeder F, 2000, J BIOL CHEM, V275, P25547, DOI 10.1074/jbc.M000431200; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; Takeuchi H, 2004, BIOCHEM J, V382, P93, DOI 10.1042/BJ20040717; Viitanen L, 2006, FEBS J, V273, P5641, DOI 10.1111/j.1742-4658.2006.05553.x; Vyazunova I, 2007, INSECT MOL BIOL, V16, P305, DOI 10.1111/j.1365-2583.2007.00729.x; Vyazunova Irina, 2008, P173; Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973; Zhou H, 2006, PROTEINS, V65, P692, DOI 10.1002/prot.21129	33	10	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e81542	10.1371/journal.pone.0081542	http://dx.doi.org/10.1371/journal.pone.0081542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454688	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100003
J	Zhong, YP; Wang, B; Yan, JH; Cheng, LJ; Yao, LM; Xiao, L; Wu, TL				Zhong, Yunpeng; Wang, Biao; Yan, Junhui; Cheng, Linjing; Yao, Luming; Xiao, Liang; Wu, Tianlong			DL-beta-Aminobutyric Acid-Induced Resistance in Soybean against Aphis glycines Matsumura (Hemiptera: Aphididae)	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; AMINO-BUTYRIC ACID; MOLECULAR-CLONING; PHYTOPHTHORA-INFESTANS; 3-AMINOBUTYRIC ACID; DISEASE RESISTANCE; GENE-EXPRESSION; DOWNY MILDEW; L-GLUTAMINE; DEFENSE	Priming can improve plant innate capability to deal with the stresses caused by both biotic and abiotic factors. In this study, the effect of DL-beta-amino-n-butyric acid (BABA) against Aphis glycines Matsumura, the soybean aphid (SA) was evaluated. We found that 25 mM BABA as a root drench had minimal adverse impact on plant growth and also efficiently protected soybean from SA infestation. In both choice and non-choice tests, SA number was significantly decreased to a low level in soybean seedlings drenched with 25 mM BABA compared to the control counterparts. BABA treatment resulted in a significant increase in the activities of several defense enzymes, such as phenylalanine ammonia-lyase (PAL), peroxidase (POX), polyphenol oxidase (PPO), chitinase (CHI), and beta-1, 3-glucanase (GLU) in soybean seedlings attacked by aphid. Meanwhile, the induction of 15 defense-related genes by aphid, such as AOS, CHS, MMP2, NPR1-1, NPR1-2, and PR genes, were significantly augmented in BABA-treated soybean seedlings. Our study suggest that BABA application is a promising way to enhance soybean resistance against SA.	[Zhong, Yunpeng; Wang, Biao; Yan, Junhui; Cheng, Linjing; Yao, Luming; Xiao, Liang; Wu, Tianlong] Shanghai Jiao Tong Univ, Sch Agr & Biol, Minist Agr, Key Lab Urban Agr South, Shanghai 200030, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Jiao Tong University	Wang, B (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Minist Agr, Key Lab Urban Agr South, Shanghai 200030, Peoples R China.	wangbiao@sjtu.edu.cn; tianlongwu@263.net	Zhong, Yun/HCH-6868-2022		Major Projects of the Ministry of Agriculture [2013ZX08004-004]; National Natural Science Fund of China [31071435]; "948'' projects of the Ministry of Agriculture [2011-G1(2)-16]; Shanghai Horticulture Key Discipline Construction Fund [B209]	Major Projects of the Ministry of Agriculture; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); "948'' projects of the Ministry of Agriculture; Shanghai Horticulture Key Discipline Construction Fund	This work was supported by grants from the Major Projects of the Ministry of Agriculture (2013ZX08004-004), the National Natural Science Fund of China (31071435), "948'' projects of the Ministry of Agriculture (2011-G1(2)-16), and the Shanghai Horticulture Key Discipline Construction Fund (B209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKADA S, 1990, NUCLEIC ACIDS RES, V18, P5899, DOI 10.1093/nar/18.19.5899; Altamiranda EAG, 2008, AUSTRALAS PLANT PATH, V37, P421, DOI 10.1071/AP08033; Andreu AB, 2006, PEST MANAG SCI, V62, P162, DOI 10.1002/ps.1142; Barilli E, 2010, EUR J PLANT PATHOL, V128, P483, DOI 10.1007/s10658-010-9678-x; Beckers GJM, 2009, PLANT CELL, V21, P944, DOI 10.1105/tpc.108.062158; Blee E, 2002, TRENDS PLANT SCI, V7, P315, DOI 10.1016/S1360-1385(02)02290-2; BOLLER T, 1983, PLANTA, V157, P22, DOI 10.1007/BF00394536; Bonner CA, 1996, PLANT SCI, V113, P43, DOI 10.1016/0168-9452(95)04284-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; Chamsai J, 2004, Z PFLANZENK PFLANZEN, V111, P273; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; Cipollini D, 2003, BASIC APPL ECOL, V4, P79, DOI 10.1078/1439-1791-00134; COHEN Y, 1994, PHYSIOL MOL PLANT P, V44, P273, DOI 10.1016/S0885-5765(05)80030-X; Cohen Y, 2011, EUR J PLANT PATHOL, V130, P13, DOI 10.1007/s10658-010-9724-8; Cohen Y, 2010, EUR J PLANT PATHOL, V126, P553, DOI 10.1007/s10658-009-9564-6; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; deSa MM, 1996, MOL BIOL EVOL, V13, P1198, DOI 10.1093/oxfordjournals.molbev.a025685; DIAS MA, 1983, J EXP BOT, V34, P537, DOI 10.1093/jxb/34.5.537; Diaz-Montano J, 2006, COMPONENTS SOYBEAN R; Frank R L, 1991, DNA Seq, V1, P335, DOI 10.3109/10425179109020788; Fu DQ, 2009, MOL PLANT MICROBE IN, V22, P86, DOI 10.1094/MPMI-22-1-0086; Gijzen M, 2001, J EXP BOT, V52, P2283, DOI 10.1093/jexbot/52.365.2283; Hamiduzzaman MM, 2005, MOL PLANT MICROBE IN, V18, P819, DOI 10.1094/MPMI-18-0819; Harmel N, 2007, INSECT SCI, V14, P57, DOI 10.1111/j.1744-7917.2007.00126.x; Hartman G.L., 2001, PLANT HLTH PROGR, DOI [10.1094/PHP-2001-0205-1001-HN, DOI 10.1094/PHP-2001-0205-1001-HN]; Hartman GL, 2011, FOOD SECUR, V3, P5, DOI 10.1007/s12571-010-0108-x; Hill CB, 2012, EUPHYTICA, V186, P635, DOI 10.1007/s10681-012-0695-z; Hill CB, 2004, CROP SCI, V44, P98, DOI 10.2135/cropsci2004.0098; Hodge S, 2006, ANN APPL BIOL, V148, P223, DOI 10.1111/j.1744-7348.2006.00061.x; Hodge S, 2005, B ENTOMOL RES, V95, P449, DOI 10.1079/BER2005375; Hodge S, 2011, BIOCONTROL, V56, P699, DOI 10.1007/s10526-011-9344-z; Hwang BK, 1997, PHYSIOL MOL PLANT P, V51, P305, DOI 10.1006/pmpp.1997.0119; Hwang BK, 2000, PLANT PATHOLOGY J, V16, P9; Jakab G, 2001, EUR J PLANT PATHOL, V107, P29, DOI 10.1023/A:1008730721037; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Justyna P-G, 2013, ACTA PHYSIOL PLANT, P1; Kim C. S., 2008, Agricultural and Resource Economics Review, V37, P227; Kim KS, 2008, CROP SCI, V48, P923, DOI 10.2135/cropsci2007.08.0447; Kongrit D, 2007, BIOSCI BIOTECH BIOCH, V71, P491, DOI 10.1271/bbb.60537; KOUKOL J, 1961, J BIOL CHEM, V236, P2692; Li Y, 2008, NEW PHYTOL, V179, P185, DOI 10.1111/j.1469-8137.2008.02443.x; Liu J, 2007, POSTHARVEST BIOL TEC, V44, P300, DOI 10.1016/j.postharvbio.2006.12.019; Liu YQ, 2001, PLANT PHYSIOL, V127, P1788, DOI 10.1104/pp.010593; Marcucci E, 2010, J PHYTOPATHOL, V158, P659, DOI 10.1111/j.1439-0434.2010.01677.x; Meng FL, 2011, THEOR APPL GENET, V123, P1459, DOI 10.1007/s00122-011-1680-y; Olivieri FP, 2009, EUR J PLANT PATHOL, V123, P47, DOI 10.1007/s10658-008-9340-z; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Pociecha E, 2008, PHYSIOL MOL PLANT P, V73, P126, DOI 10.1016/j.pmpp.2009.03.005; Porat R, 2003, EUR J PLANT PATHOL, V109, P901, DOI 10.1023/B:EJPP.0000003624.28975.45; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Ragsdale DW, 2007, J ECON ENTOMOL, V100, P1258, DOI 10.1603/0022-0493(2007)100[1258:ETFSAH]2.0.CO;2; Ragsdale DW, 2004, ANN ENTOMOL SOC AM, V97, P204, DOI 10.1603/0013-8746(2004)097[0204:SABINA]2.0.CO;2; Ramiro DA, 2006, J CHEM ECOL, V32, P1977, DOI 10.1007/s10886-006-9122-z; Sahebani N, 2011, ACTA PHYSIOL PLANT, V33, P443, DOI 10.1007/s11738-010-0564-0; Sandhu D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-105; Sasek V, 2012, EUR J PLANT PATHOL, V133, P279, DOI 10.1007/s10658-011-9897-9; SIEFERT F, 1994, PLANTA, V192, P431, DOI 10.1007/BF00198580; Siegrist J, 2000, PHYSIOL MOL PLANT P, V56, P95, DOI 10.1006/pmpp.1999.0255; Slaughter A, 2012, PLANT PHYSIOL, V158, P835, DOI 10.1104/pp.111.191593; Slaughter AR, 2008, EUR J PLANT PATHOL, V122, P185, DOI 10.1007/s10658-008-9285-2; Spoel SH, 2009, CELL, V137, P860, DOI 10.1016/j.cell.2009.03.038; TAKEUCHI Y, 1990, PLANT PHYSIOL, V93, P673, DOI 10.1104/pp.93.2.673; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Ton J, 2005, PLANT CELL, V17, P987, DOI 10.1105/tpc.104.029728; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Upchurch RG, 2011, BIOTECHNOL LETT, V33, P2397, DOI 10.1007/s10529-011-0722-5; Upchurch RG, 2010, PHYSIOL MOL PLANT P, V75, P64, DOI 10.1016/j.pmpp.2010.08.007; Van der Ent S, 2009, NEW PHYTOL, V183, P419, DOI 10.1111/j.1469-8137.2009.02851.x; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Worrall D, 2012, NEW PHYTOL, V193, P770, DOI 10.1111/j.1469-8137.2011.03987.x; Wu CC, 2010, J EXP BOT, V61, P995, DOI 10.1093/jxb/erp363; Xiao L, 2012, J ECON ENTOMOL, V105, P2167, DOI 10.1603/EC12054; Yi SY, 1998, MOL CELLS, V8, P556; Zhang CF, 2011, POSTHARVEST BIOL TEC, V61, P145, DOI 10.1016/j.postharvbio.2011.02.008; Zimmerli L, 2000, P NATL ACAD SCI USA, V97, P12920, DOI 10.1073/pnas.230416897	80	19	21	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85142	10.1371/journal.pone.0085142	http://dx.doi.org/10.1371/journal.pone.0085142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454805	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100056
J	Leigh, ND; Bian, GL; Ding, XL; Liu, H; Aygun-Sunar, S; Burdelya, LG; Gudkov, AV; Cao, XF				Leigh, Nicholas D.; Bian, Guanglin; Ding, Xilai; Liu, Hong; Aygun-Sunar, Semra; Burdelya, Lyudmila G.; Gudkov, Andrei V.; Cao, Xuefang			A Flagellin-Derived Toll-Like Receptor 5 Agonist Stimulates Cytotoxic Lymphocyte-Mediated Tumor Immunity	PLOS ONE			English	Article							T-CELL RESPONSES; NF-KAPPA-B; IN-VIVO; BACTERIAL FLAGELLIN; ANTITUMOR IMMUNITY; EFFECTIVE ADJUVANT; DENDRITIC CELLS; MESSENGER-RNAS; STRANDED-RNA; GRANZYME-B	Toll-like receptor (TLR) mediated recognition of pathogen associated molecular patterns allows the immune system to rapidly respond to a pathogenic insult. The "danger context'' elicited by TLR agonists allows an initially non-immunogenic antigen to become immunogenic. This ability to alter environment is highly relevant in tumor immunity, since it is inherently difficult for the immune system to recognize host-derived tumors as immunogenic. However, immune cells may have encountered certain TLR ligands associated with tumor development, yet the endogenous stimulation is typically not sufficient to induce spontaneous tumor rejection. Of special interest are TLR5 agonists, because there are no endogenous ligands that bind TLR5. CBLB502 is a pharmacologically optimized TLR5 agonist derived from Salmonella enterica flagellin. We examined the effect of CBLB502 on tumor immunity using two syngeneic lymphoma models, both of which do not express TLR5, and thus do not directly respond to CBLB502. Upon challenge with the T-cell lymphoma RMAS, CBLB502 treatment after tumor inoculation protects C57BL/6 mice from death caused by tumor growth. This protective effect is both natural killer (NK) cell-and perforin-dependent. In addition, CBLB502 stimulates clearance of the B-cell lymphoma A20 in BALB/c mice in a CD8(+) T cell-dependent fashion. Analysis on the cellular level via ImageStream flow cytometry reveals that CD11b(+) and CD11c(+) cells, but neither NK nor T cells, directly respond to CBLB502 as determined by NF kappa B nuclear translocation. Our findings demonstrate that CBLB502 stimulates a robust antitumor response by directly activating TLR5-expressing accessory immune cells, which in turn activate cytotoxic lymphocytes.	[Leigh, Nicholas D.; Bian, Guanglin; Ding, Xilai; Cao, Xuefang] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Liu, Hong] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Aygun-Sunar, Semra; Burdelya, Lyudmila G.; Gudkov, Andrei V.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Cao, XF (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	Xuefang.Cao@RoswellPark.org	Leigh, Nicholas/AAV-6537-2021	Leigh, Nicholas/0000-0002-6978-6254; Gudkov, Andrei/0000-0003-2548-0154	Alliance Foundation Award from Roswell Park Alliance Foundation; American Cancer Society [IRG-02-197-9]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Alliance Foundation Award from Roswell Park Alliance Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an Alliance Foundation Award (X. C.) from Roswell Park Alliance Foundation and Institutional Research Grant #IRG-02-197-9 (X. C.) from the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Bates JT, 2011, J IMMUNOL, V186, P6255, DOI 10.4049/jimmunol.1001855; Bohnhorst J, 2006, LEUKEMIA, V20, P1138, DOI 10.1038/sj.leu.2404225; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Burdelya LG, 2013, P NATL ACAD SCI USA, V110, pE1857, DOI 10.1073/pnas.1222805110; Burdelya LG, 2012, INT J RADIAT ONCOL, V83, P228, DOI 10.1016/j.ijrobp.2011.05.055; Cai ZY, 2011, CANCER RES, V71, P2466, DOI 10.1158/0008-5472.CAN-10-1993; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Chicoine MR, 2007, NEUROSURGERY, V60, P372, DOI 10.1227/01.NEU.0000249280.61761.2E; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; Ding XL, 2012, J IMMUNOL, V189, P4719, DOI 10.4049/jimmunol.1201206; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; El Andaloussi A, 2006, GLIA, V54, P526, DOI 10.1002/glia.20401; Faham A, 2010, J IMMUNOL, V185, P1744, DOI 10.4049/jimmunol.1000027; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Garaude J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002868; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; GLIMCHER LH, 1982, J EXP MED, V155, P445, DOI 10.1084/jem.155.2.445; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; KAUFMAN DS, 1993, J IMMUNOL, V150, P1429; KIM KJ, 1979, J IMMUNOL, V122, P549; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Lonsdorf AS, 2003, J IMMUNOL, V171, P3941, DOI 10.4049/jimmunol.171.8.3941; Lyakh LA, 2000, J IMMUNOL, V165, P3647, DOI 10.4049/jimmunol.165.7.3647; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Nishikado H, 2011, J IMMUNOL, V186, P5766, DOI 10.4049/jimmunol.1100370; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Salazar-Gonzalez RM, 2007, J IMMUNOL, V179, P6169, DOI 10.4049/jimmunol.179.9.6169; Scheel B, 2006, EUR J IMMUNOL, V36, P2807, DOI 10.1002/eji.200635910; Schwarz K, 2003, EUR J IMMUNOL, V33, P1465, DOI 10.1002/eji.200323919; Sfondrini L, 2006, J IMMUNOL, V176, P6624, DOI 10.4049/jimmunol.176.11.6624; Smyth MJ, 1998, J EXP MED, V188, P1611, DOI 10.1084/jem.188.9.1611; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Tsujimoto H, 2005, J LEUKOCYTE BIOL, V78, P888, DOI 10.1189/jlb.0105051; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Whitmore MM, 2004, CANCER RES, V64, P5850, DOI 10.1158/0008-5472.CAN-04-0063; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	46	38	43	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85587	10.1371/journal.pone.0085587	http://dx.doi.org/10.1371/journal.pone.0085587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454895	Green Submitted, Green Published, gold			2022-12-25	WOS:000329925800051
J	Hasselbalch, HC; Skov, V; Larsen, TS; Thomassen, M; Riley, CH; Jensen, MK; Bjerrum, OW; Kruse, TA				Hasselbalch, Hans Carl; Skov, Vibe; Larsen, Thomas Stauffer; Thomassen, Mads; Riley, Caroline Hasselbalch; Jensen, Morten K.; Bjerrum, Ole Weis; Kruse, Torben A.			Transcriptional Profiling of Whole Blood Identifies a Unique 5-Gene Signature for Myelofibrosis and Imminent Myelofibrosis Transformation	PLOS ONE			English	Article							GENE-EXPRESSION; POLYCYTHEMIA-VERA; OLFACTOMEDIN 4; ESSENTIAL THROMBOCYTHEMIA; CD34(+) CELLS; CHRONIC INFLAMMATION; MYELOID METAPLASIA; PERIPHERAL-BLOOD; MUTATION STATUS; V617F MUTATION	Identifying a distinct gene signature for myelofibrosis may yield novel information of the genes, which are responsible for progression of essential thrombocythemia and polycythemia vera towards myelofibrosis. We aimed at identifying a simple gene signature - composed of a few genes - which were selectively and highly deregulated in myelofibrosis patients. Gene expression microarray studies have been performed on whole blood from 69 patients with myeloproliferative neoplasms. Amongst the top-20 of the most upregulated genes in PMF compared to controls, we identified 5 genes (DEFA4, ELA2, OLFM4, CTSG, and AZU1), which were highly significantly deregulated in PMF only. None of these genes were significantly regulated in ET and PV patients. However, hierarchical cluster analysis showed that these genes were also highly expressed in a subset of patients with ET (n = 1) and PV (n = 4) transforming towards myelofibrosis and/or being featured by an aggressive phenotype. We have identified a simple 5-gene signature, which is uniquely and highly significantly deregulated in patients in transitional stages of ET and PV towards myelofibrosis and in patients with PMF only. Some of these genes are considered to be responsible for the derangement of bone marrow stroma in myelofibrosis. Accordingly, this gene-signature may reflect key processes in the pathogenesis and pathophysiology of myelofibrosis development.	[Hasselbalch, Hans Carl] Univ Copenhagen, Dept Hematol, Roskilde Hosp, Roskilde, Denmark; [Skov, Vibe; Thomassen, Mads; Kruse, Torben A.] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Larsen, Thomas Stauffer] Odense Univ Hosp, Dept Hematol X, DK-5000 Odense, Denmark; [Riley, Caroline Hasselbalch; Jensen, Morten K.] Univ Copenhagen, Herlev Hosp, Dept Hematol L, DK-2730 Herlev, Denmark; [Bjerrum, Ole Weis] Univ Copenhagen, Rigshosp, Dept Hematol L, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen	Hasselbalch, HC (corresponding author), Univ Copenhagen, Dept Hematol, Roskilde Hosp, Roskilde, Denmark.	hans.hasselbalch@dadlnet.dk	Bjerrum, Ole Weis/AAF-9999-2019; Hasselbalch, Hans/H-2217-2017	Larsen, Thomas Stauffer/0000-0002-8418-6708; Hasselbalch, Hans/0000-0003-3936-8032	Danish Council for Independent Research \ Medical Sciences	Danish Council for Independent Research \ Medical Sciences(Det Frie Forskningsrad (DFF))	The study has received grants from the The Danish Council for Independent Research vertical bar Medical Sciences (http://fivu.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad/radet/dff-sundhed-og-sygdom) The funders had no role in study design, data Collection and analysis, decision to publish, or preparation of the manuscript.	Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkofsky-Fessler W, 2010, CLIN CANCER RES, V16, P4339, DOI 10.1158/1078-0432.CCR-10-1092; Borregaard N, 2001, CURR OPIN HEMATOL, V8, P23, DOI 10.1097/00062752-200101000-00005; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Catani L, 2009, LEUKEMIA, V23, P997, DOI 10.1038/leu.2008.357; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Gnatenko DV, 2010, BLOOD, V115, P7, DOI 10.1182/blood-2009-05-224477; Grover PK, 2010, CANCER METAST REV, V29, P761, DOI 10.1007/s10555-010-9262-z; Guglielmelli P, 2007, STEM CELLS, V25, P165, DOI 10.1634/stemcells.2006-0351; Hager M, 2010, J INTERN MED, V268, P25, DOI 10.1111/j.1365-2796.2010.02237.x; Hasselbalch HC, 2013, CYTOKINE GROWTH F R, V24, P133, DOI 10.1016/j.cytogfr.2013.01.004; Hasselbalch HC, 2013, LEUKEMIA RES, V37, P214, DOI 10.1016/j.leukres.2012.10.020; Hasselbalch HC, 2012, BLOOD, V119, P3219, DOI 10.1182/blood-2011-11-394775; Hasselbalch HC, 2011, LEUKEMIA RES, V35, P1330, DOI 10.1016/j.leukres.2011.03.013; Hasselbalch HC, 2009, LEUKEMIA RES, V33, P11, DOI 10.1016/j.leukres.2008.06.002; Hasselbalch HC, 2013, LEUK RES; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jones LC, 2005, STEM CELLS, V23, P631, DOI 10.1634/stemcells.2004-0131; Kralovics R, 2005, BLOOD, V106, P3374, DOI 10.1182/blood-2005-05-1889; Lataillade JJ, 2008, BLOOD, V112, P3026, DOI 10.1182/blood-2008-06-158386; Liu WL, 2010, BLOOD, V116, P4938, DOI 10.1182/blood-2009-10-246439; Passamonti F, 2006, BLOOD, V107, P3676, DOI 10.1182/blood-2005-09-3826; Pellagatti A, 2003, CANCER RES, V63, P3940; Puigdecanet E, 2008, LEUKEMIA, V22, P1368, DOI 10.1038/leu.2008.112; Rosti V, 2007, BLOOD CELL MOL DIS, V38, P280, DOI 10.1016/j.bcmd.2007.01.003; Skov V, 2012, LEUKEMIA RES, V36, P1387, DOI 10.1016/j.leukres.2012.07.009; Skov V, 2012, EXP HEMATOL, V40, P771, DOI 10.1016/j.exphem.2012.05.011; Skov V, 2012, LEUKEMIA LYMPHOMA, V53, P123, DOI 10.3109/10428194.2011.597905; Skov V, 2011, EUR J HAEMATOL, V87, P54, DOI 10.1111/j.1600-0609.2011.01618.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tefferi A, 2000, NEW ENGL J MED, V342, P1255, DOI 10.1056/NEJM200004273421706; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Xu M, 2005, BLOOD, V105, P4805; Yu L, 2011, NEOPLASMA, V58, P9, DOI 10.4149/neo_2011_01_9	38	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85567	10.1371/journal.pone.0085567	http://dx.doi.org/10.1371/journal.pone.0085567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454890	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500055
J	Pham, TTK; Stinson, B; Thiyagarajan, N; Lizotte-Waniewski, M; Brew, K; Acharya, KR				Pham, Tram T. K.; Stinson, Brittany; Thiyagarajan, Nethaji; Lizotte-Waniewski, Michelle; Brew, Keith; Acharya, K. Ravi			Structures of Complexes of a Metal-independent Glycosyltransferase GT6 from Bacteroides ovatus with UDP-N-Acetylgalactosamine (UDP-GalNAc) and Its Hydrolysis Products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Crystal Structure; Enzyme Mechanisms; Glycosyltransferases; X-ray Crystallography	BLOOD-GROUP-B; GROUP-A; FAMILY; BINDING; GENE; EVOLUTION; SUBSTRATE; MUTANTS; SYSTEM	Background: Bacterial homologues of human blood group synthases (glycosyltransferase family GT6) differ in being metal-independent. Results: The structure has been determined of a GT6 from Bacteroides ovatus in a complex with the substrate UDP-GalNAc. Conclusion: Interactions with the polypeptide replace substrate-metal interactions in metal-dependent mammalian homologues. Significance: Metal independence in GT6 is attainable because the metal acts in substrate binding but not directly in catalysis. Mammalian members of glycosyltransferase family 6 (GT6) of the CAZy database have a GT-A fold containing a conserved Asp-X-Asp (DXD) sequence that binds an essential metal cofactor. Bacteroides ovatus GT6a represents a GT6 clade found in more than 30 Gram-negative bacteria that is similar in sequence to the catalytic domains of mammalian GT6, but has an Asn(95)-Ala-Asn(97) (NXN) sequence substituted for the DXD motif and metal-independent catalytic activity. Co-crystals of a low activity mutant of BoGT6a (E192Q) with UDP-GalNAc contained protein complexes with intact UDP-GalNAc and two forms with hydrolysis products (UDP plus GalNAc) representing an initial closed complex and later open form primed for product release. Two cationic residues near the C terminus of BoGT6a, Lys(231) and Arg(243), interact with the diphosphate moiety of UDP-GalNAc, but only Lys(231) interacts with the UDP product and may function in leaving group stabilization. The amide group of Asn(95), the first Asn of the NXN motif, interacts with the ribose moiety of the substrate. This metal-independent GT6 resembles its metal-dependent homologs in undergoing conformational changes on binding UDP-GalNAc that arise from structuring the C terminus to cover this substrate. It appears that in the GT6 family, the metal cofactor functions specifically in binding the UDP moiety in the donor substrate and transition state, actions that can be efficiently performed by components of the polypeptide chain.	[Pham, Tram T. K.; Thiyagarajan, Nethaji; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Stinson, Brittany; Lizotte-Waniewski, Michelle; Brew, Keith] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA	University of Bath; State University System of Florida; Florida Atlantic University	Brew, K (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, 777 Glades Rd, Boca Raton, FL 33431 USA.	kbrew@fau.edu; bsskra@bath.ac.uk	Brew, Keith/W-1643-2019	Acharya, K. Ravi/0000-0002-3009-4058	Wellcome Trust [088464]; Biotechnology Center of Ho Chi Minh City, Vietnam; University of Bath; National Science Foundation; National Institutes of Health [AR40994]	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology Center of Ho Chi Minh City, Vietnam; University of Bath; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Wellcome Trust equipment grant (number 088464) (to K. R. A.).; Supported by the Biotechnology Center of Ho Chi Minh City, Vietnam and University of Bath for a postgraduate studentship.; Partly funded by the National Science Foundation GK-12 Program.; Supported by National Institutes of Health Grant AR40994. To whom correspondence may be addressed: Dept. of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University, 777 Glades Rd., Boca Raton, FL 33431. Tel.: 561-297-0407; E-mail: kbrew@fau.edu.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alfaro JA, 2008, J BIOL CHEM, V283, P10097, DOI 10.1074/jbc.M708669200; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200; Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200; Bovin N, 2012, BBA-GEN SUBJECTS, V1820, P1373, DOI 10.1016/j.bbagen.2012.02.005; Breton C, 1998, J BIOCHEM, V123, P1000; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Brew K, 2010, J BIOL CHEM, V285, P37121, DOI 10.1074/jbc.R110.176248; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Debbink K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002921; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Hosseini-Maaf B, 2007, TRANSFUSION, V47, P864, DOI 10.1111/j.1537-2995.2007.01203.x; Jamaluddin H, 2007, J MOL BIOL, V369, P1270, DOI 10.1016/j.jmb.2007.04.012; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Pak JE, 2006, J BIOL CHEM, V281, P26693, DOI 10.1074/jbc.M603534200; Pak JE, 2011, J MOL BIOL, V414, P798, DOI 10.1016/j.jmb.2011.10.039; Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832; Seto NOL, 1997, J BIOL CHEM, V272, P14133, DOI 10.1074/jbc.272.22.14133; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; Svensson L, 2013, BLOOD, V121, P1459, DOI 10.1182/blood-2012-10-455055; Thiyagarajan N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00940; Tumbale P, 2008, BIOCHEMISTRY-US, V47, P8711, DOI 10.1021/bi800852a; Tumbale P, 2009, J BIOL CHEM, V284, P25126, DOI 10.1074/jbc.M109.033878; Tumbale P, 2008, GLYCOBIOLOGY, V18, P1036, DOI 10.1093/glycob/cwn083; Turcot-Dubois AL, 2007, GLYCOBIOLOGY, V17, P516, DOI 10.1093/glycob/cwm016; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Xu HJ, 1999, J BIOL CHEM, V274, P29390, DOI 10.1074/jbc.274.41.29390	33	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8041	8050		10.1074/jbc.M113.545384	http://dx.doi.org/10.1074/jbc.M113.545384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24459149	Green Published, hybrid			2022-12-25	WOS:000333157500004
J	Ronsard, L; Lata, S; Singh, J; Ramachandran, VG; Das, S; Banerjea, AC				Ronsard, Larance; Lata, Sneh; Singh, Jyotsna; Ramachandran, Vishnampettai G.; Das, Shukla; Banerjea, Akhil C.			Molecular and Genetic Characterization of Natural HIV-1 Tat Exon-1 Variants from North India and Their Functional Implications	PLOS ONE			English	Article							SUBTYPE-C; TRANSACTIVATION ACTIVITY; VIRUS; PROTEIN; RNA; RECOMBINATION; EXPRESSION; INFECTION; SEQUENCE; TRIAL	Background: Designing an ideal vaccine against HIV-1 has been difficult due to enormous genetic variability as a result of high replication rate and lack of proofreading activity of reverse transcriptase leading to emergence of genetic variants and recombinants. Tat transactivates HIV-1 LTR, resulting in a remarkable increase in viral gene expression, and plays a vital role in pathogenesis. The aim of this study was to characterize the genetic variations of Tat exon-1 from HIV-1 infected patients from North India. Methods: Genomic DNA was isolated from PBMCs and Tat exon-1 was PCR amplified with specific primers followed by cloning, sequencing and sequence analyses using bioinformatic tools for predicting HIV-1 subtypes, recombination events, conservation of domains and phosphorylation sites, and LTR transactivation by luciferase assay. Results: Phylogenetic analysis of Tat exon-1 variants (n = 120) revealed sequence similarity with South African Tat C sequences and distinct geographical relationships were observed for B/C recombinants. Bootscan analysis of our variants showed 90% homology to Tat C and 10% to B/C recombinants with a precise breakpoint. Natural substitutions were observed with high allelic frequencies which may be beneficial for virus. High amino acid conservation was observed in Tat among Anti Retroviral Therapy (ART) recipients. Barring few changes, most of the functional domains, predicted motifs and phosphorylation sites were well conserved in most of Tat variants. dN/dS analysis revealed purifying selection, implying the importance of functional conservation of Tat exon-1. Our Indian Tat C variants and B/C recombinants showed differential LTR transactivation. Conclusions: The possible role of Tat exon-1 variants in shaping the current HIV-1 epidemic in North India was highlighted. Natural substitutions across conserved functional domains were observed and provided evidence for the emergence of B/C recombinants within the ORF of Tat exon-1. These events are likely to have implications for viral pathogenesis and vaccine formulations.	[Ronsard, Larance; Singh, Jyotsna; Banerjea, Akhil C.] Natl Inst Immunol, Virol Lab, New Delhi 110067, India; [Ronsard, Larance; Lata, Sneh; Singh, Jyotsna; Ramachandran, Vishnampettai G.; Das, Shukla] Univ Coll Med Sci, Dept Microbiol, Delhi 110095, India; [Ronsard, Larance; Lata, Sneh; Singh, Jyotsna; Ramachandran, Vishnampettai G.; Das, Shukla] Guru Teg Bahadur Hosp, Delhi 110095, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); University of Delhi; University College of Medical Sciences; University of Delhi; University College of Medical Sciences	Banerjea, AC (corresponding author), Natl Inst Immunol, Virol Lab, New Delhi 110067, India.	akhil@nii.res.in	Singh, Jaikaran/O-5363-2015; Ronsard, Larance/H-2731-2019	Singh, Jaikaran/0000-0002-9273-6765; Ronsard, Larance/0000-0002-5307-1940	Department of Biotechnology [BT/PR10599/Med/29/76/2008]; Indian Council of Medical Research, Government of India [HIV/50/142/9/2011-ECD-II]; National Institute of Immunology, New Delhi, India	Department of Biotechnology; Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); National Institute of Immunology, New Delhi, India	This study was supported by the Department of Biotechnology (BT/PR10599/Med/29/76/2008) and the Indian Council of Medical Research (HIV/50/142/9/2011-ECD-II), Government of India, to the corresponding author, National Institute of Immunology, New Delhi, India, for the period of 3 years. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Blackard JT, 2002, CLIN INFECT DIS, V34, P1108, DOI 10.1086/339547; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; BUONAGURO L, 1994, J VIROL, V68, P2677, DOI 10.1128/JVI.68.4.2677-2682.1994; CALNAN BJ, 1991, GENE DEV, V5, P201, DOI 10.1101/gad.5.2.201; Campbell GR, 2004, J BIOL CHEM, V279, P48197, DOI 10.1074/jbc.M406195200; CHANG HK, 1994, GENE THER, V1, P208; COFFIN JM, 1979, J GEN VIROL, V42, P1, DOI 10.1099/0022-1317-42-1-1; Desfosses Y, 2005, J VIROL, V79, P9180, DOI 10.1128/JVI.79.14.9180-9191.2005; DOUGHERTY JP, 1988, J VIROL, V62, P2817, DOI 10.1128/JVI.62.8.2817-2822.1988; Endo-Munoz L, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-17; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Ensoli B, 2008, AIDS, V22, P2207, DOI 10.1097/QAD.0b013e32831392d4; Fanales-Belasio E, 2002, J IMMUNOL, V168, P197, DOI 10.4049/jimmunol.168.1.197; Gavioli R, 2004, J IMMUNOL, V173, P3838, DOI 10.4049/jimmunol.173.6.3838; Goldstein G, 1996, NAT MED, V2, P960, DOI 10.1038/nm0996-960; Gupta N, 2009, AIDS, V23, P141, DOI 10.1097/QAD.0b013e32831c8b08; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hetzer C, 2005, MICROBES INFECT, V7, P1364, DOI 10.1016/j.micinf.2005.06.003; Hinkula J, 1997, J VIROL, V71, P5528, DOI 10.1128/JVI.71.7.5528-5539.1997; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Huang L, 1998, J VIROL, V72, P8952, DOI 10.1128/JVI.72.11.8952-8960.1998; Huo LH, 2011, J BIOL CHEM, V286, P9280, DOI 10.1074/jbc.M110.208884; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; JUNGHANS RP, 1982, CELL, V30, P53, DOI 10.1016/0092-8674(82)90011-3; Kim DT, 1997, J IMMUNOL, V159, P1666; Konings FAJ, 2006, J MED VIROL, V78, P523, DOI 10.1002/jmv.20572; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Lakhashe S, 2008, J BIOSCIENCES, V33, P515, DOI 10.1007/s12038-008-0070-3; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; Lata S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082128; Li L, 2012, ADV VIROL, V2012, DOI 10.1155/2012/123605; Loer B, 2008, NAT CELL BIOL, V10, P422, DOI 10.1038/ncb1704; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Longo O, 2009, VACCINE, V27, P3306, DOI 10.1016/j.vaccine.2009.01.090; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; MCMILLAN NAJ, 1995, VIROLOGY, V213, P413, DOI 10.1006/viro.1995.0014; Mohankumar K, 2013, CHEM BIOL INTERACT; Monaco DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017185; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Mullick R, 2010, VIRUS RES, V147, P195, DOI 10.1016/j.virusres.2009.10.024; Neogi U, 2011, INDIAN J MED RES, V134, P769, DOI 10.4103/0971-5916.92624; Pagni M, 2007, NUCLEIC ACIDS RES, V35, pW433, DOI 10.1093/nar/gkm352; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Rana TM, 1999, ARCH BIOCHEM BIOPHYS, V365, P175, DOI 10.1006/abbi.1999.1206; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Reza SM, 2003, J VIROL, V77, P8602, DOI 10.1128/JVI.77.15.8602-8606.2003; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Rodriguez MA, 2009, VIROLOGY, V385, P416, DOI 10.1016/j.virol.2008.12.025; ROY S, 1990, GENE DEV, V4, P1365, DOI 10.1101/gad.4.8.1365; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Shankarappa R, 2001, J VIROL, V75, P10479, DOI 10.1128/JVI.75.21.10479-10487.2001; Siddappa NB, 2005, AIDS, V19, P1426, DOI 10.1097/01.aids.0000180795.49016.89; Sood V, 2008, AIDS, V22, P1683, DOI 10.1097/QAD.0b013e3282f56114; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan RY, 1998, P NATL ACAD SCI USA, V95, P4247, DOI 10.1073/pnas.95.8.4247; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripathy SP, 2005, AIDS RES HUM RETROV, V21, P152, DOI 10.1089/aid.2005.21.152; Turk G, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-14; Van Duyne R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-40; Verhoef K, 1997, VIROLOGY, V237, P228, DOI 10.1006/viro.1997.8786; Verma S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059283; Zhang M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-25; Zheng Lin, 2005, J Zhejiang Univ Sci B, V6, P668, DOI 10.1631/jzus.2005.B0668	70	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85452	10.1371/journal.pone.0085452	http://dx.doi.org/10.1371/journal.pone.0085452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465566	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000015
J	Lacey, MG; Gooding-Williams, G; Prokic, EJ; Yamawaki, N; Hall, SD; Stanford, IM; Woodhall, GL				Lacey, Michael G.; Gooding-Williams, Gerard; Prokic, Emma J.; Yamawaki, Naoki; Hall, Stephen D.; Stanford, Ian M.; Woodhall, Gavin L.			Spike Firing and IPSPs in Layer V Pyramidal Neurons during Beta Oscillations in Rat Primary Motor Cortex (M1) In Vitro	PLOS ONE			English	Article							PARKINSONS-DISEASE; INHIBITORY INTERNEURONS; GAMMA-OSCILLATIONS; SOMATOSENSORY CORTEX; RECEPTOR ACTIVATION; SUBTHALAMIC NUCLEUS; MOUSE NEOCORTEX; CEREBRAL-CORTEX; 40 HZ; HIPPOCAMPUS	Beta frequency oscillations (10-35 Hz) in motor regions of cerebral cortex play an important role in stabilising and suppressing unwanted movements, and become intensified during the pathological akinesia of Parkinson's Disease. We have used a cortical slice preparation of rat brain, combined with concurrent intracellular and field recordings from the primary motor cortex (M1), to explore the cellular basis of the persistent beta frequency (27-30 Hz) oscillations manifest in local field potentials (LFP) in layers II and V of M1 produced by continuous perfusion of kainic acid (100 nM) and carbachol (5 mu M). Spontaneous depolarizing GABA-ergic IPSPs in layer V cells, intracellularly dialyzed with KCl and IEM1460 (to block glutamatergic EPSCs), were recorded at -80 mV. IPSPs showed a highly significant (P<0.01) beta frequency component, which was highly significantly coherent with both the Layer II and V LFP oscillation (which were in antiphase to each other). Both IPSPs and the LFP beta oscillations were abolished by the GABA(A) antagonist bicuculline. Layer V cells at rest fired spontaneous action potentials at sub-beta frequencies (mean of 7.1+1.2 Hz; n = 27) which were phase-locked to the layer V LFP beta oscillation, preceding the peak of the LFP beta oscillation by some 20 ms. We propose that M1 beta oscillations, in common with other oscillations in other brain regions, can arise from synchronous hyperpolarization of pyramidal cells driven by synaptic inputs from a GABA-ergic interneuronal network (or networks) entrained by recurrent excitation derived from pyramidal cells. This mechanism plays an important role in both the physiology and pathophysiology of control of voluntary movement generation.	[Lacey, Michael G.] Univ Birmingham, Sch Clin & Expt Med, Neuronal Networks Grp, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Gooding-Williams, Gerard; Prokic, Emma J.; Yamawaki, Naoki; Hall, Stephen D.; Stanford, Ian M.; Woodhall, Gavin L.] Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	University of Birmingham; Aston University	Woodhall, GL (corresponding author), Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	G.L.woodhall@aston.ac.uk	Yamawaki, Naoki/AAD-5044-2022	Yamawaki, Naoki/0000-0001-8253-2059; Hall, Stephen/0000-0002-9274-6867; woodhall, gavin/0000-0003-1281-9008; Stanford, Ian M/0000-0002-5677-8538	BBSRC [BB/H003894/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H003894/1] Funding Source: researchfish; Parkinson&quot;s UK [G-0711] Funding Source: researchfish; Parkinson&apos;s UK [G-0711] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Parkinson&quot;s UK(Parkinson&apos;s UK); Parkinson&apos;s UK(Parkinson&apos;s UK)		Ali AB, 2001, J NEUROSCI, V21, P2992, DOI 10.1523/JNEUROSCI.21-09-02992.2001; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; Canolty R, 2006, SCIENCE; Cauli B, 1997, J NEUROSCI, V17, P3894; Chen W, 1996, NEUROSCIENCE, V73, P39, DOI 10.1016/0306-4522(96)00009-7; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; Cunningham MO, 2003, J NEUROSCI, V23, P9761; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fanselow EE, 2008, J NEUROPHYSIOL, V100, P2640, DOI 10.1152/jn.90691.2008; Fanselow EE, 2010, J NEUROPHYSIOL, V104, P596, DOI 10.1152/jn.00206.2010; Fell J, 2005, HIPPOCAMPUS; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fisher NI, 1995, STAT ANAL CIRCULAR D; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gilbertson T, 2005, J NEUROSCI, V25, P7771, DOI 10.1523/JNEUROSCI.1762-05.2005; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Hedrick T, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00001; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kuhn AA, 2006, EUR J NEUROSCI, V23, P1956, DOI 10.1111/j.1460-9568.2006.04717.x; Leventhal DK, 2012, NEURON, V73, P523, DOI 10.1016/j.neuron.2011.11.032; Li Q, 2012, NEURON, V76, P1030, DOI 10.1016/j.neuron.2012.09.032; Li XM, 2013, J NEUROPHYSIOL, V109, P2739, DOI 10.1152/jn.00397.2012; Mancilla JG, 2007, J NEUROSCI, V27, P2058, DOI 10.1523/JNEUROSCI.2715-06.2007; McAllister CJ, 2013, J NEUROSCI, V33, P7919, DOI 10.1523/JNEUROSCI.5624-12.2013; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Moran RJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002124; Morgan NH, 2009, NEUROPHARMACOLOGY, V57, P356, DOI 10.1016/j.neuropharm.2009.07.017; Pakhotin PI, 1997, NEUROREPORT, V8, P1755, DOI 10.1097/00001756-199705060-00037; Pollok B, 2012, J PHYSIOL-LONDON, V590, P3203, DOI 10.1113/jphysiol.2012.231316; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; Samoilova MV, 1999, NEUROSCIENCE, V94, P261, DOI 10.1016/S0306-4522(99)00326-7; Schomburg EW, 2012, J NEUROSCI, V32, P11798, DOI 10.1523/JNEUROSCI.0656-12.2012; Sharott A, 2005, EUR J NEUROSCI, V21, P1413, DOI 10.1111/j.1460-9568.2005.03973.x; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Silberstein P, 2005, BRAIN, V128, P1277, DOI 10.1093/brain/awh480; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Stein E, 2013, EXP NEUROL, V245, P52, DOI 10.1016/j.expneurol.2012.07.023; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tamas G, 2004, EUR J NEUROSCI, V20, P2681, DOI 10.1111/j.1460-9568.2004.03719.x; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Yamawaki N, 2008, NEUROSCIENCE, V151, P386, DOI 10.1016/j.neuroscience.2007.10.021	49	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85109	10.1371/journal.pone.0085109	http://dx.doi.org/10.1371/journal.pone.0085109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465488	Green Published, gold, Green Accepted			2022-12-25	WOS:000330240500033
J	Millan-Ucles, A; Diaz-Castro, B; Garcia-Flores, P; Baez, A; Perez-Simon, JA; Lopez-Barneo, J; Piruat, JI				Millan-Ucles, Africa; Diaz-Castro, Blanca; Garcia-Flores, Paula; Baez, Alicia; Antonio Perez-Simon, Jose; Lopez-Barneo, Jose; Piruat, Jose I.			A Conditional Mouse Mutant in the Tumor Suppressor SdhD Gene Unveils a Link between p21(WAF1/Cip1) Induction and Mitochondrial Dysfunction	PLOS ONE			English	Article							COMPLEX-II; HIF-ALPHA; HYPOXIA; PHEOCHROMOCYTOMA; PARAGANGLIOMA; ACTIVATION; HIF1-ALPHA; SUCCINATE; APOPTOSIS; MUTATION	Mutations in mitochondrial complex II (MCII; succinate dehydrogenase, Sdh) genes cause familiar pheochromocytoma/paraganglioma tumors. Several mechanisms have been proposed to account for Sdh-mutation-induced tumorigenesis, the most accepted of which is based on the constitutive expression of the hypoxia-inducible factor 1 alpha (Hif1 alpha) at normal oxygen tension, a theory referred to as "pseudo-hypoxic drive". Other molecular processes, such as oxidative stress, apoptosis, or chromatin remodeling have been also proposed to play a causative role. Nevertheless, the actual contribution of each of these mechanisms has not been definitively established. Moreover, the biological factors that determine the tissue-specificity of these tumors have not been identified. In this work, we made use of the inducible SDHD-ESR mouse, a conditional mutant in the SdhD gene, which encodes the small subunit of MCII, and that acts as a tumor suppressor gene in humans. The analysis of the Hif1 alpha pathway in SDHD-ESR tissues and in two newly derived cell lines after complete SdhD loss -a requirement for hereditary paraganglioma type-1 tumor formation in humans-partially recapitulated the "pseudohypoxic" response and rendered inconsistent results. Therefore, we performed microarray analysis of adrenal medulla and kidney in order to identify other early gene expression changes elicited by SdhD deletion. Our results revealed that each mutant tissue displayed different variations in their gene expression profiles affecting to different biological processes. However, we found that the Cdkn1a gene was up-regulated in both tissues. This gene encodes the cyclin-dependent kinase inhibitor p21(WAF1/Cip1), a factor implicated in cell cycle, senescence, and cancer. The two SDHD-ESR cell lines also showed accumulation of this protein. This new and unprecedented evidence for a link between SdhD dysfunction and p21(WAF1/Cip1) will open new avenues for the study of the mechanisms that cause tumors in Sdh mutants. Finally, we discuss the actual role of Hif1 alpha in tumorigenesis.	[Millan-Ucles, Africa; Diaz-Castro, Blanca; Garcia-Flores, Paula; Baez, Alicia; Antonio Perez-Simon, Jose; Lopez-Barneo, Jose; Piruat, Jose I.] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Seville, Spain; [Millan-Ucles, Africa; Baez, Alicia; Antonio Perez-Simon, Jose; Piruat, Jose I.] Hosp Univ Virgen del Rocio, Dept Hematol, Seville, Spain; [Diaz-Castro, Blanca; Garcia-Flores, Paula; Lopez-Barneo, Jose] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital; CIBERNED	Piruat, JI (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Seville, Spain.	jpiruat-ibis@us.es	IBIS, NEUROBIOLOGIA/O-9922-2015	PEREZ-SIMON, JOSE-ANTONIO/0000-0002-0621-5809; Perez-Simon, Jose A/0000-0003-3616-6101	Spanish Ministry of Science and Innovation [SAF2009-06970, SAF2009-12409]; Andalusian Government [CTS-4589]; Botin Foundation	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Andalusian Government; Botin Foundation	This work was supported by grants SAF2009-06970 and SAF2009-12409 of the Plan Nacional I+D+I from The Spanish Ministry of Science and Innovation, and grant CTS-4589 from the Andalusian Government. Support was also provided by the Botin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Bacon AL, 2004, ANN MED, V36, P530, DOI 10.1080/07853890410018231; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Bayley JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007987; Baysal BE, 2008, J MED GENET, V45, P689, DOI 10.1136/jmg.2008.058560; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2013, BBA-BIOENERGETICS, V1827, P573, DOI 10.1016/j.bbabio.2012.12.005; Briere JJ, 2005, HUM MOL GENET, V14, P3263, DOI 10.1093/hmg/ddi359; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Cheng XY, 2010, BIOCHEM BIOPH RES CO, V403, P103, DOI 10.1016/j.bbrc.2010.10.126; Dahia PLM, 2006, CURR OPIN ONCOL, V18, P1, DOI 10.1097/01.cco.0000198017.45982.06; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Degenhardt K, 2002, CANCER CELL, V2, P193, DOI 10.1016/S1535-6108(02)00126-5; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Diaz-Castro B, 2012, MOL CELL BIOL, V32, P3347, DOI 10.1128/MCB.00128-12; Favier J, 2010, BEST PRACT RES CL EN, V24, P957, DOI 10.1016/j.beem.2010.10.004; Favier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007094; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Gill AJ, 2011, PATHOLOGY, V43, P85, DOI 10.1097/PAT.0b013e3283410c9c; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Hensen EF, 2004, ONCOGENE, V23, P4076, DOI 10.1038/sj.onc.1207591; Hoekstra AS, 2013, BBA-BIOENERGETICS, V1827, P543, DOI 10.1016/j.bbabio.2012.11.005; Ishii T, 2005, CANCER RES, V65, P203; Ishii T, 2011, MITOCHONDRION, V11, P155, DOI 10.1016/j.mito.2010.09.006; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lopez-Jimenez E, 2010, MOL ENDOCRINOL, V24, P2382, DOI 10.1210/me.2010-0256; Mathew R, 2008, METHOD ENZYMOL, V446, P77, DOI 10.1016/S0076-6879(08)01605-4; Merlo A, 2012, J CLIN ENDOCR METAB, V97, pE2194, DOI 10.1210/jc.2012-2410; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nakamura E, 2006, ENDOCR PATHOL, V17, P97, DOI 10.1385/EP:17:2:97; Piruat JI, 2004, MOL CELL BIOL, V24, P10933, DOI 10.1128/MCB.24.24.10933-10940.2004; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; SMITH BW, 2011, MOUSE MODELS HUMAN F, P82248, DOI DOI 10.5772/25346; Smith EH, 2007, HUM MOL GENET, V16, P3136, DOI 10.1093/hmg/ddm275; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Waypa GB, 2006, CIRC RES, V99, P970, DOI 10.1161/01.RES.0000247068.75808.3f; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699	43	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85528	10.1371/journal.pone.0085528	http://dx.doi.org/10.1371/journal.pone.0085528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465590	Green Submitted, gold, Green Published			2022-12-25	WOS:000330240500056
J	Pitino, M; Hoffman, MT; Zhou, LJ; Hall, DG; Stocks, IC; Duan, YP				Pitino, Marco; Hoffman, Michele T.; Zhou, Lijuan; Hall, David G.; Stocks, Ian C.; Duan, Yongping			The Phloem-Sap Feeding Mealybug (Ferrisia virgata) Carries 'Candidatus Liberibacter asiaticus' Populations That Do Not Cause Disease in Host Plants	PLOS ONE			English	Article							REAL-TIME PCR; DIAPHORINA-CITRI; GREENING DISEASE; SWEET ORANGE; PAULO STATE; VECTOR; INSECT; HEMIPTERA; TRANSMISSION; PERIWINKLE	'Candidatus Liberibacter asiaticus' (Las) is the primary causal agent of huanglongbing (HLB), the most devastating disease of citrus worldwide. There are three known insect vectors of the HLB-associated bacteria, and all are members of the Hemiptera: Diaphorina citri (Psyllidae), Trioza erytreae (Triozidae), and Cacopsylla (Psylla) citrisuga (Psyllidae). In this study, we found that another hemipteran, the striped mealybug Ferrisia virgata (Cockerell) (Hemiptera: Pseudococcidae), was able to acquire and retain Las bacteria. The bacterial titers were positively correlated with the feeding acquisition time on Las-infected leaf discs, with a two-weeks feeding period resulting in Ct values ranging from 23.1 to 36.1 (8.24x10(7) to 1.07x10(4) Las cells per mealybug). We further discovered that the prophage/phage populations of Las in the mealybugs were different from those of Las in psyllids based on Las prophage-specific molecular markers: infected psyllids harbored the Las populations with prophage/phage FP1 and FP2, while infected mealybugs carried the Las populations with the iFP3 being the dominant prophage/phage. As in the psyllids, Las bacteria were shown to move through the insect gut wall to the salivary glands after being ingested by the mealybug based on a time-course quantitative polymerase chain reaction (qPCR) assay of the dissected digestive systems. However, Las populations transmitted by the mealybugs did not cause disease in host plants. This is the first evidence of genetic difference among Las populations harbored by different insect vectors and difference among Las populations with respect to whether or not they cause disease in host plants.	[Pitino, Marco; Hoffman, Michele T.; Zhou, Lijuan; Hall, David G.; Duan, Yongping] ARS, US Hort Res Lab, USDA, Ft Pierce, FL 34945 USA; [Zhou, Lijuan] Univ Florida, Inst Food & Agr Sci, Indian River Res & Educ Ctr, Ft Pierce, FL USA; [Stocks, Ian C.] Florida Dept Agr & Consumer Serv, Drug Policy Inst, Gainesville, FL USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Duan, YP (corresponding author), ARS, US Hort Res Lab, USDA, Ft Pierce, FL 34945 USA.	yongping.duan@ars.usda.gov	Hoffman, Michele T/D-2537-2011; Zhou, Li/GSE-4531-2022		United States Department of Agriculture; Florida Department of Agriculture and Consumer Services-Specialty Crop Block Grant [18023]	United States Department of Agriculture(United States Department of Agriculture (USDA)); Florida Department of Agriculture and Consumer Services-Specialty Crop Block Grant	Funding provided by United States Department of Agriculture and Florida Department of Agriculture and Consumer Services-Specialty Crop Block Grant #18023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar El Desouky, 1994, Advances in Disease Vector Research, V10, P289; Ammar ED, 2009, ANNU REV ENTOMOL, V54, P447, DOI 10.1146/annurev.ento.54.110807.090454; Ammar E, 2011, ANN ENTOMOL SOC AM, V104, P526, DOI 10.1603/AN10134; Article Catalogues, 1997, J APPL ENTOMOL, V121, P559; Aubert B., 1988, P 10 C INT ORG CITR, P231; Bonani JP, 2010, ENTOMOL EXP APPL, V134, P35, DOI 10.1111/j.1570-7458.2009.00937.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Bove JM, 2003, ANNU REV PHYTOPATHOL, V41, P483, DOI 10.1146/annurev.phyto.41.052102.104034; Bove JM, 2007, IUBMB LIFE, V59, P346, DOI 10.1080/15216540701299326; Capoor S. P., 1974, Proceedings of the Sixth Conference of the International Organization of Citrus Virologists., P43; Cen YJ, 2012, FLA ENTOMOL, V95, P304, DOI 10.1653/024.095.0210; Cruz-Gonzalez AG, 2011, PHYTOPATHOLOGY, V101, pS276; Fletcher J, 1998, PHYTOPATHOLOGY, V88, P1351, DOI 10.1094/PHYTO.1998.88.12.1351; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; GARNIER M, 1983, PHYTOPATHOLOGY, V73, P1358, DOI 10.1094/Phyto-73-1358; Garnier M., 1991, P 11 C INT ORG CITR, P428; GHOSH S K, 1978, Annales de Phytopathologie, V9, P525; GILDOW FE, 1993, PHYTOPATHOLOGY, V83, P1293, DOI 10.1094/Phyto-83-1293; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hall DG, 2010, ANN ENTOMOL SOC AM, V103, P611, DOI 10.1603/AN10004; Hoffman MT, 2011, PHYTOPATHOLOGY, V101, pS73; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Li WB, 2008, PLANT DIS, V92, P854, DOI 10.1094/PDIS-92-6-0854; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Morgan JK, 2012, MOL CELL PROBE, V26, P90, DOI 10.1016/j.mcp.2011.12.001; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Pitino M, 2013, MOL PLANT MICROBE IN, V26, P130, DOI 10.1094/MPMI-07-12-0172-FI; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Purcell A.H., 1991, P383; Skelley LH, 2004, BIOL CONTROL, V29, P14, DOI 10.1016/S1049-9644(03)00129-4; Teixeira DD, 2005, INT J SYST EVOL MICR, V55, P1857, DOI 10.1099/ijs.0.63677-0; Tyler HL, 2009, MOL PLANT MICROBE IN, V22, P1624, DOI 10.1094/MPMI-22-12-1624; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Zhang MQ, 2010, PHYTOPATHOLOGY, V100, P239, DOI 10.1094/PHYTO-100-3-0239; Zhou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082248; Zhou LJ, 2011, APPL ENVIRON MICROB, V77, P6663, DOI 10.1128/AEM.05111-11	39	6	7	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85503	10.1371/journal.pone.0085503	http://dx.doi.org/10.1371/journal.pone.0085503			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465578	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500052
J	Yuan, JB; Zhu, QM; Liu, B				Yuan, Jianbo; Zhu, Qingming; Liu, Bin			Phylogenetic and Biological Significance of Evolutionary Elements from Metazoan Mitochondrial Genomes	PLOS ONE			English	Article							CODON-SUBSTITUTION MODELS; WHOLE-PROTEOME PHYLOGENY; FEATURE SUBSET-SELECTION; CONSERVED REGION; SEQUENCE ALIGNMENT; ANIMAL PHYLOGENY; RIBOSOMAL-RNA; TREE; CLASSIFICATION; GENE	The evolutionary history of living species is usually inferred through the phylogenetic analysis of molecular and morphological information using various mathematical models. New challenges in phylogenetic analysis are centered mostly on the search for accurate and efficient methods to handle the huge amounts of sequence data generated from newer genome sequencing. The next major challenge is the determination of relationships between the evolution of structural elements and their functional implementation, which is largely ignored in previous analyses. Here, we described the discovery of structural elements in metazoan mitochondrial genomes, termed key K-strings, that can serve as a basis for phylogenetic tree construction. Although comprising only a small fraction (0.73%) of all K-strings, these key K-strings are pivotal to the tree construction because they allow for a significant reduction in the computational time required to construct phylogenetic trees, and more importantly, they make significant improvement to the results of phylogenetic inference. The trees constructed from the key K-strings were consistent overall to our current view of metazoan phylogeny and exhibited a more rational topology than the trees constructed by using other conventional methods. Surprisingly, the key K-strings tended to accumulate in the conserved regions of the original sequences, which were most likely due to strong selection pressure. Furthermore, the special structural features of the key K-strings should have some potential applications in the study of the structures and functions relationship of proteins and in the determination of evolutionary trajectory of species. The novelty and potential importance of key K-strings lead us to believe that they are essential evolutionary elements. As such, they may play important roles in the process of species evolution and their physical existence. Further studies could lead to discoveries regarding the relationship between evolution and processes of speciation.	[Yuan, Jianbo; Liu, Bin] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Ctr Systemat Genom, Urumqi, Xinjiang, Peoples R China; [Yuan, Jianbo; Liu, Bin] Chinese Acad Sci, Inst Oceanol, CAS Key Lab Expt Marine Biol, Qingdao, Shandong, Peoples R China; [Yuan, Jianbo; Liu, Bin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhu, Qingming] GenomeSense Inst, Beijing, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, B (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Ctr Systemat Genom, Urumqi, Xinjiang, Peoples R China.	bliu@ms.xjb.ac.cn			Innovation Grant from Xinjiang Institute of Ecology and Geography; Institute of Oceanology, Chinese Academy of Sciences	Innovation Grant from Xinjiang Institute of Ecology and Geography; Institute of Oceanology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the Innovation Grant from Xinjiang Institute of Ecology and Geography, and the Bairen fund to BL of the Institute of Oceanology, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Bayona-Bafaluy MP, 2005, MOL BIOL EVOL, V22, P716, DOI 10.1093/molbev/msi059; Blanchette M, 2002, GENOME RES, V12, P739, DOI 10.1101/gr.6902; Boussau B, 2010, TRENDS ECOL EVOL, V25, P224, DOI 10.1016/j.tree.2009.09.007; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen H, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S9; Chu KH, 2006, BIOINFORMATICS, V22, P1690, DOI 10.1093/bioinformatics/btl146; Cover TM, 1991, ELEMENTS INFORM THEO; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EERNISSE DJ, 1992, SYST BIOL, V41, P305, DOI 10.1093/sysbio/41.3.305; Gardner AE, 2007, J VIROL, V81, P8303, DOI 10.1128/JVI.00366-07; Gaucher Eric A, 2010, COLD SPRING HARB PER, V2; Gimenez Gallego G, 2002, Nefrologia, V22 Suppl 5, P21; Giribet G, 1998, MOL PHYLOGENET EVOL, V9, P481, DOI 10.1006/mpev.1998.0494; Giribet G, 1999, MOL PHYLOGENET EVOL, V13, P619, DOI 10.1006/mpev.1999.0679; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Han B, 2006, BIOINFORMATICS, V22, P2136, DOI 10.1093/bioinformatics/btl350; Hao Bailin, 2004, J Bioinform Comput Biol, V2, P1; Henz Stefan R, 2005, Bioinformatics, V21, P2329, DOI 10.1093/bioinformatics/bth324; Jelonek J, 1997, ARTIF INTELL MED, V9, P227, DOI 10.1016/S0933-3657(96)00375-2; Jun SR, 2010, P NATL ACAD SCI USA, V107, P133, DOI 10.1073/pnas.0913033107; Kishore R, 2004, CURR PROTEIN PEPT SC, V5, P435, DOI 10.2174/1389203043379396; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lavrov DV, 2005, SYST BIOL, V54, P651, DOI 10.1080/10635150500221044; Leo-Macias A, 2005, BIOPHYS J, V88, P1291, DOI 10.1529/biophysj.104.052449; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Li QA, 2010, J BIOTECHNOL, V149, P115, DOI 10.1016/j.jbiotec.2009.12.015; Li ST, 2011, IEEE INT CONF FUZZY, P2583; Lim A, 1999, BIOINFORMATICS, V15, P1068, DOI 10.1093/bioinformatics/15.12.1068; Lin J, 2000, GENOME RES, V10, P808, DOI 10.1101/gr.10.6.808; Liu WL, 2001, J MOL BIOL, V313, P711, DOI 10.1006/jmbi.2001.5082; LOCKE M, 1977, NATURE, V270, P341, DOI 10.1038/270341a0; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Magnan CN, 2009, BIOINFORMATICS, V25, P2200, DOI 10.1093/bioinformatics/btp386; McInerney JO, 2008, TRENDS ECOL EVOL, V23, P276, DOI 10.1016/j.tree.2008.01.008; Morozov A, 1998, P NATL ACAD SCI USA, V95, P1120, DOI 10.1073/pnas.95.3.1120; Morrison DA, 1996, INT J PARASITOL, V26, P589, DOI 10.1016/0020-7519(96)00044-6; Nielsen C, 1996, BIOL J LINN SOC, V57, P385; Nye TMW, 2006, BIOINFORMATICS, V22, P117, DOI 10.1093/bioinformatics/bti720; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palermo C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001427; Park YH, 2003, 2003 INTERNATIONAL CONFERENCE ON NATURAL LANGUAGE PROCESSING AND KNOWLEDGE ENGINEERING, PROCEEDINGS, P591; Pasyk EA, 1998, J BIOL CHEM, V273, P31759, DOI 10.1074/jbc.273.48.31759; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Qi J, 2004, NUCLEIC ACIDS RES, V32, pW45, DOI 10.1093/nar/gkh362; Qi J, 2004, J MOL EVOL, V58, P1, DOI 10.1007/s00239-003-2493-7; Qi ZH, 2009, J THEOR BIOL, V260, P104, DOI 10.1016/j.jtbi.2009.05.011; Saarikoski J, 2011, LECT NOTES COMPUT SC, V6593, P260, DOI 10.1007/978-3-642-20282-7_27; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schierwater Bernd, 2009, Communicative & Integrative Biology, V2, P403; Shen L, 2005, IEEE ACM T COMPUT BI, V2, P166, DOI 10.1109/TCBB.2005.22; Snel B, 2005, ANNU REV MICROBIOL, V59, P191, DOI 10.1146/annurev.micro.59.030804.121233; Stenderup JT, 2006, MOL PHYLOGENET EVOL, V41, P182, DOI 10.1016/j.ympev.2006.06.006; Stuart GW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-204; Stuart GW, 2002, BIOINFORMATICS, V18, P100, DOI 10.1093/bioinformatics/18.1.100; Stuart GW, 2002, MOL BIOL EVOL, V19, P554, DOI 10.1093/oxfordjournals.molbev.a004111; SUZUKI Y, 1987, APPL MICROBIOL BIOT, V26, P546, DOI 10.1007/BF00253030; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; Teichmann SA, 1999, NAT GENET, V21, P66, DOI 10.1038/5001; Tekaia F, 1999, GENOME RES, V9, P550; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tripathi N., 2011, INT J HYBRID INTELLI, V8, P99, DOI [10.3233/his-2011-0137, DOI 10.3233/HIS-2011-0137]; Vinogradov AE, 2010, P ROY SOC B-BIOL SCI, V277, P1403, DOI 10.1098/rspb.2009.1865; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Wang Q, 2004, J BIOL CHEM, V279, P30715, DOI 10.1074/jbc.M401930200; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wei HL, 2007, IEEE T PATTERN ANAL, V29, P162, DOI 10.1109/TPAMI.2007.250607; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; WRIGHT KA, 1992, MICROSC RES TECHNIQ, V22, P285, DOI 10.1002/jemt.1070220306; Wu GA, 2009, P NATL ACAD SCI USA, V106, P12826, DOI 10.1073/pnas.0905115106; Wu W, 2000, MOL PHYLOGENET EVOL, V17, P294, DOI 10.1006/mpev.2000.0833; Xie Q, 2011, PROTEIN CELL, V2, P161, DOI 10.1007/s13238-011-1017-2; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Xiong H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027382; Xu Z, 2009, NUCLEIC ACIDS RES, V37, pW174, DOI 10.1093/nar/gkp278; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yokobori S, 2008, MOL PHYLOGENET EVOL, V47, P612, DOI 10.1016/j.ympev.2008.02.013; Yu Z., 2007, P 11 WORLD MULT SYST, P206; Zhang C, 2011, EL MECH ENG INF TECH, P4639; Zhang YQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-174; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4; Zuo Guanghong, 2010, Genomics Proteomics & Bioinformatics, V8, P262, DOI 10.1016/S1672-0229(10)60028-9	87	6	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84330	10.1371/journal.pone.0084330	http://dx.doi.org/10.1371/journal.pone.0084330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465405	gold, Green Submitted, Green Published			2022-12-25	WOS:000330240500015
J	Kolpen, M; Kuhl, M; Bjarnsholt, T; Moser, C; Hansen, CR; Liengaard, L; Kharazmi, A; Pressler, T; Hoiby, N; Jensen, PO				Kolpen, Mette; Kuhl, Michael; Bjarnsholt, Thomas; Moser, Claus; Hansen, Christine Ronne; Liengaard, Lars; Kharazmi, Arsalan; Pressler, Tanja; Hoiby, Niels; Jensen, Peter Ostrup			Nitrous Oxide Production in Sputum from Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Lung Infection	PLOS ONE			English	Article							NITRIC-OXIDE; POLYMORPHONUCLEAR LEUKOCYTES; REDUCTASE; NITRATE; AIRWAY; OXYGEN; DENITRIFICATION; BACTERIAL; BIOFILMS; SURVIVAL	Chronic lung infection by Pseudomonas aeruginosa is the major severe complication in cystic fibrosis (CF) patients, where P. aeruginosa persists and grows in biofilms in the endobronchial mucus under hypoxic conditions. Numerous polymorphonuclear leukocytes (PMNs) surround the biofilms and create local anoxia by consuming the majority of O-2 for production of reactive oxygen species (ROS). We hypothesized that P. aeruginosa acquires energy for growth in anaerobic endobronchial mucus by denitrification, which can be demonstrated by production of nitrous oxide (N2O), an intermediate in the denitrification pathway. We measured N2O and O-2 with electrochemical microsensors in 8 freshly expectorated sputum samples from 7 CF patients with chronic P. aeruginosa infection. The concentrations of NO3- and NO2- in sputum were estimated by the Griess reagent. We found a maximum median concentration of 41.8 mu M N2O (range 1.4-157.9 mu M N2O). The concentration of N2O in the sputum was higher below the oxygenated layers. In 4 samples the N2O concentration increased during the initial 6 h of measurements before decreasing for approximately 6 h. Concomitantly, the concentration of NO3- decreased in sputum during 24 hours of incubation. We demonstrate for the first time production of N2O in clinical material from infected human airways indicating pathogenic metabolism based on denitrification. Therefore, P. aeruginosa may acquire energy for growth by denitrification in anoxic endobronchial mucus in CF patients. Such ability for anaerobic growth may be a hitherto ignored key aspect of chronic P. aeruginosa infections that can inform new strategies for treatment and prevention.	[Kolpen, Mette; Bjarnsholt, Thomas; Moser, Claus; Kharazmi, Arsalan; Hoiby, Niels; Jensen, Peter Ostrup] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Kolpen, Mette; Bjarnsholt, Thomas; Hoiby, Niels] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Kuhl, Michael; Liengaard, Lars] Univ Copenhagen, Marine Biol Sect, Dept Biol, Helsingor, Denmark; [Kuhl, Michael] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia; [Kuhl, Michael] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 639798, Singapore; [Hansen, Christine Ronne; Pressler, Tanja] Rigshosp, Copenhagen CF Ctr, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Technology Sydney; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Rigshospitalet; University of Copenhagen	Jensen, PO (corresponding author), Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark.	Peter.Oestrup.Jensen@regionh.dk	Kühl, Michael/A-1977-2009; Jensen, Peter Ostrup/HGD-7725-2022; Moser, Claus Ernst/N-5951-2017; Møller, Lars Liengård Holten/AAF-5048-2020; Moser, Claus Ernst/GPK-5546-2022; Bjarnsholt, Thomas/ABD-6178-2021	Kühl, Michael/0000-0002-1792-4790; Moser, Claus Ernst/0000-0002-7664-8570; Moser, Claus Ernst/0000-0002-7664-8570; Kolpen, Mette/0000-0001-5575-0384; Jensen, Peter Ostrup/0000-0003-1648-7186; Hoiby, Niels/0000-0002-1347-725X; Bjarnsholt, Thomas/0000-0002-8003-7414	Faculty of Health and Medical Sciences, University of Copenhagen	Faculty of Health and Medical Sciences, University of Copenhagen	This work was funded by Faculty of Health and Medical Sciences, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhede M, 2009, MICROBIOL-SGM, V155, P3500, DOI 10.1099/mic.0.031443-0; Andersen K, 2001, SENSOR ACTUAT B-CHEM, V81, P42, DOI 10.1016/S0925-4005(01)00924-8; ARAI H, 1995, BBA-GENE STRUCT EXPR, V1261, P279, DOI 10.1016/0167-4781(95)00018-C; Arai H, 2013, BIOSCI BIOTECH BIOCH, V77, P198, DOI 10.1271/bbb.120656; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Beckmann C, 2005, INFECT IMMUN, V73, P444, DOI 10.1128/IAI.73.1.444-452.2005; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P373, DOI 10.1099/mic.0.27463-0; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; BROECKER WS, 1974, TELLUS, V26, P21, DOI 10.1111/j.2153-3490.1974.tb01948.x; De Beer D, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P904, DOI 10.1007/0-387-30741-9_28; Einsle O, 1999, NATURE, V400, P476, DOI 10.1038/22802; Einsle O, 2002, J AM CHEM SOC, V124, P11737, DOI 10.1021/ja0206487; Gaston B, 2002, AM J RESP CRIT CARE, V165, P387, DOI 10.1164/ajrccm.165.3.2106006; Grasemann H, 2005, EUR RESPIR J, V25, P62, DOI 10.1183/09031936.04.00086104; Grasemann H, 2013, J CYST FIBROS, V12, P468, DOI 10.1016/j.jcf.2012.12.008; Grasemann H, 1997, PEDIATR PULM, V24, P173, DOI 10.1002/(SICI)1099-0496(199709)24:3<173::AID-PPUL2>3.0.CO;2-O; Gundersen JK, 1998, LIMNOL OCEANOGR, V43, P1932; Hampton T, 2000, ANAESTH INTENS CARE, V28, P540, DOI 10.1177/0310057X0002800510; Hassett DJ, 1996, J BACTERIOL, V178, P7322, DOI 10.1128/jb.178.24.7322-7325.1996; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; Hino T, 2010, SCIENCE, V330, P1666, DOI 10.1126/science.1195591; Hoffman LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000712; Hoiby N., 2000, CYSTIC FIBROSIS, V2nd, P83; Jensen PO, 2007, MICROBIOL-SGM, V153, P1329, DOI 10.1099/mic.0.2006/003863-0; Jones KL, 2000, PEDIATR PULM, V30, P79, DOI 10.1002/1099-0496(200008)30:2<79::AID-PPUL1>3.0.CO;2-1; Kakishima K, 2007, BIOCHEM BIOPH RES CO, V355, P587, DOI 10.1016/j.bbrc.2007.02.017; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Koch C, 2000, RESPIRATION, V67, P239, DOI 10.1159/000029503; KOCH C, 1993, LANCET, V341, P1065, DOI 10.1016/0140-6736(93)92422-P; Kolpen M, 2010, THORAX, V65, P57, DOI 10.1136/thx.2009.114512; Lee B, 2011, APMIS, V119, P263, DOI 10.1111/j.1600-0463.2011.02726.x; Liengaard L, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00433; Linnane SJ, 1998, AM J RESP CRIT CARE, V158, P207, DOI 10.1164/ajrccm.158.1.9707096; Loisel-Meyer S, 2006, INFECT IMMUN, V74, P1973, DOI 10.1128/IAI.74.3.1973-1976.2006; Markfoged R, 2013, EUROPEAN J SOIL SCI, V62, P541; Mitsui T, 2004, CLIN CHIM ACTA, V345, P129, DOI 10.1016/j.cccn.2004.03.011; Palmer KL, 2007, J BACTERIOL, V189, P4449, DOI 10.1128/JB.00162-07; PEDERSEN SS, 1992, APMIS, V100, P326, DOI 10.1111/j.1699-0463.1992.tb00879.x; Philippot L, 2005, TRENDS MICROBIOL, V13, P191, DOI 10.1016/j.tim.2005.03.001; Philippot L, 2002, BBA-GENE STRUCT EXPR, V1577, P355, DOI 10.1016/S0167-4781(02)00420-7; Planelles G, 2007, NEPHRON PHYSIOL, V105, P11, DOI 10.1159/000096979; Ratjen F, 1999, RESP MED, V93, P579, DOI 10.1016/S0954-6111(99)90158-0; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schreiber F, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-24; SENETERRE E, 1994, EUR RESPIR J, V7, P596, DOI 10.1183/09031936.94.07030596; Shimizu T, 2012, MOL MICROBIOL, V85, P492, DOI 10.1111/j.1365-2958.2012.08122.x; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; SOOHOO CK, 1991, J BIOL CHEM, V266, P2203; Stevanin TM, 2005, INFECT IMMUN, V73, P3322, DOI 10.1128/IAI.73.6.3322-3329.2005; THOMAS KL, 1994, FEMS MICROBIOL LETT, V118, P181, DOI 10.1016/0378-1097(94)90616-5; Van Alst NE, 2009, INFECT IMMUN, V77, P4446, DOI 10.1128/IAI.00822-09; Van Gennip M, 2009, APMIS, V117, P537, DOI 10.1111/j.1600-0463.2009.02466.x; WEISS RF, 1980, MAR CHEM, V8, P347, DOI 10.1016/0304-4203(80)90024-9; WILLIAMS DR, 1978, APPL ENVIRON MICROB, V36, P257, DOI 10.1128/AEM.36.2.257-263.1978; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yang L, 2008, J BACTERIOL, V190, P2767, DOI 10.1128/JB.01581-07; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	62	67	67	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84353	10.1371/journal.pone.0084353	http://dx.doi.org/10.1371/journal.pone.0084353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465406	Green Published, gold			2022-12-25	WOS:000330237000013
J	Zhang, CH; Zhang, J; Zhao, H; Liang, JM				Zhang, Chunhui; Zhang, Jun; Zhao, Heng; Liang, Jimin			A Part-Based Probabilistic Model for Object Detection with Occlusion	PLOS ONE			English	Article							CLASS RECOGNITION; FACE RECOGNITION; SPARSE	The part-based method has been a fast rising framework for object detection. It is attracting more and more attention for its detection precision and partial robustness to the occlusion. However, little research has been focused on the problem of occlusion overlapping of the part regions, which can reduce the performance of the system. This paper proposes a part-based probabilistic model and the corresponding inference algorithm for the problem of the part occlusion. The model is based on the Bayesian theory integrally and aims to be robust to the large occlusion. In the stage of the model construction, all of the parts constitute the vertex set of a fully connected graph, and a binary variable is assigned to each part to indicate its occlusion status. In addition, we introduce a penalty term to regularize the argument space of the objective function. Thus, the part detection is formulated as an optimization problem, which is divided into two alternative procedures: the outer inference and the inner inference. A stochastic tentative method is employed in the outer inference to determine the occlusion status for each part. In the inner inference, the gradient descent algorithm is employed to find the optimal positions of the parts, in term of the current occlusion status. Experiments were carried out on the Caltech database. The results demonstrated that the proposed method achieves a strong robustness to the occlusion.	[Zhang, Chunhui; Zhang, Jun; Zhao, Heng; Liang, Jimin] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China	Xidian University	Liang, JM (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	jimleung@mail.xidian.edu.cn	Liang, Jimin/B-5394-2014	Liang, Jimin/0000-0003-1428-5804	973 program [2011CB707702]; National Natural Science Foundation of China [81090272]	973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the 973 program under Grant No. 2011CB707702 and the National Natural Science Foundation of China under Grant No. 81090272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2004, IEEE T PATTERN ANAL, V26, P1475, DOI 10.1109/TPAMI.2004.108; Amit Y., 2002, 2D OBJECT DETECTION; Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; CHOU PB, 1990, INT J COMPUT VISION, V4, P185, DOI 10.1007/BF00054995; Crandall D, 2005, PROC CVPR IEEE, P10; Csurka G., 2004, WORKSH STAT LEARN CO, V1, P1, DOI DOI 10.1234/12345678; Fei-Fei L, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1134, DOI 10.1109/ICCV.2003.1238476; Fei-Fei L., 2004, C COMP VIS PATT REC, P178, DOI [10.1109/CVPR.2004.109, DOI 10.1109/CVPR.2004.109]; Felzenszwalb P., 2008, P 2008 IEEE C COMP V, P1; Felzenszwalb P.F., 2012, THEORY COMPUT, V8, P415, DOI DOI 10.4086/TOC.2012.V008A019; Felzenszwalb PF, 2005, INT J COMPUT VISION, V61, P55, DOI 10.1023/B:VISI.0000042934.15159.49; Fergus R, 2005, PROC CVPR IEEE, P380; Fergus R, 2003, PROC CVPR IEEE, P264; FISCHLER MA, 1973, IEEE T COMPUT, VC 22, P67, DOI 10.1109/T-C.1973.223602; Frey BJ, 1998, ADV NEUR IN, V10, P479; Gross R, 2004, IEEE C COMP VIS PATT, V72; Jiang XY, 2011, PATTERN RECOGN, V44, P2008, DOI 10.1016/j.patcog.2011.03.010; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kolmogorov V, 2004, IEEE T PATTERN ANAL, V26, P147, DOI 10.1109/TPAMI.2004.1262177; Lazebnik S, 2005, IEEE I CONF COMP VIS, P832, DOI 10.1109/ICCV.2005.10; Li SF, 2012, PATTERN RECOGN, V45, P3402, DOI 10.1016/j.patcog.2012.03.011; Li Y, 2009, PROC CVPR IEEE, P2458; Mikolajczyk K, 2004, LECT NOTES COMPUT SC, V3021, P69; Moghaddam B, 1997, IEEE T PATTERN ANAL, V19, P696, DOI 10.1109/34.598227; Papandreou George, 2008, COMP VIS PATT REC 20, P1; Peng YG, 2010, PROC CVPR IEEE, P763, DOI 10.1109/CVPR.2010.5540138; Rowley HA, 1998, PROC CVPR IEEE, P38, DOI 10.1109/CVPR.1998.698585; Schneiderman H, 1998, PROC CVPR IEEE, P45, DOI 10.1109/CVPR.1998.698586; Szeliski R., 2010, COMPUTER VISION ALGO, DOI DOI 10.1007/978-3-030-34372-9; Wagner A, 2009, PROC CVPR IEEE, P597, DOI 10.1109/CVPRW.2009.5206654; Wen M, 2007, LECT NOTES ARTIF INT, V4482, P526; Yang XW, 2012, PATTERN RECOGN, V45, P1927, DOI 10.1016/j.patcog.2011.11.010; Zhao XY, 2011, PATTERN RECOGN, V44, P1296, DOI 10.1016/j.patcog.2010.11.022; Zhou ZH, 2009, IEEE I CONF COMP VIS, P1050, DOI 10.1109/ICCV.2009.5459383	34	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84624	10.1371/journal.pone.0084624	http://dx.doi.org/10.1371/journal.pone.0084624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465420	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000015
J	Krist, AC; Kay, AD; Larkin, K; Neiman, M				Krist, Amy C.; Kay, Adam D.; Larkin, Katelyn; Neiman, Maurine			Response to Phosphorus Limitation Varies among Lake Populations of the Freshwater Snail Potamopyrgus antipodarum	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; LOCAL ADAPTATION; PLOIDY LEVEL; HOST SEX; TREMATODE; INFECTION; SUSCEPTIBILITY; MAINTENANCE; PLASTICITY; EVOLUTION	Local adaptation - typically recognized as higher values of fitness-related traits for native vs. non-native individuals when measured in the native environment - is common in natural populations because of pervasive spatial variation in the intensity and type of natural selection. Although local adaptation has been primarily studied in the context of biotic interactions, widespread variation in abiotic characteristics of environments suggests that local adaptation in response to abiotic factors should also be common. Potamopyrgus antipodarum, a freshwater New Zealand snail that is an important model system for invasion biology and the maintenance of sexual reproduction, exhibits local adaptation to parasites and rate of water flow. As an initial step to determining whether P. antipodarum are also locally adapted to phosphorus availability, we examined whether populations differ in their responses to phosphorus limitation. We found that field-collected juvenile P. antipodarum grew at a lower rate and reached an important size threshold more slowly when fed a relatively low vs. a relatively high- phosphorus diet. We also detected significant across-population variation in individual growth rate. A marginally significant population-by-dietary phosphorus interaction along with a two-fold difference across populations in the extent of suppression of growth by low phosphorus suggests that populations of P. antipodarum may differ in their response to phosphorus limitation. Local adaptation may explain this variation, with the implication that snails from lakes with relatively low phosphorus availability should be less severely affected by phosphorus limitation than snails from lakes with higher phosphorus availability.	[Krist, Amy C.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Krist, Amy C.] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Kay, Adam D.] Univ St Thomas, Dept Biol, St Paul, MN USA; [Larkin, Katelyn; Neiman, Maurine] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Wyoming; University of Wyoming; University of St Thomas Minnesota; University of Iowa	Krist, AC (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	krist@uwyo.edu			University of Iowa; Research Council of Norway [196468/V40]	University of Iowa; Research Council of Norway(Research Council of Norway)	Funding for Neiman comes from the University of Iowa and the Research Council of Norway (Project No. 196468/V40). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2008, HYDROBIOLOGIA, V614, P107, DOI 10.1007/s10750-008-9529-3; BRADFORD MJ, 1995, OECOLOGIA, V103, P319, DOI 10.1007/BF00328620; Dybdahl MF, 2005, ECOLOGY, V86, P1592, DOI 10.1890/04-0898; Dybdahl MF, 2004, J EVOLUTION BIOL, V17, P967, DOI 10.1111/j.1420-9101.2004.00759.x; DYBDAHL MF, 1995, J EVOLUTION BIOL, V8, P385, DOI 10.1046/j.1420-9101.1995.8030385.x; Endler J.A., 1986, Monographs in Population Biology, pviii; Fox JA, 1996, EVOLUTION, V50, P1541, DOI 10.1111/j.1558-5646.1996.tb03926.x; Frost PC, 2006, ECOL LETT, V9, P774, DOI 10.1111/j.1461-0248.2006.00919.x; Gandon S, 1998, TRENDS ECOL EVOL, V13, P214, DOI 10.1016/S0169-5347(98)01358-5; Holomuzki JR, 2006, ECOLOGY, V87, P1038, DOI 10.1890/0012-9658(2006)87[1038:HVAPTI]2.0.CO;2; Jensen LF, 2008, P ROY SOC B-BIOL SCI, V275, P2859, DOI 10.1098/rspb.2008.0870; Jokela J, 1995, EVOLUTION, V49, P1268, DOI 10.1111/j.1558-5646.1995.tb04453.x; Jokela J, 2003, BIOL J LINN SOC, V79, P165, DOI 10.1046/j.1095-8312.2003.00181.x; King KC, 2011, OIKOS, V120, P1335, DOI 10.1111/j.1600-0706.2011.19241.x; Kistner EJ, 2013, ECOL EVOL, V3, P424, DOI 10.1002/ece3.471; Krist AC, 2000, PARASITOLOGY, V121, P395, DOI 10.1017/S0031182099006538; Krist AC, 2004, J EVOLUTION BIOL, V17, P33, DOI 10.1046/j.1420-9101.2003.00661.x; Krist AC, 1998, OECOLOGIA, V116, P575, DOI 10.1007/s004420050611; Laugen AT, 2003, J EVOLUTION BIOL, V16, P996, DOI 10.1046/j.1420-9101.2003.00560.x; Laukkanen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038225; Lenth RV., 2006, JAVA APPLETS POWER S; Lively CM, 2004, AM NAT, V164, pS6, DOI 10.1086/424605; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; Lively CM, 1996, P ROY SOC B-BIOL SCI, V263, P891, DOI 10.1098/rspb.1996.0132; LIVELY CM, 1989, EVOLUTION, V43, P1663, DOI [10.2307/2409382, 10.1111/j.1558-5646.1989.tb02616.x]; McKenzie VJ, 2013, CAN J ZOOL, V91, P30, DOI 10.1139/cjz-2012-0183; Neiman M, 2006, INVERTEBR BIOL, V125, P45, DOI 10.1111/j.1744-7410.2006.00038.x; Neiman M, 2013, HEREDITY, V110, P152, DOI 10.1038/hdy.2012.78; Neiman M, 2012, HEREDITY, V109, P57, DOI 10.1038/hdy.2012.13; Neiman M, 2009, J EVOLUTION BIOL, V22, P1359, DOI 10.1111/j.1420-9101.2009.01748.x; Neiman M, 2013, EVOL ECOL, V27, P1117, DOI 10.1007/s10682-013-9632-4; Neiman M, 2013, EVOLUTION, V67, P1511, DOI 10.1111/evo.12026; Neiman M, 2011, EVOLUTION, V65, P3202, DOI 10.1111/j.1558-5646.2011.01360.x; New Zealand Ministry for the Environment, 2010, LAK WAT QUAL NZ 2010; Osnas EE, 2006, J EVOLUTION BIOL, V19, P42, DOI 10.1111/j.1420-9101.2005.00994.x; Paczesniak D, 2013, MOL ECOL, V22, P4695, DOI 10.1111/mec.12422; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Tibbets TM, 2010, OECOLOGIA, V163, P549, DOI 10.1007/s00442-009-1522-7; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; WALLACE C, 1992, J MOLLUS STUD, V58, P93, DOI 10.1093/mollus/58.2.93; Williams G. C., 1966, P307; WINTERBOURN M J, 1970, Proceedings of the Malacological Society of London, V39, P139	43	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85845	10.1371/journal.pone.0085845	http://dx.doi.org/10.1371/journal.pone.0085845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454936	gold, Green Published			2022-12-25	WOS:000330236000016
J	Costa, B; Taylor, JC; Kracker, L; Battista, T; Pittman, S				Costa, Bryan; Taylor, J. Christopher; Kracker, Laura; Battista, Tim; Pittman, Simon			Mapping Reef Fish and the Seascape: Using Acoustics and Spatial Modeling to Guide Coastal Management	PLOS ONE			English	Article							SPECIES RICHNESS; SPAWNING AGGREGATIONS; HABITAT; CLASSIFICATION; CONSERVATION; BIOGEOGRAPHY; PREDICTION; GRUNTS	Reef fish distributions are patchy in time and space with some coral reef habitats supporting higher densities (i.e., aggregations) of fish than others. Identifying and quantifying fish aggregations (particularly during spawning events) are often top priorities for coastal managers. However, the rapid mapping of these aggregations using conventional survey methods (e. g., non-technical SCUBA diving and remotely operated cameras) are limited by depth, visibility and time. Acoustic sensors (i.e., splitbeam and multibeam echosounders) are not constrained by these same limitations, and were used to concurrently map and quantify the location, density and size of reef fish along with seafloor structure in two, separate locations in the U. S. Virgin Islands. Reef fish aggregations were documented along the shelf edge, an ecologically important ecotone in the region. Fish were grouped into three classes according to body size, and relationships with the benthic seascape were modeled in one area using Boosted Regression Trees. These models were validated in a second area to test their predictive performance in locations where fish have not been mapped. Models predicting the density of large fish (>= 29 cm) performed well (i.e., AUC = 0.77). Water depth and standard deviation of depth were the most influential predictors at two spatial scales (100 and 300 m). Models of small (<= 11 cm) and medium (12-28 cm) fish performed poorly (i.e., AUC = 0.49 to 0.68) due to the high prevalence (45-79%) of smaller fish in both locations, and the unequal prevalence of smaller fish in the training and validation areas. Integrating acoustic sensors with spatial modeling offers a new and reliable approach to rapidly identify fish aggregations and to predict the density large fish in un-surveyed locations. This integrative approach will help coastal managers to prioritize sites, and focus their limited resources on areas that may be of higher conservation value.	[Costa, Bryan; Kracker, Laura; Battista, Tim; Pittman, Simon] NOAA, Biogeog Branch, Natl Ctr Coastal Ocean Sci, Silver Spring, MD 20910 USA; [Costa, Bryan] Consolidated Safety Serv, Fairfax, VA USA; [Taylor, J. Christopher] NOAA, Ctr Coastal Fisheries & Habitat Res, Natl Ctr Coastal Ocean Sci, Beaufort, NC USA; [Pittman, Simon] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); University of Plymouth	Costa, B (corresponding author), NOAA, Biogeog Branch, Natl Ctr Coastal Ocean Sci, Silver Spring, MD 20910 USA.	bryan.costa@noaa.gov		Pittman, Simon/0000-0002-4113-6970	National Oceanic and Atmospheric Administration's Coral Reef Conservation Program; Office of Coast Survey	National Oceanic and Atmospheric Administration's Coral Reef Conservation Program; Office of Coast Survey	This research was funded by the National Oceanic and Atmospheric Administration's Coral Reef Conservation Program (http://coralreef.noaa.gov/) and Office of Coast Survey (http://www.nauticalcharts.noaa.gov/). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Aubry P, 2000, ECOLOGY, V81, P543; Battista TA, 2011, MBES DATA ACQUISITIO; Battista TA, 2010, MBES DATA ACQUISITIO; Breiman L., 2017, CLASSIFICATION REGRE; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Chapire RE, 2012, BOOSTING FDN ALGORIT; Collins AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024302; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; Echoview, 2013, FISH TRACK ALG ECH A; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FishBase, 2013, FISHBASE GLOB INF SY; Foley MM, 2010, MAR POLICY, V34, P955, DOI 10.1016/j.marpol.2010.02.001; Geselbracht L, 2009, AQUAT CONSERV, V19, P408, DOI 10.1002/aqc.992; Grober-Dunsmore R, 2007, CORAL REEFS, V26, P201, DOI 10.1007/s00338-006-0180-z; Grober-Dunsmore R, 2008, LANDSCAPE ECOL, V23, P37, DOI 10.1007/s10980-007-9147-x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Heyman WD, 2008, B MAR SCI, V83, P531; Heyman WD, 2011, PROF GEOGR, V63, P429, DOI 10.1080/00330124.2011.585074; Hijmans RJ, 2012, SPECIES DISTRIBUTION; Hijmans RJ, 2012, GEOGRAPHIC DATA ANAL; Hitt S, 2011, MAR ECOL PROG SER, V427, P275, DOI 10.3354/meps09093; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; IHO-International Hydrographic Organization, 2008, IHO SPEC PUBL, V44; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Johnston Samuel V., 2006, NOAA Professional Paper NMFS, V5, P10; Kendall MS, 2003, ENVIRON BIOL FISH, V66, P19, DOI 10.1023/A:1023255022513; Knudby A, 2010, REMOTE SENS ENVIRON, V114, P1230, DOI 10.1016/j.rse.2010.01.007; Kobara S, 2013, OCEANOGR MAR BIOL, V51, P281; Koenig CC, 2000, B MAR SCI, V66, P593; Kracker LM, 2011, 130 NOS NCCOS NAT OC; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Liu C, 2009, 18TH WORLD IMACS CONGRESS AND MODSIM09 INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, P4241; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lourie SA, 2004, CONSERV BIOL, V18, P1004, DOI 10.1111/j.1523-1739.2004.00137.x; LOVE RH, 1977, J ACOUST SOC AM, V62, P1397, DOI 10.1121/1.381672; Lucieer V, 2013, ESTUAR COAST SHELF S, V117, P94, DOI 10.1016/j.ecss.2012.11.001; Mellin C, 2010, GLOBAL ECOL BIOGEOGR, V19, P212, DOI 10.1111/j.1466-8238.2009.00513.x; MEYER JL, 1985, LIMNOL OCEANOGR, V30, P146, DOI 10.4319/lo.1985.30.1.0146; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nash KL, 2013, ECOSYSTEMS, V16, P478, DOI 10.1007/s10021-012-9625-0; Nemeth R, 2013, NOAANMFSSE2013200341; OGDEN JC, 1977, MAR BIOL, V42, P273, DOI 10.1007/BF00397751; Olavo G, 2011, AQUAT CONSERV, V21, P199, DOI 10.1002/aqc.1174; Parker RO, 1998, 138 NMFS NAT OC ATM; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pittman SJ, 2007, ECOL MODEL, V204, P9, DOI 10.1016/j.ecolmodel.2006.12.017; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Pittman SJ, 2009, J COASTAL RES, V25, P27, DOI [10.2112/SI53-004.1, 10.2112/S153-004.1]; Pittman SJ, 2004, MAR ECOL PROG SER, V283, P233, DOI 10.3354/meps283233; Plach P., 2003, P 2003 UK WORKSH COM, P38; Pontius RG, 2001, AGR ECOSYST ENVIRON, V85, P239, DOI 10.1016/S0167-8809(01)00187-6; R Core Team, 2012, R STATS PACK STATS V; Ribeiro Jr PJ, 2012, ANAL GEOSTATISTICAL; Roberts CM, 2003, ECOL APPL, V13, pS215; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sale PF, 1998, AUST J ECOL, V23, P202, DOI 10.1111/j.1442-9993.1998.tb00721.x; SEDBERRY GR, 2004, CHARACTERIZATION DEE; Simmonds J., 2005, FISHERIES ACOUSTICS; Valavanis VD, 2008, HYDROBIOLOGIA, V612, P5, DOI 10.1007/s10750-008-9493-y	65	35	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85555	10.1371/journal.pone.0085555	http://dx.doi.org/10.1371/journal.pone.0085555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454886	gold, Green Published			2022-12-25	WOS:000330235100097
J	Lee, J; Groh, JM				Lee, Jungah; Groh, Jennifer M.			Different Stimuli, Different Spatial Codes: A Visual Map and an Auditory Rate Code for Oculomotor Space in the Primate Superior Colliculus	PLOS ONE			English	Article							INFERIOR COLLICULUS; EYE-MOVEMENTS; SENSORIMOTOR INTEGRATION; RESPONSE PROPERTIES; SOUND LOCALIZATION; RECEPTIVE-FIELDS; ECHOLOCATING BAT; NEURAL CODE; CAT; NEURONS	Maps are a mainstay of visual, somatosensory, and motor coding in many species. However, auditory maps of space have not been reported in the primate brain. Instead, recent studies have suggested that sound location may be encoded via broadly responsive neurons whose firing rates vary roughly proportionately with sound azimuth. Within frontal space, maps and such rate codes involve different response patterns at the level of individual neurons. Maps consist of neurons exhibiting circumscribed receptive fields, whereas rate codes involve open-ended response patterns that peak in the periphery. This coding format discrepancy therefore poses a potential problem for brain regions responsible for representing both visual and auditory information. Here, we investigated the coding of auditory space in the primate superior colliculus(SC), a structure known to contain visual and oculomotor maps for guiding saccades. We report that, for visual stimuli, neurons showed circumscribed receptive fields consistent with a map, but for auditory stimuli, they had open-ended response patterns consistent with a rate or level-of-activity code for location. The discrepant response patterns were not segregated into different neural populations but occurred in the same neurons. We show that a read-out algorithm in which the site and level of SC activity both contribute to the computation of stimulus location is successful at evaluating the discrepant visual and auditory codes, and can account for subtle but systematic differences in the accuracy of auditory compared to visual saccades. This suggests that a given population of neurons can use different codes to support appropriate multimodal behavior.	[Lee, Jungah; Groh, Jennifer M.] Duke Univ, Dept Neurobiol, Ctr Cognit Neurosci, Dept Psychol & Neurosci, Durham, NC 27710 USA	Duke University	Lee, J (corresponding author), Duke Univ, Dept Neurobiol, Ctr Cognit Neurosci, Dept Psychol & Neurosci, Durham, NC 27710 USA.	vision.jungah.lee@gmail.com		Groh, Jennifer/0000-0002-6435-3935	National Institutes of Health [NS50942]; Korea Research Foundation; Korean Government [KRF-2008-356-H00003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NS50942)(http://grants.nih.gov/grants/oer.htm). JL was also supported by the Korea Research Foundation Grant funded by the Korean Government (KRF-2008-356-H00003)(http://www.krf.or.kr/KHPapp/eng/maina.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKIN LM, 1987, J NEUROPHYSIOL, V57, P1185, DOI 10.1152/jn.1987.57.4.1185; Barone P, 1996, J NEUROPHYSIOL, V75, P1206, DOI 10.1152/jn.1996.75.3.1206; BENSON DA, 1981, BRAIN RES, V219, P249, DOI 10.1016/0006-8993(81)90290-0; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Devore S, 2009, NEURON, V62, P123, DOI 10.1016/j.neuron.2009.02.018; EISENMAN LM, 1974, BRAIN RES, V75, P203, DOI 10.1016/0006-8993(74)90742-2; Freedman EG, 1997, J NEUROPHYSIOL, V77, P2328, DOI 10.1152/jn.1997.77.5.2328; FRENS MA, 1995, EXP BRAIN RES, V107, P103, DOI 10.1007/BF00228022; Goossens HHLM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002508; Groh JM, 2003, J COGNITIVE NEUROSCI, V15, P1217, DOI 10.1162/089892903322598166; Groh JM, 2001, BIOL CYBERN, V85, P159, DOI 10.1007/s004220100249; GUITTON D, 1980, EXP BRAIN RES, V39, P63; JAY MF, 1984, NATURE, V309, P345, DOI 10.1038/309345a0; JAY MF, 1987, J NEUROPHYSIOL, V57, P35, DOI 10.1152/jn.1987.57.1.35; JAY MF, 1987, J NEUROPHYSIOL, V57, P22, DOI 10.1152/jn.1987.57.1.22; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KING AJ, 1983, J PHYSIOL-LONDON, V342, P361, DOI 10.1113/jphysiol.1983.sp014856; KING AJ, 1987, J NEUROPHYSIOL, V57, P596, DOI 10.1152/jn.1987.57.2.596; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KUSTOV AA, 1995, J NEUROPHYSIOL, V73, P1724, DOI 10.1152/jn.1995.73.4.1724; Lee J, 2012, J NEUROPHYSIOL, V108, P227, DOI 10.1152/jn.00706.2011; LEIMAN AL, 1972, EXP NEUROL, V35, P431, DOI 10.1016/0014-4886(72)90114-8; Lesica NA, 2010, J NEUROSCI, V30, P11696, DOI 10.1523/JNEUROSCI.0846-10.2010; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; Metzger RR, 2004, J NEUROPHYSIOL, V92, P2622, DOI 10.1152/jn.00326.2004; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Middlebrooks JC, 1998, J NEUROPHYSIOL, V80, P863, DOI 10.1152/jn.1998.80.2.863; MIDDLEBROOKS JC, 1984, J NEUROSCI, V4, P2621; Middlebrooks JC, 1981, J NEUROSCI, V1, P107; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; PALMER AR, 1982, NATURE, V299, P248, DOI 10.1038/299248a0; Porter KK, 2006, PROG BRAIN RES, V155, P313, DOI 10.1016/S0079-6123(06)55018-6; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Salminen NH, 2010, BRAIN RES, V1306, P93, DOI 10.1016/j.brainres.2009.09.095; Salminen NH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007600; Samson FK, 2000, J NEUROPHYSIOL, V84, P1330, DOI 10.1152/jn.2000.84.3.1330; SCHLAGREY M, 1989, EXP BRAIN RES, V76, P537, DOI 10.1007/BF00248910; SCUDDER CA, 1988, J NEUROPHYSIOL, V59, P1455, DOI 10.1152/jn.1988.59.5.1455; SHIMOZAWA T, 1984, BRAIN RES, V311, P289; Stebbins, 1990, COMP PERCEPTION, V1, P351; Stecker GC, 2005, PLOS BIOL, V3, P520, DOI 10.1371/journal.pbio.0030078; Stecker GC, 2003, BIOL CYBERN, V89, P341, DOI 10.1007/s00422-003-0439-1; Stein BE, 2009, HEARING RES, V258, P4, DOI 10.1016/j.heares.2009.03.012; STILLMAN RD, 1971, EXP NEUROL, V32, P404, DOI 10.1016/0014-4886(71)90007-0; Tollin DJ, 2002, J NEUROSCI, V22, P1468, DOI 10.1523/JNEUROSCI.22-04-01468.2002; Valentine DE, 1997, J NEUROSCI, V17, P1720; von Bekesy G, 1930, PHYS Z, V31, P824; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; Werner-Reiss U, 2008, J NEUROSCI, V28, P3747, DOI 10.1523/JNEUROSCI.5044-07.2008; WISE LZ, 1985, J NEUROPHYSIOL, V54, P185, DOI 10.1152/jn.1985.54.2.185; WONG D, 1984, HEARING RES, V16, P261, DOI 10.1016/0378-5955(84)90115-1; Woods TM, 2006, J NEUROPHYSIOL, V96, P3323, DOI 10.1152/jn.00392.2006	55	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85017	10.1371/journal.pone.0085017	http://dx.doi.org/10.1371/journal.pone.0085017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454779	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100048
J	Neely, CJ; Kartchner, LB; Mendoza, AE; Linz, BM; Frelinger, JA; Wolfgang, MC; Maile, R; Cairns, BA				Neely, Crystal J.; Kartchner, Laurel B.; Mendoza, April E.; Linz, Brandon M.; Frelinger, Jeffrey A.; Wolfgang, Matthew C.; Maile, Robert; Cairns, Bruce A.			Flagellin Treatment Prevents Increased Susceptibility to Systemic Bacterial Infection after Injury by Inhibiting Anti-Inflammatory IL-10+IL-12-Neutrophil Polarization	PLOS ONE			English	Article							T-CELLS; MACROPHAGE POLARIZATION; LYMPHOCYTE APOPTOSIS; SUPPRESSOR-CELLS; TRAUMA PATIENTS; BURN INJURY; IL-10; SEPSIS; EXPRESSION; SURVIVAL	Severe trauma renders patients susceptible to infection. In sepsis, defective bacterial clearance has been linked to specific deviations in the innate immune response. We hypothesized that innate immune modulations observed during sepsis also contribute to increased bacterial susceptibility after severe trauma. A well-established murine model of burn injury, used to replicate infection following trauma, showed that wound inoculation with P. aeruginosa quickly spreads systemically. The systemic IL-10/IL-12 axis was skewed after burn injury with infection as indicated by a significant elevation in serum IL-10 and polarization of neutrophils into an anti-inflammatory ("N2"; IL-10(+) IL-12(-)) phenotype. Infection with an attenuated P. aeruginosa strain (Delta CyaB) was cleared better than the wildtype strain and was associated with an increased proinflammatory neutrophil ("N1"; IL-10(-) IL-12(+)) response in burn mice. This suggests that neutrophil polarization influences bacterial clearance after burn injury. Administration of a TLR5 agonist, flagellin, after burn injury restored the neutrophil response towards a N1 phenotype resulting in an increased clearance of wildtype P. aeruginosa after wound inoculation. This study details specific alterations in innate cell populations after burn injury that contribute to increased susceptibility to bacterial infection. In addition, for the first time, it identifies neutrophil polarization as a therapeutic target for the reversal of bacterial susceptibility after injury.	[Neely, Crystal J.; Kartchner, Laurel B.; Linz, Brandon M.; Maile, Robert; Cairns, Bruce A.] Univ N Carolina, Dept Microbiol & Immunol, North Carolina Jaycee Burn Ctr, Chapel Hill, NC 27515 USA; [Mendoza, April E.; Maile, Robert; Cairns, Bruce A.] Univ N Carolina, Dept Surg, North Carolina Jaycee Burn Ctr, Chapel Hill, NC USA; [Frelinger, Jeffrey A.] Univ Arizona, Dept Immunobiol, Tucson, AZ USA; [Wolfgang, Matthew C.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Arizona; University of North Carolina; University of North Carolina Chapel Hill	Maile, R (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, North Carolina Jaycee Burn Ctr, Chapel Hill, NC 27515 USA.	robmaile@med.unc.edu	Frelinger, Jeffrey A/F-2448-2014	Frelinger, Jeffrey A/0000-0002-2503-6267; Maile, Robert/0000-0002-9126-4188	Cairns BA [R01 GM076250-02, 2T32GM008450-16-20]; National Institutes of General Medicine Science [04/06/2009-03/31/2014, 07/1/2009-6/30/2014]; NRSA Trauma Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008450, R01GM076250] Funding Source: NIH RePORTER	Cairns BA; National Institutes of General Medicine Science; NRSA Trauma Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R01 GM076250-02 Cairns BA (PI) 04/06/2009-03/31/2014 National Institutes of General Medicine Science 2T32GM008450-16-20 Cairns BA (PI) 07/1/2009-6/30/2014 National Institute of General Medicine Science NRSA Trauma Research Fellowship The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambarus CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035994; Balloy V, 2007, J INFECT DIS, V196, P289, DOI 10.1086/518610; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Borregaard N, 1997, ANN NY ACAD SCI, V832, P62, DOI 10.1111/j.1749-6632.1997.tb46237.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cairns BA, 2001, SURGERY, V130, P210, DOI 10.1067/msy.2001.115835; Cairns B, 2006, J TRAUMA, V61, P293, DOI 10.1097/01.ta.0000228969.46633.bb; Cairns BA, 2008, J TRAUMA, V64, P1069, DOI 10.1097/TA.0b013e318166b7d9; Centers for Disease Control and Prevention, 2012, WEB BAS INJ STAT QUE; Cohen MJ, 2007, J TRAUMA, V62, P858, DOI 10.1097/01.ta.0000222975.03874.58; Csontos C, 2010, BURNS, V36, P483, DOI 10.1016/j.burns.2009.10.009; Cuenca AG, 2012, INTENS CARE MED, V38, P928, DOI 10.1007/s00134-012-2575-3; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Fukuzuka K, 2000, J TRAUMA, V49, P710, DOI 10.1097/00005373-200010000-00020; Glance LG, 2011, ARCH SURG-CHICAGO, V146, P794, DOI 10.1001/archsurg.2011.41; Guo ZJ, 2003, J IMMUNOL, V171, P3983, DOI 10.4049/jimmunol.171.8.3983; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hart KM, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00029; Harter L, 2004, SHOCK, V22, P403, DOI 10.1097/01.shk.0000142256.23382.5d; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Jeannin P, 2011, IMMUNOTHERAPY-UK, V3, P23, DOI [10.2217/IMT.11.30, 10.2217/imt.11.30]; Jones SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064250; Kahlke V, 2002, SHOCK, V18, P24, DOI 10.1097/00024382-200207000-00005; Kalechman Y, 2002, J IMMUNOL, V169, P384, DOI 10.4049/jimmunol.169.1.384; Kasten KR, 2010, BIOCHEM BIOPH RES CO, V393, P28, DOI 10.1016/j.bbrc.2010.01.066; Kovacs EJ, 2004, MECH AGEING DEV, V125, P121, DOI 10.1016/j.mad.2003.11.007; Lien E, 2002, CRIT CARE MED, V30, pS1, DOI 10.1097/00003246-200201001-00001; MacConmara MP, 2006, ANN SURG, V244, P514, DOI 10.1097/01.sla.0000239031.06906.1f; Maile R, 2006, J IMMUNOL, V176, P6717, DOI 10.4049/jimmunol.176.11.6717; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Martins PS, 2008, CRIT CARE, V12, DOI 10.1186/cc6801; Maung AA, 2005, J LEUKOCYTE BIOL, V78, P565, DOI 10.1189/jlb.1204698; Mendoza AE, 2012, SHOCK, V38, P532, DOI 10.1097/SHK.0b013e31826c5b19; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Ni Choileain N, 2006, J IMMUNOL, V176, P225; Niven DJ, 2010, J HOSP INFECT, V76, P296, DOI 10.1016/j.jhin.2010.06.004; Noel G, 2011, SHOCK, V36, P149, DOI 10.1097/SHK.0b013e3182205cbc; Noel JG, 2007, SHOCK, V28, P684, DOI 10.1097/shk.0b013e31805362ed; Nordenfelt P, 2011, J LEUKOCYTE BIOL, V90, P271, DOI 10.1189/jlb.0810457; Papia G, 1999, J TRAUMA, V47, P923, DOI 10.1097/00005373-199911000-00018; Patel JC, 2000, J PEDIATR SURG, V35, P1174, DOI 10.1053/jpsu.2000.8722; Pellegrini JD, 2000, J SURG RES, V88, P200, DOI 10.1006/jsre.1999.5797; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Schwacha MG, 2003, SHOCK, V20, P529, DOI 10.1097/01.shk.0000095059.62263.56; Schwacha MG, 2003, BURNS, V29, P1, DOI 10.1016/S0305-4179(02)00187-0; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Shigematsu K, 2009, J LEUKOCYTE BIOL, V86, P999, DOI 10.1189/jlb.0409235; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Smith RS, 2004, INFECT IMMUN, V72, P1677, DOI 10.1128/IAI.72.3.1677-1684.2004; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Sun L, 2009, AM J RESP CELL MOL, V41, P76, DOI 10.1165/rcmb.2008-0202OC; van Putten JPM, 2010, IMMUNOL LETT, V128, P8, DOI 10.1016/j.imlet.2009.09.007; Vicente-Suarez I, 2007, EUR J IMMUNOL, V37, P3164, DOI 10.1002/eji.200737306; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4; Yamaguchi T, 2000, J MED MICROBIOL, V49, P701, DOI 10.1099/0022-1317-49-8-701; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zedler S, 1999, CRIT CARE MED, V27, P66, DOI 10.1097/00003246-199901000-00028; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284	62	39	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85623	10.1371/journal.pone.0085623	http://dx.doi.org/10.1371/journal.pone.0085623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454904	Green Submitted, gold, Green Published			2022-12-25	WOS:000330235100107
J	Yu, ZQ; Zhang, C; Chai, R; Du, Y; Gao, XH; Xing, JJ; Yu, ED; Zhang, W; Zhang, XQ; Cao, GW; Fu, CG				Yu, Zhiqi; Zhang, Chang; Chai, Rui; Du, Yan; Gao, Xianhua; Xing, Junjie; Yu, Enda; Zhang, Wei; Zhang, Xiaoqing; Cao, Guangwen; Fu, Chuangang			Prognostic Significance and Molecular Mechanism of ATP-Binding Cassette Subfamily C Member 4 in Resistance to Neoadjuvant Radiotherapy of Locally Advanced Rectal Carcinoma	PLOS ONE			English	Article							CYCLIC-ADENOSINE-MONOPHOSPHATE; PREOPERATIVE RADIOTHERAPY; COLORECTAL-CARCINOMA; DOWN-REGULATION; CELL-CYCLE; CANCER; PROTEIN; P53; RADIOSENSITIVITY; SENSITIVITY	Background: Mechanism of radioresistance in rectal carcinoma remains largely unknown. We aimed to evaluate the predictive role of ATP-binding cassette subfamily C member 4 (ABCC4) in locally advanced rectal carcinoma and explore possible molecular mechanisms by which ABCC4 confers the resistance to neoadjuvant radiotherapy. Methods: The expression of ABCC4 and P53 mutant in biopsy tissue specimens from 121 locally advanced rectal carcinoma patients was examined using immunohistochemistry. The factors contributing to 3-year overall survival and disease-free survival were evaluated using the Kaplan-Meier method and Cox proportional hazard model. Lentivirus-mediated small hairpin RNA was applied to inhibit ABCC4 expression in colorectal carcinoma cell line RKO, and investigate the radiosensitivity in xenograft model. Intracellular cyclic adenosine monophosphate concentration and cell cycle distribution following irradiation were detected. Results: High expression of ABCC4 and p53 mutant in pretreated tumors, poor pathological response, and high final tumor staging were significant factors independently predicted an unfavorable prognosis of locally advanced rectal carcinoma patients after neoadjuvant radiotherapy. Down-regulation of ABCC4 expression significantly enhanced irradiation-induced suppression of tumor growth in xenograft model. Furthermore, down-regulation of ABCC4 expression enhanced intracellular cyclic adenosine monophosphate production and noticeable deficiency of G1-S phase checkpoint in cell cycle following irradiation. Conclusions: Our study suggests that ABCC4 serves as a novel predictive biomarker that is responsible for the radioresistance and predicts a poor prognosis for locally advanced rectal carcinoma after neoadjuvant radiotherapy.	[Yu, Zhiqi; Zhang, Chang; Gao, Xianhua; Xing, Junjie; Yu, Enda; Zhang, Wei; Fu, Chuangang] Second Mil Med Univ, Changhai Hosp, Dept Colorectal Surg, Shanghai, Peoples R China; [Du, Yan; Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Coll Basic Med Sci, Shanghai, Peoples R China; [Zhang, Xiaoqing] Second Mil Med Univ, Changhai Hosp, Dept Radiotherapy, Shanghai, Peoples R China; [Chai, Rui] Zhejiang Prov Peoples Hosp, Dept Colorectal Surg, Hangzhou, Zhejiang, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Zhejiang Provincial People's Hospital	Cao, GW (corresponding author), Second Mil Med Univ, Dept Epidemiol, Coll Basic Med Sci, Shanghai, Peoples R China.	gcao@smmu.edu.cn; fugang416@126.com	Du, Yan/AAD-5510-2020	Du, Yan/0000-0001-5413-7836; Cao, Guangwen/0000-0002-8094-1278; Zhang, Wei/0000-0003-3094-9711; Gao, Xian Hua/0000-0001-8020-6946	National Natural Science Foundation of China [30973460, 81272561]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grants 30973460 and 81272561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson AB, 2012, J NATL COMPR CANC NE, V10, P1528, DOI 10.6004/jnccn.2012.0158; Candas D, 2013, J MOL CELL BIOL, V5, P166, DOI 10.1093/jmcb/mjs062; Caricato M, 2006, EJSO-EUR J SURG ONC, V32, P126, DOI 10.1016/j.ejso.2005.11.001; Chang WJ, 2011, CLIN CANCER RES, V17, P5715, DOI 10.1158/1078-0432.CCR-11-0199; Copsel S, 2011, J BIOL CHEM, V286, P6979, DOI 10.1074/jbc.M110.166868; Engstrom PF, 2009, J NATL COMPR CANC NE, V7, P838, DOI 10.6004/jnccn.2009.0057; Fu CG, 1998, DIS COLON RECTUM, V41, P68, DOI 10.1007/BF02236898; Fukushima Y, 1999, EUR J CANCER, V35, P935, DOI 10.1016/S0959-8049(99)00035-0; Gradilone A, 2008, CURR CANCER DRUG TAR, V8, P414, DOI 10.2174/156800908785133178; Haste NM, 2012, MICROBES INFECT, V14, P838, DOI 10.1016/j.micinf.2012.05.004; Huynh T, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00178; Jakob C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027402; Ji-Fu E, 2012, MOL BIOL REP, V39, P3675, DOI 10.1007/s11033-011-1142-2; Jorgensen TJ, 2009, CANCER BIOL THER, V8, P665, DOI 10.4161/cbt.8.8.8304; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Langerak P, 2011, PHILOS T R SOC B, V366, P3562, DOI 10.1098/rstb.2011.0070; Li XP, 2011, CANCER-AM CANCER SOC, V117, P4201, DOI 10.1002/cncr.26028; Lin-Lee YC, 2001, BIOCHEM PHARMACOL, V61, P555, DOI 10.1016/S0006-2952(00)00592-X; Lu C, 2009, APOPTOSIS, V14, P597, DOI 10.1007/s10495-009-0330-1; Marquez B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028368; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nantajit D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012341; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Sargent D, 2011, EUR J CANCER, V47, P990, DOI 10.1016/j.ejca.2010.12.015; Sassi Y, 2012, FASEB J, V26, P1009, DOI 10.1096/fj.11-194027; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3; Willett CG, 2009, J CLIN ONCOL, V27, P3020, DOI 10.1200/JCO.2008.21.1771; Witkowski G, 2012, J PHYSIOL PHARMACOL, V63, P457; Wittgen HGM, 2012, BIOCHEM PHARMACOL, V84, P366, DOI 10.1016/j.bcp.2012.04.012; Yu ZQ, 2013, DIS COLON RECTUM, V56, P600, DOI 10.1097/DCR.0b013e31827c2b80; Zhao LQ, 2012, CARCINOGENESIS, V33, P2220, DOI 10.1093/carcin/bgs235	32	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85446	10.1371/journal.pone.0085446	http://dx.doi.org/10.1371/journal.pone.0085446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454870	gold, Green Submitted, Green Published			2022-12-25	WOS:000330235100088
J	Fang, Y; Jaiseng, W; Ma, Y; Hu, LL; Yamazaki, S; Zhang, XB; Hayafuji, T; Shi, L; Kuno, T				Fang, Yue; Jaiseng, Wurentuya; Ma, Yan; Hu, Lingling; Yamazaki, Shizuka; Zhang, Xibo; Hayafuji, Tsutomu; Shi, Lin; Kuno, Takayoshi			E3 Ubiquitin Ligase Pub1 Is implicated in Endocytosis of a GPI-Anchored Protein Ecm33 in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; INTRACELLULAR TRAFFICKING; BINDING PROTEINS; DNA-REPAIR; CALCINEURIN; RSP5; PATHWAY; UBIQUITYLATION; CYTOKINESIS	We previously identified three glycosylphosphatidylinositol (GPI)-anchored proteins including Ecm33, as multicopy suppressors of the phenotypes of a mutant allele of cis4(+) that encodes a zinc transporter in fission yeast. Here, we further identified two multicopy suppressor genes, ubi1(+) and ubc4(+), encoding ubiquitin-ribosomal fusion protein and ubiquitin conjugating enzyme E2, respectively. In addition, Ubi1 or Ubc4 overexpression failed to suppress the phenotypes of the double deletion of cis4(+) and pub1(+) gene, which encodes a HECT-type ubiquitin ligase E3. During exponential phase GFP-Ecm33 localized at the growing cell tips of the cell surface and the medial region in wild-type cells. Notably, during the post-exponential and stationary phase, GFP-Ecm33 in wild-type cells was internalized and mostly localized to the Golgi/endosomes, but it was still stably localized at the cell surface in Delta pub1 cells. The Delta pub1 cells showed osomoremedial phenotypes to various drugs indicating their defects in cell wall integrity. Altogether, our findings reveal a novel role for Pub1 in endocytosis of Ecm33 and regulation of cell wall integrity in fission yeast.	[Fang, Yue; Zhang, Xibo; Shi, Lin; Kuno, Takayoshi] China Med Univ, Dept Biopharmaceut, Sch Pharm, Shenyang, Peoples R China; [Fang, Yue; Jaiseng, Wurentuya; Ma, Yan; Hu, Lingling; Yamazaki, Shizuka; Zhang, Xibo; Hayafuji, Tsutomu; Kuno, Takayoshi] Kobe Univ, Div Mol Pharmacol & Pharmacogen, Dept Biochem & Mol Biol, Grad Sch Med, Kobe, Hyogo 657, Japan; [Jaiseng, Wurentuya] Inner Mongolia Univ Nationalities, Coll Mongolian Med, Tongliao, Peoples R China	China Medical University; Kobe University; Inner Mongolia University for Nationalities	Fang, Y (corresponding author), China Med Univ, Dept Biopharmaceut, Sch Pharm, Shenyang, Peoples R China.	fangyue@mail.cmu.edu.cn	hu, ling/GWC-1104-2022		National Natural Science Foundation of China [31071094]; Program for Liaoning Excellent Talents in University [LJQ2012067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Liaoning Excellent Talents in University	This work was supported by the National Natural Science Foundation of China (No. 31071094) and Program for Liaoning Excellent Talents in University (No. LJQ2012067) to Yue Fang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEACH D, 1982, MOL GEN GENET, V187, P326, DOI 10.1007/BF00331138; Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Cheng H, 2002, MOL BIOL CELL, V13, P2963, DOI 10.1091/mbc.01-09-0463; Chung WL, 2008, TRAFFIC, V9, P1681, DOI 10.1111/j.1600-0854.2008.00785.x; Ciechanover A, 2004, BBA-MOL CELL RES, V1695, P3, DOI 10.1016/j.bbamcr.2004.09.018; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Erpapazoglou Z, 2012, MOL BIOL CELL, V23, P2170, DOI 10.1091/mbc.E11-10-0891; Esteban V, 2008, CELL CYCLE, V7, P1269, DOI 10.4161/cc.7.9.5947; Fang Y, 2008, MOL BIOL CELL, V19, P1295, DOI 10.1091/mbc.E07-08-0805; Fujita M, 2012, BIOCH BIOPHYS ACTA; Hiraishi H, 2009, BIOSCI BIOTECH BIOCH, V73, P2268, DOI 10.1271/bbb.90363; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Jaiseng W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041946; Kaliszewski P, 2008, ACTA BIOCHIM POL, V55, P649; Kaminska J, 2005, ACTA BIOCHIM POL, V52, P207; Karagiannis J, 1999, CURR GENET, V35, P593, DOI 10.1007/s002940050457; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Kwapisz M, 2005, RNA, V11, P1710, DOI 10.1261/rna.2131605; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Matsuo Y, 2011, J BIOL CHEM, V286, P13775, DOI 10.1074/jbc.M110.169953; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakase M, 2012, MICROBIOL-SGM, V158, P659, DOI 10.1099/mic.0.053389-0; Nefsky B, 1996, EMBO J, V15, P1301, DOI 10.1002/j.1460-2075.1996.tb00472.x; Saleki R, 1997, MOL GEN GENET, V254, P520, DOI 10.1007/s004380050447; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Seino H, 2003, MOL CELL BIOL, V23, P3497, DOI 10.1128/MCB.23.10.3497-3505.2003; Shcherbik N, 2011, RNA, V17, P1422, DOI 10.1261/rna.2615311; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Stoll KE, 2011, J BIOL CHEM, V286, P15165, DOI 10.1074/jbc.M110.203968; Takada H, 2010, MOL BIOL CELL, V21, P674, DOI 10.1091/mbc.E09-09-0810; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Toda T, 1996, MOL CELL BIOL, V16, P6752; Tsutsumi S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706869200; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yada T, 2001, J BIOL CHEM, V276, P13579, DOI 10.1074/jbc.M009260200; Zhang YJ, 2000, J BIOL CHEM, V275, P35600, DOI 10.1074/jbc.M005575200	43	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85238	10.1371/journal.pone.0085238	http://dx.doi.org/10.1371/journal.pone.0085238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454826	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800028
J	Brendel, J; Stoll, B; Lange, SJ; Sharma, K; Lenz, C; Stachler, AE; Maier, LK; Richter, H; Nickel, L; Schmitz, RA; Randau, L; Allers, T; Urlaub, H; Backofen, R; Marchfelder, A				Brendel, Jutta; Stoll, Britta; Lange, Sita J.; Sharma, Kundan; Lenz, Christof; Stachler, Aris-Edda; Maier, Lisa-Katharina; Richter, Hagen; Nickel, Lisa; Schmitz, Ruth A.; Randau, Lennart; Allers, Thorsten; Urlaub, Henning; Backofen, Rolf; Marchfelder, Anita			A Complex of Cas Proteins 5, 6, and 7 Is Required for the Biogenesis and Stability of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-derived RNAs (crRNAs) in Haloferax volcanii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Microbiology; Molecular Biology; Molecular Genetics; Protein Complexes; CRISPR; Cas; Cas6; Haloferax volcanii; crRNA; Type I-B	PROCESSES PRE-CRRNA; CRISPR RNA; ANTIVIRAL DEFENSE; IMMUNE-SYSTEM; SEQUENCE; DNA; RECOGNITION; MECHANISM; CLEAVAGE; INTERFERENCE	Background: The Cas6 protein is required for generating crRNAs in CRISPR-Cas I and III systems. Results: The Cas6 protein is necessary for crRNA production but not sufficient for crRNA maintenance in Haloferax. Conclusion: A Cascade-like complex is required in the type I-B system for a stable crRNA population. Significance: The CRISPR-Cas system I-B has a similar Cascade complex like types I-A and I-E. The clustered regularly interspaced short palindromic repeats/CRISPR-associated (CRISPR-Cas) system is a prokaryotic defense mechanism against foreign genetic elements. A plethora of CRISPR-Cas versions exist, with more than 40 different Cas protein families and several different molecular approaches to fight the invading DNA. One of the key players in the system is the CRISPR-derived RNA (crRNA), which directs the invader-degrading Cas protein complex to the invader. The CRISPR-Cas types I and III use the Cas6 protein to generate mature crRNAs. Here, we show that the Cas6 protein is necessary for crRNA production but that additional Cas proteins that form a CRISPR-associated complex for antiviral defense (Cascade)-like complex are needed for crRNA stability in the CRISPR-Cas type I-B system in Haloferax volcanii in vivo. Deletion of the cas6 gene results in the loss of mature crRNAs and interference. However, cells that have the complete cas gene cluster (cas1-8b) removed and are transformed with the cas6 gene are not able to produce and stably maintain mature crRNAs. crRNA production and stability is rescued only if cas5, -6, and -7 are present. Mutational analysis of the cas6 gene reveals three amino acids (His-41, Gly-256, and Gly-258) that are essential for pre-crRNA cleavage, whereas the mutation of two amino acids (Ser-115 and Ser-224) leads to an increase of crRNA amounts. This is the first systematic in vivo analysis of Cas6 protein variants. In addition, we show that the H. volcanii I-B system contains a Cascade-like complex with a Cas7, Cas5, and Cas6 core that protects the crRNA.	[Brendel, Jutta; Stoll, Britta; Stachler, Aris-Edda; Maier, Lisa-Katharina; Marchfelder, Anita] Univ Ulm, Dept Biol 2, D-89069 Ulm, Germany; [Lange, Sita J.; Backofen, Rolf] Univ Freiburg, Dept Comp Sci, Bioinformat Grp, D-79110 Freiburg, Germany; [Sharma, Kundan; Lenz, Christof; Urlaub, Henning] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Richter, Hagen; Randau, Lennart] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Nickel, Lisa; Schmitz, Ruth A.] Univ Kiel, Inst Gen Microbiol, D-24118 Kiel, Germany; [Allers, Thorsten] Univ Nottingham, Sch Life Sci, Queens Med Ctr, Nottingham NG7 2UH, England; [Backofen, Rolf] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Cluster Excellence, D-79110 Freiburg, Germany; [Lenz, Christof; Urlaub, Henning] Univ Med Ctr Gottingen, Inst Clin Chem, D-37075 Gottingen, Germany	Ulm University; University of Freiburg; Max Planck Society; Max Planck Society; University of Kiel; University of Nottingham; University of Freiburg; University of Gottingen	Marchfelder, A (corresponding author), Univ Ulm, Dept Biol 2, D-89069 Ulm, Germany.	anita.marchfelder@uni-ulm.de		Randau, Lennart/0000-0002-2780-2076; Marchfelder, Anita/0000-0002-1382-1794; Allers, Thorsten/0000-0002-7308-3332; Saunders, Sita/0000-0002-2243-5422; Backofen, Rolf/0000-0001-8231-3323; Schmitz-Streit, Ruth Anne/0000-0002-6788-0829	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) in the framework of Research Group 1680, "Unraveling the Prokaryotic Immune System."	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Charpentier E, 2013, CRISPR CAS SYSTEMS, P115; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; CLINE SW, 1989, J BACTERIOL, V171, P4987, DOI 10.1128/jb.171.9.4987-4991.1989; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Fischer S, 2012, J BIOL CHEM, V287, P33351, DOI 10.1074/jbc.M112.377002; Fischer S, 2010, J BIOL CHEM, V285, P34429, DOI 10.1074/jbc.M110.118950; Frols S, 2012, ENVIRON MICROBIOL, V14, P3159, DOI 10.1111/j.1462-2920.2012.02895.x; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Garrett RA, 2011, TRENDS MICROBIOL, V19, P549, DOI 10.1016/j.tim.2011.08.002; Garside EL, 2012, RNA, V18, P2020, DOI 10.1261/rna.033100.112; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Juranek S, 2012, RNA, V18, P783, DOI 10.1261/rna.031468.111; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lange SJ, 2013, NUCLEIC ACIDS RES, V41, P8034, DOI 10.1093/nar/gkt606; Li M, 2013, J BACTERIOL, V195, P867, DOI 10.1128/JB.01688-12; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Maier Lisa-Katharina, 2012, Mob Genet Elements, V2, P228; Maier LK, 2013, RNA BIOL, V10, P865, DOI 10.4161/rna.24282; Maier LK, 2013, BIOCHEM SOC T, V41, P374, DOI 10.1042/BST20120263; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marchfelder A, 2012, EXTREMOPHILES, V16, P685, DOI 10.1007/s00792-012-0469-5; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nickel L, 2013, RNA BIOL, V10, P779, DOI 10.4161/rna.23928; Nieuwlandt D. T., 1995, P161; Pfeiffer F, 2008, ARCH MICROBIOL, V190, P281, DOI 10.1007/s00203-008-0389-z; Randau L, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r63; Reeks J, 2013, RNA BIOL, V10, P762, DOI 10.4161/rna.23854; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Reeks J, 2013, BIOCHEM J, V452, P223, DOI 10.1042/BJ20130269; Richter H, 2012, NUCLEIC ACIDS RES, V40, P9887, DOI 10.1093/nar/gks737; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Scholz I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056470; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shao YM, 2013, STRUCTURE, V21, P385, DOI 10.1016/j.str.2013.01.010; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Sternberg SH, 2012, RNA, V18, P661, DOI 10.1261/rna.030882.111; Stroud A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00224; van Duijn E, 2012, MOL CELL PROTEOMICS, V11, P1430, DOI 10.1074/mcp.M112.020263; Voss B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-123; Wang RY, 2012, PROTEIN SCI, V21, P405, DOI 10.1002/pro.2028; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108	66	52	59	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7164	7177		10.1074/jbc.M113.508184	http://dx.doi.org/10.1074/jbc.M113.508184			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24459147	Green Published, hybrid			2022-12-25	WOS:000332389400075
J	Jami, E; White, BA; Mizrahi, I				Jami, Elie; White, Bryan A.; Mizrahi, Itzhak			Potential Role of the Bovine Rumen Microbiome in Modulating Milk Composition and Feed Efficiency	PLOS ONE			English	Article							GUT MICROBIOME; BACTERIAL; PREVOTELLA; COWS	Ruminants are completely dependent on their microbiota for feed digestion and consequently, their viability. It is therefore tempting to hypothesize a connection between the composition and abundance of resident rumen bacterial taxa and the physiological parameters of the host. Using a pyrosequencing approach, we characterized the rumen bacterial community composition in 15 dairy cows and their physiological parameters. We analyzed the degree of divergence between the different animals and found that some physiological parameters, such as milk yield and composition, are highly correlated with the abundance of various bacterial members of the rumen microbiome. One apparent finding was a strong correlation between the ratio of the phyla Firmicutes to Bacteroidetes and milk-fat yield. These findings paralleled human studies showing similar trends of increased adiposity with an increase in Bacteroidetes. This correlation remained evident at the genus level, where several genera showed correlations with the animals' physiological parameters. This suggests that the bacterial community has a role in shaping host physiological parameters. A deeper understanding of this process may allow us to modulate the rumen microbiome for better agricultural yield through bacterial community design.	[Jami, Elie; Mizrahi, Itzhak] Agr Res Org, Volcani Ctr, Inst Anim Sci, Dept Ruminant Sci, IL-50250 Bet Dagan, Israel; [Jami, Elie] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, Ramat Aviv, Israel; [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Tel Aviv University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Mizrahi, I (corresponding author), Agr Res Org, Volcani Ctr, Inst Anim Sci, Dept Ruminant Sci, IL-50250 Bet Dagan, Israel.	itzhakm@agri.gov.il		Jami, Elie/0000-0002-2839-0843	BARD the United States-Israel Binational Agricultural research development Fund [IS-4390-11]	BARD the United States-Israel Binational Agricultural research development Fund	This research was supported by Research Grant No. IS-4390-11 from BARD the United States-Israel Binational Agricultural research development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer JA, 1999, AUST J AGR RES, V50, P147, DOI 10.1071/A98075; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chiquette J, 2008, J DAIRY SCI, V91, P3536, DOI 10.3168/jds.2007-0849; DEHORITY BA, 1980, APPL ENVIRON MICROB, V39, P376, DOI 10.1128/AEM.39.2.376-381.1980; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hernandez-Sanabria E, 2010, APPL ENVIRON MICROB, V76, P6338, DOI 10.1128/AEM.01052-10; HURTAUD C, 1993, J DAIRY SCI, V76, P3011, DOI 10.3168/jds.S0022-0302(93)77640-7; Jami E, 2012, J DAIRY SCI, V95, P5996, DOI 10.3168/jds.2012-5537; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; KOCH RM, 1963, J ANIM SCI, V22, P486, DOI 10.2527/jas1963.222486x; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2009, J APPL MICROBIOL, V107, P1924, DOI 10.1111/j.1365-2672.2009.04376.x; Lin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053838; Mizrahi I, 2011, BENEFICIAL MICROORGA; Mizrahi I., 2013, PROKARYOTES PROKARYO, P533, DOI DOI 10.1007/978-3-642-30194-0_1; NATIONAL RESEARCH COUNCIL-NRC, 2001, NUTR REQ DAIR CATTL; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Wei T., 2012, PACKAGE CORRPLOT VIS	30	299	316	7	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85423	10.1371/journal.pone.0085423	http://dx.doi.org/10.1371/journal.pone.0085423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465556	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100041
J	Kim, SH; Yoo, C; Choo, M; Paick, JS; Oh, SJ				Kim, Sung Han; Yoo, Changwon; Choo, Minsoo; Paick, Jae-Seung; Oh, Seung-June			Factors Affecting De Novo Urinary Retention after Holmium Laser Enucleation of the Prostate	PLOS ONE			English	Article							TRANSURETHRAL RESECTION; LEARNING-CURVE; HYPERPLASIA; COMPLICATIONS; EXPERIENCE; MANAGEMENT; ABLATION; EFFICACY	Objective: Patients can experience urinary retention (UR) after Holmium laser enucleation of the prostate (HoLEP) that requires bladder distension during the procedure. The aim of this retrospective study is to identify factors affecting the UR after HoLEP. Materials and Methods: 336 patients, which underwent HoLEP for a symptomatic benign prostatic hyperplasia between July 2008 and March 2012, were included in this study. Urethral catheters were routinely removed one or two days after surgery. UR was defined as the need for an indwelling catheter placement following a failure to void after catheter removal. Demographic and clinical parameters were compared between the UR (n = 37) and the non-urinary retention (non-UR; n = 299) groups. Results: The mean age of patients was 68.3 (+/- 6.5) years and the mean operative time was 75.3 (+/- 37.4) min. Thirty seven patients (11.0%) experienced a postoperative UR. UR patients voided catheter free an average of 1.9 (+/- 1.7) days after UR. With regard to the causes of UR, 24 (7.1%) and 13 (3.9%) patients experienced a blood clot-related UR and a non-clot related UR respectively. Using multivariate analysis (p<0.05), we found significant differences between the UR and the non-UR groups with regard to a morcellation efficiency (OR 0.701, 95% CI 0.498-0.988) and a bleeding-related complication, such as, a reoperation for bleeding (OR 0.039, 95% CI 0.004-0.383) or a transfusion (OR 0.144, 95% CI 0.027-0.877). Age, history of diabetes, prostate volume, pre-operative post-void residual, bladder contractility index, learning curve, and operative time wwere not significantly associated with the UR (p>0.05). Conclusions: De novo UR after HoLEP was found to be self-limited and it was not related to learning curve, patient age, diabetes, or operative time. Efficient morcellation and careful control of bleeding, which reduces clot formation, decrease the risk of UR after HoLEP.	[Kim, Sung Han] Natl Canc Ctr, Dept Urol, Goyang, Gyeonggi, South Korea; [Yoo, Changwon] Florida Int Univ, Dept Biostat, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA; [Choo, Minsoo; Paick, Jae-Seung; Oh, Seung-June] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea	National Cancer Center - Korea (NCC); State University System of Florida; Florida International University; Seoul National University (SNU); Seoul National University Hospital	Oh, SJ (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea.	sjo@snu.ac.kr	; Oh, Seung-June/D-6015-2012	Yoo, Changwon/0000-0003-0969-7468; Oh, Seung-June/0000-0002-0322-3539; KIM, Sung Han/0000-0002-1689-5203				Bae Jungbum, 2011, Int Neurourol J, V15, P29, DOI 10.5213/inj.2011.15.1.29; Bae J, 2010, KOREAN J UROL, V51, P688, DOI 10.4111/kju.2010.51.10.688; Djavan B, 1997, J UROLOGY, V158, P1829, DOI 10.1016/S0022-5347(01)64139-9; Du CJ, 2008, J ENDOUROL, V22, P1031, DOI 10.1089/end.2007.0262; Dubey D, 2001, BJU INT, V88, P178, DOI 10.1046/j.1464-410x.2001.02273.x; Eltabey MA, 2010, CAN J UROL, V17, P5447; Elzayat EA, 2006, EUR UROL, V49, P87, DOI 10.1016/j.eururo.2005.08.015; Elzayat EA, 2005, UROLOGY, V66, P789, DOI 10.1016/j.urology.2005.04.049; Elzayat EA, 2005, UROLOGY, V66, P108, DOI 10.1016/j.urology.2005.06.006; Elzayat EA, 2006, WORLD J UROL, V24, P410, DOI 10.1007/s00345-006-0063-5; GILLING PJ, 1995, J ENDOUROL, V9, P151, DOI 10.1089/end.1995.9.151; Hettiarachchi JA, 2002, INT J UROL, V9, P233, DOI 10.1046/j.1442-2042.2002.00457.x; Jeong CW, 2012, INT BRAZ J UROL, V38, P362, DOI 10.1590/S1677-55382012000300009; Kim M, 2013, KOREAN J UROL, V54, P570, DOI 10.4111/kju.2013.54.9.570; KUO HC, 1993, EUR UROL, V24, P12; Kuo RL, 2003, UROLOGY, V62, P59, DOI 10.1016/S0090-4295(03)00124-9; Lane IF, 2000, VET CLIN N AM-SMALL, V30, P25, DOI 10.1016/S0195-5616(00)50002-3; Montorsi F, 2004, J UROLOGY, V172, P1926, DOI 10.1097/01.ju.0000140501.68841.a1; Okamura K, 2011, INT J UROL, V18, P304, DOI 10.1111/j.1442-2042.2010.02712.x; Peterson MD, 2005, J UROLOGY, V174, P998, DOI 10.1097/01.ju.0000170230.26743.e4; Placer J, 2009, UROLOGY, V73, P1042, DOI 10.1016/j.urology.2008.12.052; Rieken M, 2010, WORLD J UROL, V28, P53, DOI 10.1007/s00345-009-0504-z; Shimizu Nobutaka, 2006, Nihon Hinyokika Gakkai Zasshi, V97, P839; Suardi N, 2009, CURR OPIN UROL, V19, P38, DOI 10.1097/MOU.0b013e32831a7008; Tan A, 2007, BRIT J SURG, V94, P1201, DOI 10.1002/bjs.5916	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84938	10.1371/journal.pone.0084938	http://dx.doi.org/10.1371/journal.pone.0084938			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465454	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500023
J	Shin, JY; Kim, YI; Cho, SJ; Lee, MK; Kook, MC; Lee, JH; Lee, SS; Ashktorab, H; Smoot, DT; Ryu, KW; Kim, YW; Choi, IJ				Shin, Ji-Young; Kim, Young-Il; Cho, Soo-Jeong; Lee, Mi Kyung; Kook, Myeong-Cherl; Lee, Jun Ho; Lee, Sang Soo; Ashktorab, Hassan; Smoot, Duane T.; Ryu, Keun Won; Kim, Young-Woo; Choi, Il Ju			MicroRNA 135a Suppresses Lymph Node Metastasis through Down-Regulation of ROCK1 in Early Gastric Cancer	PLOS ONE			English	Article							UPPER GASTROINTESTINAL-TRACT; SIGNALING PATHWAY; MESENCHYMAL TRANSITION; SUBMUCOSAL INVASION; CELL-PROLIFERATION; PROMOTES; FEASIBILITY; INHIBITION; EXPRESSION	MicroRNAs (miRNAs) play a critical role in gastric cancer progression and metastasis. This study investigated the role of miRNA-135a in early gastric cancer (EGC) including lymph node (LN) metastasis. We examined the correlation between miRNA-135a expression and clinical outcomes in 59 patients who underwent surgery for EGC. Using gastric cancer cell lines, we performed functional and target gene analyses. miRNA-135a expression was down-regulated in 33.9% of patients. These patients showed a significantly more advanced stage (TNM stage >= IB, 35.0% vs. 12.8%, p = 0.045) and higher rate of LN metastasis (30.0% vs. 5.1%, p = 0.014) than those with up-regulation of miRNA-135a expression. In a multivariate analysis, down-regulation of miRNA-135a was an independent risk factor for LN metastasis (adjusted odds ratio, 8.04; 95% confidence interval, 1.08-59.81; p = 0.042). Functional analyses using gastric cancer cell lines showed that miRNA-135a suppressed cell viability, epithelial-mesenchymal transition, cell invasion, and migration. ROCK1 was a target of miRNA-135a and its expression was inversely correlated to that of miRNA-135a. ROCK1 expression was significantly increased in EGC patients with LN metastasis than in those without LN metastasis. Our results confirm the tumor-suppressive role of miRNA-135a, and demonstrate its role in LN metastasis in EGC. miRNA-135a and its target gene ROCK1 may be novel therapeutic and prognostic targets for EGC.	[Shin, Ji-Young; Kim, Young-Il; Cho, Soo-Jeong; Lee, Mi Kyung; Kook, Myeong-Cherl; Lee, Jun Ho; Ryu, Keun Won; Kim, Young-Woo; Choi, Il Ju] Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea; [Shin, Ji-Young; Lee, Sang Soo] Paichai Univ, Dept Life Sci & Biotechnol, Taejon, South Korea; [Ashktorab, Hassan; Smoot, Duane T.] Howard Univ, Dept Med, Washington, DC 20059 USA	National Cancer Center - Korea (NCC); Pai Chai University; Howard University	Cho, SJ (corresponding author), Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea.	crystal522@daum.net	Ashktorab, hassan/AAJ-2908-2020	CHO, SOO-JEONG/0000-0001-7144-0589; Kim, Young-Woo/0000-0002-1559-9672	National Cancer Center, Korea [1110532-3]	National Cancer Center, Korea	This study was funded by grant 1110532-3 from the National Cancer Center, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; An JY, 2007, ANN SURG, V246, P749, DOI 10.1097/SLA.0b013e31811f3fb7; Arigami T, 2006, ANN SURG, V243, P341, DOI 10.1097/01.sla.0000201453.65534.f1; Borie F, 2000, ARCH SURG-CHICAGO, V135, P1218, DOI 10.1001/archsurg.135.10.1218; Chen YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-111; Chiba T, 2012, GASTROENTEROLOGY, V143, P550, DOI 10.1053/j.gastro.2012.07.009; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cummins JM, 2006, ONCOGENE, V25, P6220, DOI 10.1038/sj.onc.1209914; Edge SB, 2010, AJCC CANC STAGING MA; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrand J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019569; Gao M, 2013, WORLD J GASTROENTERO, V19, P2019, DOI 10.3748/wjg.v19.i13.2019; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Isomoto H, 2009, GUT, V58, P331, DOI 10.1136/gut.2008.165381; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jia LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058637; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lynch J, 2012, CARCINOGENESIS, V33, P976, DOI 10.1093/carcin/bgs114; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Navarro A, 2009, BLOOD, V114, P2945, DOI 10.1182/blood-2009-02-204842; Park DJ, 2004, WORLD J GASTROENTERO, V10, P3549, DOI 10.3748/wjg.v10.i24.3549; Rath N, 2012, EMBO REP, V13, P900, DOI 10.1038/embor.2012.127; Roviello F, 2006, J SURG ONCOL, V94, P275, DOI 10.1002/jso.20566; Ryu KW, 2012, J GASTRIC CANCER, V12, P1, DOI 10.5230/jgc.2012.12.1.1; Shimizu Y, 2012, ANN SURG ONCOL, V19, P469, DOI 10.1245/s10434-011-2122-4; Soetikno R, 2005, J CLIN ONCOL, V23, P4490, DOI 10.1200/JCO.2005.19.935; Song SM, 2013, NAT REV GASTRO HEPAT, V10, P109, DOI 10.1038/nrgastro.2012.210; Takeuchi H, 2013, ANN SURG ONCOL, V20, P522, DOI 10.1245/s10434-012-2602-1; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Ueno K, 2011, BRIT J CANCER, V104, P308, DOI 10.1038/sj.bjc.6606028; Wu H, 2012, CANCER BIOL THER, V13, P281, DOI 10.4161/cbt.18943; Wu Y J, 2013, ASIA-PAC J CLIN ONCO, DOI [10.1111/ajco.12052, DOI 10.1111/AJC0.12052]; Xu XT, 2012, HEPATO-GASTROENTEROL, V59, P2523, DOI 10.5754/hge12147; Yamada Y, 2013, CANCER SCI, V104, P304, DOI 10.1111/cas.12072; Yoon JH, 2013, J CELL BIOCHEM, V114, P1800, DOI 10.1002/jcb.24524; Zavadil J, 2008, CANCER RES, V68, P9574, DOI 10.1158/0008-5472.CAN-08-2316; Zhang ZP, 2011, CANCER GENET-NY, V204, P486, DOI 10.1016/j.cancergen.2011.07.004; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156; Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714	42	36	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85205	10.1371/journal.pone.0085205	http://dx.doi.org/10.1371/journal.pone.0085205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465504	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500042
J	Yu, YY; Jiang, LM; Zhuang, ZQ; Liu, YW; Wang, XY; Liu, JY; Yang, MN; Chen, WH				Yu, Yanyan; Jiang, Luman; Zhuang, Ziqing; Liu, Yuewei; Wang, Xinyan; Liu, Juyuan; Yang, Mingna; Chen, Weihong			Fitting Characteristics of N95 Filtering-Facepiece Respirators Used Widely in China	PLOS ONE			English	Article							FACE ANTHROPOMETRIC SURVEY; HALF-MASK RESPIRATOR; TEST PANEL; FIT; PROTECTION; DIMENSIONS; WORKERS; SIZE	Background: Millions of people rely on N95 filtering facepiece respirators to reduce the risk of airborne particles and prevent them from respiratory infections. However, there are no respirator fit testing and training regulations in China. Meanwhile, no study has been conducted to investigate the fit of various respirators. The objective of this study was to investigate whether people obtained adequate fit when wearing N95 filtering facepiece respirators (FFRs) used widely in China. Methods: Fifty adult participants selected using the Chinese respirator fit test panel donned 10 common models of N95 FFRs. Fit factors (FF) and inward leakage were measured using the TSI PortaCount Plus. Each subject was tested with three replications for each model. A subject was considered to pass the fit test when at least two of the three FFs were greater than 100. Two models were conducted fit tests before and after training to assess the role of training. Results: The geometric mean FFs for each model and trained subjects ranged from <10 to 74.0. The fifth percentile FFs for only two individual respirator models were greater than 10 which is the expected level of performance for FFRs. The passing rates for these two models of FFRs were 44.7% and 20.0%. The passing rates were less than 10.0% for the other eight models. There were 27 (54%) participants who passed none of the 10 FFRs. The geometric mean FFs for both models when the subjects received training (49.7 and 74.0) were significantly larger than those when the same group of subjects did not receive any training (29.0 and 30.9) (P<0.05). Conclusions: FFRs used widely in China should be improved according to Chinese facial dimensions. Respirator users could benefit from respirator training and fit testing before using respirators.	[Yu, Yanyan; Jiang, Luman; Liu, Yuewei; Wang, Xinyan; Chen, Weihong] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Occupat & Environm Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Yu, Yanyan; Jiang, Luman; Chen, Weihong] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Yu, Yanyan; Jiang, Luman; Chen, Weihong] Huazhong Univ Sci & Technol, Minist Environm Protect, Wuhan 430074, Peoples R China; [Yu, Yanyan; Jiang, Luman; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubating, Wuhan 430074, Peoples R China; [Zhuang, Ziqing] NIOSH, Natl Personal Protect Technol Lab, Pittsburgh, PA USA; [Liu, Juyuan; Yang, Mingna] Guangzhou Occupat Safety & Hlth Safety Technol Co, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Chen, WH (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Occupat & Environm Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China.	wchen@mails.tjmu.edu.cn	Yu, Yan/GYV-4514-2022; Chen, Weihong/D-2177-2011; Liu, Yuewei/J-5147-2019	Chen, Weihong/0000-0001-8689-7311; Liu, Yuewei/0000-0001-5970-4262	Chinese National Basic Research Program of China [2011CB503804]; research project in Administration of Work Safety of Guangdong Province	Chinese National Basic Research Program of China; research project in Administration of Work Safety of Guangdong Province	This work was supported by research funds from Chinese National Basic Research Program of China (2011CB503804) and from research project in Administration of Work Safety of Guangdong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charles EC, 1972, TR705 AER MED RES LA; Chen WH, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001206; Chen WH, 2009, ANN OCCUP HYG, V53, P297, DOI 10.1093/annhyg/men089; China National Institute of Standardization, 2006, GB26262006 CHIN NAT; China National Institute of Standardization, 2002, 186642002 GBT CHIN N; Coffey CC, 2004, J OCCUP ENVIRON HYG, V1, P262, DOI 10.1080/15459620490433799; Du LL, 2008, ANN OCCUP HYG, V52, P773, DOI 10.1093/annhyg/men056; Europen Committee for Standardization, 2001, EN149 EUR COMM STAND; HACK AL, 1978, AM IND HYG ASSOC J, V39, P970, DOI 10.1080/0002889778507897; Han DH, 2005, ANN OCCUP HYG, V49, P569, DOI 10.1093/annhyg/mei034; Han DH, 2000, ANN OCCUP HYG, V44, P227, DOI 10.1016/S0003-4878(99)00087-3; Health BoLSNIfOSa, 2003, RESP US PRIV SECT FI; KENNEDY KW, 1986, AAMRLTR85062 WRIGHT; Kiely PM, 2009, CLIN EXP OPTOM, V92, P490, DOI 10.1111/j.1444-0938.2009.00420.x; Martyny J, 2002, NEW ENGL J MED, V347, P824, DOI 10.1056/NEJMra012670; Ministry of Agriculture of China, 2009, CHIN ANN HLTH STAT R, P24; Occupational Safety and Healh Administration, 1995, AIDS ALERT, V10, P154; OESTENSTAD RK, 1990, AM IND HYG ASSOC J, V51, P285, DOI 10.1202/0002-8894(1990)051<0285:DOFLSO>2.0.CO;2; OESTENSTAD RK, 1992, AM IND HYG ASSOC J, V53, P639, DOI 10.1202/0002-8894(1992)053<0639:AAOCAD>2.0.CO;2; Qian YG, 1998, AM IND HYG ASSOC J, V59, P128, DOI 10.1080/15428119891010389; Spies A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-17; Viscusi DJ, 2012, J OCCUP ENVIRON HYG, V9, P408, DOI 10.1080/15459624.2012.683757; Yang L, 2007, ANN OCCUP HYG, V51, P415, DOI 10.1093/annhyg/mem005; Yu Yan-yan, 2012, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V30, P348; Zhuang Z., 2007, INT WORKSH DUST PATH, P35; Zhuang ZQ, 2008, J OCCUP ENVIRON HYG, V5, P617, DOI 10.1080/15459620802293810; Zhuang ZQ, 2005, J OCCUP ENVIRON HYG, V2, P641, DOI 10.1080/15459620500391668; Zhuang ZQ, 2005, J OCCUP ENVIRON HYG, V2, P567, DOI 10.1080/15459620500324727	28	22	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85299	10.1371/journal.pone.0085299	http://dx.doi.org/10.1371/journal.pone.0085299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465528	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500051
J	Marinov, GK; Wang, YE; Chan, D; Wold, BJ				Marinov, Georgi K.; Wang, Yun E.; Chan, David; Wold, Barbara J.			Evidence for Site-Specific Occupancy of the Mitochondrial Genome by Nuclear Transcription Factors	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; ELECTRON-TRANSPORT CHAIN; NF-KAPPA-B; IN-VIVO; GENE-EXPRESSION; HEAVY-STRAND; GLUCOCORTICOID RECEPTOR; SIGNAL TRANSDUCER; THYROID-HORMONE; RNA-POLYMERASE	Mitochondria contain their own circular genome, with mitochondria-specific transcription and replication systems and corresponding regulatory proteins. All of these proteins are encoded in the nuclear genome and are post-translationally imported into mitochondria. In addition, several nuclear transcription factors have been reported to act in mitochondria, but there has been no comprehensive mapping of their occupancy patterns and it is not clear how many other factors may also be found in mitochondria. Here we address these questions by using ChIP-seq data from the ENCODE, mouseENCODE and modENCODE consortia for 151 human, 31 mouse and 35 C. elegans factors. We identified 8 human and 3 mouse transcription factors with strong localized enrichment over the mitochondrial genome that was usually associated with the corresponding recognition sequence motif. Notably, these sites of occupancy are often the sites with highest ChIP-seq signal intensity within both the nuclear and mitochondrial genomes and are thus best explained as true binding events to mitochondrial DNA, which exist in high copy number in each cell. We corroborated these findings by immunocytochemical staining evidence for mitochondrial localization. However, we were unable to find clear evidence for mitochondrial binding in ENCODE and other publicly available ChIP-seq data for most factors previously reported to localize there. As the first global analysis of nuclear transcription factors binding in mitochondria, this work opens the door to future studies that probe the functional significance of the phenomenon.	[Marinov, Georgi K.; Wang, Yun E.; Chan, David; Wold, Barbara J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Chan, David] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Marinov, GK (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	georgi@caltech.edu			Beckman Institute Functional Genomics Center; Donald Bren Endowment; NIH [U54 HG004576, U54 HG006998, GM062967]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006998, U54HG004576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062967] Funding Source: NIH RePORTER	Beckman Institute Functional Genomics Center; Donald Bren Endowment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study has been supported by the Beckman Institute Functional Genomics Center, the Donald Bren Endowment, and NIH grants U54 HG004576, U54 HG006998, and GM062967. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Aksoy O, 2012, GENE DEV, V26, P1546, DOI 10.1101/gad.196238.112; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Cammarota M, 1999, J NEUROCHEM, V72, P2272, DOI 10.1046/j.1471-4159.1999.0722272.x; CANTATORE P, 1980, NUCLEIC ACIDS RES, V8, P2605, DOI 10.1093/nar/8.12.2605; Casas F, 1999, MOL CELL BIOL, V19, P7913; Casas F, 2000, FEBS LETT, V478, P4, DOI 10.1016/S0014-5793(00)01814-7; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Chueh FY, 2010, BIOCHEM BIOPH RES CO, V402, P778, DOI 10.1016/j.bbrc.2010.10.112; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cogswell PC, 2003, J BIOL CHEM, V278, P2963, DOI 10.1074/jbc.M209995200; De Rasmo D, 2009, FEBS J, V276, P4325, DOI 10.1111/j.1742-4658.2009.07133.x; DEMONACOS C, 1993, J STEROID BIOCHEM, V46, P401, DOI 10.1016/0960-0760(93)90231-K; DEMONACOS C, 1995, J STEROID BIOCHEM, V55, P43, DOI 10.1016/0960-0760(95)00159-W; DUBUY HG, 1967, P NATL ACAD SCI USA, V57, P790; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enriquez JA, 1999, MOL CELL BIOL, V19, P657; Enriquez JA, 1999, BIOL CHEM, V380, P737, DOI 10.1515/BC.1999.094; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; FISHER RP, 1985, J BIOL CHEM, V260, P1330; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gertz J, 2012, GENOME RES, V22, P2153, DOI 10.1101/gr.135681.111; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Heyne K, 2004, FEBS LETT, V578, P198, DOI 10.1016/j.febslet.2004.10.099; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson RF, 2011, CANCER RES, V71, P5588, DOI 10.1158/0008-5472.CAN-10-4252; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Koufali MM, 2003, MOL CELL ENDOCRINOL, V209, P51, DOI 10.1016/j.mce.2003.07.003; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Leigh-Brown S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-215; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Liu XY, 2010, CELL RES, V20, P994, DOI 10.1038/cr.2010.103; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Monje P, 2001, J CELL BIOCHEM, V82, P467, DOI 10.1002/jcb.1182; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nass S, 1965, BIOCHIM BIOPHYS ACTA, V95; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Ogita K, 2003, J NEUROSCI RES, V73, P794, DOI 10.1002/jnr.10720; Ogita K, 2002, J NEUROSCI, V22, P2561, DOI 10.1523/JNEUROSCI.22-07-02561.2002; Psarra AMG, 2006, MOL CELL ENDOCRINOL, V246, P21, DOI 10.1016/j.mce.2005.11.025; Reddy TE, 2012, MOL CELL BIOL, V32, P3756, DOI 10.1128/MCB.00062-12; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; Sebastian S, 2013, GENE DEV, V27, P1247, DOI 10.1101/gad.215400.113; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Shulga N, 2012, J CELL SCI, V125, P2995, DOI 10.1242/jcs.103093; Shutt TE, 2011, TRANSCR-AUSTIN, V2, P55, DOI 10.4161/trns.2.2.14296; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Szczepanek K, 2012, TRENDS CELL BIOL, V22, P429, DOI 10.1016/j.tcb.2012.05.001; Szczepanek K, 2012, MITOCHONDRION, V12, P180, DOI 10.1016/j.mito.2011.08.011; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Szklarczyk R, 2010, PROTEOMICS, V10, P4012, DOI 10.1002/pmic.201000329; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang YE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074513; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390; WRUTNIAK C, 1995, J BIOL CHEM, V270, P16347, DOI 10.1074/jbc.270.27.16347; YANG D, 1985, P NATL ACAD SCI USA, V82, P4443, DOI 10.1073/pnas.82.13.4443; Yoshida Y, 2003, CANCER RES, V63, P3729	83	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84713	10.1371/journal.pone.0084713	http://dx.doi.org/10.1371/journal.pone.0084713			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465428	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000330240500021
J	Aujoulat, F; Romano-Bertrand, S; Masnou, A; Marchandin, H; Jumas-Bilak, E				Aujoulat, Fabien; Romano-Bertrand, Sara; Masnou, Agnes; Marchandin, Helene; Jumas-Bilak, Estelle			Niches, Population Structure and Genome Reduction in Ochrobactrum intermedium: Clues to Technology-Driven Emergence of Pathogens	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; SEQUENCE TYPING SCHEME; SP NOV.; GENETIC DIVERSITY; BRUCELLA; BACTERIA; IDENTIFICATION; RESISTANCE; REVEALS; STRAINS	Ochrobactrum intermedium is considered as an emerging human environmental opportunistic pathogen with mild virulence. The distribution of isolates and sequences described in literature and databases showed frequent association with human beings and polluted environments. As population structures are related to bacterial lifestyles, we investigated by multi-locus approach the genetic structure of a population of 65 isolates representative of the known natural distribution of O. intermedium. The population was further surveyed for genome dynamics using pulsed-field gel electrophoresis and genomics. The population displayed a clonal epidemic structure with events of recombination that occurred mainly in clonal complexes. Concerning biogeography, clones were shared by human and environments and were both cosmopolitan and local. The main cosmopolitan clone was genetically and genomically stable, and grouped isolates that all harbored an atypical insertion in the rrs. Ubiquitism and stability of this major clone suggested a clonal succes in a particular niche. Events of genomic reduction were detected in the population and the deleted genomic content was described for one isolate. O. intermedium displayed allopatric characters associated to a tendancy of genome reduction suggesting a specialization process. Considering its relatedness with Brucella, this specialization might be a commitment toward pathogenic life-style that could be driven by technological selective pressure related medical and industrial technologies.	[Aujoulat, Fabien; Romano-Bertrand, Sara; Masnou, Agnes; Marchandin, Helene; Jumas-Bilak, Estelle] Univ Montpellier I, UMR ECOSYM 5119, Equipe Pathogenes & Environm, UFR Sci Pharmaceut & Biol, Montpellier, France; [Marchandin, Helene] Ctr Hosp Reg Univ Montpellier, Lab Bacteriol, Hop Arnaud de Villeneuve, Montpellier, France; [Jumas-Bilak, Estelle] CHU Montpellier, Lab Hyg Hosp, Montpellier, France	Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Jumas-Bilak, E (corresponding author), Univ Montpellier I, UMR ECOSYM 5119, Equipe Pathogenes & Environm, UFR Sci Pharmaceut & Biol, Montpellier, France.	ebilak@univ-montp1.fr	Romano-Bertrand, Sara/N-3688-2016; MARCHANDIN, Hélène/AAM-8288-2021	MARCHANDIN, Hélène/0000-0003-2130-6335; Romano-Bertrand, Sara/0000-0002-6134-2210; Aujoulat, Fabien/0000-0001-6180-6903	French Ministry of Higher Education and Research	French Ministry of Higher Education and Research	The funder is the French Ministry of Higher Education and Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvand M, 2007, INT J MED MICROBIOL, V297, P255, DOI 10.1016/j.ijmm.2007.02.001; Aujoulat F, 2012, GENES-BASEL, V3, P191, DOI 10.3390/genes3020191; Aujoulat F, 2011, J BACTERIOL, V193, P2608, DOI 10.1128/JB.00107-11; Babic I, 2000, MICROBIOL-UK, V146, P709, DOI 10.1099/00221287-146-3-709; Barquero-Calvo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005893; Bevivino A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-228; Bidet P, 2007, J INFECT DIS, V196, P297, DOI 10.1086/518897; Boucher D, 2011, MICROB ECOL, V62, P868, DOI 10.1007/s00248-011-9887-7; Boukhatem ZF, 2012, FEMS MICROBIOL ECOL, V80, P534, DOI 10.1111/j.1574-6941.2012.01315.x; Bourg G, 2007, VET MICROBIOL, V125, P375, DOI 10.1016/j.vetmic.2007.06.002; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Caro-Hernandez P, 2007, INFECT IMMUN, V75, P4050, DOI 10.1128/IAI.00486-07; Dean AS, 2012, PLOS NEGLECT TROP D, V6, DOI [10.1371/journal.pntd.0001929, 10.1371/journal.pntd.0001865]; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eisenberg T, 2012, APPL ENVIRON MICROB, V78, P3753, DOI 10.1128/AEM.07509-11; FELSENSTEIN J, 1984, EVOLUTION, V38, P16, DOI 10.1111/j.1558-5646.1984.tb00255.x; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fischer D, 2012, J ZOO WILDLIFE MED, V43, P625, DOI 10.1638/2011-0005R2.1; Georgiades K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00151; Graindorge A, 2012, J MED MICROBIOL, V61, P394, DOI 10.1099/jmm.0.036822-0; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Higgins CS, 2001, CLIN MICROBIOL INFEC, V7, P308, DOI 10.1046/j.1198-743x.2001.00253.x; Hoffmaster AR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-191; Huber B, 2010, INT J SYST EVOL MICR, V60, P321, DOI 10.1099/ijs.0.011668-0; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Imran A, 2010, INT J SYST EVOL MICR, V60, P1548, DOI 10.1099/ijs.0.013987-0; Iwashita S, 2004, APPL MICROBIOL BIOT, V65, P620, DOI 10.1007/s00253-004-1684-5; Joyce EA, 2002, NAT REV GENET, V3, P462, DOI 10.1038/nrg820; Kaiser S, 2009, J BACTERIOL, V191, P2934, DOI 10.1128/JB.00892-08; Kavita B, 2012, 3 BIOTECH, V2, P79, DOI 10.1007/s13205-011-0038-0; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kulkarni G, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-7; Matyar F, 2008, SCI TOTAL ENVIRON, V407, P279, DOI 10.1016/j.scitotenv.2008.08.014; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; MichauxCharachon S, 1997, J BACTERIOL, V179, P3244, DOI 10.1128/jb.179.10.3244-3249.1997; Mira A, 2006, TRENDS MICROBIOL, V14, P200, DOI 10.1016/j.tim.2006.03.001; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Nishino K, 2008, IUBMB LIFE, V60, P569, DOI 10.1002/iub.90; Pandey S, 2013, J MICROBIOL, V51, P11, DOI 10.1007/s12275-013-2330-7; Pandey S, 2010, CURR MICROBIOL, V61, P106, DOI 10.1007/s00284-010-9583-8; Perkins SD, 2010, FEMS MICROBIOL ECOL, V74, P643, DOI 10.1111/j.1574-6941.2010.00976.x; Pirnay JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007740; Rezzonico F, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-204; Romano S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-267; Sallstrom B, 2005, CURR OPIN MICROBIOL, V8, P579, DOI 10.1016/j.mib.2005.08.002; Scholz HC, 2008, SYST APPL MICROBIOL, V31, P1, DOI 10.1016/j.syapm.2007.10.004; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Spilker T, 2012, J CLIN MICROBIOL, V50, P3010, DOI 10.1128/JCM.00814-12; Suen G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000743; Teyssier C, 2005, J MED MICROBIOL, V54, P945, DOI 10.1099/jmm.0.46116-0; Teyssier C, 2005, ELECTROPHORESIS, V26, P2898, DOI 10.1002/elps.200410323; Teyssier C, 2003, PATHOL BIOL, V51, P5, DOI 10.1016/S0369-8114(02)00361-9; Teyssier C, 2003, J BACTERIOL, V185, P2901, DOI 10.1128/JB.185.9.2901-2909.2003; Teyssier C, 2007, INT J SYST EVOL MICR, V57, P1007, DOI 10.1099/ijs.0.64416-0; Thoma B, 2009, INT J MED MICROBIOL, V299, P209, DOI 10.1016/j.ijmm.2008.06.009; Tian YS, 2010, APPL ENVIRON MICROB, V76, P6001, DOI 10.1128/AEM.00770-10; van Mansfeld R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013482; Wackerow-Kouzova ND, 2007, APPL BIOCHEM MICRO+, V43, P403, DOI 10.1134/S0003683807040084; Waranusantigul P, 2011, CHEMOSPHERE, V85, P584, DOI 10.1016/j.chemosphere.2011.06.086; Wattam AR, 2009, J BACTERIOL, V191, P3569, DOI 10.1128/JB.01767-08; Woo SG, 2011, INT J SYST EVOL MICR, V61, P2690, DOI 10.1099/ijs.0.025510-0; Zalasiewicz J, 2010, ENVIRON SCI TECHNOL, V44, P2228, DOI 10.1021/es903118j	64	26	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e83376	10.1371/journal.pone.0083376	http://dx.doi.org/10.1371/journal.pone.0083376			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465379	gold, Green Published			2022-12-25	WOS:000330237000008
J	Andreou, M; Yan, CYI; Skourides, PA				Andreou, Maria; Irene Yan, Chao Yun; Skourides, Paris A.			40LoVe and Samba Are Involved in Xenopus Neural Development and Functionally Distinct from hnRNP AB	PLOS ONE			English	Article							RNA-BINDING PROTEINS; MESSENGER-RNA; CELL-MIGRATION; NUCLEAR IMPORT; RICH DOMAIN; A1; LOCALIZATION; ELEMENT; INTERACTS; ADHESION	Heterogeneous nuclear ribonucleoproteins (hnRNPs) comprise a large group of modular RNA-binding proteins classified according to their conserved domains. This modular nature, coupled with a large choice of alternative splice variants generates functional diversity. Here, we investigate the biological differences between 40LoVe, its splice variant Samba and its pseudoallele hnRNP AB in neural development. Loss of function experiments lead to defects in neural development with reduction of eye size, which stem primarily from increased apoptosis and reduced proliferation in neural tissues. Despite very high homology between 40LoVe/Samba and hnRNP AB, these proteins display major differences in localization, which appear to be in part responsible for functional differences. Specifically, we show that the 40Love/Samba carboxy-terminal domain (GRD) enables nucleocytoplasmic shuttling behavior. This domain is slightly different in hnRNP AB, leading to nuclear-restricted localization. Finally, we show that shuttling is required for 40LoVe/Samba function in neural development.	[Andreou, Maria; Skourides, Paris A.] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Irene Yan, Chao Yun] Univ Sao Paulo, Dept Cell & Dev Biol, Sao Paulo, Brazil	University of Cyprus; Universidade de Sao Paulo	Skourides, PA (corresponding author), Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus.	skourip@ucy.ac.cy	Yan, Chao Yun Irene/B-4700-2011	Yan, Chao Yun Irene/0000-0003-0527-5719; Skourides, Paris/0000-0003-3502-5729	Cyprus Research Promotion Foundation [ANABAThetaMISigmaH/0609/28]; European Union	Cyprus Research Promotion Foundation; European Union(European Commission)	This work was funded by Cyprus Research Promotion Foundation (ANABA Theta MI Sigma H/0609/28) and co-funded by the Structural Funds of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bemark M, 1998, J BIOL CHEM, V273, P18881, DOI 10.1074/jbc.273.30.18881; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; Czaplinski K, 2006, RNA, V12, P213, DOI 10.1261/rna.2820106; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Yan CYI, 2009, DEV DYNAM, V238, P204, DOI 10.1002/dvdy.21826; Katz ZB, 2012, GENE DEV, V26, P1885, DOI 10.1101/gad.190413.112; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kobel HR, 1986, GENETICS POLYPLOID X; Kroll TT, 2009, MECH DEVELOP, V126, P523, DOI 10.1016/j.mod.2009.03.007; MAYEDA A, 1994, EMBO J, V13, P5483, DOI 10.1002/j.1460-2075.1994.tb06883.x; MILLER L, 1977, IN VITRO CELL DEV B, V13, P557; NcNally LM, 2006, J BIOL CHEM, V281, P2478, DOI 10.1074/jbc.M511215200; Norvell A, 1999, GENE DEV, V13, P864, DOI 10.1101/gad.13.7.864; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Sinnamon JR, 2012, RNA, V18, P704, DOI 10.1261/rna.030742.111; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Suzuki M, 2005, FEBS J, V272, P3975, DOI 10.1111/j.1742-4658.2005.04820.x; SWANSON MS, 1987, MOL CELL BIOL, V7, P1731, DOI 10.1128/MCB.7.5.1731; Van Dusen CM, 2010, MOL CELL BIOL, V30, P2552, DOI 10.1128/MCB.00230-09; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; WEIGHARDT F, 1995, J CELL SCI, V108, P545; Yaniv K, 2003, DEVELOPMENT, V130, P5649, DOI 10.1242/dev.00810; Yoo YD, 2006, J BIOL CHEM, V281, P15352, DOI 10.1074/jbc.M511825200	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85026	10.1371/journal.pone.0085026	http://dx.doi.org/10.1371/journal.pone.0085026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454782	gold, Green Submitted, Green Published			2022-12-25	WOS:000330235100049
J	Fenutria, R; Martinez, VG; Simoes, I; Postigo, J; Gil, V; Martinez-Florensa, M; Sintes, J; Naves, R; Cashman, KS; Alberola-Ila, J; Ramos-Casals, M; Soldevila, G; Raman, C; Merino, J; Merino, R; Engel, P; Lozano, F				Fenutria, Rafael; Martinez, Vanesa G.; Simoes, Ines; Postigo, Jorge; Gil, Victor; Martinez-Florensa, Mario; Sintes, Jordi; Naves, Rodrigo; Cashman, Kevin S.; Alberola-Ila, Jose; Ramos-Casals, Manel; Soldevila, Gloria; Raman, Chander; Merino, Jesus; Merino, Ramon; Engel, Pablo; Lozano, Francisco			Transgenic Expression of Soluble Human CD5 Enhances Experimentally-Induced Autoimmune and Anti-Tumoral Immune Responses	PLOS ONE			English	Article							T-CELL-ACTIVATION; B-CELLS; SIGNAL-TRANSDUCTION; MICE; RECEPTOR; DOMAIN; INHIBITION; DISEASE; SUBSET; ENCEPHALOMYELITIS	CD5 is a lymphoid-specific transmembrane glycoprotein constitutively expressed on thymocytes and mature T and B1a lymphocytes. Current data support the view that CD5 is a negative regulator of antigen-specific receptor-mediated signaling in these cells, and that this would likely be achieved through interaction with CD5 ligand/s (CD5L) of still undefined nature expressed on immune or accessory cells. To determine the functional consequence of loss of CD5/CD5L interaction in vivo, a new transgenic mouse line was generated (shCD5E mu Tg), expressing a circulating soluble form of human CD5 (shCD5) as a decoy to impair membrane-bound CD5 function. These shCD5E mu Tg mice showed an enhanced response to autologous antigens, as deduced from the presentation of more severe forms of experimentally inducible autoimmune disease (collagen-induced arthritis, CIA; and experimental autoimmune encephalitis, EAE), as well as an increased anti-tumoral response in non-orthotopic cancer models (B16 melanoma). This enhancement of the immune response was in agreement with the finding of significantly reduced proportions of spleen and lymph node Treg cells (CD4+CD25+FoxP3+), and of peritoneal IL-10-producing and CD5+ B cells, as well as an increased proportion of spleen NKT cells in shCD5E mu Tg mice. Similar changes in lymphocyte subpopulations were observed in wild-type mice following repeated administration of exogenous recombinant shCD5 protein. These data reveal the relevant role played by CD5/CD5L interactions on the homeostasis of some functionally relevant lymphocyte subpopulations and the modulation of immune responses to autologous antigens.	[Fenutria, Rafael; Martinez, Vanesa G.; Simoes, Ines; Martinez-Florensa, Mario; Lozano, Francisco] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Postigo, Jorge; Merino, Jesus; Merino, Ramon] Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain; [Gil, Victor; Ramos-Casals, Manel] Hosp Clin Barcelona, Serv Malalties Autoimmunes Sistemiques, Barcelona, Spain; [Sintes, Jordi; Engel, Pablo; Lozano, Francisco] Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Barcelona, Spain; [Naves, Rodrigo; Raman, Chander] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Cashman, Kevin S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Alberola-Ila, Jose] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Soldevila, Gloria] Univ Nacl Autonoma Mexico, Dept Inmunol, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Merino, Ramon] Univ Cantabria, SODERCAN, CSIC, Inst Biomed & Biotecnol Cantabria, E-39005 Santander, Spain; [Lozano, Francisco] Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidad de Cantabria; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Oklahoma Medical Research Foundation; Universidad Nacional Autonoma de Mexico; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); University of Barcelona; Hospital Clinic de Barcelona	Lozano, F (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	flozano@clinic.ub.es	LOZANO, FRANCISCO/AAB-7888-2019; Merino, Ramón/L-1310-2014; Lozano-Soto, Francisco/AAB-7930-2019; Naves, Rodrigo/H-4829-2014; Engel, Pablo/R-5907-2019; Sintes, Jordi/K-6551-2014; Simoes, Ines Tadeu/A-6693-2018	LOZANO, FRANCISCO/0000-0003-1119-4368; Merino, Ramón/0000-0002-5306-0635; Lozano-Soto, Francisco/0000-0003-3714-2304; Naves, Rodrigo/0000-0002-1203-3593; Engel, Pablo/0000-0001-8410-252X; Sintes, Jordi/0000-0002-1836-7076; Simoes, Ines Tadeu/0000-0003-1730-7263; Soldevila, Gloria/0000-0003-1539-2548; Ramos-Casals, Manuel/0000-0001-5709-6734; alberola-ila, Jose/0000-0003-2439-553X	Spanish Ministerio de Economia y Competitividad [Plan Nacional de I+D+i] [SAF2010-19717]; Generalitat de Catalunya [2009SGR1101]; Instituto de Salud Carlos III [Spanish Network for Research in Infectious Diseases] [REIPI RD12/0015/0018]; Spanish Ministerio de Economia y Competitividad [SAF2011-22463, IPT2011-1527-010000, JCI-2010-06378]; European Regional Development Fund; Ministerio de Economia y Competitividad [SAF2012-34059]; NIH [AI1076562]; National Multiple Sclerosis Society [RG3891]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) of the Generalitat de Catalunya [2010TEM37]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	Spanish Ministerio de Economia y Competitividad [Plan Nacional de I+D+i](Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Instituto de Salud Carlos III [Spanish Network for Research in Infectious Diseases](Instituto de Salud Carlos III); Spanish Ministerio de Economia y Competitividad(Spanish Government); European Regional Development Fund(European Commission); Ministerio de Economia y Competitividad(Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) of the Generalitat de Catalunya; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from the Spanish Ministerio de Economia y Competitividad [Plan Nacional de I+D+i, SAF2010-19717], Generalitat de Catalunya [2009SGR1101], and Instituto de Salud Carlos III [Spanish Network for Research in Infectious Diseases, REIPI RD12/0015/0018] to FL, from Spanish Ministerio de Economia y Competitividad [SAF2011-22463], co-funded by the European Regional Development Fund, to RM, from Ministerio de Economia y Competitividad [SAF2012-34059], co-funded by the European Regional Development Fund, and the Spanish Ministerio de Economia y Competitividad (IPT2011-1527-010000) associated to Fibrostatin SL, to JM, and from NIH AI1076562 and National Multiple Sclerosis Society RG3891 to CR. MM-F and VGM are recipients of fellowships from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) of the Generalitat de Catalunya [2010TEM37] and from Spanish Ministerio de Economia y Competitividad [JCI-2010-06378], respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBEROLAILA J, 1992, J IMMUNOL, V148, P1287; Axtell RC, 2004, J IMMUNOL, V173, P2928, DOI 10.4049/jimmunol.173.5.2928; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Bhandoola A, 2002, EUR J IMMUNOL, V32, P1811, DOI 10.1002/1521-4141(200206)32:6<1811::AID-IMMU1811>3.0.CO;2-G; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Bowen MA, 1997, EUR J IMMUNOL, V27, P1469, DOI 10.1002/eji.1830270625; BURGESS KE, 1992, P NATL ACAD SCI USA, V89, P9311, DOI 10.1073/pnas.89.19.9311; Calvo J, 1999, TISSUE ANTIGENS, V54, P128, DOI 10.1034/j.1399-0039.1999.540203.x; Cariappa A, 2007, J IMMUNOL, V179, P2270, DOI 10.4049/jimmunol.179.4.2270; CEUPPENS JL, 1986, J IMMUNOL, V137, P1816; Dasu T, 2008, IMMUNOL LETT, V119, P103, DOI 10.1016/j.imlet.2008.05.008; Martinez VG, 2011, PHARMACOL REV, V63, P967, DOI 10.1124/pr.111.004523; Gary-Gouy H, 2002, BLOOD, V100, P4537, DOI 10.1182/blood-2002-05-1525; Gimferrer I, 2004, J IMMUNOL, V173, P2262, DOI 10.4049/jimmunol.173.4.2262; Gimferrer I, 2003, J BIOL CHEM, V278, P8564, DOI 10.1074/jbc.M209591200; HUANG HJS, 1987, P NATL ACAD SCI USA, V84, P204, DOI 10.1073/pnas.84.1.204; Itoh M, 1999, J IMMUNOL, V162, P5317; JAMIN C, 1992, IMMUNOL LETT, V31, P79, DOI 10.1016/0165-2478(92)90014-F; JONES NH, 1986, NATURE, V323, P346, DOI 10.1038/323346a0; LEDBETTER JA, 1985, J IMMUNOL, V135, P2331; Lenz LL, 2009, P NATL ACAD SCI USA, V106, P1303, DOI 10.1073/pnas.0812579106; Lopez-Hoyos M, 2003, ARTHRITIS RHEUM, V48, P2353, DOI 10.1002/art.11107; Lozano F, 2000, CRIT REV IMMUNOL, V20, P347; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Mauri C, 2010, CURR OPIN IMMUNOL, V22, P761, DOI 10.1016/j.coi.2010.10.009; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Noh G, 2001, CLIN EXP ALLERGY, V31, P1932, DOI 10.1046/j.1365-2222.2001.01124.x; Oleinika K, 2013, CLIN EXP IMMUNOL, V171, P36, DOI 10.1111/j.1365-2249.2012.04657.x; Ordonez-Rueda D, 2009, EUR J IMMUNOL, V39, P2233, DOI 10.1002/eji.200839053; Ramos-Casals M, 2001, RHEUMATOLOGY, V40, P1056, DOI 10.1093/rheumatology/40.9.1056; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; Rodamilans B, 2007, J STRUCT BIOL, V159, P144, DOI 10.1016/j.jsb.2007.01.003; RONCHESE F, 1994, J EXP MED, V179, P809, DOI 10.1084/jem.179.3.809; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Sarrias MR, 2004, TISSUE ANTIGENS, V63, P335, DOI 10.1111/j.0001-2815.2004.00193.x; Sestero CM, 2012, J IMMUNOL, V189, P2918, DOI 10.4049/jimmunol.1200065; Soldevila G, 2011, CURR OPIN IMMUNOL, V23, P310, DOI 10.1016/j.coi.2011.03.003; Tabbekh M, 2011, J IMMUNOL, V187, P102, DOI 10.4049/jimmunol.1004145; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Vera J, 2009, P NATL ACAD SCI USA, V106, P1506, DOI 10.1073/pnas.0805846106; WEE SF, 1994, CELL IMMUNOL, V158, P353, DOI 10.1006/cimm.1994.1282; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	45	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84895	10.1371/journal.pone.0084895	http://dx.doi.org/10.1371/journal.pone.0084895			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454761	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100040
J	Luo, YM; Huang, XT; Yang, Z; Li, BL; Liu, J; Wei, DT				Luo, Yangmei; Huang, Xiting; Yang, Zhen; Li, Baolin; Liu, Jie; Wei, Dongtao			Regional Homogeneity of Intrinsic Brain Activity in Happy and Unhappy Individuals	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; CINGULATE CORTEX; WORKING-MEMORY; HAPPINESS; METAANALYSIS; PERSONALITY; DEPRESSION; ATTENTION; NETWORKS; DISORDER	Background: Why are some people happier than others? This question has intrigued many researchers. However, limited work has addressed this question within a neuroscientific framework. Methods: The present study investigated the neural correlates of trait happiness using the resting-state functional magnetic resonance imaging (rs-fMRI) approach. Specifically, regional homogeneity (ReHo) was examined on two groups of young adults: happy and unhappy individuals (N = 25 per group). Results: Decreased ReHo in unhappy relative to happy individuals was observed within prefrontal cortex, medial temporal lobe, superior temporal lobe, and retrosplenial cortex. In contrast, increased ReHo in unhappy relative to happy individuals was observed within the dorsolateral prefrontal cortex, middle cingulate gyrus, putamen, and thalamus. In addition, the ReHo within the left thalamus was negatively correlated with Chinese Happiness Inventory (CHI) score within the happy group. Limitations: As an exploratory study, we examined how general trait happiness is reflected in the regional homogeneity of intrinsic brain activity in a relatively small sample. Examining other types of happiness in a larger sample using a multitude of intrinsic brain activity indices are warranted for future work. Conclusions: The local synchronization of BOLD signal is altered in unhappy individuals. The regions implicated in this alteration partly overlapped with previously identified default mode network, emotional circuitry, and rewarding system, suggesting that these systems may be involved in happiness.	[Luo, Yangmei; Huang, Xiting; Li, Baolin; Liu, Jie; Wei, Dongtao] SWU, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Luo, Yangmei; Huang, Xiting; Li, Baolin; Liu, Jie; Wei, Dongtao] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Yang, Zhen] Ctr Developing Brain, Child Mind Inst, New York, NY USA	Southwest University - China	Huang, XT (corresponding author), SWU, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	xthuang@swu.edu.cn; zhyangpsych@gmail.com		Luo, Yangmei/0000-0002-4440-6980	Fundamental Research Funds for the Central Universities [SWU1209469]; Key Discipline Fund of the National 211 Project, China [NSKD11001]; Faculty of Psychology in Southwest University [TR201201-1]; key project of humanities and social sciences of Chongqing from Southwest University [12SKB005]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Discipline Fund of the National 211 Project, China; Faculty of Psychology in Southwest University; key project of humanities and social sciences of Chongqing from Southwest University	This study was supported by "the Fundamental Research Funds for the Central Universities'' (SWU1209469) to the first author; the Key Discipline Fund of the National 211 Project, China (NSKD11001); the Research Team's Construction Project from the Faculty of Psychology in Southwest University (2012) (TR201201-1); and the key project of humanities and social sciences of Chongqing from Southwest University (2012) (12SKB005) to the corresponding author and research fellow. Study design, data collection and analysis were supported by the Research Team's Construction Project from the Faculty of Psychology in Southwest University (2012) (TR201201-1) and the Key Discipline Fund of the National 211 Project, China (NSKD11001). The Fundamental Research Funds for the Central Universities (SWU1209469) and the key project of humanities and social sciences of Chongqing from Southwest University (2012) (12SKB005) have roles in preparation of the manuscript and decision to publish.	Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Cunningham W, 2013, SOC COGN AF IN PRESS; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Davidson RJ, 1999, CURR OPIN NEUROBIOL, V9, P228, DOI 10.1016/S0959-4388(99)80032-4; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; DeNeve KM, 1998, PSYCHOL BULL, V124, P197, DOI 10.1037/0033-2909.124.2.197; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; FELDT LS, 1961, PSYCHOMETRIKA, V26, P307, DOI 10.1007/BF02289799; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Kelly C, 2012, TRENDS COGN SCI, V16, P181, DOI 10.1016/j.tics.2012.02.001; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Kringelbach ML, 2009, TRENDS COGN SCI, V13, P479, DOI 10.1016/j.tics.2009.08.006; Lai CH, 2012, J AFFECT DISORDERS, V136, P453, DOI 10.1016/j.jad.2011.11.004; Lewis G, 2013, SOC COGN AF IN PRESS; Liu CH, 2013, PROG NEURO-PSYCHOPH, V41, P52, DOI 10.1016/j.pnpbp.2012.11.010; Liu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048181; Liu F, 2012, PROG NEURO-PSYCHOPH, V39, P326, DOI 10.1016/j.pnpbp.2012.07.004; Lu L, 1997, PERS INDIV DIFFER, V23, P453; Lyubomirsky S, 2001, AM PSYCHOL, V56, P239, DOI 10.1037/0003-066X.56.3.239; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Lyubomirsky S, 2011, EMOTION, V11, P1152, DOI 10.1037/a0025479; Ma ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053148; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pe ML, 2013, COGNITION, V126, P335, DOI 10.1016/j.cognition.2012.10.002; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Qiu CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P47, DOI 10.1016/j.pscychresns.2011.01.010; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stawarczyk D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00363; Tian LX, 2008, BRAIN DEV-JPN, V30, P342, DOI 10.1016/j.braindev.2007.10.005; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Urry HL, 2004, PSYCHOL SCI, V15, P367, DOI 10.1111/j.0956-7976.2004.00686.x; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Wang LQ, 2011, NEUROSCI LETT, V488, P275, DOI 10.1016/j.neulet.2010.11.046; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wei LQ, 2011, BRAIN RES, V1419, P68, DOI 10.1016/j.brainres.2011.08.060; Williams JMG, 1996, MEM COGNITION, V24, P116, DOI 10.3758/BF03197278; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Xu J, 1991, PSYCHOL SCI, V4, P32; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yuan R, 2013, MAGN RESON IMAGING, V31, P1492, DOI 10.1016/j.mri.2013.07.005; Yuan YG, 2008, J AFFECT DISORDERS, V111, P145, DOI 10.1016/j.jad.2008.02.016; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	72	27	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85181	10.1371/journal.pone.0085181	http://dx.doi.org/10.1371/journal.pone.0085181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454814	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100061
J	Muhsen, K; Lagos, R; Reymann, MK; Graham, DY; Pasetti, MF; Levine, MM				Muhsen, Khitam; Lagos, Rosanna; Reymann, Mardi K.; Graham, David Y.; Pasetti, Marcela F.; Levine, Myron M.			Age-Dependent Association among Helicobacter pylori Infection, Serum Pepsinogen Levels and Immune Response of Children to Live Oral Cholera Vaccine CVD 103-HgR	PLOS ONE			English	Article							DOUBLE-BLIND; ENVIRONMENTAL-ENTEROPATHY; DEVELOPING-COUNTRIES; STRAIN CVD-103-HGR; ROTAVIRUS VACCINES; GASTRIC-ACIDITY; VIBRIO-CHOLERAE; IMMUNOGENICITY; TRIAL; SAFETY	Background: Through its effects on gastric secretion, we hypothesized that Helicobacter pylori infection may influence oral immunization. Accordingly, we examined the association between H. pylori infection, serum pepsinogen (PG) (measures for H. pylori gastritis) and vibriocidal antibody (a correlate of protection) seroconversion following oral immunization with CVD 103-HgR live cholera vaccine among children of different ages. Methods: Sera from 422 Chilean children who were vaccinated with a single dose of CVD 103-HgR were tested by ELISA for serum IgG antibodies to H. pylori, PG I and PG II levels and antibodies to Shigella flexneri 2a lipopolysaccharide and hepatitis A virus (as markers of low socioeconomic status and exposure to enteric pathogens). Results: The likelihood of vibriocidal antibody seroconversion following vaccination with CVD 103-HgR was significantly decreased in H. pylori-seropositive children age 6 months to 4 years with PG II. 8 mg/L (adjusted OR 0.14 (95% CI 0.03-0.61; P = 0.009), and also in H. pylori seropositives with lower PG II level (adjusted OR 0.34, 95% CI 0.14-0.83; P = 0.017), compared to H. pylori-seronegatives. H. pylori-seropositive children aged 5-9 years with serum PG I. 30 mg/L (indicating more severe gastritis) had higher odds of vibriocidal seroconversion than those with lower PG I levels (adjusted OR 4.41, 95% CI 1.2615.38; P = 0.02). There was no significant association between exposures to S. flexneri 2a or hepatitis A virus and vibriocidal seroconversion. Conclusions: As H. pylori gastritis progresses with increasing pediatric age in developing country venues, changes in gastric secretion ensue that we believe explain the observed differences in age-related immune responses to immunization with live oral cholera vaccine. The effect of H. pylori and changes of gastric acid secretion on the immunogenicity of various oral vaccines should be studied in different developing, transitional and industrialized country settings.	[Muhsen, Khitam; Reymann, Mardi K.; Levine, Myron M.] Univ Maryland, Sch Med, Dept Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Pasetti, Marcela F.] Univ Maryland, Sch Med, Dept Pediat, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Lagos, Rosanna] Hosp Ninos Roberto del Rio, Ctr Vacunas Desarrollo, Santiago, Chile; [Graham, David Y.] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Baylor College of Medicine	Muhsen, K (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Epidemiol & Prevent Med, Sch Publ Hlth, IL-69978 Tel Aviv, Israel.	khitam15@yahoo.com; mlevine@medicine.umaryland.edu	Graham, David/AAL-2165-2021	Muhsen, Khitam/0000-0003-1086-7559; Pasetti, Marcela/0000-0003-0894-4009	World Health Organization; NIH [AI-35948, UO1AI35948]; National Institute of Allergy and Infectious Diseases [AI-45251, NO1 AI 15096]; Center for Vaccine Development, University of Maryland School of Medicine [AI-45251, NO1 AI 15096]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI045251, U01AI035948, N01AI015096] Funding Source: NIH RePORTER	World Health Organization(World Health Organization); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for Vaccine Development, University of Maryland School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the World Health Organization; NIH cooperative research agreements (AI-35948 and UO1AI35948) and research contracts (AI-45251 and NO1 AI 15096) between the National Institute of Allergy and Infectious Diseases and Center for Vaccine Development, University of Maryland School of Medicine. The funding sources did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors have financial conflicts of interest with respect to the subject of this research. Prof. M. Levine is the co-holder of patents but at present CVD 103-HgR is not available commercially. However, PaxVax, a vaccine manufacturer in San Diego, CA, has initiated a clinical development program to re-commercialize CVD 103-HgR (as VibrioVaxH) and return it to market as a licensed vaccine within the next few years.	Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Calam J, 1997, GASTROENTEROLOGY, V113, pS43, DOI 10.1016/S0016-5085(97)80010-8; CLEMENS J, 1995, J INFECT DIS, V171, P1653, DOI 10.1093/infdis/171.6.1653; Cooper PJ, 2000, J INFECT DIS, V182, P1199, DOI 10.1086/315837; CRYZ SJ, 1990, VACCINE, V8, P577, DOI 10.1016/0264-410X(90)90012-B; de Angelis GL, 2007, DIGEST DIS, V25, P206, DOI 10.1159/000103886; dos Reis JC, 2007, DIGEST DIS SCI, V52, P1253, DOI 10.1007/s10620-006-9288-9; FAGUNDESNETO U, 1984, J TROP PEDIATRICS, V30, P204, DOI 10.1093/tropej/30.4.204; Fix AD, 2002, AM J TROP MED HYG, V66, P628, DOI 10.4269/ajtmh.2002.66.628; Frenck RW, 2003, MICROBES INFECT, V5, P705, DOI 10.1016/S1286-4579(03)00112-6; Ganga-Zandzou PS, 1999, PEDIATRICS, V104, P216, DOI 10.1542/peds.104.2.216; GIANNELLA RA, 1973, ANN INTERN MED, V78, P271, DOI 10.7326/0003-4819-78-2-271; GITELSON S, 1971, ISRAEL J MED SCI, V7, P663; GOTUZZO E, 1993, INFECT IMMUN, V61, P3994, DOI 10.1128/IAI.61.9.3994-3997.1993; Guariso G, 2009, CLIN CHIM ACTA, V402, P54, DOI 10.1016/j.cca.2008.12.014; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; HOPKINS RJ, 1993, J INFECT DIS, V168, P222, DOI 10.1093/infdis/168.1.222; Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278; Kalach T, 2004, J PEDIATR GASTR NUTR, V39, P568, DOI 10.1097/00005176-200411000-00025; Kato S, 2005, ARCH PEDIAT ADOL MED, V159, P415, DOI 10.1001/archpedi.159.5.415; Kindermann A, 2001, J CLIN MICROBIOL, V39, P3591, DOI 10.1128/JCM.39.10.3591-3596.2001; Kolvusalo AI, 2007, DIAGN MICR INFEC DIS, V57, P35, DOI 10.1016/j.diagmicrobio.2006.06.022; Kotloff KL, 2004, J INFECT DIS, V190, P1745, DOI 10.1086/424680; KOTLOFF KL, 1992, INFECT IMMUN, V60, P4430, DOI 10.1128/IAI.60.10.4430-4432.1992; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; Lagos R, 1999, PEDIATR INFECT DIS J, V18, P624, DOI 10.1097/00006454-199907000-00011; Lagos R, 1999, J INFECT DIS, V180, P1709, DOI 10.1086/315051; LAGOS R, 1995, INFECT IMMUN, V63, P707, DOI 10.1128/IAI.63.2.707-709.1995; Lagos R., 1996, B HOSP INFANT MEX, P214; Leon-Barua R, 2006, T ROY SOC TROP MED H, V100, P567, DOI 10.1016/j.trstmh.2005.09.013; LEVINE MM, 1987, LANCET, V1, P1049; Levine MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-129; Lopes AI, 2006, SCAND J GASTROENTERO, V41, P524, DOI 10.1080/00365520500337098; Muhsen K, 2014, J INFECT DIS, V209, P1452, DOI 10.1093/infdis/jit625; Nugalieva ZZ, 2006, HELICOBACTER, V11, P69, DOI 10.1111/j.1523-5378.2006.00380.x; ODERDA G, 1990, J CLIN PATHOL, V43, P762, DOI 10.1136/jcp.43.9.762; Prado V, 1999, PEDIATR INFECT DIS J, V18, P500, DOI 10.1097/00006454-199906000-00005; Rennels MB, 1996, PEDIATRICS, V97, P7; SACK GH, 1972, B WORLD HEALTH ORGAN, V47, P31; SCHIRALDI O, 1974, B WORLD HEALTH ORGAN, V51, P349; Shahinian ML, 2000, LANCET, V355, P377, DOI 10.1016/S0140-6736(99)05143-0; SUAREHAWARATANA P, 1992, J INFECT DIS, V165, P1042, DOI 10.1093/infdis/165.6.1042; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; SUHARYONO, 1992, LANCET, V340, P689, DOI 10.1016/0140-6736(92)92231-4; Tacket CO, 1999, INFECT IMMUN, V67, P6341; Torres J, 2000, ARCH MED RES, V31, P431, DOI 10.1016/S0188-4409(00)00099-0	47	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83999	10.1371/journal.pone.0083999	http://dx.doi.org/10.1371/journal.pone.0083999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454714	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100016
J	van Bergen, CAM; Verdegaal, EME; Honders, MW; Hoogstraten, C; Steijn-van Tol, AQMJ; de Quartel, L; de Jong, J; Meyering, M; Falkenburg, JHF; Griffioen, M; Osanto, S				van Bergen, Cornelis A. M.; Verdegaal, Elisabeth M. E.; Honders, M. Wilhelmina; Hoogstraten, Conny; Steijn-van Tol, A. Q. M. Jeanne; de Quartel, Linda; de Jong, Joan; Meyering, Maaike; Falkenburg, J. H. Frederik; Griffioen, Marieke; Osanto, Susanne			Durable Remission of Renal Cell Carcinoma in Conjuncture with Graft versus Host Disease following Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion: Rule or Exception?	PLOS ONE			English	Article							MINOR HISTOCOMPATIBILITY ANTIGENS; ALPHA-L-FUCOSIDASE; WHOLE-GENOME ASSOCIATION; T-CELLS; CANCER; IDENTIFICATION; CONTRIBUTE; REGRESSION; VIRUS	Allogeneic stem cell transplantation (alloSCT) followed by donor lymphocyte infusion (DLI) can be applied as immunotherapeutic intervention to treat malignant diseases. Here, we describe a patient with progressive metastatic clear cell renal cell carcinoma (RCC) who was treated with T cell depleted non-myeloablative alloSCT and DLI resulting in disease regression accompanied by extensive graft versus host disease (GVHD). We characterized the specificity of this immune response, and detected a dominant T cell population recognizing a novel minor histocompatibility antigen (MiHA) designated LB-FUCA2-1V. T cells specific for LB-FUCA2-1V were shown to recognize RCC cell lines, supporting a dominant role in the graft versus tumor (GVT) reaction. However, coinciding with the gradual disappearance of chronic GVHD, the anti-tumor effect declined and 3 years after alloSCT the metastases became progressive again. To re-initiate the GVT reaction, escalating doses of DLI were given, but no immune response could be induced and the patient died of progressive disease 8.5 years after alloSCT. Gene expression studies illustrated that only a minimal number of genes shared expression between RCC and professional antigen presenting cells but were not expressed by non-malignant healthy tissues, indicating that in patients suffering from RCC, GVT reactivity after alloSCT may be unavoidably linked to GVHD.	[van Bergen, Cornelis A. M.; Honders, M. Wilhelmina; Hoogstraten, Conny; Falkenburg, J. H. Frederik; Griffioen, Marieke] Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands; [Verdegaal, Elisabeth M. E.; Steijn-van Tol, A. Q. M. Jeanne; de Quartel, Linda; de Jong, Joan; Meyering, Maaike; Osanto, Susanne] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Bergen, CAM (corresponding author), Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands.	c.a.m.van_bergen@lumc.nl; e.m.e.verdegaal@lumc.nl	Griffioen, Marieke/ABA-1561-2021; Van Bergen, Cornelis/N-4773-2019; Verdegaal, Elizabeth/Y-2597-2018; Van Bergen, Cornelis A.M./P-5782-2016	Griffioen, Marieke/0000-0002-3001-4441; Van Bergen, Cornelis/0000-0001-6386-4517; Verdegaal, Elizabeth/0000-0002-4449-8707; Van Bergen, Cornelis A.M./0000-0001-6386-4517	Dutch Cancer Society [UL-2004-3013]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society grant no. UL-2004-3013 (www.kwfkankerbestrijding.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum FR, 2003, ANNU REV MED, V54, P491, DOI 10.1146/annurev.med.54.101601.152456; Barge RMY, 2003, EXP HEMATOL, V31, P865, DOI 10.1016/S0301-472X(03)00200-5; Bishop MR, 2004, HAEMATOLOGICA, V89, P599; Bregni M, 2011, EXPERT REV ANTICANC, V11, P901, DOI [10.1586/era.11.12, 10.1586/ERA.11.12]; Broen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021699; Burrows SR, 2000, J IMMUNOL, V165, P6229, DOI 10.4049/jimmunol.165.11.6229; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Childs R, 2000, NEW ENGL J MED, V343, P750, DOI 10.1056/NEJM200009143431101; Cordero OJ, 2001, EUR J BIOCHEM, V268, P3321, DOI 10.1046/j.1432-1327.2001.02237.x; Falkenburg JHF, 2011, BIOL BLOOD MARROW TR, V17, pS33, DOI 10.1016/j.bbmt.2010.11.009; Feng X, 2008, TRENDS IMMUNOL, V29, P624, DOI 10.1016/j.it.2008.09.004; Giardina MG, 1998, CANCER-AM CANCER SOC, V83, P2468, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2468::AID-CNCR9>3.3.CO;2-P; Griffioen M, 2012, HAEMATOL-HEMATOL J, V97, P1196, DOI 10.3324/haematol.2011.049478; Heemskerk MHM, 2004, J EXP MED, V199, P885, DOI 10.1084/jem.20031110; Kawase T, 2008, BLOOD, V111, P3286, DOI 10.1182/blood-2007-10-118950; Liu TW, 2009, P NATL ACAD SCI USA, V106, P14581, DOI 10.1073/pnas.0903286106; MILLER G, 1972, P NATL ACAD SCI USA, V69, P383, DOI 10.1073/pnas.69.2.383; Norde WJ, 2011, CANCER RES, V71, P5111, DOI 10.1158/0008-5472.CAN-11-0108; Overes IM, 2009, CANCER IMMUNOL IMMUN, V58, P429, DOI 10.1007/s00262-008-0569-3; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Randolph SSB, 2004, BLOOD, V103, P347, DOI 10.1182/blood-2003-07-2603; Shah M, 2008, CANCER-AM CANCER SOC, V113, P336, DOI 10.1002/cncr.23556; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Takahashi Y, 2008, J CLIN INVEST, V118, P1099, DOI 10.1172/JCI34409; Tykodi SS, 2008, CLIN CANCER RES, V14, P5260, DOI 10.1158/1078-0432.CCR-08-0028; Tykodi SS, 2011, EXPERT OPIN BIOL TH, V11, P763, DOI 10.1517/14712598.2011.566855; Van Bergen CAM, 2010, CANCER RES, V70, P9073, DOI 10.1158/0008-5472.CAN-10-1832; van der Zouwen B, 2012, BIOL BLOOD MARROW TR, V18, P1353, DOI 10.1016/j.bbmt.2012.06.017; von Dem Borne PA, 2006, HAEMATOLOGICA, V91, P1559; WANG JW, 1995, CANCER RES, V55, P3654	30	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85198	10.1371/journal.pone.0085198	http://dx.doi.org/10.1371/journal.pone.0085198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454818	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100065
J	Zhao, XT; Yue, WT; Zhang, LN; Ma, L; Jia, WY; Qian, Z; Zhang, CY; Wang, Y				Zhao, Xiaoting; Yue, Wentao; Zhang, Lina; Ma, Li; Jia, Wenyun; Qian, Zhe; Zhang, Chunyan; Wang, Yue			Downregulation of PAX6 by shRNA Inhibits Proliferation and Cell Cycle Progression of Human Non-Small Cell Lung Cancer Cell Lines	PLOS ONE			English	Article							EXPRESSION; GROWTH; PATHWAY; METHYLATION; SUPPRESSES; RECEPTOR; PROTEIN; GENES	Background: The transcription factor PAX6 is primarily expressed in embryos. PAX6 is also expressed in several tumors and plays an oncogenic role. However, little is known about the role of PAX6 in lung cancer. Methods: The function of PAX6 in lung cancer cells was evaluated by small interfering RNA-mediated depletion of the protein followed by analyses of cell proliferation, anchorage-independent growth, and cell cycle arrest. The changes of cyclin D1, pRB, ERK1/2, p38 expression caused by PAX6 inhibition were detected using western-blotting. The PAX6 mRNA level in 52 pairs of tumors and corresponding matched adjacent normal tissues from non-small cell lung cancer patients and lung cancer cell lines was detected by real-time PCR. Results: Suppression of PAX6 expression inhibited cell growth and colony formation in A549 and H1299 cells. The percentage of cells in G1-phase increased when PAX6 expression was inhibited. The cyclin D1 protein level, as well as the pRB phosphorylation level, decreased as a result of PAX6 down-regulation. The activity of ERK1/2 and p38 was also suppressed in PAX6 knock-down cells. The PAX6 mRNA was highly expressed in lung cancer tissue and lung cancer cell lines. In most patients (about 65%), the relative ratio of PAX6 mRNA in primary NSCLC versus adjacent tissues exceeded 100. Conclusions: Our data implicated that PAX6 accelerates cell cycle progression by activating MAPK signal pathway. PAX6 mRNA levels were significantly elevated in primary lung cancer tissues compared to their matched adjacent tissues.	[Zhao, Xiaoting; Yue, Wentao; Zhang, Lina; Ma, Li; Jia, Wenyun; Qian, Zhe; Zhang, Chunyan; Wang, Yue] Capital Med Univ, Beijing Chest Hosp, Dept Cellular Biol, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China	Capital Medical University	Yue, WT (corresponding author), Capital Med Univ, Beijing Chest Hosp, Dept Cellular Biol, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China.	yue.wentao@gmail.com	; Yue, Wentao/N-7699-2013	ZHANG, LINA/0000-0003-3671-8690; Yue, Wentao/0000-0002-5917-1125	Beijing Novel Program [2006B34]; Beijing Research Foundation for Excellent Talents [20061D03]; Beijing Cultivation Project for Key Technical and Medicine Product [Z101100055610030]; Scientific Research Common Program of Beijing Municipal Commission of Education [KM201210025024]	Beijing Novel Program(Beijing Municipal Science & Technology Commission); Beijing Research Foundation for Excellent Talents; Beijing Cultivation Project for Key Technical and Medicine Product; Scientific Research Common Program of Beijing Municipal Commission of Education(Beijing Municipal Commission of Education)	This work was supported by Beijing Novel Program grant (No. 2006B34); Beijing Research Foundation for Excellent Talents (No. 20061D03); Beijing Cultivation Project for Key Technical and Medicine Product (No. Z101100055610030); the Scientific Research Common Program of Beijing Municipal Commission of Education (No. KM201210025024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai SW, 2011, INVEST OPHTH VIS SCI, V52, P4560, DOI 10.1167/iovs.10-5487; Berkhout M, 2007, MODERN PATHOL, V20, P1253, DOI 10.1038/modpathol.3800952; Bonnefont J, 2011, CELL DEATH DIFFER, V18, P293, DOI 10.1038/cdd.2010.102; Ewen ME, 2000, GENE DEV, V14, P2265, DOI 10.1101/gad.842100; Gladden AB, 2003, CANCER CELL, V4, P160, DOI 10.1016/S1535-6108(03)00217-4; Hellwinkel OJC, 2008, BJU INT, V101, P753, DOI 10.1111/j.1464-410X.2007.07322.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kanteti R, 2007, J THORACIC ONCOLOGY, V2, pS541, DOI [10.1097/1001.JTO.0000283590.0000209867.0000283563, DOI 10.1097/1001.JT0.0000283590.0000209867.0000283563]; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Lang D, 2008, MOL CARCINOGEN, V47, P148, DOI 10.1002/mc.20375; Li L, 2011, INVEST OPHTH VIS SCI, V52, P8393, DOI 10.1167/iovs.11-8139; Ma B, 2011, ONCOL REP, V26, P135, DOI 10.3892/or.2011.1291; Ma PC, 2007, BRIT J CANCER, V97, P368, DOI 10.1038/sj.bjc.6603884; Mascarenhas JB, 2009, J BIOL CHEM, V284, P27524, DOI 10.1074/jbc.M109.047209; Mayes DA, 2006, CANCER RES, V66, P9809, DOI 10.1158/0008-5472.CAN-05-3877; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Salgia R, 2011, SEMIN ONCOL, V38, P274, DOI 10.1053/j.seminoncol.2011.01.012; Sellheyer K, 2011, BRIT J DERMATOL, V164, P696, DOI 10.1111/j.1365-2133.2010.10158.x; Shahi MH, 2011, TUMOR BIOL, V32, P113, DOI 10.1007/s13277-010-0105-x; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shyr CR, 2010, PROSTATE, V70, P190, DOI 10.1002/pros.21052; Talarmin H, 1999, MOL CELL BIOL, V19, P6003; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yoshizaki Kaichi, 2010, Brain and Nerve (Tokyo), V62, P1315; Zhong XF, 2007, INT J CANCER, V121, P2125, DOI 10.1002/ijc.22880; Zhou YH, 2005, J NEURO-ONCOL, V71, P223, DOI 10.1007/s11060-004-1720-4; Zhou YH, 2003, CLIN CANCER RES, V9, P3369; Zhou YH, 2010, J NEURO-ONCOL, V96, P191, DOI 10.1007/s11060-009-9963-8	32	23	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85738	10.1371/journal.pone.0085738	http://dx.doi.org/10.1371/journal.pone.0085738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454925	Green Submitted, gold, Green Published			2022-12-25	WOS:000330235100127
J	Almeida, ICT; Soares, M; Bozza, FA; Shinotsuka, CR; Bujokas, R; Souza-Dantas, VC; Ely, EW; Salluh, JIF				Almeida, Isabel C. T.; Soares, Marcio; Bozza, Fernando A.; Shinotsuka, Cassia Righy; Bujokas, Renata; Souza-Dantas, Vicente Ces; Ely, E. Wesley; Salluh, Jorge I. F.			The Impact of Acute Brain Dysfunction in the Outcomes of Mechanically Ventilated Cancer Patients	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; CONFUSION ASSESSMENT METHOD; DELIRIUM; ICU; RELIABILITY; ADMISSION; SEDATION; VALIDITY; TRIAL	Introduction: Delirium and coma are a frequent source of morbidity for ICU patients. Several factors are associated with the prognosis of mechanically ventilated (MV) cancer patients, but no studies evaluated delirium and coma (acute brain dysfunction). The present study evaluated the frequency and impact of acute brain dysfunction on mortality. Methods: The study was performed at National Cancer Institute, Rio de Janeiro, Brazil. We prospectively enrolled patients ventilated >48 h with a diagnosis of cancer. Acute brain dysfunction was assessed during the first 14 days of ICU using RASS/CAM-ICU. Patients were followed until hospital discharge. Univariate and multivariable analysis were performed to evaluate factors associated with hospital mortality. Results: 170 patients were included. 73% had solid tumors, age 65 [53-72 (median, IQR 25%-75%)] years. SAPS II score was 54[46-63] points and SOFA score was (7 [6-9]) points. Median duration of MV was 13 (6-21) days and ICU stay was 14 (7.5-22) days. ICU mortality was 54% and hospital mortality was 66%. Acute brain dysfunction was diagnosed in 161 patients (95%). Survivors had more delirium/coma-free days [4(1,5-6) vs 1(0-2), p<0.001]. In multivariable analysis the number of days of delirium/coma-free days were associated with better outcomes as they were independent predictors of lower hospital mortality [0.771 (0.681 to 0.873), p<0.001]. Conclusions: Acute brain dysfunction in MV cancer patients is frequent and independently associated with increased hospital mortality. Future studies should investigate means of preventing or mitigating acute brain dysfunction as they may have a significant impact on clinical outcomes.	[Almeida, Isabel C. T.; Soares, Marcio; Shinotsuka, Cassia Righy; Bujokas, Renata; Souza-Dantas, Vicente Ces; Salluh, Jorge I. F.] Inst Nacl Canc, Intens Care Unit, Rio De Janeiro, Brazil; [Almeida, Isabel C. T.; Soares, Marcio; Shinotsuka, Cassia Righy; Bujokas, Renata; Souza-Dantas, Vicente Ces; Salluh, Jorge I. F.] Inst Nacl Canc, Postgrad Program, Rio De Janeiro, Brazil; [Soares, Marcio; Bozza, Fernando A.; Shinotsuka, Cassia Righy; Salluh, Jorge I. F.] DOr Inst Res & Educ, Rio De Janeiro, Brazil; [Bozza, Fernando A.] Fundacao Oswaldo Cruz, Intens Care Lab, IPEC, Rio De Janeiro, Brazil; [Ely, E. Wesley] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Ely, E. Wesley] Vet Affairs Tennessee Valley Geriatr Res Educ Cli, Nashville, TN USA	National Cancer Institute (Inca); National Cancer Institute (Inca); IDOR - Instituto D'Or de Ensino e Pesquisa; Fundacao Oswaldo Cruz; Vanderbilt University; Geriatric Research Education & Clinical Center	Salluh, JIF (corresponding author), Inst Nacl Canc, Intens Care Unit, Rio De Janeiro, Brazil.	jorgesalluh@gmail.com	Shinotsuka, Cássia Righy/H-9181-2013; Ely, E. Wesley/Z-2018-2019; Salluh, Jorge/AAF-2682-2021; Almeida, Igor C./AAF-9409-2019; dantas, vicente c souza/L-2648-2013; Soares, Marcio/B-3083-2013; Bozza, Fernando A/A-2618-2013	Shinotsuka, Cássia Righy/0000-0002-9206-9552; Ely, E. Wesley/0000-0003-3957-2172; Salluh, Jorge/0000-0002-8164-1453; Almeida, Igor C./0000-0002-2443-8213; Soares, Marcio/0000-0003-2503-6088; Bozza, Fernando A/0000-0003-4878-0256	CNPq; FAPERJ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	MS and JIFS received individual research grants from CNPq and FAPERJ, Brazilian governmental agencies for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay E, 2004, MEDICINE, V83, P360, DOI 10.1097/01.md.0000145370.63676.fb; Azoulay E, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-5; Caraceni A, 2000, CANCER-AM CANCER SOC, V89, P1145, DOI 10.1002/1097-0142(20000901)89:5<1145::AID-CNCR24>3.0.CO;2-X; Clegg A, 2011, AGE AGEING, V40, P23, DOI 10.1093/ageing/afq140; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Gusmao-Flores D, 2012, CRIT CARE, V16, DOI 10.1186/cc11407; Gusmao-Flores D, 2011, CLINICS, V66, P1917, DOI 10.1590/S1807-59322011001100011; JJS MD, 2012, BEST PRACT RES CLIN, V26, P327, DOI [10.1016/j.bpa.2012.08.003., DOI 10.1016/J.BPA.2012.08.003]; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Lawlor PG, 2000, ARCH INTERN MED, V160, P786, DOI 10.1001/archinte.160.6.786; Lecuyer L, 2007, CRIT CARE MED, V35, P808, DOI 10.1097/01.CCM.0000256846.27192.7A; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MD GM, 2012, BEST PRACT RES CLIN, V26, P311, DOI [10.1016/j.bpa.2012.07.001., DOI 10.1016/J.BPA.2012.07.001]; Milbrandt EB, 2004, CRIT CARE MED, V32, P955, DOI 10.1097/01.CCM.0000119429.16055.92; Neufeld KJ, 2011, PSYCHOSOMATICS, V52, P133, DOI 10.1016/j.psym.2010.12.018; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rosolem M, 2009, CRIT CARE, V13, pP56, DOI [10.1186/cc7858., DOI 10.1186/CC7858]; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Salluh JI, 2010, CRIT CARE, V14, DOI 10.1186/cc9333; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Soares M, 2005, CRIT CARE MED, V33, P520, DOI 10.1097/01.ccm.0000155783.46747.04; Soares M, 2010, INTENS CARE MED, V36, P1188, DOI 10.1007/s00134-010-1807-7; Soares M, 2010, CRIT CARE CLIN, V26, P41, DOI 10.1016/j.ccc.2009.09.005; Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; Takeuchi M, 2012, ANN SURG ONCOL, V19, P3963, DOI 10.1245/s10434-012-2432-1; Thiery G, 2005, J CLIN ONCOL, V23, P4406, DOI 10.1200/JCO.2005.01.487	32	20	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85332	10.1371/journal.pone.0085332	http://dx.doi.org/10.1371/journal.pone.0085332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465538	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100037
J	Marshall, ASJ; Barker, CIS; Pulickal, AS; Kibwana, E; Gautam, SC; Clutterbuck, EA; Thorson, SM; Shrestha, S; Adhikari, N; Pollard, AJ; Kelly, DF				Marshall, Andrew S. J.; Barker, Charlotte I. S.; Pulickal, Anoop S.; Kibwana, Elizabeth; Gautam, Samir C.; Clutterbuck, Elizabeth A.; Thorson, Stephen M.; Shrestha, Shrijana; Adhikari, Neelam; Pollard, Andrew J.; Kelly, Dominic F.			The Seroepidemiology of Haemophilus influenzae Type B Prior to Introduction of an Immunization Programme in Kathmandu, Nepal	PLOS ONE			English	Article							CONJUGATE VACCINE; CAPSULAR POLYSACCHARIDE; ROUTINE IMMUNIZATION; ANTIBODY; CHILDREN; DISEASE; COLONIZATION; PROTECTION; INFANTS	Haemophilus influenzae type b (Hib) is now recognized as an important pathogen in Asia. To evaluate disease susceptibility, and as a marker of Hib transmission before routine immunization was introduced in Kathmandu, 71 participants aged 7 months-77 years were recruited and 15 cord blood samples were collected for analysis of anti-polyribosylribitol phosphate antibody levels by enzyme-linked immunosorbent assay. Only 20% of children under 5 years old had levels considered protective (>0.15 mu g/ml), rising to 83% of 15-54 year-olds. Prior to introduction of Hib vaccine in Kathmandu, the majority of young children were susceptible to disease.	[Marshall, Andrew S. J.; Barker, Charlotte I. S.; Pulickal, Anoop S.; Kibwana, Elizabeth; Clutterbuck, Elizabeth A.; Pollard, Andrew J.; Kelly, Dominic F.] Univ Oxford, Oxford Vaccine Grp, Oxford, England; [Marshall, Andrew S. J.; Barker, Charlotte I. S.; Pulickal, Anoop S.; Kibwana, Elizabeth; Clutterbuck, Elizabeth A.; Pollard, Andrew J.; Kelly, Dominic F.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Gautam, Samir C.; Thorson, Stephen M.; Shrestha, Shrijana; Adhikari, Neelam] Patan Hosp, Kathmandu, Nepal	University of Oxford; University of Oxford	Marshall, ASJ (corresponding author), Univ Oxford, Oxford Vaccine Grp, Oxford, England.	a.marshall@doctors.org.uk	Barker, Charlotte I S/D-5527-2014; Barker, Charlotte/AAO-4131-2021	Barker, Charlotte I S/0000-0002-6757-5867; Barker, Charlotte/0000-0002-6757-5867; Shrestha, Shrijana/0000-0001-9484-0227; Marshall, Andrew/0000-0003-0529-0425; Kelly, Dominic/0000-0002-6063-8896	Oxford Vaccine Group; NIHR Oxford Biomedical Research Centre (BRC); Rhodes Scholarship; NIHR BRC	Oxford Vaccine Group; NIHR Oxford Biomedical Research Centre (BRC); Rhodes Scholarship; NIHR BRC	This project was funded by the Oxford Vaccine Group (www.ovg.ox.ac.uk) with support from the NIHR Oxford Biomedical Research Centre (BRC) (http://oxfordbrc.nihr.ac.uk). A. S. P. was funded by a Rhodes Scholarship. D. F. K. receives salary support from the NIHR BRC. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8; Ballereau F, 1999, EUR J EPIDEMIOL, V15, P577, DOI 10.1023/A:1007668003578; BARBOUR ML, 1995, J INFECT DIS, V171, P93, DOI 10.1093/infdis/171.1.93; Bennet JV, 2002, HAEMOPHILUS INFLUENZ; BOOY R, 1992, ARCH DIS CHILD, V67, P475, DOI 10.1136/adc.67.4.475; Fothergill LD, 1933, J IMMUNOL, V24, P273; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; Heath PT, 2000, JAMA-J AM MED ASSOC, V284, P2334, DOI 10.1001/jama.284.18.2334; KAYHTY H, 1983, J INFECT DIS, V147, P1100; KAYHTY H, 1994, BIOLOGICALS, V22, P397, DOI 10.1006/biol.1994.1062; Kelly DF, 2004, IMMUNOLOGY, V113, P163, DOI 10.1111/j.1365-2567.2004.01971.x; Kelly DF, 2011, INT J INFECT DIS, V15, pE17, DOI 10.1016/j.ijid.2010.05.021; Kelly DF, 2009, CLIN VACCINE IMMUNOL, V16, P246, DOI 10.1128/CVI.00023-08; Leino T, 2002, EPIDEMIOL INFECT, V129, P73, DOI 10.1017/S0950268802007173; Madore DV, 1996, CLIN DIAGN LAB IMMUN, V3, P84, DOI 10.1128/CDLI.3.1.84-88.1996; MAKELA PH, 1977, J INFECT DIS, V136, pS43; Metz JA, 2012, PEDIATR INFECT DIS J, V31, pE66, DOI 10.1097/INF.0b013e31824a9c37; MICHAELS RH, 1976, J CLIN MICROBIOL, V4, P413; Oh SY, 2008, J INFECT DIS, V197, P1275, DOI 10.1086/586716; Ojo LR, 2010, VACCINE, V28, P7117, DOI 10.1016/j.vaccine.2010.07.074; Olsen SJ, 2005, PEDIATR INFECT DIS J, V24, P739, DOI 10.1097/01.inf.0000172940.77549.94; Pulickal AS, 2009, CLIN VACCINE IMMUNOL, V16, P1413, DOI 10.1128/CVI.00245-09; Shah AS, 2009, CLIN INFECT DIS, V48, pS123, DOI 10.1086/596490; Trotter CL, 2003, LANCET, V361, P1523, DOI 10.1016/S0140-6736(03)13172-8; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; Williams EJ, 2011, J CLIN MICROBIOL, V49, P1323, DOI 10.1128/JCM.02200-10; World Health Organization, 2006, Wkly Epidemiol Rec, V81, P445	27	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85055	10.1371/journal.pone.0085055	http://dx.doi.org/10.1371/journal.pone.0085055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465475	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100021
J	Khan, SB; Rahman, MM; Akhtar, K; Asiri, AM; Rub, MA				Khan, Sher Bahadar; Rahman, Mohammed M.; Akhtar, Kalsoom; Asiri, Abdullah M.; Rub, Malik Abdul			Nitrophenol Chemi-Sensor and Active Solar Photocatalyst Based on Spinel Hetaerolite Nanoparticles	PLOS ONE			English	Article							PHOTO-CATALYST; HAUSMANNITE; FABRICATION; NANOHYBRID; NANORODS	In this contribution, a significant catalyst based on spinel ZnMn2O4 composite nanoparticles has been developed for electro-catalysis of nitrophenol and photo-catalysis of brilliant cresyl blue. ZnMn2O4 composite (hetaerolite) nanoparticles were prepared by easy low temperature hydrothermal procedure and structurally characterized by X-ray powder diffraction (XRD), field emission scanning electron microscopy (FESEM), X-ray photoelectron spectroscopy (XPS), Fourier transform infrared (FTIR) and UV-visible spectroscopy which illustrate that the prepared material is optical active and composed of well crystalline body-centered tetragonal nanoparticles with average size of similar to 38 +/- 10 nm. Hetaerolite nanoparticles were applied for the advancement of a nitrophenol sensor which exhibited high sensitivity (1.500 mu Acm(-2) mM(-1)), stability, repeatability and lower limit of detection (20.0 mu M) in short response time (10 sec). Moreover, hetaerolite nanoparticles executed high solar photo-catalytic degradation when applied to brilliant cresyl blue under visible light.	[Khan, Sher Bahadar; Rahman, Mohammed M.; Asiri, Abdullah M.; Rub, Malik Abdul] King Abdulaziz Univ, CEAMR, Jeddah 21413, Saudi Arabia; [Khan, Sher Bahadar; Rahman, Mohammed M.; Asiri, Abdullah M.; Rub, Malik Abdul] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia; [Akhtar, Kalsoom] Ewha Womans Univ, Div Nano Sci, Seoul, South Korea; [Akhtar, Kalsoom] Ewha Womans Univ, Dept Chem, Seoul 120750, South Korea	King Abdulaziz University; King Abdulaziz University; Ewha Womans University; Ewha Womans University	Khan, SB (corresponding author), King Abdulaziz Univ, CEAMR, Jeddah 21413, Saudi Arabia.	sbkhan@kau.edu.sa	Khan, Prof. Sher Bahadar/M-7968-2019; Rahman, Mohammed M./H-5823-2012; Asiri, Abdullah M./C-3458-2009; Akhtar, Kalsoom/Q-4743-2016; Khan, Sher Bahadar/H-5833-2012; Rub, Malik Abdul/H-6027-2012	Khan, Prof. Sher Bahadar/0000-0001-9635-7175; Rahman, Mohammed M./0000-0003-2773-1244; Asiri, Abdullah M./0000-0001-7905-3209; Khan, Sher Bahadar/0000-0001-9635-7175; Rub, Malik Abdul/0000-0002-4798-5308	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [130-031-D1433]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (130-031-D1433). The authors, therefore, acknowledge with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors	Ansari SG, 2008, BIOSENS BIOELECTRON, V23, P1838, DOI 10.1016/j.bios.2008.02.022; Ansari SG, 2008, SENSOR ACTUAT B-CHEM, V132, P265, DOI 10.1016/j.snb.2008.01.036; Ansari SG, 2009, SENSOR ACTUAT B-CHEM, V137, P566, DOI 10.1016/j.snb.2009.01.018; Apte SK, 2006, MATER RES BULL, V41, P647, DOI 10.1016/j.materresbull.2005.08.028; Banik RM, 2008, SENSOR ACTUAT B-CHEM, V131, P295, DOI 10.1016/j.snb.2007.11.022; Du J, 2006, NANOTECHNOLOGY, V17, P4923, DOI 10.1088/0957-4484/17/19/024; Faisal M, 2011, APPL SURF SCI, V258, P672, DOI 10.1016/j.apsusc.2011.07.067; Faisal M, 2011, CHEM ENG J, V173, P178, DOI 10.1016/j.cej.2011.07.067; Faisal M, 2011, MATER LETT, V65, P1400, DOI 10.1016/j.matlet.2011.02.013; Jain RK, 2005, CURR SCI INDIA, V89, P101; Jamal A, 2013, MICRONANOSYST, V5, P22; Jamal A, 2012, APPL SURF SCI, V261, P52, DOI 10.1016/j.apsusc.2012.07.066; Jha A, 2012, MATER RES BULL, V47, P813, DOI 10.1016/j.materresbull.2011.11.057; Khan SB, 2012, INT J ELECTROCHEM SC, V7, P10965; Khan SB, 2012, NEW J CHEM, V36, P2368, DOI 10.1039/c2nj40549k; Khan SB, 2012, INT J ELECTROCHEM SC, V7, P4030; Khan SB, 2011, TALANTA, V85, P943, DOI 10.1016/j.talanta.2011.05.003; Khan SB, 2011, SCI TOTAL ENVIRON, V409, P2987, DOI 10.1016/j.scitotenv.2011.04.019; Khan SB, 2011, TALANTA, V84, P1005, DOI 10.1016/j.talanta.2011.02.036; Menaka, 2009, B MATER SCI, V32, P231, DOI 10.1007/s12034-009-0035-7; Mohapatra L, 2012, SEP PURIF TECHNOL, V91, P73, DOI 10.1016/j.seppur.2011.10.028; Parida KM, 2012, CHEM ENG J, V179, P131, DOI 10.1016/j.cej.2011.10.070; Rahman MM, 2012, ELECTROCHIM ACTA, V75, P164, DOI 10.1016/j.electacta.2012.04.093; Rahman MM, 2012, TALANTA, V95, P18, DOI 10.1016/j.talanta.2012.03.027; Rahman MM, 2011, BIOSENS BIOELECTRON, V28, P127, DOI 10.1016/j.bios.2011.07.024; Rahman MM, 2011, J PHYS CHEM C, V115, P9503, DOI 10.1021/jp202252j; Rahman MM, 2011, J NANOPART RES, V13, P3789, DOI 10.1007/s11051-011-0301-7; Stanca SE, 2003, TALANTA, V61, P501, DOI 10.1016/S0039-9140(03)00310-2; Wang X, 2003, CHEM-EUR J, V9, P300, DOI 10.1002/chem.200390024; Yang J, 2000, CHEM MATER, V12, P3259, DOI 10.1021/cm0000144; Zhang P, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-323	31	37	38	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85290	10.1371/journal.pone.0085290	http://dx.doi.org/10.1371/journal.pone.0085290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465525	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500049
J	Matzke, NJ; Shih, PM; Kerfeld, CA				Matzke, Nicholas J.; Shih, Patrick M.; Kerfeld, Cheryl A.			Bayesian Analysis of Congruence of Core Genes in Prochlorococcus and Synechococcus and Implications on Horizontal Gene Transfer	PLOS ONE			English	Article							PHYLOGENETIC TREE SELECTION; GENOME EVOLUTION; PHOTOSYNTHESIS; CYANOBACTERIA; MODELS; CONFIDENCE; INFERENCE; ACCURACY; BACTERIA; SEQUENCE	It is often suggested that horizontal gene transfer is so ubiquitous in microbes that the concept of a phylogenetic tree representing the pattern of vertical inheritance is oversimplified or even positively misleading. "Universal proteins" have been used to infer the organismal phylogeny, but have been criticized as being only the "tree of one percent." Currently, few options exist for those wishing to rigorously assess how well a universal protein phylogeny, based on a relative handful of well-conserved genes, represents the phylogenetic histories of hundreds of genes. Here, we address this problem by proposing a visualization method and a statistical test within a Bayesian framework. We use the genomes of marine cyanobacteria, a group thought to exhibit substantial amounts of HGT, as a test case. We take 379 orthologous gene families from 28 cyanobacteria genomes and estimate the Bayesian posterior distributions of trees - a "treecloud" - for each, as well as for a concatenated dataset based on putative "universal proteins." We then calculate the average distance between trees within and between all treeclouds on various metrics and visualize this high-dimensional space with non-metric multidimensional scaling (NMMDS). We show that the tree space is strongly clustered and that the universal protein treecloud is statistically significantly closer to the center of this tree space than any individual gene treecloud. We apply several commonly-used tests for incongruence/HGT and show that they agree HGT is rare in this dataset, but make different choices about which genes were subject to HGT. Our results show that the question of the representativeness of the "tree of one percent" is a quantitative empirical question, and that the phylogenetic central tendency is a meaningful observation even if many individual genes disagree due to the various sources of incongruence.	[Matzke, Nicholas J.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Shih, Patrick M.; Kerfeld, Cheryl A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Kerfeld, Cheryl A.] US DOE, Joint Genome Inst, Walnut Creek, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Kerfeld, CA (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	ckerfeld@lbl.gov	Matzke, Nicholas/L-4109-2015	Matzke, Nicholas/0000-0002-8698-7656	National Science Foundation (NSF) [DEB-0919451]; Wang Fellowship; Tien Fellowship; Google Summer of Code grant; U.C. Berkeley; Department of Integrative Biology; Center for Theoretical and Evolutionary Genetics; John Huelsenbeck; NSF [MCB-0851070]; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Wang Fellowship; Tien Fellowship; Google Summer of Code grant(Google Incorporated); U.C. Berkeley; Department of Integrative Biology; Center for Theoretical and Evolutionary Genetics; John Huelsenbeck; NSF(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	NJM was supported by National Science Foundation (NSF) Grant DEB-0919451, a Wang Fellowship, and a Tien Fellowship, and a Google Summer of Code grant, as well as U.C. Berkeley, the Department of Integrative Biology, the Center for Theoretical and Evolutionary Genetics, and John Huelsenbeck. PMS and CAK were funded by NSF Grant MCB-0851070. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; Ane C, 2007, MOL BIOL EVOL, V24, P412; Boussau B, 2010, TRENDS ECOL EVOL, V25, P224, DOI 10.1016/j.tree.2009.09.007; Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; Dagan T, 2013, GENOME BIOL EVOL, V5, P31, DOI 10.1093/gbe/evs117; Doolittle WF, 2009, COLD SPRING HARBOR S; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Ge F, 2005, PLOS BIOL, V3, P1709, DOI 10.1371/journal.pbio.0030316; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Gong ZQ, 2012, P NATL ACAD SCI USA, V109, pE234, DOI 10.1073/pnas.1119859109; Hillis DM, 2005, SYST BIOL, V54, P471, DOI 10.1080/10635150590946961; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; MADDISON DR, 1991, SYST ZOOL, V40, P315, DOI 10.2307/2992325; MADDISON WP, 1991, EVOLUTION, V45, P1184, DOI [10.1111/j.1558-5646.1991.tb04385.x, 10.2307/2409726]; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; Narechania A, 2012, GENOME BIOL EVOL, V4, P30, DOI 10.1093/gbe/evr121; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Susko E, 2006, MOL BIOL EVOL, V23, P1019, DOI 10.1093/molbev/msj113; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Willyard A, 2009, MOL PHYLOGENET EVOL, V52, P498, DOI 10.1016/j.ympev.2009.02.011; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306; Zhaxybayeva O, 2011, CURR BIOL, V21, pR242, DOI 10.1016/j.cub.2011.01.045; Zhaxybayeva O, 2009, GENOME BIOL EVOL, V1, P325, DOI 10.1093/gbe/evp032	45	9	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85103	10.1371/journal.pone.0085103	http://dx.doi.org/10.1371/journal.pone.0085103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465485	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500036
J	Pires, L; Bosco, SDG; Baptista, MS; Kurachi, C				Pires, Layla; Gimenes Bosco, Sandra de Moraes; Baptista, Mauricio S.; Kurachi, Cristina			Photodynamic Therapy in Pythium insidiosum - An In Vitro Study of the Correlation of Sensitizer Localization and Cell Death	PLOS ONE			English	Article							PYTHIOSIS-INSIDIOSI; SUBCUTANEOUS PYTHIOSIS; BRAZIL; INFECTIONS; HORSES; DOGS	Pythiosis is an infectious disease caused by Pythium insidiosum, a fungus-like organism. Due to the lack of ergosterol on its cell membrane, antibiotic therapy is ineffective. The conventional treatment is surgery, but lesion recurrence is frequent, requiring several resections or limb amputation. Photodynamic therapy uses photo-activation of drugs and has the potential to be an attractive alternative option. The in vitro PDT response on the growing of Pythium insidiosum culture was investigated using three distinct photosensitizers: methylene blue, Photogem, and Photodithazine. The photosensitizer distribution in cell structures and the PDT response for incubation times of 30, 60, and 120 minutes were evaluated. Methylene blue did not penetrate in the pathogen's cell and consequently there was no PDT inactivation. Photogem showed heterogenous distribution in the hyphal structure with small concentration inside the cells. Porphyrin-PDT response was heterogenous, death and live cells were observed in the treated culture. After 48 hours, hyphae regrowth was observed. Photodithazine showed more homogenous distribution inside the cell and with the specific intracellular localization dependent on incubation time. Photodithazine first accumulates in intracellular vacuoles, and at incubation times of one hour, it is located at all cell membranes. Higher inhibition of the growing rates was achieved with Photodithazine -PDT, over 98%. Our results showed that the photosensitizers that cross more efficiently the Pythium insidiosum membranes are able to cause extensive damage to the organism under illumination and therefore, are the best options for clinical treatment.	[Pires, Layla; Kurachi, Cristina] Univ Sao Paulo, Sao Carlos Inst Phys, Sao Paulo, Brazil; [Gimenes Bosco, Sandra de Moraes] UNESP Univ Estadual Paulista, Inst Biociencias Botucatu, Sao Paulo, Brazil; [Baptista, Mauricio S.] Univ Sao Paulo, Inst Chem, Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo	Pires, L (corresponding author), Univ Sao Paulo, Sao Carlos Inst Phys, Sao Paulo, Brazil.	laylabtu@gmail.com	de Moraes Gimenes Bosco, Sandra/AAP-1467-2021; Baptista, Mauricio S/A-5140-2008; Baptista, Mauricio S/AAO-5749-2021; Kurachi, Cristina/G-3731-2012; de M. G. Bosco, Sandra/B-2570-2013	de Moraes Gimenes Bosco, Sandra/0000-0002-6363-3740; Baptista, Mauricio S/0000-0001-7079-7666; Baptista, Mauricio S/0000-0001-7079-7666; Pires, Layla/0000-0003-4558-5199; INCT de Optica Basica e Aplicada as Ciencias da Vida (CNPq), CePOF (FAPESP)/0000-0002-6403-4037	FAPESP (LP scholarhip); FAPESP (CEPID-Program); CNPq (INCT Program)	FAPESP (LP scholarhip); FAPESP (CEPID-Program); CNPq (INCT Program)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support by FAPESP (LP scholarhip, and CEPID-Program), and CNPq (INCT Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos C. J., 1996; Bosco SDG, 2005, EMERG INFECT DIS, V11, P715; Calzavara-Pinton PG, 2005, J PHOTOCH PHOTOBIO B, V78, P1, DOI 10.1016/j.jphotobiol.2004.06.006; Choudhary S, 2009, LASER MED SCI, V24, P971, DOI 10.1007/s10103-009-0716-x; Detty MR, 2004, J MED CHEM, V47, P3897, DOI 10.1021/jm040074b; Dougherty TJ, 2008, PHOTOCHEM PHOTOBIOL, V38, P377; Dovigo LN, 2011, LASER SURG MED, V43, P927, DOI 10.1002/lsm.21110; Dykstra MJ, 1999, MED MYCOL, V37, P427, DOI 10.1046/j.1365-280X.1999.00248.x; Engelmann FM, 2007, J BIOENERG BIOMEMBR, V39, P175, DOI 10.1007/s10863-007-9075-0; Garcia RB, 2007, MYCOL RES, V111, P1352, DOI 10.1016/j.mycres.2007.08.005; Gonzales FP, 2012, PHOTOCHEM PHOTOBIOL, V86, P653; Maisch T, 2005, J GERMAN SOC DERMATO, V9, P360; Mendoza L, 2003, VACCINE, V21, P2797, DOI 10.1016/S0264-410X(03)00225-1; Mendoza L, 1996, J MYCOL MED, V6, P151; MENDOZA L, 1993, J CLIN MICROBIOL, V31, P2967, DOI 10.1128/JCM.31.11.2967-2973.1993; MENDOZA L, 1992, MYCOPATHOLOGIA, V119, P89, DOI 10.1007/BF00443939; MILLER RI, 1981, AUST VET J, V57, P377, DOI 10.1111/j.1751-0813.1981.tb00526.x; Ochsner M, 1997, J PHOTOCH PHOTOBIO B, V39, P1, DOI 10.1016/S1011-1344(96)07428-3; Pereira CA, 2011, LASER MED SCI, V26, P341, DOI 10.1007/s10103-010-0852-3; Pupaibool J, 2006, EMERG INFECT DIS, V12, P517, DOI 10.3201/eid1203.051044; Santurio JM, 2003, VACCINE, V21, P2535, DOI 10.1016/S0264-410X(03)00035-5; Santurio JM, 1998, MYCOPATHOLOGIA, V141, P123, DOI 10.1023/A:1006995407665; Smolinska M, 2010, ACTA CHIMICA SLOVACA, V3, P41; Tabosa IM, 2004, VET PATHOL, V41, P412, DOI 10.1354/vp.41-4-412; TRISCOTT JA, 1993, J CUTAN PATHOL, V20, P267, DOI 10.1111/j.1600-0560.1993.tb00654.x; Wilson BC, 2008, PHYS MED BIOL, V53, pR61, DOI 10.1088/0031-9155/53/9/R01; Yangjunzhi Yinjiangzhong, 2012, MODIFIED P O ALGORIT, P1; Zeina B, 2001, BRIT J DERMATOL, V144, P274, DOI 10.1046/j.1365-2133.2001.04013.x; Zhu TC, 2008, MED PHYS, V35, P3127, DOI 10.1118/1.2937440	29	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85431	10.1371/journal.pone.0085431	http://dx.doi.org/10.1371/journal.pone.0085431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465559	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500064
J	Xu, X; Cai, Y; Wei, Y; Donate, F; Juarez, J; Parry, G; Chen, LQ; Meehan, EJ; Ahn, RW; Ugolkov, A; Dubrovskyi, O; O'Halloran, TV; Huang, MD; Mazar, AP				Xu, Xiang; Cai, Yuan; Wei, Ying; Donate, Fernando; Juarez, Jose; Parry, Graham; Chen, Liqing; Meehan, Edward J.; Ahn, Richard W.; Ugolkov, Andrey; Dubrovskyi, Oleksii; O'Halloran, Thomas V.; Huang, Mingdong; Mazar, Andrew P.			Identification of a New Epitope in uPAR as a Target for the Cancer Therapeutic Monoclonal Antibody ATN-658, a Structural Homolog of the uPAR Binding Integrin CD11b (alpha M)	PLOS ONE			English	Article							UROKINASE-PLASMINOGEN-ACTIVATOR; GROWTH-FACTOR; EXTRACELLULAR-MATRIX; CELL INVASION; BONE-MARROW; RECEPTOR; SYSTEM; EXPRESSION; MIGRATION; ASSOCIATION	The urokinase plasminogen activator receptor (uPAR) plays a role in tumor progression and has been proposed as a target for the treatment of cancer. We recently described the development of a novel humanized monoclonal antibody that targets uPAR and has anti-tumor activity in multiple xenograft animal tumor models. This antibody, ATN-658, does not inhibit ligand binding (i.e. uPA and vitronectin) to uPAR and its mechanism of action remains unclear. As a first step in understanding the anti-tumor activity of ATN-658, we set out to identify the epitope on uPAR to which ATN-658 binds. Guided by comparisons between primate and human uPAR, epitope mapping studies were performed using several orthogonal techniques. Systematic site directed and alanine scanning mutagenesis identified the region of aa 268-275 of uPAR as the epitope for ATN-658. No known function has previously been attributed to this epitope Structural insights into epitope recognition were obtained from structural studies of the Fab fragment of ATN-658 bound to uPAR. The structure shows that the ATN-658 binds to the DIII domain of uPAR, close to the C-terminus of the receptor, corroborating the epitope mapping results. Intriguingly, when bound to uPAR, the complementarity determining region (CDR) regions of ATN-658 closely mimic the binding regions of the integrin CD11b (alpha M), a previously identified uPAR ligand thought to be involved in leukocyte rolling, migration and complement fixation with no known role in tumor progression of solid tumors. These studies reveal a new functional epitope on uPAR involved in tumor progression and demonstrate a previously unrecognized strategy for the therapeutic targeting of uPAR.	[Xu, Xiang; Cai, Yuan; Huang, Mingdong] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hemostasis & Thrombosis, Boston, MA 02215 USA; [Cai, Yuan] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China; [Wei, Ying] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Donate, Fernando] Agensys, St Santa Monica, CA USA; [Juarez, Jose] GNF, San Diego, CA USA; [Parry, Graham] Attenuon, San Diego, CA USA; [Chen, Liqing; Meehan, Edward J.] Univ Alabama, Dept Chem, Huntsville, AL 35899 USA; [Ugolkov, Andrey; Dubrovskyi, Oleksii; O'Halloran, Thomas V.; Mazar, Andrew P.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL USA; [O'Halloran, Thomas V.; Mazar, Andrew P.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA; [O'Halloran, Thomas V.; Mazar, Andrew P.] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA; [Ahn, Richard W.; O'Halloran, Thomas V.] Northwestern Univ, Dept Chem, Evanston, IL USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Huntsville; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Northwestern University	Huang, MD (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hemostasis & Thrombosis, Boston, MA 02215 USA.	mhuang1@bidmc.harvard.edu; a-mazar@northwestern.edu	Ugolkov, Andrey/T-3012-2019; O'Halloran, Thomas/ABE-6125-2021; Huang, Mingdong/J-4278-2017	O'Halloran, Thomas/0000-0001-8732-5059; Huang, Mingdong/0000-0003-0085-9141	NIH [HL086584]; NCI [CA125564, CA151461]; H Foundation and Lynn Sage Breast Cancer Foundation; services of the Tumor Biology Core (TBC) of Northwestern University; NATIONAL CANCER INSTITUTE [U01CA151461, R01CA125564, P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); H Foundation and Lynn Sage Breast Cancer Foundation; services of the Tumor Biology Core (TBC) of Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from NIH (HL086584) to M. H., NCI (CA125564), to Harold Chapman (Y.W.) and (CA151461) to (T.V.O. and A. P. M) and and the H Foundation and Lynn Sage Breast Cancer Foundation (A. P. M.). This work was supported by the services of the Tumor Biology Core (TBC) of Northwestern University which benefits from philanthropic support of the Robert H. Lurie Cancer Center and the Chemistry of Life Processes Institute. X-ray data for this study were measured at beamline x29 of the National Synchrotron Light Source and at APS SER-CAT beamline 22ID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Bass R, 2009, THROMB HAEMOSTASIS, V101, P954, DOI 10.1160/TH08-08-0558; Bauer TW, 2005, CANCER RES, V65, P7775, DOI 10.1158/0008-5472.CAN-05-0946; Bdeir K, 2003, BLOOD, V102, P3600, DOI 10.1182/blood-2003-03-0949; Bene MC, 2004, LEUKEMIA, V18, P394, DOI 10.1038/sj.leu.2403250; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cantero D, 1997, BRIT J CANCER, V75, P388, DOI 10.1038/bjc.1997.63; Chaurasia P, 2006, J BIOL CHEM, V281, P14852, DOI 10.1074/jbc.M512311200; Chioda M, 2011, CANCER METAST REV, V30, P27, DOI 10.1007/s10555-011-9268-1; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Degryse B, 2011, CURR PHARM DESIGN, V17, P1872, DOI 10.2174/138161211796718161; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Ghosh S, 2006, J BIOL CHEM, V281, P13021, DOI 10.1074/jbc.M508526200; He C, 2001, J CANCER RES CLIN, V127, P180, DOI 10.1007/s004320000192; Hildenbrand R, 1999, J LEUKOCYTE BIOL, V66, P40, DOI 10.1002/jlb.66.1.40; Hildenbrand R, 2010, EXPERT OPIN INV DRUG, V19, P641, DOI 10.1517/13543781003767400; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kenny HA, 2011, CLIN CANCER RES, V17, P459, DOI 10.1158/1078-0432.CCR-10-2258; Kwaan Hau C., 2009, V148, P43, DOI 10.1007/978-0-387-79962-9_4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li S, 2009, P NATL ACAD SCI USA, V106, P4349, DOI 10.1073/pnas.0810844106; Li YD, 2007, J MOL BIOL, V365, P1117, DOI 10.1016/j.jmb.2006.10.059; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; Mazar AP, 2008, CLIN CANCER RES, V14, P5649, DOI 10.1158/1078-0432.CCR-07-4863; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; MURPHY G, 1992, ANN NY ACAD SCI, V667, P1, DOI 10.1111/j.1749-6632.1992.tb51590.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NALDINI L, 1995, J BIOL CHEM, V270, P603, DOI 10.1074/jbc.270.2.603; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; PYKE C, 1994, HISTOPATHOLOGY, V24, P131, DOI 10.1111/j.1365-2559.1994.tb01291.x; Rabbani SA, 2010, NEOPLASIA, V12, P778, DOI 10.1593/neo.10296; RIFKIN DB, 1990, CELL DIFFER DEV, V32, P313, DOI 10.1016/0922-3371(90)90045-X; SCHMITT M, 1992, BIOL CHEM H-S, V373, P611, DOI 10.1515/bchm3.1992.373.2.611; Shaked Y, 2009, BBA-REV CANCER, V1796, P1, DOI 10.1016/j.bbcan.2009.07.002; Simon DI, 2000, J BIOL CHEM, V275, P10228, DOI 10.1074/jbc.275.14.10228; STEWART M, 1995, CURR OPIN CELL BIOL, V7, P690, DOI 10.1016/0955-0674(95)80111-1; Thomas C, 2009, BJU INT, V104, P29, DOI 10.1111/j.1464-410X.2008.08298.x; Todd RF, 1997, J LAB CLIN MED, V129, P492, DOI 10.1016/S0022-2143(97)90003-2; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Buren G, 2009, CANCER-AM CANCER SOC, V115, P3360, DOI 10.1002/cncr.24371; Waltz DA, 1997, J CLIN INVEST, V100, P58, DOI 10.1172/JCI119521; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wei Y, 2007, J BIOL CHEM, V282, P3929, DOI 10.1074/jbc.M607989200; Xue W, 1997, CANCER RES, V57, P1682; YAMAMOTO M, 1994, CANCER RES, V54, P5016; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	58	25	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85349	10.1371/journal.pone.0085349	http://dx.doi.org/10.1371/journal.pone.0085349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465541	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500057
J	Boufassa, F; Lechenadec, J; Meyer, L; Costagliola, D; Hunt, PW; Pereyra, F; Deeks, S; Pancino, G; Taulera, O; Lichterfeld, M; Delobel, P; Saez-Cirion, A; Lambotte, O				Boufassa, Faroudy; Lechenadec, Jerome; Meyer, Laurence; Costagliola, Dominique; Hunt, Peter W.; Pereyra, Florencia; Deeks, Steve; Pancino, Gianfranco; Taulera, Olivier; Lichterfeld, Mathias; Delobel, Pierre; Saez-Cirion, Asier; Lambotte, Olivier		ANRS CO18 HIV Controllers Cohort; Cascade Collaboration Eurocoord; SCOPE Cohort; Int HIV Controllers Study	Blunted Response to Combination Antiretroviral Therapy in HIV Elite Controllers: An International HIV Controller Collaboration	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LOW-LEVEL VIREMIA; CD4 CELL COUNTS; DISEASE PROGRESSION; VIRAL SUPPRESSION; ABSENCE; INFECTION; INDIVIDUALS; REPLICATION; COINFECTION	Objective: HIV "elite controllers'' (ECs) spontaneously control viral load, but some eventually require combination antiretroviral treatment (cART), due to a loss of viral control or a decline in CD4 T-cell counts. Here we studied the CD4 T-cell count dynamics after cART initiation among 34 ECs followed in U.S. and European cohorts, by comparison with chronically viremic patients (VIRs). Methods: ECs were defined as patients with at least >= 5 viral load (VL) measurements below 400 copies/mL during at least a 5-year period despite never receiving ART and were selected from the French ANRS CO18 cohort, the U.S. SCOPE cohort, the International HIV Controllers study and the European CASCADE collaboration. VIRs were selected from the ANRS COPANA cohort of recently-diagnosed (< 1 year) ART-naive HIV-1-infected adults. CD4 T-cell count dynamics after cART initiation in both groups were modelled with piecewise mixed linear models. Results: After cART initiation, CD4 T-cell counts showed a biphasic rise in VIRs with: an initial rapid increase during the first 3 months (+0.63 root CD4/month), followed by +0.19 root CD4/month. This first rapid phase was not observed in ECs, in whom the CD4Tc count increased steadily, at a rate similar to that of the second phase observed in VIRs. After cART initiation at a CD4 T-cell count of 300/mm(3), the estimated mean CD4 T-cell gain during the first 12 months was 139/mm(3) in VIRs and 80/mm(3) in ECs (p = 0.048). Conclusions: cART increases CD4 T-cell counts in elite controllers, albeit less markedly than in other patients.	[Boufassa, Faroudy; Meyer, Laurence] CESP Ctr Res Epidemiol & Populat Hlth, INSERM, Epidemiol HIV & STI Team, Le Kremlin Bicetre, France; [Boufassa, Faroudy; Lechenadec, Jerome; Meyer, Laurence] Univ Paris 11, Le Kremlin Bicetre, France; [Meyer, Laurence] Hop Bicetre, AP HP, Serv Sante Publ, Le Kremlin Bicetre, France; [Costagliola, Dominique] Univ Paris 06, Paris, France; [Costagliola, Dominique] INSERM, Paris, France; [Hunt, Peter W.; Deeks, Steve] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Hunt, Peter W.; Deeks, Steve] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Hunt, Peter W.; Deeks, Steve] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; [Pereyra, Florencia] Massachusetts Gen Hosp, Ragon Inst, MIT, Cambridge, MA USA; [Pereyra, Florencia] Harvard Univ, Cambridge, MA 02138 USA; [Taulera, Olivier] Hop St Louis, Paris, France; [Lichterfeld, Mathias] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Delobel, Pierre] Hop Purpan, Serv Malad Infect & Trop, Toulouse, France; [Delobel, Pierre] Fac Med Toulouse, INSERM, F-31073 Toulouse, France; [Saez-Cirion, Asier] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Lambotte, Olivier] Hop Bicetre, AP HP, Serv Med Interne, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Massachusetts General Hospital; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Boufassa, F (corresponding author), CESP Ctr Res Epidemiol & Populat Hlth, INSERM, Epidemiol HIV & STI Team, Le Kremlin Bicetre, France.	faroudy.boufassa@inserm.fr	Hunt, Peter W./P-2976-2017; Lambotte, Olivier/GRT-0160-2022; Costagliola, Dominique/H-5849-2011; Lichterfeld, Mathias/B-2042-2008; Delobel, Pierre/Q-6028-2019; Delobel, Pierre/K-3166-2014; Saez-Cirion, Asier/A-8640-2008	Hunt, Peter W./0000-0002-4571-4870; Costagliola, Dominique/0000-0003-0765-0869; Lichterfeld, Mathias/0000-0001-9865-8350; Delobel, Pierre/0000-0002-2874-3581; Delobel, Pierre/0000-0002-2874-3581; Saez-Cirion, Asier/0000-0003-2406-7536; Deeks, Steven/0000-0001-6371-747X; Hladek, Melissa/0000-0002-0625-2474	ANRS (Agence nationale de recherches sur le sida et les hepatites virales); European Union under EuroCoord [260694]; Bill and Melinda Gates Foundation; Harvard University Center for AIDS Research [P-30-AI060354]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [P30 AI027763]; AIDS Healthcare Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, P30AI027763] Funding Source: NIH RePORTER	ANRS (Agence nationale de recherches sur le sida et les hepatites virales)(ANRSFrench National Research Agency (ANR)); European Union under EuroCoord; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Harvard University Center for AIDS Research; National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AIDS Healthcare Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The ANRS CO18 HIV Controllers Cohort was funded by ANRS (Agence nationale de recherches sur le sida et les hepatites virales). The CASCADE Collaboration has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement n<SUP>o</SUP> 260694. The Bill and Melinda Gates Foundation, AIDS Healthcare Foundation and Harvard University Center for AIDS Research (P-30-AI060354) for The International HIV Controllers Study and the SCOPE Cohort is supported by a grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases: P30 AI027763. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Bosch RJ, 2006, JAIDS-J ACQ IMM DEF, V43, P433, DOI 10.1097/01.qai.0000243097.27029.b7; De Luca A, 2002, ARCH INTERN MED, V162, P2125, DOI 10.1001/archinte.162.18.2125; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hatano H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003691; Hatano H, 2009, J VIROL, V83, P329, DOI 10.1128/JVI.01763-08; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hunt PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015924; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lifson AR, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-2; Madec Y, 2005, AIDS, V19, P2001, DOI 10.1097/01.aids.0000194134.28135.cd; Madec Y, 2013, AIDS, V27, P2451, DOI 10.1097/01.aids.0000431945.72365.01; Mocroft A, 2013, CLIN INFECT DIS, V57, P1038, DOI 10.1093/cid/cit423; Okulicz JF, 2010, CLIN INFECT DIS, V50, P1187, DOI 10.1086/651421; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Saez-Cirion A, 2007, TRENDS IMMUNOL, V28, P532, DOI 10.1016/j.it.2007.09.002; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Sajadi MM, 2012, AIDS, V26, P1879, DOI 10.1097/QAD.0b013e328357f5d1; Sauce D, 2011, BLOOD, V117, P5142, DOI 10.1182/blood-2011-01-331306; Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075; Toulowni G, 2008, JAIDS-J ACQ IMM DEF, V49, P492, DOI 10.1097/QAI.0b013e318186ead2; Vingert B, 2012, J VIROL, V86, P10661, DOI 10.1128/JVI.00056-12; Wood E, 2000, AIDS, V14, P1955, DOI 10.1097/00002030-200009080-00011; Yang Y, 2012, AIDS, V26, P701, DOI 10.1097/QAD.0b013e3283519b22	33	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85516	10.1371/journal.pone.0085516	http://dx.doi.org/10.1371/journal.pone.0085516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465584	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000041
J	Feng, SM; Cai, M; Liu, PC; Wei, L; Wang, JS; Qi, J; Deng, LF				Feng, Shengmei; Cai, Ming; Liu, Pengcheng; Wei, Li; Wang, Jinshen; Qi, Jin; Deng, Lianfu			Atp6v1c1 May Regulate Filament Actin Arrangement in Breast Cancer Cells	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; V-ATPASE; SUBUNIT-C; F-ACTIN; INVASION; PH; INVADOPODIA; OSTEOCLASTS; EXPRESSION; CARCINOMA	Previous studies have shown that the rate of breast cancer metastasis correlates with the expression of vacuolar H+-ATPases (V-ATPases). However, how V-ATPase is involved in breast cancer metastasis remains unknown. Our previous study showed that Atp6v1c1-depleted osteoclasts did not form organized actin rings and that Atp6v1c1 co-localizes with F-actin. In this study, we found that the normal arrangement of filamentous actin is disrupted in Atp6v1c1-depleted 4T1 mouse breast cancer cells and in the ATP6V1C1-depleted human breast cancer cell lines MDA-MB-231 and MDA-MB-435s. We further found that Atp6v1c1 co-localizes with F-actin in 4T1 cells. The results of our study suggest that high expression of Atp6v1c1 affects the actin structure of cancer cells such that it facilitates breast cancer metastasis. The findings also indicate that Atp6v1c1 could be a novel target for breast cancer metastasis therapy.	[Feng, Shengmei; Wei, Li; Wang, Jinshen; Qi, Jin; Deng, Lianfu] Jiao Tong Univ, Sch Med, Shanghai Key Lab Prevent & Treatment Bone & Joint, Shanghai Inst Traumatol & Orthopaed,Ruijin Hosp, Shanghai 200030, Peoples R China; [Cai, Ming; Liu, Pengcheng] Tongji Univ, Sch Med, Shanghai Peoples 10, Dept Orthopaed, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Tongji University	Feng, SM (corresponding author), Jiao Tong Univ, Sch Med, Shanghai Key Lab Prevent & Treatment Bone & Joint, Shanghai Inst Traumatol & Orthopaed,Ruijin Hosp, Shanghai 200030, Peoples R China.	fengshengmei@yahoo.com.cn; lfdeng@msn.com			National Natural Science Foundation of China [30901525]; Shanghai Natural Science Foundation [09ZR1428900]; Shanghai Education Commission Foundation [10YZ39]; Talents Cultivation Plan of Shanghai Health System [XYQ2011050]; Science and Technology Grant from the Medical School of Shanghai, Jiaotong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Shanghai Education Commission Foundation; Talents Cultivation Plan of Shanghai Health System; Science and Technology Grant from the Medical School of Shanghai, Jiaotong University	This work was supported by the National Natural Science Foundation of China (Grant 30901525), Shanghai Natural Science Foundation (Grant 09ZR1428900), Shanghai Education Commission Foundation (Grant 10YZ39), Talents Cultivation Plan of Shanghai Health System (XYQ2011050), and a Science and Technology Grant from the Medical School of Shanghai, Jiaotong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Desai B, 2008, J BIOL CHEM, V283, P13856, DOI 10.1074/jbc.M709401200; Feng SM, 2009, BIOCHEM J, V417, P195, DOI 10.1042/BJ20081073; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; KANE PM, 1995, J BIOL CHEM, V270, P17025; Martinez-Zaguilan R, 1999, BIOCHEM PHARMACOL, V57, P1037, DOI 10.1016/S0006-2952(99)00022-2; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Otero-Rey EM, 2008, ORAL ONCOL, V44, P193, DOI 10.1016/j.oraloncology.2007.02.011; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sennoune SR, 2004, CELL BIOCHEM BIOPHYS, V40, P185, DOI 10.1385/CBB:40:2:185; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Vitavska O, 2005, J BIOL CHEM, V280, P1070, DOI 10.1074/jbc.M406797200; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Xu J, 2007, HISTOL HISTOPATHOL, V22, P443, DOI 10.14670/HH-22.443; Xu T, 1999, J BIOL CHEM, V274, P28909, DOI 10.1074/jbc.274.41.28909; Yamaguchi H, 2006, EUR J CELL BIOL, V85, P213, DOI 10.1016/j.ejcb.2005.10.004; Yang SY, 2007, J CELL SCI, V120, P3362, DOI 10.1242/jcs.008300	20	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84833	10.1371/journal.pone.0084833	http://dx.doi.org/10.1371/journal.pone.0084833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454753	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100036
J	Genty, E; Clay, Z; Hobaiter, C; Zuberbuhler, K				Genty, Emilie; Clay, Zanna; Hobaiter, Catherine; Zuberbuehler, Klaus			Multi-Modal Use of a Socially Directed Call in Bonobos	PLOS ONE			English	Article							PAN-PANISCUS; GESTURAL COMMUNICATION; WILD CHIMPANZEES; REPERTOIRE; COMBINATIONS; SEQUENCES; LANGUAGE; BEHAVIOR; MODIFY; SIGNAL	'Contest hoots' are acoustically complex vocalisations produced by adult and subadult male bonobos (Pan paniscus). These calls are often directed at specific individuals and regularly combined with gestures and other body signals. The aim of our study was to describe the multi-modal use of this call type and to clarify its communicative and social function. To this end, we observed two large groups of bonobos, which generated a sample of 585 communicative interactions initiated by 10 different males. We found that contest hooting, with or without other associated signals, was produced to challenge and provoke a social reaction in the targeted individual, usually agonistic chase. Interestingly, 'contest hoots' were sometimes also used during friendly play. In both contexts, males were highly selective in whom they targeted by preferentially choosing individuals of equal or higher social rank, suggesting that the calls functioned to assert social status. Multi-modal sequences were not more successful in eliciting reactions than contest hoots given alone, but we found a significant difference in the choice of associated gestures between playful and agonistic contexts. During friendly play, contest hoots were significantly more often combined with soft than rough gestures compared to agonistic challenges, while the calls' acoustic structure remained the same. We conclude that contest hoots indicate the signaller's intention to interact socially with important group members, while the gestures provide additional cues concerning the nature of the desired interaction.	[Genty, Emilie; Zuberbuehler, Klaus] Univ Neuchatel, Ctr Cognit Sci, CH-2000 Neuchatel, Switzerland; [Genty, Emilie; Hobaiter, Catherine; Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, St Andrews KY16 9AJ, Fife, Scotland; [Clay, Zanna] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	University of Neuchatel; University of St Andrews; Emory University	Genty, E (corresponding author), Univ Neuchatel, Ctr Cognit Sci, CH-2000 Neuchatel, Switzerland.	emilie.genty@unine.ch	Zuberbühler, Klaus/A-9053-2011	Zuberbühler, Klaus/0000-0001-8378-088X; Hobaiter, Cat/0000-0002-3893-0524	Leverhulme Trust Research Leadership Award [F/00 268/AP]; European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC grant [283871]	Leverhulme Trust Research Leadership Award(Leverhulme Trust); European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC grant(European Research Council (ERC))	The research leading to these results has received funding from the Leverhulme Trust Research Leadership Award F/00 268/AP (http://www.leverhulme.ac.uk/) and the European Research Council under the European Union's Seventh Framework Programme (FP7/2007 2013)/ERC grant agreement no 283871 (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Andre C, 2008, DEV PRIMATOL-PROG PR, P303, DOI 10.1007/978-0-387-74787-3_16; Arnold K, 2006, NATURE, V441, P303, DOI 10.1038/441303a; Arnold K, 2012, BRAIN LANG, V120, P303, DOI 10.1016/j.bandl.2011.10.001; Badrian A., 1984, P325; Bavelas JB, 2000, J LANG SOC PSYCHOL, V19, P163, DOI 10.1177/0261927X00019002001; Bermejo M, 1999, FOLIA PRIMATOL, V70, P328, DOI 10.1159/000021717; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; Casar C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0535; Call J., 2007, GESTURAL COMMUNICATI; Cartmill EA, 2007, CURR BIOL, V17, P1345, DOI 10.1016/j.cub.2007.06.069; Cheney D., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; Crockford C, 2012, CURR BIOL, V22, P142, DOI 10.1016/j.cub.2011.11.053; de Luna AG, 2010, ANIM BEHAV, V79, P739, DOI 10.1016/j.anbehav.2009.12.031; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; De Waal FBM, 2003, ANN NY ACAD SCI, V1000, P7, DOI 10.1196/annals.1280.003; DEWAAL FBM, 1988, BEHAVIOUR, V106, P183, DOI 10.1163/156853988X00269; Engh AL, 2006, ANIM BEHAV, V71, P381, DOI 10.1016/j.anbehav.2005.05.009; Furuichi T, 1997, INT J PRIMATOL, V18, P855, DOI 10.1023/A:1026327627943; Fusani L, 1997, BEHAVIOUR, V134, P321, DOI 10.1163/156853997X00566; GARDNER RA, 1969, SCIENCE, V165, P664, DOI 10.1126/science.165.3894.664; Genty E, 2010, ANIM COGN, V13, P287, DOI 10.1007/s10071-009-0266-4; Genty E, 2009, ANIM COGN, V12, P527, DOI 10.1007/s10071-009-0213-4; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hammerschmidt K., 2008, EVOLUTION COMMUNICAT; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hayes K. J., 1951, Proceedings of the American Philosophical Society, V95, P105; HENNESSY DF, 1981, BEHAVIOUR, V78, P188, DOI 10.1163/156853981X00329; Herrmann E, 2013, J COMP PSYCHOL, V127, P63, DOI 10.1037/a0028929; HEWES GW, 1973, CURR ANTHROPOL, V14, P5, DOI 10.1086/201401; Hobaiter C, 2011, ANIM COGN, V14, P827, DOI 10.1007/s10071-011-0416-3; Ingmanson Ellen J., 1996, P190; Iverson JM, 1998, NATURE, V396, P228, DOI 10.1038/24300; KANO T, 1980, J HUM EVOL, V9, P243, DOI 10.1016/0047-2484(80)90053-6; Kano T., 1992, LAST APE PYGMY CHIMP; KURODA S, 1980, Primates, V21, P181, DOI 10.1007/BF02374032; Lameira AR, 2014, TRENDS COGN SCI, V18, P60, DOI 10.1016/j.tics.2013.10.013; Leavens DA, 2004, ANIM BEHAV, V67, P467, DOI 10.1016/j.anbehav.2003.04.007; Leavens DA, 2010, ANIM COGN, V13, P33, DOI 10.1007/s10071-009-0242-z; Liebal K, 2004, AM J PRIMATOL, V64, P377, DOI 10.1002/ajp.20087; Liebal Katja, 2006, GESTURE, V6, P1, DOI [10.1075/gest.6.1.02lie, DOI 10.1075/GEST.6.1.02LIE]; Micheletta J, 2013, AM J PRIMATOL, V75, P763, DOI 10.1002/ajp.22105; Miles H.L.W., 1990, P511, DOI 10.1017/CBO9780511665486.021; MORRIS D, 1977, MANWATCHING; Morris D, 1994, HUMAN ANIMAL LANGUAG; Ouattara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007808; Paoli T, 2008, DEV PRIMATOL-PROG PR, P39, DOI 10.1007/978-0-387-74787-3_3; Partan SR, 2009, ANIM BEHAV, V77, P1127, DOI 10.1016/j.anbehav.2008.12.029; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Partan SR, 2002, BEHAVIOUR, V139, P993, DOI 10.1163/15685390260337877; Patterson F., 1981, ED KOKO; Patterson F, 1979, LANGUAGE INTERVENTIO, P325; Pika S, 2005, AM J PRIMATOL, V65, P39, DOI 10.1002/ajp.20096; Pika S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1567; Pollick AS, 2007, P NATL ACAD SCI USA, V104, P8184, DOI 10.1073/pnas.0702624104; Preuschoft H., 1993, HANDS PRIMATES; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Rowe C, 1996, NATURE, V383, P520, DOI 10.1038/383520a0; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Savage S., 1978, P613; Savage-Rumbaugh E.S., 1977, P97; Seyfarth RM, 2010, BRAIN LANG, V115, P92, DOI 10.1016/j.bandl.2009.10.003; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; Slocombe KE, 2011, ANIM BEHAV, V81, P919, DOI 10.1016/j.anbehav.2011.02.002; Slocombe KE, 2005, CURR BIOL, V15, P1779, DOI 10.1016/j.cub.2005.08.068; Stevens JMG, 2006, PRIMATES, V47, P210, DOI 10.1007/s10329-005-0177-1; Tanner JE, 1996, CURR ANTHROPOL, V37, P162, DOI 10.1086/204484; TANNER JE, 1993, PRIMATES, V34, P451, DOI 10.1007/BF02382654; Tanner Joanne E., 1999, P211, DOI 10.1017/CBO9780511542305.012; TOMASELLO M, 1989, PRIMATES, V30, P35, DOI 10.1007/BF02381209; TOMASELLO M, 1994, PRIMATES, V35, P137, DOI 10.1007/BF02382050; Tomasello M., 1997, EVOLUTION COMMUNICAT, V1, P223, DOI [DOI 10.1075/EOC.1.2.04TOM, 10.1075/eoc.1.2.04tom]; Tomasello Michael, 2007, P1; Uetz GW, 2009, ANIM BEHAV, V78, P299, DOI 10.1016/j.anbehav.2009.04.023; Wiesendanger M, 1999, EXP BRAIN RES, V128, P1, DOI 10.1007/s002210050810	77	53	54	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84738	10.1371/journal.pone.0084738	http://dx.doi.org/10.1371/journal.pone.0084738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454745	Green Published, Green Accepted, gold			2022-12-25	WOS:000330235100032
J	Kakoschke, T; Kakoschke, S; Magistro, G; Schubert, S; Borath, M; Heesemann, J; Rossier, O				Kakoschke, Tamara; Kakoschke, Sara; Magistro, Giuseppe; Schubert, Soeren; Borath, Marc; Heesemann, Juergen; Rossier, Ombeline			The RNA Chaperone Hfq Impacts Growth, Metabolism and Production of Virulence Factors in Yersinia enterocolitica	PLOS ONE			English	Article							HIGH-PATHOGENICITY ISLAND; ENVELOPE STRESS-RESPONSE; ESCHERICHIA-COLI K-12; OMPA MESSENGER-RNA; GCVB GENE ENCODES; SALMONELLA-TYPHIMURIUM; TRANSCRIPTIONAL REGULATION; SIDEROPHORE PRODUCTION; CHROMOSOMAL GENES; EXPRESSION	To adapt to changes in environmental conditions, bacteria regulate their gene expression at the transcriptional but also at the post-transcriptional level, e.g. by small RNAs (sRNAs) which modulate mRNA stability and translation. The conserved RNA chaperone Hfq mediates the interaction of many sRNAs with their target mRNAs, thereby playing a global role in fine-tuning protein production. In this study, we investigated the significance of Hfq for the enteropathogen Yersina enterocolitica serotype O:8. Hfq facilitated optimal growth in complex and minimal media. Our comparative protein analysis of parental and hfq-negative strains suggested that Hfq promotes lipid metabolism and transport, cell redox homeostasis, mRNA translation and ATP synthesis, and negatively affects carbon and nitrogen metabolism, transport of siderophore and peptides and tRNA synthesis. Accordingly, biochemical tests indicated that Hfq represses ornithine decarboxylase activity, indole production and utilization of glucose, mannitol, inositol and 1,2-propanediol. Moreover, Hfq repressed production of the siderophore yersiniabactin and its outer membrane receptor FyuA. In contrast, hfq mutants exhibited reduced urease production. Finally, strains lacking hfq were more susceptible to acidic pH and oxidative stress. Unlike previous reports in other Gram-negative bacteria, Hfq was dispensable for type III secretion encoded by the virulence plasmid. Using a chromosomally encoded FLAG-tagged Hfq, we observed increased production of Hfq-FLAG in late exponential and stationary phases. Overall, Hfq has a profound effect on metabolism, resistance to stress and modulates the production of two virulence factors in Y. enterocolitica, namely urease and yersiniabactin.	[Kakoschke, Tamara; Kakoschke, Sara; Magistro, Giuseppe; Schubert, Soeren; Heesemann, Juergen; Rossier, Ombeline] Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany; [Borath, Marc] Univ Munich, Prot Anal Unit, Adolf Butenandt Inst, Munich, Germany	University of Munich; University of Munich	Rossier, O (corresponding author), Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany.	rossier@mvp.uni-muenchen.de		Rossier, Ombeline/0000-0003-4987-1811	Wissenschaftlichen Herausgeberkollegium der Munnchener Medizinischen Wochenschrift; Bayerischen Gleichstellungsforderung; Forderprogramm fur Forschung und Lehre of the Ludwig-Maximilians University Medical School	Wissenschaftlichen Herausgeberkollegium der Munnchener Medizinischen Wochenschrift; Bayerischen Gleichstellungsforderung; Forderprogramm fur Forschung und Lehre of the Ludwig-Maximilians University Medical School	This work was supported in part by grants from the Wissenschaftlichen Herausgeberkollegium der Munnchener Medizinischen Wochenschrift and from the Bayerischen Gleichstellungsforderung to O.R. T.K. received a fellowship from the Forderprogramm fur Forschung und Lehre of the Ludwig-Maximilians University Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov R, 2005, INT J MED MICROBIOL, V295, P19, DOI 10.1016/j.ijmm.2004.11.007; Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Antonenko V, 2003, FEMS MICROBIOL LETT, V219, P249, DOI 10.1016/S0378-1097(03)00047-8; Autenrieth IB, 1996, J MED MICROBIOL, V44, P285, DOI 10.1099/00222615-44-4-285; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; BADGER JL, 1995, J BACTERIOL, V177, P5370, DOI 10.1128/jb.177.18.5370-5373.1995; Bai G, 2010, J BACTERIOL, V192, P4239, DOI 10.1128/JB.00504-10; Baker CS, 2007, J BACTERIOL, V189, P5472, DOI 10.1128/JB.00529-07; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Beauregard A, 2013, RNA BIOL, V10, P397, DOI 10.4161/rna.23590; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOBIK TA, 1992, J BACTERIOL, V174, P2253, DOI 10.1128/JB.174.7.2253-2266.1992; Brem D, 2001, MICROBIOL-SGM, V147, P1115, DOI 10.1099/00221287-147-5-1115; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Chant EL, 2007, MOL MICROBIOL, V63, P35, DOI 10.1111/j.1365-2958.2006.05481.x; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Chen PE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r1; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Conner CP, 1998, P NATL ACAD SCI USA, V95, P4641, DOI 10.1073/pnas.95.8.4641; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; deKoningWard TF, 1997, FEMS MICROBIOL LETT, V147, P221, DOI 10.1016/S0378-1097(96)00528-9; DEKONINGWARD TF, 1995, INFECT IMMUN, V63, P3790, DOI 10.1128/IAI.63.10.3790-3795.1995; Diestra E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008301; Dorrell N, 1998, FEMS MICROBIOL LETT, V165, P145, DOI 10.1016/S0378-1097(98)00267-5; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Garzetti D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-467; Geng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006213; Gerhardt P., 1994, METHODS GEN MOL BACT; Gripenberg-Lerche C, 2000, INFECT IMMUN, V68, P942, DOI 10.1128/IAI.68.2.942-947.2000; GUILVOUT I, 1993, J BACTERIOL, V175, P5488, DOI 10.1128/JB.175.17.5488-5504.1993; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; Han MJ, 2006, MICROBIOL MOL BIOL R, V70, P362, DOI 10.1128/MMBR.00036-05; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983; HEESEMANN J, 1993, MOL MICROBIOL, V8, P397, DOI 10.1111/j.1365-2958.1993.tb01583.x; HEESEMANN J, 1986, INFECT IMMUN, V54, P561, DOI 10.1128/IAI.54.2.561-567.1986; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Heroven AK, 2010, RES MOL MICROBIOLOGY, P1; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hu YB, 2009, MICROBIOL-SGM, V155, P2522, DOI 10.1099/mic.0.028381-0; KINDER SA, 1993, GENE, V136, P271, DOI 10.1016/0378-1119(93)90478-L; Klumpp J, 2007, MICROBIOL-SGM, V153, P1207, DOI 10.1099/mic.0.2006/004747-0; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee T, 2008, RNA, V14, P514, DOI 10.1261/rna.531408; Lin HH, 2011, J BACTERIOL, V193, P5833, DOI 10.1128/JB.05359-11; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Lorenz C, 2010, NUCLEIC ACIDS RES, V38, P3794, DOI 10.1093/nar/gkq032; Marceau M, 2005, CURR ISSUES MOL BIOL, V7, P151; McArthur SD, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-52; Mildiner-Earley S, 2006, INFECT IMMUN, V74, P4361, DOI 10.1128/IAI.00154-06; Nakao H, 1995, MOL MICROBIOL, V18, P859, DOI 10.1111/j.1365-2958.1995.18050859.x; Oellerich MF, 2007, INFECT IMMUN, V75, P3802, DOI 10.1128/IAI.00419-07; Pelludat C, 1998, J BACTERIOL, V180, P538, DOI 10.1128/JB.180.3.538-546.1998; Pelludat C, 2003, J BACTERIOL, V185, P5648, DOI 10.1128/JB.185.18.5648-5653.2003; Pelludat C, 2002, INFECT IMMUN, V70, P1832, DOI 10.1128/IAI.70.4.1832-1841.2002; Pelludat C, 2000, MOL CHARAKTERISIERUN; PEPE JC, 1993, P NATL ACAD SCI USA, V90, P6473, DOI 10.1073/pnas.90.14.6473; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; Rabhi M, 2011, EMBO J, V30, P2805, DOI 10.1038/emboj.2011.192; RAKIN A, 1994, MOL MICROBIOL, V13, P253, DOI 10.1111/j.1365-2958.1994.tb00420.x; Ramachandran VK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-25; Reines M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002978; Richards GR, 2011, BBA-GENE REGUL MECH, V1809, P525, DOI 10.1016/j.bbagrm.2011.07.013; ROGGENKAMP A, 1995, FEMS MICROBIOL LETT, V134, P69, DOI 10.1016/0378-1097(95)00383-G; ROSE RE, 1988, NUCLEIC ACIDS RES, V16, P356, DOI 10.1093/nar/16.1.356; Ruckdeschel K, 1996, INFECT IMMUN, V64, P724, DOI 10.1128/IAI.64.3.724-733.1996; SAKEN E, 1994, J MED MICROBIOL, V41, P329, DOI 10.1099/00222615-41-5-329; Salvail H, 2012, WIRES RNA, V3, P26, DOI 10.1002/wrna.102; Salvail H, 2010, P NATL ACAD SCI USA, V107, P15223, DOI 10.1073/pnas.1007805107; Sasse J, 2009, CURR PROTOC MOL BIOL; Schiano CA, 2010, INFECT IMMUN, V78, P2034, DOI 10.1128/IAI.01046-09; Schubert S, 2004, INT J MED MICROBIOL, V294, P83, DOI 10.1016/j.ijmm.2004.06.026; Sebbane F, 2001, INFECT IMMUN, V69, P170, DOI 10.1128/IAI.69.1.170-176.2001; Shakhnovich EA, 2009, MOL MICROBIOL, V74, P347, DOI 10.1111/j.1365-2958.2009.06856.x; Sharma AK, 2006, MOL MICROBIOL, V62, P469, DOI 10.1111/j.1365-2958.2006.05376.x; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2006, MOL MICROBIOL, V59, P1542, DOI 10.1111/j.1365-2958.2006.05032.x; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Trcek J, 2002, MICROBIOL-SGM, V148, P1457, DOI 10.1099/00221287-148-5-1457; Trosky JE, 2008, CELL MICROBIOL, V10, P557, DOI 10.1111/j.1462-5822.2007.01109.x; Trulzsch K, 2003, INT J MED MICROBIOL, V293, P167, DOI 10.1078/1438-4221-00251; Tsui HCT, 1997, J BACTERIOL, V179, P7476, DOI 10.1128/jb.179.23.7476-7487.1997; Tsui HCT, 1996, J BACTERIOL, V178, P5719, DOI 10.1128/jb.178.19.5719-5731.1996; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Urbanowski ML, 2000, MOL MICROBIOL, V37, P856, DOI 10.1046/j.1365-2958.2000.02051.x; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Vytvytska O, 1998, P NATL ACAD SCI USA, V95, P14118, DOI 10.1073/pnas.95.24.14118; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wilharm G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-27; Wortham BW, 2010, ENVIRON MICROBIOL, V12, P2034, DOI 10.1111/j.1462-2920.2010.02219.x; Zhang YH, 2009, ACTA BIOCH BIOPH SIN, V41, P709, DOI 10.1093/abbs/gmp059	99	31	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86113	10.1371/journal.pone.0086113	http://dx.doi.org/10.1371/journal.pone.0086113			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454955	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100145
J	Lau, J; Zhou, Q; Sutton, SE; Herman, AE; Schmedt, C; Glynne, R				Lau, Janet; Zhou, Qiang; Sutton, Susan E.; Herman, Ann E.; Schmedt, Christian; Glynne, Richard			Inhibition of c-Kit Is Not Required for Reversal of Hyperglycemia by Imatinib in NOD Mice	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; CHRONIC MYELOID-LEUKEMIA	(1) Aim/Hypothesis: Recent studies indicate that tyrosine kinase inhibitors, including imatinib, can reverse hyperglycemia in non-obese diabetic (NOD) mice, a model of type 1 diabetes (T1D). Imatinib inhibits c-Abl, c-Kit, and PDGFRs. Next-generation tyrosine kinase inhibitors for T1D treatment should maintain activities required for efficacy while sparing inhibition of targets that might otherwise lead to adverse events. In this study, we investigated the contribution of c-Kit inhibition by imatinib in reversal of hyperglycemia in NOD mice. (2) Methods: The T670I mutation in c-Kit, which confers imatinib resistance, was engineered into the mouse genome and bred onto the NOD background. Hematopoietic stem cells (HSCs) from NOD.c-Kit(T670I) mice and NOD.c-Kit(wt) littermates were expanded in the presence or absence of imatinib to verify imatinib resistance of the c-Kit(T670I) allele. Diabetic mice were treated with imatinib at the onset of hyperglycemia for three weeks, and blood glucose was monitored. (3) Results: In vitro expansion of HSCs from NOD.c-Kit(wt) mice was sensitive to imatinib, while expansion of HSCs from NOD.c-Kit(T670I) mice was insensitive to imatinib. However, in vivo treatment with imatinib lowered blood glucose levels in both strains of mice. (4) Conclusions/Interpretation: The HSC experiment confirmed that, in NOD.c-Kit(T670I) mice, c-Kit is resistant to imatinib. As both NOD.c-Kit(T670I) and NOD.c-Kit(wt) mice responded comparably to imatinib, c-Kit inhibition does not substantially contribute to the efficacy of imatinib in T1D. Thus, we conclude that inhibition of c-Kit is not required in next-generation tyrosine kinase inhibitors for T1D treatment, and may be selected against to improve the safety profile.	[Lau, Janet; Herman, Ann E.] Novartis Res Fdn, Genom Inst, JDRF Pharmacol, San Diego, CA USA; [Zhou, Qiang; Sutton, Susan E.; Schmedt, Christian; Glynne, Richard] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Novartis; Novartis	Glynne, R (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.	rglynne@gnf.org			Novartis Research Foundation; Novartis Institute of Biomedical Research (NIBR); Genomics Institute of the Novartis Research Foundation (GNF); Juvenile Diabetes Research Foundation (JDRF)	Novartis Research Foundation; Novartis Institute of Biomedical Research (NIBR); Genomics Institute of the Novartis Research Foundation (GNF); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation)	Funding for this work was provided by the Novartis Research Foundation and the Novartis Institute of Biomedical Research (NIBR). J. Lau was supported as a postdoctoral fellow by an agreement between the Genomics Institute of the Novartis Research Foundation (GNF) and the Juvenile Diabetes Research Foundation (JDRF). The funders had no role in the study design, data collection and analysis, or preparation of the manuscript. Legal approval for publication before submission was obtained from GNF and NIBR.	Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; BERNSTEIN A, 1990, CIBA F SYMP, V148, P158; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Gitelman SE BJ, 2013, IMATINIB TREATMENT R; Hagerkvist R, 2007, FASEB J, V21, P618, DOI 10.1096/fj.06-6910com; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Pricl S, 2005, MOL CANCER THER, V4, P1167, DOI 10.1158/1535-7163.MCT-05-0101; Suttorp M, 2010, HEMATOL-AM SOC HEMAT, P368, DOI 10.1182/asheducation-2010.1.368; Tamborini E, 2004, GASTROENTEROLOGY, V127, P294, DOI 10.1053/j.gastro.2004.02.021; Tamborini E, 2006, ONCOGENE, V25, P6140, DOI 10.1038/sj.onc.1209639; Tutone M, 2011, BIOINFORMATION, V7, P296; Vandyke K, 2010, BLOOD, V115, P766, DOI 10.1182/blood-2009-08-237404; Welsh N, 2012, EXPERT OPIN INV DRUG, V21, P1743, DOI 10.1517/13543784.2012.724398	15	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84900	10.1371/journal.pone.0084900	http://dx.doi.org/10.1371/journal.pone.0084900			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454763	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100041
J	Li, LJ; Zeng, H; Ou, B; Luo, BM; Xiao, XY; Zhong, WJ; Zhao, XB; Zhao, ZZ; Yang, HY; Zhi, H				Li, Lu-Jing; Zeng, Hong; Ou, Bing; Luo, Bao-Ming; Xiao, Xiao-Yun; Zhong, Wen-Jing; Zhao, Xin-Bao; Zhao, Zi-Zhuo; Yang, Hai-Yun; Zhi, Hui			Ultrasonic Elastography Features of Phyllodes Tumors of the Breast: A Clinical Research	PLOS ONE			English	Article							MAMMOGRAPHY; LESIONS; FIBROADENOMAS; ASPIRATION; PHYLLOIDES; DIAGNOSIS; MASSES	The purpose of this study was to analyze the ultrasonic elastography features of phyllodes tumors of the breast comparing with fibroadenomas. A retrospective database was queried for the patients diagnosed as phyllodes tumors and fibroadenomas at Sun Yat-sen Memorial Hospital from January 2008 to August 2012. Three hundred and fifty lesions from 323 consecutive patients were included in the study. All the cases were examined by conventional ultrasonography and ultrasound elastography. Ultrasound elastography was used to calculate strain ratio of the lesions with bilateral breast tissue at the same depth as reference. There were 36 phyllodes tumors (27 benign, 8 borderline, 1 malignant) and 314 fibroadenomas (158 the pericanalicular type, 103 the intracanalicular type, 53 other special types). The strain ratio for phyllodes tumors (3.19 +/- 2.33) was significantly higher than for fibroadenomas (1.69 +/- 0.88) (p < 0.05). The Spearmans correlation coefficient between strain ratio of ultrasound elastography and pathological groups was significant, with a value of 0.17 (p < 0.05). Ultrasound elastography could provide additional information to differentiate phyllodes tumors from fibroadenoma in breast.	[Li, Lu-Jing; Ou, Bing; Luo, Bao-Ming; Xiao, Xiao-Yun; Zhong, Wen-Jing; Zhao, Xin-Bao; Zhao, Zi-Zhuo; Yang, Hai-Yun; Zhi, Hui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Hong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Ou, B (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ultrasound, Guangzhou 510275, Guangdong, Peoples R China.	oubing77@163.com.cn; kendy181hui@yahoo.com.cn	Li, Lujing/AAW-3653-2020					Adamietz BR, 2011, ULTRASCHALL MED, V32, P67, DOI 10.1055/s-0031-1282024; ALAGARATNAM TT, 1985, CLIN RADIOL, V36, P175, DOI 10.1016/S0009-9260(85)80104-5; Blanco AJ, 1999, EUR RADIOL, V9, P356, DOI 10.1007/s003300050680; BUCHBERGER W, 1991, AM J ROENTGENOL, V157, P715, DOI 10.2214/ajr.157.4.1654022; Chao TC, 2003, EUR RADIOL, V13, P88, DOI 10.1007/s00330-002-1370-x; COLEBEUGLET C, 1983, RADIOLOGY, V146, P481, DOI 10.1148/radiology.146.2.6294737; COSMACINI P, 1992, EUR J RADIOL, V15, P11, DOI 10.1016/0720-048X(92)90194-E; FAJARDO LL, 1988, INVEST RADIOL, V23, P505, DOI 10.1097/00004424-198807000-00004; Farria DM, 1996, AM J ROENTGENOL, V167, P187, DOI 10.2214/ajr.167.1.8659370; Feder JM, 1999, RADIOGRAPHICS, V19, pS11, DOI 10.1148/radiographics.19.suppl_1.g99oc07s11; Goel NB, 2005, RADIOGRAPHICS, V25, P1547, DOI 10.1148/rg.256045183; Hoyt K, 2006, PHYS MED BIOL, V51, P197, DOI 10.1088/0031-9155/51/2/001; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; JACKSON VP, 1993, RADIOLOGY, V188, P297, DOI 10.1148/radiology.188.2.8327668; Jacobs TW, 2005, AM J CLIN PATHOL, V124, P342, DOI 10.1309/5N2C4N5XCV8XW8JL; Jung YS, 2005, J PAEDIATR CHILD H, V41, P78, DOI 10.1111/j.1440-1754.2005.00545.x; Kaufman CS, 2002, AM J SURG, V184, P394, DOI 10.1016/S0002-9610(02)01010-3; Kinoshita Takayuki, 2004, Breast J, V10, P232, DOI 10.1111/j.1075-122X.2004.21316.x; MA L, 1992, J NATL CANCER I, V84, P781, DOI 10.1093/jnci/84.10.781; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Pacinda SJ, 1998, J ADOLESCENT HEALTH, V23, P3, DOI 10.1016/S1054-139X(97)00271-1; PAGE JE, 1991, CLIN RADIOL, V44, P8, DOI 10.1016/S0009-9260(05)80217-X; ROWELL MD, 1993, AM J SURG, V165, P376, DOI 10.1016/S0002-9610(05)80849-9; Tan HN, 2012, EUR J RADIOL, V81, pE62, DOI 10.1016/j.ejrad.2011.01.085; Wurdinger S, 2005, AM J ROENTGENOL, V185, P1317, DOI 10.2214/AJR.04.1620; Yang WT, 1996, J ULTRAS MED, V15, P637; Zhi H, 2008, ACAD RADIOL, V15, P1347, DOI 10.1016/j.acra.2008.08.003; Zhi H, 2010, ACAD RADIOL, V17, P1227, DOI 10.1016/j.acra.2010.05.004; Zissis C, 1998, BREAST CANCER RES TR, V48, P205, DOI 10.1023/A:1005980831359	29	12	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85257	10.1371/journal.pone.0085257	http://dx.doi.org/10.1371/journal.pone.0085257			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454830	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100067
J	Mussen, TD; Cocherell, D; Poletto, JB; Reardon, JS; Hockett, Z; Ercan, A; Bandeh, H; Kavvas, ML; Cech, JJ; Fangue, NA				Mussen, Timothy D.; Cocherell, Dennis; Poletto, Jamilynn B.; Reardon, Jon S.; Hockett, Zachary; Ercan, Ali; Bandeh, Hossein; Kavvas, M. Levent; Cech, Joseph J., Jr.; Fangue, Nann A.			Unscreened Water-Diversion Pipes Pose an Entrainment Risk to the Threatened Green Sturgeon, Acipenser medirostris	PLOS ONE			English	Article							PACIFIC SALMONID SMOLTS; ACCELERATING FLOW; FISH PASSAGE; LATERAL-LINE; BEHAVIOR; RIVER; STIMULI; LIGHT; SIZE	Over 3,300 unscreened agricultural water diversion pipes line the levees and riverbanks of the Sacramento River (California) watershed, where the threatened Southern Distinct Population Segment of green sturgeon, Acipenser medirostris, spawn. The number of sturgeon drawn into (entrained) and killed by these pipes is greatly unknown. We examined avoidance behaviors and entrainment susceptibility of juvenile green sturgeon (35 +/- 0.6 cm mean fork length) to entrainment in a large (>500-kl) outdoor flume with a 0.46-m-diameter water-diversion pipe. Fish entrainment was generally high (range: 26-61%), likely due to a lack of avoidance behavior prior to entering inescapable inflow conditions. We estimated that up to 52% of green sturgeon could be entrained after passing within 1.5 m of an active water-diversion pipe three times. These data suggest that green sturgeon are vulnerable to unscreened water-diversion pipes, and that additional research is needed to determine the potential impacts of entrainment mortality on declining sturgeon populations. Data under various hydraulic conditions also suggest that entrainment-related mortality could be decreased by extracting water at lower diversion rates over longer periods of time, balancing agricultural needs with green sturgeon conservation.	[Mussen, Timothy D.; Cocherell, Dennis; Poletto, Jamilynn B.; Reardon, Jon S.; Cech, Joseph J., Jr.; Fangue, Nann A.] Univ Calif Davis, Wildlife Fish & Conservat Biol Dept, Davis, CA 95616 USA; [Hockett, Zachary; Ercan, Ali; Bandeh, Hossein; Kavvas, M. Levent] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Fangue, NA (corresponding author), Univ Calif Davis, Wildlife Fish & Conservat Biol Dept, Davis, CA 95616 USA.	nafangue@ucdavis.edu	Ercan, Ali/AAI-2418-2021	Ercan, Ali/0000-0003-1052-4302; Poletto, Jamilynn/0000-0002-5779-8709	California Department of Fish and Wildlife's Ecosystem Restoration Program [E0783004]; University of California Agricultural Experiment Station [2098-H]; U.S. Department of Interior's Anadromous Fish Screen Program; National Science Foundation (NSF)	California Department of Fish and Wildlife's Ecosystem Restoration Program; University of California Agricultural Experiment Station(University of California System); U.S. Department of Interior's Anadromous Fish Screen Program; National Science Foundation (NSF)(National Science Foundation (NSF))	The authors thank the California Department of Fish and Wildlife's Ecosystem Restoration Program (Agreement # E0783004 to NAF and JJC) and the University of California Agricultural Experiment Station (grant no. 2098-H to NAF) for providing funding. This research indirectly benefited from funding from the U.S. Department of Interior's Anadromous Fish Screen Program. JBP was supported through a National Science Foundation (NSF) Graduate Student Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PB, 2007, ENVIRON BIOL FISH, V79, P339, DOI 10.1007/s10641-006-9062-z; Allen PJ, 2007, ENVIRON BIOL FISH, V79, P211, DOI 10.1007/s10641-006-9049-9; Allen PJ, 2009, T AM FISH SOC, V138, P240, DOI 10.1577/T08-061.1; [Anonymous], 2006, JWATCHER 1 0 INTRO U; BAINBRIDGE R, 1958, J EXP BIOL, V35, P109; Beamesderfer RCP, 1997, ENVIRON BIOL FISH, V48, P407, DOI 10.1023/A:1007310916515; Birstein VJ, 1997, ENVIRON BIOL FISH, V48, P427, DOI 10.1023/A:1007382724251; Bowen M., 2004, INVENTORY BARRIERS F; Castro-Santos T, 2012, TELEMETRY TECHNIQUES: A USER GUIDE FOR FISHERIES RESEARCH, P427; Enders EC, 2009, CAN J FISH AQUAT SCI, V66, P2109, DOI 10.1139/F09-141; Gessner J, 1997, ENVIRON BIOL FISH, V79, P397; Gibbs MA, 2004, BRAIN BEHAV EVOLUT, V64, P70, DOI 10.1159/000079117; GLASS CW, 1995, FISH RES, V23, P165, DOI 10.1016/0165-7836(94)00331-P; Haro A, 1998, T AM FISH SOC, V127, P118, DOI 10.1577/1548-8659(1998)127<0118:EOWAOD>2.0.CO;2; Herren JR, 1997, FISH B, V2, P343; Heublein JC, 2009, ENVIRON BIOL FISH, V84, P245, DOI 10.1007/s10641-008-9432-9; Israel JA, 2010, MOL ECOL, V19, P1058, DOI 10.1111/j.1365-294X.2010.04533.x; IUCN, 2022, IUCN RED LIST THREAT; Kemp PS, 2005, J FISH BIOL, V67, P1381, DOI 10.1111/j.0022-1112.2005.00833.x; Kemp PS, 2005, T AM FISH SOC, V134, P390, DOI 10.1577/T04-039.1; Kemp PS, 2006, RIVER RES APPL, V22, P429, DOI 10.1002/rra.913; Kynard B, 2005, ENVIRON BIOL FISH, V72, P85, DOI 10.1007/s10641-004-6584-0; Meier D, 2013, COMMUNICATION; Moyle PB, 2005, FISHERIES, V30, P20, DOI 10.1577/1548-8446(2005)30[20:UA]2.0.CO;2; Mussen TD, 2013, T AM FISH SOC, V142, P130, DOI 10.1080/00028487.2012.720633; Nobriga ML, 2004, AM FISH S S, V39, P281; Rasband W., 2006, IMAGEJ; Turnpenny A. W. H., 1998, UK GUIDE INTAKE FISH; Van Eenennaam JP, 2012, J APPL ICHTHYOL, V28, P505, DOI 10.1111/j.1439-0426.2012.02012.x; Van Eenennaam JP, 2001, T AM FISH SOC, V130, P159, DOI 10.1577/1548-8659(2001)130&lt;0159:ASALRO&gt;2.0.CO;2; Vogel D, 2011, INSIGHTS PROBLEMS PR; Vowles AS, 2012, ECOL ENG, V47, P247, DOI 10.1016/j.ecoleng.2012.06.021; Xin D, 2002, AM FISH S S, V28, P237	34	26	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86321	10.1371/journal.pone.0086321	http://dx.doi.org/10.1371/journal.pone.0086321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454967	Green Published, gold			2022-12-25	WOS:000330235100152
J	Seif, M; Impelido, ML; Apps, MG; Wheate, NJ				Seif, Marian; Impelido, Michael L.; Apps, Michael G.; Wheate, Nial J.			Topical Cream-Based Dosage Forms of the Macrocyclic Drug Delivery Vehicle Cucurbit[6]uril	PLOS ONE			English	Article							PERCUTANEOUS-ABSORPTION; DRIVING-FORCE; COMPLEXES; ENCAPSULATION; CYTOTOXICITY; RECOGNITION; PERMEATION; PEPTIDES; ENHANCE; WATER	The macrocycle family of molecules called cucurbit[n] urils are potential drug delivery vehicles as they are able to form host-guest complexes with many different classes of drugs. This study aimed to examine the utility of cucurbit[6] uril (CB[6]) in topical cream-based formulations for either localised treatment or for transdermal delivery. Cucurbit[6] uril was formulated into both buffered cream aqueous-and oily cream-based dosage forms. The solid state interaction of CB[6] with other excipients was studied by differential scanning calorimetry and the macrocycle's transdermal permeability was determined using rat skin. Significant solid state interactions were observed between CB[6] and the other dosage form excipients. At concentrations up to 32% w/w the buffered aqueous cream maintained its normal consistency and could be effectively applied to skin, but the oily cream was too stiff and is not suitable as a dosage form. Cucurbit[6] uril does not permeate through skin; as such, the results imply that cucurbituril-based topical creams may potentially only have applications for localised skin treatment and not for transdermal drug delivery.	[Seif, Marian; Impelido, Michael L.; Apps, Michael G.; Wheate, Nial J.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	University of Sydney	Wheate, NJ (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	nial.wheate@sydney.edu.au	Wheate, Nial/A-9990-2008	Wheate, Nial/0000-0002-0505-1363				[Anonymous], [No title captured]; Appel EA, 2012, CHEM COMMUN, V48, P9843, DOI 10.1039/c2cc35131e; Bhasikuttan AC, 2011, CHEM COMMUN, V47, P9959, DOI 10.1039/c1cc12091c; Biedermann F, 2012, J AM CHEM SOC, V134, P15318, DOI 10.1021/ja303309e; Biedermann F, 2010, CHEM-EUR J, V16, P13716, DOI 10.1002/chem.201002274; Cheng XJ, 2013, ANGEW CHEM INT EDIT, V52, P7252, DOI 10.1002/anie.201210267; Fan ZF, 2011, J INCL PHENOM MACRO, V71, P577, DOI 10.1007/s10847-011-9981-y; Ghosh I, 2012, ADV DRUG DELIVER REV, V64, P764, DOI 10.1016/j.addr.2012.01.015; Gupta VK, 1999, PHARMACEUT RES, V16, P1602, DOI 10.1023/A:1018916907263; Hettiarachchi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010514; Isaacs L, 2009, CHEM COMMUN, P619, DOI 10.1039/b814897j; Koner AL, 2011, CAN J CHEM, V89, P139, DOI 10.1139/V10-079; Krause-Heuer AM, 2009, J MED CHEM, V52, P5474, DOI 10.1021/jm9007104; Lagona J, 2005, ANGEW CHEM INT EDIT, V44, P4844, DOI 10.1002/anie.200460675; Li N, 2010, INT J PHARMACEUT, V387, P167, DOI 10.1016/j.ijpharm.2009.12.025; Liu H, 2011, J INCL PHENOM MACRO, V71, P583, DOI 10.1007/s10847-011-9982-x; Macartney DH, 2011, ISR J CHEM, V51, P600, DOI 10.1002/ijch.201100040; Masson E, 2012, RSC ADV, V2, P1213, DOI 10.1039/c1ra00768h; McInnes FJ, 2010, ORG BIOMOL CHEM, V8, P765, DOI 10.1039/b918372h; Montes-Navajas P, 2009, PHOTOCH PHOTOBIO SCI, V8, P1743, DOI 10.1039/b9pp00041k; Nau WM, 2011, ISR J CHEM, V51, P559, DOI 10.1002/ijch.201100044; Carvalho CP, 2011, CHEM COMMUN, V47, P8793, DOI 10.1039/c1cc12954f; Patel MR, 2011, PHARM DEV TECHNOL, V16, P250, DOI 10.3109/10837451003610845; Plumb JA, 2012, METALLOMICS, V4, P561, DOI 10.1039/c2mt20054f; Rastogi SC, 2000, CONTACT DERMATITIS, V43, P339, DOI 10.1034/j.1600-0536.2000.043006339.x; Reczek JJ, 2009, J AM CHEM SOC, V131, P2408, DOI 10.1021/ja808936y; Saleh N, 2013, J INCL PHENOM MACRO, DOI [10.1007/s10847-10013-10352-10848, DOI 10.1007/S10847-10013-10352-10848]; Saleh N, 2011, SUPRAMOL CHEM, V23, P654, DOI 10.1080/10610278.2011.593631; Sansom LN, 2012, AUSTR PHARM FORMULAR; Silva SMC, 2012, EUR J PHARM BIOPHARM, V80, P663, DOI 10.1016/j.ejpb.2011.11.010; Talukder R, 2011, AAPS PHARMSCITECH, V12, P1227, DOI 10.1208/s12249-011-9697-8; Urbach AR, 2011, ISR J CHEM, V51, P664, DOI 10.1002/ijch.201100035; Uzunova VD, 2010, ORG BIOMOL CHEM, V8, P2037, DOI 10.1039/b925555a; Walker S, 2011, ISR J CHEM, V51, P616, DOI 10.1002/ijch.201100033; Walker S, 2010, MOL PHARMACEUT, V7, P2166, DOI 10.1021/mp100191b; Wang RB, 2008, ORG BIOMOL CHEM, V6, P1955, DOI 10.1039/b801591k; Wang RB, 2009, DALTON T, P3584, DOI 10.1039/b904028e; Wheate NJ, 2008, J INORG BIOCHEM, V102, P2060, DOI 10.1016/j.jinorgbio.2008.06.005; Williams AC, 2003, TRANSDERMAL TOPICAL; Wyman IW, 2010, ORG BIOMOL CHEM, V8, P247, DOI 10.1039/b915694a; Yamada K, 2011, J OLEO SCI, V60, P31, DOI 10.5650/jos.60.31; Zhao YJ, 2010, ORG BIOMOL CHEM, V8, P3328, DOI 10.1039/c003732j; Zhao YJ, 2008, ORG BIOMOL CHEM, V6, P4509, DOI 10.1039/b813759e; Zhou YY, 2009, MICROCHIM ACTA, V164, P63, DOI 10.1007/s00604-008-0032-3	44	9	9	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85361	10.1371/journal.pone.0085361	http://dx.doi.org/10.1371/journal.pone.0085361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454850	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100074
J	Wang, L; Qian, L				Wang, Li; Qian, Li			miR-24 Regulates Intrinsic Apoptosis Pathway in Mouse Cardiomyocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CARDIAC MYOCYTE APOPTOSIS; BAX TRANSLOCATION; CELL-DEATH; HEART-FAILURE; MICRORNA; BCL-2; RECOGNITION; DISEASES; TARGET	Numerous cardiac diseases, including myocardial infarction (MI) and chronic heart failure, have been associated with cardiomyocyte apoptosis. Promoting cell survival by inhibiting apoptosis is one of the effective strategies to attenuate cardiac dysfunction caused by cardiomyocyte loss. miR-24 has been shown as an anti-apoptotic microRNA in various animal models. In vivo delivery of miR-24 into a mouse MI model suppressed cardiac cell death, attenuated infarct size, and rescued cardiac dysfunction. However, the molecular pathway by which miR-24 inhibits cardiomyocyte apoptosis is not known. Here we found that miR-24 negatively regulates mouse primary cadiomyocyte cell death through functioning in the intrinsic apoptotic pathways. In ER-mediated intrinsic pathway, miR-24 genetically interacts with the CEBP homologous gene CHOP as knocking down of CHOP partially attenuated the induced apoptosis by miR-24 inhibition. In mitochondria-involved intrinsic pathway, miR-24 inhibits the initiation of apoptosis through suppression of Cytochrome C release and Bax translocation from cytosol to mitochondria. These results provide mechanistic insights into the miR-24 mediated antiapoptotic effects in murine cardiomyocytes.	[Wang, Li; Qian, Li] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA; [Wang, Li; Qian, Li] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Qian, L (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA.	li_qian@med.unc.edu	wang, li/O-1425-2015	wang, li/0000-0001-8927-6772	UNC-Chapel Hill	UNC-Chapel Hill	This work was supported by the start-up funds to the Qian Lab from UNC-Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bedner E, 2000, CYTOMETRY, V41, P83, DOI 10.1002/1097-0320(20001001)41:2<83::AID-CYTO1>3.0.CO;2-R; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; Gao CF, 2001, EXP CELL RES, V265, P145; Gustafsson AB, 2007, AM J PHYSIOL-CELL PH, V292, pC45, DOI 10.1152/ajpcell.00229.2006; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hu SJ, 2011, CIRCULATION, V124, pS27, DOI 10.1161/CIRCULATIONAHA.111.017954; Jia L, 2001, ONCOGENE, V20, P4817, DOI 10.1038/sj.onc.1204628; Kang PM, 2000, CIRC RES, V87, P118, DOI 10.1161/01.RES.87.2.118; Kang PM, 2003, TRENDS MOL MED, V9, P177, DOI 10.1016/S1471-4914(03)00025-X; Kang PM, 2002, CIRC J, V66, P1, DOI 10.1253/circj.66.1; Kitsis RN, 2008, HEART FAIL REV, V13, P107, DOI 10.1007/s10741-008-9080-3; Kitsis RN, 2007, NAT MED, V13, P539, DOI 10.1038/nm0507-539; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Mathur A, 2004, LANCET, V364, P183, DOI 10.1016/S0140-6736(04)16632-4; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Shore GC, 2008, CELL, V135, P1004, DOI 10.1016/j.cell.2008.11.029; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Toth Ambrus, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P205, DOI 10.2174/187152907781745260; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Walker JC, 2009, GENE DEV, V23, P1046, DOI 10.1101/gad.1777709; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	41	26	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85389	10.1371/journal.pone.0085389	http://dx.doi.org/10.1371/journal.pone.0085389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454859	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100080
J	Zhang, XM; Zajac, AL; Huang, LY; Behlke, MA; Tsourkas, A				Zhang, Xuemei; Zajac, Allison L.; Huang, Lingyan; Behlke, Mark A.; Tsourkas, Andrew			Imaging the Directed Transport of Single Engineered RNA Transcripts in Real-Time Using Ratiometric Bimolecular Beacons	PLOS ONE			English	Article							BICOID MESSENGER-RNA; MOLECULAR BEACONS; LIVING CELLS; LOCALIZATION; DYNAMICS; MECHANISM; REVEALS; VISUALIZATION; EXPRESSION; PARTICLES	The relationship between RNA expression and cell function can often be difficult to decipher due to the presence of both temporal and sub-cellular processing of RNA. These intricacies of RNA regulation can often be overlooked when only acquiring global measurements of RNA expression. This has led to development of several tools that allow for the real-time imaging of individual engineered RNA transcripts in living cells. Here, we describe a new technique that utilizes an oligonucleotide-based probe, ratiometric bimolecular beacon (RBMB), to image RNA transcripts that were engineered to contain 96-tandem repeats of the RBMB target sequence in the 3'-untranslated region. Binding of RBMBs to the target RNA resulted in discrete bright fluorescent spots, representing individual transcripts, that could be imaged in real-time. Since RBMBs are a synthetic probe, the use of photostable, bright, and red-shifted fluorophores led to a high signal-to-background. RNA motion was readily characterized by both mean squared displacement and moment scaling spectrum analyses. These analyses revealed clear examples of directed, Brownian, and subdiffusive movements.	[Zhang, Xuemei; Tsourkas, Andrew] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Zajac, Allison L.] Univ Penn, Philadelphia, PA 19104 USA; [Huang, Lingyan; Behlke, Mark A.] Integrated DNA Technol Inc, Coralville, IA USA	University of Pennsylvania; University of Pennsylvania	Tsourkas, A (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	atsourk@seas.upenn.edu	Tsourkas, Andrew/AAM-8252-2020	Tsourkas, Andrew/0000-0001-7758-1753; Behlke, Mark/0000-0002-4218-857X	National Science Foundation CAREER Award [0953583]; National Institute of Health [NCI/R21-CA116102, NCI/R21-CA125088, NIBIB/R01-EB012065, NCI/R01-CA157766]; NATIONAL CANCER INSTITUTE [R01CA157766, R21CA116102, R21CA125088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012065] Funding Source: NIH RePORTER; Directorate For Engineering [0953583] Funding Source: National Science Foundation	National Science Foundation CAREER Award(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Science Foundation CAREER Award (0953583) and the National Institute of Health NCI/R21-CA116102, NCI/R21-CA125088, NIBIB/R01-EB012065, NCI/R01-CA157766. The funding agencies that supported this work had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bratu DP, 2003, P NATL ACAD SCI USA, V100, P13308, DOI 10.1073/pnas.2233244100; Cha BJ, 2001, CELL, V106, P35, DOI 10.1016/S0092-8674(01)00419-6; Chen AK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm593; Chen AK, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq436; Chen AK, 2009, J INNOV OPT HEAL SCI, V2, P315, DOI 10.1142/S179354580900070X; Chen AK, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp837; Chen AK, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn331; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Daigle N, 2007, NAT METHODS, V4, P633, DOI 10.1038/NMETH1065; Dictenberg J, 2012, TRENDS BIOTECHNOL, V30, P621, DOI 10.1016/j.tibtech.2012.09.004; Drake TJ, 2005, CHEMBIOCHEM, V6, P2041, DOI 10.1002/cbic.200500046; Dynes JL, 2007, J COMP NEUROL, V500, P433, DOI 10.1002/cne.21189; Ewers H, 2005, P NATL ACAD SCI USA, V102, P15110, DOI 10.1073/pnas.0504407102; Ferrari R, 2001, PHYSICA D, V154, P111, DOI 10.1016/S0167-2789(01)00234-2; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Grunwald D, 2011, NATURE, V475, P333, DOI 10.1038/nature10318; Ishihama Y, 2009, BIOCHEM BIOPH RES CO, V381, P33, DOI 10.1016/j.bbrc.2009.02.001; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Kang WM, 2013, NANO LETT, V13, P2448, DOI 10.1021/nl400423c; Mhlanga MM, 2005, NUCLEIC ACIDS RES, V33, P1902, DOI 10.1093/nar/gki302; Molenaar C, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e89; Nitin N, 2008, BIOCONJUGATE CHEM, V19, P2205, DOI 10.1021/bc800322a; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; Rhee WJ, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-30; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Santangelo PJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh062; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shan JG, 2003, J NEUROSCI, V23, P8859; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Tadakuma H, 2006, BIOCHEM BIOPH RES CO, V344, P772, DOI 10.1016/j.bbrc.2006.03.202; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Tyagi S, 2009, NAT METHODS, V6, P331, DOI [10.1038/NMETH.1321, 10.1038/nmeth.1321]; van den Bogaard Patrick T. C., 2008, V464, P91; Vargas DY, 2005, P NATL ACAD SCI USA, V102, P17008, DOI 10.1073/pnas.0505580102; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Xia T, 2013, ANNU REV PHYS CHEM, V64, P459, DOI 10.1146/annurev-physchem-040412-110127; Yamagishi M, 2009, EXP CELL RES, V315, P1142, DOI 10.1016/j.yexcr.2009.02.009; Zhang XM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt561; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	43	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85813	10.1371/journal.pone.0085813	http://dx.doi.org/10.1371/journal.pone.0085813			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454933	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100134
J	Mendo, T; Lyle, JM; Moltschaniwskyj, NA; Tracey, SR; Semmens, JM				Mendo, Tania; Lyle, Jeremy M.; Moltschaniwskyj, Natalie A.; Tracey, Sean R.; Semmens, Jayson M.			Habitat Characteristics Predicting Distribution and Abundance Patterns of Scallops in D'Entrecasteaux Channel, Tasmania	PLOS ONE			English	Article							DENSITY-DEPENDENT PREDATION; PLACOPECTEN-MAGELLANICUS; SETTLEMENT; SURVIVAL; CRABS; SEA; BAY; RECRUITMENT; SUBSTRATE; GROUNDS	Habitat characteristics greatly influence the patterns of distribution and abundance in scallops, providing structure for the settlement of spat and influencing predation risk and rates of survival. Establishing scallop-habitat relationships is relevant to understanding the ecological processes that regulate scallop populations and to managing critical habitats. This information is particularly relevant for the D'Entrecasteaux Channel, south-eastern Tasmania (147.335 W, 43.220 S), a region that has supported significant but highly variable scallop production over many years, including protracted periods of stock collapse. Three species of scallops are present in the region; the commercial scallop Pecten fumatus, the queen scallop Equichlamys bifrons, and the doughboy scallop Mimachlamys asperrima. We used dive surveys and Generalized Additive Modelling to examine the relationship between the distribution and abundance patterns of each species and associated habitat characteristics. The aggregated distribution of each species could be predicted as a function of sediment type and species-specific habitat structural components. While P. fumatus was strongly associated with finer sediments and E. bifrons with coarse grain sediments, M. asperrima had a less selective association, possibly related to its ability to attach on a wide range of substrates. Other habitat characteristics explaining P. fumatus abundance were depth, Asterias amurensis abundance, shell and macroalgae cover. Equichlamys bifrons was strongly associated with macroalgae and seagrass cover, whereas M. asperrima abundance was greatly explained by sponge cover. The models define a set of relationships from which plausible hypotheses can be developed. We propose that these relationships are mediated by predation pressure as well as the specific behavioural characteristics of each species. The findings also highlight the specific habitat characteristics that are relevant for spatial management and habitat restoration plans.	[Mendo, Tania; Lyle, Jeremy M.; Tracey, Sean R.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia	University of Tasmania; University of Newcastle	Mendo, T (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	taniamendow@yahoo.com	Lyle, Jeremy M/J-7170-2014; Moltschaniwskyj, Natalie/AAB-7236-2019; Mendo, Tania/AAH-7734-2020	Lyle, Jeremy M/0000-0001-9670-5854; Mendo, Tania/0000-0003-4397-2064; Semmens, Jayson/0000-0003-1742-6692; Moltschaniwskyj, Natalie/0000-0001-9709-9876	Fishwise Community Grants Scheme; Endeavour International Postgraduate Research Scholarship (EIPRS)	Fishwise Community Grants Scheme; Endeavour International Postgraduate Research Scholarship (EIPRS)(Australian Government)	This project was funded by the Fishwise Community Grants Scheme administered by the Department of Primary Industries, Parks, Water and Environment, Australia. The first author was supported by an Endeavour International Postgraduate Research Scholarship (EIPRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar M, 2000, J SHELLFISH RES, V19, P749; Andruskiw M, 2008, ECOLOGY, V89, P2273, DOI 10.1890/07-1428.1; [Anonymous], 2006, MATLAB VERS 7 2 0 23; Brand AR., 2006, DEV AQUAC FISH SCI, V35, P651, DOI [DOI 10.1016/S0167-9309(06)80039-6, 10.1016/S0167-9309(06)80039-6]; Bremec C, 2008, J SHELLFISH RES, V27, P273, DOI 10.2983/0730-8000(2008)27[273:PSSOSZ]2.0.CO;2; Byrne M, 1997, MAR BIOL, V127, P673, DOI 10.1007/s002270050058; Cantillanez M., 2000, REPROD VIE LARVAIRE; CHERNOFF H, 1987, J EXP MAR BIOL ECOL, V109, P155, DOI 10.1016/0022-0981(87)90013-X; Crawley MJ., 2007, R BOOK; Dalla Rosa L, 2012, CONT SHELF RES, V36, P89, DOI 10.1016/j.csr.2012.01.017; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; ECKMAN JE, 1989, J EXP MAR BIOL ECOL, V132, P123, DOI 10.1016/0022-0981(89)90219-0; EGGLESTON DB, 1995, ECOL MONOGR, V65, P193, DOI 10.2307/2937137; EGGLESTON DB, 1992, MAR ECOL PROG SER, V85, P55, DOI 10.3354/meps085055; Eleftheriou A., 2008, METHODS STUDY MARINE; Elliot JM, 1971, FRESHWATER BIOL ASS, V25; Fairbridge W. S., 1954, Australian Journal of Marine and Freshwater Research, V4, P1; Folk R.L., 1980, PETROLOGY SEDIMENTAR; Gatehouse JSI, 1971, PROCEDURES SEDIMENTO; HARVEY M, 1993, MAR ECOL PROG SER, V99, P283, DOI 10.3354/meps099283; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hatanaka M, 1958, TOHOKU J AGR RES, V9, P159; HECK KL, 1981, J EXP MAR BIOL ECOL, V53, P125, DOI 10.1016/0022-0981(81)90014-9; Hedger R, 2004, FISH RES, V70, P17, DOI 10.1016/j.fishres.2004.07.002; Herzfeld M, 2010, MAR FRESHWATER RES, V61, P568, DOI 10.1071/MF09134; HORTLE ME, 1987, AQUACULTURE, V66, P79, DOI 10.1016/0044-8486(87)90285-7; Howarth LM, 2011, MAR BIOL, V158, P1767, DOI 10.1007/s00227-011-1690-y; Hutson KS, 2005, MAR ECOL PROG SER, V298, P305, DOI 10.3354/meps298305; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Krebs CJ, 1994, ECOLOGY EXPT ANAL DI; LANGTON RW, 1990, J EXP MAR BIOL ECOL, V144, P157, DOI 10.1016/0022-0981(90)90026-9; Ling SD, 2012, J APPL ECOL, V49, P733, DOI 10.1111/j.1365-2664.2012.02133.x; LIPCIUS RN, 1986, ECOLOGY, V67, P1361, DOI 10.2307/1938692; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; MERRILL A S, 1976, Nautilus, V90, P54; Minchin D, 2003, AQUAT LIVING RESOUR, V16, P521, DOI 10.1016/j.aquliv.2003.07.004; MINCHIN D, 1992, J MAR BIOL ASSOC UK, V72, P807, DOI 10.1017/S0025315400060057; Minchinton TE, 1997, OECOLOGIA, V111, P45, DOI 10.1007/s004420050206; Moksnes PO, 2002, J EXP MAR BIOL ECOL, V271, P41, DOI 10.1016/S0022-0981(02)00041-2; MYERS JH, 1978, ENVIRON ENTOMOL, V7, P619, DOI 10.1093/ee/7.5.619; MYERS JP, 1980, CAN J ZOOL, V58, P1564, DOI 10.1139/z80-216; NOAA, 2013, GLOB SELF CONS HIER; OLSEN A. M., 1955, AUSTRALIAN JOUR MARINE AND FRESHWATER RES, V6, P392; Pacheco A, 2006, J EXP MAR BIOL ECOL, V333, P27, DOI 10.1016/j.jembe.2005.11.017; PERRIN R A, 1988, Papers and Proceedings of the Royal Society of Tasmania, V122, P179; PITCHER CR, 1987, J EXP MAR BIOL ECOL, V112, P233, DOI 10.1016/0022-0981(87)90071-2; POHLE DG, 1991, MAR ECOL PROG SER, V74, P47, DOI 10.3354/meps074047; R Development Core Team, 2010, R FDN R LANG ENV STA; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Seitz RD, 2001, ECOLOGY, V82, P2435, DOI 10.1890/0012-9658(2001)082[2435:DDPHVA]2.0.CO;2; STOKESBURY KDE, 1993, MAR ECOL PROG SER, V96, P159, DOI 10.3354/meps096159; SWARTZMAN G, 1995, CAN J FISH AQUAT SCI, V52, P369, DOI 10.1139/f95-039; SWEATMAN HPA, 1985, ECOL MONOGR, V55, P469, DOI 10.2307/2937132; Talman SG, 2004, MAR ECOL PROG SER, V269, P197, DOI 10.3354/meps269197; Tracey SR, 2011, FISHERIES MANAG ECOL, V18, P221, DOI 10.1111/j.1365-2400.2010.00775.x; TUPPER M, 1995, CAN J FISH AQUAT SCI, V52, P1834, DOI 10.1139/f95-176; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Wolf BM, 1997, J SHELLFISH RES, V16, P533; Wong MC, 2003, J EXP MAR BIOL ECOL, V287, P155, DOI 10.1016/S0022-0981(02)00551-8; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zacharin W, 1991, 42 MAR LAB DIV SEA F; Zacharin W. F, 1995, GROWTH REPROD RECRUI; Zacharin Will, 1994, Memoirs of the Queensland Museum, V36, P299; Zuur Alain F., 2009, P1	64	14	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85895	10.1371/journal.pone.0085895	http://dx.doi.org/10.1371/journal.pone.0085895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454945	Green Published, gold			2022-12-25	WOS:000329922500059
J	Tian, YW; Liu, YF; He, PC; Liu, F; Zhou, NC; Cheng, XY; Shi, LL; Zhu, HC; Zhao, J; Wang, Y; Zhang, M				Tian, Yuwang; Liu, Yanfeng; He, Pengcheng; Liu, Feng; Zhou, Naicen; Cheng, Xiaoyan; Shi, Lili; Zhu, Huachao; Zhao, Jing; Wang, Yuan; Zhang, Mei			Arsenic Sulfide Promotes Apoptosis in Retinoid Acid Resistant Human Acute Promyelocytic Leukemic NB4-R1 Cells through Downregulation of SET Protein	PLOS ONE			English	Article							PHOSPHATASE 2A; REALGAR NANOPARTICLES; TRIOXIDE; INHIBITOR; EXPRESSION; MANAGEMENT; FUSION; GROWTH; PP2A; ATRA	Tetra-arsenic tetra-sulfide (As4S4) is an arsenic compound with anti-tumor activity, especially in acute promyelocytic leukemia (APL) that are resistant to retinoic acid (RA). Although recent studies revealed that the therapeutic action of As4S4 is closely associated with the induction of cellular apoptosis, the exact molecular mechanism of action of As4S4 in RA-resistant APL remains to be clarified. In this study, we found that As4S4-induced apoptosis was accompanied by reduced mRNA and protein expression of SET gene in RA-resistant NB4-R1 cells. Moreover, RNAi knockdown of SET gene further promoted As4S4-induced apoptosis, while SET over-expression inhibited it, suggesting that As4S4 induces apoptosis through the reduction of SET protein in NB4-R1 cells. We also demonstrated that the knockdown of SET gene resulted in the upregulation of protein phosphatase 2 (PP2A) expression and the downregulation of promyelocytic leukemia and retinoic acid receptor alpha fusion gene (PML-RAR alpha) expression, which were enhanced by As4S4 treatments. By contrast, over-expression of SET gene resulted in PP2A downregulation and PML-RAR alpha upregulation, which were abolished by As4S4 pretreatment. Since PP2A is a pro-apoptotic factor and PMLRAR alpha is an anti-apoptotic factor, our results suggest that As4S4-induced apoptosis in NB4-R1 cells is through the downregulation of SET protein expression, which in turn increases PP2A and reduces PML-RAR alpha expressions to lead to cell apoptosis.	[Tian, Yuwang] Beijing Mil Area PLA, Gen Hosp, Dept Pathol, Beijing, Peoples R China; [Liu, Yanfeng; He, Pengcheng; Liu, Feng; Zhou, Naicen; Cheng, Xiaoyan; Shi, Lili; Zhu, Huachao; Zhao, Jing; Wang, Yuan; Zhang, Mei] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	He, PC (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Xian, Shaanxi, Peoples R China.	hepc@163.com; meizhang102@gmail.com			Natural Science Foundation of China [81000218]; Fundamental Research Funds for the Central Universities; Shaanxi Province Science, and Technology Development Fund, China [2010K01-135, 2012KTCL03-12]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shaanxi Province Science, and Technology Development Fund, China	This study was supported by the Natural Science Foundation of China (81000218), the Fundamental Research Funds for the Central Universities, the Shaanxi Province Science, and Technology Development Fund, China (nos. 2010K01-135 and 2012KTCL03-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HT, 1997, J BIOL CHEM, V272, P28407, DOI 10.1074/jbc.272.45.28407; Balaz P, 2010, TOXINS, V2, P1568, DOI 10.3390/toxins2061568; Breccia M, 2012, EXPERT OPIN PHARMACO, V13, P1031, DOI 10.1517/14656566.2012.677436; Carlson SG, 1998, J AM SOC NEPHROL, V9, P1873; Cervoni N, 2002, J BIOL CHEM, V277, P25026, DOI 10.1074/jbc.M202256200; Chen GQ, 1996, BLOOD, V88, P1052; Cristobal I, 2012, HAEMATOL-HEMATOL J, V97, P543, DOI 10.3324/haematol.2011.050542; CUNNINGHAM I, 1989, BLOOD, V73, P1116; Degos L, 2001, ONCOGENE, V20, P7140, DOI 10.1038/sj.onc.1204763; Falanga A, 2003, BEST PRACT RES CL HA, V16, P463, DOI 10.1016/S1521-6926(03)00059-8; FORNEROD M, 1995, ONCOGENE, V10, P1739; Hoffman E, 2010, POSTEP HIG MED DOSW, V64, P284; Holmes D, 2012, CASE REP ONCOL MED, V2012, DOI 10.1155/2012/313057; Irie A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051242; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2012, CURR MOL MED, V12, P268, DOI 10.2174/156652412799218930; Kamimura T, 2011, CANCER SCI, V102, P1929, DOI 10.1111/j.1349-7006.2011.02045.x; Kogan SC, 2009, CANCER CELL, V15, P7, DOI 10.1016/j.ccr.2008.12.012; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Lin Quan-de, 2007, Zhonghua Xue Ye Xue Za Zhi, V28, P19; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Lu DP, 2002, BLOOD, V99, P3136, DOI 10.1182/blood.V99.9.3136; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; Mathews V, 2006, BLOOD, V107, P2627, DOI 10.1182/blood-2005-08-3532; Mathews V, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.056; Mattson JC, 2000, CLIN LAB MED, V20, P83; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Ouellet V, 2006, INT J CANCER, V119, P2119, DOI 10.1002/ijc.22054; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Qi J, 2010, LEUKEMIA RES, V34, P1506, DOI 10.1016/j.leukres.2010.03.038; Ravandi F, 2009, J CLIN ONCOL, V27, P504, DOI 10.1200/JCO.2008.18.6130; Santa-Coloma TA, 2003, CEREBELLUM, V2, P310, DOI 10.1080/14734220310017212; Tallman MS, 2008, BEST PRACT RES CL HA, V21, P659, DOI 10.1016/j.beha.2008.09.002; Teng Zhi-ping, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P236; Tong Y, 2004, BLOOD, V104, P4219, DOI 10.1182/blood-2004-04-1433; Tse WP, 2009, INT J MOL MED, V24, P189, DOI 10.3892/ijmm_00000222; Wang Feng-rong, 2005, Zhonghua Nei Ke Za Zhi, V44, P730; Wang Jing-Zhi, 2003, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V11, P464; Wang XB, 2007, ARCH PHARM RES, V30, P653, DOI 10.1007/BF02977662; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Ye HQ, 2005, BIOL TRACE ELEM RES, V103, P117, DOI 10.1385/BTER:103:2:117; Zayed A, 2007, LEUKEMIA LYMPHOMA, V48, P489, DOI 10.1080/10428190601136163	42	4	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e83184	10.1371/journal.pone.0083184	http://dx.doi.org/10.1371/journal.pone.0083184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454695	Green Published, gold, Green Submitted			2022-12-25	WOS:000329922500003
J	Yang, GH; Liu, RR; Peng, P; Long, LL; Zhang, XH; Yang, WJ; Tan, SH; Pan, HF; Long, XJ; He, TG; Anderson, L; Lai, YR				Yang, Gaohui; Liu, Rongrong; Peng, Peng; Long, Liling; Zhang, Xinhua; Yang, Weijia; Tan, Shaohong; Pan, Hongfei; Long, Xingjiang; He, Taigang; Anderson, Lisa; Lai, Yongrong			How Early Can Myocardial Iron Overload Occur in Beta Thalassemia Major?	PLOS ONE			English	Article							MAGNETIC-RESONANCE; CARDIAC IRON; VENTRICULAR-FUNCTION; GLOBAL EPIDEMIOLOGY; TREATED PATIENTS; TRANSFUSION; COMPLICATIONS; DEFEROXAMINE; SURVIVAL; DEFERIPRONE	Background: Myocardial siderosis is the most common cause of death in patients with beta thalassemia major(TM). This study aimed at investigating the occurrence, prevalence and severity of cardiac iron overload in a young Chinese population with beta TM. Methods and Results: We analyzed T2* cardiac magnetic resonance (CMR), left ventricular ejection fraction (LVEF) and serum ferritin (SF) in 201 beta TM patients. The median age was 9 years old. Patients received an average of 13 units of blood per year. The median SF level was 4536 ng/ml and 165 patients (82.1%) had SF>2500 ng/ml. Myocardial iron overload was detected in 68 patients (33.8%) and severe myocardial iron overload was detected in 26 patients (12.6%). Twenty-two patients <= 10 years old had myocardial iron overload, three of whom were only 6 years old. No myocardial iron overload was detected under the age of 6 years. Median LVEF was 64% (measured by CMR in 175 patients). Five of 6 patients with a LVEF<56% and 8 of 10 patients with cardiac disease had myocardial iron overload. Conclusions: The TM patients under follow-up at this regional centre in China patients are younger than other reported cohorts, more poorly-chelated, and have a high burden of iron overload. Myocardial siderosis occurred in patients younger than previously reported, and was strongly associated with impaired LVEF and cardiac disease. For such poorly-chelated TM patients, our data shows that the first assessment of cardiac T2* should be performed as early as 6 years old.	[Yang, Gaohui; Liu, Rongrong; Lai, Yongrong] Guangxi Med Univ, Affiliated Hosp 1, Dept Hematol, Nanning, Peoples R China; [Peng, Peng; Long, Liling] Guangxi Med Univ, Affiliated Hosp 1, Dept Radiol, Nanning, Peoples R China; [Zhang, Xinhua] 303rd Hosp Peoples Liberat Army, Dept Hematol, Nanning, Peoples R China; [Yang, Weijia] Women & Children Hosp Guilin, Dept Pediat, Guilin, Peoples R China; [Tan, Shaohong] Women & Children Hosp Yulin, Dept Pediat, Yulin, Peoples R China; [Pan, Hongfei] Youjiang Med Univ Nationality, Affiliated Hosp, Dept Pediat, Baise, Peoples R China; [Long, Xingjiang] Peoples Hosp Liuzhou, Dept Pediat, Liuzhou, Peoples R China; [He, Taigang; Anderson, Lisa] St Georges Univ London, Cardiovasc Sci Res Ctr, London, England; [He, Taigang] Royal Brompton Hosp, Biomed Res Unit, London SW3 6LY, England	Guangxi Medical University; Guangxi Medical University; Youjiang Medical University for Nationalities; St Georges University London; Royal Brompton Hospital	Lai, YR (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Hematol, Nanning, Peoples R China.	laiyongrong@hotmail.com		Long, Liling/0000-0003-3369-8532	National Natural Science Foundations of China [30860307, 81160175]; Guangxi Natural Science Foundations [2011GXNSFD018033]; Wellcome Trust; Higher Education Funding for England (HEFCE); British Heart Foundation (BHF) [FS/08/26225]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundations; Wellcome Trust(Wellcome TrustEuropean Commission); Higher Education Funding for England (HEFCE); British Heart Foundation (BHF)(British Heart Foundation)	This work was supported by research grants from National Natural Science Foundations of China (Grant No. 30860307; No. 81160175) and Guangxi Natural Science Foundations (Grant No. 2011GXNSFD018033). Dr. He receives support from Wellcome Trust, and Higher Education Funding for England (HEFCE) and British Heart Foundation (BHF) (FS/08/26225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aessopos A, 2004, EUR J HAEMATOL, V73, P359, DOI 10.1111/j.1600-0609.2004.00304.x; ALDOURI MA, 1990, ACTA HAEMATOL-BASEL, V84, P113; Alpendurada F, 2010, EUR HEART J, V31, P1648, DOI 10.1093/eurheartj/ehq106; Anderson LJ, 2002, LANCET, V360, P516, DOI 10.1016/S0140-6736(02)09740-4; Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; Angastiniotis M, 1998, ANN NY ACAD SCI, V850, P251, DOI 10.1111/j.1749-6632.1998.tb10482.x; [Anonymous], 2008, GUIDELINES CLIN MANA, P86; [Anonymous], 2008, GUIDELINES CLIN MANA, P61; BAROSI G, 1989, EUR J HAEMATOL, V42, P382; Bejaoui M, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.002; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Brittenham GM, 2003, BLOOD, V101, P15, DOI 10.1182/blood-2002-06-1723; BRITTENHAM GM, 1994, NEW ENGL J MED, V331, P567, DOI 10.1056/NEJM199409013310902; Christianson A., 2006, GLOBAL REPORT BIRTH; Davis BA, 2004, BLOOD, V104, P263, DOI 10.1182/blood-2003-08-2841; ENGLE MA, 1964, CIRCULATION, V30, P698, DOI 10.1161/01.CIR.30.5.698; Fernandes JL, 2009, HAEMATOL-HEMATOL J, V94, P1776, DOI 10.3324/haematol.2009.013193; FITCHETT DH, 1980, CARDIOVASC RES, V14, P719, DOI 10.1093/cvr/14.12.719; He TG, 2013, J MAGN RESON IMAGING, V37, P479, DOI 10.1002/jmri.23780; Kirk P, 2009, CIRCULATION, V120, P1961, DOI 10.1161/CIRCULATIONAHA.109.874487; Kremastinos DT, 2001, AM J MED, V111, P349, DOI 10.1016/S0002-9343(01)00879-8; Lai YR, 2013, TRANSFUSION MED, V23, P389, DOI 10.1111/tme.12077; Leung AWK, 2009, PEDIATR BLOOD CANCER, V53, P1054, DOI 10.1002/pbc.22170; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Modell B, 2000, LANCET, V355, P2051, DOI 10.1016/S0140-6736(00)02357-6; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Modell B, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-42; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; Pan HF, 2007, CLIN GENET, V71, P419, DOI 10.1111/j.1399-0004.2007.00791.x; Positano V, 2009, NMR BIOMED, V22, P707, DOI 10.1002/nbm.1382; Tanner MA, 2007, CIRCULATION, V115, P1876, DOI 10.1161/CIRCULATIONAHA.106.648790; Tanner MA, 2006, J CARDIOVASC MAGN R, V8, P543, DOI 10.1080/10976640600698155; Tanner MA, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-12; Tziomalos K, 2010, WORLD J GASTROENTERO, V16, P1587, DOI 10.3748/wjg.v16.i13.1587; Weatherall D.J., 2001, THALASSAEMIA SYNDROM, Vfourth; Weatherall DJ, 1996, NAT MED, V2, P847, DOI 10.1038/nm0896-847; Westwood M, 2003, J MAGN RESON IMAGING, V18, P33, DOI 10.1002/jmri.10332; Wood JC, 2004, BLOOD, V103, P1934, DOI 10.1182/blood-2003-06-1919; Wood JC, 2008, HAEMATOLOGICA, V93, P917, DOI 10.3324/haematol.12513; Wood JC, 2008, BLOOD REV, V22, pS14, DOI 10.1016/S0268-960X(08)70004-3	41	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85379	10.1371/journal.pone.0085379	http://dx.doi.org/10.1371/journal.pone.0085379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465548	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000330283100039
J	El Ridi, R; Tallima, H; Selim, S; Donnelly, S; Cotton, S; Santana, BG; Dalton, JP				El Ridi, Rashika; Tallima, Hatem; Selim, Sahar; Donnelly, Sheila; Cotton, Sophie; Santana, Bibiana Gonzales; Dalton, John P.			Cysteine Peptidases as Schistosomiasis Vaccines with Inbuilt Adjuvanticity	PLOS ONE			English	Article							HELPER TYPE-2 RESPONSE; IGE RESPONSES; CATHEPSIN-B; LIVER FLUKE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; FASCIOLA-HEPATICA; TH2 RESPONSES; MANSONI; PROTEASE; MICE	Schistosomiasis is caused by several worm species of the genus Schistosoma and afflicts up to 600 million people in 74 tropical and sub-tropical countries in the developing world. Present disease control depends on treatment with the only available drug praziquantel. No vaccine exists despite the intense search for molecular candidates and adjuvant formulations over the last three decades. Cysteine peptidases such as papain and Der p 1 are well known environmental allergens that sensitize the immune system driving potent Th2-responses. Recently, we showed that the administration of active papain to mice induced significant protection (P<0.02, 50%) against an experimental challenge infection with Schistosoma mansoni. Since schistosomes express and secrete papain-like cysteine peptidases we reasoned that these could be employed as vaccines with inbuilt adjuvanticity to protect against these parasites. Here we demonstrate that subcutaneous injection of functionally active S. mansoni cathepsin B1 (SmCB1), or a cathepsin L from a related parasite Fasciola hepatica (FhCL1), elicits highly significant (P<0.0001) protection (up to 73%) against an experimental challenge worm infection. Protection and reduction in worm egg burden were further increased (up to 83%) when the cysteine peptidases were combined with other S. mansoni vaccine candidates, glyceraldehyde 3-phosphate dehydrogenase (SG3PDH) and peroxiredoxin (PRX-MAP), without the need to add chemical adjuvants. These studies demonstrate the capacity of helminth cysteine peptidases to behave simultaneously as immunogens and adjuvants, and offer an innovative approach towards developing schistosomiasis vaccines	[El Ridi, Rashika; Tallima, Hatem] Cairo Univ, Fac Sci, Dept Zool, Cairo, Egypt; [Selim, Sahar] Menoufiya Univ, Natl Liver Inst, Shibin Al Kawm, Menoufiya, Egypt; [Donnelly, Sheila] Univ Technol Sydney, Inst I 3, Ultimo, Sydney, NSW 2007, Australia; [Cotton, Sophie; Santana, Bibiana Gonzales; Dalton, John P.] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ, Canada; [Dalton, John P.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Menofia University; University of Technology Sydney; McGill University; Queens University Belfast	Dalton, JP (corresponding author), McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ, Canada.	john.dalton@mcgill.ca	Ridi, Rashika El/AAA-3840-2019; Dalton, John/K-4457-2014; Donnelly, Sheila/H-7733-2014; Ridi, Rashika El/ABG-2708-2020; Ibrahim, Essam Hassan/G-1960-2018; Tallima, Hatem/AAO-8061-2020	Ibrahim, Essam Hassan/0000-0003-0130-2257; Tallima, Hatem/0000-0003-3714-641X; El Ridi, Rashika/0000-0001-5094-6994; Donnelly, Sheila/0000-0003-2005-3698	Canada Institute of Health Research (CIHR) from the National Science and Engineering Research Council (NSERC) Canada; Science and Technology Development Fund (STDF), Egypt [2073]	Canada Institute of Health Research (CIHR) from the National Science and Engineering Research Council (NSERC) Canada; Science and Technology Development Fund (STDF), Egypt(Science and Technology Development Fund (STDF))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding for this study was received from the Canada Institute of Health Research (CIHR) from the National Science and Engineering Research Council (NSERC) Canada to JPD for the molecular biology studies. Financial support was also received from the Science and Technology Development Fund (STDF), Egypt, grant No. 2073 to R. El Ridi for vaccine and immunological at studies.	Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bos DH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-488; Brady CP, 2000, EXP PARASITOL, V94, P75, DOI 10.1006/expr.1999.4478; Brady CP, 1999, BIOCHEM SOC T, V27, P740, DOI 10.1042/bst0270740; Brady CP, 1999, INFECT IMMUN, V67, P368, DOI 10.1128/IAI.67.1.368-374.1999; Caffrey CR, 1997, PARASITOL RES, V83, P37, DOI 10.1007/s004360050204; Caffrey CR, 2002, MOL BIOCHEM PARASIT, V121, P49, DOI 10.1016/S0166-6851(02)00022-1; Chapman MD, 2007, CURR ALLERGY ASTHM R, V7, P363, DOI 10.1007/s11882-007-0055-6; Chapoval SP, 1999, J CLIN INVEST, V103, P1707, DOI 10.1172/JCI6175; CHAPPELL CL, 1988, AM J TROP MED HYG, V39, P463, DOI 10.4269/ajtmh.1988.39.463; CHAPPELL CL, 1990, AM J TROP MED HYG, V42, P335, DOI 10.4269/ajtmh.1990.42.335; Collins PR, 2004, J BIOL CHEM, V279, P17038, DOI 10.1074/jbc.M308831200; Cunningham PT, 2012, INT ARCH ALLERGY IMM, V158, P347, DOI 10.1159/000334280; Da'dara AA, 2002, PARASITE IMMUNOL, V24, P179, DOI 10.1046/j.1365-3024.2002.00453.x; Dalton JP, 1996, INFECT IMMUN, V64, P1328, DOI 10.1128/IAI.64.4.1328-1334.1996; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; Fraga LAD, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-56; Fraga LAD, 2010, J INFECT DIS, V201, P464, DOI 10.1086/649841; DEAN DA, 1984, AM J TROP MED HYG, V33, P97, DOI 10.4269/ajtmh.1984.33.97; DEAN DA, 1983, EXP PARASITOL, V55, P1, DOI 10.1016/0014-4894(83)90002-4; Donnelly S, 2008, FASEB J, V22, P4022, DOI 10.1096/fj.08-106278; Driguez P, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-4; Dvorak J, 2008, BIOCHIMIE, V90, P345, DOI 10.1016/j.biochi.2007.08.013; Dvorak J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000449; El Ridi R, 2003, J PARASITOL, V89, P1064, DOI 10.1645/GE-3122RN; El Ridi R, 2001, INFECT IMMUN, V69, P237, DOI 10.1128/IAI.69.1.237-244.2001; El Ridi R, 2013, J PARASITOL, V99, P194, DOI 10.1645/GE-3186.1; El Ridi R, 2010, MICROBES INFECT, V12, P700, DOI 10.1016/j.micinf.2010.04.012; ElRidi R, 1997, INT J PARASITOL, V27, P581, DOI 10.1016/S0020-7519(97)00006-4; Farias LP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000597; Figueiredo JP, 2012, PARASITE IMMUNOL, V34, P604, DOI 10.1111/pim.12001; Fitzsimmons CM, 2012, INFECT IMMUN, V80, P4264, DOI 10.1128/IAI.00641-12; GAAFAR T, 1993, PARASITOL RES, V79, P103, DOI 10.1007/BF00932254; Ganley-Leal LM, 2006, INFECT IMMUN, V74, P2169, DOI 10.1128/IAI.74.4.2169-2176.2006; Gray DJ, 2010, LANCET INFECT DIS, V10, P733, DOI 10.1016/S1473-3099(10)70099-2; Jiz M, 2009, INFECT IMMUN, V77, P2051, DOI 10.1128/IAI.00012-09; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Liang GQ, 2012, J ALLERGY CLIN IMMUN, V129, P1377, DOI 10.1016/j.jaci.2012.02.035; Maizels RM, 2012, CURR OPIN IMMUNOL, V24, P459, DOI 10.1016/j.coi.2012.06.003; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Siddiqui AA, 2011, HUM VACCINES, V7, P1192, DOI 10.4161/hv.7.11.17017; Skelly PJ, 2001, J PARASITOL, V87, P1218, DOI 10.1645/0022-3395(2001)087[1218:SMPSCB]2.0.CO;2; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2010, CURR OPIN IMMUNOL, V22, P73, DOI 10.1016/j.coi.2010.01.012; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Stack CM, 2005, J IMMUNOL METHODS, V304, P151, DOI 10.1016/j.jim.2005.07.019; Stack CM, 2008, J BIOL CHEM, V283, P9896, DOI 10.1074/jbc.M708521200; Stirewalt M.A., 1974, Advances Parasit, V12, P115, DOI 10.1016/S0065-308X(08)60388-7; Tallima H, 2003, VACCINE, V21, P3290, DOI 10.1016/S0264-410X(03)00180-4; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430; Walker AJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-203; Wynn TA, 1999, MICROBES INFECT, V1, P525, DOI 10.1016/S1286-4579(99)80092-6; Xu XD, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-54; ZERDA KS, 1988, EXP PARASITOL, V67, P238, DOI 10.1016/0014-4894(88)90071-9	58	42	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85401	10.1371/journal.pone.0085401	http://dx.doi.org/10.1371/journal.pone.0085401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465551	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500061
J	Serrano-Candelas, E; Farre, D; Aranguren-Ibanez, A; Martinez-Hoyer, S; Perez-Riba, M				Serrano-Candelas, Eva; Farre, Domenec; Aranguren-Ibanez, Alvaro; Martinez-Hoyer, Sergio; Perez-Riba, Merce			The Vertebrate RCAN Gene Family: Novel Insights into Evolution, Structure and Regulation	PLOS ONE			English	Article							CANDIDATE REGION 1; DSCR1L2 MESSENGER-RNA; CALCINEURIN INHIBITOR; GENOME DUPLICATIONS; NUCLEAR FACTOR; T-CELLS; EXPRESSION; IDENTIFICATION; SEQUENCES; PROTEINS	Recently there has been much interest in the Regulators of Calcineurin (RCAN) proteins which are important endogenous modulators of the calcineurin-NFATc signalling pathway. They have been shown to have a crucial role in cellular programmes such as the immune response, muscle fibre remodelling and memory, but also in pathological processes such as cardiac hypertrophy and neurodegenerative diseases. In vertebrates, the RCAN family form a functional subfamily of three members RCAN1, RCAN2 and RCAN3 whereas only one RCAN is present in the rest of Eukarya. In addition, RCAN genes have been shown to collocate with RUNX and CLIC genes in ACD clusters (ACD21, ACD6 and ACD1). How the RCAN genes and their clustering in ACDs evolved is still unknown. After analysing RCAN gene family evolution using bioinformatic tools, we propose that the three RCAN vertebrate genes within the ACD clusters, which evolved from single copy genes present in invertebrates and lower eukaryotes, are the result of two rounds of whole genome duplication, followed by a segmental duplication. This evolutionary scenario involves the loss or gain of some RCAN genes during evolution. In addition, we have analysed RCAN gene structure and identified the existence of several characteristic features that can be involved in RCAN evolution and gene expression regulation. These included: several transposable elements, CpG islands in the 59 region of the genes, the existence of antisense transcripts (NAT) associated with the three human genes, and considerable evidence for bidirectional promoters that regulate RCAN gene expression. Furthermore, we show that the CpG island associated with the RCAN3 gene promoter is unmethylated and transcriptionally active. All these results provide timely new insights into the molecular mechanisms underlying RCAN function and a more in depth knowledge of this gene family whose members are obvious candidates for the development of future therapies.	[Serrano-Candelas, Eva; Aranguren-Ibanez, Alvaro; Martinez-Hoyer, Sergio; Perez-Riba, Merce] Bellvitge Biomed Res Inst IDIBELL, Canc & Human Mol Genet Dept, Barcelona, Spain; [Farre, Domenec] IDIBAPS, Biol Aggress & Response Mechanisms Unit, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Perez-Riba, M (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Canc & Human Mol Genet Dept, Barcelona, Spain.	mpr@idibell.cat	Serrano Candelas, Eva/I-1892-2015; Perez-Riba, Merce/AAA-6880-2019; Farre, Domenec/K-8010-2014	Serrano Candelas, Eva/0000-0002-8929-5364; Farre, Domenec/0000-0001-8553-1983; Aranguren-Ibanez, Alvaro/0000-0001-8929-3521; Perez-Riba, Merce/0000-0003-1604-4617	Ministerio de Ciencia e Innovacion [SAF2009-08216]; Generalitat Catalunya [2009SGR1490]; Mutua Madrilena; Juan de la Cierva subprogramme (Ministerio de Economia y Competitividad); Generalitat de Catalunya;  [SAF009-08216]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Catalunya; Mutua Madrilena; Juan de la Cierva subprogramme (Ministerio de Economia y Competitividad); Generalitat de Catalunya(Generalitat de Catalunya); 	The research was supported by Ministerio de Ciencia e Innovacion grant SAF2009-08216 and Generalitat Catalunya grant 2009SGR1490. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ESC was supported by SAF009-08216 and Mutua Madrilena, DF was supported by the Juan de la Cierva subprogramme (Ministerio de Economia y Competitividad), and AAI was a recipient of a FI fellowship from Generalitat de Catalunya.	Andreakis N, 2011, MOL BIOL EVOL, V28, P163, DOI 10.1093/molbev/msq179; Aramburu J, 2004, EMBO REP, V5, P343, DOI 10.1038/sj.embor.7400133; Aubareda A, 2006, CELL SIGNAL, V18, P1430, DOI 10.1016/j.cellsig.2005.11.006; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Bassett JHD, 2012, ENDOCRINOLOGY, V153, P3537, DOI 10.1210/en.2011-1814; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Boratyn GM, 2013, NUCL ACIDS RES; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Canaider S, 2006, GENE, V372, P128, DOI 10.1016/j.gene.2005.12.029; Cao X, 2002, BIOCHEM J, V367, P459, DOI 10.1042/BJ20011797; Mulero M, 2007, BBA-MOL CELL RES, V1773, P330, DOI 10.1016/j.bbamcr.2006.12.007; Cattell M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022474; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Djuretic IM, 2009, ADV IMMUNOL, V104, P1, DOI 10.1016/S0065-2776(08)04001-7; Dores RM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00028; Dores RM, 2011, ENDOCRINOLOGY, V152, P4010, DOI 10.1210/en.2011-1694; Ermak G, 2011, FASEB J, V25, P3306, DOI 10.1096/fj.11-185728; Estecha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033313; Facchin F, 2008, GENE, V407, P159, DOI 10.1016/j.gene.2007.10.006; Facchin F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024508; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Gess RW, 2006, NATURE, V443, P981, DOI 10.1038/nature05150; Glusman G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-43; Gurgen D, 2011, HYPERTENSION, V57, P648, DOI 10.1161/HYPERTENSIONAHA.110.166157; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; He GA, 2011, EUR J IMMUNOL, V41, P1221, DOI 10.1002/eji.201041266; Hecht J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000025; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Hill JA, 2002, J BIOL CHEM, V277, P10251, DOI 10.1074/jbc.M110722200; Hirakawa Yasuko, 2009, J Mol Signal, V4, P6, DOI 10.1186/1750-2187-4-6; Ho MR, 2012, GENOMICS, V100, P231, DOI 10.1016/j.ygeno.2012.06.011; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Inoue JG, 2005, GENE, V349, P227, DOI 10.1016/j.gene.2005.01.008; Johanson Z, 2006, BIOL LETTERS, V2, P443, DOI 10.1098/rsbl.2006.0470; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; Kalitsis P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-498; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kines KJ, 2012, FRONT BIOSCI-LANDMRK, V17, P1329, DOI 10.2741/3990; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Lee JY, 2009, BBA-GEN SUBJECTS, V1790, P1673, DOI 10.1016/j.bbagen.2009.08.005; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Martin KR, 2012, HUM MOL GENET, V21, P3025, DOI 10.1093/hmg/dds134; Martinez-Hoyer S, 2013, BBA-MOL CELL RES, V1833, P2311, DOI 10.1016/j.bbamcr.2013.05.021; Martinez-Martineza S, 2009, P NATL ACAD SCI USA, V106, P6117, DOI 10.1073/pnas.0812544106; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Mulero MC, 2009, J BIOL CHEM, V284, P9394, DOI 10.1074/jbc.M805889200; Nicholas KB, 1997, EMBNEW NEWS, V4; Ohno S., 1970, P1; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Park J, 2009, BMB REP, V42, P6, DOI 10.5483/BMBRep.2009.42.1.006; Porta S, 2007, EUR J NEUROSCI, V26, P1213, DOI 10.1111/j.1460-9568.2007.05749.x; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rennert J, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-4; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; Shimeld SM, 2012, DEVELOPMENT, V139, P2091, DOI 10.1242/dev.074716; Shin SY, 2006, FEBS LETT, V580, P5965, DOI 10.1016/j.febslet.2006.09.064; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Smith JJ, 2010, INTEGR COMP BIOL, V50, P130, DOI 10.1093/icb/icq023; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Strippoli P, 2002, MAMM GENOME, V13, P456, DOI 10.1007/s00335-001-2157-0; Strippoli P, 2000, GENE, V257, P223, DOI 10.1016/S0378-1119(00)00407-8; Strippoli P, 2000, GENOMICS, V64, P252, DOI 10.1006/geno.2000.6127; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Vienne A, 2003, MOL BIOL EVOL, V20, P1290, DOI 10.1093/molbev/msg127; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wu H, 2007, J BIOL CHEM, V282, P30673, DOI 10.1074/jbc.M703622200; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yang JY, 2009, BONE, V45, P1175, DOI 10.1016/j.bone.2009.08.012; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	85	13	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85539	10.1371/journal.pone.0085539	http://dx.doi.org/10.1371/journal.pone.0085539			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465593	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500057
J	Zhang, LJ; Li, ZQ; Li, XC; Zhang, J; Zheng, L; Jiang, CH; Li, J				Zhang, Lijuan; Li, Zhiqiang; Li, Xucheng; Zhang, Jie; Zheng, Liang; Jiang, Chenghua; Li, Jue			Study on the Trend and Disease Burden of Injury Deaths in Chinese Population, 2004-2010	PLOS ONE			English	Article							HEALTH SYSTEM REFORM; REGIONAL INEQUALITY; GLOBAL BURDEN; MORTALITY; RATES; URBAN; PROVINCE; SUICIDE; AREAS; AGE	Injuries are a growing public health concern in China, accounting for more than 30% of all Person Years of Life Lost (PYLL) due to premature mortality. This study analyzes the trend and disease burden of injury deaths in Chinese population from 2004 to 2010, using data from the National Disease Surveillance Points (DSPs) system, as injury deaths are classified based on the International Classification of Disease-10th Revision (ICD-10). We observed that injury death accounted for nearly 10% of all deaths in China throughout the period 2004-2010, and the injury mortality rates were higher in males than those in females, and higher in rural areas than in urban areas. Traffic crashes (33.79-38.47% of all injury deaths) and suicides (16.20-22.01%) were the two leading causes of injury deaths. Alarmingly, suicide surpassed traffic crashes as the leading cause of injury mortality in rural females, yet adults aged 65 and older suffered the greatest number of fatal falls (20,701 deaths, 2004-2010). The burden of injury among men (72.11%) was about three times more than that of women's (28.89%). This study provides indispensible evidence that China Authority needs to improve the surveillance and deterrence of three major types of injuries: Traffic-related injury deaths should be targeted for injury prevention activities in all population, people aged 65+ should be encouraged to take individual fall precautions, and prevention of suicidal behavior in rural females should be another key priority for the government of China.	[Zhang, Lijuan; Li, Zhiqiang; Li, Xucheng; Zhang, Jie; Zheng, Liang; Jiang, Chenghua; Li, Jue] Tongji Univ, Sch Med, Dept Prevent, Shanghai 200092, Peoples R China	Tongji University	Jiang, CH (corresponding author), Tongji Univ, Sch Med, Dept Prevent, Shanghai 200092, Peoples R China.	jiangchenghua@hotmail.com; jueli@tongji.edu.cn			Fundamental Research Funds for the Central Universities; Nature Science Foundation of China [81001252]; Ministry of Education of China [20100072120053]; International Science & Technology Cooperation Program of China [2011DFB30010]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); International Science & Technology Cooperation Program of China	This study was supported by grants from Fundamental Research Funds for the Central Universities (Study on the key technology of disaster warning and relief for rural remote areas); the Nature Science Foundation of China (No. 81001252); Ministry of Education of China (No. 20100072120053), International Science & Technology Cooperation Program of China(No. 2011DFB30010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakke HK, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-14; Boland M, 2005, INJURY PREV, V11, P38, DOI 10.1136/ip.2004.005371; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Cubbin C, 2000, AM J PUBLIC HEALTH, V90, P70, DOI 10.2105/AJPH.90.1.70; Fan CC, 2008, EURASIAN GEOGR ECON, V49, P1, DOI 10.2747/1539-7216.49.1.1; Garrib A, 2011, TROP MED INT HEALTH, V16, P439, DOI 10.1111/j.1365-3156.2011.02730.x; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Herbert HK, 2011, INFECT DIS CLIN N AM, V25, P653, DOI 10.1016/j.idc.2011.06.004; Hu GQ, 2010, J RURAL HEALTH, V26, P73, DOI 10.1111/j.1748-0361.2009.00255.x; Jiang GH, 2011, INJURY, V42, P501, DOI 10.1016/j.injury.2009.10.050; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Li YH, 2013, BIOMED ENVIRON SCI, V26, P79, DOI 10.3967/0895-3988.2013.02.001; Liu Na, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P746; Liu Q, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-180; Ma JX, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-122; Ma S, 2012, TRAFFIC INJ PREV, V13, P57, DOI 10.1080/15389588.2011.633945; Mitchell RJ, 2010, RURAL REMOTE HEALTH, V10; Mock CN, 1999, B WORLD HEALTH ORGAN, V77, P955; Peek-Asa C, 2004, AM J PUBLIC HEALTH, V94, P1689, DOI 10.2105/AJPH.94.10.1689; Peng XZ, 2011, SCIENCE, V333, P581, DOI 10.1126/science.1209396; Phillips MR, 2012, LANCET, V379, P2318, DOI 10.1016/S0140-6736(12)60913-1; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Rockett Ian R H, 2012, Am J Public Health, V102, pe84, DOI 10.2105/AJPH.2012.300960; Rothman K., 1998, MODERN EPIDEMIOLOGY; Shan H, 2011, ASIA-PAC J PUBLIC HE, DOI [10.1177/1010539511428487, DOI 10.1177/1010539511428487.[]; Stone DH, 2006, INJURY PREV, V12, P327, DOI 10.1136/ip.2006.012344; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Varnik P, 2012, INT J ENV RES PUB HE, V9, P760, DOI 10.3390/ijerph9030760; Wang Li-jun, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P309; Wang P, 2010, TRAFFIC INJ PREV, V11, P425, DOI 10.1080/15389581003754593; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Zhang Jie, 2002, Arch Suicide Res, V6, P167, DOI 10.1080/13811110208951174; Zhang QH, 2012, ANN ECON FINANC, V13, P113; Zhang XJ, 2013, IRAN J PUBLIC HEALTH, V42, P7; Zhang YL, 2013, ZHONGGUO GONG GONG W, V29, P1425; Zhao ZT, 2003, HEALTH PROMOT INT, V18, P247, DOI 10.1093/heapro/dag020; Zhou Y, 2003, INJ PREV, V9, P124, DOI 10.1136/ip.9.2.124	38	25	30	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85319	10.1371/journal.pone.0085319	http://dx.doi.org/10.1371/journal.pone.0085319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297EA	24465534	Green Submitted, Green Published, gold			2022-12-25	WOS:000330237000030
J	Boddaert, J; Cohen-Bittan, J; Khiami, F; Le Manach, Y; Raux, M; Beinis, JY; Verny, M; Riou, B				Boddaert, Jacques; Cohen-Bittan, Judith; Khiami, Frederic; Le Manach, Yannick; Raux, Mathieu; Beinis, Jean-Yves; Verny, Marc; Riou, Bruno			Postoperative Admission to a Dedicated Geriatric Unit Decreases Mortality in Elderly Patients with Hip Fracture	PLOS ONE			English	Article							WORLDWIDE PREVALENCE; EXCESS MORTALITY; CONTROLLED-TRIAL; CLINICAL-TRIAL; OLDER PATIENTS; RISK; OUTCOMES; IMPACT; HOSPITALIZATION; INTERVENTION	Background: Elderly patients with hip fracture have a 5 to 8 fold increased risk of death during the months following surgery. We tested the hypothesis that early geriatric management of these patients focused on co-morbidities and rehabilitation improved long term mortality. Methods and Findings: In a cohort study over a 6 year period, we compared patients aged >70 years with hip fracture admitted to orthopedic versus geriatric departments in a time series analysis corresponding to the creation of a dedicated geriatric unit. Co-morbidities were assessed using the Cumulative Illness Rating Scale (CIRS). Each cohort was compared to matched cohorts extracted from a national registry (n = 51,275) to validate the observed results. Main outcome measure was 6-month mortality. We included 131 patients in the orthopedic cohort and 203 in the geriatric cohort. Co-morbidities were more frequent in the geriatric cohort (median CIRS: 8 vs 5, P<0.001). In the geriatric cohort, the proportion of patients who never walked again decreased (6% versus 22%, P<0.001). At 6 months, re-admission (14% versus 29%, P = 0.007) and mortality (15% versus 24%, P = 0.04) were decreased. When co-morbidities were taken into account, the risk ratio of death at 6 months was reduced (0.43, 95% CI 0.25 to 0.73, P = 0.002). Using matched cohorts, the average treatment effects on the treated associated to early geriatric management indicated a reduction in hospital mortality (263%; 95% CI: 292% to 26%, P = 0.006). Conclusions: Early admission to a dedicated geriatric unit improved 6-month mortality and morbidity in elderly patients with hip fracture.	[Boddaert, Jacques; Cohen-Bittan, Judith; Raux, Mathieu; Verny, Marc; Riou, Bruno] Univ Paris 06, UMRS 956, UMRS 1158, Paris, France; [Boddaert, Jacques; Verny, Marc] Grp Hosp GH Pitie Salpetriere, AP HP, Dept Geriatr, Paris, France; [Khiami, Frederic] GH Pitie Salpetriere, AP HP, Dept Orthoped Surg & Trauma, Paris, France; [Le Manach, Yannick] McMaster Univ, Fac Hlth Sci, Michael DeGroote Sch Med, Dept Anesthesia, Hamilton, ON, Canada; [Le Manach, Yannick] McMaster Univ, Dept Clin Epidemiol & Biostat, Michael DeGroote Sch Med, Fac Hlth Sci, Hamilton, ON, Canada; [Raux, Mathieu] GH Pitie Salpetriere, AP HP, Dept Anesthesiol & Crit Care, Paris, France; [Beinis, Jean-Yves] Grp Hosp Charles Foix, AP HP, Dept Rehabil, Ivry, France; [Riou, Bruno] GH Pitie Salpetriere, AP HP, Dept Emergency Med & Surg, Paris, France; [Raux, Mathieu; Riou, Bruno] INSERM, UMRS 956, UMRS 1158, UMR 689, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; McMaster University; McMaster University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Charles-Foix - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Boddaert, J (corresponding author), Univ Paris 06, UMRS 956, UMRS 1158, Paris, France.	jacques.boddaert@psl.aphp.fr	Le Manach, Yannick/AAE-5700-2019	Le Manach, Yannick/0000-0003-0474-8545; Verny, Marc/0000-0001-7960-9705; RAUX, Mathieu/0000-0003-2493-9146				Abrahamsen B, 2009, OSTEOPOROSIS INT, V20, P1633, DOI 10.1007/s00198-009-0920-3; Adunsky A, 2003, J GERONTOL A-BIOL, V58, P542; Agence Nationale de Securite du Medicament (ANSM), 2002, REC TRANSF GLOB ROUG; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bass E, 2007, ANN EPIDEMIOL, V17, P514, DOI 10.1016/j.annepidem.2006.12.004; Bentler SE, 2009, AM J EPIDEMIOL, V170, P1290, DOI 10.1093/aje/kwp266; BERGSTROM N, 1987, NURS CLIN N AM, V22, P417; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cram P, 2011, JAMA-J AM MED ASSOC, V305, P1560, DOI 10.1001/jama.2011.478; Endo Y, 2005, J ORTHOP TRAUMA, V19, P29, DOI 10.1097/00005131-200501000-00006; Fisher AA, 2006, J ORTHOP TRAUMA, V20, P172, DOI 10.1097/01.bot.0000202220.88855.16; Friedman SM, 2009, ARCH INTERN MED, V169, P1712, DOI 10.1001/archinternmed.2009.321; GILCHRIST WJ, 1988, BRIT MED J, V297, P1116, DOI 10.1136/bmj.297.6656.1116; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hannan EL, 2001, JAMA-J AM MED ASSOC, V285, P2736, DOI 10.1001/jama.285.21.2736; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jiang HX, 2005, J BONE MINER RES, V20, P494, DOI 10.1359/JBMR.041133; Johnell O, 2004, OSTEOPOROSIS INT, V15, P897, DOI 10.1007/s00198-004-1627-0; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kammerlander C, 2010, OSTEOPOROSIS INT, V21, pS637, DOI 10.1007/s00198-010-1396-x; Kanis JA, 2003, BONE, V32, P468, DOI 10.1016/S8756-3282(03)00061-9; KENNIE DC, 1988, BRIT MED J, V297, P1083, DOI 10.1136/bmj.297.6656.1083; Koval KJ, 2004, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.blo.0000132266.59787.d2; Leung AHC, 2011, J TRAUMA, V71, P1390, DOI 10.1097/TA.0b013e31821f7e60; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; MYERS AH, 1991, AM J EPIDEMIOL, V134, P1128, DOI 10.1093/oxfordjournals.aje.a116016; Naglie G, 2002, CAN MED ASSOC J, V167, P25; Nikkel LE, 2012, J BONE JOINT SURG AM, V94A, P9, DOI [10.2106/JBJS.J.01077, 10.2106/JBJS.K.01214]; Penrod JD, 2008, J GERONTOL A-BIOL, V63, P867, DOI 10.1093/gerona/63.8.867; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Rapp K, 2008, J BONE MINER RES, V23, P1825, DOI 10.1359/JBMR.080702; Simunovic N, 2010, CAN MED ASSOC J, V182, P1609, DOI 10.1503/cmaj.092220; Vidan M, 2005, J AM GERIATR SOC, V53, P1476, DOI 10.1111/j.1532-5415.2005.53466.x; Vidan MT, 2011, ANN INTERN MED, V155, P226, DOI 10.7326/0003-4819-155-4-201108160-00006	37	107	110	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83795	10.1371/journal.pone.0083795	http://dx.doi.org/10.1371/journal.pone.0083795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454708	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100012
J	Espinosa, O; Mitsopoulos, K; Hakas, J; Pearl, F; Zvelebil, M				Espinosa, Octavio; Mitsopoulos, Konstantinos; Hakas, Jarle; Pearl, Frances; Zvelebil, Marketa			Deriving a Mutation Index of Carcinogenicity Using Protein Structure and Protein Interfaces	PLOS ONE			English	Article							SOMATIC MUTATIONS; FUNCTIONAL CONSEQUENCES; MISSENSE VARIANTS; HOT-SPOTS; CANCER; PREDICTION; POLYMORPHISMS; BRCA1; RESIDUES; PATHWAY	With the advent of Next Generation Sequencing the identification of mutations in the genomes of healthy and diseased tissues has become commonplace. While much progress has been made to elucidate the aetiology of disease processes in cancer, the contributions to disease that many individual mutations make remain to be characterised and their downstream consequences on cancer phenotypes remain to be understood. Missense mutations commonly occur in cancers and their consequences remain challenging to predict. However, this knowledge is becoming more vital, for both assessing disease progression and for stratifying drug treatment regimes. Coupled with structural data, comprehensive genomic databases of mutations such as the 1000 Genomes project and COSMIC give an opportunity to investigate general principles of how cancer mutations disrupt proteins and their interactions at the molecular and network level. We describe a comprehensive comparison of cancer and neutral missense mutations; by combining features derived from structural and interface properties we have developed a carcinogenicity predictor, InCa (Index of Carcinogenicity). Upon comparison with other methods, we observe that InCa can predict mutations that might not be detected by other methods. We also discuss general limitations shared by all predictors that attempt to predict driver mutations and discuss how this could impact high-throughput predictions. A web interface to a server implementation is publicly available at http://inca.icr.ac.uk/.	[Espinosa, Octavio; Mitsopoulos, Konstantinos; Hakas, Jarle; Zvelebil, Marketa] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Pearl, Frances] Inst Canc Res, UK Canc Therapeut Unit, London SW3 6JB, England; [Pearl, Frances] Univ Sussex, Sch Life Sci, Translat Drug Discovery Grp, Brighton, E Sussex, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Sussex	Zvelebil, M (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	Marketa.Zvelebil@icr.ac.uk		Zvelebil, Marketa/0000-0001-8018-5591; Mitsopoulos, Costas/0000-0002-9116-5921; Pearl, Frances/0000-0002-8210-4393	Breakthrough Breast Cancer, UK; Daphne Jackson Fellowship; UK Medical Research Council	Breakthrough Breast Cancer, UK; Daphne Jackson Fellowship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Breakthrough Breast Cancer, UK (http://www.breakthrough.org.uk/). FP was supported by a Daphne Jackson Fellowship and the UK Medical Research Council. The funders provided the funding for the authors and the materials required for the investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anne TM, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/179351; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Birrane G, 2007, BIOCHEMISTRY-US, V46, P7706, DOI 10.1021/bi700323t; Boutselakis H, 2003, NUCLEIC ACIDS RES, V31, P458, DOI 10.1093/nar/gkg065; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Carlsson J, 2009, FEBS J, V276, P4142, DOI 10.1111/j.1742-4658.2009.07124.x; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Chan PA, 2007, HUM MUTAT, V28, P683, DOI 10.1002/humu.20492; Chao EC, 2008, HUM MUTAT, V29, P852, DOI 10.1002/humu.20735; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; Custodio A, 2012, J CANCER RES CLIN, V138, P867, DOI 10.1007/s00432-012-1161-y; Damm F, 2012, LEUKEMIA, V26, P2027, DOI 10.1038/leu.2012.86; David A, 2012, HUM MUTAT, V33, P359, DOI 10.1002/humu.21656; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dixit A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007485; Ferla R, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdm234; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Frederic MY, 2009, HUM MUTAT, V30, P952, DOI 10.1002/humu.20970; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenblatt MS, 2003, ONCOGENE, V22, P1150, DOI 10.1038/sj.onc.1206101; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurst JM, 2009, HUM MUTAT, V30, P616, DOI 10.1002/humu.20898; Izarzugaza JMG, 2009, PROTEINS, V77, P892, DOI 10.1002/prot.22512; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Li M, 2013, CANCER CELL, V23, P693, DOI 10.1016/j.ccr.2013.03.025; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Makishima H, 2012, BLOOD, V119, P3203, DOI 10.1182/blood-2011-12-399774; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Morris JR, 2002, J BIOL CHEM, V277, P9382, DOI 10.1074/jbc.M109249200; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pal A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-103; Rajasekaran R, 2007, GENOMICS, V90, P447, DOI 10.1016/j.ygeno.2007.07.004; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richardson CJ, 2009, NUCLEIC ACIDS RES, V37, pD824, DOI 10.1093/nar/gkn832; Sims D, 2010, BREAST CANCER RES TR, V124, P567, DOI 10.1007/s10549-010-0945-5; Srivastava P, 2012, ARCH MED RES, V43, P117, DOI 10.1016/j.arcmed.2012.02.006; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Talavera D, 2010, PROTEINS, V78, P518, DOI 10.1002/prot.22574; Velankar S, 2011, ACTA CRYSTALLOGR D, V67, P324, DOI 10.1107/S090744491004117X; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang X, 2012, NAT BIOTECHNOL; Wang XP, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-25; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999	67	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84598	10.1371/journal.pone.0084598	http://dx.doi.org/10.1371/journal.pone.0084598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454733	Green Published, Green Accepted, gold			2022-12-25	WOS:000330235100027
J	Klein, D; Rotarska-Jagiela, A; Genc, E; Sritharan, S; Mohr, H; Roux, F; Han, CE; Kaiser, M; Singer, W; Uhlhaas, PJ				Klein, Daniel; Rotarska-Jagiela, Anna; Genc, Erhan; Sritharan, Sharmili; Mohr, Harald; Roux, Frederic; Han, Cheol E.; Kaiser, Marcus; Singer, Wolf; Uhlhaas, Peter J.			Adolescent Brain Maturation and Cortical Folding: Evidence for Reductions in Gyrification	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; NEURAL SYNCHRONY; SCHIZOPHRENIA; THICKNESS; CHILDHOOD; NETWORKS; VOLUME; AREA; ASSOCIATION	Evidence from anatomical and functional imaging studies have highlighted major modifications of cortical circuits during adolescence. These include reductions of gray matter (GM), increases in the myelination of cortico-cortical connections and changes in the architecture of large-scale cortical networks. It is currently unclear, however, how the ongoing developmental processes impact upon the folding of the cerebral cortex and how changes in gyrification relate to maturation of GM/WM-volume, thickness and surface area. In the current study, we acquired high-resolution (3 Tesla) magnetic resonance imaging (MRI) data from 79 healthy subjects (34 males and 45 females) between the ages of 12 and 23 years and performed whole brain analysis of cortical folding patterns with the gyrification index (GI). In addition to GI-values, we obtained estimates of cortical thickness, surface area, GM and white matter (WM) volume which permitted correlations with changes in gyrification. Our data show pronounced and widespread reductions in GI-values during adolescence in several cortical regions which include precentral, temporal and frontal areas. Decreases in gyrification overlap only partially with changes in the thickness, volume and surface of GM and were characterized overall by a linear developmental trajectory. Our data suggest that the observed reductions in GI-values represent an additional, important modification of the cerebral cortex during late brain maturation which may be related to cognitive development.	[Klein, Daniel; Rotarska-Jagiela, Anna; Genc, Erhan; Sritharan, Sharmili; Roux, Frederic; Singer, Wolf; Uhlhaas, Peter J.] Max Planck Inst Brain Res, Dept Neurophysiol, Frankfurt, Germany; [Klein, Daniel; Genc, Erhan; Sritharan, Sharmili; Roux, Frederic; Singer, Wolf; Uhlhaas, Peter J.] Max Planck Gesell, Ernst Strungmann Inst ESI Neurosci Cooperat, Frankfurt, Germany; [Mohr, Harald] Goethe Univ Frankfurt, Inst Psychol, Dept Neurocognit Psychol, D-60054 Frankfurt, Germany; [Mohr, Harald] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, D-60054 Frankfurt, Germany; [Han, Cheol E.; Kaiser, Marcus] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea; [Kaiser, Marcus] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kaiser, Marcus] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Singer, Wolf] Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, D-60054 Frankfurt, Germany; [Uhlhaas, Peter J.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	Max Planck Society; Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt; Seoul National University (SNU); Newcastle University - UK; Newcastle University - UK; Goethe University Frankfurt; University of Glasgow	Uhlhaas, PJ (corresponding author), Max Planck Inst Brain Res, Dept Neurophysiol, Frankfurt, Germany.	peter.uhlhaas@glasgow.ac.uk	Genc, Erhan/T-9376-2018; Singer, Wolf/D-6874-2012; /AAG-3051-2020; Kaiser, Marcus/A-7166-2008; ROUX, FREDERIC/B-7436-2019	Genc, Erhan/0000-0001-6514-5479; Kaiser, Marcus/0000-0002-4654-3110; Han, Cheol/0000-0002-9994-6861; ROUX, FREDERIC/0000-0001-8854-8879	Max Planck Society; National Research Foundation of Korea; Ministry of Education, Science and Technology [R32-10142]; EPSRC [EP/K026992/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K026992/1] Funding Source: researchfish	Max Planck Society(Max Planck SocietyFoundation CELLEX); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Max Planck Society (P. J. Uhlhaas) and by National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R32-10142, C. E. Han). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG E, 1995, CEREB CORTEX, V5, P56, DOI 10.1093/cercor/5.1.56; Bakken TE, 2012, P NATL ACAD SCI USA, V109, P3985, DOI 10.1073/pnas.1105829109; Blakemore SJ, 2008, Q J EXP PSYCHOL, V61, P40, DOI 10.1080/17470210701508715; Blakemore SJ, 2012, NEUROIMAGE, V61, P397, DOI 10.1016/j.neuroimage.2011.11.080; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Colby JB, 2011, NEUROIMAGE, V54, P25, DOI 10.1016/j.neuroimage.2010.08.014; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Farmer SF, 2007, J PHYSIOL-LONDON, V579, P389, DOI 10.1113/jphysiol.2006.123174; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2008, NEUROIMAGE, V42, P1654, DOI 10.1016/j.neuroimage.2008.06.005; Fornito A, 2004, CEREB CORTEX, V14, P424, DOI 10.1093/cercor/bhh004; Galvan A, 2012, DEV COGN NEUROS-NETH, V2, P293, DOI 10.1016/j.dcn.2012.02.002; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Garvey MA, 2003, CLIN NEUROPHYSIOL, V114, P1662, DOI 10.1016/S1388-2457(03)00130-5; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Giedd JN, 1999, BIOL PSYCHIAT, V46, P892, DOI 10.1016/S0006-3223(99)00072-4; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Golarai G, 2007, NAT NEUROSCI, V10, P512, DOI 10.1038/nn1865; Harris JM, 2004, BIOL PSYCHIAT, V56, P182, DOI 10.1016/j.biopsych.2004.04.007; Hogstrom LJ, 2012, CEREB CORTEX; HUTTENLOCHER PR, 1984, AM J MENT DEF, V88, P488; Jou RJ, 2010, J CHILD NEUROL, V25, P1462, DOI 10.1177/0883073810368311; Joyner AH, 2009, P NATL ACAD SCI USA, V106, P15483, DOI 10.1073/pnas.0901866106; Kippenhan JS, 2005, J NEUROSCI, V25, P7840, DOI 10.1523/JNEUROSCI.1722-05.2005; Kulynych JJ, 1997, BIOL PSYCHIAT, V41, P995, DOI 10.1016/S0006-3223(96)00292-2; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Luders E, 2004, NAT NEUROSCI, V7, P799, DOI 10.1038/nn1277; Luders E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00034; Mutlu AK, 2013, NEUROIMAGE, V82, P200, DOI 10.1016/j.neuroimage.2013.05.076; Palaniyappan L, 2013, JAMA PSYCHIAT, V70, P1031, DOI 10.1001/jamapsychiatry.2013.203; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P399, DOI 10.1503/jpn.110119; Palaniyappan L, 2011, BIOL PSYCHIAT, V69, P974, DOI 10.1016/j.biopsych.2010.12.012; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Paus Tomas, 2008, Nat Rev Neurosci, V9, P947, DOI 10.1038/nrn2513; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Petermann F, 2010, HAWIK 4; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Ramsden S, 2011, NATURE, V479, P113, DOI 10.1038/nature10514; Raznahan A, 2011, NEURON, V72, P873, DOI 10.1016/j.neuron.2011.09.028; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; RICHMAN DP, 1975, SCIENCE, V189, P18, DOI 10.1126/science.1135626; Rimol LM, 2012, BIOL PSYCHIAT, V71, P552, DOI 10.1016/j.biopsych.2011.11.026; Rimol LM, 2010, P NATL ACAD SCI USA, V107, P384, DOI 10.1073/pnas.0908454107; Rogers J, 2010, NEUROIMAGE, V53, P1103, DOI 10.1016/j.neuroimage.2010.02.020; Rubia K, 2007, HUM BRAIN MAPP, V28, P1163, DOI 10.1002/hbm.20347; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Schaer M, 2012, JOVE-J VIS EXP, DOI 10.3791/3417; Schaer M, 2009, DEV MED CHILD NEUROL, V51, P746, DOI 10.1111/j.1469-8749.2009.03281.x; Su S, 2013, HUM BRAIN MAPP, V34, P1230, DOI 10.1002/hbm.21510; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tewes U., 1994, HAWIE R HAMBURG WECH; Uhlhaas PJ, 2011, SCHIZOPHRENIA BULL, V37, P514, DOI 10.1093/schbul/sbr034; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Vogeley K, 2000, AM J PSYCHIAT, V157, P34, DOI 10.1176/ajp.157.1.34; Werkle-Bergner M, 2009, CLIN NEUROPHYSIOL, V120, P1291, DOI 10.1016/j.clinph.2009.04.012; Zilles K, 2013, TRENDS NEUROSCI, V36, P275, DOI 10.1016/j.tins.2013.01.006	65	73	73	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84914	10.1371/journal.pone.0084914	http://dx.doi.org/10.1371/journal.pone.0084914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454765	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000330235100042
J	Ricketts, CJ; Hill, VK; Linehan, WM				Ricketts, Christopher J.; Hill, Victoria K.; Linehan, W. Marston			Tumor-Specific Hypermethylation of Epigenetic Biomarkers, Including SFRP1, Predicts for Poorer Survival in Patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) Project	PLOS ONE			English	Article							WNT ANTAGONIST GENE; SUPPRESSOR GENE; DNA METHYLATION; PROMOTER METHYLATION; CANCER; FBN2; IDENTIFICATION; INACTIVATION; EXPRESSION; MUTATIONS	The recent publication of the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project has provided an immense wealth and breadth of data providing an invaluable tool for confirmation and expansion upon previous observations in a large data set containing multiple data types including DNA methylation, somatic mutation, and clinical information. In clear cell renal cell carcinoma (CCRCC) many genes have been demonstrated to be epigenetically inactivated by promoter hypermethylated and in a small number of cases to be associated with clinical outcome. This study created two cohorts based on the Illumina BeadChip array used to confirm the frequency of tumor-specific hypermethylation of these published hypermethylated genes, assess the impact of somatic mutation or chromosomal loss and provide the most comprehensive assessment to date of the association of this hypermethylation with patient survival. Hypermethylation of the Fibrillin 2 (FBN2) gene was the most consistent epigenetic biomarker for CCRCC across both cohorts in 40.2% or 52.5% of tumors respectively. Hypermethylation of the secreted frizzled-related protein 1 (SFRP1) gene and the basonuclin 1 (BNC1) gene were both statistically associated with poorer survival in both cohorts (SFRP1 - p=<0.0001 or 0.0010 and BNC1 - p=<0.0001 or 0.0380) and represented better independent markers of survival than tumor stage, grade or dimension in one cohort and tumor stage or dimension in the other cohort. Loss of the SFRP1 protein can potentially activate the WNT pathway and this analysis highlighted hypermethylation of several other WNT pathway regulating genes and demonstrated a poorer survival outcome for patients with somatic mutation of these genes. The success of demethylating drugs in hematological malignances and the current trials in solid tumors suggest that the identification of clinically relevant hypermethylated genes combined with therapeutic advances may improve the effectiveness and usefulness of such drugs in clear cell renal cell carcinoma.	[Ricketts, Christopher J.; Linehan, W. Marston] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hill, Victoria K.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Linehan, WM (corresponding author), NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	WML@nih.gov	Ricketts, Christopher/AAV-9580-2020		Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011028, ZIABC011043, ZIABC011038, ZIDBC011089] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awakura Y, 2008, ONCOL REP, V20, P1257, DOI 10.3892/or_00000138; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Boldrup L, 2012, EUR J CANCER, V48, P1401, DOI 10.1016/j.ejca.2011.06.032; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Chen H, 2005, LUNG CANCER, V50, P43, DOI 10.1016/j.lungcan.2005.04.013; Cooper SJ, 2012, MOL CANCER THER, V11, P2105, DOI 10.1158/1535-7163.MCT-11-0873; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dulaimi E, 2004, CLIN CANCER RES, V10, P3972, DOI 10.1158/1078-0432.CCR-04-0175; Dunwell TL, 2009, EPIGENETICS-US, V4, P185, DOI 10.4161/epi.4.3.8752; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Haruki S, 2010, CARCINOGENESIS, V31, P1027, DOI 10.1093/carcin/bgq053; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Hibi K, 2012, ANTICANCER RES, V32, P4371; Hirata H, 2011, INT J CANCER, V128, P1793, DOI 10.1002/ijc.25507; Hirata H, 2009, CLIN CANCER RES, V15, P5678, DOI 10.1158/1078-0432.CCR-09-0558; Howlader N, 2013, SEER CANC STAT REV 1; Imoto I, 2006, CANCER RES, V66, P4617, DOI 10.1158/0008-5472.CAN-05-4437; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kawakami K, 2011, INT J CANCER, V128, P541, DOI 10.1002/ijc.25357; Kawamoto K, 2008, INT J CANCER, V123, P535, DOI 10.1002/ijc.23514; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Leshchenko VV, 2010, BLOOD, V116, P1025, DOI 10.1182/blood-2009-12-257485; McRonald FE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-31; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; Morris MR, 2010, ONCOGENE, V29, P2104, DOI 10.1038/onc.2009.493; Morris MR, 2010, GENOME MED, V2, DOI 10.1186/gm180; Morrissey C, 2001, CANCER RES, V61, P7277; Pawlowski R, 2013, INT J CANCER, V132, pE11, DOI 10.1002/ijc.27822; Peters I, 2012, BJU INT, V110, pE144, DOI 10.1111/j.1464-410X.2011.10862.x; Ricketts CJ, 2012, EPIGENETICS-US, V7, P278, DOI 10.4161/epi.7.3.19103; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Tong Wei-Gang, 2010, Epigenetics, V5, P499; Tsunoda S, 2009, ONCOL REP, V21, P1067, DOI 10.3892/or_00000325; Urakami S, 2006, CLIN CANCER RES, V12, P6989, DOI 10.1158/1078-0432.CCR-06-1194; van Vlodrop IJH, 2010, AM J PATHOL, V176, P575, DOI 10.2353/ajpath.2010.090442; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101; Zhang DJ, 2012, ONCOL REP, V28, P1785, DOI 10.3892/or.2012.1997	48	43	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85621	10.1371/journal.pone.0085621	http://dx.doi.org/10.1371/journal.pone.0085621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454902	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100106
J	Tamura, A; Yamada, N; Yaguchi, Y; Machida, Y; Mori, I; Osanai, M				Tamura, Atsushi; Yamada, Naohiro; Yaguchi, Yuichi; Machida, Yoshio; Mori, Issei; Osanai, Makoto			Both Neurons and Astrocytes Exhibited Tetrodotoxin-Resistant Metabotropic Glutamate Receptor-Dependent Spontaneous Slow Ca2+ Oscillations in Striatum	PLOS ONE			English	Article							SPONTANEOUS CALCIUM TRANSIENTS; GREEN FLUORESCENT PROTEIN; BASAL GANGLIA; INTRACELLULAR CALCIUM; ENDOPLASMIC-RETICULUM; EXPRESSION; MODULATION; IMMUNOREACTIVITY; TRANSMISSION; POPULATIONS	The striatum plays an important role in linking cortical activity to basal ganglia outputs. Group I metabotropic glutamate receptors (mGluRs) are densely expressed in the medium spiny projection neurons and may be a therapeutic target for Parkinson's disease. The group I mGluRs are known to modulate the intracellular Ca2+ signaling. To characterize Ca2+ signaling in striatal cells, spontaneous cytoplasmic Ca2+ transients were examined in acute slice preparations from transgenic mice expressing green fluorescent protein (GFP) in the astrocytes. In both the GFP-negative cells (putativeneurons) and astrocytes of the striatum, spontaneous slow and long-lasting intracellular Ca2+ transients (referred to as slow Ca2+ oscillations), which lasted up to approximately 200 s, were found. Neither the inhibition of action potentials nor ionotropic glutamate receptors blocked the slow Ca2+ oscillation. Depletion of the intracellular Ca2+ store and the blockade of inositol 1,4,5-trisphosphate receptors greatly reduced the transient rate of the slow Ca2+ oscillation, and the application of an antagonist against mGluR5 also blocked the slow Ca2+ oscillation in both putative-neurons and astrocytes. Thus, the mGluR5-inositol 1,4,5-trisphosphate signal cascade is the primary contributor to the slow Ca2+ oscillation in both putativeneurons and astrocytes. The slow Ca2+ oscillation features multicellular synchrony, and both putative-neurons and astrocytes participate in the synchronous activity. Therefore, the mGluR5-dependent slow Ca2+ oscillation may involve in the neuron-glia interaction in the striatum.	[Tamura, Atsushi; Mori, Issei; Osanai, Makoto] Tohoku Univ, Grad Sch Med, Dept Radiol Imaging & Informat, Sendai, Miyagi 980, Japan; [Tamura, Atsushi; Osanai, Makoto] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; [Yamada, Naohiro; Yaguchi, Yuichi] Osaka Univ, Grad Sch Engn, Div Elect Elect & Informat Engn, Suita, Osaka, Japan; [Machida, Yoshio] Tohoku Univ, Grad Sch Med, Dept Med Imaging & Appl Radiol, Sendai, Miyagi 980, Japan	Tohoku University; Japan Science & Technology Agency (JST); Osaka University; Tohoku University	Osanai, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Radiol Imaging & Informat, Sendai, Miyagi 980, Japan.	osanai@med.tohoku.ac.jp	Osanai, Makoto/B-7048-2009	Osanai, Makoto/0000-0002-3572-8195	Japan Society for the Promotion of Science KAKENHI [19300105, 23590255]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 19300105, 23590255 (http://www.jsps.go.jp/english/index.html) to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Aguado F, 2002, J NEUROSCI, V22, P9430; Ambrosi G, 2010, BRAIN RES BULL, V82, P29, DOI 10.1016/j.brainresbull.2010.01.011; Ango F, 2000, J NEUROSCI, V20, P8710; Arizono M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002498; Bargas J, 1999, NEUROSCIENCE, V88, P479, DOI 10.1016/S0306-4522(98)00211-5; Bergson C, 2003, TRENDS PHARMACOL SCI, V24, P486, DOI 10.1016/S0165-6147(03)00232-3; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Biber K, 1999, J NEUROCHEM, V72, P1671, DOI 10.1046/j.1471-4159.1999.721671.x; Blaustein MR, 2001, TRENDS NEUROSCI, V24, P602, DOI 10.1016/S0166-2236(00)01891-9; Bonsi P, 2007, AMINO ACIDS, V32, P189, DOI 10.1007/s00726-006-0320-3; Butt AM, 2011, SEMIN CELL DEV BIOL, V22, P205, DOI 10.1016/j.semcdb.2011.02.023; Carrillo-Reid L, 2008, J NEUROPHYSIOL, V99, P1435, DOI 10.1152/jn.01131.2007; Chesselet MF, 1996, TRENDS NEUROSCI, V19, P417; Clements MA, 2013, J NEUROSCI, V33, P2697, DOI 10.1523/JNEUROSCI.4759-12.2013; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; D'Ascenzo M, 2007, P NATL ACAD SCI USA, V104, P1995, DOI 10.1073/pnas.0609408104; Deister CA, 2009, J NEUROSCI, V29, P8452, DOI 10.1523/JNEUROSCI.0576-09.2009; Dietz B, 2012, J NEUROSCI, V32, P10699, DOI 10.1523/JNEUROSCI.0372-12.2012; Galarraga E, 2007, NEUROSCIENCE, V146, P537, DOI 10.1016/j.neuroscience.2007.01.032; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Mao LM, 2003, EUR J NEUROSCI, V17, P741, DOI 10.1046/j.1460-9568.2003.02495.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Muramatsu Y, 2003, GLIA, V42, P307, DOI 10.1002/glia.10225; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; North RA, 2006, PFLUG ARCH EUR J PHY, V452, P479, DOI 10.1007/s00424-006-0060-y; Osanai M, 2013, JAPANESE UNEXAMINED, Patent No. 2013-215114; Osanai M, 2010, 2010 NEUR M PLANN SA; Osanai M, 2006, NEUROSCI LETT, V402, P81, DOI 10.1016/j.neulet.2006.04.012; Osanai M, 2013, NEUROSCI RES, V75, P46, DOI 10.1016/j.neures.2012.10.008; Osanai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013738; Oueslati A, 2005, EUR J NEUROSCI, V22, P2765, DOI 10.1111/j.1460-9568.2005.04498.x; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Pasti L, 1997, J NEUROSCI, V17, P7817; RICHTERLANDSBERG C, 1995, J NEUROSCI RES, V42, P657, DOI 10.1002/jnr.490420508; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Sun W, 2013, SCIENCE, V339, P197, DOI 10.1126/science.1226740; Tallaksen-Greene SJ, 1998, BRAIN RES, V780, P210, DOI 10.1016/S0006-8993(97)01141-4; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tamura A, 2012, BOTH NEURONS ASTROCY; Tang TS, 2004, J BIOL CHEM, V279, P42082, DOI 10.1074/jbc.M407389200; TESTA CM, 1994, J NEUROSCI, V14, P3005; Vacas J, 2003, BRAIN RES, V992, P272, DOI 10.1016/j.brainres.2003.08.055; Vorndran C, 1995, BIOPHYS J, V69, P2112, DOI 10.1016/S0006-3495(95)80082-2; Wang JQ, 2002, GLUTAMATE ADDICTION, P157; Yasumoto F, 2004, CELL MOL NEUROBIOL, V24, P51, DOI 10.1023/B:CEMN.0000012724.79184.b6; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	53	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85351	10.1371/journal.pone.0085351	http://dx.doi.org/10.1371/journal.pone.0085351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454845	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100072
J	Wu, XC; Pertovaara, H; Korkola, P; Dastidar, P; Jarvenpaa, R; Eskola, H; Kellokumpu-Lehtinen, PL				Wu, Xingchen; Pertovaara, Hannu; Korkola, Pasi; Dastidar, Prasun; Jarvenpaa, Ritva; Eskola, Hannu; Kellokumpu-Lehtinen, Pirkko-Liisa			Correlations between Functional Imaging Markers Derived from PET/CT and Diffusion-Weighted MRI in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; C-REACTIVE PROTEIN; GLUCOSE-METABOLISM; FDG PET/CT; ADC MEASUREMENTS; PRIMARY TUMOR; COEFFICIENT; BETA-2-MICROGLOBULIN; PREDICTOR; PROGNOSIS	Objectives: To investigate the correlations between functional imaging markers derived from positron emission tomography/computed tomography (PET/CT) and diffusion-weighted magnetic resonance imaging (DWI) in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Further to compare the usefulness of these tumor markers in differentiating diagnosis of the two common types of Non-Hodgkin's lymphoma (NHL). Materials and Methods: Thirty-four consecutive pre-therapy adult patients with proven NHL (23 DLBCL and 11 FL) underwent PET/CT and MRI examinations and laboratory tests. The maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and metabolic tumor burden (MTB) were determined from the PET/CT images. DWI was performed in addition to conventional MRI sequences using two b values (0 and 800 s/mm(2)). The minimum and mean apparent diffusion coefficient (ADC(min) and ADC(mean)) were measured on the parametric ADC maps. Results: The SUVmax correlated inversely with the ADC(min) (r = -0.35, p<0.05). The ADC(min), ADC(mean), serum thymidine kinase (TK), Beta 2-microglobulin (B2m), lactate dehydrogenase (LD), and C-reactive protein (CRP) correlated with both whole-body MTV and whole-body MTB (p<0.05 or 0.01). The SUVmax, TK, LD, and CRP were significantly higher in the DLBCL group than in the FL group. Receiver operating characteristic curve analysis showed that they were reasonable predictors in differentiating DLBCL from FL. Conclusions: The functional imaging markers determined from PET/CT and DWI are associated, and the SUVmax is superior to the ADC(min) in differentiating DLBCL from FL. All the measured serum markers are associated with functional imaging markers. Serum LD, TK, and CRP are useful in differentiating DLBCL from FL.	[Wu, Xingchen; Pertovaara, Hannu; Kellokumpu-Lehtinen, Pirkko-Liisa] Tampere Univ Hosp, Dept Oncol, Tampere, Finland; [Wu, Xingchen; Dastidar, Prasun; Jarvenpaa, Ritva; Eskola, Hannu] Tampere Univ Hosp, Dept Radiol, Med Imaging Ctr, Tampere, Finland; [Wu, Xingchen; Dastidar, Prasun; Kellokumpu-Lehtinen, Pirkko-Liisa] Univ Tampere, Sch Med, Tampere, Finland; [Korkola, Pasi] Tampere Univ Hosp, Dept Nucl Med, Med Imaging Ctr, Tampere, Finland; [Eskola, Hannu] Tampere Univ Technol, Dept Elect & Telecommun, FIN-33101 Tampere, Finland	Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University; Tampere University; Tampere University Hospital; Tampere University	Wu, XC (corresponding author), Tampere Univ Hosp, Dept Oncol, Tampere, Finland.	Xingchen.Wu@uta.fi	Eskola, Hannu/G-4279-2014	Eskola, Hannu/0000-0003-1673-2305	Biomedical Image Quantification/University Alliance of Finland; Elna Savolainen Fund of Pirkanmaa Hospital District Research Center	Biomedical Image Quantification/University Alliance of Finland; Elna Savolainen Fund of Pirkanmaa Hospital District Research Center	This study was supported by the Biomedical Image Quantification/University Alliance of Finland and the Elna Savolainen Fund of Pirkanmaa Hospital District Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Y, 2012, TUMOR BIOL, V33, P1039, DOI 10.1007/s13277-012-0337-z; Crumley ABC, 2006, BRIT J CANCER, V94, P1568, DOI 10.1038/sj.bjc.6603150; Flowers CR, 2010, CL LYMPH MYELOM LEUK, V10, P414, DOI 10.3816/CLML.2010.n.086; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gu J, 2011, MOL IMAGING BIOL, V13, P1020, DOI 10.1007/s11307-010-0433-7; HAGBERG H, 1983, CANCER, V51, P2220, DOI 10.1002/1097-0142(19830615)51:12<2220::AID-CNCR2820511212>3.0.CO;2-A; Hashimoto K, 2005, CANCER-AM CANCER SOC, V103, P1856, DOI 10.1002/cncr.20976; Hirano M, 2012, AM J ROENTGENOL, V198, P717, DOI 10.2214/AJR.11.7093; Ho KC, 2009, EUR J NUCL MED MOL I, V36, P200, DOI 10.1007/s00259-008-0936-5; Holzapfel K, 2009, EUR J RADIOL, V72, P381, DOI 10.1016/j.ejrad.2008.09.034; Jaffe ES, 2009, HEMATOL-AM SOC HEMAT, V2009, P523, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.523; JAGANNATH S, 1986, J CLIN ONCOL, V4, P859, DOI 10.1200/JCO.1986.4.6.859; JOHNSON PWM, 1993, BRIT J CANCER, V67, P792, DOI 10.1038/bjc.1993.144; Kwee TC, 2011, MAGN RESON MATER PHY, V24, P1, DOI 10.1007/s10334-010-0226-7; LAPELA M, 1995, BLOOD, V86, P3522, DOI 10.1182/blood.V86.9.3522.bloodjournal8693522; Matsubayashi RN, 2010, J ONCOL, V2010, DOI 10.1155/2010/821048; Nakamura K, 2013, EUR J NUCL MED MOL I, V40, P52, DOI 10.1007/s00259-012-2240-7; Nakamura K, 2012, EUR J NUCL MED MOL I, V39, P283, DOI 10.1007/s00259-011-1978-7; Okada M, 2010, RADIOGRAPHICS, V30, P939, DOI 10.1148/rg.304095150; Papajik T, 2011, EUR J HAEMATOL, V86, P32, DOI 10.1111/j.1600-0609.2010.01532.x; Park S, 2012, AM J HEMATOL, V87, P937, DOI 10.1002/ajh.23267; Patterson DM, 2008, NAT CLIN PRACT ONCOL, V5, P220, DOI 10.1038/ncponc1073; Punwani S, 2010, CANCER BIOMARK, V7, P249, DOI 10.3233/CBM-2010-0197; Regier M, 2012, EUR J RADIOL, V81, P2913, DOI 10.1016/j.ejrad.2011.11.050; Schoder H, 2005, J CLIN ONCOL, V23, P4643, DOI 10.1200/JCO.2005.12.072; Shou Y, 2012, J CANCER RES THER, V8, P96, DOI 10.4103/0973-1482.95182; Tang BF, 2009, MOL IMAGING BIOL, V11, P296, DOI 10.1007/s11307-009-0226-z; Topolcan Ondrej, 2008, Expert Opin Med Diagn, V2, P129, DOI 10.1517/17530059.2.2.129; Wang JC, 2001, RADIOLOGY, V220, P621, DOI 10.1148/radiol.2202010063; Wong CS, 2012, EUR J RADIOL, V81, P2122, DOI 10.1016/j.ejrad.2011.09.003; Wu XC, 2013, EUR J RADIOL, V82, pE158, DOI 10.1016/j.ejrad.2012.11.021; Wu XC, 2012, LEUKEMIA LYMPHOMA, V53, P400, DOI 10.3109/10428194.2011.622420; Wu XC, 2011, EUR J RADIOL, V79, pE117, DOI 10.1016/j.ejrad.2011.04.062; Wu XC, 2011, MOL IMAGING BIOL, V13, P785, DOI 10.1007/s11307-010-0404-z; Wu XC, 2011, NMR BIOMED, V24, P1181, DOI 10.1002/nbm.1689; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	36	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84999	10.1371/journal.pone.0084999	http://dx.doi.org/10.1371/journal.pone.0084999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454777	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100047
J	Harihar, S; Pounds, KM; Iwakuma, T; Seidah, NG; Welch, DR				Harihar, Sitaram; Pounds, Keke M.; Iwakuma, Tomoo; Seidah, Nabil G.; Welch, Danny R.			Furin Is the Major Proprotein Convertase Required for KISS1-to-Kisspeptin Processing	PLOS ONE			English	Article							KISS1 METASTASIS SUPPRESSOR; PROTEIN-COUPLED RECEPTOR; CELL-LINES; MUTATION; PUBERTY; CANCER; GENE; KISSPEPTIN-10; REPRODUCTION; ACTIVATION	KISS1 is a broadly functional secreted proprotein that is then processed into small peptides, termed kisspeptins (KP). Since sequence analysis showed cleavage at KR or RR dibasic sites of the nascent protein, it was hypothesized that enzyme(s) belonging to the proprotein convertase family of proteases process KISS1 to generate KP. To this end, cell lines over-expressing KISS1 were treated with the proprotein convertase inhibitors, Dec-RVKR-CMK and alpha 1-PDX, and KISS1 processing was completely inhibited. To identify the specific enzyme(s) responsible for KISS1 processing, mRNA expression was systematically analyzed for six proprotein convertases found in secretory pathways. Consistent expression of the three proteases - furin, PCSK5 and PCSK7 - were potentially implicated in KISS1 processing. However, shRNA-mediated knockdown of furin - but not PCSK5 or PCSK7 - blocked KISS1 processing. Thus, furin appears to be the essential enzyme for the generation of kisspeptins.	[Harihar, Sitaram; Pounds, Keke M.; Iwakuma, Tomoo; Welch, Danny R.] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66103 USA; [Iwakuma, Tomoo; Welch, Danny R.] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66103 USA; [Pounds, Keke M.; Iwakuma, Tomoo; Welch, Danny R.] Univ Kansas, Med Ctr, Dept Mol Physiol, Kansas City, KS 66103 USA; [Welch, Danny R.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal, Montreal, PQ, Canada	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Welch, DR (corresponding author), Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66103 USA.	Dwelch@KUMC.edu	Harihar, Sitaram/Q-4088-2016; Seidah, Nabil/I-3596-2013; Welch, Danny R/B-7310-2009; harihar, sitaram/AAO-1476-2020	Harihar, Sitaram/0000-0003-4953-7282; Seidah, Nabil/0000-0001-6503-9342; Welch, Danny R/0000-0002-1951-4947; harihar, sitaram/0000-0003-4953-7282	U.S. National Cancer Institute [RO1-CA134981]; Susan G. Komen for the Cure [SAC11037]; National Foundation for Cancer Research-Center for Metastasis Research; Kansas Bioscience Authority [P30-CA168524]; American Cancer Society [RSG-09-169-01-CS]; Canada Chair Grant [216684]; NATIONAL CANCER INSTITUTE [P30CA168524, R01CA134981] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Foundation for Cancer Research-Center for Metastasis Research; Kansas Bioscience Authority; American Cancer Society(American Cancer Society); Canada Chair Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are extremely grateful for the direct financial support for this project from U.S. National Cancer Institute RO1-CA134981 (to DRW). Partial support for this project was received from Susan G. Komen for the Cure SAC11037 (to DRW), National Foundation for Cancer Research-Center for Metastasis Research (to DRW), Kansas Bioscience Authority (DRW is a Kansas Bioscience Authority Eminent Scholar), P30-CA168524 (to DRW), American Cancer Society RSG-09-169-01-CS (to TI) and Canada Chair Grant #216684 (to NGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck BH, 2012, COMP BIOCHEM PHYS A, V162, P265, DOI 10.1016/j.cbpa.2012.03.019; Beck BH, 2010, EUR J CANCER, V46, P1283, DOI 10.1016/j.ejca.2010.02.023; Beier DR, 2003, NEW ENGL J MED, V349, P1589, DOI 10.1056/NEJMp038155; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Crown A, 2007, NEUROENDOCRINOLOGY, V86, P175, DOI 10.1159/000109095; JOHNSON JP, 1981, EUR J IMMUNOL, V11, P825, DOI 10.1002/eji.1830111015; Matsui H, 2012, ENDOCRINOLOGY, V153, P5297, DOI 10.1210/en.2012-1388; Milton Nathaniel G N, 2012, J Amino Acids, V2012, P691463, DOI 10.1155/2012/691463; Milton NGN, 2012, ACS CHEM NEUROSCI, V3, P706, DOI 10.1021/cn300045d; Nash KT, 2007, JNCI-J NATL CANCER I, V99, P309, DOI 10.1093/jnci/djk053; Nash KT, 2006, FRONT BIOSCI-LANDMRK, V11, P647, DOI 10.2741/1824; Navarro VM, 2012, NAT REV ENDOCRINOL, V8, P40, DOI 10.1038/nrendo.2011.147; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Quennell JH, 2011, ENDOCRINOLOGY, V152, P1541, DOI 10.1210/en.2010-1100; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Smith JT, 2006, J NEUROENDOCRINOL, V18, P298, DOI 10.1111/j.1365-2826.2006.01417.x; Stafford LJ, 2008, INT J BIOCHEM CELL B, V40, P874, DOI 10.1016/j.biocel.2007.12.016; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Thompson EL, 2004, J NEUROENDOCRINOL, V16, P850, DOI 10.1111/j.1365-2826.2004.01240.x; Topaloglu AK, 2012, NEW ENGL J MED, V366, P629, DOI 10.1056/NEJMoa1111184; Vogel G, 2005, SCIENCE, V309, P551, DOI 10.1126/science.309.5734.551; Wang HH, 2012, AM J PATHOL, V180, P1170, DOI 10.1016/j.ajpath.2011.11.020; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	35	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84958	10.1371/journal.pone.0084958	http://dx.doi.org/10.1371/journal.pone.0084958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454770	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500028
J	Papavlassopoulos, H; Mishra, YK; Kaps, S; Paulowicz, I; Abdelaziz, R; Elbahri, M; Maser, E; Adelung, R; Rohl, C				Papavlassopoulos, Heike; Mishra, Yogendra K.; Kaps, Soeren; Paulowicz, Ingo; Abdelaziz, Ramzy; Elbahri, Mady; Maser, Edmund; Adelung, Rainer; Roehl, Claudia			Toxicity of Functional Nano-Micro Zinc Oxide Tetrapods: Impact of Cell Culture Conditions, Cellular Age and Material Properties	PLOS ONE			English	Article							HUMAN DERMAL FIBROBLASTS; INDUCE OXIDATIVE STRESS; ZNO NANOPARTICLES; CONTACT INHIBITION; CANCER-CELLS; APOPTOSIS; NANOMATERIALS; GROWTH; NANOSTRUCTURES; CYTOTOXICITY	With increasing production and applications of nanostructured zinc oxide, e. g., for biomedical and consumer products, the question of safety is getting more and more important. Different morphologies of zinc oxide structures have been synthesized and accordingly investigated. In this study, we have particularly focused on nano-micro ZnO tetrapods (ZnO-T), because their large scale fabrication has been made possible by a newly introduced flame transport synthesis approach which will probably lead to several new applications. Moreover, ZnO-T provide a completely different morphology then classical spherical ZnO nanoparticles. To get a better understanding of parameters that affect the interactions between ZnO-T and mammalian cells, and thus their biocompatibility, we have examined the impact of cell culture conditions as well as of material properties on cytotoxicity. Our results demonstrate that the cell density of fibroblasts in culture along with their age, i.e., the number of preceding cell divisions, strongly affect the cytotoxic potency of ZnO-T. Concerning the material properties, the toxic potency of ZnO-T is found to be significantly lower than that of spherical ZnO nanoparticles. Furthermore, the morphology of the ZnO-T influenced cellular toxicity in contrast to surface charges modified by UV illumination or O-2 treatment and to the material age. Finally, we have observed that direct contact between tetrapods and cells increases their toxicity compared to transwell culture models which allow only an indirect effect via released zinc ions. The results reveal several parameters that can be of importance for the assessment of ZnO-T toxicity in cell cultures and for particle development.	[Papavlassopoulos, Heike; Maser, Edmund; Roehl, Claudia] Univ Kiel, Inst Toxicol & Pharmacol Nat Scientists, Kiel, Germany; [Mishra, Yogendra K.; Kaps, Soeren; Paulowicz, Ingo; Abdelaziz, Ramzy; Elbahri, Mady; Adelung, Rainer] Univ Kiel, Inst Mat Sci, Kiel, Germany; [Elbahri, Mady] Helmholtz Zentrum Geesthacht, Polymer Res Inst, Geesthacht, Germany; [Roehl, Claudia] Fed Inst Risk Assessment, ZEBET Alternat Methods Anim Expt, Berlin, Germany	University of Kiel; University of Kiel; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Federal Institute for Risk Assessment	Mishra, YK (corresponding author), Univ Kiel, Inst Mat Sci, Kiel, Germany.	ykm@tf.uni-kiel.de; claudia.roehl@gmx.net	Mishra, Yogendra Kumar/G-6241-2010; Adelung, Rainer/AAU-1027-2021; Maser, Edmund/B-1728-2010; Elbahri, Prof. Dr. Mady/B-4273-2015	Mishra, Yogendra Kumar/0000-0002-8786-9379; Adelung, Rainer/0000-0002-2617-678X; Elbahri, Prof. Dr. Mady/0000-0002-6720-1945; Abdelaziz, Ramzy/0000-0002-8349-1751	German Research Foundation (DFG) [SFB 855-A5, Ad/183/10-1]; Humboldt Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); Humboldt Foundation(Alexander von Humboldt Foundation)	Authors HP, EM and CR would like to acknowledge a grant from Medical Faculty (Christiana Albertina University Kiel). Authors also thank the German Research Foundation (DFG) for financial support under schemes SFB 855-A5 and Ad/183/10-1. YKM acknowledges the Humboldt Foundation for postdoctoral grant. ME thanks to DFG for SFB 677 and EL554/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaziz R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3400; Adelung R., 2011, Germany Patent, Patent No. [DE 2011/000282, 2011000282, DE2011/000282]; Adelung R, 2011, Elastic material with a pore space bridged at the particle level by nanobridges between particles., Patent No. [WO2011116751-A3, 2011116751A3]; Ahamed M, 2011, NANOMED-NANOTECHNOL, V7, P904, DOI 10.1016/j.nano.2011.04.011; Akhtar MJ, 2012, INT J NANOMED, V7, P845, DOI 10.2147/IJN.S29129; Andres-Pons A, 2012, CELL SIGNAL, V24, P577, DOI 10.1016/j.cellsig.2011.10.012; Antoine TE, 2012, ANTIVIR RES, V96, P363, DOI 10.1016/j.antiviral.2012.09.020; Burnett ME, 2011, PHOTODERMATOL PHOTO, V27, P58, DOI 10.1111/j.1600-0781.2011.00557.x; Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789; Deng XY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/11/115101; Elbahri M, 2007, ADV MATER, V19, P1262, DOI 10.1002/adma.200601694; Feng XJ, 2004, J AM CHEM SOC, V126, P62, DOI 10.1021/ja038636o; Fiore M, 1999, EXP CELL RES, V251, P102, DOI 10.1006/excr.1999.4542; Han ZJ, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/17/174019; Hanley C, 2009, NANOSCALE RES LETT, V4, P1409, DOI 10.1007/s11671-009-9413-8; Heng BC, 2011, ARCH TOXICOL, V85, P695, DOI 10.1007/s00204-010-0608-7; Hsiao IL, 2011, SCI TOTAL ENVIRON, V409, P1219, DOI 10.1016/j.scitotenv.2010.12.033; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Huang ZB, 2008, LANGMUIR, V24, P4140, DOI 10.1021/la7035949; Hussain SM, 2009, ADV MATER, V21, P1549, DOI 10.1002/adma.200801395; IWANAGA H, 1993, J CRYST GROWTH, V134, P275, DOI 10.1016/0022-0248(93)90136-K; Jelaska A, 1998, J CELL PHYSIOL, V175, P19, DOI 10.1002/(SICI)1097-4652(199804)175:1<19::AID-JCP3>3.0.CO;2-F; Jin X, 2013, ADV MATER; Jin X, 2012, ADV MATER, V24, P5676, DOI 10.1002/adma.201201780; Kao YY, 2012, TOXICOL SCI, V125, P462, DOI 10.1093/toxsci/kfr319; Kathawala MH, 2013, SMALL, V9, P1504, DOI 10.1002/smll.201201452; Kocbek P, 2010, SMALL, V6, P1908, DOI 10.1002/smll.201000032; Kumar A, 2011, FREE RADICAL BIO MED, V51, P1872, DOI 10.1016/j.freeradbiomed.2011.08.025; Landsiedel R, 2010, ADV MATER, V22, P2601, DOI 10.1002/adma.200902658; Levenberg S, 1999, ONCOGENE, V18, P869, DOI 10.1038/sj.onc.1202396; Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015; Liu Jia-hui, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P790; Liu XX, 2012, P NATL ACAD SCI USA, V109, P8280, DOI 10.1073/pnas.1205880109; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mammone T, 2006, CELL BIOL INT, V30, P903, DOI 10.1016/j.cellbi.2006.06.010; Meyer K, 2011, TOXICOL IN VITRO, V25, P1721, DOI 10.1016/j.tiv.2011.08.011; Mishra YK, 2013, PART PART SYST CHAR, V30, P775, DOI 10.1002/ppsc.201300197; Mishra YK, 2011, ANTIVIR RES, V92, P305, DOI 10.1016/j.antiviral.2011.08.017; Moos PJ, 2010, CHEM RES TOXICOL, V23, P733, DOI 10.1021/tx900203v; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motti ML, 2005, CARCINOGENESIS, V26, P1021, DOI 10.1093/carcin/bgi050; Nie L, 2006, SMALL, V2, P621, DOI 10.1002/smll.200500193; Nohynek GJ, 2008, SKIN PHARMACOL PHYS, V21, P136, DOI 10.1159/000131078; Oberringer M, 2007, BIOL CELL, V99, P197, DOI 10.1042/BC20060116; Park SC, 1999, J GERONTOL A-BIOL, V54, pB78, DOI 10.1093/gerona/54.2.B78; Piacentini M, 2002, J NEUROCHEM, V81, P1061; Premanathan M, 2011, NANOMED-NANOTECHNOL, V7, P184, DOI 10.1016/j.nano.2010.10.001; Rasmussen JW, 2010, EXPERT OPIN DRUG DEL, V7, P1063, DOI 10.1517/17425247.2010.502560; Richter L, 2011, LAB CHIP, V11, P2551, DOI 10.1039/c1lc20256a; Rohl C, 2005, TOXICOL APPL PHARM, V204, P36, DOI 10.1016/j.taap.2004.08.007; Ronning C, 2005, J APPL PHYS, V98, DOI 10.1063/1.1997290; Shin DM, 2004, J BIOL CHEM, V279, P15032, DOI 10.1074/jbc.M308734200; Song WH, 2010, TOXICOL LETT, V199, P389, DOI 10.1016/j.toxlet.2010.10.003; Sun RD, 2001, J PHYS CHEM B, V105, P1984, DOI 10.1021/jp002525j; Swat A, 2009, MOL CELL BIOL, V29, P3332, DOI 10.1128/MCB.01955-08; Taccola L, 2011, INT J NANOMED, V6, DOI 10.2147/IJN.S16581; Tong XH, 2013, TOXICOLOGY, V310, P53, DOI 10.1016/j.tox.2013.05.010; Umar A, 2013, J BIOMED NANOTECHNOL, V9, P1794, DOI 10.1166/jbn.2013.1751; Wahab R, 2013, J BIOMED NANOTECHNOL, V9, P1181, DOI 10.1166/jbn.2013.1652; Wahab R, 2013, J BIOMED NANOTECHNOL, V9, P441, DOI 10.1166/jbn.2013.1593; Wahab R, 2011, J BIOL INORG CHEM, V16, P431, DOI 10.1007/s00775-010-0740-0; Wang BB, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/10/102005; Wang HJ, 2010, TOXICOL IN VITRO, V24, P1953, DOI 10.1016/j.tiv.2010.08.005; Wille S, 2011, SPIE NEWSROOM, DOI [10.1117/2.1201111.003944, DOI 10.1117/2.1201111.003944)]; Xue ZG, 2010, INT J CELL BIOL, V2010; Zhang JH, 2012, ADV MATER, V24, P1232, DOI 10.1002/adma.201104535	66	85	85	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84983	10.1371/journal.pone.0084983	http://dx.doi.org/10.1371/journal.pone.0084983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454775	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500029
J	Zhang, ZZ; Guo, X; Herrera, C; Tao, YL; Wu, Q; Wu, AM; Wang, H; Bartnikas, TB; Wang, FD				Zhang, Zhuzhen; Guo, Xin; Herrera, Carolina; Tao, Yunlong; Wu, Qian; Wu, Aimin; Wang, Hao; Bartnikas, Thomas B.; Wang, Fudi			Bmp6 Expression Can Be Regulated Independently of Liver Iron in Mice	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN 6; HEPCIDIN EXPRESSION; TRANSFERRIN RECEPTOR; HYPOTRANSFERRINEMIC MICE; PEPTIDE HEPCIDIN; GENE-EXPRESSION; MOUSE-LIVER; IN-VIVO; HEMOJUVELIN; OVERLOAD	The liver is the primary organ for storing iron and plays a central role in the regulation of body iron levels by secretion of the hormone Hamp1. Although many factors modulate Hamp1 expression, their regulatory mechanisms are poorly understood. Here, we used conditional knockout mice for the iron exporter ferroportin1 (Fpn1) to modulate tissue iron in specific tissues in combination with iron-deficient or iron-rich diets and transferrin (Tf) supplementation to investigate the mechanisms underlying Hamp1 expression. Despite liver iron overload, expression of bone morphogenetic protein 6 (Bmp6), a potent-stimulator of Hamp1 expression that is expressed under iron-loaded conditions, was decreased. We hypothesized that factors other than liver iron must play a role in controlling Bmp6 expression. Our results show that erythropoietin and Tf-bound iron do not underlie the down-regulation of Bmp6 in our mice models. Moreover, Bmp6 was down-regulated under conditions of high iron demand, irrespective of the presence of anemia. We therefore inferred that the signals were driven by high iron demand. Furthermore, we also confirmed previous suggestions that Tf-bound iron regulates Hamp1 expression via Smad1/5/8 phosphorylation without affecting Bmp6 expression, and the effect of Tf-bound iron on Hamp1 regulation appeared before a significant change in Bmp6 expression. Together, these results are consistent with novel mechanisms for regulating Bmp6 and Hamp1 expression.	[Zhang, Zhuzhen; Guo, Xin; Tao, Yunlong; Wu, Qian; Wu, Aimin; Wang, Hao; Wang, Fudi] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Inst Nutr & Food Safety,Sch Publ Hlth, Lab Nutr & Metab,Ctr Nutr & Hlth,Dept Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Zhuzhen; Guo, Xin; Tao, Yunlong; Wu, Qian; Wu, Aimin; Wang, Hao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab,Grad Sch, Shanghai, Peoples R China; [Herrera, Carolina; Bartnikas, Thomas B.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Brown University	Wang, FD (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Inst Nutr & Food Safety,Sch Publ Hlth, Lab Nutr & Metab,Ctr Nutr & Hlth,Dept Nutr, Hangzhou 310003, Zhejiang, Peoples R China.	fwang@zju.edu.cn	Wang, Fudi/L-7888-2018; Wu, Aimin/AAD-8903-2020; Tao, Yunlong/I-8328-2019; Wang, Hao/Z-1709-2018	Wang, Fudi/0000-0001-8730-0003; Tao, Yunlong/0000-0003-0377-7133; Zhang, Zhuzhen/0000-0001-6787-3920; Wu, Qian/0000-0003-3934-0128; Wang, Hao/0000-0001-7661-3688	Ministry of Science and Technology of China (973 Program) [2011CB966200, 2012BAD33B05]; National Natural Science Foundation of China [31200892, 31225013, 31330036, 31030039]; National Institutes of Health (NIH) [R00DK084122]; Postdoctoral Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2012KIP512]; SA-SIBS Scholarship Program; Zhejiang University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK084122] Funding Source: NIH RePORTER	Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Postdoctoral Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; SA-SIBS Scholarship Program; Zhejiang University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the Ministry of Science and Technology of China (973 Program) (grant numbers 2011CB966200, 2012BAD33B05); the National Natural Science Foundation of China (grant numbers 31200892 to ZZ, 31225013, 31330036, and 31030039 to FW); National Institutes of Health (NIH) grant to TBB (grant number R00DK084122); The Postdoctoral Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (grant number 2012KIP512) and SA-SIBS Scholarship Program. This work was also supported by the Distinguished Professorship Program from Zhejiang University (to FW). FW is Principal Investigator at the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2007, AM J HEMATOL, V82, P1128, DOI 10.1002/ajh.21075; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bartnikas TB, 2012, HAEMATOL-HEMATOL J, V97, P189, DOI 10.3324/haematol.2011.054031; Bartnikas TB, 2011, BLOOD, V117, P630, DOI 10.1182/blood-2010-05-287359; Chen W, 2011, BLOOD, V117, P6319, DOI 10.1182/blood-2010-12-327957; Corradini E, 2011, HEPATOLOGY, V54, P273, DOI 10.1002/hep.24359; Feng Q, 2012, AM J PHYSIOL-GASTR L, V302, pG1397, DOI 10.1152/ajpgi.00020.2012; Fleming RE, 2002, P NATL ACAD SCI USA, V99, P10653, DOI 10.1073/pnas.162360699; Frazer DM, 2012, BRIT J HAEMATOL, V157, P615, DOI 10.1111/j.1365-2141.2012.09104.x; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; HAYASHI A, 1993, AM J HUM GENET, V53, P201; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Krijt J, 2010, BLOOD CELL MOL DIS, V44, P257, DOI 10.1016/j.bcmd.2010.02.012; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Li HH, 2010, NAT MED, V16, P177, DOI 10.1038/nm.2073; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Parrow NL, 2012, BLOOD, V119, P3187, DOI 10.1182/blood-2012-01-405563; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Ramey G, 2009, HAEMATOL-HEMATOL J, V94, P765, DOI 10.3324/haematol.2008.003541; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Trenor CC, 2000, BLOOD, V96, P1113, DOI 10.1182/blood.V96.3.1113.015k03_1113_1118; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Wilkins SJ, 2006, BLOOD, V107, P1659, DOI 10.1182/blood-2005-07-2614; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang ZZ, 2012, HEPATOLOGY, V56, P961, DOI 10.1002/hep.25746; Zhang ZZ, 2011, BLOOD, V118, P1912, DOI 10.1182/blood-2011-01-330324; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492	42	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84906	10.1371/journal.pone.0084906	http://dx.doi.org/10.1371/journal.pone.0084906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454764	gold, Green Published, Green Submitted			2022-12-25	WOS:000329922500024
J	Lee, KP; Choi, S; Hong, JH; Ahuja, M; Graham, S; Ma, R; So, I; Shin, DM; Muallem, S; Yuan, JP				Lee, Kyu Pil; Choi, Seok; Hong, Jeong Hee; Ahuja, Malini; Graham, Sarabeth; Ma, Rong; So, Insuk; Shin, Dong Min; Muallem, Shmuel; Yuan, Joseph P.			Molecular Determinants Mediating Gating of Transient Receptor Potential Canonical (TRPC) Channels by Stromal Interaction Molecule 1 (STIM1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Calcium Signaling; Gating; Signaling; TRP Channels; Gating Mechanism; STIM1	STORE-OPERATED CHANNELS; PLASMA-MEMBRANE; ORAI CHANNELS; CA2+ INFLUX; MECHANISTIC INSIGHTS; CRAC CHANNELS; DOMAIN; ENTRY; CALCIUM; OLIGOMERIZATION	Background: STIM1 gates TRPC channels, but the interacting domains are unknown. Results: The TRPC N and C terminus coiled coil domains interact to restrict access of STIM1. Their dissociation by cell stimulation promotes STIM1 interaction. Conclusion: The STIM1 Orai1-activating region (SOAR) domain interacts with the TRPC C terminus CCD to open the channels. Significance: The findings reveal how STIM1 opens the TRPC channels to control receptor-stimulated Ca2+ influx. Transient receptor potential canonical (TRPC) channels mediate a critical part of the receptor-evoked Ca2+ influx. TRPCs are gated open by the endoplasmic reticulum Ca2+ sensor STIM1. Here we asked which stromal interaction molecule 1 (STIM1) and TRPC domains mediate the interaction between them and how this interaction is used to open the channels. We report that the STIM1 Orai1-activating region domain of STIM1 interacts with the TRPC channel coiled coil domains (CCDs) and that this interaction is essential for opening the channels by STIM1. Thus, disruption of the N-terminal (NT) CCDs by triple mutations eliminated TRPC surface localization and reduced binding of STIM1 to TRPC1 and TRPC5 while increasing binding to TRPC3 and TRPC6. Single mutations in TRPC1 NT or C-terminal (CT) CCDs reduced interaction and activation of TRPC1 by STIM1. Remarkably, single mutations in the TRPC3 NT CCD enhanced interaction and regulation by STIM1. Disruption in the TRPC3 CT CCD eliminated regulation by STIM1 and the enhanced interaction caused by NT CCD mutations. The NT CCD mutations converted TRPC3 from a TRPC1-dependent to a TRPC1-independent, STIM1-regulated channel. TRPC1 reduced the FRET between BFP-TRPC3 and TRPC3-YFP and between CFP-TRPC3-YFP upon stimulation. Accordingly, knockdown of TRPC1 made TRPC3 STIM1-independent. STIM1 dependence of TRPC3 was reconstituted by the TRPC1 CT CCD alone. Knockout of Trpc1 and Trpc3 similarly inhibited Ca2+ influx, and inhibition of Trpc3 had no further effect on Ca2+ influx in Trpc1(-/-) cells. Cell stimulation enhanced the formation of Trpc1-Stim1-Trpc3 complexes. These findings support a model in which the TRPC3 NT and CT CCDs interact to shield the CT CCD from interaction with STIM1. The TRPC1 CT CCD dissociates this interaction to allow the STIM1 Orai1-activating region within STIM1 access to the TRPC3 CT CCD and regulation of TRPC3 by STIM1. These studies provide evidence that the TRPC channel CCDs participate in channel gating.	[Lee, Kyu Pil] Chungnam Natl Univ, Coll Vet Med, Dept Physiol, Taejon 305764, South Korea; [Choi, Seok; Hong, Jeong Hee; Ahuja, Malini; Muallem, Shmuel] NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Graham, Sarabeth; Ma, Rong; Yuan, Joseph P.] Univ N Texas, Hlth Sci Ctr, Cardiovasc Res Inst, Dept Integrat Physiol, Ft Worth, TX 76107 USA; [So, Insuk] Seoul Natl Univ, Coll Med, Dept Physiol & Biophys, Seoul 110799, South Korea; [Shin, Dong Min] Yonsei Univ, Dept Oral Biol, PLUS Project BK21, Seoul 120752, South Korea; [Choi, Seok] Chosun Univ, Coll Med, Dept Physiol, Kwangju 501759, South Korea	Chungnam National University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of North Texas System; University of North Texas Health Science Center; Seoul National University (SNU); Yonsei University; Chosun University	Muallem, S (corresponding author), NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA.	shmuel.muallem@nih.gov	rchnds, rchnds/D-7595-2016; Hong, Jeong Hee/AAX-7824-2020; ma, rong/GVU-3096-2022	Shin, Dong Min/0000-0001-6042-0435; lee, kyu pil/0000-0002-7192-4791	National Institute of Health [Z1A-DE000735, Z01-ES101684, 5R00HL093297]; National Research Foundation of Korea (NRF) [NRF-2013R1A1A1010783, 20070056092, 2012R1A2A1A01003487]; Korean government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL093297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101684] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government(Korean Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded, in whole or in part, by intramural National Institute of Health grant Z1A-DE000735 (to S. M.); National Institutes of Health Grant Z01-ES101684 (to L. B.); and National Institutes of Health Grant 5R00HL093297 (to J. P. Y.). This work was also supported by National Research Foundation of Korea (NRF) grants (MSIP) NRF-2013R1A1A1010783 (to K. P. L.) and 20070056092 and 2012R1A2A1A01003487 (to D. M. S.) funded by the Korean government.	Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Cheung KK, 2011, MUSCLE NERVE, V44, P358, DOI 10.1002/mus.22060; Derler I, 2012, FRONT BIOSCI-LANDMRK, V17, P1304, DOI 10.2741/3988; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jardin I, 2013, CELL SIGNAL, V25, P1328, DOI 10.1016/j.cellsig.2013.01.025; Jha A, 2013, J CELL BIOL, V202, P71, DOI 10.1083/jcb.201301148; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Kim MS, 2009, GASTROENTEROLOGY, V137, P1509, DOI 10.1053/j.gastro.2009.07.042; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Lee KP, 2010, J BIOL CHEM, V285, P38666, DOI 10.1074/jbc.M110.155036; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Lee MG, 1998, J PHYSIOL-LONDON, V513, P341, DOI 10.1111/j.1469-7793.1998.341bb.x; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schleifer H, 2012, BRIT J PHARMACOL, V167, P1712, DOI 10.1111/j.1476-5381.2012.02126.x; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Tong Q, 2008, J BIOL CHEM, V283, P10385, DOI 10.1074/jbc.M710231200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wedel BJ, 2003, J BIOL CHEM, V278, P25758, DOI 10.1074/jbc.M303890200; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	34	71	72	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6372	6382		10.1074/jbc.M113.546556	http://dx.doi.org/10.1074/jbc.M113.546556			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24464579	Green Published, hybrid			2022-12-25	WOS:000332389400006
J	Tian, L; Li, CW; Liu, YH; Chen, YC; Fu, MD				Tian, Li; Li, Chuanwei; Liu, Yinghui; Chen, Yucheng; Fu, Mingde			The Value and Distribution of High-Density Lipoprotein Subclass in Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							CHOLESTEROL LEVELS; HEART-DISEASE; CARDIOVASCULAR RISK; HDL; PARTICIPANTS; PREVALENCE; PREDICTORS; MECHANISMS; PREVENTION; MIRACL	Background: High-density lipoprotein (HDL) enhances cholesterol efflux from the arterial wall and exhibits potent anti-inflammatory and anti-atherosclerosis (AS) properties. Whether raised HDL levels will clinically benefit patients with acute coronary syndrome (ACS) and the value at which these effects will be apparent, however, is debatable. This study examined the HDL subclass distribution profile in patients with ACS. Methods: Plasma HDL subclasses were measured in 158 patients with established ACS and quantified by two-dimensional gel electrophoresis and immunoblotting. ACS diagnosis was based on symptoms of cardiac ischemia, electrocardiogram (ECG) abnormalities, speciality cardiac enzyme change along with presence of coronary heart disease (CHD) on coronary angiography. Results: The small-sized pre beta 1-HDL, HDL3b, and HDL3a levels were significantly higher, and the large-sized HDL2a and HDL2b levels were significantly lower in patients with ACS than in those with stable angina pectoris (SAP) and in normal control subjects. Meanwhile, with an elevation in the low-density lipoprotein cholesterol (LDL-C), fasting plasma glucose (FPG), body mass index (BMI), and blood pressure (BP), and the reduction in the high density lipoprotein cholesterol (HDL-C) levels, the HDL2b contents significantly decreased and the preb1-HDL contents significantly increased in patients with ACS. The correlation analysis revealed that the apolipoprotein (apo) A-I levels were positively and significantly with all HDL subclasses contents; plasma total cholesterol (TC) and fasting plasma glucose (FPG) levels were inversely associated with HDL2a, and HDL2b. Moreover, the FPG levels were positively related to HDL3c, HDL3b, and HDL3a in ACS patients. Conclusion: The HDL subclass distribution profile remodeling was noted in the patients with ACS. Plasma lipoprotein and FPG levels, BP, and BMI play an important role in the HDL subclass metabolism disorder for patients with ACS. The HDL subclass distribution phenotype might be useful as a novel biomarker to assist in the risk stratification of patients with ACS.	[Tian, Li; Liu, Yinghui; Fu, Mingde] Sichuan Univ, West China Hosp, Lab Endocrinol & Metab, Chengdu 610064, Sichuan, Peoples R China; [Li, Chuanwei; Chen, Yucheng] Sichuan Univ, West China Hosp, Cardiovasc Dept, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Fu, MD (corresponding author), Sichuan Univ, West China Hosp, Lab Endocrinol & Metab, Chengdu 610064, Sichuan, Peoples R China.	apolipoprotein2009@126.com	Tian, Li/M-8251-2015; Chen, Yucheng/AAF-6181-2020; Chen, Yu/Y-3292-2019	Tian, Li/0000-0003-0807-2634; 	National Natural Science Foundation of China [31300648]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the grants from National Natural Science Foundation of China (Grant NO. 31300648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rasadi K, 2011, OPEN CARDIOVASC MED, V5, P203, DOI 10.2174/1874192401105010203; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Asztalos BF, 2004, ARTERIOSCL THROM VAS, V24, P2181, DOI 10.1161/01.ATV.0000146325.93749.a8; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Ballantyne CM, 1999, CIRCULATION, V99, P736, DOI 10.1161/01.CIR.99.6.736; Borggreve SE, 2003, EUR J CLIN INVEST, V33, P1051, DOI 10.1111/j.1365-2362.2003.01263.x; Chapman MJ, 2004, CURR MED RES OPIN, V20, P1253, DOI 10.1185/030079904125004402; Chenevard R, 2012, CARDIOVASC THER, V30, pe51, DOI 10.1111/j.1755-5922.2010.00221.x; CHEUNG MC, 1991, J LIPID RES, V32, P383; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hausenloy DJ, 2008, HEART, V94, P706, DOI 10.1136/hrt.2007.125401; HESLER CB, 1987, J BIOL CHEM, V262, P2275; Hovingh GK, 2005, CIRCULATION, V112, P879, DOI 10.1161/CIRCULATIONAHA.105.540427; Kontush A, 2006, NAT CLIN PRACT CARD, V3, P144, DOI 10.1038/ncpcardio0500; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Olsson AG, 2005, EUR HEART J, V26, P890, DOI 10.1093/eurheartj/ehi186; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacks FM, 2002, AM J CARDIOL, V90, P139, DOI 10.1016/S0002-9149(02)02436-0; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13; WU X, 1999, CHIN J ARTERIOSCLER, V7, P253; Xu YH, 2003, CLIN CHIM ACTA, V332, P95, DOI 10.1016/S0009-8981(03)00138-4; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zambon A, 1998, ARTERIOSCL THROM VAS, V18, P1723, DOI 10.1161/01.ATV.18.11.1723	26	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85114	10.1371/journal.pone.0085114	http://dx.doi.org/10.1371/journal.pone.0085114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465490	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000012
J	Chong, Y; Shimoda, S; Yakushiji, H; Ito, Y; Aoki, T; Miyamoto, T; Kamimura, T; Shimono, N; Akashi, K				Chong, Yong; Shimoda, Shinji; Yakushiji, Hiroko; Ito, Yoshikiyo; Aoki, Takatoshi; Miyamoto, Toshihiro; Kamimura, Tomohiko; Shimono, Nobuyuki; Akashi, Koichi			Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis	PLOS ONE			English	Article							FEBRILE NEUTROPENIA; CANCER-PATIENTS; CIPROFLOXACIN PROPHYLAXIS; ANTIBIOTIC-PROPHYLAXIS; KLEBSIELLA-PNEUMONIAE; SPECTRUM; INFECTION; TRANSPLANTATION; CHEMOTHERAPY; NORFLOXACIN	Background: Fluoroquinolone prophylaxis in patients with neutropenia and hematological malignancies is said to be effective on febrile netropenia (FN)-related infection and mortality; however, the emergence of antibiotic resistance has become a concern. Ciprofloxacin and levofloxacin prophylaxis are most commonly recommended. A significant increase in the rate of quinolone-resistant Escherichia coli in fecal flora has been reported following ciprofloxacin prophylaxis. The acquisition of quinolone-resistant E. coli after levofloxacin use has not been evaluated. Methods: We prospectively examined the incidence of quinolone-resistant E. coli isolates recovered from stool cultures before and after levofloxacin prophylaxis in patients with neutropenia from August 2011 to May 2013. Some patients received chemotherapy multiple times. Results: In this trial, 68 patients were registered. Levofloxacin-resistant E. coli isolates were detected from 11 and 13 of all patients before and after the prophylaxis, respectively. However, this was not statistically significant (P = 0.65). Multiple prophylaxis for sequential chemotherapy did not induce additional quinolone resistance among E. coli isolates. Interestingly, quinolone-resistant E. coli, most of which were extended-spectrum beta-lactamase (ESBL) producers, were already detected in approximately 20% of all patients before the initiation of prophylaxis. FN-related bacteremia developed in 2 patients, accompanied by a good prognosis. Conclusions: Levofloxacin prophylaxis for neutropenia did not result in a significant acquisition of quinolone-resistant E. coli. However, we detected previous colonization of quinolone-resistant E. coli before prophylaxis, which possibly reflects the spread of ESBL. The epidemic spread of resistant E. coli as a local factor may influence strategies toward the use of quinolone prophylaxis.	[Chong, Yong; Shimoda, Shinji; Miyamoto, Toshihiro; Akashi, Koichi] Kyushu Univ Grad Sch Med Sci, Fukuoka, Japan; [Yakushiji, Hiroko] Hara Sanshin Hosp, Dept Clin Lab, Fukuoka, Japan; [Ito, Yoshikiyo; Aoki, Takatoshi; Kamimura, Tomohiko] Hara Sanshin Hosp, Dept Blood & Marrow Transplantat, Fukuoka, Japan; [Shimono, Nobuyuki] Kyushu Univ Hosp, Ctr Study Global Infect, Fukuoka 812, Japan	Kyushu University; Kyushu University	Chong, Y (corresponding author), Kyushu Univ Grad Sch Med Sci, Fukuoka, Japan.	ychong@gj9.so-net.ne.jp						Bow EJ, 2011, CURR OPIN INFECT DIS, V24, P545, DOI 10.1097/QCO.0b013e32834cf054; Bucaneve G, 2005, NEW ENGL J MED, V353, P977, DOI 10.1056/NEJMoa044097; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; CARRATALA J, 1995, CLIN INFECT DIS, V20, P557, DOI 10.1093/clinids/20.3.557; Carratala J, 1996, ANTIMICROB AGENTS CH, V40, P503, DOI 10.1128/AAC.40.2.503; Chong Y, 2013, J MED MICROBIOL, V62, P1038, DOI 10.1099/jmm.0.059279-0; Chong Y, 2011, INFECT GENET EVOL, V11, P1499, DOI 10.1016/j.meegid.2011.06.001; Chong Y, 2011, INT J INFECT DIS, V15, pE277, DOI 10.1016/j.ijid.2010.12.010; COMETTA A, 1994, NEW ENGL J MED, V330, P1240, DOI 10.1056/NEJM199404283301717; Craig M, 2007, BONE MARROW TRANSPL, V39, P477, DOI 10.1038/sj.bmt.1705591; Cullen M, 2009, BRIT J CANCER, V101, pS11, DOI 10.1038/sj.bjc.6605270; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Gafter-Gvili A, 2005, ANN INTERN MED, V142, P979, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00008; Gomez L, 2003, CANCER-AM CANCER SOC, V97, P419, DOI 10.1002/cncr.11044; Leibovici L, 2006, CANCER-AM CANCER SOC, V107, P1743, DOI 10.1002/cncr.22205; National Committee for Clinical Laboratory Standards, 2004, PERF STAND ANT SUS S; Ng EST, 2011, LEUKEMIA LYMPHOMA, V52, P131, DOI 10.3109/10428194.2010.518655; Oteo J, 2010, CURR OPIN INFECT DIS, V23, P320, DOI 10.1097/QCO.0b013e3283398dc1; Pascoe J, 2009, CURR OPIN HEMATOL, V16, P48, DOI 10.1097/MOH.0b013e32831ac543; Perea S, 1999, J ANTIMICROB CHEMOTH, V44, P117, DOI 10.1093/jac/44.1.117; Ramphal R, 2004, CLIN INFECT DIS, V39, pS25, DOI 10.1086/383048; Reuter S, 2005, CLIN INFECT DIS, V40, P1087, DOI 10.1086/428732; Saito T, 2008, EUR J CLIN MICROBIOL, V27, P209, DOI 10.1007/s10096-007-0428-8; Sohn BS, 2012, EUR J CLIN MICROBIOL, V31, P1653, DOI 10.1007/s10096-011-1489-2; Viscoli C, 2002, CURR OPIN INFECT DIS, V15, P377, DOI 10.1097/00001432-200208000-00004	25	17	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85210	10.1371/journal.pone.0085210	http://dx.doi.org/10.1371/journal.pone.0085210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465506	gold, Green Submitted, Green Published			2022-12-25	WOS:000330283100026
J	Cheah, KY; Howarth, GS; Bastian, SEP				Cheah, Ker Yeaw; Howarth, Gordon Stanley; Bastian, Susan Elaine Putnam			Grape Seed Extract Dose-Responsively Decreases Disease Severity in a Rat Model of Mucositis; Concomitantly Enhancing Chemotherapeutic Effectiveness in Colon Cancer Cells	PLOS ONE			English	Article							SMALL-INTESTINAL MUCOSITIS; PROANTHOCYANIDIN EXTRACT; LINE CACO-2; BREATH TEST; 5-FLUOROURACIL; APOPTOSIS; EXPRESSION; GROWTH; METHOTREXATE; INFLAMMATION	Objective: Mucositis is a serious disorder of the gastrointestinal tract that results from cancer chemotherapy. We investigated the effects of increasing grape seed extract doses on the severity of chemotherapy in a rat model and its coincident impact on chemotherapeutic effectiveness in colon cancer cells. Design: Female Dark Agouti rats were gavaged with grape seed extract (400-1000 mg/kg) or water (day 3-11) and were injected intraperitoneally with 5-Fluorouracil (150 mg/kg) or saline (control) on day 9 to induce mucositis. Daily metabolic data were collected and rats were sacrificed on day 12. Intestinal tissues were collected for histological and myeloperoxidase analyses. Caco-2 cell viability was examined in response to grape seed extract in combination with 5-Fluorouracil by 3-(4,5-Dimethylthiazol-2yl)-2,5-diphenyl-tetrazolium bromide) assay. Results: Compared with 5-Fluorouracil controls, grape seed extract (400-1000 mg/kg) significantly decreased the histological damage score (P<0.05) in the jejunum. Grape seed extract (1000 mg/kg) increased jejunal crypt depth by 25% (P<0.05) in 5-Fluorouracil treated rats compared to 5-Fluorouracil controls, and attenuated the 5-Fluorouracil -induced reduction of mucosal thickness (25%, P<0.05). Grape seed extract (600 mg/kg) decreased myeloperoxidase activity by 55% (P<0.01) compared to 5-Fluorouracil controls. Grape seed extract was more effective at ameliorating 5-Fluorouracil induced intestinal injury, with effects most pronounced in the proximal jejunum. Grape seed extract (10-25 ug/mL) significantly enhanced the growth-inhibitory effects of 5-Fluorouracil by 26% (P<0.05) in Caco-2 cells and was more potent than 5-Fluorouracil at 50-100 mu g/mL. Conclusion: Grape seed extract may represent a new therapeutic option to decrease the symptoms of intestinal mucositis while concurrently impacting on the viability of colon cancer cells.	[Cheah, Ker Yeaw; Bastian, Susan Elaine Putnam] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA 5005, Australia; [Cheah, Ker Yeaw; Howarth, Gordon Stanley] Children Youth & Womens Hlth Serv, Ctr Paediat & Adolescent Gastroenterol, Adelaide, SA, Australia; [Howarth, Gordon Stanley] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA 5005, Australia	University of Adelaide; University of Adelaide	Bastian, SEP (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Waite Campus, Adelaide, SA 5005, Australia.	sue.bastian@adelaide.edu.au	Howarth, Gordon/AAM-8699-2020	Howarth, Gordon/0000-0001-6979-6084; Bastian, Susan/0000-0002-8790-2044	South Australian Health and Medical Research Institute Cancer Council Senior Research Fellowship; University of Adelaide	South Australian Health and Medical Research Institute Cancer Council Senior Research Fellowship; University of Adelaide	Professor Gordon Howarth is supported by a South Australian Health and Medical Research Institute Cancer Council Senior Research Fellowship. No financial agreements are in place. This research was supported by The University of Adelaide, being a member of the Wine Innovation Cluster, Waite Campus, Adelaide, South Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2002, CARCINOGENESIS, V23, P1869, DOI 10.1093/carcin/23.11.1869; Appeldoorn MM, 2009, J AGR FOOD CHEM, V57, P1084, DOI 10.1021/jf803059z; Bagchi D, 1997, RES COMMUN MOL PATH, V95, P179; Bagchi DB, 2003, MUTAT RES-FUND MOL M, V523, P87, DOI 10.1016/S0027-5107(02)00324-X; Bindon KA, 2010, J AGR FOOD CHEM, V58, P2520, DOI 10.1021/jf9037453; Bowen JM, 2007, CANCER CHEMOTH PHARM, V59, P337, DOI 10.1007/s00280-006-0275-9; Cheah KY, 2013, DIGEST DIS SCI, V58, P970, DOI 10.1007/s10620-012-2464-1; Cheah KY, 2009, CANCER BIOL THER, V8, P382, DOI 10.4161/cbt.8.4.7453; Cho ML, 2009, IMMUNOL LETT, V124, P102, DOI 10.1016/j.imlet.2009.05.001; D'Archivio Massimo, 2007, Ann Ist Super Sanita, V43, P348; Dinicola S, 2010, BRIT J NUTR, V104, P824, DOI 10.1017/S0007114510001522; Duncan M, 2003, ALIMENT PHARM THER, V18, P853, DOI 10.1046/j.1365-2036.2003.01784.x; Engelbrecht AM, 2007, CANCER LETT, V258, P144, DOI 10.1016/j.canlet.2007.08.020; Fine A M, 2000, Altern Med Rev, V5, P144; Fishbein AB, 2009, ARCH PHARM RES, V32, P505, DOI 10.1007/s12272-009-1405-9; GLICK Z, 1970, J NUTR, V100, P509, DOI 10.1093/jn/100.5.509; Gu LW, 2004, J NUTR, V134, P613, DOI 10.1093/jn/134.3.613; Howarth GS, 1996, J NUTR, V126, P2519, DOI 10.1093/jn/126.10.2519; Hsu CP, 2009, ANTICANCER RES, V29, P283; Huynh-Delerme C, 2005, TOXICOL IN VITRO, V19, P439, DOI 10.1016/j.tiv.2004.08.003; Jordan A, 2003, EUR J NUTR, V42, P324, DOI 10.1007/s00394-003-0427-1; Keefe DM, 2008, EXPERT OPIN EMERG DR, V13, P511, DOI 10.1517/14728214.13.3.511 ; Kodach LL, 2006, CARCINOGENESIS, V27, P508, DOI 10.1093/carcin/bgi307; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Li WG, 2001, ACTA PHARMACOL SIN, V22, P1117; Logan RM, 2007, CANCER TREAT REV, V33, P448, DOI 10.1016/j.ctrv.2007.03.001; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mauger CA, 2007, DIGEST DIS SCI, V52, P612, DOI 10.1007/s10620-006-9464-y; Pelton NS, 2004, SCAND J GASTROENTERO, V39, P1015, DOI 10.1080/00365520410003416; Santos-Buelga C, 2000, J SCI FOOD AGR, V80, P1094, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1094::AID-JSFA569&gt;3.0.CO;2-1, 10.1002/(SICI)1097-0010(20000515)80:7<1094::AID-JSFA569>3.3.CO;2-T]; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Scalbert A, 2002, BIOMED PHARMACOTHER, V56, P276, DOI 10.1016/S0753-3322(02)00205-6; Soares PMG, 2008, CANCER CHEMOTH PHARM, V63, P91, DOI 10.1007/s00280-008-0715-9; Sonis ST, 1999, CANCER-AM CANCER SOC, V85, P2103, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0; Stringer Andrea M, 2007, J Support Oncol, V5, P259; Terra X, 2011, J NUTR BIOCHEM, V22, P380, DOI 10.1016/j.jnutbio.2010.03.006; Terra X, 2009, J NUTR BIOCHEM, V20, P210, DOI 10.1016/j.jnutbio.2008.02.005; TOMAS FM, 1991, BIOCHEM J, V276, P547, DOI 10.1042/bj2760547; Tooley KL, 2006, CANCER BIOL THER, V5, P1275, DOI 10.4161/cbt.5.10.3303; Tsang C, 2005, BRIT J NUTR, V94, P170, DOI 10.1079/BJN20051480; Urpi-Sarda M, 2009, ANAL BIOANAL CHEM, V394, P1545, DOI 10.1007/s00216-009-2676-1; Watanabe H, 2013, MED MOL MORPHOL, V46, P97, DOI 10.1007/s00795-013-0012-5; Wren AF, 2002, J AGR FOOD CHEM, V50, P2180, DOI 10.1021/jf011066w; Yamakoshi J, 2002, FOOD CHEM TOXICOL, V40, P599, DOI 10.1016/S0278-6915(02)00006-6	44	39	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85184	10.1371/journal.pone.0085184	http://dx.doi.org/10.1371/journal.pone.0085184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465501	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500041
J	Pontes, D; Azevedo, M; Innocentin, S; Blugeon, S; Lefevre, F; Azevedo, V; Miyoshi, A; Courtin, P; Chapot-Chartier, MP; Langella, P; Chatel, JM				Pontes, Daniela; Azevedo, Marcela; Innocentin, Silvia; Blugeon, Sebastien; Lefevre, Francois; Azevedo, Vasco; Miyoshi, Anderson; Courtin, Pascal; Chapot-Chartier, Marie-Pierre; Langella, Philippe; Chatel, Jean-Marc			Immune Response Elicited by DNA Vaccination Using Lactococcus lactis Is Modified by the Production of Surface Exposed Pathogenic Protein	PLOS ONE			English	Article							MAMMALIAN EPITHELIAL-CELLS; LISTERIA-MONOCYTOGENES; GENETIC IMMUNIZATION; BETA-LACTOGLOBULIN; INTESTINAL BARRIER; ESCHERICHIA-COLI; MUCOSAL DELIVERY; ALLERGEN; INTERNALIN; PLASMID	In this study, we compared immune responses elicited by DNA immunization using Lactococcus lactis or L. lactis expressing the Staphylococcus aureus invasin Fibronectin Binding Protein A (FnBPA) at its surface. Both strains carried pValac:BLG, a plasmid containing the cDNA of Beta-Lactoglobulin (BLG), and were designated LL-BLG and LL-FnBPA+ BLG respectively. A T(H)2 immune response characterized by the secretion of IL-4 and IL-5 in medium of BLG reactivated splenocytes was detected after either oral or intranasal administration of LL-FnBPA+ BLG. In contrast, intranasal administration of LL-BLG elicited a T(H)1 immune response. After BLG sensitization, mice previously intranasally administered with LL-BLG showed a significantly lower concentration of BLG-specific IgE than the mice non-administered. Altenatively administration of LL-FnBPA+ BLG didn't modify the BLG-specific IgE concentration obtained after sensitization, thus confirming the T(H)2 orientation of the immune response. To determine if the T(H)2-skewed immune response obtained with LL-FnBpA+ BLG was FnBPA-specific or not, mice received another L. lactis strain producing a mutated form of the Listeria monocytogenes invasin Internalin A intranasally, allowing thus the binding to murine E-cadherin, and containing pValac: BLG (LL-mInlA+ BLG). As with LL-FnBPA+ BLG, LL-mInlA+ BLG was not able to elicit a T(H)1 immune response. Furthermore, we observed that these difference were not due to the peptidoglycan composition of the cell wall as LL-FnBPA+ BLG, LL-mInlA+ BLG and LL-BLG strains shared a similar composition. DNA vaccination using LL-BLG elicited a pro-inflammatory T(H)1 immune response while using LL-FnBPA+ BLG or LL-mInlA+ BLG elicited an anti-inflammatory T(H)2 immune response.	[Pontes, Daniela] State Univ Paraiba, Dept Biol Sci, Joao Pessoa, Paraiba, Brazil; [Pontes, Daniela; Azevedo, Marcela; Innocentin, Silvia; Blugeon, Sebastien; Courtin, Pascal; Chapot-Chartier, Marie-Pierre; Langella, Philippe; Chatel, Jean-Marc] INRA, Micalis UMR1319, Domaine Vilvert, Jouy En Josas, France; [Pontes, Daniela; Azevedo, Marcela; Innocentin, Silvia; Blugeon, Sebastien; Courtin, Pascal; Chapot-Chartier, Marie-Pierre; Langella, Philippe; Chatel, Jean-Marc] AgroParisTech, Micalis UMR1319, Jouy En Josas, France; [Azevedo, Marcela; Azevedo, Vasco; Miyoshi, Anderson] Fed Univ Minas Gerais UFMG ICB, Inst Biol Sci, Belo Horizonte, MG, Brazil; [Innocentin, Silvia] Babraham Inst, Lymphocyte Signaling & Dev Lab, Cambridge, England; [Lefevre, Francois] INRA, VIM, Domaine Vilvert, Jouy En Josas, France	Universidade Estadual da Paraiba; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Chatel, JM (corresponding author), INRA, Micalis UMR1319, Domaine Vilvert, Jouy En Josas, France.	jean-marc.chatel@jouy.inra.fr	Chatel, Jean-marc/ABB-9837-2020; de Azevedo, Marcela Santiago Pacheco/AAO-2859-2020; Azevedo, Vasco/B-1556-2019; Langella, Philippe/N-8368-2017; Azevedo, Vasco A.C/F-4315-2011; PONTES, DANIELA SANTOS/O-2040-2015	de Azevedo, Marcela Santiago Pacheco/0000-0001-5694-4578; Azevedo, Vasco/0000-0002-4775-2280; Langella, Philippe/0000-0001-5960-4341; Azevedo, Vasco A.C/0000-0002-4775-2280; Chatel, Jean-Marc/0000-0003-4967-1414; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	LABHEALTH program [MEST-CT-2004-514428]; French-Brazilian CAPES COFECUB project [539/06]; Region Ile de France DIM ASTREA; European Community [215553-2]	LABHEALTH program; French-Brazilian CAPES COFECUB project; Region Ile de France DIM ASTREA(Region Ile-de-France); European Community(European Commission)	Silvia Innocentin was a recipient of a European Marie Curie Ph.D grant from the LABHEALTH program (MEST-CT-2004-514428). Daniela Pontes was a recipient of grants from the French-Brazilian CAPES COFECUB project no539/06 and from Region Ile de France DIM ASTREA. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no215553-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Wahid A, 2007, VACCINE, V25, P8372, DOI 10.1016/j.vaccine.2007.10.012; Adel-Patient K, 2003, CLIN EXP ALLERGY, V33, P376, DOI 10.1046/j.1365-2222.2003.01613.x; Adel-Patient K, 2001, INT ARCH ALLERGY IMM, V126, P59, DOI 10.1159/000049495; Adel-Patient K, 2000, J IMMUNOL METHODS, V235, P21, DOI 10.1016/S0022-1759(99)00210-0; Bermudez-Humaran LG, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S4; Brun P, 2008, VACCINE, V26, P1934, DOI 10.1016/j.vaccine.2008.02.023; Chatel JM, 2008, GENE THER, V15, P1184, DOI 10.1038/gt.2008.59; Chatel JM, 2003, ALLERGY, V58, P641, DOI 10.1034/j.1398-9995.2003.00182.x; Cortes-Perez NG, 2007, VACCINE, V25, P6581, DOI 10.1016/j.vaccine.2007.06.062; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; Critchley-Thorne RJ, 2006, MOL THER, V14, P183, DOI 10.1016/j.ymthe.2006.01.011; de Azevedo M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-299; Feltquate DM, 1997, J IMMUNOL, V158, P2278; Fredriksen L, 2012, APPL ENVIRON MICROB, V78, P5864, DOI 10.1128/AEM.01227-12; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Guimaraes VD, 2006, APPL ENVIRON MICROB, V72, P7091, DOI 10.1128/AEM.01325-06; Guimaraes VD, 2005, MICROBES INFECT, V7, P836, DOI 10.1016/j.micinf.2005.02.012; Harms Jerome S, 2009, J Immune Based Ther Vaccines, V7, P1, DOI 10.1186/1476-8518-7-1; Hartl A, 1999, INT ARCH ALLERGY IMM, V120, P17, DOI 10.1159/000024216; Innocentin S, 2009, APPL ENVIRON MICROB, V75, P4870, DOI 10.1128/AEM.00825-09; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lee SW, 1998, IMMUNOLOGY, V94, P285, DOI 10.1046/j.1365-2567.1998.00557.x; Li XM, 1999, J IMMUNOL, V162, P3045; Macho Fernandez E, GUT, V60, P1050; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Negroni L, 1998, J IMMUNOL METHODS, V220, P25, DOI 10.1016/S0022-1759(98)00150-1; Nikitas G, 2011, J EXP MED, V208, P2263, DOI 10.1084/jem.20110560; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pontes D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044892; Raz E, 1996, P NATL ACAD SCI USA, V93, P5141, DOI 10.1073/pnas.93.10.5141; Scheiblhofer S, 2007, MOL IMMUNOL, V44, P1879, DOI 10.1016/j.molimm.2006.09.023; Schoen C, 2004, INT J MED MICROBIOL, V294, P319, DOI 10.1016/j.ijmm.2004.03.001; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; Toda M, 2000, IMMUNOLOGY, V99, P179, DOI 10.1046/j.1365-2567.2000.00935.x; Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049	38	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84509	10.1371/journal.pone.0084509	http://dx.doi.org/10.1371/journal.pone.0084509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465412	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500006
J	Song, B; Wang, YL; Zhao, XQ; Liu, LP; Wang, CX; Wang, AX; Du, WL; Wang, YJ				Song, Bo; Wang, Yilong; Zhao, Xingquan; Liu, Liping; Wang, Chunxue; Wang, Anxin; Du, Wanliang; Wang, Yongjun			Association between Statin Use and Short-Term Outcome Based on Severity of Ischemic Stroke: A Cohort Study	PLOS ONE			English	Article							SIMVASTATIN; ATTACK; ONSET; PHASE	Background: Statins reportedly improve clinical outcomes for ischemic stroke patients. However, it is unclear whether the contribution of statin treatment varies depending on the severity of stroke. We sought to investigate the relationship between statin use and the outcome of acute first-ever ischemic stroke patients stratified by stroke severity. Methods: A total of 7,455 acute first-ever ischemic stroke patients without statin treatment before onset were eligible from the China National Stroke Registry. A National Institutes of Health Stroke Scale (NIHSS) score of 0 to 4 was defined as minor stroke, and a NIHSS score of >4 was defined as non-minor stroke. We analyzed the association between statin use during hospitalization and mortality as well as functional outcome (measured by a modified Rankin Scale score of 0-5) at 3 months after onset using multivariable logistic regression models. Results: A total of 3,231 (43.3%) patients received statin treatment during hospitalization. Multivariable analysis showed that statin use during hospitalization decreased mortality of ischemic stroke patients (OR, 0.51; 95% CI, 0.38-0.67), but did not improve poor functional outcomes (OR, 0.95; 95CI%, 0.81-1.11) at 3 months. The interaction between statin use and stroke severity was significant both in dependence and death outcome (P = 0.04 for dependence outcome, P = 0.03 for death outcome). After stratification by stroke severity, statin use during hospitalization decreased the mortality of stroke (OR, 0.44; 95% CI, 0.31-0.62) and poor functional outcome (OR, 0.73; 95% CI, 0.57-0.92) at 3 months in the non-minor stroke group. Conclusions: Statin use during hospitalization may improve the clinical outcome of acute first-ever ischemic stroke depending on the severity of stroke. Non-minor stroke patients may obtain benefit from statin treatment with improvements in poor functional outcomes and mortality.	[Song, Bo; Wang, Yilong; Zhao, Xingquan; Liu, Liping; Wang, Chunxue; Wang, Anxin; Du, Wanliang; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University	Wang, YL (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	yongjunwang1962@gmail.com	liu, li/HGC-0900-2022		Ministry of Science and Technology [2008ZX09312-008]; Ministry of Health of the People's Republic of China [2009CB521905]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China	This study was funded by the Ministry of Science and Technology (grant no. 2008ZX09312-008) and the Ministry of Health of the People's Republic of China (grant no. 2009CB521905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; [Anonymous], 1989, STROKE, V20, P1407; Aslanyan S, 2005, EUR J NEUROL, V12, P493, DOI 10.1111/j.1468-1331.2005.01049.x; Biffi A, 2011, STROKE, V42, P1314, DOI 10.1161/STROKEAHA.110.605923; Blanco M, 2007, NEUROLOGY, V69, P904, DOI 10.1212/01.wnl.0000269789.09277.47; Chroinin DN, 2011, STROKE, V42, P1021, DOI 10.1161/STROKEAHA.110.596734; Colivicchi F, 2007, STROKE, V38, P2652, DOI 10.1161/STROKEAHA.107.487017; Coutts SB, 2012, STROKE, V43, P3018, DOI 10.1161/STROKEAHA.112.665141; Fisher Marc, 2012, Curr Treat Options Cardiovasc Med, V14, P252, DOI 10.1007/s11936-012-0174-9; Flint AC, 2012, STROKE, V43, P147, DOI 10.1161/STROKEAHA.111.627729; Fuentes B, 2009, CEREBROVASC DIS, V27, P126, DOI 10.1159/000200450; Hassan Y, 2011, FUND CLIN PHARMACOL, V25, P388, DOI 10.1111/j.1472-8206.2010.00846.x; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marti-Fabregas J, 2004, STROKE, V35, P1117, DOI 10.1161/01.STR.0000125863.93921.3f; Martinez-Sanchez P, 2009, EUR J NEUROL, V16, P127, DOI 10.1111/j.1468-1331.2008.02370.x; Martinez-Sanchez P, 2013, NEUROLOGY, V80, P1800, DOI 10.1212/WNL.0b013e3182918d38; Montaner J, 2008, EUR J NEUROL, V15, P82, DOI 10.1111/j.1468-1331.2007.02015.x; Moonis M, 2005, STROKE, V36, P1298, DOI 10.1161/01.STR.0000165920.67784.58; Nedeltchev K, 2007, STROKE, V38, P2531, DOI 10.1161/STROKEAHA.107.482554; Ntaios G, 2010, CEREBROVASC DIS, V29, P484, DOI 10.1159/000297964; Reeves MJ, 2008, STROKE, V39, P1779, DOI 10.1161/STROKEAHA.107.501700; Squizzato A, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007551, 10.1002/14651858.CD007551.pub2]; Szczepanska-Szerej A, 2011, CLIN NEUROPHARMACOL, V34, P191, DOI 10.1097/WNF.0b013e3182309418; Wang YL, 2011, STROKE, V42, P1658, DOI 10.1161/STROKEAHA.110.604249; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Yeh PS, 2010, AM J CARDIOL, V105, P1490, DOI 10.1016/j.amjcard.2009.07.065	27	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84389	10.1371/journal.pone.0084389	http://dx.doi.org/10.1371/journal.pone.0084389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465409	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500003
J	Stoeckel, S; Masson, JP				Stoeckel, Solenn; Masson, Jean-Pierre			The Exact Distributions of F-IS under Partial Asexuality in Small Finite Populations with Mutation	PLOS ONE			English	Article							GENETIC DIVERSITY; SEXUAL REPRODUCTION; CLONALITY; ORGANISMS; EVOLUTION; SELECTION; DIPLOIDS; COSTS; SIZE	Reproductive systems like partial asexuality participate to shape the evolution of genetic diversity within populations, which is often quantified by the inbreeding coefficient F-IS. Understanding how those mating systems impact the possible distributions of F-IS values in theoretical populations helps to unravel forces shaping the evolution of real populations. We proposed a population genetics model based on genotypic states in a finite population with mutation. For populations with less than 400 individuals, we assessed the impact of the rates of asexuality on the full exact distributions of F-IS, the probabilities of positive and negative F-IS, the probabilities of fixation and the probabilities to observe changes in the sign of F-IS over one generation. After an infinite number of generations, we distinguished three main patterns of effects of the rates of asexuality on genetic diversity that also varied according to the interactions of mutation and genetic drift. Even rare asexual events in mainly sexual populations impacted the balance between negative and positive F-IS and the occurrence of extreme values. It also drastically modified the probability to change the sign of F-IS value at one locus over one generation. When mutation prevailed over genetic drift, increasing rates of asexuality continuously increased the variance of F-IS that reached its highest value in fully asexual populations. In consequence, even ancient asexual populations showed the entire F-IS spectrum, including strong positive F-IS. The prevalence of heterozygous loci only occurred in full asexual populations when genetic drift dominated.	[Stoeckel, Solenn; Masson, Jean-Pierre] INRA, Inst Genet Environm & Plant Protect UMR1349, Le Rheu, France	INRAE	Stoeckel, S (corresponding author), INRA, Inst Genet Environm & Plant Protect UMR1349, Le Rheu, France.	Solenn.Stoeckel@rennes.inra.fr	Stoeckel, Solenn/K-8086-2017	Stoeckel, Solenn/0000-0001-6064-5941	French National Research Agency [CLONIX: ANR-11-BSV7-007]; Plant Health and Environment division of the French National Institute of Agricultural Research	French National Research Agency(French National Research Agency (ANR)); Plant Health and Environment division of the French National Institute of Agricultural Research	This study was funded by the French National Research Agency (project CLONIX: ANR-11-BSV7-007) and by the Plant Health and Environment division of the French National Institute of Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2006, CURR BIOL, V16, pR696, DOI 10.1016/j.cub.2006.07.063; Allen DE, 2012, EVOLUTION, V66, P919, DOI 10.1111/j.1558-5646.2011.01488.x; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2012, PLOS ONE, V7; Balloux F, 2001, J HERED, V92, P301, DOI 10.1093/jhered/92.3.301; Balloux F, 2003, GENETICS, V164, P1635; Bengtsson BO, 2003, J EVOLUTION BIOL, V16, P189, DOI 10.1046/j.1420-9101.2003.00523.x; Berg LM, 2000, J EVOLUTION BIOL, V13, P488; Birky CW, 2010, J HERED, V101, pS42, DOI 10.1093/jhered/esq014; Birky CW, 1996, GENETICS, V144, P427; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; Ceplitis A, 2003, GENET RES, V82, P183, DOI 10.1017/S0016672303006487; Choleva L, 2012, EVOLUTION, V66, P2191, DOI 10.1111/j.1558-5646.2012.01589.x; Ramirez JD, 2012, MOL ECOL, V21, P4216, DOI 10.1111/j.1365-294X.2012.05699.x; de Meeus T, 2007, CELL MOL LIFE SCI, V64, P1355, DOI 10.1007/s00018-007-6515-2; De Meeus T, 2006, INFECT GENET EVOL, V6, P163, DOI 10.1016/j.meegid.2005.02.004; de Meeus T, 2004, INFECT GENET EVOL, V4, P345, DOI 10.1016/j.meegid.2004.05.002; Ewens W.J., 2004, MATH POPULATION GENE, DOI [DOI 10.1007/978-0-387-21822-9, 10.1007/978-0-387-21822-9]; Fehrer J, 2010, HEREDITY, V104, P421, DOI 10.1038/hdy.2010.12; FELSENSTEIN J, 1974, GENETICS, V78, P737; Flot JF, 2013, NATURE, V500, P453, DOI 10.1038/nature12326; Gale JS, 1990, THEORETICAL POPULATI; Goyeau H, 2007, FUNGAL GENET BIOL, V44, P474, DOI 10.1016/j.fgb.2007.02.006; GREEN RF, 1995, J THEOR BIOL, V174, P87, DOI 10.1006/jtbi.1995.0081; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Honnay O, 2005, OIKOS, V108, P427, DOI 10.1111/j.0030-1299.2005.13569.x; Honnay O, 2010, EVOL ECOL, V24, P1393, DOI 10.1007/s10682-010-9408-z; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; KIMURA M., 1964, J. appl. Prob., V1, P177, DOI 10.2307/3211856; Lewis W M Jr, 1987, Experientia Suppl, V55, P33; Marriage TN, 2012, J THEOR BIOL, V308, P25, DOI 10.1016/j.jtbi.2012.04.033; McConnell R, 2007, GENETICS, V177, P1499, DOI 10.1534/genetics.107.076067; Meirmans S, 2012, Q REV BIOL, V87, P19, DOI 10.1086/663945; Ferreira GEM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036242; Navascues M, 2010, HEREDITY, V104, P482, DOI 10.1038/hdy.2009.159; Ness RW, 2012, GENETICS, V192, P1447, DOI 10.1534/genetics.112.145078; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Perron O, 1907, MATH ANN, V64, P248, DOI 10.1007/BF01449896; Rabeling C, 2011, P NATL ACAD SCI USA, V108, P12366, DOI 10.1073/pnas.1105467108; Ross L, 2013, EVOLUTION, V67, P196, DOI 10.1111/j.1558-5646.2012.01784.x; ROUSSET F, 2001, HDB STAT GENETICS; Saxer G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046759; Schon I, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P1; Schurko AM, 2009, TRENDS ECOL EVOL, V24, P208, DOI 10.1016/j.tree.2008.11.010; Shreve SM, 2011, MOL ECOL, V20, P4433, DOI 10.1111/j.1365-294X.2011.05298.x; Stoeckel S, 2006, MOL ECOL, V15, P2109, DOI 10.1111/j.1365-294X.2006.02926.x; Stott I, 2010, METHODS ECOL EVOL, V1, P242, DOI 10.1111/j.2041-210X.2010.00032.x; Tibayrenc M, 2012, P NATL ACAD SCI USA, V109, pE3305, DOI 10.1073/pnas.1212452109; Vallejo-Marin M, 2010, ANNU REV ECOL EVOL S, V41, P193, DOI 10.1146/annurev.ecolsys.110308.120258; Vanoverbeke J, 2010, J EVOLUTION BIOL, V23, P997, DOI 10.1111/j.1420-9101.2010.01970.x; Villate L, 2010, MOL ECOL, V19, P856, DOI 10.1111/j.1365-294X.2009.04511.x; Whittaker JC, 2003, GENETICS, V164, P781; Wright S., 1969, THEORY GENE FREQUENC; Yonezawa K, 2004, GENETICS, V166, P1529, DOI 10.1534/genetics.166.3.1529	54	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85228	10.1371/journal.pone.0085228	http://dx.doi.org/10.1371/journal.pone.0085228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465510	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500045
J	Ji, XL; Wang, Q; Li, XF; Qi, XL; Wang, YQ; Gao, HL; Gao, YL; Wang, XM				Ji, Xiaolin; Wang, Qi; Li, Xiaofei; Qi, Xiaole; Wang, Yongqiang; Gao, Honglei; Gao, Yulong; Wang, Xiaomei			A 19-Nucleotide Insertion in the Leader Sequence of Avian Leukosis Virus Subgroup J Contributes to Its Replication in Vitro but Is Not Related to Its Pathogenicity in Vivo	PLOS ONE			English	Article							ROUS-SARCOMA VIRUS; DISEASE VIRUS; DESIGNATED-J; HOST-RANGE; CHICKENS; CHINA; VIRULENCE; ANTIBODIES; CLONE; RNA	Subgroup J avian leukosis virus (ALV-J) was first isolated from meat-type chickens that had developed myeloid leukosis and since 2008, ALV-J infections in chickens have become widespread in China. A comparison of the sequence of ALV-J epidemic isolates with HPRS-103, the ALV-J prototype virus, revealed several distinct features, one of which is a 19-nucleotide (nt) insertion in the leader sequence. To determine the role of the 19-nt insertion in ALV-J pathogenicity, a pair of viruses were constructed and rescued. The first virus was an ALV-J Chinese isolate (designated rSD1009) containing the 19-nt insertion in its leader sequence. The second virus was a clone, in which the leader sequence had a deleted 19-nt sequence (designated rSD1009 Delta 19). Compared with rSD1009 Delta 19, rSD1009 displayed a moderate growth advantage in vitro. However, no differences were demonstrated in either viral replication or oncogenicity between the two rescued viruses in chickens. These results indicated that the 19-nt insertion contributed to ALV-J replication in vitro but was not related to its pathogenicity in vivo.	[Ji, Xiaolin; Wang, Qi; Li, Xiaofei; Qi, Xiaole; Wang, Yongqiang; Gao, Honglei; Gao, Yulong; Wang, Xiaomei] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Avian Infect Dis, State Key Lab Vet Biotechnol, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Gao, YL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Avian Infect Dis, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	ylg@hvri.ac.cn; xmw@hvri.ac.cn	Li, xiaofei/GXF-7187-2022		National Natural Science Foundation of China [31072146, 31201923]; earmarked fund for the Modern Agro-industry Technology Research System [nycytx-42-G3-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the Modern Agro-industry Technology Research System	This study was funded by the National Natural Science Foundation of China (31072146), the National Natural Science Foundation of China 31201923) and the earmarked fund for the Modern Agro-industry Technology Research System (no. nycytx-42-G3-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI J, 1995, J GEN VIROL, V76, P181, DOI 10.1099/0022-1317-76-1-181; Cheng Zi-qiang, 2005, Weishengwu Xuebao, V45, P584; Cheng ZQ, 2010, J VET MED SCI, V72, P1027, DOI 10.1292/jvms.09-0564; Chesters PM, 2006, J GEN VIROL, V87, P2685, DOI 10.1099/vir.0.81884-0; Deng XY, 2012, VIRUS RES, V167, P146, DOI 10.1016/j.virusres.2012.02.011; DONZE O, 1992, EMBO J, V11, P3747, DOI 10.1002/j.1460-2075.1992.tb05460.x; Dortmans JCFM, 2010, J VIROL, V84, P10113, DOI 10.1128/JVI.00097-10; Du Y., 1999, CHINA POULTRY SCI, V3, P1; Ebert D, 2003, TRENDS MICROBIOL, V11, P15, DOI 10.1016/S0966-842X(02)00003-3; Gao Y, 2011, J CLIN MICROBIOL; Gao YL, 2010, EMERG INFECT DIS, V16, P1637, DOI 10.3201/eid1610.100780; Gao YL, 2012, J CLIN MICROBIOL, V50, P953, DOI 10.1128/JCM.06179-11; HACKETT PB, 1982, J VIROL, V41, P527, DOI 10.1128/JVI.41.2.527-534.1982; Lai HZ, 2011, VET MICROBIOL, V151, P275, DOI 10.1016/j.vetmic.2011.03.037; Maas R, 2006, BIOLOGICALS, V34, P177, DOI 10.1016/j.biologicals.2005.09.002; Ogert RA, 1996, J VIROL, V70, P3834, DOI 10.1128/JVI.70.6.3834-3843.1996; Payne LN, 2012, AVIAN PATHOL, V41, P11, DOI 10.1080/03079457.2011.646237; PAYNE LN, 1991, J GEN VIROL, V72, P801, DOI 10.1099/0022-1317-72-4-801; PAYNE LN, 1992, J GEN VIROL, V73, P2995, DOI 10.1099/0022-1317-73-11-2995; PAYNE LN, 1993, VET REC, V132, P555, DOI 10.1136/vr.132.22.555; Qin AJ, 2001, AVIAN DIS, V45, P938, DOI 10.2307/1592872; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sacco MA, 2004, J VIROL, V78, P10525, DOI 10.1128/JVI.78.19.10525-10535.2004; Sun HL, 2010, ACTA VET HUNG, V58, P441, DOI 10.1556/AVet.58.2010.4.5; Suzuki K, 2009, J VIROL, V83, P7475, DOI 10.1128/JVI.01434-08; TSUKAMOTO K, 1985, AVIAN DIS, V29, P1118, DOI 10.2307/1590466; Venugopal K, 1999, RES VET SCI, V67, P113, DOI 10.1053/rvsc.1998.0283; Wang Q, 2012, J VIROL, V86, P12849, DOI 10.1128/JVI.01113-12; Wang Qi, 2011, Zhongguo Yufang Shouyi Xuebao / Chinese Journal of Preventive Veterinary Medicine, V33, P593; Yu F, 2013, VIROLOGY, V440, P204, DOI 10.1016/j.virol.2013.02.026	30	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84797	10.1371/journal.pone.0084797	http://dx.doi.org/10.1371/journal.pone.0084797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465434	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500024
J	Kaufusi, PH; Kelley, JF; Yanagihara, R; Nerurkar, VR				Kaufusi, Pakieli H.; Kelley, James F.; Yanagihara, Richard; Nerurkar, Vivek R.			Induction of Endoplasmic Reticulum-Derived Replication-Competent Membrane Structures by West Nile Virus Non-Structural Protein 4B	PLOS ONE			English	Article							HEPATITIS-C VIRUS; CELL-ADHESION MOLECULES; AMINO-ACID SUBSTITUTION; DENGUE-VIRUS; NS4B PROTEIN; SUBCELLULAR-LOCALIZATION; GENETIC INTERACTION; SECRETORY PATHWAY; VIRAL REPLICATION; RNA REPLICATION	Replication of flaviviruses (family Flaviviridae) occurs in specialized virus-induced membrane structures (IMS). The cellular composition of these IMS varies for different flaviviruses implying different organelle origins for IMS biogenesis. The role of flavivirus non-structural (NS) proteins for the alteration of IMS remains controversial. In this report, we demonstrate that West Nile virus strain New York 99 (WNVNY99) remodels the endoplasmic reticulum (ER) membrane to generate specialized IMS. Within these structures, we observed an element of the cis-Golgi, viral double-stranded RNA, and viral-envelope, NS1, NS4A and NS4B proteins using confocal immunofluorescence microscopy. Biochemical analysis and microscopy revealed that NS4B lacking the 2K-signal peptide associates with the ER membrane where it initiates IMS formation in WNV-infected cells. Co-transfection studies indicated that NS4A and NS4B always remain co-localized in the IMS and are associated with the same membrane fractions, suggesting that these proteins function cooperatively in virus replication and may be an ideal target for antiviral drug discovery.	[Kaufusi, Pakieli H.; Kelley, James F.; Yanagihara, Richard; Nerurkar, Vivek R.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA; [Yanagihara, Richard] Univ Hawaii Manoa, John A Burns Sch Med, Dept Pediat, Honolulu, HI 96822 USA; [Kaufusi, Pakieli H.; Kelley, James F.; Yanagihara, Richard; Nerurkar, Vivek R.] Univ Hawaii Manoa, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Nerurkar, VR (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.	nerurkar@hawaii.edu	Nerurkar, Vivek R/F-5533-2011		Hawaii Community Foundation [43055]; Centers of Biomedical Research Excellence [P20GM103516]; National Institute of General Medical Sciences, National Institutes of Health (NIH); Institutional Funds; Research Centers in Minority Institutions Program [G12MD007601]; FOGARTY INTERNATIONAL CENTER [R25TW009345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER	Hawaii Community Foundation; Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Institutional Funds; Research Centers in Minority Institutions Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was partially supported by grants from the Hawaii Community Foundation (43055), Centers of Biomedical Research Excellence (P20GM103516), National Institute of General Medical Sciences, National Institutes of Health (NIH), and Institutional Funds. Also Research Centers in Minority Institutions Program (G12MD007601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu CI, 2012, FEBS LETT; Blaney JE, 2003, VACCINE, V21, P4317, DOI 10.1016/S0264-410X(03)00487-0; Blum R, 1999, J CELL SCI, V112, P537; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654; Chapagain ML, 2008, J NEUROVIROL, V14, P448, DOI 10.1080/13550280802235916; Cho NJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000331; CHU PWG, 1992, ARCH VIROL, V125, P177, DOI 10.1007/BF01309636; CHU PWG, 1992, J VIROL METHODS, V37, P219, DOI 10.1016/0166-0934(92)90049-J; De Vries L, 1998, MOL BIOL CELL, V9, P1123, DOI 10.1091/mbc.9.5.1123; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Evans JD, 2007, J VIROL, V81, P11809, DOI 10.1128/JVI.00791-07; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Gretton SN, 2005, J GEN VIROL, V86, P1415, DOI 10.1099/vir.0.80768-0; Hanley KA, 2003, VIROLOGY, V312, P222, DOI 10.1016/S0042-6822(03)00197-1; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hsieh SC, 2010, J VIROL, V84, P4782, DOI 10.1128/JVI.01963-09; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Huang Z, 2012, J BIOL CHEM, V287, P4492, DOI 10.1074/jbc.M111.315598; Jones DM, 2009, J VIROL, V83, P2163, DOI 10.1128/JVI.01885-08; Kelley JF, 2012, VIROLOGY, V422, P326, DOI 10.1016/j.virol.2011.10.030; Kelley JF, 2011, VIROLOGY, V418, P27, DOI 10.1016/j.virol.2011.07.006; Khromykh AA, 2000, J VIROL, V74, P3253, DOI 10.1128/JVI.74.7.3253-3263.2000; Krause R, 2004, BIOESSAYS, V26, P1333, DOI 10.1002/bies.20141; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993; Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005; Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003; Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156; Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999; Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Mackenzie JM, 2001, VIROLOGY, V279, P161, DOI 10.1006/viro.2000.0691; Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200; Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200; Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005; Nakamura N, 2010, J PHARMACOL SCI, V112, P255, DOI 10.1254/jphs.09R03CR; NG ML, 1987, J GEN VIROL, V68, P577; NI HL, 1995, J GEN VIROL, V76, P409, DOI 10.1099/0022-1317-76-2-409; Paredes AM, 2008, J VIROL, V82, P10671, DOI 10.1128/JVI.00875-08; PETHEL M, 1992, J VIROL, V66, P7225, DOI 10.1128/JVI.66.12.7225-7231.1992; Pletnev AG, 2002, P NATL ACAD SCI USA, V99, P3036, DOI 10.1073/pnas.022652799; Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006; Sambrook J, 2001, MOL CLONING LAB MANU, V1, P110; SPEIGHT G, 1989, VIROLOGY, V170, P299, DOI 10.1016/0042-6822(89)90383-8; Tajima S, 2011, ARCH VIROL, V156, P63, DOI 10.1007/s00705-010-0816-8; Umareddy I, 2006, J GEN VIROL, V87, P2605, DOI 10.1099/vir.0.81844-0; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; WENDLAND B, 1994, MOL ENDOCRINOL, V8, P1070, DOI 10.1210/me.8.8.1070; Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997; Westaway EG, 1997, VIROLOGY, V234, P31, DOI 10.1006/viro.1997.8629; Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200; Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082; Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12; Zou G, 2009, VIROLOGY, V384, P242, DOI 10.1016/j.virol.2008.11.003	60	64	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84040	10.1371/journal.pone.0084040	http://dx.doi.org/10.1371/journal.pone.0084040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465392	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500007
J	Oh, SW; Ahn, SY; Jianwei, X; Kim, KW; Kim, S; Na, KY; Chae, DW; Kim, S; Chin, HJ				Oh, Se Won; Ahn, Shin Young; Jianwei, Xu; Kim, Ki Woong; Kim, Sejoong; Na, Ki Young; Chae, Dong Wan; Kim, Suhnggwon; Chin, Ho Jun			Relationship between Changes in Body Fat and a Decline of Renal Function in the Elderly	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; MASS INDEX; WEIGHT CHANGE; OBESITY; ASSOCIATION; RISK; AGE; ADULTS; LIFE	Obesity is a risk factor for chronic kidney disease, and its prevalence among the elderly is increasing. We investigated the effects of changes in body fat percentage (BFP) on the longitudinal changes in the estimated glomerular filtration rate (eGFR) in the elderly. This prospective cohort study included 390 participants aged >65 years who underwent bioelectrical impedance analysis at baseline and follow-up as a part of the Korean Longitudinal Study on Health and Aging. After a median follow-up period of 5.3 years, BFP was significantly higher than that at the start point (P<0.05). Participants who had the largest increase in BFP had the highest BMI and waist circumference (WC) (P<0.001). The highest tertile had the highest white blood cell count and erythrocyte sedimentation rate, incidence of rapid progression, and decline in eGFR >25% (P <= 0.017, P = 0.025, P = 0.005, respectively). The lowest tertile had the lowest triglyceride and highest high-density lipoprotein levels (P<0.05). The adjusted decline rate in eGFR was correlated with a change in BFP (P = 0.039), but not with that in BMI or WC. The highest tertile had a 4.875-fold increase in the risk for rapid progression to a decline in eGFR (95% CI: 1.366-17.397) and a 4.931-fold decrease in the risk to a decline in eGFR>25% (95% CI: 1.617-15.037), when compared with the lowest tertile. In subgroup analysis, the incidence of renal outcomes was significantly increased according to the increase in BFP in patients with lower eGFR (P <= 0.010). A change in BFP may be associated with inflammation and dyslipidemia development, and longitudinal changes in body fat are related to a decrease in eGFR in the elderly.	[Oh, Se Won] Eulji Univ, Coll Med, Eulji Gen Hosp, Dept Internal Med, Seoul, South Korea; [Ahn, Shin Young; Jianwei, Xu; Kim, Sejoong; Na, Ki Young; Chae, Dong Wan; Chin, Ho Jun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Kyeong Kido, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Ahn, Shin Young; Kim, Sejoong; Na, Ki Young; Chae, Dong Wan; Kim, Suhnggwon; Chin, Ho Jun] Seoul Natl Univ, Dept Internal Med, Seoul, South Korea; [Kim, Suhnggwon; Chin, Ho Jun] Seoul Natl Univ, Med Res Ctr, Renal Inst, Seoul, South Korea	Eulji University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chin, HJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Kyeong Kido, South Korea.	mednep@snubh.org	Kim, Ki Woong/D-5801-2012; Kim, Sejoong/J-5356-2015; Oh, Se Won/G-2632-2017	Kim, Ki Woong/0000-0002-1103-3858; Kim, Sejoong/0000-0002-7238-9962; Oh, Se Won/0000-0003-3795-9322; Xu, Jinawei/0000-0001-8049-0422	Pfizer Global Pharmaceuticals [06-05-039]; Seongnam City Government in Korea [800-20050211]	Pfizer Global Pharmaceuticals(Pfizer); Seongnam City Government in Korea	This work was supported by an independent Research Grant (IRG) from Pfizer Global Pharmaceuticals (grant no. 06-05-039) and a Grant for developing Seongnam Health Promotion Program for the Elderly from Seongnam City Government in Korea (grant no. 800-20050211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMGARTNER RN, 1995, J GERONTOL A-BIOL, V50, pM307, DOI 10.1093/gerona/50A.6.M307; Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498; Carvalho LK, 2012, NEPHROL DIAL TRANSPL, V27, P1423, DOI 10.1093/ndt/gfr450; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20; Corrada MM, 2006, AM J EPIDEMIOL, V163, P938, DOI 10.1093/aje/kwj114; de Boer IH, 2009, AM J KIDNEY DIS, V54, P1043, DOI 10.1053/j.ajkd.2009.07.018; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dey DK, 2001, EUR J CLIN NUTR, V55, P482, DOI 10.1038/sj.ejcn.1601208; Diehr P, 2008, J AM GERIATR SOC, V56, P76, DOI 10.1111/j.1532-5415.2007.01500.x; Ejerblad E, 2006, J AM SOC NEPHROL, V17, P1695, DOI 10.1681/ASN.2005060638; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Elia M, 2000, EUR J CLIN NUTR, V54, pS92, DOI 10.1038/sj.ejcn.1601030; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Foster MC, 2011, HYPERTENSION, V58, P784, DOI 10.1161/HYPERTENSIONAHA.111.175315; Gaba A, 2013, EUR J NUTR IN PRESS; Grabowski DC, 2001, J AM GERIATR SOC, V49, P968, DOI 10.1046/j.1532-5415.2001.49189.x; Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367; Han SS, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-39; Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kramer H, 2011, AM J KIDNEY DIS, V58, P177, DOI 10.1053/j.ajkd.2011.02.390; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LUKASKI HC, 1986, J APPL PHYSIOL, V60, P1327, DOI 10.1152/jappl.1986.60.4.1327; Matsumoto AM, 2002, J GERONTOL A-BIOL, V57, pM76, DOI 10.1093/gerona/57.2.M76; Ramkumar N, 2004, J RENAL NUTR, V14, P201, DOI 10.1053/j.jm.2004.07.009; Reuser M, 2008, EUR J EPIDEMIOL, V23, P601, DOI 10.1007/s10654-008-9269-8; Ricks J, 2011, AM J KIDNEY DIS, V58, P574, DOI 10.1053/j.ajkd.2011.03.023; Tamba S, 2010, ATHEROSCLEROSIS, V211, P601, DOI 10.1016/j.atherosclerosis.2010.02.037; TZANKOFF SP, 1977, J APPL PHYSIOL, V43, P1001, DOI 10.1152/jappl.1977.43.6.1001; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WILLIAMSON DF, 1993, INT J OBESITY, V17, P279; Yamashita K, 2012, CIRC J, V76, P2435, DOI 10.1253/circj.CJ-12-0337; Zoccali C, 2012, CURR OPIN NEPHROL HY, V21, P641, DOI 10.1097/MNH.0b013e328358a02b	39	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e84052	10.1371/journal.pone.0084052	http://dx.doi.org/10.1371/journal.pone.0084052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454716	Green Published, gold, Green Submitted			2022-12-25	WOS:000330236000006
J	Funabara, D; Ohmori, F; Kinoshita, S; Koyama, H; Mizutani, S; Ota, A; Osakabe, Y; Nagai, K; Maeyama, K; Okamoto, K; Kanoh, S; Asakawa, S; Watabe, S				Funabara, Daisuke; Ohmori, Fumito; Kinoshita, Shigeharu; Koyama, Hiroki; Mizutani, Saeri; Ota, Ayaka; Osakabe, Yuki; Nagai, Kiyohito; Maeyama, Kaoru; Okamoto, Kikuhiko; Kanoh, Satoshi; Asakawa, Shuichi; Watabe, Shugo			Novel Genes Participating in the Formation of Prismatic and Nacreous Layers in the Pearl Oyster as Revealed by Their Tissue Distribution and RNA Interference Knockdown	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; MATRIX PROTEIN; PINCTADA-FUCATA; SHELL MATRIX; CALCIFICATION; GLYCOSYLATION; PREDICTION; MANTLE; FAMILY	In our previous publication, we identified novel gene candidates involved in shell formation by EST analyses of the nacreous and prismatic layer-forming tissues in the pearl oyster Pinctada fucata. In the present study, 14 of those genes, including two known genes, were selected and further examined for their involvement in shell formation using the RNA interference. Molecular characterization based on the deduced amino acid sequences showed that seven of the novel genes encode secretory proteins. The tissue distribution of the transcripts of the genes, as analyzed by RT-PCR and in situ hybridization, was mostly consistent with those obtained by the EST analysis reported previously. Shells in the pearl oysters injected with dsRNAs targeting genes 000027, 000058, 000081, 000096, 000113 (nacrein), 000118, 000133 and 000411 (MSI60), which showed expression specific to the nacreous layer forming tissues, showed abnormal surface appearance in this layer. Individuals injected with dsRNAs targeting genes 000027, 000113 and 000133 also exhibited abnormal prismatic layers. Individuals injected with dsRNAs targeting genes 000031, 000066, 000098, 000145, 000194 and 000200, which showed expression specific to prismatic layer forming tissues, displayed an abnormal surface appearance in both the nacreous and prismatic layers. Taken together, the results suggest that the genes involved in prismatic layer formation might also be involved in the formation of the nacreous layers.	[Funabara, Daisuke; Mizutani, Saeri; Ota, Ayaka; Osakabe, Yuki; Kanoh, Satoshi] Mie Univ, Grad Sch Bioresources, Tsu, Mie 514, Japan; [Ohmori, Fumito; Kinoshita, Shigeharu; Koyama, Hiroki; Asakawa, Shuichi; Watabe, Shugo] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Nagai, Kiyohito] K Mikimoto & Co Ltd, Pearl Res Lab, Shima, Mie, Japan; [Maeyama, Kaoru; Okamoto, Kikuhiko] Mikimoto Pharmaceut Co Ltd, Ise, Mie, Japan; [Watabe, Shugo] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 228, Japan	Mie University; University of Tokyo; Kitasato University	Funabara, D (corresponding author), Mie Univ, Grad Sch Bioresources, Tsu, Mie 514, Japan.	funabara@bio.mie-u.ac.jp	Kinoshita, Shigeharu/AGY-8644-2022					Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Fabioux C, 2009, FEBS J, V276, P2566, DOI 10.1111/j.1742-4658.2009.06982.x; Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GORDON J, 1980, MAR BIOL, V57, P251, DOI 10.1007/BF00387568; Hausdorf B, 2007, MOL BIOL EVOL, V24, P2723, DOI 10.1093/molbev/msm214; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Marin F, 2005, J BIOL CHEM, V280, P33895, DOI 10.1074/jbc.M506526200; Marin F, 2000, J BIOL CHEM, V275, P20667, DOI 10.1074/jbc.M003006200; Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyashita T, 2000, MAR BIOTECHNOL, V2, P409; Miyashita T, 2002, VELIGER, V45, P250; Norizuki Michiko, 2008, Frontiers of Materials Science in China, V2, P167, DOI 10.1007/S11706-008-0028-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Sarashina I, 2001, MAR BIOTECHNOL, V3, P362, DOI 10.1007/s10126-001-0013-6; Southgate P, 2008, PEARL OYSTER, pVII; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takakura D, 2008, MAR BIOTECHNOL, V10, P290, DOI 10.1007/s10126-007-9063-8; Walker J. M, 2005, PROTEOMICS PROTOCOLS; Wang N, 2012, MAR BIOTECHNOL, V14, P177, DOI 10.1007/s10126-011-9400-9; Wang N, 2009, COMP BIOCHEM PHYS B, V154, P346, DOI 10.1016/j.cbpb.2009.07.012; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6	35	26	29	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84706	10.1371/journal.pone.0084706	http://dx.doi.org/10.1371/journal.pone.0084706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454739	gold, Green Submitted, Green Published			2022-12-25	WOS:000330235100029
J	Hayat, T; Shafiq, A; Alsaedi, A				Hayat, Tasawar; Shafiq, Anum; Alsaedi, Ahmed			Effect of Joule Heating and Thermal Radiation in Flow of Third Grade Fluid over Radiative Surface	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; STAGNATION-POINT FLOW; HOMOTOPY ANALYSIS METHOD; STRETCHING SHEET; MHD FLOW; ENTROPY GENERATION; MICROPOLAR FLUID; DISK	This article addresses the boundary layer flow and heat transfer in third grade fluid over an unsteady permeable stretching sheet. The transverse magnetic and electric fields in the momentum equations are considered. Thermal boundary layer equation includes both viscous and Ohmic dissipations. The related nonlinear partial differential system is reduced first into ordinary differential system and then solved for the series solutions. The dependence of velocity and temperature profiles on the various parameters are shown and discussed by sketching graphs. Expressions of skin friction coefficient and local Nusselt number are calculated and analyzed. Numerical values of skin friction coefficient and Nusselt number are tabulated and examined. It is observed that both velocity and temperature increases in presence of electric field. Further the temperature is increased due to the radiation parameter. Thermal boundary layer thickness increases by increasing Eckert number.	[Hayat, Tasawar; Shafiq, Anum] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Fac Sci, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Shafiq, A (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	anumshafiq@ymail.com	Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/E-9449-2015; Shafiq, Anum/F-9967-2018; Hayat, Tasawar/Y-2524-2019; Alsaedi, Ahmed/A-2094-2013	Shafiq, Anum/0000-0001-7186-7216; Alsaedi, Ahmed/0000-0003-3452-8922	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [10-130/1433 HiCi]	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah	This paper was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah under grant no. (10-130/1433 HiCi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasbandy S, 2011, COMMUN NONLINEAR SCI, V16, P3140, DOI 10.1016/j.cnsns.2010.11.018; Abel MS, 2008, COMMUN NONLINEAR SCI, V13, P1808, DOI 10.1016/j.cnsns.2007.04.007; Ahmad K., 2010, JQMA, V6, P117; Bataineh AS, 2009, COMMUN NONLINEAR SCI, V14, P409, DOI 10.1016/j.cnsns.2007.10.007; Bhattacharyya K, 2013, AIN SHAMS ENG J, V4, P259, DOI 10.1016/j.asej.2012.07.002; Ellahi R, 2012, INT J HEAT MASS TRAN, V55, P6384, DOI 10.1016/j.ijheatmasstransfer.2012.06.026; Emam T., 2012, J EGYPT MATH SOC, V20, P215, DOI [10.1016/j.joems.2012.08.016, DOI 10.1016/J.JOEMS.2012.08.016]; Hassan HN, 2012, APPL MATH COMPUT, V219, P708, DOI 10.1016/j.amc.2012.06.065; Hayat T, 2013, J THERMOPHYS HEAT TR, V27, P761, DOI 10.2514/1.T4059; Hayat T, 2012, APPL MATH MECH-ENGL, V33, P749, DOI 10.1007/s10483-012-1584-9; Hayat T, 2012, INT J NUMER METH FL, V69, P1350, DOI 10.1002/fld.2642; Hayat T, 2012, J MECH, V28, P209, DOI 10.1017/jmech.2012.21; Hayat T, 2011, INT J NUMER METH FL, V66, P820, DOI 10.1002/fld.2285; Hayat T, 2011, INT J NUMER METH FL, V67, P1073, DOI 10.1002/fld.2405; Hussain M, 2013, J FRANKLIN I, V350, P194, DOI 10.1016/j.jfranklin.2012.07.005; Jamil M, 2011, COMMUN NONLINEAR SCI, V16, P1378, DOI 10.1016/j.cnsns.2010.07.004; Keimanesh M, 2011, COMPUT MATH APPL, V62, P2871, DOI 10.1016/j.camwa.2011.07.054; Liao S., 2012, HOMOTOPY ANAL METHOD; Liao SJ, 2009, COMMUN NONLINEAR SCI, V14, P983, DOI 10.1016/j.cnsns.2008.04.013; Loureiro JBR, 2013, J NON-NEWTON FLUID, V199, P20, DOI 10.1016/j.jnnfm.2013.05.003; Mahmoud MAA, 2011, MATH COMPUT MODEL, V54, P1228, DOI 10.1016/j.mcm.2011.03.034; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Mandal IC, 2013, AIN SHAMS ENG J, V4, P103, DOI 10.1016/j.asej.2012.06.004; Motsa SS, 2010, COMPUT FLUIDS, V39, P1219, DOI 10.1016/j.compfluid.2010.03.004; Mukhopadhyay S, 2013, ALEX ENG J, V52, P259, DOI 10.1016/j.aej.2013.02.003; Mustafa M, 2012, Z NATURFORSCH A, V67, P70, DOI 10.5560/ZNA.2011-0057; Olanrewaju PO., 2012, WORLD APPL SCI J, V16, P37; Pal D, 2010, COMMUN NONLINEAR SCI, V15, P1197, DOI 10.1016/j.cnsns.2009.05.051; Ramzan M, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13049-5; Rana P, 2012, COMMUN NONLINEAR SCI, V17, P212, DOI 10.1016/j.cnsns.2011.05.009; Raptis A, 1998, INT COMMUN HEAT MASS, V25, P289, DOI 10.1016/S0735-1933(98)00016-5; Rashidi MM, 2013, ENERGY, V55, P497, DOI 10.1016/j.energy.2013.01.036; Rashidi MM, 2013, INT J HEAT MASS TRAN, V62, P515, DOI 10.1016/j.ijheatmasstransfer.2013.03.004; Rashidi MM, 2011, COMMUN NONLINEAR SCI, V16, P1874, DOI 10.1016/j.cnsns.2010.08.016; Renardy M, 2012, J NON-NEWTON FLUID, V189, P14, DOI 10.1016/j.jnnfm.2012.09.010; Sahoo B, 2012, COMPUT MATH APPL, V63, P1244, DOI 10.1016/j.camwa.2011.12.041; Sajid M, 2008, INT COMMUN HEAT MASS, V35, P347, DOI 10.1016/j.icheatmasstransfer.2007.08.006; Shafiq A, 2013, BRAZILIAN J CHEM ENG, V30; Sparrow EM., 1978, RAD HEAT TRANSFER; Turkyilmazoglu M, 2012, COMMUN NONLINEAR SCI, V17, P4097, DOI 10.1016/j.cnsns.2012.01.030; Turkyilmazoglu M, 2011, INT J NONLIN MECH, V46, P306, DOI 10.1016/j.ijnonlinmec.2010.09.012	41	115	115	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83153	10.1371/journal.pone.0083153	http://dx.doi.org/10.1371/journal.pone.0083153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454694	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100006
J	Gao, Y; Song, CY; Hui, LP; Li, CY; Wang, JY; Tian, Y; Han, X; Chen, Y; Tian, DL; Qiu, XS; Wang, EH				Gao, Ying; Song, Chengyang; Hui, Linping; Li, Chun-yu; Wang, Junying; Tian, Ye; Han, Xu; Chen, Yong; Tian, Da-Li; Qiu, Xueshan; Wang, Enhua			Overexpression of RNF146 in Non-Small Cell Lung Cancer Enhances Proliferation and Invasion of Tumors through the Wnt/beta-catenin Signaling Pathway	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; BREAST-CANCER; BETA-CATENIN; AXIN; PROGRESSION; LIGASE	Studies have suggested a possible correlation between the newly identified E3 ubiquitin ligase ring finger protein 146 (RNF146) and tumor development. However, until now, studies on RNF146 have been restricted to poly(ADP-ribosyl)ation and ubiquitin ligation, whereas the role of RNF146 in tumor biology has rarely been reported. In the present study, the role of RNF146 in non-small cell lung cancer (NSCLC) was investigated. The results showed that the expression of RNF146 was increased in clinical lung cancer samples and cell lines. RNF146 expression correlated with tumor size, differentiation level, lymphatic metastasis, pTNM staging, and prognosis of patients in stage I. RNF146 expression was negatively correlated with Axin expression but positively correlated with the nuclear expression of beta-catenin in NSCLC tissues. RNF146 downregulated the expression of Axin in lung cancer cell lines and induced the expression and nuclear distribution of b-catenin. Overexpression of RNF146 in NSCLC cell lines increased the levels of cyclinD1, cyclinE, and CDK4, promoted cell cycle G(0)/G(1)-S transitions, and regulated cell proliferation. Overexpression of RNF146 led to upregulated levels of matrix metalloproteinases 2 and 7 and enhanced lung cancer cell invasiveness, events that were mediated by the classical Wnt/beta-catenin signaling pathway. In summary, the data in the present study indicate that RNF146 regulated the development and progression of NSCLC by enhancing cell growth, invasion, and survival, suggesting that RNF146 may be a potential treatment target in NSCLC.	[Gao, Ying; Wang, Junying; Qiu, Xueshan; Wang, Enhua] China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Gao, Ying; Wang, Junying; Qiu, Xueshan; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang, Liaoning, Peoples R China; [Gao, Ying] China Med Univ, Dept Pathol, Affiliated Hosp 4, Shenyang, Liaoning, Peoples R China; [Song, Chengyang; Li, Chun-yu; Tian, Ye; Han, Xu; Chen, Yong; Tian, Da-Li] China Med Univ, Dept Thorac Surg, Affiliated Hosp 4, Shenyang, Liaoning, Peoples R China; [Hui, Linping] China Med Univ, Lab Ctr, Affiliated Hosp 4, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University; China Medical University	Qiu, XS (corresponding author), China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China.	xueshanqiu@gmail.com.cn			National Science Foundation of China [30972967, 30973502]; Specialized Research Fund for the Doctoral Program of Higher Education [20092104110018]; Program for Liaoning Excellent Talents in University and Liaoning Provincial Science and technology [2012225072]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for Liaoning Excellent Talents in University and Liaoning Provincial Science and technology	This work was supported by grants from the National Science Foundation of China (No. 30972967 and 30973502), Specialized Research Fund for the Doctoral Program of Higher Education (No. 20092104110018), Program for Liaoning Excellent Talents in University and Liaoning Provincial Science and technology plan program (No. 2012225072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aken EV, 1998, VIRCHOWS ARCH, V439, P725; Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; Callow MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022595; Degot S, 2002, ONCOGENE, V21, P4422, DOI 10.1038/sj.onc.1205611; Duprez E, 1997, ONCOGENE, V14, P1563, DOI 10.1038/sj.onc.1200995; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Impola U, 2004, J PATHOL, V202, P14, DOI 10.1002/path.1479; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Menachem TD, 2009, FAM CANCER, V8, P399, DOI 10.1007/s10689-009-9255-7; Nakajima M, 2003, BRIT J CANCER, V88, P1734, DOI 10.1038/sj.bjc.6600941; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Sobin L, 2009, TNM CLASSIFICATION M; Thomas P, 2000, J PATHOL, V190, P150; Wilson CL, 1996, INT J BIOCHEM CELL B, V28, P123, DOI 10.1016/1357-2725(95)00121-2; Xu HT, 2007, ANN SURG ONCOL, V14, P3251, DOI 10.1245/s10434-007-9555-9; Xu HT, 2006, AM J CLIN PATHOL, V125, P534, DOI 10.1309/0MDY02KHEW1F6RT6; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	23	33	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85377	10.1371/journal.pone.0085377	http://dx.doi.org/10.1371/journal.pone.0085377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454854	Green Published, Green Submitted, gold			2022-12-25	WOS:000329925800042
J	Jackson, D; Atkinson, J; Guevara, CI; Zhang, CY; Kery, V; Moon, SJ; Virata, C; Yang, P; Lowe, C; Pinkstaff, J; Cho, H; Knudsen, N; Manibusan, A; Tian, F; Sun, Y; Lu, YC; Sellers, A; Jia, XC; Joseph, I; Anand, B; Morrison, K; Pereira, DS; Stover, D				Jackson, Dowdy; Atkinson, John; Guevara, Claudia I.; Zhang, Chunying; Kery, Vladimir; Moon, Sung-Ju; Virata, Cyrus; Yang, Peng; Lowe, Christine; Pinkstaff, Jason; Cho, Ho; Knudsen, Nick; Manibusan, Anthony; Tian, Feng; Sun, Ying; Lu, Yingchun; Sellers, Aaron; Jia, Xiao-Chi; Joseph, Ingrid; Anand, Banmeet; Morrison, Kendall; Pereira, Daniel S.; Stover, David			In Vitro and In Vivo Evaluation of Cysteine and Site Specific Conjugated Herceptin Antibody-Drug Conjugates	PLOS ONE			English	Article							BREAST-CANCER; TRASTUZUMAB-DM1; ONCOGENE	Antibody drug conjugates (ADCs) are monoclonal antibodies designed to deliver a cytotoxic drug selectively to antigen expressing cells. Several components of an ADC including the selection of the antibody, the linker, the cytotoxic drug payload and the site of attachment used to attach the drug to the antibody are critical to the activity and development of the ADC. The cytotoxic drugs or payloads used to make ADCs are typically conjugated to the antibody through cysteine or lysine residues. This results in ADCs that have a heterogeneous number of drugs per antibody. The number of drugs per antibody commonly referred to as the drug to antibody ratio (DAR), can vary between 0 and 8 drugs for a IgG(1) antibody. Antibodies with 0 drugs are ineffective and compete with the ADC for binding to the antigen expressing cells. Antibodies with 8 drugs per antibody have reduced in vivo stability, which may contribute to non target related toxicities. In these studies we incorporated a non-natural amino acid, para acetyl phenylalanine, at two unique sites within an antibody against Her2/neu. We covalently attached a cytotoxic drug to these sites to form an ADC which contains two drugs per antibody. We report the results from the first direct preclinical comparison of a site specific non-natural amino acid antiHer2 ADC and a cysteine conjugated anti-Her2 ADC. We report that the site specific non-natural amino acid anti-Her2 ADCs have superior in vitro serum stability and preclinical toxicology profile in rats as compared to the cysteine conjugated antiHer2 ADCs. We also demonstrate that the site specific non-natural amino acid anti-Her2 ADCs maintain their in vitro potency and in vivo efficacy against Her2 expressing human tumor cell lines. Our data suggests that site specific non-natural amino acid ADCs may have a superior therapeutic window than cysteine conjugated ADCs.	[Jackson, Dowdy; Atkinson, John; Guevara, Claudia I.; Zhang, Chunying; Kery, Vladimir; Moon, Sung-Ju; Virata, Cyrus; Yang, Peng; Lowe, Christine; Jia, Xiao-Chi; Joseph, Ingrid; Anand, Banmeet; Morrison, Kendall; Pereira, Daniel S.; Stover, David] Agensys Inc, Santa Monica, CA 90404 USA; [Pinkstaff, Jason; Cho, Ho; Knudsen, Nick; Manibusan, Anthony; Tian, Feng; Sun, Ying; Lu, Yingchun; Sellers, Aaron] Ambrx Inc, La Jolla, CA USA		Jackson, D (corresponding author), Agensys Inc, Santa Monica, CA 90404 USA.	djackson@agensys.com			Agensys, Inc; Ambrx, Inc	Agensys, Inc; Ambrx, Inc	All studies were funded by Agensys, Inc and/or Ambrx, Inc. There were no private or government funding agencies used to fund these studies. All studies were conceived and performed by Agensys or Ambrx employees, with the exception of the rat toxicology studies, which were designed by Agensys and Ambrx employees and paid for by Agensys, Inc. The data analysis, preparation of the manuscript and the decision to publish were made by Agensys, Inc and Ambrx, Inc.	Axup JY, 2012, P NATL ACAD SCI US; Barok M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2868; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Crisalli P, 2013, J ORG CHEM, V78, P1184, DOI 10.1021/jo302746p; Goldmacher VS, 2011, THER DELIV, V2, P397, DOI 10.4155/TDE.10.98; Guha M., 2012, NAT BIOTECHNOL, V30, P728; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Hubalek M, 2010, WIEN MED WOCHENSCHR, V160, P506, DOI 10.1007/s10354-010-0838-6; Hurvitz SA, 2012, THER ADV MED ONCOL, V4, P235, DOI 10.1177/1758834012451205; Junutula JR, 2010, CLIN CANCER RES, V16, P4769, DOI 10.1158/1078-0432.CCR-10-0987; Meden H, 1997, EUR J OBSTET GYN R B, V71, P173, DOI 10.1016/S0301-2115(96)02630-9; Papazisis KT, 2004, INT J CLIN PRACT, V58, P581, DOI 10.1111/j.1368-5031.2004.00203.x; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sutherland MSK, 2013, BLOOD, V122, P1455, DOI 10.1182/blood-2013-03-491506; TRAIL PA, 1993, SCIENCE, V261, P212, DOI 10.1126/science.8327892; Valliere-Douglass JF, 2012, ANAL CHEM, V84, P2843, DOI 10.1021/ac203346c; Xu K, 2011, ANAL BIOCHEM, V412, P56, DOI 10.1016/j.ab.2011.01.004	19	85	96	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e83865	10.1371/journal.pone.0083865	http://dx.doi.org/10.1371/journal.pone.0083865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454709	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800011
J	Tsai, MH; Chu, SM; Hsu, JF; Lien, RY; Huang, HR; Chiang, MC; Fu, RH; Lee, CW; Huang, YC				Tsai, Ming-Horng; Chu, Shih-Ming; Hsu, Jen-Fu; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei; Lee, Chiang-Wen; Huang, Yhu-Chering			Polymicrobial Bloodstream Infection in Neonates: Microbiology, Clinical Characteristics, and Risk Factors	PLOS ONE			English	Article							CENTRAL VENOUS CATHETERS; BIRTH-WEIGHT INFANTS; INTENSIVE-CARE-UNIT; LATE-ONSET SEPSIS; ENTEROCOCCAL BACTEREMIA; PEDIATRIC-PATIENTS; MORTALITY; CHILDREN; EPIDEMIOLOGY	Background: Polymicrobial bloodstream infections (PBSIs) have been associated with complex underlying medical conditions and a high incidence of specific microorganisms in several settings, but the relevant data are scarce in neonates. Methods: Positive blood cultures from January 2004 to December 2011 in the neonatal intensive care unit (NICU) of Chang Gung Memorial Hospital (CGMH) were reviewed. Each neonate with PBSI (case episode) was matched to two episodes of monomicrobial BSI (control episode) by birth weight, gestational age and gender. Records were reviewed to compare their underlying medical conditions, organisms isolated, adequacy of therapy, clinical characteristics and outcomes. Results: Forty-five episodes of PBSI (4.4% of all neonatal BSIs) were identified in 43 neonates. Gram-negative organisms constituted 59.8% of all PBSI pathogens, and 33 (73.3%) of PBSIs were caused by at least one Gram-negative organism. PBSIs were significantly more likely to be the recurrent episode and have endotracheal tube in place. No significant difference was found between PBSIs and controls in terms of demographics and most chronic conditions. PBSIs were significantly associated with a higher severity of illness, a longer duration of septic symptoms, and a higher rate of modification of antimicrobial regimens than monomicrobial BSIs. However, the sepsis-attributable mortality rates were comparable between these two groups. Conclusions: In the NICU, PBSIs were more often caused by Gram-negative bacilli, and often occurred in neonates without any chronic conditions. The clinical significance of PBSIs included a more severe illness, longer duration of septic symptoms and a higher rate of modification of antimicrobial regimens.	[Tsai, Ming-Horng] Chang Gung Mem Hosp, Dept Pediat, Div Neonatol & Pediat Hematol Oncol, Yunlin, Taiwan; [Huang, Yhu-Chering] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan; [Chu, Shih-Ming; Hsu, Jen-Fu; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Neonatol, Tao Yuan, Taiwan; [Tsai, Ming-Horng; Chu, Shih-Ming; Hsu, Jen-Fu; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Tsai, Ming-Horng; Lee, Chiang-Wen] Chang Gung Univ Sci & Technol, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology	Huang, YC (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan.	ychuang@adm.cgmh.org.tw						Armenian SH, 2005, PEDIATR INFECT DIS J, V24, P309, DOI 10.1097/01.inf.0000157086.97503.bd; Beekmann SE, 2003, J CLIN MICROBIOL, V41, P3119, DOI 10.1128/JCM.41.7.3119-3125.2003; Bizzarro MJ, 2008, INFECT CONT HOSP EP, V29, P914, DOI 10.1086/591323; BONADIO WA, 1988, AM J DIS CHILD, V142, P1158, DOI 10.1001/archpedi.1988.02150110036014; CHRISTIE C, 1994, J PEDIATR-US, V125, P392, DOI 10.1016/S0022-3476(05)83282-2; Clinical and Laboratory Standards Institute, 2009, M02A10 CLSI; Cohen-Wolkowiez M, 2009, PEDIATR INFECT DIS J, V28, P1052, DOI 10.1097/INF.0b013e3181acf6bd; Das I, 1998, PEDIATR INFECT DIS J, V17, P1154, DOI 10.1097/00006454-199812000-00011; Downes KJ, 2008, CLIN INFECT DIS, V46, P387, DOI 10.1086/525265; EI-Mahallawy H, 2005, INT J INFECT DIS, V9, P43; Gordon A, 2006, PEDIATR INFECT DIS J, V25, P25, DOI 10.1097/01.inf.0000195628.35980.2e; GRAY JE, 1992, PEDIATRICS, V90, P561; Gupta P, 2005, J PAEDIATR CHILD H, V41, P365, DOI 10.1111/j.1440-1754.2005.00633.x; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kermorvant-Duchemin E, 2008, PEDIATR CRIT CARE ME, V9, P186, DOI 10.1097/PCC.0b013e31816689a8; Klotz SA, 2007, DIAGN MICR INFEC DIS, V59, P401, DOI 10.1016/j.diagmicrobio.2007.07.001; Makhoul IR, 2005, CLIN INFECT DIS, V40, P218, DOI 10.1086/426444; McKenzie FE, 2006, J CLIN EPIDEMIOL, V59, P760, DOI 10.1016/j.jclinepi.2005.12.009; McNeeley DF, 1996, PEDIATR INFECT DIS J, V15, P800, DOI 10.1097/00006454-199609000-00013; RELLO J, 1993, INTENS CARE MED, V19, P22, DOI 10.1007/BF01709273; Sutter D, 2008, PEDIATR INFECT DIS J, V27, P400, DOI 10.1097/INF.0b013e31816591be; Tsai MH, 2011, INFECT CONT HOSP EP, V32, P258, DOI 10.1086/658335; Tsai MH, 2009, PEDIATR INFECT DIS J, V28, P966, DOI 10.1097/INF.0b013e3181aa3a29; WEINSTEIN MP, 1986, DIAGN MICR INFEC DIS, V5, P185, DOI 10.1016/0732-8893(86)90001-5; William Taeusch H, 2006, AVERYS DIS NEWBORN; Wisplinghoff H, 2003, PEDIATR INFECT DIS J, V22, P686, DOI 10.1097/01.inf.0000078159.53132.40	26	12	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e83082	10.1371/journal.pone.0083082	http://dx.doi.org/10.1371/journal.pone.0083082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454692	Green Published, Green Submitted, gold			2022-12-25	WOS:000329925800006
J	Wu, SY; Gao, YL; Zhang, YP; Wang, ED; Xu, XN; Lei, ZR				Wu, Shengyong; Gao, Yulin; Zhang, Yaping; Wang, Endong; Xu, Xuenong; Lei, Zhongren			An Entomopathogenic Strain of Beauveria bassiana against Frankliniella occidentalis with no Detrimental Effect on the Predatory Mite Neoseiulus barkeri : Evidence from Laboratory Bioassay and Scanning Electron Microscopic Observation	PLOS ONE			English	Article							WESTERN FLOWER THRIPS; 2 NATURAL ENEMIES; METARHIZIUM-ANISOPLIAE; PERGANDE THYSANOPTERA; BIOLOGICAL-CONTROL; RESISTANCE; MECHANISMS; CUCUMBER; FUNGUS	Among 28 isolates of Beauveria bassiana tested for virulence against F. occidentalis in laboratory bioassays, we found strain SZ-26 as the most potent, causing 96% mortality in adults at 1 x10(7) mL(-1) conidia after 4 days. The effect of the strain SZ-26 on survival, longevity and fecundity of the predatory mite Neoseiulus (Amblyseius) barkeri Hughes were studied under laboratory conditions. The bioassay results showed that the corrected mortalities were less than 4 and 8% at 10 days following inoculation of the adult and the larvae of the predator, respectively, with 1x10(7) conidia mL(-1) of SZ-26. Furthermore, no fungal hyphae were found in dead predators. The oviposition and postoviposition durations, longevity, and fecundity displayed no significant differences after inoculation with SZ-26 using first-instar larvae of F. occidentalis as prey in comparison with untreated predator. In contrast, the preoviposition durations were significantly longer. Observations with a scanning electron microscope, revealed that many conidia were attached to the cuticles of F. occidentalis at 2 h after treatment with germ tubes oriented toward cuticle at 24 h, penetration of the insect cuticle at 36 h, and finally, fungal colonization of the whole insect body at 60 h. In contrast, we never observed penetration of the predator's cuticle and conidia were shed gradually from the body, further demonstrating that B. bassiana strain SZ-26 show high toxicity against F. occidentalis but no pathogenicity to predatory mite.	[Wu, Shengyong; Gao, Yulin; Zhang, Yaping; Wang, Endong; Xu, Xuenong; Lei, Zhongren] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Lei, ZR (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	zrlei@ippcaas.cn	Gao, Yu/HGE-1937-2022		National Special Fund for the Commonwealth Agricultural Research [200903032]; National Modern Agricultural Science and Technology City Industry of Beijing [Z121100001212006]; National Key Basic Research Program [2009CB119004]	National Special Fund for the Commonwealth Agricultural Research; National Modern Agricultural Science and Technology City Industry of Beijing; National Key Basic Research Program(National Basic Research Program of China)	This research was supported by the National Special Fund for the Commonwealth Agricultural Research (200903032), National Modern Agricultural Science and Technology City Industry of Beijing (Z121100001212006) and the National Key Basic Research Program (973 Projects Grant 2009CB119004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Bielza P, 2008, PEST MANAG SCI, V64, P1131, DOI 10.1002/ps.1620; Boaria A., 2011, IOBC/WPRS Bulletin, V66, P245; Broadbent AB, 1997, CAN ENTOMOL, V129, P907, DOI 10.4039/Ent129907-5; BRODSGAARD H F, 1989, Tidsskrift for Planteavl, V93, P83; Charnley A.K., 1991, P267; FARISH DJ, 1972, ANIM BEHAV, V20, P662, DOI 10.1016/S0003-3472(72)80139-8; Furtado I.P., 1997, Ecossistema, V21, P85; Gao YL, 2012, BIOCONTROL SCI TECHN, V22, P803, DOI 10.1080/09583157.2012.691158; GILLESPIE DR, 1989, ENTOMOPHAGA, V34, P185, DOI 10.1007/BF02372667; Gonzalez-Zamora J. E., 1992, Boletin de Sanidad Vegetal, Plagas, V18, P265; Jacobson RJ, 2001, BIOCONTROL SCI TECHN, V11, P391, DOI 10.1080/09583150120055808; Jarosik Vojtech, 1995, Acta Societatis Zoologicae Bohemicae, V59, P177; Kirk WDJ, 2003, AGR FOREST ENTOMOL, V5, P301, DOI 10.1046/j.1461-9563.2003.00192.x; Lacey L. A., 2002, Documentos - Embrapa Soja, P31; Leckie BM, 2008, BIOCONTROL SCI TECHN, V18, P697, DOI 10.1080/09583150802262906; Liang XH, 2010, INSECT SCI, V17, P535, DOI 10.1111/j.1744-7917.2010.01337.x; [吕丁丁 LV DingDing], 2008, [微生物学通报, Microbiology], V35, P443; Maniania NK, 2002, MYCOPATHOLOGIA, V155, P229, DOI 10.1023/A:1021177626246; Morse JG, 2006, ANNU REV ENTOMOL, V51, P67, DOI 10.1146/annurev.ento.51.110104.151044; Poprawski TJ, 1998, ENVIRON ENTOMOL, V27, P785, DOI 10.1093/ee/27.3.785; Pozzebon A, 2010, TRENDS IN ACAROLOGY, P465, DOI 10.1007/978-90-481-9837-5_77; Rodriguez-Reina J.M., 1992, Boletin de Sanidad Vegetal Plagas, V18, P253; Roy HE, 1998, J INVERTEBR PATHOL, V71, P236, DOI 10.1006/jipa.1997.4736; Seiedy M, 2012, BIOCONTROL SCI TECHN, V22, P873, DOI 10.1080/09583157.2012.695010; Seyed-Talebi FS, 2012, BIOCONTROL SCI TECHN, V22, P293, DOI 10.1080/09583157.2012.655709; SHAW JG, 1967, J ECON ENTOMOL, V60, P1751, DOI 10.1093/jee/60.6.1751; Shipp JL, 1998, J ECON ENTOMOL, V91, P671, DOI 10.1093/jee/91.3.671; Shipp L., 2002, Bulletin OILB/SROP, V25, P237; Simelane DO, 2008, BIOL CONTROL, V44, P128, DOI 10.1016/j.biocontrol.2007.10.004; SPSS, 2005, SPSS US GUID VERS 14; STLEGER RJ, 1995, CAN J BOT, V73, pS1119, DOI 10.1139/b95-367; Van de Veire M, 2002, BIOCONTROL, V47, P101, DOI 10.1023/A:1014473023912; van der Hoeven W.A.D., 1990, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V1, P25; VESTERGAARD S, 1995, BIOCONTROL SCI TECHN, V5, P185, DOI 10.1080/09583159550039909; Wang CS, 2005, FUNGAL GENET BIOL, V42, P704, DOI 10.1016/j.fgb.2005.04.006; Wang JH, 2011, MICROB BIOTECHNOL, V4, P479, DOI 10.1111/j.1751-7915.2010.00197.x; Wang YaHui, 2011, Chinese Journal of Biological Control, V27, P324; Wekesa VW, 2007, BIOL CONTROL, V41, P408, DOI 10.1016/j.biocontrol.2007.03.003; Wen JinZeng, 2003, Plant Protection, V29, P50; Yuan SY, 2011, J HUAZHONG AGR U, V2, P177; YUDIN LS, 1986, ENVIRON ENTOMOL, V15, P1292, DOI 10.1093/ee/15.6.1292; Zhang SY, 2008, INSECT SCI, V15, P125, DOI 10.1111/j.1744-7917.2008.00192.x	43	39	46	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e84732	10.1371/journal.pone.0084732	http://dx.doi.org/10.1371/journal.pone.0084732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454744	Green Submitted, gold, Green Published			2022-12-25	WOS:000329925800014
J	Ceccarelli, V; Nocentini, G; Billi, M; Racanicchi, S; Riccardi, C; Roberti, R; Grignani, F; Binaglia, L; Vecchini, A				Ceccarelli, Veronica; Nocentini, Giuseppe; Billi, Monia; Racanicchi, Serena; Riccardi, Carlo; Roberti, Rita; Grignani, Francesco; Binaglia, Luciano; Vecchini, Alba			Eicosapentaenoic Acid Activates RAS/ERK/C/EBP beta Pathway through H-Ras Intron 1 CpG Island Demethylation in U937 Leukemia Cells	PLOS ONE			English	Article							DNA METHYLATION; MONOCYTIC DIFFERENTIATION; GENE-EXPRESSION; CANCER-CELLS; LIPID RAFTS; C/EBP-BETA; TRANSCRIPTION; EPIGENETICS; PCR; HYPERMETHYLATION	Epigenetic alterations, including aberrant DNA methylation, contribute to tumor development and progression. Silencing of tumor suppressor genes may be ascribed to promoter DNA hypermethylation, a reversible phenomenon intensely investigated as potential therapeutic target. Previously, we demonstrated that eicosapentaenoic acid (EPA) exhibits a DNA demethylating action that promotes the re-expression of the tumor suppressor gene CCAAT/enhancer-binding protein delta (C/EBP delta). The C/EBPb/C/EBP delta heterodimer formed appears essential for the monocyte differentiation commitment. The present study aims to evaluate the effect of EPA on RAS/extracellular signal regulated kinases (ERK1/2)/C/EBP beta pathway, known to be induced during the monocyte differentiation program. We found that EPA conditioning of U937 leukemia cells activated RAS/ERK/C/EBP beta pathway, increasing the C/EBP beta and ERK1/2 active phosphorylated forms. Transcriptional induction of the upstream activator H-Ras gene resulted in increased expression of H-Ras protein in the active pool of non raft membrane fraction. H-Ras gene analysis identified an hypermethylated CpG island in intron 1 that can affect the DNA-protein interaction modifying RNA polymerase II (RNAPII) activity. EPA treatment demethylated almost completely this CpG island, which was associated with an enrichment of active RNAPII. The increased binding of the H-Ras transcriptional regulator p53 to its consensus sequence within the intronic CpG island further confirmed the effect of EPA as demethylating agent. Our results provide the first evidence that an endogenous polyunsaturated fatty acid (PUFA) promotes a DNA demethylation process responsible for the activation of RAS/ERK/C/EBP beta pathway during the monocyte differentiation commitment. The new role of EPA as demethylating agent paves the way for studying PUFA action when aberrant DNA methylation is involved.	[Ceccarelli, Veronica; Billi, Monia; Racanicchi, Serena; Roberti, Rita; Grignani, Francesco; Binaglia, Luciano; Vecchini, Alba] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Nocentini, Giuseppe; Riccardi, Carlo] Univ Perugia, Dept Med, I-06100 Perugia, Italy	University of Perugia; University of Perugia	Vecchini, A (corresponding author), Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy.	alba.vecchini@unipg.it	Nocentini, Giuseppe/B-9412-2013; Riccardi, Carlo/N-4610-2014; Nocentini, Giuseppe/GZB-0146-2022; Grignani, Francesco/AAC-2565-2022	Nocentini, Giuseppe/0000-0002-5209-0488; Riccardi, Carlo/0000-0001-9257-3997; ROBERTI, Rita/0000-0003-4131-5933; Ceccarelli, Veronica/0000-0003-0424-6940; Vecchini, Alba/0000-0003-1253-7625	Ministero delle Politiche Agricole, Alimentari e Forestali; Italian Association for Cancer Research (AIRC) [IG-9390]; Fondazione Cassa di Risparmio di Perugia [2012.0137.021]	Ministero delle Politiche Agricole, Alimentari e Forestali; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	This research was supported by grants from Ministero delle Politiche Agricole, Alimentari e Forestali to LB, Italian Association for Cancer Research (AIRC) to FG (project IG-9390), and Fondazione Cassa di Risparmio di Perugia to CR (project 2012.0137.021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Ceccarelli V, 2011, J BIOL CHEM, V286, P27092, DOI 10.1074/jbc.M111.253609; Dai ZY, 2004, ONCOGENE, V23, P3521, DOI 10.1038/sj.onc.1207441; Diakiw SM, 2012, LEUKEMIA RES, V36, P110, DOI 10.1016/j.leukres.2011.09.013; Dorrell C, 2004, MOL CELL BIOL, V24, P6993, DOI 10.1128/MCB.24.16.6993-7002.2004; Esteller M, 2003, ADV EXP MED BIOL, V532, P39; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galm O, 2006, BLOOD REV, V20, P1, DOI 10.1016/j.blre.2005.01.006; HASHIMOTOGOTOH T, 1988, ANTICANCER RES, V8, P851; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; HIBI S, 1993, BLOOD, V81, P1841; HONKAWA H, 1987, MOL CELL BIOL, V7, P2933, DOI 10.1128/MCB.7.8.2933; Hu XT, 2000, CELL GROWTH DIFFER, V11, P191; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; ITOH YH, 1986, ANAL BIOCHEM, V154, P200, DOI 10.1016/0003-2697(86)90515-4; Jones PA, 2005, CANCER RES, V65, P11241, DOI 10.1158/0008-5472.CAN-05-3865; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KHARBANDA S, 1994, J BIOL CHEM, V269, P872; Klug M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r46; Ko M, 2013, NATURE, V497, P122, DOI 10.1038/nature12052; Ko YG, 1999, J IMMUNOL, V162, P7217; Kotsinas A, 2001, CANCER GENET CYTOGEN, V126, P147, DOI 10.1016/S0165-4608(00)00407-6; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Lee S, 2010, MOL CELL BIOL, V30, P2621, DOI 10.1128/MCB.00782-09; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Luo J, 2010, INT J BIOL SCI, V6, P784; MACALA LJ, 1983, J LIPID RES, V24, P1243; Mack GS, 2006, J NATL CANCER I, V98, P1443, DOI 10.1093/jnci/djj447; Maher J, 1996, LEUKEMIA, V10, P83; Marcinkowska E, 2006, EXP CELL RES, V312, P2054, DOI 10.1016/j.yexcr.2006.03.003; Medvedeva YA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-48; Membrino A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024421; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Pethe V, 1999, J BIOL CHEM, V274, P30969, DOI 10.1074/jbc.274.43.30969; Plowman SJ, 2005, BBA-MOL CELL RES, V1746, P274, DOI 10.1016/j.bbamcr.2005.06.004; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; Siddiqui RA, 2007, NUTR CLIN PRACT, V22, P74, DOI 10.1177/011542650702200174; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; van Roon EHJ, 2011, EUR J HUM GENET, V19, P307, DOI 10.1038/ejhg.2010.187; Williams JA, 2012, BIOPHYS J, V103, P228, DOI 10.1016/j.bpj.2012.06.016; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Zachos G, 1997, CRIT REV ONCOL HEMAT, V26, P65, DOI 10.1016/S1040-8428(97)00013-9	55	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85025	10.1371/journal.pone.0085025	http://dx.doi.org/10.1371/journal.pone.0085025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454781	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500032
J	Moll, G; Hult, A; von Bahr, L; Alm, JJ; Heldring, N; Hamad, OA; Stenbeck-Funke, L; Larsson, S; Teramura, Y; Roelofs, H; Nilsson, B; Fibbe, WE; Olsson, ML; Le Blanc, K				Moll, Guido; Hult, Annika; von Bahr, Lena; Alm, Jessica J.; Heldring, Nina; Hamad, Osama A.; Stenbeck-Funke, Lillemor; Larsson, Stella; Teramura, Yuji; Roelofs, Helene; Nilsson, Bo; Fibbe, Willem E.; Olsson, Martin L.; Le Blanc, Katarina			Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; STEM-CELLS; STEROID-RESISTANT; WHOLE-BLOOD; CALF SERUM; TRANSPLANTATION; EXPANSION; IDENTIFICATION; ALTERNATIVES; EXPRESSION	Investigation into predictors for treatment outcome is essential to improve the clinical efficacy of therapeutic multipotent mesenchymal stromal cells (MSCs). We therefore studied the possible harmful impact of immunogenic ABO blood groups antigens - genetically governed antigenic determinants - at all given steps of MSC-therapy, from cell isolation and preparation for clinical use, to final recipient outcome. We found that clinical MSCs do not inherently express or upregulate ABO blood group antigens after inflammatory challenge or in vitro differentiation. Although antigen adsorption from standard culture supplements was minimal, MSCs adsorbed small quantities of ABO antigen from fresh human AB plasma (ABP), dependent on antigen concentration and adsorption time. Compared to cells washed in non-immunogenic human serum albumin (HSA), MSCs washed with ABP elicited stronger blood responses after exposure to blood from healthy O donors in vitro, containing high titers of ABO antibodies. Clinical evaluation of hematopoietic stem cell transplant (HSCT) recipients found only very low titers of anti-A/B agglutination in these strongly immunocompromised patients at the time of MSC treatment. Patient analysis revealed a trend for lower clinical response in blood group O recipients treated with ABP-exposed MSC products, but not with HSA-exposed products. We conclude, that clinical grade MSCs are ABO-neutral, but the ABP used for washing and infusion of MSCs can contaminate the cells with immunogenic ABO substance and should therefore be substituted by non-immunogenic HSA, particularly when cells are given to immunocompentent individuals.	[Moll, Guido; Alm, Jessica J.; Heldring, Nina; Larsson, Stella; Le Blanc, Katarina] Karolinska Inst, Div Clin Immunol & Transfus Med, Dept Lab Med, Stockholm, Sweden; [Hult, Annika; Olsson, Martin L.] Lund Univ, Div Hematol & Transfus Med, Dept Lab Med, Lund, Sweden; [von Bahr, Lena; Le Blanc, Katarina] Karolinska Univ, Huddinge Hosp, Hematol Ctr, Stockholm, Sweden; [Hamad, Osama A.; Stenbeck-Funke, Lillemor; Teramura, Yuji; Nilsson, Bo] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Uppsala, Sweden; [Roelofs, Helene; Fibbe, Willem E.] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands	Karolinska Institutet; Lund University; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Moll, G (corresponding author), Karolinska Inst, Div Clin Immunol & Transfus Med, Dept Lab Med, Stockholm, Sweden.	guido.moll@ki.se	Le Blanc, Katarina/L-4631-2019; Moll, Guido/Q-1044-2018; Moll, Guido/L-6321-2019; Nilsson, Bo/B-3102-2012	Moll, Guido/0000-0001-6173-5957; Nilsson, Bo/0000-0003-0057-2730; Olsson, Martin L/0000-0003-1647-9610	Swedish Cancer Society [11 0315]; Children's Cancer Foundation [PROJ11/034]; Swedish Medical Research Council [K2011-??X-20742-04-6, K2011-65X-12219-15-6, K2011-14251]; VINNOVA [2010-00501]; Stockholm County Council (ALF) [20110152]; Cancer Society in Stockholm; Swedish Society of Medicine; Tobias Foundation; Karolinska Institutet; Swedish Research Council/VINNOVA/Swedish Foundation Strategic Research [6076170]; Juvenile Diabetes Foundation International; NIH [2U01AI065192-06]; governmental research grants to the university and regional laboratories in Lund (ALF); Region Skane Fund for Research and Development; Medical Faculty at Lund University, Sweden; Netherlands Institute for Regenerative Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI065192] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26106709] Funding Source: KAKEN	Swedish Cancer Society(Swedish Cancer Society); Children's Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); VINNOVA(Vinnova); Stockholm County Council (ALF)(Stockholm County Council); Cancer Society in Stockholm; Swedish Society of Medicine; Tobias Foundation; Karolinska Institutet(Karolinska Institutet); Swedish Research Council/VINNOVA/Swedish Foundation Strategic Research(VinnovaSwedish Research Council); Juvenile Diabetes Foundation International; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); governmental research grants to the university and regional laboratories in Lund (ALF); Region Skane Fund for Research and Development; Medical Faculty at Lund University, Sweden; Netherlands Institute for Regenerative Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Swedish Cancer Society (11 0315), the Children's Cancer Foundation (PROJ11/034), the Swedish Medical Research Council (K2011-??X-20742-04-6), VINNOVA (2010-00501), the Stockholm County Council (ALF) (20110152), the Cancer Society in Stockholm, the Swedish Society of Medicine, the Tobias Foundation, and Karolinska Institutet (to K. L. B); the Swedish Medical Research Council (K2011-65X-12219-15-6), the Swedish Research Council/VINNOVA/Swedish Foundation Strategic Research (6076170), the Juvenile Diabetes Foundation International, and the NIH (2U01AI065192-06) (to B.N.); the Swedish Medical Research Council (K2011-14251), governmental research grants to the university and regional laboratories in Lund (ALF), Region Skane Fund for Research and Development, the Medical Faculty at Lund University, Sweden (to M.L.O.); and the Netherlands Institute for Regenerative Medicine (to W. E. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Bianco-Miotto T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004788; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Connolly-Andersen AM, 2011, J VIROL, V85, P7766, DOI 10.1128/JVI.02469-10; Deak E, 2010, CYTOTHERAPY, V12, P260, DOI 10.3109/14653240903401840; Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420; Galili U, 2006, TRANSFUS APHER SCI, V35, P45, DOI 10.1016/j.transci.2006.05.007; Galipeau J, 2013, CYTOTHERAPY, V15, P2, DOI 10.1016/j.jcyt.2012.10.002; Gustafson EK, 2011, TRANSPLANTATION, V91, P632, DOI 10.1097/TP.0b013e31820ae459; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Heiskanen A, 2009, GLYCOCONJUGATE J, V26, P367, DOI 10.1007/s10719-008-9217-6; Hirvonen T, 2012, STEM CELLS DEV, V21, P455, DOI 10.1089/scd.2011.0405; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Hosseini-Maaf B, 2007, TRANSFUSION, V47, P2110, DOI 10.1111/j.1537-2995.2007.01436.x; Kocaoemer A, 2007, STEM CELLS, V25, P1270, DOI 10.1634/stemcells.2006-0627; Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Moll G, 2012, STEM CELLS, V30, P1565, DOI 10.1002/stem.1111; Nilsson B, 1998, BLOOD, V92, P1661, DOI 10.1182/blood.V92.5.1661; Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005; OLSSON ML, 1995, VOX SANG, V69, P242; Olsson ML, 2001, BLOOD, V98, P1585, DOI 10.1182/blood.V98.5.1585; Orntoft TF, 1996, CANCER RES, V56, P1031; Phinney DG, 2013, CYTOTHERAPY, V15, P140, DOI 10.1016/j.jcyt.2012.11.005; Ringden O, 2011, BONE MARROW TRANSPL, V46, P1158, DOI 10.1038/bmt.2010.262; Schafer R, 2011, BRIT J HAEMATOL, V153, P520, DOI 10.1111/j.1365-2141.2011.08652.x; Schallmoser Katharina, 2013, Methods Mol Biol, V946, P349, DOI 10.1007/978-1-62703-128-8_22; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Storry J R, 2009, Immunohematology, V25, P48; Stussi G, 2007, SWISS MED WKLY, V137, P15; Sundin M, 2007, HAEMATOLOGICA, V92, P1208, DOI 10.3324/haematol.11446; Toki D, 2009, TRANSPLANTATION, V88, P1186, DOI 10.1097/TP.0b013e3181ba07ec; von Bahr L, 2012, BIOL BLOOD MARROW TR, V18, P557, DOI 10.1016/j.bbmt.2011.07.023	37	44	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85040	10.1371/journal.pone.0085040	http://dx.doi.org/10.1371/journal.pone.0085040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454787	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500034
J	Servillo, L; Giovane, A; Cautela, D; Castaldo, D; Balestrieri, ML				Servillo, Luigi; Giovane, Alfonso; Cautela, Domenico; Castaldo, Domenico; Balestrieri, Maria Luisa			Where Does N-epsilon-Trimethyllysine for the Carnitine Biosynthesis in Mammals Come from?	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; GAMMA-BUTYROBETAINE; AMINO-ACIDS; LYSINE; METABOLISM; PURIFICATION; DERIVATIVES; DEFICIENCY; SKELETAL; LIVER	N-epsilon-trimethyllysine (TML) is a non-protein amino acid which takes part in the biosynthesis of carnitine. In mammals, the breakdown of endogenous proteins containing TML residues is recognized as starting point for the carnitine biosynthesis. Here, we document that one of the main sources of TML could be the vegetables which represent an important part of daily alimentation for most mammals. A HPLC-ESI-MS/ MS method, which we previously developed for the analysis of N-G-methylarginines, was utilized to quantitate TML in numerous vegetables. We report that TML, believed to be rather rare in plants as free amino acid, is, instead, ubiquitous in them and at not negligible levels. The occurrence of TML has been also confirmed in some vegetables by a HPLC method with fluorescence detection. Our results establish that TML can be introduced as free amino acid in conspicuous amounts from vegetables. The current opinion is that mammals utilize the breakdown of their endogenous proteins containing TML residues as starting point for carnitine biosynthesis. However, our finding raises the question of whether a tortuous and energy expensive route as the one of TML formation from the breakdown of endogenous proteins is really preferred when the substance is so easily available in vegetable foods. On the basis of this result, it must be taken into account that in mammals TML might be mainly introduced by diet. However, when the alimentary intake becomes insufficient, as during starvation, it might be supplied by endogenous protein breakdown.	[Servillo, Luigi; Giovane, Alfonso; Balestrieri, Maria Luisa] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy; [Cautela, Domenico] Stn Sperimentale Ind Essenze & Derivati Dagli Agr, Reggio Di Calabria, Italy; [Castaldo, Domenico] Univ Salerno, Dipartimento Ingn Ind & ProdAl Scarl, Fisciano, SA, Italy	Universita della Campania Vanvitelli; University of Salerno	Servillo, L (corresponding author), Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy.	luigi.servillo@unina2.it	Cautela, Domenico/J-5235-2013	Cautela, Domenico/0000-0003-4894-0299; Giovane, Alfonso/0000-0002-2508-2597; Balestrieri, Maria Luisa/0000-0001-6001-1789	grant PON Nutrafast [01_01226]; Ministero dell' Istruzione, dell' Universita e della Ricerca (MIUR)	grant PON Nutrafast; Ministero dell' Istruzione, dell' Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the grant PON Nutrafast no. 01_01226 sponsored by the Ministero dell' Istruzione, dell' Universita e della Ricerca (MIUR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIJN: Association of the Industry of Juice and Nectars, 1994, COD PRACT EV FRUIT V; BLUNDEN G, 1982, J NAT PROD, V45, P449, DOI 10.1021/np50022a015; BORUM PR, 1977, J BIOL CHEM, V252, P5651; Bruckner H, 2003, AMINO ACIDS, V24, P43, DOI 10.1007/s00726-002-0322-8; CASTALDO D, 1992, J AGR FOOD CHEM, V40, P594, DOI 10.1021/jf00016a013; Cautela D, 2008, J AGR FOOD CHEM, V56, P5407, DOI 10.1021/jf8006823; Celestino-Soper PBS, 2012, P NATL ACAD SCI USA, V109, P7974, DOI 10.1073/pnas.1120210109; Curtis TY, 2009, J AGR FOOD CHEM, V57, P1013, DOI 10.1021/jf8031292; D'Argenio G, 2006, FASEB J, V20, P2544, DOI 10.1096/fj.06-5950fje; DIMARIA P, 1982, BIOCHEMISTRY-US, V21, P1036, DOI 10.1021/bi00534a033; DUNN WA, 1981, J BIOL CHEM, V256, P2437; DUNN WA, 1984, J BIOL CHEM, V259, P764; HOUTZ RL, 1989, P NATL ACAD SCI USA, V86, P1855, DOI 10.1073/pnas.86.6.1855; Houtz RL, 2008, J EXP BOT, V59, P1635, DOI 10.1093/jxb/erm360; HUSZAR G, 1975, J MOL BIOL, V94, P311, DOI 10.1016/0022-2836(75)90205-3; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; LABADIE J, 1976, BIOCHEM J, V160, P85, DOI 10.1042/bj1600085; LOIUDICE R, 1995, FOOD CHEM, V53, P81, DOI 10.1016/0308-8146(95)95791-4; LOMBARD KA, 1989, AM J CLIN NUTR, V50, P301, DOI 10.1093/ajcn/50.2.301; MacKinnon SL, 2010, J APPL PHYCOL, V22, P489, DOI 10.1007/s10811-009-9483-0; MORSE RK, 1975, BIOCHEMISTRY-US, V14, P4316, DOI 10.1021/bi00690a028; Piergiovanni A. R., 2011, Food and Nutrition Sciences, V2, P207, DOI 10.4236/fns.2011.23028; REBOUCHE CJ, 1995, METABOLISM, V44, P624, DOI 10.1016/0026-0495(95)90120-5; REBOUCHE CJ, 1986, J NUTR, V116, P751; Rippa S, 2012, PLANT PHYSIOL BIOCH, V60, P109, DOI 10.1016/j.plaphy.2012.08.001; Rozan P, 2001, PHYTOCHEMISTRY, V58, P281, DOI 10.1016/S0031-9422(01)00200-X; Servillo L, 2013, NITRIC OXIDE-BIOL CH, V30, P43, DOI 10.1016/j.niox.2013.02.080; Shek PYI, 2006, J PHYS CHEM A, V110, P8282, DOI 10.1021/jp055426k; Stanley CA, 2004, ANN NY ACAD SCI, V1033, P42, DOI 10.1196/annals.1320.004; Stephens FB, 2011, AM J CLIN NUTR, V94, P938, DOI 10.3945/ajcn.111.012047; Teerlink T, 2005, VASC MED, V10, pS73, DOI 10.1191/1358863x05vm597oa; THOMPSON MP, 1989, PLANT PHYSIOL, V89, P501, DOI 10.1104/pp.89.2.501; vanWandelen C, 1997, J CHROMATOGR A, V763, P11, DOI 10.1016/S0021-9673(96)00891-6; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; WATTERSON DM, 1980, BIOCHEMISTRY-US, V19, P5762, DOI 10.1021/bi00566a015	35	44	45	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84589	10.1371/journal.pone.0084589	http://dx.doi.org/10.1371/journal.pone.0084589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454731	gold, Green Published, Green Submitted			2022-12-25	WOS:000329922500013
J	Dahl, JM; Wang, HY; Lazaro, JM; Salas, M; Lieberman, KR				Dahl, Joseph M.; Wang, Hongyun; Lazaro, Jose M.; Salas, Margarita; Lieberman, Kate R.			Dynamics of Translocation and Substrate Binding in Individual Complexes Formed with Active Site Mutants of Phi 29 DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Polymerase; Enzyme Kinetics; Enzyme Mechanisms; Molecular Motors; Single Molecule Biophysics; Translocation Mechanism	DNTP BINDING; REPLICATION; MECHANISM; MOLECULES; NANOPORE	Background: Tyr-226 and Tyr-390 in the 29 DNA polymerase active site are implicated in the mechanism of translocation. Results: Y226F and Y390F differ in their effects on translocation and on dNTP and pyrophosphate binding. Conclusion: Mutations in the 29 DNA polymerase and exonuclease active sites perturb dNTP or pyrophosphate binding rates. Significance: DNA polymerase architecture is finely tuned to integrate translocation and substrate binding. The phi 29 DNA polymerase (DNAP) is a processive B-family replicative DNAP. Fluctuations between the pre-translocation and post-translocation states can be quantified from ionic current traces, when individual phi 29 DNAP-DNA complexes are held atop a nanopore in an electric field. Based upon crystal structures of the phi 29 DNAP-DNA binary complex and the phi 29 DNAP-DNA-dNTP ternary complex, residues Tyr-226 and Tyr-390 in the polymerase active site were implicated in the structural basis of translocation. Here, we have examined the dynamics of translocation and substrate binding in complexes formed with the Y226F and Y390F mutants. The Y226F mutation diminished the forward and reverse rates of translocation, increased the affinity for dNTP in the post-translocation state by decreasing the dNTP dissociation rate, and increased the affinity for pyrophosphate in the pre-translocation state. The Y390F mutation significantly decreased the affinity for dNTP in the post-translocation state by decreasing the association rate approximate to 2-fold and increasing the dissociation rate approximate to 10-fold, implicating this as a mechanism by which this mutation impedes DNA synthesis. The Y390F dissociation rate increase is suppressed when complexes are examined in the presence of Mn2+ rather than Mg2+. The same effects of the Y226F or Y390F mutations were observed in the background of the D12A/D66A mutations, located in the exonuclease active site, approximate to 30 from the polymerase active site. Although translocation rates were unaffected in the D12A/D66A mutant, these exonuclease site mutations caused a decrease in the dNTP dissociation rate, suggesting that they perturb phi 29 DNAP interdomain architecture.	[Dahl, Joseph M.; Lieberman, Kate R.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Wang, Hongyun] Univ Calif Santa Cruz, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA; [Lazaro, Jose M.; Salas, Margarita] Univ Autonoma Madrid, Inst Biol Mol Eladio Vinuela, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Wang, HY (corresponding author), Univ Calif Santa Cruz, Baskin Sch Engn, Dept Appl Math & Stat, 1156 High St, Santa Cruz, CA 95064 USA.	hongwang@soe.ucsc.edu; msalas@cbm.uam.es; krlieberman@gmail.com	Salas, Margarita/J-9873-2014	Salas, Margarita/0000-0001-5939-3441	National Institutes of Health, NIGMS [1R01GM087484]; United States National Science Foundation [DMS-0719361]; Spanish Ministry of Economy and Competitiveness [BFU2011-23645]; University of California Santa Cruz Research Mentoring Institute fellowship from the National Genome Research Institute [R25HG006836]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087484] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Economy and Competitiveness(Spanish Government); University of California Santa Cruz Research Mentoring Institute fellowship from the National Genome Research Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant 1R01GM087484 (to K. R. L.). This work was also supported by United States National Science Foundation Grant DMS-0719361 (to H. W.) and by Spanish Ministry of Economy and Competitiveness Grant BFU2011-23645 (to M. S.).; Supported by a University of California Santa Cruz Research Mentoring Institute fellowship from the National Genome Research Institute Grant R25HG006836.	Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Benner S, 2007, NAT NANOTECHNOL, V2, P718, DOI 10.1038/nnano.2007.344; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; BLANCO L, 1989, J BIOL CHEM, V264, P8935; BLANCO L, 1991, GENE, V100, P27, DOI 10.1016/0378-1119(91)90346-D; Blanco L, 1996, J BIOL CHEM, V271, P8509, DOI 10.1074/jbc.271.15.8509; BLASCO MA, 1992, J BIOL CHEM, V267, P19427; Colquhoun David, 1995, P483; Dahl JM, 2012, J BIOL CHEM, V287, P13407, DOI 10.1074/jbc.M111.338418; ESTEBAN JA, 1994, J BIOL CHEM, V269, P31946; Garalde DR, 2011, J BIOL CHEM, V286, P14480, DOI 10.1074/jbc.M111.218750; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; Lazaro JM, 1995, METHOD ENZYMOL, V262, P42; Lieberman KR, 2013, J AM CHEM SOC, V135, P9149, DOI 10.1021/ja403640b; Lieberman KR, 2012, J AM CHEM SOC, V134, P18816, DOI 10.1021/ja3090302; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Morin JA, 2012, P NATL ACAD SCI USA, V109, P8115, DOI 10.1073/pnas.1204759109; Salas M, 2008, IUBMB LIFE, V60, P82, DOI 10.1002/iub.19; Saturno J, 1995, J BIOL CHEM, V270, P31235, DOI 10.1074/jbc.270.52.31235; Truniger V, 1996, EMBO J, V15, P3430, DOI 10.1002/j.1460-2075.1996.tb00709.x; Wang MN, 2011, BIOCHEMISTRY-US, V50, P581, DOI 10.1021/bi101192f	21	5	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6350	6361		10.1074/jbc.M113.535666	http://dx.doi.org/10.1074/jbc.M113.535666			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24464581	Green Published, hybrid			2022-12-25	WOS:000332389400004
J	Lindner, C; Dannlowski, U; Walhofer, K; Rodiger, M; Maisch, B; Bauer, J; Ohrmann, P; Lencer, R; Zwitserlood, P; Kersting, A; Heindel, W; Arolt, V; Kugel, H; Suslow, T				Lindner, Christian; Dannlowski, Udo; Walhoefer, Kirsten; Roediger, Maike; Maisch, Birgit; Bauer, Jochen; Ohrmann, Patricia; Lencer, Rebekka; Zwitserlood, Pienie; Kersting, Anette; Heindel, Walter; Arolt, Volker; Kugel, Harald; Suslow, Thomas			Social Alienation in Schizophrenia Patients: Association with Insula Responsiveness to Facial Expressions of Disgust	PLOS ONE			English	Article							DIFFERENTIAL NEURAL RESPONSE; BACKWARD-MASKING DEFICITS; EMOTION RECOGNITION; HUMAN AMYGDALA; FMRI; METAANALYSIS; ACTIVATION; FEARFUL; DISCRIMINATION; DEPRESSION	Introduction: Among the functional neuroimaging studies on emotional face processing in schizophrenia, few have used paradigms with facial expressions of disgust. In this study, we investigated whether schizophrenia patients show less insula activation to macro-expressions (overt, clearly visible expressions) and micro-expressions (covert, very brief expressions) of disgust than healthy controls. Furthermore, departing from the assumption that disgust faces signal social rejection, we examined whether perceptual sensitivity to disgust is related to social alienation in patients and controls. We hypothesized that high insula responsiveness to facial disgust predicts social alienation. Methods: We used functional magnetic resonance imaging to measure insula activation in 36 schizophrenia patients and 40 healthy controls. During scanning, subjects passively viewed covert and overt presentations of disgust and neutral faces. To measure social alienation, a social loneliness scale and an agreeableness scale were administered. Results: Schizophrenia patients exhibited reduced insula activation in response to covert facial expressions of disgust. With respect to macro-expressions of disgust, no between-group differences emerged. In patients, insula responsiveness to covert faces of disgust was positively correlated with social loneliness. Furthermore, patients' insula responsiveness to covert and overt faces of disgust was negatively correlated with agreeableness. In controls, insula responsiveness to covert expressions of disgust correlated negatively with agreeableness. Discussion: Schizophrenia patients show reduced insula responsiveness to micro-expressions but not macro-expressions of disgust compared to healthy controls. In patients, low agreeableness was associated with stronger insula response to micro- and macro-expressions of disgust. Patients with a strong tendency to feel uncomfortable with social interactions appear to be characterized by a high sensitivity for facial expression signaling social rejection. Given the associations of insula responsiveness to covert disgust expression with low agreeableness in healthy individuals, insula responsiveness to expressions of disgust might be in general a neural marker of the personality trait of agreeableness.	[Lindner, Christian; Dannlowski, Udo; Walhoefer, Kirsten; Roediger, Maike; Bauer, Jochen; Ohrmann, Patricia; Lencer, Rebekka; Arolt, Volker; Suslow, Thomas] Univ Munster, Dept Psychiat, D-48149 Munster, Germany; [Dannlowski, Udo] Univ Marburg, Dept Psychiat, Marburg, Germany; [Maisch, Birgit] Klin Schlossgarten, Dulmen, Germany; [Zwitserlood, Pienie] Univ Munster, Inst Psychol, D-48149 Munster, Germany; [Kersting, Anette; Suslow, Thomas] Univ Leipzig, Dept Psychosomat Med & Psychotherapy, D-04109 Leipzig, Germany; [Heindel, Walter; Kugel, Harald] Univ Munster, Dept Clin Radiol, D-48149 Munster, Germany	University of Munster; Philipps University Marburg; University of Munster; Leipzig University; University of Munster	Lindner, C (corresponding author), Univ Munster, Dept Psychiat, D-48149 Munster, Germany.	Christian.Lindner@ukmuenster.de	Bauer, Jochen/AAW-4539-2021; , Rebekka/A-4994-2009	Bauer, Jochen/0000-0001-9345-2126; , Rebekka/0000-0003-4032-7297; Kugel, Harald/0000-0002-4349-1984; Dannlowski, Udo/0000-0002-0623-3759; Suslow, Thomas/0000-0003-4560-0555	German Research Foundation DFG [SU 222/5-1, 5-2]	German Research Foundation DFG(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation DFG (www.dfg.de) to Thomas Suslow and Harald Kugel (SU 222/5-1 and 5-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Gonzalez-Torres MA, 2007, SOC PSYCH PSYCH EPID, V42, P14, DOI 10.1007/s00127-006-0126-3; Beck AT., 1996, BECK DEPRESSION INVE; Butler PD, 2003, SCHIZOPHR RES, V59, P199, DOI 10.1016/S0920-9964(01)00341-3; Butzlaff RL, 1998, ARCH GEN PSYCHIAT, V55, P547, DOI 10.1001/archpsyc.55.6.547; Cadenhead KS, 1998, BIOL PSYCHIAT, V43, P132, DOI 10.1016/S0006-3223(97)00316-8; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dannlowski U, 2007, PSYCHIAT RES-NEUROIM, V154, P13, DOI 10.1016/j.pscychresns.2006.05.005; Dannlowski U, 2009, INT J NEUROPSYCHOPH, V12, P11, DOI 10.1017/S1461145708008973; DeWall CN, 2012, SOC COGN AFFECT NEUR, V7, P184, DOI 10.1093/scan/nsq107; DeWall CN, 2010, PSYCHOL SCI, V21, P931, DOI 10.1177/0956797610374741; Eisenberger NI, 2012, NAT REV NEUROSCI, V13, P421, DOI 10.1038/nrn3231; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Ekman P, 2003, ANN NY ACAD SCI, V1000, P205, DOI 10.1196/annals.1280.010; EKMAN P, 1969, PSYCHIATR, V32, P88, DOI 10.1080/00332747.1969.11023575; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gur RE, 2007, ARCH GEN PSYCHIAT, V64, P1356, DOI 10.1001/archpsyc.64.12.1356; Gurrera RJ, 2005, J NERV MENT DIS, V193, P714, DOI 10.1097/01.nmd.0000185938.30783.6b; Holt DJ, 2006, SCHIZOPHR RES, V82, P153, DOI 10.1016/j.schres.2005.09.021; Horstmann G, 2003, EMOTION, V3, P150, DOI 10.1037/1528-3542.3.2.150; Johnston PJ, 2005, EUR J NEUROSCI, V22, P1221, DOI 10.1111/j.1460-9568.2005.04294.x; Killgore WDS, 2007, SOC NEUROSCI-UK, V2, P28, DOI 10.1080/17470910701214186; Kohler CG, 2003, AM J PSYCHIAT, V160, P1768, DOI 10.1176/appi.ajp.160.10.1768; Kosaka H, 2002, SCHIZOPHR RES, V57, P87, DOI 10.1016/S0920-9964(01)00324-3; KRAUSE R, 1989, PSYCHIATRY, V52, P1; Lehrl S, 1995, ACTA NEUROL SCAND, V91, P333; Lundqvist D., 1998, KAROLINSKA DIRECTED; Lysaker Paul H, 2004, Health Qual Life Outcomes, V2, P15, DOI 10.1186/1477-7525-2-15; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mandal MK, 1998, SCHIZOPHRENIA BULL, V24, P399, DOI 10.1093/oxfordjournals.schbul.a033335; Masten CL, 2011, J COGNITIVE NEUROSCI, V23, P1042, DOI 10.1162/jocn.2010.21520; Morris JS, 2002, NEUROIMAGE, V17, P214, DOI 10.1006/nimg.2002.1220; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; MORRISON RL, 1988, SCHIZOPHRENIA BULL, V14, P67, DOI 10.1093/schbul/14.1.67; NEELEMAN J, 1994, SOC PSYCH PSYCH EPID, V29, P46; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Phillips ML, 1998, BRIT J PSYCHIAT, V172, P373, DOI 10.1192/bjp.172.5.373; Phillips ML, 1999, PSYCHIAT RES-NEUROIM, V92, P11, DOI 10.1016/S0925-4927(99)00031-1; Rozin P., 1993, HDB EMOTIONS, P575; Russell TA, 2006, BRIT J CLIN PSYCHOL, V45, P579, DOI 10.1348/014466505X90866; Schneider F, 1998, SCHIZOPHR RES, V34, P133, DOI 10.1016/S0920-9964(98)00085-1; Schwab R., 1997, EINSAMKEIT GRUNDLAGE; Shepherd AM, 2012, BIOL PSYCHIAT, V72, P775, DOI 10.1016/j.biopsych.2012.04.020; Sherman GD, 2011, EMOT REV, V3, P245, DOI 10.1177/1754073911402396; Singh Manpreet K, 2006, J Psychiatr Pract, V12, P90, DOI 10.1097/00131746-200603000-00004; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Suslow T, 2003, COMPR PSYCHIAT, V44, P303, DOI 10.1016/S0010-440X(03)00085-3; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wittchen H.-U., 1997, SKID 1 STRUKTURIERTE; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027	54	23	23	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85014	10.1371/journal.pone.0085014	http://dx.doi.org/10.1371/journal.pone.0085014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465469	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100020
J	Degache, F; Van Zaen, J; Oehen, L; Guex, K; Trabucchi, P; Millet, G				Degache, Francis; Van Zaen, Jerome; Oehen, Lukas; Guex, Kenny; Trabucchi, Pietro; Millet, Gegoire			Alterations in Postural Control during the World's Most Challenging Mountain Ultra-Marathon	PLOS ONE			English	Article							ANKLE PLANTARFLEXOR FATIGUE; SLEEP-DEPRIVATION; LOCAL FATIGUE; OPEN-LOOP; COGNITIVE PERFORMANCE; MUSCLE FATIGUE; FOOT MUSCLES; LOWER-LIMBS; BALANCE; STABILITY	We investigated postural control (PC) effects of a mountain ultra-marathon (MUM): a 330-km trail run with 24000 m of positive and negative change in elevation. PC was assessed prior to (PRE), during (MID) and after (POST) the MUM in experienced ultra-marathon runners (n = 18; finish time = 126 +/- 16 h) and in a control group (n = 8) with a similar level of sleep deprivation. Subjects were instructed to stand upright on a posturographic platform over a period of 51.2 seconds using a double-leg stance under two test conditions: eyes open (EO) and eyes closed (EC). Traditional measures of postural stability (center of pressure trajectory analysis) and stabilogram-diffusion analysis (SDA) parameters were analysed. For the SDA, a significantly greater short-term effective diffusion was found at POST compared with PRE in the medio-lateral (ML; Dxs) and antero-posterior (AP) directions (Dys) in runners (p<0.05) The critical time interval (Ctx) in the ML direction was significantly higher at MID (p<0.001) and POST (p<0.05) than at PRE in runners. At MID (p<0.001) and POST (p<0.05), there was a significant difference between the two groups. The critical displacement (Cdx) in the ML was significantly higher at MID and at POST (p<0.001) compared with PRE for runners. A significant difference in Cdx was observed between groups in EO at MID (p<0.05) and POST (p<0.005) in the ML direction and in EC at POST in the ML and AP directions (p<0.05). Our findings revealed significant effects of fatigue on PC in runners, including, a significant increase in Ctx (critical time in ML plan) in EO and EC conditions. Thus, runners take longer to stabilise their body at POST than at MID. It is likely that the mountainous characteristics of MUM (unstable ground, primarily uphill/downhill running, and altitude) increase this fatigue, leading to difficulty in maintaining balance.	[Degache, Francis] Univ Appl Sci Western Switzerland, Sch Hlth Sci, Hlth Res Unit, Lausanne, Switzerland; [Van Zaen, Jerome] Ecole Polytech Fed Lausanne, Appl Signal Proc Grp, Lausanne, Switzerland; [Oehen, Lukas; Millet, Gegoire] Univ Lausanne, Dept Physiol, Inst Sports Sci, Fac Biol & Med, Lausanne, Switzerland; [Guex, Kenny] Univ Appl Sci Western Switzerland, Dept Physiotherapy, Sch Hlth Sci, Lausanne, Switzerland; [Trabucchi, Pietro] Univ Verona, Fac Sports Sci, I-37100 Verona, Italy	University of Applied Sciences & Arts Western Switzerland; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; University of Applied Sciences & Arts Western Switzerland; University of Verona	Degache, F (corresponding author), Univ Appl Sci Western Switzerland, Sch Hlth Sci, Hlth Res Unit, Lausanne, Switzerland.	francis.degache@hesav.ch	Degache, Francis/Y-8618-2019	Degache, Francis/0000-0002-1620-9330; Millet, Gregoire/0000-0001-8081-4423				Avni N, 2006, PSYCHIAT CLIN NEUROS, V60, P340, DOI 10.1111/j.1440-1819.2006.01511.x; BIGLANDRITCHIE BR, 1986, J PHYSIOL-LONDON, V379, P451, DOI 10.1113/jphysiol.1986.sp016263; Bove M, 2007, NEUROSCI LETT, V418, P276, DOI 10.1016/j.neulet.2007.03.036; Boyas S, 2013, NEUROSCI LETT, V547, P48, DOI 10.1016/j.neulet.2013.05.003; Boyas S, 2013, GAIT POSTURE, V37, P547, DOI 10.1016/j.gaitpost.2012.09.014; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Burdet C, 2004, SCI SPORT, V19, P308, DOI 10.1016/j.scispo.2004.02.003; Caron O, 2003, NEUROSCI LETT, V340, P83, DOI 10.1016/S0304-3940(02)01455-6; Caron O, 2004, NEUROSCI LETT, V363, P18, DOI 10.1016/j.neulet.2004.03.038; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; COLLINS JJ, 1995, EXP BRAIN RES, V103, P151, DOI 10.1007/BF00241972; COLLINS JJ, 1995, CHAOS, V5, P57, DOI 10.1063/1.166086; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; Corbeil P, 2003, GAIT POSTURE, V18, P92, DOI 10.1016/S0966-6362(02)00198-4; Delignieres D, 2003, J MOTOR BEHAV, V35, P86, DOI 10.1080/00222890309602124; Doppelmayr MM, 2005, PERCEPT MOTOR SKILL, V100, P473; Drummond SPA, 1999, NEUROREPORT, V10, P3745, DOI 10.1097/00001756-199912160-00004; Duarte M, 2002, EXP BRAIN RES, V146, P60, DOI 10.1007/s00221-002-1154-1; Fabbri M, 2006, NEUROPSYCHOLOGIA, V44, P2520, DOI 10.1016/j.neuropsychologia.2006.03.033; Fourchet F, 2012, EUR J APPL PHYSIOL, V112, P2645, DOI 10.1007/s00421-011-2220-9; Gimmon Y, 2011, J ELECTROMYOGR KINES, V21, P922, DOI 10.1016/j.jelekin.2011.08.005; Gribble PA, 2004, PERCEPT MOTOR SKILL, V99, P1035, DOI 10.2466/pms.99.3.1035-1045; Gribble PA, 2004, ARCH PHYS MED REHAB, V85, P589, DOI 10.1016/j.apmr.2003.06.031; Harkins KM, 2005, J ATHL TRAINING, V40, P191; Headlee DL, 2008, J ELECTROMYOGR KINES, V18, P420, DOI 10.1016/j.jelekin.2006.11.004; Henriksson N.G., 1967, ACTA OTO-LARYNGOL, V224, P272; Hoffman MD, 2012, WILD ENVIRON MED, V23, P56, DOI 10.1016/j.wem.2011.11.001; INGLIN B, 1988, J GERONTOL, V43, pM105, DOI 10.1093/geronj/43.4.M105; JETTE AM, 1990, J GERONTOL, V45, pM203, DOI 10.1093/geronj/45.6.M203; Johnston RB, 1998, MED SCI SPORT EXER, V30, P1703, DOI 10.1097/00005768-199812000-00008; Kelly LA, 2011, CLIN BIOMECH BRISTOL; Laughton CA, 2003, GAIT POSTURE, V18, P101, DOI 10.1016/S0966-6362(02)00200-X; Ledin T, 2004, GAIT POSTURE, V19, P184, DOI 10.1016/S0966-6362(03)00061-4; Lepers R, 1997, EUR J APPL PHYSIOL, V76, P55, DOI 10.1007/s004210050212; Liebovitch LS, 1997, PHYS REV E, V56, P4557, DOI 10.1103/PhysRevE.56.4557; Liu Y, 2001, OCCUP MED-OXFORD, V51, P490, DOI 10.1093/occmed/51.8.490; Ma J, 2009, J INT MED RES, V37, P1311, DOI 10.1177/147323000903700506; Mello RGT, 2010, IEEE ENG MED BIO, P2415, DOI 10.1109/IEMBS.2010.5626154; Mello RGT, 2009, IEEE ENG MED BIO, P1351, DOI 10.1109/IEMBS.2009.5334148; Millet GP, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-77; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Millet GY, 2002, J APPL PHYSIOL, V92, P486, DOI 10.1152/japplphysiol.00122.2001; Morad Y, 2007, AVIAT SPACE ENVIR MD, V78, P859; Nagy E, 2004, EUR J APPL PHYSIOL, V92, P407, DOI 10.1007/s00421-004-1157-7; Nakano T, 2001, PSYCHIAT CLIN NEUROS, V55, P277, DOI 10.1046/j.1440-1819.2001.00858.x; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; NELSON DL, 1985, MED SCI SPORT EXER, V17, P445, DOI 10.1249/00005768-198508000-00007; O'Connor KM, 2004, CLIN BIOMECH, V19, P71, DOI 10.1016/j.clinbiomech.2003.09.001; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; Patel M, 2008, EXP BRAIN RES, V185, P165, DOI 10.1007/s00221-007-1143-5; Pedersen J, 1998, NEUROSCIENCE, V84, P953, DOI 10.1016/S0306-4522(97)00403-X; Robach P, 2012, SCAND J MED SCI SPOR; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; Sargent C, 2010, CHRONOBIOL INT, V27, P911, DOI 10.3109/07420528.2010.488901; Saugy J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065596; Schlesinger A, 1998, NEUROREPORT, V9, P49, DOI 10.1097/00001756-199801050-00010; Schutz UHW, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-78; Shumway-Cook A, 2007, MOTOR CONTROL THEY P; SKINNER HB, 1984, CLIN ORTHOP RELAT R, P208; Springer BK, 2009, GAIT POSTURE, V30, P50, DOI 10.1016/j.gaitpost.2009.02.014; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Tseng BY, 2010, STROKE RES TREAT, V2010, DOI 10.4061/2010/412964; Vitiello D, 2013, INT J CARDIOL, V165, P391, DOI 10.1016/j.ijcard.2012.08.053; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Wojcik LA, 2011, HUM MOVEMENT SCI, V30, P574, DOI 10.1016/j.humov.2010.03.008; Wuehr M, 2013, J NEUROL, V260, P1314, DOI 10.1007/s00415-012-6797-7; Yaggie JA, 2002, ARCH PHYS MED REHAB, V83, P224, DOI 10.1053/apmr.2002.28032	68	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84554	10.1371/journal.pone.0084554	http://dx.doi.org/10.1371/journal.pone.0084554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465417	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500008
J	Liu, Y; Cao, L; Li, ZQ; Zhou, DZ; Liu, WQ; Shen, Q; Wu, YT; Zhang, D; Hu, X; Wang, T; Ye, JY; Weng, XL; Zhang, H; Zhang, D; Zhang, Z; Liu, FT; He, L; Shi, YY				Liu, Yun; Cao, Lan; Li, Zhiqiang; Zhou, Daizhan; Liu, Wanqing; Shen, Qin; Wu, Yanting; Zhang, Dan; Hu, Xun; Wang, Ting; Ye, Junyi; Weng, Xiaoling; Zhang, Hong; Zhang, Di; Zhang, Zhou; Liu, Fatao; He, Lin; Shi, Yongyong			A Genome-Wide Association Study Identifies a Locus on TERT for Mean Telomere Length in Han Chinese	PLOS ONE			English	Article							GENETIC-VARIATION; QUANTITATIVE PCR; COMMON VARIANTS; LUNG-CANCER; RISK; POPULATION; SUSCEPTIBILITY	Leukocyte telomere length (LTL) is a predictor of aging and a number of age-related diseases. We performed genome-wide association studies of mean LTL in 2632 individuals, with a two-stage replication in 3917 individuals from Chinese populations. To further validate our findings, we get the results of 696 samples from a cohort of European ancestry. We identified two loci associated with LTL that map in telomerase reverse transcriptase (TERT; rs2736100, P = 1.93x10(-5)) on chromosome 5p15.33 and near keratin 80 (KRT80; rs17653722, P = 6.96x10(-6)) on 12q13.13. In Chinese population each C allele of rs2736100 and T allele of rs17653722 was associated with a longer mean telomere length of 0.026 and 0.059 T/S, respectively, equivalent to about 3 and 7 years of average age-related telomere attrition. Our findings provide new insights into telomere regulatory mechanism and even pathogenesis of age-related diseases.	[Liu, Yun; Cao, Lan; Ye, Junyi; Weng, Xiaoling; Zhang, Hong] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Li, Zhiqiang; Zhou, Daizhan; Zhang, Di; Zhang, Zhou; He, Lin; Shi, Yongyong] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Liu, Wanqing] Purdue Univ, Dept Med Chem & Mol Pharmacol, Coll Pharm, W Lafayette, IN 47907 USA; [Shen, Qin; Wang, Ting; Liu, Fatao] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Grad Sch, Shanghai, Peoples R China; [Wu, Yanting; Zhang, Dan] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou, Zhejiang, Peoples R China; [Hu, Xun] Ruijin Hosp, Luwan Branch, Dept Stomatol, Shanghai, Peoples R China	Fudan University; Shanghai Jiao Tong University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang University; Shanghai Jiao Tong University	He, L (corresponding author), Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China.	helin@bio-x.cn; shiyongyong@gmail.com	Li, Zhiqiang/AAI-4003-2021; wang, tingting/AAK-2640-2020; Shi, Yongyong/GSO-1627-2022	Li, Zhiqiang/0000-0002-0174-9254; Shi, Yongyong/0000-0003-1710-1505; Wu, Yanting/0000-0002-2293-1792	Natural Science Foundation of China [81130022, 81272302, 31000553, 81121001]; National 863 project [2012AA02A515]; 973 Program [2010CB529600]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1025]; Foundation for the Author of National Excellent Doctoral Dissertation of China [201026]; Shanghai Rising-Star Program [12QA1401900]; "Shu Guang" project; Shanghai Municipal Education Commission; Shanghai Education Development Foundation [12SG17]; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 project(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Shanghai Rising-Star Program; "Shu Guang" project(Chinese Academy of Sciences); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University	This work was supported by the Natural Science Foundation of China (81130022, 81272302, 31000553, 81121001); the National 863 project (2012AA02A515); the 973 Program (2010CB529600); Program for Changjiang Scholars and Innovative Research Team in University (IRT1025); the Foundation for the Author of National Excellent Doctoral Dissertation of China (201026); Shanghai Rising-Star Program (12QA1401900); "Shu Guang" project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation (12SG17); and start-up fund (WL) from the Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Gu JA, 2011, CANCER PREV RES, V4, P514, DOI 10.1158/1940-6207.CAPR-11-0063; Hosgood HD, 2009, LUNG CANCER, V66, P157, DOI 10.1016/j.lungcan.2009.02.005; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Jang JS, 2008, CANCER SCI, V99, P1385, DOI 10.1111/j.1349-7006.2008.00831.x; Ke JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062485; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lan Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059230; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Liu Y, 2008, DIABETOLOGIA, V51, P2134, DOI 10.1007/s00125-008-1141-6; Mangino M, 2012, HUM MOL GENET, V21, P5385, DOI 10.1093/hmg/dds382; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Prescott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019635; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shay JW, 2007, J PATHOL, V211, P114, DOI 10.1002/path.2090; Shen M, 2011, LUNG CANCER, V73, P133, DOI 10.1016/j.lungcan.2010.11.009; Shen Q, 2012, J CLIN ENDOCR METAB, V97, P1371, DOI 10.1210/jc.2011-1562; Shen Q, 2011, EUR J HUM GENET, V19, P721, DOI 10.1038/ejhg.2011.4; Soerensen M, 2012, AGING CELL, V11, P223, DOI 10.1111/j.1474-9726.2011.00775.x; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Zhong R, 2013, MOL CARCINOGEN, V52, P118, DOI 10.1002/mc.22043	37	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85043	10.1371/journal.pone.0085043	http://dx.doi.org/10.1371/journal.pone.0085043			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465473	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500030
J	Steidl, S; Wang, HL; Wise, RA				Steidl, Stephan; Wang, Huiling; Wise, Roy A.			Lesions of Cholinergic Pedunculopontine Tegmental Nucleus Neurons Fail to Affect Cocaine or Heroin Self-Administration or Conditioned Place Preference in Rats	PLOS ONE			English	Article							ACETYLCHOLINE-RELEASE; GLUTAMATE RECEPTORS; DOPAMINE EFFLUX; BRAIN; AREA; STIMULATION; REWARD; INVOLVEMENT; ACTIVATION; ACCUMBENS	Cholinergic input to the ventral tegmental area (VTA) is known to contribute to reward. Although it is known that the pedunculopontine tegmental nucleus (PPTg) provides an important source of excitatory input to the dopamine system, the specific role of PPTg cholinergic input to the VTA in cocaine reward has not been previously determined. We used a diphtheria toxin conjugated to urotensin-II (Dtx::UII), the endogenous ligand for urotensin-II receptors expressed by PPTg cholinergic but not glutamatergic or GABAergic cells, to lesion cholinergic PPTg neurons. Dtx::UII toxin infusion resulted in the loss of 95.78 (+/- 0.65)% of PPTg cholinergic cells but did not significantly alter either cocaine or heroin self-administration or the development of cocaine or heroin conditioned place preferences. Thus, cholinergic cells originating in PPTg do not appear to be critical for the rewarding effects of cocaine or of heroin.	[Steidl, Stephan; Wang, Huiling; Wise, Roy A.] NIDA, Intramural Res Program, NIH, US Dept HHS, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Steidl, S (corresponding author), Loyola Univ, Dept Psychol, 6525 N Sheridan Rd, Chicago, IL 60626 USA.	ssteidl@luc.edu			National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000471] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by the Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile AS, 2002, P NATL ACAD SCI USA, V99, P11452, DOI 10.1073/pnas.162371899; BECHARA A, 1992, BEHAV NEUROSCI, V106, P798, DOI 10.1037/0735-7044.106.5.798; Clark SD, 2007, J NEUROCHEM, V102, P112, DOI 10.1111/j.1471-4159.2007.04529.x; Clark SD, 2001, BRAIN RES, V923, P120, DOI 10.1016/S0006-8993(01)03208-5; Forster GL, 2000, EUR J NEUROSCI, V12, P3596, DOI 10.1046/j.1460-9568.2000.00250.x; Forster GL, 2003, EUR J NEUROSCI, V17, P751, DOI 10.1046/j.1460-9568.2003.02511.x; Forster GL, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0001.2002; Geisler S, 2005, J COMP NEUROL, V490, P270, DOI 10.1002/cne.20668; Ikemoto S, 2002, J NEUROSCI, V22, P9895; OAKMAN SA, 1995, J NEUROSCI, V15, P5859; Olmstead MC, 1998, J NEUROSCI, V18, P5035; Omelchenko N, 2006, J COMP NEUROL, V494, P863, DOI 10.1002/cne.20852; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Rada PV, 2000, PHARMACOL BIOCHEM BE, V65, P375, DOI 10.1016/S0091-3057(99)00218-X; Rezayof A, 2007, EUR J PHARMACOL, V562, P92, DOI 10.1016/j.ejphar.2007.01.081; Schmidt HD, 2009, EUR J NEUROSCI, V30, P1358, DOI 10.1111/j.1460-9568.2009.06904.x; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Steidl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027538; Thomsen M, 2009, J PHARMACOL EXP THER, V331, P204, DOI 10.1124/jpet.109.156265; Thomsen M, 2009, J NEUROSCI, V29, P1087, DOI 10.1523/JNEUROSCI.4037-08.2009; Wang HL, 2009, EUR J NEUROSCI, V29, P340, DOI 10.1111/j.1460-9568.2008.06576.x; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Westerink BHC, 1996, J NEUROSCI, V16, P2605; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Yeomans J, 1997, PHARMACOL BIOCHEM BE, V57, P915, DOI 10.1016/S0091-3057(96)00467-4; YEOMANS JS, 1993, BEHAV NEUROSCI, V107, P1077, DOI 10.1037/0735-7044.107.6.1077; YEOMANS JS, 1985, BRAIN RES, V329, P19, DOI 10.1016/0006-8993(85)90508-6; You ZB, 2008, J NEUROSCI, V28, P9021, DOI 10.1523/JNEUROSCI.0694-08.2008	28	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84412	10.1371/journal.pone.0084412	http://dx.doi.org/10.1371/journal.pone.0084412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465410	gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500004
J	Hagiwara, K; Obayashi, T; Sakayori, N; Yamanishi, E; Hayashi, R; Osumi, N; Nakazawa, T; Nishida, K				Hagiwara, Kunie; Obayashi, Takeshi; Sakayori, Nobuyuki; Yamanishi, Emiko; Hayashi, Ryuhei; Osumi, Noriko; Nakazawa, Toru; Nishida, Kohji			Molecular and Cellular Features of Murine Craniofacial and Trunk Neural Crest Cells as Stem Cell-Like Cells	PLOS ONE			English	Article							DORSAL-ROOT GANGLIA; GENE; MIGRATION; DEFICIENT; MESODERM; LINEAGE; ORIGIN; SOX10; BETA	The outstanding differentiation capacities and easier access from adult tissues, cells derived from neural crest cells (NCCs) have fascinated scientists in developmental biology and regenerative medicine. Differentiation potentials of NCCs are known to depend on their originating regions. Here, we report differential molecular features between craniofacial (cNCCs) and trunk (tNCCs) NCCs by analyzing transcription profiles and sphere forming assays of NCCs from P0-Cre/floxed-EGFP mouse embryos. We identified up-regulation of genes linked to carcinogenesis in cNCCs that were not previously reported to be related to NCCs, which was considered to be, an interesting feature in regard with carcinogenic potentials of NCCs such as melanoma and neuroblastoma. Wnt signal related genes were statistically up-regulated in cNCCs, also suggesting potential involvement of cNCCs in carcinogenesis. We also noticed intense expression of mesenchymal and neuronal markers in cNCCs and tNCCs, respectively. Consistent results were obtained from in vitro sphere-forming and differentiation assays. These results were in accordance with previous notion about differential potentials of cNCCs and tNCCs. We thus propose that sorting NCCs from P0-Cre/floxed-EGFP mice might be useful for the basic and translational research of NCCs. Furthermore, these newly-identified genes up-regulated in cNCC would provide helpful information on NC-originating tumors, developmental disorders in NCC derivatives, and potential applications of NCCs in regenerative medicine.	[Hagiwara, Kunie; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Aoba Ku, Sendai, Miyagi 980, Japan; [Obayashi, Takeshi] Tohoku Univ, Grad Sch Informat Sci, Div Appl Informat Human & Life Sci, Aoba Ku, Sendai, Miyagi 980, Japan; [Sakayori, Nobuyuki; Yamanishi, Emiko; Osumi, Noriko] Tohoku Univ, Grad Sch Med, Div Dev Neurosci, Aoba Ku, Sendai, Miyagi 980, Japan; [Hagiwara, Kunie; Hayashi, Ryuhei; Nishida, Kohji] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka, Japan	Tohoku University; Tohoku University; Tohoku University; Osaka University	Osumi, N (corresponding author), Tohoku Univ, Grad Sch Med, Div Dev Neurosci, Aoba Ku, Seiryo Cho, Sendai, Miyagi 980, Japan.	osumi@med.tohoku.ac.jp	Osumi, Noriko/T-2823-2019; Obayashi, Takeshi/E-9663-2011; Hayashi, Ryuhei/AAW-4737-2020	Osumi, Noriko/0000-0003-0548-6452; Obayashi, Takeshi/0000-0002-3106-722X; Nishida, Kohji/0000-0001-9069-3610; Sakayori, Nobuyuki/0000-0003-1611-4187; Hayashi, Ryuhei/0000-0002-4699-8617	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; KAKENHI from MEXT; Grants-in-Aid for Scientific Research [12J08042] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI from MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a project for the realization of regenerative medicine from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan given to K.N. and by KAKENHI from MEXT to N.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betters E, 2010, DEV BIOL, V344, P578, DOI 10.1016/j.ydbio.2010.05.012; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Brault V, 2001, DEVELOPMENT, V128, P1253; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Calzolari F, 2010, BRAIN PATHOL, V20, P527, DOI 10.1111/j.1750-3639.2009.00335.x; Chandrasekharan S, 2002, MOL CELL BIOL, V22, P5235, DOI 10.1128/MCB.22.14.5235-5247.2002; Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7; Chung KF, 2009, STEM CELLS, V27, P2602, DOI 10.1002/stem.180; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Conway SJ, 1997, DEVELOPMENT, V124, P505; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Gage PJ, 2005, INVEST OPHTH VIS SCI, V46, P4200, DOI 10.1167/iovs.05-0691; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Kanakubo S, 2006, GENES CELLS, V11, P919, DOI 10.1111/j.1365-2443.2006.00992.x; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kikuchi M, 2011, GENES CELLS, V16, P273, DOI 10.1111/j.1365-2443.2011.01485.x; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325; Le Douarin N, 1999, NEURAL CREST, V36; LEE J, 1994, GENE, V138, P247, DOI 10.1016/0378-1119(94)90817-6; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mansouri A, 1996, DEVELOPMENT, V122, P831; Mishra SK, 2012, CANCER METAST REV, V31, P163, DOI 10.1007/s10555-011-9338-4; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Mundell NA, 2011, DEVELOPMENT, V138, P641, DOI 10.1242/dev.054718; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; O'Neill ID, 2011, STEM CELLS, V29, P1909, DOI 10.1002/stem.751; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Platt JB, 1894, ECTODERMIC ORIGIN CA; Ros MA, 1997, DEVELOPMENT, V124, P1821; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schulte JH, 2013, ONCOGENE, V32, P1059, DOI 10.1038/onc.2012.106; Soriano P, 1997, DEVELOPMENT, V124, P2691; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Stone L S, 1929, Wilhelm Roux Arch Entwickl Mech Org, V118, P40, DOI 10.1007/BF02108871; Stone LS, 1926, J EXP ZOOL, V44, P95, DOI 10.1002/jez.1400440104; Suzuki J, 2013, NEUROSCI RES, V75, P112, DOI 10.1016/j.neures.2012.11.005; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Team R, 2010, R LANG ENV STAT COMP; TEILLET MA, 1987, DEV BIOL, V120, P329, DOI 10.1016/0012-1606(87)90236-3; TISSIERSETA JP, 1995, MECH DEVELOP, V51, P3, DOI 10.1016/0925-4773(94)00343-L; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Trentin A, 2004, P NATL ACAD SCI USA, V101, P4495, DOI 10.1073/pnas.0400629101; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; Wend P, 2010, SEMIN CELL DEV BIOL, V21, P855, DOI 10.1016/j.semcdb.2010.09.004; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Wu JL, 2003, TRENDS NEUROSCI, V26, P40, DOI 10.1016/S0166-2236(02)00011-5; Xu LS, 2012, MOL CELL BIOCHEM, V364, P235, DOI 10.1007/s11010-011-1222-6; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156; Young HM, 2003, J COMP NEUROL, V456, P1, DOI 10.1002/cne.10448	58	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84072	10.1371/journal.pone.0084072	http://dx.doi.org/10.1371/journal.pone.0084072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465393	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500008
J	Lodder, SS; van Putten, MJAM				Lodder, Shaun S.; van Putten, Michel J. A. M.			A Self-Adapting System for the Automated Detection of Inter-Ictal Epileptiform Discharges	PLOS ONE			English	Article							LONG-TERM EEG; SPIKE DETECTION; EPILEPSY; CLASSIFICATION; EVENTS	Purpose: Scalp EEG remains the standard clinical procedure for the diagnosis of epilepsy. Manual detection of inter-ictal epileptiform discharges (IEDs) is slow and cumbersome, and few automated methods are used to assist in practice. This is mostly due to low sensitivities, high false positive rates, or a lack of trust in the automated method. In this study we aim to find a solution that will make computer assisted detection more efficient than conventional methods, while preserving the detection certainty of a manual search. Methods: Our solution consists of two phases. First, a detection phase finds all events similar to epileptiform activity by using a large database of template waveforms. Individual template detections are combined to form "IED nominations'', each with a corresponding certainty value based on the reliability of their contributing templates. The second phase uses the ten nominations with highest certainty and presents them to the reviewer one by one for confirmation. Confirmations are used to update certainty values of the remaining nominations, and another iteration is performed where ten nominations with the highest certainty are presented. This continues until the reviewer is satisfied with what has been seen. Reviewer feedback is also used to update template accuracies globally and improve future detections. Key Findings: Using the described method and fifteen evaluation EEGs (241 IEDs), one third of all inter-ictal events were shown after one iteration, half after two iterations, and 74%, 90%, and 95% after 5, 10 and 15 iterations respectively. Reviewing fifteen iterations for the 20-30 min recordings 1took approximately 5 min. Significance: The proposed method shows a practical approach for combining automated detection with visual searching for inter-ictal epileptiform activity. Further evaluation is needed to verify its clinical feasibility and measure the added value it presents.	[Lodder, Shaun S.; van Putten, Michel J. A. M.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [van Putten, Michel J. A. M.] Med Spectrum Twente, Dept Neurol & Clin Neurophysiol, Enschede, Netherlands	University of Twente; Medical Spectrum Twente	Lodder, SS (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.	s.s.lodder@utwente.nl	van Putten, Michel J.A.M./D-6519-2018	van Putten, Michel J.A.M./0000-0001-8319-3626				Agbenu J, 2012, SEIZURE-EUR J EPILEP, V21, P422, DOI 10.1016/j.seizure.2012.04.006; Argoud FIM, 2006, MED BIOL ENG COMPUT, V44, P459, DOI 10.1007/s11517-006-0056-y; De Lucia M, 2008, MED BIOL ENG COMPUT, V46, P263, DOI 10.1007/s11517-007-0289-4; Faulkner HJ, 2012, CLIN NEUROPHYSIOL, V123, P1732, DOI 10.1016/j.clinph.2012.01.023; Friedman DE, 2009, J CLIN NEUROPHYSIOL, V26, P213, DOI 10.1097/WNP.0b013e3181b2f2da; Halford JJ, 2013, J NEUROSCI METH, V212, P308, DOI 10.1016/j.jneumeth.2012.11.005; Halford JJ, 2009, CLIN NEUROPHYSIOL, V120, P1909, DOI 10.1016/j.clinph.2009.08.007; Inan ZH, 2007, COMPUT BIOL MED, V37, P1160, DOI 10.1016/j.compbiomed.2006.10.010; Indiradevi KP, 2008, COMPUT BIOL MED, V38, P805, DOI 10.1016/j.compbiomed.2008.04.010; Ji ZF, 2011, IEEE T BIO-MED ENG, V58, P2478, DOI 10.1109/TBME.2011.2157917; Kumar Y, 2012, RES J APPL SCI ENG T, V4, P3588; Leach JP, 2006, J NEUROL NEUROSUR PS, V77, P1040, DOI 10.1136/jnnp.2005.084871; Lodder SS, 2013, CLIN NEUROPHYSIOL; Nonclercq A, 2009, NEUROPHYSIOL CLIN, V39, P123, DOI 10.1016/j.neucli.2008.12.001; Nonclercq A, 2012, J NEUROSCI METH, V210, P259, DOI 10.1016/j.jneumeth.2012.07.015; Scherg M, 2012, EPILEPSIA, V53, P1196, DOI 10.1111/j.1528-1167.2012.03503.x; Shen CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065862; Subasi A, 2006, EXPERT SYST APPL, V31, P320, DOI 10.1016/j.eswa.2005.09.027; Van Hese P, 2008, CLIN NEUROPHYSIOL, V119, P1756, DOI 10.1016/j.clinph.2008.04.009; Wang CM, 2010, COGN NEURODYNAMICS, V4, P233, DOI 10.1007/s11571-010-9120-2; Wilson SB, 2002, CLIN NEUROPHYSIOL, V113, P1873, DOI 10.1016/S1388-2457(02)00297-3; Zhou J, 2012, IEEE ENG MED BIO, P3959, DOI 10.1109/EMBC.2012.6346833	22	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85180	10.1371/journal.pone.0085180	http://dx.doi.org/10.1371/journal.pone.0085180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454813	gold, Green Submitted, Green Published			2022-12-25	WOS:000330235100060
J	Havird, JC; Santos, SR				Havird, Justin C.; Santos, Scott R.			Performance of Single and Concatenated Sets of Mitochondrial Genes at Inferring Metazoan Relationships Relative to Full Mitogenome Data	PLOS ONE			English	Article							AMINO-ACID REPLACEMENT; PHYLOGENETIC-RELATIONSHIPS; EUTHYNEURAN GASTROPODS; GENOMES; EVOLUTION; INFORMATION; SYSTEMATICS; CHARACTERS; SEQUENCES; RATES	Mitochondrial (mt) genes are some of the most popular and widely-utilized genetic loci in phylogenetic studies of metazoan taxa. However, their linked nature has raised questions on whether using the entire mitogenome for phylogenetics is overkill (at best) or pseudoreplication (at worst). Moreover, no studies have addressed the comparative phylogenetic utility of mitochondrial genes across individual lineages within the entire Metazoa. To comment on the phylogenetic utility of individual mt genes as well as concatenated subsets of genes, we analyzed mitogenomic data from 1865 metazoan taxa in 372 separate lineages spanning genera to subphyla. Specifically, phylogenies inferred from these datasets were statistically compared to ones generated from all 13 mt protein-coding (PC) genes (i.e., the "supergene" set) to determine which single genes performed "best" at, and the minimum number of genes required to, recover the "supergene" topology. Surprisingly, the popular marker COX1 performed poorest, while ND5, ND4, and ND2 were most likely to reproduce the "supergene" topology. Averaged across all lineages, the longest similar to 2 mt PC genes were sufficient to recreate the "supergene" topology, although this average increased to,5 genes for datasets with 40 or more taxa. Furthermore, concatenation of the three "best" performing mt PC genes outperformed that of the three longest mt PC genes (i.e, ND5, COX1, and ND4). Taken together, while not all mt PC genes are equally interchangeable in phylogenetic studies of the metazoans, some subset can serve as a proxy for the 13 mt PC genes. However, the exact number and identity of these genes is specific to the lineage in question and cannot be applied indiscriminately across the Metazoa.	[Havird, Justin C.; Santos, Scott R.] Auburn Univ, Dept Biol Sci, Molette Biol Lab Environm & Climate Change Studie, Auburn, AL 36849 USA; [Havird, Justin C.; Santos, Scott R.] Auburn Univ, Cellular & Mol Biosci Program, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Havird, JC (corresponding author), Auburn Univ, Dept Biol Sci, Molette Biol Lab Environm & Climate Change Studie, Auburn, AL 36849 USA.	jhavird@auburn.edu	Santos, Scott R/A-7472-2009	Havird, Justin/0000-0002-8692-6503				Abascal F, 2007, MOL BIOL EVOL, V24, P1; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise JC, 1983, EVOLUTION GENES PROT, P223; Avise John C., 1994, pi; Belinky F, 2012, MOL PHYLOGENET EVOL, V63, P702, DOI 10.1016/j.ympev.2012.02.008; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P352, DOI 10.1016/j.ympev.2013.05.002; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Dayrat B, 2002, ZOOL J LINN SOC-LOND, V135, P403, DOI 10.1046/j.1096-3642.2002.00018.x; DEQUEIROZ K, 1994, TRENDS ECOL EVOL, V9, P27, DOI 10.1016/0169-5347(94)90231-3; Dinapoli A, 2010, MOL PHYLOGENET EVOL, V55, P60, DOI 10.1016/j.ympev.2009.09.019; Douglas DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-14; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; GODDARD W, 1994, MATH BIOSCI, V123, P215, DOI 10.1016/0025-5564(94)90012-4; Grande C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-61; GRAYBEAL A, 1994, SYST BIOL, V43, P174, DOI 10.2307/2413460; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Havird JC, 2010, ZOOTAXA, P1; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Howe CJ, 2008, CURR BIOL, V18, pR429, DOI 10.1016/j.cub.2008.04.007; Hua JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-134; Jenner RA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-21; Jorger KM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-323; Karl SA, 2012, MOL ECOL, V21, P4171, DOI 10.1111/j.1365-294X.2012.05576.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lavoue S, 2010, MOL PHYLOGENET EVOL, V56, P480, DOI 10.1016/j.ympev.2009.11.022; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Mansion G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050076; Medina M, 2011, MAR GENOM, V4, P51, DOI 10.1016/j.margen.2010.12.006; Mereschkovsky K.S, 1905, BIOL ZBL, V85, P593, DOI DOI 10.1017/S0967026299002231; Miya M, 2001, MOL BIOL EVOL, V18, P1993, DOI 10.1093/oxfordjournals.molbev.a003741; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Miya M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-58; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Nosenko T, 2013, MOL PHYLOGENET EVOL, V67, P223, DOI 10.1016/j.ympev.2013.01.010; Okajima Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-141; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Russo CAM, 1996, MOL BIOL EVOL, V13, P525, DOI 10.1093/oxfordjournals.molbev.a025613; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; San Mauro D, 2009, SYST BIOL, V58, P425, DOI 10.1093/sysbio/syp043; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Simmons MP, 2004, MOL PHYLOGENET EVOL, V32, P913, DOI 10.1016/j.ympev.2004.04.011; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoger I, 2013, MOL PHYLOGENET EVOL, V69, P376, DOI 10.1016/j.ympev.2012.11.017; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Talavera G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-315; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Vrijenhoek RC, 2012, MOL ECOL, V21, P4155, DOI 10.1111/j.1365-294X.2012.05658.x; White TR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-295; Zardoya R, 1996, MOL BIOL EVOL, V13, P933, DOI 10.1093/oxfordjournals.molbev.a025661	63	31	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84080	10.1371/journal.pone.0084080	http://dx.doi.org/10.1371/journal.pone.0084080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24454717	Green Submitted, Green Published, gold			2022-12-25	WOS:000329862500092
J	Wheatley, NM; Sundberg, CD; Gidaniyan, SD; Cascio, D; Yeates, TO				Wheatley, Nicole M.; Sundberg, Christopher D.; Gidaniyan, Soheil D.; Cascio, Duilio; Yeates, Todd O.			Structure and Identification of a Pterin Dehydratase-like Protein as a Ribulose-bisphosphate Carboxylase/Oxygenase (RuBisCO) Assembly Factor in the alpha-Carboxysome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbon Dioxide; Molecular Chaperone; Protein Assembly; Protein Evolution; Protein Folding; RuBisCO; Carbon Fixation; Carboxysome; Pseudo-enzyme; Pterin Dehydratase	PENTAMERIC VERTEX PROTEINS; CRYSTAL-STRUCTURES; SHELL; ORGANELLES; MICROCOMPARTMENTS; CYANOBACTERIA; MECHANISMS; EVOLUTION; BACTERIA; SEQUENCE	Background: A gene encoding a distant homolog of pterin-4-carbinolamine dehydratase (PCD) is present in all -type carboxysome operons. Results: This conserved PCD-like protein promotes the assembly of native RuBisCO when overexpressed together with GroELS. Conclusion: The protein, named here acRAF for -carboxysome RuBisCO assembly factor, is a newly identified molecular chaperone. Significance: The activity of this chaperone toward RuBisCO has potential agricultural application. Carboxysomes are proteinaceous bacterial microcompartments that increase the efficiency of the rate-limiting step in carbon fixation by sequestering reaction substrates. Typically, -carboxysomes are genetically encoded as a single operon expressing the structural proteins and the encapsulated enzymes of the microcompartment. In addition, depending on phylogeny, as many as 13 other genes are found to co-occur near or within -carboxysome operons. One of these genes codes for a protein with distant homology to pterin-4-carbinolamine dehydratase (PCD) enzymes. It is present in all -carboxysome containing bacteria and has homologs in algae and higher plants. Canonical PCDs play an important role in amino acid hydroxylation, a reaction not associated with carbon fixation. We determined the crystal structure of an -carboxysome PCD-like protein from the chemoautotrophic bacterium Thiomonas intermedia K12, at 1.3- resolution. The protein retains a three-dimensional fold similar to canonical PCDs, although the prominent active site cleft present in PCD enzymes is disrupted in the -carboxysome PCD-like protein. Using a cell-based complementation assay, we tested the PCD-like proteins from T. intermedia and two additional bacteria, and found no evidence for PCD enzymatic activity. However, we discovered that heterologous co-expression of the PCD-like protein from Halothiobacillus neapolitanus with RuBisCO and GroELS in Escherichia coli increased the amount of soluble, assembled RuBisCO recovered from cell lysates compared with co-expression of RuBisCO with GroELS alone. We conclude that this conserved PCD-like protein, renamed here -carboxysome RuBisCO assembly factor (or acRAF), is a novel RuBisCO chaperone integral to -carboxysome function.	[Wheatley, Nicole M.; Yeates, Todd O.] Univ Calif Los Angeles, Mol Biol Interdept PhD Program, Los Angeles, CA 90095 USA; [Sundberg, Christopher D.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Gidaniyan, Soheil D.; Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Cascio, Duilio; Yeates, Todd O.] Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yeates, TO (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles Young Dr, Los Angeles, CA 90095 USA.	yeates@mbi.ucla.edu		Yeates, Todd/0000-0001-5709-9839	Department of Energy [DE-FC02-02ER63421, DE-AC02-06CH11357]; National Institutes of Health [P41RR015301, P41GM103403]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, P41GM103403] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Andrew Hanson and Mike Ziemak for providing PCD constructs, Dr. Sabeeha Merchant and Dr. Rikard Fristedt for valuable discussions and Arabidopsis constructs, Drs. Alice Barkan, Leila Feiz, and David Stern for discussions on acRAF homologs in plants. We thank M. Capel, K. Rajashankar, N. Sukumar, J. Schuermann, I. Kourinov, and F. Murphy at NECAT for synchrotron x-ray assistance. We thank Mike Collazo and Michael Sawaya in the UCLA-DOE x-ray Crystallization and Crystallography Core Facilities. We are indebted to an anonymous reviewer for making suggestions that were critical in establishing the function of acRAF. The UCLA-DOE X-ray Crystallography Core Facility is supported by Department of Energy Grant DE-FC02-02ER63421. APS beamline 24-ID is supported by National Institutes of Health Grants P41RR015301 and P41GM103403. Use of the APS is supported by the Department of Energy under contract DE-AC02-06CH11357.	Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Bracher A, 2011, NAT STRUCT MOL BIOL, V18, P875, DOI 10.1038/nsmb.2090; Bricogne G., 2011, BUSTER VERSION X Y Z; Cai F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007521; Chen DH, 2013, CELL, V153, P1354, DOI 10.1016/j.cell.2013.04.052; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cronk JD, 1996, PROTEIN SCI, V5, P1963, DOI 10.1002/pro.5560051002; Ellis RJ, 2001, CURR BIOL, V11, pR1038, DOI 10.1016/S0960-9822(01)00620-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espie GS, 2011, PHOTOSYNTH RES, V109, P7, DOI 10.1007/s11120-011-9656-y; Feiz L, 2012, PLANT CELL, V24, P3435, DOI 10.1105/tpc.112.102012; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hayashi NR, 1997, BIOCHEM BIOPH RES CO, V241, P565, DOI 10.1006/bbrc.1997.7853; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Jeffery CJ, 2004, CURR OPIN STRUC BIOL, V14, P663, DOI 10.1016/j.sbi.2004.10.001; Jorda J, 2013, PROTEIN SCI, V22, P179, DOI 10.1002/pro.2196; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Leslie M, 2013, SCIENCE, V340, P25, DOI 10.1126/science.340.6128.27; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marcus Y, 2011, J EXP BOT, V62, P4173, DOI 10.1093/jxb/err116; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; Naponelli V, 2008, PLANT PHYSIOL, V146, P1515, DOI 10.1104/pp.107.114090; Onizuka T, 2004, PLANT CELL PHYSIOL, V45, P1390, DOI 10.1093/pcp/pch160; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Piatigorsky Joram, 2003, Journal of Structural and Functional Genomics, V3, P131; Rae BD, 2013, MICROBIOL MOL BIOL R, V77, P357, DOI 10.1128/MMBR.00061-12; Roberts EW, 2012, J BACTERIOL, V194, P787, DOI 10.1128/JB.06444-11; Sage RF, 2002, J EXP BOT, V53, P609, DOI 10.1093/jexbot/53.369.609; Satagopan S, 2009, BIOCHEMISTRY-US, V48, P9076, DOI 10.1021/bi9006385; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; Sourdive DJD, 1997, NUCLEIC ACIDS RES, V25, P1476, DOI 10.1093/nar/25.8.1476; Starkenburg SR, 2006, APPL ENVIRON MICROB, V72, P2050, DOI 10.1128/AEM.72.3.2050-2063.2006; Sutter M, 2013, PHOTOSYNTH RES, V118, P9, DOI 10.1007/s11120-013-9909-z; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Volner A, 2003, J BIOL INORG CHEM, V8, P121, DOI 10.1007/s00775-002-0395-6; Wheatley NM, 2013, PROTEIN SCI, V22, P660, DOI 10.1002/pro.2246; YEATES TO, 1995, J MOL BIOL, V249, P804, DOI 10.1006/jmbi.1995.0339; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377	44	39	41	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7973	7981		10.1074/jbc.M113.531236	http://dx.doi.org/10.1074/jbc.M113.531236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24459150	Green Published, hybrid			2022-12-25	WOS:000332761500061
J	Di, DD; Cui, BY; Wang, H; Zhao, HY; Piao, DR; Tian, LL; Tian, GZ; Kang, JL; Mao, X; Zhang, XJ; Du, PF; Zhu, L; Zhao, Z; Mao, LL; Yao, WQ; Guan, PY; Fan, WX; Jiang, H				Di, Dongdong; Cui, Buyun; Wang, Heng; Zhao, Hongyan; Piao, Dongri; Tian, Lili; Tian, Guozhong; Kang, Jingli; Mao, Xiang; Zhang, Xiaojun; Du, Pengfei; Zhu, Lin; Zhao, Zhuo; Mao, Lingling; Yao, Wenqing; Guan, Pingyuan; Fan, Weixing; Jiang, Hai			Genetic Polymorphism Characteristics of Brucella canis Isolated in China	PLOS ONE			English	Article							MULTIPLEX PCR ASSAY; SINGLE-NUCLEOTIDE POLYMORPHISMS; OUTER-MEMBRANE PROTEINS; TANDEM-REPEAT ANALYSIS; RAPID IDENTIFICATION; NUMBER; MELITENSIS; LADDER; SUIS; DISCRIMINATION	In China, brucellosis is an endemic disease typically caused by Brucella melitensis infection (biovars 1 and 3). Brucella canis infection in dogs has not traditionally recognized as a major problem. In recent years however, brucellosis resulting from Brucella canis infection has also been reported, suggesting that infections from this species may be increasing. Data concerning the epidemiology of brucellosis resulting from Brucella canis infection is limited. Therefore, the purpose of this study was to assess the diversity among Chinese Brucella canis strains for epidemiological purposes. First, we employed a 16-marker VNTR assay (Brucella MLVA-16) to assess the diversity and epidemiological relationship of 29 Brucella canis isolates from diverse locations throughout China with 38 isolates from other countries. MLVA-16 analysis separated the 67 Brucella canis isolates into 57 genotypes that grouped into five clusters with genetic similarity coefficients ranging from 67.73 to 100%. Moreover, this analysis revealed a new genotype (2-3-9-11-3-1-5-1:118), which was present in two isolates recovered from Guangxi in 1986 and 1987. Second, multiplex PCR and sequencing analysis were used to determine whether the 29 Chinese Brucella canis isolates had the characteristic BMEI1435 gene deletion. Only two isolates had this deletion. Third, amplification of the omp25 gene revealed that 26 isolates from China had a T545C mutation. Collectively, this study reveals that considerable diversity exists among Brucella canis isolates in China and provides resources for studying the genetic variation and microevolution of Brucella.	[Di, Dongdong; Tian, Lili; Kang, Jingli; Du, Pengfei; Zhu, Lin; Fan, Weixing] MOA, China Anim Hlth & Epidemiol Ctr, Lab Zoonoses, Qingdao, Peoples R China; [Cui, Buyun; Zhao, Hongyan; Piao, Dongri; Tian, Guozhong; Jiang, Hai] Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, Heng] Hangzhou Ctr Dis Control & Prevent, Lab Endem & Parasit Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Mao, Xiang] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiaojun] Jining Dist Agr & Anim Husb Bur, Jining Dist Anim Dis Control Ctr, Wulanchabu, Peoples R China; [Zhao, Zhuo; Mao, Lingling; Yao, Wenqing] Liaoning Ctr Dis Control & Prevent, Shenyang, Peoples R China; [Guan, Pingyuan] Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Peoples R China	China Animal Health & Epidemiology Center; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Nanjing Agricultural University; Inner Mongolia Agricultural University	Yao, WQ (corresponding author), Liaoning Ctr Dis Control & Prevent, Shenyang, Peoples R China.	yaowenqing@lncdc.com; gpynm@sina.com; fwxsjl@126.com; jianghai@icdc.cn	zhang, jin/GXV-9154-2022		National Natural Science Foundation of China [81271900]; Science and Technology Basic Work Program [2012FY111000]; MOST (Ministry of Science and Technology of the People's Republic of China) [2012ZX10004-209]; NIH	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Basic Work Program; MOST (Ministry of Science and Technology of the People's Republic of China)(Ministry of Science and Technology, China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Natural Science Foundation of China (81271900), the Science and Technology Basic Work Program (2012FY111000), MOST (Ministry of Science and Technology of the People's Republic of China) (2012ZX10004-209), and the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Alton GG, 1975, MONOGR SER WHO, P1; Bricker BJ, 2002, VET MICROBIOL, V90, P435, DOI 10.1016/S0378-1135(02)00228-6; Cloeckaert A, 1996, FEMS MICROBIOL LETT, V145, P1, DOI 10.1016/0378-1097(96)00373-4; CLOECKAERT A, 1995, MICROBIOL-UK, V141, P2111, DOI 10.1099/13500872-141-9-2111; Ferreira AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042514; Foster JT, 2008, J CLIN MICROBIOL, V46, P296, DOI 10.1128/JCM.01496-07; Gandara B, 2001, J CLIN MICROBIOL, V39, P235, DOI 10.1128/JCM.39.1.235-240.2001; Garcia-Yoldi D, 2006, CLIN CHEM, V52, P779, DOI 10.1373/clinchem.2005.062596; Garcia-Yoldi D, 2007, J CLIN MICROBIOL, V45, P4070, DOI 10.1128/JCM.01096-07; Gopaul KK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-86; Halling SM, 2005, J BACTERIOL, V187, P2715, DOI 10.1128/JB.187.8.2715-2726.2005; Holst BS, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-18; Huber B, 2009, INT J MED MICROBIOL, V299, P563, DOI 10.1016/j.ijmm.2009.05.002; Jiang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076332; Jiang H, 2012, VET MICROBIOL, V154, P419, DOI 10.1016/j.vetmic.2011.07.014; Jiang H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-256; Kang SI, 2011, J VET MED SCI, V73, P779, DOI 10.1292/jvms.10-0334; Kattar MM, 2008, J CLIN MICROBIOL, V46, P3935, DOI 10.1128/JCM.00464-08; Koylass MS, 2010, VET MICROBIOL, V142, P450, DOI 10.1016/j.vetmic.2009.10.013; Kulakov YK, 2012, MOL GENET MICROBIOL+, V27, P167, DOI 10.3103/S0891416812040052; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Lopez-Goni I, 2008, J CLIN MICROBIOL, V46, P3484, DOI 10.1128/JCM.00837-08; Lopez-Goni I, 2011, VET MICROBIOL, V154, P152, DOI 10.1016/j.vetmic.2011.06.035; Marianelli C, 2008, J HOSP INFECT, V68, P274, DOI 10.1016/j.jhin.2008.01.003; MichauxCharachon S, 1997, J BACTERIOL, V179, P3244, DOI 10.1128/jb.179.10.3244-3249.1997; Moreno E, 2002, VET MICROBIOL, V90, P209, DOI 10.1016/S0378-1135(02)00210-9; Nomura A, 2010, EMERG INFECT DIS, V16, P1183, DOI 10.3201/eid1607.090209; OUAHRANI S, 1993, J GEN MICROBIOL, V139, P3265, DOI 10.1099/00221287-139-12-3265; Rajashekara G, 2004, J BACTERIOL, V186, P5040, DOI 10.1128/jb.186.15.5040-5051.2004; Sayan M, 2011, JPN J INFECT DIS, V64, P516; Scott JC, 2007, APPL ENVIRON MICROB, V73, P7331, DOI 10.1128/AEM.00976-07; Shang DQ, 2002, VET MICROBIOL, V90, P165, DOI 10.1016/S0378-1135(02)00252-3; Valdezate S, 2010, J CLIN MICROBIOL, V48, P2734, DOI 10.1128/JCM.00533-10; Vizcaino N, 2000, MICROBES INFECT, V2, P1089, DOI 10.1016/S1286-4579(00)01263-6; Whatmore AM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-34; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001; Whatmore AM, 2005, J CLIN MICROBIOL, V43, P761, DOI 10.1128/JCM.43.2.761-769.2005	38	20	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e84862	10.1371/journal.pone.0084862	http://dx.doi.org/10.1371/journal.pone.0084862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465442	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000007
J	Ngarina, M; Tarimo, EAM; Naburi, H; Kilewo, C; Mwanyika-Sando, M; Chalamilla, G; Biberfeld, G; Ekstrom, AM				Ngarina, Matilda; Tarimo, Edith A. M.; Naburi, Helga; Kilewo, Charles; Mwanyika-Sando, Mary; Chalamilla, Guerino; Biberfeld, Gunnel; Ekstrom, Anna Mia			Women's Preferences Regarding Infant or Maternal Antiretroviral Prophylaxis for Prevention of Mother-To-Child Transmission of HIV during Breastfeeding and Their Views on Option B plus in Dar es Salaam, Tanzania	PLOS ONE			English	Article							THERAPY; PREGNANCY; BOTSWANA; STIGMA	Background: The WHO 2010 guidelines for prevention of mother-to-child transmission (PMTCT) of HIV recommended prophylactic antiretroviral treatment (ART) either for infants (Option A) or mothers (Option B) during breastfeeding for pregnant women with a CD4 count of >350 cell/mu L in low-income countries. In 2012, WHO proposed that all HIV-infected pregnant women should receive triple ART for life (B+) irrespective of CD4 count. Tanzania has recently switched from Option A to B+, with a few centers practicing B. However, more information on the real-life feasibility of these options is needed. This qualitative study explored women's preferences for Option A vs B and their views on Option B+ in Dar es Salaam, Tanzania. Methods: We conducted four focus group discussions with a total of 27 pregnant women with unknown HIV status, attending reproductive and child health clinics, and 31 in-depth interviews among HIV-infected pregnant and post-delivery women, 17 of whom were also asked about B+. Results: Most participants were in favor of Option B compared to A. The main reasons for choosing Option B were: HIV-associated stigma, fear of drug side-effects on infants and difficult logistics for postnatal drug adherence. Some of the women asked about B+ favored it as they agreed that they would eventually need ART for their own survival. Some were against B+ anticipating loss of motivation after protecting the child, fearing drug side-effects and not feeling ready to embark on lifelong medication. Some were undecided. Conclusion: Option B was preferred. Since Tanzania has recently adopted Option B+, women with CD4 counts of >350 cell/mu L should be counseled about the possibility to "opt-out" from ART after cessation of breastfeeding. Drug safety and benefits, economic concerns and available resources for laboratory monitoring and evaluation should be addressed during B+ implementation to enhance long-term feasibility and effectiveness.	[Ngarina, Matilda] Muhimbili Natl Hosp, Dept Obstet & Gynaecol, Dar Es Salaam, Tanzania; [Ngarina, Matilda; Biberfeld, Gunnel] Swedish Inst Communicable Dis Control, Solna, Sweden; [Ngarina, Matilda; Biberfeld, Gunnel] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Tarimo, Edith A. M.] Muhimbili Univ Hlth & Allied Sci, Dept Nursing Management, Dar Es Salaam, Tanzania; [Naburi, Helga] Muhimbili Univ Hlth & Allied Sci, Dept Pediat, Dar Es Salaam, Tanzania; [Naburi, Helga; Ekstrom, Anna Mia] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Naburi, Helga; Ekstrom, Anna Mia] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Kilewo, Charles] Muhimbili Univ Hlth & Allied Sci, Dept Obstet & Gynaecol, Dar Es Salaam, Tanzania; [Mwanyika-Sando, Mary; Chalamilla, Guerino] Management & Dev Hlth, Dar Es Salaam, Tanzania	Swedish Institute for Infectious Disease Control; Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Muhimbili University of Health & Allied Sciences	Ngarina, M (corresponding author), Muhimbili Natl Hosp, Dept Obstet & Gynaecol, Dar Es Salaam, Tanzania.	mmosi_2@yahoo.com		Naburi, Helga/0000-0003-1659-5224	Swedish International Development Cooperation Agency (Sida)	Swedish International Development Cooperation Agency (Sida)	This study was funded by the Swedish International Development Cooperation Agency (Sida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarson AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053993; Amuri M, 2011, AIDS CARE, V23, P378, DOI 10.1080/09540121.2010.507739; [Anonymous], 2012, COUNTRY PROGR REPORT; [Anonymous], 2005, QUALITATIVE INTERVIE; Bloor M, 2001, FOCUS GROUPS SOCIAL, DOI DOI 10.4135/9781849209175; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; Coutsoudis A, 2013, LANCET, V381, P269, DOI 10.1016/S0140-6736(12)61807-8; Creek TL, 2010, JAIDS-J ACQ IMM DEF, V53, P14, DOI 10.1097/QAI.0b013e3181bdf676; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Gamell A, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13775; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Kagaayi J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003877; Kilewo C, 2008, JAIDS-J ACQ IMM DEF, V48, P315, DOI 10.1097/QAI.0b013e31816e395c; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Kuhn L, 2012, ADV EXP MED BIOL, V743, P273, DOI 10.1007/978-1-4614-2251-8_20; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Kvale S., 1996, INTERVIEWS INTRO QUA; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mepham SO, 2011, BJOG-INT J OBSTET GY, V118, P202, DOI 10.1111/j.1471-0528.2010.02733.x; Myers G, 2001, DEV FOCUS GROUP RES; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Ngarina M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-450; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; Patton M. Q., 1990, QUALITATIVE EVALUATI; Rankin WW, 2005, PLOS MED, V2, P702, DOI 10.1371/journal.pmed.0020247; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Tenthani LN, 2013, 7 INT AIDS SOC C HIV; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Thomas KT, 2011, PLOS MED, V8; Turan JM, 2013, AIDS BEHAV, V17, P2528, DOI 10.1007/s10461-013-0446-8; UNAIDS, REG FACT SHEET 2012; UNAIDS, 2011, COUNTD ZER GLOB PLAN; Unge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013613; United republic of Tanzania, TANZ EL MTCT HIV PLA; *WHO, UN ACC SCAL PRIOR HI; WHO, 2010, WHO 2010 REVISED REC; WHO HIV/AIDS Programme, 2010, ANT DRUGS TREAT PREG; WHO/UNAIDS/UNICEF, 2011, GLOBAL HIV AIDS RESP; World Health Organization, 2012, PROGR UPD US ANT DRU	41	47	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85310	10.1371/journal.pone.0085310	http://dx.doi.org/10.1371/journal.pone.0085310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465532	Green Submitted, gold, Green Published			2022-12-25	WOS:000330283100036
J	Sharma, A; Vandenberg, B; Hollingsworth, B				Sharma, Anurag; Vandenberg, Brian; Hollingsworth, Bruce			Minimum Pricing of Alcohol versus Volumetric Taxation: Which Policy Will Reduce Heavy Consumption without Adversely Affecting Light and Moderate Consumers?	PLOS ONE			English	Article							DEMAND; TAX; US; METAANALYSIS; ENGLAND; PRICES; IMPACT; INCOME; SALES	Background: We estimate the effect on light, moderate and heavy consumers of alcohol from implementing a minimum unit price for alcohol (MUP) compared with a uniform volumetric tax. Methods: We analyse scanner data from a panel survey of demographically representative households (n = 885) collected over a one-year period (24 Jan 2010-22 Jan 2011) in the state of Victoria, Australia, which includes detailed records of each household's off-trade alcohol purchasing. Findings: The heaviest consumers (3% of the sample) currently purchase 20% of the total litres of alcohol (LALs), are more likely to purchase cask wine and full strength beer, and pay significantly less on average per standard drink compared to the lightest consumers (A$1.31 [95% CI 1.20-1.41] compared to $2.21 [95% CI 2.10-2.31]). Applying a MUP of A$1 per standard drink has a greater effect on reducing the mean annual volume of alcohol purchased by the heaviest consumers of wine (15.78 LALs [95% CI 14.86-16.69]) and beer (1.85 LALs [95% CI 1.64-2.05]) compared to a uniform volumetric tax (9.56 LALs [95% CI 9.10-10.01] and 0.49 LALs [95% CI 0.46-0.41], respectively). A MUP results in smaller increases in the annual cost for the heaviest consumers of wine ($393.60 [95% CI 374.19-413.00]) and beer ($108.26 [95% CI 94.76-121.75]), compared to a uniform volumetric tax ($552.46 [95% CI 530.55-574.36] and $163.92 [95% CI 152.79-175.03], respectively). Both a MUP and uniform volumetric tax have little effect on changing the annual cost of wine and beer for light and moderate consumers, and likewise little effect upon their purchasing. Conclusions: While both a MUP and a uniform volumetric tax have potential to reduce heavy consumption of wine and beer without adversely affecting light and moderate consumers, a MUP offers the potential to achieve greater reductions in heavy consumption at a lower overall annual cost to consumers.	[Sharma, Anurag] Monash Univ, Ctr Hlth Econ, Melbourne, Vic 3004, Australia; [Vandenberg, Brian] Canc Council Victoria, Melbourne, Vic, Australia; [Hollingsworth, Bruce] Univ Lancaster, Div Hlth Res, Lancaster LA1 4YW, England	Monash University; Cancer Council Victoria; Lancaster University	Sharma, A (corresponding author), Monash Univ, Ctr Hlth Econ, Melbourne, Vic 3004, Australia.	anurag.sharma@monash.edu	Hollingsworth, Bruce/ABH-7283-2020; SHARMA, ANURAG/GQA-9578-2022; Sharma, Anurag/B-4769-2008	SHARMA, ANURAG/0000-0002-5769-8185; Vandenberg, Brian/0000-0003-3325-6152; Sharma, Anurag/0000-0001-7570-852X; Hollingsworth, Bruce/0000-0002-4314-6523	Australian Research Council [DP120102252]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Discovery Project Grant number DP120102252. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjemian MK, 2012, AGR APPL EC ASS ANN; AIHW, 2011, 2010 NAT DRUG STRAT; Alviola PA, 2010, AGRIBUSINESS, V26, P369, DOI 10.1002/agr.20227; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Australia's Future Tax System (AFTS), 2010, REP TREAS; Australian Bureau of Statistics (ABS), 2013, 2011 CENS QUICK STAT; Australian Bureau of Statistics (ABS), 2007, TAX HOUS INC 2003 04; Australian National Preventive Health Agency (ANPHA), 2012, EXPL PUBL I IN PRESS; Australian Tax Office (ATO), 2010, EXC ESS WORK PAG; Ayyagari P, 2013, HEALTH ECON, V22, P89, DOI 10.1002/hec.1817; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; BBC News, 2013, BBC NEWS; Bergman U.M., 2010, ARE EXCISE TAX UNPUB; Black H, 2011, ADDICTION, V106, P729, DOI 10.1111/j.1360-0443.2010.03225.x; Boffa J, 2009, REDUCING HARM ALCOHO; Brennan A., 2008, INDEPENDENT REV EFFE; Byrnes J, 2012, APPL HEALTH ECON HEA, V10, P37, DOI 10.2165/11594850-000000000-00000; Byrnes JM, 2010, MED J AUSTRALIA, V192, P439, DOI 10.5694/j.1326-5377.2010.tb03581.x; Caetano R, 2012, ADDICTION, V107, P60, DOI 10.1111/j.1360-0443.2011.03567.x; Carragher N, 2011, WHAT ARE OPTIONS PRI; Centre for Economics and Business Research (CEBR), 2010, MIN ALC PRIC TARG ME; Chikritzhs T, 2005, ADDICTION, V100, P1625, DOI 10.1111/j.1360-0443.2005.01234.x; Cnossen S, 2009, MELB I C AUSTR FUT T; Cobiac L, 2009, ADDICTION, V104, P1646, DOI 10.1111/j.1360-0443.2009.02708.x; Collins D., 2008, AVOIDABLE COSTS ALCO; Craven BM, 2013, ECON AFFA, V33, P174, DOI 10.1111/ecaf.12015; Crawford MJ, 2012, ALCOHOL ALCOHOLISM, V47, P738, DOI 10.1093/alcalc/ags091; Einav L., 2008, 69 USDA EC RES SERV; Euromonitor International, 2012, ALC DRINKS AUSTR; Farrell S, 2003, J HEALTH ECON, V22, P117, DOI 10.1016/S0167-6296(02)00099-1; Finkelstein EA, 2012, J HLTH EC, V32, P219; Fogarty J, 2006, BRIT FOOD J, V108, P316, DOI 10.1108/00070700610657155; Fogarty JJ, 2012, FORUM HLTH EC POLICY, V15; Gallet CA, 2007, AUST J AGR RESOUR EC, V51, P121, DOI 10.1111/j.1467-8489.2007.00365.x; Greenfield TK, 1999, J STUD ALCOHOL, V60, P78, DOI 10.15288/jsa.1999.60.78; Gruenewald PJ, 2006, ALCOHOL CLIN EXP RES, V30, P96, DOI 10.1111/j.1530-0277.2006.00011.x; Harding M, 2010, HETEROGENEOUS GEOGRA; Hill L, 2011, ADDRESSING HARMFUL U; HM Treasury, 2010, REV ALC TAX; Kenkel DS, 2005, AM ECON REV, V95, P273, DOI 10.1257/000282805774670284; Kerr WC, 2007, ALCOHOL CLIN EXP RES, V31, P1714, DOI 10.1111/j.1530-0277.2007.00467.x; Leppanen K., 2001, CONSUMPTION ALCOHOL; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Marsden Jacob Associates (MJA), 2012, BING COLL DAM BEN CO; Meier PS, 2010, ADDICTION, V105, P383, DOI 10.1111/j.1360-0443.2009.02721.x; Meng Y, 2013, ESTIMATION OWN CROSS; Ng SW, 2012, J ACAD NUTR DIET, V112, P1828, DOI 10.1016/j.jand.2012.07.009; OECD, 2012, TRENDS ADM ISS; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Rabinovich L, 2012, FURTHER STUDY AFFORD; Ramstedt M, 2010, ADDICTION, V105, P649, DOI 10.1111/j.1360-0443.2009.02839.x; Robinson M, 2013, ALCOHOL ALCOHOLISM, V48, P231, DOI 10.1093/alcalc/ags098; Ruhm CJ, 2012, J HEALTH ECON, V31, P851, DOI 10.1016/j.jhealeco.2012.08.002; Sornpaisarn B, 2012, ADDICTION, V107, P1372, DOI 10.1111/j.1360-0443.2011.03681.x; Stockwell T., 2013, IS ALCOHOL TOO CHEAP; Stockwell T, 2012, AM J PUBLIC HLTH, V102, P10; Stockwell T, 2012, ADDICTION, V107, P912, DOI 10.1111/j.1360-0443.2011.03763.x; Thamarangsi T, 2006, ALCOHOL TAXATION W P; Thomas G., 2012, ALCOHOL PRICE POLICY; UK Home Office, 2013, NEXT STEPS FOLL CONS; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; Warren N, 2005, EJOURNAL TAX RES, V3, P114; Woodhouse J, 2013, SNHA5021 HOUS COMM L; World Health Organization, 2000, INT GUID MON ALC CON; Young DJ, 2002, NATL TAX J, V55, P57, DOI 10.17310/ntj.2002.1.04; Zhao JH, 2013, ADDICTION, V108, P1059, DOI 10.1111/add.12139	66	35	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e80936	10.1371/journal.pone.0080936	http://dx.doi.org/10.1371/journal.pone.0080936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465368	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000330283100002
J	Zajac, D; Spolnik, G; Roszkowski, P; Danikiewicz, W; Czarnocki, Z; Pokorski, M				Zajac, Dominika; Spolnik, Grzegorz; Roszkowski, Piotr; Danikiewicz, Witold; Czarnocki, Zbigniew; Pokorski, Mieczyslaw			Metabolism of N-Acylated-Dopamine	PLOS ONE			English	Article							OLEOYL-DOPAMINE; AGONIST ACTIVITY; CAROTID-BODY; RAT; CAPSAICIN; BRAIN; OLEOYLDOPAMINE; TRPV1; ACTIVATION; INHIBITORS	N-oleoyl-dopamine (OLDA) is a novel lipid derivative of dopamine. Its biological action includes the interaction with dopamine and the transient receptor potential vanilloid (TRPV1) receptors. It seems to be synthesized in a dopamine-like manner, but there has been no information on its degradation. The aim of the study was, therefore, to determine whether OLDA metabolism proceeds the way dopamine proper does. We addressed the issue by examining the occurrence of O-methylation of exogenously supplemented OLDA via catechol-O-methyltransferase (COMT) under in vitro, ex vivo, and in vivo conditions using rat brain tissue. The results show that OLDA was methylated by COMT in all conditions studied, yielding the O-methylated derivative. The methylation was reversed by tolcapone, a potent COMT inhibitor, in a dose-dependent manner. We conclude that OLDA enters the metabolic pathway of dopamine. Methylation of OLDA may enhance its bioactive properties, such as the ability to interact with TRPV1 receptors.	[Zajac, Dominika; Pokorski, Mieczyslaw] Polish Acad Sci, Med Res Ctr, Dept Resp Res, Warsaw, Poland; [Spolnik, Grzegorz; Danikiewicz, Witold] Polish Acad Sci, Inst Organ Chem, Mass Spectrometry Grp 1, Warsaw, Poland; [Roszkowski, Piotr; Czarnocki, Zbigniew] Warsaw Univ, Lab Nat Prod Chem, Fac Chem, Warsaw, Poland	Polish Academy of Sciences; Polish Academy of Sciences; Institute of Organic Chemistry of the Polish Academy of Sciences; University of Warsaw	Pokorski, M (corresponding author), Polish Acad Sci, Med Res Ctr, Dept Resp Res, Warsaw, Poland.	m_pokorski@hotmail.com	Danikiewicz, Witold/H-2257-2016; Pokorski, Mieczyslaw/K-6395-2018; Zając, Dominika/ADT-7442-2022	Danikiewicz, Witold/0000-0003-0484-2689; Pokorski, Mieczyslaw/0000-0002-8710-9775; Zajac, Dominika/0000-0002-0910-5912; Spolnik, Grzegorz/0000-0002-7779-7690	Polish Academy of Sciences Medical Research Center in Warsaw	Polish Academy of Sciences Medical Research Center in Warsaw	This research was funded by the statutory budget of the Polish Academy of Sciences Medical Research Center in Warsaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov MG, 2009, BIOCHEMISTRY-MOSCOW+, V74, P681, DOI 10.1134/S0006297909060133; Almasi R, 2008, LIFE SCI, V82, P644, DOI 10.1016/j.lfs.2007.12.022; Bezuglov V, 2001, BIOORG MED CHEM LETT, V11, P447, DOI 10.1016/S0960-894X(00)00689-2; Brannan T, 1997, J NEURAL TRANSM, V104, P77, DOI 10.1007/BF01271296; Chu CJ, 2003, J BIOL CHEM, V278, P13633, DOI 10.1074/jbc.M211231200; Czarnocki Z, 1998, ORG PREP PROCED INT, V30, P699, DOI 10.1080/00304949809355327; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Hu SSJ, 2009, PROSTAG LEUKOTR ESS, V81, P291, DOI 10.1016/j.plefa.2009.05.026; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; Institute for Laboratory Animal Research (ILAR), 1996, GUIDE CARE USE LAB A; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; KLOPMAN G, 1995, J COMPUT AID MOL DES, V9, P283, DOI 10.1007/BF00124458; Konieczny J, 2009, INT J IMMUNOPATH PH, V22, P21, DOI 10.1177/039463200902200104; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Pokorski M, 2003, DRUG DEVELOP RES, V60, P217, DOI 10.1002/ddr.10298; Pokorski M, 1998, MED HYPOTHESES, V50, P131, DOI 10.1016/S0306-9877(98)90198-0; Pokorski M, 2006, ADV EXP MED BIOL, V580, P173, DOI 10.1007/0-387-31311-7_26; Przegalinski E, 2006, INT J IMMUNOPATH PH, V19, P897, DOI 10.1177/039463200601900419; Smythies J, 1998, BBA-GEN SUBJECTS, V1380, P159, DOI 10.1016/S0304-4165(97)00131-1; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Szallasi A, 1999, PHARMACOL REV, V51, P159; Szolcsanyi J, 2004, NEUROSCI LETT, V361, P155, DOI 10.1016/j.neulet.2003.12.025; WALPOLE CSJ, 1993, J MED CHEM, V36, P2362, DOI 10.1021/jm00068a014; Zajac D, 2006, J PHYSIOL PHARMACOL, V57, P403; Zajac D, 2007, INT C ADV PNEUM 10 1; Zhong BH, 2008, AM J PHYSIOL-HEART C, V295, pH728, DOI 10.1152/ajpheart.00022.2008	27	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85259	10.1371/journal.pone.0085259	http://dx.doi.org/10.1371/journal.pone.0085259			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465516	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100031
J	Blasiak, LC; Schmidt, AW; Andriamiarinoro, H; Mulaw, T; Rasolomampianina, R; Applequist, WL; Birkinshaw, C; Rejo-Fienena, F; Lowry, PP; Schmidt, TM; Hill, RT				Blasiak, Leah C.; Schmidt, Alex W.; Andriamiarinoro, Honore; Mulaw, Temesgen; Rasolomampianina, Rado; Applequist, Wendy L.; Birkinshaw, Chris; Rejo-Fienena, Felicitee; Lowry, Porter P., II; Schmidt, Thomas M.; Hill, Russell T.			Bacterial Communities in Malagasy Soils with Differing Levels of Disturbance Affecting Botanical Diversity	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; PH; FERTILIZATION; BIOGEOGRAPHY; MANAGEMENT; PREDICTOR; IMPACT; FOREST; CARBON; SHIFTS	Madagascar is well-known for the exceptional biodiversity of its macro-flora and fauna, but the biodiversity of Malagasy microbial communities remains relatively unexplored. Understanding patterns of bacterial diversity in soil and their correlations with above-ground botanical diversity could influence conservation planning as well as sampling strategies to maximize access to bacterially derived natural products. We present the first detailed description of Malagasy soil bacterial communities from a targeted 16S rRNA gene survey of greater than 290,000 sequences generated using 454 pyrosequencing. Two sampling plots in each of three forest conservation areas were established to represent different levels of disturbance resulting from human impact through agriculture and selective exploitation of trees, as well as from natural impacts of cyclones. In parallel, we performed an in-depth characterization of the total vascular plant morphospecies richness within each plot. The plots representing different levels of disturbance within each forest did not differ significantly in bacterial diversity or richness. Changes in bacterial community composition were largest between forests rather than between different levels of impact within a forest. The largest difference in bacterial community composition with disturbance was observed at the Vohibe forest conservation area, and this difference was correlated with changes in both vascular plant richness and soil pH. These results provide the first survey of Malagasy soil bacterial diversity and establish a baseline of botanical diversity within important conservation areas.	[Blasiak, Leah C.; Mulaw, Temesgen; Hill, Russell T.] Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA; [Schmidt, Alex W.; Schmidt, Thomas M.] Univ Maryland, Ctr Microbial Sci, Baltimore, MD 21201 USA; [Andriamiarinoro, Honore; Applequist, Wendy L.; Birkinshaw, Chris; Lowry, Porter P., II] Missouri Bot Garden, St Louis, MO USA; [Rasolomampianina, Rado; Rejo-Fienena, Felicitee] Ctr Natl Rech Environm, Lab Microbiol Environm, Antananarivo, Madagascar; [Lowry, Porter P., II] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR 7205, F-75231 Paris, France	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; University System of Maryland; University of Maryland Baltimore; Missouri Botanical Gardens; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Hill, RT (corresponding author), Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA.	hill@umces.edu	Hill, Russell/AAF-4190-2019	Hill, Russell/0000-0002-9832-1851; Schmidt, Thomas/0000-0002-8209-6055	National Science Foundation (NSF) Directorate for Biological Sciences Integrative Organismal Systems [IOS-0919728]; Fogarty International Center; National Cancer Institute; National Institute of Allergy and Infectious Diseases; National Institute of Mental Health; National Institute on Drug Abuse; National Heart Lung and Blood Institute; National Center for Complementary and Alternative Medicine; Office of Dietary Supplements; National Institute of General Medical Sciences; Office of Biological and Environmental Research of the U.S. Department of Energy [U01 TW00313]; International Cooperative Biodiversity Groups; National Research Initiative of the Cooperative State Research, Education and Extension Service, USDA [2008-35621-04732]; Biological Sciences Directorate of the NSF; FOGARTY INTERNATIONAL CENTER [U01TW000313] Funding Source: NIH RePORTER	National Science Foundation (NSF) Directorate for Biological Sciences Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Biological and Environmental Research of the U.S. Department of Energy(United States Department of Energy (DOE)); International Cooperative Biodiversity Groups; National Research Initiative of the Cooperative State Research, Education and Extension Service, USDA(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Biological Sciences Directorate of the NSF(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by a grant from the National Science Foundation (NSF) Directorate for Biological Sciences Integrative Organismal Systems (IOS-0919728), Fogarty International Center, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Mental Health, National Institute on Drug Abuse, National Heart Lung and Blood Institute, National Center for Complementary and Alternative Medicine, Office of Dietary Supplements, National Institute of General Medical Sciences, Biological Sciences Directorate of the NSF, and the Office of Biological and Environmental Research of the U.S. Department of Energy under Cooperative Agreement U01 TW00313 with the International Cooperative Biodiversity Groups. This project was also supported by the National Research Initiative of the Cooperative State Research, Education and Extension Service, USDA, Grant #2008-35621-04732. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Suleiman AKA, 2013, SYST APPL MICROBIOL, V36, P137, DOI 10.1016/j.syapm.2012.10.007; Andrew DR, 2012, APPL ENVIRON MICROB, V78, P7527, DOI 10.1128/AEM.01459-12; Aubert G., 1978, METHODE ANAL SOLS; Berthrong ST, 2013, MICROB ECOL, V66, P158, DOI 10.1007/s00248-013-0225-0; Bremner JM, 1982, METHODS SOIL ANAL 2, P610; Buckley DH, 2003, ENVIRON MICROBIOL, V5, P441, DOI 10.1046/j.1462-2920.2003.00404.x; Callmander MW, 2011, PLANT ECOL EVOL, V144, P121, DOI 10.5091/plecevo.2011.513; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cornet A., 1974, NOTICE EXPLICATIVE, V55, P1; Daniel R, 2004, CURR OPIN BIOTECH, V15, P199, DOI 10.1016/j.copbio.2004.04.005; Du Puy DJ, 1996, REFINED CLASSIFICATI, P205; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ferrenberg S, 2013, ISME J, V7, P1102, DOI 10.1038/ismej.2013.11; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Hartmann M, 2012, ISME J, V6, P2199, DOI 10.1038/ismej.2012.84; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Keddy P, 2005, ANN BOT-LONDON, V96, P177, DOI 10.1093/aob/mci166; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Levine UY, 2011, ISME J, V5, P1683, DOI 10.1038/ismej.2011.40; Liliensiek AK, 2012, MICROB ECOL, V63, P509, DOI 10.1007/s00248-011-9985-6; Lupwayi NZ, 1998, SOIL BIOL BIOCHEM, V30, P1733, DOI 10.1016/S0038-0717(98)00025-X; Mitchell RJ, 2010, PLANT SOIL, V333, P417, DOI 10.1007/s11104-010-0357-7; Moat P, 2007, ATLAS VEGETATION MAD; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naether A, 2012, APPL ENVIRON MICROB, V78, P7398, DOI 10.1128/AEM.01325-12; Nemergut DR, 2010, SOIL BIOL BIOCHEM, V42, P2153, DOI 10.1016/j.soilbio.2010.08.011; Oksanen J., 2013, VEGAN COMMUNITY ECOL, V2; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Phillipson P.B., 2006, TAXONOMY ECOLOGY AFR, P613; Pilloni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040467; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Reddy BVB, 2012, APPL ENVIRON MICROB, V78, P3744, DOI 10.1128/AEM.00102-12; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stopnisek N, 2014, ENVIRON MICROBIOL, V16, P1503, DOI 10.1111/1462-2920.12211; Suarez-Moreno ZR, 2012, MICROB ECOL, V63, P249, DOI 10.1007/s00248-011-9929-1; Team RC., 2012, LANG ENV STAT COMP; Tripathi BM, 2012, MICROB ECOL, V64, P474, DOI 10.1007/s00248-012-0028-8; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu T, 2008, MICROB ECOL, V55, P293, DOI 10.1007/s00248-007-9276-4; Zabinski CA, 1997, ENVIRON MANAGE, V21, P233, DOI 10.1007/s002679900022	55	6	6	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85097	10.1371/journal.pone.0085097	http://dx.doi.org/10.1371/journal.pone.0085097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465484	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500032
J	Ma, RCW; Lee, HM; Lam, VKL; Tam, CHT; Ho, JSK; Zhao, HL; Guan, J; Kong, APS; Lau, E; Zhang, GZ; Luk, A; Wang, Y; Tsui, SKW; Chan, TF; Hu, C; Jia, WP; Park, KS; Lee, HK; Furuta, H; Nanjo, K; Tai, ES; Ng, DPK; Tang, NLS; Woo, J; Leung, PC; Xue, H; Wong, J; Leung, PS; Lau, TCK; Tong, PCY; Xu, G; Ng, MCY; So, WY; Chan, JCN				Ma, Ronald Ching Wan; Lee, Heung Man; Lam, Vincent Kwok Lim; Tam, Claudia Ha Ting; Ho, Janice Siu Ka; Zhao, Hai-Lu; Guan, Jing; Kong, Alice Pik Shan; Lau, Eric; Zhang, Guozhi; Luk, Andrea; Wang, Ying; Tsui, Stephen Kwok Wing; Chan, Ting Fung; Hu, Cheng; Jia, Wei Ping; Park, Kyong Soo; Lee, Hong Kyu; Furuta, Hiroto; Nanjo, Kishio; Tai, E. Shyong; Ng, Daniel Peng-Keat; Tang, Nelson Leung Sang; Woo, Jean; Leung, Ping Chung; Xue, Hong; Wong, Jeffrey; Leung, Po Sing; Lau, Terrence C. K.; Tong, Peter Chun Yip; Xu, Gang; Ng, Maggie Chor Yin; So, Wing Yee; Chan, Juliana Chung Ngor			Familial Young-Onset Diabetes, Pre-Diabetes and Cardiovascular Disease Are Associated with Genetic Variants of DACH1 in Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HONG-KONG CHINESE; METABOLIC SYNDROME; SUSCEPTIBILITY LOCUS; CONSERVED ROLE; TYPE-2; GROWTH; RISK; BETA; PATHOPHYSIOLOGY	In Asia, young-onset type 2 diabetes (YOD) is characterized by obesity and increased risk for cardiovascular disease (CVD). In a genome-wide association study (GWAS) of 99 Chinese obese subjects with familial YOD diagnosed before 40-year-old and 101 controls, the T allele of rs1408888 in intron 1 of DACH1(Dachshund homolog 1) was associated with an odds ratio (OR) of 2.49(95% confidence intervals: 1.57-3.96, P = 8.4610(-5)). Amongst these subjects, we found reduced expression of DACH1 in peripheral blood mononuclear cells (PBMC) from 63 cases compared to 65 controls (P = 0.02). In a random cohort of 1468 cases and 1485 controls, amongst top 19 SNPs from GWAS, rs1408888 was associated with type 2 diabetes with a global P value of 0.0176 and confirmation in a multiethnic Asian case-control cohort (7370/7802) with an OR of 1.07(1.02-1.12, P-meta = 0.012). In 599 Chinese non-diabetic subjects, rs1408888 was linearly associated with systolic blood pressure and insulin resistance. In a case-control cohort (n = 953/953), rs1408888 was associated with an OR of 1.54(1.07-2.22, P = 0.019) for CVD in type 2 diabetes. In an autopsy series of 173 non-diabetic cases, TT genotype of rs1408888 was associated with an OR of 3.31(1.19-9.19, P = 0.0214) and 3.27(1.25-11.07, P = 0.0184) for coronary heart disease (CHD) and coronary arteriosclerosis. Bioinformatics analysis revealed that rs1408888 lies within regulatory elements of DACH1 implicated in islet development and insulin secretion. The T allele of rs1408888 of DACH1 was associated with YOD, prediabetes and CVD in Chinese.	[Ma, Ronald Ching Wan; Lee, Heung Man; Lam, Vincent Kwok Lim; Tam, Claudia Ha Ting; Ho, Janice Siu Ka; Zhao, Hai-Lu; Guan, Jing; Kong, Alice Pik Shan; Lau, Eric; Zhang, Guozhi; Luk, Andrea; Wang, Ying; Woo, Jean; Tong, Peter Chun Yip; Xu, Gang; Ng, Maggie Chor Yin; So, Wing Yee; Chan, Juliana Chung Ngor] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Ma, Ronald Ching Wan; Tong, Peter Chun Yip; Xu, Gang; So, Wing Yee; Chan, Juliana Chung Ngor] Chinese Univ Hong Kong, Hong Kong Inst Diabet & Obes, Hong Kong, Hong Kong, Peoples R China; [Ma, Ronald Ching Wan; Lee, Heung Man; Lam, Vincent Kwok Lim; Kong, Alice Pik Shan; Tang, Nelson Leung Sang; Xu, Gang; So, Wing Yee; Chan, Juliana Chung Ngor] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Tsui, Stephen Kwok Wing; Leung, Po Sing; Lau, Terrence C. K.] Chinese Univ Hong Kong, Sch Biomed Sci, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Chan, Ting Fung] Chinese Univ Hong Kong, Sch Life Sci, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Hu, Cheng; Jia, Wei Ping] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab,Affiliated Peoples Hosp 6, Shanghai Diabet Inst,Shanghai Key Clin Ctr Metab, Shanghai Key Lab Diabet Mellitus,Shanghai Clin Ct, Shanghai 200030, Peoples R China; [Park, Kyong Soo; Lee, Hong Kyu] Seoul Natl Univ, Coll Med, Dept Mol Med & Biopharmaceut Sci, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Park, Kyong Soo; Lee, Hong Kyu] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Furuta, Hiroto; Nanjo, Kishio] Wakayama Med Univ, Dept Med 1, Wakayama, Japan; [Tai, E. Shyong; Ng, Daniel Peng-Keat] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Tang, Nelson Leung Sang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Leung, Ping Chung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China; [Xue, Hong; Wong, Jeffrey] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Shanghai Jiao Tong University; Seoul National University (SNU); Seoul National University (SNU); Wakayama Medical University; National University of Singapore; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Hong Kong University of Science & Technology	Chan, JCN (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	jchan@cuhk.edu.hk	Woo, Jean/K-2625-2014; Luk, Andrea/B-5766-2016; Chan, Juliana/B-7918-2016; Hu, Cheng/C-3346-2008; Lau, Eric S.H./AGZ-2920-2022; Tang, Nelson L/P-5018-2017; Kong, Alice/P-3703-2015; Park, Kyong Soo/C-2265-2008; Jia, Weiping/B-7483-2012; Ma, Ronald/C-2788-2009; Chan, TingFung/A-6161-2013; Leung, Po Sing/P-5758-2014; Tsui, Stephen Kwok-Wing/E-4385-2015; Lau, Terrence/ABB-7900-2021	Woo, Jean/0000-0001-7593-3081; Chan, Juliana/0000-0003-1325-1194; Hu, Cheng/0000-0003-4314-2386; Tang, Nelson L/0000-0002-3607-5819; Kong, Alice/0000-0001-8927-6764; Park, Kyong Soo/0000-0003-3597-342X; Ma, Ronald/0000-0002-1227-803X; Chan, TingFung/0000-0002-0489-3884; Leung, Po Sing/0000-0001-8074-3178; Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Lau, Terrence/0000-0002-7505-7306; Wong, J. Tze-Fei/0000-0001-8539-8537; Xue, Hong/0000-0002-8133-9828; Tai, E Shyong/0000-0003-2929-8966; Lau, Eric S.H./0000-0003-1581-5643	Research Grant Council (RGC) Central Allocation Scheme [CUHK 1/04C]; RGC earmarked grant [CUHK4462/06M]; US National Institutes of Health [U01-DK085545-05]; Hong Kong Foundation for Research and Development in Diabetes; Liao Wun Yuk Diabetes Research Memorial Fund established under the CUHK; National Natural Scientific Foundation of China [30630061]; Shanghai Key Laboratory of Diabetes Mellitus [08DZ2230200]; Ministry of Health, Welfare and Family Affair, Republic of Korea [00-PJ3-PG6-GN07-001]; Ministry of Education, Culture, Sports, Science and Technology of Japan [17019047]; Biomedical Research Council of Singapore [BMRC 05/1/36/19/413, 03/1/27/18/216]; National Medical Research Council of Singapore [NMRC/1174/2008]; NationalMedical Research Council [NMRC 0796/2003, IRG07nov013, NMRC/STaR/0003/2008]; Biomedical Research Council (BMRC) [09/1/35/19/616]; National Medical Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085545] Funding Source: NIH RePORTER	Research Grant Council (RGC) Central Allocation Scheme; RGC earmarked grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong Foundation for Research and Development in Diabetes; Liao Wun Yuk Diabetes Research Memorial Fund established under the CUHK; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Laboratory of Diabetes Mellitus; Ministry of Health, Welfare and Family Affair, Republic of Korea; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore(National Medical Research Council, Singapore); NationalMedical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was partly supported by the Research Grant Council (RGC) Central Allocation Scheme (CUHK 1/04C), RGC earmarked grant (CUHK4462/06M), US National Institutes of Health (U01-DK085545-05) as well as the Hong Kong Foundation for Research and Development in Diabetes and Liao Wun Yuk Diabetes Research Memorial Fund established under the CUHK. The research in Shanghai Chinese was supported by grants from National Natural Scientific Foundation of China (30630061) and Shanghai Key Laboratory of Diabetes Mellitus (08DZ2230200). The study in Korea was funded by a grant from the Korea Health 21 R&D Project, Ministry of Health, Welfare and Family Affair, Republic of Korea (00-PJ3-PG6-GN07-001 to K. S. P.). The work in Japan was supported by Grant-in-Aid for Scientific Research on Priority Areas 'Applied Genomics' no. 17019047 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The Singapore Prospective Study Program was funded through grants from the Biomedical Research Council of Singapore (BMRC 05/1/36/19/413 and 03/1/27/18/216) and the National Medical Research Council of Singapore (NMRC/1174/2008). The Singapore Malay Eye Study was funded by the NationalMedical Research Council (NMRC 0796/2003, IRG07nov013, and NMRC/STaR/0003/2008) and Biomedical Research Council (BMRC, 09/1/35/19/616). EST also receives additional support from the National Medical Research Council through a clinician scientist award. The Singapore BioBank and the Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore provided services for tissue archival and genotyping, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax L, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-40; Chan JCN, 2011, CURR CARDIOVASC RISK, V5, P230, DOI 10.1007/s12170-011-0172-6; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Davis RJ, 2001, MOL CELL BIOL, V21, P1484, DOI 10.1128/MCB.21.5.1484-1490.2001; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Dreja T, 2010, DIABETOLOGIA, V53, P309, DOI 10.1007/s00125-009-1576-4; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Guan J, 2009, NEPHROL DIAL TRANSPL, V24, P1889, DOI 10.1093/ndt/gfn734; Hu C, 2009, DIABETOLOGIA, V52, P451, DOI 10.1007/s00125-008-1241-3; Kalousova A, 2010, DEV BIOL, V348, P143, DOI 10.1016/j.ydbio.2010.09.007; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Li JKY, 2006, DIABETES-METAB RES, V22, P46, DOI 10.1002/dmrr.577; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Liu KH, 2006, DIABETES CARE, V29, P379, DOI 10.2337/diacare.29.02.06.dc05-1578; Ma RCW, 2013, DIABETOLOGIA, V56, P1291, DOI 10.1007/s00125-013-2874-4; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Ng MCY, 2004, DIABETES, V53, P2676, DOI 10.2337/diabetes.53.10.2676; Ng MCY, 2001, DIABETES CARE, V24, P663, DOI 10.2337/diacare.24.4.663; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Novembre J, 2009, NAT REV GENET, V10, P745, DOI 10.1038/nrg2632; Okamoto N, 2012, P NATL ACAD SCI USA, V109, P2406, DOI 10.1073/pnas.1116050109; Ozaki R, 2007, ARCH DIS CHILD, V92, P224, DOI 10.1136/adc.2006.100453; Park KS, 2008, DIABETOLOGIA, V51, P602, DOI 10.1007/s00125-008-0933-z; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Popov VM, 2010, TRENDS ENDOCRIN MET, V21, P41, DOI 10.1016/j.tem.2009.08.002; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Ramos-Mondragon R, 2008, VASC HEALTH RISK MAN, V4, P1289; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sengupta U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008100; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shu XO, 2010, PLOS GENET, V6; Suen PM, 2008, INT J BIOCHEM CELL B, V40, P789, DOI 10.1016/j.biocel.2007.10.020; Tan JT, 2010, J CLIN ENDOCR METAB, V95, P390, DOI 10.1210/jc.2009-0688; Wang Y, 2013, BMC PUBLIC IN PRESS; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Wu KM, 2003, J BIOL CHEM, V278, P51673, DOI 10.1074/jbc.M310021200; Wu KM, 2007, MOL BIOL CELL, V18, P755, DOI 10.1091/mbc.E06-09-0793; Yang SNY, 2010, J DIABETES, V2, P233, DOI 10.1111/j.1753-0407.2010.00089.x; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhao HL, 2004, DIABETES, V53, P2984, DOI 10.2337/diabetes.53.11.2984; Zhou J, 2010, P NATL ACAD SCI USA, V107, P6864, DOI 10.1073/pnas.1002746107	47	11	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84770	10.1371/journal.pone.0084770	http://dx.doi.org/10.1371/journal.pone.0084770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465431	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500022
J	Moura, CS; Lollo, PCB; Morato, PN; Nisishima, LH; Carneiro, EM; Amaya-Farfan, J				Moura, Carolina Soares; Barboza Lollo, Pablo Christiano; Morato, Priscila Neder; Nisishima, Luciana Hisayama; Carneiro, Everardo Magalhaes; Amaya-Farfan, Jaime			Whey Protein Hydrolysate Enhances HSP90 but Does Not Alter HSP60 and HSP25 in Skeletal Muscle of Rats	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CHAPERONE; HSP70	Whey protein hydrolysate (WPH) intake has shown to increase HSP70 expression. The aim of the present study was to investigate whether WPH intake would also influences HSP90, HSP60 and HSP25 expression, as well as associated parameters. Forty-eight male Wistar rats were divided into sedentary (unstressed) and exercised (stressed) groups, and were fed with three different sources of protein: whey protein (WP), whey protein hydrolysate (WPH) and casein (CAS) as a control, based on the AIN93G diet for 3 weeks. WPH intake increased HSP90 expression in both sedentary and exercised animals compared to WP or CAS, however no alteration was found from exercise or diet to HSP60 or HSP25. Co-chaperone Aha1 and p-HSF1 were also increased in the exercised animals fed with WPH in comparison with WP or CAS, consistent with enhanced HSP90 expression. VEGF and p-AKT were increased in the WPH exercised group. No alteration was found in BCKDH, PI3-Kinase (p85), GFAT, OGT or PGC for diet or exercise. The antioxidant system GPx, catalase and SOD showed different responses to diet and exercise. The data indicate that WPH intake enhanced factors related to cell survival, such as HSP90 and VEGF, but does not alter HSP60 or HSP25 in rat skeletal muscle.	[Moura, Carolina Soares; Barboza Lollo, Pablo Christiano; Morato, Priscila Neder; Nisishima, Luciana Hisayama; Amaya-Farfan, Jaime] Univ Campinas UNICAMP, Fac Food Engn, Dept Food & Nutr, Sao Paulo, Brazil; [Carneiro, Everardo Magalhaes] Univ Campinas UNICAMP, Inst Biol, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Moura, CS (corresponding author), Univ Campinas UNICAMP, Fac Food Engn, Dept Food & Nutr, Sao Paulo, Brazil.	linanutricao@yahoo.com.br	Morato, Priscila Neder/AAN-6178-2021; Carneiro, Everardo/D-4758-2012		Foundation for Research of the State of Sao Paulo, Brazil (FAPESP) [2011/13035-1]	Foundation for Research of the State of Sao Paulo, Brazil (FAPESP)	The authors are grateful to the Foundation for Research of the State of Sao Paulo, Brazil (FAPESP no 2011/13035-1) for financial support and to Hilmar Ingredients (Hilmar, California, USA) for providing the whey protein products. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilo A, 2005, PHYSIOL BEHAV, V84, P1, DOI 10.1016/j.physbeh.2004.07.034; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Lollo PCB, 2011, J HUM KINET, V30, P49, DOI 10.2478/v10078-011-0072-3; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; de Moura CS, 2013, FOOD CHEM, V136, P1350, DOI 10.1016/j.foodchem.2012.09.070; Folkesson ALM, 2013, ACTA PHYSL, P1; FRIDOVICH I, 1978, PHOTOCHEM PHOTOBIOL, V28, P733, DOI 10.1111/j.1751-1097.1978.tb07009.x; Gad AS, 2011, NUTRITION, V27, P582, DOI 10.1016/j.nut.2010.04.002; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Hamiel CR, 2009, AM J PHYSIOL-CELL PH, V297, pC1509, DOI 10.1152/ajpcell.00240.2009; HIGUCHI M, 1985, J GERONTOL, V40, P281, DOI 10.1093/geronj/40.3.281; Jiang YQ, 2013, BRAIN RES, V1519, P105, DOI 10.1016/j.brainres.2013.04.059; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Khassaf M, 2001, J APPL PHYSIOL, V90, P1031, DOI 10.1152/jappl.2001.90.3.1031; Kinnunen S, 2009, RES VET SCI, V87, P462, DOI 10.1016/j.rvsc.2009.04.009; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; Latchman DS, 2004, CURR NEUROVASC RES, V1, P21, DOI 10.2174/1567202043480206; Lee MW, 2005, J THERM BIOL, V30, P43, DOI 10.1016/j.jtherbio.2004.06.005; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maglara AA, 2003, J PHYSIOL-LONDON, V548, P837, DOI 10.1113/jphysiol.2002.034520; Mayer MP, 2002, MOL CELL, V10, P1255, DOI 10.1016/S1097-2765(02)00793-1; Milne KJ, 2002, J APPL PHYSIOL, V93, P561, DOI 10.1152/japplphysiol.00528.2001; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Morato PN, 2013, FOOD CHEM, V139, P853, DOI 10.1016/j.foodchem.2012.12.062; Nery-Diez ACC, 2010, J MED FOOD, V13, P992, DOI 10.1089/jmf.2009.0149; OhIshi S, 1997, AM J RESP CRIT CARE, V156, P1579, DOI 10.1164/ajrccm.156.5.96-11035; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pinho RA, 2006, CELL BIOL INT, V30, P848, DOI 10.1016/j.cellbi.2006.03.011; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; SALO DC, 1991, FREE RADICAL BIO MED, V11, P239, DOI 10.1016/0891-5849(91)90119-N; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Shimomura Y, 2004, J NUTR, V134, p1583S, DOI 10.1093/jn/134.6.1583S; Terblanche SE, 1999, CELL BIOL INT, V23, P749, DOI 10.1006/cbir.1999.0442; Pimenta FMV, 2006, INT DAIRY J, V16, P984, DOI 10.1016/j.idairyj.2005.12.006; Waring WS, 2006, DIABETES, V55, P3127, DOI 10.2337/db06-0283; WHITE JA, 1986, J AUTOM CHEM, V8, P170, DOI 10.1155/S1463924686000330; Wischmeyer PE, 2001, J APPL PHYSIOL, V90, P2403, DOI 10.1152/jappl.2001.90.6.2403; Zhang QX, 2012, BIOTECHNOL LETT, V34, P2001, DOI 10.1007/s10529-012-1017-1	39	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e83437	10.1371/journal.pone.0083437	http://dx.doi.org/10.1371/journal.pone.0083437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465380	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500005
J	Feng, H; Hu, GQ; Wang, HL; Liang, M; Liang, HR; Guo, H; Zhao, PS; Yang, YJ; Zheng, XX; Zhang, ZF; Zhao, YK; Gao, YW; Yang, ST; Xia, XZ				Feng, Hao; Hu, Gui-qiu; Wang, Hua-lei; Liang, Meng; Liang, Hongru; Guo, He; Zhao, Pingsen; Yang, Yu-jiao; Zheng, Xue-xing; Zhang, Zhi-fang; Zhao, Yong-kun; Gao, Yu-wei; Yang, Song-tao; Xia, Xian-zhu			Canine Parvovirus VP2 Protein Expressed in Silkworm Pupae Self-Assembles into Virus-Like Particles with High Immunogenicity	PLOS ONE			English	Article							CYTOTOXIC T-CELLS; NEUTRALIZING ANTIBODIES; FOREIGN EPITOPES; DENDRITIC CELLS; SURFACE-ANTIGEN; CLADE-A; VACCINE; RESPONSES; INFECTION; MICE	The VP2 structural protein of parvovirus can produce virus-like particles (VLPs) by a self-assembly process in vitro, making VLPs attractive vaccine candidates. In this study, the VP2 protein of canine parvovirus (CPV) was expressed using a baculovirus expression system and assembled into parvovirus-like particles in insect cells and pupae. Electron micrographs of VLPs showed that they were very similar in size and morphology when compared to the wild-type parvovirus. The immunogenicity of the VLPs was investigated in mice and dogs. Mice immunized intramuscularly with purified VLPs, in the absence of an adjuvant, elicited CD4(+) and CD8(+) T cell responses and were able to elicit a neutralizing antibody response against CPV, while the oral administration of raw homogenates containing VLPs to the dogs resulted in a systemic immune response and long-lasting immunity. These results demonstrate that the CPV-VLPs stimulate both cellular and humoral immune responses, and so CPV-VLPs may be a promising candidate vaccine for the prevention of CPV-associated disease.	[Feng, Hao; Wang, Hua-lei; Liang, Hongru; Zheng, Xue-xing; Zhao, Yong-kun; Gao, Yu-wei; Yang, Song-tao; Xia, Xian-zhu] Acad Mil Med Sci, Inst Mil Vet, Changchun, Jilin Province, Peoples R China; [Hu, Gui-qiu; Liang, Meng; Guo, He; Yang, Yu-jiao] Jilin Univ, Div Agr, Coll Anim Sci & Vet Med, Changchun 130023, Jilin Province, Peoples R China; [Hu, Gui-qiu] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin Province, Peoples R China; [Zhao, Pingsen] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing, Peoples R China; [Zhao, Pingsen] Peking Union Med Coll, Beijing, Peoples R China; [Zhang, Zhi-fang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Academy of Military Medical Sciences - China; Jilin University; Jilin Agricultural University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Yang, ST (corresponding author), Acad Mil Med Sci, Inst Mil Vet, Changchun, Jilin Province, Peoples R China.	yst610223@hotmail.com; xiaxianzhu@gmail.com	Wang, Hualei/S-7920-2018; Zhao, Pingsen/GON-6370-2022	Wang, Hualei/0000-0001-8008-3878; Feng, Hao/0000-0001-6873-1174	Special Fund for Agri-scientific Research in the Public Interest [201303042]	Special Fund for Agri-scientific Research in the Public Interest	This work was supported by the Special Fund for Agri-scientific Research in the Public Interest (No. 201303042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonis AFG, 2006, VACCINE, V24, P5481, DOI 10.1016/j.vaccine.2006.03.089; Appel JJG, 1979, VET REC, V105, P156; Buonaguro L, 2007, VACCINE, V25, P5968, DOI 10.1016/j.vaccine.2007.05.052; Buonaguro L, 2006, J VIROL, V80, P9134, DOI 10.1128/JVI.00050-06; Buonaguro L, 2005, J VIROL, V79, P7059, DOI 10.1128/JVI.79.11.7059-7067.2005; Buonaguro L, 2002, ANTIVIR RES, V54, P189, DOI 10.1016/S0166-3542(02)00004-9; Buonaguro L, 2009, J VIROL, V83, P304, DOI 10.1128/JVI.01606-08; BUONAVOGLIA C, 1983, ZBL VET MED B, V30, P526; CARMICHAEL LE, 1980, AM J VET RES, V41, P784; Chalmers WSK, 1999, VET MICROBIOL, V69, P41, DOI 10.1016/S0378-1135(99)00085-1; CHANG SF, 1992, J VIROL, V66, P6858, DOI 10.1128/JVI.66.12.6858-6867.1992; Feng H, 2011, VET MICROBIOL, V154, P49, DOI 10.1016/j.vetmic.2011.06.022; Gamvrellis A, 2004, IMMUNOL CELL BIOL, V82, P506, DOI 10.1111/j.0818-9641.2004.01271.x; Kato T, 2010, APPL MICROBIOL BIOT, V85, P459, DOI 10.1007/s00253-009-2267-2; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Madalinski K, 2001, VACCINE, V20, P92, DOI 10.1016/S0264-410X(01)00312-7; Maranga Luis, 2002, Adv Biochem Eng Biotechnol, V74, P183; MCCANCE DJ, 1977, INFECT IMMUN, V18, P196, DOI 10.1128/IAI.18.1.196-202.1977; Murata K, 2003, P NATL ACAD SCI USA, V100, P6753, DOI 10.1073/pnas.1131929100; Muzyczka N., 2001, FIELDS VIROLOGY, P2327; NATHANSON N, 1995, AM J EPIDEMIOL, V142, P109, DOI 10.1093/oxfordjournals.aje.a117611; Paliard X, 2000, AIDS RES HUM RETROV, V16, P273, DOI 10.1089/088922200309368; POLLOCK RVH, 1982, CORNELL VET, V72, P103; ROY P, 1992, VACCINE, V10, P28, DOI 10.1016/0264-410X(92)90415-G; ROY P, 1994, VACCINE, V12, P805, DOI 10.1016/0264-410X(94)90289-5; Schirmbeck R, 1996, INTERVIROLOGY, V39, P111, DOI 10.1159/000150482; Sedlik C, 1997, P NATL ACAD SCI USA, V94, P7503, DOI 10.1073/pnas.94.14.7503; Tacket CO, 2003, CLIN IMMUNOL, V108, P241, DOI 10.1016/S1521-6616(03)00120-7; Truyen U, 2006, VET MICROBIOL, V117, P9, DOI 10.1016/j.vetmic.2006.04.003; Warfield KL, 2003, P NATL ACAD SCI USA, V100, P15889, DOI 10.1073/pnas.2237038100; Woo WP, 2006, J VIROL, V80, P3975, DOI 10.1128/JVI.80.8.3975-3984.2006; Wu XF, 2004, J BIOTECHNOL, V111, P253, DOI 10.1016/j.jbiotec.2004.04.016; Yule TD, 1997, VACCINE, V15, P720, DOI 10.1016/S0264-410X(96)00232-0	33	25	29	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e79575	10.1371/journal.pone.0079575	http://dx.doi.org/10.1371/journal.pone.0079575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465364	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000001
J	Fogelson, B; Mogilner, A				Fogelson, Ben; Mogilner, Alex			Computational Estimates of Membrane Flow and Tension Gradient in Motile Cells	PLOS ONE			English	Article							LEADING-EDGE; TETHER FORMATION; PLASMA-MEMBRANE; LIPID FLOW; ACTIN; SHAPE; ENDOCYTOSIS; MODULATION; EXOCYTOSIS; DIFFUSION	All parts of motile cells, including the plasma membrane, have to translocate in the direction of locomotion. Both directed intracellular membrane transport coupled with polarized endo- and exocytosis and fluid flow in the plane of the plasma membrane can contribute to this overall plasma membrane translocation. It remains unclear how strong a force is required to generate this flow. We numerically solve Stokes equations for the viscous membrane flow across a flat plasma membrane surface in the presence of transmembrane proteins attached to the cytoskeleton and find the membrane tension gradient associated with this flow. This gradient is sensitive to the size and density of the transmembrane proteins attached to the cytoskeleton and can become significant enough to slow down cell movement. We estimate the influence of intracellular membrane transport and actin growth and contraction on the tension gradient, and discuss possible 'tank tread' flow at ventral and dorsal surfaces.	[Mogilner, Alex] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; Univ Calif Davis, Dept Math, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Mogilner, A (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	mogilner@math.ucdavis.edu		Fogelson, Ben/0000-0002-3606-3340	National Institute of Health; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068952] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was funded by the National Institute of Health and the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Velasco C, 1999, MOL BIOL CELL, V10, P4419, DOI 10.1091/mbc.10.12.4419; Anderson KI, 1996, J CELL BIOL, V134, P1209, DOI 10.1083/jcb.134.5.1209; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Bray D., 2000, CELL MOVEMENTS MOL M; Bretscher MS, 1998, CURR OPIN CELL BIOL, V10, P537, DOI 10.1016/S0955-0674(98)80070-7; Carman PC, 1937, T I CHEM ENG-LOND, V15, P150; Chizmadzhev YA, 1999, BIOPHYS J, V76, P2951, DOI 10.1016/S0006-3495(99)77450-3; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Cooper GM, 2000, CELL MOL APPROACH; Cortez R, 2001, SIAM J SCI COMPUT, V23, P1204, DOI 10.1137/S106482750038146X; Dai J, 1995, COLD SPRING HARB SYM, V60, P567, DOI 10.1101/SQB.1995.060.01.060; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; DAI JW, 1995, CELL, V83, P693; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; EVANS EA, 1979, CRC CR REV BIOM ENG, V3, P181; Fletcher SJ, 2010, TRENDS CELL BIOL, V20, P71, DOI 10.1016/j.tcb.2009.11.006; Fournier MF, 2010, J CELL BIOL, V188, P287, DOI 10.1083/jcb.200906139; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gauthier NC, 2011, P NATL ACAD SCI USA, V108, P14467, DOI 10.1073/pnas.1105845108; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Jiang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055408; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Keren K, 2011, EUR BIOPHYS J BIOPHY, V40, P1013, DOI 10.1007/s00249-011-0741-0; KUCIK DF, 1989, NATURE, V340, P315, DOI 10.1038/340315a0; KUCIK DF, 1990, J CELL BIOL, V111, P1617, DOI 10.1083/jcb.111.4.1617; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; LEE J, 1990, SCIENCE, V247, P1229, DOI 10.1126/science.2315695; Lieber AD, 2013, CURR BIOL, V23, P1409, DOI 10.1016/j.cub.2013.05.063; Mohl C, 2012, J CELL SCI, V125, P155, DOI 10.1242/jcs.090746; Ofera N, 2011, P NATL ACAD SCI USA, V108, P20394, DOI 10.1073/pnas.1105333108; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Schweitzer Y, 2013, SOFT MATTER, V9, P5186, DOI 10.1039/c3sm50723h; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7; SHEETZ MP, 1990, CELL, V61, P231, DOI 10.1016/0092-8674(90)90804-N; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Sohn JS, 2010, J COMPUT PHYS, V229, P119, DOI 10.1016/j.jcp.2009.09.017; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Tajparast M, 2009, BBA-BIOMEMBRANES, V1788, P1009, DOI 10.1016/j.bbamem.2009.01.019; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Traynor D, 2007, J CELL SCI, V120, P2318, DOI 10.1242/jcs.007732; WAUGH RE, 1982, BIOPHYS J, V38, P29, DOI 10.1016/S0006-3495(82)84527-X; Weisswange I, 2005, J CELL SCI, V118, P4375, DOI 10.1242/jcs.02551; Wessels D, 2000, J CELL SCI, V113, P21	51	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84524	10.1371/journal.pone.0084524	http://dx.doi.org/10.1371/journal.pone.0084524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465414	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000014
J	Zhou, Z; Yu, FL; Buchanan, A; Fu, YY; Campos, M; Wu, KK; Chambless, LE; Folsom, AR; Boerwinkle, E; Dong, JF				Zhou, Zhou; Yu, Fuli; Buchanan, Ashley; Fu, Yuanyuan; Campos, Marco; Wu, Kenneth K.; Chambless, Lloyd E.; Folsom, Aaron R.; Boerwinkle, Eric; Dong, Jing-fei			Possible Race and Gender Divergence in Association of Genetic Variations with Plasma von Willebrand Factor: A Study of ARIC and 1000 Genome Cohorts	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; CORONARY-HEART-DISEASE; ABO BLOOD-GROUP; FACTOR-VIII; ATHEROSCLEROSIS RISK; HEMOSTATIC FACTORS; DIAGNOSIS; LOCUS	The synthesis, secretion and clearance of von Willebrand factor (VWF) are regulated by genetic variations in coding and promoter regions of the VWF gene. We have previously identified 19 single nucleotide polymorphisms (SNPs), primarily in introns that are associated with VWF antigen levels in subjects of European descent. In this study, we conducted race by gender analyses to compare the association of VWF SNPs with VWF antigen among 10,434 healthy Americans of European (EA) or African (AA) descent from the Atherosclerosis Risk in Communities (ARIC) study. Among 75 SNPs analyzed, 13 and 10 SNPs were associated with VWF antigen levels in EA male and EA female subjects, respectively. However, only one SNP (RS1063857) was significantly associated with VWF antigen in AA females and none was in AA males. Haplotype analysis of the ARIC samples and studying racial diversities in the VWF gene from the 1000 genomes database suggest a greater degree of variations in the VWF gene in AA subjects as compared to EA subjects. Together, these data suggest potential race and gender divergence in regulating VWF expression by genetic variations.	[Zhou, Zhou; Fu, Yuanyuan] CAMS, Fuwai Hosp, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Zhou, Zhou; Fu, Yuanyuan] PUMC, Fuwai Hosp, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Yu, Fuli] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Human & Mol Genet, Houston, TX 77030 USA; [Yu, Fuli] Tianjin Med Univ, Gen Hosp, Inst Neurol, Tianjin, Peoples R China; [Buchanan, Ashley; Chambless, Lloyd E.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Campos, Marco] Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA; [Wu, Kenneth K.] Natl Hlth Res Inst, Taipei, Taiwan; [Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Boerwinkle, Eric] Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA; [Dong, Jing-fei] Puget Sound Blood Ctr, Puget Sound Blood Res Inst, Seattle, WA 98104 USA; [Dong, Jing-fei] Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Baylor College of Medicine; Tianjin Medical University; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; National Health Research Institutes - Taiwan; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Puget Sound Blood Center; University of Washington; University of Washington Seattle	Dong, JF (corresponding author), Puget Sound Blood Ctr, Puget Sound Blood Res Inst, Seattle, WA 98104 USA.	jfdong@psbc.org			ARIC [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; National Heart, Lung, and Blood Institute [HL71895, HL085769]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055021, N01HC055016, N01HC055018, N01HC055020, N01HC055022, N01HC055015, N01HC055019] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071895, R01HL085769] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	ARIC; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by the ARIC contracts (N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022) and the grants HL71895 and HL085769 from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellissimo DB, 2012, BLOOD, V119, P2135, DOI 10.1182/blood-2011-10-384610; Bongers TN, 2006, STROKE, V37, P2672, DOI 10.1161/01.STR.0000244767.39962.f7; Campos M, 2012, BLOOD, V119, P1929, DOI 10.1182/blood-2011-10-383661; Campos M, 2011, BLOOD, V117, P5224, DOI 10.1182/blood-2010-08-300152; CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380; FOLSOM A R, 1992, Ethnicity and Disease, V2, P35; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; Franchini M, 2006, ANN HEMATOL, V85, P415, DOI 10.1007/s00277-006-0085-5; Franchini M, 2008, SEMIN THROMB HEMOST, V34, P663, DOI 10.1055/s-0028-1104545; GILL JC, 1987, BLOOD, V69, P1691; Goodeve AC, 2010, BLOOD REV, V24, P123, DOI 10.1016/j.blre.2010.03.003; GREEN D, 1994, ARTERIOSCLER THROMB, V14, P686, DOI 10.1161/01.ATV.14.5.686; Johnsen JM, 2013, BLOOD, V122, P590, DOI 10.1182/blood-2013-02-485094; Keightley AM, 1999, BLOOD, V93, P4277, DOI 10.1182/blood.V93.12.4277.412k03_4277_4283; Lacquemant C, 2000, KIDNEY INT, V57, P1437, DOI 10.1046/j.1523-1755.2000.00988.x; Miller CH, 2001, AM J HEMATOL, V67, P125, DOI 10.1002/ajh.1090; Morange PE, 2004, CIRCULATION, V109, P1343, DOI 10.1161/01.CIR.0000120705.55512.EC; Pareti FI, 2000, CIRCULATION, V102, P1290, DOI 10.1161/01.CIR.102.11.1290; SHIMA M, 1995, VOX SANG, V68, P236, DOI 10.1111/j.1423-0410.1995.tb02579.x; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Souto JC, 2000, ARTERIOSCL THROM VAS, V20, P2024, DOI 10.1161/01.ATV.20.8.2024; TAKAHASHI Y, 1987, BLOOD, V70, P1679; VERWEIJ CL, 1987, EMBO J, V6, P2885, DOI 10.1002/j.1460-2075.1987.tb02591.x; Vischer UM, 1998, BLOOD, V91, P118, DOI 10.1182/blood.V91.1.118.118_118_127; Wang QY, 2013, J THROMB HAEMOST, V11, P261, DOI 10.1111/jth.12093; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	26	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84810	10.1371/journal.pone.0084810	http://dx.doi.org/10.1371/journal.pone.0084810			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465435	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000016
J	Evangelista, D; Cardona, G; Guenther-Gleason, E; Huynh, T; Kwong, A; Marks, D; Ray, N; Tisbe, A; Tse, K; Koehl, M				Evangelista, Dennis; Cardona, Griselda; Guenther-Gleason, Eric; Huynh, Tony; Kwong, Austin; Marks, Dylan; Ray, Neil; Tisbe, Adrian; Tse, Kyle; Koehl, Mimi			Aerodynamic Characteristics of a Feathered Dinosaur Measured Using Physical Models. Effects of Form on Static Stability and Control Effectiveness	PLOS ONE			English	Article							4-WINGED DINOSAURS; JIUFOTANG FORMATION; LONG FEATHERS; EVOLUTION; CHINA; ARCHAEOPTERYX; MICRORAPTOR; PERFORMANCE; FLIGHT; THEROPOD	We report the effects of posture and morphology on the static aerodynamic stability and control effectiveness of physical models based on the feathered dinosaur, Microraptor gui, from the Cretaceous of China. Postures had similar lift and drag coefficients and were broadly similar when simplified metrics of gliding were considered, but they exhibited different stability characteristics depending on the position of the legs and the presence of feathers on the legs and the tail. Both stability and the function of appendages in generating maneuvering forces and torques changed as the glide angle or angle of attack were changed. These are significant because they represent an aerial environment that may have shifted during the evolution of directed aerial descent and other aerial behaviors. Certain movements were particularly effective ( symmetric movements of the wings and tail in pitch, asymmetric wing movements, some tail movements). Other appendages altered their function from creating yaws at high angle of attack to rolls at low angle of attack, or reversed their function entirely. While M. gui lived after Archaeopteryx and likely represents a side experiment with feathered morphology, the general patterns of stability and control effectiveness suggested from the manipulations of forelimb, hindlimb and tail morphology here may help understand the evolution of flight control aerodynamics in vertebrates. Though these results rest on a single specimen, as further fossils with different morphologies are tested, the findings here could be applied in a phylogenetic context to reveal biomechanical constraints on extinct flyers arising from the need to maneuver.	[Evangelista, Dennis; Guenther-Gleason, Eric; Huynh, Tony; Marks, Dylan; Tisbe, Adrian; Koehl, Mimi] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Cardona, Griselda; Tse, Kyle] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Kwong, Austin; Ray, Neil] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Evangelista, D (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	devangel77b@gmail.com	Evangelista, Dennis/N-4434-2013	Evangelista, Dennis/0000-0002-6565-8300; Huynh, Tony/0000-0003-2964-1795	National Science Foundation (NSF) Minority Graduate Research Fellowship; NSF Integrative Graduate Education and Research Traineeship (IGERT) [DGE-0903711]; Virginia G. and Robert E. Gill Chair	National Science Foundation (NSF) Minority Graduate Research Fellowship(National Science Foundation (NSF)); NSF Integrative Graduate Education and Research Traineeship (IGERT)(National Science Foundation (NSF)); Virginia G. and Robert E. Gill Chair	The work was funded in part by a National Science Foundation (NSF) Minority Graduate Research Fellowship (to DE), NSF Integrative Graduate Education and Research Traineeship (IGERT) # DGE-0903711 (to R Full, MK, R Dudley, and R Fearing), and the Virginia G. and Robert E. Gill Chair (to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DE, 2010, P NATL ACAD SCI USA, V107, P2972, DOI 10.1073/pnas.0911852107; Allen V, 2013, NATURE, V497, P104, DOI 10.1038/nature12059; Anderson JD., 2017, FUNDAMENTALS AERODYN; Angst D, 2011, NATURWISSENSCHAFTEN, P1; Beebe CW, 1915, ZOOLOGICA, V2, P39; Benton MJ, 1997, VERTEBRATE PALEONTOL; Byrnes G, 2011, INTEGR COMP BIOL, V51, P991, DOI 10.1093/icb/icr069; Cardona G, 2011, AM SOC BIOMECH; Chatterjee S, 2003, NATURWISSENSCHAFTEN, V90, P27, DOI 10.1007/s00114-002-0385-0; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; CHEER AYL, 1987, J THEOR BIOL, V129, P17, DOI 10.1016/S0022-5193(87)80201-1; COLBERT EDWIN H., 1962, AMER MUS NOVITATES, V2076, P1; Davis M, 2008, 4 WINGED DIANOSAUR N; Duan S.-Y., 1995, WOOD ANATOMY RES P I, P166; Dudley R, 2011, INTEGR COMP BIOL, V51, P926, DOI 10.1093/icb/icr002; Dyke G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3489; EMERSON SB, 1990, EVOLUTION, V44, P2153, DOI 10.1111/j.1558-5646.1990.tb04320.x; EMERSON SB, 1990, EVOLUTION, V44, P1931, DOI 10.1111/j.1558-5646.1990.tb04300.x; Etkin B., 1996, DYNAMICS FLIGHT STAB, V3rd; Evangelista D. J., 2013, THESIS U CALIFORNIA; Evangelista DJ, 2012, SO INT COMP BIOL ANN; Fish FE, 2006, ANNU REV FLUID MECH, V38, P193, DOI 10.1146/annurev.fluid.38.050304.092201; GANS C, 1987, PALEOBIOLOGY, V13, P415; Gatesy SM, 1996, EVOLUTION, V50, P2037, DOI 10.1111/j.1558-5646.1996.tb03590.x; Godefroit P, 2013, NATURE, V498, P359, DOI 10.1038/nature12168; Habib M, 2012, SOC VERT PAL ANN M 2; Hall J, 2012, SOC VERTEBRATE PALEO; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019790; Hedenstrom A, 2001, J EXP BIOL, V204, P1167; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; HEPTONSTALL WB, 1970, NATURE, V228, P185, DOI 10.1038/228185a0; Hoerner SF, 1993, FLUID DYNAMIC DRAG; Hone DWE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009223; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Huynh T, 2013, SOC INT COMP BIOL AN; Huynh T, 2011, SOC VERTEBRATE PALEO; JENKINS FA, 1984, J MORPHOL, V182, P197, DOI 10.1002/jmor.1051820207; Jones AR, 2008, J AIRCRAFT, V45, P342, DOI 10.2514/1.33001; Jusufi A, 2008, P NATL ACAD SCI USA, V105, P4215, DOI 10.1073/pnas.0711944105; Koehl MAR, 2011, INTEGR COMP BIOL, V51, P1002, DOI 10.1093/icb/icr112; KOEHL MAR, 1981, LIMNOL OCEANOGR, V26, P1062, DOI 10.4319/lo.1981.26.6.1062; KUNDU P.K., 2004, FLUID MECH-SOV RES; Kwong A, 2013, SOC INT COMP BIOL AN; Lauder GV, 2002, INTEGR COMP BIOL, V42, P1009, DOI 10.1093/icb/42.5.1009; Lehmann FO, 2007, J EXP BIOL, V210, P1362, DOI 10.1242/jeb.02746; Liem K.F., 2000, FUNCTIONAL ANATOMY V; Lighthill J., 1975, P423; Lippincott WA, 1920, AM NAT, V54, P535, DOI 10.1086/279784; Longrich N, 2006, PALEOBIOLOGY, V32, P417, DOI 10.1666/04014.1; McCay MG, 2003, BIOTROPICA, V35, P94, DOI 10.1646/0006-3606(2003)035[0094:WUTRFC]2.0.CO;2; McCay MG, 2001, J EXP BIOL, V204, P2817; McCay MG, 2001, THESIS U CALIFORNIA; McCormick B.W., 1995, AERODYNAMICS AERONAU; McMasters J. H., 1979, NASA LANGLEY RES C 1, V1; Munk JD, 2011, THESIS U CALIFORNIA; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; O'Connor JK., 2011, LIVING DINOSAURS EVO, P39, DOI [10.1002/9781119990475.ch3, DOI 10.1002/9781119990475.CH3]; Padian K, 2003, BIOSCIENCE, V53, P450; Park H, 2010, J EXP BIOL, V213, P3269, DOI 10.1242/jeb.046052; Peterson K, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046008; Peterson K, 2011, SO INT COMP BIOL ANN; Peterson K, 2013, SOC INT COMP BIOL AN; Peterson K, 2011, IEEE INT C INT ROBOT; Phillips WF, 2004, MECH FLIGHT; R Core Team, 2016, R FDN STAT COMP; Reynolds O, 1875, COLLECTED PAPERS MEC, V1903, P1; Saunders G, 1977, DYNAMICS HELICOPTER; Shapiro AH, 1961, SHAPE FLOW FLUID DYN; Smith J. M., 1953, New Biol, VNo. 14, P64; Standen EM, 2007, J EXP BIOL, V210, P325, DOI 10.1242/jeb.02661; Standen EM, 2005, J EXP BIOL, V208, P2753, DOI 10.1242/jeb.01706; Stengel R.F., 2004, FLIGHT DYNAMICS; Tedrake R., 2009, 14 INT S ROB RES LUC; Tisbe A, 2011, SOC INT COMP BIOL AN; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Waldrop LD, 2012, THESIS U CALIFORNIA; Wang JK, 2005, J EXP BIOL, V208, P3785, DOI 10.1242/jeb.01852; Wang XL, 2008, P NATL ACAD SCI USA, V105, P1983, DOI 10.1073/pnas.0707728105; Wang XL, 2003, CHINESE SCI BULL, V48, P16, DOI 10.1360/03tb9003; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2005, NATURE, V438, pE3, DOI 10.1038/nature04355; Xu X, 2004, J VERTEBR PALEONTOL, V24, p251A, DOI DOI 10.1671/21; Xu X, 2006, INTEGR ZOOL, V1, P4, DOI 10.1111/j.1749-4877.2006.00004.x; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Zeng Y, THESI U CALIFORNIA B; Zhang FC, 2004, NATURE, V431, P925, DOI 10.1038/431925a; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753; Zhou ZH, 2003, NATURWISSENSCHAFTEN, V90, P220, DOI 10.1007/s00114-003-0416-5; Zhou ZH, 2004, CHINESE SCI BULL, V49, P754, DOI 10.1360/04wd0120; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhou Zhong-He, 2006, Vertebrata Palasiatica, V44, P74	94	16	16	0	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85203	10.1371/journal.pone.0085203	http://dx.doi.org/10.1371/journal.pone.0085203			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454820	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100066
J	Kota, S; Charaka, VK; Ringgaard, S; Waldor, MK; Misra, HS				Kota, Swathi; Charaka, Vijaya K.; Ringgaard, Simon; Waldor, Matthew K.; Misra, Hari S.			PprA Contributes to Deinococcus radiodurans Resistance to Nalidixic Acid, Genome Maintenance after DNA Damage and Interacts with Deinococcal Topoisomerases	PLOS ONE			English	Article							RADIATION-RESISTANCE; SIGNAL-TRANSDUCTION; KINASE-ACTIVITY; CELL-DIVISION; PROTEIN; BACTERIUM; FAMILY; REPAIR; RADIORESISTANCE; MECHANISMS	PprA is known to contribute to Deinococcus radiodurans' remarkable capacity to survive a variety of genotoxic assaults. The molecular bases for PprA's role(s) in the maintenance of the damaged D. radiodurans genome are incompletely understood, but PprA is thought to promote D. radiodurans's capacity for DSB repair. PprA is found in a multiprotein DNA processing complex along with an ATP type DNA ligase, and the D. radiodurans toposiomerase IB (DraTopoIB) as well as other proteins. Here, we show that PprA is a key contributor to D. radiodurans resistance to nalidixic acid (Nal), an inhibitor of topoisomerase II. Growth of wild type D. radiodurans and a pprA mutant were similar in the absence of exogenous genotoxic insults; however, the pprA mutant exhibited marked growth delay and a higher frequency of anucleate cells following treatment with DNA-damaging agents. We show that PprA interacts with both DraTopoIB and the Gyrase A subunit (DraGyrA) in vivo and that purified PprA enhances DraTopoIB catalysed relaxation of supercoiled DNA. Thus, besides promoting DNA repair, our findings suggest that PprA also contributes to preserving the integrity of the D. radiodurans genome following DNA damage by interacting with DNA topoisomerases and by facilitating the actions of DraTopoIB.	[Kota, Swathi; Charaka, Vijaya K.; Misra, Hari S.] Bhabha Atom Res Ctr, Div Mol Biol, Mumbai 400085, Maharashtra, India; [Charaka, Vijaya K.; Ringgaard, Simon; Waldor, Matthew K.; Misra, Hari S.] Harvard Univ, Brigham & Womens Hosp, Dept Microbiol & Immunobiol, Sch Med,Div Infect Dis, Boston, MA 02115 USA; [Charaka, Vijaya K.; Ringgaard, Simon; Waldor, Matthew K.; Misra, Hari S.] HHMI, Boston, MA USA	Bhabha Atomic Research Center (BARC); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Misra, HS (corresponding author), Bhabha Atom Res Ctr, Div Mol Biol, Mumbai 400085, Maharashtra, India.	hsmisra@barc.gov.in	Charaka, Vijaya/Q-5198-2019	Misra, Hari/0000-0002-9349-1229; Ringgaard, Simon/0000-0002-4980-5964; Waldor, Matthew/0000-0003-1843-7000	Bhabha Atomic Research Centre; Harvard Medical School; HHMI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347] Funding Source: NIH RePORTER	Bhabha Atomic Research Centre; Harvard Medical School; HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Bhabha Atomic Research Centre, Harvard Medical School and HHMI. HSM is grateful to Fulbright Commission, United States- India Education Foundation (USIEF) for Fulbright-Nehru Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NM, 2009, NUCLEIC ACIDS RES, V37, P693, DOI 10.1093/nar/gkn1009; Battista JR, 2000, CURR BIOL, V10, pR204, DOI 10.1016/S0960-9822(00)00353-5; Battista JR, 2001, CRYOBIOLOGY, V43, P133, DOI 10.1006/cryo.2001.2357; Blasius M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-69; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Charaka VK, 2012, J BACTERIOL, V194, P5739, DOI 10.1128/JB.00610-12; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Das AD, 2012, BBA-GEN SUBJECTS, V1820, P1052, DOI 10.1016/j.bbagen.2012.03.014; Devigne A, 2013, DNA REPAIR, V12, P265, DOI 10.1016/j.dnarep.2013.01.004; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Garinther WI, 1997, MOL CELL BIOL, V17, P3520, DOI 10.1128/MCB.17.7.3520; Hiraku Y, 2000, ARCH BIOCHEM BIOPHYS, V382, P211, DOI 10.1006/abbi.2000.2025; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kota S, 2006, APPL MICROBIOL BIOT, V72, P790, DOI 10.1007/s00253-006-0340-7; Kota S, 2010, BIOCHEM CELL BIOL, V88, P783, DOI [10.1139/O10-075, 10.1139/o10-075]; Kota S, 2008, BIOCHEM CELL BIOL, V86, P448, DOI [10.1139/O08-122, 10.1139/o08-122]; Krogh BO, 2002, P NATL ACAD SCI USA, V99, P1853, DOI 10.1073/pnas.032613199; Lecointe F, 2004, GENE, V336, P25, DOI 10.1016/j.gene.2004.04.006; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Misra HS, 2006, MOL MICROBIOL, V59, P1308, DOI 10.1111/j.1365-2958.2005.05005.x; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Narumi I, 2003, TRENDS MICROBIOL, V11, P422, DOI 10.1016/S0966-842X(03)00204-X; Rajpurohit YS, 2008, J BACTERIOL, V190, P3948, DOI 10.1128/JB.00026-08; Rajpurohit YS, 2013, INT J BIOCHEM CELL B, V45, P2541, DOI 10.1016/j.biocel.2013.08.011; Ringgaard S, 2011, GENE DEV, V25, P1544, DOI 10.1101/gad.2061811; Sambrook J, 2001, MOL CLONING LAB MANU; Schafer M, 2000, PHOTOCHEM PHOTOBIOL, V71, P514, DOI 10.1562/0031-8655(2000)071<0514:SSOPIT>2.0.CO;2; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Surette MG, 1996, J BIOL CHEM, V271, P939, DOI 10.1074/jbc.271.2.939; Taneja B, 2006, EMBO J, V25, P398, DOI 10.1038/sj.emboj.7600922; Tian B, 2010, TRENDS MICROBIOL, V18, P512, DOI 10.1016/j.tim.2010.07.007; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003; Zimmerman JM, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-17	40	29	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85288	10.1371/journal.pone.0085288	http://dx.doi.org/10.1371/journal.pone.0085288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454836	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100069
J	Moon, J; Lee, ST; Choi, J; Jung, KH; Yang, H; Khalid, A; Kim, JM; Park, KI; Shin, JW; Ban, JJ; Yi, GS; Lee, SK; Jeon, D; Chu, K				Moon, Jangsup; Lee, Soon-Tae; Choi, Jiye; Jung, Keun-Hwa; Yang, Hyunwoo; Khalid, Arshi; Kim, Jeong-Min; Park, Kyung-Il; Shin, Jung-Won; Ban, Jae-Jun; Yi, Gwan-Su; Lee, Sang Kun; Jeon, Daejong; Chu, Kon			Unique Behavioral Characteristics and microRNA Signatures in a Drug Resistant Epilepsy Model	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; RAT PILOCARPINE MODEL; ELEVATED PLUS-MAZE; SPONTANEOUS SEIZURES; PSYCHIATRIC COMORBIDITY; MULTIDRUG-RESISTANCE; STATUS EPILEPTICUS; P-GLYCOPROTEIN; MOUSE MODEL; LEVETIRACETAM	Background: Pharmacoresistance is a major issue in the treatment of epilepsy. However, the mechanism underlying pharmacoresistance to antiepileptic drugs (AEDs) is still unclear, and few animal models have been established for studying drug resistant epilepsy (DRE). In our study, spontaneous recurrent seizures (SRSs) were investigated by video-EEG monitoring during the entire procedure. Methods/Principal Findings: In the mouse pilocarpine-induced epilepsy model, we administered levetiracetam (LEV) and valproate (VPA) in sequence. AED-responsive and AED-resistant mice were naturally selected after 7-day treatment of LEV and VPA. Behavioral tests (open field, object exploration, elevated plus maze, and light-dark transition test) and a microRNA microarray test were performed. Among the 37 epileptic mice with SRS, 23 showed significantly fewer SRSs during administration of LEV (n = 16, LEV sensitive (LS) group) or VPA (n = 7, LEV resistant/VPA sensitive (LRVS) group), while 7 epileptic mice did not show any amelioration with either of the AEDs (n = 7, multidrug resistant (MDR) group). On the behavioral assessment, MDR mice displayed distinctive behaviors in the object exploration and elevated plus maze tests, which were not observed in the LS group. Expression of miRNA was altered in LS and MDR groups, and we identified 4 miRNAs (miR-206, miR-374, miR-468, and miR-142-5p), which were differently modulated in the MDR group versus both control and LS groups. Conclusion: This is the first study to identify a pharmacoresistant subgroup, resistant to 2 AEDs, in the pilocarpine-induced epilepsy model. We hypothesize that modulation of the identified miRNAs may play a key role in developing pharmacoresistance and behavioral alterations in the MDR group.	[Choi, Jiye; Yang, Hyunwoo; Khalid, Arshi; Yi, Gwan-Su; Jeon, Daejong] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp,Biomed Res Inst, Lab Neurotherapeut,Comprehens Epilepsy Ctr,Dept N, Seoul, South Korea; [Choi, Jiye; Yang, Hyunwoo; Khalid, Arshi; Yi, Gwan-Su; Jeon, Daejong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kim, Jeong-Min] Chung Ang Univ, Coll Med, Chung Ang Univ Hosp, Dept Neurol, Seoul 156756, South Korea; [Park, Kyung-Il] Inje Univ, Coll Med, Seoul Paik Hosp, Dept Neurol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Korea Advanced Institute of Science & Technology (KAIST); Chung Ang University; Chung Ang University Hospital; Inje University	Jeon, D (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	clark@kaist.ac.kr; stemcell.snu@gmail.com	Yi, Gwan-Su/A-7896-2011; Jeon, Daejong/C-1814-2011	Yi, Gwan-Su/0000-0003-0012-6546; Choi, Jiye/0000-0001-8719-5151; Kim, Jeong-Min/0000-0001-7213-5527; Lee, Soon-Tae/0000-0003-4767-7564; Park, Kyung-Il/0000-0001-8064-6749; Moon, Jangsup/0000-0003-1282-4528; Jeon, Daejong/0000-0002-6998-7603; Jung, Keun-Hwa/0000-0003-1433-8005; Chu, Kon/0000-0001-5863-0302	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A111393]; Korea Health 21 R&D grant, Ministry of Health and Welfare, Republic of Korea [A120051]; Seoul National University Hospital Research Funds [0420120630]	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Korea Health 21 R&D grant, Ministry of Health and Welfare, Republic of Korea; Seoul National University Hospital Research Funds	This study was supported by the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A111393; K. C.) and the Korea Health 21 R&D grant, Ministry of Health and Welfare, Republic of Korea (A120051; D.J.). K. C. was supported by Seoul National University Hospital Research Funds (0420120630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes S, 2007, J PHARMACOL EXP THER, V320, P331, DOI 10.1124/jpet.106.102491; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Bethmann K, 2008, NEUROBIOL DIS, V31, P169, DOI 10.1016/j.nbd.2008.01.005; Bethmann K, 2007, EPILEPSIA, V48, P816, DOI 10.1111/j.1528-1167.2007.00980.x; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Brandt C, 2004, EPILEPSIA, V45, P1488, DOI 10.1111/j.0013-9580.2004.16904.x; CHAPMAN A, 1982, PROG NEUROBIOL, V19, P315, DOI 10.1016/0301-0082(82)90010-7; Chu K, 2008, EPILEPSIA, V49, P1723, DOI 10.1111/j.1528-1167.2008.01644.x; Chuang JC, 2007, PEDIATR RES, V61, p24R, DOI 10.1203/pdr.0b013e3180457684; Eccleston A, 2007, NATURE, V447, P395, DOI 10.1038/447395a; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; French JA, 2007, EPILEPSIA, V48, P3, DOI 10.1111/j.1528-1167.2007.00992.x; Gastens AM, 2008, EPILEPSIA, V49, P1759, DOI 10.1111/j.1528-1167.2008.01659.x; Glien M, 2002, EPILEPSIA, V43, P350, DOI 10.1046/j.1528-1157.2002.18101.x; Groticke I, 2008, EXP NEUROL, V213, P71, DOI 10.1016/j.expneurol.2008.04.036; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Hellwig S, 2012, EPILEPSY BEHAV, V23, P272, DOI 10.1016/j.yebeh.2011.12.001; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Jeon D, 2011, EPILEPSIA; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Kanner AM, 2011, EPILEPSIA, V52, P21, DOI 10.1111/j.1528-1167.2010.02907.x; Klitgaard H, 1998, EUR J PHARMACOL, V353, P191, DOI 10.1016/S0014-2999(98)00410-5; Klitgaard H, 2003, SEIZURE-EUR J EPILEP, V12, P92, DOI 10.1016/S1059131102001930; Kobow K, 2013, EPILEPSIA, V54, P41, DOI 10.1111/epi.12183; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lee ST, 2012, ANN NEUROL, V72, P269, DOI 10.1002/ana.23588; Loscher W, 2011, SEIZURE-EUR J EPILEP, V20, P359, DOI 10.1016/j.seizure.2011.01.003; Loscher W, 1999, PROG NEUROBIOL, V58, P31, DOI 10.1016/S0301-0082(98)00075-6; LOSCHER W, 1991, J PHARMACOL EXP THER, V258, P483; Motamedi G, 2003, EPILEPSY BEHAV, V4, pS25, DOI 10.1016/j.yebeh.2003.07.004; Muller CJ, 2009, EUR J PHARMACOL, V619, P15, DOI 10.1016/j.ejphar.2009.07.020; Muller CJ, 2009, EXP NEUROL, V219, P284, DOI 10.1016/j.expneurol.2009.05.035; NOYER M, 1995, EUR J PHARMACOL, V286, P137, DOI 10.1016/0014-2999(95)00436-O; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Postma T, 2000, EPILEPSIA, V41, P1514; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; RODGERS RJ, 1995, PHARMACOL BIOCHEM BE, V52, P297, DOI 10.1016/0091-3057(95)00138-M; Rogawski Michael A, 2008, Epilepsy Curr, V8, P127, DOI 10.1111/j.1535-7511.2008.00272.x; Schmidt D, 2005, EPILEPSIA, V46, P858, DOI 10.1111/j.1528-1167.2005.54904.x; Schmidt D, 2009, EPILEPSY CURR, V9, P47, DOI 10.1111/j.1535-7511.2008.01289.x; Seo J, 2013, EXP NEUROL, V241, P38, DOI 10.1016/j.expneurol.2012.11.024; Smyth MD, 2002, EPILEPSY RES, V50, P251, DOI 10.1016/S0920-1211(02)00051-7; Swinkels WAM, 2005, EPILEPSY BEHAV, V7, P37, DOI 10.1016/j.yebeh.2005.04.012; van Vliet EA, 2008, EPILEPSIA, V49, P1151, DOI 10.1111/j.1528-1167.2007.01516.x; Volk HA, 2005, BRAIN, V128, P1358, DOI 10.1093/brain/awh437	48	29	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85617	10.1371/journal.pone.0085617	http://dx.doi.org/10.1371/journal.pone.0085617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454901	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100105
J	Zhao, L; Zhang, LH; Zhang, XL; Li, ZZ; Tian, LW; Wang, YXJ				Zhao, Lin; Zhang, Lihong; Zhang, Xiaolin; Li, Zhenzhong; Tian, Linwei; Wang, Yi-Xiang J.			An Analysis of 1256 Cases of Sporadic Ruptured Cerebral Aneurysm in a Single Chinese Institution	PLOS ONE			English	Article							INTRACRANIAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; RISK-FACTORS; SIZE; LOCATION; POPULATION	Background: To review the epidemiology of sporadic ruptured cerebral aneurysm. Methods: This is a retrospective study of consecutive 1256 Chinese patients between January 2006 and January 2013, who were admitted to the Second Hospital of Hebei Medical University, China, for spontaneous subarachnoid hemorrhage due to a rupture of cerebral artery aneurysm. In 288 males and 478 females, the size of aneurysms was measured by a neuroradiologist on DSA. In 123 males and 184 females, the size of the ruptured aneurysms was not measured. The remaining patients, with 61 males and 122 females, had multiple aneurysms, and the medical record could not reliably determine the specific aneurysm responsible for the rupture. Results: In total there were 784 females and 472 males with a female/male ratio of 1.66. The female/male ratio was down to 0.50 for patients younger than 35 yrs. For both males and females, aneurysm rupture was most common during the age of 50-59 yrs. Ruptured aneurysms were mostly of 2 mm-5 mm in size (47.1%), followed by 5 mm-10 mm (39.7%). Ruptured single cerebral aneurysm occurred in anterior circulation in 95.0% of the cases, with 5.0% occurred in posterior circulation. Ruptured aneurysm most commonly occurred at posterior communicating artery (34.9%) and anterior communicating artery (29.5%). 183 cases (14.6%) had multiple aneurysms. Conclusions: With younger patients, there is a male predominance in our series. Ninety percent of patients have ruptured aneurysms less than 10 mm in size.	[Zhao, Lin] Hebei Med Univ, Hosp 2, Dept Neurosurg, Shijiazhuang, Hebei Province, Peoples R China; [Zhang, Lihong; Li, Zhenzhong] Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Hebei Province, Peoples R China; [Zhang, Xiaolin] Hebei Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Shijiazhuang, Hebei Province, Peoples R China; [Tian, Linwei] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Wang, Yi-Xiang J.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Zhang, LH (corresponding author), Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Hebei Province, Peoples R China.	lihongzhang.med@gmail.com; yixiang_wang@cuhk.edu.hk	Tian, Linwei/A-9736-2009; Wang, Yi Xiang/I-5952-2016	Tian, Linwei/0000-0002-4739-1534; Wang, Yi Xiang/0000-0001-5697-0717; Tian, Linwei/0000-0003-2240-8886				Aarhus M, 2009, ACTA NEUROCHIR, V151, P1569, DOI 10.1007/s00701-009-0316-3; Baccin CE, 2006, ACTA NEUROCHIR, V148, P1091, DOI 10.1007/s00701-006-0860-z; Baumann F, 2008, ACT NEUR S, V103, P19; Clarke G, 2005, ACTA NEUROCHIR, V147, P259, DOI 10.1007/s00701-004-0473-3; Clarke M, 2008, NEURORADIOLOGY, V50, P653, DOI 10.1007/s00234-008-0411-9; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Dickey P, 1994, Conn Med, V58, P583; Ellamushi HE, 2001, J NEUROSURG, V94, P728, DOI 10.3171/jns.2001.94.5.0728; Forget TR, 2001, NEUROSURGERY, V49, P1322, DOI 10.1097/00006123-200112000-00006; Howng Shen-Long, 1995, Journal of the Formosan Medical Association, V94, pS73; Juvela S, 2000, STROKE, V31, P392, DOI 10.1161/01.STR.31.2.392; Juvela S, 2008, J NEUROSURG, V108, P1052, DOI 10.3171/JNS/2008/108/5/1052; Kaminogo M, 2003, STROKE, V34, P16, DOI 10.1161/01.STR.0000046763.48330.AD; KASSELL NF, 1983, NEUROSURGERY, V12, P291, DOI 10.1227/00006123-198303000-00007; Lai H. P., 2009, Hong Kong Medical Journal, V15, P262; Meissner I, 2012, J NEUROSURG, V116, P1238, DOI 10.3171/2012.1.JNS11779; NAKAGAWA T, 1994, J NEUROSURG, V80, P217, DOI 10.3171/jns.1994.80.2.0217; Ohashi Y, 2004, SURG NEUROL, V61, P239, DOI 10.1016/S0090-3019(03)00427-0; Osawa M, 2001, ACTA NEUROCHIR, V143, P655, DOI 10.1007/s007010170043; PAKARINEN S, 1967, ACTA NEUROL SCAND, VS 43, P9; PHILLIPS LH, 1980, NEUROLOGY, V30, P1034, DOI 10.1212/WNL.30.10.1034; Qureshi AI, 1998, NEUROSURGERY, V43, P22, DOI 10.1097/00006123-199807000-00013; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Roessler K, 2011, WIEN KLIN WOCHENSCHR, V123, P444, DOI 10.1007/s00508-011-1598-z; Salunke P, 2010, BRIT J NEUROSURG, V24, P686, DOI 10.3109/02688697.2010.515320; Shiue I, 2011, CEREBROVASC DIS, V31, P573, DOI 10.1159/000324938; SO SC, 1979, SURG NEUROL, V12, P319; UJIIE H, 1993, STROKE, V24, P1850, DOI 10.1161/01.STR.24.12.1850; Weir B, 2002, J NEUROSURG, V96, P64, DOI 10.3171/jns.2002.96.1.0064; Wiebers D, 1998, NEW ENGL J MED, V339, P1725, DOI 10.1056/nejm199812103392401	30	30	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85668	10.1371/journal.pone.0085668	http://dx.doi.org/10.1371/journal.pone.0085668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454914	gold, Green Published			2022-12-25	WOS:000330235100117
J	Fraiman, D; Saunier, G; Martins, EF; Vargas, CD				Fraiman, Daniel; Saunier, Ghislain; Martins, Eduardo F.; Vargas, Claudia D.			Biological Motion Coding in the Brain: Analysis of Visually Driven EEG Functional Networks	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SYNCHRONIZATION LIKELIHOOD; RECOGNIZING GENDER; PERCEPTION; PREMOTOR; AREAS; CONNECTIVITY; INFORMATION; MODULATION; EFFICIENCY	Herein, we address the time evolution of brain functional networks computed from electroencephalographic activity driven by visual stimuli. We describe how these functional network signatures change in fast scale when confronted with point-light display stimuli depicting biological motion (BM) as opposed to scrambled motion (SM). Whereas global network measures (average path length, average clustering coefficient, and average betweenness) computed as a function of time did not discriminate between BM and SM, local node properties did. Comparing the network local measures of the BM condition with those of the SM condition, we found higher degree and betweenness values in the left frontal (F7) electrode, as well as a higher clustering coefficient in the right occipital (O2) electrode, for the SM condition. Conversely, for the BM condition, we found higher degree values in central parietal (Pz) electrode and a higher clustering coefficient in the left parietal (P3) electrode. These results are discussed in the context of the brain networks involved in encoding BM versus SM.	[Fraiman, Daniel] Univ San Andres, Lab Invest Neurociencia, Dept Matemat & Ciencias, Buenos Aires, DF, Argentina; [Fraiman, Daniel] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Saunier, Ghislain; Martins, Eduardo F.; Vargas, Claudia D.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Neurobiol 2, BR-21941 Rio De Janeiro, Brazil; [Saunier, Ghislain] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade Federal do Rio de Janeiro; Universidade Federal do Para	Vargas, CD (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Neurobiol 2, BR-21941 Rio De Janeiro, Brazil.	cdvargas@biof.ufrj.br	Saunier, Ghislain/D-8488-2016; Vargas, Claudia D./A-1523-2016; Fraiman, Daniel/E-1581-2018	Saunier, Ghislain/0000-0002-0882-7788; Vargas, Claudia D./0000-0001-6202-3580; Fraiman, Daniel/0000-0002-0482-9137	Fundacao de amparo a pesquisa do Estado de Sao Paulo (FAPESP) [2011/51350-6]; Conselho Nacional de Pesquisa (CNPq) [480108/2012-9, 478537/2012-3]; Fundacao de amparo a pesquisa do Rio de JAneiro FAPERJ [E-26/111.655/2012, E-26/110.526/2012]; Programa de apoyo a la investigacion de la Universidad San Andres (PAI UdeSA); University of Sao Paulo (USP)	Fundacao de amparo a pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de amparo a pesquisa do Rio de JAneiro FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de apoyo a la investigacion de la Universidad San Andres (PAI UdeSA); University of Sao Paulo (USP)	This work is part of University of Sao Paulo (USP) project Mathematics, computation, language and the brain, Fundacao de amparo a pesquisa do Estado de Sao Paulo (FAPESP) project NeuroMat (grant 2011/51350-6), Conselho Nacional de Pesquisa (CNPq) (grants 480108/2012-9 and 478537/2012-3), Fundacao de amparo a pesquisa do Rio de JAneiro FAPERJ (grants E-26/111.655/2012 and E-26/110.526/2012) and Programa de apoyo a la investigacion de la Universidad San Andres (PAI UdeSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Battelli L, 2003, NEUROPSYCHOLOGIA, V41, P1808, DOI 10.1016/S0028-3932(03)00182-9; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Boersma M, 2011, HUM BRAIN MAPP, V32, P413, DOI 10.1002/hbm.21030; Bonda E, 1996, J NEUROSCI, V16, P3737; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calmels C, 2012, NEUROSCIENCE, V212, P49, DOI 10.1016/j.neuroscience.2012.03.045; Chu CJ, 2012, J NEUROSCI, V32, P2703, DOI 10.1523/JNEUROSCI.5669-11.2012; Dayan E, 2007, P NATL ACAD SCI USA, V104, P20582, DOI 10.1073/pnas.0710033104; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fontana AP, 2012, NEUROIMAGE, V59, P556, DOI 10.1016/j.neuroimage.2011.07.046; Fraiman D, 2012, FRONT PHYSIOL, V307, P1; Fraiman D, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061922; Grezes J, 2001, NEUROIMAGE, V13, P775, DOI 10.1006/nimg.2000.0740; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hamilton AF, 2007, ATTENTION PERFORM, P381, DOI DOI 10.1093/ACPR0F:0S0/9780199231447.003.0018; Hars M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025903; Hirai M, 2003, NEUROSCI LETT, V344, P41, DOI 10.1016/S0304-3940(03)00413-0; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jokisch D, 2005, BEHAV BRAIN RES, V157, P195, DOI 10.1016/j.bbr.2004.06.025; KALASKA JF, 1990, EXP BRAIN RES, V80, P351; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; KOZLOWSKI LT, 1978, PERCEPT PSYCHOPHYS, V23, P459, DOI 10.3758/BF03204150; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; Krakowski AI, 2011, NEUROIMAGE, V56, P373, DOI 10.1016/j.neuroimage.2011.01.058; McKay LS, 2012, NEUROIMAGE, V59, P1524, DOI 10.1016/j.neuroimage.2011.08.033; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Pavlova M, 2006, CEREB CORTEX, V16, P321, DOI 10.1093/cercorbhi108; Pavlova M, 2004, CEREB CORTEX, V14, P181, DOI 10.1093/cercor/bhg117; Peraza LR, 2012, J NEUROSCI METH, V207, P189, DOI 10.1016/j.jneumeth.2012.04.007; Pollick FE, 2002, VISION RES, V42, P2345, DOI 10.1016/S0042-6989(02)00196-7; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; Ptito M, 2003, NEUROIMAGE, V19, P246, DOI 10.1016/S1053-8119(03)00082-X; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Saunier G, 2013, BEHAV BRAIN RES, V236, P166, DOI 10.1016/j.bbr.2012.08.038; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Schenk T, 1997, NEUROPSYCHOLOGIA, V35, P1299, DOI 10.1016/S0028-3932(97)00005-5; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Sporns O., 2016, NETWORKS BRAIN; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Thornton IM, 2002, PERCEPTION, V31, P837, DOI 10.1068/p3072; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; van Kemenade BM, 2012, J COGNITIVE NEUROSCI, V24, P896, DOI 10.1162/jocn_a_00194; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239	58	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e84612	10.1371/journal.pone.0084612	http://dx.doi.org/10.1371/journal.pone.0084612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454734	Green Published, Green Submitted, gold			2022-12-25	WOS:000329925800012
J	Meier, K; Hansen, MM; Normandeau, E; Mensberg, KLD; Frydenberg, J; Larsen, PF; Bekkevold, D; Bernatchez, L				Meier, Kristian; Hansen, Michael Moller; Normandeau, Eric; Mensberg, Karen-Lise D.; Frydenberg, Jane; Larsen, Peter Foged; Bekkevold, Dorte; Bernatchez, Louis			Local Adaptation at the Transcriptome Level in Brown Trout: Evidence from Early Life History Temperature Genomic Reaction Norms	PLOS ONE			English	Article							CHARR SALVELINUS-FONTINALIS; SALMON SALMO-SALAR; ATLANTIC SALMON; GENE-EXPRESSION; CLIMATE-CHANGE; LAKE WHITEFISH; ECOLOGICAL SPECIATION; POPULATION-STRUCTURE; SPAWNING MIGRATION; SELECTION	Local adaptation and its underlying molecular basis has long been a key focus in evolutionary biology. There has recently been increased interest in the evolutionary role of plasticity and the molecular mechanisms underlying local adaptation. Using transcriptome analysis, we assessed differences in gene expression profiles for three brown trout (Salmo trutta) populations, one resident and two anadromous, experiencing different temperature regimes in the wild. The study was based on an F2 generation raised in a common garden setting. A previous study of the F1 generation revealed different reaction norms and significantly higher Q(ST) than F-ST among populations for two early life-history traits. In the present study we investigated if genomic reaction norm patterns were also present at the transcriptome level. Eggs from the three populations were incubated at two temperatures (5 and 8 degrees C) representing conditions encountered in the local environments. Global gene expression for fry at the stage of first feeding was analysed using a 32k cDNA microarray. The results revealed differences in gene expression between populations and temperatures and population x temperature interactions, the latter indicating locally adapted reaction norms. Moreover, the reaction norms paralleled those observed previously at early life-history traits. We identified 90 cDNA clones among the genes with an interaction effect that were differently expressed between the ecologically divergent populations. These included genes involved in immune-and stress response. We observed less plasticity in the resident as compared to the anadromous populations, possibly reflecting that the degree of environmental heterogeneity encountered by individuals throughout their life cycle will select for variable level of phenotypic plasticity at the transcriptome level. Our study demonstrates the usefulness of transcriptome approaches to identify genes with different temperature reaction norms. The responses observed suggest that populations may vary in their susceptibility to climate change.	[Meier, Kristian; Mensberg, Karen-Lise D.; Bekkevold, Dorte] Tech Univ Denmark, Natl Inst Aquat Resources, Silkeborg, Denmark; [Hansen, Michael Moller; Frydenberg, Jane; Larsen, Peter Foged] Aarhus Univ, Dept Biosci, Aarhus C, Denmark; [Normandeau, Eric; Bernatchez, Louis] Univ Laval, Dept Biol, IBIS, Quebec City, PQ G1K 7P4, Canada	Technical University of Denmark; Aarhus University; Laval University	Hansen, MM (corresponding author), Aarhus Univ, Dept Biosci, Aarhus C, Denmark.	mmh@biology.au.dk	Hansen, Michael/I-5979-2013; Bekkevold, Dorte/AAT-1098-2021; Hansen, Michael M./Z-5047-2019	Hansen, Michael/0000-0001-5372-4828; Hansen, Michael M./0000-0001-5372-4828; Bernatchez, Louis/0000-0002-8085-9709; Bekkevold, Dorte/0000-0002-5297-032X				Aguilar A, 2006, MOL ECOL, V15, P923, DOI 10.1111/j.1365-294X.2006.02843.x; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; ALLENDORF FW, 1984, EVOL GENET, P55; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amstutz U, 2006, AQUACULTURE, V260, P326, DOI 10.1016/j.aquaculture.2006.06.007; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Aubin-Horth N, 2009, MOL ECOL, V18, P3763, DOI 10.1111/j.1365-294X.2009.04313.x; Beldade P, 2011, MOL ECOL, V20, P1347, DOI 10.1111/j.1365-294X.2011.05016.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Bougas B, 2013, HEREDITY, V110, P484, DOI 10.1038/hdy.2012.113; Boulet M, 2012, CURR ZOOL, V58, P158, DOI 10.1093/czoolo/58.1.158; Bourret V, 2013, MOL ECOL, V22, P532, DOI 10.1111/mec.12003; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croisetiere S, 2010, MOL IMMUNOL, V47, P1817, DOI 10.1016/j.molimm.2009.12.012; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Derome N, 2006, MOL BIOL EVOL, V23, P2370, DOI 10.1093/molbev/msl110; Elliott J.M., 1994, QUANTITATIVE ECOLOGY; Evans ML, 2012, MOL ECOL, V21, P4038, DOI 10.1111/j.1365-294X.2012.05682.x; Evans TG, 2011, MOL ECOL, V20, P4472, DOI 10.1111/j.1365-294X.2011.05276.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Franks SJ, 2012, ANNU REV GENET, V46, P185, DOI 10.1146/annurev-genet-110711-155511; Fraser DJ, 2011, HEREDITY, V106, P404, DOI 10.1038/hdy.2010.167; Galliano M, 2003, BIOCHEM J, V376, P433, DOI 10.1042/BJ20030413; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Gibson G, 2002, MOL ECOL, V11, P17, DOI 10.1046/j.0962-1083.2001.01425.x; Giger T, 2006, CURR BIOL, V16, pR281, DOI 10.1016/j.cub.2006.03.053; Giger T, 2008, MOL ECOL, V17, P3095, DOI 10.1111/j.1365-294X.2008.03820.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; Hansen MM, 2002, MOL ECOL, V11, P2523, DOI 10.1046/j.1365-294X.2002.01634.x; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hutchings JA, 2011, HEREDITY, V106, P421, DOI 10.1038/hdy.2010.166; Huttenhuis HBT, 2006, FISH SHELLFISH IMMUN, V20, P586, DOI 10.1016/j.fsi.2005.07.008; Jensen LF, 2008, P ROY SOC B-BIOL SCI, V275, P2859, DOI 10.1098/rspb.2008.0870; Kao CM, 2008, COMP BIOCHEM PHYS B, V149, P541, DOI 10.1016/j.cbpb.2006.05.017; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kerr RA, 2007, SCIENCE, V316, P188, DOI 10.1126/science.316.5822.188; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Larsen PF, 2011, J FISH BIOL, V78, P1, DOI 10.1111/j.1095-8649.2010.02834.x; Larsen PF, 2007, MOL ECOL, V16, P4674, DOI 10.1111/j.1365-294X.2007.03530.x; Meier K, 2011, HEREDITY, V106, P488, DOI 10.1038/hdy.2010.164; Merila J, 2014, EVOLUTIONAR IN PRESS, V7; Miller KM, 2011, SCIENCE, V331, P214, DOI 10.1126/science.1196901; Mommsen TP, 2004, COMP BIOCHEM PHYS B, V139, P383, DOI 10.1016/j.cbpc.2004.09.018; Narum SR, 2010, MOL ECOL, V19, P4622, DOI 10.1111/j.1365-294X.2010.04839.x; Nath S, 2006, IMMUNOGENETICS, V58, P443, DOI 10.1007/s00251-006-0094-5; Neves JV, 2009, DEV COMP IMMUNOL, V33, P848, DOI 10.1016/j.dci.2009.02.001; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Pigliucci M, 1998, J EVOLUTION BIOL, V11, P285, DOI 10.1007/s000360050089; Quinn NL, 2011, PHYSIOL GENOMICS, V43, P685, DOI 10.1152/physiolgenomics.00008.2011; Quinn NL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-539; Renaut S, 2011, MOL ECOL, V20, P545, DOI 10.1111/j.1365-294X.2010.04952.x; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Roberge C, 2006, MOL ECOL, V15, P9, DOI 10.1111/j.1365-294X.2005.02807.x; Rogers SM, 2005, MOL ECOL, V14, P351, DOI 10.1111/j.1365-294X.2004.02396.x; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; SPITZE K, 1993, GENETICS, V135, P367; St-Cyr J, 2008, MOL ECOL, V17, P1850, DOI 10.1111/j.1365-294X.2008.03696.x; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Tang SJ, 1999, FEBS LETT, V459, P95, DOI 10.1016/S0014-5793(99)01229-6; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; Tonteri A, 2010, MOL ECOL, V19, P1273, DOI 10.1111/j.1365-294X.2010.04573.x; Tymchuk WV, 2010, MOL ECOL, V19, P1842, DOI 10.1111/j.1365-294X.2010.04596.x; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; von Schalburg KR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-126; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weber RE, 2011, ACTA PHYSIOL, V202, P549, DOI 10.1111/j.1748-1716.2010.02204.x	76	39	39	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85171	10.1371/journal.pone.0085171	http://dx.doi.org/10.1371/journal.pone.0085171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454810	Green Published, Green Submitted, gold			2022-12-25	WOS:000329925800025
J	Nemati, F; de Montrion, C; Lang, G; Kraus-Berthier, L; Carita, G; Sastre-Garau, X; Berniard, A; Vallerand, D; Geneste, O; de Plater, L; Pierre, A; Lockhart, B; Desjardins, L; Piperno-Neumann, S; Depil, S; Decaudin, D				Nemati, Fariba; de Montrion, Catherine; Lang, Guillaume; Kraus-Berthier, Laurence; Carita, Guillaume; Sastre-Garau, Xavier; Berniard, Aurelie; Vallerand, David; Geneste, Olivier; de Plater, Ludmilla; Pierre, Alain; Lockhart, Brian; Desjardins, Laurence; Piperno-Neumann, Sophie; Depil, Stephane; Decaudin, Didier			Targeting Bcl-2/Bcl-X-L Induces Antitumor Activity in Uveal Melanoma Patient-Derived Xenografts	PLOS ONE			English	Article							INTRAARTERIAL HEPATIC FOTEMUSTINE; BCL-2 ANTISENSE OLIGONUCLEOTIDE; CHRONIC LYMPHOCYTIC-LEUKEMIA; RANDOMIZED PHASE-II; CELL-LUNG-CANCER; OBLIMERSEN SODIUM; LIVER METASTASES; CARCINOMA-CELLS; LYMPHOMA-CELLS; EXPRESSION	Purpose: Uveal melanoma (UM) is associated with a high risk of metastases and lack of efficient therapies. Reduced capacity for apoptosis induction by chemotherapies is one obstacle to efficient treatments. Human UM is characterized by high expression of the anti-apoptotic protein Bcl-2. Consequently, regulators of apoptosis such as Bcl-2 family inhibitors may constitute an attractive approach to UM therapeutics. In this aim, we have investigated the efficacy of the Bcl-2/Bcl-X-L inhibitor S44563 on 4 UM Patient-Derived Xenografts (PDXs) and derived-cell lines. Experimental Design: Four well characterized UM PDXs were used for in vivo experiments. S44563 was administered alone or combined with fotemustine either concomitantly or after the alkylating agent. Bcl-2, Bcl-X-L, and Mcl-1 expressions after S44563 administration were evaluated by immunohistochemistry (IHC). Results: S44563 administered alone by at 50 and 100 mg/kg i.p. induced a significant tumour growth inhibition in only one xenograft model with a clear dose effect. However, when S44563 was concomitantly administered with fotemustine, we observed a synergistic activity in 3 out of the 4 tested models. In addition, S44563 administered after fotemustine induced a tumour growth delay in 2 out of 3 tested xenografts. Finally, IHC analyses showed that Bcl-2, Bcl-X-L, and Mcl-1 expression were not modified after S44563 administration. Conclusion: The novel anti-apoptotic experimental compound S44563, despite a relative low efficacy when administered alone, increased the efficacy of fotemustine in either concomitant or sequential combinations or indeed subsequent to fotemustine. These data support further exploration of potential therapeutic effect of Bcl-2/Bcl-X-L inhibition in human UM.	[Nemati, Fariba; Lang, Guillaume; Carita, Guillaume; Berniard, Aurelie; Vallerand, David; de Plater, Ludmilla; Decaudin, Didier] Inst Curie, Dept Translat Res, Lab Preclin Invest, Paris, France; [de Montrion, Catherine; Pierre, Alain; Lockhart, Brian; Depil, Stephane] Inst Rech Servier, IDRS, Croissy Sur Seine, France; [Kraus-Berthier, Laurence; Geneste, Olivier; Depil, Stephane] Inst Rech Int Servier, IRIS, Suresnes, France; [Sastre-Garau, Xavier] Inst Curie, Dept Tumor Biol, Paris, France; [Desjardins, Laurence] Inst Curie, Dept Ophthalmol Oncol, Paris, France; [Piperno-Neumann, Sophie; Decaudin, Didier] Inst Curie, Dept Med Oncol, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Servier; Institut de Recherches Internationales Servier; Servier; Institut de Recherches Internationales Servier; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Decaudin, D (corresponding author), Inst Curie, Dept Translat Res, Lab Preclin Invest, Paris, France.	Didier.decaudin@curie.net		Sastre-Garau, Xavier/0000-0001-5992-2083	Servier Laboratories	Servier Laboratories	The study was supported by Servier Laboratories. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackler S, 2010, CANCER CHEMOTH PHARM, V66, P869, DOI 10.1007/s00280-009-1232-1; Al-Harbi S, 2011, BLOOD, V118, P3579, DOI 10.1182/blood-2011-03-340364; Augsburger JJ, 2009, AM J OPHTHALMOL, V148, P119, DOI 10.1016/j.ajo.2009.01.023; Bedikian AY, 2006, J CLIN ONCOL, V24, P4738, DOI 10.1200/JCO.2006.06.0483; Chana JS, 1999, BRIT J OPHTHALMOL, V83, P110, DOI 10.1136/bjo.83.1.110; Chanan-Khan AA, 2009, LEUKEMIA LYMPHOMA, V50, P559, DOI 10.1080/10428190902748971; Coupland SE, 1998, BRIT J OPHTHALMOL, V82, P961, DOI 10.1136/bjo.82.8.961; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Guo Lin-jie, 2003, Zhonghua Yan Ke Za Zhi, V39, P73; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hussein MR, 2005, J CLIN PATHOL, V58, P486, DOI 10.1136/jcp.2004.023291; Jain HV, 2011, CANCER RES, V71, P705, DOI 10.1158/0008-5472.CAN-10-3174; Jay V, 1996, ARCH PATHOL LAB MED, V120, P497; Kim KW, 2009, CLIN CANCER RES, V15, P6096, DOI 10.1158/1078-0432.CCR-09-0589; Kujala E, 2003, OPHTHALMOLOGY, V110, P962; Laurent C, 2013, MOL ONCOL, V7, P625, DOI 10.1016/j.molonc.2013.02.004; Lawry J, 1999, EYE, V13, P301, DOI 10.1038/eye.1999.79; Loriot Y, 2012, AM ASS CANC RES ANN; Lucas KM, 2012, CLIN CANCER RES, V18, P783, DOI 10.1158/1078-0432.CCR-11-1166; Malik SA, 2011, ONCOGENE, V30, P3918, DOI 10.1038/onc.2011.104; MOOY CM, 1995, AM J PATHOL, V147, P1097; Nemati F, 2010, CLIN CANCER RES, V16, P2352, DOI 10.1158/1078-0432.CCR-09-3066; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; O'Brien S, 2009, J CLIN ONCOL, V27, P5208, DOI 10.1200/JCO.2009.22.5748; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pepper C, 2001, LEUKEMIA LYMPHOMA, V42, P491, DOI 10.3109/10428190109064606; Peters S, 2006, ANN ONCOL, V17, P578, DOI 10.1093/annonc/mdl009; PRESCHER G, 1992, LANCET, V339, P691, DOI 10.1016/0140-6736(92)90861-V; Reuland SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024294; Rudin CM, 2008, J CLIN ONCOL, V26, P870, DOI 10.1200/JCO.2007.14.3461; Salmon RJ, 1998, EUR J SURG ONCOL, V24, P127, DOI 10.1016/S0748-7983(98)91485-8; Simoes-Wust AP, 2002, BREAST CANCER RES TR, V76, P157, DOI 10.1023/A:1020543004400; Sternberg CN, 2009, ANN ONCOL, V20, P1264, DOI 10.1093/annonc/mdn784; Sulkowska M, 2001, TUMORI, V87, P54, DOI 10.1177/030089160108700112; Tan N, 2011, CLIN CANCER RES, V17, P1394, DOI 10.1158/1078-0432.CCR-10-2353; Touzeau C, 2011, CLIN CANCER RES, V17, P5973, DOI 10.1158/1078-0432.CCR-11-0955; Trolet J, 2009, INVEST OPHTH VIS SCI, V50, P2572, DOI 10.1167/iovs.08-2296; Trudel S, 2007, CLIN CANCER RES, V13, P621, DOI 10.1158/1078-0432.CCR-06-1526; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Voelter V, 2008, MELANOMA RES, V18, P220, DOI 10.1097/CMR.0b013e32830317de; Voss V, 2010, MOL CANCER RES, V8, P1002, DOI 10.1158/1541-7786.MCR-09-0562; Weber A, 2009, TRANSL ONCOL, V2, P73, DOI 10.1593/tlo.08223; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Xu HS, 2010, CLIN CANCER RES, V16, P4392, DOI 10.1158/1078-0432.CCR-10-0640; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Zall H, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-164; Zhang C, 2011, MOL CANCER THER, V10, P1264, DOI 10.1158/1535-7163.MCT-10-1091	49	34	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e80836	10.1371/journal.pone.0080836	http://dx.doi.org/10.1371/journal.pone.0080836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454684	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500001
J	Vazquez-Cintron, EJ; Vakulenko, M; Band, PA; Stanker, LH; Johnson, EA; Ichtchenko, K				Vazquez-Cintron, Edwin J.; Vakulenko, Maksim; Band, Philip A.; Stanker, Larry H.; Johnson, Eric A.; Ichtchenko, Konstantin			Atoxic Derivative of Botulinum Neurotoxin A as a Prototype Molecular Vehicle for Targeted Delivery to the Neuronal Cytoplasm	PLOS ONE			English	Article							LIGHT-CHAIN; PROTEIN; TOXIN; TRANSLOCATION; CELLS; MEMBRANES; SEQUENCE; ANTIBODY; SNAP-25; BINDING	We have previously described genetic constructs and expression systems that enable facile production of recombinant derivatives of botulinum neurotoxins (BoNTs) that retain the structural and trafficking properties of wt BoNTs. In this report we describe the properties of one such derivative, BoNT/A ad, which was rendered atoxic by introducing two amino acid mutations to the light chain (LC) of wt BoNT/A, and which is being developed as a molecular vehicle for delivering drugs to the neuronal cytoplasm. The neuronal binding, internalization, and intracellular trafficking of BoNT/A ad in primary hippocampal cultures was evaluated using three complimentary techniques: flow cytometry, immunohistochemistry, and Western blotting. Neuronal binding of BoNT ad was significantly increased when neurons were incubated in depolarizing medium. Flow cytometry demonstrated that BoNT/A ad internalized into neurons but not glia. After 24 hours, the majority of the neuron-bound BoNT/A ad became internalized, as determined by its resistance to pronase E-induced proteolytic degradation of proteins associated with the plasma membrane of intact cells. Significant amounts of the atoxic LC accumulated in a Triton X-100-extractable fraction of the neurons, and persisted as such for at least 11 days with no evidence of degradation. Immunocytochemical analysis demonstrated that the LC of BoNT/A ad was translocated to the neuronal cytoplasm after uptake and was specifically targeted to SNARE proteins. The atoxic LC consistently co-localized with synaptic markers SNAP-25 and VAMP-2, but was rarely co-localized with markers for early or late endosomes. These data demonstrate that BoNT/A ad mimics the trafficking properties of wt BoNT/A, confirming that our platform for designing and expressing BoNT derivatives provides an accessible system for elucidating the molecular details of BoNT trafficking, and can potentially be used to address multiple medical and biodefense needs.	[Vazquez-Cintron, Edwin J.; Vakulenko, Maksim; Band, Philip A.; Ichtchenko, Konstantin] New York Univ Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA; [Band, Philip A.] New York Univ Hosp Joint Dis, Dept Orthopaed Surg, New York, NY USA; [Stanker, Larry H.] ARS, USDA, Albany, CA USA; [Johnson, Eric A.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	New York University; New York University; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Ichtchenko, K (corresponding author), New York Univ Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA.	ichtck01@med.nyu.edu		Ichtchenko, Konstantin/0000-0002-2198-1325; Vazquez-Cintron, Edwin/0000-0002-4397-3713; BAND, PHILIP/0000-0002-5363-853X	National Institute Of Allergy And Infectious Diseases [R01-AI093504]; USDA CRIS [5325-42000-043-00D]; National Cancer Institute [5P30CA016087-32]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093504] Funding Source: NIH RePORTER	National Institute Of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USDA CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the National Institute Of Allergy And Infectious Diseases R01-AI093504 to KI and EAJ and by USDA CRIS Project 5325-42000-043-00D to LHS. The NYU SoM Flow Cytometry Core is supported in part by grant 5P30CA016087-32 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Bade S, 2004, J NEUROCHEM, V91, P1461, DOI 10.1111/j.1471-4159.2004.02844.x; Band PA, 2010, PROTEIN EXPRES PURIF, V71, P62, DOI 10.1016/j.pep.2009.12.013; Barash JR, 2013, J INFECT DIS; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brunger AT, 2007, PLOS PATHOG, V3, P1191, DOI 10.1371/journal.ppat.0030113; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dover N, 2013, J INFECT DIS; Dressler D, 2012, CURR OPIN MICROBIOL, V15, P325, DOI 10.1016/j.mib.2012.05.012; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; FRANCIS JW, 1995, J BIOL CHEM, V270, P15434, DOI 10.1074/jbc.270.25.15434; Fujinaga Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/974943; Gibert M, 2007, FEBS LETT, V581, P1287, DOI 10.1016/j.febslet.2007.02.041; Goodnough MC, 2002, FEBS LETT, V513, P163, DOI 10.1016/S0014-5793(02)02268-8; Hill KK, 2013, CURR TOP MICROBIOL, V364, P1, DOI 10.1007/978-3-642-33570-9_1; Ho MF, 2011, PROTEIN ENG DES SEL, V24, P247, DOI 10.1093/protein/gzq093; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johnson EA, 2005, J CLIN MICROBIOL, V43, P2602, DOI 10.1128/JCM.43.6.2602-2607.2005; Johnson EA, 1999, ANNU REV MICROBIOL, V53, P551, DOI 10.1146/annurev.micro.53.1.551; Keller JE, 1999, FEBS LETT, V456, P137, DOI 10.1016/S0014-5793(99)00948-5; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kuo CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020352; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Pellett S, 2011, BIOCHEM BIOPH RES CO, V405, P673, DOI 10.1016/j.bbrc.2011.01.093; Sanders JD, 1998, J NEUROSCI RES, V53, P670, DOI 10.1002/(SICI)1097-4547(19980915)53:6<670::AID-JNR5>3.3.CO;2-H; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Scotcher MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004924; Simpson LL, 2004, J PHARMACOL EXP THER, V308, P857, DOI 10.1124/jpet.103.058149; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Singh BR, 2010, BIOCHIMIE, V92, P1252, DOI 10.1016/j.biochi.2010.03.005; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Stanker LH, 2008, J IMMUNOL METHODS, V336, P1, DOI 10.1016/j.jim.2008.03.003; Sugawara Y, 2010, J CELL BIOL, V189, P691, DOI 10.1083/jcb.200910119; Vicario-Abejon Carlos, 2004, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0302s26; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zhang Peng, 2009, BMC Pharmacology, V9, P12, DOI 10.1186/1471-2210-9-12	42	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85517	10.1371/journal.pone.0085517	http://dx.doi.org/10.1371/journal.pone.0085517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465585	gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100045
J	Karlsson, E; Macellaro, A; Bystrom, M; Forsman, M; Frangoulidis, D; Janse, I; Larsson, P; Lindgren, P; Ohrman, C; van Rotterdam, B; Sjodin, A; Myrtennas, K				Karlsson, Edvin; Macellaro, Anna; Bystrom, Mona; Forsman, Mats; Frangoulidis, Dimitrios; Janse, Ingmar; Larsson, Par; Lindgren, Petter; Ohrman, Caroline; van Rotterdam, Bart; Sjodin, Andreas; Myrtennas, Kerstin			Eight New Genomes and Synthetic Controls Increase the Accessibility of Rapid Melt-MAMA SNP Typing of Coxiella burnetii	PLOS ONE			English	Article							Q-FEVER OUTBREAK; BULK-TANK MILK; REAL-TIME PCR; FRANCISELLA-TULARENSIS; MOLECULAR CHARACTERIZATION; SEQUENCE; PHYLOGEOGRAPHY; DIVERSITY; TRANSMISSION; NETHERLANDS	The case rate of Q fever in Europe has increased dramatically in recent years, mainly because of an epidemic in the Netherlands in 2009. Consequently, there is a need for more extensive genetic characterization of the disease agent Coxiella burnetii in order to better understand the epidemiology and spread of this disease. Genome reference data are essential for this purpose, but only thirteen genome sequences are currently available. Current methods for typing C. burnetii are criticized for having problems in comparing results across laboratories, require the use of genomic control DNA, and/or rely on markers in highly variable regions. We developed in this work a method for single nucleotide polymorphism (SNP) typing of C. burnetii isolates and tissue samples based on new assays targeting ten phylogenetically stable synonymous canonical SNPs (canSNPs). These canSNPs represent previously known phylogenetic branches and were here identified from sequence comparisons of twenty-one C. burnetii genomes, eight of which were sequenced in this work. Importantly, synthetic control templates were developed, to make the method useful to laboratories lacking genomic control DNA. An analysis of twenty-one C. burnetii genomes confirmed that the species exhibits high sequence identity. Most of its SNPs (7,493/7,559 shared by >1 genome) follow a clonal inheritance pattern and are therefore stable phylogenetic typing markers. The assays were validated using twenty-six genetically diverse C. burnetii isolates and three tissue samples from small ruminants infected during the epidemic in the Netherlands. Each sample was assigned to a clade. Synthetic controls (vector and PCR amplified) gave identical results compared to the corresponding genomic controls and are viable alternatives to genomic DNA. The results from the described method indicate that it could be useful for cheap and rapid disease source tracking at non-specialized laboratories, which requires accurate genotyping, assay accessibility and inter-laboratory comparisons.	[Karlsson, Edvin; Macellaro, Anna; Bystrom, Mona; Forsman, Mats; Larsson, Par; Lindgren, Petter; Ohrman, Caroline; Sjodin, Andreas; Myrtennas, Kerstin] Swedish Def Res Agcy, CBRN Def & Secur, Umea, Sweden; [Frangoulidis, Dimitrios] Bundeswehr Inst Microbiol, Munich, Germany; [Janse, Ingmar; van Rotterdam, Bart] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Saab Group; Bundeswehr Institute of Microbiology (IMB); Netherlands National Institute for Public Health & the Environment	Myrtennas, K (corresponding author), Swedish Def Res Agcy, CBRN Def & Secur, Umea, Sweden.	kerstin.myrtennas@foi.se	Forsman, Mats/A-1426-2016; Sjödin, Andreas/A-7245-2008	Forsman, Mats/0000-0002-4466-5325; Sjödin, Andreas/0000-0001-5350-4219; Ohrman, Caroline/0000-0001-8489-757X; Karlsson, Edvin/0000-0002-1260-769X; van Rotterdam, Bart/0000-0003-2837-9465	Coxiella Genome Sequencing Consortium (CGSC); Swedish Ministry of Defence; German Bundeswehr as a part of the European Biodefense Laboratory Network (EBLN)	Coxiella Genome Sequencing Consortium (CGSC); Swedish Ministry of Defence; German Bundeswehr as a part of the European Biodefense Laboratory Network (EBLN)	This work was performed under the auspices of the Coxiella Genome Sequencing Consortium (CGSC) (http://coxiella.net) and was funded by the Swedish Ministry of Defence and the German Bundeswehr as a part of the European Biodefense Laboratory Network (EBLN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Agger JF, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-5; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Arricau-Bouvery N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-38; Beare PA, 2006, J BACTERIOL, V188, P2309, DOI 10.1128/JB.188.7.2309-2324.2006; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Chanturia G, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-139; Charrel RN, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-21; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Bruin A, 2011, APPL ENVIRON MICROB, V77, P6516, DOI 10.1128/AEM.05097-11; de Bruin A, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-165; ECDC, 2010, EUR CTR DIS PREV CON; Garcia-Perez AL, 2009, J DAIRY SCI, V92, P1581, DOI 10.3168/jds.2008-1672; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; Gyuranecz M, 2012, EMERG INFECT DIS, V18, P290, DOI 10.3201/eid1802.111305; HEINZEN R, 1990, ANN NY ACAD SCI, V590, P504, DOI 10.1111/j.1749-6632.1990.tb42260.x; Hornstra HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026201; Howe GB, 2009, MOL CELL PROBE, V23, P127, DOI 10.1016/j.mcp.2009.01.004; Huijsmans CJJ, 2011, APPL ENVIRON MICROB, V77, P2051, DOI 10.1128/AEM.02293-10; Jager C, 1998, EPIDEMIOL INFECT, V120, P157, DOI 10.1017/S0950268897008510; Karlsson E, 2013, ENVIRON MICROBIOL, V15, P634, DOI 10.1111/1462-2920.12052; Klee SR, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-2; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li Kelvin, 2010, BMC Res Notes, V3, P191, DOI 10.1186/1756-0500-3-191; Loftis AD, 2006, EXP APPL ACAROL, V40, P67, DOI 10.1007/s10493-006-9025-2; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Miceli MH, 2010, VECTOR-BORNE ZOONOT, V10, P539, DOI 10.1089/vbz.2009.0101; Murphy K, 2004, BIOINFORMATICS, V20, P588, DOI 10.1093/bioinformatics/btg466; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Papp AC, 2003, BIOTECHNIQUES, V34, P1068, DOI 10.2144/03345dd03; Pearson T, 2013, SYST BIOL, V62, P752, DOI 10.1093/sysbio/syt038; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Roest HIJ, 2011, EMERG INFECT DIS, V17, P668, DOI 10.3201/eid1704.101562; Roest HJ, 2009, TIJDSCHR DIERGENEESK, V134, P300; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Rouli L, 2012, J BACTERIOL, V194, P6939, DOI 10.1128/JB.01856-12; Rustscheff S, 2000, SCAND J INFECT DIS, V32, P605, DOI 10.1080/003655400459496; Schimmer B, 2009, EUROSURVEILLANCE, V14, P14; Schneeberger Peter M, 2010, Clin Vaccine Immunol, V17, P286, DOI 10.1128/CVI.00454-09; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Sidi-Boumedine K, 2009, CLIN MICROBIOL INFEC, V15, P194, DOI 10.1111/j.1469-0691.2008.02271.x; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sukrija Z, 2006, ANN NY ACAD SCI, V1078, P124, DOI 10.1196/annals.1374.128; Svensson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008360; Svraka S, 2006, FEMS MICROBIOL LETT, V254, P268, DOI 10.1111/j.1574-6968.2005.00036.x; Tilburg JJHC, 2012, J CLIN MICROBIOL, V50, P1076, DOI 10.1128/JCM.05497-11; Valergakis GE, 2012, VET REC, V171, DOI 10.1136/vr.100908; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; VOGLER AJ, 2009, J BACTERIOL; Vogler AJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001319	54	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85417	10.1371/journal.pone.0085417	http://dx.doi.org/10.1371/journal.pone.0085417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465554	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500062
J	Wu, YC; Coulson, S				Wu, Ying Choon; Coulson, Seana			A Psychometric Measure of Working Memory Capacity for Configured Body Movement	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; ICONIC GESTURES; COMMUNICATION; RELIABILITY; INFORMATION; STABILITY; PATTERNS; SPEECH; EYE	Working memory (WM) models have traditionally assumed at least two domain-specific storage systems for verbal and visuo-spatial information. We review data that suggest the existence of an additional slave system devoted to the temporary storage of body movements, and present a novel instrument for its assessment: the movement span task. The movement span task assesses individuals' ability to remember and reproduce meaningless configurations of the body. During the encoding phase of a trial, participants watch short videos of meaningless movements presented in sets varying in size from one to five items. Immediately after encoding, they are prompted to reenact as many items as possible. The movement span task was administered to 90 participants along with standard tests of verbal WM, visuo-spatial WM, and a gesture classification test in which participants judged whether a speaker's gestures were congruent or incongruent with his accompanying speech. Performance on the gesture classification task was not related to standard measures of verbal or visuo-spatial working memory capacity, but was predicted by scores on the movement span task. Results suggest the movement span task can serve as an assessment of individual differences in WM capacity for body-centric information.	[Wu, Ying Choon; Coulson, Seana] Univ Calif San Diego, Ctr Res Language, La Jolla, CA 92093 USA; [Wu, Ying Choon] Univ Calif San Diego, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA; [Coulson, Seana] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Wu, YC (corresponding author), Univ Calif San Diego, Ctr Res Language, La Jolla, CA 92093 USA.	yingchoon@gmail.com		Coulson, Seana/0000-0003-1246-9394	National Science Foundation [BCS-0843946, SMA 1041755]	National Science Foundation(National Science Foundation (NSF))	This study was funded by generous grants from the National Science Foundation (BCS-0843946) to S.C. and (SMA 1041755) to the Temporal Dynamics of Learning Center, an NSF Science of Learning Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibali MW., 2005, SPAT COGN COMPUT, V5, P307, DOI [10.1207/s15427633scc0504_2, DOI 10.1207/S15427633SCC0504_2]; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bangerter A, 2004, PSYCHOL SCI, V15, P415, DOI 10.1111/j.0956-7976.2004.00694.x; BAVELAS JB, 1992, DISCOURSE PROCESS, V15, P469, DOI 10.1080/01638539209544823; Berch DB, 1998, BRAIN COGNITION, V38, P317, DOI 10.1006/brcg.1998.1039; Cassell J., 1999, PRAGMAT COGN, V7, P1, DOI [DOI 10.1075/PC.7.1.03CAS, 10.1075/pc.7.1.03cas]; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Cook SW, 2009, COGNITION, V113, P98, DOI 10.1016/j.cognition.2009.06.006; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; ENGLE RW, 1992, J EXP PSYCHOL LEARN, V18, P972, DOI 10.1037/0278-7393.18.5.972; Friedman NP, 2005, BEHAV RES METHODS, V37, P581, DOI 10.3758/BF03192728; Goldin-Meadow S, 1999, TRENDS COGN SCI, V3, P419, DOI 10.1016/S1364-6613(99)01397-2; Goldin-Meadow S., 2005, HEARING GESTURE OUR; Goodwin C, 2000, J PRAGMATICS, V32, P1489, DOI 10.1016/S0378-2166(99)00096-X; Hegarty M, 2005, SPAT COGN COMPUT, V5, P333, DOI DOI 10.1207/S15427633SCC0504_3; Holle H, 2007, J COGNITIVE NEUROSCI, V19, P1175, DOI 10.1162/jocn.2007.19.7.1175; Klein K, 1999, BEHAV RES METH INS C, V31, P429, DOI 10.3758/BF03200722; Lawrence BM, 2004, PSYCHON B REV, V11, P488, DOI 10.3758/BF03196600; Lawrence BM, 2001, MEMORY, V9, P433, DOI 10.1080/09658210143000047; Mecklinger A, 2002, CEREB CORTEX, V12, P1115, DOI 10.1093/cercor/12.11.1115; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Ozyurek A, 2007, J COGNITIVE NEUROSCI, V19, P605, DOI 10.1162/jocn.2007.19.4.605; Pearson DG, 2003, Q J EXP PSYCHOL-A, V56, P1089, DOI 10.1080/02724980343000044; Repovs G, 2006, NEUROSCIENCE, V139, P5, DOI 10.1016/j.neuroscience.2005.12.061; Rumiati RI, 1998, J EXP PSYCHOL HUMAN, V24, P631, DOI 10.1037/0096-1523.24.2.631; Rumiati RI, 2002, EXP BRAIN RES, V142, P425, DOI 10.1007/s00221-001-0956-x; Shah P, 1996, J EXP PSYCHOL GEN, V125, P4, DOI 10.1037/0096-3445.125.1.4; Smyrnis N, 2005, J NEUROPHYSIOL, V93, P3703, DOI 10.1152/jn.00972.2004; Smyrnis N, 2013, EXPT BRAIN RES; SMYTH MM, 1988, Q J EXP PSYCHOL-A, V40, P497, DOI 10.1080/02724988843000041; SMYTH MM, 1990, Q J EXP PSYCHOL-A, V42, P291, DOI 10.1080/14640749008401223; SMYTH MM, 1989, Q J EXP PSYCHOL-A, V41, P235, DOI 10.1080/14640748908402363; Theeuwes J, 2005, PSYCHOL SCI, V16, P196, DOI 10.1111/j.0956-7976.2005.00803.x; Vandierendonck A, 2004, BRIT J PSYCHOL, V95, P57, DOI 10.1348/000712604322779460; Waters GS, 2003, BEHAV RES METH INS C, V35, P550, DOI 10.3758/BF03195534; Waters GS, 1996, Q J EXP PSYCHOL-A, V49, P51, DOI 10.1080/027249896392801; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE; Wilson M, 2001, PSYCHON B REV, V8, P44, DOI 10.3758/BF03196138; Woodin ME, 1996, Q J EXP PSYCHOL-A, V49, P357, DOI 10.1080/027249896392685; Wu YC, 2007, BRAIN LANG, V101, P234, DOI 10.1016/j.bandl.2006.12.003; Wu YC, 2011, BRAIN LANG, V119, P184, DOI 10.1016/j.bandl.2011.07.002	43	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84834	10.1371/journal.pone.0084834	http://dx.doi.org/10.1371/journal.pone.0084834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297GT	24465437	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500017
J	Abdulle, A; Al-Junaibi, A; Nagelkerke, N				Abdulle, Abdishakur; Al-Junaibi, Abdulla; Nagelkerke, Nicolaas			High Blood Pressure and Its Association with Body Weight among Children and Adolescents in the United Arab Emirates	PLOS ONE			English	Article							4 AUTOMATIC DEVICES; INTERNATIONAL PROTOCOL; SCIENTIFIC STATEMENT; WAIST CIRCUMFERENCE; CHILDHOOD OBESITY; EUROPEAN-SOCIETY; SELF-MEASUREMENT; HYPERTENSION; PREVENTION; PREVALENCE	Objectives: To estimate the prevalence of high blood pressure (BP) and its relationship with obesity among children and adolescents. Methodology/Principal Findings: In this cross-sectional population (Emirati) representative study, we invited a random sample of 1600 students (grades 1-12) attending 23 out of all 246 schools in the Emirate of Abu Dhabi, United Arab Emirates. But analysis was restricted to Emirati nationals aged 6-17 years. We measured BP, height, weight, waist circumferences (WC), and calculated body mass index (BMI) by standard methods. BP levels >= 90th percentile but <95th percentile and >= 95th for age, sex, and height (CDC percentiles) were classified as pre-hypertension (pre-HTN) and hypertension (HTN), respectively. Associations between BP, age, BMI, WC, and sex, were investigated by (multiple) linear regression methods. A total of 999 (47% girls) students provided complete results. The prevalence of pre-HTN was 10.5% and 11.4% and the prevalence of HTN was 15.4% and 17.8% among boys and girls, respectively. The prevalence of systolic/diastolic HTN was 14.4%/2.5% and 14.8/7.4% among boys and girls, respectively. BMI CDC percentile was positively correlated with WC percentile (r = 0.734, p<0.01), and both systolic (r = 0.34, p<0.001) and diastolic (r = 0.21, p<0.001) standardized BP. WC percentile was less strongly correlated with standardized SBP (r = 0.255, p<0.01) and DBP (r = 0.175, p<0.01) than BMI. Conclusions/Significance: The prevalence of elevated BP, notably systolic was significantly high among the Emirati children and adolescents in Abu Dhabi. High BP was strongly related to body weight, and appears more strongly associated with BMI than WC. Further studies are required to investigate the impact of childhood obesity on HTN.	[Abdulle, Abdishakur] UAE Univ, Coll Med & Hlth Sci, Dept Internal Med, Abu Dhabi, U Arab Emirates; [Al-Junaibi, Abdulla] Zayed Mil Hosp, Dept Pediat, Abu Dhabi, U Arab Emirates; [Nagelkerke, Nicolaas] UAE Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Abu Dhabi, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Abdulle, A (corresponding author), UAE Univ, Coll Med & Hlth Sci, Dept Internal Med, Abu Dhabi, U Arab Emirates.	shakur.a@uaeu.ac.ae			Medical Services Corps, UAE Armed Forces	Medical Services Corps, UAE Armed Forces	This research was supported by a grant from Medical Services Corps, UAE Armed Forces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Junaibi A, 2013, INT J OBESITY, V37, P68, DOI 10.1038/ijo.2012.131; Altunkan S, 2008, BLOOD PRESS MONIT, V13, P117, DOI 10.1097/MBP.0b013e3282f3fb50; Belghazi J, 2007, VASC HEALTH RISK MAN, V3, P389; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Chiolero A, 2007, PEDIATRICS, V119, P544, DOI 10.1542/peds.2006-2136; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Croix B, 2006, PEDIATR NEPHROL, V21, P527, DOI 10.1007/s00467-006-0013-x; Daniels SR, 1999, J PEDIATR-US, V134, P665, DOI 10.1016/S0022-3476(99)70277-5; Duncan MJ, 2013, ANN HUM BIOL, V40, P163, DOI 10.3109/03014460.2012.752861; Falkner B, 2004, HYPERTENSION, V43, P203, DOI 10.1161/01.HYP.0000109322.72948.24; Feber J, 2010, CLIN SCI, V119, P151, DOI 10.1042/CS20090544; Flynn J, 2013, PEDIATR NEPHROL, V28, P1059, DOI 10.1007/s00467-012-2344-0; Gauer R, 2012, J FAM PRACTICE, V61, P425; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; Jayawardana R, 2013, DIABETES RES CLIN PR, V99, P292, DOI 10.1016/j.diabres.2012.12.013; Kuczmarski RJ, 2002, SERIES-J SPAN ECON, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; LaRosa Christopher, 2010, J Med Liban, V58, P132; Li JS, 2013, CIRCULATION, V127, P260, DOI 10.1161/CIR.0b013e3182756d8e; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McNiece KL, 2007, J PEDIATR-US, V150, P640, DOI 10.1016/j.jpeds.2007.01.052; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; O'Brien E, 2001, BMJ-BRIT MED J, V322, P1167, DOI 10.1136/bmj.322.7295.1167; Okafor Christian I, 2012, Indian J Endocrinol Metab, V16, P56, DOI 10.4103/2230-8210.91191; Raj M, 2013, INDIAN J PEDIATR, V80, pS71, DOI 10.1007/s12098-012-0851-4; Redwine KM, 2012, J PEDIATR-US, V160, P98, DOI 10.1016/j.jpeds.2011.07.010; Reilly JJ, 2012, ADV NUTR, V3, p636S, DOI 10.3945/an.112.002014; Saadi H, 2007, DIABETES RES CLIN PR, V78, P369, DOI 10.1016/j.diabres.2007.04.008; Topouchian J, 2011, VASC HEALTH RISK MAN, V7, P709, DOI 10.2147/VHRM.S27193; Zhang YX, 2013, INT J CARDIOL, V168, P1516, DOI 10.1016/j.ijcard.2012.12.097	32	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85129	10.1371/journal.pone.0085129	http://dx.doi.org/10.1371/journal.pone.0085129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465493	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500034
J	Zhang, W; Chen, S; Li, N; Zhang, JZ; Chen, W				Zhang, Wei; Chen, Song; Li, Na; Zhang, Jia Zheng; Chen, Wei			Correlated Diffusion of Colloidal Particles near a Liquid-Liquid Interface	PLOS ONE			English	Article							TIME SELF-DIFFUSION; HYDRODYNAMIC INTERACTION; QUASI-2-DIMENSIONAL SUSPENSIONS; SPHERICAL-PARTICLE; PLANAR BOUNDARY; WATER-INTERFACE; BROWNIAN-MOTION; SPHERES; MICRORHEOLOGY; MEMBRANE	Optical microscopy and multi-particle tracking are used to investigate the cross-correlated diffusion of quasi two-dimensional colloidal particles near an oil-water interface. The behaviors of the correlated diffusion along longitudinal and transverse direction are asymmetric. It is shown that the characteristic length for longitudinal and transverse correlated diffusion are particle diameter d and the distance z from particle center to the interface, respectively, for large particle separation r. The longitudinal and transverse correlated diffusion coefficient D-parallel to(r) and D-perpendicular to(r) are independent of the colloidal area fraction n when n<0.3, which indicates that the hydrodynamic interactions(HIs) among the particles are dominated by HIs through the surrounding fluid for small n. For high area fraction n>0.4, the power law exponent for the spatial decay of D-perpendicular to(r) begins to decrease, which suggests the HIs are more contributed from the 2D particle monolayer self for large n.	[Zhang, Wei; Chen, Song; Li, Na; Zhang, Jia Zheng; Chen, Wei] Fudan Univ, Dept Phys, State Key Lab Surface Phys, Shanghai 200433, Peoples R China; [Zhang, Wei] Northwestern Polytech Univ, Dept Appl Phys, Xian 710072, Peoples R China; [Zhang, Wei] Jinan Univ, Dept Phys, Guangzhou, Guangdong, Peoples R China; [Chen, Wei] Chinese Acad Sci, Kavli Inst Theoret Phys China, Beijing, Peoples R China	Fudan University; Northwestern Polytechnical University; Jinan University; Chinese Academy of Sciences	Zhang, W (corresponding author), Fudan Univ, Dept Phys, State Key Lab Surface Phys, Shanghai 200433, Peoples R China.	wzhangph@gmail.com; phchenwei@fudan.edu.cn	Chen, Song/AAB-1137-2021	Chen, Song/0000-0003-0813-2545	National Science Fund for Talent Trainning in Basic Science [J1103204]	National Science Fund for Talent Trainning in Basic Science	National Science Fund for Talent Trainning in Basic Science (Grant No. J1103204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickel T, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041403; Binks BP, 2006, COLLOIDAL PARTICLES; Blawzdziewicz J, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3475217; Chen W, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/28003; Cichocki B, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2724815; Crocker JC, 2000, PHYS REV LETT, V85, P888, DOI 10.1103/PhysRevLett.85.888; Cui BX, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.258301; Diamant H, 2005, J PHYS-CONDENS MAT, V17, pS4047, DOI 10.1088/0953-8984/17/49/003; Diamant H, 2005, J PHYS-CONDENS MAT, V17, pS2787, DOI 10.1088/0953-8984/17/31/003; Dufresne ER, 2000, PHYS REV LETT, V85, P3317, DOI 10.1103/PhysRevLett.85.3317; LEE SH, 1979, J FLUID MECH, V93, P705, DOI 10.1017/S0022112079001981; Levine AJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.061606; Lin BH, 2000, PHYS REV E, V62, P3909, DOI 10.1103/PhysRevE.62.3909; Mbamala EC, 2002, J PHYS-CONDENS MAT, V14, P4881, DOI 10.1088/0953-8984/14/19/313; Oppenheimer N, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041912; Oppenheimer N, 2009, BIOPHYS J, V96, P3041, DOI 10.1016/j.bpj.2009.01.020; Ortega F, 2010, CURR OPIN COLLOID IN, V15, P237, DOI 10.1016/j.cocis.2010.03.001; Peng Y, 2009, J FLUID MECH, V618, P243, DOI 10.1017/S0022112008004114; PERKINS GS, 1992, PHYSICA A, V189, P447, DOI 10.1016/0378-4371(92)90056-V; PERKINS GS, 1991, PHYSICA A, V171, P575, DOI 10.1016/0378-4371(91)90302-S; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Pushkar P L, 2011, SOFT MATTER, V7, P6844; SAFFMAN PG, 1976, J FLUID MECH, V73, P593, DOI 10.1017/S0022112076001511; Savin T, 2005, BIOPHYS J, V88, P623, DOI 10.1529/biophysj.104.04245; Shlomovitz R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.137802; Sickert M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.126104; Wang GM, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/4/044009; Wang GM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.248303; Whitesides GM, 2001, PHYS TODAY, V54, P42, DOI 10.1063/1.1387591; Wu CY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3243334; Wu J, 2006, APPL PHYS LETT, V89; Zhang W, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.168304	33	9	9	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85173	10.1371/journal.pone.0085173	http://dx.doi.org/10.1371/journal.pone.0085173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465498	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500036
J	Zhao, J; Ni, T; Li, Y; Xiong, W; Ran, W; Shen, BA; Shen, QR; Zhang, RF				Zhao, Jun; Ni, Tian; Li, Yong; Xiong, Wu; Ran, Wei; Shen, Biao; Shen, Qirong; Zhang, Ruifu			Responses of Bacterial Communities in Arable Soils in a Rice-Wheat Cropping System to Different Fertilizer Regimes and Sampling Times	PLOS ONE			English	Article							MICROBIAL BIOMASS CALIBRATION; FUMIGATION-EXTRACTION METHOD; 16S RIBOSOMAL-RNA; MANAGEMENT INFLUENCES; FUNGAL COMMUNITIES; DIVERSITY; PH; BIODIVERSITY; GRADIENT; NITROGEN	Soil physicochemical properties, soil microbial biomass and bacterial community structures in a rice-wheat cropping system subjected to different fertilizer regimes were investigated in two seasons (June and October). All fertilizer regimes increased the soil microbial biomass carbon and nitrogen. Both fertilizer regime and time had a significant effect on soil physicochemical properties and bacterial community structure. The combined application of inorganic fertilizer and manure organic-inorganic fertilizer significantly enhanced the bacterial diversity in both seasons. The bacterial communities across all samples were dominated by Proteobacteria, Acidobacteria and Chloroflexi at the phylum level. Permutational multivariate analysis confirmed that both fertilizer treatment and season were significant factors in the variation of the composition of the bacterial community. Hierarchical cluster analysis based on Bray-Curtis distances further revealed that bacterial communities were separated primarily by season. The effect of fertilizer treatment is significant (P = 0.005) and accounts for 7.43% of the total variation in bacterial community. Soil nutrients (e. g., available K, total N, total P and organic matter) rather than pH showed significant correlation with the majority of abundant taxa. In conclusion, both fertilizer treatment and seasonal changes affect soil properties, microbial biomass and bacterial community structure. The application of NPK plus manure organic-inorganic fertilizer may be a sound fertilizer practice for sustainable food production.	[Zhao, Jun; Ni, Tian; Xiong, Wu; Ran, Wei; Shen, Biao; Shen, Qirong; Zhang, Ruifu] Minist Agr, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Nanjing, Jiangsu, Peoples R China; [Zhao, Jun; Ni, Tian; Xiong, Wu; Ran, Wei; Shen, Biao; Shen, Qirong; Zhang, Ruifu] Nanjing Agr Univ, Jiangsu Key Lab, Nanjing, Jiangsu, Peoples R China; [Zhao, Jun; Ni, Tian; Xiong, Wu; Ran, Wei; Shen, Biao; Shen, Qirong; Zhang, Ruifu] Nanjing Agr Univ, Engn Ctr Solid Organ Waste Utilizat, Nanjing, Jiangsu, Peoples R China; [Li, Yong] Jintan Agr & Forestry Bur, Soil & Fertilizer Tech Guidance Stn Jintan City, Jintan, Jiangsu, Peoples R China; [Shen, Qirong; Zhang, Ruifu] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Nanjing Agricultural University; Nanjing Agricultural University	Zhang, RF (corresponding author), Minist Agr, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Nanjing, Jiangsu, Peoples R China.	rfzhang@njau.edu.cn	Zhang, Ruifu/HDN-0340-2022; Zhao, Jun/U-8586-2018; Zhang, Kevin/F-5215-2010; Shen, Qirong/AAB-6531-2020; Zhang, Ruifu/HDN-0417-2022	Zhao, Jun/0000-0002-6691-2999; 	Agricultural Ministry of China [201103004]; Chinese Ministry of Science and Technology [2011BAD11B03]; 111 Project [B12009]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	Agricultural Ministry of China(Ministry of Agriculture & Rural Affairs); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); 111 Project(Ministry of Education, China - 111 Project); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This research was financially supported by the Agricultural Ministry of China (201103004) and the Chinese Ministry of Science and Technology (2011BAD11B03), RZ and QS were also supported by the 111 Project (B12009) and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bending GD, 2004, SOIL BIOL BIOCHEM, V36, P1785, DOI 10.1016/j.soilbio.2004.04.035; Brady N.C., 1996, NATURE PROPERTIES SO; Bremer C, 2009, FEMS MICROBIOL ECOL, V70, P377, DOI 10.1111/j.1574-6941.2009.00732.x; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Chaer G, 2009, MICROB ECOL, V58, P414, DOI 10.1007/s00248-009-9508-x; Chao A, 1984, SCAND J STAT, P265; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; DIAZRAVINA M, 1995, BIOL FERT SOILS, V19, P220, DOI 10.1007/BF00336163; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Esperschuetz J, 2007, FEMS MICROBIOL ECOL, V61, P26, DOI 10.1111/j.1574-6941.2007.00318.x; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Ge GF, 2010, PLANT SOIL, V326, P31, DOI 10.1007/s11104-009-0186-8; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; Griffiths RI, 2003, FEMS MICROBIOL ECOL, V43, P35, DOI 10.1111/j.1574-6941.2003.tb01043.x; Gu YF, 2009, EUR J SOIL BIOL, V45, P239, DOI 10.1016/j.ejsobi.2009.02.005; Hannula SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033819; Islam MR, 2011, BIOL FERT SOILS, V47, P599, DOI 10.1007/s00374-010-0524-2; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P25, DOI 10.1016/0038-0717(95)00102-6; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P33, DOI 10.1016/0038-0717(95)00101-8; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; KENNEDY AC, 1995, PLANT SOIL, V170, P75, DOI 10.1007/BF02183056; Kennedy N, 2006, CAN J MICROBIOL, V52, P689, DOI 10.1139/W06-015; Kennedy NM, 2005, FEMS MICROBIOL ECOL, V53, P329, DOI 10.1016/j.femsec.2005.01.013; Kikuchi H, 2007, SOIL SCI PLANT NUTR, V53, P448, DOI 10.1111/j.1747-0765.2007.00177.x; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Li R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051897; Lv MR, 2011, BIOL FERT SOILS, V47, P777, DOI 10.1007/s00374-011-0584-y; Masto RE, 2006, SOIL BIOL BIOCHEM, V38, P1577, DOI 10.1016/j.soilbio.2005.11.012; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Navarrete AA, 2013, FEMS MICROBIOL ECOL, V83, P607, DOI 10.1111/1574-6941.12018; Noll M, 2005, ENVIRON MICROBIOL, V7, P382, DOI 10.1111/j.1462-2920.2005.00700.x; Oksanen J., 2009, VEGAN COMMUNITY ECOL; Orr CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052891; Plaza C, 2004, SOIL BIOL BIOCHEM, V36, P1577, DOI 10.1016/j.soilbio.2004.07.017; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Saha S, 2008, EUR J SOIL BIOL, V44, P309, DOI 10.1016/j.ejsobi.2008.02.004; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schutter ME, 2001, BIOL FERT SOILS, V34, P397, DOI 10.1007/s00374-001-0423-7; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Shi ChunYu, 2004, Plant Nutrition and Fertilizer Science, V10, P584; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singh BK, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2119-c1; Sparling G. P., 1997, P97; van Diepeningen AD, 2006, APPL SOIL ECOL, V31, P120, DOI 10.1016/j.apsoil.2005.03.003; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WASHINGTON HG, 1984, WATER RES, V18, P653, DOI 10.1016/0043-1354(84)90164-7; Xiong JB, 2012, ENVIRON MICROBIOL, V14, P2457, DOI 10.1111/j.1462-2920.2012.02799.x; Yu WT, 2013, MICROBIAL BIOMASS CO; Zhong WH, 2007, APPL SOIL ECOL, V36, P84, DOI 10.1016/j.apsoil.2006.12.001	70	115	144	12	175	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85301	10.1371/journal.pone.0085301	http://dx.doi.org/10.1371/journal.pone.0085301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465530	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500040
J	Lacroix, L; Post, SF; Valent, A; Melkane, AE; Vielh, P; Egile, C; Castell, C; Larois, C; Micallef, S; Saulnier, P; Goulaouic, H; Lefebvre, AM; Temam, S				Lacroix, Ludovic; Post, Sophie F.; Valent, Alexander; Melkane, Antoine E.; Vielh, Philippe; Egile, Coumaran; Castell, Christelle; Larois, Christelle; Micallef, Sandrine; Saulnier, Patrick; Goulaouic, Helene; Lefebvre, Anne-Marie; Temam, Stephane			MET Genetic Abnormalities Unreliable for Patient Selection for Therapeutic Intervention in Oropharyngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; C-MET; HUMAN-PAPILLOMAVIRUS; COPY NUMBER; HEAD; EXPRESSION; SURVIVAL; CANCER; OVEREXPRESSION	Background: Identification of MET genetic alteration, mutation, or amplification in oropharyngeal squamous cell carcinoma (OPSCC) could lead to development of MET selective kinase inhibitors. The aim of this study was to assess the frequency and prognostic value of MET gene mutation, amplification, and protein expression in primary OPSCC. Methods: A retrospective chart review was conducted of patients treated for single primary OPSCC between January 2007 and December 2009. Pre-treatment OPSCC tissue samples were analyzed for MET mutations, gene amplification, and overexpression using Sanger sequencing, FISH analysis, and immunohistochemistry respectively. Univariate and multivariate analyses were used to analyze correlations between molecular abnormalities and patient survival. Results: 143 patients were included in this study. Six cases (4%) were identified that had a genetic variation, but previously described mutations such as p. Tyr1235Asp (Y1235D) or p.Tyr1230Cys (Y1230C) were not detected. There were 15 high polysomy cases, and only 3 cases met the criteria for true MET amplification, with >= 10% amplified cells per case. Immunohistochemistry evaluation showed 43% of cases were c-MET negative and in 57% c-MET was observed at the tumor cell level. Multivariate analysis showed no significant association between MET mutation, amplification, or expression and survival. Conclusions: Our study shows a low frequency of MET mutations and amplification in this cohort of OPSCC. There was no significant correlation between MET mutations, amplification, or expression and patient survival. These results suggest that patient selection based on these MET genetic abnormalities may not be a reliable strategy for therapeutic intervention in OPSCC.	[Lacroix, Ludovic; Valent, Alexander; Vielh, Philippe] Inst Gustave Roussy, Dept Med Biol & Pathol, Villejuif, France; [Lacroix, Ludovic; Valent, Alexander; Vielh, Philippe; Saulnier, Patrick] Inst Gustave Roussy, Translat Res Lab, Villejuif, France; [Lacroix, Ludovic; Valent, Alexander; Vielh, Philippe; Saulnier, Patrick] Inst Gustave Roussy, Biobank, Villejuif, France; [Post, Sophie F.; Melkane, Antoine E.; Temam, Stephane] Inst Gustave Roussy, Dept Head & Neck Surg Oncol, Villejuif, France; [Post, Sophie F.] Univ Groningen, Univ Med Ctr Groningen, Dept Plast Surg, NL-9713 AV Groningen, Netherlands; [Egile, Coumaran; Castell, Christelle; Goulaouic, Helene] Sanofi, Dept Oncol, Vitry Sur Seine, France; [Larois, Christelle; Lefebvre, Anne-Marie] Sanofi, Dept Biol Sci Core Platform BioSCP, Vitry Sur Seine, France; [Micallef, Sandrine] Sanofi, Dept Sci Core Platform Clin & Sci Operat SCP CSO, Vitry Sur Seine, France	UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; University of Groningen; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France	Temam, S (corresponding author), Inst Gustave Roussy, Dept Head & Neck Surg Oncol, Villejuif, France.	stephane.temam@igr.fr		Lefebvre, Anne-Marie/0000-0001-5644-0441	Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	Funding was received from Sanofi-Aventis for laboratory work done at the Gustave Roussy Cancer Institute (labor, assay development, reagents). Sanofi performed the immunohistochemistry, and provided xenograft tumor tissue with different levels of MET amplification for the characterization of the MET FISH probe. Sanofi also provided assistance for statistical analysis and was involved in data analysis.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aebersold DM, 2003, ONCOGENE, V22, P8519, DOI 10.1038/sj.onc.1206968; Aebersold DM, 2001, INT J CANCER, V96, P41, DOI 10.1002/1097-0215(20010220)96:1<41::AID-IJC5>3.0.CO;2-F; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Cappuzzo F, 2009, J CLIN ONCOL, V27, P1667, DOI 10.1200/JCO.2008.19.1635; Chen YS, 2004, J ORAL PATHOL MED, V33, P209, DOI 10.1111/j.0904-2512.2004.00118.x; Cortesina G, 2000, INT J CANCER, V89, P286, DOI 10.1002/1097-0215(20000520)89:3<286::AID-IJC12>3.3.CO;2-L; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; De Herdt MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P2516, DOI 10.2741/2863; Di Renzo MF, 2000, ONCOGENE, V19, P1547, DOI 10.1038/sj.onc.1203455; Druzgal CH, 2005, HEAD NECK-J SCI SPEC, V27, P771, DOI 10.1002/hed.20246; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Galeazzi E, 1997, EUR ARCH OTO-RHINO-L, V254, pS138, DOI 10.1007/BF02439745; Garcia S, 2007, BRIT J CANCER, V96, P329, DOI 10.1038/sj.bjc.6603569; Ghadjar P, 2009, CLIN EXP METASTAS, V26, P809, DOI 10.1007/s10585-009-9280-9; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim CH, 2006, ACTA OTO-LARYNGOL, V126, P88, DOI 10.1080/00016480510037014; Kim CH, 2007, ORAL ONCOL, V43, P1021, DOI 10.1016/j.oraloncology.2006.11.016; Kim CH, 2010, HEAD NECK-J SCI SPEC, V32, P1655, DOI 10.1002/hed.21383; Knowles LM, 2009, CLIN CANCER RES, V15, P3740, DOI 10.1158/1078-0432.CCR-08-3252; Krishnaswamy S, 2009, CLIN CANCER RES, V15, P5714, DOI 10.1158/1078-0432.CCR-09-0070; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Lim YC, 2012, ORAL ONCOL; Lo Muzio L, 2006, TUMOR BIOL, V27, P115, DOI 10.1159/000092716; Ma PC, 2008, GENE CHROMOSOME CANC, V47, P1025, DOI 10.1002/gcc.20604; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; Mehanna H, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1439; Melkane AE, 2013, HEAD NECK; Miyata Y, 2006, CLIN CANCER RES, V12, P4876, DOI 10.1158/1078-0432.CCR-06-0362; Morello S, 2001, J CELL PHYSIOL, V189, P285, DOI 10.1002/jcp.10010; Nakajima M, 1999, CANCER, V85, P1894; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Park S, 2012, HISTOL HISTOPATHOL, V27, P197, DOI 10.14670/HH-27.197; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Peters S, 2012, NAT REV CLIN ONCOL; Seiwert TY, 2009, CANCER RES, V69, P3021, DOI 10.1158/0008-5472.CAN-08-2881; Shi J, 2012, INT J MOL SCI, V13, P4714, DOI 10.3390/ijms13044714; Taniguchi K, 1998, CANCER, V82, P2112, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2112::AID-CNCR5>3.3.CO;2-U; Uchida D, 2001, INT J CANCER, V93, P489, DOI 10.1002/ijc.1368; van Monsjou HS, 2012, INT J CANCER, V130, P1806, DOI 10.1002/ijc.26195; van Monsjou HS, 2010, ORAL ONCOL, V46, P780, DOI 10.1016/j.oraloncology.2010.08.011; Zhang YW, 2003, J CELL BIOCHEM, V88, P408, DOI 10.1002/jcb.10358	50	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84319	10.1371/journal.pone.0084319	http://dx.doi.org/10.1371/journal.pone.0084319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465403	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000011
J	Pinto, C; Pinho, D; Sousa, S; Pinheiro, M; Egas, C; Gomes, AC				Pinto, Catia; Pinho, Diogo; Sousa, Susana; Pinheiro, Miguel; Egas, Conceicao; Gomes, Ana C.			Unravelling the Diversity of Grapevine Microbiome	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; VITIS-VINIFERA; ACID BACTERIA; WINE GRAPES; BIOCONTROL; RESISTANCE; BOTRYTIS; ECOLOGY; FUNGAL; YEASTS	Vitis vinifera is one of the most widely cultivated fruit crops with a great economic impact on the global industry. As a plant, it is naturally colonised by a wide variety of both prokaryotic and eukaryotic microorganisms that interact with grapevine, having either beneficial or phytopathogenic effects, who play a major role in fruit yield, grape quality and, ultimately, in the evolution of grape fermentation and wine production. Therefore, the objective of this study was to extensively characterize the natural microbiome of grapevine. Considering that the majority of microorganisms are uncultivable, we have deeply studied the microflora of grapevine leaves using massive parallel rDNA sequencing, along its vegetative cycle. Among eukaryotic population the most abundant microorganisms belonged to the early diverging fungi lineages and Ascomycota phylum, whereas the Basidiomycota were the least abundant. Regarding prokaryotes, a high diversity of Proteobacteria, Firmicutes and Actinobacteria was unveiled. Indeed, the microbial communities present in the vineyard during its vegetative cycle were shown to be highly structured and dynamic. In all cases, the major abundant microorganisms were the yeast-like fungus Aureobasidium and the prokaryotic Enterobacteriaceae. Herein, we report the first complete microbiome landscape of the vineyard, through a metagenomic approach, and highlight the analysis of the microbial interactions within the vineyard and its importance for the equilibrium of the microecosystem of grapevines.	[Pinto, Catia; Pinho, Diogo; Sousa, Susana; Gomes, Ana C.] Biocant Biotechnol Innovat Ctr, Genom Unit, Cantanhede, Portugal; [Pinheiro, Miguel; Egas, Conceicao] Biocant Biotechnol Innovat Ctr, Adv Serv Unit, Cantanhede, Portugal		Gomes, AC (corresponding author), Biocant Biotechnol Innovat Ctr, Genom Unit, Cantanhede, Portugal.	acgomes@biocant.pt	rolshausen, philippe/F-7999-2011; Pinheiro, Miguel/K-6572-2017; Gomes, Ana Catarina/A-2628-2015; Egas, Conceição/K-4866-2014; Pinho, Diogo/ABG-5993-2021	Pinheiro, Miguel/0000-0002-6601-7513; Gomes, Ana Catarina/0000-0002-4989-6026; Egas, Conceição/0000-0002-2307-5414; Pinho, Diogo/0000-0002-0377-2802	FEDER - COMPETE through "Quadro de Referencia Estrategico Nacional" - QREN [FCOMP-01-0202-FEDER-011498, FCOMP-01-0124-FEDER-008749]; FEDER through "Programa Operacional Factores de Competitividade" - COMPETE; FEDER through FCT - "Fundacao para a Ciencia e a Tecnologia"	FEDER - COMPETE through "Quadro de Referencia Estrategico Nacional" - QREN; FEDER through "Programa Operacional Factores de Competitividade" - COMPETE; FEDER through FCT - "Fundacao para a Ciencia e a Tecnologia"	This work was carried out within the InovWine project, which funded by FEDER - COMPETE, through "Quadro de Referencia Estrategico Nacional" - QREN, with the reference FCOMP-01-0202-FEDER-011498, and within the project FCOMP-01-0124-FEDER-008749, which is financed with funds from FEDER through the "Programa Operacional Factores de Competitividade" - COMPETE, and FCT - "Fundacao para a Ciencia e a Tecnologia". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2006, J APPL MICROBIOL, V100, P712, DOI 10.1111/j.1365-2672.2006.02890.x; Barata A, 2008, J APPL MICROBIOL, V104, P1182, DOI 10.1111/j.1365-2672.2007.03631.x; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Batta Y. A., 2006, Journal of Applied Horticulture (Lucknow), V8, P29; Bisson Linda F., 2009, P47, DOI 10.1007/978-3-540-85463-0_3; Botha A, 2011, SOIL BIOL BIOCHEM, V43, P1, DOI 10.1016/j.soilbio.2010.10.001; Bulgari D, 2011, APPL ENVIRON MICROB, V77, P5018, DOI 10.1128/AEM.00051-11; Cabras P, 1999, J AGR FOOD CHEM, V47, P3854, DOI 10.1021/jf990005j; Cabras P, 1997, J AGR FOOD CHEM, V45, P476, DOI 10.1021/jf960353a; Calonnec A, 2004, PLANT PATHOL, V53, P434, DOI 10.1111/j.0032-0862.2004.01016.x; Chervin C., 2012, Crop post-harvest: science and technology. Volume 3: perishables, P187; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Comitini F, 2008, ANN MICROBIOL, V58, P489, DOI 10.1007/BF03175547; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Compant S, 2011, MICROB ECOL, V62, P188, DOI 10.1007/s00248-011-9883-y; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferreira RB, 2004, TRENDS BIOTECHNOL, V22, P168, DOI 10.1016/j.tibtech.2004.02.001; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Fusi M, 2010, FOOD CONTROL, V21, P830, DOI 10.1016/j.foodcont.2009.11.009; Garijo P, 2011, EUR FOOD RES TECHNOL, V233, P359, DOI 10.1007/s00217-011-1528-3; Gomes E., 2009, GRAPEVINE MOL PHYSL, P407, DOI DOI 10.1007/978-90-481-2305-6_15; Grube M, 2011, FUNGAL BIOL-UK, V115, P978, DOI 10.1016/j.funbio.2011.04.004; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Jackson R.S., 2000, WINE SCI PRINCIPLES, P375, DOI [10.1016/B978-0-12-373646-8.50004-4, DOI 10.1016/B978-0-12-373646-8.50004-4]; JOYEUX A, 1984, APPL ENVIRON MICROB, V48, P153, DOI 10.1128/AEM.48.1.153-156.1984; Koenig Helmut, 2009, P3, DOI 10.1007/978-3-540-85463-0_1; Laimer M, 2009, J PLANT PATHOL, V91, P7; Lodewyckx C, 2002, CRIT REV PLANT SCI, V21, P583, DOI 10.1080/0735-260291044377; Loureiro V, 2003, INT J FOOD MICROBIOL, V86, P23, DOI 10.1016/S0168-1605(03)00246-0; Manuel Guillamon Jose, 2009, P31, DOI 10.1007/978-3-540-85463-0_2; Martins I, 2010, RELATORIO ACTIVIDADE, P1; Mocali S, 2010, RES MICROBIOL, V161, P497, DOI 10.1016/j.resmic.2010.04.010; Mostert L, 2001, MYCOLOGIA, V93, P146, DOI 10.2307/3761612; Nisiotou AA, 2011, INT J FOOD MICROBIOL, V145, P432, DOI 10.1016/j.ijfoodmicro.2011.01.017; Pereira A, 2003, PROTECCAO INTEGRADA; Phalip V, 2006, FEMS MICROBIOL ECOL, V56, P321, DOI 10.1111/j.1574-6941.2006.00102.x; Prakitchaiwattana CJ, 2004, FEMS YEAST RES, V4, P865, DOI 10.1016/j.femsyr.2004.05.004; Raspor P, 2010, FOOD TECHNOL BIOTECH, V48, P336; Rego C, 2007, ACT 7 S VIT AL EV PO, P107; Renker C, 2004, FEMS YEAST RES, V4, P597, DOI 10.1016/j.femsyr.2004.01.001; Renouf V, 2007, APPL MICROBIOL BIOT, V75, P149, DOI 10.1007/s00253-006-0798-3; Schloss PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-34; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schulz B, 1999, MYCOL RES, V103, P1275, DOI 10.1017/S0953756299008540; Serra R, 2005, RES MICROBIOL, V156, P515, DOI 10.1016/j.resmic.2004.12.005; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Sipiczki M, 2006, APPL ENVIRON MICROB, V72, P6716, DOI 10.1128/AEM.01275-06; Siqueira Jose F Jr, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.10743; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Toit W, 2002, ANAL MICROBIOL, V52, P155; Trotel-Aziz P, 2008, ENVIRON EXP BOT, V64, P21, DOI 10.1016/j.envexpbot.2007.12.009; Urbez-Torres JR, 2006, PLANT DIS, V90, P1490, DOI 10.1094/PD-90-1490; van der Waals JE, 2004, PLANT DIS, V88, P959, DOI 10.1094/PDIS.2004.88.9.959; Visconti A, 2008, FOOD ADDIT CONTAM A, V25, P193, DOI 10.1080/02652030701744546; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Xu J, 2009, MICROBIOL-SGM, V155, P174, DOI 10.1099/mic.0.022103-0; Zahavi T, 2000, POSTHARVEST BIOL TEC, V20, P115, DOI 10.1016/S0925-5214(00)00118-6	60	179	184	1	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85622	10.1371/journal.pone.0085622	http://dx.doi.org/10.1371/journal.pone.0085622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454903	Green Published, gold, Green Submitted			2022-12-25	WOS:000330236000014
J	Uhernik, AL; Li, L; LaVoy, N; Velasquez, MJ; Smith, JP				Uhernik, Amy L.; Li, Lun; LaVoy, Nathan; Velasquez, Micah J.; Smith, Jeffrey P.			Regulation of Monocarboxylic Acid Transporter-1 by cAMP Dependent Vesicular Trafficking in Brain Microvascular Endothelial Cells	PLOS ONE			English	Article							INTRACELLULAR PH INDICATOR; TISSUE-SPECIFIC POLARITY; EXPRESSION; EPITHELIA; GREEN; NEOVASCULARIZATION; ACIDIFICATION; MECHANISMS; PROTEINS; PATHWAY	In this study, a detailed characterization of Monocarboxylic Acid Transporter-1 (Mct1) in cytoplasmic vesicles of cultured rat brain microvascular endothelial cells shows them to be a diverse population of endosomes intrinsic to the regulation of the transporter by a brief 25 to 30 minute exposure to the membrane permeant cAMP analog, 8Br-cAMP. The vesicles are heterogeneous in size, mobility, internal pH, and co-localize with discreet markers of particular types of endosomes including early endosomes, clathrin coated vesicles, caveolar vesicles, trans-golgi, and lysosomes. The vesicular localization of Mct1 was not dependent on its N or C termini, however, the size and pH of Mct1 vesicles was increased by deletion of either terminus demonstrating a role for the termini in vesicular trafficking of Mct1. Using a novel BCECF-AM based assay developed in this study, 8Br-cAMP was shown to decrease the pH of Mct1 vesicles after 25 minutes. This result and method were confirmed in experiments with a ratiometric pH-sensitive EGFP-mCherry dual tagged Mct1 construct. Overall, the results indicate that cAMP signaling reduces the functionality of Mct1 in cerebrovascular endothelial cells by facilitating its entry into a highly dynamic vesicular trafficking pathway that appears to lead to the transporter's trafficking to autophagosomes and lysosomes.	[Uhernik, Amy L.; Li, Lun; LaVoy, Nathan; Velasquez, Micah J.; Smith, Jeffrey P.] Colorado State Univ Pueblo, Dept Biol, Pueblo, CO 81001 USA	Colorado State University	Smith, JP (corresponding author), Colorado State Univ Pueblo, Dept Biol, Pueblo, CO 81001 USA.	jeff.smith@colostate-pueblo.edu			National Institutes of Health, National Institute of Neurological Disorders and Stroke [1R15NS062404-01A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS062404] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institutes of Health, National Institute of Neurological Disorders and Stroke, Grant 1R15NS062404-01A2. The authors have no conflicts of interest to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby MC, 2004, TRENDS NEUROSCI, V27, P257, DOI 10.1016/j.tins.2004.03.010; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Candela P, 2008, ENDOTHELIUM-J ENDOTH, V15, P254, DOI 10.1080/10623320802487759; CARPENTER L, 1994, BIOCHEM J, V304, P751, DOI 10.1042/bj3040751; Castorino JJ, 2011, TRAFFIC, V12, P483, DOI 10.1111/j.1600-0854.2010.01155.x; Deora AA, 2005, P NATL ACAD SCI USA, V102, P16245, DOI 10.1073/pnas.0504419102; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Froberg MK, 2001, NEUROREPORT, V12, P761, DOI 10.1097/00001756-200103260-00030; Gallagher SM, 2009, AM J PHYSIOL-CELL PH, V296, pC414, DOI 10.1152/ajpcell.00430.2008; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Koryakina Y, 2012, CELL BIOL INT, V36, P1171, DOI 10.1042/CBI20120134; Kraft C, 2012, CURR OPIN CELL BIOL, V24, P496, DOI 10.1016/j.ceb.2012.05.001; Liman TG, 2012, CEREBROVASC DIS, V33, P492, DOI 10.1159/000337155; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; MELLMAN I, 1992, J EXP BIOL, V172, P39; Miranda-Goncalves V, 2013, NEURO-ONCOLOGY, V15, P172, DOI 10.1093/neuonc/nos298; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1305, DOI 10.1167/iovs.02-0552; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; ROUX F, 1994, J CELL PHYSIOL, V159, P101, DOI 10.1002/jcp.1041590114; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; SHI LB, 1991, BIOPHYS J, V59, P1208, DOI 10.1016/S0006-3495(91)82336-0; Smith JK, 2012, PSYCHOL AESTHET CREA, V6, P1, DOI 10.1037/a0027241; Smith JP, 2006, J BIOL CHEM, V281, P2053, DOI 10.1074/jbc.M511577200; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; STRAUBINGER RM, 1990, BIOCHEMISTRY-US, V29, P4929, DOI 10.1021/bi00472a025; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Uhernik AL, 2011, BRAIN RES, V1376, P10, DOI 10.1016/j.brainres.2010.12.060; Urquhart BL, 2009, EUR J CLIN PHARMACOL, V65, P1063, DOI 10.1007/s00228-009-0714-8; Vijay N, 2013, CURR PHARM DES; Virgintino D, 2002, NEUROSCIENCE, V115, P145, DOI 10.1016/S0306-4522(02)00374-3; Yang LL, 2008, J BIOL CHEM, V283, P21703, DOI 10.1074/jbc.M800809200	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85957	10.1371/journal.pone.0085957	http://dx.doi.org/10.1371/journal.pone.0085957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454947	Green Published, Green Submitted, gold			2022-12-25	WOS:000330236000021
J	van Ooyen, A; Carnell, A; de Ridder, S; Tarigan, B; Mansvelder, HD; Bijma, F; de Gunst, M; van Pelt, J				van Ooyen, Arjen; Carnell, Andrew; de Ridder, Sander; Tarigan, Bernadetta; Mansvelder, Huibert D.; Bijma, Fetsje; de Gunst, Mathisca; van Pelt, Jaap			Independently Outgrowing Neurons and Geometry-Based Synapse Formation Produce Networks with Realistic Synaptic Connectivity	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; GRAPH-THEORETICAL ANALYSIS; MEDIAL PREFRONTAL CORTEX; COMPLEX BRAIN NETWORKS; RAT BARREL CORTEX; PYRAMIDAL NEURONS; VISUAL-CORTEX; FUNCTIONAL CONNECTIVITY; DENDRITIC MORPHOLOGY; SCHIZOPHRENIA	Neuronal signal integration and information processing in cortical networks critically depend on the organization of synaptic connectivity. During development, neurons can form synaptic connections when their axonal and dendritic arborizations come within close proximity of each other. Although many signaling cues are thought to be involved in guiding neuronal extensions, the extent to which accidental appositions between axons and dendrites can already account for synaptic connectivity remains unclear. To investigate this, we generated a local network of cortical L2/3 neurons that grew out independently of each other and that were not guided by any extracellular cues. Synapses were formed when axonal and dendritic branches came by chance within a threshold distance of each other. Despite the absence of guidance cues, we found that the emerging synaptic connectivity showed a good agreement with available experimental data on spatial locations of synapses on dendrites and axons, number of synapses by which neurons are connected, connection probability between neurons, distance between connected neurons, and pattern of synaptic connectivity. The connectivity pattern had a small-world topology but was not scale free. Together, our results suggest that baseline synaptic connectivity in local cortical circuits may largely result from accidentally overlapping axonal and dendritic branches of independently outgrowing neurons.	[van Ooyen, Arjen; Carnell, Andrew; de Ridder, Sander; Mansvelder, Huibert D.; van Pelt, Jaap] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, Amsterdam, Netherlands; [Tarigan, Bernadetta; Bijma, Fetsje; de Gunst, Mathisca] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Ooyen, A (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, Amsterdam, Netherlands.	arjen.van.ooyen@falw.vu.nl	Tarigan, Bernadetta/AAD-1843-2019; Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340; de Ridder, Sander/0000-0001-7250-7239	European Union [216593]; Netherlands Organization for Scientific Research [635.100.017]	European Union(European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the BIO-ICT project SECO (grant number 216593) of the 7th Framework Programme of the European Union, and the NETFORM project (grant number 635.100.017) of the Computational Life Sciences program of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirikian B, 2005, PLOS COMPUT BIOL, V1, P74, DOI 10.1371/journal.pcbi.0010011; Arendt T, 1997, J NEUROSCI, V17, P516; Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen W, 2011, FRONT COMPUT NEUROSC, V5, DOI DOI 10.3389/FNC0M.2011.00014; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Cho MW, 2010, INT J IMAG SYST TECH, V20, P108, DOI 10.1002/ima.20229; CHU PH, 1994, INT J BIFURCAT CHAOS, V4, P237, DOI 10.1142/S0218127494000198; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Costa LD, 2002, NETWORK-COMP NEURAL, V13, P283, DOI 10.1088/0954-898X/13/3/303; Courchesne E, 2005, DEV PSYCHOPATHOL, V17, P577, DOI 10.1017/S0954579405050285; Cullen TJ, 2006, BRIT J PSYCHIAT, V188, P26, DOI 10.1192/bjp.bp.104.008169; da Silva S, 2011, CURR OPIN NEUROBIOL, V21, P61, DOI 10.1016/j.conb.2010.07.007; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Gaiteri C, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00010; Gerhard F, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI [10.3389/fncom.2011.00004, 10.3389/fncom.2011.00023]; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Hill SL, 2012, P NATL ACAD SCI USA, V109, pE2885, DOI 10.1073/pnas.1202128109; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Isbister CM, 1999, J NEUROSCI, V19, P2589; Kaiser M, 2009, CEREB CORTEX, V19, P3001, DOI 10.1093/cercor/bhp071; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Koene RA, 2009, NEUROINFORMATICS, V7, P195, DOI 10.1007/s12021-009-9052-3; Kotter R, 2002, NEUROSCIENCE DATABAS, P171; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; LARKMAN AU, 1991, J COMP NEUROL, V306, P307, DOI 10.1002/cne.903060207; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; LOHMANN H, 1994, J COMP NEUROL, V344, P543, DOI 10.1002/cne.903440405; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Magarinos AM, 1996, J NEUROSCI, V16, P3534; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Morelli LG, 2004, EUR PHYS J B, V38, P495, DOI 10.1140/epjb/e2004-00144-7; Neymotin SA, 2011, J COMPUT NEUROSCI, V30, P69, DOI 10.1007/s10827-010-0253-4; Nisbach F, 2007, EUR PHYS J B, V58, P185, DOI 10.1140/epjb/e2007-00214-4; Nunez JL, 1998, DEV BRAIN RES, V111, P89, DOI 10.1016/S0165-3806(98)00125-4; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Pernice V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002059; PETERS A, 1979, TRENDS NEUROSCI, V2, P183, DOI 10.1016/0166-2236(79)90074-2; Polinsky M, 2000, J NEUROSCI, V20, P1044, DOI 10.1523/JNEUROSCI.20-03-01044.2000; Polleux F, 2005, NEURON, V46, P395, DOI 10.1016/j.neuron.2005.04.017; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Roxin A, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00008; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Takahashi N, 2010, P NATL ACAD SCI USA, V107, P10244, DOI 10.1073/pnas.0914594107; TESSIERLAVIGNE M, 1994, CURR OPIN GENET DEV, V4, P596, DOI 10.1016/0959-437X(94)90078-H; Tigerholm J, 2013, HIPPOCAMPUS, V23, P87, DOI 10.1002/hipo.22061; UYLINGS HBM, 1994, PROG BRAIN RES, V102, P109; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van Pelt J, 2001, METH NE FRO NEUROSCI, P179; van Pelt J, 2001, ANAT EMBRYOL, V204, P255, DOI 10.1007/s004290100197; Van Pelt J., 2005, MODELING NEUROSCIENC, P89, DOI DOI 10.1201/9780203390979.CH5; van Pelt J, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00148; VANPELT J, 2003, BRAIN MIND, V4, P51, DOI DOI 10.1023/A:1024160131897; Voges N, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00041; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; YAMADA M, 1988, J NEUROL NEUROSUR PS, V51, P1088, DOI 10.1136/jnnp.51.8.1088; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047	76	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85858	10.1371/journal.pone.0085858	http://dx.doi.org/10.1371/journal.pone.0085858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454938	Green Published, gold			2022-12-25	WOS:000330236000017
J	Gach, JS; Achenbach, CJ; Chromikova, V; Berzins, B; Lambert, N; Landucci, G; Forthal, DN; Katlama, C; Jung, BH; Murphy, RL				Gach, Johannes S.; Achenbach, Chad J.; Chromikova, Veronika; Berzins, Baiba; Lambert, Nina; Landucci, Gary; Forthal, Donald N.; Katlama, Christine; Jung, Barbara H.; Murphy, Robert L.			HIV-1 Specific Antibody Titers and Neutralization among Chronically Infected Patients on Long-Term Suppressive Antiretroviral Therapy (ART): A Cross-Sectional Study	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; B-CELL RESPONSES; POTENT NEUTRALIZATION; ENVELOPE GLYCOPROTEIN; DISEASE PROGRESSION; ELITE SUPPRESSORS; IMMUNE-RESPONSES; VACCINE TARGET; C INFECTION	The majority of potent and broadly neutralizing antibodies against HIV-1 have been isolated from untreated patients with acute or chronic infection. To assess the extent of HIV-1 specific antibody response and neutralization after many years of virologic suppression from potent combination ART, we examined antibody binding titers and neutralization of 51 patients with chronic HIV-1 infection on suppressive ART for at least three years. In this cross-sectional analysis, we found high antibody titers against gp120, gp41, and the membrane proximal external region (MPER) in 59%, 43%, and 27% of patients, respectively. We observed significantly higher endpoint binding titers for gp120 and gp41 for patients with.10 compared to <= 10 years of detectable HIV RNA. Additionally, we observed higher median gp120 and gp41 antibody titers in patients with HIV RNA < 50 copies/mL for <= 5 years. 22% of patients neutralized a HIV-1 primary isolate (HIV-1(JR-FL)) and 8% neutralized a HIV-2/HIV-1 MPER chimera. Significantly greater HIV-1(JR-FL) neutralization was found among patients with.10 years of detectable HIV RNA (8/20 [40.0%] versus 3/31 [9.7%] for <= 10 years, p = 0.02) and a trend toward greater neutralization in patients with <= 5 years of HIV RNA,50 copies/mL (7/20 [35.0%] versus 4/31 [12.9%] for > 5 years, p = 0.08). All patients with neutralizing activity mediated successful phagocytosis of VLPs by THP-1 cells after antibody opsonization. Our findings of highly specific antibodies to several structural epitopes of HIV-1 with antibody effector functions and neutralizing activity after long-term suppressive ART, suggest continuous antigenic stimulation and evolution of HIV-specific antibody response occurs before and after suppression with ART. These patients, particularly those with slower HIV progression and more time with detectable viremia prior to initiation of suppressive ART, are a promising population to identify and further study functional antibodies against HIV-1.	[Gach, Johannes S.; Jung, Barbara H.] Northwestern Univ, Div Gastroenterol, Chicago, IL 60611 USA; [Achenbach, Chad J.; Berzins, Baiba; Lambert, Nina; Murphy, Robert L.] Northwestern Univ, Div Infect Dis, Chicago, IL 60611 USA; [Achenbach, Chad J.; Berzins, Baiba; Lambert, Nina; Murphy, Robert L.] Northwestern Univ, Ctr Global Hlth, Chicago, IL 60611 USA; [Gach, Johannes S.; Chromikova, Veronika; Landucci, Gary; Forthal, Donald N.] Univ Calif Irvine, Div Infect Dis, Irvine, CA USA; [Chromikova, Veronika] Univ Bodenkultur Wien, Inst Appl Microbiol, Vienna, Austria; [Katlama, Christine] Univ Paris 06, Hop Pitie Salpetriere, Paris, France	Northwestern University; Northwestern University; Northwestern University; University of California System; University of California Irvine; University of Natural Resources & Life Sciences, Vienna; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Gach, JS (corresponding author), Northwestern Univ, Div Gastroenterol, Chicago, IL 60611 USA.	jgach@uci.edu	Achenbach, Chad/AAQ-4035-2020	Murphy, Robert/0000-0003-3936-2052; Gach, Johannes/0000-0002-5043-5710; Achenbach, Chad/0000-0003-4847-7249	Objectif Recherche Vaccin SIDA (ORVACS); National Institutes of Health [R01 CA141057-01, P30 CA060553, R01AI084136]; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA141057] Funding Source: NIH RePORTER	Objectif Recherche Vaccin SIDA (ORVACS); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Objectif Recherche Vaccin SIDA (ORVACS) and the National Institutes of Health (grant numbers R01 CA141057-01 and P30 CA060553 to BHJ; R01AI084136 to DNF) provided support for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman ME, 2011, J IMMUNOL METHODS, V366, P8, DOI 10.1016/j.jim.2010.12.016; Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Bailey JR, 2006, J VIROL, V80, P4758, DOI 10.1128/JVI.80.10.4758-4770.2006; Binley JM, 2000, J INFECT DIS, V182, P945, DOI 10.1086/315774; Blankson JN, 2010, DISCOV MED, V9, P261; Braibant M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-103; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Davis KL, 2009, VIROLOGY, V387, P414, DOI 10.1016/j.virol.2009.02.022; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Falkensammer B, 2007, FRONT BIOSCI, V12, P2148, DOI 10.2741/2218; Forthal DN, 2009, CURR OPIN HIV AIDS, V4, P388, DOI 10.1097/COH.0b013e32832f0a89; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gach JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072054; Gach JS, 2011, CURR TOP MED CHEM, V11, P2997; Gach JS, 2010, J BIOL CHEM, V285, P1122, DOI 10.1074/jbc.M109.058792; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Holl V, 2009, VIRUSES-BASEL, V1, P1265, DOI 10.3390/v1031265; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Humbert M, 2006, AIDS REV, V8, P51; Ingale S, 2010, J PEPT SCI, V16, P716, DOI 10.1002/psc.1325; Killian MS, 2006, AIDS RES HUM RETROV, V22, P640, DOI 10.1089/aid.2006.22.640; Kim JH, 2001, AIDS RES HUM RETROV, V17, P1021, DOI 10.1089/088922201300343708; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Langedijk JPM, 2012, NAT MED, V18, P1616, DOI 10.1038/nm.2993; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liu L, 2011, P NATL ACAD SCI USA, V108, P20148, DOI 10.1073/pnas.1104840108; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Markowitz M, 1999, J INFECT DIS, V179, P527, DOI 10.1086/314628; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Massanella M, 2013, CURR HIV-AIDS REP, V10, P33, DOI 10.1007/s11904-012-0150-8; Medina-Ramirez M, 2011, J VIROL, V85, P5804, DOI 10.1128/JVI.02482-10; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; Morris L, 1998, J EXP MED, V188, P233, DOI 10.1084/jem.188.2.233; Nakamura K, 2010, J SYN ORG CHEM JPN, V68, P1, DOI 10.5059/yukigoseikyokaishi.68.1; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Overbaugh J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007039; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Pinter A, 1998, VACCINE, V16, P1803, DOI 10.1016/S0264-410X(98)00182-0; Regidor DL, 2011, AIDS, V25, P303, DOI 10.1097/QAD.0b013e32834273ad; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; Saksena NK, 2010, HIV AIDS-RES PALLIAT, V2, P103; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; van Gils MJ, 2009, AIDS, V23, P2405, DOI 10.1097/QAD.0b013e32833243e7; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zolla-Pazner Susan, 2005, Human Antibodies, V14, P69; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	73	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85371	10.1371/journal.pone.0085371	http://dx.doi.org/10.1371/journal.pone.0085371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454852	Green Published, gold			2022-12-25	WOS:000330235100076
J	Kis, A; Bence, M; Lakatos, G; Pergel, E; Turcsan, B; Pluijmakers, J; Vas, J; Elek, Z; Bruder, I; Foldi, L; Sasvari-Szekely, M; Miklosi, A; Ronai, Z; Kubinyi, E				Kis, Anna; Bence, Melinda; Lakatos, Gabriella; Pergel, Eniko; Turcsan, Borbala; Pluijmakers, Jolanda; Vas, Judit; Elek, Zsuzsanna; Bruder, Ildiko; Foeldi, Levente; Sasvari-Szekely, Maria; Miklosi, Adam; Ronai, Zsolt; Kubinyi, Eniko			Oxytocin Receptor Gene Polymorphisms Are Associated with Human Directed Social Behavior in Dogs (Canis familiaris)	PLOS ONE			English	Article							PURE-BRED DOGS; ATTACHMENT; GAZE; OXTR; INTELLIGENCE; METHYLATION; COGNITION; MICRORNA; GENOME	The oxytocin system has a crucial role in human sociality; several results prove that polymorphisms of the oxytocin receptor gene are related to complex social behaviors in humans. Dogs' parallel evolution with humans and their adaptation to the human environment has made them a useful species to model human social interactions. Previous research indicates that dogs are eligible models for behavioral genetic research, as well. Based on these previous findings, our research investigated associations between human directed social behaviors and two newly described (-212AG, 19131AG) and one known (rs8679684) single nucleotide polymorphisms (SNPs) in the regulatory regions (59 and 39 UTR) of the oxytocin receptor gene in German Shepherd (N = 104) and Border Collie (N = 103) dogs. Dogs' behavior traits have been estimated in a newly developed test series consisting of five episodes: Greeting by a stranger, Separation from the owner, Problem solving, Threatening approach, Hiding of the owner. Buccal samples were collected and DNA was isolated using standard protocols. SNPs in the 39 and 59 UTR regions were analyzed by polymerase chain reaction based techniques followed by subsequent electrophoresis analysis. The gene-behavior association analysis suggests that oxytocin receptor gene polymorphisms have an impact in both breeds on (i) proximity seeking towards an unfamiliar person, as well as their owner, and on (ii) how friendly dogs behave towards strangers, although the mediating molecular regulatory mechanisms are yet unknown. Based on these results, we conclude that similarly to humans, the social behavior of dogs towards humans is influenced by the oxytocin system.	[Kis, Anna; Turcsan, Borbala; Bruder, Ildiko; Foeldi, Levente; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Kis, Anna; Turcsan, Borbala] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Bence, Melinda; Lakatos, Gabriella; Miklosi, Adam; Kubinyi, Eniko] MTA ELTE, Comparat Ethol Res Grp, Budapest, Hungary; [Pergel, Eniko; Elek, Zsuzsanna; Sasvari-Szekely, Maria; Ronai, Zsolt] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary; [Pluijmakers, Jolanda] Catholic Univ Coll Ghent, Dept Ethol & Anim Welf, Brugge, Belgium; [Vas, Judit] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway	Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; MTA-ELTE Comparative Ethology Research Group; Semmelweis University; Norwegian University of Life Sciences	Kis, A (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	vargane.kis.anna@ttk.mta.hu; bencemelinda@gmail.com	Kubinyi, Eniko/B-5824-2013; Turcsán, Borbála/I-7983-2018; Vas, Judit/GRJ-7640-2022; Ronai, Zsolt/A-2473-2008; Miklosi, Adam/N-5147-2017	Kubinyi, Eniko/0000-0002-4468-9845; Turcsán, Borbála/0000-0002-0197-5243; Ronai, Zsolt/0000-0002-0909-7932; Miklosi, Adam/0000-0003-4831-8985; Kis, Anna/0000-0001-8728-4795	Hungarian Academy of Sciences [MTA 01 031]; Hungarian Scientific Research Fund [OTKA K100695, K84036, 107726]; Bolyai Foundation of the Hungarian Academy of Sciences; ESF [06-RNP-020]	Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Foundation of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); ESF(European Commission)	Financial support was provided by the Hungarian Academy of Sciences (MTA 01 031), the Hungarian Scientific Research Fund (OTKA K100695; K84036; 107726), the Bolyai Foundation of the Hungarian Academy of Sciences, and an ESF Research Networking Programme "CompCog'': The Evolution of Social Cognition (06-RNP-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, FRONT PSYCHOL, DOI DOI 10.3389/FPSYG.2012.00234; [Anonymous], 2012, CURRENT OPINION NEUR; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Bertino JR, 2007, PHARMACOGENOMICS, V8, P1625, DOI 10.2217/14622416.8.12.1625; Bradshaw JWS, 1999, RES VET SCI, V66, P73, DOI 10.1053/rvsc.1998.0246; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Chase K, 2009, J HERED, V100, pS37, DOI 10.1093/jhered/esp011; Chen FS, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00200; Dayeh TA, 2013, DIABETOLOGIA, V56, P1036, DOI 10.1007/s00125-012-2815-7; Diederich C, 2006, APPL ANIM BEHAV SCI, V97, P51, DOI 10.1016/j.applanim.2005.11.018; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Falkenberg VR, 2011, NEUROMOL MED, V13, P66, DOI 10.1007/s12017-010-8138-2; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Gillath O, 2008, PERS SOC PSYCHOL B, V34, P1396, DOI 10.1177/0146167208321484; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hejjas K, 2007, ANIM GENET, V38, P629, DOI 10.1111/j.1365-2052.2007.01657.x; Hernadi A, 2013, ANIMAL COGNITI UNPUB; Hernadi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043267; Herzmann G, 2013, PSYCHONEURO IN PRESS; Hollander E, 2007, BIOL PSYCHIAT, V61, P498, DOI 10.1016/j.biopsych.2006.05.030; Jones P, 2008, GENETICS, V179, P1033, DOI 10.1534/genetics.108.087866; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; Kovacs-Nagy R, 2013, AM J MED GENET B, V162B, P404, DOI 10.1002/ajmg.b.32157; Kubinyi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030271; Lakatos G, 2011, ANIM COGN, V15, P18; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lischke A, 2012, PSYCHONEUROENDOCRINO, V37, P475, DOI 10.1016/j.psyneuen.2011.07.015; Liu JCJ, 2012, HORM BEHAV, V62, P585, DOI 10.1016/j.yhbeh.2012.09.002; Lucht MJ, 2009, PROG NEURO-PSYCHOPH, V33, P860, DOI 10.1016/j.pnpbp.2009.04.004; Marx Peter, 2011, Neuropsychopharmacol Hung, V13, P139; McGraw LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029345; Munafo MR, 2009, ADDICTION, V104, P1439, DOI 10.1111/j.1360-0443.2009.02662.x; Notari L, 2007, APPL ANIM BEHAV SCI, V103, P118, DOI 10.1016/j.applanim.2006.03.018; Overall KL, 2000, PROG NEURO-PSYCHOPH, V24, P727, DOI 10.1016/S0278-5846(00)00104-4; Parker HG, 2010, ANNU REV GENET, V44, P309, DOI 10.1146/annurev-genet-102808-115200; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Prato-Previde E, 2003, BEHAVIOUR, V140, P225, DOI 10.1163/156853903321671514; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Saphire-Bernstein S, 2011, P NATL ACAD SCI USA, V108, P15118, DOI 10.1073/pnas.1113137108; Stallen M, 2012, PSYCHOL SCI, V23, P1288, DOI 10.1177/0956797612446026; Takeuchi Y, 2006, J VET MED SCI, V68, P789, DOI 10.1292/jvms.68.789; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Wan M, 2013, ANIMAL GENE IN PRESS; Wood E, 2006, TXB BIOCH CLIN CORRE; Yamasue H, 2012, J NEUROSCI, V32, P14109, DOI 10.1523/JNEUROSCI.3327-12.2012	55	73	74	0	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83993	10.1371/journal.pone.0083993	http://dx.doi.org/10.1371/journal.pone.0083993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454713	gold, Green Published, Green Accepted			2022-12-25	WOS:000330235100015
J	Mugisha, V; Teasdale, CA; Wang, CH; Lahuerta, M; Nuwagaba-Biribonwoha, H; Tayebwa, E; Ingabire, E; Ingabire, P; Sahabo, R; Twyman, P; Abrams, EJ				Mugisha, Veronicah; Teasdale, Chloe A.; Wang, Chunhui; Lahuerta, Maria; Nuwagaba-Biribonwoha, Harriet; Tayebwa, Edwin; Ingabire, Eugenie; Ingabire, Pacifique; Sahabo, Ruben; Twyman, Peter; Abrams, Elaine J.		Identifying Optimal Models HIV	Determinants of Mortality and Loss to Follow-Up among Adults Enrolled in HIV Care Services in Rwanda	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY PROGRAM; SUB-SAHARAN AFRICA; SOUTH-AFRICA; SCALE-UP; OUTCOMES; COHORT; RETENTION; SURVIVAL; UGANDA; RISK	Background: Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, however high rates of loss to follow-up (LTF) and mortality have been documented in HIV care and treatment programs. Methods: We analyzed routinely-collected data on HIV-infected patients >= 15 years enrolled at 41 healthcare facilities in Rwanda from 2005 to 2010. LTF was defined as not attending clinic in the last 12 months for pre-ART patients and 6 months for ART patients. For the pre-ART period, sub-distribution hazards models were constructed to estimate LTF and death to account for competing risks. Kaplan-Meier (KM) and Cox proportional hazards models were used for patients on ART. Results: 31,033 ART-naive adults were included, 64% were female and 75% were WHO stage I or II at enrollment. 17,569 (56%) patients initiated ART. Pre-ART competing risk estimates of LTF at 2 years was 11.2% (95% CI, 10.9-11.6%) and 2.9% for death (95% CI 2.7-3.1%). Among pre-ART patients, male gender was associated with higher LTF (adjusted sub-hazard ratio (aSHR) 1.3, 95% CI 1.1-1.5) and death (aSHR 1.7, 95% CI 1.4-2.1). Low CD4 count (CD4,<100 vs. $ 350 aSHR 0.2, 95% CI 0.1-0.3) and higher WHO stage (WHO stage IV vs. stage I aSHR 0.4, 95% CI 0.2-0.6) were protective against pre-ART LTF. KM estimates for LTF and death in ART patients at 2 years were 4.4% (95% CI 4.4-4.5%) and 6.3% (95% CI 6.2-6.4%). In patients on ART, male gender was associated with LTF (adjusted hazard ratio (AHR) 1.4, 95% CI 1.2-1.7) and death (AHR1.3, 95% CI 1.2-1.5). Mortality was higher for ART patients >= 40 years and in those with lower CD4 count at ART initiation. Conclusions: Low rates of LTF and death were founds among pre-ART and ART patients in Rwanda but greater efforts are needed to retain patients in care prior to ART initiation, particularly among those who are healthy at enrollment.	[Mugisha, Veronicah; Teasdale, Chloe A.; Wang, Chunhui; Lahuerta, Maria; Nuwagaba-Biribonwoha, Harriet; Tayebwa, Edwin; Ingabire, Eugenie; Sahabo, Ruben; Twyman, Peter; Abrams, Elaine J.] Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs, New York, NY 10027 USA; [Mugisha, Veronicah; Teasdale, Chloe A.; Wang, Chunhui; Lahuerta, Maria; Nuwagaba-Biribonwoha, Harriet; Abrams, Elaine J.] Columbia Univ, Identifying Optimal Models HIV Care Africa Study, Int Ctr AIDS Care & Treatment Programs, New York, NY USA; [Teasdale, Chloe A.; Lahuerta, Maria; Ingabire, Pacifique; Abrams, Elaine J.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Twyman, Peter] Minist Hlth Rwanda, Kigali, Rwanda; Keep Child Alive Fdn, New York, NY USA	Columbia University; Columbia University; Columbia University	Teasdale, CA (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs, New York, NY 10027 USA.	ct116@columbia.edu			The President's Emergency Plan for AIDS Relief through the United States Centers for Disease Control and Prevention [5U62PS223540, 5U2GPS001537]; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U62PS223540] Funding Source: NIH RePORTER	The President's Emergency Plan for AIDS Relief through the United States Centers for Disease Control and Prevention; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by The President's Emergency Plan for AIDS Relief through the United States Centers for Disease Control and Prevention (Grant numbers: 5U62PS223540 and 5U2GPS001537). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of any of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-39; Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Druyts E, 2012, AIDS; El-Sadr WM, 2012, JAIDS-J ACQ IMM DEF, V60, pS96, DOI 10.1097/QAI.0b013e31825eb27b; Elul B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053586; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Ford N, 2010, AIDS, V24, P2645, DOI 10.1097/QAD.0b013e32833ec5b2; Hassan AS, 2012, TROP MED INT HEALTH, V17, P82, DOI 10.1111/j.1365-3156.2011.02889.x; Health M. o., 2009, GUID PROV COMPR CAR; Ingle SM, 2010, AIDS, V24, P2717, DOI 10.1097/QAD.0b013e32833fb71f; Lahuerta M, 2011, JAIDS-J ACQ IMM DEF, V58, pE75, DOI 10.1097/QAI.0b013e31822ac0a9; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lessells RJ, 2011, JAIDS-J ACQ IMM DEF, V56, pE79, DOI 10.1097/QAI.0b013e3182075ae2; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Mugglin C, 2012, C RETR OPP INF SEATT; Mugglin C, 2012, TROPICAL MED INT HLT; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; R. Ministry of Health, 2006, HUM RES HLTH STRAT P; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Rogers WH., 1993, STATA TECHNICAL B RE, V13, P19; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rwanda MoH, 2011, ANN REP JUL 2010 JUN; Rwanda Rd, 2003, GUIDE UTILISATION ME; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; UNAIDS, 2012, WORLD AIDS DAY REP G; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; WHO, 2011, HIV AIDS; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x	36	32	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85774	10.1371/journal.pone.0085774	http://dx.doi.org/10.1371/journal.pone.0085774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454931	Green Published, gold			2022-12-25	WOS:000330235100132
J	Tang, RD; Dai, JP				Tang, Rendong; Dai, Jiapei			Spatiotemporal Imaging of Glutamate-Induced Biophotonic Activities and Transmission in Neural Circuits	PLOS ONE			English	Article							PHOTON-EMISSION; BRAIN; LIGHT; PHOSPHORYLATION; BIOLUMINESCENCE; NEURONS; FORM	The processing of neural information in neural circuits plays key roles in neural functions. Biophotons, also called ultra-weak photon emissions (UPE), may play potential roles in neural signal transmission, contributing to the understanding of the high functions of nervous system such as vision, learning and memory, cognition and consciousness. However, the experimental analysis of biophotonic activities (emissions) in neural circuits has been hampered due to technical limitations. Here by developing and optimizing an in vitro biophoton imaging method, we characterize the spatiotemporal biophotonic activities and transmission in mouse brain slices. We show that the long-lasting application of glutamate to coronal brain slices produces a gradual and significant increase of biophotonic activities and achieves the maximal effect within approximately 90 min, which then lasts for a relatively long time (>200 min). The initiation and/or maintenance of biophotonic activities by glutamate can be significantly blocked by oxygen and glucose deprivation, together with the application of a cytochrome c oxidase inhibitor (sodium azide), but only partly by an action potential inhibitor (TTX), an anesthetic (procaine), or the removal of intracellular and extracellular Ca2+. We also show that the detected biophotonic activities in the corpus callosum and thalamus in sagittal brain slices mostly originate from axons or axonal terminals of cortical projection neurons, and that the hyperphosphorylation of microtubule-associated protein tau leads to a significant decrease of biophotonic activities in these two areas. Furthermore, the application of glutamate in the hippocampal dentate gyrus results in increased biophotonic activities in its intrahippocampal projection areas. These results suggest that the glutamate-induced biophotonic activities reflect biophotonic transmission along the axons and in neural circuits, which may be a new mechanism for the processing of neural information.	[Tang, Rendong; Dai, Jiapei] South Cent Univ Nationalities, Wuhan Inst Neurosci & Neuroengn, Wuhan, Peoples R China; [Tang, Rendong; Dai, Jiapei] South Cent Univ Nationalities, Coll Biomed Engn, Wuhan, Peoples R China; [Dai, Jiapei] South Cent Univ Nationalities, Coll Pharm, Dept Pharmacol, Wuhan, Peoples R China	South Central Minzu University; South Central Minzu University; South Central Minzu University	Dai, JP (corresponding author), South Cent Univ Nationalities, Wuhan Inst Neurosci & Neuroengn, Wuhan, Peoples R China.	jdai@mail.scuec.edu.cn		Tang, Rendong/0000-0002-3622-3383; Dai, Jiapei/0000-0002-1474-5754	National Natural Science Foundation of China [31070961]; Research Foundation for the Key Laboratory of Neuroscience and Neuroengineering from the South-Central University for Nationalities [XJS09001, CJS12001, CJS12002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation for the Key Laboratory of Neuroscience and Neuroengineering from the South-Central University for Nationalities	This work was supported by the National Natural Science Foundation of China (31070961) and the Research Foundation for the Key Laboratory of Neuroscience and Neuroengineering from the South-Central University for Nationalities (XJS09001, CJS12001 and CJS12002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; ALBRECHTBUEHLER G, 1992, P NATL ACAD SCI USA, V89, P8288, DOI 10.1073/pnas.89.17.8288; ARIAS C, 1993, J NEUROCHEM, V61, P673; Barth AL, 2012, TRENDS NEUROSCI, V35, P345, DOI 10.1016/j.tins.2012.03.008; BERNROIDER G, 2004, FORMA, V19, P55; Bokkon I, 2011, J PHOTOCH PHOTOBIO B, V103, P192, DOI 10.1016/j.jphotobiol.2011.03.011; Bruno V, 1993, Funct Neurol, V8, P279; Buzsaki G, 2007, NATURE, V446, P267, DOI 10.1038/446267a; Chalifoux JR, 2011, J NEUROSCI, V31, P16435, DOI 10.1523/JNEUROSCI.2777-11.2011; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Cohen S., 2003, Indian Journal of Experimental Biology, V41, P440; COLLI L, 1955, EXPERIENTIA, V11, P479, DOI 10.1007/BF02166829; Debanne D, 2008, NAT PROTOC, V3, P1559, DOI 10.1038/nprot.2008.147; Devaraj B, 1997, CURR OPIN SOLID ST M, V2, P188, DOI 10.1016/S1359-0286(97)80064-2; Dotta BT, 2012, NEUROSCI LETT, V513, P151, DOI 10.1016/j.neulet.2012.02.021; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Grass F, 2004, MED HYPOTHESES, V62, P169, DOI 10.1016/S0306-9877(03)00308-6; Gurvitch A.G., 1926, PROBLEM ZELLTEILUNG; Hameroff SR, 2007, COGNITIVE SCI, V31, P1035, DOI 10.1080/03640210701704004; Hameroff SR, 2013, BEHAV BRAIN SCI, V36, P287, DOI 10.1017/S0140525X1200297X; Kataoka Y, 2001, BIOCHEM BIOPH RES CO, V285, P1007, DOI 10.1006/bbrc.2001.5285; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Lee WCA, 2011, CURR OPIN NEUROBIOL, V21, P801, DOI 10.1016/j.conb.2011.07.004; Nakano M., 2005, J BIOLUMIN CHEMILUM, V4, P231, DOI DOI 10.1002/BI0.1170040133; Obrenovitch TP, 1999, ANN NY ACAD SCI, V890, P273, DOI 10.1111/j.1749-6632.1999.tb08004.x; OBRENOVITCH TP, 1994, BRIT J PHARMACOL, V113, P1295, DOI 10.1111/j.1476-5381.1994.tb17139.x; Popp F.A., 1994, BIOELECTRODYNAMICS B, P293; Popp FA, 2003, INTEGRATIVE BIOPHYSICS: BIOPHOTONICS, P387; Prasad A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01211; Purves D, 2012, NEUROSCIENCE; Rahnama M, 2011, J INTEGR NEUROSCI, V10, P65, DOI 10.1142/S0219635211002622; Run XQ, 2009, J ALZHEIMERS DIS, V16, P619, DOI 10.3233/JAD-2009-1003; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Sun Y, 2010, PHOTOCH PHOTOBIO SCI, V9, P315, DOI 10.1039/b9pp00125e; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Vladimirov Iu A, 1971, Biofizika, V16, P952; Wang C, 2011, BRAIN RES, V1369, P1, DOI 10.1016/j.brainres.2010.10.077; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958; ZHURAVLE.AI, 1973, BIOFIZIKA+, V18, P1037	42	39	39	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85643	10.1371/journal.pone.0085643	http://dx.doi.org/10.1371/journal.pone.0085643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454909	gold, Green Submitted, Green Published			2022-12-25	WOS:000330235100112
J	Calingacion, M; Laborte, A; Nelson, A; Resurreccion, A; Concepcion, JC; Daygon, VD; Mumm, R; Reinke, R; Dipti, S; Bassinello, PZ; Manful, J; Sophany, S; Lara, KC; Bao, JS; Xie, LH; Loaiza, K; El-hissewy, A; Gayin, J; Sharma, N; Rajeswari, S; Manonmani, S; Rani, NS; Kota, S; Indrasari, SD; Habibi, F; Hosseini, M; Tavasoli, F; Suzuki, K; Umemoto, T; Boualaphanh, C; Lee, HH; Hung, YP; Ramli, A; Aung, PP; Ahmad, R; Wattoo, JI; Bandonill, E; Romero, M; Brites, CM; Hafeel, R; Lur, HS; Cheaupun, K; Jongdee, S; Blanco, P; Bryant, R; Lang, NT; Hall, RD; Fitzgerald, M				Calingacion, Mariafe; Laborte, Alice; Nelson, Andrew; Resurreccion, Adoracion; Concepcion, Jeanaflor Crystal; Daygon, Venea Dara; Mumm, Roland; Reinke, Russell; Dipti, Sharifa; Bassinello, Priscila Zaczuk; Manful, John; Sophany, Sakhan; Lara, Karla Cordero; Bao, Jinsong; Xie, Lihong; Loaiza, Katerine; El-hissewy, Ahmad; Gayin, Joseph; Sharma, Neerja; Rajeswari, Sivakami; Manonmani, Swaminathan; Rani, N. Shobha; Kota, Suneetha; Indrasari, Siti Dewi; Habibi, Fatemeh; Hosseini, Maryam; Tavasoli, Fatemeh; Suzuki, Keitaro; Umemoto, Takayuki; Boualaphanh, Chanthkone; Lee, Huei Hong; Hung, Yiu Pang; Ramli, Asfaliza; Aung, Pa Pa; Ahmad, Rauf; Wattoo, Javed Iqbal; Bandonill, Evelyn; Romero, Marissa; Brites, Carla Moita; Hafeel, Roshni; Lur, Huu-Sheng; Cheaupun, Kunya; Jongdee, Supanee; Blanco, Pedro; Bryant, Rolfe; Nguyen Thi Lang; Hall, Robert D.; Fitzgerald, Melissa			Diversity of Global Rice Markets and the Science Required for Consumer-Targeted Rice Breeding	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; STARCH-SYNTHASE-IIA; GRAIN LENGTH; GELATINIZATION TEMPERATURE; EATING QUALITY; GENE; GS3; ASSOCIATION; ALLELE; YIELD	With the ever-increasing global demand for high quality rice in both local production regions and with Western consumers, we have a strong desire to understand better the importance of the different traits that make up the quality of the rice grain and obtain a full picture of rice quality demographics. Rice is by no means a 'one size fits all' crop. Regional preferences are not only striking, they drive the market and hence are of major economic importance in any rice breeding/improvement strategy. In this analysis, we have engaged local experts across the world to perform a full assessment of all the major rice quality trait characteristics and importantly, to determine how these are combined in the most preferred varieties for each of their regions. Physical as well as biochemical characteristics have been monitored and this has resulted in the identification of no less than 18 quality trait combinations. This complexity immediately reveals the extent of the specificity of consumer preference. Nevertheless, further assessment of these combinations at the variety level reveals that several groups still comprise varieties which consumers can readily identify as being different. This emphasises the shortcomings in the current tools we have available to assess rice quality and raises the issue of how we	[Calingacion, Mariafe; Laborte, Alice; Nelson, Andrew; Resurreccion, Adoracion; Concepcion, Jeanaflor Crystal; Daygon, Venea Dara; Fitzgerald, Melissa] Int Rice Res Inst, Los Banos, Laguna, Philippines; [Calingacion, Mariafe] Wageningen Univ, Lab Plant Physiol, NL-6700 AP Wageningen, Netherlands; [Calingacion, Mariafe; Resurreccion, Adoracion; Concepcion, Jeanaflor Crystal; Daygon, Venea Dara; Reinke, Russell; Dipti, Sharifa; Bassinello, Priscila Zaczuk; Manful, John; Sophany, Sakhan; Lara, Karla Cordero; Bao, Jinsong; Xie, Lihong; Loaiza, Katerine; El-hissewy, Ahmad; Gayin, Joseph; Sharma, Neerja; Rajeswari, Sivakami; Manonmani, Swaminathan; Rani, N. Shobha; Kota, Suneetha; Indrasari, Siti Dewi; Habibi, Fatemeh; Hosseini, Maryam; Tavasoli, Fatemeh; Suzuki, Keitaro; Umemoto, Takayuki; Boualaphanh, Chanthkone; Lee, Huei Hong; Ramli, Asfaliza; Aung, Pa Pa; Ahmad, Rauf; Wattoo, Javed Iqbal; Bandonill, Evelyn; Romero, Marissa; Brites, Carla Moita; Hafeel, Roshni; Lur, Huu-Sheng; Cheaupun, Kunya; Jongdee, Supanee; Blanco, Pedro; Bryant, Rolfe; Nguyen Thi Lang; Hall, Robert D.; Fitzgerald, Melissa] Int Network Qual Rice, Wageningen, Netherlands; [Mumm, Roland; Hall, Robert D.] Plant Res Int, Wageningen, Netherlands; [Mumm, Roland; Hall, Robert D.] Ctr BioSyst Genom, Wageningen, Netherlands; [Reinke, Russell] NSW Dept Ind & Investment, Yanco Agr Inst, Yanco, NSW, Australia; [Dipti, Sharifa] Bangladesh Rice Res Inst, Grain Qual & Nutr Div, Gazipur, Bangladesh; [Bassinello, Priscila Zaczuk] EMBRAPA Rice & Beans, Santo Antonio De Goias, Go, Brazil; [Manful, John] Africa Rice Ctr AfricaRice, Cotonou, Benin; [Sophany, Sakhan] Cambodian Agr Res & Dev Inst, Phnom Penh, Cambodia; [Lara, Karla Cordero] Mejoramiento Genet Arroz INIA CRI Quilamapu, Vicente Mendez, Chile; [Bao, Jinsong] Zhejiang Univ, Inst Nucl Agr Sci, Hangzhou 310029, Zhejiang, Peoples R China; [Xie, Lihong] China Natl Rice Res Inst, Hangzhou, Zhejiang, Peoples R China; [Loaiza, Katerine] CIAT, Lab Calidad FLAR CIAT, Cali, Colombia; [El-hissewy, Ahmad] Rice Res & Training Ctr, ARC, Rice Res Sect, Field Crops Res Inst, Sakha, Kafr El Shiekh, Egypt; [Gayin, Joseph] CSIR Food Res Inst, Accra, Ghana; [Sharma, Neerja] Punjab Agr Univ, Dept Plant Breeding & Genet, Rice Sect, Ludhiana 141004, Punjab, India; [Rajeswari, Sivakami; Manonmani, Swaminathan] Tamil Nadu Agr Univ, Ctr Plant Breeding & Genet, Dept Rice, Coimbatore 641003, Tamil Nadu, India; [Rani, N. Shobha; Kota, Suneetha] Directorate Rice Res, Crop Improvement Sect, Hyderabad, Andhra Pradesh, India; [Indrasari, Siti Dewi] Indonesian Ctr Rice Res ICRR BB Padi, Sukamandi, Subang Jawa Bar, Indonesia; [Habibi, Fatemeh; Hosseini, Maryam; Tavasoli, Fatemeh] Rice Res Inst Iran, Rasht, Iran; [Suzuki, Keitaro] NARO Inst Crop Sci, Tsukuba, Ibaraki, Japan; [Umemoto, Takayuki] NARO Hokkaido Agr Res Ctr, Sapporo, Hokkaido, Japan; [Boualaphanh, Chanthkone] NAFRI, Rice & Cash Crop Res Inst, Viangchan, Lao PDR, Laos; [Lee, Huei Hong; Hung, Yiu Pang] Univ Putra Malaysia, Fac Agr & Food Sci, Bintulu Sarawak, Malaysia; [Ramli, Asfaliza] MARDI Seberang Perai Beg Berkunci, Pusat Penyelidikan Padi Dan Tanaman Ind, Seberang Perai Pulau Pen, Malaysia; [Aung, Pa Pa] Minist Agr & Irrigat, Myanmar Agr Serv, Ctr Plant Biotechnol, Yangon, Myanmar; [Ahmad, Rauf] Natl Agr Res Ctr, Rice Programme, Islamabad, Pakistan; [Wattoo, Javed Iqbal] Natl Inst Biotechnol & Genet Engn, Faislabad, Pakistan; [Bandonill, Evelyn; Romero, Marissa] Philippine Rice Res Inst, Rice Chem & Food Sci Div, Sci City Munoz, Nueva Ecija, Philippines; [Brites, Carla Moita] Inst Nacl Invest Agr & Vet, Oeiras, Portugal; [Hafeel, Roshni] Dept Agr, Rice Res Stn, Ambalantota, Sri Lanka; [Lur, Huu-Sheng] Natl Taiwan Univ, Dept Agron, Taipei, Taiwan; [Jongdee, Supanee] Khon Kaen Rice Res Ctr, Khon Kaen, Thailand; [Blanco, Pedro] INIA Treinta Tres, Natl Agr Res Inst, Rice Res Program, Treinta Tres, CP, Uruguay; [Bryant, Rolfe] USDA ARS, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR USA; [Nguyen Thi Lang] Cuulong Delta Rice Res Inst, Genet & Plant Breeding Div, Can Tho, Vietnam	CGIAR; International Rice Research Institute (IRRI); Wageningen University & Research; Centre for BioSystems Genomics; NSW Department of Primary Industries; Bangladesh Rice Research Institute (BRRI); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CGIAR; Africa Rice Center; Zhejiang University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Alliance; International Center for Tropical Agriculture - CIAT; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Punjab Agricultural University; Tamil Nadu Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Rice Research; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; Universiti Putra Malaysia; National Agricultural Research Council - Pakistan; Pakistan Institute of Engineering & Applied Science; Philippine Rice Research Institute; National Taiwan University; Instituto Nacional de Investigacion Agropecuaria Uruguay (INIA); United States Department of Agriculture (USDA)	Fitzgerald, M (corresponding author), Int Rice Res Inst, Los Banos, Laguna, Philippines.	m.fitzgerald2@uq.edu.au	Nelson, Andy/G-3649-2012; Concepcion, Crystal/ABO-1212-2022; Bao, Jinsong/A-7413-2008; Fitzgerald, Melissa/AAP-6672-2020; Brites, Carla/C-4792-2009; HALL, ROBERT D/B-8707-2015; Brites, Carla/AAT-5977-2020; Hosseni chakeshtori, Maryam/N-8325-2017; Daygon, Venea Dara/Y-2263-2018; Calingacion, Mariafe/O-6252-2016	Nelson, Andy/0000-0002-7249-3778; Concepcion, Crystal/0000-0003-4524-2794; Bao, Jinsong/0000-0002-9606-6615; Fitzgerald, Melissa/0000-0002-0761-764X; Brites, Carla/0000-0003-1949-172X; HALL, ROBERT D/0000-0002-5786-768X; Brites, Carla/0000-0003-1949-172X; Hosseni chakeshtori, Maryam/0000-0003-0911-8251; Daygon, Venea Dara/0000-0003-0805-5148; YIU, Panghung/0000-0001-6223-9859; Calingacion, Mariafe/0000-0002-7560-2036; Mumm, Roland/0000-0002-0603-1508; Lee, Huei Hong/0000-0002-0257-3203	International Network for Quality Rice (INQR); International Rice Research Institute (IRRI); Wageningen University Research (WUR); Monsanto Beachell Borlaug Scholarship Foundation	International Network for Quality Rice (INQR); International Rice Research Institute (IRRI)(CGIAR); Wageningen University Research (WUR); Monsanto Beachell Borlaug Scholarship Foundation	This work was supported by International Network for Quality Rice (INQR), International Rice Research Institute (IRRI), Wageningen University Research (WUR), and the Monsanto Beachell Borlaug Scholarship Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abazari A, 2012, AM J SCI RES, P70; Anang B. T., 2011, International Journal of AgriScience, V1, P67; ANZ, 2012, GREEN PAST GLOB SOFT; Asian Development Bank (ADB), 2012, FOOD SEC POV AS PAC; Ayres NM, 1997, THEOR APPL GENET, V94, P773, DOI 10.1007/s001220050477; Azabagaoglu M. O., 2009, Agricultura Tropica et Subtropica, V42, P118; Bao JS, 2006, THEOR APPL GENET, V113, P1171, DOI 10.1007/s00122-006-0355-6; Boualaphanh C, 2011, CROP SCI, V51, P2067, DOI 10.2135/cropsci2011.02.0103; Bryant RJ, 2011, FOOD CHEM, V124, P501, DOI 10.1016/j.foodchem.2010.06.061; BUTTERY RG, 1983, J AGR FOOD CHEM, V31, P823, DOI 10.1021/jf00118a036; CAGAMPANG GB, 1973, J SCI FOOD AGR, V24, P1589, DOI 10.1002/jsfa.2740241214; Calingacion MN, 2012, METABOLOMICS, V8, P771, DOI 10.1007/s11306-011-0374-4; Champagne ET, 2010, RICE, V3, P270, DOI 10.1007/s12284-010-9057-4; Chen MH, 2008, J CEREAL SCI, V47, P536, DOI 10.1016/j.jcs.2007.06.013; Commission E, 2003, OFFICIAL J EUROPEAN, P1; Courtois B, 2012, CROP SCI, V52, P1663, DOI 10.2135/cropsci2011.11.0588; Cuevas R P, 2012, GENETIC DIVERSITY; Cuevas RP, 2010, FUNCT PLANT BIOL, V37, P439, DOI 10.1071/FP09258; Diako C, 2010, CONSUMER PERCEPTIONS; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fan CC, 2009, THEOR APPL GENET, V118, P465, DOI 10.1007/s00122-008-0913-1; FAO WaI, 2012, STAT FOOD INS WORLD; Fitzgerald MA, 2010, WOODHEAD PUBL FOOD S, P212, DOI 10.1533/9781845699529.2.212; Fitzgerald MA, 2008, PLANT BIOTECHNOL J, V6, P416, DOI 10.1111/j.1467-7652.2008.00327.x; Fitzgerald MA, 2009, CEREAL CHEM, V86, P492, DOI 10.1094/CCHEM-86-5-0492; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Foundation TG, 2012, FEED AS WORLD AUSTR; Government A, 2012, AUSTR AS CENT; HALL T, 1999, BIOEDIT USER FRIENDL, V98, P41; Huang R, 2012, TRENDS PLANT SCI; International Organization for Standardization, 2011, 618503 IEC, P10; Juliano B. O., 1985, RICE CHEM TECHNOLOGY, V2nd, P43; Khush GS, 1979, RICE GRAIN QUALITY E, P22; Larkin PD, 2003, MOL BREEDING, V12, P335, DOI 10.1023/B:MOLB.0000006797.51786.92; Lee JW, 2012, JPN WORLD ECON, V24, P101, DOI 10.1016/j.japwor.2012.01.005; Limpawattana M, 2010, J FOOD SCI, V75, pS199, DOI 10.1111/j.1750-3841.2010.01577.x; Little R, 1958, CEREAL CHEM J, V35; Lommen A, 2012, METABOLOMICS, V8, P719, DOI 10.1007/s11306-011-0369-1; Mikami I, 2008, THEOR APPL GENET, V116, P979, DOI 10.1007/s00122-008-0729-z; Minten B, 2013, WORLD DEV, V42, P100, DOI 10.1016/j.worlddev.2012.06.015; Mohanty S, 2013, RICE TODAY, V13, P44; Musa M., 2011, AM INT J CONT RES, V1, P159; Pingali P, 2007, FOOD POLICY, V32, P281, DOI 10.1016/j.foodpol.2006.08.001; Rachmat R., 2006, Indonesian Journal of Agricultural Science, V7, P27; Rozen S, 2000, Methods Mol Biol, V132, P365; SANO Y, 1984, THEOR APPL GENET, V68, P467, DOI 10.1007/BF00254822; Slade L., 1989, FRONTIERS CARBOHYDRA, P215; Smith AM, 1997, ANNU REV PLANT PHYS, V48, P65, DOI 10.1146/annurev.arplant.48.1.67; Stern N, 2006, EC CLIMATE CHANGE ST, P700; Supakornchuwong C, 2012, J SENS STUD, V27, P71, DOI 10.1111/j.1745-459X.2011.00369.x; Suwannaporn P, 2008, BRIT FOOD J, V110, P595, DOI 10.1108/00070700810877906; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Tikunov YM, 2012, METABOLOMICS, V8, P714, DOI 10.1007/s11306-011-0368-2; Tomlins KI, 2005, FOOD QUAL PREFER, V16, P79, DOI 10.1016/j.foodqual.2004.02.002; Tran NA, 2011, THEOR APPL GENET, V123, P519, DOI 10.1007/s00122-011-1604-x; Umemoto T, 2002, THEOR APPL GENET, V104, P1, DOI 10.1007/s001220200000; Umemoto T, 2005, FUNCT PLANT BIOL, V32, P763, DOI 10.1071/FP04214; Umemoto T, 2008, PLANT PROD SCI, V11, P472, DOI 10.1626/pps.11.472; VIRK PS, 1995, HEREDITY, V74, P170, DOI 10.1038/hdy.1995.25; Wanchana S, 2003, PLANT SCI, V165, P1193, DOI 10.1016/S0168-9452(03)00326-1; Ward RM, 2006, BIOMACROMOLECULES, V7, P866, DOI 10.1021/bm050617e; Ware DH, 2002, PLANT PHYSIOL, V130, P1606, DOI 10.1104/pp.015248; Waters DLE, 2006, PLANT BIOTECHNOL J, V4, P115, DOI 10.1111/j.1467-7652.2005.00162.x; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110; Zhao XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066218	65	168	177	8	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85106	10.1371/journal.pone.0085106	http://dx.doi.org/10.1371/journal.pone.0085106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	292TQ	24454799	Green Submitted, Green Published, gold			2022-12-25	WOS:000329925800022
J	Ehashi, T; Takemura, T; Hanagata, N; Minowa, T; Kobayashi, H; Ishihara, K; Yamaoka, T				Ehashi, Tomo; Takemura, Taro; Hanagata, Nobutaka; Minowa, Takashi; Kobayashi, Hisatoshi; Ishihara, Kazuhiko; Yamaoka, Tetsuji			Comprehensive Genetic Analysis of Early Host Body Reactions to the Bioactive and Bio-Inert Porous Scaffolds	PLOS ONE			English	Article							IN-VIVO; MACROPHAGE ACTIVATION; PHOSPHOLIPID POLYMERS; ADHERENT CELLS; TISSUE; ANGIOGENESIS; EXPRESSION; IMPLANT; BIOMATERIALS; ADHESION	To design scaffolds for tissue regeneration, details of the host body reaction to the scaffolds must be studied. Host body reactions have been investigated mainly by immunohistological observations for a long time. Despite of recent dramatic development in genetic analysis technologies, genetically comprehensive changes in host body reactions are hardly studied. There is no information about host body reactions that can predict successful tissue regeneration in the future. In the present study, porous polyethylene scaffolds were coated with bioactive collagen or bio-inert poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) (PMB) and were implanted subcutaneously and compared the host body reaction to those substrates by normalizing the result using control non-coat polyethylene scaffold. The comprehensive analyses of early host body reactions to the scaffolds were carried out using a DNA microarray assay. Within numerous genes which were expressed differently among these scaffolds, particular genes related to inflammation, wound healing, and angiogenesis were focused upon. Interleukin (IL)-1 beta and IL-10 are important cytokines in tissue responses to biomaterials because IL-1 beta promotes both inflammation and wound healing and IL-10 suppresses both of them. IL-1 beta was up-regulated in the collagen-coated scaffold. Collagen-specifically up-regulated genes contained both M1-and M2-macrophage- related genes. Marked vessel formation in the collagen-coated scaffold was occurred in accordance with the up-regulation of many angiogenesis-inducible factors. The DNA microarray assay provided global information regarding the host body reaction. Interestingly, several up-regulated genes were detected even on the very bio-inert PMB-coated surfaces and those genes include inflammation-suppressive and wound healing-suppressive IL-10, suggesting that not only active tissue response but also the inert response may relates to these genetic regulations.	[Ehashi, Tomo; Yamaoka, Tetsuji] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, Osaka, Japan; [Ehashi, Tomo; Yamaoka, Tetsuji] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Takemura, Taro; Hanagata, Nobutaka; Minowa, Takashi] Natl Inst Mat Sci, Nanotechnol Innovat Stn, Ibaraki, Japan; [Kobayashi, Hisatoshi] Natl Inst Mat Sci, Biomat Ctr, Ibaraki, Japan; [Ishihara, Kazuhiko] Univ Tokyo, Dept Mat Engn, Sch Engn, Tokyo, Japan; [Ishihara, Kazuhiko] Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo, Japan	National Cerebral & Cardiovascular Center - Japan; Japan Science & Technology Agency (JST); National Institute for Materials Science; National Institute for Materials Science; University of Tokyo; University of Tokyo	Yamaoka, T (corresponding author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, Osaka, Japan.	yamtet@ri.ncvc.go.jp	kobayashi, hisatoshi/H-2720-2011; EHASHI, Tomo/H-4817-2016	kobayashi, hisatoshi/0000-0001-9487-0725; Hanagata, Nobutaka/0000-0001-6079-3426; Minowa, Takashi/0000-0003-0046-5230	Core Research Evolutional Science and Technology (CREST) [20106014]; Grants-in-Aid for Scientific Research [26670623] Funding Source: KAKEN	Core Research Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Core Research Evolutional Science and Technology (CREST; http://www.jst.go.jp/crest/nanoif/english/index.html) and Grant-in-Aid for Scientific Research on Innovation Areas (20106014; http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425; Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048; Calzada MJ, 2004, J BIOL CHEM, V279, P41734, DOI 10.1074/jbc.M406267200; Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025; Crawford DC, 2012, J BONE JOINT SURG AM, V94A, P979, DOI 10.2106/JBJS.K.00533; DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403; Druecke D, 2004, J BIOMED MATER RES A, V68A, P10, DOI 10.1002/jbm.a.20016; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70; Hanagata N, 2007, J BIOMED MATER RES A, V83A, P362, DOI 10.1002/jbm.a.31240; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.3.CO;2-0; ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107; ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355; Jabbarzadeh E, 2008, P NATL ACAD SCI USA, V105, P11099, DOI 10.1073/pnas.0800069105; Jiang F, 2008, J CELL MOL MED, V12, P2062, DOI 10.1111/j.1582-4934.2008.00199.x; Jing CB, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/6/065001; Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649; Kihara S, 2003, ARTIF ORGANS, V27, P188, DOI 10.1046/j.1525-1594.2003.t01-2-06993.x; Kyomoto M, 2011, CLIN ORTHOP RELAT R, V469, P2327, DOI 10.1007/s11999-010-1718-5; LAWLER J, 1989, BLOOD, V74, P2022; LAWLER JW, 1977, THROMB HAEMOSTASIS, V37, P355; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Lips PAM, 2006, J BIOMED MATER RES A, V76A, P699, DOI 10.1002/jbm.a.30530; Lu XY, 2009, BIOMATERIALS, V30, P141, DOI 10.1016/j.biomaterials.2008.09.011; Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Matheson LA, 2006, J BIOMED MATER RES A, V76A, P52, DOI 10.1002/jbm.a.30448; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mitragotri S, 2011, NAT MATER, V8, P15; Myers T, 2009, INVEST NEW DRUG, V27, P304, DOI 10.1007/s10637-008-9175-7; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Patel JD, 2005, J BIOMED MATER RES A, V73A, P359, DOI 10.1002/jbm.a.30302; Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8; Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939; Sandor M, 2008, TISSUE ENG PT A, V14, P2021, DOI 10.1089/ten.tea.2007.0317; Sawada S, 2003, J BIOMED MATER RES A, V64A, P411, DOI 10.1002/jbm.a.10433; Sawada SI, 2006, J BIOMED MATER RES A, V79A, P476, DOI 10.1002/jbm.a.30820; Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863; Sharkawy AA, 1998, J BIOMED MATER RES, V40, P586, DOI 10.1002/(SICI)1097-4636(19980615)40:4<586::AID-JBM10>3.3.CO;2-V; Shchors K, 2007, CANCER RES, V67, P7059, DOI 10.1158/0008-5472.CAN-07-2053; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Stenina OI, 2003, CIRCULATION, V108, P1514, DOI 10.1161/01.CIR.0000089085.76320.4E; Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066; Underwood RA, 2011, J BIOMED MATER RES A, V98A, P499, DOI 10.1002/jbm.a.33125; Wijeyekoon R, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00078; Wilshaw SP, 2008, TISSUE ENG PT A, V14, P463, DOI 10.1089/tea.2007.0145; Ye SH, 2010, COLLOID SURFACE B, V79, P357, DOI 10.1016/j.colsurfb.2010.04.018; Yeo Y, 2007, BIOMATERIALS, V28, P3704, DOI 10.1016/j.biomaterials.2007.04.033; Zong XH, 2004, ANN SURG, V240, P910, DOI 10.1097/01.sla.0000143302.48223.7e	54	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85132	10.1371/journal.pone.0085132	http://dx.doi.org/10.1371/journal.pone.0085132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454803	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800023
J	Lin, XXB; Farhangfar, A; Valcheva, R; Sawyer, MB; Dieleman, L; Schieber, A; Ganzle, MG; Baracos, V				Lin, Xiaoxi B.; Farhangfar, Arazm; Valcheva, Rosica; Sawyer, Michael B.; Dieleman, Levinus; Schieber, Andreas; Gaenzle, Michael G.; Baracos, Vickie			The Role of Intestinal Microbiota in Development of Irinotecan Toxicity and in Toxicity Reduction through Dietary Fibres in Rats	PLOS ONE			English	Article							BETA-GLUCURONIDASE ACTIVITY; MONOCARBOXYLATE TRANSPORTER; BACTERIAL TRANSLOCATION; BUTYRATE; MICROFLORA; EXPRESSION; CANCER; INULIN; BIFIDOBACTERIA; CHEMOTHERAPY	CPT-11 is a drug used as chemotherapy for colorectal cancer. CPT-11 causes toxic side-effects in patients. CPT-11 toxicity has been attributed to the activity of intestinal microbiota, however, intestinal microbiota may also have protective effects in CP!-11 chemotherapy. This study aimed to elucidate mechanisms through which microbiota and dietary fibres could modify host health. Rats bearing a Ward colon carcinoma were treated with a two-cycle CPT-11/5-fluorouracil therapy recapitulating clinical therapy of colorectal cancer. Animals were fed with a semi-purified diet or a semi-purified diet was supplemented with non-digestible carbohydrates (isomalto-oligosaccharides, resistant starch, fructo-oligosaccharides, or inulin) in 3 independent experiments. Changes in intestinal microbiota, bacteria translocating to mesenteric lymphnodes, cecal GUD activity, and cecal SCFA production, and the intestinal concentration of CPT-11 and its metabolites were analysed. Non-digestible carbohydrates significantly influenced feed intake, body weight and other indicators of animal health. The identification of translocating bacteria and their quantification in cecal microbiota indicated that overgrowth of the intestine by opportunistic pathogens was not a major contributor to CPT-11 toxicity. Remarkably, fecal GUD activity positively correlated to body weight and feed intake but negatively correlated to cecal SN-38 concentrations and IL1-beta. The reduction in CPT-11 toxicity by non-digestible carbohydrates did not correlate to stimulation of specific bacterial taxa. However, cecal butyrate concentrations and feed intake were highly correlated. The protective role of intestinal butyrate production was substantiated by a positive correlation of the host expression of MCT1 (monocarboxylate transporter 1) with body weight as well as a positive correlation of the abundance of bacterial butyryl-CoA gene with cecal butyrate concentrations. These correlations support the interpretation that the influence of dietary fibre on CPT-11 toxicity is partially mediated by an increased cecal production of butyrate.	[Lin, Xiaoxi B.; Farhangfar, Arazm; Schieber, Andreas; Gaenzle, Michael G.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Farhangfar, Arazm; Sawyer, Michael B.; Baracos, Vickie] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Valcheva, Rosica; Dieleman, Levinus] Univ Alberta, Ctr Excellence Gastrointestinal Inflammat & Immun, Edmonton, AB, Canada; [Schieber, Andreas] Univ Bonn, Dept Nutr & Food Sci, Bonn, Germany	University of Alberta; University of Alberta; University of Alberta; University of Bonn	Ganzle, MG (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	mgaenzle@ualberta.ca	Dieleman, Levinus/AAT-8198-2021; Gänzle, Michael/F-1432-2017	Gänzle, Michael/0000-0003-0972-928X; Baracos, Vickie/0000-0002-9609-1001; Dieleman, Levinus/0000-0001-7852-2122	Canadian Institute of Health Research; National Science and Engineering Research Council	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by the Canadian Institute of Health Research and the National Science and Engineering Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dasooqi N, 2011, CHEMOTHERAPY, V57, P43, DOI 10.1159/000321477; Anthony Lowell, 2007, Curr Opin Support Palliat Care, V1, P35, DOI 10.1097/SPC.0b013e328133f2ad; Beaud D, 2005, MICROBIOL-SGM, V151, P2323, DOI 10.1099/mic.0.27712-0; Berg RD, 1999, ADV EXP MED BIOL, V473, P11; Brandi G, 2006, CLIN CANCER RES, V12, P1299, DOI 10.1158/1078-0432.CCR-05-0750; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Cenci G, 2000, J BASIC MICROB, V40, P311, DOI 10.1002/1521-4028(200012)40:5/6<311::AID-JOBM311>3.0.CO;2-5; CHAPMAN MAS, 1994, GUT, V35, P73, DOI 10.1136/gut.35.1.73; Corona G, 2010, THER DRUG MONIT, V32, P638, DOI 10.1097/FTD.0b013e3181ec3bf5; Cuff MA, 2002, J PHYSIOL-LONDON, V539, P361, DOI 10.1113/jphysiol.2001.014241; Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x; Farhangfar A, 2012, THESIS U ALBERTA; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gill CIR, 2002, BRIT J NUTR, V88, pS73, DOI 10.1079/BJN2002632; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; HORECKER BL, 1966, ANNU REV MICROBIOL, V20, P253, DOI 10.1146/annurev.mi.20.100166.001345; Innocenti F, 2009, J CLIN ONCOL, V27, P2604, DOI 10.1200/JCO.2008.20.6300; Iwanaga T, 2006, BIOMED RES-TOKYO, V27, P243, DOI 10.2220/biomedres.27.243; Juskiewicz J, 2006, J ANIM PHYSIOL AN N, V90, P200, DOI 10.1111/j.1439-0396.2005.00591.x; Lin XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039764; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Martinez-Beamonte R, 2011, J BIOTECHNOL, V151, P325, DOI 10.1016/j.jbiotec.2010.12.017; Nakao T, 2012, J SURG RES, V173, P341, DOI 10.1016/j.jss.2010.10.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Ranganna K, 2007, FEBS J, V274, P5962, DOI 10.1111/j.1742-4658.2007.06119.x; Raninen K, 2011, NUTR REV, V69, P9, DOI 10.1111/j.1753-4887.2010.00358.x; Regmi PR, 2011, J NUTR, V141, P1273, DOI 10.3945/jn.111.140509; Reiter WD, 2008, CURR OPIN PLANT BIOL, V11, P236, DOI 10.1016/j.pbi.2008.03.009; Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S; ROWLAND IR, 1985, CRC CR REV TOXICOL, V16, P31, DOI 10.3109/10408448509041324; SHIAU SY, 1983, J NUTR, V113, P138, DOI 10.1093/jn/113.1.138; Sparreboom A, 1998, CLIN CANCER RES, V4, P2747; Stringer AM, 2009, CURR DRUG METAB, V10, P79, DOI 10.2174/138920009787048419; Takasuna K, 1996, CANCER RES, V56, P3752; Takesue Y, 2005, WORLD J SURG, V29, P198, DOI 10.1007/s00268-004-7576-0; Thibault R, 2007, GASTROENTEROLOGY, V133, P1916, DOI 10.1053/j.gastro.2007.08.041; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Van den Abbeele P, 2011, ENVIRON MICROBIOL, V13, P2667, DOI 10.1111/j.1462-2920.2011.02533.x; van der Logt EMJ, 2003, CARCINOGENESIS, V24, P1651, DOI 10.1093/carcin/bgg117; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Wu WT, 2011, BRIT J NUTR, V105, P593, DOI 10.1017/S0007114510004009; Xue HY, 2008, J NUTR, V138, P740, DOI 10.1093/jn/138.4.740; Xue HY, 2007, CLIN CANCER RES, V13, P7146, DOI 10.1158/1078-0432.CCR-07-0823; Zwielehner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028654	48	118	121	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e83644	10.1371/journal.pone.0083644	http://dx.doi.org/10.1371/journal.pone.0083644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454707	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800010
J	Smith, K; Zeng, XM; Lin, J				Smith, Katie; Zeng, Ximin; Lin, Jun			Discovery of Bile Salt Hydrolase Inhibitors Using an Efficient High-Throughput Screening System	PLOS ONE			English	Article							ANTIBIOTIC GROWTH PROMOTERS; ACID PHENETHYL ESTER; BROILER-CHICKENS; CAFFEIC ACID; LACTOBACILLUS-SALIVARIUS; INTESTINAL MICROBIOTA; CAMPYLOBACTER-JEJUNI; COPPER-SULFATE; CARNOSIC ACID; SUBTHERAPEUTIC LEVELS	The global trend of restricting the use of antibiotic growth promoters (AGP) in animal production necessitates the need to develop valid alternatives to maintain productivity and sustainability of food animals. Previous studies suggest inhibition of bile salt hydrolase (BSH), an intestinal bacteria-produced enzyme that exerts negative impact on host fat digestion and utilization, is a promising approach to promote animal growth performance. To achieve the long term goal of developing novel alternatives to AGPs, in this study, a rapid and convenient high-throughput screening (HTS) system was developed and successfully used for identification of BSH inhibitors. With the aid of a high-purity BSH from a chicken Lactobacillus salivarius strain, we optimized various screening conditions (e.g. BSH concentration, reaction buffer pH, incubation temperature and length, substrate type and concentration) and establish a precipitation-based screening approach to identify BSH inhibitors using 96-well or 384-well microplates. A pilot HTS was performed using a small compound library comprised of 2,240 biologically active and structurally diverse compounds. Among the 107 hits, several promising and potent BSH inhibitors (e. g. riboflavin and phenethyl caffeate) were selected and validated by standard BSH activity assay. Interestingly, the HTS also identified a panel of antibiotics as BSH inhibitor; in particular, various tetracycline antibiotics and roxarsone, the widely used AGP, have been demonstrated to display potent inhibitory effect on BSH. Together, this study developed an efficient HTS system and identified several BSH inhibitors with potential as alternatives to AGP. In addition, the findings from this study also suggest a new mode of action of AGP for promoting animal growth.	[Smith, Katie; Zeng, Ximin; Lin, Jun] Univ Tennessee, Dept Anim Sci, Knoxville, TN 37901 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Lin, J (corresponding author), Univ Tennessee, Dept Anim Sci, Knoxville, TN 37901 USA.	jlin6@utk.edu			University of Tennessee AgResearch Innovation Grant	University of Tennessee AgResearch Innovation Grant	No current external funding sources for this study. The work was supported by internal grant award (University of Tennessee AgResearch Innovation Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol S, 2012, CELL BIOCHEM FUNCT, V30, P438, DOI 10.1002/cbf.2817; Altug ME, 2008, BRAIN RES, V1201, P135, DOI 10.1016/j.brainres.2008.01.053; [Anonymous], 2012, VET REC, V170, P404; [Anonymous], 1987, VITAMIN TOLERANCE AN; Arias VJ, 2006, POULTRY SCI, V85, P999, DOI 10.1093/ps/85.6.999; Armstrong TA, 2004, J ANIM SCI, V82, P1234; Azad N, 2011, CELL J, V13, P39; Basu P, 2008, ENVIRON HEALTH PERSP, V116, P520, DOI 10.1289/ehp.10885; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Casewell M, 2003, J ANTIMICROB CHEMOTH, V52, P159, DOI 10.1093/jac/dkg313; Chan GCF, 2013, CLIN REV ALLERG IMMU, V44, P262, DOI 10.1007/s12016-012-8322-2; Chapman HD, 2002, POULTRY SCI, V81, P356, DOI 10.1093/ps/81.3.356; Chung TW, 2004, FASEB J, V18, P1670, DOI 10.1096/fj.04-2126com; Collier CT, 2003, J ANIM SCI, V81, P3035; Combs GF, 2012, VITAMINS: FUNDAMENTAL ASPECTS IN NUTRITION AND HEALTH, 4TH EDITION, P277, DOI 10.1016/B978-0-12-381980-2.00011-6; Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Dos Santos JS, 2013, J BURN CARE RES; Du GJ, 2012, NUTRIENTS, V4, P1679, DOI 10.3390/nu4111679; Dumonceaux TJ, 2006, APPL ENVIRON MICROB, V72, P2815, DOI 10.1128/AEM.72.4.2815-2823.2006; Engberg RM, 2000, POULTRY SCI, V79, P1311, DOI 10.1093/ps/79.9.1311; Ewing HP, 1998, POULTRY SCI, V77, P445, DOI 10.1093/ps/77.3.445; FEIGHNER SD, 1987, APPL ENVIRON MICROB, V53, P331, DOI 10.1128/AEM.53.2.331-336.1987; Guban J, 2006, POULTRY SCI, V85, P2186, DOI 10.1093/ps/85.12.2186; Hamilton-Miller JMT, 2000, J ANTIMICROB CHEMOTH, V46, P852, DOI 10.1093/jac/46.5.852; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Jacela JY, 2010, J SWINE HEALTH PROD, V18, P87, DOI 10.4148/2378-5977.7068; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Kelsey NA, 2010, MOLECULES, V15, P7792, DOI 10.3390/molecules15117792; Kim HB, 2012, P NATL ACAD SCI USA, V109, P15485, DOI 10.1073/pnas.1205147109; Knarreborg A, 2004, J NUTR, V134, P1487, DOI 10.1093/jn/134.6.1487; Knarreborg A, 2002, APPL ENVIRON MICROB, V68, P5918, DOI 10.1128/AEM.68.12.5918-5924.2002; Kuo CF, 2011, J AGR FOOD CHEM, V59, P3674, DOI 10.1021/jf104837w; La-Ongkhum O, 2011, POULTRY SCI, V90, P1532, DOI 10.3382/ps.2010-01288; Lee KJ, 2008, FOOD CHEM TOXICOL, V46, P2445, DOI 10.1016/j.fct.2008.03.032; Lin J, 2005, ANTIMICROB AGENTS CH, V49, P1067, DOI 10.1128/AAC.49.3.1067-1075.2005; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Lin J, 2013, FOODBORNE PATHOG DIS, V10, P331, DOI 10.1089/fpd.2012.1348; Liu ZH, 2011, POULTRY SCI, V90, P1782, DOI 10.3382/ps.2010-01215; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Miles RD, 1998, POULTRY SCI, V77, P416, DOI 10.1093/ps/77.3.416; Moran L, 2012, MEAT SCI, V91, P430, DOI 10.1016/j.meatsci.2012.02.027; Mounnissamy VM, 2002, INDIAN J HETEROCY CH, V12, P85; Mountzouris KC, 2010, POULTRY SCI, V89, P58, DOI 10.3382/ps.2009-00308; Nachman KE, 2013, ENVIRON HEALTH PERSP, V121, P818, DOI 10.1289/ehp.1206245; Oldenburg K, 2005, COMB CHEM HIGH T SCR, V8, P499, DOI 10.2174/1386207054867364; Patel AK, 2010, APPL BIOCHEM BIOTECH, V162, P166, DOI 10.1007/s12010-009-8738-1; Rettedal E, 2009, APPL ENVIRON MICROB, V75, P5489, DOI 10.1128/AEM.02220-08; Sharifi SD, 2012, POULTRY SCI, V91, P918, DOI 10.3382/ps.2011-01844; Shelton NW, 2011, J ANIM SCI, V89, P2440, DOI 10.2527/jas.2010-3432; Smith JW, 1997, J ANIM SCI, V75, P1861; Stern NJ, 2006, ANTIMICROB AGENTS CH, V50, P3111, DOI 10.1128/AAC.00259-06; Tanaka H, 2000, APPL ENVIRON MICROB, V66, P2502, DOI 10.1128/AEM.66.6.2502-2512.2000; TERAO J, 1994, ARCH BIOCHEM BIOPHYS, V308, P278, DOI 10.1006/abbi.1994.1039; Trendafilova A, 2011, NAT PROD COMMUN, V6, P1851; van den Bogaard AE, 1999, DRUGS, V58, P589, DOI 10.2165/00003495-199958040-00002; Wang Z, 2012, APPL ENVIRON MICROB, V78, P8795, DOI 10.1128/AEM.02519-12; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Xiang QS, 2013, FOOD CHEM TOXICOL, V53, P1, DOI 10.1016/j.fct.2012.11.001; Yilmaz A, 2005, CURR EYE RES, V30, P755, DOI 10.1080/02713680590967962; Zhou H, 2007, POULTRY SCI, V86, P2541, DOI 10.3382/ps.2007-00267	62	34	37	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85344	10.1371/journal.pone.0085344	http://dx.doi.org/10.1371/journal.pone.0085344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454844	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800039
J	Zhao, BH; Li, L; Liu, JT; Li, HZ; Zhang, CL; Han, PF; Zhang, YF; Yuan, XH; Ge, RS; Chu, YH				Zhao, Binghai; Li, Li; Liu, Jieting; Li, Hongzhi; Zhang, Chunlei; Han, Pengfei; Zhang, Yufei; Yuan, Xiaohuan; Ge, Ren Shan; Chu, Yanhui			Exposure to Perfluorooctane Sulfonate In Utero Reduces Testosterone Production in Rat Fetal Leydig Cells	PLOS ONE			English	Article							TESTICULAR DYSGENESIS SYNDROME; SERUM CONCENTRATIONS; PERFLUORINATED COMPOUNDS; PERFLUOROALKYL ACIDS; GENE-EXPRESSION; BLOOD-SERUM; TESTIS; DIFFERENTIATION; POPULATION; SUBSTANCES	Background: Perfluorooctane sulfonate (PFOS) is a synthetic material that has been widely used in industrial applications for decades. Exposure to PFOS has been associated with decreased adult testosterone level, and Leydig cell impairment during the time of adulthood. However, little is known about PFOS effects in utero on fetal Leydig cells (FLC). Methods and Results: The present study investigated effects of PFOS on FLC function. Pregnant Sprague Dawley female rats received vehicle (0.05% Tween20) or PFOS (5, 20 mg/kg) by oral gavage from gestational day (GD) 11-19. At GD20, testosterone (T) production, FLC numbers and ultrastructure, testicular gene and protein expression levels were examined. The results indicate that exposures to PFOS have affected FLC function as evidenced by decreased T production, impaired FLC, reduced FLC number, and decreased steroidogenic capacity and cholesterol level in utero. Conclusion: The present study shows that PFOS is an endocrine disruptor of male reproductive system as it causes reduction of T production and impairment of rat fetal Leydig cells.	[Zhao, Binghai; Li, Li; Liu, Jieting; Li, Hongzhi; Zhang, Chunlei; Zhang, Yufei; Yuan, Xiaohuan; Chu, Yanhui] Heilongjiang Key Lab Antifibrosis Biotherapy, Heilongjiang, Peoples R China; [Han, Pengfei] Mudanjiang Med Univ, Hong Qi Hosp, Heilongjiang, Peoples R China; [Ge, Ren Shan] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China	Mudanjiang Medical University; Wenzhou Medical University	Chu, YH (corresponding author), Heilongjiang Key Lab Antifibrosis Biotherapy, Heilongjiang, Peoples R China.	yanhui_chu@163.com	Zhang, yufei/HHC-7375-2022		Natural Science Foundation of China [81102149, 81372951, 81070329]; Heilongjiang Province Education Fund [1252G065]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Education Fund	This work was supported in part by Natural Science Foundation of China (No. 81102149 and No. 81372951 to Binghai Zhao, No. 81070329 to Yanhui Chu) and the Heilongjiang Province Education Fund (1252G065) to Binghai Zhao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbarossa A, 2013, ENVIRON INT, V51, P27, DOI 10.1016/j.envint.2012.10.001; Beumer TL, 2000, MOL REPROD DEV, V56, P353, DOI 10.1002/1098-2795(200007)56:3&lt;353::AID-MRD4&gt;3.0.CO;2-3; BIEGEL LB, 1995, TOXICOL APPL PHARM, V134, P18, DOI 10.1006/taap.1995.1164; Chang SC, 2009, REPROD TOXICOL, V27, P387, DOI 10.1016/j.reprotox.2009.01.005; Chen MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042474; CODESAL J, 1990, J ANAT, V172, P103; Crawford BA, 1997, J PEDIATR ENDOCR MET, V10, P401; Du GZ, 2013, ENVIRON TOXICOL CHEM, V32, P353, DOI 10.1002/etc.2034; Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025; Fowler PA, 2009, J CLIN ENDOCR METAB, V94, P4688, DOI 10.1210/jc.2009-0994; Ge RS, 2006, P NATL ACAD SCI USA, V103, P2719, DOI 10.1073/pnas.0507692103; Ge RS, 1998, ENDOCRINOLOGY, V139, P3787, DOI 10.1210/en.139.9.3787; Ge RS, 2005, ENDOCRINOLOGY, V146, P2657, DOI 10.1210/en.2005-0046; Giesy JP, 2002, ENVIRON SCI TECHNOL, V36, p146A, DOI 10.1021/es022253t; Glynn A, 2012, ENVIRON SCI TECHNOL, V46, P9071, DOI 10.1021/es301168c; Goldman JM, 2000, CRIT REV TOXICOL, V30, P135, DOI 10.1080/10408440091159185; Habert R, 2001, MOL CELL ENDOCRINOL, V179, P47, DOI 10.1016/S0303-7207(01)00461-0; Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6; Hasegawa T, 2000, MOL ENDOCRINOL, V14, P1462, DOI 10.1210/me.14.9.1462; Hu GX, 2009, TRENDS ENDOCRIN MET, V20, P139, DOI 10.1016/j.tem.2008.12.001; Jensen AA, 2008, INT J ANDROL, V31, P161, DOI 10.1111/j.1365-2605.2008.00870.x; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; Ji K, 2012, ENVIRON INT, V45, P78, DOI 10.1016/j.envint.2012.03.007; Lau C, 2004, TOXICOL APPL PHARM, V198, P231, DOI 10.1016/j.taap.2003.11.031; Lee YJ, 2013, CHEMOSPHERE, V90, P1603, DOI 10.1016/j.chemosphere.2012.08.035; Lindh CH, 2012, CHEMOSPHERE, V88, P1269, DOI 10.1016/j.chemosphere.2012.03.049; LORDING DW, 1972, J REPROD FERTIL, V29, P261; Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075; Maisonet M, 2012, ENVIRON HEALTH PERSP, V120, P1432, DOI 10.1289/ehp.1003096; Mendis-Handagama SMLC, 2001, BIOL REPROD, V65, P660, DOI 10.1095/biolreprod65.3.660; Miyake H, 2000, CANCER RES, V60, P2547; MONTPETIT ML, 1986, PROSTATE, V8, P25, DOI 10.1002/pros.2990080105; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Olsen GW, 2003, ENVIRON SCI TECHNOL, V37, P888, DOI 10.1021/es020955c; PAYNE AH, 1980, ENDOCRINOLOGY, V106, P1424, DOI 10.1210/endo-106-5-1424; Payne AH, 2007, LEYDIG CELL HLTH DIS, P135; Shi ZM, 2007, TOXICOL SCI, V98, P206, DOI 10.1093/toxsci/kfm070; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Vestergren R, 2012, ENVIRON INT, V49, P120, DOI 10.1016/j.envint.2012.08.016; Wei Liu, 2007, Huanjing Kexue, V28, P2068; Zhang W, 2011, ECOTOX ENVIRON SAFE, V74, P1787, DOI 10.1016/j.ecoenv.2011.04.027; Zhao BH, 2010, CHEM-BIOL INTERACT, V188, P38, DOI 10.1016/j.cbi.2010.07.001; Zhao BH, 2010, J STEROID BIOCHEM, V118, P13, DOI 10.1016/j.jsbmb.2009.09.010	43	46	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e78888	10.1371/journal.pone.0078888	http://dx.doi.org/10.1371/journal.pone.0078888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454680	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800002
J	Buard, J; Rivals, E; de Segonzac, DD; Garres, C; Caminade, P; de Massy, B; Boursot, P				Buard, Jerome; Rivals, Eric; de Segonzac, Denis Dunoyer; Garres, Charlotte; Caminade, Pierre; de Massy, Bernard; Boursot, Pierre			Diversity of Prdm9 Zinc Finger Array in Wild Mice Unravels New Facets of the Evolutionary Turnover of this Coding Minisatellite	PLOS ONE			English	Article							MEIOTIC RECOMBINATION HOTSPOTS; HYBRID MALE-STERILITY; MOUSE MUS-MUSCULUS; HOUSE MOUSE; GENUS MUS; DNA RECOGNITION; MITOCHONDRIAL; HISTORY; INSTABILITY; LANDSCAPE	In humans and mice, meiotic recombination events cluster into narrow hotspots whose genomic positions are defined by the PRDM9 protein via its DNA binding domain constituted of an array of zinc fingers (ZnFs). High polymorphism and rapid divergence of the Prdm9 gene ZnF domain appear to involve positive selection at DNA-recognition amino-acid positions, but the nature of the underlying evolutionary pressures remains a puzzle. Here we explore the variability of the Prdm9 ZnF array in wild mice, and uncovered a high allelic diversity of both ZnF copy number and identity with the caracterization of 113 alleles. We analyze features of the diversity of ZnF identity which is mostly due to non-synonymous changes at codons -1, 3 and 6 of each ZnF, corresponding to amino-acids involved in DNA binding. Using methods adapted to the minisatellite structure of the ZnF array, we infer a phylogenetic tree of these alleles. We find the sister species Mus spicilegus and M. macedonicus as well as the three house mouse (Mus musculus) subspecies to be polyphyletic. However some sublineages have expanded independently in Mus musculus musculus and M. m. domesticus, the latter further showing phylogeographic substructure. Compared to random genomic regions and non-coding minisatellites, none of these patterns appears exceptional. In silico prediction of DNA binding sites for each allele, overlap of their alignments to the genome and relative coverage of the different families of interspersed repeated elements suggest a large diversity between PRDM9 variants with a potential for highly divergent distributions of recombination events in the genome with little correlation to evolutionary distance. By compiling PRDM9 ZnF protein sequences in Primates, Muridae and Equids, we find different diversity patterns among the three amino-acids most critical for the DNA-recognition function, suggesting different diversification timescales.	[Buard, Jerome; de Segonzac, Denis Dunoyer; Garres, Charlotte; de Massy, Bernard] CNRS, Inst Human Genet, UPR 1142, Montpellier, France; [Rivals, Eric] Univ Montpellier 2, Lab Informat Robot & Microelect Montpellier, UMR 5506, CNRS, Montpellier, France; [de Segonzac, Denis Dunoyer; Garres, Charlotte; Caminade, Pierre; Boursot, Pierre] Univ Montpellier 2, Inst Sci Evolut Montpellier, CNRS, Inst Rech Dev, Montpellier, France; [Rivals, Eric] Inst Biol Computat, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier	de Massy, B (corresponding author), CNRS, Inst Human Genet, UPR 1142, Montpellier, France.	bernard.de-massy@igh.cnrs.fr	Boursot, Pierre/D-5860-2011	Boursot, Pierre/0000-0001-6366-2341; Rivals, Eric/0000-0003-3791-3973	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [09-BLAN-0269-01]; Fondation pour la Recherche Medicale; Labex "EpigenMed" program of MENRT; Conseil Scientifique of Universite Montpellier 2 [AAP2011]; Region Languedoc Roussillon (grant Chercheur d'Avenir); NUMEV Labex; MASTODONS Defi from CNRS; Investissements d'Avenir (grant Institut Computational Biology)	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Labex "EpigenMed" program of MENRT; Conseil Scientifique of Universite Montpellier 2; Region Languedoc Roussillon (grant Chercheur d'Avenir)(Region Occitanie); NUMEV Labex; MASTODONS Defi from CNRS; Investissements d'Avenir (grant Institut Computational Biology)(French National Research Agency (ANR))	JB and BdM are supported by the Centre National de la Recherche Scientifique, the Agence Nationale de la Recherche (09-BLAN-0269-01), and the Fondation pour la Recherche Medicale. DD is recipient of a fellowship by from the Labex "EpigenMed" program of MENRT. The project was partly funded by the Conseil Scientifique of Universite Montpellier 2 (AAP2011 to PB). ER is supported by the Region Languedoc Roussillon (grant Chercheur d'Avenir), the NUMEV Labex, the MASTODONS Defi from CNRS, and by Investissements d'Avenir (grant Institut Computational Biology). The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Axelsson E, 2012, GENOME RES, V22, P51, DOI 10.1101/gr.124123.111; Baines JF, 2007, GENETICS, V175, P1911, DOI 10.1534/genetics.106.069419; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Berard S, 2003, J COMPUT BIOL, V10, P357, DOI 10.1089/10665270360688066; Berard S, 2006, EVOL BIOINFORM, V2, P303; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Billings T, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r35; Bonhomme F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r80; Bonhomme F, 2011, P ROY SOC B-BIOL SCI, V278, P1034, DOI 10.1098/rspb.2010.1228; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; BOURSOT P, 1993, ANNU REV ECOL SYST, V24, P119, DOI 10.1146/annurev.es.24.110193.001003; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Britton-Davidian J, 2005, BIOL J LINN SOC, V84, P379, DOI 10.1111/j.1095-8312.2005.00441.x; Carvalho AM, 2006, IEEE ACM T COMPUT BI, V3, P126, DOI 10.1109/TCBB.2006.16; Chevret P, 2005, BIOL J LINN SOC, V84, P417, DOI 10.1111/j.1095-8312.2005.00444.x; Clement Y, 2013, MOL BIOL EV IN PRESS; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Coop G, 2007, PLOS GENET, V3, P377, DOI 10.1371/journal.pgen.0030035; Darvish J, 2006, FOLIA ZOOL, V55, P349; de Massy B, 2013, ANN REV GEN IN PRESS; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Duvaux L, 2011, MOL ECOL, V20, P5248, DOI 10.1111/j.1365-294X.2011.05343.x; Geraldes A, 2011, MOL ECOL, V20, P4722, DOI 10.1111/j.1365-294X.2011.05285.x; Geraldes A, 2008, MOL ECOL, V17, P5349, DOI 10.1111/j.1365-294X.2008.04005.x; Good JM, 2008, GENETICS, V179, P2213, DOI 10.1534/genetics.107.085340; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Groeneveld LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039064; Guenoche A., 2001, Computational Biology. First International Conference on Biology, Informatics, and Mathematics, JOBIM 2000. Selected Papers (Lecture Notes in Computer Science Vol.2066), P45; Halligan DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000825; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; Jeffreys AJ, 2013, P NATL ACAD SCI USA, V110, P600, DOI 10.1073/pnas.1220813110; Karn RC, 2002, MOL BIOL EVOL, V19, P462, DOI 10.1093/oxfordjournals.molbev.a004102; Kauppi L, 2013, GENE DEV, V27, P873, DOI 10.1101/gad.213652.113; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lichten M, 2011, CELL, V147, P267, DOI 10.1016/j.cell.2011.09.038; Maheshwari S, 2011, ANNU REV GENET, V45, P331, DOI 10.1146/annurev-genet-110410-132514; Mckee B. D., 2009, V5, P56, DOI 10.1159/000166619; McVean G, 2010, PHILOS T R SOC B, V365, P1213, DOI 10.1098/rstb.2009.0299; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Munoz-Fuentes V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025498; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Oka A, 2010, GENETICS, V186, P339, DOI 10.1534/genetics.110.118976; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Persikov AV, 2009, BIOINFORMATICS, V25, P22, DOI 10.1093/bioinformatics/btn580; Persikov AV, 2013, NUCL ACIDS IN PRESS; Phifer-Rixey M, 2012, MOL BIOL EVOL, V29, P2949, DOI 10.1093/molbev/mss105; Ponting CP, 2011, TRENDS GENET, V27, P165, DOI 10.1016/j.tig.2011.02.001; Pool JE, 2009, GENETICS, V181, P711, DOI 10.1534/genetics.108.098095; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; R Core Team, 2012, R LANG ENV STAT COMP; Rajabi-Maham H, 2012, BIOL J LINN SOC, V107, P295, DOI 10.1111/j.1095-8312.2012.01957.x; SHE JX, 1990, BIOL J LINN SOC, V41, P83, DOI 10.1111/j.1095-8312.1990.tb00823.x; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Staubach F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002891; Steiner CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061746; Suzuki H, 2004, MOL PHYLOGENET EVOL, V33, P626, DOI 10.1016/j.ympev.2004.08.003; Suzuki H, 2013, HEREDITY, V111, P375, DOI 10.1038/hdy.2013.60; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas JH, 2011, GENOME RES, V21, P1800, DOI 10.1101/gr.121749.111; Tucker PK, 2005, BIOL J LINN SOC, V84, P653, DOI 10.1111/j.1095-8312.2005.00462.x; Turner LM, 2012, EVOLUTION, V66, P443, DOI 10.1111/j.1558-5646.2011.01445.x; Vyskocilova M, 2009, MAMM GENOME, V20, P83, DOI 10.1007/s00335-008-9164-3; Webster MT, 2012, TRENDS GENET, V28, P101, DOI 10.1016/j.tig.2011.11.002; White MA, 2012, GENETICS, V191, P917, DOI 10.1534/genetics.112.140251; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	80	45	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85021	10.1371/journal.pone.0085021	http://dx.doi.org/10.1371/journal.pone.0085021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454780	Green Submitted, Green Published, gold			2022-12-25	WOS:000329922500031
J	Sandor, ME; Chazdon, RL				Sandor, Manette E.; Chazdon, Robin L.			Remnant Trees Affect Species Composition but Not Structure of Tropical Second-Growth Forest	PLOS ONE			English	Article							BURN AGRICULTURAL SYSTEM; SEED RAIN; ABANDONED PASTURE; RECRUITMENT; VEGETATION; CONSERVATION; REGENERATION; SUCCESSION; DISPERSAL; DIVERSITY	Remnant trees, spared from cutting when tropical forests are cleared for agriculture or grazing, act as nuclei of forest regeneration following field abandonment. Previous studies on remnant trees were primarily conducted in active pasture or old fields abandoned in the previous 2-3 years, and focused on structure and species richness of regenerating forest, but not species composition. Our study is among the first to investigate the effects of remnant trees on neighborhood forest structure, biodiversity, and species composition 20 years post-abandonment. We compared the woody vegetation around individual remnant trees to nearby plots without remnant trees in the same second-growth forests ("control plots"). Forest structure beneath remnant trees did not differ significantly from control plots. Species richness and species diversity were significantly higher around remnant trees. The species composition around remnant trees differed significantly from control plots and more closely resembled the species composition of nearby old-growth forest. The proportion of old-growth specialists and generalists around remnant trees was significantly greater than in control plots. Although previous studies show that remnant trees may initially accelerate secondary forest growth, we found no evidence that they locally affect stem density, basal area, and seedling density at later stages of regrowth. Remnant trees do, however, have a clear effect on the species diversity, composition, and ecological groups of the surrounding woody vegetation, even after 20 years of forest regeneration. To accelerate the return of diversity and old-growth forest species into regrowing forest on abandoned land, landowners should be encouraged to retain remnant trees in agricultural or pastoral fields.	[Sandor, Manette E.; Chazdon, Robin L.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	University of Connecticut	Sandor, ME (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	manette.sandor@uconn.edu	; Chazdon, Robin/O-9766-2018	Sandor, Manette/0000-0002-3665-4837; Chazdon, Robin/0000-0002-7349-5687	Blue Moon Fund; Ronald Bamford Endowment Fund Award	Blue Moon Fund; Ronald Bamford Endowment Fund Award	Our study was funded by Blue Moon Fund (http://www.bluemoonfund.org/) and a Ronald Bamford Endowment Fund Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R., 2018, ADELANTE VASCULAR PL; [Anonymous], 2011, PROGRAM CLAM CLASSIF; Barrantes G., 1999, EVALUACION PLANES MA; Carriere SM, 2002, J TROP ECOL, V18, P353, DOI 10.1017/S0266467402002250; Carriere SM, 2002, J TROP ECOL, V18, P375, DOI 10.1017/S0266467402002262; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; Chazdon RL, 2014, SOCIAL LIVE IN PRESS; Chazdon RL, 2011, ECOLOGY, V92, P1332, DOI 10.1890/10-1345.1; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Colwell R, 2012, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Cubina A, 2001, BIOTROPICA, V33, P260, DOI 10.1111/j.1744-7429.2001.tb00177.x; de la Pena-Domene M, 2013, ECOL APPL, V23, P1124, DOI 10.1890/12-1728.1; Elmqvist T, 2002, CONSERV ECOL, V5; Fischer J, 2002, BIODIVERS CONSERV, V11, P833, DOI 10.1023/A:1015318328007; Galindo-Gonzalez J, 2003, SOUTHWEST NAT, V48, P579, DOI 10.1894/0038-4909(2003)048&lt;0579:FBIITA&gt;2.0.CO;2; Galindo-Gonzalez J, 2000, CONSERV BIOL, V14, P1693, DOI [10.1046/j.1523-1739.2000.99072.x, 10.1111/j.1523-1739.2000.99072.x]; Guevara S, 2004, BIOTROPICA, V36, P99, DOI 10.1646/02111; GUEVARA S, 1992, J VEG SCI, V3, P655, DOI 10.2307/3235833; GUEVARA S, 1986, VEGETATIO, V66, P77; GUEVARA S, 1993, VEGETATIO, V108, P319; Harvey CA, 2006, ECOL APPL, V16, P1986, DOI 10.1890/1051-0761(2006)016[1986:POADID]2.0.CO;2; Harvey CA, 2011, FOREST ECOL MANAG, V261, P1664, DOI 10.1016/j.foreco.2010.11.004; Herrera W, 1986, CLIMA COSTA RICA, P118; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holdridge L.R., 1971, FOREST ENV TROPICAL; Holl KD, 2011, RESTOR ECOL, V19, P470, DOI 10.1111/j.1526-100X.2010.00674.x; Holl KD, 1999, BIOTROPICA, V31, P229, DOI 10.1111/j.1744-7429.1999.tb00135.x; Janzen D.H., 1983, P619; KERNAN C, 1995, J ECOL, V83, P65, DOI 10.2307/2261151; Laborde J, 2008, ECOSCIENCE, V15, P6, DOI 10.2980/1195-6860(2008)15[6:TASSDI]2.0.CO;2; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; MCDONNELL MJ, 1983, OECOLOGIA, V56, P109, DOI 10.1007/BF00378225; Morales-Salazar MS, 2013, REV FOR MESOAM KURU-, V10, P1; Murray K. Greg, 2008, P192, DOI 10.1007/978-0-387-33642-8_8; Nadkarni NM, 2009, CONSERV BIOL, V23, P1117, DOI 10.1111/j.1523-1739.2009.01235.x; Nepstad DC, 1996, OIKOS, V76, P25, DOI 10.2307/3545745; Oksanen J., 2016, R PACKAG; Oliver C.D., 1990, FOREST STAND DYNAMIC; Quesada F.J., 1997, ARBOLES PENINSULA OS; R Development Core Team, 2011, R LANG ENV STAT COMP; Schlawin J, 2008, J VEG SCI, V19, P485, DOI 10.3170/2008-8-18387; Sekercioglu CH, 2007, CONSERV BIOL, V21, P482, DOI 10.1111/j.1523-1739.2007.00655.x; Slocum MG, 2001, ECOLOGY, V82, P2547, DOI 10.1890/0012-9658(2001)082[2547:HTSDAR]2.0.CO;2; Slocum MG, 2000, PLANT ECOL, V149, P51, DOI 10.1023/A:1009892821864; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; White GM, 2002, P NATL ACAD SCI USA, V99, P2038, DOI 10.1073/pnas.042649999; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]; YARRANTON GA, 1974, J ECOL, V62, P417, DOI 10.2307/2258988; Zambrano A. M. A., 2010, Journal of Ecotourism, V9, P62, DOI 10.1080/14724040902953076	54	48	49	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e83284	10.1371/journal.pone.0083284	http://dx.doi.org/10.1371/journal.pone.0083284			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454700	gold, Green Published, Green Submitted			2022-12-25	WOS:000329922500007
J	Islam, MA; Thomas, SD; Murty, VV; Sedoris, KJ; Miller, DM				Islam, Md Ashraful; Thomas, Shelia D.; Murty, Vundavalli V.; Sedoris, Kara J.; Miller, Donald M.			c-Myc Quadruplex-forming Sequence Pu-27 Induces Extensive Damage in Both Telomeric and Nontelomeric Regions of DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; DNA Damage; Myc; Survivin; Telomeres; ATM; Alt Cell; G-quadruplex; Phospho-H2AX; Shelterin	NUCLEOTIDE EXCISION-REPAIR; SYNTHETIC LETHALITY; CELL-CYCLE; ATM; PROTEIN; GENOME; TRF2; APOPTOSIS; CANCER; RECOMBINATION	Background: G-quadruplex forming DNA of gene promoter associated with cell death and growth arrest. Results: G-quadruplex forming DNA at c-Myc promoter Pu27 destabilizes proteins at telomere and inhibits DNA repair molecules. Conclusion: Pu27 shows extensive DNA damage primarily at telomere that contributes to cell death. Significance: Learning how Pu27 destabilizes at telomeric region is crucial to understanding G-quadruplex-mediated cancer biology. Quadruplex-forming DNA sequences are present throughout the eukaryotic genome, including in telomeric DNA. We have shown that the c-Myc promoter quadruplex-forming sequence Pu-27 selectively kills transformed cells (Sedoris, K. C., Thomas, S. D., Clarkson, C. R., Muench, D., Islam, A., Singh, R., and Miller, D. M. (2012) Genomic c-Myc quadruplex DNA selectively kills leukemia. Mol. Cancer Ther. 11, 66-76). In this study, we show that Pu-27 induces profound DNA damage, resulting in striking chromosomal abnormalities in the form of chromatid or chromosomal breaks, radial formation, and telomeric DNA loss, which induces -H2AX in U937 cells. Pu-27 down-regulates telomeric shelterin proteins, DNA damage response mediators (RAD17 and RAD50), double-stranded break repair molecule 53BP1, G(2) checkpoint regulators (CHK1 and CHK2), and anti-apoptosis gene survivin. Interestingly, there are no changes of DNA repair molecules H(2)AX, BRCA1, and the telomere maintenance gene, hTERT. B-U937, where U937 cells stably transfected with deleted basic domain of TRF2 is partially sensitive to Pu-27 but exhibits no changes in expression of shelterin proteins. However, there is an up-regulation of CHK1, CHK2, H(2)AX, BRCA1, and survivin. Telomere dysfunction-induced foci assay revealed co-association of TRF1with -H2AX in ATM deficient cells, which are differentially sensitive to Pu-27 than ATM proficient cells. Alt (alternating lengthening of telomere) cells are relatively resistant to Pu-27, but there are no significant changes of telomerase activity in both Alt and non-Alt cells. Lastly, we show that this Pu-27-mediated sensitivity is p53-independent. The data therefore support two conclusions. First, Pu-27 induces DNA damage within both telomeric and nontelomeric regions of the genome. Second, Pu-27-mediated telomeric damage is due, at least in part, to compromise of the telomeric shelterin protein complex.	[Islam, Md Ashraful; Thomas, Shelia D.; Sedoris, Kara J.; Miller, Donald M.] Univ Louisville, James Graham Brown Canc Ctr, Dept Med, Louisville, KY 40202 USA; [Islam, Md Ashraful; Thomas, Shelia D.; Sedoris, Kara J.; Miller, Donald M.] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA; [Murty, Vundavalli V.] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Murty, Vundavalli V.] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA	University of Louisville; University of Louisville; Columbia University; Columbia University	Islam, MA (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Dept Med, 505 S Hancock St,Ctr Bldg 442C, Louisville, KY 40202 USA.	ashrafulislam01@gmail.com	Islam, Ashraful/GYR-1579-2022	Islam, Ashraful/0000-0002-1742-6804	Grant COBRE National Institutes of Health: UPHS [1P30GM10639601]	Grant COBRE National Institutes of Health: UPHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Grant COBRE National Institutes of Health: UPHS Grant 1P30GM10639601 (to the James Graham Brown Cancer Center of the University of Louisville).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Farokhzad OO, 1996, J IMMUNOL, V157, P5597; Flores I, 2006, MOL CELL BIOL, V26, P6130, DOI 10.1128/MCB.00543-06; FRIEDBERG EC, 1995, PHILOS T ROY SOC B, V347, P63, DOI 10.1098/rstb.1995.0010; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hoogstraten D, 2008, J CELL SCI, V121, P2850, DOI 10.1242/jcs.031708; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Liu HL, 2000, J BIOL CHEM, V275, P40155, DOI 10.1074/jbc.M001565200; Louis SF, 2005, P NATL ACAD SCI USA, V102, P9613, DOI 10.1073/pnas.0407512102; Lundblad V, 2000, MUTAT RES-FUND MOL M, V451, P227, DOI 10.1016/S0027-5107(00)00052-X; McLuckie KIE, 2013, J AM CHEM SOC, V135, P9640, DOI 10.1021/ja404868t; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Muraki K, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00135; Neidle S, 2010, FEBS J, V277, P1118, DOI 10.1111/j.1742-4658.2009.07463.x; OKAZAKI S, 1993, MOL CELL BIOL, V13, P1424, DOI 10.1128/MCB.13.3.1424; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pandita TK, 2000, ONCOGENE, V19, P1386, DOI 10.1038/sj.onc.1203444; Pandita TK, 2002, ONCOGENE, V21, P611, DOI 10.1038/sj.onc.1205060; POTTER H, 1984, P NATL ACAD SCI-BIOL, V81, P7161, DOI 10.1073/pnas.81.22.7161; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Robertson HM, 2006, GENOME RES, V16, P1345, DOI 10.1101/gr.5085606; Sedoris KC, 2012, MOL CANCER THER, V11, P66, DOI 10.1158/1535-7163.MCT-11-0515; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; Smilenov LB, 1999, MOL CELL BIOL, V19, P6963; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tauchi T, 2003, ONCOGENE, V22, P5338, DOI 10.1038/sj.onc.1206833; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Xu Y, 1997, J CELL PHYSIOL, V170, P192, DOI 10.1002/(SICI)1097-4652(199702)170:2<192::AID-JCP11>3.0.CO;2-K; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	43	16	16	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8521	8531		10.1074/jbc.M113.505073	http://dx.doi.org/10.1074/jbc.M113.505073			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24464582	hybrid, Green Published			2022-12-25	WOS:000333157500043
J	Zeraik, AE; Pereira, HM; Santos, YV; Brandao-Neto, J; Spoerner, M; Santos, MS; Colnago, LA; Garratt, RC; Araujo, APU; DeMarco, R				Zeraik, Ana E.; Pereira, Humberto M.; Santos, Yuri V.; Brandao-Neto, Jose; Spoerner, Michael; Santos, Maiara S.; Colnago, Luiz A.; Garratt, Richard C.; Araujo, Ana P. U.; DeMarco, Ricardo			Crystal Structure of a Schistosoma mansoni Septin Reveals the Phenomenon of Strand Slippage in Septins Dependent on the Nature of the Bound Nucleotide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; GTPase; Protein Conformation; Protein Structure; X-ray Crystallography; Conformational Change; Filament; GTPase Domain; Schistosoma; Septin	FILAMENT FORMATION; MAMMALIAN SEPTINS; GTP-BINDING; FORMS FILAMENTS; YEAST SEPTIN; ARF; HYDROLYSIS; COMPLEXES; PROTEINS; FAMILY	Background: Septins are filament-forming proteins involved in membrane-remodeling events. Results: Two crystal structures of a septin with the highest resolution to date reveal the phenomenon of -strand slippage. Conclusion: A novel mechanistic framework for the influence of the nature of the bound nucleotide and the presence of Mg2+ in septins is proposed. Significance: Identification of strand slippage might contribute to elucidating the mechanism of septin association with membranes. Septins are filament-forming GTP-binding proteins involved in important cellular events, such as cytokinesis, barrier formation, and membrane remodeling. Here, we present two crystal structures of the GTPase domain of a Schistosoma mansoni septin (SmSEPT10), one bound to GDP and the other to GTP. The structures have been solved at an unprecedented resolution for septins (1.93 and 2.1 , respectively), which has allowed for unambiguous structural assignment of regions previously poorly defined. Consequently, we provide a reliable model for functional interpretation and a solid foundation for future structural studies. Upon comparing the two complexes, we observe for the first time the phenomenon of a strand slippage in septins. Such slippage generates a front-back communication mechanism between the G and NC interfaces. These data provide a novel mechanistic framework for the influence of nucleotide binding to the GTPase domain, opening new possibilities for the study of the dynamics of septin filaments.	[Zeraik, Ana E.; Pereira, Humberto M.; Santos, Yuri V.; Garratt, Richard C.; Araujo, Ana P. U.; DeMarco, Ricardo] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13563120 Sao Carlos, SP, Brazil; [Brandao-Neto, Jose] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Spoerner, Michael] Univ Regensburg, Ctr Magnet Resonance Chem & Biomed, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany; [Santos, Maiara S.; Colnago, Luiz A.] Embrapa Instrumentacao, BR-13560970 Sao Carlos, SP, Brazil; [Santos, Maiara S.] Univ Sao Paulo, Inst Quim Sao Carlos, BR-13566590 Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Diamond Light Source; University of Regensburg; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo	DeMarco, R (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, BR-13563120 Sao Carlos, SP, Brazil.	rdemarco@ifsc.usp.br	Santos, Maiara/F-7766-2012; Colnago, Luiz Alberto/E-9693-2012; DeMarco, Ricardo/A-7773-2008; garratt, richard c/F-6921-2011; Spoerner, Michael/C-9035-2012; Araujo, Ana Paula U/I-6664-2012; Pereira, Humberto M/J-7824-2016; Zeraik, Ana/G-2974-2013	Colnago, Luiz Alberto/0000-0002-9516-9022; DeMarco, Ricardo/0000-0001-8944-1301; Araujo, Ana Paula U/0000-0001-5455-084X; Pereira, Humberto M/0000-0002-8652-6729; garratt, richard/0000-0002-2016-3179; Zeraik, Ana Eliza/0000-0001-9508-4283; Brandao-Neto, Jose/0000-0001-6015-320X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [550514/2011-2]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57910-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Grant 550514/2011-2 and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant 2008/57910-0 (to the Instituto Nacional de Ciencia e Tecnologia-Instituto Nacional de Biotecnologia Estrutural e Quimica Mecicinal em Doencas Infecciosas (INCT-INBEQMeDI).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Serrao VHB, 2011, FEBS LETT, V585, P3868, DOI 10.1016/j.febslet.2011.10.043; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Cao LH, 2009, CELL MOL LIFE SCI, V66, P3309, DOI 10.1007/s00018-009-0087-2; Casamayor A, 2003, MOL CELL BIOL, V23, P2762, DOI 10.1128/MCB.23.8.2762-2777.2003; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Eigenbrot C, 2001, STRUCTURE, V9, P627, DOI 10.1016/S0969-2126(01)00624-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eneqvist T, 2000, MOL CELL, V6, P1207, DOI 10.1016/S1097-2765(00)00117-9; Estey MP, 2011, CURR BIOL, V21, pR384, DOI 10.1016/j.cub.2011.03.067; Farkasovsky M, 2005, BIOL CHEM, V386, P643, DOI 10.1515/BC.2005.075; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; Garcia W, 2008, BBA-PROTEINS PROTEOM, V1784, P1720, DOI 10.1016/j.bbapap.2008.06.005; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; GREASLEY SE, 1995, NAT STRUCT BIOL, V2, P797, DOI 10.1038/nsb0995-797; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Hall P. A., 2008, SEPTINS, P35; HEINZ DW, 1993, NATURE, V361, P561, DOI 10.1038/361561a0; Huang YW, 2006, FEBS J, V273, P3248, DOI 10.1111/j.1742-4658.2006.05333.x; JOHN J, 1993, J BIOL CHEM, V268, P923; KEEFE LJ, 1993, P NATL ACAD SCI USA, V90, P3275, DOI 10.1073/pnas.90.8.3275; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Lazarowski ER, 1997, J BIOL CHEM, V272, P20402, DOI 10.1074/jbc.272.33.20402; Macedo JNA, 2013, BIOCHEM J, V450, P95, DOI 10.1042/BJ20120851; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Marques ID, 2012, CELL BIOCHEM BIOPHYS, V62, P317, DOI 10.1007/s12013-011-9307-0; Martinez C, 2004, BIOCHEM J, V382, P783, DOI 10.1042/BJ20040372; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Nahum Laila A., 2012, Journal of Parasitology Research, P849132, DOI 10.1155/2012/849132; Nishihama R, 2011, BIOL CHEM, V392, P681, DOI 10.1515/BC.2011.086; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Petkova AT, 2004, J MOL BIOL, V335, P247, DOI 10.1016/j.jmb.2003.10.044; Russell SEH, 2011, BIOL CHEM, V392, P763, DOI 10.1515/BC.2011.079; SECKLER R, 1990, J BIOL CHEM, V265, P7655; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sirajuddin M, 2009, P NATL ACAD SCI USA, V106, P16592, DOI 10.1073/pnas.0902858106; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tellinghuisen J, 2008, ANAL BIOCHEM, V373, P395, DOI 10.1016/j.ab.2007.08.039; van Boxel GI, 2010, J MOL BIOL, V400, P828, DOI 10.1016/j.jmb.2010.05.053; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Zent E, 2011, BIOL CHEM, V392, P791, DOI 10.1515/BC.2011.082; Zeraik AE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002602; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	54	24	27	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7799	7811		10.1074/jbc.M113.525352	http://dx.doi.org/10.1074/jbc.M113.525352			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24464615	hybrid, Green Published			2022-12-25	WOS:000332761500046
J	Ebel, ME; Kansas, GS				Ebel, Mark E.; Kansas, Geoffrey S.			Defining the Functional Boundaries of the Murine alpha 1,3-Fucosyltransferase Fut7 Reveals a Remarkably Compact Locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Gene Expression; Glycobiology; Glycosyltransferases; Immunology; Leukocyte; Transcription Regulation	SELECTIN-DEFICIENT MICE; ALPHA(1,3)FUCOSYLTRANSFERASE FUC-TVII; HIGH ENDOTHELIAL VENULES; JURKAT T-CELLS; SIALYL-LEWIS-X; P-SELECTIN; GENE-EXPRESSION; ALPHA(1,3)-FUCOSYL-TRANSFERASE VII; LEUKOCYTE RECRUITMENT; LIGAND EXPRESSION	Background: Fut7 gene expression is tightly regulated and controls leukocyte traffic. Results: A 12.7 kb genomic interval controls Fut7 gene expression in all cell types. Conclusion: This interval therefore represents the functional boundaries of the Fut7 locus. Significance: All cis-acting genetic elements that control Fut7 expression are within this genomic interval. Fut7 encodes an 1,3-fucosyltransferase critical for biosynthesis of glycan ligands for all three selectins. Consistent with this function, Fut7 expression is limited to hematopoietic cells and high endothelial cells which express selectin ligands. Mechanisms that govern Fut7 expression are poorly defined. To begin to understand the molecular genetic basis for transcriptional regulation of Fut7, a transgenic, gain-of-function, genetic complementation approach in mice was used to define the functional boundaries of the murine Fut7 locus, defined here as any uninterupted stretch of genomic DNA that contains all cis-acting genetic elements essential for accurate physiologic expression. A 12.7-kb contiguous genomic interval, which lies completely between the highly conserved flanking Npdc1 and Abca2 loci on chromosome 2 and which contains the complete transcriptional unit plus approximate to 7.4 kb upstream of the transcriptional start site and approximate to 2 kb downstream of the transcriptional termination and polyadenylation sites, was used as a transgene (Tg) on a Fut7 null background. Tg+ mice exhibited restoration of Fut7 gene expression and physiologic levels of selectin ligand expression and function on neutrophils, activated T cells, and high endothelial cells and corrected the functional defects in these cells found in Fut7 null mice without leading to detectable expression of Fut7 in normally non-expressing tissues. These results demonstrate that all genetic information essential for appropriate and selective expression of Fut7 in diverse cell types and in response to distinct developmental signals is contained within this comparatively small genetic region.	[Ebel, Mark E.; Kansas, Geoffrey S.] Northwestern Univ, Feinberg Med Sch, Dept Microbiol Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Kansas, GS (corresponding author), Northwestern Univ, Feinberg Med Sch, Dept Microbiol Immunol, 320 E Super Ave, Chicago, IL 60611 USA.	gsk@northwestern.edu		Ebel, Mark/0000-0001-8833-7115	National Institutes of Health [CA60553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We gratefully acknowledge the efforts of Mark Singer and Dr. Steven D. Rosen, University of California, San Francisco, for performing immunohistochemistry for L-selectin ligands and MECA79 on peripheral lymph nodes (Fig. 5C) and for helpful advice and Dr. Dragana Jankovic, Laboratory of Parasitic Diseases, NIAID, National Institutes of Health for provision of T. gondii-containing brain lysates and critical advice. The genetically engineered mice were generated with the assistance of Northwestern University Transgenic and Targeted Mutagenesis Laboratory. The Northwestern University Transgenic and Targeted Mutagenesis Laboratory is supported in part by National Institutes of Health Grant CA60553 (to the Robert H. Lurie Comprehensive Cancer Center at Northwestern University).	ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Barry SM, 2003, BLOOD, V102, P1771, DOI 10.1182/blood-2002-11-3551; Blander JM, 1999, J IMMUNOL, V163, P3746; Brandt W, 2008, J BIOL CHEM, V283, P8976, DOI 10.1074/jbc.M709364200; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; Chen GY, 2006, P NATL ACAD SCI USA, V103, P16894, DOI 10.1073/pnas.0607926103; Dagia NM, 2006, NAT MED, V12, P1185, DOI 10.1038/nm1470; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Hiraiwa N, 1997, BIOCHEM BIOPH RES CO, V231, P183, DOI 10.1006/bbrc.1997.6068; Hiraiwa N, 2003, BLOOD, V101, P3615, DOI 10.1182/blood-2002-07-2301; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; KISHIMOTO TK, 1990, P NATL ACAD SCI USA, V87, P2244, DOI 10.1073/pnas.87.6.2244; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; Moussion C, 2011, NATURE, V479, P542, DOI 10.1038/nature10540; Nabors LK, 2013, EXP HEMATOL, V41, P588, DOI 10.1016/j.exphem.2013.02.014; Pipkin ME, 2007, IMMUNITY, V26, P29, DOI 10.1016/j.immuni.2006.11.009; Robert C, 1999, J EXP MED, V189, P627, DOI 10.1084/jem.189.4.627; Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452; Smith PL, 1996, J BIOL CHEM, V271, P8250, DOI 10.1074/jbc.271.14.8250; STOOLMAN LM, 1987, BLOOD, V70, P1842; Underhill GH, 2005, BLOOD, V106, P3867, DOI 10.1182/blood-2005-03-0984; Underhill GH, 2002, BLOOD, V99, P2905, DOI 10.1182/blood.V99.8.2905; VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460; Wagers AJ, 2000, J IMMUNOL, V165, P5011, DOI 10.4049/jimmunol.165.9.5011; Wagers AJ, 1998, J EXP MED, V188, P2225, DOI 10.1084/jem.188.12.2225; White SJ, 2001, J IMMUNOL, V167, P628, DOI 10.4049/jimmunol.167.2.628; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Zisoulis DG, 2004, J BIOL CHEM, V279, P39495, DOI 10.1074/jbc.M407904200	38	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6341	6349		10.1074/jbc.M113.511790	http://dx.doi.org/10.1074/jbc.M113.511790			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24459148	Green Published, hybrid			2022-12-25	WOS:000332389400003
J	Nangia-Makker, P; Yu, YJ; Vasudevan, A; Farhana, L; Rajendra, SG; Levi, E; Majumdar, APN				Nangia-Makker, Pratima; Yu, Yingjie; Vasudevan, Anita; Farhana, Lulu; Rajendra, Sindhu G.; Levi, Edi; Majumdar, Adhip P. N.			Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ABERRANT CRYPT FOCI; CELL-CYCLE ARREST; STEM-CELLS; BREAST-CANCER; MESENCHYMAL TRANSITION; MATRIX METALLOPROTEASES; OCIMUM-GRATISSIMUM; IN-VIVO; GROWTH	Accumulating evidence suggests that metformin, a biguanide class of anti-diabetic drugs, possesses anti-cancer properties. However, most of the studies to evaluate therapeutic efficacy of metformin have been on primary cancer. No information is available whether metformin could be effectively used for recurrent cancer, specifically colorectal cancer (CRC) that affects up to 50% of patients treated by conventional chemotherapies. Although the reasons for recurrence are not fully understood, it is thought to be due to re-emergence of chemotherapy-resistant cancer stem/stem-like cells (CSCs/CSLCs). Therefore, development of non-toxic treatment strategies targeting CSCs would be of significant therapeutic benefit. In the current investigation, we have examined the effectiveness of metformin, in combination with 5-fluorouracil and oxaliplatin (FuOx), the mainstay of colon cancer therapeutics, on survival of chemo-resistant colon cancer cells that are highly enriched in CSCs/CSLCs. Our data show that metformin acts synergistically with FuOx to (a) induce cell death in chemo resistant (CR) HT-29 and HCT-116 colon cancer cells, (b) inhibit colonospheres formation and (c) enhance colonospheres disintegration. In vitro cell culture studies have further demonstrated that the combinatorial treatment inhibits migration of CR colon cancer cells. These changes were associated with increased miRNA 145 and reduction in miRNA 21. Wnt/beta-catenin signaling pathway was also down-regulated indicating its pivotal role in regulating the growth of CR colon cancer cells. Data from SCID mice xenograft model of CR HCT-116 and CR HT-29 cells show that the combination of metformin and FuOX is highly effective in inhibiting the growth of colon tumors as evidenced by similar to 50% inhibition in growth following 5 weeks of combination treatment, when compared with the vehicle treated controls. Our current data suggest that metformin together with conventional chemotherapy could be an effective treatment regimen for recurring colorectal cancer (CRC).	[Nangia-Makker, Pratima; Yu, Yingjie; Vasudevan, Anita; Farhana, Lulu; Rajendra, Sindhu G.; Levi, Edi; Majumdar, Adhip P. N.] Wayne State Univ, Vet Affairs Med Ctr, Detroit, MI 48202 USA; [Nangia-Makker, Pratima; Majumdar, Adhip P. N.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Nangia-Makker, Pratima; Yu, Yingjie; Vasudevan, Anita; Farhana, Lulu; Majumdar, Adhip P. N.] Wayne State Univ, Dept Internal Med, Detroit, MI 48202 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University	Majumdar, APN (corresponding author), Wayne State Univ, Vet Affairs Med Ctr, Detroit, MI 48202 USA.	a.majumdar@wayne.edu		Nangia-Makker, Pratima/0000-0002-1917-169X; Levi, Edi/0000-0003-1809-2866	NIH [AG014343]; Department of Veteran Affairs [I101BX001927]; NATIONAL INSTITUTE ON AGING [R01AG014343] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001927] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by grants from the NIH (AG014343) and the Department of Veteran Affairs (I101BX001927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Algire C, 2010, ENDOCR-RELAT CANCER, V17, P351, DOI 10.1677/ERC-09-0252; Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brabletz S, 2009, J PATHOL, V217, P307, DOI 10.1002/path.2475; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cantrell LA, 2010, GYNECOL ONCOL, V116, P92, DOI 10.1016/j.ygyno.2009.09.024; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Del Barco S, 2011, ONCOTARGET, V2, P896, DOI 10.18632/oncotarget.387; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Feng YH, 2012, INT J MOL MED, V29, P920, DOI 10.3892/ijmm.2012.910; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Hosono K, 2010, CANCER PREV RES, V3, P1077, DOI 10.1158/1940-6207.CAPR-10-0186; Hosono K, 2010, MOL CARCINOGEN, V49, P662, DOI 10.1002/mc.20637; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Isakovic A, 2007, CELL MOL LIFE SCI, V64, P1290, DOI 10.1007/s00018-007-7080-4; Ishimoto T, 2010, CANCER SCI, V101, P673, DOI 10.1111/j.1349-7006.2009.01430.x; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Kanwar SS, 2011, PHARM RES-DORDR, V28, P827, DOI 10.1007/s11095-010-0336-y; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Lee JH, 2012, INT J CANCER, V131, P752, DOI 10.1002/ijc.26421; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Martinez JA, 1999, CELL MOL BIOL, V45, P137; Memmott RM, 2010, CANCER PREV RES, V3, P1066, DOI 10.1158/1940-6207.CAPR-10-0055; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nangia-Makker P, 2007, INT J CANCER, V121, P884, DOI 10.1002/ijc.22733; Nangia-Makker P, 2013, CANCER BIOL THER, V14, P417, DOI 10.4161/cbt.23762; Nangia-Makker P, 2010, INT J CANCER, V127, P2530, DOI 10.1002/ijc.25254; Nautiyal Jyoti, 2011, J Mol Signal, V6, P7, DOI 10.1186/1750-2187-6-7; Oh PS, 2011, AM J PHYSIOL-GASTR L, V301, pG347, DOI 10.1152/ajpgi.00403.2010; Padhye S, 2009, PHARM RES-DORDR, V26, P1874, DOI 10.1007/s11095-009-9900-8; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Roy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068543; Roy Sanchita, 2012, J Mol Signal, V7, P11, DOI 10.1186/1750-2187-7-11; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Schulenburg A, 2010, CRIT REV ONCOL HEMAT, V76, P79, DOI 10.1016/j.critrevonc.2010.01.001; Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomimoto A, 2008, CANCER SCI, V99, P2136, DOI 10.1111/j.1349-7006.2008.00933.x; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yu YJ, 2013, TRANSL ONCOL, V6, P180, DOI 10.1593/tlo.12397; Yu YJ, 2012, CARCINOGENESIS, V33, P68, DOI 10.1093/carcin/bgr246; Yu YJ, 2009, TRANSL ONCOL, V2, P321, DOI 10.1593/tlo.09193; Zakikhani M, 2008, CANCER PREV RES, V1, P369, DOI 10.1158/1940-6207.CAPR-08-0081	66	87	95	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84369	10.1371/journal.pone.0084369	http://dx.doi.org/10.1371/journal.pone.0084369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465408	gold, Green Submitted, Green Published			2022-12-25	WOS:000330240500017
J	Loescher, H; Ayres, E; Duffy, P; Luo, HY; Brunke, M				Loescher, Henry; Ayres, Edward; Duffy, Paul; Luo, Hongyan; Brunke, Max			Spatial Variation in Soil Properties among North American Ecosystems and Guidelines for Sampling Designs	PLOS ONE			English	Article							WATER CONTENT; SPATIOTEMPORAL VARIABILITY; MOISTURE VARIABILITY; SURFACE MOISTURE; FOREST SOIL; TEMPERATURE; FIELD; CATCHMENT; RESOURCES; PATTERNS	Soils are highly variable at many spatial scales, which makes designing studies to accurately estimate the mean value of soil properties across space challenging. The spatial correlation structure is critical to develop robust sampling strategies (e. g., sample size and sample spacing). Current guidelines for designing studies recommend conducting preliminary investigation(s) to characterize this structure, but are rarely followed and sampling designs are often defined by logistics rather than quantitative considerations. The spatial variability of soils was assessed across similar to 1 ha at 60 sites. Sites were chosen to represent key US ecosystems as part of a scaling strategy deployed by the National Ecological Observatory Network. We measured soil temperature (T-s) and water content (SWC) because these properties mediate biological/biogeochemical processes below-and above-ground, and quantified spatial variability using semivariograms to estimate spatial correlation. We developed quantitative guidelines to inform sample size and sample spacing for future soil studies, e. g., 20 samples were sufficient to measure T-s to within 10% of the mean with 90% confidence at every temperate and subtropical site during the growing season, whereas an order of magnitude more samples were needed to meet this accuracy at some high-latitude sites. SWC was significantly more variable than T-s at most sites, resulting in at least 10x more SWC samples needed to meet the same accuracy requirement. Previous studies investigated the relationship between the mean and variability (i.e., sill) of SWC across space at individual sites across time and have often (but not always) observed the variance or standard deviation peaking at intermediate values of SWC and decreasing at low and high SWC. Finally, we quantified how far apart samples must be spaced to be statistically independent. Semivariance structures from 10 of the 12-dominant soil orders across the US were estimated, advancing our continental-scale understanding of soil behavior.	[Loescher, Henry; Ayres, Edward; Luo, Hongyan; Brunke, Max] NEON, Sci Team, Boulder, CO 80301 USA; [Loescher, Henry; Ayres, Edward; Luo, Hongyan] Univ Colorado, Inst Arctic & Alpine Res INSTAAR, Boulder, CO 80309 USA; [Ayres, Edward] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Duffy, Paul] Neptune & Co Inc, Lakewood, CO USA	University of Colorado System; University of Colorado Boulder; Colorado State University	Loescher, H (corresponding author), NEON, Sci Team, Boulder, CO 80301 USA.	hloescher@neoninc.org	Ayres, Edward/A-4172-2008	Ayres, Edward/0000-0001-5190-258X	National Science Foundation (NSF); Direct For Biological Sciences [1029808] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The National Ecological Observatory Network (NEON) is a project sponsored by the National Science Foundation (NSF) and managed under cooperative agreement by NEON, Inc. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the NSF.' be formally acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anctil F, 2002, J HYDROL, V260, P30, DOI 10.1016/S0022-1694(01)00600-X; Ayres E, 2011, SOIL TEMPERATURE MOI; Beckett PHT, 1971, SOILS FERTILIZERS, V34, P1; Bond-Lamberty B, 2006, CAN J FOREST RES, V36, P2794, DOI 10.1139/X06-160; Boone RD, 1999, LT EC RES NETWK SER, V2, P3; Brocca L, 2007, J HYDROL, V333, P356, DOI 10.1016/j.jhydrol.2006.09.004; Brocca L, 2012, J HYDROL, V422, P63, DOI 10.1016/j.jhydrol.2011.12.039; Brocca L, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008016; BURGESS TM, 1980, J SOIL SCI, V31, P315, DOI 10.1111/j.1365-2389.1980.tb02084.x; Castrignano A, 2000, GEODERMA, V97, P39, DOI 10.1016/S0016-7061(00)00025-2; Chaplot V, 2003, HYDROL PROCESS, V17, P2567, DOI 10.1002/hyp.1273; Choi M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028247; CHUNG CK, 1995, COMMUN SOIL SCI PLAN, V26, P741, DOI 10.1080/00103629509369332; Coffey G. N., 1912, USDA BUR SOILS B, V85; DI HJ, 1989, SOIL SCI SOC AM J, V53, P1163, DOI 10.2136/sssaj1989.03615995005300040028x; Dobermann A, 1997, SOIL SCI SOC AM J, V61, P1483, DOI 10.2136/sssaj1997.03615995006100050028x; Dokuchaev V.V., 1883, ISRAEL PROG SCI T; ELKINS NZ, 1986, OECOLOGIA, V68, P521, DOI 10.1007/BF00378766; Ettema CH, 1998, ECOLOGY, V79, P2721, DOI 10.1890/0012-9658(1998)079[2721:SDOBNA]2.0.CO;2; Famiglietti JS, 2008, WATER RESOUR RES, V44, DOI 10.1029/2006WR005804; Famiglietti JS, 1998, J HYDROL, V210, P259, DOI 10.1016/S0022-1694(98)00187-5; Famiglietti JS, 1999, WATER RESOUR RES, V35, P1839, DOI 10.1029/1999WR900047; Fitzjohn C, 1998, CATENA, V32, P55, DOI 10.1016/S0341-8162(97)00045-3; Gallardo A, 2003, ECOSYSTEMS, V6, P564, DOI 10.1007/s10021-003-0198-9; GIESE K, 1975, ADV MOL RELAX INT PR, V7, P45, DOI 10.1016/0001-8716(75)80013-7; Global Carbon Observing System GCOS, 2007, GLOB CLIM OBS SYST E; Goovaerts P, 1998, BIOL FERT SOILS, V27, P315, DOI 10.1007/s003740050439; Gorres JH, 1998, SOIL BIOL BIOCHEM, V30, P219, DOI 10.1016/S0038-0717(97)00107-7; GRIGAL DF, 1991, SOIL SCI, V151, P282, DOI 10.1097/00010694-199104000-00003; Hargrove WW, 2004, ENVIRON MANAGE, V34, pS39, DOI 10.1007/s00267-003-1084-0; Hargrove WW, 1999, COMPUT SCI ENG, V1, P18, DOI 10.1109/5992.774837; Herbst M, 2009, VADOSE ZONE J, V8, P762, DOI 10.2136/vzj2008.0068; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; HORST TW, 1995, J ATMOS OCEAN TECH, V12, P447, DOI 10.1175/1520-0426(1995)012<0447:>2.0.CO;2; Huang XD, 2011, SCI TOTAL ENVIRON, V409, P4572, DOI 10.1016/j.scitotenv.2011.07.044; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jenny H., 1941, FACTORS SOIL FORMATI; KAIMAL JC, 1990, BOUND-LAY METEOROL, V50, P31, DOI 10.1007/BF00120517; KASPAR TC, 1992, SOIL SCI, V154, P290, DOI 10.1097/00010694-199210000-00005; Keller M, 2008, FRONT ECOL ENVIRON, V6, P282, DOI 10.1890/1540-9295(2008)6[282:ACSFTN]2.0.CO;2; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Klironomos JN, 1999, APPL SOIL ECOL, V12, P227, DOI 10.1016/S0929-1393(99)00014-1; Kosugi Y, 2007, AGR FOREST METEOROL, V147, P35, DOI 10.1016/j.agrformet.2007.06.005; Larson KM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036013; Lee H, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2008JG000906; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; LEMON EDGAR R., 1960, AGRON JOUR, V52, P697; Li B, 2013, HYDROL EARTH SYST SC, V17, P1177, DOI 10.5194/hess-17-1177-2013; LOAGUE K, 1992, J HYDROL, V139, P233, DOI 10.1016/0022-1694(92)90204-9; Loescher HW, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006932; Loescher HW, 2002, J TROP ECOL, V18, P397, DOI 10.1017/S0266467402002274; MCBRATNEY AB, 1983, SOIL SCI, V135, P177, DOI 10.1097/00010694-198303000-00007; MCBRATNEY AB, 1986, J SOIL SCI, V37, P617, DOI 10.1111/j.1365-2389.1986.tb00392.x; Mittelbach H, 2012, HYDROL EARTH SYST SC, V16, P2169, DOI 10.5194/hess-16-2169-2012; MOHANTY BP, 1995, SOIL SCI SOC AM J, V59, P752, DOI 10.2136/sssaj1995.03615995005900030017x; MONTEITH JL, 1960, Q J ROY METEOR SOC, V86, P205, DOI 10.1002/qj.49708636810; Nyberg L, 1996, HYDROL PROCESS, V10, P89, DOI 10.1002/(SICI)1099-1085(199601)10:1&lt;89::AID-HYP303&gt;3.0.CO;2-W; Panosso AR, 2009, SOIL TILL RES, V105, P275, DOI 10.1016/j.still.2009.09.008; Petersen R. G., 1996, Methods of soil analysis. Part 3 - chemical methods., P1; PIERSON FB, 1991, J RANGE MANAGE, V44, P491, DOI 10.2307/4002751; Rey A, 2005, EUR J SOIL SCI, V56, P589, DOI 10.1111/j.1365-2389.2004.00699.x; ROBERTSON GP, 1988, ECOLOGY, V69, P1517, DOI 10.2307/1941649; Robertson GP, 1997, ECOL APPL, V7, P158, DOI 10.1890/1051-0761(1997)007[0158:SRMAAP]2.0.CO;2; Ryu D, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025831; Schaefer GL, 2007, J ATMOS OCEAN TECH, V24, P2073, DOI 10.1175/2007JTECHA930.1; SCHARRINGA M, 1976, AGR METEOROL, V16, P263, DOI 10.1016/0002-1571(76)90046-7; Schimel D.S., 2011, NEON 2011 SCI STRATE; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; SCHMID HP, 1994, BOUND-LAY METEOROL, V67, P293, DOI 10.1007/BF00713146; Schmid HP, 1997, AGR FOREST METEOROL, V87, P179, DOI 10.1016/S0168-1923(97)00011-7; Shaw DC, 2004, ECOSYSTEMS, V7, P427, DOI 10.1007/s10021-004-0135-6; SITAULA BK, 1993, SOIL BIOL BIOCHEM, V25, P1415, DOI 10.1016/0038-0717(93)90056-H; Sokal RR, 1995, BIOMETRY; Teuling AJ, 2006, HYDROL EARTH SYST SC, V10, P755, DOI 10.5194/hess-10-755-2006; TOPP GC, 1980, WATER RESOUR RES, V16, P574, DOI 10.1029/WR016i003p00574; TRANGMAR BB, 1985, ADV AGRON, V38, P45; Wang CM, 2008, J HYDROL, V352, P309, DOI 10.1016/j.jhydrol.2008.01.011; WEBSTER R, 1992, J SOIL SCI, V43, P177, DOI 10.1111/j.1365-2389.1992.tb00128.x; Western AW, 1998, J HYDROL, V205, P20, DOI 10.1016/S0022-1694(97)00142-X; Western AW, 2004, J HYDROL, V286, P113, DOI 10.1016/j.jhydrol.2003.09.014; Zreda M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035655; [No title captured]; [No title captured]	83	43	45	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e83216	10.1371/journal.pone.0083216	http://dx.doi.org/10.1371/journal.pone.0083216			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465377	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000006
J	Wong, MM; Yin, XK; Potter, C; Yu, BQ; Cai, H; Di Bernardini, E; Xu, QB				Wong, Mei Mei; Yin, Xiaoke; Potter, Claire; Yu, Baoqi; Cai, Hao; Di Bernardini, Elisabetta; Xu, Qingbo			Over-Expression of HSP47 Augments Mouse Embryonic Stem Cell Smooth Muscle Differentiation and Chemotaxis	PLOS ONE			English	Article							NEOINTIMAL FORMATION; CHEMOKINE RECEPTOR; HEMATOPOIETIC STEM; PROTEIN HSP47; COLLAGEN; MIGRATION; GRAFTS; GROWTH; HEAT-SHOCK-PROTEIN-47; FIBROBLASTS	In the recent decade, embryonic stem cells (ESC) have emerged as an attractive cell source of smooth muscle cells (SMC) for vascular tissue engineering owing to their unlimited self-renewal and differentiation capacities. Despite their promise in therapy, their efficacy is still hampered by the lack of definitive SMC differentiation mechanisms and difficulties in successful trafficking of the ESC towards a site of injury or target tissue. Heat shock protein 47 (HSP47) is a 47-kDa molecular chaperone that is required for the maturation of various types of collagen and has been shown to be a critical modulator of different pathological and physiological processes. To date, the role of HSP47 on ESC to SMC differentiation or ESC chemotaxis is not known and may represent a potential molecular approach by which ESC can be manipulated to increase their efficacy in clinic. We provide evidence that HSP47 is highly expressed during ESC differentiation into the SMC lineage and that HSP47 reduction results in an attenuation of the differentiation. Our experiments using a HSP47 plasmid transfection system show that gene over-expression is sufficient to induce ESC-SMC differentiation, even in the absence of exogenous stimuli. Furthermore, HSP47 over-expression in ESC also increases their chemotaxis and migratory responses towards a panel of chemokines, likely via the upregulation of chemokine receptors. Our findings provide direct evidence of induced ESC migration and differentiation into SMC via the over-expression of HSP47, thus identifying a novel approach of molecular manipulation that can potentially be exploited to improve stem cell therapy for vascular repair and regeneration.	[Wong, Mei Mei; Yin, Xiaoke; Potter, Claire; Yu, Baoqi; Cai, Hao; Di Bernardini, Elisabetta; Xu, Qingbo] Kings Coll London, Div Cardiovasc, British Heart Fdn Ctr, London WC2R 2LS, England	University of London; King's College London	Xu, QB (corresponding author), Kings Coll London, Div Cardiovasc, British Heart Fdn Ctr, London WC2R 2LS, England.	qingbo.xu@kcl.ac.uk	Yin, Xiaoke/AAZ-2658-2020	Yin, Xiaoke/0000-0002-5172-0935	British Heart Foundation/United Kingdom [BHFPG/04/29]; British Heart Foundation [RG/09/004/27647] Funding Source: researchfish	British Heart Foundation/United Kingdom(British Heart Foundation); British Heart Foundation(British Heart Foundation)	Grant Number: BHFPG/04/29/British Heart Foundation/United Kingdom. FunderWebsite: http://www.bhf.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Chen YK, 2013, ARTERIOSCL THROM VAS, V33, P1844, DOI 10.1161/ATVBAHA.113.300902; Cho C, 2002, J NEUROVIROL, V8, P573, DOI 10.1080/13550280290101003; DeVries ME, 1999, SEMIN IMMUNOL, V11, P95, DOI 10.1006/smim.1999.0165; Du ZY, 2013, LIVER TRANSPLANT, V19, P215, DOI 10.1002/lt.23577; Grudzinska MK, 2013, ARTERIOSCL THROM VAS, V33, P1271, DOI 10.1161/ATVBAHA.112.300773; Hartmann TN, 2005, ONCOGENE, V24, P4462, DOI 10.1038/sj.onc.1208621; Hebert C, 1999, J CELL BIOCHEM, V73, P248, DOI 10.1002/(SICI)1097-4644(19990501)73:2<248::AID-JCB11>3.0.CO;2-A; Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030; Iwashita T, 2000, HUM PATHOL, V31, P1498, DOI 10.1053/hupa.2000.20378; Karamariti E, 2013, CIRC RES, V112, P1433, DOI 10.1161/CIRCRESAHA.111.300415; Kiefer F, 2011, CELL MOL LIFE SCI, V68, P2811, DOI 10.1007/s00018-011-0677-7; Margariti A, 2012, P NATL ACAD SCI USA, V109, P13793, DOI 10.1073/pnas.1205526109; Margariti A, 2009, J CELL SCI, V122, P460, DOI 10.1242/jcs.034850; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; MINOWADA G, 1995, J CLIN INVEST, V95, P3, DOI 10.1172/JCI117655; Moore MAS, 2001, ANN NY ACAD SCI, V938, P36; Moriyama T, 1998, KIDNEY INT, V54, P110, DOI 10.1046/j.1523-1755.1998.00964.x; Murakami S, 2001, ATHEROSCLEROSIS, V157, P361, DOI 10.1016/S0021-9150(00)00743-7; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; NATSUME T, 1994, J BIOL CHEM, V269, P31224; Pepe AE, 2010, CIRC RES, V106, P870, DOI 10.1161/CIRCRESAHA.109.211417; Razzaque MS, 2000, NEPHRON, V86, P339, DOI 10.1159/000045790; Rocnik EF, 2002, J BIOL CHEM, V277, P38571, DOI 10.1074/jbc.M206689200; Smart N, 2008, CIRC RES, V102, P1155, DOI 10.1161/CIRCRESAHA.108.175158; Umehara H, 2001, TRENDS IMMUNOL, V22, P602, DOI 10.1016/S1471-4906(01)02051-8; vanderLoop FTL, 1997, ARTERIOSCL THROM VAS, V17, P665, DOI 10.1161/01.ATV.17.4.665; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Wong MM, 2013, ARTERIOSCL THROM VAS, V33, P2397, DOI 10.1161/ATVBAHA.113.301595; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Xiao QZ, 2012, ARTERIOSCL THROM VAS, V32, P730, DOI 10.1161/ATVBAHA.111.243188; Xiao QZ, 2010, THROMB HAEMOSTASIS, V104, P440, DOI 10.1160/TH09-11-0794; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Xie CQ, 2011, BIOMATERIALS, V32, P4369, DOI 10.1016/j.biomaterials.2011.02.049; Yokota SI, 2003, BIOCHEM BIOPH RES CO, V303, P413, DOI 10.1016/S0006-291X(03)00352-8; Zhang L, 2010, J BIOL CHEM, V285, P38463, DOI 10.1074/jbc.M110.153999	37	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e86118	10.1371/journal.pone.0086118	http://dx.doi.org/10.1371/journal.pone.0086118			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454956	Green Published, Green Submitted, gold			2022-12-25	WOS:000330236000023
J	Ahn, YY; Lee, DS; Burd, H; Blank, W; Kapatral, V				Ahn, Yong-Yeol; Lee, Deok-Sun; Burd, Henry; Blank, William; Kapatral, Vinayak			Metabolic Network Analysis-Based Identification of Antimicrobial Drug Targets in Category A Bioterrorism Agents	PLOS ONE			English	Article							FRANCISELLA-TULARENSIS; ESCHERICHIA-COLI; BACILLUS-ANTHRACIS; YERSINIA-PESTIS; STAPHYLOCOCCUS-AUREUS; GENE; RECONSTRUCTION; NOVICIDA; BACTERIA; STRAINS	The 2001 anthrax mail attacks in the United States demonstrated the potential threat of bioterrorism, hence driving the need to develop sophisticated treatment and diagnostic protocols to counter biological warfare. Here, by performing flux balance analyses on the fully-annotated metabolic networks of multiple, whole genome-sequenced bacterial strains, we have identified a large number of metabolic enzymes as potential drug targets for each of the three Category A-designated bioterrorism agents including Bacillus anthracis, Francisella tularensis and Yersinia pestis. Nine metabolic enzymes-belonging to the coenzyme A, folate, phosphatidyl-ethanolamine and nucleic acid pathways common to all strains across the three distinct genera were identified as targets. Antimicrobial agents against some of these enzymes are available. Thus, a combination of cross species-specific antibiotics and common antimicrobials against shared targets may represent a useful combinatorial therapeutic approach against all Category A bioterrorism agents.	[Ahn, Yong-Yeol] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA; [Lee, Deok-Sun] Inha Univ, Dept Nat Med Sci, Inchon, South Korea; [Lee, Deok-Sun] Inha Univ, Dept Phys, Inchon, South Korea; [Burd, Henry; Blank, William; Kapatral, Vinayak] Igenbio Inc, Chicago, IL 60607 USA	Indiana University System; Indiana University Bloomington; Inha University; Inha University	Kapatral, V (corresponding author), Igenbio Inc, Chicago, IL 60607 USA.	vinayak@integratedgenomics.com	Ahn, Yong-Yeol/C-6334-2011; Lee, Deok-Sun/D-1335-2011	Ahn, Yong-Yeol/0000-0002-4352-4301; KAPATRAL, VINAYAK/0000-0002-0501-3738; Lee, Deok-Sun/0000-0002-5093-6582	National Institutes of Health [5U01AI070499-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant 5U01AI070499-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Barrow EW, 2007, ANTIMICROB AGENTS CH, V51, P4447, DOI 10.1128/AAC.00628-07; Bourne CR, 2010, ANTIMICROB AGENTS CH, V54, P3825, DOI 10.1128/AAC.00361-10; Boyle DS, 1998, J BACTERIOL, V180, P6429; Champion MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000459; Chaperon DN, 2006, APPL ENVIRON MICROB, V72, P1288, DOI 10.1128/AEM.72.2.1288-1294.2006; Charusanti P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-163; Chaudhuri RR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000352; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gilligan PH, 2002, CURR OPIN MICROBIOL, V5, P489, DOI 10.1016/S1369-5274(02)00359-4; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Hare RS, 2001, J BACTERIOL, V183, P1694, DOI 10.1128/JB.183.5.1694-1706.2001; Johansson A, 2001, J CLIN MICROBIOL, V39, P3140, DOI 10.1128/JCM.39.9.3140-3146.2001; Joyce Andrew R., 2008, V416, P433, DOI 10.1007/978-1-59745-321-9_30; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; Kwon YK, 2008, NAT CHEM BIOL, V4, P602, DOI 10.1038/nchembio.108; Lee DS, 2009, J BACTERIOL, V191, P4015, DOI 10.1128/JB.01743-08; Mathieu M, 2005, J BIOL CHEM, V280, P18916, DOI 10.1074/jbc.M413799200; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Pilo P, 2011, INFECT GENET EVOL, V11, P1218, DOI 10.1016/j.meegid.2011.05.013; Pohanka M, 2009, FOLIA MICROBIOL, V54, P263, DOI 10.1007/s12223-009-0046-1; Shen Y, 2010, P NATL ACAD SCI USA, V107, P1082, DOI 10.1073/pnas.0909181107; Sorci L, 2009, P NATL ACAD SCI USA, V106, P3083, DOI 10.1073/pnas.0811718106; Titball RW, 2007, ANN NY ACAD SCI, V1105, P98, DOI 10.1196/annals.1409.015; Wei Y, 2000, MOL MICROBIOL, V43, P1651; Wong JD, 2000, ANTIMICROB AGENTS CH, V44, P1995, DOI 10.1128/AAC.44.7.1995-1996.2000; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	33	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85195	10.1371/journal.pone.0085195	http://dx.doi.org/10.1371/journal.pone.0085195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454817	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100064
J	Jin, YX; Jeon, Y; Lee, SH; Kwon, MS; Kim, T; Cui, XS; Hyun, SH; Kim, NH				Jin, Yong-Xun; Jeon, Yubyeol; Lee, Sung-Hyun; Kwon, Mo-Sun; Kim, Teoan; Cui, Xiang-Shun; Hyun, Sang-Hwan; Kim, Nam-Hyung			Production of Pigs Expressing a Transgene under the Control of a Tetracycline-Inducible System	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NUCLEAR TRANSFER EMBRYOS; GENE-EXPRESSION; MICE; DOXYCYCLINE; TRANSCRIPTION; ACTIVATION; GENERATION; CHICKENS; PROMOTER	Pigs are anatomically and physiologically closer to humans than other laboratory animals. Transgenic (TG) pigs are widely used as models of human diseases. The aim of this study was to produce pigs expressing a tetracycline (Tet)-inducible transgene. The Tet-on system was first tested in infected donor cells. Porcine fetal fibroblasts were infected with a universal doxycycline-inducible vector containing the target gene enhanced green fluorescent protein (eGFP). At 1 day after treatment with 1 mu g/ml doxycycline, the fluorescence intensity of these cells was increased. Somatic cell nuclear transfer (SCNT) was then performed using these donor cells. The Tet-on system was then tested in the generated porcine SCNT-TG embryos. Of 4,951 porcine SCNT-TG embryos generated, 850 were cultured in the presence of 1 mu g/ml doxycycline in vitro. All of these embryos expressed eGFP and 15 embryos developed to blastocyst stage. The remaining 4,101 embryos were transferred to thirty three surrogate pigs from which thirty eight cloned TG piglets were obtained. PCR analysis showed that the transgene was inserted into the genome of each of these piglets. Two TG fibroblast cell lines were established from these TG piglets, and these cells were used as donor cells for re-cloning. The re-cloned SCNT embryos expressed the eGFP transgene under the control of doxycycline. These data show that the expression of transgenes in cloned TG pigs can be regulated by the Tet-on/off systems.	[Jin, Yong-Xun; Lee, Sung-Hyun; Cui, Xiang-Shun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea; [Jeon, Yubyeol; Hyun, Sang-Hwan] Chungbuk Natl Univ, Coll Vet Med, Cheongju, South Korea; [Kwon, Mo-Sun; Kim, Teoan] Catholic Univ Daegu, Sch Med, Taegu, South Korea	Chungbuk National University; Chungbuk National University; Catholic University of Daegu	Hyun, SH (corresponding author), Chungbuk Natl Univ, Coll Vet Med, Cheongju, South Korea.	shhyun@cbu.ac.kr; nhkim@chungbuk.ac.kr			Next-Generation Bio Green 21 Program, Rural Development Administration, Republic of Korea [PJ00956901, PJ00956302, PJ009080]	Next-Generation Bio Green 21 Program, Rural Development Administration, Republic of Korea	This work was supported by grants (# PJ00956901, PJ00956302 and PJ009080) from the Next-Generation Bio Green 21 Program, Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas D, 2011, THERIOGENOLOGY, V75, P256, DOI 10.1016/j.theriogenology.2010.08.012; Bockamp E, 2008, REGEN MED, V3, P217, DOI 10.2217/17460751.3.2.217; Cho YS, 2011, TRANSGENIC RES, V20, P1333, DOI 10.1007/s11248-011-9501-2; Choi BR, 2006, MOL REPROD DEV, V73, P1221, DOI 10.1002/mrd.20543; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gil GC, 2008, GLYCOBIOLOGY, V18, P526, DOI 10.1093/glycob/cwn035; Giraldo Angelica M, 2012, Methods Mol Biol, V885, P105, DOI 10.1007/978-1-61779-845-0_8; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Hemann M, 2012, VET RES COMMUN, V36, P187, DOI 10.1007/s11259-012-9524-z; Hong SG, 2009, GENESIS, V47, P314, DOI 10.1002/dvg.20504; Jiang BC, 2012, GENET MOL RES, V11, P2946, DOI 10.4238/2012.July.10.5; Jin YX, 2009, ANIM REPROD SCI, V115, P137, DOI 10.1016/j.anireprosci.2008.10.021; Jin YX, 2013, REPROD FERTIL DEV; Katter K, 2013, FASEB J, V27, P930, DOI 10.1096/fj.12-205526; Kim MJ, 2011, GENESIS, V49, P472, DOI 10.1002/dvg.20737; Klymiuk N, 2012, FASEB J, V26, P1086, DOI 10.1096/fj.11-185041; Koo BC, 2010, TRANSGENIC RES, V19, P437, DOI 10.1007/s11248-009-9327-3; Kues WA, 2006, FASEB J, V20, P1200, DOI 10.1096/fj.05-5415fje; Kwak SS, 2012, THERIOGENOLOGY, V77, P1186, DOI 10.1016/j.theriogenology.2011.10.025; Kwak SS, 2012, J VET MED SCI, V74, P1095, DOI 10.1292/jvms.12-0050; Lamartina S, 2003, MOL THER, V7, P271, DOI 10.1016/S1525-0016(02)00051-5; Lee SH, 2007, POULTRY SCI, V86, P2221, DOI 10.1093/ps/86.10.2221; ORIAN JM, 1989, ENDOCRINOLOGY, V124, P455, DOI 10.1210/endo-124-1-455; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; Popa I, 2002, MOL CELL BIOL, V22, P2057, DOI 10.1128/MCB.22.7.2057-2067.2002; Roth S, 2009, GENESIS, V47, P7, DOI 10.1002/dvg.20446; Song K, 2009, MOL REPROD DEV, V76, P611, DOI 10.1002/mrd.20989; Takiguchi M, 2010, J THROMB HAEMOST, V8, P2751, DOI 10.1111/j.1538-7836.2010.04077.x; Tong J, 2011, TRANSGENIC RES, V20, P933, DOI 10.1007/s11248-010-9454-x; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Watanabe M, 2012, TRANSGENIC RES, V21, P605, DOI 10.1007/s11248-011-9561-3; Weidenfeld-Baranboim K, 2009, NUCLEIC ACIDS RES, V37, P2194, DOI 10.1093/nar/gkp083; Yeom HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046646; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	34	16	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86146	10.1371/journal.pone.0086146	http://dx.doi.org/10.1371/journal.pone.0086146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454957	gold, Green Submitted, Green Published			2022-12-25	WOS:000330235100146
J	Wu, CL; Qu, XH; Mao, YQ; Li, HW; Liu, FX; Zhu, ZN				Wu, Chuanlong; Qu, Xinhua; Mao, Yuanqing; Li, Huiwu; Liu, Fengxiang; Zhu, Zhenan			Developmental Dysplasia of the Hip, Age, BMI, Place of Residence and Tobacco Abuse Increase the Odds of Aseptic Loosening in Chinese Patients	PLOS ONE			English	Article							POSTOPERATIVE COMPLICATIONS; KNEE ARTHROPLASTY; RISK-FACTORS; SMOKING; TRIAL; INTERVENTION; COMPONENT	Purpose: The purpose of this hospital-based case-control study was to evaluate the patient-related risk factors for aseptic loosening after total hip arthroplasty (THA) and total knee arthroplasty (TKA) in Chinese patients. Methods: From January 2000 to December 2012, 67 patients undergoing THA and TKA who developed aseptic loosening were detected as case subjects and 336 patients without aseptic loosening, matched by the year of index surgery and type of surgery, were selected as controls. Conditional logistic regression was used to compute odds ratios (ORs) and 95% confidence intervals (CIs). Results: The demographic factors and comorbid conditions associated with a risk-adjusted increase in aseptic loosening (in decreasing order of significance) were a rural place of residence (OR = 2.28; 95% CI: 1.21-4.30; p = 0.011), body mass index (BMI) >= 28 kg/m(2) (vs. 18.5-28 kg/m(2)) (OR = 2.29; 95% CI: 1.19-4.41; p = 0.013), developmental dysplasia of the hip (DDH) (OR = 2.91; 95% CI: 1.11-7.66; p = 0.030), tobacco abuse (OR = 2.88; 95% CI: 1.05-7.89; p = 0.039), and age <45 years (vs. 45-65 years) (OR = 2.63; 95% CI: 1.01-6.80; p = 0.047). Conclusions: Patients aged <45 years and those with a BMI of >= 28 kg/m(2), a preoperative diagnosis of DDH, history of tobacco abuse, or living in rural areas are at increased risk for aseptic loosening after THA and TKA in Chinese population. Additional systematic large-scale studies are needed to verify these results.	[Wu, Chuanlong; Qu, Xinhua; Mao, Yuanqing; Li, Huiwu; Liu, Fengxiang; Zhu, Zhenan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Orthopaed, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, FX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Orthopaed, Shanghai 200030, Peoples R China.	liu_fengxiang@126.com; zhenan_zhu@126.com	Qu, Xinhua/Q-3950-2016	Qu, Xinhua/0000-0002-8889-0890	National Natural Science Foundation of China [81171729]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (number 81171729). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordini B, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-69; Bozic KJ, 2013, J ARTHROPLASTY; Bozic KJ, 2013, CLIN ORTHOP RELAT RE; BRAND RA, 1986, CLIN ORTHOP RELAT R, P185; CARLSSON AS, 1980, CLIN ORTHOP RELAT R, P262; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Corten K, 2011, CLIN ORTHOP RELAT R, V469, P209, DOI 10.1007/s11999-010-1459-5; DIHLMANN W, 1991, RADIOLOGE, V31, P496; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Flugsrud GB, 2007, ACTA ORTHOP, V78, P99, DOI 10.1080/17453670610013493; Greiner B, 1997, Z ORTHOP GRENZGEB, V135, P292, DOI 10.1055/s-2008-1039391; GRUEN TA, 1979, CLIN ORTHOP RELAT R, P17; Hailer NP, 2010, ACTA ORTHOP, V81, P34, DOI 10.3109/17453671003685400; Haverkamp D, 2008, CLIN ORTHOP RELAT R, V466, P1162, DOI 10.1007/s11999-008-0129-3; Kapadia BH, 2012, J ARTHROPLASTY, V27, P1690, DOI 10.1016/j.arth.2012.03.057; Lindstrom D, 2008, ANN SURG, V248, P739, DOI 10.1097/SLA.0b013e3181889d0d; Malik MHA, 2004, INT ORTHOP, V28, P211, DOI 10.1007/s00264-004-0556-z; Manley M, 2009, J ARTHROPLASTY, V24, P1061, DOI 10.1016/j.arth.2008.06.011; Moller AM, 2002, LANCET, V359, P114, DOI 10.1016/S0140-6736(02)07369-5; Munger P, 2006, ACTA ORTHOP, V77, P567, DOI 10.1080/17453670610012629; Namba RS, 2013, J ARTHROPLASTY, V28, P122, DOI 10.1016/j.arth.2013.04.050; Poultsides LA, 2013, J ARTHROPLASTY, V28, P385, DOI 10.1016/j.arth.2012.06.027; Sadoghi P, 2013, J ARTHROPLASTY, V28, P1329, DOI 10.1016/j.arth.2013.01.012; Santaguida PL, 2008, CAN J SURG, V51, P428; Streit MR, 2013, CLIN ORTHOP RELAT R, V471, P3262, DOI 10.1007/s11999-013-3033-4	25	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85562	10.1371/journal.pone.0085562	http://dx.doi.org/10.1371/journal.pone.0085562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454888	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100099
J	Zhong, YF; Zhang, XW; Cai, XF; Wang, K; Chen, YP; Deng, YY				Zhong, Yifei; Zhang, Xianwen; Cai, Xianfan; Wang, Ke; Chen, Yiping; Deng, Yueyi			Puerarin Attenuated Early Diabetic Kidney Injury through Down-Regulation of Matrix Metalloproteinase 9 in Streptozotocin-Induced Diabetic Rats	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; SIGNALING PATHWAY; RENAL-DISEASE; NEPHROPATHY; ALBUMINURIA; PODOCYTES; MMP-9; MICROALBUMINURIA; PROGRESSION; GENE	Radix puerariae, a traditional Chinese herbal medication, has been used successfully to treat patients with early stage of diabetic nephropathy. However, the underlined mechanism of this renal protective effect has not been determined. In the current study, we investigated the effects and the mechanism of puerarin in Streptozotocin (STZ)-induced diabetic rats. We treated STZ-rats with either puerarin or losartan, an angiotensin II receptor blocker, as compared to those treated with vehicle. We found that both puerarin and losartan attenuated kidney hypertrophy, mesangial expansion, proteinuria, and podocyte foot process effacement in STZ rats. In addition, both puerarin and losartan increased expression of podocyte slit diaphragm proteins such as nephrin and podocin. Interestingly, we found that puerarin treatment induced a more pronounced suppression of oxidative stress production and S-nitrosylation of proteins in the diabetic kidneys as compared to losartan treatment. Furthermore, we found that matrix metalloproteinase-9 (MMP-9), which is known to be activated by oxidative stress and S-nitrosylation of proteins, was also suppressed more extensively by puerarin than losartan. In conclusion, these data provide for the first time the potential mechanism to support the use of puerarin in the treatment of early diabetic nephropathy.	[Zhong, Yifei; Zhang, Xianwen; Cai, Xianfan; Chen, Yiping; Deng, Yueyi] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Div Nephrol, Shanghai, Peoples R China; [Wang, Ke] Natl Engn Res Ctr Biochip Shanghai, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine	Zhong, YF (corresponding author), Shanghai Univ Tradit Chinese Med, Longhua Hosp, Div Nephrol, Shanghai, Peoples R China.	yifeilily@126.com; dengyueyi@medmail.com.cn	zhang, xian/GYA-0290-2022		National Natural Science Foundation of China for Young Investigators [1999-30901944]; Shanghai Bureau of Health for Young Investigators [2011-XYQ2011059]; National Natural Science Foundation of China [30973725]; Shanghai Natural Science Foundation for Young Investigators [2012-ZR1450500]; Graduate student creative project of the Shanghai University of Traditional Chinese Medicine [22]	National Natural Science Foundation of China for Young Investigators; Shanghai Bureau of Health for Young Investigators; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation for Young Investigators; Graduate student creative project of the Shanghai University of Traditional Chinese Medicine	YF Zhong is supported by National Natural Science Foundation of China for Young Investigators (1999-30901944) and Shanghai Bureau of Health for Young Investigators (2011-XYQ2011059); YY Deng is supported by National Natural Science Foundation of China (30973725); XW Zhang is supported by Shanghai Natural Science Foundation for Young Investigators (2012-ZR1450500); XF Cai is supported by Graduate student creative project of the Shanghai University of Traditional Chinese Medicine (22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KL, 2000, AM J PATHOL, V157, P303, DOI 10.1016/S0002-9440(10)64541-5; Araki SI, 2003, J AM SOC NEPHROL, V14, P2015, DOI 10.1097/01.ASN.0000077347.27669.5C; Asanuma K, 2002, KIDNEY INT, V62, P822, DOI 10.1046/j.1523-1755.2002.00539.x; Bai YL, 2006, CELL PHYSIOL BIOCHEM, V17, P57, DOI 10.1159/000091464; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Choi YE, 2010, EVID-BASED COMPL ALT, V7, P433, DOI 10.1093/ecam/nen021; Dong D C, 1987, Zhong Xi Yi Jie He Za Zhi, V7, P403; Duan Hui-jun, 2004, Yaoxue Xuebao, V39, P481; Dubois B, 1999, J CLIN INVEST, V104, P1507, DOI 10.1172/JCI6886; Dunlop M, 2000, KIDNEY INT, V58, pS3, DOI 10.1046/j.1523-1755.2000.07702.x; Fernandez D, 2011, BBA-MOL CELL RES, V1813, P1504, DOI 10.1016/j.bbamcr.2011.05.009; Fioretto P, 1996, DIABETOLOGIA, V39, P1569, DOI 10.1007/s001250050616; Forbes JM, 2003, J AM SOC NEPHROL, V14, pS254, DOI 10.1097/01.ASN.0000077413.41276.17; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Hammond J B, 1988, Methods Mol Biol, V3, P25, DOI 10.1385/0-89603-126-8:25; Hirakawa S, 2003, AM J KIDNEY DIS, V42, P133, DOI 10.1016/S0272-6386(03)00416-5; IJpelaar DHT, 2008, AM J PHYSIOL-RENAL, V294, pF758, DOI 10.1152/ajprenal.00457.2007; Jia WP, 2009, NEPHROL DIAL TRANSPL, V24, P3724, DOI 10.1093/ndt/gfp349; Kataya HAH, 2008, EVID-BASED COMPL ALT, V5, P281, DOI 10.1093/ecam/nem029; Kluger MA, 2013, KIDNEY INT, V83, P865, DOI 10.1038/ki.2012.483; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Lahdenkari AT, 2004, J AM SOC NEPHROL, V15, P2611, DOI 10.1097/01.ASN.0000139478.03463.D9; Lelongt B, 1997, J CELL BIOL, V136, P1363, DOI 10.1083/jcb.136.6.1363; Lelongt B, 2001, CURR OPIN NEPHROL HY, V10, P7, DOI 10.1097/00041552-200101000-00002; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; lian S., 2010, SHANGHAI J TRAD CHIN, V44, P3; Liu RN, 2006, AM J CHINESE MED, V34, P1037, DOI 10.1142/S0192415X06004508; Liu SY, 2005, CELL PHYSIOL BIOCHEM, V16, P207, DOI 10.1159/000089846; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; MOGENSEN CE, 1993, AM J KIDNEY DIS, V22, P174, DOI 10.1016/S0272-6386(12)70184-1; Noriega-Cisneros R, 2013, MITOCHONDRION; Okada R, 2012, AM J NEPHROL, V36, P444, DOI 10.1159/000343742; Osicka TM, 2000, DIABETES, V49, P87, DOI 10.2337/diabetes.49.1.87; Packham DK, 2012, J AM SOC NEPHROL, V23, P123, DOI 10.1681/ASN.2011040378; Parving HH, 2002, DIABETES CARE, V25, P406, DOI 10.2337/diacare.25.2.406; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; ROSSING P, 1993, DIABETES, V42, P715, DOI 10.2337/diabetes.42.5.715; Rossing P, 2013, NAT REV NEPHROL, V9, P128, DOI 10.1038/nrneph.2013.13; Schleicher ED, 2000, KIDNEY INT, V58, pS13, DOI 10.1046/j.1523-1755.2000.07703.x; Steffes MW, 2001, KIDNEY INT, V59, P2104, DOI 10.1046/j.1523-1755.2001.0590062104.x; Susztak K, 2004, DIABETES, V53, P784, DOI 10.2337/diabetes.53.3.784; von Luttichau I, 2002, BIOL CHEM, V383, P1271; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wan YG, 2005, NEPHRON EXP NEPHROL, V99, pE121, DOI 10.1159/000083980; Wang G.G., 2011, EVID-BASED COMPL ALT, V2011; Wu L, 2007, PHYTOMEDICINE, V14, P652, DOI 10.1016/j.phymed.2007.07.060; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang HY, 2011, EXP GERONTOL, V46, P30, DOI 10.1016/j.exger.2010.09.013; Zhang XW, 2009, THEORY PRACTICE DIAG, V8, P4	52	39	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85690	10.1371/journal.pone.0085690	http://dx.doi.org/10.1371/journal.pone.0085690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454919	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100121
J	Hibert, P; Prunier-Mirebeau, D; Beseme, O; Chwastyniak, M; Tamareille, S; Pinet, F; Prunier, F				Hibert, Pierre; Prunier-Mirebeau, Delphine; Beseme, Olivia; Chwastyniak, Maggy; Tamareille, Sophie; Pinet, Florence; Prunier, Fabrice			Modifications in Rat Plasma Proteome after Remote Ischemic Preconditioning (RIPC) Stimulus: Identification by a SELDI-TOF-MS Approach	PLOS ONE			English	Article							APOLIPOPROTEIN-C-III; PEPTIDE B-BETA(15-42); MYOCARDIAL-INFARCTION; CARDIAC-SURGERY; HUMORAL-FACTORS; TROPONIN-T; INJURY; TRANSTHYRETIN; HAPTOGLOBIN; PROTECTS	Remote ischemic preconditioning's (RIPC) ability to render the myocardium resistant to subsequent prolonged ischemia is now clearly established in different species, including humans. Strong evidence suggests that circulating humoral mediators play a key role in signal transduction, but their identities still need to be established. Our study sought to identify potential circulating RIPC mediators using a proteomic approach. Rats were exposed to 10-min limb ischemia followed by 5-(RIPC 5') or 10-min (RIPC 109) reperfusion prior to blood sampling. The control group only underwent blood sampling. Plasma samples were isolated for proteomic analysis using surface-enhanced laser desorption and ionization - time of flight - mass spectrometry (SELDI-TOF-MS). A total of seven proteins, including haptoglobin and transthyretin, were detected as up-or down-regulated in response to RIPC. These proteins had previously been identified as associated with organ protection, anti-inflammation, and various cellular and molecular responses to ischemia. In conclusion, this study indicates that RIPC results in significant modulations of plasma proteome.	[Hibert, Pierre; Prunier-Mirebeau, Delphine; Tamareille, Sophie; Prunier, Fabrice] UNAM Univ, Angers, France; [Hibert, Pierre; Tamareille, Sophie; Prunier, Fabrice] Univ Angers, Lab Cardioprotect Remodelage & Thrombose, Angers, France; [Prunier-Mirebeau, Delphine] Univ Angers, INSERM, U771, CNRS,UMR 6214,CHU Angers,Dept Biochim & Genet, Angers, France; [Beseme, Olivia; Chwastyniak, Maggy; Pinet, Florence] INSERM, U744, F-59045 Lille, France; [Beseme, Olivia; Chwastyniak, Maggy; Pinet, Florence] Inst Pasteur, F-59019 Lille, France; [Beseme, Olivia; Chwastyniak, Maggy; Pinet, Florence] Univ Lille Nord France, IFR142, Lille, France; [Pinet, Florence] Ctr Hosp Reg & Univ Lille, F-59037 Lille, France; [Prunier, Fabrice] CHU Angers, Serv Cardiol, Angers, France	Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Prunier, F (corresponding author), UNAM Univ, Angers, France.	faprunier@chu-angers.fr	Tamareille, Sophie/K-1770-2015; Prunier, Fabrice/A-5210-2011; Pinet, Florence/F-2892-2013; Prunier, Delphine/K-3301-2015	Tamareille, Sophie/0000-0001-8563-6558; Pinet, Florence/0000-0002-5471-1487; 	Servier and Conseil General du Maine et Loire; ANR [ANR-11-EMMA-029-01]; Fondation Coeur Recherche	Servier and Conseil General du Maine et Loire(Region Pays de la Loire); ANR(French National Research Agency (ANR)); Fondation Coeur Recherche	Pierre Hibert was supported by fellowships from Servier and Conseil General du Maine et Loire. This work was supported in part by grants from ANR (ANR-11-EMMA-029-01) and the Fondation Coeur & Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martin AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028698; Ali ZA, 2007, CIRCULATION, V116, pI98, DOI 10.1161/circulationaha.106.679167; Beseme O, 2010, ELECTROPHORESIS, V31, P2697, DOI 10.1002/elps.201000188; Birnbaum Y, 1997, CIRCULATION, V96, P1641, DOI 10.1161/01.CIR.96.5.1641; BORISH L, 1992, INFLAMMATION, V16, P471, DOI 10.1007/BF00918973; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Breivik L, 2011, BASIC RES CARDIOL, V106, P135, DOI 10.1007/s00395-010-0133-0; Brevoord D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042179; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Cubedo J, 2012, ATHEROSCLEROSIS, V222, P263, DOI 10.1016/j.atherosclerosis.2012.02.024; de Kleijn DPV, 2002, FASEB J, V16, P1123, DOI 10.1096/fj.02-0019fje; Dickson EW, 2001, J MOL CELL CARDIOL, V33, P1751, DOI 10.1006/jmcc.2001.1436; Dickson EW, 1999, J THROMB THROMBOLYS, V8, P123, DOI 10.1023/A:1008911101951; Dickson EW, 1999, AM J PHYSIOL-HEART C, V277, pH2451, DOI 10.1152/ajpheart.1999.277.6.H2451; Dubois E, 2011, EUR HEART J, V32, P115, DOI 10.1093/eurheartj/ehq108; Fernandez V, 2007, HEPATOLOGY, V45, P170, DOI 10.1002/hep.21476; Fertin M, 2011, J PROTEOMICS, V74, P420, DOI 10.1016/j.jprot.2010.12.005; Fertin M, 2010, PROTEOM CLIN APPL, V4, P654, DOI 10.1002/prca.200900178; Gerber Y, 2003, PREV MED, V37, P18, DOI 10.1016/S0091-7435(03)00051-3; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hepponstall M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048284; Hibert P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077211; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Jenkins DP, 1997, HEART, V77, P314, DOI 10.1136/hrt.77.4.314; Kawakami A, 2009, J ATHEROSCLER THROMB, V16, P6, DOI 10.5551/jat.E607; Kharbanda RK, 2002, CIRCULATION, V106, P2881, DOI 10.1161/01.CIR.0000043806.51912.9B; Konstantinov IE, 2005, TRANSPLANTATION, V79, P1691, DOI 10.1097/01.TP.0000159137.76400.5D; Konstantinov IE, 2004, PHYSIOL GENOMICS, V19, P143, DOI 10.1152/physiolgenomics.00046.2004; Krishnamoorthy A, 2011, BLOOD, V118, P1934, DOI 10.1182/blood-2011-02-338061; Lang SC, 2006, BASIC RES CARDIOL, V101, P149, DOI 10.1007/s00395-005-0565-0; Massberg S, 1999, BLOOD, V94, P3829, DOI 10.1182/blood.V94.11.3829.423k35_3829_3838; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; Pell TJ, 1998, AM J PHYSIOL-HEART C, V275, pH1542, DOI 10.1152/ajpheart.1998.275.5.H1542; Petzelbauer P, 2005, NAT MED, V11, P298, DOI 10.1038/nm1198; Pinet F, 2008, PROTEOMICS, V8, P1798, DOI 10.1002/pmic.200700781; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Roesner JP, 2007, CRIT CARE MED, V35, P1730, DOI 10.1097/01.CCM.0000269035.30231.76; Salvatore A, 2007, BIOCHEMISTRY-US, V46, P11158, DOI 10.1021/bi7006349; Santos SD, 2010, J NEUROCHEM, V115, P1434, DOI 10.1111/j.1471-4159.2010.07047.x; Schoemaker RG, 2000, AM J PHYSIOL-HEART C, V278, pH1571, DOI 10.1152/ajpheart.2000.278.5.H1571; Serejo FC, 2007, J CARDIOVASC PHARM, V49, P214, DOI 10.1097/FJC.0b013e3180325ad9; Shimizu M, 2009, CLIN SCI, V117, P191, DOI 10.1042/CS20080523; Sousa MM, 2000, J LIPID RES, V41, P58; Suzuyama K, 2004, MOL BRAIN RES, V129, P44, DOI 10.1016/j.molbrainres.2004.06.021; Thielmann M, 2010, BASIC RES CARDIOL, V105, P657, DOI 10.1007/s00395-010-0104-5; Walsh SR, 2008, EUR J CARDIO-THORAC, V34, P985, DOI 10.1016/j.ejcts.2008.07.062; Yao ZM, 2012, CURR OPIN LIPIDOL, V23, P206, DOI 10.1097/MOL.0b013e328352dc70; Zacharowski K, 2007, SHOCK, V27, P631, DOI 10.1097/SHK.0b013e31802fa038	51	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85669	10.1371/journal.pone.0085669	http://dx.doi.org/10.1371/journal.pone.0085669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454915	Green Published, gold			2022-12-25	WOS:000329922500058
J	Kinker, KG; Gibson, AM; Bass, SA; Day, BP; Deng, JY; Medvedovic, M; Figueroa, JAL; Hershey, GKK; Chen, WG				Kinker, Kayla G.; Gibson, Aaron M.; Bass, Stacey A.; Day, Brandy P.; Deng, Jingyuan; Medvedovic, Mario; Figueroa, Julio A. Landero; Hershey, Gurjit K. Khurana; Chen, Weiguo			Overexpression of Dimethylarginine Dimethylaminohydrolase 1 Attenuates Airway Inflammation in a Mouse Model of Asthma	PLOS ONE			English	Article							MASS-SPECTROMETRY METHOD; NITRIC-OXIDE SYNTHESIS; ASYMMETRIC DIMETHYLARGININE; METHYLARGININE METABOLISM; GENE-EXPRESSION; DNA METHYLATION; IDENTIFICATION; LUNG; INHIBITORS; SYNTHASE	Levels of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, are increased in lung, sputum, exhaled breath condensate and plasma samples from asthma patients. ADMA is metabolized primarily by dimethylarginine dimethylaminohydrolase 1 (DDAH1) and DDAH2. We determined the effect of DDAH1 overexpression on development of allergic inflammation in a mouse model of asthma. The expression of DDAH1 and DDAH2 in mouse lungs was determined by RT-quantitative PCR (qPCR). ADMA levels in bronchoalveolar lavage fluid (BALF) and serum samples were determined by mass spectrometry. Wild type and DDAH1-transgenic mice were intratracheally challenged with PBS or house dust mite (HDM). Airway inflammation was assessed by bronchoalveolar lavage (BAL) total and differential cell counts. The levels of IgE and IgG1 in BALF and serum samples were determined by ELISA. Gene expression in lungs was determined by RNA-Seq and RT-qPCR. Our data showed that the expression of DDAH1 and DDAH2 was decreased in the lungs of mice following HDM exposure, which correlated with increased ADMA levels in BALF and serum. Transgenic overexpression of DDAH1 resulted in decreased BAL total cell and eosinophil numbers following HDM exposure. Total IgE levels in BALF and serum were decreased in HDM-exposed DDAH1-transgenic mice compared to HDM-exposed wild type mice. RNA-Seq results showed downregulation of genes in the inducible nitric oxide synthase (iNOS) signaling pathway in PBS-treated DDAH1-transgenic mice versus PBS-treated wild type mice and downregulation of genes in IL-13/FOXA2 signaling pathway in HDM-treated DDAH1-transgenic mice versus HDM-treated wild type mice. Our findings suggest that decreased expression of DDAH1 and DDAH2 in the lungs may contribute to allergic asthma and overexpression of DDAH1 attenuates allergen-induced airway inflammation through modulation of Th2 responses.	[Kinker, Kayla G.; Gibson, Aaron M.; Bass, Stacey A.; Day, Brandy P.; Hershey, Gurjit K. Khurana; Chen, Weiguo] Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA; [Deng, Jingyuan; Medvedovic, Mario] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Figueroa, Julio A. Landero] Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA; [Hershey, Gurjit K. Khurana] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Chen, WG (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA.	Weiguo.Chen@cchmc.org		Landero, Julio/0000-0001-8641-0497	National Institutes of Health [NIAID R01-AI058157, NIAMS R01-AR054490, NHLBI P01-HL076383, NIAID R56-AI084414]; NIH, Center for Environmental Genetics [NIEHS P30-ES006096]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058157, R56AI084414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, Center for Environmental Genetics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants NIAID R01-AI058157 (GKKH), NIAMS R01-AR054490 (GKKH), NHLBI P01-HL076383 (GKKH), NIAID R56-AI084414 (GKKH) and Center for Environmental Genetics NIEHS P30-ES006096 (WC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BOGLE RG, 1992, BRIT J PHARMACOL, V105, P768, DOI 10.1111/j.1476-5381.1992.tb09053.x; Brandt EB, 2013, J ALLERGY CLIN IMMUN, DOI [10.1016/j.jaci.2013.06.048, DOI 10.1016/J.JACI.2013.06.048.[]; Bulau P, 2007, AM J PHYSIOL-LUNG C, V292, pL18, DOI 10.1152/ajplung.00076.2006; Carraro S, 2013, CHEST; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Chen WG, 2004, J ALLERGY CLIN IMMUN, V114, P553, DOI 10.1016/j.jaci.2004.04.044; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; Dayoub H, 2008, STROKE, V39, P180, DOI 10.1161/STROKEAHA.107.490631; Di Gangi IM, 2012, ANAL CHIM ACTA, V754, P67, DOI 10.1016/j.aca.2012.09.032; Holguin F, 2013, AM J RESP CRIT CARE, V187, P153, DOI 10.1164/rccm.201207-1270OC; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jacobi J, 2005, CIRCULATION, V111, P1431, DOI 10.1161/01.CIR.0000158487.80483.09; Kelada SNP, 2011, AM J RESP CELL MOL, V45, P817, DOI 10.1165/rcmb.2010-0315OC; Kimoto M, 1998, EUR J BIOCHEM, V258, P863, DOI 10.1046/j.1432-1327.1998.2580863.x; Klein E, 2010, AM J PHYSL LUNG CELL; Kramer EL, 2009, AM J RESP CELL MOL, V41, P415, DOI 10.1165/rcmb.2008-0470OC; Kwon NH, 2008, J CLIN IMMUNOL, V28, P139, DOI 10.1007/s10875-007-9148-1; Lara A, 2008, AM J RESP CRIT CARE, V178, P673, DOI 10.1164/rccm.200710-1542OC; Lee GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060632; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Malerba Giovanni, 2005, Journal of Applied Genetics, V46, P93; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; Pullamsetti S, 2005, FASEB J, V19, P1175, DOI 10.1096/fj.04-3223fje; Ricciardolo FLM, 2004, PHYSIOL REV, V84, P731, DOI 10.1152/physrev.00034.2003; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; SCHMIDT K, 1993, MOL PHARMACOL, V44, P615; Schwedhelm E, 2005, CLIN CHEM, V51, P1268, DOI 10.1373/clinchem.2004.046037; Scott JA, 2011, AM J RESP CRIT CARE, V184, P779, DOI 10.1164/rccm.201011-1810OC; Sivaprasad U, 2010, J IMMUNOL, V185, P6802, DOI 10.4049/jimmunol.1002118; Smith CL, 2005, PLOS MED, V2, P1031, DOI 10.1371/journal.pmed.0020264; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tomikawa J, 2006, J BIOL CHEM, V281, P12163, DOI 10.1074/jbc.M513782200; Tran CTL, 2000, GENOMICS, V68, P101, DOI 10.1006/geno.2000.6262; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VALLANCE P, 1992, LANCET, V339, P572; Warrier MR, 2008, J ASTHMA, V45, P257, DOI 10.1080/02770900801966180; Webb DC, 2001, J BIOL CHEM, V276, P41969, DOI 10.1074/jbc.M106223200; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Wells SM, 2009, AM J RESP CELL MOL, V40, P179, DOI 10.1165/rcmb.2008-0148OC; Ye SJ, 2008, BIOINFORMATION, V2, P335, DOI 10.6026/97320630002335; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336; Zimmermann N, 2006, EUR J PHARMACOL, V533, P253, DOI 10.1016/j.ejphar.2005.12.047	46	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85148	10.1371/journal.pone.0085148	http://dx.doi.org/10.1371/journal.pone.0085148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291YG	24465497	Green Published, Green Submitted, gold			2022-12-25	WOS:000329868200041
J	Liu, H; Yanamandala, M; Lee, TC; Kim, JK				Liu, Han; Yanamandala, Mounica; Lee, Tiffany C.; Kim, Jin Kyung			Mitochondrial p38 beta and Manganese Superoxide Dismutase Interaction Mediated by Estrogen in Cardiomyocytes	PLOS ONE			English	Article							ANTIOXIDANT ENZYME EXPRESSION; ACTIVATED PROTEIN-KINASES; P38 MAP-KINASES; REPERFUSION INJURY; CARDIAC MYOCYTES; RECEPTOR-BETA; NITRIC-OXIDE; IN-VITRO; LOCALIZATION; APOPTOSIS	Aims: While etiology behind the observed acceleration of ischemic heart disease in postmenopausal women is poorly understood, collective scientific data suggest cardioprotective effects of the endogenous female sex hormone, estrogen. We have previously shown that 17 beta-estradiol (E2) protects cardiomyocytes exposed to hypoxia-reoxygenation (H/R) by inhibiting p38 alpha - p53 signaling in apoptosis and activating pro-survival p38 beta mitogen activated protein kinase (p38 beta MAPK), leading to suppression of reactive oxygen species (ROS) post H/R. However, little is known about the mechanism behind the antioxidant actions of E2-dependent p38 beta. The aim of this study is to determine whether the cytoprotection by estrogen involves regulation of manganese superoxide dismutase (MnSOD), a major mitochondrial ROS scavenging enzyme, via cardiac p38 beta. Methods and Results: We identified mitochondrial p38 beta by immunocytochemistry and by immunoblotting in mitochondria isolated from neonatal cardiomyocytes of Sprague-Dawley rats. E2 facilitated the mitochondrial localization of the active form of the kinase, phosphorylated p38 beta (p-p38 beta). E2 also reduced the H/R-induced mitochondrial membrane potential decline, augmented the MnSOD activity and suppressed anion superoxide generation, while the dismutase protein expression remained unaltered. Co-immunoprecipitation studies showed physical association between MnSOD and p38 beta. p38 beta phosphorylated MnSOD in an E2-dependent manner in in-vitro kinase assays. Conclusion: This work demonstrates for the first time a mitochondrial pool of active p38 beta and E2-mediated phosphorylation of MnSOD by the kinase. The results shed light on the mechanism behind the cytoprotective actions of E2 in cardiomyocytes under oxidative stress.	[Liu, Han; Kim, Jin Kyung] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Liu, Han; Yanamandala, Mounica; Lee, Tiffany C.; Kim, Jin Kyung] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Kim, JK (corresponding author), Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA.	jkim13@uci.edu			National Heart, Lung, Blood Institute at the National Institutes of Health [K08HL89066, R01HL111180]; University of California, Irvine School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089066, R01HL111180] Funding Source: NIH RePORTER	National Heart, Lung, Blood Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of California, Irvine School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, Blood Institute at the National Institutes of Health (K08HL89066 and R01HL111180 to J.K.K.) and the Faculty Research Grant 2012-2013 from the University of California, Irvine School of Medicine to J.K.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asikainen TM, 1998, AM J RESP CELL MOL, V19, P942, DOI 10.1165/ajrcmb.19.6.3248; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Borras C, 2005, AGING CELL, V4, P113, DOI 10.1111/j.1474-9726.2005.00151.x; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Chakraborty S, 2012, BIOPHYS CHEM, V170, P42, DOI 10.1016/j.bpc.2012.09.002; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Cowley SM, 1997, J BIOL CHEM, V272, P19858, DOI 10.1074/jbc.272.32.19858; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Barrantes IDB, 2011, P NATL ACAD SCI USA, V108, P12764, DOI 10.1073/pnas.1015013108; DILISA F, 1995, J PHYSIOL-LONDON, V486, P1; Dingar D, 2010, CELL SIGNAL, V22, P1634, DOI 10.1016/j.cellsig.2010.06.002; Gottipati S, 2008, MOL VIS, V14, P898; Hisamoto K, 2001, J BIOL CHEM, V276, P3459, DOI 10.1074/jbc.M005036200; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; Lee SH, 2000, J NEUROSCI RES, V60, P623, DOI 10.1002/(SICI)1097-4547(20000601)60:5<623::AID-JNR7>3.0.CO;2-4; Li QX, 2008, J BIOL CHEM, V283, P11014, DOI 10.1074/jbc.M709682200; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Liu H, 2011, CARDIOVASC RES, V89, P119, DOI 10.1093/cvr/cvq265; Mackay J, 2004, ATLAS HEART DIS STRO; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; Murph E, 2007, CARDIOVASC RES, V75, P478, DOI 10.1016/j.cardiores.2007.03.025; Murphy E, 2007, HEART FAIL REV, V12, P293, DOI 10.1007/s10741-007-9035-0; Mutharasan RK, 2011, AM J PHYSIOL-HEART C, V301, pH1519, DOI 10.1152/ajpheart.01080.2010; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; Patten RD, 2006, TRENDS CARDIOVAS MED, V16, P69, DOI 10.1016/j.tcm.2006.01.002; Patten RD, 2004, CIRC RES, V95, P692, DOI 10.1161/01.RES.0000144126.57786.89; Pedram A, 2005, J BIOL CHEM, V280, P26339, DOI 10.1074/jbc.M414409200; Pelzer T, 2000, BIOCHEM BIOPH RES CO, V268, P192, DOI 10.1006/bbrc.2000.2073; REIS SE, 1994, CIRCULATION, V89, P52, DOI 10.1161/01.CIR.89.1.52; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI 10.1089/ARS.2008.2331; Strassburger M, 2005, FREE RADICAL BIO MED, V38, P1458, DOI 10.1016/j.freeradbiomed.2005.02.009; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; Tourian L, 2004, J CELL SCI, V117, P6459, DOI 10.1242/jcs.01573; Vilatoba M, 2005, TRANSPL P, V37, P399, DOI 10.1016/j.transproceed.2004.12.053; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Yamakura F, 2010, BBA-PROTEINS PROTEOM, V1804, P318, DOI 10.1016/j.bbapap.2009.10.010; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101	42	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85272	10.1371/journal.pone.0085272	http://dx.doi.org/10.1371/journal.pone.0085272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465521	Green Published, gold			2022-12-25	WOS:000330283100033
J	Capurro, A; Baroni, F; Kuebler, LS; Karpati, Z; Dekker, T; Lei, H; Hansson, BS; Pearce, TC; Olsson, SB				Capurro, Alberto; Baroni, Fabiano; Kuebler, Linda S.; Karpati, Zsolt; Dekker, Teun; Lei, Hong; Hansson, Bill S.; Pearce, Timothy C.; Olsson, Shannon B.			Temporal Features of Spike Trains in the Moth Antennal Lobe Revealed by a Comparative Time-Frequency Analysis	PLOS ONE			English	Article							APERIODIC STOCHASTIC RESONANCE; FALSE DISCOVERY RATE; NEURAL CODES; PHEROMONE; DYNAMICS; PATTERNS; INSECTS; DISTANT; SYSTEMS; ODORS	The discrimination of complex sensory stimuli in a noisy environment is an immense computational task. Sensory systems often encode stimulus features in a spatiotemporal fashion through the complex firing patterns of individual neurons. To identify these temporal features, we have developed an analysis that allows the comparison of statistically significant features of spike trains localized over multiple scales of time-frequency resolution. Our approach provides an original way to utilize the discrete wavelet transform to process instantaneous rate functions derived from spike trains, and select relevant wavelet coefficients through statistical analysis. Our method uncovered localized features within olfactory projection neuron (PN) responses in the moth antennal lobe coding for the presence of an odor mixture and the concentration of single component odorants, but not for compound identities. We found that odor mixtures evoked earlier responses in biphasic response type PNs compared to single components, which led to differences in the instantaneous firing rate functions with their signal power spread across multiple frequency bands (ranging from 0 to 45.71 Hz) during a time window immediately preceding behavioral response latencies observed in insects. Odor concentrations were coded in excited response type PNs both in low frequency band differences (2.86 to 5.71 Hz) during the stimulus and in the odor trace after stimulus offset in low (0 to 2.86 Hz) and high (22.86 to 45.71 Hz) frequency bands. These high frequency differences in both types of PNs could have particular relevance for recruiting cellular activity in higher brain centers such as mushroom body Kenyon cells. In contrast, neurons in the specialized pheromone-responsive area of the moth antennal lobe exhibited few stimulus-dependent differences in temporal response features. These results provide interesting insights on early insect olfactory processing and introduce a novel comparative approach for spike train analysis applicable to a variety of neuronal data sets.	[Capurro, Alberto; Pearce, Timothy C.] Univ Leicester, Dept Engn, Leicester LE1 7RH, Leics, England; [Baroni, Fabiano] Monash Univ, Sch Psychol & Psychiat, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Baroni, Fabiano] Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Melbourne, Vic, Australia; [Baroni, Fabiano] Univ Melbourne, Ctr Neural Engn, Melbourne, Vic, Australia; [Kuebler, Linda S.; Hansson, Bill S.; Olsson, Shannon B.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany; [Karpati, Zsolt] Hungarian Acad Sci, Inst Plant Protect, Dept Zool, Agr Res Ctr, Budapest, Hungary; [Dekker, Teun] Swedish Univ Agr Sci, Div Chem Ecol, Alnarp, Sweden; [Lei, Hong] Univ Arizona, Sch Mind Brain & Behav, Dept Neurosci, Tucson, AZ USA	University of Leicester; Monash University; University of Melbourne; University of Melbourne; Max Planck Society; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Swedish University of Agricultural Sciences; University of Arizona	Olsson, SB (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany.	solsson@ice.mpg.de	Baroni, Fabiano/R-8180-2019; Dekker, Teun/R-9396-2018; Hansson, Bill S/G-2774-2013; Karpati, Zsolt/AAX-9991-2021; Lei, Hong/ABH-1356-2020	Baroni, Fabiano/0000-0001-6047-8100; Dekker, Teun/0000-0001-5395-6602; Hansson, Bill S/0000-0002-4811-1223; Karpati, Zsolt/0000-0002-5767-460X; Capurro, Alberto/0000-0001-6773-6512; Olsson, Shannon/0000-0003-4126-7353	Hungarian Scientific Research Fund [PD 1041310]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; Max Planck Society; Future and Emerging Technologies EU Framework Programme 6 Specific Targeted Research Project iChem (Biosynthetic Infochemical Communication) [FP6-IST: 032275];  [DMS-1200004]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Max Planck Society(Max Planck Society); Future and Emerging Technologies EU Framework Programme 6 Specific Targeted Research Project iChem (Biosynthetic Infochemical Communication); 	The authors acknowledge the following sources of funding: Hungarian Scientific Research Fund PD 1041310 and Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences for support of ZK; HL is supported by DMS-1200004; SO and BSH are supported by the Max Planck Society; AC, TCP, SO, and BSH also supported by the Future and Emerging Technologies EU Framework Programme 6 Specific Targeted Research Project iChem (Biosynthetic Infochemical Communication; FP6-IST: 032275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi M, 2013, NEUROIMAGE, V66, P672, DOI 10.1016/j.neuroimage.2012.10.062; Belmabrouk H, 2011, P NATL ACAD SCI USA, V108, P19790, DOI 10.1073/pnas.1112367108; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cao S, 2003, SPIKE TRAIN CHARACTE; Capurro A, 1998, PHYSICA A, V257, P149, DOI 10.1016/S0378-4371(98)00137-X; Capurro A, 1998, PHYS REV E, V58, P4820, DOI 10.1103/PhysRevE.58.4820; Capurro A, 1999, PHYSICA A, V265, P235, DOI 10.1016/S0378-4371(98)00471-3; Capurro Alberto, 2012, Front Neuroeng, V5, P6, DOI 10.3389/fneng.2012.00006; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; Chong KY, 2012, PLOS ONE, V7, P107, DOI 10.1371/journal.pone.0029602; Christensen TA, 2002, CURR OPIN NEUROBIOL, V12, P393, DOI 10.1016/S0959-4388(02)00336-7; COLLINS JJ, 1995, PHYS REV E, V52, pR3321, DOI 10.1103/PhysRevE.52.R3321; Daubechies I, 1992, CMBS NSF REGIONAL C; Debdas S., 2011, INT J SCI ENG RES, V2, P1; Galili DS, 2011, J NEUROSCI, V31, P7240, DOI 10.1523/JNEUROSCI.6667-10.2011; Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gerstner W, 1997, P NATL ACAD SCI USA, V94, P12740, DOI 10.1073/pnas.94.24.12740; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Ito I, 2009, NEURON, V64, P692, DOI 10.1016/j.neuron.2009.10.004; Jarriault D, 2010, CHEM SENSES, V35, P705, DOI 10.1093/chemse/bjq069; Junek S, 2010, NEURON, V67, P872, DOI 10.1016/j.neuron.2010.08.005; KAISSLING KE, 1989, ARCH INSECT BIOCHEM, V10, P273, DOI 10.1002/arch.940100403; Karpati Z, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-286; Klampfl S, 2010, NEURAL COMPUT, V22, P2979, DOI 10.1162/NECO_a_00050; Krofczik S, 2009, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.009.2008; Kuebler LS, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00007; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Laubach M, 2004, J NEUROSCI METH, V134, P159, DOI 10.1016/j.jneumeth.2003.11.007; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lei H, 2008, J CHEM ECOL, V34, P915, DOI 10.1007/s10886-008-9487-2; Lei Hong, 2009, Journal of Biology (London), V8, P21, DOI 10.1186/jbiol120; Mallat S., 2009, WAVELET TOUR SIGNAL; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Meisel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030371; MURLIS J, 1981, PHYSIOL ENTOMOL, V6, P71, DOI 10.1111/j.1365-3032.1981.tb00262.x; Namiki S, 2011, BIOSYSTEMS, V103, P348, DOI 10.1016/j.biosystems.2010.11.007; Nawrot MP, 2012, APIDOLOGIE, V43, P269, DOI 10.1007/s13592-012-0131-3; Olsson SB, 2011, J NEUROSCI METH, V195, P1, DOI 10.1016/j.jneumeth.2010.09.020; Olsson SB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-285; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Quiroga RQ, 2000, PHYSICA D, V145, P278, DOI 10.1016/S0167-2789(00)00116-0; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Rath L, 2011, EUR J NEUROSCI, V34, P352, DOI 10.1111/j.1460-9568.2011.07753.x; Sakurai T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002115; Szyszka P, 2011, J NEUROSCI, V31, P7229, DOI 10.1523/JNEUROSCI.6668-10.2011; Wang ZS, 2007, COMPUT BIOL MED, V37, P463, DOI 10.1016/j.compbiomed.2006.08.011; Wiskott L, 2003, ZOOLOGY, V106, P373, DOI 10.1078/0944-2006-00132; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938; Wright GA, 2009, BEHAV NEUROSCI, V123, P36, DOI 10.1037/a0014040	54	3	3	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84037	10.1371/journal.pone.0084037	http://dx.doi.org/10.1371/journal.pone.0084037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465391	Green Published, Green Accepted, gold			2022-12-25	WOS:000330240500006
J	Andresen, LC; Dungait, JAJ; Bol, R; Selsted, MB; Ambus, P; Michelsen, A				Andresen, Louise C.; Dungait, Jennifer A. J.; Bol, Roland; Selsted, Merete B.; Ambus, Per; Michelsen, Anders			Bacteria and Fungi Respond Differently to Multifactorial Climate Change in a Temperate Heathland, Traced with C-13-Glycine and FACE CO2	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; ELEVATED ATMOSPHERIC CO2; PHOSPHOLIPID FATTY-ACID; SOIL ORGANIC-MATTER; UTILIZATION PATTERNS; CARBON-DIOXIDE; NITROGEN; PLANT; MICROORGANISMS; TURNOVER	It is vital to understand responses of soil microorganisms to predicted climate changes, as these directly control soil carbon (C) dynamics. The rate of turnover of soil organic carbon is mediated by soil microorganisms whose activity may be affected by climate change. After one year of multifactorial climate change treatments, at an undisturbed temperate heathland, soil microbial community dynamics were investigated by injection of a very small concentration (5.12 mu g Cg(-1) soil) of C-13-labeled glycine (C-13(2), 99 atom %) to soils in situ. Plots were treated with elevated temperature (+1 degrees C, T), summer drought (D) and elevated atmospheric carbon dioxide (510 ppm [CO2]), as well as combined treatments (TD, TCO2, DCO2 and TDCO2). The C-13 enrichment of respired CO2 and of phospholipid fatty acids (PLFAs) was determined after 24 h. C-13-glycine incorporation into the biomarker PLFAs for specific microbial groups (Gram positive bacteria, Gram negative bacteria, actinobacteria and fungi) was quantified using gas chromatography-combustion-stable isotope ratio mass spectrometry (GC-C-IRMS). Gram positive bacteria opportunistically utilized the freshly added glycine substrate, i.e. incorporated C-13 in all treatments, whereas fungi had minor or no glycine derived C-13-enrichment, hence slowly reacting to a new substrate. The effects of elevated CO2 did suggest increased direct incorporation of glycine in microbial biomass, in particular in G(+) bacteria, in an ecosystem subjected to elevated CO2. Warming decreased the concentration of PLFAs in general. The FACE CO2 was C-13-depleted (delta C-13 = 12.2 parts per thousand) compared to ambient (delta C-13=similar to-8 parts per thousand), and this enabled observation of the integrated longer term responses of soil microorganisms to the FACE over one year. All together, the bacterial (and not fungal) utilization of glycine indicates substrate preference and resource partitioning in the microbial community, and therefore suggests a diversified response pattern to future changes in substrate availability and climatic factors.	[Andresen, Louise C.; Michelsen, Anders] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Dungait, Jennifer A. J.; Bol, Roland] Rothamsted Res North Wyke, Sustainable Soils & Grassland Syst Dept, Okehampton, England; [Bol, Roland] Forschungszentrum Julich, Inst Bio & Geosci, D-52425 Julich, Germany; [Selsted, Merete B.; Ambus, Per] Tech Univ Denmark, DK-2800 Lyngby, Denmark	University of Copenhagen; Helmholtz Association; Research Center Julich; Technical University of Denmark	Andresen, LC (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	louise.andresen@gu.se	Ambus, Per L/B-2514-2015; Dungait, Jennifer/AAV-7301-2021; Dungait, Jenni/F-1110-2013; Michelsen, Anders/L-5279-2014	Ambus, Per L/0000-0001-7580-524X; Dungait, Jenni/0000-0001-9074-4174; Michelsen, Anders/0000-0002-9541-8658; Andresen, Louise C./0000-0002-4890-889X; bol, roland/0000-0003-3015-7706	Villum Kann Rasmussen Foundation; Air Liquide; DONG Energy; SMC Pneutmatic A/S; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005214] Funding Source: researchfish; BBSRC [BBS/E/C/00005214] Funding Source: UKRI	Villum Kann Rasmussen Foundation(Villum Fonden); Air Liquide; DONG Energy; SMC Pneutmatic A/S; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The CLIMAITE experiment is sponsored by the Villum Kann Rasmussen Foundation with co-funding from Air Liquide, DONG Energy and SMC Pneutmatic A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Albert KR, 2011, J EXP BOT, V62, P4253, DOI 10.1093/jxb/err133; Amelung W, 2008, ADV AGRON, V100, P155, DOI 10.1016/S0065-2113(08)00606-8; Andresen LC, 2005, OECOLOGIA, V144, P585, DOI 10.1007/s00442-005-0044-1; Andresen LC, 2009, ACTA OECOL, V313, P283; Andresen LC, 2011, APPL SOIL ECOL, V51, P94, DOI 10.1016/j.apsoil.2011.09.005; Andresen LC, 2011, RAPID COMMUN MASS SP, V25, P1485, DOI 10.1002/rcm.4907; Bardgett RD, 1997, SOIL BIOL BIOCHEM, V29, P1285, DOI 10.1016/S0038-0717(97)00019-9; Bardgett RD, 2003, ECOLOGY, V84, P1277, DOI 10.1890/0012-9658(2003)084[1277:SMCEWP]2.0.CO;2; Bardgett RD, 2007, BIOLOGY LETT, V3, P487, DOI 10.1098/rsbl.2007.0242; Begon M., 1996, ECOLOGY; Blagodatskaya E, 2010, GLOBAL CHANGE BIOL, V16, P836, DOI 10.1111/j.1365-2486.2009.02006.x; Bol R, 2005, RAPID COMMUN MASS SP, V19, P3216, DOI 10.1002/rcm.2156; Bull ID, 2000, NATURE, V405, P175, DOI 10.1038/35012061; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Denef K, 2007, BIOGEOSCIENCES, V4, P769, DOI 10.5194/bg-4-769-2007; Dieleman WIJ, 2012, GLOBAL CHANGE BIOL, V18, P2681, DOI 10.1111/j.1365-2486.2012.02745.x; Dorrepaal E, 2009, NATURE, V460, P616, DOI 10.1038/nature08216; Drissner D, 2007, EUR J SOIL SCI, V58, P260, DOI 10.1111/j.1365-2389.2006.00838.x; Dungait JAJ, 2011, EUR J SOIL SCI, V62, P117, DOI 10.1111/j.1365-2389.2010.01321.x; Dungait JAJ, 2013, SOIL BIOL BIOCHEM, V64, P57, DOI 10.1016/j.soilbio.2013.03.036; Dungait JAJ, 2009, ORG GEOCHEM, V40, P1210, DOI 10.1016/j.orggeochem.2009.08.001; Evershed RP, 2006, CURR OPIN BIOTECH, V17, P72, DOI 10.1016/j.copbio.2006.01.003; Feng XJ, 2010, GLOBAL CHANGE BIOL, V16, P2104, DOI 10.1111/j.1365-2486.2009.02080.x; Feng XJ, 2010, ORG GEOCHEM, V41, P573, DOI 10.1016/j.orggeochem.2010.02.013; Frey SD, 2008, SOIL BIOL BIOCHEM, V40, P2904, DOI 10.1016/j.soilbio.2008.07.020; Frey SD, 1999, SOIL BIOL BIOCHEM, V31, P573, DOI 10.1016/S0038-0717(98)00161-8; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Glaser B, 2006, GLOBAL CHANGE BIOL, V12, P1521, DOI 10.1111/j.1365-2486.2006.01186.x; Gray SB, 2011, SOIL SCI SOC AM J, V75, P2217, DOI 10.2136/sssaj2011.0135; Guenet B, 2012, GEODERMA, V170, P331, DOI 10.1016/j.geoderma.2011.12.002; Haei M, 2011, SOIL BIOL BIOCHEM, V43, P2069, DOI 10.1016/j.soilbio.2011.06.005; Hobbie EA, 2004, PLANT SOIL, V259, P331, DOI 10.1023/B:PLSO.0000020975.75850.ca; Illeris L, 1999, ARCT ANTARCT ALP RES, V31, P264, DOI 10.2307/1552256; Ineson P, 1998, PLANT SOIL, V198, P89, DOI 10.1023/A:1004298309606; Jin VL, 2010, GLOBAL CHANGE BIOL, V16, P2334, DOI 10.1111/j.1365-2486.2010.02207.x; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kaur A, 2005, CURR SCI INDIA, V89, P1103; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lesuffleur F, 2010, PLANT SOIL, V333, P191, DOI 10.1007/s11104-010-0334-1; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; MCGILL WB, 1975, SOIL BIOL BIOCHEM, V7, P57, DOI 10.1016/0038-0717(75)90032-2; Mehring M, 2011, AGRON SUSTAIN DEV, V31, P719, DOI 10.1007/s13593-011-0013-5; Meidute S, 2008, SOIL BIOL BIOCHEM, V40, P2334, DOI 10.1016/j.soilbio.2008.05.011; Meli SM, 2003, BIOL FERT SOILS, V37, P96, DOI 10.1007/s00374-002-0570-5; Michelsen A, 2012, AMBIO, V41, P218, DOI 10.1007/s13280-012-0303-4; Mikkelsen TN, 2008, FUNCT ECOL, V22, P185, DOI 10.1111/j.1365-2435.2007.01362.x; Nowak RS, 2004, NEW PHYTOL, V162, P253, DOI 10.1111/j.1469-8137.2004.01033.x; Paterson E, 2008, SOIL BIOL BIOCHEM, V40, P2434, DOI 10.1016/j.soilbio.2008.06.005; Paterson E, 2009, NEW PHYTOL, V184, P19, DOI 10.1111/j.1469-8137.2009.03001.x; PERETTO R, 1993, FEMS MICROBIOL LETT, V114, P85, DOI [10.1111/j.1574-6968.1993.tb06555.x, 10.1016/0378-1097(93)90146-S]; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Pritchard SG, 1999, GLOB CHANGE BIOL, V5, P807, DOI 10.1046/j.1365-2486.1999.00268.x; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; Rinnan R, 2007, SOIL BIOL BIOCHEM, V39, P3014, DOI 10.1016/j.soilbio.2007.05.035; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Rinnan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056532; Rinnan R, 2009, APPL ENVIRON MICROB, V75, P3611, DOI 10.1128/AEM.02865-08; SAS Institute, 2004, SAS SYST WIND; Schmidt IK, 2000, SOIL BIOL BIOCHEM, V32, P707, DOI 10.1016/S0038-0717(99)00207-2; Selsted MB, 2012, GLOBAL CHANGE BIOL, V18, P1216, DOI 10.1111/j.1365-2486.2011.02634.x; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; Thornton B, 2011, RAPID COMMUN MASS SP, V25, P2433, DOI 10.1002/rcm.5148; Waldrop MP, 2004, BIOGEOCHEMISTRY, V67, P235, DOI 10.1023/B:BIOG.0000015321.51462.41; Wiesenberg GLB, 2008, ORG GEOCHEM, V39, P103, DOI 10.1016/j.orggeochem.2007.09.006; Wiesenberg GLB, 2008, ORG GEOCHEM, V39, P91, DOI 10.1016/j.orggeochem.2007.09.005; Wixon DL, 2013, SOIL BIOL BIOCHEM, V57, P769, DOI 10.1016/j.soilbio.2012.08.016; Wookey PA, 2009, GLOBAL CHANGE BIOL, V15, P1153, DOI 10.1111/j.1365-2486.2008.01801.x; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533	72	34	42	5	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85070	10.1371/journal.pone.0085070	http://dx.doi.org/10.1371/journal.pone.0085070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454793	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100053
J	Lagah, S; Tan, IL; Radhakrishnan, P; Hirst, RA; Ward, JH; O'Callaghan, C; Smith, SJ; Stevens, MFG; Grundy, RG; Rahman, R				Lagah, Sunil; Tan, I-Li; Radhakrishnan, Priya; Hirst, Robert A.; Ward, Jennifer H.; O'Callaghan, Chris; Smith, Stuart J.; Stevens, Malcolm F. G.; Grundy, Richard G.; Rahman, Ruman			RHPS4 G-Quadruplex Ligand Induces Anti-Proliferative Effects in Brain Tumor Cells	PLOS ONE			English	Article							C-MYC; TELOMERASE INHIBITION; IN-VITRO; INITIATING CELLS; CANCER; GROWTH; PROLIFERATION; METHOSULFATE; THERAPEUTICS; MAINTENANCE	Background: Telomeric 39 overhangs can fold into a four-stranded DNA structure termed G-quadruplex (G4), a formation which inhibits telomerase. As telomerase activation is crucial for telomere maintenance in most cancer cells, several classes of G4 ligands have been designed to directly disrupt telomeric structure. Methods: We exposed brain tumor cells to the G4 ligand 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl] acridinium methosulfate (RHPS4) and investigated proliferation, cell cycle dynamics, telomere length, telomerase activity and activated c-Myc levels. Results: Although all cell lines tested were sensitive to RHPS4, PFSK-1 central nervous system primitive neuroectodermal cells, DAOY medulloblastoma cells and U87 glioblastoma cells exhibited up to 30-fold increased sensitivity compared to KNS42 glioblastoma, C6 glioma and Res 196 ependymoma cells. An increased proportion of S-phase cells were observed in medulloblastoma and high grade glioma cells whilst CNS PNET cells showed an increased proportion of G1-phase cells. RHPS4-induced phenotypes were concomitant with telomerase inhibition, manifested in a telomere length-independent manner and not associated with activated c-Myc levels. However, anti-proliferative effects were also observed in normal neural/endothelial cells in vitro and ex vivo. Conclusion: This study warrants in vivo validation of RHPS4 and alternative G4 ligands as potential anti-cancer agents for brain tumors but highlights the consideration of dose-limiting tissue toxicities.	[Lagah, Sunil; Tan, I-Li; Ward, Jennifer H.; Smith, Stuart J.; Grundy, Richard G.; Rahman, Ruman] Univ Nottingham, Sch Clin Sci, Childrens Brain Tumour Res Ctr, Nottingham NG7 2RD, England; [Radhakrishnan, Priya; Hirst, Robert A.] Univ Leicester, Leicester Royal Infirm, Dept Infect Immun & Inflammat, Leicester, Leics, England; [O'Callaghan, Chris] UCL, Dept Resp Med, Portex Unit, Inst Child Hlth, London, England; [O'Callaghan, Chris] Great Ormond St Hosp Sick Children, London, England; [Stevens, Malcolm F. G.] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Nottingham; University of Leicester; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Nottingham	Rahman, R (corresponding author), Univ Nottingham, Sch Clin Sci, Childrens Brain Tumour Res Ctr, Nottingham NG7 2RD, England.	ruman.rahman@nottingham.ac.uk	Hirst, Robert/AAD-1649-2022; Rahman, Ruman/FFR-5799-2022	Rahman, Ruman/0000-0002-6541-9983; Ward, Jennifer/0000-0002-3906-0858; Smith, Stuart/0000-0002-4556-2707	Joseph Foote Trust; University of Nottingham	Joseph Foote Trust; University of Nottingham	This work was funded by the Joseph Foote Trust and a Nottingham Advanced Research Fellowship from the University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066242; Bax DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005209; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2004, CARCINOGENESIS, V25, P1083, DOI 10.1093/carcin/bgh185; Bobola MS, 2005, CLIN CANCER RES, V11, P2747, DOI 10.1158/1078-0432.CCR-04-2045; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Burger AM, 2005, CANCER RES, V65, P1489, DOI 10.1158/0008-5472.CAN-04-2910; Castelo-Branco P, 2011, CLIN CANCER RES, V17, P111, DOI 10.1158/1078-0432.CCR-10-2075; Cookson JC, 2005, MOL PHARMACOL, V68, P1551, DOI 10.1124/mol.105.013300; De Cian A, 2007, P NATL ACAD SCI USA, V104, P17347, DOI 10.1073/pnas.0707365104; Dikmen ZG, 2005, CANCER RES, V65, P7866, DOI 10.1158/0008-5472.CAN-05-1215; DOROVINIZIS K, 1991, LAB INVEST, V64, P425; Gomez D, 2002, CANCER RES, V62, P3365; Gomez D, 2006, J BIOL CHEM, V281, P38721, DOI 10.1074/jbc.M605828200; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Gowan SM, 2002, MOL PHARMACOL, V61, P1154, DOI 10.1124/mol.61.5.1154; Gowan SM, 2001, MOL PHARMACOL, V60, P981, DOI 10.1124/mol.60.5.981; Grand CL, 2002, EUR J CANCER, V38, pS106; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; Heald RA, 2002, J MED CHEM, V45, P590, DOI 10.1021/jm011015q; Hirst RA, 2000, PEDIATR RES, V47, P381, DOI 10.1203/00006450-200003000-00016; Horikawa I, 1999, CANCER RES, V59, P826; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Husby J, 2013, BIOPOLYMERS, V99, P989, DOI 10.1002/bip.22340; Incles CM, 2004, MOL CANCER THER, V3, P1201; Kim Julie, 2013, Frontiers in Genetics, V4, P162, DOI 10.3389/fgene.2013.00162; Lemarteleur T, 2004, BIOCHEM BIOPH RES CO, V323, P802, DOI 10.1016/j.bbrc.2004.08.150; Leonetti C, 2004, MOL PHARMACOL, V66, P1138, DOI 10.1124/mol.104.001537; Leonetti C, 2008, CLIN CANCER RES, V14, P7284, DOI 10.1158/1078-0432.CCR-08-0941; Liu JP, 2010, BBA-REV CANCER, V1805, P35, DOI 10.1016/j.bbcan.2009.09.001; Marian CO, 2010, CLIN CANCER RES, V16, P154, DOI 10.1158/1078-0432.CCR-09-2850; Miller S, 2011, NEURO-ONCOLOGY, V13, P866, DOI 10.1093/neuonc/nor070; Miyazaki T, 2012, CLIN CANCER RES, V18, P1268, DOI 10.1158/1078-0432.CCR-11-1795; Neidle S, 2002, NAT REV DRUG DISCOV, V1, P383, DOI 10.1038/nrd793; Ou TM, 2011, J MED CHEM, V54, P5671, DOI 10.1021/jm200062u; Patel KP, 2004, CYTOTECHNOLOGY, V45, P91, DOI 10.1007/s10616-004-5132-2; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Pennarun G, 2005, ONCOGENE, V24, P2917, DOI 10.1038/sj.onc.1208468; Phatak P, 2007, BRIT J CANCER, V96, P1223, DOI 10.1038/sj.bjc.6603691; Rahman R, 2010, MOL CANCER THER, V9, P2568, DOI 10.1158/1535-7163.MCT-10-0272; Reed J, 2008, ANAL BIOCHEM, V380, P99, DOI 10.1016/j.ab.2008.05.013; Ruden M, 2013, CANCER TREAT REV, V39, P444, DOI 10.1016/j.ctrv.2012.06.007; Sagi J, 2013, J BIOMOL STRUCT 0325; Salvati E, 2007, J CLIN INVEST, V117, P3236, DOI 10.1172/JCI32461; Shalaby T, 2010, MOL CANCER THER, V9, P167, DOI 10.1158/1535-7163.MCT-09-0586; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Tahara H, 2006, EJC SUPPL, V4, P189, DOI 10.1016/S1359-6349(06)70632-2; Williams HE, 2003, CLIN CANCER RES, V9, p6083S; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Wu XP, 2012, BBA-MOL CELL RES, V1823, P2130, DOI 10.1016/j.bbamcr.2012.08.003; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102	56	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86187	10.1371/journal.pone.0086187	http://dx.doi.org/10.1371/journal.pone.0086187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454961	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100149
J	Terao, C; Hashimoto, M; Furu, M; Nakabo, S; Ohmura, K; Nakashima, R; Imura, Y; Yukawa, N; Yoshifuji, H; Matsuda, F; Ito, H; Fujii, T; Mimori, T				Terao, Chikashi; Hashimoto, Motomu; Furu, Moritoshi; Nakabo, Shuichiro; Ohmura, Koichiro; Nakashima, Ran; Imura, Yoshitaka; Yukawa, Naoichiro; Yoshifuji, Hajime; Matsuda, Fumihiko; Ito, Hiromu; Fujii, Takao; Mimori, Tsuneyo			Inverse Association between Air Pressure and Rheumatoid Arthritis Synovitis	PLOS ONE			English	Article							DISEASE-ACTIVITY INDEX; RAT MODEL; PAIN; WEATHER; SEASON; PREDICTORS; CONSENSUS; DAMAGE	Rheumatoid arthritis (RA) is a bone destructive autoimmune disease. Many patients with RA recognize fluctuations of their joint synovitis according to changes of air pressure, but the correlations between them have never been addressed in large-scale association studies. To address this point we recruited large-scale assessments of RA activity in a Japanese population, and performed an association analysis. Here, a total of 23,064 assessments of RA activity from 2,131 patients were obtained from the KURAMA (Kyoto University Rheumatoid Arthritis Management Alliance) database. Detailed correlations between air pressure and joint swelling or tenderness were analyzed separately for each of the 326 patients with more than 20 assessments to regulate intra-patient correlations. Association studies were also performed for seven consecutive days to identify the strongest correlations. Standardized multiple linear regression analysis was performed to evaluate independent influences from other meteorological factors. As a result, components of composite measures for RA disease activity revealed suggestive negative associations with air pressure. The 326 patients displayed significant negative mean correlations between air pressure and swellings or the sum of swellings and tenderness (p = 0.00068 and 0.00011, respectively). Among the seven consecutive days, the most significant mean negative correlations were observed for air pressure three days before evaluations of RA synovitis (p = 1.7 x 10(-7), 0.00027, and 8.3 x 10(-8), for swellings, tenderness and the sum of them, respectively). Standardized multiple linear regression analysis revealed these associations were independent from humidity and temperature. Our findings suggest that air pressure is inversely associated with synovitis in patients with RA.	[Terao, Chikashi; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Hashimoto, Motomu; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan; [Nakabo, Shuichiro; Ohmura, Koichiro; Nakashima, Ran; Imura, Yoshitaka; Yukawa, Naoichiro; Yoshifuji, Hajime; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University	Terao, C (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan.	a0001101@kuhp.kyoto-u.ac.jp	Yoshifuji, Hajime/AAZ-1657-2020		Grants-in-Aid for Scientific Research [24659274] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aletaha D, 2007, BEST PRACT RES CL RH, V21, P663, DOI 10.1016/j.berh.2007.02.004; de Rooy DPC, 2012, ANN RHEUM DIS, V71, P2055, DOI 10.1136/annrheumdis-2012-201565; Drossaers-Bakker KW, 1999, ARTHRITIS RHEUM, V42, P1854, DOI 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO;2-F; EDSTROM G, 1948, ANN RHEUM DIS, V7, P76, DOI 10.1136/ard.7.2.76; Furst DE, 2012, ANN RHEUM DIS, V71, P2, DOI 10.1136/annrheumdis-2011-201036; Gorin AA, 1999, PAIN, V81, P173, DOI 10.1016/S0304-3959(99)00010-X; HAWLEY DJ, 1994, PAIN, V59, P227, DOI 10.1016/0304-3959(94)90075-2; HOLLANDER JL, 1963, ARCH ENVIRON HEALTH, V6, P527, DOI 10.1080/00039896.1963.10663436; Iikuni N, 2007, RHEUMATOLOGY, V46, P846, DOI 10.1093/rheumatology/kel414; Jin Y, 2008, PAIN, V135, P221, DOI 10.1016/j.pain.2007.05.020; Mouterde G, 2011, ANN RHEUM DIS, V70, P1251, DOI 10.1136/ard.2010.144402; Patberg WR, 2004, J RHEUMATOL, V31, P1327; PATBERG WR, 1985, J RHEUMATOL, V12, P711; Redelmeier DA, 1996, P NATL ACAD SCI USA, V93, P2895, DOI 10.1073/pnas.93.7.2895; Sato J, 2004, NEUROSCI LETT, V354, P46, DOI 10.1016/j.neulet.2003.09.057; Sato J, 1999, NEUROSCI LETT, V266, P21, DOI 10.1016/S0304-3940(99)00260-8; Sato J, 2000, EXP BRAIN RES, V133, P442, DOI 10.1007/s002210000451; SIBLEY JT, 1985, J RHEUMATOL, V12, P707; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Smolen JS, 2006, ARTHRITIS RHEUM-US, V54, P702, DOI 10.1002/art.21678; Strusberg I, 2002, J RHEUMATOL, V29, P335; Terao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059341; Terao C, 2012, MOD RHEUMATOL, V22, P426, DOI 10.1007/s10165-011-0535-3; van Riel PLCM, 2000, ANN RHEUM DIS, V59, P28; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; VANDERHEIJDE DMFM, 1992, ANN RHEUM DIS, V51, P177, DOI 10.1136/ard.51.2.177	26	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85376	10.1371/journal.pone.0085376	http://dx.doi.org/10.1371/journal.pone.0085376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454853	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100077
J	Edwards, DN; Machwe, A; Wang, ZG; Orren, DK				Edwards, Deanna N.; Machwe, Amrita; Wang, Zhigang; Orren, David K.			Intramolecular Telomeric G-Quadruplexes Dramatically Inhibit DNA Synthesis by Replicative and Translesion Polymerases, Revealing their Potential to Lead to Genetic Change	PLOS ONE			English	Article							K+ SOLUTION; SYNDROME HELICASE; REPEAT SEQUENCE; HUMAN GENOME; HUMAN-CELLS; IN-VITRO; STABILITY; TETRAPLEX; D(CGG)(N); ETA	Recent research indicates that hundreds of thousands of G-rich sequences within the human genome have the potential to form secondary structures known as G-quadruplexes. Telomeric regions, consisting of long arrays of TTAGGG/AATCCC repeats, are among the most likely areas in which these structures might form. Since G-quadruplexes assemble from certain G-rich single-stranded sequences, they might arise when duplex DNA is unwound such as during replication. Coincidentally, these bulky structures when present in the DNA template might also hinder the action of DNA polymerases. In this study, single-stranded telomeric templates with the potential to form G-quadruplexes were examined for their effects on a variety of replicative and translesion DNA polymerases from humans and lower organisms. Our results demonstrate that single-stranded templates containing four telomeric GGG runs fold into intramolecular G-quadruplex structures. These intramolecular G quadruplexes are somewhat dynamic in nature and stabilized by increasing KCl concentrations and decreasing temperatures. Furthermore, the presence of these intramolecular G-quadruplexes in the template dramatically inhibits DNA synthesis by various DNA polymerases, including the human polymerase d employed during lagging strand replication of G-rich telomeric strands and several human translesion DNA polymerases potentially recruited to sites of replication blockage. Notably, misincorporation of nucleotides is observed when certain translesion polymerases are employed on substrates containing intramolecular G-quadruplexes, as is extension of the resulting mismatched base pairs upon dynamic unfolding of this secondary structure. These findings reveal the potential for blockage of DNA replication and genetic changes related to sequences capable of forming intramolecular G-quadruplexes.	[Edwards, Deanna N.; Machwe, Amrita; Wang, Zhigang; Orren, David K.] Univ Kentucky, Grad Ctr Toxicol, Coll Med, Lexington, KY 40536 USA; [Machwe, Amrita; Wang, Zhigang; Orren, David K.] Univ Kentucky, Markey Canc Ctr, Coll Med, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Orren, DK (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Coll Med, Lexington, KY 40536 USA.	dkorre2@uky.edu		Edwards, Deanna/0000-0001-5481-5879	National Institute on Aging [R01 AG027258]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027258] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant R01 AG027258 from the National Institute on Aging to David K. Orren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALAGURUMOORTHY P, 1994, J BIOL CHEM, V269, P21858; Betous R, 2009, MOL CARCINOGEN, V48, P369, DOI 10.1002/mc.20509; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; CLARK JM, 1987, J MOL BIOL, V198, P123, DOI 10.1016/0022-2836(87)90462-1; Damerla RR, 2012, CELL CYCLE, V11, P3036, DOI 10.4161/cc.21399; DOETSCH PW, 1985, NUCLEIC ACIDS RES, V13, P3285, DOI 10.1093/nar/13.9.3285; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; Han HY, 1999, NUCLEIC ACIDS RES, V27, P537, DOI 10.1093/nar/27.2.537; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Kamath-Loeb AS, 2001, J BIOL CHEM, V276, P16439, DOI 10.1074/jbc.M100253200; KETTANI A, 1995, J MOL BIOL, V254, P638, DOI 10.1006/jmbi.1995.0644; Lee JY, 2005, P NATL ACAD SCI USA, V102, P18938, DOI 10.1073/pnas.0506144102; Lee MYWT, 2012, ENVIRON MOL MUTAGEN, V53, P683, DOI 10.1002/em.21743; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Maxam A M, 1980, Methods Enzymol, V65, P499; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Phan AT, 2007, NUCLEIC ACIDS RES, V35, P6517, DOI 10.1093/nar/gkm706; Phan AT, 2006, NUCLEIC ACIDS RES, V34, P5715, DOI 10.1093/nar/gkl726; Prakash A, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/896947; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Searle MS, 2004, ORG BIOMOL CHEM, V2, P810, DOI 10.1039/b314559j; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; Tang J, 2008, NUCLEIC ACIDS RES, V36, P1200, DOI 10.1093/nar/gkm1137; THIER SO, 1986, AM J MED, V80, P3, DOI 10.1016/0002-9343(86)90334-7; Vorlickova M, 2005, NUCLEIC ACIDS RES, V33, P5851, DOI 10.1093/nar/gki898; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Washington MT, 2001, J BIOL CHEM, V276, P2263, DOI 10.1074/jbc.M009049200; Weitzmann MN, 1996, J BIOL CHEM, V271, P20958, DOI 10.1074/jbc.271.34.20958; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; WOODFORD KJ, 1994, J BIOL CHEM, V269, P27029; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x; Xu Y, 2009, ANGEW CHEM INT EDIT, V48, P7833, DOI 10.1002/anie.200903858; Yamtich J, 2010, BBA-PROTEINS PROTEOM, V1804, P1136, DOI 10.1016/j.bbapap.2009.07.008; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102; Zhang ML, 2010, NAT STRUCT MOL BIOL, V17, P202, DOI 10.1038/nsmb.1760; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4147, DOI 10.1093/nar/28.21.4147; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zhang YB, 2002, J BIOL CHEM, V277, P44582, DOI 10.1074/jbc.M207297200; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	55	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e80664	10.1371/journal.pone.0080664	http://dx.doi.org/10.1371/journal.pone.0080664			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454683	gold, Green Submitted, Green Published			2022-12-25	WOS:000329925800004
J	Jimbo, R; Tovar, N; Janal, MN; Mousa, R; Marin, C; Yoo, D; Teixeira, HS; Anchieta, RB; Bonfante, EA; Konishi, A; Takeda, K; Kurihara, H; Coelho, PG				Jimbo, Ryo; Tovar, Nick; Janal, Malvin N.; Mousa, Ramy; Marin, Charles; Yoo, Daniel; Teixeira, Hellen S.; Anchieta, Rodolfo B.; Bonfante, Estevam A.; Konishi, Akihiro; Takeda, Katsuhiro; Kurihara, Hidemi; Coelho, Paulo G.			The Effect of Brain-Derived Neurotrophic Factor on Periodontal Furcation Defects	PLOS ONE			English	Article							GUIDED TISSUE REGENERATION; HYALURONIC-ACID; BEAGLE DOGS; BDNF; MAINTENANCE; EXPRESSION; NEURONS; DISEASE; GENE	This study aimed to observe the regenerative effect of brain-derived neurotrophic factor (BDNF) in a non-human primate furcation defect model. Class II furcation defects were created in the first and second molars of 8 non-human primates to simulate a clinical situation. The defect was filled with either, Group A: BDNF (500 mu g/ml) in high-molecular weight-hyaluronic acid (HMW-HA), Group B: BDNF (50 mu g/ml) in HMW-HA, Group C: HMW-HA acid only, Group D: empty defect, or Group E: BDNF (500 mu g/ml) in saline. The healing status for all groups was observed at different time-points with micro computed tomography. The animals were euthanized after 11 weeks, and the tooth-bone specimens were subjected to histologic processing. The results showed that all groups seemed to successfully regenerate the alveolar buccal bone, however, only Group A regenerated the entire periodontal tissue, i.e., alveolar bone, cementum and periodontal ligament. It is suggested that the use of BDNF in combination with a scaffold such as the hyaluronic acid in periodontal furcation defects may be an effective treatment option.	[Jimbo, Ryo] Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden; [Tovar, Nick; Mousa, Ramy; Yoo, Daniel; Teixeira, Hellen S.; Anchieta, Rodolfo B.; Coelho, Paulo G.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY USA; [Janal, Malvin N.] NYU, Dept Epidemiol & Hlth Promot, New York, NY USA; [Marin, Charles; Konishi, Akihiro] UNIGRANRIO, Dept Dent, Rio De Janeiro, Brazil; [Marin, Charles; Bonfante, Estevam A.; Konishi, Akihiro] Univ Sao Paulo, Bauru Sch Dent, Dept Prosthodont, Integrated Ctr Res, Sao Paulo, Brazil; [Takeda, Katsuhiro; Kurihara, Hidemi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Periodontal Med, Div Appl Life Sci,Minami Ku, Hiroshima, Japan	Malmo University; New York University; New York University; Universidade do Grande Rio; Universidade de Sao Paulo; Hiroshima University	Jimbo, R (corresponding author), Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden.	ryo.jimbo@mah.se	Anchieta, Rodolfo Bruniera/H-2000-2011; Janal, Malvin/AAA-2036-2020; Bonfante, Estevam/F-7238-2012; Coelho, Paulo G/B-2999-2014; Anchieta, Rodolfo/M-4142-2017	Bonfante, Estevam/0000-0001-6867-8350; Coelho, Paulo G/0000-0001-8347-6124; Yoo, Doo-Yeol/0000-0003-2814-5482; Anchieta, Rodolfo/0000-0002-7920-7885	Dentsply IH	Dentsply IH	This study was funded by Dentsply IH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizuki T, 2005, J PERIODONTAL RES, V40, P245, DOI 10.1111/j.1600-0765.2005.00799.x; Altar CA, 1999, TRENDS PHARMACOL SCI, V20, P59, DOI 10.1016/S0165-6147(99)01309-7; AXELSSON P, 1981, J CLIN PERIODONTOL, V8, P281, DOI 10.1111/j.1600-051X.1981.tb02039.x; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Gilbert GH, 2002, J PERIODONTOL, V73, P1427, DOI 10.1902/jop.2002.73.12.1427; GOTTLOW J, 1986, J CLIN PERIODONTOL, V13, P604, DOI 10.1111/j.1600-051X.1986.tb00854.x; GOTTLOW J, 1992, J CLIN PERIODONTOL, V19, P315, DOI 10.1111/j.1600-051X.1992.tb00651.x; Jepsen S, 2002, J CLIN PERIODONTOL, V29, P103, DOI 10.1034/j.1600-051X.29.s3.6.x; Kajiya M, 2008, J BIOL CHEM, V283, P16259, DOI 10.1074/jbc.M800668200; Kajiya M, 2009, J CELL PHYSIOL, V221, P696, DOI 10.1002/jcp.21909; KUBO T, 1995, DEV BRAIN RES, V85, P249, DOI 10.1016/0165-3806(94)00220-T; Kurihara H, 2003, J PERIODONTOL, V74, P76, DOI 10.1902/jop.2003.74.1.76; LINDHE J, 1982, J CLIN PERIODONTOL, V9, P115, DOI 10.1111/j.1600-051X.1982.tb01227.x; LINDHE J, 1975, Journal of Clinical Periodontology, V2, P67, DOI 10.1111/j.1600-051X.1975.tb01727.x; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; MITSIADIS TA, 1995, INT J DEV BIOL, V39, P195; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Needleman I, 2002, J PERIODONTAL RES, V37, P380, DOI 10.1034/j.1600-0765.2002.01369.x; Oortgiesen DA, 2012, J TISSUE ENG REGEN M; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; PARK JB, 1995, J PERIODONTOL, V66, P462, DOI 10.1902/jop.1995.66.6.462; Pirnazar P, 1999, J PERIODONTOL, V70, P370, DOI 10.1902/jop.1999.70.4.370; PONTORIERO R, 1992, J CLIN PERIODONTOL, V19, P159, DOI 10.1111/j.1600-051X.1992.tb00632.x; Prato GPP, 2003, J PERIODONTOL, V74, P262, DOI 10.1902/jop.2003.74.2.262; Saruta J, 2010, STRESS, V13, P238, DOI 10.3109/10253890903296728; Takeda K, 2005, TISSUE ENG, V11, P1618, DOI 10.1089/ten.2005.11.1618; Takeda K, 2011, TISSUE ENG PT A, V17, P955, DOI [10.1089/ten.tea.2010.0070, 10.1089/ten.TEA.2010.0070]; Tsuboi Y, 2001, J DENT RES, V80, P881, DOI 10.1177/00220345010800030701; Yamashiro T, 2001, BONE, V28, P404, DOI 10.1016/S8756-3282(01)00405-7	29	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e84845	10.1371/journal.pone.0084845	http://dx.doi.org/10.1371/journal.pone.0084845			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454754	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800015
J	Lin, CN; Sun, WSW; Lu, HY; Ng, SC; Liao, YS; Syu, WJ				Lin, Ching-Nan; Sun, Wei-Sheng W.; Lu, Hui-Yin; Ng, Swee-Chuan; Liao, Ying-Shu; Syu, Wan-Jr			Protein Interactions and Regulation of EscA in Enterohemorrhagic E. coli	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; III SECRETION SYSTEMS; PATHOGENICITY ISLAND; 2ND CHAPERONE; O157-H7; LOCUS; PATHOGENESIS; APPARATUS; SEQUENCE; ESPB	Infections caused by enterohemorrhagic Escherichia coli (EHEC) can lead to diarrhea with abdominal cramps and sometimes are complicated by severe hemolytic uremic syndrome. EHEC secretes effector proteins into host cells through a type III secretion system that is composed of proteins encoded by a chromosomal island, locus for the enterocyte effacement (LEE). EspA is the major component of the filamentous structure connecting the bacteria and the host's cells. Synthesis and secretion of EspA must be carefully controlled since the protein is prone to polymerize. CesAB, CesA2, and EscL have been identified as being able to interact with EspA. Furthermore, the intracellular level of EspA declines when cesAB, cesA2, and escL are individually deleted. Here, we report a LEE gene named l0033, which also affects the intracellular level of EspA. We renamed l0033 as escA since its counterpart in enteropathogenic E. coli has been recently described. Similar to CesAB, EscL, and CesA2, EscA interacts with EspA and enhances the protein stability of EspA. However, EscA is also able to interact with inner membrane-associated EscL, CesA2, and EscN, but not with cytoplasmic CesAB. In terms of gene organizations, escA locates in LEE3. Expression of EscA is faithfully regulated via Mpc, the first gene product of LEE3. Since Mpc is tightly regulated to low level, we suggest that EscA is highly synchronized and critical to the process of escorting EspA to its final destination.	[Lin, Ching-Nan; Lu, Hui-Yin; Ng, Swee-Chuan; Liao, Ying-Shu; Syu, Wan-Jr] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Sun, Wei-Sheng W.] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Sun, Wei-Sheng W.; Syu, Wan-Jr] Acad Sinica, Taiwan Int Grad Program Mol Med, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Syu, WJ (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	wjsyu@ym.edu.tw			Ministry of Education, Aim for the Top University Plan and Grant from the National Science Council, Republic of China ( Taiwan) [NSC101-2320-B-010-048-MY2]	Ministry of Education, Aim for the Top University Plan and Grant from the National Science Council, Republic of China ( Taiwan)	This work was supported in part by a Grant from Ministry of Education, Aim for the Top University Plan and Grant NSC101-2320-B-010-048-MY2 from the National Science Council, Republic of China ( Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Aizawa S, 2001, FEMS MICROBIOL LETT, V202, P157, DOI 10.1111/j.1574-6968.2001.tb10797.x; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269; Biemans-Oldehinkel E, 2011, J BACTERIOL, V193, P5514, DOI 10.1128/JB.05235-11; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Chen L, 2011, MOL CELL, V44, P734, DOI 10.1016/j.molcel.2011.09.022; Chen L, 2013, MANAGE COMMUN Q, V27, P3, DOI 10.1177/0893318913475485; Chiu HJ, 2005, MICROBIOL-SGM, V151, P3277, DOI 10.1099/mic.0.28115-0; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Creasey EA, 2003, MICROBIOL-SGM, V149, P3639, DOI 10.1099/mic.0.26735-0; Creasey EA, 2003, MICROBIOL-SGM, V149, P2093, DOI 10.1099/mic.0.26355-0; Deane JE, 2010, CELL MOL LIFE SCI, V67, P1065, DOI 10.1007/s00018-009-0230-0; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Gauthier A, 2003, INFECT IMMUN, V71, P3310, DOI 10.1128/IAI.71.6.3310-3319.2003; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Ku CP, 2009, J BIOL CHEM, V284, P1686, DOI 10.1074/jbc.M807478200; Lin CN, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-84; Neves BC, 2003, INFECT IMMUN, V71, P2130, DOI 10.1128/IAI.71.4.2130-2141.2003; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Sal-Man N, 2012, J BACTERIOL, V194, P2819, DOI 10.1128/JB.00103-12; Spears KJ, 2006, FEMS MICROBIOL LETT, V255, P187, DOI 10.1111/j.1574-6968.2006.00119.x; Su MSW, 2008, MICROBIOL-SGM, V154, P1094, DOI 10.1099/mic.0.2007/013946-0; Tsai NP, 2006, BIOCHEM J, V393, P591, DOI 10.1042/BJ20051201; Yu YC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-52	31	112	114	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85354	10.1371/journal.pone.0085354	http://dx.doi.org/10.1371/journal.pone.0085354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454847	gold, Green Submitted, Green Published			2022-12-25	WOS:000329922500053
J	Nagao, M; Asai, A; Inaba, W; Kawahara, M; Shuto, Y; Kobayashi, S; Sanoyama, D; Sugihara, H; Yagihashi, S; Oikawa, S				Nagao, Mototsugu; Asai, Akira; Inaba, Wataru; Kawahara, Momoyo; Shuto, Yuki; Kobayashi, Shunsuke; Sanoyama, Daisuke; Sugihara, Hitoshi; Yagihashi, Soroku; Oikawa, Shinichi			Characterization of Pancreatic Islets in Two Selectively Bred Mouse Lines with Different Susceptibilities to High-Fat Diet-Induced Glucose Intolerance	PLOS ONE			English	Article							BETA-CELL MASS; IMPAIRED INSULIN-SECRETION; GOTO-KAKIZAKI RATS; GENE-EXPRESSION; ANIMAL-MODELS; MICE; NIDDM; BIOSYNTHESIS; PATHOGENESIS; CONTRIBUTES	Hereditary predisposition to diet-induced type 2 diabetes has not yet been fully elucidated. We recently established 2 mouse lines with different susceptibilities (resistant and prone) to high-fat diet (HFD)-induced glucose intolerance by selective breeding (designated selectively bred diet-induced glucose intolerance-resistant [SDG-R] and -prone [SDG-P], respectively). To investigate the predisposition to HFD-induced glucose intolerance in pancreatic islets, we examined the islet morphological features and functions in these novel mouse lines. Male SDG-P and SDG-R mice were fed a HFD for 5 weeks. Before and after HFD feeding, glucose tolerance was evaluated by oral glucose tolerance test (OGTT). Morphometry and functional analyses of the pancreatic islets were also performed before and after the feeding period. Before HFD feeding, SDG-P mice showed modestly higher postchallenge blood glucose levels and lower insulin increments in OGTT than SDG-R mice. Although SDG-P mice showed greater beta cell proliferation than SDG-R mice under HFD feeding, SDG-P mice developed overt glucose intolerance, whereas SDG-R mice maintained normal glucose tolerance. Regardless of whether it was before or after HFD feeding, the isolated islets from SDG-P mice showed impaired glucose-and KCl-stimulated insulin secretion relative to those from SDG-R mice; accordingly, the expression levels of the insulin secretion-related genes in SDG-P islets were significantly lower than those in SDG-R islets. These findings suggest that the innate predispositions in pancreatic islets may determine the susceptibility to diet-induced diabetes. SDG-R and SDG-P mice may therefore be useful polygenic animal models to study the gene-environment interactions in the development of type 2 diabetes.	[Nagao, Mototsugu; Asai, Akira; Kawahara, Momoyo; Shuto, Yuki; Kobayashi, Shunsuke; Sanoyama, Daisuke; Sugihara, Hitoshi; Oikawa, Shinichi] Nippon Med Sch, Grad Sch Med, Dept Endocrinol Diabet & Metab, Tokyo 113, Japan; [Inaba, Wataru; Yagihashi, Soroku] Hirosaki Univ, Grad Sch Med, Dept Pathol & Mol Med, Hirosaki, Aomori, Japan	Nippon Medical School; Hirosaki University	Oikawa, S (corresponding author), Nippon Med Sch, Grad Sch Med, Dept Endocrinol Diabet & Metab, 1-1-5 Sendagi, Tokyo 113, Japan.	shinichi@nms.ac.jp	Nagao, Mototsugu/D-3473-2018	Nagao, Mototsugu/0000-0001-6880-5161; Asai, Akira/0000-0003-2557-9111	Japan Society for the Promotion of Science; Nippon Medical School; Lilly Grant Office; Japan Metabolic Syndrome Study Group	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nippon Medical School; Lilly Grant Office; Japan Metabolic Syndrome Study Group	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, a Grant-in-Aid for Medical Research from Nippon Medical School, a grant from the Lilly Grant Office, and a grant from the Japan Metabolic Syndrome Study Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Asai A, 2013, ATHEROSCLEROSIS, V231, P421, DOI 10.1016/j.atherosclerosis.2013.10.009; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Babaya N, 2010, DIABETOLOGIA, V53, P1362, DOI 10.1007/s00125-010-1737-5; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Cefalu WT, 2006, ILAR J, V47, P186, DOI 10.1093/ilar.47.3.186; CHEN KW, 1995, DIABETES CARE, V18, P747, DOI 10.2337/diacare.18.6.747; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Ernst SJ, 2009, ENDOCRINOLOGY, V150, P1132, DOI 10.1210/en.2008-0991; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Inaba W, 2012, EUR J PHARMACOL, V691, P297, DOI 10.1016/j.ejphar.2012.07.030; Ishida H, 2004, METABOLISM, V53, P488, DOI 10.1016/j.metabol.2003.11.021; Jacqueminet S, 2000, METABOLISM, V49, P532, DOI 10.1016/S0026-0495(00)80021-9; KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262; KIMURA K, 1982, TOHOKU J EXP MED, V137, P453, DOI 10.1620/tjem.137.453; Koyama M, 1998, AM J PATHOL, V153, P537, DOI 10.1016/S0002-9440(10)65596-4; Koyama M, 2000, METABOLISM, V49, P347, DOI 10.1016/S0026-0495(00)90242-7; Ktorza A, 1997, DIABETES METAB, V23, P38; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; LEAHY JL, 1986, J CLIN INVEST, V77, P908, DOI 10.1172/JCI112389; Marshall JA, 2002, DIABETES CARE, V25, P620, DOI 10.2337/diacare.25.3.620; Matsumoto K, 1997, DIABETES CARE, V20, P1562, DOI 10.2337/diacare.20.10.1562; Mizukami H, 2008, VIRCHOWS ARCH, V452, P383, DOI 10.1007/s00428-007-0508-2; Movassat J, 1997, DIABETOLOGIA, V40, P916, DOI 10.1007/s001250050768; Nagao M, 2012, J DIABETES INVEST, V3, P245, DOI 10.1111/j.2040-1124.2011.00175.x; Nesher R, 1999, DIABETES, V48, P731, DOI 10.2337/diabetes.48.4.731; Noushmehr H, 2005, DIABETES, V54, P472, DOI 10.2337/diabetes.54.2.472; Ostenson CG, 2007, DIABETES OBES METAB, V9, P180, DOI 10.1111/j.1463-1326.2007.00787.x; PERMUTT MA, 1984, J CLIN INVEST, V73, P1344, DOI 10.1172/JCI111337; Portha B, 2001, DIABETES, V50, pS89, DOI 10.2337/diabetes.50.2007.S89; Ritz-Laser B, 1999, ENDOCRINOLOGY, V140, P4005, DOI 10.1210/en.140.9.4005; Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827; SHIBATA M, 1980, TOHOKU J EXP MED, V130, P139, DOI 10.1620/tjem.130.139; Thaler JP, 2010, ENDOCRINOLOGY, V151, P4109, DOI 10.1210/en.2010-0336; UEDA H, 1995, DIABETOLOGIA, V38, P503, DOI 10.1007/BF00400717; Wallin T, 2010, BBA-MOL CELL BIOL L, V1801, P191, DOI 10.1016/j.bbalip.2009.11.002; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355	39	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84725	10.1371/journal.pone.0084725	http://dx.doi.org/10.1371/journal.pone.0084725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454742	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500017
J	Kapoor-Vazirani, P; Vertino, PM				Kapoor-Vazirani, Priya; Vertino, Paula M.			A Dual Role for the Histone Methyltransferase PR-SET7/SETD8 and Histone H4 Lysine 20 Monomethylation in the Local Regulation of RNA Polymerase II Pausing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Histone Modification; Chromatin Structure; Gene Regulation; RNA Polymerase; Transcription Regulation; H4K20me1; MSL Complex; PR-SET7; SETD8; RNA Polymerase II Promoter-proximal Pausing; SUV420H2	BROMODOMAIN PROTEIN BRD4; P-TEFB; S-PHASE; TRANSCRIPTION ELONGATION; DOSAGE COMPENSATION; DNA METHYLATION; MSL COMPLEX; DEPENDENT TRANSCRIPTION; DROSOPHILA-MELANOGASTER; PRODUCTIVE ELONGATION	Background: MSL-mediated H4K16Ac allows release from Pol II promoter-proximal pausing, and SUV420H2-mediated H4K20me3 enforces pausing. Results: PR-SET7-mediated H4K20me1 is necessary for MSL recruitment and H4K16Ac and serves as a substrate for conversion to H4K20me3. Conclusion: H4K20me1 plays a dual role in pausing by regulating both H4K16Ac and H4K20me3. Significance: The local balance between H4K20me3 and H4K20me1/H4K16Ac levels controls pausing and, ultimately, transcriptional output. RNA polymerase II (Pol II) promoter-proximal pausing plays a critical role in postinitiation transcriptional regulation at many metazoan genes. We showed recently that histone H4 lysine 16 acetylation (H4K16Ac), mediated by the MSL complex, facilitates the release of paused Pol II. In contrast, H4 lysine 20 trimethylation (H4K20me3), mediated by SUV420H2, enforces Pol II pausing by inhibiting MSL recruitment. However, how the balance between H4K16Ac and H4K20me3 is locally regulated remains unclear. Here, we demonstrate that PR-SET7/SETD8, which monomethylates histone H4 lysine 20 (H4K20me1), controls both H4K16Ac and H4K20me3 and in doing so, regulates Pol II pausing dynamics. We find that PR-SET7-mediated H4K20me1 is necessary for the recruitment of the MSL complex, subsequent H4K16Ac, and release of Pol II into active elongation. Although dispensable for SUV420H2 recruitment, PR-SET7-mediated H4K20me1 is required for H4K20me3. Although depletion of SUV420H2 is sufficient to deplete H4K20me3 and relieve an H4K20me3-induced pause, pausing is maintained in the absence of PR-SET7 despite H4K20me3 depletion because of an inability to recruit the MSL complex in the absence of H4K20me1. These findings highlight the requirement for PR-SET7 and H4K20me1 in establishing both the H4K16Ac and H4K20me3 marks and point to a dual role in the local regulation of Pol II pausing.	[Vertino, Paula M.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Vertino, PM (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, 1365-C Clifton Rd,NE,Rm 4086, Atlanta, GA 30322 USA.	pvertin@emory.edu			National Institute of Health [2R01-CA077337, 5R01-CA132065]; NATIONAL CANCER INSTITUTE [P30CA138292, R01CA077337, R01CA132065] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institute of Health Grants 2R01-CA077337 and 5R01-CA132065 (to P. M. V.).	Abbas T, 2013, MOL CELL, V49, P1147, DOI 10.1016/j.molcel.2013.02.003; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Barbieri I, 2013, BRIEF FUNCT GENOMICS, V12, P219, DOI 10.1093/bfgp/elt007; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bateman JR, 2012, G3-GENES GENOM GENET, V2, P731, DOI 10.1534/g3.112.002840; Beck DB, 2012, GENE DEV, V26, P2580, DOI 10.1101/gad.195636.112; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Byun JS, 2009, P NATL ACAD SCI USA, V106, P19292, DOI 10.1073/pnas.0905469106; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Congdon LM, 2010, J CELL BIOCHEM, V110, P609, DOI 10.1002/jcb.22570; Conrad T, 2012, DEV CELL, V22, P610, DOI 10.1016/j.devcel.2011.12.016; Conway KE, 2000, CANCER RES, V60, P6236; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Demakova OV, 2003, CHROMOSOMA, V112, P103, DOI 10.1007/s00412-003-0249-1; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Hallacli E, 2009, CHROMOSOME RES, V17, P603, DOI 10.1007/s10577-009-9054-x; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Kagey JD, 2010, MOL CANCER RES, V8, P1048, DOI 10.1158/1541-7786.MCR-10-0189; Kapoor-Vazirani P, 2011, MOL CELL BIOL, V31, P1594, DOI 10.1128/MCB.00524-10; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; Kim D, 2010, NAT STRUCT MOL BIOL, V17, P1027, DOI 10.1038/nsmb.1856; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Li YY, 2011, J BIOL CHEM, V286, P13925, DOI 10.1074/jbc.M111.223198; Li ZF, 2011, P NATL ACAD SCI USA, V108, P3116, DOI 10.1073/pnas.1009353108; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Lucchesi JC, 2009, CURR OPIN GENET DEV, V19, P550, DOI 10.1016/j.gde.2009.10.004; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Melendy T, 2001, FRONT BIOSCI-LANDMRK, V6, pD1048, DOI 10.2741/Melendy; Moore SA, 2010, J BIOL CHEM, V285, P40879, DOI 10.1074/jbc.M110.134312; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Pannetier M, 2008, EMBO REP, V9, P998, DOI 10.1038/embor.2008.147; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Pfister S, 2008, INT J CANCER, V122, P1207, DOI 10.1002/ijc.23283; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Sims JK, 2008, MOL CELL BIOL, V28, P4459, DOI 10.1128/MCB.00410-08; Sural TH, 2008, NAT STRUCT MOL BIOL, V15, P1318, DOI 10.1038/nsmb.1520; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Takawa M, 2012, CANCER RES, V72, P3217, DOI 10.1158/0008-5472.CAN-11-3701; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Venters Bryan J, 2007, Genome Biol, V8, P319, DOI 10.1186/gb-2007-8-11-319; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wells MB, 2012, MOL CELL BIOL, V32, P1710, DOI 10.1128/MCB.06546-11; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	78	24	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7425	7437		10.1074/jbc.M113.520783	http://dx.doi.org/10.1074/jbc.M113.520783			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24459145	Green Published, hybrid			2022-12-25	WOS:000332761500014
J	Dames, DN; Blackman, E; Butler, R; Taioli, E; Eckstein, S; Devarajan, K; Griffith-Bowe, A; Gomez, P; Ragin, C				Dames, Dionne N.; Blackman, Elizabeth; Butler, Raleigh; Taioli, Emanuela; Eckstein, Stacy; Devarajan, Karthik; Griffith-Bowe, Andrea; Gomez, Perry; Ragin, Camille		African Caribbean Canc Consortium	High-Risk Cervical Human Papillomavirus Infections among Human Immunodeficiency Virus-Positive Women in the Bahamas	PLOS ONE			English	Article							HIV; HPV; PREVALENCE; ABNORMALITIES; PERSISTENCE; GENOTYPES; CYTOLOGY; IMPACT	Background: High-risk (HR) HPV genotypes other than 16 and 18 have been detected in a significant proportion of immunocompromised females. We aim to evaluate the frequency of HR HPV genotypes in a population of HIV-positive Caribbean women. Methods: One hundred sixty-seven consecutive, non-pregnant, HIV-positive females >= 18 years were recruited in this study. Each participant received a vaginal examination, PAP smear, and completed a questionnaire. DNA was extracted for HPV testing in 86 patients. Results: Mean age was 39.1 years for women positive for HR HPV and 43.1 years for women negative for HR HPV (P value = 0.040). 78% (130/167) of the women had HR HPV infections; the prevalence of abnormal cervical cytology was 38% among women who were HR HPV-positive compared to women who were HR HPV-negative (22%). Fifty-one percent of the 86 women with available genotype carried infections with HPV 16 and/or HPV 18; genotypes of unknown risk were also frequently observed. Women who had a CD4+ count of <= 200 had 7 times increased odds of carrying HR HPV infection in comparison to women with CD4+>200. Conclusions: HR HPV infections in HIV infected females may consist of more than just HPV 16 and 18, but also HPV 52 and 58. Further studies are needed to determine whether HPV 52 and 58 play a significant role in the development of cervical cytological abnormalities in HIV+ women.	[Dames, Dionne N.; Gomez, Perry] Princess Margaret Hosp, Dept Med, Nassau, Bahamas; [Blackman, Elizabeth; Ragin, Camille] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Canc Prevent & Control Program, Philadelphia, PA 19122 USA; [Butler, Raleigh; Griffith-Bowe, Andrea] Princess Margaret Hosp, Dept Obstet & Gynecol, Nassau, Bahamas; [Taioli, Emanuela] North Shore Long Isl Jewish Hofstra Sch Med, Dept Populat Hlth, Manhasset, NY USA; [Eckstein, Stacy] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Eckstein, Stacy] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Devarajan, Karthik] Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Hofstra University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fox Chase Cancer Center	Ragin, C (corresponding author), Temple Univ Hlth Syst, Fox Chase Canc Ctr, Canc Prevent & Control Program, Philadelphia, PA 19122 USA.	camille.ragin@fccc.edu		Blackman, Eric/0000-0002-9405-8435	National Cancer Institute, National Institutes of Health [R13CA130596A, P20CA132385-01, CA006927]; Commonwealth of Pennsylvania; University of Pittsburgh Graduate School of Public Health, Dean's Office; University of Pittsburgh Cancer Institute; NATIONAL CANCER INSTITUTE [P30CA006927, P20CA132385] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Commonwealth of Pennsylvania; University of Pittsburgh Graduate School of Public Health, Dean's Office; University of Pittsburgh Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Cancer Institute, National Institutes of Health [R13CA130596A, P20CA132385-01, and CA006927] and by an appropriation from the Commonwealth of Pennsylvania. This work was also supported in part by funds from the University of Pittsburgh Graduate School of Public Health, Dean's Office and the University of Pittsburgh Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DH, 2010, CURR HIV RES, V8, P493, DOI 10.2174/157016210793499240; Ahdieh L, 2001, J INFECT DIS, V184, P682, DOI 10.1086/323081; Banura C, 2008, J INFECT DIS, V197, P555, DOI 10.1086/526792; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Dames Dionne N, 2009, Infect Agent Cancer, V4 Suppl 1, pS8, DOI 10.1186/1750-9378-4-S1-S8; De Vuyst H, 2013, INT J CANCER, V133, P1441, DOI 10.1002/ijc.28131; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Luque AE, 2006, J INFECT DIS, V194, P428, DOI 10.1086/505876; Maranga Innocent O, 2013, Open Virol J, V7, P19, DOI 10.2174/1874357901307010019; Massad LS, 2001, J ACQ IMMUN DEF SYND, V27, P432, DOI 10.1097/00126334-200108150-00003; MASSAD LS, 2013, J LOW GENIT IN PRESS; Minkoff H, 1998, AM J OBSTET GYNECOL, V178, P982, DOI 10.1016/S0002-9378(98)70535-6; Moscicki AB, 2004, J INFECT DIS, V190, P37, DOI 10.1086/421467; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Patel SJ, 2013, INT J STD AIDS, V24, P221, DOI 10.1177/0956462412472446; Pista A, 2011, CLIN MICROBIOL INFEC, V17, P941, DOI 10.1111/j.1469-0691.2010.03387.x; Ragin CCR, 2007, BIOMARKERS, V12, P510, DOI 10.1080/13547500701340384; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Shrestha S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-295; WHO/ICO Information Centre on HPV and Cervical Cancer, 2007, Vaccine, V25 Suppl 3, pC1	22	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85429	10.1371/journal.pone.0085429	http://dx.doi.org/10.1371/journal.pone.0085429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465558	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000330288000014
J	Notari, L; Riera, DC; Sun, R; Bohl, JA; McLean, LP; Madden, KB; van Rooijen, N; Vanuytsel, T; Urban, JF; Zhao, AP; Shea-Donohue, T				Notari, Luigi; Riera, Diana C.; Sun, Rex; Bohl, Jennifer A.; McLean, Leon P.; Madden, Kathleen B.; van Rooijen, Nico; Vanuytsel, Tim; Urban, Joseph F., Jr.; Zhao, Aiping; Shea-Donohue, Terez			Role of Macrophages in the Altered Epithelial Function during a Type 2 Immune Response Induced by Enteric Nematode Infection	PLOS ONE			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; HELIGMOSOMOIDES-POLYGYRUS INFECTION; INDUCIBLE FACTOR-I; BRUSH-BORDER; GLUCOSE-METABOLISM; SUGAR ABSORPTION; TASTE RECEPTORS; GLUT2; EXPRESSION; LEPTIN	Parasitic enteric nematodes induce a type 2 immune response characterized by increased production of Th2 cytokines, IL-4 and IL-13, and recruitment of alternatively activated macrophages ( M2) to the site of infection. Nematode infection is associated with changes in epithelial permeability and inhibition of sodium-linked glucose absorption, but the role of M2 in these effects is unknown. Clodronate-containing liposomes were administered prior to and during nematode infection to deplete macrophages and prevent the development of M2 in response to infection with Nippostrongylus brasiliensis. The inhibition of epithelial glucose absorption that is associated with nematode infection involved a macrophage-dependent reduction in SGLT1 activity, with no change in receptor expression, and a macrophage-independent down-regulation of GLUT2 expression. The reduced transport of glucose into the enterocyte is compensated partially by an up-regulation of the constitutive GLUT1 transporter consistent with stress-induced activation of HIF-1 alpha. Thus, nematode infection results in a "lean" epithelial phenotype that features decreased SGLT1 activity, decreased expression of GLUT2 and an emergent dependence on GLUT1 for glucose uptake into the enterocyte. Macrophages do not play a role in enteric nematode infection-induced changes in epithelial barrier function. There is a greater contribution, however, of paracellular absorption of glucose to supply the energy demands of host resistance. These data provide further evidence of the ability of macrophages to alter glucose metabolism of neighboring cells.	[Notari, Luigi; Sun, Rex; Bohl, Jennifer A.; McLean, Leon P.; Zhao, Aiping; Shea-Donohue, Terez] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Notari, Luigi; Sun, Rex; Bohl, Jennifer A.; McLean, Leon P.; Zhao, Aiping; Shea-Donohue, Terez] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Riera, Diana C.] Walter Reed Army Med Ctr, Dept Pediat, Washington, DC 20307 USA; [Riera, Diana C.; Madden, Kathleen B.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, VUMC, Dept Mol Cell Biol, Amsterdam, Netherlands; [Vanuytsel, Tim] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Translat Res Ctr Gastrointestinal Disorders, Louvain, Belgium; [Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA; Vrije Universiteit Amsterdam; KU Leuven; University Hospital Leuven; United States Department of Agriculture (USDA)	Shea-Donohue, T (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	tdonohue@mbrc.maryland.edu	Van Rooijen, Nico/Z-1578-2019; Vanuytsel, Tim/O-9972-2016	Urban, Joseph/0000-0002-1590-8869; Vanuytsel, Tim/0000-0001-8728-0903	National Institutes of Health [R01-AI/DK49316, DK083418, T32 DK-067872]; U.S. Department of Agriculture CRIS Project [1235-52000-053]; Flanders research foundation (FWO, Fonds Wetenschappelijk Onderzoek); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083418, T32DK067872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture CRIS Project; Flanders research foundation (FWO, Fonds Wetenschappelijk Onderzoek); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01-AI/DK49316 (to T.S.-D.), DK083418 (to A.Z.), T32 DK-067872 (to L. P. M., J.A.B., and R. S.), by U.S. Department of Agriculture CRIS Project 1235-52000-053 (to J.F.U.) and by a grant from the Flanders research foundation (FWO, Fonds Wetenschappelijk Onderzoek) (to T. V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Omar A, 2011, DIABETES, V60, P2598, DOI 10.2337/db10-1740; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Au A, 2002, BIOCHEM J, V367, P247, DOI 10.1042/BJ20020393; Barrenetxe J, 2002, GUT, V50, P797, DOI 10.1136/gut.50.6.797; Batra A, 2010, ENDOCRINOLOGY, V151, P56, DOI 10.1210/en.2009-0565; Blum AM, 2012, J IMMUNOL, V189, P2512, DOI 10.4049/jimmunol.1102892; Boudry G, 2007, AM J PHYSIOL-REG I, V292, pR862, DOI 10.1152/ajpregu.00655.2006; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Colgan SP, 2012, ANNU REV PHYSIOL, V74, P153, DOI 10.1146/annurev-physiol-020911-153230; Corpe CP, 1996, PFLUG ARCH EUR J PHY, V432, P192, DOI 10.1007/s004240050124; Dehne N, 2010, EXP CELL RES, V316, P1179, DOI 10.1016/j.yexcr.2010.02.019; Dyer J, 1997, GUT, V41, P56, DOI 10.1136/gut.41.1.56; Fukuzumi M, 1996, INFECT IMMUN, V64, P108, DOI 10.1128/IAI.64.1.108-112.1996; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Gouyon F, 2003, J PHYSIOL-LONDON, V552, P823, DOI 10.1113/jphysiol.2003.049247; Greijer AE, 2008, VIRCHOWS ARCH, V452, P535, DOI 10.1007/s00428-008-0578-9; Halaihel N, 2000, J VIROL, V74, P9464, DOI 10.1128/JVI.74.20.9464-9470.2000; Hang L, 2010, J IMMUNOL, V185, P3184, DOI 10.4049/jimmunol.1000941; Helliwell PA, 2000, BIOCHEM J, V350, P163, DOI 10.1042/0264-6021:3500163; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Inigo C, 2007, ACTA PHYSIOL, V190, P303, DOI 10.1111/j.1748-1716.2007.01707.x; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kihira Y, 2011, INT J BIOCHEM CELL B, V43, P1602, DOI 10.1016/j.biocel.2011.07.009; Kinne RKH, 2011, HANDB EXP PHARMACOL, V203, P105, DOI 10.1007/978-3-642-17214-4_5; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Krimi RB, 2009, DIABETES, V58, P2032, DOI 10.2337/db08-1786; Lehrke M, 2004, NAT MED, V10, P126, DOI 10.1038/nm0204-126; Liu Q, 2009, INFECT IMMUN, V77, P5347, DOI 10.1128/IAI.01170-08; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Mace OJ, 2009, J PHYSIOL-LONDON, V587, P195, DOI 10.1113/jphysiol.2008.159616; MADDEN KB, 1991, J IMMUNOL, V147, P1387; Madden KB, 2002, J IMMUNOL, V169, P4417, DOI 10.4049/jimmunol.169.8.4417; Madden KB, 2002, J IMMUNOL, V172, P5616; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Morimoto M, 2006, J IMMUNOL, V176, P491, DOI 10.4049/jimmunol.176.1.491; Morimoto M, 2003, PCR PRIMER; Ochiai D, 2011, BIOCHEM BIOPH RES CO, V415, P445, DOI 10.1016/j.bbrc.2011.10.089; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Park SK, 2007, INT J ONCOL, V30, P341; Reyes JL, 2007, PARASITE IMMUNOL, V29, P609, DOI 10.1111/j.1365-3024.2007.00973.x; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Sakar Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007935; Saunders KA, 2007, INFECT IMMUN, V75, P397, DOI 10.1128/IAI.00664-06; Sekikawa S, 2003, INT J PARASITOL, V33, P1419, DOI 10.1016/S0020-7519(03)00183-8; Shay JES, 2012, SEMIN CELL DEV BIOL, V23, P389, DOI 10.1016/j.semcdb.2012.04.004; Shepherd EJ, 2004, J PHYSIOL-LONDON, V560, P281, DOI 10.1113/jphysiol.2004.072447; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Smith PD, 2005, IMMUNOL REV, V206, P149, DOI 10.1111/j.0105-2896.2005.00288.x; Sutton TL, 2008, INFECT IMMUN, V76, P4772, DOI 10.1128/IAI.00744-07; vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wong T, 2007, GASTROENTEROLOGY, V133, P1979, DOI 10.1053/j.gastro.2007.09.006; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yang ZH, 2013, INFECT IMMUN, V81, P1905, DOI 10.1128/IAI.00053-13; Yoshikawa T, 2011, HISTOCHEM CELL BIOL, V135, P183, DOI 10.1007/s00418-011-0779-1; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zhao AP, 2006, GASTROENTEROLOGY, V131, P568, DOI 10.1053/j.gastro.2006.05.013; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948	66	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e84763	10.1371/journal.pone.0084763	http://dx.doi.org/10.1371/journal.pone.0084763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465430	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000006
J	Kijanka, G; Prokopowicz, M; Schellekens, H; Brinks, V				Kijanka, Grzegorz; Prokopowicz, Malgorzata; Schellekens, Huub; Brinks, Vera			Influence of Aggregation and Route of Injection on the Biodistribution of Mouse Serum Albumin	PLOS ONE			English	Article							HUMAN INTERFERON-BETA; MULTIPLE-SCLEROSIS; GROWTH-HORMONE; IMMUNOGENICITY; BIOAVAILABILITY; ANTIBODIES; PROTEINS	Protein aggregates are a major risk factor for immunogenicity. Until now most studies on aggregate-driven immunogenicity have focused on linking physicochemical features of the aggregates to the formation of anti-drug antibodies. Lacking is however, basic knowledge on the effect of aggregation on the biodistribution and clearance of therapeutic proteins in vivo. The aim of current study was to get insight into the effect of aggregation on biodistribution in mice using different routes of administration. Fluorescently labeled stressed and unstressed mouse serum albumin was injected via different routes in mice and detected via in vivo fluorescence imaging up to 48 hrs post-injection. We found that biodistribution of stressed MSA significantly differed from its unstressed counterpart. Subcutaneous and intramuscular administration resulted in accumulation of protein at the site of injection, from which clearance of stressed MSA was considerably slower than clearance of unstressed MSA. Upon intravenous and intraperitoneal injection of stressed MSA, fluorescent "hotspots" were observed in the spleens, livers and lungs. Further and more detailed examination of biodistribution after intraperitoneal injection showed higher fluorescence in most of tested organs suggesting more efficient diffusion and/or lymphatic uptake from peritoneum of unstressed MSA than the stressed formulation.	[Kijanka, Grzegorz; Prokopowicz, Malgorzata; Schellekens, Huub; Brinks, Vera] Univ Utrecht, Dept Pharmaceut, UIPS, Utrecht, Netherlands; [Schellekens, Huub] Univ Utrecht, Dept Innovat Management, Utrecht, Netherlands	Utrecht University; Utrecht University	Brinks, V (corresponding author), Univ Utrecht, Dept Pharmaceut, UIPS, Utrecht, Netherlands.	V.Brinks@uu.nl	Prokopowicz, Małgorzata/G-6565-2014	Prokopowicz, Małgorzata/0000-0002-0160-9884	Utrecht University	Utrecht University	This study was funded by Utrecht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration. FaD. Adalimumab, 2002, PHARM REV AD PROD AP; Bertolotto A, 2000, IMMUNOPHARMACOLOGY, V48, P95, DOI 10.1016/S0162-3109(00)00182-X; Braun A, 1997, PHARMACEUT RES, V14, P1472, DOI 10.1023/A:1012193326789; Brunskill NJ, 2004, CELLULAR PROTEINS TH, P79; Drummond DC, 1999, PHARMACOL REV, V51, P691; Filipe V, 2010, AGGREGATION THERAPEU, P403; Filipe V, 2012, PHARM RES-DORDR, V29, P2202, DOI 10.1007/s11095-012-0749-x; Hermeling S, 2006, J PHARM SCI-US, V95, P1084, DOI 10.1002/jps.20599; Kijanka G, 2013, PHARM RES-DORDR, V30, P1553, DOI 10.1007/s11095-013-0992-9; Laursen T, 1996, CLIN ENDOCRINOL, V45, P333, DOI 10.1046/j.1365-2265.1996.00814.x; MOORE WV, 1980, J CLIN ENDOCR METAB, V51, P691, DOI 10.1210/jcem-51-4-691; OCKNER RK, 1983, AM J PHYSIOL, V245, pG13, DOI 10.1152/ajpgi.1983.245.1.G13; Oliveira S, 2012, MOL IMAGING, V11, P33, DOI 10.2310/7290.2011.00025; Peng A, 2012, AAPS J, V14, P35, DOI 10.1208/s12248-011-9309-2; Porter CJH, 2001, ADV DRUG DELIVER REV, V50, P157, DOI 10.1016/S0169-409X(01)00153-3; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Ross C, 2000, ANN NEUROL, V48, P706, DOI 10.1002/1531-8249(200011)48:5<706::AID-ANA3>3.3.CO;2-M; Schellekens H, 2005, NEPHROL DIAL TRANSPL, V20, P3, DOI 10.1093/ndt/gfh1092; Schellekens H, 2004, J NEUROL, V251, P4, DOI 10.1007/s00415-004-1202-9; Singh SK, 2011, J PHARM SCI, V100, P4; Srinivas NR, 1997, PHARM RES-DORDR, V14, P911, DOI 10.1023/A:1012156001831; van Beers MMC, 2010, J INTERF CYTOK RES, V30, P767, DOI 10.1089/jir.2010.0086	22	21	21	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85281	10.1371/journal.pone.0085281	http://dx.doi.org/10.1371/journal.pone.0085281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465523	Green Published, gold			2022-12-25	WOS:000330283100034
J	Chen, C; Liu, Q; Hao, Q; Xu, B; Ma, C; Zhang, HJ; Shen, QJ; Lu, JP				Chen, Chao; Liu, Qi; Hao, Qiang; Xu, Bing; Ma, Chao; Zhang, Huojun; Shen, Qianjin; Lu, Jianping			Study of 320-Slice Dynamic Volume CT Perfusion in Different Pathologic Types of Kidney Tumor: Preliminary Results	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; MINIMAL FAT DIFFERENTIATION; HELICAL CT; ANGIOMYOLIPOMA; SUBTYPES; HETEROGENEITY; NEOPLASMS; DIAGNOSIS; PHASE	Objective: To investigate microcirculatory differences between pathologic types of kidney tumor using 320-slice dynamic volume CT perfusion. Methods: Perfusion imaging with 320-slice dynamic volume CT was prospectively performed in 85 patients with pathologically proven clear cell renal cell carcinoma (RCC) (n = 66), papillary RCC (n = 7), chromophobe RCC (n = 5), angiomyolipoma (AML) with minimal fat (n = 7), or RCC (n = 78). Equivalent blood volume (Equiv BV), permeability surface-area product (PS; clearance/unit volume = permeability), and blood flow (BF) of tumor and normal renal cortex were measured and analyzed. Effective radiation dose was calculated. Results: There was a significant difference in all three parameters between tumor and normal renal cortex (P<0.001). Equiv BV was significantly different between RCC and AML with minimal fat (P = 0.038) and between clear cell RCC and AML with minimal fat (P<0.001). Mean Equiv BV and BF were significantly higher in clear cell RCC than in papillary RCC (P<0.001 for both) and mean Equiv BV was higher in clear cell RCC than in chromophobe RCC (P<0.001). The effective radiation dose of the CT perfusion protocol was 18.5 mSv. Conclusion: Perfusion imaging using 320-slice dynamic volume CT can be used to evaluate hemodynamic features of the whole kidney and kidney tumors, which may be useful in the differential diagnosis of these four pathologic types of kidney tumor.	[Chen, Chao; Liu, Qi; Hao, Qiang; Xu, Bing; Ma, Chao; Zhang, Huojun; Shen, Qianjin; Lu, Jianping] Second Mil Med Univ, Changhai Hosp Shang Hai, Dept Radiol, Shanghai, Peoples R China	Naval Medical University	Lu, JP (corresponding author), Second Mil Med Univ, Changhai Hosp Shang Hai, Dept Radiol, Shanghai, Peoples R China.	cjr.lujianping@vip.163.com		Ma, Chao/0000-0002-2473-387X	Changhai Hospital of Shanghai [CH125520800, CH125520303]; Youth Scientific Research Funds of Changhai Hospital	Changhai Hospital of Shanghai; Youth Scientific Research Funds of Changhai Hospital	This work was supported by the "1255 Academic Discipline Project of Changhai Hospital of Shanghai (CH125520800, CH125520303) and Youth Scientific Research Funds of Changhai Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Said J, 2010, SAUDI J KIDNEY DIS T, V21, P123; BOSNIAK MA, 1988, AM J ROENTGENOL, V151, P497, DOI 10.2214/ajr.151.3.497; Chen Y, 2010, ABDOM IMAGING, V35, P622, DOI 10.1007/s00261-009-9565-0; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Eberhard A, 2000, CANCER RES, V60, P1388; Goh V, 2012, INVEST RADIOL, V47, P2, DOI 10.1097/RLI.0b013e318229ff3e; Helck A, 2010, INVEST RADIOL, V45, P387, DOI 10.1097/RLI.0b013e3181e332d0; Helenon O, 2012, Diagn Interv Imaging, V93, P232, DOI 10.1016/j.diii.2012.01.016; Helenon O, 1997, RADIOGRAPHICS, V17, P129, DOI 10.1148/radiographics.17.1.9017804; Herts BR, 2002, AM J ROENTGENOL, V178, P367, DOI 10.2214/ajr.178.2.1780367; Jiang T, 2012, INVEST RADIOL, V47, P11, DOI 10.1097/RLI.0b013e3182199bb5; Jin HW, 2006, AM J ROENTGENOL, V186, P1423, DOI 10.2214/AJR.04.1408; Jinzaki M, 2000, J COMPUT ASSIST TOMO, V24, P835, DOI 10.1097/00004728-200011000-00002; Jinzaki M, 1997, RADIOLOGY, V205, P497, DOI 10.1148/radiology.205.2.9356635; Jung SC, 2012, ACTA RADIOL, V53, P112, DOI 10.1258/ar.2011.110221; Kambadakone AR, 2011, EUR RADIOL, V21, P1293, DOI 10.1007/s00330-010-2048-4; Kandel S, 2009, EUR RADIOL, V19, P2641, DOI 10.1007/s00330-009-1453-z; Kim JK, 2004, RADIOLOGY, V230, P677, DOI 10.1148/radiol.2303030003; Kim JK, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781499; Lam JS, 2005, J UROLOGY, V173, P1853, DOI 10.1097/01.ju.0000165693.68449.c3; MCCLENNAN BL, 1994, RADIOL CLIN N AM, V32, P55; MILES KA, 1994, INVEST RADIOL, V29, P911, DOI 10.1097/00004424-199410000-00008; MILES KA, 1991, BRIT J RADIOL, V64, P409, DOI 10.1259/0007-1285-64-761-409; Miles KA, 2003, BRIT J RADIOL, V76, pS36, DOI 10.1259/bjr/18486642; Miles KA, 2003, BRIT J RADIOL, V76, P220, DOI 10.1259/bjr/13564625; Ng CS, 2010, AM J ROENTGENOL, V194, P166, DOI 10.2214/AJR.09.3105; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Paul JF, 2001, RADIOLOGY, V221, P261, DOI 10.1148/radiol.2211001558; PRESS GA, 1984, AM J ROENTGENOL, V143, P1005, DOI 10.2214/ajr.143.5.1005; Reiner CS, 2012, INVEST RADIOL, V47, P33, DOI 10.1097/RLI.0b013e31822598c3; Ruppert-Kohlmayr AJ, 2004, AM J ROENTGENOL, V183, P1387, DOI 10.2214/ajr.183.5.1831387; SANT GR, 1984, UROLOGY, V24, P293, DOI 10.1016/0090-4295(84)90365-0; Sasiwimonphan K, 2012, RADIOLOGY, V263, P160, DOI 10.1148/radiol.12111205; Schrader AJ, 2008, BJU INT, V101, P1343, DOI 10.1111/j.1464-410X.2008.07462.x; Shamalov NA, 2012, ZH NEVROL PSIKHIATR, V112, P3; Sheir KZ, 2005, J UROLOGY, V174, P451, DOI 10.1097/01.ju.0000165341.08396.a9; Squillaci E, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-138; Sun MRM, 2009, RADIOLOGY, V250, P793, DOI 10.1148/radiol.2503080995; Valentin Jack, 2007, Annals of the ICRP, V37, P3; Yan G, 2011, CHINESE GERMAN J CLI, V10, P35; Yilmaz O, 2009, J PEDIATR SURG, V44, P1977, DOI 10.1016/j.jpedsurg.2009.01.072; Young JR, 2013, RADIOLOGY, V267, P444, DOI 10.1148/radiol.13112617; Zhang J, 2007, RADIOLOGY, V244, P494, DOI 10.1148/radiol.2442060927; Zhang YY, 2013, CLIN RADIOL, V68, P365, DOI 10.1016/j.crad.2012.08.028; Zhao XJ, 2013, CHINESE MED J-PEKING, V126, P991, DOI 10.3760/cma.j.issn.0366-6999.20120672	45	32	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85522	10.1371/journal.pone.0085522	http://dx.doi.org/10.1371/journal.pone.0085522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465588	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500070
J	Song, YJC; Korgaonkar, MS; Armstrong, LV; Eagles, S; Williams, LM; Grieve, SM				Song, Yun Ju C.; Korgaonkar, Mayuresh S.; Armstrong, Lucy V.; Eagles, Sarah; Williams, Leanne M.; Grieve, Stuart M.			Tractography of the Brainstem in Major Depressive Disorder Using Diffusion Tensor Imaging	PLOS ONE			English	Article							VAGUS NERVE-STIMULATION; PREDICT OPTIMIZED TREATMENT; CONNECTIVITY; AMYGDALA; NUCLEUS; STRESS; ACTIVATION; MECHANISMS; PROTOCOL; NEURONS	Background: The brainstem is the main region that innervates neurotransmitter release to the Hypothalamic-Pituitary Adrenal (HPA) axis and fronto-limbic circuits, two key brain circuits found to be dysfunctional in Major Depressive Disorder (MDD). However, the brainstem's role in MDD has only been evaluated in limited reports. Using Diffusion Tensor Imaging (DTI), we investigated whether major brainstem white matter tracts that relate to these two circuits differ in MDD patients compared to healthy controls. Methods: MDD patients (n = 95) and age-and gender-matched controls (n = 34) were assessed using probabilistic tractography of DTI to delineate three distinct brainstem tracts: the nigrostriatal tract (connecting brainstem to striatum), solitary tract (connecting brainstem to amygdala) and corticospinal tract (connecting brainstem to precentral cortex). Fractional anisotropy (FA) was used to measure the white matter integrity of these tracts, and measures were compared between MDD and control participants. Results: MDD participants were characterized by a significant and specific decrease in white matter integrity of the right solitary tract (p<0.009 using independent t-test), which is a "bottom up'' afferent pathway that connects the brainstem to the amygdala. This decrease was not related to symptom severity. Conclusions: The results provide new evidence to suggest that structural connectivity between the brainstem and the amygdala is altered in MDD. These results are interesting in light of predominant theories regarding amygdala-mediated emotional reactivity observed in functional imaging studies of MDD. The characterization of altered white matter integrity in the solitary tract in MDD supports the possibility of dysfunctional brainstem-amygdala connectivity impacting vulnerable circuits in MDD.	[Song, Yun Ju C.; Korgaonkar, Mayuresh S.; Armstrong, Lucy V.; Eagles, Sarah; Williams, Leanne M.; Grieve, Stuart M.] Univ Sydney, Sydney Med Sch, Brain Dynam Ctr, Sydney, NSW 2006, Australia; [Song, Yun Ju C.; Korgaonkar, Mayuresh S.; Armstrong, Lucy V.; Eagles, Sarah; Williams, Leanne M.; Grieve, Stuart M.] Westmead Millennium Inst, Sydney, NSW, Australia; [Song, Yun Ju C.; Korgaonkar, Mayuresh S.; Williams, Leanne M.] Univ Sydney, Westmead Hosp, Sydney Med Sch, Discipline Psychiat, Sydney, NSW 2006, Australia; [Williams, Leanne M.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Stanford University	Grieve, SM (corresponding author), Univ Sydney, Sydney Med Sch, Brain Dynam Ctr, Sydney, NSW 2006, Australia.	sgrieve@med.usyd.edu.au	Williams, Leanne/GLU-4975-2022; Williams, Leanne M/B-4095-2012; Korgaonkar, Mayuresh/K-7447-2014; Grieve, Stuart/A-5093-2012	Williams, Leanne/0000-0001-9987-7360; Korgaonkar, Mayuresh/0000-0002-1339-2221; Grieve, Stuart/0000-0002-2712-157X	Brain Resource Company Operations Pty Ltd.	Brain Resource Company Operations Pty Ltd.	This study was sponsored by the Brain Resource Company Operations Pty Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2010, PSYCHIAT RES-NEUROIM, V181, P64, DOI 10.1016/j.pscychresns.2009.07.007; Ahdidan J, 2011, ACTA PSYCHIAT SCAND, V123, P211, DOI 10.1111/j.1600-0447.2010.01644.x; Aihara M, 2007, PSYCHIAT RES-NEUROIM, V155, P245, DOI 10.1016/j.pscychresns.2006.11.002; Arnold JF, 2012, PSYCHIAT RES-NEUROIM, V204, P40, DOI 10.1016/j.pscychresns.2012.07.010; Barnes A, 2003, EUR J NUCL MED MOL I, V30, P301, DOI 10.1007/s00259-002-1026-8; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Berry SM, 2013, MED DEVICES-EVID RES, V6, P17, DOI 10.2147/MDER.S41017; Blier P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0536; Blood AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013945; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Commons KG, 2003, NEUROPSYCHOPHARMACOL, V28, P206, DOI 10.1038/sj.npp.1300045; Curtis AL, 2002, J NEUROENDOCRINOL, V14, P667, DOI 10.1046/j.1365-2826.2002.00821.x; Drevets WC, 2002, PHARMACOL BIOCHEM BE, V71, P431, DOI 10.1016/S0091-3057(01)00687-6; GRAY TS, 1993, ANN NY ACAD SCI, V697, P53, DOI 10.1111/j.1749-6632.1993.tb49922.x; Grieve SM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-224; Karavidas MK, 2007, APPL PSYCHOPHYS BIOF, V32, P19, DOI 10.1007/s10484-006-9029-z; Korgaonkar MS, 2012, NEUROREPORT, V23, P566, DOI 10.1097/WNR.0b013e3283546264; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; Krahl SE, 1998, EPILEPSIA, V39, P709, DOI 10.1111/j.1528-1157.1998.tb01155.x; Lee HY, 2011, J AFFECT DISORDERS, V133, P128, DOI 10.1016/j.jad.2011.04.006; Lemos JC, 2012, NATURE, V490, P402, DOI 10.1038/nature11436; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Morimoto M, 1996, NEUROSCI RES, V26, P235, DOI 10.1016/S0168-0102(96)01105-4; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Nemeroff CB, 2006, NEUROPSYCHOPHARMACOL, V31, P1345, DOI 10.1038/sj.npp.1301082; Schutter DJLG, 2012, MED HYPOTHESES, V79, P779, DOI 10.1016/j.mehy.2012.08.027; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; SHAH SA, 1992, ACTA PSYCHIAT SCAND, V85, P474, DOI 10.1111/j.1600-0447.1992.tb03214.x; Soriano-Mas C, 2011, BIOL PSYCHIAT, V69, P318, DOI 10.1016/j.biopsych.2010.07.029; Sperling W, 2010, PHARMACOPSYCHIATRY, V43, P7, DOI 10.1055/s-0029-1237374; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van Marle HJF, 2010, NEUROIMAGE, V53, P348, DOI 10.1016/j.neuroimage.2010.05.070; Wang JJ, 2001, ANN NY ACAD SCI, V940, P237; Watson S., 2006, PSYCHIATRY, V5, P166, DOI [DOI 10.1383/PSYT.2006.5.5.166, 10.1383/psyt.2006.5.5.166]; Williams LM, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-4; Zobel A, 2005, PSYCHIAT RES-NEUROIM, V139, P165, DOI 10.1016/j.pscychresns.2005.02.010	36	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84825	10.1371/journal.pone.0084825	http://dx.doi.org/10.1371/journal.pone.0084825			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465436	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500016
J	Noonan, MJ; Markham, A; Newman, C; Trigoni, N; Buesching, CD; Ellwood, SA; Macdonald, DW				Noonan, Michael J.; Markham, Andrew; Newman, Chris; Trigoni, Niki; Buesching, Christina D.; Ellwood, Stephen A.; Macdonald, David W.			Climate and the Individual: Inter-Annual Variation in the Autumnal Activity of the European Badger (Meles meles)	PLOS ONE			English	Article							FOOD AVAILABILITY; BODY-MASS; SPATIAL-ORGANIZATION; REPRODUCTIVE SUCCESS; POPULATION-DYNAMICS; LIFE-HISTORIES; ACCELERATION; BEHAVIOR; DENSITY; PATTERNS	We establish intra-individual and inter-annual variability in European badger (Meles meles) autumnal nightly activity in relation to fine-scale climatic variables, using tri-axial accelerometry. This contributes further to understanding of causality in the established interaction between weather conditions and population dynamics in this species. Modelling found that measures of daylight, rain/humidity, and soil temperature were the most supported predictors of ACTIVITY, in both years studied. In 2010, the drier year, the most supported model included the SOLAR*RH interaction, RAIN, and30cmTEMP (w=0.557), while in 2012, a wetter year, the most supported model included the SOLAR*RH interaction, and the RAIN*10cmTEMP (w=0.999). ACTIVITY also differed significantly between individuals. In the 2012 autumn study period, badgers with the longest per noctem activity subsequently exhibited higher Body Condition Indices (BCI) when recaptured. In contrast, under drier 2010 conditions, badgers in good BCI engaged in less per noctem activity, while badgers with poor BCI were the most active. When compared on the same calendar dates, to control for night length, duration of mean badger nightly activity was longer (9.5 hrs 63.3 SE) in 2010 than in 2012 (8.3 hrs 61.9 SE). In the wetter year, increasing nightly activity was associated with net-positive energetic gains (from BCI), likely due to better foraging conditions. In a drier year, with greater potential for net-negative energy returns, individual nutritional state proved crucial in modifying activity regimes; thus we emphasise how a 'one size fits all' approach should not be applied to ecological responses.	[Noonan, Michael J.; Newman, Chris; Buesching, Christina D.; Ellwood, Stephen A.; Macdonald, David W.] Univ Oxford, Wildlife Conservat Res Unit, Dept Zool, Recanati Kaplan Ctr, Tubney, Oxon, England; [Markham, Andrew; Trigoni, Niki] Univ Oxford, Dept Comp Sci, Tubney, Oxon, England	University of Oxford; University of Oxford	Macdonald, DW (corresponding author), Univ Oxford, Wildlife Conservat Res Unit, Dept Zool, Recanati Kaplan Ctr, Tubney House, Tubney, Oxon, England.	david.macdonald@zoo.ox.ac.uk	Noonan, Michael J/H-9613-2019	Markham, Andrew/0000-0001-5716-3941; Trigoni, Niki/0000-0001-6236-9645	Peoples Trust for Endangered Species; Rhodes Trust; NSERC; EPSRC C-DIP postdoctoral fellowship [3D EP/I026959/1]; EPSRC [EP/E013678/1, EP/I026959/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E013678/1, EP/I026959/1] Funding Source: researchfish	Peoples Trust for Endangered Species; Rhodes Trust; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); EPSRC C-DIP postdoctoral fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The Peoples Trust for Endangered Species generously supported much of this core study. MJN is supported by the Rhodes Trust and an NSERC postgraduate scholarship. ACM is supported by an EPSRC C-DIP postdoctoral fellowship (EPSRC Undertracker: Underground Animal Tracking and Mapping in 3D EP/I026959/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.R., 2008, MODEL BASED INFERENC; [Anonymous], 1987, SYM ZOOL SOC; Barclay RMR, 2001, CAN J ZOOL, V79, P1885, DOI 10.1139/cjz-79-10-1885; Barth JAC, 1999, CHEM GEOL, V159, P107, DOI 10.1016/S0009-2541(99)00036-4; Blank James L., 1992, P186; BOYCE MS, 1979, AM NAT, V114, P569, DOI 10.1086/283503; BOYLE K, 1990, Irish Naturalists' Journal, V23, P199; Buesching CD, 2003, BEHAVIOUR, V140, P965, DOI 10.1163/156853903322589597; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Byrne AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050807; Campbell RD, 2013, GLOBAL CHANGE BIOL, V19, P1311, DOI 10.1111/gcb.12114; CASWELL H, 1982, ECOLOGY, V63, P1218, DOI 10.2307/1938846; Catalan J, 2002, J PALEOLIMNOL, V28, P125; CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; DASILVA J, 1993, OECOLOGIA, V95, P558, DOI 10.1007/BF00317441; Do Linh San E, 2007, CAN J ZOOL, V85, P973, DOI 10.1139/Z07-085; Dugdale HL, 2007, MOL ECOL, V16, P5294, DOI 10.1111/j.1365-294X.2007.03571.x; Dyo V., 2010, P 8 ACM C EMBEDDED N, P127, DOI DOI 10.1145/1869983.1869997; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Ellwood Stephen A., 2006, P105; Ferguson SH, 2004, J ZOOL, V262, P125, DOI 10.1017/S0952836903004552; Fero O, 2008, ECOL APPL, V18, P1563, DOI 10.1890/07-1012.1; Fisher N, 2010, WYTHAM WOODS: OXFORD'S ECOLOGICAL LABORATORY, P197; FOWLER PA, 1988, J ZOOL, V214, P635, DOI 10.1111/j.1469-7998.1988.tb03763.x; GAEDKE U, 1994, MARINE MICROBIAL FOOD WEBS, 1994, VOL 8, NO 1 AND 2, P163; Giroud Sylvain, 2012, P481; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Goransson G, 1983, ACTA ZOOL FENN, V174, P179; Goszczynski J, 2000, J ZOOL, V250, P495, DOI 10.1111/j.1469-7998.2000.tb00792.x; Greco S, 1996, GLOBAL CHANGE BIOL, V2, P183, DOI 10.1111/j.1365-2486.1996.tb00071.x; HARLOW HJ, 1981, PHYSIOL ZOOL, V54, P267, DOI 10.1086/physzool.54.3.30159941; Hays GC, 2007, J ANIM ECOL, V76, P183, DOI 10.1111/j.1365-2656.2006.01181.x; HOFER H, 1988, MAMMAL REV, V18, P25, DOI 10.1111/j.1365-2907.1988.tb00068.x; Holmstrup M, 1996, COMP BIOCHEM PHYS A, V115, P91, DOI 10.1016/0300-9629(96)00010-2; Huxman TE, 2003, OECOLOGIA, V134, P537, DOI 10.1007/s00442-002-1131-1; Ishii HT, 2004, FOREST SCI, V50, P342; Johnson DDP, 2002, J BIOGEOGR, V29, P411, DOI 10.1046/j.1365-2699.2002.00680.x; Johnson DDP, 2001, BMC ECOL, V2, P1, DOI DOI 10.1186/1472-6785-1-2; Kaneko Yayoi, 2010, International Journal of Ecology, V2010, P1; Kilshaw K, 2009, J MAMMAL, V90, P1188, DOI 10.1644/08-MAMM-A-200.1; KIMMEL E, 1991, J AGR ENG RES, V49, P227, DOI 10.1016/0021-8634(91)80041-C; King D, 2005, J APPL ECOL, V42, P779, DOI 10.1111/j.1365-2664.2005.01089.x; Kowalczyk R, 2004, ACTA THERIOL, V49, P75, DOI 10.1007/BF03192510; Kowalczyk R, 2003, J BIOGEOGR, V30, P463, DOI 10.1046/j.1365-2699.2003.00804.x; KRUUK H, 1981, J ANIM ECOL, V50, P773, DOI 10.2307/4136; KRUUK H, 1985, J APPL ECOL, V22, P705, DOI 10.2307/2403223; Kruuk H., 1989, SOCIAL BADGER; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; Lenart EA, 2002, CAN J ZOOL, V80, P664, DOI 10.1139/Z02-034; Lima SL, 1998, ADV STUD BEHAV, V27, P215; Macdonald D.W., 1983, P393; Macdonald DW, 2010, GLOBAL CHANGE BIOL, V16, P2913, DOI 10.1111/j.1365-2486.2010.02208.x; Macdonald DW, 2009, J MAMMAL, V90, P1392, DOI 10.1644/08-MAMM-A-356R1.1; MACDONALD DW, 1976, Z TIERPSYCHOL, V42, P170; Macdonald DW, 2002, J ZOOL, V256, P121, DOI 10.1017/S0952836902000158; Macdonald DW, 2002, ECOLOGY, V83, P2056, DOI 10.2307/3071787; Markham A, 2012, IEEE SENS J, V12, P1809, DOI 10.1109/JSEN.2011.2178064; MAY RM, 1986, PROC R SOC SER B-BIO, V228, P241, DOI 10.1098/rspb.1986.0054; McDermott R, 2008, J POLIT, V70, P335, DOI 10.1017/S0022381608080341; McLaren GW, 2005, VET ANAESTH ANALG, V32, P48, DOI 10.1111/j.1467-2995.2004.00182.x; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Muldowney J, 2003, PEDOBIOLOGIA, V47, P913, DOI 10.1016/S0031-4056(04)70289-9; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Newman C, 2013, TERRESTRIAL BIODIVER; Newman C, 2011, MAMM STUDY, V36, P169, DOI 10.3106/041.036.0401; Nouvellet P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068116; Nuutinen V, 2009, SOIL BIOL BIOCHEM, V41, P1580, DOI 10.1016/j.soilbio.2009.04.019; Okuyama Junichi, 2010, Endangered Species Research, V10, P39, DOI 10.3354/esr00215; OWEN M, 1992, ORNIS SCAND, V23, P451, DOI 10.2307/3676676; Palphramand KL, 2007, BEHAV ECOL SOCIOBIOL, V61, P401, DOI 10.1007/s00265-006-0268-z; Post DM, 2006, FUNCT ECOL, V20, P717, DOI 10.1111/j.1365-2435.2006.01142.x; Post Eric, 1999, Ecological Bulletins, V47, P117; Revilla E, 2002, J ANIM ECOL, V71, P497, DOI 10.1046/j.1365-2656.2002.00617.x; Roff Derek, 2002, pi; Ropert-Coudert Y, 2009, J AVIAN BIOL, V40, P380, DOI 10.1111/j.1600-048X.2008.04592.x; SANDELL M, 1990, Q REV BIOL, V65, P23, DOI 10.1086/416583; Shamoun-Baranes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037997; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Stewart PD, 2001, J ZOOL, V255, P191, DOI 10.1017/S0952836901001261; Thornton PD, 2005, VET ANAESTH ANALG, V32, P40, DOI 10.1111/j.1467-2995.2004.00163.x; THORNTON PS, 1988, MAMMAL REV, V18, P11, DOI 10.1111/j.1365-2907.1988.tb00066.x; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Tinkler E, 2009, J ZOOL, V278, P313, DOI 10.1111/j.1469-7998.2009.00578.x; Tuljapurkar S, 2010, J ANIM ECOL, V79, P1, DOI 10.1111/j.1365-2656.2009.01619.x; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; WEBB DR, 1984, J THERM BIOL, V9, P189, DOI 10.1016/0306-4565(84)90020-2; Whitney Nicholas M., 2010, Endangered Species Research, V10, P71, DOI 10.3354/esr00247; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; WOODROFFE R, 1995, J ZOOL, V236, P183, DOI 10.1111/j.1469-7998.1995.tb04486.x; WOODROFFE R, 1995, J ANIM ECOL, V64, P12, DOI 10.2307/5823; Yamaguchi N, 2006, Q REV BIOL, V81, P33, DOI 10.1086/503923; Yoda K, 1999, J EXP BIOL, V202, P3121	95	41	41	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e83156	10.1371/journal.pone.0083156	http://dx.doi.org/10.1371/journal.pone.0083156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465376	Green Submitted, Green Published, gold			2022-12-25	WOS:000330237000005
J	Roy, AH; Rhea, LK; Mayer, AL; Shuster, WD; Beaulieu, JJ; Hopton, ME; Morrison, MA; St Amand, A				Roy, Allison H.; Rhea, Lee K.; Mayer, Audrey L.; Shuster, William D.; Beaulieu, Jake J.; Hopton, Matthew E.; Morrison, Matthew A.; St Amand, Ann			How Much Is Enough? Minimal Responses of Water Quality and Stream Biota to Partial Retrofit Stormwater Management in a Suburban Neighborhood	PLOS ONE			English	Article							IMPACT DEVELOPMENT PRACTICES; ENVIRONMENTAL IMPACTS; COMMUNITY STRUCTURE; RESTORATION; SYSTEMS; SCALE; BIORETENTION; ECOLOGY; RUNOFF; BACI	Decentralized stormwater management approaches (e. g., biofiltration swales, pervious pavement, green roofs, rain gardens) that capture, detain, infiltrate, and filter runoff are now commonly used to minimize the impacts of stormwater runoff from impervious surfaces on aquatic ecosystems. However, there is little research on the effectiveness of retrofit, parcel-scale stormwater management practices for improving downstream aquatic ecosystem health. A reverse auction was used to encourage homeowners to mitigate stormwater on their property within the suburban, 1.8 km(2) Shepherd Creek catchment in Cincinnati, Ohio (USA). In 2007-2008, 165 rain barrels and 81 rain gardens were installed on 30% of the properties in four experimental (treatment) subcatchments, and two additional subcatchments were maintained as controls. At the base of the subcatchments, we sampled monthly baseflow water quality, and seasonal (5x/year) physical habitat, periphyton assemblages, and macroinvertebrate assemblages in the streams for the three years before and after treatment implementation. Given the minor reductions in directly connected impervious area from the rain barrel installations (11.6% to 10.4% in the most impaired subcatchment) and high total impervious levels (13.1% to 19.9% in experimental subcatchments), we expected minor or no responses of water quality and biota to stormwater management. There were trends of increased conductivity, iron, and sulfate for control sites, but no such contemporaneous trends for experimental sites. The minor effects of treatment on streamflow volume and water quality did not translate into changes in biotic health, and the few periphyton and macroinvertebrate responses could be explained by factors not associated with the treatment (e.g., vegetation clearing, drought conditions). Improvement of overall stream health is unlikely without additional treatment of major impervious surfaces (including roads, apartment buildings, and parking lots). Further research is needed to define the minimum effect threshold and restoration trajectories for retrofitting catchments to improve the health of stream ecosystems.	[Roy, Allison H.] Univ Massachusetts, US Geol Survey, Massachusetts Cooperat Fish & Wildlife Res Unit, Amherst, MA 01003 USA; [Rhea, Lee K.; Shuster, William D.; Beaulieu, Jake J.; Hopton, Matthew E.] US EPA, Off Res & Dev, Cincinnati, OH 45268 USA; [Mayer, Audrey L.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Mayer, Audrey L.] Michigan Technol Univ, Dept Social Sci, Houghton, MI 49931 USA; [Morrison, Matthew A.] SABIC, Mt Vernon, IN USA; [St Amand, Ann] PhycoTech Inc, St Joseph, MI USA	United States Department of the Interior; United States Geological Survey; University of Massachusetts System; University of Massachusetts Amherst; United States Environmental Protection Agency; Michigan Technological University; Michigan Technological University	Roy, AH (corresponding author), Univ Massachusetts, US Geol Survey, Massachusetts Cooperat Fish & Wildlife Res Unit, Amherst, MA 01003 USA.	aroy@eco.umass.edu	Hopton, Matthew E/E-4464-2018; Mayer, AL/AAO-3225-2020; Hopton, Matt/AAX-9079-2020	Hopton, Matthew E/0000-0001-7962-6820; Mayer, AL/0000-0003-3278-1182; Hopton, Matt/0000-0001-7962-6820; Shuster, William/0000-0001-7688-0110	U.S. Environmental Protection Agency (USEPA) through the Office of Research and Development (ORD); Pegasus Technical Services, Inc. under EPA [EP-C-05-056]; USEPA's ORD under the Scientific, Technical, Research, Engineering and Modeling Support (STREAMS) [EP-C-05-061]; USEPA's ORD through simplified acquisitions [3C-R312-TTSA, EP10C000111, EP05C00134]; Rhithron Associates, Inc. [EP07C000170, EP10C000110]	U.S. Environmental Protection Agency (USEPA) through the Office of Research and Development (ORD); Pegasus Technical Services, Inc. under EPA; USEPA's ORD under the Scientific, Technical, Research, Engineering and Modeling Support (STREAMS); USEPA's ORD through simplified acquisitions; Rhithron Associates, Inc.	The project was largely funded by the U.S. Environmental Protection Agency (USEPA) through the Office of Research and Development (ORD). Field sampling was conducted by USEPA employees and volunteers and supported in part by Pegasus Technical Services, Inc. under EPA Contract # EP-C-05-056. The auction, installation, and maintenance of rain gardens and rain barrels was funded by the USEPA's ORD under the Scientific, Technical, Research, Engineering and Modeling Support (STREAMS) contract EP-C-05-061, Task Order 8 to TetraTech, Inc. Biotic identification was funded by the USEPA's ORD through simplified acquisitions to PhycoTech, Inc. in 2003-2004 (3C-R312-TTSA) and 2007-2010 (EP10C000111), to EnviroScience, Inc. in 2005-06 (EP05C00134), and Rhithron Associates, Inc. in 2007-2010 (EP07C000170 and EP10C000110). As such, the funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahiablame LM, 2012, WATER AIR SOIL POLL, V223, P4253, DOI 10.1007/s11270-012-1189-2; Alig RJ, 2004, LANDSCAPE URBAN PLAN, V69, P219, DOI 10.1016/j.landurbplan.2003.07.004; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; American Society for Testing and Materials (ASTM), 1997, STAND TEST METH DET; Ando AW, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR011070; ARAR E. J, 1997, 4460 US EPA; Arnscheidt J, 2007, SCI TOTAL ENVIRON, V382, P1, DOI 10.1016/j.scitotenv.2007.03.036; Barbour MT, 1999, RAPID BIOASSESSMENT, V2nd; Beaulieu JJ, 2013, FRESHWATER BIOL, DOI [10.111/fwb12097, DOI 10.111/FWB12097]; Bedan ES, 2009, J AM WATER RESOUR AS, V45, P998, DOI 10.1111/j.1752-1688.2009.00342.x; Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447; Bernhardt ES, 2007, FRESHWATER BIOL, V52, P738, DOI 10.1111/j.1365-2427.2006.01718.x; Booth DB, 1997, J AM WATER RESOUR AS, V33, P1077, DOI 10.1111/j.1752-1688.1997.tb04126.x; Bradley DC, 2001, J ANIM ECOL, V70, P987, DOI 10.1046/j.0021-8790.2001.00551.x; Burns MJ, 2012, LANDSCAPE URBAN PLAN, V105, P230, DOI 10.1016/j.landurbplan.2011.12.012; Clarke A, 2010, CAN J FISH AQUAT SCI, V67, P1649, DOI 10.1139/F10-087; Davis AP, 2009, J ENVIRON ENG, V135, P109, DOI 10.1061/(ASCE)0733-9372(2009)135:3(109); DENICOLA DM, 1992, J N AM BENTHOL SOC, V11, P391; Dietz ME, 2007, WATER AIR SOIL POLL, V186, P351, DOI 10.1007/s11270-007-9484-z; FAITH DP, 1991, AUST J MAR FRESH RES, V42, P589; Fletcher TD, 2011, WATER SCI TECHNOL, V64, P494, DOI 10.2166/wst.2011.184; Gilroy KL, 2009, J HYDROL, V367, P228, DOI 10.1016/j.jhydrol.2009.01.008; Green R. H., 1979, Sampling design and statistical methods for environmental biologists.; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hamilton SK, 2012, FRESHWATER BIOL, V57, P43, DOI 10.1111/j.1365-2427.2011.02685.x; Hatt BE, 2009, J HYDROL, V365, P310, DOI 10.1016/j.jhydrol.2008.12.001; Hill BH, 2000, J N AM BENTHOL SOC, V19, P50, DOI 10.2307/1468281; Hunt WF, 2012, J ENVIRON ENG, V138, P698, DOI 10.1061/(ASCE)EE.1943-7870.0000504; Jackson JK, 2006, FRESHWATER BIOL, V51, P591, DOI 10.1111/j.1365-2427.2006.01503.x; Kaushal SS, 2012, URBAN ECOSYST, V15, P409, DOI 10.1007/s11252-012-0226-7; King RS, 2010, J N AM BENTHOL SOC, V29, P998, DOI 10.1899/09-144.1; Konrad CP, 2005, AM FISH S S, V47, P157; Lee JG, 2012, ENVIRON MODELL SOFTW, V37, P6, DOI 10.1016/j.envsoft.2012.04.011; Lepori F, 2005, ECOL APPL, V15, P2060, DOI 10.1890/04-1372; Li H, 2009, J HYDROL ENG, V14, P407, DOI 10.1061/(ASCE)1084-0699(2009)14:4(407); Line DE, 2012, J ENVIRON ENG-ASCE, V138, P680, DOI 10.1061/(ASCE)EE.1943-7870.0000515; Louhi P, 2011, ECOL APPL, V21, P1950, DOI 10.1890/10-0591.1; Mayer AL, 2012, ENVIRON PRAC, V14, P57, DOI 10.1017/S1466046611000494; Meals DW, 2010, J ENVIRON QUAL, V39, P85, DOI 10.2134/jeq2009.0108; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; *OH ENV PROT AG, 2002, FIELD EV MAN OH PRIM; Palmer MA, 2010, FRESHWATER BIOL, V55, P205, DOI 10.1111/j.1365-2427.2009.02372.x; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Perez-Pedini C, 2005, J WATER RES PLAN MAN, V131, P441, DOI 10.1061/(ASCE)0733-9496(2005)131:6(441); PhycoTech, 2011, TECHN APPR ALG ID; POFF NL, 1989, CAN J FISH AQUAT SCI, V46, P1805, DOI 10.1139/f89-228; Rice E.W., 2005, STANDARD METHODS EXA; Rosen BH, 1995, BIOL ASSESSMENT CRIT, P209; Roy AH, 2003, J N AM BENTHOL SOC, V22, P292, DOI 10.2307/1467999; Roy AH, 2008, ENVIRON MANAGE, V42, P344, DOI 10.1007/s00267-008-9119-1; Roy AH, 2009, J AM WATER RESOUR AS, V45, P198, DOI 10.1111/j.1752-1688.2008.00271.x; Shuster W, 2013, J HYDROL, V485, P177, DOI 10.1016/j.jhydrol.2012.10.043; Sieker F, 1998, WATER SCI TECHNOL, V38, P65, DOI 10.1016/S0273-1223(98)00734-3; Smith RF, 2009, J N AM BENTHOL SOC, V28, P1022, DOI 10.1899/08-176.1; STEWARTOATEN A, 1986, ECOLOGY, V67, P929, DOI 10.2307/1939815; Thurston HW, 2010, ENVIRON SCI POLICY, V13, P405, DOI 10.1016/j.envsci.2010.03.008; Thurston HW, 2003, J WATER RES PL-ASCE, V129, P409, DOI 10.1061/(ASCE)0733-9496(2003)129:5(409); Thurston HW, 2008, EPA600R08129; Trowsdale SA, 2011, J HYDROL, V397, P167, DOI 10.1016/j.jhydrol.2010.11.023; UNDERWOOD AJ, 1992, J EXP MAR BIOL ECOL, V161, P145, DOI 10.1016/0022-0981(92)90094-Q; UNDERWOOD AJ, 1991, AUST J MAR FRESH RES, V42, P569, DOI 10.1071/MF9910569; United Nations, 2011, WORLD URB PROSP 2010; United States Environmental Protection Agency, 1991, 883R91100 US EPA OFF; Urbonas B., 1993, STORMWATER BEST MANA; Walsh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045814; Walsh CJ, 2000, HYDROBIOLOGIA, V431, P107, DOI 10.1023/A:1004029715627; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI [10.1899/04-020.1, 10.1899/04-028.1]; Wenger SJ, 2009, J N AM BENTHOL SOC, V28, P1080, DOI 10.1899/08-186.1; Williams DD, 1996, J N AM BENTHOL SOC, V15, P634, DOI 10.2307/1467813	70	78	79	3	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85011	10.1371/journal.pone.0085011	http://dx.doi.org/10.1371/journal.pone.0085011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465468	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000020
J	Gutierrez, MAC; Vivero, RJ; Velez, ID; Porter, CH; Uribe, S				Contreras Gutierrez, Maria Angelica; Vivero, Rafael J.; Velez, Ivan D.; Porter, Charles H.; Uribe, Sandra			DNA Barcoding for the Identification of Sand Fly Species (Diptera, Psychodidae, Phlebotominae) in Colombia	PLOS ONE			English	Article							OXIDASE SUBUNIT-I; FLIES DIPTERA; LUTZOMYIA-LONGIPALPIS; MITOCHONDRIAL PSEUDOGENES; MOLECULAR-IDENTIFICATION; CYTOCHROME-B; VECTORS; LEISHMANIASIS; EVOLUTIONARY; TAXONOMY	Sand flies include a group of insects that are of medical importance and that vary in geographic distribution, ecology, and pathogen transmission. Approximately 163 species of sand flies have been reported in Colombia. Surveillance of the presence of sand fly species and the actualization of species distribution are important for predicting risks for and monitoring the expansion of diseases which sand flies can transmit. Currently, the identification of phlebotomine sand flies is based on morphological characters. However, morphological identification requires considerable skills and taxonomic expertise. In addition, significant morphological similarity between some species, especially among females, may cause difficulties during the identification process. DNA-based approaches have become increasingly useful and promising tools for estimating sand fly diversity and for ensuring the rapid and accurate identification of species. A partial sequence of the mitochondrial cytochrome oxidase gene subunit I (COI) is currently being used to differentiate species in different animal taxa, including insects, and it is referred as a barcoding sequence. The present study explored the utility of the DNA barcode approach for the identification of phlebotomine sand flies in Colombia. We sequenced 700 bp of the COI gene from 36 species collected from different geographic localities. The COI barcode sequence divergence within a single species was <2% in most cases, whereas this divergence ranged from 9% to 26.6% among different species. These results indicated that the barcoding gene correctly discriminated among the previously morphologically identified species with an efficacy of nearly 100%. Analyses of the generated sequences indicated that the observed species groupings were consistent with the morphological identifications. In conclusion, the barcoding gene was useful for species discrimination in sand flies from Colombia.	[Contreras Gutierrez, Maria Angelica; Vivero, Rafael J.; Velez, Ivan D.] Univ Antioquia, Program Study & Control Trop Dis, Medellin, Colombia; [Porter, Charles H.] Ctr Dis Control & Prevent CDC, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Uribe, Sandra] Univ Nacl Colombia, Mol Systemat Grp, Medellin, Colombia	Universidad de Antioquia; Centers for Disease Control & Prevention - USA; Universidad Nacional de Colombia	Gutierrez, MAC (corresponding author), Univ Antioquia, Program Study & Control Trop Dis, Medellin, Colombia.	maria.contreras@pecet-colombia.org	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; VIVERO GOMEZ, RAFAEL JOSE/0000-0001-6768-4097; Uribe Soto, Sandra Ines/0000-0002-4762-0552	Program of Study and Control of Tropical Diseases (PECET); Molecular Systematics Group; Centers for Disease Control and Prevention (CDC)	Program of Study and Control of Tropical Diseases (PECET); Molecular Systematics Group; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work received financial support from Program of Study and Control of Tropical Diseases (PECET), Molecular Systematics Group and Centers for Disease Control and Prevention (CDC) project Influence of Global Warming on Vector-borne Disease Transmission in Colombia. The funding institutions, PECET, GSM and CDC, had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Acevedo M, 2008, B DIR MALARIOL SANEA, V48, P2; Aliabadian M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004119; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amora SSA, 2009, NEOTROP ENTOMOL, V38, P303, DOI 10.1590/S1519-566X2009000300001; Contreras MA, 2012, BIOMEDICA, V32, P263, DOI 10.1590/S0120-41572012000300014; Aransay AM, 1999, INSECT MOL BIOL, V8, P179, DOI 10.1046/j.1365-2583.1999.820179.x; Avise J.C, 2000, PHYLOGEOGRAPHY HIST, DOI DOI 10.2307/J.CTV1NZFGJ7; Azpurua J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000627; Beati L, 2004, INT J PARASITOL, V34, P225, DOI 10.1016/j.ijpara.2003.10.012; Bejarano Eduar Elias, 2006, Folia Entomologica Mexicana, V45, P47; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Besansky NJ, 2003, TRENDS PARASITOL, V19, P545, DOI 10.1016/j.pt.2003.09.015; Blouin MS, 1998, MOL BIOL EVOL, V15, P1719, DOI 10.1093/oxfordjournals.molbev.a025898; Carrasquilla MC, 2012, MEM I OSWALDO CRUZ, V107, P993, DOI 10.1590/S0074-02762012000800005; Casiraghi M., 2010, TOOLS IDENTIFYING BI, P269; Clare EL, 2008, J MOL EVOL, V66, P362, DOI 10.1007/s00239-008-9088-2; Cohnstaedt LW, 2011, AM J TROP MED HYG, V84, P913, DOI 10.4269/ajtmh.2011.11-0040; COMER JA, 1991, PARASSITOLOGIA, VOL 33, SUPPLEMENTO, DECEMBER 1991, P143; CROZIER RH, 1993, GENETICS, V133, P97; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; De la Herran R, 2001, HEREDITY, V87, P691, DOI 10.1046/j.1365-2540.2001.00967.x; De Oliveira MT, 2005, DNA SEQUENCE, V16, P156, DOI 10.1080/10425170500039901; Depaquit J, 2000, INSECT MOL BIOL, V9, P293, DOI 10.1046/j.1365-2583.2000.00179.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Bejarano EE, 2010, MEM I OSWALDO CRUZ, V105, P322, DOI 10.1590/S0074-02762010000300014; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferro C, 2011, BIOMEDICA S3, V31, P50; Ferro C, 1988, I NACL SALUD 1917 19, P219; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Galati EAB, 2010, PHLEBOTOMINAE DIPTER, VI; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hanel R, 2000, J MOL EVOL, V50, P276, DOI 10.1007/s002399910032; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Herbeck JT, 2003, J MOL EVOL, V56, P691, DOI 10.1007/s00239-002-2437-7; Hodgkinson VH, 2003, AM J TROP MED HYG, V69, P386, DOI 10.4269/ajtmh.2003.69.386; Hoy M, 2006, INSECT MOL GENETICS; Hoyos R, 2012, REV COLOMB ENTOMOL, V38, P134; Ibanez-Bernal Sergio, 1999, Folia Entomologica Mexicana, V107, P61; Ishikawa EAY, 1999, MEM I OSWALDO CRUZ, V94, P339, DOI 10.1590/S0074-02761999000300010; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Vivero RJ, 2009, REV COLOMB ENTOMOL, V35, P83; Kato H, 2008, AM J TROP MED HYG, V79, P719, DOI 10.4269/ajtmh.2008.79.719; Kato H, 2007, AM J TROP MED HYG, V77, P324, DOI 10.4269/ajtmh.2007.77.324; Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; Kumar NP, 2012, MOL ECOL RESOUR, V12, P414, DOI 10.1111/j.1755-0998.2012.03117.x; Kuwahara K, 2009, ACTA TROP, V112, P131, DOI 10.1016/j.actatropica.2009.07.010; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Marin D, 2008, MEM 35 C, P135; Martins AVWP, 1978, AM SAND FLIES DIPTER; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; MEMMOTT J, 1991, MED VET ENTOMOL, V5, P403, DOI 10.1111/j.1365-2915.1991.tb00568.x; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moftah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027001; MONTOYALERMA J, 1999, INSECTOS COLOMBIA, V13, P211; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Morlais I, 2002, DNA SEQUENCE, V13, P123, DOI 10.1080/10425170290030051; Munstermann L.E., 2004, BIOL DIS VECTORS, P141; OSORNO-MESA E, 1972, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V14, P45; Polly R, 2007, FIELDS VIROLOGY, P1975; Quintero L, 2009, B MAL SALUD AMB, V52; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Leite LAR, 2012, BIOTA NEOTROP, V12, P301, DOI 10.1590/S1676-06032012000300029; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scarpassa VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037341; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Soto SIU, 2001, MOL PHYLOGENET EVOL, V18, P84, DOI 10.1006/mpev.2000.0863; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; Testa JM, 2002, ACTA TROP, V84, P205, DOI 10.1016/S0001-706X(02)00187-0; Torgerson DG, 2003, AM J TROP MED HYG, V69, P484, DOI 10.4269/ajtmh.2003.69.484; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; VIVERO RAFAEL J, 2011, Acta biol.Colomb., V16, P209; Vivero RJ, 2007, BIOMEDICA, V27, P429, DOI 10.7705/biomedica.v27i3.205; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Young D.G., 1979, REV BLOODSUCKING PSY; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1; Zapata S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-144; Zhang AB, 2010, MOL PHYLOGENET EVOL, V54, P1035, DOI 10.1016/j.ympev.2009.09.014; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	86	57	59	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85496	10.1371/journal.pone.0085496	http://dx.doi.org/10.1371/journal.pone.0085496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454877	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100093
J	Lipp, AM; Juhasz, K; Paar, C; Ogris, C; Eckerstorfer, P; Thuenauer, R; Hesse, J; Nimmervoll, B; Stockinger, H; Schutz, GJ; Bodenhofer, U; Balogi, Z; Sonnleitner, A				Lipp, Anna M.; Juhasz, Kata; Paar, Christian; Ogris, Christoph; Eckerstorfer, Paul; Thuenauer, Roland; Hesse, Jan; Nimmervoll, Benedikt; Stockinger, Hannes; Schuetz, Gerhard J.; Bodenhofer, Ulrich; Balogi, Zsolt; Sonnleitner, Alois			Lck Mediates Signal Transmission from CD59 to the TCR/CD3 Pathway in Jurkat T Cells	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; PLASMA-MEMBRANE; ANCHORED PROTEINS; LYMPHOCYTE-ACTIVATION; QUANTITATIVE-ANALYSIS; CUTTING EDGE; ZETA-CHAIN; TRANSDUCTION; RAFTS; MOLECULES	The glycosylphosphatidylinositol (GPI)-anchored molecule CD59 has been implicated in the modulation of T cell responses, but the underlying molecular mechanism of CD59 influencing T cell signaling remained unclear. Here we analyzed Jurkat T cells stimulated via anti-CD3 epsilon- or anti-CD59-coated surfaces, using time-resolved single-cell Ca2+ imaging as a read-out for stimulation. This analysis revealed a heterogeneous Ca2+ response of the cell population in a stimulus-dependent manner. Further analysis of T cell receptor (TCR)/CD3 deficient or overexpressing cells showed that CD59-mediated signaling is strongly dependent on TCR/CD3 surface expression. In protein co-patterning and fluorescence recovery after photobleaching experiments no direct physical interaction was observed between CD59 and CD3 at the plasma membrane upon anti-CD59 stimulation. However, siRNA-mediated protein knock-downs of downstream signaling molecules revealed that the Src family kinase Lck and the adaptor molecule linker of activated T cells (LAT) are essential for both signaling pathways. Furthermore, flow cytometry measurements showed that knock-down of Lck accelerates CD3 re-expression at the cell surface after anti-CD59 stimulation similar to what has been observed upon direct TCR/CD3 stimulation. Finally, physically linking Lck to CD3 xi completely abolished CD59-triggered Ca2+ signaling, while signaling was still functional upon direct TCR/CD3 stimulation. Altogether, we demonstrate that Lck mediates signal transmission from CD59 to the TCR/CD3 pathway in Jurkat T cells, and propose that CD59 may act via Lck to modulate T cell responses.	[Lipp, Anna M.; Juhasz, Kata; Paar, Christian; Thuenauer, Roland; Hesse, Jan; Nimmervoll, Benedikt; Balogi, Zsolt; Sonnleitner, Alois] Ctr Adv Bioanal GmbH, Linz, Austria; [Ogris, Christoph; Bodenhofer, Ulrich] Johannes Kepler Univ Linz, Inst Bioinformat, Linz, Austria; [Eckerstorfer, Paul; Stockinger, Hannes] Med Univ Vienna, Mol Immunol Unit, Inst Hyg & Appl Immunol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Schuetz, Gerhard J.] Vienna Univ Technol, Inst Appl Phys, A-1040 Vienna, Austria	Johannes Kepler University Linz; Medical University of Vienna; Technische Universitat Wien	Balogi, Z (corresponding author), Ctr Adv Bioanal GmbH, Linz, Austria.	zsolt.balogi@cbl.at; alois.sonnleitner@cbl.at	Nimmervoll, Benedikt/N-7649-2016; Ogris, Christoph/R-9248-2018; Ogris, Christoph/AAG-3120-2020; Schuetz, Gerhard/B-1243-2008; Stockinger, Hannes/E-5173-2011; Juhasz, Kata/ABB-9246-2020; Bodenhofer, Ulrich/B-7030-2008	Nimmervoll, Benedikt/0000-0003-3908-4603; Ogris, Christoph/0000-0003-3969-1585; Ogris, Christoph/0000-0003-3969-1585; Schuetz, Gerhard/0000-0003-1542-1089; Stockinger, Hannes/0000-0001-6404-4430; Bodenhofer, Ulrich/0000-0001-6859-8828; Hesse, Jan/0000-0001-9648-7316	European Regional Development Fund (EFRE); state of Upper Austria; GEN-AU Project of the Austrian Federal Ministry for Science and Research	European Regional Development Fund (EFRE)(European Commission); state of Upper Austria; GEN-AU Project of the Austrian Federal Ministry for Science and Research(Austrian Science Fund (FWF))	This work was supported by the European Regional Development Fund (EFRE), the state of Upper Austria and the GEN-AU Project of the Austrian Federal Ministry for Science and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL NGB, 1995, BIOPHYS J, V69, P1178, DOI 10.1016/S0006-3495(95)79992-1; ALCOVER A, 1990, J BIOL CHEM, V265, P4131; ANDERSON SJ, 1994, ADV IMMUNOL, V56, P151, DOI 10.1016/S0065-2776(08)60451-4; Anton O, 2008, J EXP MED, V205, P3201, DOI 10.1084/jem.20080552; Arrol HP, 2008, CLIN EXP IMMUNOL, V153, P86, DOI 10.1111/j.1365-2249.2008.03677.x; Balagopalan L, 2011, NAT REV IMMUNOL, V11, P21, DOI 10.1038/nri2903; Balagopalan L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005512; Bartelt RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005430; Bijlmakers MJJE, 1999, J CELL BIOL, V145, P457, DOI 10.1083/jcb.145.3.457; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Criado G, 2004, J IMMUNOL, V172, P222, DOI 10.4049/jimmunol.172.1.222; DAVIES A, 1993, IMMUNOL RES, V12, P258, DOI 10.1007/BF02918257; de Wet B, 2011, J BIOL CHEM, V286, P4072, DOI 10.1074/jbc.M110.165415; DECKERT M, 1995, EUR J IMMUNOL, V25, P1815, DOI 10.1002/eji.1830250704; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; DONNADIEU E, 1992, J BIOL CHEM, V267, P25864; Drbal K, 2007, INT IMMUNOL, V19, P675, DOI 10.1093/intimm/dxm032; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; Horejsi V, 1998, IMMUNOL LETT, V63, P63, DOI 10.1016/S0165-2478(98)00054-6; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; KORTY PE, 1991, J IMMUNOL, V146, P4092; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Legembre P, 2006, J IMMUNOL, V176, P716, DOI 10.4049/jimmunol.176.2.716; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Loertscher R, 2002, TRANSPL IMMUNOL, V9, P93, DOI 10.1016/S0966-3274(02)00013-8; Longhi MP, 2005, J IMMUNOL, V175, P7098, DOI 10.4049/jimmunol.175.11.7098; Methi T, 2005, J IMMUNOL, V175, P7398, DOI 10.4049/jimmunol.175.11.7398; Methi T, 2008, EUR J IMMUNOL, V38, P2557, DOI 10.1002/eji.200737837; Millan J, 1998, EUR J IMMUNOL, V28, P3675, DOI 10.1002/(SICI)1521-4141(199811)28:11<3675::AID-IMMU3675>3.3.CO;2-X; Mitchell JS, 2002, J IMMUNOL, V168, P2737, DOI 10.4049/jimmunol.168.6.2737; Paar C, 2007, EUR J CELL BIOL, V86, P253, DOI 10.1016/j.ejcb.2007.03.001; PAIGE LA, 1993, J BIOL CHEM, V268, P8669; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Paster W, 2009, J IMMUNOL, V182, P2160, DOI 10.4049/jimmunol.0802639; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; Schwarzenbacher M, 2008, NAT METHODS, V5, P1053, DOI 10.1038/nmeth.1268; Sivasankar B, 2009, J IMMUNOL, V182, P5203, DOI 10.4049/jimmunol.0804243; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.3.CO;2-C; Wang TY, 2005, J BIOL CHEM, V280, P22839, DOI 10.1074/jbc.M502920200; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; Xie XH, 2012, CELL IMMUNOL, V274, P1, DOI 10.1016/j.cellimm.2012.02.013; Zimmermann L, 2010, J BIOL CHEM, V285, P6063, DOI 10.1074/jbc.M109.025981	50	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85934	10.1371/journal.pone.0085934	http://dx.doi.org/10.1371/journal.pone.0085934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454946	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100140
J	Samson, H; Fiori-Duharcourt, N; Dore-Mazars, K; Lemoine, C; Vergilino-Perez, D				Samson, Helene; Fiori-Duharcourt, Nicole; Dore-Mazars, Karine; Lemoine, Christelle; Vergilino-Perez, Dorine			Perceptual and Gaze Biases during Face Processing: Related or Not?	PLOS ONE			English	Article							VISUAL HEMISPACE BIAS; CHIMERIC FACES; SACCADIC LATENCY; ASYMMETRIES; RECOGNITION; TASK; DIFFICULTY; JUDGMENTS; PATTERNS; BEHAVIOR	Previous studies have demonstrated a left perceptual bias while looking at faces, due to the fact that observers mainly use information from the left side of a face (from the observer's point of view) to perform a judgment task. Such a bias is consistent with the right hemisphere dominance for face processing and has sometimes been linked to a left gaze bias, i.e. more and/or longer fixations on the left side of the face. Here, we recorded eye-movements, in two different experiments during a gender judgment task, using normal and chimeric faces which were presented above, below, right or left to the central fixation point or on it (central position). Participants performed the judgment task by remaining fixated on the fixation point or after executing several saccades (up to three). A left perceptual bias was not systematically found as it depended on the number of allowed saccades and face position. Moreover, the gaze bias clearly depended on the face position as the initial fixation was guided by face position and landed on the closest half-face, toward the center of gravity of the face. The analysis of the subsequent fixations revealed that observers move their eyes from one side to the other. More importantly, no apparent link between gaze and perceptual biases was found here. This implies that we do not look necessarily toward the side of the face that we use to make a gender judgment task. Despite the fact that these results may be limited by the absence of perceptual and gaze biases in some conditions, we emphasized the inter-individual differences observed in terms of perceptual bias, hinting at the importance of performing individual analysis and drawing attention to the influence of the method used to study this bias.	[Samson, Helene; Fiori-Duharcourt, Nicole; Dore-Mazars, Karine; Lemoine, Christelle; Vergilino-Perez, Dorine] Univ Paris 05, Lab Vis Act Cognit, Inst Univ Paris Descartes Psychol, Inst Psychol, Boulogne Billancourt, France; [Samson, Helene; Fiori-Duharcourt, Nicole; Dore-Mazars, Karine; Lemoine, Christelle; Vergilino-Perez, Dorine] Univ Paris 05, INC, Boulogne Billancourt, France; [Samson, Helene; Fiori-Duharcourt, Nicole; Dore-Mazars, Karine; Lemoine, Christelle; Vergilino-Perez, Dorine] Sorbonne Paris Cite, Boulogne Billancourt, France; [Dore-Mazars, Karine; Vergilino-Perez, Dorine] Inst Univ France, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Institut Universitaire de France	Vergilino-Perez, D (corresponding author), Univ Paris 05, Lab Vis Act Cognit, Inst Univ Paris Descartes Psychol, Inst Psychol, Boulogne Billancourt, France.	dorine.vergilino-perez@parisdescartes.fr						Arizpe J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031106; Armann R, 2009, ATTEN PERCEPT PSYCHO, V71, P1107, DOI 10.3758/APP.71.5.1107; Bava S, 2005, BRAIN COGNITION, V59, P1, DOI 10.1016/j.bandc.2005.03.004; Becker W., 1989, NEUROBIOLOGY SACCADI; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bindemann M, 2009, J VISION, V9, DOI 10.1167/9.2.7; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Brady N, 2005, BRAIN COGNITION, V58, P334, DOI 10.1016/j.bandc.2005.01.001; BROWN E, 1993, PERCEPTION, V22, P829, DOI 10.1068/p220829; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Burt DM, 1997, NEUROPSYCHOLOGIA, V35, P685, DOI 10.1016/S0028-3932(96)00111-X; BURTON AM, 1993, PERCEPTION, V22, P153, DOI 10.1068/p220153; Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P2051, DOI 10.1016/j.neuropsychologia.2010.03.026; Butler S, 2005, NEUROPSYCHOLOGIA, V43, P52, DOI 10.1016/j.neuropsychologia.2004.06.005; Butler SH, 2008, CORTEX, V44, P665, DOI 10.1016/j.cortex.2007.02.001; Butler SH, 2006, BRAIN RES, V1124, P96, DOI 10.1016/j.brainres.2006.09.069; Carbary TJ, 2002, BRAIN COGNITION, V48, P304, DOI 10.1006/brcg.2001.1367; Carbary TJ, 2001, BRAIN COGNITION, V46, P57; Coolican J, 2008, BRAIN COGNITION, V66, P176, DOI 10.1016/j.bandc.2007.07.001; Cooper TJ, 2007, NEUROPSYCHOLOGIA, V45, P2910, DOI 10.1016/j.neuropsychologia.2007.06.005; Everdell IT, 2007, PERCEPTION, V36, P1535, DOI 10.1068/p5852; GALLOIS P, 1989, REV NEUROL, V145, P661; GILBERT C, 1973, NEUROPSYCHOLOGIA, V11, P355, DOI 10.1016/0028-3932(73)90049-3; GREGA DM, 1988, CORTEX, V24, P91, DOI 10.1016/S0010-9452(88)80019-4; Guo K, 2011, PSYCHOL RES; Guo K, 2010, PERCEPTION, V39, P533, DOI 10.1068/p6517; Guo K, 2009, ANIM COGN, V12, P409, DOI 10.1007/s10071-008-0199-3; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; HEYWOOD S, 1980, Q J EXP PSYCHOL, V32, P335, DOI 10.1080/14640748008401169; Hsiao JH, 2012, J VISION, V12, DOI 10.1167/12.2.22; Hsiao JHW, 2008, PSYCHOL SCI, V19, P998, DOI 10.1111/j.1467-9280.2008.02191.x; Iwanaga Keisuke, 2011, Rinsho Shinkeigaku, V51, P354; KAPOULA Z, 1985, VISION RES, V25, P1155, DOI 10.1016/0042-6989(85)90105-1; KAPOULA Z, 1986, VISION RES, V26, P735, DOI 10.1016/0042-6989(86)90087-8; Le Grand R, 2003, NAT NEUROSCI, V6, P1108, DOI 10.1038/nn1121; Leonards U, 2005, VISION RES, V45, P2677, DOI 10.1016/j.visres.2005.03.009; LEVINE SC, 1986, BRAIN COGNITION, V5, P291, DOI 10.1016/0278-2626(86)90033-3; LUH KE, 1991, BRAIN COGNITION, V16, P83, DOI 10.1016/0278-2626(91)90087-O; MATTINGLEY JB, 1994, NEUROPSYCHOLOGIA, V32, P805, DOI 10.1016/0028-3932(94)90019-1; MERTENS I, 1993, NEUROPSYCHOLOGIA, V31, P989, DOI 10.1016/0028-3932(93)90154-R; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; MORENO CR, 1990, NEUROPSYCHOLOGIA, V28, P199, DOI 10.1016/0028-3932(90)90101-S; Perez DV, 2012, NEUROPSYCHOLOGIA, V50, P2796, DOI 10.1016/j.neuropsychologia.2012.07.039; Peterson MF, 2013, PSYCHOL SCI, V24, P1216, DOI 10.1177/0956797612471684; Peterson MF, 2012, P NATL ACAD SCI USA, V109, pE3314, DOI 10.1073/pnas.1214269109; Phillips ML, 1997, BRAIN COGNITION, V35, P225, DOI 10.1006/brcg.1997.0939; Quinn KA, 2011, BRIT J PSYCHOL, V102, P849, DOI 10.1111/j.2044-8295.2011.02030.x; RHODES G, 1985, BRAIN COGNITION, V4, P197, DOI 10.1016/0278-2626(85)90070-3; Saether L, 2009, VISION RES, V49, P2870, DOI 10.1016/j.visres.2009.09.001; Said CP, 2011, PHILOS T R SOC B, V366, P1660, DOI 10.1098/rstb.2010.0351; Schyns PG, 2002, PSYCHOL SCI, V13, P402, DOI 10.1111/1467-9280.00472; SERGENT J, 1989, BRAIN, V112, P975, DOI 10.1093/brain/112.4.975; Vinette C, 2004, COGNITIVE SCI, V28, P289, DOI 10.1016/j.cogsci.2004.01.002; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Young AW, 2011, BRIT J PSYCHOL, V102, P959, DOI 10.1111/j.2044-8295.2011.02045.x; Yovel G, 2008, NEUROPSYCHOLOGIA, V46, P3061, DOI 10.1016/j.neuropsychologia.2008.06.017	58	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85746	10.1371/journal.pone.0085746	http://dx.doi.org/10.1371/journal.pone.0085746			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454927	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100129
J	Toth, A; Fodor, K; Praznovszky, T; Tubak, V; Udvardy, A; Hadlaczky, G; Katona, RL				Toth, Anna; Fodor, Katalin; Praznovszky, Tuende; Tubak, Vilmos; Udvardy, Andor; Hadlaczky, Gyula; Katona, Robert L.			Novel Method to Load Multiple Genes onto a Mammalian Artificial Chromosome	PLOS ONE			English	Article							ALPHA-SATELLITE; ENGINEERED CHROMOSOMES; HUMAN MINICHROMOSOMES; CELL THERAPY; GENERATION; VECTORS; DNA; CONSTRUCTION; PROSPECTS; DELIVERY	Mammalian artificial chromosomes are natural chromosome-based vectors that may carry a vast amount of genetic material in terms of both size and number. They are reasonably stable and segregate well in both mitosis and meiosis. A platform artificial chromosome expression system (ACEs) was earlier described with multiple loading sites for a modified lambda-integrase enzyme. It has been shown that this ACEs is suitable for high-level industrial protein production and the treatment of a mouse model for a devastating human disorder, Krabbe's disease. ACEs-treated mutant mice carrying a therapeutic gene lived more than four times longer than untreated counterparts. This novel gene therapy method is called combined mammalian artificial chromosome-stem cell therapy. At present, this method suffers from the limitation that a new selection marker gene should be present for each therapeutic gene loaded onto the ACEs. Complex diseases require the cooperative action of several genes for treatment, but only a limited number of selection marker genes are available and there is also a risk of serious side-effects caused by the unwanted expression of these marker genes in mammalian cells, organs and organisms. We describe here a novel method to load multiple genes onto the ACEs by using only two selectable marker genes. These markers may be removed from the ACEs before therapeutic application. This novel technology could revolutionize gene therapeutic applications targeting the treatment of complex disorders and cancers. It could also speed up cell therapy by allowing researchers to engineer a chromosome with a predetermined set of genetic factors to differentiate adult stem cells, embryonic stem cells and induced pluripotent stem (iPS) cells into cell types of therapeutic value. It is also a suitable tool for the investigation of complex biochemical pathways in basic science by producing an ACEs with several genes from a signal transduction pathway of interest.	[Toth, Anna; Fodor, Katalin; Praznovszky, Tuende; Tubak, Vilmos; Hadlaczky, Gyula; Katona, Robert L.] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary; [Udvardy, Andor] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Katona, RL (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary.	katona.robert@brc.mta.hu	Udvardy, Andor/AAA-1473-2022		Hungarian National Technology Program [TECH_09_A1-DKMACTER]	Hungarian National Technology Program	This work was supported by Hungarian National Technology Program Grant: TECH_09_A1-DKMACTER (http://www.nih.gov.hu/english). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascenzioni F, 1997, CANCER LETT, V118, P135, DOI 10.1016/S0304-3835(97)00323-6; Au HC, 1999, CYTOGENET CELL GENET, V86, P194, DOI 10.1159/000015338; Auriche C, 2001, EMBO REP, V2, P102, DOI 10.1093/embo-reports/kve018; Basu J, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-21; Basu J, 2005, TRENDS MOL MED, V11, P251, DOI 10.1016/j.molmed.2005.03.006; Basu J, 2005, NUCLEIC ACIDS RES, V33, P587, DOI 10.1093/nar/gki207; Basu J, 2006, PEDIATR CLIN N AM, V53, P843, DOI 10.1016/j.pcl.2006.08.013; Bridger JM, 2004, CYTOGENET GENOME RES, V107, P5, DOI 10.1159/000079563; Brown WRA, 2000, TRENDS BIOTECHNOL, V18, P218, DOI 10.1016/S0167-7799(00)01438-4; CARINE K, 1986, SOMAT CELL MOLEC GEN, V12, P479, DOI 10.1007/BF01539919; Carl FP, 2004, BIOPROCESSING, P61; Cooke H, 2001, Cloning Stem Cells, V3, P243, DOI 10.1089/15362300152725963; Csonka E, 2000, J CELL SCI, V113, P3207; Duncan A, 2007, CURR OPIN BIOTECH, V18, P420, DOI 10.1016/j.copbio.2007.09.004; Ehrhardt A, 2008, CURR GENE THER, V8, P147, DOI 10.2174/156652308784746440; FARR CJ, 1995, EMBO J, V14, P5444, DOI 10.1002/j.1460-2075.1995.tb00228.x; Grimes BR, 2005, CHROMOSOMA, V114, P230, DOI 10.1007/s00412-005-0017-5; Grimes BR, 2002, GENE THER, V9, P713, DOI 10.1038/sj.gt.3301763; Grimes BR, 2002, MOL THER, V5, P798, DOI 10.1006/mthe.2002.0612; HADLACZKY G, 1991, P NATL ACAD SCI USA, V88, P8106, DOI 10.1073/pnas.88.18.8106; Hadlaczky G, 2001, CURR OPIN MOL THER, V3, P125; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Heller R, 1996, P NATL ACAD SCI USA, V93, P7125, DOI 10.1073/pnas.93.14.7125; Henning KA, 1999, P NATL ACAD SCI USA, V96, P592, DOI 10.1073/pnas.96.2.592; Hollo G, 1996, CHROMOSOME RES, V4, P240, DOI 10.1007/BF02254965; Ikeno M, 1998, NAT BIOTECHNOL, V16, P431, DOI 10.1038/nbt0598-431; Ikeno M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp058; Irvine DV, 2005, TRENDS BIOTECHNOL, V23, P575, DOI 10.1016/j.tibtech.2005.10.001; Kaname T, 2005, CHROMOSOME RES, V13, P411, DOI 10.1007/s10577-005-0979-4; Katoh M, 2004, BIOCHEM BIOPH RES CO, V321, P280, DOI 10.1016/j.bbrc.2004.06.145; Katona RL, 2008, CELL MOL LIFE SCI, V65, P3830, DOI 10.1007/s00018-008-8442-2; Katona RL, 2011, METHODS MOL BIOL, V738, P199, DOI 10.1007/978-1-61779-099-7_14; Kazuki Y, 2011, MOL THER, V19, P1591, DOI 10.1038/mt.2011.136; Kennard ML, 2009, BIOTECHNOL BIOENG, V104, P526, DOI 10.1002/bit.22407; Kennard ML, 2009, BIOTECHNOL BIOENG, V104, P540, DOI 10.1002/bit.22406; Kereso J, 1996, CHROMOSOME RES, V4, P226, DOI 10.1007/BF02254964; Kouprina N, 2003, NUCLEIC ACIDS RES, V31, P922, DOI 10.1093/nar/gkg182; Kouprina N, 2013, CELL MOL LIFE SCI, V70, P1135, DOI 10.1007/s00018-012-1113-3; Larin Z, 2002, TRENDS GENET, V18, P313, DOI 10.1016/S0168-9525(02)02679-3; Lewis MES, 2001, CLIN GENET, V59, P12, DOI 10.1034/j.1399-0004.2001.59012.1.x; LIM HN, 2003, METH MOL B, V240, P167; Lindenbaum M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh169; Lipps HJ, 2003, GENE, V304, P23, DOI 10.1016/S0378-1119(02)01215-5; Macnab S, 2009, GENE THER, V16, P1180, DOI 10.1038/gt.2009.102; Mills W, 1999, HUM MOL GENET, V8, P751, DOI 10.1093/hmg/8.5.751; Nakashima H, 2005, J CELL SCI, V118, P5885, DOI 10.1242/jcs.02702; PRAZNOVSZKY T, 1991, P NATL ACAD SCI USA, V88, P11042, DOI 10.1073/pnas.88.24.11042; Raimondi E, 2011, METHODS MOL BIOL, V738, P41, DOI 10.1007/978-1-61779-099-7_3; Ren XY, 2006, STEM CELL REV, V2, P43, DOI 10.1385/SCR:2:1:43; Saffery R, 2001, P NATL ACAD SCI USA, V98, P5705, DOI 10.1073/pnas.091468498; Seymour LW, 2009, HUM GENE THER, V20, P291, DOI 10.1089/hum.2009.1309; Shen MH, 2000, CURR BIOL, V10, P31, DOI 10.1016/S0960-9822(99)00261-4; Suzuki N, 2006, J BIOL CHEM, V281, P26615, DOI 10.1074/jbc.M603053200; Voet T, 2001, GENOME RES, V11, P124, DOI 10.1101/gr.159901; Wong LH, 2002, GENE THER, V9, P724, DOI 10.1038/sj.gt.3301756; Yamaguchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017267; Yoshimi K, 2000, NAT BIOTECHNOL, V18, P1086, DOI 10.1038/80287	57	4	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85565	10.1371/journal.pone.0085565	http://dx.doi.org/10.1371/journal.pone.0085565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454889	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100100
J	Edvardsen, E; Hem, E; Anderssen, SA				Edvardsen, Elisabeth; Hem, Erlend; Anderssen, Sigmund A.			End Criteria for Reaching Maximal Oxygen Uptake Must Be Strict and Adjusted to Sex and Age: A Cross-Sectional Study	PLOS ONE			English	Article							BLOOD LACTATE; CARDIORESPIRATORY RESPONSE; EXERCISE TESTS; MEN; PLATEAU; FITNESS; WOMEN; CONSUMPTION; LIFE; POPULATION	Objective: To describe different end criteria for reaching maximal oxygen uptake (VO2max) during a continuous graded exercise test on the treadmill, and to explore the manner by which different end criteria have an impact on the magnitude of the VO2max result. Methods: A sample of 861 individuals (390 women) aged 20-85 years performed an exercise test on a treadmill until exhaustion. Gas exchange, heart rate, blood lactate concentration and Borg Scale(6-20) rating were measured, and the impact of different end criteria on VO2max was studied;VO2 leveling off, maximal heart rate (HRmax), different levels of respiratory exchange ratio (RER), and postexercise blood lactate concentration. Results: Eight hundred and four healthy participants (93%) fulfilled the exercise test until voluntary exhaustion. There were no sex-related differences in HRmax, RER, or Borg Scale rating, whereas blood lactate concentration was 18% lower in women (P<0.001). Forty-two percent of the participants achieved a plateau in VO2; these individuals had 5% higher ventilation (P= 0.033), 4% higher RER (P<0.001), and 5% higher blood lactate concentration (P= 0.047) compared with participants who did not reach a VO2 plateau. When using RER >= 1.15 or blood lactate concentration >= 8.0 mmol center dot L-1, VO2max was 4% (P= 0.012) and 10% greater (P<0.001), respectively. A blood lactate concentration >= 8.0 mmol center dot L-1 excluded 63% of the participants in the 50-85-year-old cohort. Conclusions: A range of typical end criteria are presented in a random sample of subjects aged 20-85 years. The choice of end criteria will have an impact on the number of the participants as well as the VO2max outcome. Suggestions for new recommendations are given.	[Edvardsen, Elisabeth; Hem, Erlend; Anderssen, Sigmund A.] Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway; [Edvardsen, Elisabeth] Oslo Univ Hosp, Dept Pulm Med, Oslo, Norway	Norwegian School of Sport Sciences; University of Oslo	Edvardsen, E (corresponding author), Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway.	elisabeth.edvardsen@nih.no						AASTRAND P, 2003, TXB WORK PHYSL; Aastrand P O, 1952, EXPT STUDIES PHYS WO; American College of Sports Medicine, 2010, ACMS GUID EX TEST PR; Armstrong RB, 1988, EXERCISE NUTR ENERGY, P9; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; Astorino TA, 2005, BRIT J SPORT MED, V39, P655, DOI 10.1136/bjsm.2004.016550; ASTRAND I, 1973, J APPL PHYSIOL, V35, P649, DOI 10.1152/jappl.1973.35.5.649; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; BALKE B, 1959, U S Armed Forces Med J, V10, P675; BORG G, 1987, EUR J APPL PHYSIOL O, V56, P679, DOI 10.1007/BF00424810; Borg G A, 1974, Exerc Sport Sci Rev, V2, P131; Brown JD, 2002, J SPORT MED PHYS FIT, V42, P135; Chen MJ, 2002, J SPORT SCI, V20, P873, DOI 10.1080/026404102320761787; Church TS, 2008, J AGING PHYS ACTIV, V16, P408, DOI 10.1123/japa.16.4.408; Davis JA, 2002, CLIN PHYSIOL FUNCT I, V22, P332, DOI 10.1046/j.1475-097X.2002.00440.x; Doherty M, 2003, EUR J APPL PHYSIOL, V89, P619, DOI 10.1007/s00421-003-0845-z; DRINKWATER BL, 1975, J GERONTOL, V30, P385, DOI 10.1093/geronj/30.4.385; Edvardsen E, 2013, CHEST, V144, P241, DOI 10.1378/chest.12-1458; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; HANSEN JE, 1984, AM REV RESPIR DIS, V129, pS49, DOI 10.1164/arrd.1984.129.2P2.S49; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; INBAR O, 1994, MED SCI SPORT EXER, V26, P538; ISSEKUTZ B, 1962, J APPL PHYSIOL, V17, P47, DOI 10.1152/jappl.1962.17.1.47; ISSEKUTZ B, 1961, J APPL PHYSIOL, V16, P606, DOI 10.1152/jappl.1961.16.4.606; Jackson AS, 2009, ARCH INTERN MED, V169, P1781, DOI 10.1001/archinternmed.2009.312; Lacour JR, 2007, EUR J APPL PHYSIOL, V101, P241, DOI 10.1007/s00421-007-0487-7; Medbo JI, 2000, SCAND J CLIN LAB INV, V60, P367, DOI 10.1080/003655100750019279; Misquita NA, 2001, J WOMEN HEALTH GEN-B, V10, P879, DOI 10.1089/152460901753285787; MYERS J, 1990, J APPL PHYSIOL, V68, P404, DOI 10.1152/jappl.1990.68.1.404; Naughton GA, 1997, EUR J APPL PHYSIOL O, V76, P525, DOI 10.1007/s004210050285; Nelson MD, 2010, MED SCI SPORT EXER, V42, P255, DOI 10.1249/MSS.0b013e3181b0e534; Noakes TD, 1998, MED SCI SPORT EXER, V30, P1381, DOI 10.1097/00005768-199809000-00007; Paterson DH, 1999, MED SCI SPORT EXER, V31, P1813, DOI 10.1097/00005768-199912000-00018; Poole DC, 2008, EUR J APPL PHYSIOL, V102, P403, DOI 10.1007/s00421-007-0596-3; Ramos-Barbon D, 1999, CHEST, V115, P410, DOI 10.1378/chest.115.2.410; Sandoval DA, 2002, J APPL PHYSIOL, V92, P504, DOI 10.1152/japplphysiol.00526.2001; SIDNEY KH, 1977, J APPL PHYSIOL, V43, P280, DOI 10.1152/jappl.1977.43.2.280; TAYLOR HL, 1955, J APPL PHYSIOL, V8, P73, DOI 10.1152/jappl.1955.8.1.73; Weber GL, 2000, EUR J APPL PHYSIOL, V82, P255, DOI 10.1007/s004210000214; Yoon BK, 2007, MED SCI SPORT EXER, V39, P1186, DOI 10.1249/mss.0b13e318054e304	41	180	181	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85276	10.1371/journal.pone.0085276	http://dx.doi.org/10.1371/journal.pone.0085276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454832	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000329925800032
J	Zhang, JS; Zhao, J; Zhang, SH; He, CY				Zhang, Ji-Si; Zhao, Jing; Zhang, Shaohua; He, Chaoying			Efficient Gene Silencing Mediated by Tobacco Rattle Virus in an Emerging Model Plant Physalis	PLOS ONE			English	Article							INFLATED CALYX SYNDROME; MORPHOLOGICAL NOVELTY; FUNCTIONAL-ANALYSIS; CHINESE LANTERN; EVOLUTION; TOOL; BIOSYNTHESIS; RESISTANCE; MPF2	The fruit of Physalis has a berry and a novelty called inflated calyx syndrome (ICS, also named the 'Chinese lantern'). Elucidation of the underlying developmental mechanisms of fruit diversity demands an efficient gene functional inference platform. Here, we tested the application of the tobacco rattle virus (TRV)-mediated gene-silencing system in Physalis floridana. First, we characterized the putative gene of a phytoene desaturase in P. floridana (PfPDS). Infecting the leaves of the Physalis seedlings with the PfPDS-TRV vector resulted in a bleached plant, including the developing leaves, floral organs, ICS, berry, and seed. These results indicated that a local VIGS treatment can efficiently induce a systemic mutated phenotype. qRT-PCR analyses revealed that the bleaching extent correlated to the mRNA reduction of the endogenous PfPDS. Detailed comparisons of multiple infiltration and growth protocols allowed us to determine the optimal methodologies for VIGS manipulation in Physalis. We subsequently utilized this optimized VIGS methodology to downregulate the expression of two MADS-box genes, MPF2 and MPF3, and compared the resulting effects with gene-downregulation mediated by RNA interference (RNAi) methods. The VIGS-mediated gene knockdown plants were found to resemble the mutated phenotypes of floral calyx, fruiting calyx and pollen maturation of the RNAi transgenic plants for both MPF2 and MPF3. Moreover, the two MADS-box genes were appeared to have a novel role in the pedicel development in P. floridana. The major advantage of VIGS-based gene knockdown lies in practical aspects of saving time and easy manipulation as compared to the RNAi. Despite the lack of heritability and mosaic mutation phenotypes observed in some organs, the TRV-mediated gene silencing system provides an alternative efficient way to infer gene function in various developmental processes in Physalis, thus facilitating understanding of the genetic basis of the evolution and development of the morphological diversities within the Solanaceae.	[Zhang, Ji-Si; Zhao, Jing; Zhang, Shaohua; He, Chaoying] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Zhang, Ji-Si; Zhao, Jing; Zhang, Shaohua] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, CY (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	chaoying@ibcas.ac.cn	zhao, jing/B-3868-2019		National Natural Science Foundation of China [31070203, 30870175]; Hundred Talent Program of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talent Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants (31070203, 30870175) from the National Natural Science Foundation of China ( to C.H.) and by the Hundred Talent Program of the Chinese Academy of Sciences to C.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Borevitz JO, 2004, CURR OPIN PLANT BIOL, V7, P132, DOI 10.1016/j.pbi.2004.01.011; Brigneti G, 2004, PLANT J, V39, P264, DOI 10.1111/j.1365-313X.2004.02122.x; Burch-Smith TM, 2006, PLANT PHYSIOL, V142, P21, DOI 10.1104/pp.106.084624; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Chen JC, 2005, PLANT J, V44, P16, DOI 10.1111/j.1365-313X.2005.02505.x; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Chung E, 2004, MOL CELLS, V17, P377; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ekengren SK, 2003, PLANT J, V36, P905, DOI 10.1046/j.1365-313X.2003.01944.x; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Gould B, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-6; He CY, 2007, PLANT J, V49, P935, DOI 10.1111/j.1365-313X.2006.03008.x; He CY, 2010, PLANTA, V231, P767, DOI 10.1007/s00425-009-1087-z; He CY, 2005, P NATL ACAD SCI USA, V102, P5779, DOI 10.1073/pnas.0501877102; Hileman LC, 2005, PLANT J, V44, P334, DOI 10.1111/j.1365-313X.2005.02520.x; HINTON WF, 1975, AM J BOT, V62, P198, DOI 10.2307/2441596; Hu JY, 2007, MOL BIOL EVOL, V24, P2443, DOI 10.1093/molbev/msm177; Khan MR, 2009, MOL BIOL EVOL, V26, P2463, DOI 10.1093/molbev/msp159; Kjemtrup S, 1998, PLANT J, V14, P91, DOI 10.1046/j.1365-313X.1998.00101.x; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lonnig WE., 2010, FLORICULTURE ORNAM B, V4, P1; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Nagamatsu A, 2007, PLANT BIOTECHNOL J, V5, P778, DOI 10.1111/j.1467-7652.2007.00288.x; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Orzaez D, 2006, PLANT PHYSIOL, V140, P3, DOI 10.1104/pp.105.068221; Price AH, 2006, TRENDS PLANT SCI, V11, P213, DOI 10.1016/j.tplants.2006.03.006; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Ryu CM, 2004, PLANT J, V40, P322, DOI 10.1111/j.1365-313X.2004.02211.x; Senthil-Kumar M, 2011, PLANT BIOTECHNOL J, V9, P797, DOI 10.1111/j.1467-7652.2011.00589.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turnage MA, 2002, PLANT J, V30, P107, DOI 10.1046/j.1365-313X.2002.01261.x; Wang L, 2012, J EXP BOT, V63, P6457, DOI 10.1093/jxb/ers299; Waterhouse PM, 2006, SCIENCE, V313, P54, DOI 10.1126/science.1130818; Wuriyanghan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066050; Zhang J, 2012, PLANTA, V236, P1247, DOI 10.1007/s00425-012-1684-0; Zhao J, 2013, PLANT CELL, V25, P2002, DOI 10.1105/tpc.113.111757	41	17	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85534	10.1371/journal.pone.0085534	http://dx.doi.org/10.1371/journal.pone.0085534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454885	Green Published, Green Submitted, gold			2022-12-25	WOS:000329925800049
J	Richmond, TK; Elliott, MN; Franzini, L; Kawachi, I; Caughy, MO; Gilliland, MJ; Walls, CE; Franklin, FA; Lowry, R; Banspach, SW; Schuster, MA				Richmond, Tracy K.; Elliott, Marc N.; Franzini, Luisa; Kawachi, Ichiro; Caughy, Margaret O.; Gilliland, M. Janice; Walls, Courtney E.; Franklin, Frank A.; Lowry, Richard; Banspach, Stephen W.; Schuster, Mark A.			School Programs and Characteristics and Their Influence on Student BMI: Findings from Healthy Passages	PLOS ONE			English	Article							OBESITY	Background: Little is known about the contribution of school contextual factors to individual student body mass index (BMI). We set out to determine if school characteristics/resources: (1) are associated with student BMI; (2) explain racial/ethnic disparities in student BMI; and (3) explain school-level differences in student BMI. Methods: Using gender-stratified multi-level modeling strategies we examined the association of school characteristics/resources and individual BMI in 4,387 5th graders in the Healthy Passages Longitudinal Study of Adolescent Health. Additionally, we examined the association of race/ethnicity and individual BMI as well as the between-school variance in BMI before and after adding individual and school characteristics to test for attenuation. Results: The school-level median household income, but not physical activity or nutrition resources, was inversely associated with female BMI (beta = 20.12, CI: -0.21,-0.02). Neither school demographics nor physical activity/nutrition resources were predictive of individual BMI in males. In Black females, school characteristics attenuated the association of race/ethnicity and BMI. Individual student characteristics-not school characteristics/resources-reduced the between-school variation in BMI in males by nearly one-third and eliminated it in females. Conclusions: In this cohort of 5th graders, school SES was inversely associated with female BMI while school characteristics and resources largely explained Black/White disparities in female weight status. Between-school differences in average student weight status were largely explained by the composition of the student body not by school characteristics or programming.	[Richmond, Tracy K.] Boston Childrens Hosp, Div Adolescent Med, Boston, MA 02115 USA; [Elliott, Marc N.] RAND Corp, Stat, Santa Monica, CA USA; [Franzini, Luisa] Univ Texas Sch Publ Hlth, Div Management Policy & Community Hlth, Blue Cross & Blue Shield Texas Res Program Paymen, Houston, TX USA; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Caughy, Margaret O.] Univ Texas Sch Publ Hlth, Dallas, TX USA; [Walls, Courtney E.] Decis Resources, Epidemiol, Burlington, MA USA; [Franklin, Frank A.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Maternal & Child Hlth, Birmingham, AL 35294 USA; [Lowry, Richard; Banspach, Stephen W.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Schuster, Mark A.] Boston Childrens Hosp, Dept Med, Boston, MA USA	Harvard University; Boston Children's Hospital; RAND Corporation; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Alabama System; University of Alabama Birmingham; Centers for Disease Control & Prevention - USA; Harvard University; Boston Children's Hospital	Richmond, TK (corresponding author), Boston Childrens Hosp, Div Adolescent Med, Boston, MA 02115 USA.	tracy.richmond@childrens.harvard.edu			Centers for Disease Control and Prevention, Prevention Research Centers [U48DP000046, U48DP000057, U48DP000056]; National Institutes of Health (NIH) [NICHD K01 HD058042]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD058042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000046, U48DP000057, U48DP000056] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention, Prevention Research Centers(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Healthy Passages Study is funded by the Centers for Disease Control and Prevention, Prevention Research Centers (cooperative agreements U48DP000046, U48DP000057, and U48DP000056). Tracy Richmond is funded by the National Institutes of Health (NIH) Career Development award (NICHD K01 HD058042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fox MK, 2009, J AM DIET ASSOC, V109, pS108, DOI 10.1016/j.jada.2008.10.065; Frankenberg E, 2002, RACE AM SCH RAPIDLY; GLEASON PM, 2001, CHILDRENS DIETS MID; Johnston LD, 2007, AM J PREV MED, V33, pS195, DOI 10.1016/j.amepre.2007.07.015; O'Malley PM, 2007, AM J PREV MED, V33, pS187, DOI 10.1016/j.amepre.2007.07.001; O'Malley PM, 2009, J ADOLESCENT HEALTH, V45, pS71, DOI 10.1016/j.jadohealth.2009.04.008; Richmond TK, 2008, OBESITY, V16, P1324, DOI 10.1038/oby.2008.48; Schuster MA, 2012, NEW ENGL J MED, V367, P735, DOI 10.1056/NEJMsa1114353; StataCorp, 2011, STAT STAT SOFTW REL, P173; Story M, 2006, FUTURE CHILD, V16, P109, DOI 10.1353/foc.2006.0007; Terry-McElrath YM, 2009, J ADOLESCENT HEALTH, V45, pS45, DOI 10.1016/j.jadohealth.2009.04.007; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 2010, ARCH PEDIAT ADOL MED, V164, P1167, DOI 10.1001/archpediatrics.2010.218; Windle M, 2004, AM J PREV MED, V27, P164, DOI 10.1016/j.amepre.2004.04.007	14	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e83254	10.1371/journal.pone.0083254	http://dx.doi.org/10.1371/journal.pone.0083254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454697	Green Published, gold			2022-12-25	WOS:000329922500005
J	Turoczi, Z; Aranyi, P; Lukats, A; Garbaisz, D; Lotz, G; Harsanyi, L; Szijarto, A				Turoczi, Zsolt; Aranyi, Peter; Lukats, Akos; Garbaisz, David; Lotz, Gabor; Harsanyi, Laszlo; Szijarto, Attila			Muscle Fiber Viability, a Novel Method for the Fast Detection of Ischemic Muscle Injury in Rats	PLOS ONE			English	Article							ACUTE LIMB ISCHEMIA; SKELETAL-MUSCLE; REPERFUSION INJURY; FROZEN-SECTION; TISSUE; METABOLISM; PROTECTION; MANAGEMENT; DIAGNOSIS; OXIDASE	Acute lower extremity ischemia is a limb- and life-threatening clinical problem. Rapid detection of the degree of injury is crucial, however at present there are no exact diagnostic tests available to achieve this purpose. Our goal was to examine a novel technique -which has the potential to accurately assess the degree of ischemic muscle injury within a short period of time - in a clinically relevant rodent model. Male Wistar rats were exposed to 4, 6, 8 and 9 hours of bilateral lower limb ischemia induced by the occlusion of the infrarenal aorta. Additional animals underwent 8 and 9 hours of ischemia followed by 2 hours of reperfusion to examine the effects of revascularization. Muscle samples were collected from the left anterior tibial muscle for viability assessment. The degree of muscle damage (muscle fiber viability) was assessed by morphometric evaluation of NADH-tetrazolium reductase reaction on frozen sections. Right hind limbs were perfusion-fixed with paraformaldehyde and glutaraldehyde for light and electron microscopic examinations. Muscle fiber viability decreased progressively over the time of ischemia, with significant differences found between the consecutive times. High correlation was detected between the length of ischemia and the values of muscle fiber viability. After reperfusion, viability showed significant reduction in the 8-hour-ischemia and 2-hour-reperfusion group compared to the 8-hour-ischemia-only group, and decreased further after 9 hours of ischemia and 2 hours of reperfusion. Light- and electron microscopic findings correlated strongly with the values of muscle fiber viability: lesser viability values represented higher degree of ultrastructural injury while similar viability results corresponded to similar morphological injury. Muscle fiber viability was capable of accurately determining the degree of muscle injury in our rat model. Our method might therefore be useful in clinical settings in the diagnostics of acute ischemic muscle injury.	[Turoczi, Zsolt; Aranyi, Peter; Garbaisz, David; Harsanyi, Laszlo; Szijarto, Attila] Semmelweis Univ, Dept Surg 1, H-1085 Budapest, Hungary; [Lukats, Akos] Semmelweis Univ, Dept Human Morphol & Dev Biol, H-1085 Budapest, Hungary; [Lotz, Gabor] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University	Turoczi, Z (corresponding author), Semmelweis Univ, Dept Surg 1, H-1085 Budapest, Hungary.	zsturoczi@gmail.com	David, Garbaisz/C-8022-2014	David, Garbaisz/0000-0001-8047-3665; Lukats, Akos/0000-0003-3468-2866				BARIE PS, 1988, J SURG RES, V44, P284, DOI 10.1016/0022-4804(88)90059-5; BELKIN M, 1988, AM J SURG, V156, P83, DOI 10.1016/S0002-9610(88)80360-X; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; BLEBEA J, 1987, J SURG RES, V43, P311, DOI 10.1016/0022-4804(87)90087-4; Brandao ML, 2003, J SURG RES, V110, P235, DOI 10.1016/S0022-4804(02)00093-8; BRYANT RE, 1958, CIRC RES, V6, P699, DOI 10.1161/01.RES.6.6.699; Cahoon NJ, 2013, PLAST RECONSTR SURG, V131, P473, DOI 10.1097/PRS.0b013e31827c6e0b; Carmo-Araujo EM, 2007, INT J EXP PATHOL, V88, P147, DOI 10.1111/j.1365-2613.2007.00526.x; Chan RK, 2004, J SURG RES, V122, P54, DOI 10.1016/j.jss.2004.05.003; Ciena AP, 2011, MICRON, V42, P871, DOI 10.1016/j.micron.2011.06.003; COLBURN MD, 1992, J SURG RES, V52, P309, DOI 10.1016/0022-4804(92)90108-C; Creager MA, 2012, NEW ENGL J MED, V366, P2198, DOI 10.1056/NEJMcp1006054; FARBER JL, 1981, AM J PATHOL, V102, P271; Gillani S, 2012, INJURY, V43, P670, DOI 10.1016/j.injury.2011.03.008; Gyurkovics E, 2011, J SURG RES, V169, P139, DOI 10.1016/j.jss.2009.10.014; HARRIS K, 1986, AM J PHYSIOL, V250, pH213, DOI 10.1152/ajpheart.1986.250.2.H213; Heatley MK, 2012, INT J GYNECOL PATHOL, V31, P111, DOI 10.1097/PGP.0b013e318226043b; Henke PK, 2009, SEMIN VASC SURG, V22, P34, DOI 10.1053/j.semvascsurg.2009.01.002; Herbert KJ, 2001, EUR J PHARMACOL, V424, P59, DOI 10.1016/S0014-2999(01)01133-5; HICKEY MJ, 1992, J SURG RES, V53, P369, DOI 10.1016/0022-4804(92)90063-6; Homer-Vanniasinkam S, 2001, EUR J VASC ENDOVASC, V22, P523, DOI 10.1053/ejvs.2001.1467; IDSTROM JP, 1990, AM J PHYSIOL, V258, pH1668, DOI 10.1152/ajpheart.1990.258.6.H1668; JANDA J, 1974, PHYSIOL BOHEMOSLOV, V23, P521; JENNINGS RB, 1975, AM J PATHOL, V81, P179; JENNINGS RB, 1969, AM J CARDIOL, V24, P753, DOI 10.1016/0002-9149(69)90464-0; JENNISCHE E, 1985, ACTA PHYSIOL SCAND, V125, P727, DOI 10.1111/j.1748-1716.1985.tb07776.x; KARPATI G, 1974, J NEUROL SCI, V23, P129, DOI 10.1016/0022-510X(74)90148-8; KLEIN HH, 1981, VIRCHOWS ARCH A, V393, P287, DOI 10.1007/BF00430828; Knight KR, 1997, EUR J PHARMACOL, V332, P273, DOI 10.1016/S0014-2999(97)01101-1; LINDSAY TF, 1990, J VASC SURG, V12, P8, DOI 10.1067/mva.1990.19946; MALAN E, 1963, J CARDIOVASC SURG, V4, P212; McAllister SE, 2008, AM J PHYSIOL-REG I, V295, pR681, DOI 10.1152/ajpregu.90303.2008; Merrick MA, 1999, MED SCI SPORT EXER, V31, P1516, DOI 10.1097/00005768-199911000-00004; Miedema JR, 2010, J GASTROINTEST LIVER, V19, P181; MOORE DH, 1956, J BIOPHYS BIOCHEM CY, V2, P755, DOI 10.1083/jcb.2.6.755; Nanobashvili J, 2003, SURGERY, V133, P91, DOI 10.1067/msy.2003.65; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; NOVIKOFF AB, 1961, J BIOPHYS BIOCHEM CY, V9, P47, DOI 10.1083/jcb.9.1.47; Pemberton M, 1999, EUR J VASC ENDOVASC, V17, P72, DOI 10.1053/ejvs.1998.0709; PETRASEK PF, 1994, J VASC SURG, V19, P623, DOI 10.1016/S0741-5214(94)70035-4; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Rutherford RB, 2009, SEMIN VASC SURG, V22, P5, DOI 10.1053/j.semvascsurg.2008.12.003; SCHAPER W, 1979, BASIC RES CARDIOL, V74, P46, DOI 10.1007/BF01907684; Schmidt RL, 2011, AM J CLIN PATHOL, V136, P729, DOI 10.1309/AJCP2SD8RFQEUZJW; SEIFERT FC, 1985, J CARDIOVASC SURG, V26, P502; Troitzsch D, 2013, SHOCK, V39, P220, DOI 10.1097/SHK.0b013e31828044f6; Troitzsch D, 2011, J SURG RES, V169, P156, DOI 10.1016/j.jss.2009.08.017; Tsubota H, 2010, EUR J VASC ENDOVASC, V40, P804, DOI 10.1016/j.ejvs.2010.08.014; WACHSTEIN M, 1955, AM J PATHOL, V31, P353; Walters TJ, 2011, J TRAUMA, V70, P1192, DOI 10.1097/TA.0b013e318217879a; Wang JX, 2005, ACTA PHARMACOL SIN, V26, P821, DOI 10.1111/j.1745-7254.2005.00128.x; Wang WZ, 2011, PLAST RECONSTR SURG, V128, p685E, DOI 10.1097/PRS.0b013e318230c57b; Woitaske MD, 1998, PLAST RECONSTR SURG, V102, P2052, DOI 10.1097/00006534-199811000-00037	53	11	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84783	10.1371/journal.pone.0084783	http://dx.doi.org/10.1371/journal.pone.0084783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454750	gold, Green Published, Green Submitted			2022-12-25	WOS:000329922500021
J	Wei, B; Zhang, RZ; Guo, JJ; Liu, DM; Li, AL; Fan, RC; Mao, L; Zhang, XQ				Wei, Bo; Zhang, Rong-Zhi; Guo, Juan-Juan; Liu, Dan-Mei; Li, Ai-Li; Fan, Ren-Chun; Mao, Long; Zhang, Xiang-Qi			Genome-Wide Analysis of the MADS-Box Gene Family in Brachypodium distachyon	PLOS ONE			English	Article							FLORAL ORGAN IDENTITY; ENDOSPERM DEVELOPMENT; DOMAIN PROTEIN; EVOLUTIONARY ANALYSIS; TRANSCRIPTION FACTORS; CENTRAL CELL; ARABIDOPSIS; RICE; DUPLICATION; DIVERGENCE	MADS-box genes are important transcription factors for plant development, especially floral organogenesis. Brachypodium distachyon is a model for biofuel plants and temperate grasses such as wheat and barley, but a comprehensive analysis of MADS-box family proteins in Brachypodium is still missing. We report here a genome-wide analysis of the MADS-box gene family in Brachypodium distachyon. We identified 57 MADS-box genes and classified them into 32 MIKCc-type, 7 MIKC*-type, 9 M alpha, 7 M beta and 2 M gamma MADS-box genes according to their phylogenetic relationships to the Arabidopsis and rice MADS-box genes. Detailed gene structure and motif distribution were then studied. Investigation of their chromosomal localizations revealed that Brachypodium MADS-box genes distributed evenly across five chromosomes. In addition, five pairs of type II MADS-box genes were found on synteny blocks derived from whole genome duplication blocks. We then performed a systematic expression analysis of Brachypodium MADS-box genes in various tissues, particular floral organs. Further detection under salt, drought, and low-temperature conditions showed that some MADS-box genes may also be involved in abiotic stress responses, including type I genes. Comparative studies of MADS-box genes among Brachypodium, rice and Arabidopsis showed that Brachypodium had fewer gene duplication events. Taken together, this work provides useful data for further functional studies of MADS-box genes in Brachypodium distachyon.	[Wei, Bo; Fan, Ren-Chun; Zhang, Xiang-Qi] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Zhang, Rong-Zhi; Guo, Juan-Juan; Liu, Dan-Mei; Li, Ai-Li; Mao, Long] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Zhang, Rong-Zhi; Guo, Juan-Juan; Liu, Dan-Mei; Li, Ai-Li; Mao, Long] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Mao, L (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	maolong@caas.net.cn; xqzhang@genetics.ac.cn	GUO, JUAN/HIK-2220-2022		National Key Technology R D Program [2011BAD07B00]; National Natural Science Foundation of China [31101141]; National High Tech Program [2012AA100108]; National Science Foundation of China [31070260]	National Key Technology R D Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech Program; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by National Key Technology R & D Program (2011BAD07B00), National Natural Science Foundation of China (31101141), National High Tech Program (2012AA100108) and National Science Foundation of China (31070260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk BJ, 2009, PLANT PHYSIOL, V149, P1713, DOI 10.1104/pp.109.135806; Airoldi CA, 2012, J GENET GENOMICS, V39, P157, DOI 10.1016/j.jgg.2012.02.008; Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Angenent GC, 1996, TRENDS PLANT SCI, V1, P228; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Bemer M, 2008, PLANT CELL, V20, P2088, DOI 10.1105/tpc.108.058958; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; BOWMAN JL, 1991, PLANT CELL, V3, P749, DOI 10.1105/tpc.3.8.749; Burland T. G., 1999, BIOINFORMATICS METHO; Causier B, 2002, SCIENCE, V296, P275, DOI 10.1126/science.1071401; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; COLOMBO L, 1995, PLANT CELL, V7, P1859, DOI 10.1105/tpc.7.11.1859; Davies B, 1996, EMBO J, V15, P4330, DOI 10.1002/j.1460-2075.1996.tb00807.x; Day RC, 2008, PLANT PHYSIOL, V148, P1964, DOI 10.1104/pp.108.128108; De Bodt S, 2003, J MOL EVOL, V56, P573, DOI 10.1007/s00239-002-2426-x; Diaz-Riquelme J, 2009, PLANT PHYSIOL, V149, P354, DOI 10.1104/pp.108.131052; Eckardt N.A, 2008, PLANT CELL, V20, P3, DOI [10.1105/tpc.108.058586, DOI 10.1105/TPC.108.058586]; Fan CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062288; FISCHER A, 1995, NUCLEIC ACIDS RES, V23, P1901, DOI 10.1093/nar/23.11.1901; Fornara F, 2004, PLANT PHYSIOL, V135, P2207, DOI 10.1104/pp.104.045039; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo X. Y., 2004, RICE SINENCE, V12, P173; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Henschel K, 2002, MOL BIOL EVOL, V19, P801, DOI 10.1093/oxfordjournals.molbev.a004137; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu LF, 2012, GENOME, V55, P245, DOI [10.1139/G2012-009, 10.1139/g2012-009]; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Kang IH, 2008, PLANT CELL, V20, P635, DOI 10.1105/tpc.107.055137; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Kramer EM, 1998, GENETICS, V149, P765; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee HL, 2011, MOL BIOL EVOL, V28, P3367, DOI 10.1093/molbev/msr169; Lee JH, 2012, PLANT SCI, V185, P97, DOI 10.1016/j.plantsci.2011.09.003; Lee S, 2008, PLANT J, V54, P93, DOI 10.1111/j.1365-313X.2008.03406.x; Leseberg CH, 2006, GENE, V378, P84, DOI 10.1016/j.gene.2006.05.022; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Liu C, 2013, DEV CELL, V24, P612, DOI 10.1016/j.devcel.2013.02.013; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; Ma H, 2000, CELL, V101, P5, DOI 10.1016/S0092-8674(00)80618-2; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; Masiero S, 2011, PLANT CELL, V23, P865, DOI 10.1105/tpc.110.081737; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; Nayar S, 2013, J EXP BOT, V64, P4239, DOI 10.1093/jxb/ert231; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Portereiko MF, 2006, PLANT CELL, V18, P1862, DOI 10.1105/tpc.106.040824; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sang XC, 2012, PLANT PHYSIOL, V160, P788, DOI 10.1104/pp.112.200980; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shan HY, 2009, MOL BIOL EVOL, V26, P2229, DOI 10.1093/molbev/msp129; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tiwari S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-72; Trevaskis B, 2003, P NATL ACAD SCI USA, V100, P13099, DOI 10.1073/pnas.1635053100; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wei B, 2013, J PLANT PHYSIOL, V170, P424, DOI 10.1016/j.jplph.2012.11.013; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Xiao H, 2003, PLANT MOL BIOL, V52, P957, DOI 10.1023/A:1025401611354; Yamaguchi T, 2006, PLANT CELL, V18, P15, DOI 10.1105/tpc.105.037200; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Yao SG, 2008, PLANT CELL PHYSIOL, V49, P853, DOI 10.1093/pcp/pcn050; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zhao T, 2006, MOL GENET GENOMICS, V276, P334, DOI 10.1007/s00438-006-0147-3	79	63	76	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84781	10.1371/journal.pone.0084781	http://dx.doi.org/10.1371/journal.pone.0084781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454749	Green Submitted, Green Published, gold			2022-12-25	WOS:000329922500020
J	Carter, RR; DiFeo, A; Bogie, K; Zhang, GQ; Sun, JY				Carter, Rebecca R.; DiFeo, Analisa; Bogie, Kath; Zhang, Guo-Qiang; Sun, Jiayang			Crowdsourcing Awareness: Exploration of the Ovarian Cancer Knowledge Gap through Amazon Mechanical Turk	PLOS ONE			English	Article							BREAST; WOMEN; MAMMOGRAPHY; STATISTICS; ACCURACY; SYMPTOMS	Background: Ovarian cancer is the most lethal gynecologic disease in the United States, with more women dying from this cancer than all gynecological cancers combined. Ovarian cancer has been termed the "silent killer" because some patients do not show clear symptoms at an early stage. Currently, there is a lack of approved and effective early diagnostic tools for ovarian cancer. There is also an apparent severe knowledge gap of ovarian cancer in general and of its indicative symptoms among both public and many health professionals. These factors have significantly contributed to the late stage diagnosis of most ovarian cancer patients (63% are diagnosed at Stage III or above), where the 5-year survival rate is less than 30%. The paucity of knowledge concerning ovarian cancer in the United States is unknown. Methods: The present investigation examined current public awareness and knowledge about ovarian cancer. The study implemented design strategies to develop an unbiased survey with quality control measures, including the modern application of multiple statistical analyses. The survey assessed a reasonable proxy of the US population by crowdsourcing participants through the online task marketplace Amazon Mechanical Turk, at a highly condensed rate of cost and time compared to traditional recruitment methods. Conclusion: Knowledge of ovarian cancer was compared to that of breast cancer using repeated measures, bias control and other quality control measures in the survey design. Analyses included multinomial logistic regression and categorical data analysis procedures such as correspondence analysis, among other statistics. We confirmed the relatively poor public knowledge of ovarian cancer among the US population. The simple, yet novel design should set an example for designing surveys to obtain quality data via Amazon Mechanical Turk with the associated analyses.	[Carter, Rebecca R.; Sun, Jiayang] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [DiFeo, Analisa; Zhang, Guo-Qiang] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Bogie, Kath] Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA; [Bogie, Kath] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Sun, JY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	jsun@case.edu		Sun, Jiayang/0000-0002-0870-7014; DiFeo, Analisa/0000-0001-8319-6763; Bogie, Kath/0000-0003-1020-9695	Choose Ohio First Scholarship program in Biomedical Informatics through the EECS Department in Computer Science & Engineering at Case Western Reserve University; Division of Medical Informatics at Case Western School of Medicine; NIH/NCATS [UL1TR000439]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	Choose Ohio First Scholarship program in Biomedical Informatics through the EECS Department in Computer Science & Engineering at Case Western Reserve University; Division of Medical Informatics at Case Western School of Medicine; NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the Choose Ohio First Scholarship program in Biomedical Informatics through the EECS Department in Computer Science & Engineering at Case Western Reserve University and the Division of Medical Informatics at Case Western School of Medicine for RRC. GQZ acknowledges support from NIH/NCATS award UL1TR000439. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abel EK, 1998, SELECTIVE COMPLIANCE, P310; Baldwin LM, 2012, ANN INTERN MED, V156, P182, DOI 10.7326/0003-4819-156-3-201202070-00006; Bergh J, 2001, ACTA ONCOL, V40, P253, DOI 10.1080/02841860151116349; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Breen N, 2007, CANCER-AM CANCER SOC, V109, P2405, DOI 10.1002/cncr.22723; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Catalano R, 2003, EUR J EPIDEMIOL, V18, P545, DOI 10.1023/A:1024620617272; d'Agincourt-Canning Lori, 2005, J Genet Couns, V14, P55, DOI 10.1007/s10897-005-1500-0; FRISON L, 1992, STAT MED, V11, P1685, DOI 10.1002/sim.4780111304; Gardner RM, 2012, BODY IMAGE, V9, P532, DOI 10.1016/j.bodyim.2012.06.006; Goff BA, 2004, JAMA-J AM MED ASSOC, V291, P2705, DOI 10.1001/jama.291.22.2705; Goff BA, 2007, CANCER, V109, P221, DOI 10.1002/cncr.22371; Goodman JK, 2012, J BEHAV DECIS MAK; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Green PE, 1978, RES MARKETING DECISI; Greenlaw C, 2009, EVALUATION REV, V33, P464, DOI 10.1177/0193841X09340214; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Howden LM, 2010, AGE SEX COMPOSITION; Jacobsen GD, 2011, J HEALTH ECON, V30, P55, DOI 10.1016/j.jhealeco.2010.11.005; Kenen R, 2004, PSYCHO-ONCOL, V13, P335, DOI 10.1002/pon.745; Kenen R, 2003, SOCIOL HEALTH ILL, V25, P838, DOI 10.1046/j.1467-9566.2003.00372.x; Kobel M, 2010, AM J SURG PATHOL, V34, P984, DOI 10.1097/PAS.0b013e3181e1a3bb; Lerner BH, 2002, NAT REV CANCER, V2, P225, DOI 10.1038/nrc744; Low EL, 2013, J FAM PLAN REPROD H, V39, P163, DOI 10.1136/jfprhc-2012-100473; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; McAllister M, 2002, J HEALTH PSYCHOL, V7, P491, DOI 10.1177/1359105302007005628; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; R Development Core Team, 2008, R LANG ENV STAT COMP; RADLOW R, 1975, J AM STAT ASSOC, V70, P811, DOI 10.2307/2285440; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Schonlau M, 2002, MR1480RC RAND; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simon AE, 2012, J FAM PLAN REPROD H, V38, P167, DOI 10.1136/jfprhc-2011-100118; Slomski A, 2012, JAMA-J AM MED ASSOC, V307, P2474, DOI 10.1001/jama.2012.5646; Sulik G. A., 2007, QUAL SOCIOL, V30, P297, DOI DOI 10.1007/S11133-007-9057-X; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Tabar L, 2003, LANCET, V361, P1405, DOI 10.1016/S0140-6736(03)13143-1; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; VENABLES WN, 1997, MODERN APPL STAT S P; Wu S, 2003, J HEALTH ECON, V22, P675, DOI 10.1016/S0167-6296(03)00042-0	41	41	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85508	10.1371/journal.pone.0085508	http://dx.doi.org/10.1371/journal.pone.0085508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465580	gold, Green Submitted, Green Published			2022-12-25	WOS:000330283100043
J	Bean, GJ; Jaeger, PA; Bahr, S; Ideker, T				Bean, Gordon J.; Jaeger, Philipp A.; Bahr, Sondra; Ideker, Trey			Development of Ultra-High-Density Screening Tools for Microbial "Omics"	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; SCALE; MAP	High-throughput genetic screens in model microbial organisms are a primary means of interrogating biological systems. In numerous cases, such screens have identified the genes that underlie a particular phenotype or a set of gene-gene, gene-environment or protein-protein interactions, which are then used to construct highly informative network maps for biological research. However, the potential test space of genes, proteins, or interactions is typically much larger than current screening systems can address. To push the limits of screening technology, we developed an ultra-high-density, 6144-colony arraying system and analysis toolbox. Using budding yeast as a benchmark, we find that these tools boost genetic screening throughput 4-fold and yield significant cost and time reductions at quality levels equal to or better than current methods. Thus, the new ultra-high-density screening tools enable researchers to significantly increase the size and scope of their genetic screens.	[Bean, Gordon J.] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Jaeger, Philipp A.; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Jaeger, Philipp A.; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Bahr, Sondra] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Ideker, Trey] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Toronto; University of California System; University of California San Diego	Ideker, T (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	tideker@ucsd.edu		Jaeger, Philipp A./0000-0002-3624-0802; Ideker, Trey/0000-0002-1708-8454	National Institutes of Health [GM084279, GM085764]; Genomics Ontario Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, R01GM084279, T32GM008666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genomics Ontario Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM084279 and GM085764 to TI and a grant to develop a "High density replicator System" by Genomics Ontario Inc. to SB. This research was conducted while PAJ was an Ellison Medical Foundation/AFAR Postdoctoral Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Baryshnikova A, 2010, METHOD ENZYMOL, V470, P145, DOI 10.1016/S0076-6879(10)70007-0; Bean GJ, 2013, COLONY ANAL TOOLKIT, P1; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Collins SR, 2010, METHOD ENZYMOL, V470, P205, DOI 10.1016/S0076-6879(10)70009-4; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Ryan CJ, 2012, MOL CELL, V46, P691, DOI 10.1016/j.molcel.2012.05.028; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wagih O, 2013, NUCLEIC ACIDS RES, V41, pW591, DOI 10.1093/nar/gkt400	15	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85177	10.1371/journal.pone.0085177	http://dx.doi.org/10.1371/journal.pone.0085177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465499	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500040
J	Westmoreland, SV; Converse, AP; Hrecka, K; Hurley, M; Knight, H; Piatak, M; Lifson, J; Mansfield, KG; Skowronski, J; Desrosiers, RC				Westmoreland, Susan V.; Converse, A. Peter; Hrecka, Kasia; Hurley, Mollie; Knight, Heather; Piatak, Michael; Lifson, Jeffrey; Mansfield, Keith G.; Skowronski, Jacek; Desrosiers, Ronald C.			SIV Vpx Is Essential for Macrophage Infection but Not for Development of AIDS	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; COLONY-STIMULATING FACTOR; SAMHD1 RESTRICTS; RHESUS-MONKEYS; HIV-1 INFECTION; PRIMATE LENTIVIRUSES; DISEASE PROGRESSION; VACCINE PROTECTION; IMMUNE-RESPONSES	Analysis of rhesus macaques infected with a vpx deletion mutant virus of simian immunodeficiency virus mac239 (SIV Delta vpx) demonstrates that Vpx is essential for efficient monocyte/macrophage infection in vivo but is not necessary for development of AIDS. To compare myeloid-lineage cell infection in monkeys infected with SIV Delta vpx compared to SIVmac239, we analyzed lymphoid and gastrointestinal tissues from SIV Delta vpx-infected rhesus (n = 5), SIVmac239-infected rhesus with SIV encephalitis (7 SIV239E), those without encephalitis (4 SIV239noE), and other SIV mutant viruses with low viral loads (4 SIV Delta nef, 2 SIV Delta 3). SIV+ macrophages and the percentage of total SIV+ cells that were macrophages in spleen and lymph nodes were significantly lower in rhesus infected with SIV Delta vpx (2.2%) compared to those infected with SIV239E (22.7%), SIV239noE (8.2%), and SIV mutant viruses (10.1%). In colon, SIV Delta vpx monkeys had fewer SIV+ cells, no SIV+ macrophages, and lower percentage of SIV+ cells that were macrophages than the other 3 groups. Only 2 SIV Delta vpx monkeys exhibited detectable virus in the colon. We demonstrate that Vpx is essential for efficient macrophage infection in vivo and that simian AIDS and death can occur in the absence of detectable macrophage infection.	[Westmoreland, Susan V.; Converse, A. Peter; Hurley, Mollie; Knight, Heather; Mansfield, Keith G.] Harvard Univ, Sch Med, New England Primate Res Ctr, Div Comparat Pathol, Southborough, MA 01772 USA; [Piatak, Michael; Lifson, Jeffrey] NCI, AIDS & Canc Virus Program, SAIC Frederick, Frederick, MD 21701 USA; [Hrecka, Kasia; Skowronski, Jacek] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Desrosiers, Ronald C.] Harvard Univ, Sch Med, New England Primate Res Ctr, Div Microbiol, Southborough, MA 01772 USA	Harvard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Case Western Reserve University; Harvard University	Westmoreland, SV (corresponding author), Harvard Univ, Sch Med, New England Primate Res Ctr, Div Comparat Pathol, Southborough, MA 01772 USA.	susan_westmoreland@hms.harvard.edu			NIH [P51 1OD011103, 5 R01 AI25328-22, R01 AI077459, T32 OD011064]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100673, R01AI025328, R01AI077459] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011103, T32OD011064] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH grants P51 1OD011103, 5 R01 AI25328-22, R01 AI077459, T32 OD011064, National Cancer Institute, National Institutes of Health under contract No. HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2013, CURR HIV-AIDS REP, V10, P3, DOI 10.1007/s11904-012-0149-1; Alexander L, 2003, J VIROL, V77, P6823, DOI 10.1128/JVI.77.12.6823-6835.2003; Annamalai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014429; Ayinde D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-35; BAGASRA O, 1992, P NATL ACAD SCI USA, V89, P6285, DOI 10.1073/pnas.89.14.6285; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; BERGAMINI A, 1994, BLOOD, V84, P3405; Bloch N, 2013, AIDS RES HUMAN RETRO; Borda JT, 2004, AM J PATHOL, V165, P2111, DOI 10.1016/S0002-9440(10)63261-0; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Breed MW, 2013, J VIROL, V87, P1528, DOI 10.1128/JVI.01928-12; Campbell BJ, 1997, J VIROL, V71, P5593, DOI 10.1128/JVI.71.7.5593-5602.1997; Cline AN, 2005, J MED PRIMATOL, V34, P303; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; DESROSIERS RC, 1991, AM J PATHOL, V139, P29; Desrosiers RC, 1998, J VIROL, V72, P1431, DOI 10.1128/JVI.72.2.1431-1437.1998; Fletcher TM, 1996, EMBO J, V15, P6155, DOI 10.1002/j.1460-2075.1996.tb01003.x; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P607, DOI 10.1089/aid.1994.10.607; Goujon C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-23; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; Igarashi T, 2003, J VIROL, V77, P13042, DOI 10.1128/JVI.77.24.13042-13052.2003; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchoff V, 2002, ARCH VIROL, V147, P321, DOI 10.1007/s705-002-8322-9; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Ling BH, 2002, AIDS, V16, P1489, DOI 10.1097/00002030-200207260-00005; Mansfield K, 2008, J VIROL, V82, P4135, DOI 10.1128/JVI.00015-08; Masliah E, 1996, CRIT REV NEUROBIOL, V10, P57, DOI 10.1615/CritRevNeurobiol.v10.i1.30; Newstein MC, 2001, J INFECT DIS, V184, P1262, DOI 10.1086/324079; O'Neil SP, 2004, AM J PATHOL, V164, P1157, DOI 10.1016/S0002-9440(10)63204-X; O'Neil SP, 2000, J INFECT DIS, V182, P1051, DOI 10.1086/315823; Puigdomenech I, 2013, J VIROL, V87, P2846, DOI 10.1128/JVI.02514-12; RINGLER DJ, 1988, ANN NEUROL, V23, pS101, DOI 10.1002/ana.410230726; Serra-Moreno R, 2011, CELL HOST MICROBE, V9, P46, DOI 10.1016/j.chom.2010.12.005; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sharp PM, 1996, NATURE, V383, P586, DOI 10.1038/383586a0; SIMON MA, 1992, AIDS RES HUM RETROV, V8, P327, DOI 10.1089/aid.1992.8.327; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; TRISTEM M, 1992, EMBO J, V11, P3405, DOI 10.1002/j.1460-2075.1992.tb05419.x; Tristem M, 1998, VIROLOGY, V240, P232, DOI 10.1006/viro.1997.8929; VALLANCE SJ, 1990, BIOCHEM J, V265, P359, DOI 10.1042/bj2650359; WILEY CA, 1994, ADV NEUROIMMUNOL, V4, P319, DOI 10.1016/S0960-5428(06)80272-X; Wyand MS, 1996, J VIROL, V70, P3724, DOI 10.1128/JVI.70.6.3724-3733.1996; Yearley JH, 2009, LAB INVEST, V89, P657, DOI 10.1038/labinvest.2009.29	51	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84463	10.1371/journal.pone.0084463	http://dx.doi.org/10.1371/journal.pone.0084463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465411	Green Submitted, gold, Green Published			2022-12-25	WOS:000330244500005
J	Dunmire, SK; Odumade, OA; Porter, JL; Reyes-Genere, J; Schmeling, DO; Bilgic, H; Fan, DH; Baechler, EC; Balfour, HH; Hogquist, KA				Dunmire, Samantha K.; Odumade, Oludare A.; Porter, Jean L.; Reyes-Genere, Juan; Schmeling, David O.; Bilgic, Hatice; Fan, Danhua; Baechler, Emily C.; Balfour, Henry H., Jr.; Hogquist, Kristin A.			Primary EBV Infection Induces an Expression Profile Distinct from Other Viruses but Similar to Hemophagocytic Syndromes	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PERIPHERAL-BLOOD; MACROPHAGE ACTIVATION; POSSIBLE ETIOLOGY; INTERFERON; GAMMA; PREVALENCE; RESPONSES; REACTIVATION	Epstein-Barr Virus (EBV) causes infectious mononucleosis and establishes lifelong infection associated with cancer and autoimmune disease. To better understand immunity to EBV, we performed a prospective study of natural infection in healthy humans. Transcriptome analysis defined a striking and reproducible expression profile during acute infection but no lasting gene changes were apparent during latent infection. Comparing the EBV response profile to multiple other acute viral infections, including influenza A (influenza), respiratory syncytial virus (RSV), human rhinovirus (HRV), attenuated yellow fever virus (YFV), and Dengue fever virus (DENV), revealed similarity only to DENV. The signature shared by EBV and DENV was also present in patients with hemophagocytic syndromes, suggesting these two viruses cause uncontrolled inflammatory responses. Interestingly, while EBV induced a strong type I interferon response, a subset of interferon induced genes, including MX1, HERC5, and OAS1, were not upregulated, suggesting a mechanism by which viral antagonism of immunity results in a profound inflammatory response. These data provide an important first description of the response to a natural herpesvirus infection in humans.	[Dunmire, Samantha K.; Odumade, Oludare A.; Porter, Jean L.; Reyes-Genere, Juan; Hogquist, Kristin A.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Schmeling, David O.; Balfour, Henry H., Jr.; Hogquist, Kristin A.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Bilgic, Hatice; Baechler, Emily C.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Fan, Danhua] Univ Minnesota, Sch Med, Biostat & Bioinformat Core, Minneapolis, MN 55455 USA; [Schmeling, David O.; Balfour, Henry H., Jr.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hogquist, KA (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA.	hogqu001@umn.edu		Hogquist, Kristin/0000-0001-9963-5687; Reyes Genere, Juan/0000-0001-9818-110X	National Institutes of Health [T32 AI007313, F31 AI084524, T32 GM008244, PO1 AI35296]; International Center for Antiviral Research and Epidemiology; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313, F31AI084524, P01AI035296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Center for Antiviral Research and Epidemiology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (T32 AI007313 to SKD, F31 AI084524 and T32 GM008244 to OAO, and PO1 AI35296 to KAH) and by the International Center for Antiviral Research and Epidemiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Arvey A, 2012, CELL HOST MICROBE, V12, P233, DOI 10.1016/j.chom.2012.06.008; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Balfour HH, 2013, J INFECT DIS, V207, P80, DOI 10.1093/infdis/jis646; Balfour Jr HH, 2012, J INFECT DIS; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Chen CJ, 2005, J RHEUMATOL, V32, P44; de Bruin AM, 2012, BLOOD, V119, P1543, DOI 10.1182/blood-2011-07-367706; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Diercks A, 2012, CURR TOP MICROBIOL I; Englebienne P, 2003, MED HYPOTHESES, V60, P175, DOI 10.1016/S0306-9877(02)00353-5; Fall N, 2007, ARTHRITIS RHEUM-US, V56, P3793, DOI 10.1002/art.22981; Fraser AR, 2006, J LEUKOCYTE BIOL, V80, P862, DOI 10.1189/jlb.0605297; Grom AA, 2004, ARTHRITIS RHEUM, V50, P689, DOI 10.1002/art.20198; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Harley JB, 2010, ARTHRITIS RHEUM-US, V62, P1571, DOI 10.1002/art.27421; Hermesh T, 2010, VIRUSES-BASEL, V2, P2541, DOI 10.3390/v2112541; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; HOAGLAND RJ, 1955, AM J MED SCI, V229, P262; James JA, 1997, J CLIN INVEST, V100, P3019, DOI 10.1172/JCI119856; James JA, 2001, ARTHRITIS RHEUM-US, V44, P1122, DOI 10.1002/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D; James JA, 2012, CURR OPIN RHEUMATOL, V24, P383, DOI 10.1097/BOR.0b013e3283535801; Khan G, 1996, IMMUNITY, V5, P173, DOI 10.1016/S1074-7613(00)80493-8; Lin Z, 2010, J VIROL, V84, P13053, DOI 10.1128/JVI.01521-10; MALEFYT RD, 1991, J EXP MED, V174, P1209; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Moon UY, 2004, ARTHRITIS RES THER, V6, pR295, DOI 10.1186/ar1181; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007892; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; Odumade OA, 2012, J EXP MED, V209, P471, DOI 10.1084/jem.20112401; Odumade OA, 2011, CLIN MICROBIOL REV, V24, P193, DOI 10.1128/CMR.00044-10; PANITCH HS, 1987, NEUROLOGY, V37, P1097, DOI 10.1212/WNL.37.7.1097; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Quan TE, 2010, ARTHRITIS RHEUM-US, V62, P1693, DOI 10.1002/art.27408; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SAVOIE A, 1994, BLOOD, V83, P2715; Selman M, 2003, AM J RESP CRIT CARE, V167, P945, DOI 10.1164/rccm.2301004; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Sumegi J, 2011, BLOOD, V117, pE151, DOI 10.1182/blood-2010-08-300046; Takeuchi K, 2006, PATHOL INT, V56, P112, DOI 10.1111/j.1440-1827.2006.01936.x; Tselis A, 2012, CURR OPIN RHEUMATOL, V24, P424, DOI 10.1097/BOR.0b013e3283542cf8; van Esser JWJ, 2001, BLOOD, V98, P972, DOI 10.1182/blood.V98.4.972; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Yager EJ, 2009, VIRAL IMMUNOL, V22, P67, DOI 10.1089/vim.2008.0086; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	51	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85422	10.1371/journal.pone.0085422	http://dx.doi.org/10.1371/journal.pone.0085422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465555	Green Submitted, Green Published, gold			2022-12-25	WOS:000330237000033
J	Cui, J; Liu, SK; Zhang, B; Wang, HD; Sun, HJ; Song, SH; Qiu, XM; Liu, Y; Wang, XL; Jiang, ZQ; Liu, ZJ				Cui, Jun; Liu, Shikai; Zhang, Bing; Wang, Hongdi; Sun, Hongjuan; Song, Shuhui; Qiu, Xuemei; Liu, Yang; Wang, Xiuli; Jiang, Zhiqiang; Liu, Zhanjiang			Transciptome Analysis of the Gill and Swimbladder of Takifugu rubripes by RNA-Seq	PLOS ONE			English	Article							RECEPTOR GENE FAMILY; EXPRESSION ANALYSIS; JAPANESE PUFFERFISH; BRANCHING-MORPHOGENESIS; REDUNDANT ROLES; CCR9 EXPRESSION; READ ALIGNMENT; FUGU-RUBRIPES; CHEMOKINE; SOX17	The fish gill, as one of the mucosal barriers, plays an important role in mucosal immune response. The fish swimbladder functions for regulating buoyancy. The fish swimbladder has long been postulated as a homologous organ of the tetrapod lung, but the molecular evidence is scarce. In order to provide new information that is complementary to gill immune genes, initiate new research directions concerning the genetic basis of the gill immune response and understand the molecular function of swimbladder as well as its relationship with lungs, transcriptome analysis of the fugu Takifugu rubripes gill and swimbladder was carried out by RNA-Seq. Approximately 55,061,524 and 44,736,850 raw sequence reads from gill and swimbladder were generated, respectively. Gene ontology (GO) and KEGG pathway analysis revealed diverse biological functions and processes. Transcriptome comparison between gill and swimbladder resulted in 3,790 differentially expressed genes, of which 1,520 were up-regulated in the swimbladder while 2,270 were down-regulated. In addition, 406 up regulated isoforms and 296 down regulated isoforms were observed in swimbladder in comparison to gill. By the gene enrichment analysis, the three immune-related pathways and 32 immune-related genes in gill were identified. In swimbladder, five pathways including 43 swimbladder-enriched genes were identified. This work should set the foundation for studying immune-related genes for the mucosal immunity and provide genomic resources to study the relatedness of the fish swimbladder and mammalian lung.	[Cui, Jun; Wang, Hongdi; Sun, Hongjuan; Qiu, Xuemei; Liu, Yang; Wang, Xiuli; Jiang, Zhiqiang] Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China; [Zhang, Bing; Song, Shuhui] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Dept Fisheries & Allied Aquacultures, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Aquat Genom Unit, Program Cell & Mol Biosci, Auburn, AL 36849 USA	Dalian Ocean University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Auburn University System; Auburn University; Auburn University System; Auburn University	Wang, XL (corresponding author), Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian, Peoples R China.	xiuliwang417@sina.com; zhqjiang@dlou.edu.cn; LIUZHAN@auburn.edu	Liu, Shikai/AAO-2247-2021; Liu, Zhanjiang/R-9633-2019; Cui, Jun/P-9378-2015	Liu, Shikai/0000-0001-5777-489X; 	Program for Liaoning Excellent Talents in University [LR201010]; Dalian Ocean University [2012HYDX07]	Program for Liaoning Excellent Talents in University; Dalian Ocean University	This project was supported by the Program for Liaoning Excellent Talents in University (LR201010) and the grant of Dalian Ocean University (2012HYDX07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabyev BY, 2000, DEV COMP IMMUNOL, V24, P765, DOI 10.1016/S0145-305X(00)00035-5; Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Arena A, 2000, MICROBIOLOGICA, V23, P105; Beck BH, 2012, FISH SHELLFISH IMMUN, V33, P1008, DOI 10.1016/j.fsi.2012.08.018; Bei JX, 2006, MOL IMMUNOL, V43, P860, DOI 10.1016/j.molimm.2005.06.040; Bird S, 2005, DEV COMP IMMUNOL, V29, P775, DOI 10.1016/j.dci.2005.01.002; Bird S, 2005, IMMUNOGENETICS, V56, P909, DOI 10.1007/s00251-004-0741-7; Boucherat O, 2012, BIOL OPEN, V1, P677, DOI 10.1242/bio.20121701; Brocker Chad, 2010, Human Genomics, V5, P30; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Chan TM, 2009, DEV BIOL, V326, P456, DOI 10.1016/j.ydbio.2008.11.010; Chong SW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-54; Chong SW, 2001, MECH DEVELOP, V109, P347, DOI 10.1016/S0925-4773(01)00520-2; Clarke RL, 2013, NAT CELL BIOL, V15, P502, DOI 10.1038/ncb2724; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Daniels GD, 1999, J LEUKOCYTE BIOL, V65, P684, DOI 10.1002/jlb.65.5.684; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Dean CH, 2005, DEV BIOL, V286, P270, DOI 10.1016/j.ydbio.2005.07.034; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; Dickerson H, 1998, IMMUNOL REV, V22, P465; Dong Wei-ren, 2006, Journal of Zhejiang University Science Edition, V33, P688; Fang W, 2006, COMP BIOCHEM PHYS B, V143, P335, DOI 10.1016/j.cbpb.2005.12.009; Fu Jian-hua, 2008, Zhonghua Er Ke Za Zhi, V46, P540; Fujiki K, 1999, IMMUNOGENETICS, V49, P909, DOI 10.1007/s002510050573; Goostrey A, 2005, DEV COMP IMMUNOL, V29, P229, DOI 10.1016/j.dci.2004.06.012; Grier DG, 2009, NEONATOLOGY, V96, P50, DOI 10.1159/000201739; Gunimaladevi I, 2007, FISH SHELLFISH IMMUN, V22, P351, DOI 10.1016/j.fsi.2006.05.009; Jault C, 2004, MOL IMMUNOL, V40, P759, DOI 10.1016/j.molimm.2003.10.001; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kobayashi D, 2006, DEV GROWTH DIFFER, V48, P283, DOI 10.1111/j.1440-169x.2006.00870.x; Kono T, 2008, FEBS J, V275, P1213, DOI 10.1111/j.1742-4658.2008.06281.x; Korenaga H, 2010, FISH SHELLFISH IMMUN, V28, P809, DOI 10.1016/j.fsi.2010.01.016; Lange AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005711; Lee HS, 2012, IMMUNOBIOLOGY, V217, P402, DOI 10.1016/j.imbio.2011.10.014; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2013, ARCH IMMUNOL THER EX, V61, P237, DOI 10.1007/s00005-013-0223-4; Liu SK, 2013, PHYSIOL GENOMICS, V45, P462, DOI 10.1152/physiolgenomics.00026.2013; Liu SK, 2013, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-595; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Liu Y, 2009, MOL IMMUNOL, V46, P498, DOI 10.1016/j.molimm.2008.10.003; Long QM, 2000, MECH DEVELOP, V97, P183, DOI 10.1016/S0925-4773(00)00408-1; Lu C, 2013, FISH SHELLFISH IMMUN, V34, P372, DOI 10.1016/j.fsi.2012.11.004; Lu IN, 2012, DEV COMP IMMUNOL, V38, P203, DOI 10.1016/j.dci.2012.07.003; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Melik-Parsadaniantz S, 2008, J NEUROIMMUNOL, V198, P62, DOI 10.1016/j.jneuroim.2008.04.022; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Oshiumi H, 2003, IMMUNOGENETICS, V54, P791, DOI 10.1007/s00251-002-0519-8; Owen R, 1846, LECT COMP ANATOMY PH; Park J, 2010, DEV DYNAM, V239, P514, DOI 10.1002/dvdy.22192; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; Park KS, 2006, DEV BIOL, V294, P192, DOI 10.1016/j.ydbio.2006.02.038; Perry SF, 2001, COMP BIOCHEM PHYS A, V129, P37, DOI 10.1016/S1095-6433(01)00304-X; Perry SF, 2004, RESP PHYSIOL NEUROBI, V144, P125, DOI 10.1016/j.resp.2004.06.018; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Schepers GE, 2000, NUCLEIC ACIDS RES, V28, P1473, DOI 10.1093/nar/28.6.1473; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Shu WG, 2002, DEVELOPMENT, V129, P4831; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Su Jian-Guo, 2008, Acta Hydrobiologica Sinica, V32, P728, DOI 10.3724/SP.J.0000.2008.50728; Sun FY, 2012, DEV COMP IMMUNOL, V38, P169, DOI 10.1016/j.dci.2012.05.006; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; Wang FS, 2003, AM J RESP CELL MOL, V29, P62, DOI 10.1165/rcmb.2002-0180OC; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang T, 2007, J IMMUNOL, V179, P1475, DOI 10.4049/jimmunol.179.3.1475; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Winata CL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-3; Winata CL, 2009, DEV BIOL, V331, P222, DOI 10.1016/j.ydbio.2009.04.035; Xia XH, 2011, BIOCHEM GENET, V49, P161, DOI 10.1007/s10528-010-9396-2; Xia XH, 2010, J GENET, V89, P183, DOI 10.1007/s12041-010-0024-z; Yang ChunRong, 2011, Journal of Fisheries of China, V35, P641; Yang Ming, 2006, Journal of Oceanography in Taiwan Strait, V25, P330; Yin A, 2012, BBA-MOL CELL RES, V1823, P236, DOI 10.1016/j.bbamcr.2011.09.018; Yin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018431; Yin DT, 2012, DISCOV MED, V14, P33; Yoshiura Y, 2003, IMMUNOGENETICS, V55, P296, DOI 10.1007/s00251-003-0582-9; Zheng WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024019; Zou J, 2003, IMMUNOGENETICS, V55, P325, DOI 10.1007/s00251-003-0580-y	87	30	32	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85505	10.1371/journal.pone.0085505	http://dx.doi.org/10.1371/journal.pone.0085505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454879	Green Submitted, gold, Green Published			2022-12-25	WOS:000330236000010
J	Trapecar, M; Goropevsek, A; Gorenjak, M; Gradisnik, L; Rupnik, MS				Trapecar, Martin; Goropevsek, Ales; Gorenjak, Mario; Gradisnik, Lidija; Rupnik, Marjan Slak			A Co-Culture Model of the Developing Small Intestine Offers New Insight in the Early Immunomodulation of Enterocytes and Macrophages by Lactobacillus spp. through STAT1 and NF-kB p65 Translocation	PLOS ONE			English	Article							KAPPA-B ACTIVATION; IMMUNE CELLS; GUT; MODULATION; PATHWAYS; RECEPTOR; STRAINS; ELICIT	The early establishment of a complete microbiome has been shown to play an integral part in the development and maintenance of an intact intestine and its immune system, although much remains unknown about the specific mechanisms of immune modulation in newborns. In our study we show in a co-culture model of the undeveloped small intestine that members of Lactobacillus spp. influence STAT1 and NF-kB p65 nuclear translocation in both intestinal epithelial cells as well as underlying macrophages. Moreover, by using imaging flow cytometry we were able to monitor each individual cell and create a framework of the percentage of cells in which translocation occurred in challenged versus control cell populations. We also observed a significant difference in baseline translocation in intestinal cells when cultured alone versus those in a co-culture model, underpinning the importance of 3D models over monolayer set-ups in epithelial in vitro research. In conclusion, our work offers new insights into the potential routes by which the commensal microbiome primes the early immune system to fight pathogens, and shows how strain-specific these mechanisms really are.	[Trapecar, Martin; Gradisnik, Lidija; Rupnik, Marjan Slak] Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia; [Goropevsek, Ales] Univ Clin Ctr Maribor, Dept Lab Diagnost, Maribor, Slovenia; [Gorenjak, Mario] Univ Maribor, Fac Med, SLO-2000 Maribor, Slovenia	University of Maribor; University of Maribor; University of Maribor	Trapecar, M (corresponding author), Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia.	martin.trapecar@gmail.com	Slak Rupnik, Marjan/E-6246-2015; Rupnik, Marjan Slak/R-4738-2019; Trapecar, Martin/AAL-5800-2020	Slak Rupnik, Marjan/0000-0002-3744-4882; Rupnik, Marjan Slak/0000-0002-3744-4882; Trapecar, Martin/0000-0002-0860-8948; Goropevsek, Ales/0000-0002-2188-578X; Gorenjak, Mario/0000-0003-4208-9683				Boirivant M, 2008, MUCOSAL IMMUNOL, V1, pS47, DOI 10.1038/mi.2008.52; Botic T, 2007, INT J FOOD MICROBIOL, V115, P227, DOI 10.1016/j.ijfoodmicro.2006.10.044; Bruno MEC, 2011, MUCOSAL IMMUNOL, V4, P468, DOI 10.1038/mi.2011.8; Cencic A, 2010, INT J FOOD MICROBIOL, V141, pS4, DOI 10.1016/j.ijfoodmicro.2010.03.026; Clavel Thomas, 2007, Curr Issues Intest Microbiol, V8, P25; Cross ML, 2001, INT IMMUNOPHARMACOL, V1, P891, DOI 10.1016/S1567-5769(01)00025-X; Curtis MM, 2011, MUCOSAL IMMUNOL, V4, P133, DOI 10.1038/mi.2010.89; de Kivit S, 2011, IMMUNOBIOLOGY, V216, P518, DOI 10.1016/j.imbio.2010.08.005; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Haller D, 2004, IMMUNOLOGY, V112, P310, DOI 10.1111/j.1365-2567.2004.01874.x; Haller D, 2000, GUT, V47, P79, DOI 10.1136/gut.47.1.79; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Ivec M, 2007, ANTIVIR RES, V75, P266, DOI 10.1016/j.antiviral.2007.03.013; Kim YG, 2006, MICROBES INFECT, V8, P994, DOI 10.1016/j.micinf.2005.10.019; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Maragkoudakis PA, 2010, INT J FOOD MICROBIOL, V141, pS91, DOI 10.1016/j.ijfoodmicro.2009.12.024; Matsuguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P259, DOI 10.1128/CDLI.10.2.259-266.2003; Matsumoto S, 2005, CLIN EXP IMMUNOL, V140, P417, DOI 10.1111/j.1365-2249.2005.02790.x; Miettinen M, 2000, J IMMUNOL, V164, P3733, DOI 10.4049/jimmunol.164.7.3733; Mileti E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007056; MohanKumar K, 2012, AM J PHYSIOL-GASTR L, V303, pG93, DOI 10.1152/ajpgi.00016.2012; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Nissen L, 2009, INT J FOOD MICROBIOL, V135, P288, DOI 10.1016/j.ijfoodmicro.2009.08.027; Parlesak A, 2004, SCAND J IMMUNOL, V60, P477, DOI 10.1111/j.0300-9475.2004.01495.x; Patel RM, 2010, GUT MICROBES, V1, P186, DOI 10.4161/gmic.1.3.12484; Reich NC, 2007, CYTOKINE GROWTH F R, V18, P511, DOI 10.1016/j.cytogfr.2007.06.021; Sanz Y, 2009, INT REV IMMUNOL, V28, P397, DOI 10.3109/08830180903215613; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; Trapecar M, 2011, APMIS, V119, P877, DOI 10.1111/j.1600-0463.2011.02797.x; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41	30	34	35	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e86297	10.1371/journal.pone.0086297	http://dx.doi.org/10.1371/journal.pone.0086297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454965	gold, Green Submitted, Green Published			2022-12-25	WOS:000330236000025
J	Yamamoto, T; Kodama, T; Lee, J; Utsunomiya, N; Hayashi, S; Sakamoto, H; Kuramoto, H; Kadowaki, M				Yamamoto, Takeshi; Kodama, Toshihisa; Lee, Jaemin; Utsunomiya, Naho; Hayashi, Shusaku; Sakamoto, Hiroshi; Kuramoto, Hirofumi; Kadowaki, Makoto			Anti-Allergic Role of Cholinergic Neuronal Pathway via alpha 7 Nicotinic ACh Receptors on Mucosal Mast Cells in a Murine Food Allergy Model	PLOS ONE			English	Article							ANTIINFLAMMATORY PATHWAY; ACETYLCHOLINE-RECEPTOR; VAGUS NERVE; ULCERATIVE-COLITIS; IMMUNE-RESPONSES; MICE; INFLAMMATION; DIARRHEA; CHYMASE	The prevalence of food allergy (FA) has increased in developed countries over the past few decades. However, no effective drug therapies are currently available. Therefore, we investigated cholinergic anti-inflammatory pathway as a regulatory system to ameliorate disrupted mucosal immune homeostasis in the gut based on the pathophysiological elucidation of mucosal mast cells (MMCs) in a murine FA model. BALB/c mice sensitized with ovalbumin received repeated oral ovalbumin for the development of FA. FA mice developed severe allergic diarrhea and exhibited enhanced type 2 helper T (Th2) cell immune responses in both systemic immunity and mucosal immunity, along with MMCs hyperplasia in the colon. MMCs were localized primarily in the strategic position of the mucosal epithelium. Furthermore, the allergic symptoms did not develop in p85 alpha disrupted phosphoinositide-3 kinase-deficient mice that lacked mast cells in the gut. Vagal stimulation by 2-deoxy-D-glucose and drug treatment with nicotinic ACh receptor (nAChR) agonists (nicotine and alpha 7 nAChR agonist GTS-21) alleviated the allergic symptoms in the FA mice. Nicotine treatment suppressed MMCs hyperplasia, enhanced MPO and upregulated mRNA expression of Th1 and Th2 cytokines in the FA mice colon. MMCs, which are negatively regulated by alpha 7 nAChRs, were often located in close proximity to cholinergic CGRP-immunoreactive nerve fibers in the FA mice colon. The present results reveal that the cholinergic neuroimmune interaction via alpha 7 nAChRs on MMCs is largely involved in maintaining intestinal immune homeostasis and can be a target for a new therapy against mucosal immune diseases with homeostatic disturbances such as FA.	[Yamamoto, Takeshi; Kodama, Toshihisa; Lee, Jaemin; Utsunomiya, Naho; Hayashi, Shusaku; Kadowaki, Makoto] Toyama Univ, Inst Nat Med, Div Gastrointestinal Pathophysiol, Toyama 930, Japan; [Sakamoto, Hiroshi] Hlth Sci Univ, Dept Phys Therapy, Fujikawaguchiko, Yamanashi, Japan; [Kuramoto, Hirofumi] Kyoto Inst Technol, Dept Appl Biol, Kyoto 606, Japan	University of Toyama; Kyoto Institute of Technology	Kadowaki, M (corresponding author), Toyama Univ, Inst Nat Med, Div Gastrointestinal Pathophysiol, Toyama 930, Japan.	makotok@inm.u-toyama.ac.jp	Hayashi, Shusaku/AAP-1185-2020	Hayashi, Shusaku/0000-0002-8304-7255; YAMAMOTO, Takeshi/0000-0002-4383-6954	Ministry of Education, Culture, Sports, Science and Technology of Japan [25460891, 24590879]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp/j-grantsinaid/index.html) to T. Yamamoto (No. 25460891) and M. Kadowaki (No. 24590879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Bauer O, 2000, NEWS PHYSIOL SCI, V15, P213, DOI 10.1152/physiologyonline.2000.15.5.213; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; BIENENSTOCK J, 2003, AUTONOMIC NEUROIMMUN; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Dhawan S, 2012, LIFE SCI, V91, P1038, DOI 10.1016/j.lfs.2012.04.042; Eigenmann PA, 2003, CURR OPIN ALLERGY CL, V3, P199, DOI [10.1097/00130832-200306000-00008, 10.1097/01.all.0000072715.82112.5e]; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Furness JB, 2004, CELL TISSUE RES, V317, P1, DOI 10.1007/s00441-004-0895-5; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; Kageyama-Yahara N, 2008, BIOCHEM BIOPH RES CO, V377, P321, DOI 10.1016/j.bbrc.2008.10.004; Kageyama-Yahara N, 2010, FEBS LETT, V584, P111, DOI 10.1016/j.febslet.2009.11.007; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Kweon MN, 2000, J CLIN INVEST, V106, P199, DOI 10.1172/JCI8490; Lakhan SE, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-129; MacDonald TT, 2009, CURR OPIN GASTROEN, V25, P521, DOI 10.1097/MOG.0b013e3283306236; Mazzoni A, 2006, J IMMUNOL, V177, P3577, DOI 10.4049/jimmunol.177.6.3577; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; MILLER HRP, 1972, AM J PATHOL, V69, P195; Nakajima T, 2002, BLOOD, V100, P3861, DOI 10.1182/blood-2002-02-0602; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; PULLAN RD, 1994, NEW ENGL J MED, V330, P811, DOI 10.1056/NEJM199403243301202; Qu ZD, 2008, CELL TISSUE RES, V334, P147, DOI 10.1007/s00441-008-0684-7; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; The FO, 2007, GASTROENTEROLOGY, V133, P1219, DOI 10.1053/j.gastro.2007.07.022; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Van der Zanden EP, 2009, NEUROGASTROENT MOTIL, V21, P6, DOI 10.1111/j.1365-2982.2008.01252.x; van Diest SA, 2012, BBA-MOL BASIS DIS, V1822, P74, DOI 10.1016/j.bbadis.2011.03.019; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wastling JM, 1998, AM J PATHOL, V153, P491, DOI 10.1016/S0002-9440(10)65592-7; Yamamoto T, 2009, INT ARCH ALLERGY IMM, V148, P175, DOI 10.1159/000161578; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x	40	49	52	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85888	10.1371/journal.pone.0085888	http://dx.doi.org/10.1371/journal.pone.0085888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454942	gold, Green Submitted, Green Published			2022-12-25	WOS:000330236000019
J	Demetriou, C; Abu-Amero, S; Thomas, AC; Ishida, M; Aggarwal, R; Al-Olabi, L; Leon, LJ; Stafford, JL; Syngelaki, A; Peebles, D; Nicolaides, KH; Regan, L; Stanier, P; Moore, GE				Demetriou, Charalambos; Abu-Amero, Sayeda; Thomas, Anna C.; Ishida, Miho; Aggarwal, Reena; Al-Olabi, Lara; Leon, Lydia J.; Stafford, Jaime L.; Syngelaki, Argyro; Peebles, Donald; Nicolaides, Kypros H.; Regan, Lesley; Stanier, Philip; Moore, Gudrun E.			Paternally Expressed, Imprinted Insulin-Like Growth Factor-2 in Chorionic Villi Correlates Significantly with Birth Weight	PLOS ONE			English	Article							IGF-I RECEPTOR; GESTATIONAL-AGE; FETAL-GROWTH; CORD-BLOOD; PLACENTAL EXPRESSION; PHLDA2 GENE; INTRAUTERINE; RESTRICTION; METHYLATION; IGFBP-1	Context: Fetal growth involves highly complex molecular pathways. IGF2 is a key paternally expressed growth hormone that is critical for in utero growth in mice. Its role in human fetal growth has remained ambiguous, as it has only been studied in term tissues. Conversely the maternally expressed growth suppressor, PHLDA2, has a significant negative correlation between its term placental expression and birth weight. Objective: The aim of this study is to address the role in early gestation of expression of IGF1, IGF2, their receptors IGF1R and IGF2R, and PHLDA2 on term birth weight. Design: Real-time quantitative PCR was used to investigate mRNA expression of IGF1, IGF2, IGF1R, IGF2R and PHLDA2 in chorionic villus samples (CVS) (n = 260) collected at 11-13 weeks' gestation. Expression was correlated with term birth weight using statistical package R including correction for several confounding factors. Results: Transcript levels of IGF2 and IGF2R revealed a significant positive correlation with birth weight (0.009 and 0.04, respectively). No effect was observed for IGF1, IGF1R or PHLDA2 and birth weight. Critically, small for gestational age (SGA) neonates had significantly lower IGF2 levels than appropriate for gestational age neonates (p = 3.6 x 10(-7)). Interpretation: Our findings show that IGF2 mRNA levels at 12 weeks gestation could provide a useful predictor of future fetal growth to term, potentially predicting SGA babies. SGA babies are known to be at a higher risk for type 2 diabetes. This research reveals an imprinted, parentally driven rheostat for in utero growth.	[Demetriou, Charalambos; Abu-Amero, Sayeda; Thomas, Anna C.; Ishida, Miho; Al-Olabi, Lara; Leon, Lydia J.; Stafford, Jaime L.; Stanier, Philip; Moore, Gudrun E.] UCL, Fetal Dev & Growth Res Grp, Clin & Mol Genet Unit, Inst Child Hlth, London, England; [Demetriou, Charalambos; Regan, Lesley] Univ London Imperial Coll Sci Technol & Med, Dept Obstet & Gynaecol, London, England; [Aggarwal, Reena; Peebles, Donald] UCL, Inst Womens Hlth, London, England; [Syngelaki, Argyro; Nicolaides, Kypros H.] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London, England	University of London; University College London; Imperial College London; University of London; University College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Moore, GE (corresponding author), UCL, Fetal Dev & Growth Res Grp, Clin & Mol Genet Unit, Inst Child Hlth, London, England.	gudrun.moore@ucl.ac.uk	Moore, Gudrun/A-2092-2009; Stanier, Philip/C-1593-2008	Stanier, Philip/0000-0001-9340-8117; Nicolaides, Kypros/0000-0003-1266-0711; Syngelaki, Argyro/0000-0001-5856-6072; Lopes, Jaime/0000-0002-9795-1093; Leon, Lydia/0000-0001-5228-9713	Save the Baby Unit; Great Ormond Street Hospital Children's Charity; MRC; Wellbeing of Women; Sparks; Wellcome Trust; MRC [G0801438, G1001689] Funding Source: UKRI; Medical Research Council [G0801438, G1001689] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1241] Funding Source: researchfish	Save the Baby Unit; Great Ormond Street Hospital Children's Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellbeing of Women(Wellbeing of Women (WoW)); Sparks; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity	CD is funded by Save the Baby Unit (http://www.savethebabyunit.org/). PS is funded by Great Ormond Street Hospital Children's Charity (http://www.gosh.org/gen/). GEM Fetal growth and development research team is funded by the MRC (http://www.mrc.ac.uk/index.htm), Wellbeing of Women (http://www.wellbeingofwomen.org.uk/), Sparks (http://www.sparks.org.uk/) and the Wellcome Trust (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero SN, 1998, MOL REPROD DEV, V49, P229, DOI 10.1002/(SICI)1098-2795(199803)49:3<229::AID-MRD2>3.0.CO;2-Q; Abuzzahab MJ, 2003, NEW ENGL J MED, V349, P2211, DOI 10.1056/NEJMoa010107; ALBERTSSONWIKLAND K, 1993, ACTA PAEDIATR, V82, P438, DOI 10.1111/j.1651-2227.1993.tb12718.x; Apostolidou S, 2007, J MOL MED, V85, P379, DOI 10.1007/s00109-006-0131-8; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1992, BRIT J OBSTET GYNAEC, V99, P275, DOI 10.1111/j.1471-0528.1992.tb13719.x; Brodsky Dara, 2004, J Intensive Care Med, V19, P307, DOI 10.1177/0885066604269663; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Demendi C, 2012, EUR J OBSTET GYN R B, V160, P40, DOI 10.1016/j.ejogrb.2011.10.005; Eggermann T, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.028936; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; Guo L, 2008, DEV BIOL, V320, P79, DOI 10.1016/j.ydbio.2008.04.025; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Iniguez G, 2010, HORM RES PAEDIAT, V73, P320, DOI 10.1159/000308163; Ishida M, 2012, AM J HUM GENET, V90, P715, DOI 10.1016/j.ajhg.2012.02.021; Klammt J, 2008, TRENDS ENDOCRIN MET, V19, P197, DOI 10.1016/j.tem.2008.03.003; Klauwer D, 1997, ACTA PAEDIATR, V86, P826; Koukoura O, 2011, INT J MOL MED, V28, P481, DOI 10.3892/ijmm.2011.754; Koutsaki M, 2011, GROWTH HORM IGF RES, V21, P31, DOI 10.1016/j.ghir.2010.12.002; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; Laviola L, 2005, ENDOCRINOLOGY, V146, P1498, DOI 10.1210/en.2004-1332; Le Bouc Y, 2003, B ACAD NAT MED PARIS, V187, P1225, DOI 10.1016/S0001-4079(19)33906-8; Le Roith D, 2001, TRENDS ENDOCRIN MET, V12, P48; McMinn J, 2006, PLACENTA, V27, P540, DOI 10.1016/j.placenta.2005.07.004; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Ong K, 2000, J CLIN ENDOCR METAB, V85, P4266, DOI 10.1210/jc.85.11.4266; Petry CJ, 2011, DIABETES, V60, P3090, DOI 10.2337/db11-0689; POLLACK RN, 1992, CLIN OBSTET GYNECOL, V35, P99, DOI 10.1097/00003081-199203000-00015; Qian N, 1997, HUM MOL GENET, V6, P2021, DOI 10.1093/hmg/6.12.2021; Smerieri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029562; Street ME, 2006, EUR J ENDOCRINOL, V155, P567, DOI 10.1530/eje.1.02251; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; WILLISON K, 1991, TRENDS GENET, V7, P107, DOI 10.1016/0168-9525(91)90441-R	40	34	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85454	10.1371/journal.pone.0085454	http://dx.doi.org/10.1371/journal.pone.0085454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454871	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100089
J	Desamericq, G; Dolbeau, G; Verny, C; Charles, P; Durr, A; Youssov, K; Simonin, C; Azulay, JP; Tranchant, C; Goizet, C; Damier, P; Broussolle, E; Demonet, JF; Morgado, G; de Langavant, LC; Macquin-Mavier, I; Bachoud-Levi, AC; Maison, P				Desamericq, Gaelle; Dolbeau, Guillaume; Verny, Christophe; Charles, Perrine; Durr, Alexandra; Youssov, Katia; Simonin, Clemence; Azulay, Jean-Philippe; Tranchant, Christine; Goizet, Cyril; Damier, Philippe; Broussolle, Emmanuel; Demonet, Jean-Francois; Morgado, Graca; de Langavant, Laurent Cleret; Macquin-Mavier, Isabelle; Bachoud-Levi, Anne-Catherine; Maison, Patrick			Effectiveness of Anti-Psychotics and Related Drugs in the Huntington French-Speaking Group Cohort	PLOS ONE			English	Article							FOLLOW-UP; OPEN-LABEL; DISEASE; OLANZAPINE; TETRABENAZINE; INDIVIDUALS; THERAPY; CHOREA; GENE	Purpose: Huntington's disease is a rare condition. Patients are commonly treated with antipsychotics and tetrabenazine. The evidence of their effect on disease progression is limited and no comparative study between these drugs has been conducted. We therefore compared the effectiveness of antipsychotics on disease progression. Methods: 956 patients from the Huntington French Speaking Group were followed for up to 8 years between 2002 and 2010. The effectiveness of treatments was assessed using Unified Huntington's Disease Rating Scale (UHDRS) scores and then compared using a mixed model adjusted on a multiple propensity score. Results: 63% of patients were treated with antipsychotics during the survey period. The most commonly prescribed medications were dibenzodiazepines (38%), risperidone (13%), tetrabenazine (12%) and benzamides (12%). There was no difference between treatments on the motor and behavioural declines observed, after taking the patient profiles at the start of the drug prescription into account. In contrast, the functional decline was lower in the dibenzodiazepine group than the other antipsychotic groups (Total Functional Capacity: 0.41 +/- 0.17 units per year vs. risperidone and 0.54 +/- 0.19 vs. tetrabenazine, both p<0.05). Benzamides were less effective than other antipsychotics on cognitive evolution (Stroop interference, Stroop color and Literal fluency: p<0.05). Conclusions: Antipsychotics are widely used to treat patients with Huntington's disease. Although differences in motor or behavioural profiles between patients according to the antipsychotics used were small, there were differences in drug effectiveness on the evolution of functional and cognitive scores.	[Desamericq, Gaelle; Dolbeau, Guillaume; Youssov, Katia; de Langavant, Laurent Cleret; Bachoud-Levi, Anne-Catherine; Maison, Patrick] Hop Henri Mondor, INSERM, Equipe 01, U955, F-94010 Creteil, France; [Desamericq, Gaelle; Dolbeau, Guillaume; Youssov, Katia; Morgado, Graca; de Langavant, Laurent Cleret; Macquin-Mavier, Isabelle; Bachoud-Levi, Anne-Catherine; Maison, Patrick] Univ Paris Est, Fac Med, Creteil, France; [Desamericq, Gaelle; Macquin-Mavier, Isabelle] Hop H Mondor A Chenevier, Serv Pharmacol Clin, Creteil, France; [Desamericq, Gaelle; Youssov, Katia; de Langavant, Laurent Cleret; Bachoud-Levi, Anne-Catherine; Maison, Patrick] Ecole Normale Super, Dept Etud Cognit, F-75231 Paris, France; [Dolbeau, Guillaume] Hop H Mondor A Chenevier, Unite Rech Clin, Creteil, France; [Verny, Christophe] CHU Angers, Serv Neurol, Ctr Reference Malad Neurogenet, Angers, France; [Verny, Christophe] CNRS, INSERM, UMR 6214, U1083, Angers, France; [Charles, Perrine; Durr, Alexandra; Youssov, Katia; de Langavant, Laurent Cleret; Bachoud-Levi, Anne-Catherine; Maison, Patrick] Hop H Mondor A Chenevier, Ctr Reference Malad Huntington, Creteil, France; [Charles, Perrine] Hop La Pitie Salpetriere, AP HP, Dept Genet, Paris, France; [Simonin, Clemence] CHRU Lille, Dept Neurol & Movement Disorders, F-59037 Lille, France; [Simonin, Clemence] INSERM, JPArc Team 6, UMR837, F-59045 Lille, France; [Simonin, Clemence] Univ Lille 2 Law & Hlth, Lille, France; [Azulay, Jean-Philippe] Hop Enfants La Timone, Serv Neurol & Pathol Mouvement, Marseille, France; [Tranchant, Christine] CHU Hautepierre, Serv Neurol, F-67098 Strasbourg, France; [Tranchant, Christine] Univ Strasbourg, Strasbourg, France; [Goizet, Cyril] CHU Bordeaux, Serv Genet Med, EA4576, Univ Bordeaux Segalen,Lab Malad Rares Genet & Met, Bordeaux, France; [Damier, Philippe] INSERM, Ctr Invest Clin 004, Nantes, France; [Broussolle, Emmanuel] Univ Lyon 1, Fac Med, F-69365 Lyon, France; [Broussolle, Emmanuel] Univ Lyon 1, Maieut Lyon Sud Charles Merieux, F-69365 Lyon, France; [Broussolle, Emmanuel] Hosp Civils Lyon, Hop Neurol Pierre Wertheimer, Serv Neurol C, Lyon, France; [Broussolle, Emmanuel] CNRS, Ctr Neurosci Cognit, UMR5229, Bron, France; [Demonet, Jean-Francois] CHU Vaudois, Dept Clin Neurosci, Ctr Leenaards Memoire, Lausanne, Switzerland; [Morgado, Graca] Hop Henri Mondor, INSERM, Ctr Invest Clin 006, F-94010 Creteil, France; [Morgado, Graca] Hop H Mondor A Chenevier, AP HP, Pole Rech Clin Sante Publ, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Maison, P (corresponding author), Hop Henri Mondor, INSERM, Equipe 01, U955, F-94010 Creteil, France.	patrick.maison@hmn.aphp.fr	Bachoud-Lévi, Anne-Catherine/GYU-8680-2022; Broussolle, Emmanuel/H-1592-2017; Damier, Philippe/T-7829-2019; GOIZET, Cyril/M-4576-2014	Bachoud-Lévi, Anne-Catherine/0000-0003-3000-2210; Broussolle, Emmanuel/0000-0002-0410-9519; GOIZET, Cyril/0000-0002-1913-889X; tranchant, christine/0000-0002-2895-1292; Cleret de Langavant, Laurent/0000-0001-6551-4641; Simonin, Clemence/0000-0002-2282-4372; Demonet, Jean-Francois/0000-0003-0100-6175	Institut National de la Sante et la recherche Medicale (INSERM); Association Francaise contre les Myopathies (AFM); Association Huntington France (AHF); Groupement d'Interet Scientifique (GIS) - Institut des Maladies Rares et I'AP-HP (DRCD); EUSA Pharma	Institut National de la Sante et la recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Association Huntington France (AHF); Groupement d'Interet Scientifique (GIS) - Institut des Maladies Rares et I'AP-HP (DRCD); EUSA Pharma	This work was supported by cooperative contracts between the Institut National de la Sante et la recherche Medicale (INSERM), the Association Francaise contre les Myopathies (AFM), the Association Huntington France (AHF), and the Groupement d'Interet Scientifique (GIS) - Institut des Maladies Rares et I'AP-HP (DRCD). The team received a grant (about 5000 euro) from EUSA Pharma but EUSA Pharma did not fund directly this study. They wish only data on the use of tetrabenazine, not any result about effectiveness and comparisons. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, NEUROLOGY, V66, P366, DOI [10.1212/01.wnl.0000198586.85250.13, DOI 10.1212/01.WNL.0000198586.85250.13]; Bonelli RM, 2006, CURR PHARM DESIGN, V12, P2701, DOI 10.2174/138161206777698693; Bonelli RM, 2004, INT CLIN PSYCHOPHARM, V19, P51, DOI 10.1097/00004850-200403000-00001; Bonelli RM, 2002, CLIN NEUROPHARMACOL, V25, P263, DOI 10.1097/00002826-200209000-00007; Erdemoglu AK, 2002, EUR J NEUROL, V9, P182, DOI 10.1046/j.1468-1331.2002.0354e.x; FEIGIN A, 1995, MOVEMENT DISORD, V10, P211, DOI 10.1002/mds.870100213; Frank S, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-62; Guo XF, 2011, NEUROSCI LETT, V503, P141, DOI 10.1016/j.neulet.2011.08.027; Jankovic J, 1997, NEUROLOGY, V48, P358, DOI 10.1212/WNL.48.2.358; Laks J, 2004, ARQ NEURO-PSIQUIAT, V62, P1092, DOI 10.1590/S0004-282X2004000600030; Mestre T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006456.pub2; Mulrow CD, 1997, ANN INTERN MED, V126, P389, DOI 10.7326/0003-4819-126-5-199703010-00008; Nance MA, 1996, MOVEMENT DISORD, V11, P542, DOI 10.1002/mds.870110509; Orth M., 2010, PLOS CURR, V2; Paleacu D, 2002, ACTA NEUROL SCAND, V105, P441, DOI 10.1034/j.1600-0404.2002.01197.x; PENNEY JB, 1990, MOVEMENT DISORD, V5, P93, DOI 10.1002/mds.870050202; Priller J, 2008, MOVEMENT DISORD, V23, P1788, DOI 10.1002/mds.22188; Quinn N, 1985, J Neurol Neurosurg Psychiatry, V48, P292, DOI 10.1136/jnnp.48.3.292; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rummel-Kluge C, 2010, SCHIZOPHR RES, V123, P225, DOI 10.1016/j.schres.2010.07.012; Schneeweiss S, 2007, CLIN PHARMACOL THER, V82, P143, DOI 10.1038/sj.clpt.6100249; SHOULSON I, 1981, NEUROLOGY, V31, P1333, DOI 10.1212/WNL.31.10.1333; Spreeuwenberg MD, 2010, MED CARE, V48, P166, DOI 10.1097/MLR.0b013e3181c1328f; Squitieri F, 2001, NEUROPSY NEUROPSY BE, V14, P69; van Duijn E, 2007, J NEUROPSYCH CLIN N, V19, P441, DOI 10.1176/appi.neuropsych.19.4.441; van Vugt JPP, 2004, MOVEMENT DISORD, V19, P285, DOI 10.1002/mds.10718; Venuto CS, 2012, MOVEMENT DISORD, V27, P31, DOI 10.1002/mds.23953; 1996, MOVEMENT DISORD, V11, P136, DOI DOI 10.1002/MDS.870110204; 1993, CELL, V72, P971	29	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85430	10.1371/journal.pone.0085430	http://dx.doi.org/10.1371/journal.pone.0085430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454865	Green Published, gold			2022-12-25	WOS:000330235100083
J	Jayaraman, A; Jamil, K				Jayaraman, Archana; Jamil, Kaiser			Drug Targets for Cell Cycle Dysregulators in Leukemogenesis: In Silico Docking Studies	PLOS ONE			English	Article							ACUTE LYMPHOCYTIC-LEUKEMIA; DEPENDENT KINASES CDK2; EXPRESSION; CHILDHOOD; PROTEIN; ACTIVATION; INHIBITORS; D3; DIFFERENTIATION; PROGRESSION	Alterations in cell cycle regulating proteins are a key characteristic in neoplastic proliferation of lymphoblast cells in patients with Acute Lymphoblastic Leukemia (ALL). The aim of our study was to investigate whether the routinely administered ALL chemotherapeutic agents would be able to bind and inhibit the key deregulated cell cycle proteins such as - Cyclins E1, D1, D3, A1 and Cyclin Dependent Kinases (CDK) 2 and 6. We used Schrodinger Glide docking protocol to dock the chemotherapeutic drugs such as Doxorubicin and Daunorubicin and others which are not very common including Clofarabine, Nelarabine and Flavopiridol, to the crystal structures of these proteins. We observed that the drugs were able to bind and interact with cyclins E1 and A1 and CDKs 2 and 6 while their docking to cyclins D1 and D3 were not successful. This binding proved favorable to interact with the G1/S cell cycle phase proteins that were examined in this study and may lead to the interruption of the growth of leukemic cells. Our observations therefore suggest that these drugs could be explored for use as inhibitors for these cell cycle proteins. Further, we have also highlighted residues which could be important in the designing of pharmacophores against these cell cycle proteins. This is the first report in understanding the mechanism of action of the drugs targeting these cell cycle proteins in leukemia through the visualization of drug-target binding and molecular docking using computational methods.	[Jayaraman, Archana; Jamil, Kaiser] Jawaharlal Nehru Inst Adv Studies, Sch Life Sci, Ctr Biotechnol & Bioinformat, Secunderabad, Andhra Pradesh, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Jamil, K (corresponding author), Jawaharlal Nehru Inst Adv Studies, Sch Life Sci, Ctr Biotechnol & Bioinformat, Secunderabad, Andhra Pradesh, India.	kj.bmmrc@gmail.com						Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Ahmed M, 2012, OPEN ACCESS SCI REPO, V1, P458; Ahmed M., 2011, BIOL MED PARIS, V3, P60; Ahmed M, 2012, INT J PHARM SCI HLTH, V2, P76; Ardekani Ali M., 2011, Avicenna Journal of Medical Biotechnology, V3, P177; Aref S, 2006, HEMATOLOGY, V11, P31, DOI 10.1080/10245330500322321; Betzi S, 2011, ACS CHEM BIOL, V6, P492, DOI 10.1021/cb100410m; Bonet J, 2006, PROTEINS, V63, P65, DOI 10.1002/prot.20791; BOSTROM B, 1993, AM J PEDIAT HEMATOL, V15, P80; Bueso-Ramos C, 2005, J CLIN ONCOL, V23, P3932, DOI 10.1200/JCO.2005.02.998; Byth KF, 2009, MOL CANCER THER, V8, P1856, DOI 10.1158/1535-7163.MCT-08-0836; Chilosi M, 1998, AM J PATHOL, V152, P209; Cho YS, 2010, J MED CHEM, V53, P7938, DOI 10.1021/jm100571n; Clare PM, 2001, J BIOL CHEM, V276, P48292, DOI 10.1074/jbc.M102034200; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Einsiedel HG, 2002, BLOOD, V99, P4629, DOI 10.1182/blood.V99.12.4629; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Goto H, 2012, ANTI-CANCER DRUG, V23, P417, DOI 10.1097/CAD.0b013e32834fb731; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Holm C, 2006, LEUKEMIA RES, V30, P254, DOI 10.1016/j.leukres.2005.07.010; Honda R, 2005, EMBO J, V24, P452, DOI 10.1038/sj.emboj.7600554; Hu ZJ, 2000, PROTEINS, V39, P331, DOI 10.1002/(SICI)1097-0134(20000601)39:4<331::AID-PROT60>3.0.CO;2-A; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Jamil Kaiser, 2012, Avicenna Journal of Medical Biotechnology, V4, P121; Jamil Kaiser, 2011, BIOL MED, V3, P70; Jayaraman A, 2011, BIOL MED, V3; Jayaraman A., 2012, BIOL MED, V4, P37; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Ji P, 2005, ONCOGENE, V24, P2739, DOI 10.1038/sj.onc.1208356; Joshi I, 2009, BLOOD, V113, P1689, DOI 10.1182/blood-2008-03-147967; Joyce Michael J, 2013, J Pediatr Hematol Oncol, V35, P32, DOI 10.1097/MPH.0b013e318279afdd; Karp JE, 2011, BLOOD, V117, P3302, DOI 10.1182/blood-2010-09-310862; Kim SH, 2009, ARCH PHARM RES, V32, P915, DOI 10.1007/s12272-009-1614-2; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kotra S, 2008, J MOL GRAPH MODEL, V27, P244, DOI 10.1016/j.jmgm.2008.04.010; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Kuo TC, 2011, MOL CELL BIOL, V31, P2566, DOI 10.1128/MCB.01349-10; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Markaki EA, 2006, PEDIATR BLOOD CANCER, V47, P14, DOI 10.1002/pbc.20730; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Miller ME, 2005, YEAST, V22, P1021, DOI 10.1002/yea.1292; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Rivera G K, 1992, Semin Oncol, V19, P51; Sasaki E, 2007, PATHOL INT, V57, P53, DOI 10.1111/j.1440-1827.2006.02058.x; Schmitz NMR, 2005, LEUKEMIA, V19, P1783, DOI 10.1038/sj.leu.2403900; Scuderi R, 1996, BLOOD, V87, P3360, DOI 10.1182/blood.V87.8.3360.bloodjournal8783360; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shorey LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034975; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; Stockwell SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028568; Volm M, 1997, INT J CANCER, V74, P508, DOI 10.1002/(SICI)1097-0215(19971021)74:5<508::AID-IJC5>3.0.CO;2-7; Wu SY, 2003, STRUCTURE, V11, P399, DOI 10.1016/S0969-2126(03)00060-1; Zunino SJ, 2006, CANCER LETT, V240, P123, DOI 10.1016/j.canlet.2005.09.001	56	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e86310	10.1371/journal.pone.0086310	http://dx.doi.org/10.1371/journal.pone.0086310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454966	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100151
J	Klaasen, M; Roest, HJ; van der Hoek, W; Goossens, B; Secka, A; Stegeman, A				Klaasen, Marieke; Roest, Hendrik-Jan; van der Hoek, Wim; Goossens, Bart; Secka, Arss; Stegeman, Arjan			Coxiella burnetii Seroprevalence in Small Ruminants in The Gambia	PLOS ONE			English	Article							HOSPITALIZED FEBRILE PATIENTS; Q-FEVER; DOMESTIC RUMINANTS; GOATS; PREVALENCE; ANTIBODIES; DIAGNOSIS; CHILDREN; MALARIA; SHEEP	Background: Q fever is a zoonosis caused by Coxiella burnetii, a Gram negative bacterium present worldwide. Small ruminants are considered the main reservoirs for infection of humans. This study aimed to estimate the extent of C. burnetii infection among sheep and goats in part of The Gambia. Methodology/Principal Findings: This survey was carried out from March to May 2012 at two areas in The Gambia. The first area comprised a cluster of seven rural villages situated 5-15 km west of Farafenni as well as the local abattoir. A second sampling was done at the central abattoir in Abuko (30 km from the capital, Banjul) in the Western Region. Serum samples were obtained from 490 goats and 398 sheep. In addition, 67 milk samples were obtained from lactating dams. Sera were tested with a Q fever ELISA kit. C. burnetii DNA was extracted from milk samples and then detected using a specific quantitative multiplex PCR assay, targeting the IS1111a element. A multivariable mixed logistic regression model was used to examine the relationship between seropositivity and explanatory variables. An overall seroprevalence of 21.6% was found. Goats had a significantly higher seroprevalence than sheep, respectively 24.2% and 18.5%. Seropositive animals were significantly older than seronegative animals. Animals from the villages had a significantly lower seroprevalence than animals from the central abattoir (15.1% versus 29.1%). C. burnetii DNA was detected in 2 out of 67 milk samples, whereas 8 samples gave a doubtful result. Conclusion/Significance: A substantial C. burnetii seroprevalence in sheep and goats in The Gambia was demonstrated. People living in close proximity to small ruminants are exposed to C. burnetii. Q fever should be considered as a possible cause of acute febrile illness in humans in The Gambia. Future studies should include a simultaneous assessment of veterinary and human serology, and include aetiology of febrile illness in local clinics.	[Klaasen, Marieke; Stegeman, Arjan] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Roest, Hendrik-Jan] Cent Vet Inst, Dept Bacteriol & TSEs, Lelystad, Netherlands; [van der Hoek, Wim] Natl Inst Publ Hlth & Environm, Epidemiol & Surveillance Unit, NL-3720 BA Bilthoven, Netherlands; [Goossens, Bart] SOS Childrens Villages Int, Bakau, Gambia; [Secka, Arss] Int Trypanotolerance Ctr, Banjul, Gambia	Utrecht University; Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	Stegeman, A (corresponding author), Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands.	J.A.Stegeman@uu.nl			Dutch Ministry of Economic Affairs	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This project was funded by a grant of the Dutch Ministry of Economic Affairs. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN ID, 1987, INFECTION, V15, P323, DOI 10.1007/BF01647731; Bates D., 2011, PACKAGE LME4 LINEAR; Biggs HM, 2011, AM J TROP MED HYG, V85, P275, DOI 10.4269/ajtmh.2011.11-0176; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Devendra C., 2005, Livestock and wealth creation: improving the husbandry of animals kept by resource-poor people in developing countries, P29; Dohoo I. R., 2009, VET EPIDEMIOLOGIC RE, V2, P584; DUPONT HT, 1995, CLIN INFECT DIS, V21, P1126, DOI 10.1093/clinids/21.5.1126; Geerts S, 2009, TRENDS PARASITOL, V25, P132, DOI 10.1016/j.pt.2008.12.004; Georgiev M, 2013, EURO SURVEILL, V18; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Goossens B, 1998, VET REC, V142, P277, DOI 10.1136/vr.142.11.277; Guatteo R, 2011, VET MICROBIOL, V149, P1, DOI 10.1016/j.vetmic.2010.10.007; Horigan MW, 2011, J VET DIAGN INVEST, V23, P924, DOI 10.1177/1040638711416971; Kampschreur LM, 2012, EMERG INFECT DIS, V18, P563, DOI 10.3201/eid1804.111478; KELLY PJ, 1993, S AFR MED J, V83, P21; Kobbe R, 2008, EMERG INFECT DIS, V14, P344, DOI 10.3201/eid1402.070971; Maichomo M W, 2000, Afr J Health Sci, V7, P114; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; McQuiston JH, 2002, J AM VET MED ASSOC, V221, P796, DOI 10.2460/javma.2002.221.796; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000654; Ndip LM, 2004, EMERG INFECT DIS, V10, P432, DOI 10.3201/eid1003.020713; Osaer S, 1999, VET PARASITOL, V82, P101, DOI 10.1016/S0304-4017(99)00011-4; Osaer S, 1999, THESIS UTRECHT U UTR, P300; Prabhu M, 2011, CLIN INFECT DIS, V53, pe8, DOI 10.1093/cid/cir411; R Development Core Team, 2011, R LANG ENV STAT COMP; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Rodrigues A, 2008, TROP MED INT HEALTH, V13, P410, DOI 10.1111/j.1365-3156.2008.02016.x; Roest HIJ, 2011, EMERG INFECT DIS, V17, P668, DOI 10.3201/eid1704.101562; Roest HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048949; Ruiz-Fons F, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-3; Ryan E, 2011, VET REC, V169, p280B, DOI 10.1136/vr.d5208; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Thrusfield M, 2001, VET REC, V148, P567, DOI 10.1136/vr.148.18.567; Vaidya VM, 2010, COMP IMMUNOL MICROB, V33, P307, DOI 10.1016/j.cimid.2008.10.006; van der Hoek W, 2013, TROP MED INT HEALTH, V18, P850, DOI 10.1111/tmi.12116; van der Hoek W, 2011, INT J ENVIRON HEAL R, V21, P441, DOI 10.1080/09603123.2011.574270	37	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85424	10.1371/journal.pone.0085424	http://dx.doi.org/10.1371/journal.pone.0085424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454863	Green Submitted, gold, Green Published			2022-12-25	WOS:000330235100082
J	Basner, A; Antranikian, G				Basner, Alexander; Antranikian, Garabed			Isolation and Biochemical Characterization of a Glucose Dehydrogenase from a Hay Infusion Metagenome	PLOS ONE			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; THERMOPLASMA-ACIDOPHILUM; HALOFERAX-MEDITERRANEI; PURIFICATION; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; METABOLISM; ENZYME; EXPRESSION; MECHANISM; OXIDATION	Glucose hydrolyzing enzymes are essential to determine blood glucose level. A high-throughput screening approach was established to identify NAD(P)-dependent glucose dehydrogenases for the application in test stripes and the respective blood glucose meters. In the current report a glucose hydrolyzing enzyme, derived from a metagenomic library by expressing recombinant DNA fragments isolated from hay infusion, was characterized. The recombinant clone showing activity on glucose as substrate exhibited an open reading frame of 987 bp encoding for a peptide of 328 amino acids. The isolated enzyme showed typical sequence motifs of short-chain-dehydrogenases using NAD(P) as a co-factor and had a sequence similarity between 33 and 35% to characterized glucose dehydrogenases from different Bacillus species. The identified glucose dehydrogenase gene was expressed in E. coli, purified and subsequently characterized. The enzyme, belonging to the superfamily of short-chain dehydrogenases, shows a broad substrate range with a high affinity to glucose, xylose and glucose-6-phosphate. Due to its ability to be strongly associated with its cofactor NAD(P), the enzyme is able to directly transfer electrons from glucose oxidation to external electron acceptors by regenerating the cofactor while being still associated to the protein.	[Basner, Alexander; Antranikian, Garabed] Hamburg Univ Technol, Inst Tech Microbiol, Hamburg, Germany	Hamburg University of Technology	Antranikian, G (corresponding author), Hamburg Univ Technol, Inst Tech Microbiol, Hamburg, Germany.	antranikian@tuhh.de			Hamburg University of Technology	Hamburg University of Technology	The project was funded by the Hamburg University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anastassiadis Savas, 2007, Recent Pat Biotechnol, V1, P167, DOI 10.2174/187220807780809472; Avigad G, 1975, Methods Enzymol, V41, P142; BACH JA, 1962, J BACTERIOL, V83, P699, DOI 10.1128/JB.83.4.699-707.1962; Baik SH, 2003, APPL MICROBIOL BIOT, V61, P329, DOI 10.1007/s00253-002-1215-1; Bhatti HN, 2006, CAN J MICROBIOL, V52, P519, DOI 10.1139/W05-158; Bonete MJ, 1996, FEBS LETT, V383, P227, DOI 10.1016/0014-5793(96)00235-9; Bottoms CA, 2002, PROTEIN SCI, V11, P2125, DOI 10.1110/ps.0213502; Carius Y, 2010, J BIOL CHEM, V285, P20006, DOI 10.1074/jbc.M110.113738; DAHMS AS, 1972, J BIOL CHEM, V247, P2222; DEMURA M, 1989, BIOSENSORS, V4, P361, DOI 10.1016/0265-928X(89)80002-1; Filling C, 2001, BIOCHEM BIOPH RES CO, V289, P712, DOI 10.1006/bbrc.2001.6032; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; FUJITA Y, 1977, J BACTERIOL, V132, P282, DOI 10.1128/JB.132.1.282-293.1977; GIARDINA P, 1986, BIOCHEM J, V239, P517, DOI 10.1042/bj2390517; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hansen T, 2002, FEMS MICROBIOL LETT, V216, P249, DOI 10.1016/S0378-1097(02)01021-2; HILT W, 1991, BIOCHIM BIOPHYS ACTA, V1076, P298, DOI 10.1016/0167-4838(91)90281-4; Hones J, 2008, DIABETES TECHNOL THE, V10, pS10, DOI 10.1089/dia.2008.0005; Inose K, 2003, BBA-PROTEINS PROTEOM, V1645, P133, DOI 10.1016/S1570-9639(02)00534-4; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kallberg Y, 2010, FEBS J, V277, P2375, DOI 10.1111/j.1742-4658.2010.07656.x; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; Kristan Katja, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-28; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; METZGER RP, 1972, ARCH BIOCHEM BIOPHYS, V149, P102, DOI 10.1016/0003-9861(72)90303-7; NAGAO T, 1992, J BACTERIOL, V174, P5013, DOI 10.1128/JB.174.15.5013-5020.1992; Nishiya Y, 2004, BIOSCI BIOTECH BIOCH, V68, P2451, DOI 10.1271/bbb.68.2451; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Pennacchio A, 2010, EXTREMOPHILES, V14, P193, DOI 10.1007/s00792-009-0298-3; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Pire C, 2000, J MOL CATAL B-ENZYM, V10, P409, DOI 10.1016/S1381-1177(99)00113-7; RAGUNATHAN S, 1994, ARCH BIOCHEM BIOPHYS, V310, P360, DOI 10.1006/abbi.1994.1179; Ramchandani N, 2012, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2012-28; Siebers B, 1997, ARCH MICROBIOL, V168, P120, DOI 10.1007/s002030050477; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TSAI CS, 1995, ARCH BIOCHEM BIOPHYS, V316, P163, DOI 10.1006/abbi.1995.1024; Tsujimura S, 2006, BIOSCI BIOTECH BIOCH, V70, P654, DOI 10.1271/bbb.70.654; Wohlfahrt G, 2004, MOL CELL BIOCHEM, V260, P69, DOI 10.1023/B:MCBI.0000026056.75937.98; Wohlsen TD, 2011, LETT APPL MICROBIOL, V53, P155, DOI 10.1111/j.1472-765X.2011.03086.x; Yamamoto K, 2001, J BIOCHEM, V129, P303, DOI 10.1093/oxfordjournals.jbchem.a002858; Yamazawa R, 2011, J BIOCHEM, V149, P701, DOI 10.1093/jb/mvr024; Yasutaka M, 1989, J FERMENTATION BIOEN, P374; Yasutake Y, 2007, J MOL BIOL, V367, P1034, DOI 10.1016/j.jmb.2007.01.029	49	12	12	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85844	10.1371/journal.pone.0085844	http://dx.doi.org/10.1371/journal.pone.0085844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454935	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800053
J	Girotto, G; Vuckovic, D; Buniello, A; Lorente-Canovas, B; Lewis, M; Gasparini, P; Steel, KP				Girotto, Giorgia; Vuckovic, Dragana; Buniello, Annalisa; Lorente-Canovas, Beatriz; Lewis, Morag; Gasparini, Paolo; Steel, Karen P.			Expression and Replication Studies to Identify New Candidate Genes Involved in Normal Hearing Function	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PROTEIN; GRM7; IMPAIRMENT; MULTIPLE; ISOFORMS; DEAFNESS; TUBULIN; CELLS; PTPRQ	Considerable progress has been made in identifying deafness genes, but still little is known about the genetic basis of normal variation in hearing function. We recently carried out a Genome Wide Association Study (GWAS) of quantitative hearing traits in southern European populations and found several SNPs with suggestive but none with significant association. In the current study, we followed up these SNPs to investigate which of them might show a genuine association with auditory function using alternative approaches. Firstly, we generated a shortlist of 19 genes from the published GWAS results. Secondly, we carried out immunocytochemistry to examine expression of these 19 genes in the mouse inner ear. Twelve of them showed distinctive cochlear expression patterns. Four showed expression restricted to sensory hair cells (Csmd1, Arsg, Slc16a6 and Gabrg3), one only in marginal cells of the stria vascularis (Dclk1) while the others (Ptprd, Grm8, GlyBP, Evi5, Rimbp2, Ank2, Cdh13) in multiple cochlear cell types. In the third step, we tested these 12 genes for replication of association in an independent set of samples from the Caucasus and Central Asia. Nine out of them showed nominally significant association (p<0.05). In particular, 4 were replicated at the same SNP and with the same effect direction while the remaining 5 showed a significant association in a gene-based test. Finally, to look for genotype-phenotype relationship, the audiometric profiles of the three genotypes of the most strongly associated gene variants were analyzed. Seven out of the 9 replicated genes (CDH13, GRM8, ANK2, SLC16A6, ARSG, RIMBP2 and DCLK1) showed an audiometric pattern with differences between different genotypes further supporting their role in hearing function. These data demonstrate the usefulness of this multistep approach in providing new insights into the molecular basis of hearing and may suggest new targets for treatment and prevention of hearing impairment.	[Girotto, Giorgia; Vuckovic, Dragana; Gasparini, Paolo] Univ Trieste, Dept Med Sci, Trieste, Italy; [Buniello, Annalisa; Lorente-Canovas, Beatriz; Lewis, Morag; Steel, Karen P.] Wellcome Trust Sanger Inst, Cambridge, England; [Buniello, Annalisa; Lorente-Canovas, Beatriz; Lewis, Morag; Steel, Karen P.] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Gasparini, Paolo] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy	University of Trieste; Wellcome Trust Sanger Institute; University of London; King's College London; IRCCS Burlo Garofolo	Girotto, G (corresponding author), Univ Trieste, Dept Med Sci, Trieste, Italy.	giorgia.girotto@burlo.trieste.it	Gasparini, Paolo/B-6173-2014; Girotto, Giorgia/I-9452-2018	Vuckovic, Dragana/0000-0001-9343-6142; Buniello, Annalisa/0000-0002-4623-8642; Lewis, Morag/0000-0002-1846-8600; Girotto, Giorgia/0000-0003-4507-6589; Gasparini, Paolo/0000-0002-0859-0856	Italian Ministry of Health; Telethon Foundation [GGP09037]; Welcome Trust [098051, WT100669MA]; Medical Research Council (MRC); MRC [MC_qA137918, G0300212] Funding Source: UKRI; Medical Research Council [MC_qA137918, G0300212] Funding Source: researchfish	Italian Ministry of Health(Ministry of Health, Italy); Telethon Foundation(Fondazione Telethon); Welcome Trust(Wellcome Trust); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Results have been obtained thanks to funds from a) Italian Ministry of Health (RF and RC to PG), b) Telethon Foundation (GGP09037) to PG, c) Welcome Trust (grant no. 098051) to KPS, d) Welcome Trust (grant no. WT100669MA) to KPS, e) Medical Research Council (MRC) to KPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Baig SM, 2011, NAT NEUROSCI, V14, P77, DOI 10.1038/nn.2694; Blanton SH, 2002, J MED GENET, V39, P567, DOI 10.1136/jmg.39.8.567; Bryant EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063469; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dror AA, 2010, NEURON, V68, P293, DOI 10.1016/j.neuron.2010.10.011; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; El-Amraoui A, 2013, PROG MOL BIOL TRANSL, V116, P361, DOI 10.1016/B978-0-12-394311-8.00016-9; Faitar SL, 2005, GENOMICS, V86, P594, DOI 10.1016/j.ygeno.2005.06.002; Friedman RA, 2009, HUM MOL GENET, V18, P785, DOI 10.1093/hmg/ddn402; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Girotto G, 2011, AUDIOL MED, V9, P135; Girotto G, 2011, J MED GENET, V48, P369, DOI 10.1136/jmg.2010.088310; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Lin PT, 2000, J NEUROSCI, V20, P9152; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Mittelstaedt T, 2007, GENE, V403, P70, DOI 10.1016/j.gene.2007.08.004; Nayak G, 2011, DEV NEUROBIOL, V71, P129, DOI 10.1002/dneu.20831; Newman DL, 2012, HEARING RES, V294, P125, DOI 10.1016/j.heares.2012.08.016; Parsons MJ, 2013, AM J MED GENET B, V162B, P431, DOI 10.1002/ajmg.b.32106; Plenge RM, 2011, ARTHRITIS RHEUM-US, V63, P2839, DOI 10.1002/art.30509; Schulz HL, 2002, NEUROSCI LETT, V326, P37, DOI 10.1016/S0304-3940(02)00306-3; Shahin H, 2010, J MED GENET, V47, P643, DOI 10.1136/jmg.2009.075697; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Tannenbaum J, 1997, CELL MOTIL CYTOSKEL, V38, P146, DOI 10.1002/(SICI)1097-0169(1997)38:2<146::AID-CM4>3.0.CO;2-5; Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266	32	33	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85352	10.1371/journal.pone.0085352	http://dx.doi.org/10.1371/journal.pone.0085352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454846	Green Published, Green Submitted, gold			2022-12-25	WOS:000329925800040
J	Gadwal, S; Korotkov, KV; Delarosa, JR; Hol, WGJ; Sandkvist, M				Gadwal, Shilpa; Korotkov, Konstantin V.; Delarosa, Jaclyn R.; Hol, Wim G. J.; Sandkvist, Maria			Functional and Structural Characterization of Vibrio cholerae Extracellular Serine Protease B, VesB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Crystal Structure; Protein Domains; Protein Secretion; Proteolytic Enzymes; Serine Protease; Thrombin; Immunoglobulin-fold; Substrate Specificity; Trypsin	REFINED CRYSTAL-STRUCTURE; OUTER-MEMBRANE; SECRETION; TRYPSIN; BACTERIAL; DOMAIN; SITE; FLEXIBILITY; MECHANISM; REVEALS	Background: The extracellular Vibrio cholerae protease, VesB, is expressed in vitro and in stools of cholera patients. Results: VesB is homologous to trypsin and thrombin and the C-terminal domain has an immunoglobulin-fold. Conclusion: In contrast to thrombin, but similar to trypsin, VesB is not activated by sodium. Significance: This is the first structure of a bacterial modular trypsin-like protease. The chymotrypsin subfamily A of serine proteases consists primarily of eukaryotic proteases, including only a few proteases of bacterial origin. VesB, a newly identified serine protease that is secreted by the type II secretion system in Vibrio cholerae, belongs to this subfamily. VesB is likely produced as a zymogen because sequence alignment with trypsinogen identified a putative cleavage site for activation and a catalytic triad, His-Asp-Ser. Using synthetic peptides, VesB efficiently cleaved a trypsin substrate, but not chymotrypsin and elastase substrates. The reversible serine protease inhibitor, benzamidine, inhibited VesB and served as an immobilized ligand for VesB affinity purification, further indicating its relationship with trypsin-like enzymes. Consistent with this family of serine proteases, N-terminal sequencing implied that the propeptide is removed in the secreted form of VesB. Separate mutagenesis of the activation site and catalytic serine rendered VesB inactive, confirming the importance of these features for activity, but not for secretion. Similar to trypsin but, in contrast to thrombin and other coagulation factors, Na+ did not stimulate the activity of VesB, despite containing the Tyr(250) signature. The crystal structure of catalytically inactive pro-VesB revealed that the protease domain is structurally similar to trypsinogen. The C-terminal domain of VesB was found to adopt an immunoglobulin (Ig)-fold that is structurally homologous to Ig-folds of other extracellular Vibrio proteins. Possible roles of the Ig-fold domain in stability, substrate specificity, cell surface association, and type II secretion of VesB, the first bacterial multidomain trypsin-like protease with known structure, are discussed.	[Gadwal, Shilpa; Sandkvist, Maria] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Korotkov, Konstantin V.; Delarosa, Jaclyn R.; Hol, Wim G. J.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Korotkov, Konstantin V.; Delarosa, Jaclyn R.; Hol, Wim G. J.] Univ Washington, Biomol Struct Ctr, Seattle, WA 98195 USA	University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sandkvist, M (corresponding author), 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	mariasan@umich.edu		Korotkov, Konstantin/0000-0002-2182-6843	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034501, R01AI081705, T32AI007528, R01AI049294] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the staff of beamline 8.2.2 at ALS for assistance during data collection. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract No. DE-AC02-05CH11231.	Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Connell TD, 1998, J BACTERIOL, V180, P5591, DOI 10.1128/JB.180.21.5591-5600.1998; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dang QD, 1996, P NATL ACAD SCI USA, V93, P10653, DOI 10.1073/pnas.93.20.10653; Deng JP, 2004, ACTA CRYSTALLOGR D, V60, P203, DOI 10.1107/S0907444903024491; Di Cera E, 2007, PHYS CHEM CHEM PHYS, V9, P1292, DOI 10.1039/b616819a; DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089; Douzi B, 2012, PHILOS T R SOC B, V367, P1059, DOI 10.1098/rstb.2011.0204; Edwin A, 2013, FEBS OPEN BIO, V3, P263, DOI 10.1016/j.fob.2013.06.003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Forneris F, 2012, CURR OPIN STRUC BIOL, V22, P333, DOI 10.1016/j.sbi.2012.04.001; Friedrich R, 2002, J BIOL CHEM, V277, P2160, DOI 10.1074/jbc.M109830200; Giglio KM, 2013, J BACTERIOL, V195, P3277, DOI 10.1128/JB.00374-13; GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Haft DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028886; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; Hedstrom L., 2002, CURRENT PROTOCOLS PR, V10, P1; Johnson TL, 2007, J BACTERIOL, V189, P9082, DOI 10.1128/JB.01256-07; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Knight SD, 2002, ACTA CRYSTALLOGR D, V58, P1016, DOI 10.1107/S0907444902005954; Kobayashi H, 2009, J BIOL CHEM, V284, P27655, DOI 10.1074/jbc.M109.006114; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LaRocque RC, 2008, INFECT IMMUN, V76, P4145, DOI 10.1128/IAI.00585-08; LINDBERG F, 1989, J BACTERIOL, V171, P6052, DOI 10.1128/jb.171.11.6052-6058.1989; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lybarger SR, 2009, J BACTERIOL, V191, P3149, DOI 10.1128/JB.01701-08; Magnusdottir A, 2009, NAT METHODS, V6, P477, DOI 10.1038/nmeth0709-477; MARQUART M, 1983, ACTA CRYSTALLOGR B, V39, P480, DOI 10.1107/S010876818300275X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLaughlin LS, 2012, CURR OPIN STRUC BIOL, V22, P208, DOI 10.1016/j.sbi.2012.02.005; Murayama K, 2012, J MOL BIOL, V423, P386, DOI 10.1016/j.jmb.2012.07.013; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nonaka T, 2004, J BIOL CHEM, V279, P47344, DOI 10.1074/jbc.M409089200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2006, BIOCHEMISTRY-US, V45, P2987, DOI 10.1021/bi052481a; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pozzi N, 2013, J BIOL CHEM, V288, P22734, DOI 10.1074/jbc.M113.466946; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; READ RJ, 1988, J MOL BIOL, V200, P523, DOI 10.1016/0022-2836(88)90541-4; Rojas A, 2002, J MOL EVOL, V55, P790, DOI 10.1007/s00239-002-2361-x; RYPNIEWSKI WR, 1994, PROTEIN ENG, V7, P57, DOI 10.1093/protein/7.1.57; SANDKVIST M, 1993, GENE, V123, P81, DOI 10.1016/0378-1119(93)90543-C; Sauer FG, 2000, SEMIN CELL DEV BIOL, V11, P27, DOI 10.1006/scdb.1999.0348; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sikora A. E., 2013, PLOS ONE, V9; Sikora AE, 2007, J BACTERIOL, V189, P8484, DOI 10.1128/JB.00583-07; Sikora AE, 2011, J BIOL CHEM, V286, P16555, DOI 10.1074/jbc.M110.211078; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Syngkon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013122; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Uesugi Y, 2008, BBA-PROTEINS PROTEOM, V1784, P716, DOI 10.1016/j.bbapap.2008.01.017; Uesugi Y, 2009, FEBS J, V276, P5634, DOI 10.1111/j.1742-4658.2009.07256.x; VANZONNEVELD AJ, 1986, J CELL BIOCHEM, V32, P169, DOI 10.1002/jcb.240320302; Vezzulli L, 2010, ENV MICROBIOL REP, V2, P27, DOI 10.1111/j.1758-2229.2009.00128.x; Wong E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002373; Xu Q, 2003, P NATL ACAD SCI USA, V100, P1286, DOI 10.1073/pnas.0337479100; YAMANE T, 1995, J BIOCHEM-TOKYO, V118, P882, DOI 10.1093/jb/118.5.882	65	21	21	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8288	8298		10.1074/jbc.M113.525261	http://dx.doi.org/10.1074/jbc.M113.525261			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24459146	Green Published, hybrid			2022-12-25	WOS:000333157500023
J	Tran, CM; Schoepflin, ZR; Markova, DZ; Kepler, CK; Anderson, DG; Shapiro, IM; Risbud, MV				Tran, Cassie M.; Schoepflin, Zachary R.; Markova, Dessislava Z.; Kepler, Christopher K.; Anderson, D. Greg; Shapiro, Irving M.; Risbud, Makarand V.			CCN2 Suppresses Catabolic Effects of Interleukin-1 beta through alpha 5 beta 1 and alpha V beta 3 Integrins in Nucleus Pulposus Cells IMPLICATIONS IN INTERVERTEBRAL DISC DEGENERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cartilage Biology; Chondrocytes; Cytokine; Extracellular Matrix Proteins; Integrins	TISSUE-GROWTH-FACTOR; NF-KAPPA-B; HEPATIC STELLATE CELLS; TNF-ALPHA; EXTRACELLULAR-MATRIX; CYTOKINE EXPRESSION; BINDING-SITES; FACTOR-BETA; CHONDROCYTES; FIBROBLASTS	Background: The relationship between inflammatory cytokines TNF- and IL-1 and CCN2 in nucleus pulposus cells is unknown. Results: Cytokines suppress CCN2 expression, whereas CCN2 represses catabolic action of IL-1. Conclusion: In nucleus pulposus, cytokines and CCN2 form a negative regulatory circuit. Significance: CCN2 may play an important role in pathogenesis of intervertebral disc degeneration. The objective of the study was to examine the regulation of CCN2 by inflammatory cytokines, IL-1, and TNF- and to determine whether CCN2 modulates IL-1-dependent catabolic gene expression in nucleus pulposus (NP) cells. IL-1 and TNF- suppress CCN2 mRNA and protein expression in an NF-B-dependent but MAPK-independent manner. The conserved B sites located at -93/-86 and -546/-537 bp in the CCN2 promoter mediated this suppression. On the other hand, treatment of NP cells with IL-1 in combination with CCN2 suppressed the inductive effect of IL-1 on catabolic genes, including MMP-3, ADAMTS-5, syndecan 4, and prolyl hydroxylase 3. Likewise, silencing of CCN2 in human NP cells resulted in elevated basal expression of several catabolic genes and inflammatory cytokines like IL-6, IL-4, and IL-12 as measured by gene expression and cytokine protein array, respectively. Interestingly, the suppressive effect of CCN2 on IL-1 was independent of modulation of NF-B signaling. Using disintegrins, echistatin, and VLO4, peptide inhibitors to v3 and 51 integrins, we showed that CCN2 binding to both integrins was required for the inhibition of IL-1-induced catabolic gene expression. It is noteworthy that analysis of human tissues showed a trend of altered expression of these integrins during degeneration. Taken together, these results suggest that CCN2 and inflammatory cytokines form a functional negative feedback loop in NP cells that may be important in the pathogenesis of disc disease.	[Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1025 Walnut St,Ste 511 Coll Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu			National Institutes of Health [AR050087, AR055655, F31AG038125, T32 AR052273]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050087, T32AR052273, R01AR055655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG038125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050087 and AR055655 (to M. V. R.), F31AG038125 (to C. M. T.), and T32 AR052273 (to Z. R. S.).	Abbott RD, 2013, J SPINAL DISORD TECH, V26, pE86, DOI 10.1097/BSD.0b013e31826e0ca4; Abraham DJ, 2000, J BIOL CHEM, V275, P15220, DOI 10.1074/jbc.275.20.15220; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Aoyama E, 2009, BIOCHEM J, V420, P413, DOI 10.1042/BJ20081991; Bachmeier BE, 2007, ANN NY ACAD SCI, V1096, P44, DOI 10.1196/annals.1397.069; Bedore J, 2013, ARTHRITIS RHEUM-US, V65, P2634, DOI 10.1002/art.38075; Bogatkevich GS, 2007, ARTHRITIS RHEUM-US, V56, P3468, DOI 10.1002/art.22874; Bridgen DT, 2013, J ORTHOP RES, V31, P1661, DOI 10.1002/jor.22395; Burkhart BA, 2005, J BIOL CHEM, V280, P6349, DOI 10.1074/jbc.M411147200; Chaqour B, 2006, J BIOL CHEM, V281, P20608, DOI 10.1074/jbc.M600214200; Chen A, 2008, BRIT J PHARMACOL, V153, P557, DOI 10.1038/sj.bjp.0707542; Davidson ENB, 2006, ARTHRITIS RHEUM-US, V54, P1653, DOI 10.1002/art.21795; Erwin WM, 2006, ARTHRITIS RHEUM-US, V54, P3859, DOI 10.1002/art.22258; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; Gao RP, 2004, J BIOL CHEM, V279, P8848, DOI 10.1074/jbc.M313204200; Gilchrist CL, 2007, J ORTHOP RES, V25, P829, DOI 10.1002/jor.20343; Gressner OA, 2011, WORLD J GASTROENTERO, V17, P151, DOI 10.3748/wjg.v17.i2.151; Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Le Maitre CL, 2009, ARTHRITIS RHEUM-US, V60, P460, DOI 10.1002/art.24248; Lee JM, 2011, J ORTHOP RES, V29, P265, DOI 10.1002/jor.21210; Liu S, 2012, PLOS ONE, P7; Liu SC, 2013, BBA-MOL CELL RES, V1833, P1114, DOI 10.1016/j.bbamcr.2012.12.014; Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159; Marcinkiewicz C, 1996, BIOCHEM J, V317, P817, DOI 10.1042/bj3170817; Masuko Kayo, 2010, BMC Res Notes, V3, P5, DOI 10.1186/1756-0500-3-5; Moritani Norifumi H, 2005, Cell Commun Signal, V3, P6, DOI 10.1186/1478-811X-3-6; Nishida T, 2004, J BONE MINER RES, V19, P1308, DOI 10.1359/JBMR.040322; Nishida T, 2007, J CELL COMMUN SIGNAL, V1, P45, DOI 10.1007/s12079-007-0005-z; Nishida T, 2011, ENDOCRINOLOGY, V152, P4232, DOI 10.1210/en.2011-0234; Peng BG, 2009, SPINE, V34, pE178, DOI 10.1097/BRS.0b013e3181908ab3; Phillips KLE, 2013, ANN RHEUM DIS, V72, P1860, DOI 10.1136/annrheumdis-2012-202266; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Rittie L, 2011, J CELL COMMUN SIGNAL, V5, P69, DOI 10.1007/s12079-010-0114-y; Sanchez-Lopez E, 2009, J AM SOC NEPHROL, V20, P1513, DOI 10.1681/ASN.2008090999; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; Su G, 2012, AM J RESP CRIT CARE, V185, P58, DOI 10.1164/rccm.201108-1381OC; Tian Y, 2013, AM J PATHOL, V182, P2310, DOI 10.1016/j.ajpath.2013.02.037; Tran CM, 2013, J BIOL CHEM, V288, P12654, DOI 10.1074/jbc.M112.448860; Tran CM, 2011, ARTHRITIS RHEUM-US, V63, P3022, DOI 10.1002/art.30468; Tran CM, 2010, ARTHRITIS RHEUM-US, V62, P1983, DOI 10.1002/art.27445; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Wu QH, 2012, ARTHRITIS RHEUM-US, V64, P3324, DOI 10.1002/art.34570; Xia MS, 2011, J ORTHOP RES, V29, P556, DOI 10.1002/jor.21273; Xia MS, 2008, CONNECT TISSUE RES, V49, P464, DOI 10.1080/03008200802325425; Xia W, 2007, ANN SURG, V246, P886, DOI 10.1097/SLA.0b013e318070d54f	50	47	50	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7374	7387		10.1074/jbc.M113.526111	http://dx.doi.org/10.1074/jbc.M113.526111			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24464580	hybrid, Green Published			2022-12-25	WOS:000332761500010
J	Rotheram-Borus, MJ; Richter, LM; van Heerden, A; van Rooyen, H; Tomlinson, M; Harwood, JM; Comulada, WS; Stein, A				Rotheram-Borus, Mary Jane; Richter, Linda M.; van Heerden, Alastair; van Rooyen, Heidi; Tomlinson, Mark; Harwood, Jessica M.; Comulada, W. Scott; Stein, Alan			A Cluster Randomized Controlled Trial Evaluating the Efficacy of Peer Mentors to Support South African Women Living with HIV and Their Infants	PLOS ONE			English	Article							CHILD-DEVELOPMENT; DEPRESSION; SERVICES; MOTHERS; PMTCT; TRANSMISSION; SURVIVAL; OUTCOMES; RISK	Objective: We evaluate the effect of clinic-based support by HIV-positive Peer Mentors, in addition to standard clinic care, on maternal and infant well-being among Women Living with HIV (WLH) from pregnancy through the infant's first year of life. Methods: In a cluster randomized controlled trial in KwaZulu-Natal, South Africa, eight clinics were randomized for pregnant WLH to receive either: a Standard Care condition (SC; 4 clinics; n = 656 WLH); or an Enhanced Intervention (EI; 4 clinics; n = 544 WLH). WLH in the EI were invited to attend four antenatal and four postnatal meetings led by HIV-positive Peer Mentors, in addition to SC. WLH were recruited during pregnancy, and at least two post-birth assessment interviews were completed by 57% of WLH at 1.5, 6 or 12 months. EI's effect was ascertained on 19 measures of maternal and infant wellbeing using random effects regressions to control for clinic clustering. A binomial test for correlated outcomes evaluated EI's overall efficacy. Findings: WLH attended an average of 4.1 sessions (SD = 2.0); 13% did not attend any sessions. Significant overall benefits were found in EI compared to SC using the binomial test. Secondarily, over time, WLH in the EI reported significantly fewer depressive symptoms and fewer underweight infants than WLH in the SC condition. EI WLH were significantly more likely to use one feeding method for six months and exclusively breastfeed their infants for at least 6 months. Conclusions: WLH benefit by support from HIV-positive Peer Mentors, even though EI participation was partial, with incomplete follow-up rates from 6-12 months.	[Rotheram-Borus, Mary Jane; Harwood, Jessica M.; Comulada, W. Scott] Univ Calif Los Angeles, Global Ctr Children & Families, Los Angeles, CA 90095 USA; [Richter, Linda M.; van Heerden, Alastair; van Rooyen, Heidi] Univ Witwatersrand, Dev Pathways Hlth Res Unit, Johannesburg, Gauteng, South Africa; [Richter, Linda M.] Human Sci Res Council, Durban, South Africa; [Tomlinson, Mark] Univ Stellenbosch, Dept Psychol, Matieland, South Africa; [Stein, Alan] Univ Oxford, Dept Psychiat, Oxford, England	University of California System; University of California Los Angeles; University of Witwatersrand; Human Sciences Research Council-South Africa; Stellenbosch University; University of Oxford	Rotheram-Borus, MJ (corresponding author), Univ Calif Los Angeles, Global Ctr Children & Families, Los Angeles, CA 90095 USA.	CCHPublications@mednet.ucla.edu	Van Heerden, Alastair/AAY-6262-2020	Van Heerden, Alastair/0000-0003-2530-6885; Stein, Alan/0000-0001-8207-2822	NIMH [R01MH077553]; Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH [P30MH058107]; UCLA AIDS Institute; UCLA Center for AIDS Research (CFAR) NIH [P30AI028697]; National Center for Advancing Translational Sciences through UCLA CSTI [UL1TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107, R01MH077553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA022919] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH; UCLA AIDS Institute; UCLA Center for AIDS Research (CFAR) NIH; National Center for Advancing Translational Sciences through UCLA CSTI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was funded by the NIMH grant R01MH077553. In addition, this work was supported by the Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH grant P30MH058107; the UCLA AIDS Institute and the UCLA Center for AIDS Research (CFAR) NIH grant P30AI028697; and the National Center for Advancing Translational Sciences through UCLA CSTI grant UL1TR000124. The content is solely the responsibility of the authors and does not necessarily represent the views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin RR., 1995, PSYCHOL ASSESSMENT R; [Anonymous], 2001, MOB RES VERS 4 0 0 S; Brockington IF, 2006, ARCH WOMEN MENT HLTH, V9, P233, DOI 10.1007/s00737-006-0132-1; Childinfo, MON SIT CHILDR WOM W; Cogill B, 2003, ANTHROPOMETRIC INDIC; Doherty T, 2011, B WORLD HEALTH ORGAN, V89, P62, DOI 10.2471/BLT.10.079798; Fisher EB, 2012, HEALTH AFFAIR, V31, P130, DOI 10.1377/hlthaff.2011.0914; Futterman D, 2010, AIDS CARE, V22, P1093, DOI 10.1080/09540121003600352; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Hartley M, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-9; Kharsany ABM, 2004, 15 INT AIDS C BANGK; le Roux IM, 2013, AIDS, V27, P1461, DOI 10.1097/QAD.0b013e3283601b53; le Roux IM, 2011, VULNERABLE CHILD YOU, V6, P91, DOI 10.1080/17450128.2011.564224; Leshabari SC, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-22; Mothers2Mothers South Africa website, 2011 ANN REP; National Department of Health, 2008, POLICY IMPLEMENTATIO, P1; Parsons CE, 2012, BRIT MED BULL, V101, P57, DOI 10.1093/bmb/ldr047; Rahman A, 2007, J AFFECT DISORDERS, V100, P115, DOI 10.1016/j.jad.2006.10.004; Rotheram-Borus MJ, 2011, PREV SCI, V12, P372, DOI 10.1007/s11121-011-0238-1; Rotheram-Borus MJ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-2; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Smedslund G, 2004, J PSYCHOSOM RES, V57, P123, DOI 10.1016/S0022-3999(03)00575-0; Spensley A, 2009, AM J PUBLIC HEALTH, V99, P631, DOI 10.2105/AJPH.2007.114421; Sprague C, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-10; Stringer EM, 2010, JAMA-J AM MED ASSOC, V304, P293, DOI 10.1001/jama.2010.990; Teasdale CA, 2008, S AFR J HIV MED, P60; Tomlinson M, 2006, CHILD CARE HLTH DEV, V32, P81, DOI 10.1111/j.1365-2214.2006.00598.x; UNAIDS, 2011, GLOB HIV AIDS RESP E; UNAIDS, 2009, 4 UNAIDS; UNICEF website, 2012, INF COUNTR PROGR; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; World Health Organization, 2008, MAT MENT HLTH CHILD; World Health Organization, 2007, TASK SHIFT TACKL HLT; World Health Organization website, PERC MEAN DAYS MONTH	34	52	52	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e84867	10.1371/journal.pone.0084867	http://dx.doi.org/10.1371/journal.pone.0084867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VL	24465444	Green Published, gold			2022-12-25	WOS:000330283100015
J	Kotlo, K; Xing, YN; Lather, S; Grillon, JM; Johnson, K; Skidgel, RA; Solaro, RJ; Danziger, RS				Kotlo, Kumar; Xing, Yongna; Lather, Sonia; Grillon, Jean Michel; Johnson, Keven; Skidgel, Randal A.; Solaro, R. John; Danziger, Robert S.			PR65A Phosphorylation Regulates PP2A Complex Signaling	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; HEART-FAILURE; CARDIAC MYOCYTES; TUMOR-ANTIGENS; A-SUBUNIT; DEPHOSPHORYLATION; HOLOENZYME; STIMULATION; MECHANISM; INSIGHTS	Serine-threonine Protein phosphatase 2 A (PP2A), a member of the PPP family of phosphatases, regulates a variety of essential cellular processes, including cell-cycling, DNA replication, transcription, translation, and secondary signaling pathways. In the heart, increased PP2A activity/signaling has been linked to cardiac remodeling, contractile dysfunction and, in failure, arrythmogenicity. The core PP2A complex is a hetero-trimeric holoenzyme consisting of a 36 kDa catalytic subunit (PP2Ac); a regulatory scaffold subunit of 65 kDa (PR65A or PP2Aa); and one of at least 18 associated variable regulatory proteins (B subunits) classified into 3 families. In the present study, three in vivo sites of phosphorylation in cardiac PR65A are identified (S303, T268, S314). Using HEK cells transfected with recombinant forms of PR65A with phosphomimetic (P-PR65A) and non-phosphorylated (N-PR65A) amino acid substitutions at these sites, these phosphorylations were shown to inhibit the interaction of PR65A with PP2Ac and PP2A holoenzyme signaling. Forty-seven phospho-proteins were increased in abundance in HEK cells transfected with P-PR65A versus N-PR65A by phospho-protein profiling using 2D-DIGE analysis on phospho-enriched whole cell protein extracts. Among these proteins were elongation factor 1 alpha (EF1A), elongation factor 2, heat shock protein 60 (HSP60), NADPH-dehydrogenase 1 alpha sub complex, annexin A, and PR65A. Compared to controls, failing hearts from the Dahl rat had less phosphorylated PR65A protein abundance and increased PP2A activity. Thus, PR65A phosphorylation is an in vivo mechanism for regulation of the PP2A signaling complex and increased PP2A activity in heart failure.	[Kotlo, Kumar; Grillon, Jean Michel; Solaro, R. John; Danziger, Robert S.] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Kotlo, Kumar; Grillon, Jean Michel; Solaro, R. John; Danziger, Robert S.] Univ Illinois, Cardiovasc Res Ctr, Chicago, IL USA; [Solaro, R. John; Danziger, Robert S.] Univ Illinois, Dept Physiol, Chicago, IL USA; [Lather, Sonia; Danziger, Robert S.] Jesse Brown Vet Adm, Chicago, IL USA; [Xing, Yongna] Univ Wisconsin, Dept Oncol, Madison, WI USA; [Johnson, Keven; Skidgel, Randal A.; Danziger, Robert S.] Univ Illinois, Dept Pharmacol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Danziger, RS (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	rdanzig@uic.edu			R21 Veterans Administration Merit Award; NIH [R21HL096031, KO1 DK071641, T32 HL 07692]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692, R21HL096031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK071641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096060] Funding Source: NIH RePORTER	R21 Veterans Administration Merit Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by R21 Veterans Administration Merit Award (RSD) and NIH grants R21HL096031 (RSD), KO1 DK071641 (KK), and T32 HL 07692 (KRJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; ALTSCHULD RA, 1995, CIRCULATION, V92, P1612, DOI 10.1161/01.CIR.92.6.1612; Basu S, 2011, CURR PROTEIN PEPT SC, V12, P3, DOI 10.2174/138920311795659443; Briston SJ, 2011, J PHYSIOL-LONDON, V589, P1367, DOI 10.1113/jphysiol.2010.203984; Buscemi N, 2002, CIRC RES, V91, P509, DOI 10.1161/01.RES.0000035246.27856.53; Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; DeGrande ST, 2013, J BIOL CHEM, V288, P1032, DOI 10.1074/jbc.M112.426957; Dorovkov MV, 2011, BIOCHEMISTRY-US, V50, P2187, DOI 10.1021/bi101963h; Freeley M, 2011, CELL SIGNAL, V23, P753, DOI 10.1016/j.cellsig.2010.10.013; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jiang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2663; Ke YB, 2004, CIRC RES, V94, P194, DOI 10.1161/01.RES.0000111522.02730.56; Khan IU, 1998, P NATL ACAD SCI USA, V95, P10425, DOI 10.1073/pnas.95.18.10425; Kim AS, 2011, J MOL CELL CARDIOL, V51, P24, DOI 10.1016/j.yjmcc.2011.03.003; Kohr MJ, 2009, NITRIC OXIDE-BIOL CH, V20, P217, DOI 10.1016/j.niox.2009.01.003; Kotlo K, 2012, J PROTEOMICS, V77, P1, DOI 10.1016/j.jprot.2012.05.041; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; MOVSESIAN MA, 1990, J CLIN INVEST, V85, P1698, DOI 10.1172/JCI114623; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Niizeki T, 2008, AM J CARDIOL, V102, P606, DOI 10.1016/j.amjcard.2008.04.030; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Qin C, 2012, BR J PHARM; Ritchie RH, 2003, EUR J PHARMACOL, V461, P171, DOI 10.1016/S0014-2999(03)01314-1; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Vittone L, 2008, FRONT BIOSCI-LANDMRK, V13, P5988, DOI 10.2741/3131; Wlodarchak N, 2013, CELL RES, V23, P931, DOI 10.1038/cr.2013.77; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200	34	8	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85000	10.1371/journal.pone.0085000	http://dx.doi.org/10.1371/journal.pone.0085000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465463	gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500025
J	Kiparsky, M; Joyce, B; Purkey, D; Young, C				Kiparsky, Michael; Joyce, Brian; Purkey, David; Young, Charles			Potential Impacts of Climate Warming on Water Supply Reliability in the Tuolumne and Merced River Basins, California	PLOS ONE			English	Article							SIERRA-NEVADA; HYDROLOGY; MODEL; RESOURCES; DRIVEN	We present an integrated hydrology/water operations simulation model of the Tuolumne and Merced River Basins, California, using the Water Evaluation and Planning (WEAP) platform. The model represents hydrology as well as water operations, which together influence water supplied for agricultural, urban, and environmental uses. The model is developed for impacts assessment using scenarios for climate change and other drivers of water system behavior. In this paper, we describe the model structure, its representation of historical streamflow, agricultural and urban water demands, and water operations. We describe projected impacts of climate change on hydrology and water supply to the major irrigation districts in the area, using uniform 2 degrees C, 4 degrees C, and 6 degrees C increases applied to climate inputs from the calibration period. Consistent with other studies, we find that the timing of hydrology shifts earlier in the water year in response to temperature warming (5-21 days). The integrated agricultural model responds with increased water demands 2 degrees C (1.4-2.0%), 4 degrees C (2.8-3.9%), and 6 degrees C (4.2-5.8%). In this sensitivity analysis, the combination of altered hydrology and increased demands results in decreased reliability of surface water supplied for agricultural purposes, with modeled quantity-based reliability metrics decreasing from a range of 0.84-0.90 under historical conditions to 0.75-0.79 under 6 degrees C warming scenario.	[Kiparsky, Michael] Univ Calif Berkeley, Wheeler Inst Water Law & Policy, Berkeley, CA 94720 USA; [Joyce, Brian; Purkey, David; Young, Charles] Stockholm Environm Inst, Davis, CA USA	University of California System; University of California Berkeley	Kiparsky, M (corresponding author), Univ Calif Berkeley, Wheeler Inst Water Law & Policy, Berkeley, CA 94720 USA.	kiparsky@berkeley.edu			NSF Graduate Research Fellowship; NSF Doctoral Dissertation Research Improvement Grant; CALFED Bay-Delta Program Fellowship; California Energy Commission PIER program	NSF Graduate Research Fellowship(National Science Foundation (NSF)); NSF Doctoral Dissertation Research Improvement Grant; CALFED Bay-Delta Program Fellowship; California Energy Commission PIER program	This study received funding from an NSF Graduate Research Fellowship, an NSF Doctoral Dissertation Research Improvement Grant, a CALFED Bay-Delta Program Fellowship, and the California Energy Commission PIER program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami NK, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004745; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; BEVEN K, 1993, ADV WATER RESOUR, V16, P41, DOI 10.1016/0309-1708(93)90028-E; Beven K, 2001, HYDROL EARTH SYST SC, V5, P1, DOI 10.5194/hess-5-1-2001; California Department of Water Resources, 2006, CAL LAND WAT US DAT; Cayan D, 2009, CLIMATE CHANGE SCENA; CH2M Hill, 2001, MERC WAT SUPPL PLAN; Cooley H, 2008, MORE LESS AGR WATER; Dettinger M.D., 2005, SAN FRANCISCO ESTUAR, V3; Dettinger MD, 2004, CLIMATIC CHANGE, V62, P283, DOI 10.1023/B:CLIM.0000013683.13346.4f; Dracup J.A., 2005, CEC5002005053 PIER E; Draper AJ, 2004, J WATER RES PLAN MAN, V130, P480, DOI 10.1061/(ASCE)0733-9496(2004)130:6(480); DWR, 2004, BULLETIN, V118; DWR, 2003, BULLETIN, V118; DWR, 1975, BULLETIN, V113-3; ESRI, 2007, ARCGIS 9 2; ESRI, 2007, ARCHYDRO TOOLK; Evolving Logic, 2010, COMP AID REAS SOFTW; Flint LE, 2007, 1703B USGS; Getches DH, 2003, WATER AND CLIMATE IN THE WESTERN UNITED STATES, P183; GLEICK PH, 1987, CLIMATIC CHANGE, V10, P137, DOI 10.1007/BF00140252; Groves DG, 2005, QUANTIFIED SCENARIOS; HASHIMOTO T, 1982, WATER RESOUR RES, V18, P14, DOI 10.1029/WR018i001p00014; Joyce B, 2006, CLIMATE CHANGE IMPAC; Kiparsky M, 2005, WORLDS WATER 2004 20; Kiparsky M, 2003, CEC5002004073ED2; Kiparsky M, 2011, P AWRA 2011 SPRING S; Kiparsky M, 2012, ANNU REV ENV RESOUR, V37, P163, DOI 10.1146/annurev-environ-050311-093931; Knowles N, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014339; Knowles N, 2000, HYDROCLIMATE SAN FRA; Koczot KM, 2005, 20045202 US GEOL SUR; Loucks DP, 2005, WATER RESOURCES SYST, P255; Lundquist J, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006995; Maurer EP, 2002, J CLIMATE, V15, P3237, DOI [10.1175/1520-0442(2002)015<3237:ALTHBD>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3237:ALTHBD&gt;2.0.CO;2]; MBK Engineers, 2001, MERC WAT SUPPL PLAN; Multi-Resolution Land Characteristics Consortium, 2001, NAT LAND COV DAT; Nash J.E., 1970, J HYDROL, V10, P282, DOI [DOI 10.1016/0022-1694(70)90255-6, 10.1016/0022-1694(70)90255-6]; National Atlas of the United States, 2006, MAJ DAMS US; Natural Resources Conservation Service, 2006, US GEN SOIL MAP STAT; Null SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009932; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Purkey DR, 2008, CLIMATIC CHANGE, V87, pS109, DOI 10.1007/s10584-007-9375-8; San Joaquin River Group Authority, 2001, ADD WAT SAN JOAQ RIV; Sanstad AH, 2009, LONG RUN SO IN PRESS; Schwarzenegger A., 2005, EXECUTIVE ORDER S 3; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; State Water Resources Control Board, 1999, FIN ENV IMP REP IMPL, V1; State Water Resources Control Board, 1999, FIN ENV IMP REP IMPL, V2; State Water Resources Control Board, 2009, 20X2020 WAT CONS PLA; Stewart IT, 2004, CLIMATIC CHANGE, V62, P217, DOI 10.1023/B:CLIM.0000013702.22656.e8; STINE S, 1994, NATURE, V369, P546, DOI 10.1038/369546a0; Stockholm Environment Institute, 2011, WAT EV PLANN VERS 3; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; United States Bureau of Reclamation, 2003, STAT WAT DISTR CAL V; United States Bureau of Reclamation, 2006, FED WAT DISTR MIDP R; United States Department of Agriculture, 2006, SOIL SURV GEOGR SSUR; United States Geological Survey, 2007, NAT EL DAT; United States Geological Survey, 2013, NAT WAT INF SYST; URS, 2008, DELT MEND CAN REC IN; USBR, 2005, CALSIM 2 SA IN PRESS; USGS, 2007, NAT WAT INF SYST; Vicuna S, 2007, CLIMATIC CHANGE, V82, P327, DOI 10.1007/s 10584-006-9207-2; Vicuna S., 2010, CLIMATIC CHANGE; Wilby RL, 2009, INT J CLIMATOL, V29, P1193, DOI 10.1002/joc.1839; Yates D, 2005, WATER INT, V30, P487, DOI 10.1080/02508060508691893; Yates D, 2009, J WATER RES PLAN MAN, V135, P303, DOI 10.1061/(ASCE)0733-9496(2009)135:5(303); Young CA, 2009, J AM WATER RESOUR AS, V45, P1409, DOI 10.1111/j.1752-1688.2009.00375.x	68	15	15	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84946	10.1371/journal.pone.0084946	http://dx.doi.org/10.1371/journal.pone.0084946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465455	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500025
J	Di Caro, V; Phillips, B; Engman, C; Harnaha, J; Trucco, M; Giannoukakis, N				Di Caro, Valentina; Phillips, Brett; Engman, Carl; Harnaha, Jo; Trucco, Massimo; Giannoukakis, Nick			Involvement of Suppressive B-Lymphocytes in the Mechanism of Tolerogenic Dendritic Cell Reversal of Type 1 Diabetes in NOD Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; ANTIGEN-PRESENTING CELLS; ISLET BETA-CELLS; RETINOIC ACID; B10 CELLS; IN-VIVO; HOMEOSTATIC PROLIFERATION; DELAYED-HYPERSENSITIVITY; ANTIBODY PREVENTS; IMMUNE-RESPONSES	The objective of the study was to identify immune cell populations, in addition to Foxp3+ T-regulatory cells, that participate in the mechanisms of action of tolerogenic dendritic cells shown to prevent and reverse type 1 diabetes in the Non-Obese Diabetic (NOD) mouse strain. Co-culture experiments using tolerogenic dendritic cells and B-cells from NOD as well as transgenic interleukin-10 promoter-reporter mice along with transfer of tolerogenic dendritic cells and CD19+ B-cells into NOD and transgenic mice, showed that these dendritic cells increased the frequency and numbers of interleukin-10-expressing B-cells in vitro and in vivo. The expansion of these cells was a consequence of both the proliferation of preexisting interleukin-10-expressing B-lymphocytes and the conversion of CD19+ B-lymphcytes into interleukin-10-expressing cells. The tolerogenic dendritic cells did not affect the suppressive activity of these B-cells. Furthermore, we discovered that the suppressive murine B-lymphocytes expressed receptors for retinoic acid which is produced by the tolerogenic dendritic cells. These data assist in identifying the nature of the B-cell population increased in response to the tolerogenic dendritic cells in a clinical trial and also validate very recent findings demonstrating a mechanistic link between human tolerogenic dendritic cells and immunosuppressive regulatory B-cells.	[Di Caro, Valentina; Engman, Carl; Harnaha, Jo; Trucco, Massimo; Giannoukakis, Nick] Univ Pittsburgh, Sch Med, Dept Pediat, Div Immunogenet, Pittsburgh, PA 15261 USA; [Di Caro, Valentina] RiMed Fdn, Palermo, Italy; [Phillips, Brett] Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA; [Giannoukakis, Nick] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Giannoukakis, N (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Div Immunogenet, Pittsburgh, PA 15261 USA.	ngiann1@pitt.edu		Phillips, Brett/0000-0001-6062-4892	RiMed Foundation; NIH NIDDK [DK063499]; JDRF [17-2007-1066]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK063499, R33DK063499] Funding Source: NIH RePORTER	RiMed Foundation; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the RiMed Foundation (to Massimo Trucco and Valentina Di Caro), and in part by NIH NIDDK DK063499 (to Massimo Trucco) and JDRF 17-2007-1066 (to Nick Giannoukakis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Anderson SM, 2006, IMMUNOL REV, V211, P280, DOI 10.1111/j.0105-2896.2006.00398.x; Anolik JH, 2009, IMMUNOL RES, V45, P144, DOI 10.1007/s12026-009-8096-7; Basten A, 2010, CURR OPIN IMMUNOL, V22, P566, DOI 10.1016/j.coi.2010.08.001; Bettini M, 2011, CURR OPIN IMMUNOL, V23, P754, DOI 10.1016/j.coi.2011.10.002; Bishop GA, 2003, CYTOKINE GROWTH F R, V14, P297, DOI 10.1016/S1359-6101(03)00024-8; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blair PA, 2009, J IMMUNOL, V182, P3492, DOI 10.4049/jimmunol.0803052; Bresson D, 2007, AUTOIMMUN REV, V6, P315, DOI 10.1016/j.autrev.2006.09.013; Brezar V, 2011, ENDOCR REV, V32, P623, DOI 10.1210/er.2011-0010; Cabatingan MS, 2002, J IMMUNOL, V169, P6795, DOI 10.4049/jimmunol.169.12.6795; Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Carvello M, 2012, DIABETES, V61, P155, DOI 10.2337/db11-0684; Chaparro RJ, 2010, EXPERT REV CLIN IMMU, V6, P939, DOI [10.1586/eci.10.68, 10.1586/ECI.10.68]; Chentoufi AA, 2004, DIABETES, V53, P354, DOI 10.2337/diabetes.53.2.354; CLARESALZLER MJ, 1992, J CLIN INVEST, V90, P741, DOI 10.1172/JCI115946; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, SEMIN IMMUNOL, V19, P116, DOI 10.1016/j.smim.2007.01.001; Di Caro V, 2013, CLIN EXP IMMUNOL, V174, P302, DOI 10.1111/cei.12177; Di Caro V, 2013, CLIN EXPT IMMUNOLOGY; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; Dong P, 2010, NUTRITION, V26, P740, DOI 10.1016/j.nut.2009.08.011; DORNER T, 2013, CURR OPIN RHEUMATOL; El-Amine M, 2000, J IMMUNOL, V165, P5631, DOI 10.4049/jimmunol.165.10.5631; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Falcone M, 1998, J IMMUNOL, V161, P1163; Fan Y, 2009, EMBO J, V28, P2812, DOI 10.1038/emboj.2009.212; Fiorina P, 2008, DIABETES, V57, P3013, DOI 10.2337/db08-0420; Fiorina Paolo, 2009, F1000 Biol Rep, V1, P39, DOI 10.3410/B1-39; Fousteri G, 2007, ADV EXP MED BIOL, V601, P313; Giannoukakis N, 2000, MOL THER, V1, P430, DOI 10.1006/mthe.2000.0060; Giannoukakis N, 2011, DIABETES CARE, V34, P2026, DOI 10.2337/dc11-0472; Greeley SAW, 2002, NAT MED, V8, P399, DOI 10.1038/nm0402-399; Grupillo M, 2012, CELL IMMUNOL, V273, P115, DOI 10.1016/j.cellimm.2011.12.010; Harnaha J, 2006, DIABETES, V55, P158, DOI 10.2337/diabetes.55.01.06.db05-0340; Herold KC, 2005, DIABETES, V54, P1763, DOI 10.2337/diabetes.54.6.1763; Herold KC, 2011, J IMMUNOL, V187, P1998, DOI 10.4049/jimmunol.1100539; Hilkens CMU, 2010, INT REV IMMUNOL, V29, P156, DOI 10.3109/08830180903281193; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Hussain S, 2007, J IMMUNOL, V179, P7225, DOI 10.4049/jimmunol.179.11.7225; Inoue Y, 2007, J IMMUNOL, V179, P764, DOI 10.4049/jimmunol.179.2.764; ITOH K, 1995, J IMMUNOL, V154, P4341; Iwata M, 2011, VITAM HORM, V86, P127, DOI 10.1016/B978-0-12-386960-9.00006-X; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jayasimhan A, 2014, CLIN SCI, V126, P1, DOI 10.1042/CS20120627; Johnson S, 2009, IMMUNITY, V30, P218, DOI 10.1016/j.immuni.2008.11.015; Kehry MR, 1996, J IMMUNOL, V156, P2345; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Keymeulen B, 2010, DIABETOLOGIA, V53, P614, DOI 10.1007/s00125-009-1644-9; Kretschmer Karsten, 2008, V94, P8, DOI 10.1159/000154846; Lee KM, 2014, CELL TRANSPLANT, V23, P51, DOI 10.3727/096368912X658962; LeGuern C, 2011, CRIT REV IMMUNOL, V31, P189, DOI 10.1615/CritRevImmunol.v31.i3.20; LEVY Y, 1994, J CLIN INVEST, V93, P424, DOI 10.1172/JCI116977; Li YP, 2006, BIO-MED MATER ENG, V16, pS163; Lipsky PE, 1997, ANN NY ACAD SCI, V815, P372, DOI 10.1111/j.1749-6632.1997.tb52088.x; Luce S, 2013, DIABETES OBES METAB, V15, P89, DOI 10.1111/dom.12159; Ma LL, 2003, DIABETES, V52, P1976, DOI 10.2337/diabetes.52.8.1976; Machen J, 2004, J IMMUNOL, V173, P4331, DOI 10.4049/jimmunol.173.7.4331; Manjarrez-Orduno N, 2009, J INVEST DERMATOL, V129, P278, DOI 10.1038/jid.2008.240; Marino E, 2008, DIABETES, V57, P395, DOI 10.2337/db07-0589; Marino E, 2012, AUTOIMMUNITY, V45, P377, DOI 10.3109/08916934.2012.665527; Maseda D, 2012, J IMMUNOL, V188, P1036, DOI 10.4049/jimmunol.1102500; Matsushita T, 2011, METHODS MOL BIOL, V677, P99, DOI 10.1007/978-1-60761-869-0_7; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Mauri C, 2010, NAT REV RHEUMATOL, V6, P636, DOI 10.1038/nrrheum.2010.140; Michels AW, 2011, CURR OPIN ENDOCRINOL, V18, P235, DOI 10.1097/MED.0b013e32834803ae; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Moreb JS, 2007, CYTOM PART B-CLIN CY, V72B, P281, DOI 10.1002/cyto.b.20161; Moreb JS, 2011, CHEM BIOL INTERACT; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; NETA R, 1974, J IMMUNOL, V113, P1716; Noorchashm H, 1999, J IMMUNOL, V163, P743; Noorchashm H, 1997, DIABETES, V46, P941, DOI 10.2337/diabetes.46.6.941; Nouri-Shirazi M, 2006, EXPERT OPIN BIOL TH, V6, P325, DOI 10.1517/14712598.6.4.325; O'Gorman MR, 2001, CURR PROTOC CYTOM; Palanichamy A, 2009, J IMMUNOL, V182, P5982, DOI 10.4049/jimmunol.0801859; PARKER D, 1975, INT ARCH ALLER A IMM, V49, P276, DOI 10.1159/000231407; Parsons RF, 2012, SEMIN IMMUNOL, V24, P109, DOI 10.1016/j.smim.2011.08.016; Parsons RF, 2011, J IMMUNOL, V186, P614, DOI 10.4049/jimmunol.1002873; Pescovitz MD, 2011, J ALLERGY CLIN IMMUN, V128, P1295, DOI 10.1016/j.jaci.2011.08.008; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Peterson RA, 2012, TOXICOL PATHOL, V40, P186, DOI 10.1177/0192623311430693; Roll P, 2008, ARTHRITIS RHEUM-US, V58, P1566, DOI 10.1002/art.23473; Ryan GA, 2010, J IMMUNOL, V185, P2800, DOI 10.4049/jimmunol.1000856; Serreze DV, 1998, J IMMUNOL, V161, P3912; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; Silveira PA, 2002, EUR J IMMUNOL, V32, P3657, DOI 10.1002/1521-4141(200212)32:12<3657::AID-IMMU3657>3.0.CO;2-E; Steinbrink K, 2009, HUM IMMUNOL, V70, P289, DOI 10.1016/j.humimm.2009.02.003; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Tchao NK, 2012, AM J TRANSPLANT, V12, P1079, DOI 10.1111/j.1600-6143.2012.04008.x; Tian J, 2006, J IMMUNOL, V176, P2654, DOI 10.4049/jimmunol.176.4.2654; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; Vavassori S, 2009, EUR J IMMUNOL, V39, P2224, DOI 10.1002/eji.200839163; Xiu Y, 2008, J IMMUNOL, V180, P2863, DOI 10.4049/jimmunol.180.5.2863; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yarkoni Y, 2010, IMMUNOL REV, V237, P249, DOI 10.1111/j.1600-065X.2010.00936.x; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501	102	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e83575	10.1371/journal.pone.0083575	http://dx.doi.org/10.1371/journal.pone.0083575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465383	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000330237000009
J	Eckel, SP; Linn, WS; Berhane, K; Rappaport, EB; Salam, MT; Zhang, Y; Gilliland, FD				Eckel, Sandrah P.; Linn, William S.; Berhane, Kiros; Rappaport, Edward B.; Salam, Muhammad T.; Zhang, Yue; Gilliland, Frank D.			Estimation of Parameters in the Two-Compartment Model for Exhaled Nitric Oxide	PLOS ONE			English	Article							EXTENDED NO ANALYSIS; ALVEOLAR; ASTHMA; SYNTHASE; DIFFUSION; POLLUTION; AIRWAYS	The fractional concentration of exhaled nitric oxide (FeNO) is a biomarker of airway inflammation that is being increasingly considered in clinical, occupational, and epidemiological applications ranging from asthma management to the detection of air pollution health effects. FeNO depends strongly on exhalation flow rate. This dependency has allowed for the development of mathematical models whose parameters quantify airway and alveolar compartment contributions to FeNO. Numerous methods have been proposed to estimate these parameters using FeNO measured at multiple flow rates. These methods-which allow for non-invasive assessment of localized airway inflammation-have the potential to provide important insights on inflammatory mechanisms. However, different estimation methods produce different results and a serious barrier to progress in this field is the lack of a single recommended method. With the goal of resolving this methodological problem, we have developed a unifying framework in which to present a comprehensive set of existing and novel statistical methods for estimating parameters in the simple two-compartment model. We compared statistical properties of the estimators in simulation studies and investigated model fit and parameter estimate sensitivity across methods using data from 1507 schoolchildren from the Southern California Children's Health Study, one of the largest multiple flow FeNO studies to date. We recommend a novel nonlinear least squares model with natural log transformation on both sides that produced estimators with good properties, satisfied model assumptions, and fit the Children's Health Study data well.	[Eckel, Sandrah P.; Linn, William S.; Berhane, Kiros; Rappaport, Edward B.; Salam, Muhammad T.; Gilliland, Frank D.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Zhang, Yue] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA	University of Southern California; Utah System of Higher Education; University of Utah	Eckel, SP (corresponding author), Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA.	eckel@usc.edu		Salam, Muhammad/0000-0002-3565-8916	National Heart, Lung and Blood Institute [5R01HL61768, 5R01HL76647]; Southern California Environmental Health Sciences Center [5P30ES007048]; National Institute of Environmental Health Sciences; Children's Environmental Health Center [5P01ES009581, R826708-01, RD831861-01]; National Institute of Environmental Health Sciences and the Environmental Protection Agency; National Institute of Environmental Health Sciences [5P01ES011627]; James H. Zumberge Research and Innovation Fund; Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061768, R01HL076647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048, K22ES022987, P01ES011627, R01ES023262, P01ES009581] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Southern California Environmental Health Sciences Center; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Children's Environmental Health Center; National Institute of Environmental Health Sciences and the Environmental Protection Agency(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); James H. Zumberge Research and Innovation Fund; Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Heart, Lung and Blood Institute (grants 5R01HL61768 and 5R01HL76647); the Southern California Environmental Health Sciences Center (grant 5P30ES007048) funded by the National Institute of Environmental Health Sciences; the Children's Environmental Health Center (grants 5P01ES009581, R826708-01 and RD831861-01) funded by the National Institute of Environmental Health Sciences and the Environmental Protection Agency; the National Institute of Environmental Health Sciences (grant 5P01ES011627); the James H. Zumberge Research and Innovation Fund, and the Hastings Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Barnes PJ, 2010, CHEST, V138, P682, DOI 10.1378/chest.09-2090; Bastain TM, 2010, EUR RESP J; Bates D., 1988, NONLINEAR REGRESSION; Bates D.M., 1992, STAT MODELS S; Berhane K, 2011, EUR RESPIR J, V37, P1029, DOI 10.1183/09031936.00081410; Breton CV, 2011, AM J RESP CRIT CARE, V184, P191, DOI 10.1164/rccm.201012-2029OC; Condorelli P, 2007, J APPL PHYSIOL, V102, P417, DOI 10.1152/japplphysiol.00533.2006; Davidian M, 2003, J AGR BIOL ENVIR ST, V8, P387, DOI 10.1198/1085711032697; Davidian M., 1995, NONLINEAR MODELS REP; DENNIS JE, 1981, ACM T MATH SOFTWARE, V7, P369, DOI 10.1145/355958.355966; Eckel SP, 2013, OCCUP ENVIRON MED, V70, P519, DOI 10.1136/oemed-2013-101458; Eckel SP, 2011, ENV HLTH PERSPECT; Eco Medics AG, 2006, ANAL CLD 88 SERIES O; FIELLER EC, 1957, BIOMETRIKA, V44, P470, DOI 10.2307/2332878; Garcia-Rio F, 2011, J ASTHMA, V48, P329, DOI 10.3109/02770903.2011.565847; GAY DM, 1981, SIAM J SCI STAT COMP, V2, P186, DOI 10.1137/0902016; Gelb AF, 2010, THORAX, V65, P619, DOI 10.1136/thx.2009.132696; George SC, 2004, J APPL PHYSIOL, V96, P831, DOI 10.1152/japplphysiol.00950.2003; George SC, 2008, J APPL PHYSIOL, V104, P909, DOI 10.1152/japplphysiol.00111.2008; Hogman M, 2000, RESP MED, V94, P985, DOI 10.1053/rmed.2000.0872; Hogman M, 1997, ACTA PHYSIOL SCAND, V159, P345, DOI 10.1046/j.1365-201X.1997.00101.x; Hogman M, 2002, RESP MED, V96, P24, DOI 10.1053/rmed.2001.1204; Hogman M, 2007, J BREATH RES, V1, DOI 10.1088/1752-7155/1/2/024001; Hogman M, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/4/047103; Hogman M, 2009, CLIN PHYSIOL FUNCT I, V29, P18, DOI 10.1111/j.1475-097X.2008.00831.x; Keen C, 2011, RESP MED, V105, P1476, DOI 10.1016/j.rmed.2011.04.004; Kerckx Y, 2008, J APPL PHYSIOL, V104, P918, DOI 10.1152/japplphysiol.01032.2007; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lehouck A, 2010, RESP MED, V104, P1020, DOI 10.1016/j.rmed.2010.01.001; Linn WS, 2009, J EXPO SCI ENV EPID, V19, P674, DOI 10.1038/jes.2008.64; Linn WS, 2009, PEDIATR PULM, V44, P1033, DOI 10.1002/ppul.21101; Linn WS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-28; Linn WS, 2013, PEDIAT PULMONOL; Mahut B, 2010, ALLERGY, V65, P636, DOI 10.1111/j.1398-9995.2009.02221.x; Malinovschi A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-92; Pietropaoli AP, 1999, J APPL PHYSIOL, V87, P1532, DOI 10.1152/jappl.1999.87.4.1532; Puckett JL, 2010, PEDIATR PULM, V45, P174, DOI 10.1002/ppul.21172; R Core Team, 2021, R LANG ENV STAT COMP; Rodway G W, 2009, Chron Respir Dis, V6, P19, DOI 10.1177/1479972308095936; Rosa MJ, 2011, PEDIATR PULM, V46, P83, DOI 10.1002/ppul.21328; Rottier BL, 2005, J APPL PHYSIOL, V99, P378, DOI 10.1152/japplphysiol.00163.2005; Roy K, 2007, EUR RESPIR J, V29, P651, DOI 10.1183/09031936.00149706; Salam MT, 2011, ALLERGY, V66, P412, DOI 10.1111/j.1398-9995.2010.02492.x; Salam MT, 2012, J ALLERGY CLIN IMMUN, V129, P232, DOI 10.1016/j.jaci.2011.09.037; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Shorter JH, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/037108; Silkoff PE, 2000, AM J RESP CRIT CARE, V161, P1218, DOI 10.1164/ajrccm.161.4.9903111; Silkoff PE, 1997, AM J RESP CRIT CARE, V155, P260, DOI 10.1164/ajrccm.155.1.9001322; Suresh V, 2008, J APPL PHYSIOL, V104, P1743, DOI 10.1152/japplphysiol.01355.2007; Tsoukias NM, 1998, J APPL PHYSIOL, V85, P653, DOI 10.1152/jappl.1998.85.2.653; Verbanck S, 2012, EUR RESPIR J, V39, P1258, DOI 10.1183/09031936.00105611	52	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85471	10.1371/journal.pone.0085471	http://dx.doi.org/10.1371/journal.pone.0085471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465571	Green Submitted, gold, Green Published			2022-12-25	WOS:000330237000037
J	Hung, SF; Chung, SD; Kuo, HC				Hung, Shun-Fa; Chung, Shiu-Dong; Kuo, Hann-Chorng			Increased Serum C-Reactive Protein Level Is Associated with Increased Storage Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia	PLOS ONE			English	Article							OVERACTIVE BLADDER SYNDROME; GROWTH-FACTOR LEVELS; ERECTILE DYSFUNCTION; ANTIMUSCARINIC THERAPY; SUBSCORE RATIO; DISEASE; INFLAMMATION; SCORE; RISK; HEALTH	Objective: Chronic inflammation is considered as one of the contributing mechanisms of lower urinary tract symptoms (LUTS). Serum C-reactive protein (CRP) level is the widely used biomarker of inflammatory status. This study investigated the association between serum CRP level in men with benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) before and after medical treatment. Methods: A total of 853 men with BPH and LUTS were enrolled. All patients completed the International Prostate Symptoms Score (IPSS) questionnaire and urological examinations. The parameters of uroflowmetry (maximum flow rate, Qmax; voided volume, VV), post-void residual (PVR), total prostate volume (TPV) and transition zone index (TZI), serum prostate specific antigen (PSA), and serum CRP levels were obtained. All patients were treated with alpha-blocker or antimuscarinic agent based on the IPSS voiding to storage subscore ratio (IPSS-V/S). Correlation analyses were performed between serum CRP levels with age, IPSS, TPV, TZI, Qmax, PVR, VV, PSA and between baseline and post treatment. Results: The mean age was 66.9+/-11.6 years old and the mean serum CRP levels were 0.31+/-0.43 mg/dL. Univariate analyses revealed serum CRP levels were significantly associated with age (p<0.001), PSA levels (p=0.005) and VV (p=0.017), but not significantly associated with TPV (p=0.854) or PVR (p=0.068). CRP levels were positively associated with urgency (p<0.001) and nocturia (p<0.001) subscore of IPSS, total IPSS (p=0.008) and storage IPSS (p<0.001) and negatively associated with IPSS-V/S ratio (p=0.014). Multivariate analyses revealed that serum CRP levels were significantly associated with age (p=0.004) and storage IPSS subscore p<0.001). Patients with IPSS-V/S<1 and treated with tolterodine for 3 months had significant decrease of CRP levels after treatment. Conclusion: Serum CRP levels are associated with storage LUTS and sensory bladder disorders, suggesting chronic inflammation might play a role in the patients with storage predominant LUTS.	[Hung, Shun-Fa; Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, New Taipei City, Taiwan; [Chung, Shiu-Dong; Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Chung, Shiu-Dong; Kuo, Hann-Chorng] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Far Eastern Memorial Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw						Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Bank AJ, 2003, INT J IMPOT RES, V15, P231, DOI 10.1038/sj.ijir.3901012; Chiu AF, 2012, INT J UROL, V19, P995, DOI 10.1111/j.1442-2042.2012.03095.x; Chiu AF, 2012, UROLOGY, V79, P260, DOI 10.1016/j.urology.2011.10.020; Chiurlia E, 2005, J AM COLL CARDIOL, V46, P1503, DOI 10.1016/j.jacc.2005.06.068; Chung SD, 2011, NEUROUROL URODYNAM, V30, P417, DOI 10.1002/nau.20938; Di Silverio F, 2003, EUR UROL, V43, P164, DOI 10.1016/S0302-2838(02)00548-1; Gervaix A, 2001, PEDIATR INFECT DIS J, V20, P507, DOI 10.1097/00006454-200105000-00007; Giugliano F, 2004, J ENDOCRINOL INVEST, V27, P665, DOI 10.1007/BF03347500; Glasser DB, 2007, INT J CLIN PRACT, V61, P1294, DOI 10.1111/j.1742-1241.2007.01454.x; Heinrich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020792; Hsiao SM, 2012, INT UROGYNECOL J, V23, P935, DOI 10.1007/s00192-012-1715-1; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Jiang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059176; KOHNEN PW, 1979, J UROLOGY, V121, P755, DOI 10.1016/S0022-5347(17)56980-3; Kuo HC, 2007, UROLOGY, V70, P272, DOI 10.1016/j.urology.2007.03.063; Kupelian V, 2012, BJU INT, V110, P401, DOI 10.1111/j.1464-410X.2011.10769.x; Kupelian V, 2009, UROLOGY, V73, P950, DOI 10.1016/j.urology.2008.12.012; Lehrer S, 2005, BJU INT, V95, P961, DOI 10.1111/j.1464-410X.2005.05447.x; Liao CH, 2011, INT J CLIN PRACT, V65, P552, DOI 10.1111/j.1742-1241.2011.02638.x; Liao CH, 2012, INT J CLIN PRACT, V66, P139, DOI 10.1111/j.1742-1241.2011.02864.x; Liao CH, 2011, UROLOGY, V78, P1373, DOI 10.1016/j.urology.2011.04.076; Liu HT, 2011, NEUROUROL URODYNAM, V30, P1525, DOI 10.1002/nau.21118; Liu HT, 2009, BJU INT, V103, P1668, DOI 10.1111/j.1464-410X.2009.08380.x; Mora S, 2009, CLIN CHEM, V55, P219, DOI 10.1373/clinchem.2008.109728; Nickel JC, 2008, EUR UROL, V54, P1379, DOI 10.1016/j.eururo.2007.11.026; Nickel JC, 2007, J UROLOGY, V178, P896, DOI 10.1016/j.juro.2007.05.041; Ohgaki K, 2012, UROLOGY, V79, P1372, DOI 10.1016/j.urology.2012.03.006; Sauver JLS, 2009, AM J EPIDEMIOL, V169, P1281, DOI 10.1093/aje/kwp085; Tyagi P, 2010, INT UROL NEPHROL, V42, P629, DOI 10.1007/s11255-009-9647-5; Vlachopoulos C, 2006, EUR HEART J, V27, P2640, DOI 10.1093/eurheartj/ehl341	31	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85588	10.1371/journal.pone.0085588	http://dx.doi.org/10.1371/journal.pone.0085588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454896	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100102
J	Vasilaki, E; Giugliano, M				Vasilaki, Eleni; Giugliano, Michele			Emergence of Connectivity Motifs in Networks of Model Neurons with Short- and Long-Term Plastic Synapses	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; WORKING-MEMORY; FIRE MODEL; LAYER 2/3; CELLS; HETEROGENEITY; INPUTS; RULE	Recent experimental data from the rodent cerebral cortex and olfactory bulb indicate that specific connectivity motifs are correlated with short-term dynamics of excitatory synaptic transmission. It was observed that neurons with short-term facilitating synapses form predominantly reciprocal pairwise connections, while neurons with short-term depressing synapses form predominantly unidirectional pairwise connections. The cause of these structural differences in excitatory synaptic microcircuits is unknown. We show that these connectivity motifs emerge in networks of model neurons, from the interactions between short-term synaptic dynamics (SD) and long-term spike-timing dependent plasticity (STDP). While the impact of STDP on SD was shown in simultaneous neuronal pair recordings in vitro, the mutual interactions between STDP and SD in large networks are still the subject of intense research. Our approach combines an SD phenomenological model with an STDP model that faithfully captures long-term plasticity dependence on both spike times and frequency. As a proof of concept, we first simulate and analyze recurrent networks of spiking neurons with random initial connection efficacies and where synapses are either all short-term facilitating or all depressing. For identical external inputs to the network, and as a direct consequence of internally generated activity, we find that networks with depressing synapses evolve unidirectional connectivity motifs, while networks with facilitating synapses evolve reciprocal connectivity motifs. We then show that the same results hold for heterogeneous networks, including both facilitating and depressing synapses. This does not contradict a recent theory that proposes that motifs are shaped by external inputs, but rather complements it by examining the role of both the external inputs and the internally generated network activity. Our study highlights the conditions under which SD-STDP might explain the correlation between facilitation and reciprocal connectivity motifs, as well as between depression and unidirectional motifs.	[Vasilaki, Eleni; Giugliano, Michele] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Vasilaki, Eleni; Giugliano, Michele] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Giugliano, Michele] Swiss Fed Inst Technol Lausanne, Brain Mind Inst, Lausanne, Switzerland	University of Sheffield; University of Antwerp; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Giugliano, M (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England.	michele.giugliano@uantwerpen.be	Giugliano, Michele/A-5666-2012	Giugliano, Michele/0000-0003-2626-594X; Vasilaki, Eleni/0000-0003-3705-7070	European Commission (FP7 Marie Curie Initial Training Network "NAMASEN") [264872]; European Commission (Future Emerging Technology programme project "BRAINLEAP") [306502]; Royal Society [JP091330-2009/R4]; Flemish agency for Innovation by Science and Technology [90455/1955]; Interuniversity Attraction Poles Program (IUAP); Belgian Science Policy Office; Engineering and Physical Sciences Research Council [EP/J019534/1]; Engineering and Physical Sciences Research Council (e-futures award) [EFXD12003/EFXD12004]; EPSRC [EP/J019534/1] Funding Source: UKRI	European Commission (FP7 Marie Curie Initial Training Network "NAMASEN")(European Commission); European Commission (Future Emerging Technology programme project "BRAINLEAP")(European Commission); Royal Society(Royal Society of London); Flemish agency for Innovation by Science and Technology; Interuniversity Attraction Poles Program (IUAP)(Belgian Federal Science Policy Office); Belgian Science Policy Office(Belgian Federal Science Policy Office); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council (e-futures award)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was partly supported by the European Commission (FP7 Marie Curie Initial Training Network "NAMASEN," grant n. 264872, http://cordis.europa.eu/fp7; the Future Emerging Technology programme project "BRAINLEAP" grant n. 306502, http://cordis.europa.eu/fp7/ict/fet-open) and by the Royal Society (travel grant JP091330-2009/R4, http://royalsociety.org). MG also acknowledges additional support from the Flemish agency for Innovation by Science and Technology (grant n. 90455/1955, http://www.iwt.be) and from the Interuniversity Attraction Poles Program (IUAP), initiated by the Belgian Science Policy Office (http://www.belspo.be); EV acknowledges additional support from the Engineering and Physical Sciences Research Council (grant n. EP/J019534/1 and e-futures award EFXD12003/EFXD12004, http://efutures.ac.uk/xd). Access to the supercomputer facilities CalcUA (University of Antwerp) and Tier 1 (Flemish Supercomputer Center - VSC) is warmly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; [Anonymous], 2009, PLOS COMPUT BIOL, V5; Barabasi AL, 2005, NAT PHYS, V1, P68, DOI 10.1038/nphys162; Barak O, 2007, PLOS COMPUT BIOL, V3, P323, DOI 10.1371/journal.pcbi.0030035; Bi GQ, 2005, TRENDS NEUROSCI, V28, P222, DOI 10.1016/j.tins.2005.02.002; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bourjaily MA, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00037; BOWER JM, 1986, P NATL ACAD SCI USA, V83, P1115, DOI 10.1073/pnas.83.4.1115; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brunel N, 1997, CEREB CORTEX, V7, P237; Buonomano DV, 1999, J NEUROSCI, V19, P6748, DOI 10.1523/JNEUROSCI.19-16-06748.1999; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Clopath C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000248; Cowan W, 2003, SYNAPSES; Dayan P., 2001, THEORETICAL NEUROSCI; Del Giudice P, 2003, J PHYSIOL-PARIS, V97, P659, DOI 10.1016/j.jphysparis.2004.01.021; Del Giudice P, 2001, NEUROCOMPUTING, V38, P1175, DOI 10.1016/S0925-2312(01)00557-4; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Gao Y, 2009, NAT NEUROSCI, V12, P731, DOI 10.1038/nn.2319; Geracitano R, 2007, J PHYSIOL-LONDON, V585, P117, DOI 10.1113/jphysiol.2007.142570; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gilson M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00023; Gilson M, 2009, BIOL CYBERN, V101, P411, DOI 10.1007/s00422-009-0343-4; Giugliano M, 2008, BIOL CYBERN, V99, P303, DOI 10.1007/s00422-008-0270-9; Gjorgjieva J, 2011, P NATL ACAD SCI USA, V108, P19383, DOI 10.1073/pnas.1105933108; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; HUBERT LJ, 1979, QUAL QUANT, V13, P77; Kempter R, 1996, ADV NEUR IN, V8, P124; Kunkel S, 2011, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00160; La Camera G, 2008, BIOL CYBERN, V99, P279, DOI 10.1007/s00422-008-0272-7; Le Be JV, 2006, P NATL ACAD SCI USA, V103, P13214, DOI 10.1073/pnas.0604691103; Linster C, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00157; Liu YH, 2001, J COMPUT NEUROSCI, V10, P25, DOI 10.1023/A:1008916026143; Loebel A, 2013, J NEUROSCI, V33, P6257, DOI 10.1523/JNEUROSCI.3740-12.2013; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 1998, NEUROPHARMACOLOGY, V37, P489, DOI 10.1016/S0028-3908(98)00049-5; Markram H, 1998, P NAT ACAD SCI US, V95; Markram Henry, 2011, Front Synaptic Neurosci, V3, P4, DOI 10.3389/fnsyn.2011.00004; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Pfister JP, 2006, ADV NEURAL INF PROC, V17, P1409; Pignatelli M, 2009, THESIS ECOLE POLYTEC; Pimentel DO, 2008, J PHYSIOL-LONDON, V586, P2107, DOI 10.1113/jphysiol.2007.149575; Renart A, 2004, MATH COMP BIOL SER, P431; Reyes A, 1999, J NEUROSCI, V19, P3827; Richmond P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018539; Roxin A, 2011, J NEUROSCI, V31, P16217, DOI 10.1523/JNEUROSCI.1677-11.2011; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sterrat D, 2011, PRINCIPLES COMPUTATI; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks M, 2005, SYNAPTIC DYNAMICS, P245; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Tuckwell H. C., 1989, STOCHASTIC PROCESSES; Varela JA, 1997, J NEUROSCI, V17, P7926; Vasilaki E, 2012, ICANN 2012; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5	69	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84626	10.1371/journal.pone.0084626	http://dx.doi.org/10.1371/journal.pone.0084626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454735	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000330235100028
J	Cho, SY; Choo, MS; Jung, JH; Jeong, CW; Oh, S; Lee, SB; Son, H; Jeong, H				Cho, Sung Yong; Choo, Min Soo; Jung, Jae Hyun; Jeong, Chang Wook; Oh, Sohee; Lee, Seung Bae; Son, Hwancheol; Jeong, Hyeon			Cumulative Sum Analysis for Experiences of a Single-Session Retrograde Intrarenal Stone Surgery and Analysis of Predictors for Stone-Free Status	PLOS ONE			English	Article							DIGITAL FLEXIBLE URETEROSCOPES; MATCHED-PAIR ANALYSIS; PERCUTANEOUS NEPHROLITHOTOMY; RENAL STONES; SHOCKWAVE LITHOTRIPSY; KIDNEY-STONES; LOWER-POLE; MANAGEMENT; EFFICACY; DIAMETER	Introduction: This study investigated the learning curve of a single-session retrograde intrarenal surgery (RIRS) in patients with mid-sized stones. Competence and trainee proficiency for RIRS was assessed using cumulative sum analysis (CUSUM). Materials and Methods: The study design and the use of patients' information stored in the hospital database were approved by the Institutional Review Board of our institution. A retrospective review was performed for 100 patients who underwent a single-session RIRS. Patients were included if the main stone had a maximal diameter between 10 and 30 mm. The presence of a residual stone was checked on postoperative day 1 and at one-month follow-up visit. Fragmentation efficacy was calculated "removed stone volume (mm 3) divided by operative time (min)''. CUSUM analysis was used for monitoring change in fragmentation efficacy, and we tested whether or not acceptable surgical outcomes were achieved. Results: The mean age was 54.7 +/- 14.8 years. Serum creatinine level did not change significantly. Estimated GFR and hemoglobin were within normal limits postoperatively. The CUSUM curve tended to be flat until the 25th case and showed a rising pattern but declined again until the 56th case. After that point, the fragmentation efficacy reached a plateau. The acceptable level of fragmentation efficacy was 25 ml/min. Multivariate logistic regression analyses showed that stone-free rate was significantly lower for cases with multiple stones than those with a single stone (OR = 0.147, CI 0.032 - 0.674, P value = 0.005) and for cases with higher number of sites (OR = 0.676, CI 0.517 - 0.882, P value = 0.004). Conclusions: The statistical analysis of RIRS learning experience revealed that 56 cases were required for reaching a plateau in the learning curve. The number of stones and the number of sites were significant predictors for stone-free status.	[Cho, Sung Yong; Lee, Seung Bae; Son, Hwancheol; Jeong, Hyeon] Seoul Natl Univ, Dept Urol, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea; [Choo, Min Soo; Jung, Jae Hyun; Jeong, Chang Wook] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea; [Oh, Sohee] Seoul Natl Univ, Dept Biostat, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Jeong, H (corresponding author), Seoul Natl Univ, Dept Urol, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea.	drjh@brm.co.kr						Akman T, 2012, J ENDOUROL, V26, P625, DOI 10.1089/end.2011.0526; Akman T, 2012, BJU INT, V109, P1384, DOI 10.1111/j.1464-410X.2011.10691.x; Atkinson S, 1994, Manag Care Q, V2, P57; Bach C, 2012, UROL INT, V89, P408, DOI 10.1159/000341429; Bozkurt OF, 2011, J ENDOUROL, V25, P1131, DOI 10.1089/end.2010.0737; Bryniarski P, 2012, J ENDOUROL, V26, P52, DOI 10.1089/end.2011.0235; Goli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076404; Havel D, 1998, EUR UROL, V33, P396, DOI 10.1159/000019623; Hussain M, 2011, J ENDOUROL, V25, P45, DOI 10.1089/end.2010.0236; Jeong CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065888; Jeong CW, 2012, INT BRAZ J UROL, V38, P362, DOI 10.1590/S1677-55382012000300009; Karaolides T, 2013, UROLOGY, V81, P717, DOI 10.1016/j.urology.2013.01.016; Kim TB, 2013, CUAJ-CAN UROL ASSOC, V7, pE156, DOI 10.5489/cuaj.473; Lim TO, 2002, INT J QUAL HEALTH C, V14, P251, DOI 10.1093/oxfordjournals.intqhc.a002616; Lucio J, 2011, INT BRAZ J UROL, V37, P477, DOI 10.1590/S1677-55382011000400006; Miller NL, 2007, BMJ-BRIT MED J, V334, P468, DOI 10.1136/bmj.39113.480185.80; Resorlu B, 2013, WORLD J UROL, V31, P1581, DOI 10.1007/s00345-012-0991-1; Zeng GH, 2013, J UROLOGY, V190, P2133, DOI 10.1016/j.juro.2013.06.085	18	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e84878	10.1371/journal.pone.0084878	http://dx.doi.org/10.1371/journal.pone.0084878			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454757	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800016
J	Fazzari, M; Trostchansky, A; Schopfer, FJ; Salvatore, SR; Sanchez-Calvo, B; Vitturi, D; Valderrama, R; Barroso, JB; Radi, R; Freeman, BA; Rubbo, H				Fazzari, Marco; Trostchansky, Andres; Schopfer, Francisco J.; Salvatore, Sonia R.; Sanchez-Calvo, Beatriz; Vitturi, Dario; Valderrama, Raquel; Barroso, Juan B.; Radi, Rafael; Freeman, Bruce A.; Rubbo, Homero			Olives and Olive Oil Are Sources of Electrophilic Fatty Acid Nitroalkenes	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; NITRO-OLEIC ACID; NITROLINOLEIC ACID; ANTIINFLAMMATORY PROPERTIES; VASCULAR INFLAMMATION; MEDITERRANEAN DIET; ALPHA-TOCOPHEROL; HUMAN BLOOD; GENERATION; TRANSDUCTION	Extra virgin olive oil (EVOO) and olives, key sources of unsaturated fatty acids in the Mediterranean diet, provide health benefits to humans. Nitric oxide (center dot NO) and nitrite (NO2-)-dependent reactions of unsaturated fatty acids yield electrophilic nitroalkene derivatives (NO2-FA) that manifest salutary pleiotropic cell signaling responses in mammals. Herein, the endogenous presence of NO2-FA in both EVOO and fresh olives was demonstrated by mass spectrometry. The electrophilic nature of these species was affirmed by the detection of significant levels of protein cysteine adducts of nitro-oleic acid (NO2-OA-cysteine) in fresh olives, especially in the peel. Further nitration of EVOO by NO2- under acidic gastric digestive conditions revealed that human consumption of olive lipids will produce additional nitro-conjugated linoleic acid (NO2-cLA) and nitro-oleic acid (NO2-OA). The presence of free and protein-adducted NO2-FA in both mammalian and plant lipids further affirm a role for these species as signaling mediators. Since NO2-FA instigate adaptive anti-inflammatory gene expression and metabolic responses, these redox-derived metabolites may contribute to the cardiovascular benefits associated with the Mediterranean diet.	[Fazzari, Marco; Schopfer, Francisco J.; Salvatore, Sonia R.; Vitturi, Dario; Freeman, Bruce A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Fazzari, Marco] Fdn Ri MED, Palermo, Italy; [Sanchez-Calvo, Beatriz; Valderrama, Raquel; Barroso, Juan B.] Univ Jaen, Dept Biol Expt, Jaen, Andalucia, Spain; [Trostchansky, Andres; Radi, Rafael; Rubbo, Homero] Univ Republica, Fac Med, Dept Bioquim, Montevideo, Uruguay; [Trostchansky, Andres; Radi, Rafael; Rubbo, Homero] Univ Republica, Fac Med, Ctr Free Rad & Biomed Res, Montevideo, Uruguay	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidad de Jaen; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Freeman, BA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	freerad@pitt.edu; hrubbo@fmed.edu.uy	Barroso, Juan B./G-8041-2014; Trostchansky, Andres/I-5624-2019; Vitturi, Dario/Z-3469-2019; Marco, Fazzari/AAA-2229-2019; Albarracín, Juan Bautista Barroso/ABC-2908-2020; Valderrama, Raquel/H-5937-2015; Schopfer, Francisco/AAW-6505-2021; Schopfer, Francisco Jose/AAE-8125-2020	Trostchansky, Andres/0000-0002-9721-7577; Marco, Fazzari/0000-0002-4051-4431; Albarracín, Juan Bautista Barroso/0000-0002-9477-9195; Schopfer, Francisco Jose/0000-0001-9526-695X; Valderrama Rodriguez, Raquel/0000-0003-2253-0101; Rubbo, Homero/0000-0002-7897-6551; Vitturi, Dario/0000-0003-0354-4567; Salvatore, Sonia/0000-0002-9942-3905	Fondo Clemente Estable-ANII [FCE_516]; Fondo Maria Vinas-ANII [FMV_2009_2913]; ICGEB-Italy; CSIC-Uruguay; Junta de Andalucia [AGR-6374, BIO286]; NIH [R01-HL058115, R01-HL64937, P30DK072506, P01-HL103455, R01 AT006822-01]; Society for Free Radical Biology and Medicine Mini-fellowship; National Center for Complementary & Integrative Health [R01AT006822] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103455, R37HL058115, R01HL058115, R01HL064937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	Fondo Clemente Estable-ANII; Fondo Maria Vinas-ANII; ICGEB-Italy; CSIC-Uruguay; Junta de Andalucia(Junta de Andalucia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society for Free Radical Biology and Medicine Mini-fellowship; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from Fondo Clemente Estable-ANII (FCE_516) and Fondo Maria Vinas-ANII (FMV_2009_2913) to AT; ICGEB-Italy and CSIC-Uruguay (HR); ERDF-cofinanced grant from Junta de Andalucia (project AGR-6374 and group BIO286) to JBB; NIH grants R01-HL058115, R01-HL64937, P30DK072506, P01-HL103455 (BAF) and R01 AT006822-01 (FJS); and a Society for Free Radical Biology and Medicine Mini-fellowship to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonacci G, 2012, J BIOL CHEM, V287, P44071, DOI 10.1074/jbc.M112.401356; Bonacci G, 2011, J AM SOC MASS SPECTR, V22, P1534, DOI 10.1007/s13361-011-0185-x; Carluccio MA, 2003, ARTERIOSCL THROM VAS, V23, P622, DOI 10.1161/01.ATV.0000062884.69432.A0; Catharino RR, 2005, ANAL CHEM, V77, P7429, DOI 10.1021/ac0512507; Cert A, 2000, J CHROMATOGR A, V881, P131, DOI 10.1016/S0021-9673(00)00389-7; Cheng WL, 2004, J AGR FOOD CHEM, V52, P71, DOI 10.1021/jf0348626; Chin S. F., 1992, Journal of Food Composition and Analysis, V5, P185, DOI 10.1016/0889-1575(92)90037-K; Cole MP, 2009, CIRC RES, V105, P965, DOI 10.1161/CIRCRESAHA.109.199075; Coles B, 2002, CIRC RES, V91, P375, DOI 10.1161/01.RES.0000032114.68919.EF; Coles B, 2002, J BIOL CHEM, V277, P5832, DOI 10.1074/jbc.M105209200; Corpas FJ, 2013, NEW PHYTOL, V199, P633, DOI 10.1111/nph.12380; Covas MI, 2007, PHARMACOL RES, V55, P175, DOI 10.1016/j.phrs.2007.01.010; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Evans ME, 2002, J NUTR BIOCHEM, V13, P508, DOI 10.1016/S0955-2863(02)00211-5; Ferreira AM, 2009, BIOCHEM J, V417, P223, DOI 10.1042/BJ20080701; Frankel EN, 2011, J AGR FOOD CHEM, V59, P785, DOI 10.1021/jf103813t; Freeman BA, 2008, J BIOL CHEM, V283, P15515, DOI 10.1074/jbc.R800004200; Jansson EA, 2008, NAT CHEM BIOL, V4, P411, DOI 10.1038/nchembio.92; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Kansanen E, 2009, J BIOL CHEM, V284, P33233, DOI 10.1074/jbc.M109.064873; Kelley EE, 2008, J BIOL CHEM, V283, P36176, DOI 10.1074/jbc.M802402200; Lavelli V, 2006, J AGR FOOD CHEM, V54, P3002, DOI 10.1021/jf052918l; Li Y, 2008, NAT STRUCT MOL BIOL, V15, P865, DOI 10.1038/nsmb.1447; Lima ES, 2002, BIOCHEMISTRY-US, V41, P10717, DOI 10.1021/bi025504j; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Lundberg JO, 2013, GUT, V62, P616, DOI 10.1136/gutjnl-2011-301649; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Lundberg JO, 2009, ARCH PHARM RES, V32, P1119, DOI 10.1007/s12272-009-1803-z; Nadtochiy SM, 2011, NUTRITION, V27, P733, DOI 10.1016/j.nut.2010.12.006; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Napolitano A, 2004, CHEM RES TOXICOL, V17, P1329, DOI 10.1021/tx049880b; Rastrelli L, 2002, J AGR FOOD CHEM, V50, P5566, DOI 10.1021/jf011063j; Reynolds CM, 2010, PROSTAG LEUKOTR ESS, V82, P199, DOI 10.1016/j.plefa.2010.02.021; Rocha BS, 2012, FREE RADICAL BIO MED, V52, P693, DOI 10.1016/j.freeradbiomed.2011.11.011; Romani A, 2007, J AGR FOOD CHEM, V55, P1315, DOI 10.1021/jf062335r; Rubbo H, 2009, ARCH BIOCHEM BIOPHYS, V484, P167, DOI 10.1016/j.abb.2008.11.007; Rudolph TK, 2010, ARTERIOSCL THROM VAS, V30, P938, DOI 10.1161/ATVBAHA.109.201582; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2005, J BIOL CHEM, V280, P19289, DOI 10.1074/jbc.M414689200; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Teissier E, 1996, CLIN CHEM, V42, P430; Trostchansky A, 2007, BIOCHEMISTRY-US, V46, P4645, DOI 10.1021/bi602652j; Trostchansky A, 2011, J BIOL CHEM, V286, P12891, DOI 10.1074/jbc.M110.154518; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Villacorta L, 2013, CARDIOVASC RES, V98, P116, DOI 10.1093/cvr/cvt002; Woodcock SR, 2006, ORG LETT, V8, P3931, DOI 10.1021/ol0613463; Wright MM, 2006, P NATL ACAD SCI USA, V103, P4299, DOI 10.1073/pnas.0506541103; Zhang JF, 2010, CIRC RES, V107, P540, DOI 10.1161/CIRCRESAHA.110.218404	56	73	74	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e84884	10.1371/journal.pone.0084884	http://dx.doi.org/10.1371/journal.pone.0084884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454759	Green Published, Green Accepted, gold			2022-12-25	WOS:000329925800017
J	Yi, SL; Liu, XJ; Zhong, JQ; Zhang, Y				Yi, Shao-lei; Liu, Xiao-jun; Zhong, Jing-quan; Zhang, Yun			Role of Caveolin-1 in Atrial Fibrillation as an Anti-Fibrotic Signaling Molecule in Human Atrial Fibroblasts	PLOS ONE			English	Article							RAT CARDIAC FIBROBLASTS; P42/44 MAP KINASE; IN-VIVO; DOWN-REGULATION; HEART-FAILURE; KNOCKOUT MICE; EXPRESSION; FIBROSIS; CARDIOMYOPATHY; TGF-BETA-1	Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the general population; yet, the precise mechanisms resulting in AF are not fully understood. Caveolin-1 (Cav-1), the principal structural component of caveolae organelles in cardiac fibroblasts, is involved in several cardiovascular conditions; however, the study on its function in atrium, in particular, in AF, is still lacking. This report examines the hypothesis that Cav-1 confers an anti-AF effect by mediating atrial structural remodeling through its anti-fibrotic action. We evaluated the expression of Cav-1, transforming growth factor-beta 1 (TGF-beta 1), and fibrosis in atrial specimens of 13 patients with AF and 10 subjects with sinus rhythm, and found that the expression of Cav-1 was significantly downregulated, whereas TGF-beta 1 level, collagens I/III contents and atrial fibrosis were markedly increased, in AF. Western blot analysis demonstrated that treatment of human atrial fibroblasts (HAFs) with TGF-beta 1 resulted in a concentration-and time-dependent repression of Cav-1. Downregulation of Cav-1 with siRNA increased the TGF-beta 1-induced activation of Smad signal pathway and collagens production in HAFs. Furthermore, incubation of HAFs with the peptides derived from Cav-1 to achieve Cav-1 gain-of-function abolished the TGF-beta 1-induced production of collagens I/III and decreases of MMP-2/-9 expression. Therefore it was concluded that Cav-1 is an important anti-AF signaling mediator by conferring its anti-fibrotic effects in atrium.	[Yi, Shao-lei; Liu, Xiao-jun; Zhong, Jing-quan; Zhang, Yun] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan, Shandong, Peoples R China; [Yi, Shao-lei; Liu, Xiao-jun; Zhong, Jing-quan; Zhang, Yun] Shandong Univ, Chinese Minist Publ Hlth, Dept Cardiol, Qilu Hosp, Jinan, Shandong, Peoples R China; [Yi, Shao-lei] Shandong Univ, Sch Med, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Zhong, JQ (corresponding author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan, Shandong, Peoples R China.	haifeng200314@live.whut.edu.cn			Natural Science Foundation of China [81270238]; Scientific Research Foundation for the Doctoral Degree, State Education Ministry of China [20100131110059]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Doctoral Degree, State Education Ministry of China	This study was sponsored by the Natural Science Foundation of China (81270238) and the Scientific Research Foundation for the Doctoral Degree, State Education Ministry of China (20100131110059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed HS, 2013, HEART RHYTHM, V10, P90, DOI 10.1016/j.hrthm.2012.08.043; Barth K, 2010, HISTOCHEM CELL BIOL, V134, P31, DOI 10.1007/s00418-010-0716-8; Bernatchez PN, 2005, P NATL ACAD SCI USA, V102, P761, DOI 10.1073/pnas.0407224102; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Chaudhary KR, 2013, J CARDIOVASC PHARM, V61, P258, DOI 10.1097/FJC.0b013e31827afcee; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V284, pC457, DOI 10.1152/ajpcell.00380.2002; Cruz JA, 2012, AM J PHYSIOL-HEART C, V302, pH2518, DOI 10.1152/ajpheart.01140.2011; Engel D, 2011, FASEB J, V25, P3838, DOI 10.1096/fj.11-183350; Everett TH, 2007, HEART RHYTHM, V4, pS24, DOI 10.1016/j.hrthm.2006.12.040; Fu CL, 2010, BBA-MOL CELL BIOL L, V1801, P702, DOI 10.1016/j.bbalip.2010.04.001; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Gramley F, 2010, INT J CARDIOL, V143, P405, DOI 10.1016/j.ijcard.2009.03.110; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; Hori Y, 2012, AM J PHYSIOL-CELL PH, V303, pC947, DOI 10.1152/ajpcell.00401.2011; Jasmin JF, 2011, AM J PHYSIOL-HEART C, V300, pH1274, DOI 10.1152/ajpheart.01173.2010; Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Kostin S, 2002, CARDIOVASC RES, V54, P361, DOI 10.1016/S0008-6363(02)00273-0; Lei B, 2011, J PHARMACOL SCI, V117, P98, DOI 10.1254/jphs.11065FP; Levick SP, 2008, AM J PHYSIOL-HEART C, V295, pH1375, DOI 10.1152/ajpheart.907.2008; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Lin CS, 2008, CELL MOL LIFE SCI, V65, P1489, DOI 10.1007/s00018-008-7408-8; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; Mariscalco G, 2006, J THORAC CARDIOV SUR, V131, P1364, DOI 10.1016/j.jtcvs.2006.01.040; Miyasato SK, 2011, MATRIX BIOL, V30, P318, DOI 10.1016/j.matbio.2011.05.003; Moe GW, 2008, J CARD FAIL, V14, P768, DOI 10.1016/j.cardfail.2008.07.229; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; Pan CH, 2007, FEBS LETT, V581, P526, DOI 10.1016/j.febslet.2007.01.014; Patani N, 2012, BREAST CANCER RES TR, V131, P1, DOI 10.1007/s10549-011-1751-4; Piech A, 2002, AM J PHYSIOL-HEART C, V282, pH219, DOI 10.1152/ajpheart.2002.282.1.H219; Porter KE, 2004, CARDIOVASC RES, V64, P507, DOI 10.1016/j.cardiores.2004.07.020; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Redondo S, 2012, VASC HEALTH RISK MAN, V8, P533, DOI 10.2147/VHRM.S28041; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Seto SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058481; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Tourkina E, 2008, AM J PHYSIOL-LUNG C, V294, pL843, DOI 10.1152/ajplung.00295.2007; Turner NA, 2003, CARDIOVASC RES, V57, P784, DOI 10.1016/S0008-6363(02)00729-0; Uray IP, 2003, CARDIOVASC RES, V59, P57, DOI 10.1016/S0008-6363(03)00352-3; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; Volonte D, 2008, AM J PHYSIOL-HEART C, V294, pH392, DOI 10.1152/ajpheart.01039.2007; Xiao H, 2010, CLIN CARDIOL, V33, P149, DOI 10.1002/clc.20713; Xu YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011004; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	47	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85144	10.1371/journal.pone.0085144	http://dx.doi.org/10.1371/journal.pone.0085144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454806	gold, Green Submitted, Green Published			2022-12-25	WOS:000329925800024
J	Zhao, R; Meng, FY; Wang, NS; Ma, WL; Yan, QT				Zhao, Rui; Meng, Fanyi; Wang, Nisha; Ma, Wenli; Yan, Qitao			Silencing of CHD5 Gene by Promoter Methylation in Leukemia	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; INACTIVATING MUTATIONS; HUMAN BREAST; ALLELIC LOSS; DNA-BINDING; 1P; CHROMOSOME-1; DELETION; REGIONS; FAMILY	Chromodomain helicase DNA binding protein 5 (CHD5) was previously proposed to function as a potent tumor suppressor by acting as a master regulator of a tumor-suppressive network. CHD5 is down-regulated in several cancers, including leukemia and is responsible for tumor generation and progression. However, the mechanism of CHD5 down-regulation in leukemia is largely unknown. In this study, quantitative reverse-transcriptase polymerase chain reaction and western blotting analyses revealed that CHD5 was down-regulated in human leukemia cell lines and samples. Luciferase reporter assays showed that most of the baseline regulatory activity was localized from 500 to 200 bp upstream of the transcription start site. Bisulfite DNA sequencing of the identified regulatory element revealed that the CHD5 promoter was hypermethylated in human leukemia cells and samples. Thus, CHD5 expression was inversely correlated with promoter DNA methylation in these samples. Treatment with DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine (DAC) activates CHD5 expression in human leukemia cell lines. In vitro luciferase reporter assays demonstrated that methylation of the CHD5 promoter repressed its promoter activity. Furthermore, a chromatin immunoprecipitation assay combined with qualitative PCR identified activating protein 2 (AP2) as a potential transcription factor involved in CHD5 expression and indicated that treatment with DAC increases the recruitment of AP2 to the CHD5 promoter. In vitro transcription-factor activity studies showed that AP2 over-expression was able to activate CHD5 promoter activity. Our findings indicate that repression of CHD5 gene expression in human leukemia is mediated in part by DNA methylation of its promoter.	[Zhao, Rui; Wang, Nisha; Ma, Wenli; Yan, Qitao] Southern Med Univ, Inst Mol Biol, Guangzhou, Guangdong, Peoples R China; [Meng, Fanyi] Southern Med Univ, Dept Hematol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Yan, QT (corresponding author), Southern Med Univ, Inst Mol Biol, Guangzhou, Guangdong, Peoples R China.	wenlima1964@163.com			National Natural Science Foundation of China [81100383/H0812, 81000226/H0812]; Natural Science Foundation of Guangdong Province [S2011040005521, A2011360]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was funded by the National Natural Science Foundation of China (81100383/H0812, 81000226/H0812) and the Natural Science Foundation of Guangdong Province (S2011040005521, A2011360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Baylin SB, 1998, ADV CANCER RES, V72, P141; BELLO MJ, 1995, INT J CANCER, V64, P207; BELLO MJ, 1995, CANCER GENET CYTOGEN, V83, P160, DOI 10.1016/0165-4608(95)00064-V; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; BIECHE I, 1993, CANCER RES, V53, P1990; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; Cai CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029750; Cheung TH, 2005, GYNECOL ONCOL, V96, P510, DOI 10.1016/j.ygyno.2004.10.035; Du XL, 2013, CLIN TRANSL ONCOL, V15, P198, DOI 10.1007/s12094-012-0903-2; Fujita T, 2008, JNCI-J NATL CANCER I, V100, P940, DOI 10.1093/jnci/djn176; Garcia I, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-277; Gorringe KL, 2008, NEOPLASIA, V10, P1253, DOI 10.1593/neo.08718; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HERMANN R, 1991, FEBS LETT, V281, P191, DOI 10.1016/0014-5793(91)80391-F; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kleer CG, 2000, ENDOCR PATHOL, V11, P137, DOI 10.1385/EP:11:2:137; Koyama H, 2012, CLIN CANCER RES, V18, P1588, DOI 10.1158/1078-0432.CCR-11-2644; Lang J, 2011, BRIT J DERMATOL, V164, P1010, DOI 10.1111/j.1365-2133.2011.10223.x; Law ME, 2005, CANCER GENET CYTOGEN, V160, P1, DOI 10.1016/j.cancergencyto.2004.11.012; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Mallette FA, 2012, CELL REP, V2, P1233, DOI 10.1016/j.celrep.2012.09.033; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; McPherson LA, 1999, NUCLEIC ACIDS RES, V27, P4040, DOI 10.1093/nar/27.20.4040; McPherson LA, 1997, P NATL ACAD SCI USA, V94, P4342, DOI 10.1073/pnas.94.9.4342; Melendez B, 2003, LEUKEMIA RES, V27, P627, DOI 10.1016/S0145-2126(02)00278-3; Mokarram P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007012; MOLEY JF, 1992, CANCER RES, V52, P770; Mori N, 2003, BRIT J HAEMATOL, V122, P226, DOI 10.1046/j.1365-2141.2003.04434.x; Mori N, 1998, BLOOD, V92, P3405, DOI 10.1182/blood.V92.9.3405.421k44_3405_3409; Mulero-Navarro S, 2008, EPIGENETICS-US, V3, P210, DOI 10.4161/epi.3.4.6610; Okawa ER, 2008, ONCOGENE, V27, P803, DOI 10.1038/sj.onc.1210675; Paul S, 2013, CELL REP, V3, P92, DOI 10.1016/j.celrep.2012.12.009; Piaskowski S, 2005, CANCER GENET CYTOGEN, V162, P63, DOI 10.1016/j.cancergencyto.2005.02.009; Poetsch M, 2003, MELANOMA RES, V13, P29, DOI 10.1097/00008390-200302000-00006; PRAML C, 1995, ONCOGENE, V11, P1357; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Wang X, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-95; White PS, 2005, ONCOGENE, V24, P2684, DOI 10.1038/sj.onc.1208306; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; Wong RRY, 2011, GYNECOL OBSTET INVES, V72, P203, DOI 10.1159/000323883; Wu X, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3182; Zhao R, 2012, LUNG CANCER, V76, P324, DOI 10.1016/j.lungcan.2011.11.019	50	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85172	10.1371/journal.pone.0085172	http://dx.doi.org/10.1371/journal.pone.0085172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454811	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500046
J	Mizui, T; Sekino, Y; Yamazaki, H; Ishizuka, Y; Takahashi, H; Kojima, N; Kojima, M; Shirao, T				Mizui, Toshiyuki; Sekino, Yuko; Yamazaki, Hiroyuki; Ishizuka, Yuta; Takahashi, Hideto; Kojima, Nobuhiko; Kojima, Masami; Shirao, Tomoaki			Myosin II ATPase Activity Mediates the Long-Term Potentiation-Induced Exodus of Stable F-Actin Bound by Drebrin A from Dendritic Spines	PLOS ONE			English	Article							REGULATED BRAIN PROTEINS; HIPPOCAMPAL-NEURONS; AMPA RECEPTORS; IN-VIVO; PLASTICITY; MORPHOGENESIS; CYTOSKELETON; FILAMENTS; RAT; PHOSPHORYLATION	The neuronal actin-binding protein drebrin A forms a stable structure with F-actin in dendritic spines. NMDA receptor activation causes an exodus of F-actin bound by drebrin A (DA-actin) from dendritic spines, suggesting a pivotal role for DA-actin exodus in synaptic plasticity. We quantitatively assessed the extent of DA-actin localization to spines using the spine-dendrite ratio of drebrin A in cultured hippocampal neurons, and found that (1) chemical long-term potentiation (LTP) stimulation induces rapid DA-actin exodus and subsequent DA-actin re-entry in dendritic spines, (2) Ca2+ influx through NMDA receptors regulates the exodus and the basal accumulation of DA-actin, and (3) the DA-actin exodus is blocked by myosin II ATPase inhibitor, but is not blocked by myosin light chain kinase (MLCK) or Rho-associated kinase (ROCK) inhibitors. These results indicate that myosin II mediates the interaction between NMDA receptor activation and DA-actin exodus in LTP induction. Furthermore, myosin II seems to be activated by a rapid actin-linked mechanism rather than slow MLC phosphorylation. Thus the myosin-II mediated DA-actin exodus might be an initial event in LTP induction, triggering actin polymerization and spine enlargement.	[Mizui, Toshiyuki; Sekino, Yuko; Yamazaki, Hiroyuki; Ishizuka, Yuta; Takahashi, Hideto; Kojima, Nobuhiko; Shirao, Tomoaki] Gunma Univ, Grad Sch Med, Dept Neurobiol & Behav, Maebashi, Gunma 371, Japan; [Sekino, Yuko; Kojima, Masami] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; [Mizui, Toshiyuki; Kojima, Masami] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Biointerface Res Grp, Ikeda, Osaka, Japan	Gunma University; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST)	Sekino, Y (corresponding author), Natl Inst Hlth Sci, Div Pharmacol, Setagaya Ku, Tokyo, Japan.	yukos@nihs.go.jp; tshirao@gunma-u.ac.jp	Mizui, Toshiyuki/M-3502-2018; Ishizuka, Yuta/ACN-8245-2022; Takahashi, Hideto/T-2650-2018; Ishizuka, Yuta/AAB-9170-2019; Shirao, Tomoaki/I-9257-2016	Mizui, Toshiyuki/0000-0001-9142-5626; Ishizuka, Yuta/0000-0002-2036-902X; Takahashi, Hideto/0000-0002-6473-5060; Shirao, Tomoaki/0000-0003-4323-028X	Ministry of Education, Culture, Sports, Science and Technology of Japan [16300117, 19200029, 20021002]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (16300117, 19200029) and on Priority Areas - Elucidation of neural network function in the brain - from the Ministry of Education, Culture, Sports, Science and Technology of Japan (20021002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki C, 2005, J COMP NEUROL, V483, P383, DOI 10.1002/cne.20449; ASADA H, 1994, J NEUROSCI RES, V38, P149, DOI 10.1002/jnr.490380205; Cheng XT, 2000, NEUROSCI RES, V36, P167, DOI 10.1016/S0168-0102(99)00123-6; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Grintsevich EE, 2010, J MOL BIOL, V398, P542, DOI 10.1016/j.jmb.2010.03.039; Hanamura K, 2010, NEUROSCIENCE, V169, P1489, DOI 10.1016/j.neuroscience.2010.06.043; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hayashi K, 1996, J NEUROSCI, V16, P7161; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Iki J, 2005, EUR J NEUROSCI, V22, P2985, DOI 10.1111/j.1460-9568.2005.04510.x; ISHIKAWA R, 1994, J BIOL CHEM, V269, P29928; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Konishi M, 1998, JPN J PHYSIOL, V48, P421, DOI 10.2170/jjphysiol.48.421; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mikati MA, 2013, J BIOL CHEM, V288, P19926, DOI 10.1074/jbc.M113.472647; Mizui T, 2009, J NEUROCHEM, V109, P611, DOI 10.1111/j.1471-4159.2009.05993.x; Murrell MP, 2012, P NATL ACAD SCI USA, V109, P20820, DOI 10.1073/pnas.1214753109; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Rex CS, 2010, NEURON, V67, P603, DOI 10.1016/j.neuron.2010.07.016; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Sekino Y, 2006, MOL CELL NEUROSCI, V31, P493, DOI 10.1016/j.mcn.2005.11.003; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Sharma S, 2011, NANO LETT, V11, P825, DOI 10.1021/nl104159v; SHIRAO T, 1986, DEV BRAIN RES, V29, P233, DOI 10.1016/0165-3806(86)90099-4; SHIRAO T, 1989, P JPN ACAD B-PHYS, V65, P169, DOI 10.2183/pjab.65.169; Shirao T, 2013, J NEUROCHEM, V126, P155, DOI 10.1111/jnc.12313; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Swayze RD, 2004, NEUROPHARMACOLOGY, V47, P764, DOI 10.1016/j.neuropharm.2004.07.014; Takahashi H, 2003, J NEUROSCI, V23, P6586; Takahashi H, 2009, J CELL SCI, V122, P1211, DOI 10.1242/jcs.043729; Worth DC, 2013, J CELL BIOL, V202, P793, DOI 10.1083/jcb.201303005; Xie H, 1984, CELL STRUCT FUNCT, V8, P315; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609	39	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85367	10.1371/journal.pone.0085367	http://dx.doi.org/10.1371/journal.pone.0085367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465547	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100038
J	Pettinato, L; Calistri, E; Di Patti, F; Livi, R; Luccioli, S				Pettinato, Lucia; Calistri, Elisa; Di Patti, Francesca; Livi, Roberto; Luccioli, Stefano			Genome-Wide Analysis of Promoters: Clustering by Alignment and Analysis of Regular Patterns	PLOS ONE			English	Article							FACTOR-BINDING SITES; TRANSCRIPTION-FACTOR; NONLINEAR MODEL; NEURAL-NETWORK; DNA; SEQUENCE; IDENTIFICATION; EVOLUTION; INSIGHTS; DATABASE	In this paper we perform a genome-wide analysis of H. sapiens promoters. To this aim, we developed and combined two mathematical methods that allow us to (i) classify promoters into groups characterized by specific global structural features, and (ii) recover, in full generality, any regular sequence in the different classes of promoters. One of the main findings of this analysis is that H. sapiens promoters can be classified into three main groups. Two of them are distinguished by the prevalence of weak or strong nucleotides and are characterized by short compositionally biased sequences, while the most frequent regular sequences in the third group are strongly correlated with transposons. Taking advantage of the generality of these mathematical procedures, we have compared the promoter database of H. sapiens with those of other species. We have found that the above-mentioned features characterize also the evolutionary content appearing in mammalian promoters, at variance with ancestral species in the phylogenetic tree, that exhibit a definitely lower level of differentiation among promoters.	[Pettinato, Lucia; Di Patti, Francesca; Livi, Roberto] Univ Firenze, Dipartimento Fis & Astron, Sesto Fiorentino, Italy; [Pettinato, Lucia; Livi, Roberto] Ist Nazl Fis Nucl, Sesto Fiorentino, Italy; [Calistri, Elisa; Di Patti, Francesca; Livi, Roberto] Ctr Interdipartimentale Studio Dinam Complesse, Sesto Fiorentino, Italy; [Calistri, Elisa] Univ Firenze, Dipartimento Biol, Sesto Fiorentino, Italy; [Livi, Roberto; Luccioli, Stefano] CNR, Ist Sistemi Complessi, Sesto Fiorentino, Italy; [Luccioli, Stefano] Tel Aviv Univ, Joint Italian Israeli Lab Integrat Network Neuros, Ramat Aviv, Israel	University of Florence; Istituto Nazionale di Fisica Nucleare (INFN); University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Tel Aviv University	Livi, R (corresponding author), Univ Firenze, Dipartimento Fis & Astron, Sesto Fiorentino, Italy.	livi@fi.infn.it	Di Patti, Francesca/G-7072-2011	Di Patti, Francesca/0000-0003-1288-0079	Ente Cassa di Risparmio di Firenze; program PRIN of the Italian Ministery of University and Research	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); program PRIN of the Italian Ministery of University and Research(Ministry of Education, Universities and Research (MIUR))	This work has been partially supported by Ente Cassa di Risparmio di Firenze and by the program PRIN2009 of the Italian Ministery of University and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2008, GENOME RES, V18, P310, DOI 10.1101/gr.6991408; Aerts S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-34; Akiyama Yutaka, TFSEARCH SEARCHING T; Avino A, 2003, J AM CHEM SOC, V125, P16127, DOI 10.1021/ja035039t; Bais AS, 2007, J BIOSCIENCES, V32, P841, DOI 10.1007/s12038-007-0084-2; Bejerano G, 2004, BIOINFORMATICS, V20, P40, DOI 10.1093/bioinformatics/bth946; Blanco E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-138; Bolshoy A, 2000, GENOME RES, V10, P1185, DOI 10.1101/gr.10.8.1185; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Bourque G, 2009, CURR OPIN GENET DEV, V19, P607, DOI 10.1016/j.gde.2009.10.013; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Calistri E., 2008, THESIS; Calistri E, 2011, MOL PHYLOGENET EVOL, V60, P228, DOI 10.1016/j.ympev.2011.04.015; Campa A, 1998, PHYS REV E, V58, P3585, DOI 10.1103/PhysRevE.58.3585; Carey MF, 2012, COLD SPRING HARBOR P, V2012; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; DAUXOIS T, 1993, PHYS REV E, V47, P684, DOI 10.1103/PhysRevE.47.684; DAUXOIS T, 1993, PHYS REV E, V47, pR44, DOI 10.1103/PhysRevE.47.R44; DEMELER B, 1991, NUCLEIC ACIDS RES, V19, P1593, DOI 10.1093/nar/19.7.1593; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Grandi FC, 2013, MOL BIOL EVOL, V30, P503, DOI 10.1093/molbev/mss251; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hemberg M, 2012, NUCLEIC ACIDS RES, V40, P7858, DOI 10.1093/nar/gks477; Jacques PE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003504; Jaumot J, 2010, BIOCHIMIE, V92, P1016, DOI 10.1016/j.biochi.2010.04.024; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Koch KA, 1999, J BIOL CHEM, V274, P23752, DOI 10.1074/jbc.274.34.23752; Landolin JM, 2010, GENOME RES, V20, P890, DOI 10.1101/gr.100370.109; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Levy S, 2001, BIOINFORMATICS, V17, P871, DOI 10.1093/bioinformatics/17.10.871; Loots G, 2007, BIOINFORMATICS, V23, P122, DOI 10.1093/bioinformatics/btl546; Louie E, 2003, GENOME RES, V13, P2594, DOI 10.1101/gr.1317703; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Matsunami M, 2010, J MOL EVOL, V71, P427, DOI 10.1007/s00239-010-9396-1; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Parker BJ, 2011, GENOME RES, V21, P1929, DOI 10.1101/gr.112516.110; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; PEYRARD M, 1989, PHYS REV LETT, V62, P2755, DOI 10.1103/PhysRevLett.62.2755; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Sela I, 2011, BIOPHYS J, V101, P160, DOI 10.1016/j.bpj.2011.04.037; Shelenkov A, 2009, COMPUT BIOL CHEM, V33, P196, DOI 10.1016/j.compbiolchem.2009.03.001; Shibata Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002789; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stewart G.W., 1990, MATRIX PERTURBATION; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Taher L, 2011, GENOME RES, V21, P1139, DOI 10.1101/gr.119016.110; Tchernaenko V, 2008, BIOCHEMISTRY-US, V47, P1871, DOI 10.1021/bi701289g; Testori A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-400; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Venkataram S, 2010, GENOME BIOL EVOL, V2, P851, DOI 10.1093/gbe/evq066; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Weirauch MT, 2010, TRENDS GENET, V26, P66, DOI 10.1016/j.tig.2009.12.002; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Yamashita R, 2006, NUCLEIC ACIDS RES, V34, pD86, DOI 10.1093/nar/gkj129; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; YANG ZY, 1994, J BIOL CHEM, V269, P10079	73	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85260	10.1371/journal.pone.0085260	http://dx.doi.org/10.1371/journal.pone.0085260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465517	gold, Green Submitted, Green Published			2022-12-25	WOS:000330283100032
J	Dermauw, V; Alonso, ML; Duchateau, L; Du Laing, G; Tolosa, T; Dierenfeld, E; Clauss, M; Janssens, GPJ				Dermauw, Veronique; Lopez Alonso, Marta; Duchateau, Luc; Du Laing, Gijs; Tolosa, Tadele; Dierenfeld, Ellen; Clauss, Marcus; Janssens, Geert Paul Jules			Trace Element Distribution in Selected Edible Tissues of Zebu (Bos indicus) Cattle Slaughtered at Jimma, SW Ethiopia	PLOS ONE			English	Article							DISTRICTS SURROUNDING KARATINA; MINERAL STATUS; COPPER STATUS; SHEEP LIVER; MUSCLE; GRASS; ZINC; MEAT; KIDNEY; BLOOD	The amount of trace elements present in edible bovine tissues is of importance for both animal health and human nutrition. This study presents data on trace element concentrations in semitendinosus and cardiac muscles, livers and kidneys of 60 zebu (Bos indicus) bulls, sampled at Jimma, Ethiopia. From 28 of these bulls, blood samples were also obtained. Deficient levels of copper were found in plasma, livers, kidneys and semitendinosus muscles. Suboptimal selenium concentrations were found in plasma and semitendinosus muscles. Semitendinosus muscles contained high iron concentrations. Trace elements were mainly stored in the liver, except for iron and selenium. Cardiac muscles generally contained higher concentrations of trace elements than semitendinous muscles except for zinc. A strong association was found between liver and kidney concentrations of copper, iron, cobalt and molybdenum. Liver storage was well correlated with storage in semitendinosus muscle for selenium and with cardiac muscle for cobalt and selenium. Plasma concentrations of copper, selenium, cobalt were well related with their respective liver concentrations and for cobalt and selenium, also with cardiac muscle concentrations. The data suggest multiple trace element deficiencies in zebu cattle in South-West Ethiopia, with lowered tissue concentrations as a consequence. Based on the comparison of our data with other literature, trace element concentrations in selected edible tissues of Bos indicus seem quite similar to those in Bos taurus. However, tissue threshold values for deficiency in Bos taurus cattle need to be refined and their applicability for Bos indicus cattle needs to be evaluated.	[Dermauw, Veronique; Janssens, Geert Paul Jules] Univ Ghent, Fac Vet Med, Anim Nutr Lab, Merelbeke, Belgium; [Lopez Alonso, Marta] Univ Santiago de Compostela, Dept Patol Anim, Lugo, Spain; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Comparat Physiol & Biometr, Merelbeke, Belgium; [Du Laing, Gijs] Univ Ghent, Fac Biosci Engn, Lab Analyt Chem & Appl Ecochem, B-9000 Ghent, Belgium; [Tolosa, Tadele] Jimma Univ, Coll Agr & Vet Med, Sch Vet Med, Jimma, Ethiopia; [Tolosa, Tadele] Univ Ghent, Fac Vet Med, Dept Reprod Obstet & Herd Hlth, M Team & Mastitis Qual Res Unit, Merelbeke, Belgium; [Dierenfeld, Ellen] Univ Missouri Columbia, Div Anim Sci, Columbia, MO USA; [Clauss, Marcus] Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, Zurich, Switzerland	Ghent University; Universidade de Santiago de Compostela; Ghent University; Ghent University; Jimma University; Ghent University; University of Missouri System; University of Missouri Columbia; University of Zurich	Dermauw, V (corresponding author), Univ Ghent, Fac Vet Med, Anim Nutr Lab, Merelbeke, Belgium.	veronique.dermauw@ugent.be	López-Alonso, Marta/K-9437-2013; Dermauw, Veronique/AFO-8354-2022; Clauss, Marcus/GRR-7996-2022; Clauss, Marcus/A-4710-2008; Janssens, Geert/C-2264-2008; Tolosa, Tadele/N-9237-2014; Clauss, Marcus/M-8702-2019	López-Alonso, Marta/0000-0001-6426-4273; Dermauw, Veronique/0000-0001-8745-5304; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Tolosa, Tadele/0000-0002-4492-688X; Clauss, Marcus/0000-0003-3841-6207; Du Laing, Gijs/0000-0001-6661-1312	Agency for the Promotion of Innovation through Science in Flanders (IWT-Vlaanderen) [093348]	Agency for the Promotion of Innovation through Science in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was performed within the doctoral research project of Veronique Dermauw, funded by the Agency for the Promotion of Innovation through Science in Flanders (IWT-Vlaanderen), grant no. 093348. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso ML, 2000, SCI TOTAL ENVIRON, V246, P237, DOI 10.1016/S0048-9697(99)00461-1; Alonso ML, 2000, FOOD ADDIT CONTAM A, V17, P447, DOI 10.1080/02652030050034028; Alonso ML, 2004, BIOMETALS, V17, P389, DOI 10.1023/B:BIOM.0000029434.89679.a2; Amare B, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-108; BENEMARIYA H, 1993, SCI TOTAL ENVIRON, V128, P83, DOI 10.1016/0048-9697(93)90181-5; Berger MM, 2005, CLIN NUTR, V24, P172, DOI 10.1016/j.clnu.2004.10.003; Blanco-Penedo I, 2006, ENVIRON INT, V32, P901, DOI 10.1016/j.envint.2006.05.012; Blanco-Penedo I, 2010, FOOD ADDIT CONTAM A, V27, P36, DOI 10.1080/02652030903161598; Bradley DG, 1998, EVOL ANTHROPOL, V6, P79, DOI 10.1002/(SICI)1520-6505(1998)6:3<79::AID-EVAN2>3.0.CO;2-R; Cabrera MC, 2010, MEAT SCI, V84, P518, DOI 10.1016/j.meatsci.2009.10.007; Caramelli D., 2006, HUM EVOL, V21, P107; CLAYPOOL DW, 1975, J ANIM SCI, V41, P911, DOI 10.2527/jas1975.413911x; de Freitas AK, 2014, MEAT SCI, V96, P353, DOI 10.1016/j.meatsci.2013.07.021; Dermauw V, 2013, LIVEST SCI, V155, P255, DOI 10.1016/j.livsci.2013.05.027; Dermauw V, 2013, TROP ANIM HEALTH PRO, V45, P1139, DOI 10.1007/s11250-012-0337-4; Duckett SK, 2009, J ANIM SCI, V87, P2961, DOI 10.2527/jas.2009-1850; FROSLIE A, 1983, NORD VET MED, V35, P213; FROSLIE A, 1983, NORD VET MED, V35, P209; Garcia-Vaquero M, 2011, FOOD CHEM TOXICOL, V49, P1443, DOI 10.1016/j.fct.2011.03.041; Giuffrida-Mendoza M, 2007, MEAT SCI, V75, P487, DOI 10.1016/j.meatsci.2006.08.011; Herdt TH, 2011, VET CLIN N AM-FOOD A, V27, P255, DOI 10.1016/j.cvfa.2011.02.004; HUBAUX A, 1970, ANAL CHEM, V42, P849, DOI 10.1021/ac60290a013; Huerta-Leidenz N, 2003, ARCH LATINOAM NUTR, V53, P96; KHALILI M, 1993, TROP ANIM HEALTH PRO, V25, P193, DOI 10.1007/BF02250867; Kincaid R.L., 1999, J ANIM SCI, V77, P1, DOI [10.2527/jas2000.77E-Suppl1x, DOI 10.2527/JAS2000.77E-SUPPL1X]; KORSRUD GO, 1985, CAN J COMP MED, V49, P159; Leheska JM, 2008, J ANIM SCI, V86, P3575, DOI 10.2527/jas.2007-0565; McTavish EJ, 2013, P NATL ACAD SCI USA, V110, pE1398, DOI 10.1073/pnas.1303367110; Mullis LA, 2003, J ANIM SCI, V81, P318; Nriagu J, 2009, ECOTOX ENVIRON SAFE, V72, P564, DOI 10.1016/j.ecoenv.2008.05.001; Pavlata L, 2001, ACTA VET BRNO, V70, P277, DOI 10.2754/avb200170030277; Puls R., 1994, Mineral levels in animal health: diagnostic data.; Sedki A, 2003, SCI TOTAL ENVIRON, V317, P201, DOI 10.1016/S0048-9697(03)00050-0; Suttle N, 2010, MINERAL NUTRITION OF LIVESTOCK, 4TH EDITION, P306, DOI 10.1079/9781845934729.0306; TARTOUR G, 1975, Tropical Animal Health and Production, V7, P87; Waegeneers N, 2009, FOOD ADDIT CONTAM A, V26, P326, DOI 10.1080/02652030802429096; WARD JD, 1995, J ANIM SCI, V73, P571; WHO, 1996, TRAC EL HUM NUTR HLT; Windisch W., 2008, P187	39	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85300	10.1371/journal.pone.0085300	http://dx.doi.org/10.1371/journal.pone.0085300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465529	Green Accepted, gold, Green Published			2022-12-25	WOS:000330244500052
J	Mehmood, R; Varga, G; Mohanty, SQ; Laing, SW; Lu, YF; Johnson, CL; Kharitonenkov, A; Pin, CL				Mehmood, Rashid; Varga, Gabor; Mohanty, Sonali Q.; Laing, Scott W.; Lu, Yuefeng; Johnson, Charis L.; Kharitonenkov, Alexei; Pin, Christopher L.			Epigenetic Reprogramming in Mist1(-/-) Mice Predicts the Molecular Response to Cerulein-Induced Pancreatitis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MIST1; HISTONE H3; ACTIVE GENES; METHYLATION; EXPRESSION; EXOCRINE; ACTIVATION; MECHANISMS; REGIONS; STRESS	Gene expression is affected by modifications to histone core proteins within chromatin. Changes in these modifications, or epigenetic reprogramming, can dictate cell fate and promote susceptibility to disease. The goal of this study was to determine the extent of epigenetic reprogramming in response to chronic stress that occurs following ablation of MIST1 (Mist1(-/-)), which is repressed in pancreatic disease. Chromatin immunoprecipitation for trimethylation of lysine residue 4 on histone 3 (H3K4Me3) in purified acinar cells from wild type and Mist1(-/-) mice was followed by Next Generation sequencing (ChIP-seq) or ChIP-qPCR. H3K4Me3-enriched genes were assessed for expression by qRT-PCR in pancreatic tissue before and after induction of cerulein-induced pancreatitis. While most of H3K4Me3-enrichment is restricted to transcriptional start sites, >25% of enrichment sites are found within, downstream or between annotated genes. Less than 10% of these sites were altered in Mist1(-/-) acini, with most changes in H3K4Me3 enrichment not reflecting altered gene expression. Ingenuity Pathway Analysis of genes differentially-enriched for H3K4Me3 revealed an association with pancreatitis and pancreatic ductal adenocarcinoma in Mist1(-/-) tissue. Most of these genes were not differentially expressed but several were readily induced by acute experimental pancreatitis, with significantly increased expression in Mist1(-/-) tissue relative to wild type mice. We suggest that the chronic cell stress observed in the absence of MIST1 results in epigenetic reprogramming of genes involved in promoting pancreatitis to a poised state, thereby increasing the sensitivity to events that promote disease.	[Mehmood, Rashid; Laing, Scott W.; Johnson, Charis L.; Pin, Christopher L.] Childrens Hlth Res Inst, London, ON, Canada; [Mehmood, Rashid; Laing, Scott W.; Johnson, Charis L.; Pin, Christopher L.] Childrens Hlth Res Inst, Dept Paediat, London, ON, Canada; [Laing, Scott W.; Pin, Christopher L.] Childrens Hlth Res Inst, Dept Physiol & Pharmacol, London, ON, Canada; [Pin, Christopher L.] Univ Western Ontario, London, ON, Canada; [Varga, Gabor; Mohanty, Sonali Q.; Kharitonenkov, Alexei] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Lu, Yuefeng] Sanofi US, Biostat & Programming, Framingham, MA USA	Western University (University of Western Ontario); Eli Lilly	Pin, CL (corresponding author), Childrens Hlth Res Inst, London, ON, Canada.	cpin@uwo.ca		Pin, Christopher/0000-0002-1245-1058	Canadian Institutes of Health Research [MOE 58083]; Children's Health Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Children's Health Foundation	This work was supported by operating grant MOE 58083 from the Canadian Institutes of Health Research (www.cihr.ca), as well as local support from the Children's Health Research Institute (www.chri.org) and Lawson Health Research Institute (www.lawsonresearch.com). RM was supported by a postdoctoral fellowship from the Children's Health Foundation (childhealth.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahari S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028863; Arda HE, 2013, DEV CELL, V25, P5, DOI 10.1016/j.devcel.2013.03.016; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Direnzo D, 2012, GASTROENTEROLOGY; Dupont C, 2009, SEMIN REPROD MED, V27, P351, DOI 10.1055/s-0029-1237423; Dusetti NJ, 2000, BIOCHEM BIOPH RES CO, V277, P660, DOI 10.1006/bbrc.2000.3734; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; Goicoechea SM, 2013, ONCOGENE; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; IOVANNA JL, 1991, AM J PHYSIOL, V261, pG485, DOI 10.1152/ajpgi.1991.261.3.G485; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Jia D, 2008, GASTROENTEROLOGY, V135, P1687, DOI 10.1053/j.gastro.2008.07.026; Johnson CL, 2012, J PATHOL, V228, P351, DOI 10.1002/path.4015; Johnson CL, 2009, GASTROENTEROLOGY, V137, P1795, DOI 10.1053/j.gastro.2009.07.064; Johnson CL, 2004, MECH DEVELOP, V121, P261, DOI 10.1016/j.mod.2004.01.003; Johnstone SE, 2010, NAT REV GENET, V11, P806, DOI 10.1038/nrg2881; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kowalik AS, 2007, AM J PHYSIOL-GASTR L, V292, pG1123, DOI 10.1152/ajpgi.00512.2006; Kubisch CH, 2006, AM J PHYSIOL-GASTR L, V291, pG238, DOI 10.1152/ajpgi.00471.2005; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Lardon J, 2004, HEPATOLOGY, V39, P1499, DOI 10.1002/hep.20213; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lillycrop KA, 2012, BEST PRACT RES CL EN, V26, P667, DOI 10.1016/j.beem.2012.03.009; Luo X, 2005, J BIOL CHEM, V280, P12668, DOI 10.1074/jbc.M411973200; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Pinho AV, 2011, GUT, V60, P958, DOI 10.1136/gut.2010.225920; Pogribny I. P., 2010, Experimental Oncology, V32, P132; Pogue-Geile KL, 2006, PLOS MED, V3, P2216, DOI 10.1371/journal.pmed.0030516; Puri S, 2010, DEV CELL, V18, P342, DOI 10.1016/j.devcel.2010.02.005; Rukstalis JM, 2003, J CELL SCI, V116, P3315, DOI 10.1242/jcs.00631; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Suter MA, 2012, EPIGENOMICS-UK, V4, P115, DOI [10.2217/epi.12.7, 10.2217/EPI.12.7]; Tian XL, 2010, MOL CELL BIOL, V30, P1269, DOI 10.1128/MCB.01328-09; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Xu CR, 2011, SCIENCE, V332, P963, DOI 10.1126/science.1202845; Xu H, 2012, METHODS MOL BIOL, V802, P293, DOI 10.1007/978-1-61779-400-1_19; Yaragatti M, 2008, GENOME RES, V18, P930, DOI 10.1101/gr.073460.107; Zhang ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038112	50	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84182	10.1371/journal.pone.0084182	http://dx.doi.org/10.1371/journal.pone.0084182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465395	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500001
J	Miklavc, P; Ehinger, K; Thompson, KE; Hobi, N; Shimshek, DR; Frick, M				Miklavc, Pika; Ehinger, Konstantin; Thompson, Kristin E.; Hobi, Nina; Shimshek, Derya R.; Frick, Manfred			Surfactant Secretion in LRRK2 Knock-Out Rats: Changes in Lamellar Body Morphology and Rate of Exocytosis	PLOS ONE			English	Article							REPEAT KINASE 2; II CELLS; LYSOSOMAL COMPARTMENT; CONTENT RELEASE; VESICLE; PATHWAYS; FUSION; CA2+; PARKINSONISM; LOCALIZATION	Leucine-rich repeat kinase 2 (LRRK2) is known to play a role in the pathogenesis of various diseases including Parkinson disease, morbus Crohn, leprosy and cancer. LRRK2 is suggested to be involved in a number of cell biological processes such as vesicular trafficking, transcription, autophagy and lysosomal pathways. Recent histological studies of lungs of LRRK2 knock-out (LRRK2 -/-) mice revealed significantly enlarged lamellar bodies (LBs) in alveolar type II (ATII) epithelial cells. LBs are large, lysosome-related storage organelles for pulmonary surfactant, which is released into the alveolar lumen upon LB exocytosis. In this study we used high-resolution, subcellular live-cell imaging assays to investigate whether similar morphological changes can be observed in primary ATII cells from LRRK2 -/- rats and whether such changes result in altered LB exocytosis. Similarly to the report in mice, ATII cells from LRRK2 -/-rats contained significantly enlarged LBs resulting in a >50% increase in LB volume. Stimulation of ATII cells with ATP elicited LB exocytosis in a significantly increased proportion of cells from LRRK2 -/- animals. LRRK2 -/- cells also displayed increased intracellular Ca2+ release upon ATP treatment and significant triggering of LB exocytosis. These findings are in line with the strong Ca2+-dependence of LB fusion activity and suggest that LRRK2 -/- affects exocytic response in ATII cells via modulating intracellular Ca2+ signaling. Post-fusion regulation of surfactant secretion was unaltered. Actin coating of fused vesicles and subsequent vesicle compression to promote surfactant expulsion were comparable in cells from LRRK2 -/- and wt animals. Surprisingly, surfactant (phospholipid) release from LRRK2 -/- cells was reduced following stimulation of LB exocytosis possibly due to impaired LB maturation and surfactant loading of LBs. In summary our results suggest that LRRK2 -/- affects LB size, modulates intracellular Ca2+ signaling and promotes LB exocytosis upon stimulation of ATII cells with ATP.	[Miklavc, Pika; Ehinger, Konstantin; Thompson, Kristin E.; Hobi, Nina; Frick, Manfred] Univ Ulm, Inst Gen Physiol, D-89069 Ulm, Germany; [Hobi, Nina] Med Univ Innsbruck, Dept Physiol & Med Phys, A-6020 Innsbruck, Austria; [Shimshek, Derya R.] Novartis Inst BioMed Res, Dept Autoimmun Transplantat Inflammat Neurosci, Basel, Switzerland	Ulm University; Medical University of Innsbruck; Novartis	Frick, M (corresponding author), Univ Ulm, Inst Gen Physiol, D-89069 Ulm, Germany.	manfred.frick@uni-ulm.de	Frick, Manfred/E-1374-2012	Frick, Manfred/0000-0002-4763-1104; Ehinger, Konstantin/0000-0002-3018-343X; Shimshek, Derya/0000-0001-8602-7850	BiU grant [D.5006]; DFG [D-1402/3-1]; Ministry of Science, Research and the Arts Baden-Wurttemberg	BiU grant; DFG(German Research Foundation (DFG)); Ministry of Science, Research and the Arts Baden-Wurttemberg	This work was funded by BiU grant D.5006 and DFG grant D-1402/3-1 (www.dfg.de). P. M. is supported by a Margarete von Wrangell fellowship from the Ministry of Science, Research and the Arts Baden-Wurttemberg (www.margarete-von-wrangell.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; de la Serna JB, 2009, BIOPHYS J, V97, P1381, DOI 10.1016/j.bpj.2009.06.040; Berwick DC, 2011, TRENDS CELL BIOL, V21, P257, DOI 10.1016/j.tcb.2011.01.001; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Cherra SJ, 2013, AM J PATHOL, V182, P474, DOI 10.1016/j.ajpath.2012.10.027; Dietl P, 2005, ANNU REV PHYSIOL, V67, P595, DOI 10.1146/annurev.physiol.67.040403.102553; Dietl P, 2001, NEWS PHYSIOL SCI, V16, P239; Dietl P, 2012, CELL CALCIUM, V52, P296, DOI 10.1016/j.ceca.2012.04.010; Dihanich S, 2011, J NEUROSCI, V31, P9787, DOI 10.1523/JNEUROSCI.1976-11.2011; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; Drolet RE, 2011, J NEUROGENET, V25, P140, DOI 10.3109/01677063.2011.627072; Frick M, 2001, AM J RESP CELL MOL, V25, P306, DOI 10.1165/ajrcmb.25.3.4493; Garcia-Verdugo I, 2008, AM J PHYSIOL-LUNG C, V295, pL708, DOI 10.1152/ajplung.00536.2007; Gomez-Suaga P, 2012, AUTOPHAGY, V8, P692, DOI 10.4161/auto.19305; Gomez-Suaga P, 2012, HUM MOL GENET, V21, P511, DOI 10.1093/hmg/ddr481; Greggio E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-94; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; Haller T, 1999, AM J PHYSIOL-LUNG C, V277, pL893, DOI 10.1152/ajplung.1999.277.5.L893; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Haller T, 2001, J CELL BIOL, V155, P279, DOI 10.1083/jcb.200102106; Haller T, 1996, CELL CALCIUM, V19, P157, DOI 10.1016/S0143-4160(96)90084-6; Hassin-Baer S, 2009, J NEUROL, V256, P483, DOI 10.1007/s00415-009-0117-x; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; Higashi S, 2009, J NEUROPATH EXP NEUR, V68, P994, DOI 10.1097/NEN.0b013e3181b44ed8; Hills BA, 1999, J APPL PHYSIOL, V87, P1567, DOI 10.1152/jappl.1999.87.5.1567; Kanao T, 2010, HUM MOL GENET, V19, P3747, DOI 10.1093/hmg/ddq289; Kett LR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009407; Kim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034693; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Mair N, 2004, AM J PHYSIOL-LUNG C, V287, pL1284, DOI 10.1152/ajplung.00177.2004; Mair N, 1999, AM J PHYSIOL-LUNG C, V276, pL376, DOI 10.1152/ajplung.1999.276.2.L376; Miklavc P, 2012, JCELL SCI; Miklavc P, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00171; Miklavc P, 2011, P NATL ACAD SCI USA, V108, P14503, DOI 10.1073/pnas.1101039108; Miklavc P, 2009, BIOCHEM J, V424, P7, DOI 10.1042/BJ20091094; Miklavc P, 2009, ANN NY ACAD SCI, V1152, P43, DOI 10.1111/j.1749-6632.2008.03989.x; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Ravasio A, 2011, AM J PHYSIOL-CELL PH, V300, pC1456, DOI 10.1152/ajpcell.00427.2010; Sanna G, 2012, BIOCHEM SOC T, V40, P1117, DOI 10.1042/BST20120117; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Singer W, 2003, BIOPHYS J, V84, P1344, DOI 10.1016/S0006-3495(03)74950-9; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; Tofaris GK, 2012, MOVEMENT DISORD, V27, P1364, DOI 10.1002/mds.25136; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Wang ZD, 1996, J LIPID RES, V37, P790; Wozniak AL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001087; Yang YX, 2009, NEUROREPORT, V20, P150, DOI 10.1097/WNR.0b013e32831c50df; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	58	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84926	10.1371/journal.pone.0084926	http://dx.doi.org/10.1371/journal.pone.0084926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465451	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500021
J	Pioz, M; Guis, H; Pleydell, D; Gay, E; Calavas, D; Durand, B; Ducrot, C; Lancelot, R				Pioz, Maryline; Guis, Helene; Pleydell, David; Gay, Emilie; Calavas, Didier; Durand, Benoit; Ducrot, Christian; Lancelot, Renaud			Did Vaccination Slow the Spread of Bluetongue in France?	PLOS ONE			English	Article							VIRUS SEROTYPE 8; CULICOIDES-OBSOLETUS GROUP; SPATIAL AUTOCORRELATION; CONTROL STRATEGY; ABIOTIC FACTORS; FLIGHT ACTIVITY; RACCOON RABIES; GREAT-BRITAIN; CERATOPOGONIDAE; DISTRIBUTIONS	Vaccination is one of the most efficient ways to control the spread of infectious diseases. Simulations are now widely used to assess how vaccination can limit disease spread as well as mitigate morbidity or mortality in susceptible populations. However, field studies investigating how much vaccines decrease the velocity of epizootic wave-fronts during outbreaks are rare. This study aimed at investigating the effect of vaccination on the propagation of bluetongue, a vector-borne disease of ruminants. We used data from the 2008 bluetongue virus serotype 1 (BTV-1) epizootic of southwest France. As the virus was newly introduced in this area, natural immunity of livestock was absent. This allowed determination of the role of vaccination in changing the velocity of bluetongue spread while accounting for environmental factors that possibly influenced it. The average estimated velocity across the country despite restriction on animal movements was 5.4 km/day, which is very similar to the velocity of spread of the bluetongue virus serotype 8 epizootic in France also estimated in a context of restrictions on animal movements. Vaccination significantly reduced the propagation velocity of BTV-1. In comparison to municipalities with no vaccine coverage, the velocity of BTV-1 spread decreased by 1.7 km/day in municipalities with immunized animals. For the first time, the effect of vaccination has been quantified using data from a real epizootic whilst accounting for environmental factors known to modify the velocity of bluetongue spread. Our findings emphasize the importance of vaccination in limiting disease spread across natural landscape. Finally, environmental factors, specifically those related to vector abundance and activity, were found to be good predictors of the velocity of BTV-1 spread, indicating that these variables need to be adequately accounted for when evaluating the role of vaccination on bluetongue spread.	[Pioz, Maryline; Guis, Helene; Lancelot, Renaud] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, Montpellier, France; [Pioz, Maryline; Guis, Helene; Lancelot, Renaud] Inst Natl Rech Agron INRA, Unite Mixte Rech Controle Malad Anim Exot & Emerg, Montpellier, France; [Pleydell, David] Inst Natl Rech Agron INRA, Unite Mixte Rech Controle Malad Anim Exot & Emerg, Petit Bourg, Guadeloupe, France; [Pleydell, David] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, Petit Bourg, Guadeloupe, France; [Gay, Emilie; Calavas, Didier] Agence Natl Securite Sanit Alimentat Environm & T, Unite Epidemiol, Lyon, France; [Durand, Benoit] Agence Natl Securite Sanit Alimentat Environm & T, Lab Sante Anim, Maisons Alfort, France; [Ducrot, Christian] Inst Natl Rech Agron INRA, Unite Rech Epidemiol Anim 346, St Genes Champanelle, France	CIRAD; INRAE; INRAE; CIRAD; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE	Pioz, M (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, Montpellier, France.	maryline.pioz@hotmail.fr	Lancelot, Renaud/HGE-1086-2022; Pioz, Maryline/AAI-3325-2020; Durand, Benoit/GSE-2511-2022	Lancelot, Renaud/0000-0002-5826-5242; Durand, Benoit/0000-0003-0669-1394; Pioz, Maryline/0000-0003-0331-4403; Guis, Helene/0000-0002-0355-0898	EU [FP7-261504 EDENext]; Direction Generale de l'Alimentation (DGAL) of the French Ministry of Agriculture; EU [FP7-261504 EDENext]; Direction Generale de l'Alimentation (DGAL) of the French Ministry of Agriculture	EU(European Commission); Direction Generale de l'Alimentation (DGAL) of the French Ministry of Agriculture; EU(European Commission); Direction Generale de l'Alimentation (DGAL) of the French Ministry of Agriculture	This study was funded by EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext122 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and don't necessarily reflect the views of the European Commission. HG and RL are partially funded by the Direction Generale de l'Alimentation (DGAL) of the French Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjemian JZ, 2007, AM J TROP MED HYG, V76, P365, DOI 10.4269/ajtmh.2007.76.365; Allepuz A, 2010, PREV VET MED, V96, P263, DOI 10.1016/j.prevetmed.2010.06.005; [Anonymous], 2012, R PACKAGE VERSION 2; [Anonymous], 2012, R PACKAGE VERSION 1; Ball F.G., 1985, P255; Breard E, 2011, VACCINE, V29, P2495, DOI 10.1016/j.vaccine.2010.12.105; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calvete C, 2008, MED VET ENTOMOL, V22, P124, DOI 10.1111/j.1365-2915.2008.00728.x; Caporale V, 2010, REV SCI TECH OIE, V29, P573, DOI 10.20506/rst.29.3.2001; Carpenter S, 2006, J MED ENTOMOL, V43, P73, DOI 10.1603/0022-2585(2006)043[0073:OSTBVO]2.0.CO;2; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; Crase B, 2012, ECOGRAPHY, V35, P879, DOI 10.1111/j.1600-0587.2011.07138.x; de Diego ACP, 2012, SCI WORLD J, DOI 10.1100/2012/147158; De Liberato C, 2010, J MED ENTOMOL, V47, P313, DOI 10.1603/ME09148; Dohoo I, 2009, METHODS EPIDEMIOLOGI, V2nd, P365; Ducheyne E, 2011, PREV VET MED, V99, P48, DOI 10.1016/j.prevetmed.2011.01.003; Durand B, 2010, EMERG INFECT DIS, V16, P1861, DOI 10.3201/eid1612.100412; Eschbaumer M, 2009, VACCINE, V27, P4169, DOI 10.1016/j.vaccine.2009.04.056; Fassotte C, 2008, PREV VET MED, V87, P74, DOI 10.1016/j.prevetmed.2008.06.007; Gerbier G, 2004, Vet Ital, V40, P611; Gethmann J, 2009, VACCINE, V27, P4118, DOI 10.1016/j.vaccine.2009.04.072; Giovannini A, 2004, RISK ANAL, V24, P1737, DOI 10.1111/j.0272-4332.2004.00563.x; Gubbins S, 2012, PREV VET MED, V105, P297, DOI 10.1016/j.prevetmed.2012.02.016; Haining R, 1990, SPATIAL DATA ANAL SO; Hanspach J, 2011, GLOBAL ECOL BIOGEOGR, V20, P779, DOI 10.1111/j.1466-8238.2011.00649.x; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Lorusso A, 2013, INFECT GENET EVOL, V19, P81, DOI 10.1016/j.meegid.2013.06.028; Lucey BT, 2002, VECTOR-BORNE ZOONOT, V2, P77, DOI 10.1089/153036602321131878; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; McKillup S, 2006, STAT EXPLAINED INTRO; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Meroc E, 2008, VET MICROBIOL, V131, P133, DOI 10.1016/j.vetmic.2008.03.012; Moore DA, 1999, PREV VET MED, V40, P19, DOI 10.1016/S0167-5877(99)00005-7; Moore DA, 1999, EPIDEMIOL REV, V21, P143, DOI 10.1093/oxfordjournals.epirev.a017993; Olden JD, 2000, ECOSCIENCE, V7, P501, DOI 10.1080/11956860.2000.11682622; Patta C, 2004, Vet Ital, V40, P601; Pioz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043360; Pioz M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-60; ProMED-mail, 2013, BLUET EUR 05 FRANC C; Purse BV, 2004, MED VET ENTOMOL, V18, P90, DOI 10.1111/j.0269-283X.2004.00492.x; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; R Development Core Team, 2010, R FDN STAT COMP R ST; R package version 1.6-35, 2001, R PACKAGE VERSION 1; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Sanchez-Cordon PJ, 2013, VET MICROBIOL, V166, P184, DOI 10.1016/j.vetmic.2013.05.032; Sanders CJ, 2011, J APPL ECOL, V48, P1355, DOI 10.1111/j.1365-2664.2011.02051.x; Sedda L, 2012, P ROY SOC B-BIOL SCI, V279, P2354, DOI 10.1098/rspb.2011.2555; Sumner T, 2013, EPIDEMIOL INFECT, V141, P102, DOI 10.1017/S0950268812000532; Szmaragd C, 2010, EPIDEMICS-NETH, V2, P139, DOI 10.1016/j.epidem.2010.05.002; Szmaragd C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009353; Velthuis AGJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019612; Vidal JP, 2010, INT J CLIMATOL, V30, P1627, DOI 10.1002/joc.2003; Wackerlin R, 2010, VACCINE, V28, P4348, DOI 10.1016/j.vaccine.2010.04.055; Willgert KJE, 2011, GEOSPATIAL HEALTH, V5, P227, DOI 10.4081/gh.2011.175; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091	58	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85444	10.1371/journal.pone.0085444	http://dx.doi.org/10.1371/journal.pone.0085444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465562	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500066
J	Hui, SP; Sengupta, D; Lee, SGP; Sen, T; Kundu, S; Mathavan, S; Ghosh, S				Hui, Subhra Prakash; Sengupta, Dhriti; Lee, Serene Gek Ping; Sen, Triparna; Kundu, Sudip; Mathavan, Sinnakaruppan; Ghosh, Sukla			Genome Wide Expression Profiling during Spinal Cord Regeneration Identifies Comprehensive Cellular Responses in Zebrafish	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CYCLIN D1 EXPRESSION; DORSAL-ROOT GANGLIA; GENE-EXPRESSION; WALLERIAN DEGENERATION; AXONAL REGENERATION; FIN REGENERATION; HOX GENES; TGF-BETA; DIFFERENTIAL EXPRESSION	Background: Among the vertebrates, teleost and urodele amphibians are capable of regenerating their central nervous system. We have used zebrafish as a model to study spinal cord injury and regeneration. Relatively little is known about the molecular mechanisms underlying spinal cord regeneration and information based on high density oligonucleotide microarray was not available. We have used a high density microarray to profile the temporal transcriptome dynamics during the entire phenomenon. Results: A total of 3842 genes expressed differentially with significant fold changes during spinal cord regeneration. Cluster analysis revealed event specific dynamic expression of genes related to inflammation, cell death, cell migration, cell proliferation, neurogenesis, neural patterning and axonal regrowth. Spatio-temporal analysis of stat3 expression suggested its possible function in controlling inflammation and cell proliferation. Genes involved in neurogenesis and their dorsoventral patterning (sox2 and dbx2) are differentially expressed. Injury induced cell proliferation is controlled by many cell cycle regulators and some are commonly expressed in regenerating fin, heart and retina. Expression pattern of certain pathway genes are identified for the first time during regeneration of spinal cord. Several genes involved in PNS regeneration in mammals like stat3, socs3, atf3, mmp9 and sox11 are upregulated in zebrafish SCI thus creating PNS like environment after injury. Conclusion: Our study provides a comprehensive genetic blue print of diverse cellular response(s) during regeneration of zebrafish spinal cord. The data highlights the importance of different event specific gene expression that could be better understood and manipulated further to induce successful regeneration in mammals.	[Hui, Subhra Prakash; Sengupta, Dhriti; Kundu, Sudip; Ghosh, Sukla] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, India; [Lee, Serene Gek Ping; Mathavan, Sinnakaruppan] Genome Inst Singapore, Singapore, Singapore; [Sen, Triparna] Chittaranjan Natl Canc Res Inst, Kolkata, India	University of Calcutta; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Ghosh, S (corresponding author), Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, India.	suklagh2010@gmail.com		Sengupta, Dhriti/0000-0001-6315-7804	Department of Science and Technology, Department of Biotechnology [BT/PR13953/AAQ/03/523/2010]; Ministry of Science and Technology, Govt. of India [INT/CP-STIO/2006-2007/39/2006, BT/BI/04/001/93]; Department of Biophysics, Molecular Biology and Bioinformatics at the University of Calcutta; Genome Institute of Singapore	Department of Science and Technology, Department of Biotechnology(Department of Science & Technology (India)); Ministry of Science and Technology, Govt. of India; Department of Biophysics, Molecular Biology and Bioinformatics at the University of Calcutta; Genome Institute of Singapore	This work was supported by Department of Science and Technology, Department of Biotechnology (BT/PR13953/AAQ/03/523/2010), Ministry of Science and Technology (INT/CP-STIO/2006-2007/39/2006), Govt. of India to SG and DIC (Establishment ... BT/BI/04/001/93), and the Department of Biophysics, Molecular Biology and Bioinformatics at the University of Calcutta. Generous funding was extended by the Genome Institute of Singapore for zebrafish array work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Alldridge LC, 2003, EXP CELL RES, V290, P93, DOI 10.1016/S0014-4827(03)00310-0; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bai S, 2005, MATRIX BIOL, V24, P247, DOI 10.1016/j.matbio.2005.03.007; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Bernhardt RR, 1999, EXP NEUROL, V157, P223, DOI 10.1006/exnr.1999.7059; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Brewer KL, 1999, EXP NEUROL, V159, P484, DOI 10.1006/exnr.1999.7173; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Byrnes KR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-130; Cameron DA, 2005, MOL VIS, V11, P775; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Carpenter EM, 2002, DEV NEUROSCI-BASEL, V24, P24, DOI 10.1159/000064943; Caubit X, 1997, DEV DYNAM, V210, P1, DOI 10.1002/(SICI)1097-0177(199709)210:1<1::AID-AJA1>3.0.CO;2-L; Chernoff EAG, 2003, DEV DYNAM, V226, P295, DOI 10.1002/dvdy.10240; Cheung KK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-76; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DAKSIS JI, 1994, ONCOGENE, V9, P3635; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Deonarine K, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-11; Devine CA, 2008, DEV BIOL, V313, P371, DOI 10.1016/j.ydbio.2007.10.040; DING AH, 1988, J IMMUNOL, V141, P2407; Dutta A, 2009, J ONCOL, V2009, DOI 10.1155/2009/627840; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Ghosh S, 2008, DEV GROWTH DIFFER, V50, P289, DOI [10.1111/j.1440-169x.2008.01000.x, 10.1111/j.1440-169X.2008.01000.x]; Goldman D, 2001, TRANSGENIC RES, V10, P21, DOI 10.1023/A:1008998832552; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guner B, 2007, GENE EXPR PATTERNS, V7, P596, DOI 10.1016/j.modgep.2007.01.002; Harris TE, 2001, J BIOL CHEM, V276, P29200, DOI 10.1074/jbc.M011587200; Harrison MRM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-24; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hedtjarn M, 2004, J CEREBR BLOOD F MET, V24, P1333, DOI 10.1097/01.WCB.0000141559.17620.36; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Ho DM, 2008, DEV BIOL, V315, P203, DOI 10.1016/j.ydbio.2007.12.031; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hu P, 2003, EXP NEUROL, V184, P590, DOI 10.1016/S0014-4886(03)00307-8; Hui SP, 2010, DEV DYNAM, V239, P2962, DOI 10.1002/dvdy.22438; Hunt D, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-9; Hwan AY, 2006, BIOCHEM BIOPH RES CO, V348, P560, DOI 10.1016/j.bbrc.2006.07.105; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Jarnicki A, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-14; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; Kedinger V, 2005, GENE EXPR PATTERNS, V5, P545, DOI 10.1016/j.modgep.2004.10.011; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Koshida S, 1998, DEVELOPMENT, V125, P1957; Kronenberg G, 2010, J CLIN INVEST, V120, P1383, DOI 10.1172/JCI40764; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liao Q, 2001, FEBS LETT, V503, P151, DOI 10.1016/S0014-5793(01)02728-4; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Ling CC, 2006, BIOCHEM BIOPH RES CO, V349, P906, DOI 10.1016/j.bbrc.2006.08.111; Liu JP, 2006, DEVELOPMENT, V133, P2865, DOI 10.1242/dev.02478; LU X, 1993, J NEUROCYTOL, V22, P334, DOI 10.1007/BF01195557; Lufkin T, 1996, CURR OPIN GENET DEV, V6, P575, DOI 10.1016/S0959-437X(96)80086-4; Luk HW, 2003, J NEUROSCI RES, V73, P644, DOI 10.1002/jnr.10701; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Mattson MP, 1997, BRAIN RES REV, V23, P47, DOI 10.1016/S0165-0173(96)00014-8; McEwen ML, 2005, J HISTOCHEM CYTOCHEM, V53, P809, DOI 10.1369/jhc.4A6467.2005; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mladinic M, 2010, BRAIN RES, V1363, P20, DOI 10.1016/j.brainres.2010.09.024; Monaghan JR, 2007, J NEUROCHEM, V101, P27, DOI 10.1111/j.1471-4159.2006.04344.x; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mori M, 2000, BIOCHEM BIOPH RES CO, V275, P715, DOI 10.1006/bbrc.2000.3169; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; MUNEOKA K, 1982, NATURE, V298, P369, DOI 10.1038/298369a0; Nishidate M, 2007, DEV DYNAM, V236, P2685, DOI 10.1002/dvdy.21274; Nona SN, 2000, J NEUROCYTOL, V29, P285, DOI 10.1023/A:1026575805331; Padhi BK, 2004, DEV DYNAM, V231, P527, DOI 10.1002/dvdy.20153; Poh A, 2002, INT J DEV BIOL, V46, P597; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Prince VE, 1998, DEVELOPMENT, V125, P407; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Roos M, 1999, MECH DEVELOP, V87, P103, DOI 10.1016/S0925-4773(99)00153-7; Ryu S, 2005, P NATL ACAD SCI USA, V102, P18467, DOI 10.1073/pnas.0506187102; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Saul KE, 2010, COMP BIOCHEM PHYS A, V155, P172, DOI 10.1016/j.cbpa.2009.10.042; Schebesta M, 2006, THESCIENTIFICWORLDJO, V6, P38, DOI 10.1100/tsw.2006.326; Schlueter PJ, 2007, CELL DEATH DIFFER, V14, P1095, DOI 10.1038/sj.cdd.4402109; Schnapp E, 2005, DEVELOPMENT, V132, P3243, DOI 10.1242/dev.01906; Schweitzer J, 2007, MOL CELL NEUROSCI, V35, P194, DOI 10.1016/j.mcn.2007.02.018; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Sheppard AM, 1995, DEV BIOL, V172, P504, DOI 10.1006/dbio.1995.8034; Shou J, 1999, NAT NEUROSCI, V2, P339, DOI 10.1038/7251; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Smith A, 2008, DEV DYNAM, V237, P417, DOI 10.1002/dvdy.21417; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Stadler JA, 2005, DEV DYNAM, V233, P883, DOI 10.1002/dvdy.20427; Stocum DL, 1996, INT J DEV BIOL, V40, P773; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tysseling VM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-16; van den Akker E, 2002, DEVELOPMENT, V129, P2181; Wakatsuki S, 2011, NAT CELL BIOL, V13, P1415, DOI 10.1038/ncb2373; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Xu QL, 1996, NATURE, V381, P319, DOI 10.1038/381319a0; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yamaguchi M, 2005, DEVELOPMENT, V132, P3027, DOI 10.1242/dev.01881; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Yudkovsky Y, 2000, BIOCHEM BIOPH RES CO, V271, P299, DOI 10.1006/bbrc.2000.2622; Zou T, 2006, J NEUROPATH EXP NEUR, V65, P78, DOI 10.1097/01.jnen.0000195942.25163.f5	126	56	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84212	10.1371/journal.pone.0084212	http://dx.doi.org/10.1371/journal.pone.0084212			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465396	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500010
J	Irvine, AG; Wallis, AK; Sanghera, N; Rowe, ML; Ruddock, LW; Howard, MJ; Williamson, RA; Blindauer, CA; Freedman, RB				Irvine, Alistair G.; Wallis, A. Katrine; Sanghera, Narinder; Rowe, Michelle L.; Ruddock, Lloyd W.; Howard, Mark J.; Williamson, Richard A.; Blindauer, Claudia A.; Freedman, Robert B.			Protein Disulfide-Isomerase Interacts with a Substrate Protein at All Stages along Its Folding Pathway	PLOS ONE			English	Article							PANCREATIC TRYPSIN-INHIBITOR; ENDOPLASMIC-RETICULUM; RIBONUCLEASE-A; BOND FORMATION; BINDING-SITE; STRUCTURAL-CHARACTERIZATION; IN-VITRO; INTERMEDIATE; CATALYSIS; DOMAINS	In contrast to molecular chaperones that couple protein folding to ATP hydrolysis, protein disulfide-isomerase (PDI) catalyzes protein folding coupled to formation of disulfide bonds (oxidative folding). However, we do not know how PDI distinguishes folded, partly-folded and unfolded protein substrates. As a model intermediate in an oxidative folding pathway, we prepared a two-disulfide mutant of basic pancreatic trypsin inhibitor (BPTI) and showed by NMR that it is partly-folded and highly dynamic. NMR studies show that it binds to PDI at the same site that binds peptide ligands, with rapid binding and dissociation kinetics; surface plasmon resonance shows its interaction with PDI has a K-d of ca. 10(-5) M. For comparison, we characterized the interactions of PDI with native BPTI and fully-unfolded BPTI. Interestingly, PDI does bind native BPTI, but binding is quantitatively weaker than with partly-folded and unfolded BPTI. Hence PDI recognizes and binds substrates via permanently or transiently unfolded regions. This is the first study of PDI's interaction with a partly-folded protein, and the first to analyze this folding catalyst's changing interactions with substrates along an oxidative folding pathway. We have identified key features that make PDI an effective catalyst of oxidative protein folding - differential affinity, rapid ligand exchange and conformational flexibility.	[Irvine, Alistair G.; Wallis, A. Katrine; Sanghera, Narinder; Freedman, Robert B.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Irvine, Alistair G.; Blindauer, Claudia A.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Rowe, Michelle L.; Howard, Mark J.; Williamson, Richard A.] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Ruddock, Lloyd W.] Univ Oulu, Dept Biochem, Oulu, Finland	University of Warwick; University of Warwick; University of Kent; Finland National Institute for Health & Welfare; University of Oulu	Freedman, RB (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	r.b.freedman@warwick.ac.uk	Blindauer, Claudia/G-3237-2011	Blindauer, Claudia/0000-0001-8396-9332; Ruddock, Lloyd/0000-0002-6247-686X; Howard, Mark/0000-0002-0762-2887; Wallis, Katrine/0000-0002-2162-6454	MOAC Doctoral Training Programme; Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/D017807]; Wellcome Trust [093125/Z/10Z, 047795/Z/96]; Royal Society; Biotechnology and Biological Sciences Research Council [BB/D017807/1, BB/D018072/1] Funding Source: researchfish; BBSRC [BB/D017807/1, BB/D018072/1] Funding Source: UKRI	MOAC Doctoral Training Programme; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AGI was supported by a studentship from the MOAC Doctoral Training Programme, funded by the Engineering and Physical Sciences Research Council. The research was also supported by grants from the Biotechnology and Biological Sciences Research Council (BB/D017807) and the Wellcome Trust (093125/Z/10Z and 047795/Z/96), and by the Royal Society (Olga Kennard Fellowship to CAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Biamonti C, 1996, THESIS RUTGERS U; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; CREIGHTON TE, 1974, J MOL BIOL, V87, P603, DOI 10.1016/0022-2836(74)90106-5; CREIGHTON TE, 1980, J MOL BIOL, V142, P43, DOI 10.1016/0022-2836(80)90205-3; CREIGHTON TE, 1975, J MOL BIOL, V95, P167, DOI 10.1016/0022-2836(75)90389-7; CREIGHTON TE, 1993, J MOL BIOL, V232, P1176, DOI 10.1006/jmbi.1993.1470; DARBY NJ, 1995, J MOL BIOL, V249, P463, DOI 10.1006/jmbi.1995.0309; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; GOLDBERGER RF, 1963, J BIOL CHEM, V238, P628; GOLDENBERG DP, 1992, TRENDS BIOCHEM SCI, V17, P257, DOI 10.1016/0968-0004(92)90405-X; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jimenez-Roldan JE, 2013, DYNAMICS FLEXI UNPUB; Karala AR, 2007, ANTIOXID REDOX SIGN, V9, P527, DOI 10.1089/ars.2006.1473; Karala AR, 2009, ANTIOXID REDOX SIGN, V11, P963, DOI 10.1089/ARS.2008.2326; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Laity JH, 1997, BIOCHEMISTRY-US, V36, P12683, DOI 10.1021/bi970878b; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Narayan M, 2000, ACCOUNTS CHEM RES, V33, P805, DOI 10.1021/ar000063m; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Shin HC, 2000, J MOL BIOL, V300, P995, DOI 10.1006/jmbi.2000.3928; TALLURI S, 1994, BIOCHEMISTRY-US, V33, P10437, DOI 10.1021/bi00200a027; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; van den Berg B, 1999, J MOL BIOL, V290, P781, DOI 10.1006/jmbi.1999.2915; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; van den Berg P, 1999, EMBO J, V18, P4794, DOI 10.1093/emboj/18.17.4794; VANMIERLO CPM, 1994, J MOL BIOL, V235, P1044, DOI 10.1006/jmbi.1994.1056; VANMIERLO CPM, 1993, J MOL BIOL, V229, P1125, DOI 10.1006/jmbi.1993.1108; VENETIANER P, 1963, BIOCHIM BIOPHYS ACTA, V67, P166; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WAGNER G, 1984, EUR J BIOCHEM, V145, P431, DOI 10.1111/j.1432-1033.1984.tb08572.x; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091	45	35	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e82511	10.1371/journal.pone.0082511	http://dx.doi.org/10.1371/journal.pone.0082511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465374	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500004
J	Jappelli, R; Perrin, MH; Lewis, KA; Vaughan, JM; Tzitzilonis, C; Rivier, JE; Vale, WW; Riek, R				Jappelli, Roberto; Perrin, Marilyn H.; Lewis, Kathy A.; Vaughan, Joan M.; Tzitzilonis, Christos; Rivier, Jean E.; Vale, Wylie W.; Riek, Roland			Expression and Functional Characterization of Membrane-Integrated Mammalian Corticotropin Releasing Factor Receptors 1 and 2 in Escherichia coli	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; PERIPHERAL CANNABINOID RECEPTOR; 1ST EXTRACELLULAR DOMAIN; RAT NEUROTENSIN RECEPTOR; N-TERMINAL DOMAIN; SIGNAL-PEPTIDE; NMR STRUCTURE; STRUCTURAL BASIS; HIGH-AFFINITY; SOLUBLE FORM	Corticotropin-Releasing Factor Receptors (CRFRs) are class B1 G-protein-coupled receptors, which bind peptides of the corticotropin releasing factor family and are key mediators in the stress response. In order to dissect the receptors' binding specificity and enable structural studies, full-length human CRFR1 alpha and mouse CRFR2 beta as well as fragments lacking the N-terminal extracellular domain, were overproduced in E. coli. The characteristics of different CRFR2 beta -PhoA gene fusion products expressed in bacteria were found to be in agreement with the predicted ones in the hepta-helical membrane topology model. Recombinant histidine-tagged CRFR1 alpha and CRFR2 beta expression levels and bacterial subcellular localization were evaluated by cell fractionation and Western blot analysis. Protein expression parameters were assessed, including the influence of E. coli bacterial hosts, culture media and the impact of either PelB or DsbA signal peptide. In general, the large majority of receptor proteins became inserted in the bacterial membrane. Across all experimental conditions significantly more CRFR2 beta product was obtained in comparison to CRFR1 alpha. Following a detergent screen analysis, bacterial membranes containing CRFR1 alpha and CRFR2 beta were best solubilized with the zwitterionic detergent FC-14. Binding of different peptide ligands to CRFR1 alpha and CRFR2 beta membrane fractions were similar, in part, to the complex pharmacology observed in eukaryotic cells. We suggest that our E. coli expression system producing functional CRFRs will be useful for large-scale expression of these receptors for structural studies.	[Jappelli, Roberto] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Perrin, Marilyn H.; Lewis, Kathy A.; Vaughan, Joan M.] Salk Inst Biol Studies, Lab Neuronal Struct & Funct, La Jolla, CA 92037 USA; [Tzitzilonis, Christos; Riek, Roland] ETH, Phys Chem Lab, CH-8092 Zurich, Switzerland; [Rivier, Jean E.; Vale, Wylie W.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; Salk Institute	Riek, R (corresponding author), ETH, Phys Chem Lab, CH-8092 Zurich, Switzerland.	roland.riek@phys.chem.ethz.ch			National Institute of Diabetes and Digestive and Kidney Diseases [DK026741-33]; Clayton Medical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Clayton Medical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by award DK026741-33 from the National Institute of Diabetes and Digestive and Kidney Diseases and by the Clayton Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alken M, 2005, BIOCHEM J, V390, P455, DOI 10.1042/BJ20050113; Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; BERTIN B, 1992, J BIOL CHEM, V267, P8200; Bouvier M, 2013, NAT STRUCT MOL BIOL, V20, P539, DOI 10.1038/nsmb.2584; BOYD D, 1993, J BACTERIOL, V175, P553, DOI 10.1128/JB.175.2.553-556.1993; CHAPOT MP, 1990, EUR J BIOCHEM, V187, P137, DOI 10.1111/j.1432-1033.1990.tb15287.x; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; Couvineau A, 2004, REGUL PEPTIDES, V123, P181, DOI 10.1016/j.regpep.2004.06.025; Furukawa H, 2000, J BIOCHEM-TOKYO, V127, P151, DOI 10.1093/oxfordjournals.jbchem.a022577; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2010, J BIOL CHEM, V285, P38580, DOI 10.1074/jbc.M110.121897; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Grammatopoulos DK, 2012, BRIT J PHARMACOL, V166, P85, DOI 10.1111/j.1476-5381.2011.01631.x; GRISSHAMMER R, 1993, BIOCHEM J, V295, P571, DOI 10.1042/bj2950571; GRISSHAMMER R, 1994, RECEPTOR CHANNEL, V2, P295; Hampe W, 2000, J BIOTECHNOL, V77, P219, DOI 10.1016/S0168-1656(99)00216-3; Harmar AJ, 2001, GENOME BIOL, V2; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Hofmann BA, 2001, PROTEIN SCI, V10, P2050, DOI 10.1110/ps.12101; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hulme Edward C., 1998, Biochemical Society Transactions, V26, pS361; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Klammt C, 2007, J STRUCT BIOL, V158, P482, DOI 10.1016/j.jsb.2007.01.006; Klammt C, 2011, PROTEIN SCI, V20, P1030, DOI 10.1002/pro.636; Kochl R, 2002, J BIOL CHEM, V277, P16131, DOI 10.1074/jbc.M111674200; Krepkiy D, 2006, PROTEIN EXPRES PURIF, V49, P60, DOI 10.1016/j.pep.2006.03.002; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LACATENA RM, 1994, P NATL ACAD SCI USA, V91, P10521, DOI 10.1073/pnas.91.22.10521; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Liaw CW, 1997, MOL ENDOCRINOL, V11, P2048, DOI 10.1210/me.11.13.2048; Link AJ, 2008, PROTEIN SCI, V17, P1857, DOI 10.1110/ps.035980.108; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Luttrell LM, 2008, MOL BIOTECHNOL, V39, P239, DOI 10.1007/s12033-008-9031-1; Mancia F, 2007, MOL BIOSYST, V3, P723, DOI 10.1039/B713558K; MARULLO S, 1988, P NATL ACAD SCI USA, V85, P7551, DOI 10.1073/pnas.85.20.7551; McCusker EC, 2007, BIOTECHNOL PROGR, V23, P540, DOI 10.1021/bp060349b; Michalke K, 2010, ANAL BIOCHEM, V401, P74, DOI 10.1016/j.ab.2010.02.017; Michalke K, 2009, ANAL BIOCHEM, V386, P147, DOI 10.1016/j.ab.2008.12.016; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; Perrin MH, 2003, J BIOL CHEM, V278, P15595, DOI 10.1074/jbc.M210476200; Perrin MH, 2001, J BIOL CHEM, V276, P31528, DOI 10.1074/jbc.M101838200; Perrin MH, 1999, J PHARMACOL EXP THER, V288, P729; Petrovskaya LE, 2010, BIOCHEMISTRY-MOSCOW+, V75, P881, DOI 10.1134/S0006297910070102; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Schmidt P, 2009, BIOTECHNOL PROGR, V25, P1732, DOI 10.1002/btpr.266; Schulein R, 2012, EUR J CELL BIOL, V91, P294, DOI 10.1016/j.ejcb.2011.02.006; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; WALLIN E, 1995, PROTEIN ENG, V8, P693, DOI 10.1093/protein/8.7.693; Weiss HM, 2002, EUR J BIOCHEM, V269, P82, DOI 10.1046/j.0014-2956.2002.02618.x; Yeliseev AA, 2005, PROTEIN SCI, V14, P2638, DOI 10.1110/ps.051550305; Zhou Y, 2012, AMINO ACIDS, V43, P1147, DOI 10.1007/s00726-011-1170-1; Zmijewski MA, 2010, ACTA BIOCHIM POL, V57, P1	67	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e84013	10.1371/journal.pone.0084013	http://dx.doi.org/10.1371/journal.pone.0084013			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465390	gold, Green Published, Green Submitted			2022-12-25	WOS:000330237000010
J	Huang, YJ; Qi, AM; King, GJ; Fitt, BDL				Huang, Yong-Ju; Qi, Aiming; King, Graham J.; Fitt, Bruce D. L.			Assessing Quantitative Resistance against Leptosphaeria maculans (Phoma Stem Canker) in Brassica napus (Oilseed Rape) in Young Plants	PLOS ONE			English	Article							POLYGENIC RESISTANCE; MAJOR GENE; IN-FIELD; A-GROUP; DISEASE; POPULATIONS; AVIRULENCE; BLACKLEG; FRANCE; WHEAT	Quantitative resistance against Leptosphaeria maculans in Brassica napus is difficult to assess in young plants due to the long period of symptomless growth of the pathogen from the appearance of leaf lesions to the appearance of canker symptoms on the stem. By using doubled haploid (DH) lines A30 (susceptible) and C119 (with quantitative resistance), quantitative resistance against L. maculans was assessed in young plants in controlled environments at two stages: stage 1, growth of the pathogen along leaf veins/petioles towards the stem by leaf lamina inoculation; stage 2, growth in stem tissues to produce stem canker symptoms by leaf petiole inoculation. Two types of inoculum (ascospores; conidia) and three assessment methods (extent of visible necrosis; symptomless pathogen growth visualised using the GFP reporter gene; amount of pathogen DNA quantified by PCR) were used. In stage 1 assessments, significant differences were observed between lines A30 and C119 in area of leaf lesions, distance grown along veins/petioles assessed by visible necrosis or by viewing GFP and amount of L. maculans DNA in leaf petioles. In stage 2 assessments, significant differences were observed between lines A30 and C119 in severity of stem canker and amount of L. maculans DNA in stem tissues. GFP-labelled L. maculans spread more quickly from the stem cortex to the stem pith in A30 than in C119. Stem canker symptoms were produced more rapidly by using ascospore inoculum than by using conidial inoculum. These results suggest that quantitative resistance against L. maculans in B. napus can be assessed in young plants in controlled conditions. Development of methods to phenotype quantitative resistance against plant pathogens in young plants in controlled environments will help identification of stable quantitative resistance for control of crop diseases.	[Huang, Yong-Ju; Qi, Aiming; Fitt, Bruce D. L.] Univ Hertfordshire, Sch Life & Med Sci, Hatfield AL10 9AB, Herts, England; [Huang, Yong-Ju; Qi, Aiming; King, Graham J.; Fitt, Bruce D. L.] Rothamsted Res, Dept Plant Pathol & Microbiol, Harpenden, Herts, England; [King, Graham J.] So Cross Univ, Southern Cross Plant Sci, Lismore, NSW 2480, Australia	University of Hertfordshire; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Southern Cross University	Huang, YJ (corresponding author), Univ Hertfordshire, Sch Life & Med Sci, Hatfield AL10 9AB, Herts, England.	y.huang8@herts.ac.uk	King, Graham J/AAW-3368-2020; Qi, Aiming/AAH-7872-2021	King, Graham J/0000-0002-5975-6051; Qi, Aiming/0000-0002-0784-9520; Bruce D. L., Fitt/0000-0003-3981-6456	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E001610/1, BB/I017585/1]; Department for Environment, Food and Rural Affairs (Defra); HGCA; British Council; DuPont; Perry Foundation; Felix Thornley Cobbold Agricultural Trust; Chadacre Agricultural Trust; Biotechnology and Biological Sciences Research Council [BB/I017585/1, BB/D015200/1, BBS/E/C/00004693, BB/E001610/1, BB/I017585/2] Funding Source: researchfish; BBSRC [BB/D015200/1, BB/I017585/1, BB/I017585/2, BB/E001610/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); HGCA; British Council(The British Council in India); DuPont; Perry Foundation; Felix Thornley Cobbold Agricultural Trust; Chadacre Agricultural Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC, BB/E001610/1, and BB/I017585/1), the Department for Environment, Food and Rural Affairs (Defra), HGCA, the British Council, DuPont, the Perry Foundation, the Felix Thornley Cobbold Agricultural Trust, and the Chadacre Agricultural Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balesdent MH, 2001, PHYTOPATHOLOGY, V91, P70, DOI 10.1094/PHYTO.2001.91.1.70; Beddington J, 2010, PHILOS T R SOC B, V365, P61, DOI 10.1098/rstb.2009.0201; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Brun H, 2011, 13 INT RAP C CROP PR, P507; Brun H, 2010, NEW PHYTOL, V185, P285, DOI 10.1111/j.1469-8137.2009.03049.x; Chartrain L, 2004, PHYTOPATHOLOGY, V94, P497, DOI 10.1094/PHYTO.2004.94.5.497; Czembor PC, 2003, GENOME, V46, P546, DOI 10.1139/G03-036; da Silva MR, 2012, EUR J PLANT PATHOL, V134, P315, DOI 10.1007/s10658-012-9991-7; Delourme R, 2008, ANN APPL BIOL, V153, P259, DOI 10.1111/j.1744-7348.2008.00258.x; Delourme R, 2006, EUR J PLANT PATHOL, V114, P41, DOI 10.1007/s10658-005-2108-9; Delourme R, 2011, 13 INT RAP C CROP PR, P505; Fitt BDL, 2011, PLANT PATHOL, V60, P44, DOI 10.1111/j.1365-3059.2010.02413.x; Fitt BDL, 2006, EUR J PLANT PATHOL, V114, P3, DOI 10.1007/s10658-005-2233-5; Hammond-Kosack KE, 2007, RESISTANCE GENES R G, DOI [10.1002/9780470015902.a0020119, DOI 10.1002/9780470015902.A0020119]; Hayward A, 2012, PLANT BIOLOGY, V14, P1, DOI 10.1111/j.1438-8677.2011.00481.x; Huang YJ, 2009, PLANT PATHOL, V58, P314, DOI 10.1111/j.1365-3059.2008.01957.x; Huang YJ, 2006, NEW PHYTOL, V170, P129, DOI 10.1111/j.1469-8137.2006.01651.x; Huang YJ, 2005, EUR J PLANT PATHOL, V111, P263, DOI 10.1007/s10658-004-4421-0; Huang YJ, 2003, PLANT PATHOL, V52, P245, DOI 10.1046/j.1365-3059.2003.00813.x; Jestin C, 2011, MOL BREEDING, V27, P271, DOI 10.1007/s11032-010-9429-x; Larkan NJ, 2013, NEW PHYTOL, V197, P595, DOI 10.1111/nph.12043; Lindhout P, 2002, EUPHYTICA, V124, P217, DOI 10.1023/A:1015686601404; Liu SY, 2006, PLANT PATHOL, V55, P401, DOI 10.1111/j.1365-3059.2006.01354.x; Marcroft SJ, 2012, PLANT PATHOL, V61, P934, DOI 10.1111/j.1365-3059.2011.02580.x; Marcroft SJ, 2012, CROP PASTURE SCI, V63, P338, DOI 10.1071/CP11341; McDonald Bruce, 2010, New Phytol, V185, P3, DOI 10.1111/j.1469-8137.2009.03108.x; Oliver RP, 2008, PLANT PATHOL, V57, P527, DOI 10.1111/j.1365-3059.2007.01787.x; Payne RW, 2011, GUIDE GENSTAT RELE 2; Pilet ML, 1998, THEOR APPL GENET, V96, P23, DOI 10.1007/s001220050704; Powers SJ, 2010, ANN APPL BIOL, V157, P55, DOI 10.1111/j.1744-7348.2010.00409.x; Raman R, 2012, THEOR APPL GENET, V125, P405, DOI 10.1007/s00122-012-1842-6; Rimmer SR, 2006, CAN J PLANT PATHOL, V28, pS288, DOI 10.1080/07060660609507386; Rouxel T, 2003, EUR J PLANT PATHOL, V109, P871, DOI 10.1023/A:1026189225466; Rouxel T, 2013, NEW PHYTOL, V197, P356, DOI 10.1111/nph.12099; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Soanes DM, 2008, TRENDS MICROBIOL, V16, P507, DOI 10.1016/j.tim.2008.08.002; Sprague SJ, 2006, EUR J PLANT PATHOL, V114, P33, DOI 10.1007/s10658-005-3683-5; Sprague SJ, 2007, NEW PHYTOL, V176, P211, DOI 10.1111/j.1469-8137.2007.02156.x; Stachowiak A, 2006, EUR J PLANT PATHOL, V114, P67, DOI 10.1007/s10658-005-2931-z; Stonard JF, 2010, EUR J PLANT PATHOL, V126, P97, DOI 10.1007/s10658-009-9525-0; Talukder ZI, 2004, NEW PHYTOL, V162, P197, DOI 10.1111/j.1469-8137.2004.01010.x; Toscano-Underwood C, 2001, PLANT PATHOL, V50, P28, DOI 10.1046/j.1365-3059.2001.00526.x; Travadon R, 2007, PLANT PATHOL, V56, P595, DOI 10.1111/j.1365-3059.2007.01572.x; Travadon R, 2009, PLANT PATHOL, V58, P461, DOI 10.1111/j.1365-3059.2008.02014.x; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Zhou Y, 1999, EUR J PLANT PATHOL, V105, P715, DOI 10.1023/A:1008761219493	47	35	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84924	10.1371/journal.pone.0084924	http://dx.doi.org/10.1371/journal.pone.0084924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454767	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100043
J	Lin, CJ; Tu, PC; Chern, CM; Hsiao, FJ; Chang, FC; Cheng, HL; Tang, CW; Lee, YC; Chen, WT; Lee, IH				Lin, Chun-Jen; Tu, Pei-Chi; Chern, Chang-Ming; Hsiao, Fu-Jung; Chang, Feng-Chi; Cheng, Hsien-Lin; Tang, Chih-Wei; Lee, Yi-Chung; Chen, Wei-Ta; Lee, I-Hui			Connectivity Features for Identifying Cognitive Impairment in Presymptomatic Carotid Stenosis	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; HUMAN BRAIN; STROKE; SCALE; RISK; PERFORMANCE; PREDICTION; DIZZINESS; NETWORKS	Severe asymptomatic stenosis of the internal carotid artery (ICA) leads to increased incidence of mild cognitive impairment (MCI) likely through silent embolic infarcts and/or chronic hypoperfusion, but the brain dysfunction is poorly understood and difficult to diagnose. Thirty cognitively intact subjects with asymptomatic, severe (>= 70%), unilateral stenosis of the ICA were compared with 30 healthy controls, matched for age, sex, cardiovascular risk factors and education level, on a battery of neuropsychiatric tests, voxel-based morphometry of magnetic resonance imaging (MRI), diffusion tensor imaging and brain-wise, seed-based analysis of resting-state functional MRI. Multivariate regression models and multivariate pattern classification (support vector machines) were computed to assess the relationship between connectivity measures and neurocognitive performance. The patients had worse dizziness scores and poorer verbal memory, executive function and complex visuo-spatial performance than controls. Twelve out of the 30 patients (40%) were considered to have MCI. Nonetheless, the leukoaraiosis Sheltens scores, hippocampal and brain volumes were not different between groups. Their whole-brain mean fractional anisotropy (FA) was significantly reduced and regional functional connectivity (Fc) was significantly impaired in the dorsal attention network (DAN), frontoparietal network, sensorimotor network and default mode network. In particular, the Fc strength at the insula of the DAN and the mean FA were linearly related with attention performance and dizziness severity, respectively. The multivariate pattern classification gave over 90% predictive accuracy of individuals with MCI or severe dizziness. Cognitive decline in stroke-free individuals with severe carotid stenosis may arise from nonselective widespread disconnections of long-range, predominantly interhemispheric non-hippocampal pathways. Connectivity measures may serve as both predictors for cases at risk and therapeutic targets for mitigating vascular cognitive impairment.	[Lin, Chun-Jen] Taipei Vet Gen Hosp, Hsinchu Branch, Dept Internal Med, Hsinchu, Taiwan; [Lin, Chun-Jen; Tu, Pei-Chi; Chern, Chang-Ming; Hsiao, Fu-Jung; Tang, Chih-Wei; Chen, Wei-Ta; Lee, I-Hui] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Tu, Pei-Chi] Taipei Vet Gen Hosp, Dept Med Educ & Res, Taipei, Taiwan; [Chern, Chang-Ming; Lee, Yi-Chung; Chen, Wei-Ta; Lee, I-Hui] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Hsiao, Fu-Jung] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Chang, Feng-Chi] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Cheng, Hsien-Lin] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Tang, Chih-Wei] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Lee, Yi-Chung; Chen, Wei-Ta] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei City Hospital; Taipei Veterans General Hospital; Taipei Medical University; Taipei Medical University Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University	Lee, IH (corresponding author), Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan.	ihlee@vghtpe.gov.tw	Lee, Yi-Chung/GZK-7162-2022; Lee, Yi-Chung/H-8813-2019	Lee, Yi-Chung/0000-0003-0102-164X	National Science Council [NSC-100-2314-B-075-021, NSC-101-2314-B-075-035]; National Yang-Ming University [101AC-B16, 102AC-B17]; Taipei Veterans General Hospital in Taiwan [V101C-062, V101E1-008, V102C-080, V102E1-0036]	National Science Council(Ministry of Science and Technology, Taiwan); National Yang-Ming University; Taipei Veterans General Hospital in Taiwan	This work was supported by The National Science Council (NSC-100-2314-B-075-021, NSC-101-2314-B-075-035), the National Yang-Ming University (101AC-B16, 102AC-B17), and the Taipei Veterans General Hospital (V101C-062, V101E1-008, V102C-080, V102E1-0036) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Calhoun VD, 2001, NEUROIMAGE, V14, P1080, DOI 10.1006/nimg.2001.0921; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Chen YH, 2012, INT J CARDIOL, V157, P104, DOI 10.1016/j.ijcard.2011.10.086; Cheng HL, 2012, STROKE, V43, P2567, DOI 10.1161/STROKEAHA.111.645614; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Derdeyn CP, 2002, BRAIN, V125, P595, DOI 10.1093/brain/awf047; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; Inzitari D, 2000, NEW ENGL J MED, V342, P1693, DOI 10.1056/NEJM200006083422302; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Johnston SC, 2004, ANN INTERN MED, V140, P237, DOI 10.7326/0003-4819-140-4-200402170-00005; Joy S, 2003, ASSESSMENT, V10, P56, DOI 10.1177/0095399702250335; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LEHERICY S, 1994, AM J NEURORADIOL, V15, P929; Liu CY, 1998, PSYCHOL REP, V82, P211, DOI 10.2466/PR0.82.1.211-214; Liu MG, 2013, J NEUROPHYSIOLOGY; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Markus HS, 2010, LANCET NEUROL, V9, P663, DOI 10.1016/S1474-4422(10)70120-4; Marshall RS, 2011, STROKE, V42, P221, DOI 10.1161/STROKEAHA.110.595645; Mendiz OA, 2012, J NEUROSURG, V116, P179, DOI 10.3171/2011.9.JNS11532; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Popovic IM, 2011, COGN BEHAV NEUROL, V24, P145, DOI 10.1097/WNN.0b013e3182313020; Post RE, 2010, AM FAM PHYSICIAN, V82, P361; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Shin BM, 2011, J NEUROL SCI, V305, P121, DOI 10.1016/j.jns.2011.02.031; Silvestrini M, 2009, NEUROLOGY, V72, P1062, DOI 10.1212/01.wnl.0000345015.35520.52; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sun YW, 2011, BEHAV BRAIN RES, V223, P388, DOI 10.1016/j.bbr.2011.05.006; Sztriha LK, 2009, J NEUROL SCI, V283, P36, DOI 10.1016/j.jns.2009.02.307; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tu PC, 2012, NEUROIMAGE, V59, P238, DOI 10.1016/j.neuroimage.2011.07.086; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang PN, 2006, NEUROBIOL AGING, V27, P1797, DOI 10.1016/j.neurobiolaging.2005.10.002; Wang PN, 2011, J NEUROL NEUROSUR PS, V82, P165, DOI 10.1136/jnnp.2010.209122; Yoshizaki K, 2008, EXP NEUROL, V210, P585, DOI 10.1016/j.expneurol.2007.12.005	42	13	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85441	10.1371/journal.pone.0085441	http://dx.doi.org/10.1371/journal.pone.0085441			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454868	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100086
J	Sipka, A; Klaessig, S; Duhamel, GE; Swinkels, J; Rainard, P; Schukken, Y				Sipka, Anja; Klaessig, Suzanne; Duhamel, Gerald E.; Swinkels, Jantijn; Rainard, Pascal; Schukken, Ynte			Impact of Intramammary Treatment on Gene Expression Profiles in Bovine Escherichia coli Mastitis	PLOS ONE			English	Article							ENDOTOXIN-INDUCED MASTITIS; MAMMARY-GLAND; EPITHELIAL-CELLS; BINDING-PROTEIN; INNATE IMMUNITY; LACTATING COWS; IN-VITRO; EFFICACY; NEUTROPHILS; INFECTION	Clinical mastitis caused by E. coli accounts for significant production losses and animal welfare concerns on dairy farms worldwide. The benefits of therapeutic intervention in mild to moderate cases are incompletely understood. We investigated the effect of intramammary treatment with cefapirin alone or in combination with prednisolone on gene expression profiles in experimentally-induced E. coli mastitis in six mid-lactating Holstein Friesian cows. Cows were challenged with E. coli in 3 quarters and received 4 doses of 300 mg cefapirin in one quarter and 4 doses of 300 mg cefapirin together with 20 mg prednisolone in another quarter. At 24 h (n = 3) or 48 h (n = 3) post-challenge, tissue samples from control and treated quarters were collected for microarray analysis. Gene expression analysis of challenged, un-treated quarters revealed an up-regulation of transcripts associated with immune response functions compared to un-challenged quarters. Both treatments resulted in down-regulation of these transcripts compared to challenged, un-treated quarters most prominently for genes representing Chemokine and TLR-signaling pathways. Gene expression of Lipopolysaccharide Binding Protein (LBP), CCL2 and CXCL2 were only significantly down-regulated in cefapirin-prednisolone-treated quarters compared to un-treated controls. Down-regulation of chemokines was further confirmed on the basis of protein levels in milk whey for CXCL1, CXCL2 and CXCL8 in both treatments with a greater decrease in cefapirin-prednisolone-treated quarters. The data reveal a significant effect of treatment on cell recruitment with a more pronounced effect in cefapirin-prednisolone- treated quarters. Provided a rapid bacteriological clearance, combination therapy may prevent neutrophil-induced tissue damage and promote recovery of the gland.	[Sipka, Anja; Klaessig, Suzanne; Schukken, Ynte] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Duhamel, Gerald E.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Swinkels, Jantijn] GD Anim Hlth Ctr, Deventer, Netherlands; [Rainard, Pascal] INRA, UMR1282, F-37380 Nouzilly, France; [Rainard, Pascal] Univ Tours, ISP UMR1282, Tours, France	Cornell University; Cornell University; INRAE; Universite de Tours	Sipka, A (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	ass233@cornell.edu	Schukken, Ynte H/C-3405-2008; Schukken, Ynte/ABD-3352-2021	Schukken, Ynte H/0000-0002-8250-4194; Schukken, Ynte/0000-0002-8250-4194; Rainard, Pascal/0000-0002-5477-2626; Swinkels, Jantijn/0000-0001-7267-8097	Merck Animal Health	Merck Animal Health(Merck & Company)	The study was partially funded by Merck Animal Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bannerman DD, 2004, CLIN DIAGN LAB IMMUN, V11, P463, DOI 10.1128/CDLI.11.3.463-472.2004; Bradley AJ, 2001, J CLIN MICROBIOL, V39, P1845, DOI 10.1128/JCM.39.5.1845-1849.2001; Buitenhuis B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-130; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; Cannizzo FT, 2013, RES VET SCI, V95, P540, DOI 10.1016/j.rvsc.2013.03.025; CAPUCO AV, 1986, AM J VET RES, V47, P663; Ci XX, 2008, INFLAMMATION, V31, P422, DOI 10.1007/s10753-008-9094-y; Constable P. D., 2009, Guide to antimicrobial use in animals, P143, DOI 10.1002/9781444302639.ch9; Dogan B, 2006, VET MICROBIOL, V116, P270, DOI 10.1016/j.vetmic.2006.04.023; Dogan B, 2012, VET MICROBIOL, V159, P163, DOI 10.1016/j.vetmic.2012.03.033; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gunther J, 2009, VET RES, V40, DOI 10.1051/vetres/2009014; Hewson J, 2011, AM J VET RES, V72, P1613, DOI 10.2460/ajvr.72.12.1613; Hirvonen J, 1999, ACTA VET SCAND, V40, P35; Jia T, 2009, J IMMUNOL, V183, P1271, DOI 10.4049/jimmunol.0900460; Kadegowda AKG, 2009, J DAIRY SCI, V92, P2007, DOI 10.3168/jds.2008-1655; Ledbetter TK, 2001, AM J VET RES, V62, P286, DOI 10.2460/ajvr.2001.62.286; LOHUIS JACM, 1988, J DAIRY SCI, V71, P2782, DOI 10.3168/jds.S0022-0302(88)79872-0; LOHUIS JACM, 1989, J DAIRY SCI, V72, P241, DOI 10.3168/jds.S0022-0302(89)79102-5; Malazdrewich C, 2004, MICROB PATHOGENESIS, V36, P227, DOI 10.1016/j.micpath.2003.12.002; Mercer PF, 2013, AM J RESP CELL MOL B; Mitterhuemer S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-138; Murphy PM, 2000, PHARMACOL REV, V52, P145; Paape M, 2002, J MAMMARY GLAND BIOL, V7, P109, DOI 10.1023/A:1020343717817; Petzl W, 2008, VET RES, V39, DOI 10.1051/vetres:2007057; Poutrel B, 2008, J DAIRY RES, V75, P310, DOI 10.1017/S0022029908003348; PYORALA S, 1994, J DAIRY SCI, V77, P453, DOI 10.3168/jds.S0022-0302(94)76973-3; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; Rainard P, 2010, CLIN VACCINE IMMUNOL, V17, P848, DOI 10.1128/CVI.00447-09; Rainard P, 2008, MOL IMMUNOL, V45, P4020, DOI 10.1016/j.molimm.2008.06.010; Schukken YH, 2011, J DAIRY SCI, V94, P6203, DOI 10.3168/jds.2011-4290; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Seegers H, 2003, VET RES, V34, P475, DOI 10.1051/vetres:2003027; SHAPIRA L, 1995, INFLAMMATION, V19, P289, DOI 10.1007/BF01534388; Shpigel NY, 1997, J DAIRY SCI, V80, P318, DOI 10.3168/jds.S0022-0302(97)75941-1; Sipka A., 2013, J DAIRY SCI; Smith GW, 2005, VET CLIN N AM-FOOD A, V21, P595, DOI 10.1016/j.cvfa.2005.07.005; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Suojala L, 2013, J VET PHARMACOL THER, V36, P521, DOI 10.1111/jvp.12057; Suojala L, 2010, J DAIRY SCI, V93, P1960, DOI 10.3168/jds.2009-2462; Troelstra A, 1997, J LEUKOCYTE BIOL, V61, P173, DOI 10.1002/jlb.61.2.173; Wagner SA, 2004, AM J VET RES, V65, P64, DOI 10.2460/ajvr.2004.65.64; Wenz JR, 2006, J DAIRY SCI, V89, P3408, DOI 10.3168/jds.S0022-0302(06)72377-3; Ziegeler S, 2006, ACTA ANAESTH SCAND, V50, P1103, DOI 10.1111/j.1399-6576.2006.01112.x	45	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85579	10.1371/journal.pone.0085579	http://dx.doi.org/10.1371/journal.pone.0085579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454893	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800050
J	Gnjidic, D; Hilmer, SN; Hartikainen, S; Tolppanen, AM; Taipale, H; Koponen, M; Bell, JS				Gnjidic, Danijela; Hilmer, Sarah N.; Hartikainen, Sirpa; Tolppanen, Anna-Maija; Taipale, Heidi; Koponen, Marjaana; Bell, J. Simon			Impact of High Risk Drug Use on Hospitalization and Mortality in Older People with and without Alzheimer's Disease: A National Population Cohort Study	PLOS ONE			English	Article							BURDEN INDEX; ANTICHOLINERGIC DRUGS; FUNCTIONAL DECLINE; PHYSICAL FUNCTION; MEDICATION USE; CO-MORBIDITY; REGISTER; POLYPHARMACY; RESIDENTS; DEMENTIA	Background: Evidence is lacking about outcomes associated with the cumulative use of anticholinergic and sedative drugs in people with Alzheimer's disease (AD). This retrospective cohort study investigated the relationship between cumulative exposure to anticholinergic and sedative drugs and hospitalization and mortality in people with and without AD in Finland. Methods: Community-dwelling people aged 65 years and over, with AD on December 31st 2005 (n = 16,603) and individually matched (n = 16,603) comparison persons (age, sex, region of residence) were identified by the Social Insurance Institution of Finland. Drug utilization data were extracted from the Finnish National Prescription Register. Exposure to anticholinergic and sedative drugs was defined using the Drug Burden Index (DBI). Hospitalization and mortality data were extracted from national registers. Cox and zero-inflated negative binomial analyses were used to investigate the relationship between DBI and hospitalization and mortality over a one-year follow-up. Results: In total, 5.8% of people with AD and 3.7% without AD died during 2006. For every unit increase in DBI, the adjusted hazard ratio for mortality was 1.21 (95% confidence intervals [CI]: 1.09-1.33) among people with AD, and 1.37 (95% CI: 1.20-1.56) among people without AD. Overall, 44.3% of people with AD and 33.4% without AD were hospitalized. When using no DBI exposure as the reference group, the adjusted incidence rate ratio for length of hospital stay among high DBI group (>= 1) in people with AD was 1.15 (95% CI: 1.05-1.26) and 1.63 (95% CI: 1.41-1.88) in people without AD. Conclusion: There is a dose-response relationship between cumulative anticholinergic and sedative drug use and hospitalization and mortality in people with and without AD.	[Gnjidic, Danijela] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Gnjidic, Danijela; Hilmer, Sarah N.] Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW, Australia; [Gnjidic, Danijela; Hilmer, Sarah N.] Royal N Shore Hosp, Dept Aged Care, Sydney, NSW, Australia; [Gnjidic, Danijela; Hilmer, Sarah N.] Royal N Shore Hosp, Kolling Inst Med Res, Sydney, NSW, Australia; [Gnjidic, Danijela; Hilmer, Sarah N.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Gnjidic, Danijela] Ctr Educ & Res Ageing, Sydney, NSW, Australia; [Gnjidic, Danijela] Concord RG Hosp, Sydney, NSW, Australia; [Hartikainen, Sirpa; Taipale, Heidi; Koponen, Marjaana; Bell, J. Simon] Univ Eastern Finland, Sch Pharm, Kuopio Res Ctr Geriatr Care, Kuopio, Finland; [Tolppanen, Anna-Maija] Univ Eastern Finland, Dept Neurol, Kuopio, Finland; [Bell, J. Simon] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst, Adelaide, SA 5001, Australia; [Bell, J. Simon] Monash Univ, Fac Pharm & Pharmaceut Sci, Ctr Med Use & Safety, Melbourne, Vic 3004, Australia	University of Sydney; Royal North Shore Hospital; University of Sydney; Royal North Shore Hospital; University of Sydney; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney; Concord Repatriation General Hospital; University of Eastern Finland; University of Eastern Finland; University of South Australia; Monash University	Gnjidic, D (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	danijela.gnjidic@sydney.edu.au	Hilmer, Sarah N/AAW-8554-2020	Hilmer, Sarah/0000-0002-5970-1501	Alzheimer's Australia Dementia Research Foundation; Australian National Health and Medical Research Council (NHMRC); University of Eastern Finland, Faculty of Health Sciences	Alzheimer's Australia Dementia Research Foundation; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Eastern Finland, Faculty of Health Sciences	This study was supported by the Alzheimer's Australia Dementia Research Foundation. The sponsor had no role in the study design, data collection, data analysis, data interpretation, writing of this report or the decision to submit for publication. Danijela Gnjidic is supported by the Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship. Anna-Maija Tolppanen, Heidi Taipale, Marjaana Koponen and Sirpa Hartikainen acknowledge strategic funding received from the University of Eastern Finland, Faculty of Health Sciences.	Andersen F, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-58; Boudreau RM, 2009, PHARMACOEPIDEM DR S, V18, P916, DOI 10.1002/pds.1797; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gnjidic D, 2012, CLIN PHARMACOL THER, V91, P521, DOI 10.1038/clpt.2011.258; Gnjidic D, 2012, FUNDAM CLIN PHARM; Gnjidic D, 2012, ANN MED, V44, P458, DOI 10.3109/07853890.2011.573499; Gnjidic D, 2012, NEW ENGL J MED, V366, P859, DOI 10.1056/NEJMc1114768; Gnjidic D, 2012, J CLIN PHARMACOL, V52, P258, DOI 10.1177/0091270010395591; Gray SL, 2006, J AM GERIATR SOC, V54, P224, DOI 10.1111/j.1532-5415.2005.00571.x; Hilmer SN, 2009, CLIN PHARMACOL THER, V85, P86, DOI 10.1038/clpt.2008.224; Hilmer SN, 2007, ARCH INTERN MED, V167, P781, DOI 10.1001/archinte.167.8.781; Hilmer SN, 2013, MED J AUSTRALIA, V198, P77, DOI 10.5694/mja12.11593; Hilmer SN, 2012, J GERONTOL A-BIOL, V67, P181, DOI 10.1093/gerona/glr066; Hilmer SN, 2009, AM J MED, V122, P1142, DOI 10.1016/j.amjmed.2009.02.021; Johnell K, 2008, DRUG AGING, V25, P871, DOI 10.2165/00002512-200825100-00006; JOST BC, 1995, J AM GERIATR SOC, V43, P1248, DOI 10.1111/j.1532-5415.1995.tb07401.x; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Kumpula EK, 2011, J CLIN PHARMACOL, V51, P256, DOI 10.1177/0091270010368410; Laitinen ML, 2011, INT PSYCHOGERIATR, V23, P1623, DOI 10.1017/S1041610211001621; Landi F, 2007, CLIN PHARMACOL THER, V81, P235, DOI 10.1038/sj.clpt.6100035; Lau DT, 2011, AM J ALZHEIMERS DIS, V26, P606, DOI 10.1177/1533317511432734; Lau DT, 2010, ALZ DIS ASSOC DIS, V24, P56, DOI 10.1097/WAD.0b013e31819d6ec9; Lieberman Joseph A 3rd, 2004, Prim Care Companion J Clin Psychiatry, V6, P20; Lonnroos E, 2013, J ALZHEIMERS DIS, V33, P157, DOI 10.3233/JAD-2012-120808; Lonnroos E, 2012, DRUG AGING, V29, P395, DOI 10.2165/11631420-000000000-00000; Lowry E, 2012, J CLIN PHARMACOL, V52, P1584, DOI 10.1177/0091270011421489; Lu CJ, 2003, AM J GERIAT PSYCHIAT, V11, P458, DOI 10.1176/appi.ajgp.11.4.458; Mangoni AA, 2013, AM J GERIAT PSYCHIAT, V21, P785, DOI 10.1016/j.jagp.2013.01.012; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4; Onder G, 2013, J GERONTOL A; Panula J, 2009, DRUG AGING, V26, P963, DOI 10.2165/11317660-000000000-00000; Runciman WB, 2003, INT J QUAL HEALTH C, V15, pI49, DOI 10.1093/intqhc/mzg085; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Taipale HT, 2012, J CLIN PSYCHOPHARM, V32, P218, DOI 10.1097/JCP.0b013e3182485802; Tjia J, 2010, J AM GERIATR SOC, V58, P880, DOI 10.1111/j.1532-5415.2010.02819.x; Wilson NM, 2012, DRUG AGING, V29, P157, DOI 10.2165/11598570-000000000-00000; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501; Zilkens RR, 2009, NEUROEPIDEMIOLOGY, V32, P61, DOI 10.1159/000170908	42	70	71	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e83224	10.1371/journal.pone.0083224	http://dx.doi.org/10.1371/journal.pone.0083224			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	292SL	24454696	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000329922500004
J	McNally, A; McNally, M; Galea, R; Thomas, R; Steptoe, RJ				McNally, Alice; McNally, Michael; Galea, Ryan; Thomas, Ranjeny; Steptoe, Raymond J.			Immunogenic, but Not Steady-State, Antigen Presentation Permits Regulatory T-Cells To Control CD8+T-Cell Effector Differentiation by IL-2 Modulation	PLOS ONE			English	Article							DENDRITIC CELLS; PERIPHERAL TOLERANCE; ACTIVATION; BLOCKADE; HELPER; MAINTENANCE; SUPPRESSION; LYMPHOCYTES; HOMEOSTASIS; INDUCTION	Absorption of IL-2 is one proposed mechanism of CD4+CD25+FoxP3+ regulatory T cell (Treg) suppression. Direct in vivo experimental evidence for this has recently been obtained. While modulation of IL-2 bioavailability controls CD8+ T-cell effector differentiation under strongly immunogenic conditions it is not known whether Treg modulate CD8+ T cell responses through this mechanism under steady-state conditions. Here we assess this using a mouse model in which dendritic cells (DC) are manipulated to present cognate antigen to CD8+ T cells either in the steady-state or after activation. Our observations show that Treg exert a check on expansion and effector differentiation of CD8+ T cells under strongly immunogenic conditions associated with TLR ligand activation of DC, and this is mediated by limiting IL-2 availability. In contrast, when DC remain unactivated, depletion of Treg has little apparent effect on effector differentiation or IL-2 homeostasis. We conclude that while modulation of IL-2 homeostasis is an important mechanism through which Treg control CD8+ effector differentiation under immunogenic conditions, this mechanism plays little role in modulating CD8+ T-cell differentiation under steady-state conditions.	[McNally, Alice; McNally, Michael; Galea, Ryan; Thomas, Ranjeny; Steptoe, Raymond J.] Univ Queensland, UQ Diamantina Inst, Brisbane, Qld, Australia	University of Queensland	Steptoe, RJ (corresponding author), Univ Queensland, UQ Diamantina Inst, Brisbane, Qld, Australia.	r.steptoe@uq.edu.au	Thomas, Ranjeny/B-4504-2013; Steptoe, Raymond/B-3843-2011	Thomas, Ranjeny/0000-0002-0518-8386; Steptoe, Raymond/0000-0002-6513-6406	National Health and Medical Research Council [1013066]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (project # 1013066). www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ARM, 2006, J IMMUNOL, V177, P192, DOI 10.4049/jimmunol.177.1.192; Bertin-Maghit S, 2011, DIABETES, V60, P248, DOI 10.2337/db10-0104; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Cheng LE, 2002, J IMMUNOL, V169, P4990, DOI 10.4049/jimmunol.169.9.4990; Drutman SB, 2010, J IMMUNOL, V185, P2140, DOI 10.4049/jimmunol.1000642; Ertelt JM, 2013, J LEUKOCYTE BIOL, V94, P367, DOI 10.1189/jlb.0313118; Grinberg-Bleyer Y, 2010, J CLIN INVEST, V120, P4558, DOI 10.1172/JCI42945; Hernandez J, 2001, J EXP MED, V194, P707, DOI 10.1084/jem.194.6.707; Hofer T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00268; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holz LE, 2012, J HEPATOL, V57, P830, DOI 10.1016/j.jhep.2012.05.015; Hsieh CS, 2010, J EXP MED, V207, P1819, DOI 10.1084/jem.20101606; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Kastenmuller W, 2011, J IMMUNOL, V187, P3186, DOI 10.4049/jimmunol.1101649; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kornete M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00165; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Luckashenak N, 2008, IMMUNITY, V28, P521, DOI 10.1016/j.immuni.2008.02.018; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; McNally A, 2011, P NATL ACAD SCI USA, V108, P7529, DOI 10.1073/pnas.1103782108; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Muth S, 2012, P NATL ACAD SCI USA, V109, P9059, DOI 10.1073/pnas.1110620109; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Schildknecht A, 2010, P NATL ACAD SCI USA, V107, P199, DOI 10.1073/pnas.0910620107; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shah JA, 2003, J EXP MED, V198, P281, DOI 10.1084/jem.20030645; Steptoe RJ, 2007, J IMMUNOL, V178, P2094, DOI 10.4049/jimmunol.178.4.2094; Steptoe RJ, 2004, J AUTOIMMUN, V22, P131, DOI 10.1016/j.jaut.2003.12.003; Steptoe RJ, 2002, J IMMUNOL, V168, P5032, DOI 10.4049/jimmunol.168.10.5032; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Toka FN, 2004, J VIROL, V78, P13082, DOI 10.1128/JVI.78.23.13082-13089.2004; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343	41	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85455	10.1371/journal.pone.0085455	http://dx.doi.org/10.1371/journal.pone.0085455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454872	Green Published, gold, Green Submitted			2022-12-25	WOS:000329922500054
J	Sakamoto, R; Mori, S; Miller, MI; Okada, T; Togashi, K				Sakamoto, Ryo; Mori, Susumu; Miller, Michael I.; Okada, Tomohisa; Togashi, Kaori			Detection of Time-Varying Structures by Large Deformation Diffeomorphic Metric Mapping to Aid Reading of High-Resolution CT Images of the Lung	PLOS ONE			English	Article							SMALL PULMONARY NODULES; MUTUAL INFORMATION; GROWTH-RATE; REGISTRATION; CHEST; SEGMENTATION; METASTASES; RECIST; OPTIMIZATION; SUBTRACTION	Objectives: To evaluate the accuracy of advanced non-linear registration of serial lung Computed Tomography (CT) images using Large Deformation Diffeomorphic Metric Mapping (LDDMM). Methods: Fifteen cases of lung cancer with serial lung CT images (interval: 62.2 +/- 26.9 days) were used. After affine transformation, three dimensional, non-linear volume registration was conducted using LDDMM with or without cascading elasticity control. Registration accuracy was evaluated by measuring the displacement of landmarks placed on vessel bifurcations for each lung segment. Subtraction images and Jacobian color maps, calculated from the transformation matrix derived from image warping, were generated, which were used to evaluate time-course changes of the tumors. Results: The average displacement of landmarks was 0.02 +/- 0.16 mm and 0.12 +/-.60 mm for proximal and distal landmarks after LDDMM transformation with cascading elasticity control, which was significantly smaller than 3.11 +/- 2.47 mm and 3.99 +/- 3.05 mm, respectively, after affine transformation. Emerged or vanished nodules were visualized on subtraction images, and enlarging or shrinking nodules were displayed on Jacobian maps enabled by highly accurate registration of the nodules using LDDMM. However, some residual misalignments were observed, even with non-linear transformation when substantial changes existed between the image pairs. Conclusions: LDDMM provides accurate registration of serial lung CT images, and temporal subtraction images with Jacobian maps help radiologists to find changes in pulmonary nodules.	[Sakamoto, Ryo; Okada, Tomohisa; Togashi, Kaori] Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Grad Sch Med, Kyoto, Japan; [Mori, Susumu] Kennedy Krieger Inst, Dept Radiol, Baltimore, MD 21205 USA; [Mori, Susumu] Kennedy Krieger Inst, FM Kirby Funct Imaging Ctr, Baltimore, MD USA; [Miller, Michael I.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Miller, Michael I.] Johns Hopkins Univ, Ctr Imaging Sci, Baltimore, MD USA	Kyoto University; Kennedy Krieger Institute; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University	Mori, S (corresponding author), Kennedy Krieger Inst, Dept Radiol, Baltimore, MD 21205 USA.	susumu@mri.jhu.edu	Okada, Tomohisa/C-5939-2008	Okada, Tomohisa/0000-0003-2312-5677	National Institutes of Health (NIH) [P41 EB 015909]; JSPS [25670530]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015909] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study supported by National Institutes of Health (NIH) through the Grant Number P41 EB 015909 to the co-author Susumu Mori and JSPS Grant-in-Aid for Challenging Exploratory Research Number 25670530 provided to the last author Kaori Togashi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigelman-Aubrey C, 2007, AM J ROENTGENOL, V189, P948, DOI 10.2214/AJR.07.2302; Betke M, 2003, MED IMAGE ANAL, V7, P265, DOI 10.1016/S1361-8415(03)00007-0; Blaffert T, 2004, PROC SPIE, V5370, P1701, DOI 10.1117/12.535345; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; Dougherty L, 2003, ACAD RADIOL, V10, P249, DOI 10.1016/S1076-6332(03)80098-3; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Erasmus JJ, 2003, J CLIN ONCOL, V21, P2574, DOI 10.1200/JCO.2003.01.144; Gee J, 2003, ACAD RADIOL, V10, P1147, DOI 10.1016/S1076-6332(03)00329-5; Glaunes J, 2008, INT J COMPUT VISION, V80, P317, DOI 10.1007/s11263-008-0141-9; Gorbunova V, 2012, MED IMAGE ANAL, V16, P786, DOI 10.1016/j.media.2011.11.001; Gorbunova V, 2008, LECT NOTES COMPUT SC, V5242, P863, DOI 10.1007/978-3-540-85990-1_104; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Hill DLG, 2001, PHYS MED BIOL, V46, pR1, DOI 10.1088/0031-9155/46/3/201; Hung PCK, 2007, IEEE INT ENTERP, P12, DOI 10.1109/EDOCW.2007.24; Keil S, 2008, EUR RADIOL, V18, P2456, DOI 10.1007/s00330-008-1050-6; Keil S, 2010, J VASC INTERV RADIOL, V21, P245, DOI 10.1016/j.jvir.2009.10.024; Klein S, 2007, IEEE T IMAGE PROCESS, V16, P2879, DOI 10.1109/TIP.2007.909412; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kostis WJ, 2003, IEEE T MED IMAGING, V22, P1259, DOI 10.1109/TMI.2003.817785; Lee KW, 2007, AM J ROENTGENOL, V189, P1077, DOI 10.2214/AJR.07.2057; Lester H, 1999, PATTERN RECOGN, V32, P129, DOI 10.1016/S0031-3203(98)00095-8; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Marten K, 2006, EUR RADIOL, V16, P781, DOI 10.1007/s00330-005-0036-x; Mullally W, 2004, MED PHYS, V31, P839, DOI 10.1118/1.1656593; Munden RF, 1997, RADIOLOGY, V202, P105, DOI 10.1148/radiology.202.1.8988198; Murphy K, 2008, LECT NOTES COMPUT SC, V5242, P1006, DOI 10.1007/978-3-540-85990-1_121; Murphy K, 2011, IEEE T MED IMAGING, V30, P1901, DOI 10.1109/TMI.2011.2158349; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Nakamoto Y, 2007, AM J ROENTGENOL, V188, P257, DOI 10.2214/AJR.05.0708; Patriarche J, 2004, J DIGIT IMAGING, V17, P158, DOI 10.1007/s10278-004-1010-x; Patriarche JW, 2007, J DIGIT IMAGING, V20, P203, DOI 10.1007/s10278-006-1038-1; Pock T, 2007, LECT NOTES COMPUT SC, V4792, P511; Prasad SR, 2002, RADIOLOGY, V225, P416, DOI 10.1148/radiol.2252011604; Qiu AQ, 2009, NEUROIMAGE, V45, pS51, DOI 10.1016/j.neuroimage.2008.10.039; Rey D, 2002, MED IMAGE ANAL, V6, P163, DOI 10.1016/S1361-8415(02)00056-7; Silva JS, 2011, J APPL CLIN MED PHYS, V12, P362, DOI 10.1120/jacmp.v12i2.3450; Staring M, 2007, MED PHYS, V34, P4098, DOI 10.1118/1.2776236; Staring M, 2009, INVEST RADIOL, V44, P61, DOI 10.1097/RLI.0b013e318197fcb7; Takao H, 2007, BRIT J RADIOL, V80, P85, DOI 10.1259/bjr/29418923; Takashima S, 2003, AM J ROENTGENOL, V180, P1255, DOI 10.2214/ajr.180.5.1801255; Tao C, 2009, AM J ROENTGENOL, V192, P624, DOI 10.2214/AJR.08.1307; Thevenaz P, 2000, IEEE T IMAGE PROCESS, V9, P2083, DOI 10.1109/83.887976; Uchiyama Y, 2003, MED PHYS, V30, P2440, DOI 10.1118/1.1597431; Winer-Muram HT, 2002, RADIOLOGY, V223, P798, DOI 10.1148/radiol.2233011026; Wormanns D, 2004, EUR RADIOL, V14, P86, DOI 10.1007/s00330-003-2132-0; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251; Zhang JY, 2003, NEUROIMAGE, V20, P1639, DOI 10.1016/S1053-8119(03)00410-5; Zhao BS, 2006, INVEST RADIOL, V41, P753, DOI 10.1097/01.rli.0000236907.81400.18; Zhao BS, 2006, J COMPUT ASSIST TOMO, V30, P777, DOI 10.1097/01.rct.0000228164.08968.e8	49	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85580	10.1371/journal.pone.0085580	http://dx.doi.org/10.1371/journal.pone.0085580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454894	Green Submitted, Green Published, gold			2022-12-25	WOS:000329922500056
J	Lee, JJ; Yeh, CY; Jung, CJ; Chen, CW; Du, MK; Yu, HM; Yang, CJ; Lin, HY; Sun, A; Ko, JY; Cheng, SJ; Chang, YL; Chia, JS				Lee, Jang-Jaer; Yeh, Chiou-Yueh; Jung, Chiau-Jing; Chen, Ching-Wen; Du, Mao-Kuang; Yu, Hui-Ming; Yang, Chia-Ju; Lin, Hui-yi; Sun, Andy; Ko, Jenq-Yuh; Cheng, Shih Jung; Chang, Yen-Liang; Chia, Jean-San			Skewed Distribution of IL-7 Receptor-alpha-Expressing Effector Memory CD8(+) T Cells with Distinct Functional Characteristics in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; IMMUNE CELLS; CANCER; INTERLEUKIN-7; IMMUNOTHERAPY; GENERATION; HEAD; IDENTIFICATION; PROLIFERATION; LYMPHOCYTES	CD8(+) T cells play important roles in anti-tumor immunity but distribution profile or functional characteristics of effector memory subsets during tumor progression are unclear. We found that, in oral squamous carcinoma patients, circulating CD8(+) T cell pools skewed toward effector memory subsets with the distribution frequency of CCR7(-) CD45RA(-) CD8(+) T cells and CCR7(-) CD45RA(+) CD8(+) T cells negatively correlated with each other. A significantly higher frequency of CD127(lo) CCR7(-) CD45RA(-) CD8(+) T cells or CCR7(-) CD45RA(+) CD8(+) T cells among total CD8(+) T cells was found in peripheral blood or tumor infiltrating lymphocytes, but not in regional lymph nodes. The CD127(hi) CCR7(-) CD45RA(-) CD8(+) T cells or CCR7(-) CD45RA(+) CD8(+) T cells maintained significantly higher IFN-gamma, IL-2 productivity and ex vivo proliferative capacity, while the CD127(lo) CCR7(-) CD45RA(-) CD8(+) T cells or CCR7(-) CD45RA(+) CD8(+) T cells exhibited higher granzyme B productivity and susceptibility to activation induced cell death. A higher ratio of CCR7(-) CD45RA(+) CD8(+) T cells to CCR7(-) CD45RA(-) CD8(+) T cells was associated with advanced cancer staging and poor differentiation of tumor cells. Therefore, the CD127(lo) CCR7(-) CD45RA(-) CD8(+) T cells and CCR7(-) CD45RA(+) CD8(+) T cells are functionally similar CD8(+) T cell subsets which exhibit late differentiated effector phenotypes and the shift of peripheral CD8(+) effector memory balance toward CCR7(-) CD45RA(+) CD8(+) T cells is associated with OSCC progression.	[Lee, Jang-Jaer; Sun, Andy; Cheng, Shih Jung] Natl Taiwan Univ Hosp, Dept Oral Maxillofacial Surg, Taipei, Taiwan; [Yeh, Chiou-Yueh; Jung, Chiau-Jing; Chen, Ching-Wen; Du, Mao-Kuang; Yang, Chia-Ju; Chia, Jean-San] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan; [Yu, Hui-Ming] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lin, Hui-yi; Chia, Jean-San] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan; [Ko, Jenq-Yuh] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Chang, Yen-Liang] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Chang, Yen-Liang] Cathay Gen Hosp, Dept Otolaryngol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; Cathay General Hospital	Chia, JS (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan.	chiajs@ntu.edu.tw	Chen, Ching-wen/ABH-8484-2020	Sun, Andy/0000-0002-4912-5424; LEE, JANG-JAER/0000-0003-0964-0840; CHIA, JEAN-SAN/0000-0002-5431-0712; Cheng, Shih-Jung/0000-0003-4674-4892	National Taiwan University Hospital [NTUH.97-S-833, NTUH.99-S1334, NTUH.100-S1603, NTUH.101-S1834]; National Science Council [NSC100-2314-B-002-096, NSC101-2314-B-002-101-MY2, NSC101-2321-B-002-074, NSC 101-2321-B-002-016]	National Taiwan University Hospital(National Taiwan University); National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by National Taiwan University Hospital (NTUH.97-S-833, NTUH.99-S1334, NTUH.100-S1603, and NTUH.101-S1834); National Science Council (NSC100-2314-B-002-096, NSC101-2314-B-002-101-MY2, NSC101-2321-B-002-074 and NSC 101-2321-B-002-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON MR, 1990, J EXP MED, V172, P577, DOI 10.1084/jem.172.2.577; Czystowska M, 2013, CLIN CANC RES, V19, P889; Duray A, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/701657; Fagnoni FF, 2000, BLOOD, V95, P2860, DOI 10.1182/blood.V95.9.2860.009k35_2860_2868; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; Govekar RB, 2009, PROTEOM CLIN APPL, V3, P1451, DOI 10.1002/prca.200900023; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Henson SM, 2012, CURR OPIN IMMUNOL, V24, P476, DOI 10.1016/j.coi.2012.04.001; Hoffmann TK, 2000, J IMMUNOL, V165, P5938, DOI 10.4049/jimmunol.165.10.5938; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jewett A, 2006, J DENT RES, V85, P1061, DOI 10.1177/154405910608501201; Kim HR, 2006, BLOOD, V107, P2855, DOI 10.1182/blood-2005-09-3560; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Lai MJ, 2010, HUM IMMUNOL, V71, P777, DOI 10.1016/j.humimm.2010.05.013; Laimer K, 2011, ORAL ONCOL, V47, P352, DOI 10.1016/j.oraloncology.2011.03.007; Lee JJ, 2011, HEAD NECK-J SCI SPEC, V33, P1301, DOI 10.1002/hed.21607; Maecker HT, 2001, J IMMUNOL METHODS, V255, P27, DOI 10.1016/S0022-1759(01)00416-1; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Pretscher D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-292; Ralhan R, 2011, PROTEOMICS, V11, P2363, DOI 10.1002/pmic.201000186; Reichert TE, 2002, CLIN CANCER RES, V8, P3137; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; SMYTH MJ, 1991, CELL IMMUNOL, V138, P390, DOI 10.1016/0008-8749(91)90163-6; Sun HY, 2007, J ANTIMICROB CHEMOTH, V60, P599, DOI 10.1093/jac/dkm243; Takata H, 2012, BLOOD, V119, P1390, DOI 10.1182/blood-2011-03-343251; Thompson JA, 2003, CLIN CANCER RES, V9, P3562; Timar J, 2005, J CLIN ONCOL, V23, P3421, DOI 10.1200/JCO.2005.06.005; Tomiyama H, 2002, J IMMUNOL, V168, P5538, DOI 10.4049/jimmunol.168.11.5538; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Waller ECP, 2007, BLOOD, V110, P4360, DOI 10.1182/blood-2007-07-104604; WANG A, 2012, SCI TRANSL MED, V4, P149, DOI DOI 10.1126/SCITRANSLMED.3004306; WHITESIDE TL, 1993, CANCER RES, V53, P5654	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85521	10.1371/journal.pone.0085521	http://dx.doi.org/10.1371/journal.pone.0085521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465587	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000016
J	Damaj, G; Joris, M; Chandesris, O; Hanssens, K; Soucie, E; Canioni, D; Kolb, B; Durieu, I; Gyan, E; Livideanu, C; Cheze, S; Diouf, M; Garidi, R; Georgin-Lavialle, S; Asnafi, V; Lhermitte, L; Lavigne, C; Launay, D; Arock, M; Lortholary, O; Dubreuil, P; Hermine, O				Damaj, Gandhi; Joris, Magalie; Chandesris, Olivia; Hanssens, Katia; Soucie, Erinn; Canioni, Danielle; Kolb, Brigitte; Durieu, Isabelle; Gyan, Emanuel; Livideanu, Cristina; Cheze, Stephane; Diouf, Momar; Garidi, Reda; Georgin-Lavialle, Sophie; Asnafi, Vahid; Lhermitte, Ludovic; Lavigne, Christian; Launay, David; Arock, Michel; Lortholary, Olivier; Dubreuil, Patrice; Hermine, Olivier			ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases	PLOS ONE			English	Article							POLYCYTHEMIA-VERA; LINEAGE DISEASES; KITD816V; CRITERIA	Systemic mastocytosis with associated hematologic clonal non-mast cell disease (SM-AHNMD) is a rare and heterogeneous subtype of SM and few studies on this specific entity have been reported. Sixty two patients with Systemic mastocytosis with associated hematologic clonal non-mast cell disease (SM-AHNMD) were presented. Myeloid AHNMD was the most frequent (82%) cases. This subset of patients were older, had more cutaneous lesions, splenomegaly, liver enlargement, ascites; lower bone mineral density and hemoglobin levels and higher tryptase level than lymphoid AHNMD. Defects in KIT, TET2, ASXL1 and CBL were positive in 87%, 27%, 14%, and 11% of cases respectively. The overall survival of patients with SM-AHNMD was 85.2 months. Within the myeloid group, SM-MPN fared better than SM-MDS or SM-AML (p = 0.044,). In univariate analysis, the presence of C-findings, the AHNMD subtypes (SM-MDS/CMML/AML versus SM-MPN/hypereosinophilia) (p = 0.044), Neutropenia (p = 0.015), high monocyte level (p = 0.015) and the presence of ASXL1 mutation had detrimental effects on OS (p = 0.007). In multivariate analysis and penalized Cox model, only the presence of ASXL1 mutation remained an independent prognostic factor that negatively affected OS (p = 0.035). SM-AHNMD is heterogeneous with variable prognosis according to the type of the AHNMD. ASXL1 is mutated in a subset of myeloid AHNMD and adversely impact on OS.	[Damaj, Gandhi; Joris, Magalie] Hop Sud, Ctr Hosp Univ, Serv Hematol, Amiens, France; [Damaj, Gandhi; Chandesris, Olivia; Hermine, Olivier] Univ Paris 06, Ctr Reference Mastocytoses, Paris, France; [Damaj, Gandhi; Chandesris, Olivia; Canioni, Danielle; Asnafi, Vahid; Lhermitte, Ludovic; Lortholary, Olivier; Hermine, Olivier] AP HP Necker Enfants Malad, Paris, France; [Damaj, Gandhi; Hermine, Olivier] Hop Necker Enfants Malad, AP HP, CNRS UMR 8147, Paris, France; [Damaj, Gandhi; Hermine, Olivier] Hop Necker Enfants Malad, AP HP, Inst Imagine, Paris, France; [Chandesris, Olivia; Hermine, Olivier] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Serv Hematol Adulte, Paris, France; [Hanssens, Katia; Soucie, Erinn; Dubreuil, Patrice] CRCM, INSERM, U1068, Marseille, France; [Hanssens, Katia; Soucie, Erinn; Dubreuil, Patrice] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Hanssens, Katia; Soucie, Erinn; Dubreuil, Patrice] Aix Marseille Univ, Marseille, France; [Hanssens, Katia; Soucie, Erinn; Dubreuil, Patrice] CNRS, UMR7258, Marseille, France; [Canioni, Danielle] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Serv Anatomopathol, Paris, France; [Kolb, Brigitte] Ctr Hosp Univ, Serv Hematol, Reims, France; [Durieu, Isabelle] Grp Hosp Sud Hosp Civils, Serv Med Interne, Lyon, France; [Gyan, Emanuel] CHU Tours, CIC INSERMU202, Serv Hematol & Therapie Cellulaire, Tours, France; [Livideanu, Cristina] Ctr Hosp Univ, Dept Dermatol, Toulouse, France; [Cheze, Stephane] CHU Caen, Serv Hematol, F-14000 Caen, France; [Diouf, Momar] Ctr Hosp Univ, Dept Biostat & Rech Clin, Amiens, France; [Garidi, Reda] Ctr Hosp, Serv Hematol, St Quentin en Yvelines, France; [Georgin-Lavialle, Sophie] Univ Paris 06, Hop Tenon, AP HP, Serv Med Interne, Paris, France; [Asnafi, Vahid; Lhermitte, Ludovic] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Lab Hematol Biol, Paris, France; [Asnafi, Vahid; Lhermitte, Ludovic] Univ Paris 05, Sorbonne Paris Cite, Fac Med, UMR CNRS 8147, Paris, France; [Lavigne, Christian] CHU Angers, Serv Hematol, Angers, France; [Launay, David] CHRU Lille, Serv Med Interne, F-59037 Lille, France; [Arock, Michel] Ecole Normale Super, CNRS UMR 8113, Lab Biol & Pharmacol Appl, Cachan, France; [Arock, Michel] Grp Hosp Pitie Salpetriere, Lab Cent Hematol, F-75634 Paris, France; [Lortholary, Olivier] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Serv Med Interne & Malad Infect, Paris, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Cite; CHU de Reims; CHU Lyon; CHU Tours; CHU de Toulouse; CHU de Caen NORMANDIE; Universite de Caen Normandie; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Damaj, G (corresponding author), Hop Sud, Ctr Hosp Univ, Serv Hematol, Amiens, France.	damaj.gandhi@chu-amiens.fr	Dubreuil, Patrice/V-4816-2019; Launay, David/A-5270-2018; Launay, David/H-1674-2016; Soucie, Erinn L/R-1731-2016; Hermine, Olivier/Q-7072-2018; dubreuil, patrice/F-5346-2011	Dubreuil, Patrice/0000-0003-1155-1150; Launay, David/0000-0003-1840-1817; Launay, David/0000-0003-1840-1817; Soucie, Erinn L/0000-0001-6347-3954; dubreuil, patrice/0000-0003-1155-1150; GYAN, Emmanuel/0000-0002-7651-9189; Bulai Livideanu, Cristina/0000-0002-5275-6868; CHANDESRIS, Marie-Olivia/0000-0002-9795-1085; Hermine, Olivier/0000-0003-2574-3874				Ambler G, 2012, STAT MED, V31, P1150, DOI 10.1002/sim.4371; Delhommeau F, 2007, BLOOD, V109, P71, DOI 10.1182/blood-2006-03-007146; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Gelsi-Boyer V, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-12; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Hermine O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002266; Horny AC, 2008, WHO CLASSIFICATION T, P53; Horny HP, 2001, LEUKEMIA RES, V25, P543, DOI 10.1016/S0145-2126(01)00021-2; Horny HP, 2004, J CLIN PATHOL, V57, P604, DOI 10.1136/jcp.2003.014860; Lanternier F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001906; Metzeler KH, 2011, J CLIN ONCOL, V29, P1373, DOI 10.1200/JCO.2010.32.7742; Pardanani A, 2009, BLOOD, V114, P3769, DOI 10.1182/blood-2009-05-220145; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Sotlar K, 2010, J PATHOL, V220, P586, DOI 10.1002/path.2677; Soucie E, 2012, BLOOD, V120, P4846, DOI 10.1182/blood-2011-12-397588; Tefferi A, 2009, LEUKEMIA, V23, P1343, DOI 10.1038/leu.2009.59; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Tefferi A, 2009, LEUKEMIA, V23, P900, DOI 10.1038/leu.2009.37; Thol F, 2011, J CLIN ONCOL, V29, P2499, DOI 10.1200/JCO.2010.33.4938; Traina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043090; TRAVIS WD, 1988, MEDICINE, V67, P345, DOI 10.1097/00005792-198811000-00001; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8	23	56	57	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85362	10.1371/journal.pone.0085362	http://dx.doi.org/10.1371/journal.pone.0085362			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465546	Green Published, Green Submitted			2022-12-25	WOS:000330244500060
J	Simpson, MJ; Haridas, P; McElwain, DLS				Simpson, Matthew J.; Haridas, Parvathi; McElwain, D. L. Sean			Do Pioneer Cells Exist?	PLOS ONE			English	Article							TIME-LAPSE; IN-VITRO; MIGRATION ASSAY; NERVOUS-SYSTEM; INVASION; MODEL; PROLIFERATION; BEHAVIOR; CANCER; MECHANISMS	Most mathematical models of collective cell spreading make the standard assumption that the cell diffusivity and cell proliferation rate are constants that do not vary across the cell population. Here we present a combined experimental and mathematical modeling study which aims to investigate how differences in the cell diffusivity and cell proliferation rate amongst a population of cells can impact the collective behavior of the population. We present data from a three-dimensional transwell migration assay that suggests that the cell diffusivity of some groups of cells within the population can be as much as three times higher than the cell diffusivity of other groups of cells within the population. Using this information, we explore the consequences of explicitly representing this variability in a mathematical model of a scratch assay where we treat the total population of cells as two, possibly distinct, subpopulations. Our results show that when we make the standard assumption that all cells within the population behave identically we observe the formation of moving fronts of cells where both subpopulations are well-mixed and indistinguishable. In contrast, when we consider the same system where the two subpopulations are distinct, we observe a very different outcome where the spreading population becomes spatially organized with the more motile subpopulation dominating at the leading edge while the less motile subpopulation is practically absent from the leading edge. These modeling predictions are consistent with previous experimental observations and suggest that standard mathematical approaches, where we treat the cell diffusivity and cell proliferation rate as constants, might not be appropriate.	[Simpson, Matthew J.; Haridas, Parvathi; McElwain, D. L. Sean] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Simpson, Matthew J.; Haridas, Parvathi] Queensland Univ Technol, Inst Hlth & Biomed Innovat IHBI, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Simpson, MJ (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia.	matthew.simpson@qut.edu.au		Simpson, Matthew/0000-0001-6254-313X; McElwain, Sean/0000-0002-7046-0251	Australian Research Council [DP120100551]	Australian Research Council(Australian Research Council)	We acknowledge the Australian Research Council Discovery Project Grant DP120100551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigouy B, 2004, DEVELOPMENT, V131, P5127, DOI 10.1242/dev.01398; Aigouy B, 2008, J NEUROSCI, V28, P11635, DOI 10.1523/JNEUROSCI.1361-08.2008; [Anonymous], 2011, PRINCIPLES DEV; Baker RE, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041905; Binder BJ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031912; Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808; Cai AQ, 2007, J THEOR BIOL, V245, P576, DOI 10.1016/j.jtbi.2006.10.024; Carey SP, 2013, CLIN EXP METASTAS, V30, P615, DOI 10.1007/s10585-013-9565-x; Carrithers MD, 2000, BRAIN, V123, P1092, DOI 10.1093/brain/123.6.1092; Chapra S. C., 1998, NUMERICAL METHODS EN; Chowdhury D, 2005, PHYS LIFE REV, V2, P318, DOI 10.1016/j.plrev.2005.09.001; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Decaestecker C, 2007, MED RES REV, V27, P149, DOI 10.1002/med.20078; Druckenbrod NR, 2007, DEV DYNAM, V236, P84, DOI 10.1002/dvdy.20974; Druckenbrod NR, 2005, DEV BIOL, V287, P125, DOI 10.1016/j.ydbio.2005.08.040; Fisher R A, 1937, ANN EUGEN, V7, P353, DOI DOI 10.1111/J.1469-1809.1937.TB02153.X; Gatenby RA, 1996, CANCER RES, V56, P5745; GREENSPAN HP, 1972, STUD APPL MATH, V52, P317; Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654; Hickey WF, 2000, BRAIN, V123, P1073, DOI 10.1093/brain/123.6.1073; Hickey WF, 1999, SEMIN IMMUNOL, V11, P125, DOI 10.1006/smim.1999.0168; Hughes B. D., 1995, RANDOM WALKS RANDOM, VI; Johnston ST, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051922; Kam Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-198; Kashyap AS, 2011, ENDOCRINOLOGY, V152, P1388, DOI 10.1210/en.2010-0897; Khain E, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011904; Kolmogoroff A., 1937, MOSCOW U B MATH, V1, P1; Kramer N, 2013, MUTAT RES-REV MUTAT, V752, P10, DOI 10.1016/j.mrrev.2012.08.001; Kulesa PM, 2010, DEV BIOL, V344, P566, DOI 10.1016/j.ydbio.2010.05.005; Kulesa PM, 1998, DEV BIOL, V204, P327, DOI 10.1006/dbio.1998.9082; Maini PK, 2004, APPL MATH LETT, V17, P575, DOI 10.1016/S0893-9659(04)90128-0; Maini PK, 2004, TISSUE ENG, V10, P475, DOI 10.1089/107632704323061834; Nishiyama C, 2012, NAT NEUROSCI, V15, P1211, DOI 10.1038/nn.3184; Omelchenko T, 2003, P NATL ACAD SCI USA, V100, P10788, DOI 10.1073/pnas.1834401100; Research Services Branch National Institute of Health, 2012, IMAGEJ US GUID; Sato A, 2013, J NEUROSCI, V33, P556, DOI 10.1523/JNEUROSCI.4568-12.2013; Scott J, 2012, NAT REV CANCER, V12, P445, DOI 10.1038/nrc3287; Sengers BG, 2009, ANN BIOMED ENG, V37, P1165, DOI 10.1007/s10439-009-9676-3; Sengers BG, 2007, J R SOC INTERFACE, V4, P1107, DOI 10.1098/rsif.2007.0233; SHERRATT JA, 1990, P ROY SOC B-BIOL SCI, V241, P29, DOI 10.1098/rspb.1990.0061; SHERRATT JA, 1991, J MATH BIOL, V29, P389, DOI 10.1007/BF00160468; Simpson MJ, 2007, ADV WATER RESOUR, V30, P2026, DOI 10.1016/j.advwatres.2007.04.005; Simpson MJ, 2007, DEV BIOL, V302, P553, DOI 10.1016/j.ydbio.2006.10.017; Simpson MJ, 2013, B MATH BIOL, V75, P871, DOI 10.1007/s11538-013-9839-0; Simpson MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0007; Simpson MJ, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051922; Simpson MJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041901; Simpson MJ, 2010, PHYSICA A, V389, P3779, DOI 10.1016/j.physa.2010.05.020; Simpson MJ, 2009, PHYSICA A, V388, P399, DOI 10.1016/j.physa.2008.10.038; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Treloar KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067389; van Horssen R, 2011, J CELL PHYSIOL, V226, P288, DOI 10.1002/jcp.22330; Wanner SJ, 2013, DEVELOPMENT, V140, P906, DOI 10.1242/dev.087148; Weinberg RA, 2006, BIOL CANC; Wynn ML, 2012, J R SOC INTERFACE, V9, P1576, DOI 10.1098/rsif.2011.0726; Young HM, 2004, DEV BIOL, V270, P455, DOI 10.1016/j.ydbio.2004.03.015	56	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85488	10.1371/journal.pone.0085488	http://dx.doi.org/10.1371/journal.pone.0085488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465576	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500069
J	Biswas, N; Friese, RS; Gayen, JR; Bandyopadhyay, G; Mahata, SK; O'Connor, DT				Biswas, Nilima; Friese, Ryan S.; Gayen, Jiaur R.; Bandyopadhyay, Gautam; Mahata, Sushil K.; O'Connor, Daniel T.			Discovery of a Novel Target for the Dysglycemic Chromogranin A Fragment Pancreastatin: Interaction with the Chaperone GRP78 to Influence Metabolism	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; RAT-LIVER MEMBRANES; PROSTATE-CANCER CELLS; REGULATOR GRP78/BIP; INHIBITS INSULIN; ER STRESS; ESSENTIAL-HYPERTENSION; DIABETES-MELLITUS; HEPATIC STEATOSIS	Rationale: The chromogranin A-derived peptide pancreastatin (PST) is a dysglycemic, counter-regulatory peptide for insulin action, especially in liver. Although previous evidence for a PST binding protein has been reported, such a receptor has not been identified or sequenced. Methods and Results: We used ligand affinity to purify the PST target, with biotinylated human PST (hCHGA(273-301)-amide) as "bait" and mouse liver homogenate as "prey", and identified GRP78 (a.k.a. "78 kDa Glucose Regulated Protein", HSPA5, BIP) as a major interacting partner of PST. GRP78 belongs to the family of heat shock proteins (chaperones), involved in several cellular processes including protein folding and glucose metabolism. We analyzed expression of GRP78 in the absence of PST in a mouse knockout model lacking its precursor CHGA: hepatic transcriptome data revealed global overexpression of not only GRP78 but also other heat shock transcripts (of the "adaptive UPR") in CHGA(2/2) mice compared to wild-type (+/+). By contrast, we found a global decline in expression of hepatic pro-apoptotic transcripts in CHGA(-/-) mice. GRP78's ATPase enzymatic activity was dose-dependently inhibited by PST (IC50 similar to 5.2 mu M). PST also inhibited the up-regulation of GRP78 expression during UPR activation (by tunicamycin) in hepatocytes. PST inhibited insulin-stimulated glucose uptake in adipocytes, and increased hepatic expression of G6Pase (the final step in gluconeogenesis/glycogenolysis). In hepatocytes not only PST but also other GRP78-ATPase inhibitors (VER-155008 or ADP) increased G6Pase expression. GRP78 over-expression inhibited G6Pase expression in hepatocytes, with partial restoration by GRP78-ATPase inhibitors PST, VER-155008, or ADP. Conclusions: Our results indicate that an unexpected major hepatic target of PST is the adaptive UPR chaperone GRP78. PST not only binds to GRP78 (in pH-dependent fashion), but also inhibits GRP78's ATPase enzymatic activity, and impairs its biosynthetic response to UPR activation. PST decreases insulin-stimulated cellular glucose uptake, and PST as well as other chaperone ATPase activity inhibitors augment expression of G6Pase; GRP78 over-expression antagonizes this PST action. Analysis of the novel PST/GRP78 interaction may provide a new avenue of investigation into cellular glycemic control as well as dysglycemia.	[Biswas, Nilima; Friese, Ryan S.; Gayen, Jiaur R.; Bandyopadhyay, Gautam; Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [O'Connor, Daniel T.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [O'Connor, Daniel T.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Mahata, Sushil K.; O'Connor, Daniel T.] VA San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	O'Connor, DT (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	doconnor@ucsd.edu	Mahata, Sushil/AAF-8781-2021		National Institutes of Health; Department of Veterans Affairs	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institutes of Health and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; CARLINO A, 1992, P NATL ACAD SCI USA, V89, P2081, DOI 10.1073/pnas.89.6.2081; Chan JY, 2011, DIABETOLOGIA, V54, P1766, DOI 10.1007/s00125-011-2139-z; Chan JY, 2013, DIABETES, V62, P1557, DOI 10.2337/db12-0701; Chevalier M, 2000, J BIOL CHEM, V275, P19620, DOI 10.1074/jbc.M001333200; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Flamment M, 2010, CURR OPIN LIPIDOL, V21, P239, DOI 10.1097/MOL.0b013e3283395e5c; Friese RS, 2010, PHYSIOL GENOMICS, V40, P195, DOI 10.1152/physiolgenomics.00164.2009; FUNAKOSHI A, 1990, REGUL PEPTIDES, V30, P159, DOI 10.1016/0167-0115(90)90056-3; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gayen JR, 2009, J BIOL CHEM, V284, P28498, DOI 10.1074/jbc.M109.020636; Gonzalez-Yanes C, 2001, CELL SIGNAL, V13, P43, DOI 10.1016/S0898-6568(00)00127-3; Gonzalez-Yanes C, 1999, BBA-MOL CELL RES, V1451, P153, DOI 10.1016/S0167-4889(99)00084-1; HAKANSON R, 1995, GASTROENTEROLOGY, V108, P1445, DOI 10.1016/0016-5085(95)90693-2; Inageda K, 2010, FEBS LETT, V584, P3649, DOI 10.1016/j.febslet.2010.07.040; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; KITAYAMA N, 1994, LIFE SCI, V54, P1571; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Misra UK, 2010, APOPTOSIS, V15, P173, DOI 10.1007/s10495-009-0430-y; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Novosyadlyy R, 2008, CELL DEATH DIFFER, V15, P1304, DOI 10.1038/cdd.2008.52; O'Connor DT, 2005, J CLIN ENDOCR METAB, V90, P5414, DOI 10.1210/jc.2005-0408; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; OSTENSON CG, 1989, PANCREAS, V4, P441; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; SANCHEZ V, 1990, BIOSCIENCE REP, V10, P87, DOI 10.1007/BF01116856; Sanchez-Margalet V, 2000, ADV EXP MED BIOL, V482, P247; Sanchez-Margalet V, 2000, EUR J PHARMACOL, V397, P229, DOI 10.1016/S0014-2999(00)00253-3; Sanchez-Margalet V, 1998, DIABETES CARE, V21, P1951, DOI 10.2337/diacare.21.11.1951; Sanchez-Margalet V, 1998, AM J PHYSIOL-ENDOC M, V275, pE1055, DOI 10.1152/ajpendo.1998.275.6.E1055; Sanchez-Margalet V, 2010, REGUL PEPTIDES, V165, P71, DOI 10.1016/j.regpep.2010.10.004; SanchezMargalet V, 1996, J MOL ENDOCRINOL, V16, P1, DOI 10.1677/jme.0.0160001; SANCHEZMARGALET V, 1992, HORM METAB RES, V24, P455, DOI 10.1055/s-2007-1003361; SANCHEZMARGALET V, 1995, NEUROPEPTIDES, V29, P97, DOI 10.1016/0143-4179(95)90090-X; SANCHEZMARGALET V, 1995, J HYPERTENS, V13, P251; SANCHEZMARGALET V, 1994, J CELL BIOCHEM, V55, P173, DOI 10.1002/jcb.240550204; SANCHEZMARGALET V, 1994, BIOCHEM J, V303, P51, DOI 10.1042/bj3030051; SANCHEZMARGALET V, 1994, MOL PHARMACOL, V46, P24; Santos-Alvarez J, 1999, J CELL BIOCHEM, V73, P469, DOI 10.1002/(SICI)1097-4644(19990615)73:4<469::AID-JCB5>3.0.CO;2-U; Santos-Alvarez J, 2000, ARCH BIOCHEM BIOPHYS, V378, P151, DOI 10.1006/abbi.2000.1789; SCHMIDT WE, 1988, P NATL ACAD SCI USA, V85, P8231, DOI 10.1073/pnas.85.21.8231; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Streeper RS, 2000, J BIOL CHEM, V275, P12108, DOI 10.1074/jbc.275.16.12108; TAMAMURA H, 1990, EUR J BIOCHEM, V191, P33, DOI 10.1111/j.1432-1033.1990.tb19090.x; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Yamagishi N, 2012, BIOCHEM BIOPH RES CO, V417, P364, DOI 10.1016/j.bbrc.2011.11.118; Ye RS, 2010, DIABETES, V59, P6, DOI 10.2337/db09-0755; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	62	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84132	10.1371/journal.pone.0084132	http://dx.doi.org/10.1371/journal.pone.0084132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465394	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500009
J	Choi, SH; Lee, HJ; Jin, YB; Jang, J; Kang, GY; Lee, M; Kim, CH; Kim, J; Yoon, SS; Lee, YS; Lee, YJ				Choi, Seo-hyun; Lee, Hae-June; Jin, Yeung Bae; Jang, Junho; Kang, Ga-Young; Lee, Minyoung; Kim, Chun-Ho; Kim, Joon; Yoon, Sam S.; Lee, Yun-Sil; Lee, Yoon-Jin			MMP9 Processing of HSPB1 Regulates Tumor Progression	PLOS ONE			English	Article							SHOCK-PROTEIN EXPRESSION; MATRIX METALLOPROTEINASES; CANCER-THERAPY; LUNG-CANCER; CELL-DEATH; HSP27; ANGIOGENESIS; INHIBITION; CARCINOMA; SERUM	Matrix metalloproteinases regulate pathophysiological events by processing matrix proteins and secreted proteins. Previously, we demonstrated that soluble heat shock protein B1 (HSPB1) is released primarily from endothelial cells (ECs) and regulates angiogenesis via direct interaction with vascular endothelial growth factor (VEGF). Here we report that MMP9 can cleave HSPB1 and release anti-angiogenic fragments, which play a key role in tumorprogression. We mapped the cleavage sites and explored their physiological relevance during these processing events. HSPB1 cleavage by MMP9 inhibited VEGF-induced ECs activation and the C-terminal HSPB1 fragment exhibited more interaction with VEGF than did full-length HSPB1. HSPB1 cleavage occurs during B16F10 lung progression in wild-type mice. Also, intact HSPB1 was more detected on tumor endothelium of MMP9 null mice than wild type mice. Finally, we confirmed that secretion of C-terminal HSPB1 fragment was significantly inhibited lung and liver tumor progression of B16F10 melanoma cells and lung tumor progression of CT26 colon carcinoma cells, compared to full-length HSPB1. These data suggest that in vivo MMP9-mediated processing of HSPB1 acts to regulate VEGF-induced ECs activation for tumor progression, releasing anti-angiogenic HSPB1 fragments. Moreover, these findings potentially explain an anti-target effect for the failure of MMP inhibitors in clinical trials, suggesting that MMP inhibitors may have pro-tumorigenic effects by reducing HSPB1 fragmentation.	[Choi, Seo-hyun; Lee, Hae-June; Jin, Yeung Bae; Jang, Junho; Lee, Minyoung; Lee, Yoon-Jin] Korea Inst Radiol & Med Sci, Div Radiat Effects, Seoul, South Korea; [Choi, Seo-hyun; Kim, Joon] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea; [Kang, Ga-Young; Lee, Yun-Sil] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Kang, Ga-Young; Lee, Yun-Sil] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Kim, Chun-Ho] Korea Inst Radiol & Med Sci, Lab Tissue Engn, Seoul, South Korea; [Yoon, Sam S.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Yoon, Sam S.] Harvard Univ, Sch Med, Boston, MA USA	Korea Institute of Radiological & Medical Sciences; Korea University; Ewha Womans University; Ewha Womans University; Korea Institute of Radiological & Medical Sciences; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, YS (corresponding author), Ewha Womans Univ, Coll Pharm, Seoul, South Korea.	yslee0425@ewha.ac.kr; yjlee8@kcch.re.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	Nuclear Research and Development Program [NRF-2012M2A2A7012483, NRF-2011-0031697, NRF-2013M2A2A7043580]; KIRAMS research project [50520-2013]; Nuclear Research and Development Program; Basic Science Research Program [R1A4A002]; Mid-career Researcher Program of the National Research Foundation of Korea (NRF) [2011-0013364]; Korean Ministry of Education, Science, and Technology (MEST); Ewha Womans University	Nuclear Research and Development Program; KIRAMS research project; Nuclear Research and Development Program; Basic Science Research Program; Mid-career Researcher Program of the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ewha Womans University	This work was supported by the Nuclear Research and Development Program (Grant No. NRF-2012M2A2A7012483, NRF-2011-0031697 and NRF-2013M2A2A7043580) and a KIRAMS research project (Grant No. 50520-2013) funded by the Nuclear Research and Development Program. This work also supported by the Basic Science Research Program (Grant No. R1A4A002), Mid-career Researcher Program (Grant No. 2011-0013364) of the National Research Foundation of Korea (NRF), funded by the Korean Ministry of Education, Science, and Technology (MEST) and the Ewha Global Top5 Grant 2011 of Ewha Womans University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Berrieman HK, 2006, ONCOL REP, V15, P283; Cho NH, 2003, EUR UROL, V44, P560, DOI 10.1016/S0302-2838(03)00362-2; Cornford PA, 2000, CANCER RES, V60, P7099; De AK, 2004, J IMMUNOASS IMMUNOCH, V25, P159, DOI 10.1081/IAS-120030525; Deraz EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025438; Didelot C, 2006, HANDB EXP PHARM, V172, P171; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Feldman AL, 2000, CLIN CANCER RES, V6, P4628; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; Geisler JP, 2004, EUR J GYNAECOL ONCOL, V25, P165; Genersch E, 2000, J CELL SCI, V113, P4319; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; Guo H, 2010, J CLIN ONCOL, V28, P1928, DOI 10.1200/JCO.2009.24.4954; Guo K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-100; Huang QJ, 2010, CLIN CHEM LAB MED, V48, P263, DOI 10.1515/CCLM.2010.043; Hwang SJ, 2008, PROTEIN J, V27, P319, DOI 10.1007/s10930-008-9140-5; Jimenez RE, 2000, ANN SURG, V231, P644, DOI 10.1097/00000658-200005000-00004; Kang SH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-286; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Kruger A, 2010, BBA-MOL CELL RES, V1803, P95, DOI 10.1016/j.bbamcr.2009.09.016; Lee YJ, 2005, ONCOGENE, V24, P3715, DOI 10.1038/sj.onc.1208440; Lee YJ, 2005, J BIOL CHEM, V280, P18108, DOI 10.1074/jbc.M501131200; Lee YJ, 2012, ANGIOGENESIS; Lee YJ, 2012, ANGIOGENESIS, V15, P229, DOI 10.1007/s10456-012-9255-3; Lee YJ, 2010, CANCER RES, V70, P948, DOI 10.1158/0008-5472.CAN-09-3094; Liao WC, 2009, PANCREAS, V38, P422, DOI 10.1097/MPA.0b013e318198281d; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Marquez E, 2012, CLIN CHIM ACTA; Martin-Ventura JL, 2006, ARTERIOSCL THROM VAS, V26, P1337, DOI 10.1161/01.ATV.0000220108.97208.67; McDonald ET, 2012, BIOCHEMISTRY-US, V51, P1257, DOI 10.1021/bi2017624; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Missotten GS, 2003, INVEST OPHTH VIS SCI, V44, P3059, DOI 10.1167/iovs.02-1038; Okazaki I, 2012, ANTICANCER AGENTS ME; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Overall Christopher M, 2004, Biochem J, V383, pe5; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Ren H, 2006, WORLD J GASTROENTERO, V12, P2789, DOI 10.3748/wjg.v12.i17.2789; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Vallon M, 2006, J BIOL CHEM, V281, P34179, DOI 10.1074/jbc.M605291200; Zaslavsky A, 2010, BLOOD, V115, P4605, DOI 10.1182/blood-2009-09-242065	48	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85509	10.1371/journal.pone.0085509	http://dx.doi.org/10.1371/journal.pone.0085509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465581	Green Published, gold, Green Submitted			2022-12-25	WOS:000330240500054
J	Hargreaves, MK; Liu, JG; Buchowski, MS; Patel, KA; Larson, CO; Schlundt, DG; Kenerson, DM; Hill, KE; Burk, RF; Blot, WJ				Hargreaves, Margaret K.; Liu, Jianguo; Buchowski, Maciej S.; Patel, Kushal A.; Larson, Celia O.; Schlundt, David G.; Kenerson, Donna M.; Hill, Kristina E.; Burk, Raymond F.; Blot, William J.			Plasma Selenium Biomarkers in Low Income Black and White Americans from the Southeastern United States	PLOS ONE			English	Article							3RD NATIONAL-HEALTH; FOOD FREQUENCY QUESTIONNAIRE; NUTRITION EXAMINATION SURVEY; SOUTHERN COMMUNITY COHORT; BODY-MASS INDEX; SERUM SELENIUM; SELENOPROTEIN-P; GLUTATHIONE-PEROXIDASE; CANCER INCIDENCE; PROSTATE-CANCER	Biomarkers of selenium are necessary for assessing selenium status in humans, since soil variation hinders estimation of selenium intake from foods. In this study, we measured the concentration of plasma selenium, selenoprotein P (SEPP1), and glutathione peroxidase (GPX3) activity and their interindividual differences in 383 low-income blacks and whites selected from a stratified random sample of adults aged 40-79 years, who were participating in a long-term cohort study in the southeastern United States (US). We assessed the utility of these biomarkers to determine differences in selenium status and their association with demographic, socio-economic, dietary, and other indicators. Dietary selenium intake was assessed using a validated food frequency questionnaire designed for the cohort, matched with region-specific food selenium content, and compared with the US Recommended Dietary Allowances (RDA) set at 55 mu g/day. We found that SEPP1, a sensitive biomarker of selenium nutritional status, was significantly lower among blacks than whites (mean 4.4 +/- 1.1 vs. 4.7 +/- 1.0 mg/L, p = 0.006), with blacks less than half as likely to have highest vs. lowest quartile SEPP1 concentration (Odds Ratio (OR) 0.4, 95% Confidence Interval (CI) 0.2-0.8). The trend in a similar direction was observed for plasma selenium among blacks and whites, (mean 115 +/- 15.1 vs. 118 +/- 17.7 mu g/L, p = 0.08), while GPX3 activity did not differ between blacks and whites (136 +/- 33.3 vs. 132 +/- 33.5 U/L, p = 0.320). Levels of the three biomarkers were not correlated with estimated dietary selenium intake, except for SEPP1 among 10% of participants with the lowest selenium intake (<= 57 mu g/day). The findings suggest that SEPP1 may be an effective biomarker of selenium status and disease risk in adults and that low selenium status may disproportionately affect black and white cohort participants.	[Hargreaves, Margaret K.; Liu, Jianguo; Kenerson, Donna M.] Meharry Med Coll, Dept Internal Med, Nashville, TN 37208 USA; [Buchowski, Maciej S.; Hill, Kristina E.; Burk, Raymond F.] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA; [Patel, Kushal A.] Tennessee State Univ, Dept Publ Hlth Hlth Adm & Hlth Sci, Nashville, TN 37203 USA; [Larson, Celia O.] Metro Publ Hlth Dept, Dept Populat Hlth, Nashville, TN USA; [Schlundt, David G.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Blot, William J.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Meharry Medical College; Vanderbilt University; Tennessee State University; Vanderbilt University; Vanderbilt University	Hargreaves, MK (corresponding author), Meharry Med Coll, Dept Internal Med, Nashville, TN 37208 USA.	mhargreaves@mmc.edu	Kenerson, Donna/GPX-3456-2022	Buchowski, Maciej/0000-0002-0566-1743	National Institutes of Health from the National Cancer Institute [R01CA092447, U01CA114641, U54CA153708]; NATIONAL CANCER INSTITUTE [R01CA092447, U01CA114641, U54CA153708] Funding Source: NIH RePORTER	National Institutes of Health from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This manuscript was supported in part by National Institutes of Health grants R01CA092447, U01CA114641, and U54CA153708 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Taie OH, 2003, NUTR CANCER, V46, P125, DOI 10.1207/S15327914NC4602_04; Ashton K, 2009, AM J CLIN NUTR, V89, p2025S, DOI 10.3945/ajcn.2009.27230F; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Buchowski MS, 2003, CELL MOL BIOL, V49, P1295; Burk RF, 2006, BBA-GEN SUBJECTS, V1760, P1789, DOI 10.1016/j.bbagen.2006.08.010; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Burk RF, 2006, CANCER EPIDEM BIOMAR, V15, P804, DOI 10.1158/1055-9965.EPI-05-0950; Burk RF, 2003, J NUTR, V133, p1517S, DOI 10.1093/jn/133.5.1517S; Cohen SS, 2012, ANN NUTR METAB, V60, P90, DOI 10.1159/000336180; Cohen SS, 2011, ANN EPIDEMIOL, V21, P86, DOI 10.1016/j.annepidem.2010.10.011; Combs GF, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-75; Combs GF, 2005, J NUTR, V135, P343, DOI 10.1093/jn/135.2.343; Daniels LA, 2004, MED J AUSTRALIA, V180, P373, DOI 10.5694/j.1326-5377.2004.tb05986.x; DEAGEN JT, 1993, ANAL BIOCHEM, V208, P176, DOI 10.1006/abio.1993.1025; Devesa SS, 1999, NIH PUBLICATION; Donaldson MS, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-19; Duffield-Lillico AJ, 2002, CANCER EPIDEM BIOMAR, V11, P630; Duffield-Lillico AJ, 2003, BJU INT, V91, P608, DOI 10.1046/j.1464-410X.2003.04167.x; Epplein M, 2011, CANCER PREV RES, V4, P871, DOI 10.1158/1940-6207.CAPR-10-0398; Fairweather-Tait SJ, 2010, AM J CLIN NUTR, V91, p1484S, DOI 10.3945/ajcn.2010.28674J; Hargreaves MK, 2005, MULTICULTURAL MED HL, P485; Hill KE, 1996, J NUTR, V126, P138, DOI 10.1093/jn/126.1.138; Holben DH, 1999, J AM DIET ASSOC, V99, P836, DOI 10.1016/S0002-8223(99)00198-4; Hurst R, 2010, AM J CLIN NUTR, V91, P923, DOI 10.3945/ajcn.2009.28169; Institute of Medicine (US) Panel on Micronutrients, 2000, DIET REF INT VIT C V, P284, DOI [10.17226/9810, DOI 10.17226/9810]; JASKIEWICZ K, 1988, CANCER, V62, P2635, DOI 10.1002/1097-0142(19881215)62:12<2635::AID-CNCR2820621232>3.0.CO;2-5; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kafai MR, 2003, J TRACE ELEM MED BIO, V17, P13, DOI 10.1016/S0946-672X(03)80040-8; Klapcinska B, 2005, BIOL TRACE ELEM RES, V108, P1, DOI 10.1385/BTER:108:1-3:001; KOH TS, 1983, J ASSOC OFF ANA CHEM, V66, P918; Lee B. L., 2005, J ANIM SCI S, V62, P2414; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lyons GH, 2004, MED J AUSTRALIA, V180, P383, DOI 10.5694/j.1326-5377.2004.tb05990.x; MACPHERSON AK, 1988, ANALYST, V113, P281, DOI 10.1039/an9881300281; Mark SD, 2000, J NATL CANCER I, V92, P1753, DOI 10.1093/jnci/92.21.1753; MCCOY KEM, 1969, J NUTR, V98, P383, DOI 10.1093/jn/98.4.383; Neve J, 2000, TRACE ELEMENTS IN MAN AND ANIMALS 10, P317; Niskar AS, 2003, BIOL TRACE ELEM RES, V91, P1, DOI 10.1385/BTER:91:1:1; Nomura AMY, 2000, CANCER EPIDEM BIOMAR, V9, P883; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rayman MP, 2009, BBA-GEN SUBJECTS, V1790, P1533, DOI 10.1016/j.bbagen.2009.03.014; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Reid ME, 2002, CANCER EPIDEM BIOMAR, V11, P1285; Saito Y, 2001, J HEALTH SCI, V47, P346, DOI 10.1248/jhs.47.346; SCHWARZ K, 1957, J AM CHEM SOC, V79, P3292, DOI 10.1021/ja01569a087; SHEEHAN TMT, 1990, CLIN CHEM, V36, P2124; Signorello LB, 2005, J NATL MED ASSOC, V97, P972; Signorello LB, 2010, J HEALTH CARE POOR U, V21, P26, DOI 10.1353/hpu.0.0245; Signorello LB, 2009, AM J EPIDEMIOL, V170, P104, DOI 10.1093/aje/kwp098; Thomson CD, 2004, EUR J CLIN NUTR, V58, P391, DOI 10.1038/sj.ejcn.1601800; Vogt TM, 2007, AM J EPIDEMIOL, V166, P280, DOI 10.1093/aje/kwm075; Vogt TM, 2003, INT J CANCER, V103, P664, DOI 10.1002/ijc.10866; Wasowicz W, 2003, TOXICOL LETT, V137, P95, DOI 10.1016/S0378-4274(02)00383-1; Xia YM, 2010, AM J CLIN NUTR, V92, P525, DOI 10.3945/ajcn.2010.29642; Xia YM, 2005, AM J CLIN NUTR, V81, P829, DOI 10.1093/ajcn/81.4.829; XIA YM, 1989, J NUTR, V119, P1318, DOI 10.1093/jn/119.9.1318; Zhang XL, 2008, DIS MARKERS, V24, P351, DOI 10.1155/2008/509138	58	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84972	10.1371/journal.pone.0084972	http://dx.doi.org/10.1371/journal.pone.0084972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465457	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500026
J	Hochmeister, S; Pekar, T; Lindner, M; Kitic, M; Haindl, M; Storch, M; Fazekas, F; Linington, C				Hochmeister, Sonja; Pekar, Thomas; Lindner, Maren; Kitic, Maja; Haindl, Michaela; Storch, Maria; Fazekas, Franz; Linington, Christopher			Maternal Neurofascin-Specific Autoantibodies Bind to Structures of the Fetal Nervous System during Pregnancy, but Have No Long Term Effect on Development in the Rat	PLOS ONE			English	Article							AXON INITIAL SEGMENT; CELL-ADHESION MOLECULE; MULTIPLE-SCLEROSIS; LUPUS-ERYTHEMATOSUS; MYASTHENIA-GRAVIS; RANVIER; NODES; DISRUPTION; DOMAINS; DEMYELINATION	Neurofascin was recently reported as a target for axopathic autoantibodies in patients with multiple sclerosis (MS), a response that will exacerbate axonal pathology and disease severity in an animal model of multiple sclerosis. As transplacental transfer of maternal autoantibodies can permanently damage the developing nervous system we investigated whether intrauterine exposure to this neurofascin-specific response had any detrimental effect on white matter tract development. To address this question we intravenously injected pregnant rats with either a pathogenic anti-neurofascin monoclonal antibody or an appropriate isotype control on days 15 and 18 of pregnancy, respectively, to mimic the physiological concentration of maternal antibodies in the circulation of the fetus towards the end of pregnancy. Pups were monitored daily with respect to litter size, birth weight, growth and motor development. Histological studies were performed on E20 embryos and pups sacrificed on days 2, 10, 21, 32 and 45 days post partum. Results: Immunohistochemistry for light and confocal microscopy confirmed passively transferred anti-neurofascin antibody had crossed the placenta to bind to distinct structures in the developing cortex and cerebellum. However, this did not result in any significant differences in litter size, birth weight, or general physical development between litters from control mothers or those treated with the neurofascin-specific antibody. Histological analysis also failed to identify any neuronal or white matter tract abnormalities induced by the neurofascin-specific antibody. Conclusions: We show that transplacental transfer of circulating anti-neurofascin antibodies can occur and targets specific structures in the CNS of the developing fetus. However, this did not result in any pre- or post-natal abnormalities in the offspring of the treated mothers. These results assure that even if anti-neurofascin responses are detected in pregnant women with multiple sclerosis these are unlikely to have a negative effect on their children.	[Hochmeister, Sonja; Pekar, Thomas; Haindl, Michaela; Storch, Maria; Fazekas, Franz] Med Univ Graz, Dept Neurol, Graz, Austria; [Kitic, Maja] Med Univ Vienna, Brain Res Inst, Dept Neuroimmunol, Vienna, Austria; [Lindner, Maren; Linington, Christopher] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Medical University of Graz; Medical University of Vienna; University of Glasgow	Hochmeister, S (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	sonja.hochmeister@medunigraz.at	Linington, Chris/M-4883-2019	Pekar, Thomas/0000-0002-2331-0488; Linington, Christopher/0000-0002-0937-9526				Basak S, 2007, DEV BIOL, V311, P408, DOI 10.1016/j.ydbio.2007.08.045; Buttermore ED, 2012, J NEUROSCI, V32, P4724, DOI 10.1523/JNEUROSCI.5602-11.2012; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Elliott C, 2012, BRAIN, V135, P1819, DOI 10.1093/brain/aws105; GIACOIA G P, 1991, Obstetrical and Gynecological Survey, V46, P723; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Hughes RAC, 2012, NEUROLOGY, V79, P2224, DOI 10.1212/WNL.0b013e3182768b55; King G, 1997, J PATHOL, V183, P237, DOI 10.1002/(SICI)1096-9896(199710)183:2<237::AID-PATH893>3.0.CO;2-0; Koticha D, 2006, DEV BIOL, V293, P1, DOI 10.1016/j.ydbio.2005.05.028; Kriebel M, 2012, INT J BIOCHEM CELL B, V44, P694, DOI 10.1016/j.biocel.2012.01.012; Kriebel M, 2011, J BIOL CHEM, V286, P24385, DOI 10.1074/jbc.M110.212191; LAHITA RG, 1988, PSYCHONEUROENDOCRINO, V13, P385, DOI 10.1016/0306-4530(88)90045-5; Lee JY, 2009, NAT MED, V15, P91, DOI 10.1038/nm.1892; Liu HL, 2011, J BIOL CHEM, V286, P797, DOI 10.1074/jbc.M110.180281; Lonigro A, 2009, BRAIN, V132, P260, DOI 10.1093/brain/awn281; Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053; Mathey EK, 2013, J NEUROL SCI, V333, P37, DOI 10.1016/j.jns.2012.10.020; McAllister D L, 1997, J Int Neuropsychol Soc, V3, P370; Meinl E, 2011, J NEUROL SCI, V306, P180, DOI 10.1016/j.jns.2010.08.009; Neri F, 2004, LUPUS, V13, P805, DOI 10.1191/0961203304lu2018oa; Ng JKM, 2012, NEUROLOGY, V79, P2241, DOI 10.1212/WNL.0b013e31827689ad; Oskoui M, 2008, NEUROLOGY, V71, P2010, DOI 10.1212/01.wnl.0000336929.38733.7a; Pillai AM, 2009, J NEUROSCI RES, V87, P1773, DOI 10.1002/jnr.22015; Pomicter AD, 2010, BRAIN, V133, P389, DOI 10.1093/brain/awp341; Pruss H, 2011, BRAIN, V134, DOI 10.1093/brain/awq372; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Ross G, 2003, ARCH PEDIAT ADOL MED, V157, P397, DOI 10.1001/archpedi.157.4.397; Saint-Faust M, 2010, AM J PERINAT, V27, P107, DOI 10.1055/s-0029-1224873; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Thaxton C, 2011, NEURON, V69, P244, DOI 10.1016/j.neuron.2010.12.016; Tincani A, 2006, LUPUS, V15, P801, DOI 10.1177/0961203306071005; VASS K, 1986, ACTA NEUROPATHOL, V70, P149, DOI 10.1007/BF00691433; Wang L, 2012, J EXP MED, V209, P1083, DOI 10.1084/jem.20111986; Zonta B, 2008, J CELL BIOL, V181, P1169, DOI 10.1083/jcb.200712154; Zonta B, 2011, NEURON, V69, P945, DOI 10.1016/j.neuron.2011.02.021	37	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85393	10.1371/journal.pone.0085393	http://dx.doi.org/10.1371/journal.pone.0085393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465550	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000330240500045
J	Rodkey, EA; Winkler, ML; Bethel, CR; Pagadala, SRR; Buynak, JD; Bonomo, RA; van den Akker, F				Rodkey, Elizabeth A.; Winkler, Marisa L.; Bethel, Christopher R.; Pagadala, Sundar Ram Reddy; Buynak, John D.; Bonomo, Robert A.; van den Akker, Focco			Penam Sulfones and beta-Lactamase Inhibition: SA2-13 and the Importance of the C2 Side Chain Length and Composition	PLOS ONE			English	Article							TRANS-ENAMINE INTERMEDIATE; CLASS-A; CLAVULANIC ACID; CRYSTAL-STRUCTURES; BORONIC ACID; RESISTANCE; STABILIZATION; MUTAGENESIS; COMPLEX; VARIANT	beta-Lactamases are the major reason beta-lactam resistance is seen in Gram-negative bacteria. To combat this resistance mechanism, beta-lactamase inhibitors are currently being developed. Presently, there are only three that are in clinical use (clavulanate, sulbactam and tazobactam). In order to address this important medical need, we explored a new inhibition strategy that takes advantage of a long-lived inhibitory trans-enamine intermediate. SA2-13 was previously synthesized and shown to have a lower k(react) than tazobactam. We investigated here the importance of the carboxyl linker length and composition by synthesizing three analogs of SA2-13 (PSR-4-157, PSR-4-155, and PSR-3-226). All SA2-13 analogs yielded higher turnover numbers and k(react) compared to SA2-13. We next demonstrated using protein crystallography that increasing the linker length by one carbon allowed for better capture of a trans-enamine intermediate; in contrast, this trans-enamine intermediate did not occur when the C2 linker length was decreased by one carbon. If the linker was altered by both shortening it and changing the carboxyl moiety into a neutral amide moiety, the stable trans-enamine intermediate in wt SHV-1 did not form; this intermediate could only be observed when a deacylation deficient E166A variant was studied. We subsequently studied SA2-13 against a relatively recently discovered inhibitor-resistant (IR) variant of SHV-1, SHV K234R. Despite the alteration in the mechanism of resistance due to the K -> R change in this variant, SA2-13 was effective at inhibiting this IR enzyme and formed a trans-enamine inhibitory intermediate similar to the intermediate seen in the wt SHV-1 structure. Taken together, our data reveals that the C2 side chain linker length and composition profoundly affect the formation of the trans-enamine intermediate of penam sulfones. We also show that the design of SA2-13 derivatives offers promise against IR SHV beta-lactamases that possess the K234R substitution.	[Rodkey, Elizabeth A.; van den Akker, Focco] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Winkler, Marisa L.; Bonomo, Robert A.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Winkler, Marisa L.; Bethel, Christopher R.; Bonomo, Robert A.] Louis Stokes Cleveland Vet Affairs Med Ctr, Div Res, Cleveland, OH USA; [Pagadala, Sundar Ram Reddy; Buynak, John D.] So Methodist Univ, Dept Chem, Dallas, TX 75275 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Southern Methodist University; Case Western Reserve University; Case Western Reserve University	Bonomo, RA (corresponding author), Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	robert.bonomo@va.gov; focco.vandenakker@case.edu			National Institutes of Health (NIH) [R01 AI062968, R01 AI063517]; US Department of Veterans Affairs, Merit Review Program; Cleveland Geriatric Research Education and Clinical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063517, R01AI062968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs, Merit Review Program(US Department of Veterans Affairs); Cleveland Geriatric Research Education and Clinical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the National Institutes of Health (NIH) (R01 AI062968 to FVDA; R01 AI063517 to RAB), US Department of Veterans Affairs, Merit Review Program (to RAB), and Cleveland Geriatric Research Education and Clinical Center (to RAB) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Dubois V, 2008, ANTIMICROB AGENTS CH, V52, P3792, DOI 10.1128/AAC.00387-08; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Helfand MS, 2003, J BIOL CHEM, V278, P52724, DOI 10.1074/jbc.M306059200; Hujer AM, 2001, BBA-PROTEIN STRUCT M, V1547, P37, DOI 10.1016/S0167-4838(01)00164-9; Ke W, 2012, CHEMMEDCHEM, V7, P1002, DOI 10.1002/cmdc.201200006; Ke W, 2012, ANTIMICROB AGENTS CH, V56, P2713, DOI 10.1128/AAC.06099-11; Kuzin AP, 1999, BIOCHEMISTRY-US, V38, P5720, DOI 10.1021/bi990136d; Kuzin AP, 2001, BIOCHEMISTRY-US, V40, P1861, DOI 10.1021/bi0022745; LENFANT F, 1991, J BIOL CHEM, V266, P17187; Lin S, 1998, BIOCHEM J, V333, P395, DOI 10.1042/bj3330395; Manageiro V, 2010, ANTIMICROB AGENTS CH, V54, P2271, DOI 10.1128/AAC.01442-09; Mendonca N, 2008, ANTIMICROB AGENTS CH, V52, P1806, DOI 10.1128/AAC.01381-07; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padayatti PS, 2006, J AM CHEM SOC, V128, P13235, DOI 10.1021/ja063715w; Padayatti PS, 2004, BIOCHEMISTRY-US, V43, P843, DOI 10.1021/bi035985m; Padayatti PS, 2005, J BIOL CHEM, V280, P34900, DOI 10.1074/jbc.M505333200; Papp-Wallace KM, 2012, BIOCHEM PHARMACOL, V83, P462, DOI 10.1016/j.bcp.2011.11.015; Pattanaik P, 2009, J BIOL CHEM, V284, P945, DOI 10.1074/jbc.M806833200; Sampson JM, 2011, ANTIMICROB AGENTS CH, V55, P2303, DOI 10.1128/AAC.01360-10; SANDERS CC, 1992, CLIN INFECT DIS, V15, P824, DOI 10.1093/clind/15.5.824; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Winkler ML, 2013, J MED CHEM, V56, P1084, DOI 10.1021/jm301490d	27	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85892	10.1371/journal.pone.0085892	http://dx.doi.org/10.1371/journal.pone.0085892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454944	gold, Green Submitted, Green Published			2022-12-25	WOS:000330236000020
J	Abeln, S; Vendruscolo, M; Dobson, CM; Frenkel, D				Abeln, Sanne; Vendruscolo, Michele; Dobson, Christopher M.; Frenkel, Daan			A Simple Lattice Model That Captures Protein Folding, Aggregation and Amyloid Formation	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; MONTE-CARLO; ALPHA-SYNUCLEIN; HEAT-CAPACITY; FREE-ENERGY; CONFORMATION; ENERGETICS; ENSEMBLES; SEQUENCES; FIBRILS	The ability of many proteins to convert from their functional soluble state to amyloid fibrils can be attributed to intermolecular beta strand formation. Such amyloid formation is associated with neurodegenerative disorders like Alzheimer's and Parkinson's. Molecular modelling can play a key role in providing insight into the factors that make proteins prone to fibril formation. However, fully atomistic models are computationally too expensive to capture the length and time scales associated with fibril formation. As the ability to form fibrils is the rule rather than the exception, much insight can be gained from the study of coarse-grained models that capture the key generic features associated with amyloid formation. Here we present a simple lattice model that can capture both protein folding and beta strand formation. Unlike standard lattice models, this model explicitly incorporates the formation of hydrogen bonds and the directionality of side chains. The simplicity of our model makes it computationally feasible to investigate the interplay between folding, amorphous aggregation and fibril formation, and maintains the capability of classic lattice models to simulate protein folding with high specificity. In our model, the folded proteins contain structures that resemble naturally occurring beta-sheets, with alternating polar and hydrophobic amino acids. Moreover, fibrils with intermolecular cross-beta strand conformations can be formed spontaneously out of multiple short hydrophobic peptide sequences. Both the formation of hydrogen bonds in folded structures and in fibrils is strongly dependent on the amino acid sequence, indicating that hydrogen-bonding interactions alone are not strong enough to initiate the formation of beta sheets. This result agrees with experimental observations that beta sheet and amyloid formation is strongly sequence dependent, with hydrophobic sequences being more prone to form such structures. Our model should open the way to a systematic study of the interplay between the factors that lead to amyloid formation.	[Abeln, Sanne] Vrije Univ Amsterdam, IBIVU Deptartment Comp Sci, Amsterdam, Netherlands; [Vendruscolo, Michele; Dobson, Christopher M.; Frenkel, Daan] Univ Cambridge, Deptartment Chem, Cambridge, England	Vrije Universiteit Amsterdam; University of Cambridge	Abeln, S (corresponding author), Vrije Univ Amsterdam, IBIVU Deptartment Comp Sci, Amsterdam, Netherlands.	s.abeln@vu.nl	Frenkel, Daan/G-2580-2014; Vendruscolo, Michele/F-5901-2012	Frenkel, Daan/0000-0002-6362-2021; Vendruscolo, Michele/0000-0002-3616-1610	Veni grant from Netherlands Organisation for Scientic Research (NWO); European Molecular Biology Organization (EMBO); Wellcome Trust; ERC [227758]; Wolfson Merit Award of the Royal Society of London; BBSRC [BB/H003843/1] Funding Source: UKRI; EPSRC [EP/I000844/1, EP/I001352/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H003843/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I001352/1, EP/I000844/1] Funding Source: researchfish	Veni grant from Netherlands Organisation for Scientic Research (NWO); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); ERC(European Research Council (ERC)European Commission); Wolfson Merit Award of the Royal Society of London; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	SA has been supported by a Veni grant on the project 'Understanding toxic protein oligomers through ensemble characteristics' from Netherlands Organisation for Scientic Research (NWO), and a travel-fellowship from the European Molecular Biology Organization (EMBO). MV and CMD acknowledge support from the Wellcome Trust (ref.). DF acknowledges support of ERC Advanced Grant 227758, a Wolfson Merit Award of the Royal Society of London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeln S, 2011, BIOPHYS J, V101, P1014, DOI 10.1016/j.bpj.2011.07.032; Abeln S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000241; Auer S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000222; Baldwin RL, 2007, J MOL BIOL, V371, P283, DOI 10.1016/j.jmb.2007.05.078; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Coluzza I, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046703; Coluzza I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020853; Combe N, 2007, MOL PHYS; DAVIDSON AR, 1994, P NATL ACAD SCI USA, V91, P2146, DOI 10.1073/pnas.91.6.2146; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; GEYER CJ, 1995, J AM STAT ASSOC, V90, P909, DOI 10.1080/01621459.1995.10476590; Hoang TX, 2004, P NATL ACAD SCI USA, V101, P7960, DOI 10.1073/pnas.0402525101; Kim S, 2010, BIOPHYS J, V99, P1949, DOI 10.1016/j.bpj.2010.07.008; Li DW, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000238; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li MS, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2989981; LYUBARTSEV AP, 1992, J CHEM PHYS, V96, P1776, DOI 10.1063/1.462133; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; Matthes D, 2012, J MOL BIOL, V421, P390, DOI 10.1016/j.jmb.2012.02.004; Naganathan AN, 2005, J AM CHEM SOC, V127, P17970, DOI 10.1021/ja055996y; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nguyen HD, 2004, P NATL ACAD SCI USA, V101, P16180, DOI 10.1073/pnas.0407273101; Ni R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.058101; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; PRIVALOV PL, 1989, J MOL BIOL, V205, P737, DOI 10.1016/0022-2836(89)90318-5; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; SALI A, 1994, J MOL BIOL, V235, P1614, DOI 10.1006/jmbi.1994.1110; SHAKHNOVICH EI, 1994, PHYS REV LETT, V72, P3907, DOI 10.1103/PhysRevLett.72.3907; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Takeda T, 2009, BIOPHYS J, V96, P442, DOI 10.1016/j.bpj.2008.10.008; Thirumalai D, 2012, ACCOUNTS CHEM RES, V45, P83, DOI 10.1021/ar2000869; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x	34	53	53	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85185	10.1371/journal.pone.0085185	http://dx.doi.org/10.1371/journal.pone.0085185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454816	Green Published, Green Submitted, gold			2022-12-25	WOS:000330235100063
J	Shinzato, C; Inoue, M; Kusakabe, M				Shinzato, Chuya; Inoue, Mayuri; Kusakabe, Makoto			A Snapshot of a Coral "Holobiont": A Transcriptome Assembly of the Scleractinian Coral, Porites, Captures a Wide Variety of Genes from Both the Host and Symbiotic Zooxanthellae	PLOS ONE			English	Article							AMINO-ACID SYNTHESIS; CLIMATE-CHANGE; ANEMONE AIPTASIA; ALGAL SYMBIONTS; GENOME; DIVERSITY; SEQUENCE; CALCIFICATION; ACIDIFICATION; RESILIENCE	Massive scleractinian corals of the genus Porites are important reef builders in the Indo-Pacific, and they are more resistant to thermal stress than other stony corals, such as the genus Acropora. Because coral health and survival largely depend on the interaction between a coral host and its symbionts, it is important to understand the molecular interactions of an entire "coral holobiont". We simultaneously sequenced transcriptomes of Porites australiensis and its symbionts using the Illumina Hiseq2000 platform. We obtained 14.3 Gbp of sequencing data and assembled it into 74,997 contigs (average: 1,263 bp, N50 size: 2,037 bp). We successfully distinguished contigs originating from the host (Porites) and the symbiont (Symbiodinium) by aligning nucleotide sequences with the decoded Acropora digitifera and Symbiodinium minutum genomes. In contrast to previous coral transcriptome studies, at least 35% of the sequences were found to have originated from the symbionts, indicating that it is possible to analyze both host and symbiont transcriptomes simultaneously. Conserved protein domain and KEGG analyses showed that the dataset contains broad gene repertoires of both Porites and Symbiodinium. Effective utilization of sequence reads revealed that the polymorphism rate in P. australiensis is 1.0% and identified the major symbiotic Symbiodinium as Type C15. Analyses of amino acid biosynthetic pathways suggested that this Porites holobiont is probably able to synthesize most of the common amino acids and that Symbiodinium is potentially able to provide essential amino acids to its host. We believe this to be the first molecular evidence of complementarity in amino acid metabolism between coral hosts and their symbionts. We successfully assembled genes originating from both the host coral and the symbiotic Symbiodinium to create a snapshot of the coral holobiont transcriptome. This dataset will facilitate a deeper understanding of molecular mechanisms of coral symbioses and stress responses.	[Shinzato, Chuya] Okinawa Inst Sci & Technol Grad Univ, Marine Genom Unit, Onna, Okinawa, Japan; [Inoue, Mayuri; Kusakabe, Makoto] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	Okinawa Institute of Science & Technology Graduate University; University of Tokyo	Shinzato, C (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Marine Genom Unit, Onna, Okinawa, Japan.	c.shinzato@oist.jp	Shinzato, Chuya/G-2958-2015	Shinzato, Chuya/0000-0001-7843-3381	Interdisciplinary Collaborative Research Program of the Atmosphere and Ocean Research Institute; University of Tokyo; Canon Foundation; KAKENHI [24241071, 25660172]	Interdisciplinary Collaborative Research Program of the Atmosphere and Ocean Research Institute; University of Tokyo; Canon Foundation(Canon Foundation); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Interdisciplinary Collaborative Research Program of the Atmosphere and Ocean Research Institute, the University of Tokyo and by The Canon Foundation and in part by KAKENHI (24241071 and 25660172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Appeltans W, 2012, WORLD REGISTER MARIN; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bayer T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035269; BECK JW, 1992, SCIENCE, V257, P644, DOI 10.1126/science.257.5070.644; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; de Jong DM, 2006, DEV BIOL, V298, P632, DOI 10.1016/j.ydbio.2006.07.034; Dubuc TQ, 2012, INTEGR COMP BIOL; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Furst P, 2004, J NUTR, V134, p1558S, DOI 10.1093/jn/134.6.1558S; Gagan MK, 2000, QUATERNARY SCI REV, V19, P45, DOI 10.1016/S0277-3791(99)00054-2; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HOHMAN TC, 1982, J CELL BIOL, V94, P56, DOI 10.1083/jcb.94.1.56; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Iguchi A, 2012, MAR ENVIRON RES, V73, P32, DOI 10.1016/j.marenvres.2011.10.008; Inoue M, 2008, SCI TOTAL ENVIRON, V406, P123, DOI 10.1016/j.scitotenv.2008.07.032; Kawashima T, 2009, GENOME RES, V19, P1393, DOI 10.1101/gr.087072.108; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; Lehnert EM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-271; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Ohde S, 2004, GEOCHEM J, V38, P613, DOI 10.2343/geochemj.38.613; Pochon X, 2007, CORAL REEFS, V26, P867, DOI 10.1007/s00338-007-0279-x; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Polato NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028634; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SHEN GT, 1987, NATURE, V328, P794, DOI 10.1038/328794a0; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Shinzato C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-311; Shoguchi E, 2013, CURR BIOL; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Stat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015854; Swanson R, 1998, MAR BIOL, V131, P83, DOI 10.1007/s002270050299; Traylor-Knowles N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-585; Wang JT, 1999, MAR BIOL, V135, P219, DOI 10.1007/s002270050619; Weis VM, 2010, MOL ECOL, V19, P1515, DOI 10.1111/j.1365-294X.2010.04575.x; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	56	63	64	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85182	10.1371/journal.pone.0085182	http://dx.doi.org/10.1371/journal.pone.0085182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454815	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100062
J	Zaveri, HP; Beck, TF; Hernandez-Garcia, A; Shelly, KE; Montgomery, T; van Haeringen, A; Anderlid, BM; Patel, C; Goel, H; Houge, G; Morrow, BE; Cheung, SW; Lalani, SR; Scott, DA				Zaveri, Hitisha P.; Beck, Tyler F.; Hernandez-Garcia, Andres; Shelly, Katharine E.; Montgomery, Tara; van Haeringen, Arie; Anderlid, Britt-Marie; Patel, Chirag; Goel, Himanshu; Houge, Gunnar; Morrow, Bernice E.; Cheung, Sau Wai; Lalani, Seema R.; Scott, Daryl A.			Identification of Critical Regions and Candidate Genes for Cardiovascular Malformations and Cardiomyopathy Associated with Deletions of Chromosome 1p36	PLOS ONE			English	Article							LEFT-VENTRICULAR NONCOMPACTION; MONOSOMY 1P36; SIGNALING PATHWAY; TERMINAL DELETION; MUTATIONS; MICE; ABNORMALITIES; PERLECAN; DISEASE; BREAKPOINTS	Cardiovascular malformations and cardiomyopathy are among the most common phenotypes caused by deletions of chromosome 1p36 which affect approximately 1 in 5000 newborns. Although these cardiac-related abnormalities are a significant source of morbidity and mortality associated with 1p36 deletions, most of the individual genes that contribute to these conditions have yet to be identified. In this paper, we use a combination of clinical and molecular cytogenetic data to define five critical regions for cardiovascular malformations and two critical regions for cardiomyopathy on chromosome 1p36. Positional candidate genes which may contribute to the development of cardiovascular malformations associated with 1p36 deletions include DVL1, SKI, RERE, PDPN, SPEN, CLCNKA, ECE1, HSPG2, LUZP1, and WASF2. Similarly, haploinsufficiency of PRDM16-a gene which was recently shown to be sufficient to cause the left ventricular noncompaction-SKI, PRKCZ, RERE, UBE4B and MASP2 may contribute to the development of cardiomyopathy. When treating individuals with 1p36 deletions, or providing prognostic information to their families, physicians should take into account that 1p36 deletions which overlie these cardiac critical regions may portend to cardiovascular complications. Since several of these cardiac critical regions contain more than one positional candidate gene-and large terminal and interstitial 1p36 deletions often overlap more than one cardiac critical region-it is likely that haploinsufficiency of two or more genes contributes to the cardiac phenotypes associated with many 1p36 deletions.	[Zaveri, Hitisha P.; Beck, Tyler F.; Hernandez-Garcia, Andres; Shelly, Katharine E.; Cheung, Sau Wai; Lalani, Seema R.; Scott, Daryl A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Scott, Daryl A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Montgomery, Tara] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [van Haeringen, Arie] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Anderlid, Britt-Marie] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Anderlid, Britt-Marie] Karolinska Inst, Inst Mol Med & Surg, Stockholm, Sweden; [Patel, Chirag] Birmingham Womens Hosp, Dept Clin Genet, Birmingham, W Midlands, England; [Goel, Himanshu] Univ Newcastle, Fac Hlth & Med, Callaghan, NSW 2308, Australia; [Houge, Gunnar] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Morrow, Bernice E.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA	Baylor College of Medicine; Baylor College of Medicine; Newcastle University - UK; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Birmingham Women's Hospital; University of Newcastle; University of Bergen; Haukeland University Hospital; Yeshiva University; Albert Einstein College of Medicine	Scott, DA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	dscott@bcm.edu	Patel, Chirag/AAF-4953-2019; HERNANDEZ-GARCIA, ANDRES/B-9051-2014; Lalani, Seema/AAI-5090-2020	Patel, Chirag/0000-0002-6374-5224; HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; Beck, Tyler/0000-0002-7373-0640; Morrow, Bernice/0000-0002-8076-4726	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008307] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; Arndt AK, 2013, AM J HUM GENET, V93, P67, DOI 10.1016/j.ajhg.2013.05.015; Battaglia A, 2008, PEDIATRICS, V121, P404, DOI 10.1542/peds.2007-0929; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Boldt ABW, 2011, CLIN IMMUNOL, V140, P63, DOI 10.1016/j.clim.2011.03.008; Bursztejn AC, 2009, AM J MED GENET A, V149A, P2493, DOI 10.1002/ajmg.a.33051; Campeau PM, 2008, AM J MED GENET A, V146A, P3062, DOI 10.1002/ajmg.a.32563; Cappola TP, 2011, P NATL ACAD SCI USA, V108, P2456, DOI 10.1073/pnas.1017494108; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Cremer K, 2008, EUR J MED GENET, V51, P685, DOI 10.1016/j.ejmg.2008.07.006; Douglas YL, 2009, PEDIATR RES, V65, P27, DOI 10.1203/PDR.0b013e31818bc11a; Doyle AJ, 2012, NAT GENET, V44, P1249, DOI 10.1038/ng.2421; El-Hattab AW, 2010, AM J MED GENET A, V152A, P504, DOI 10.1002/ajmg.a.33226; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Gajecka M, 2010, AM J MED GENET A, V152A, P3074, DOI 10.1002/ajmg.a.33733; Heilstedt HA, 2003, AM J HUM GENET, V72, P1200, DOI 10.1086/375179; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; Hofstra RMW, 1999, AM J HUM GENET, V64, P304, DOI 10.1086/302184; Hsu CY, 2008, BIOCHEM BIOPH RES CO, V376, P466, DOI 10.1016/j.bbrc.2008.08.170; Kaneko-Oshikawa C, 2005, MOL CELL BIOL, V25, P10953, DOI 10.1128/MCB.25.24.10953-10964.2005; Kang SHL, 2007, CLIN GENET, V72, P329, DOI 10.1111/j.1399-0004.2007.00876.x; Kim BJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057460, 10.1371/journal.pone.0068422]; Klaassen S, 2008, CIRCULATION, V117, P2893, DOI 10.1161/CIRCULATIONAHA.107.746164; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Luedde M, 2010, CARDIOVASC RES, V86, P452, DOI 10.1093/cvr/cvq009; Mahtab EAF, 2008, DEV DYNAM, V237, P847, DOI 10.1002/dvdy.21463; Mahtab EAF, 2009, DEV DYNAM, V238, P183, DOI 10.1002/dvdy.21819; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; Nicoulaz A, 2011, AM J MED GENET A, V155A, P1964, DOI 10.1002/ajmg.a.33210; Peddy SB, 2006, PEDIATRICS, V117, P1830, DOI 10.1542/peds.2005-2301; Pizzuti A, 2003, HUM MUTAT, V22, P372, DOI 10.1002/humu.10261; Saito S, 2008, AM J MED GENET A, V146A, P2891, DOI 10.1002/ajmg.a.32556; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shapria SK, 1997, AM J HUM GENET, V61, P642, DOI 10.1086/515520; Slavotinek A, 1999, J MED GENET, V36, P657; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Wat MJ, 2009, AM J MED GENET A, V149A, P1661, DOI 10.1002/ajmg.a.32896; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Wu YQ, 1999, HUM MOL GENET, V8, P313, DOI 10.1093/hmg/8.2.313; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Yanagisawa H, 1998, J CLIN INVEST, V102, P22, DOI 10.1172/JCI2698; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	47	37	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85600	10.1371/journal.pone.0085600	http://dx.doi.org/10.1371/journal.pone.0085600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454898	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100103
J	Zhang, XF; Wei, T; Liu, XM; Liu, C; Lv, Y				Zhang, Xu-Feng; Wei, Tao; Liu, Xue-Min; Liu, Chang; Lv, Yi			Impact of Cigarette Smoking on Outcome of Hepatocellular Carcinoma after Surgery in Patients with Hepatitis B	PLOS ONE			English	Article							POSTOPERATIVE COMPLICATIONS; PROSTATE-CANCER; LIVER-DISEASE; ALCOHOL-USE; RISK; RECURRENCE; TOBACCO; INTERVENTION; SINGAPORE; CIRRHOSIS	Background and Objectives: Cigarette smoking is a potential risk factor for hepatocellular carcinoma (HCC) initiation, partially through interaction with hepatitis B virus (HBV). We examined the hypothesis that cigarette smoking might be associated with HBV-related HCC recurrence and patient survival after curative surgery. Patients and Methods: Data of 302 patients with HBV infection who had undergone curative resection for HCC were prospectively collected from 2008 to 2011. Smoking status and smoking quantity (pack-years, PY) were asked at admission. Factors affecting recurrence-free survival (RFS) were examined. RFS and liver-specific mortality (LSM) stratified by risk factors were compared with log-rank test. Results: 109 were current smokers. Current smokers were not different from non-smokers in tumor burden and surgical procedure. Univariate and multivariate analysis identified that heavy smoking (PY >= 20) was the most significant factor associated with HBV-related HCC recurrence after curative surgical resection (p = 0.001), followed by anti-HBV treatment (p < 0.01), current smoking (p = 0.028), surgical margin < 1 cm (p = 0.048) and blood transfusion > 600 ml (p = 0.028). The median RFS in non-smokers, ex-smokers and current smokers was 34 months, 24 months and 26 months, respectively (p = 0.033). Current smokers had significantly worse RFS rate and increased 5-year cumulative LSM than non-smokers (p = 0.024, and p < 0.001, respectively). Heavy smokers had significantly worse RFS than non-and light smokers (0 < PY < 20) (p < 0.001, respectively) and higher cumulative LSM than non-smokers and light smokers (p = 0.003 and 0.001, respectively). Furthermore, in current smokers, continuing smoking postoperatively was strongly associated with poorer RFS and higher LSM than those who quit smoking postoperatively (p = 0.016 and p = 0.003, respectively). Conclusions: Smoking history and quantity appears to be risk factors for HBV-related HCC recurrence and LSM of patients after surgery. For smokers, continued smoking postoperatively might accelerate tumor recurrence and patient death. Therefore, smoking abstinence should be strongly recommended to patients pre- and postoperatively.	[Zhang, Xu-Feng; Wei, Tao; Liu, Xue-Min; Liu, Chang; Lv, Yi] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Peoples R China	Xi'an Jiaotong University	Lv, Y (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Peoples R China.	luyi169@126.com	zhang, xu/GYE-3558-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GRX-9733-2022; zhang, xian/GYA-0290-2022		National Natural Science Foundation [81372582, 81101873]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation (numbers 81372582, 81101873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano J, 2010, GUT, V59, P1159, DOI 10.1136/gut.2008.162453; Azzalini L, 2010, HEPATOLOGY, V51, P1567, DOI 10.1002/hep.23516; CHEN JG, 2010, ZHONGHUA YU FANG YI, V44, P383; Chen ZM, 2003, INT J CANCER, V107, P106, DOI 10.1002/ijc.11342; Chuang SC, 2010, CANCER EPIDEM BIOMAR, V19, P1261, DOI 10.1158/1055-9965.EPI-09-1297; El-Zayadi AR, 2006, WORLD J GASTROENTERO, V12, P6098, DOI 10.3748/wjg.v12.i38.6098; Giovannucci E, 1999, CANCER EPIDEM BIOMAR, V8, P277; Grosse Y, 2007, LANCET ONCOL, V8, P679, DOI 10.1016/S1470-2045(07)70235-8; Hagiwara M, 2013, J UROLOGY, V189, P2062, DOI 10.1016/j.juro.2013.01.024; Helen A, 1997, J APPL TOXICOL, V17, P289, DOI 10.1002/(SICI)1099-1263(199709)17:5&lt;289::AID-JAT448&gt;3.0.CO;2-9; Hezode C, 2003, GUT, V52, P126, DOI 10.1136/gut.52.1.126; Janjigian YY, 2010, CANCER-AM CANCER SOC, V116, P670, DOI 10.1002/cncr.24813; Joshu CE, 2011, JNCI-J NATL CANCER I, V103, P835, DOI 10.1093/jnci/djr124; Kao JH, 2002, J FORMOS MED ASSOC, V101, P239; Koh WP, 2011, BRIT J CANCER, V105, P1430, DOI 10.1038/bjc.2011.360; Koh WP, 2005, J NUTR, V135, P2473, DOI 10.1093/jn/135.10.2473; Liaw KM, 1998, TOB CONTROL, V7, P141, DOI 10.1136/tc.7.2.141; Lindstrom D, 2008, ANN SURG, V248, P739, DOI 10.1097/SLA.0b013e3181889d0d; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Lok ASF, 2004, HEPATOLOGY, V39, P857, DOI 10.1002/hep.20110; Marrero JA, 2005, J HEPATOL, V42, P218, DOI 10.1016/j.jhep.2004.10.005; Moller AM, 2002, LANCET, V359, P114, DOI 10.1016/S0140-6736(02)07369-5; Nagle CM, 2006, CANCER EPIDEM BIOMAR, V15, P2557, DOI 10.1158/1055-9965.EPI-06-0592; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pessione F, 2001, HEPATOLOGY, V34, P121, DOI 10.1053/jhep.2001.25385; Peters MG, 2002, HEPATOLOGY, V36, pS220, DOI 10.1053/jhep.2002.36811; Phipps AI, 2013, J CLIN ONCOL, V31, P2016, DOI 10.1200/JCO.2012.46.2457; Rudin CM, 2009, CLIN CANCER RES, V15, P5646, DOI 10.1158/1078-0432.CCR-09-0377; Sanchez-Cespedes M, 2001, CANCER RES, V61, P1309; Shih WL, 2012, INT J CANCER, V131, P2612, DOI 10.1002/ijc.27508; Smyth EC, 2012, ANN SURG ONCOL, V19, P2088, DOI 10.1245/s10434-012-2230-9; Tammemagi MC, 2000, ANN EPIDEMIOL, V10, P176, DOI 10.1016/S1047-2797(99)00048-4; Wang LY, 1998, AM J EPIDEMIOL, V147, P315; Yu MC, 2000, CAN J GASTROENTEROL, V14, P703, DOI 10.1155/2000/371801; Yu MW, 1999, HEPATOLOGY, V29, P697, DOI 10.1002/hep.510290330; Zhang XF, 2009, EJSO-EUR J SURG ONC, V35, P622, DOI 10.1016/j.ejso.2008.08.003	36	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85077	10.1371/journal.pone.0085077	http://dx.doi.org/10.1371/journal.pone.0085077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454795	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100054
J	Janssen, BH; Voet, NBM; Nabuurs, CI; Kan, HE; de Rooy, JWJ; Geurts, AC; Padberg, GW; van Engelen, BGM; Heerschap, A				Janssen, Barbara H.; Voet, Nicoline B. M.; Nabuurs, Christine I.; Kan, Hermien E.; de Rooy, Jacky W. J.; Geurts, Alexander C.; Padberg, George W.; van Engelen, Baziel G. M.; Heerschap, Arend			Distinct Disease Phases in Muscles of Facioscapulohumeral Dystrophy Patients Identified by MR Detected Fat Infiltration	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MYOTONIC-DYSTROPHY; SPECTROSCOPY; PHOSPHOCREATINE; QUANTIFICATION; PROGRESSION; PATTERNS; EXERCISE	Facioscapulohumeral muscular dystrophy (FSHD) is an untreatable disease, characterized by asymmetric progressive weakness of skeletal muscle with fatty infiltration. Although the main genetic defect has been uncovered, the downstream mechanisms causing FSHD are not understood. The objective of this study was to determine natural disease state and progression in muscles of FSHD patients and to establish diagnostic biomarkers by quantitative MRI of fat infiltration and phosphorylated metabolites. MRI was performed at 3T with dedicated coils on legs of 41 patients (28 men/13 women, age 34-76 years), of which eleven were re-examined after four months of usual care. Muscular fat fraction was determined with multi spin-echo and T1 weighted MRI, edema by TIRM and phosphorylated metabolites by 3D P-31 MR spectroscopic imaging. Fat fractions were compared to clinical severity, muscle force, age, edema and phosphocreatine (PCr)/ATP. Longitudinal intramuscular fat fraction variation was analyzed by linear regression. Increased intramuscular fat correlated with age (p<0.05), FSHD severity score (p<0.0001), inversely with muscle strength (p<0.0001), and also occurred subclinically. Muscles were nearly dichotomously divided in those with high and with low fat fraction, with only 13% having an intermediate fat fraction. The intramuscular fat fraction along the muscle's length, increased from proximal to distal. This fat gradient was the steepest for intermediate fat infiltrated muscles (0.07 +/- 0.01/cm, p<0.001). Leg muscles in this intermediate phase showed a decreased PCr/ATP (p<0.05) and the fastest increase in fatty infiltration over time (0.18 +/- 0.15/year, p<0.001), which correlated with initial edema (p<0.01), if present. Thus, in the MR assessment of fat infiltration as biomarker for diseased muscles, the intramuscular fat distribution needs to be taken into account. Our results indicate that healthy individual leg muscles become diseased by entering a progressive phase with distal fat infiltration and altered energy metabolite levels. Fat replacement then relatively rapidly spreads over the whole muscle.	[Janssen, Barbara H.; Nabuurs, Christine I.; Kan, Hermien E.; de Rooy, Jacky W. J.; Heerschap, Arend] Radboud Univ Nijmegen, Dept Radiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Voet, Nicoline B. M.; Geurts, Alexander C.] Radboud Univ Nijmegen, Dept Rehabil, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kan, Hermien E.] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Padberg, George W.; van Engelen, Baziel G. M.] Radboud Univ Nijmegen, Dept Neurol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Janssen, BH (corresponding author), Radboud Univ Nijmegen, Dept Radiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	Barbara.Janssen@radboudumc.nl	Kan, Hermien/L-2385-2013; Voet, Nicole/A-1395-2016; Padberg, G.W.A.M./H-8079-2014; Geurts, Alexander/H-8032-2014; Janssen, Barbara/M-9165-2013; van Engelen, Baziel/H-8027-2014; Heerschap, Arend/G-5228-2010	Kan, Hermien/0000-0002-5772-7177; Voet, Nicole/0000-0001-7381-2817; Geurts, Alexander/0000-0001-7478-1119; van Engelen, Baziel/0000-0001-9867-9047; 	Prinses Beatrix Spierfonds [WAR08-15]; ZonMW [89000003]; FSHD Global Research Foundation; FSH Society	Prinses Beatrix Spierfonds; ZonMW(Netherlands Organization for Health Research and Development); FSHD Global Research Foundation; FSH Society	This work was supported by the Prinses Beatrix Spierfonds [WAR08-15] (https://www.prinsesbeatrixspierfonds.nl), ZonMW [89000003 (http://www.zonmw.nl/en/), the FSHD Global Research Foundation (http://www.fshdglobal.org/), and the FSH Society (http://www.fshsociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee B, 2010, MAGN RESON IMAGING, V28, P698, DOI 10.1016/j.mri.2010.03.008; BARBIROLI B, 1992, J NEUROL SCI, V109, P188, DOI 10.1016/0022-510X(92)90167-J; Barnes PRJ, 1997, BRAIN, V120, P1699, DOI 10.1093/brain/120.10.1699; Dubowitz V, 2007, MUSCULAR DYSTROPHIES; FELMLEE JP, 1987, RADIOLOGY, V164, P559, DOI 10.1148/radiology.164.2.3602402; Fischmann A, 2012, J NEUROL, V259, P1648, DOI 10.1007/s00415-011-6393-2; Friedman SD, 2013, MUSCLE NERVE, V31, P155; Friedman SD, 2012, MUSCLE NERVE, V45, P500, DOI 10.1002/mus.22342; Frisullo G, 2011, J CLIN IMMUNOL, V31, P155, DOI 10.1007/s10875-010-9474-6; Gaeta M, 2012, SKELETAL RADIOL, V41, P955, DOI 10.1007/s00256-011-1301-5; Gaeta M, 2012, SKELETAL RADIOL, V41, P515, DOI 10.1007/s00256-011-1199-y; Grehl T, 1998, NEUROMUSCULAR DISORD, V8, P480, DOI 10.1016/S0960-8966(98)00066-2; HEERSCHAP A, 1993, MUSCLE NERVE, V16, P367, DOI 10.1002/mus.880160405; Kan HE, 2010, NMR BIOMED, V23, P563, DOI 10.1002/nbm.1494; Kan HE, 2009, NEUROMUSCULAR DISORD, V19, P357, DOI 10.1016/j.nmd.2009.02.009; KEMP GJ, 1993, J NEUROL SCI, V116, P201, DOI 10.1016/0022-510X(93)90326-T; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; KUSHMERICK MJ, 1992, P NATL ACAD SCI USA, V89, P7521, DOI 10.1073/pnas.89.16.7521; LAMMINEN AE, 1990, BRIT J RADIOL, V63, P946, DOI 10.1259/0007-1285-63-756-946; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lodi R, 1997, NEUROMUSCULAR DISORD, V7, P505, DOI 10.1016/S0960-8966(97)00108-9; May DA, 2000, RADIOGRAPHICS, V20, pS295, DOI 10.1148/radiographics.20.suppl_1.g00oc18s295; McMahon CJ, 2010, AM J ROENTGENOL, V194, pW284, DOI 10.2214/AJR.10.4247; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Padberg G., 1982, THESIS U LEIDEN LEID; Pandya S, 2008, PHYS THER, V88, P105, DOI 10.2522/ptj.20070104; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Richards M, 2012, HUM GENET, V131, P325, DOI 10.1007/s00439-011-1100-z; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Sookhoo S, 2007, CLIN RADIOL, V62, P160, DOI 10.1016/j.crad.2006.08.012; Statland JM, 2013, NEUROMUSCULAR DISORD, V23, P306, DOI 10.1016/j.nmd.2013.01.008; Statland JM, 2011, CURR OPIN NEUROL, V24, P423, DOI 10.1097/WCO.0b013e32834959af; Takahashi H, 1996, NMR BIOMED, V9, P8, DOI 10.1002/(SICI)1099-1492(199602)9:1<8::AID-NBM387>3.0.CO;2-F; Tasca G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038779; Tassin A, 2013, J CELL MOL MED, V17, P76, DOI 10.1111/j.1582-4934.2012.01647.x; Tawil R, 2008, NEUROTHERAPEUTICS, V5, P601, DOI 10.1016/j.nurt.2008.07.005; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Taylor D J, 1983, Mol Biol Med, V1, P77; Trenell MI, 2006, ANN NEUROL, V59, P871, DOI 10.1002/ana.20841; van der Kooi EL, 2004, NEUROLOGY, V63, P702, DOI 10.1212/01.WNL.0000134660.30793.1F; van der Maarel SM, 2011, TRENDS MOL MED, V17, P252, DOI 10.1016/j.molmed.2011.01.001; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Voet NBM, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-56; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2; Wren TAL, 2008, AM J ROENTGENOL, V190, pW8, DOI 10.2214/AJR.07.2732	45	96	97	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85416	10.1371/journal.pone.0085416	http://dx.doi.org/10.1371/journal.pone.0085416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454861	Green Published, Green Submitted, gold			2022-12-25	WOS:000329925800046
J	Jiricny, N; Molin, S; Foster, K; Diggle, SP; Scanlan, PD; Ghoul, M; Johansen, HK; Santorelli, LA; Popat, R; West, SA; Griffin, AS				Jiricny, Natalie; Molin, Soren; Foster, Kevin; Diggle, Stephen P.; Scanlan, Pauline D.; Ghoul, Melanie; Johansen, Helle Krogh; Santorelli, Lorenzo A.; Popat, Roman; West, Stuart A.; Griffin, Ashleigh S.			Loss of Social Behaviours in Populations of Pseudomonas aeruginosa Infecting Lungs of Patients with Cystic Fibrosis	PLOS ONE			English	Article							QUORUM-SENSING HIERARCHY; VIRULENCE; COOPERATION; ADAPTATION; EVOLUTION; AIRWAYS; GENES; LASR; EPIDEMIOLOGY; EXPRESSION	Pseudomonas aeruginosa, is an opportunistic, bacterial pathogen causing persistent and frequently fatal infections of the lung in patients with cystic fibrosis. Isolates from chronic infections differ from laboratory and environmental strains in a range of traits and this is widely interpreted as the result of adaptation to the lung environment. Typically, chronic strains carry mutations in global regulation factors that could effect reduced expression of social traits, raising the possibility that competitive dynamics between cooperative and selfish, cheating strains could also drive changes in P. aeruginosa infections. We compared the expression of cooperative traits -biofilm formation, secretion of exo-products and quorum sensing (QS) in P. aeruginosa isolates that were estimated to have spent different lengths of time in the lung based on clinical information. All three exo-products involved in nutrient acquisition were produced in significantly smaller quantities with increased duration of infection, and patterns across four QS signal molecules were consistent with accumulation over time of mutations in lasR, which are known to disrupt the ability of cells to respond to QS signal. Pyocyanin production, and the proportion of cells in biofilm relative to motile, free-living cells in liquid culture, did not change. Overall, our results confirm that the loss of social behaviour is a consistent trend with time spent in the lung and suggest that social dynamics are potentially relevant to understanding the behaviour of P. aeruginosa in lung infections.	[Jiricny, Natalie; Foster, Kevin; Scanlan, Pauline D.; Ghoul, Melanie; Santorelli, Lorenzo A.; West, Stuart A.; Griffin, Ashleigh S.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Molin, Soren] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Diggle, Stephen P.] Univ Nottingham, Sch Life Sci, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Johansen, Helle Krogh] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Popat, Roman] Univ Edinburgh, Ctr Immun Infect & Evolut, Ashworth Labs, Edinburgh, Midlothian, Scotland	University of Oxford; Technical University of Denmark; University of Nottingham; University of Copenhagen; University of Edinburgh	Griffin, AS (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	ashleigh.griffin@zoo.ox.ac.uk	Scanlan, Pauline/AAE-7713-2019; West, Stuart A/M-3608-2014; Griffin, Ashleigh/C-6244-2014	Scanlan, Pauline/0000-0002-6733-9653; West, Stuart A/0000-0003-2152-3153; Griffin, Ashleigh/0000-0001-7674-9825; Santorelli, Lorenzo/0000-0002-8392-801X; Foster, Kevin/0000-0003-4687-6633; Molin, Soren/0000-0002-7973-2639	BBSRC; ERC; Royal Society and L'Oreal/UNESCO Fellowship for Women in Science; NERC [NE/J007064/]; NERC [NE/J010642/1, NE/J007064/1] Funding Source: UKRI; Natural Environment Research Council [NE/J007064/1, NE/J010642/1] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); Royal Society and L'Oreal/UNESCO Fellowship for Women in Science(L'Oreal Group); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Novo Nordisk Fonden(Novo Nordisk Foundation)	Work was funded by BBSRC studentship to NJ; ERC to SAW; Royal Society and L'Oreal/UNESCO Fellowship for Women in Science to ASG; NERC grant to SAW and SPD Grant Ref: NE/J007064/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKENBAUER R, 1985, INFECT IMMUN, V49, P132, DOI 10.1128/IAI.49.1.132-140.1985; AYORA S, 1994, MOL GEN GENET, V242, P421, DOI 10.1007/BF00281792; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Bodilis J, 2009, ENVIRON MICROBIOL, V11, P2123, DOI 10.1111/j.1462-2920.2009.01932.x; Buckling A, 2007, FEMS MICROBIOL ECOL, V62, P135, DOI 10.1111/j.1574-6941.2007.00388.x; Carlsson M, 2011, J CYST FIBROS, V10, P265, DOI 10.1016/j.jcf.2011.03.004; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; De Vos D, 2001, ARCH MICROBIOL, V175, P384, DOI 10.1007/s002030100278; Dekimpe V, 2009, MICROBIOL-SGM, V155, P712, DOI 10.1099/mic.0.022764-0; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dubern JF, 2008, MOL BIOSYST, V4, P882, DOI 10.1039/b803796p; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Fletcher MP, 2010, PSEUDOMONAS, VOL 6: MOLECULAR MICROBIOLOGY, INFECTION AND BIODIVERSITY, P29, DOI 10.1007/978-90-481-3909-5_2; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; GAMBELLO MJ, 1993, INFECT IMMUN, V61, P1180, DOI 10.1128/IAI.61.4.1180-1184.1993; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HANCOCK REW, 1983, INFECT IMMUN, V42, P170, DOI 10.1128/IAI.42.1.170-177.1983; Hansen SK, 2012, ISME J, V6, P31, DOI 10.1038/ismej.2011.83; Harrison F, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-21; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Hogardt M, 2013, CURR TOP MICROBIOL, V358, P91, DOI 10.1007/82_2011_199; Holloway B., 1975, GENETICS BIOCH PSEUD; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; Jiricny N, 2010, J EVOLUTION BIOL, V23, P738, DOI 10.1111/j.1420-9101.2010.01939.x; Johansen HK, 2004, PEDIATR PULM, V37, P427, DOI 10.1002/ppul.10457; Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09; Kohler T, 2009, P NATL ACAD SCI USA, V106, P6339, DOI 10.1073/pnas.0811741106; Kurachi M, 1958, B I CHEM RES, V36; Lee B, 2005, J CLIN MICROBIOL, V43, P5247, DOI 10.1128/JCM.43.10.5247-5255.2005; Lee B, 2011, APMIS, V119, P263, DOI 10.1111/j.1600-0463.2011.02726.x; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; Ortori C, 2011, ANAL BIOANAL CHEM, V399, P497; Ortori CA, 2007, ANAL BIOANAL CHEM, V387, P497, DOI 10.1007/s00216-006-0710-0; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Rau MH, 2010, ENVIRON MICROBIOL, V12, P1643, DOI 10.1111/j.1462-2920.2010.02211.x; Reid DW, 2007, EUR RESPIR J, V30, P286, DOI 10.1183/09031936.00154006; ROMLING U, 1994, J INFECT DIS, V170, P1616, DOI 10.1093/infdis/170.6.1616; Rumbaugh KP, 2012, P ROY SOC B-BIOL SCI, V279, P3584, DOI 10.1098/rspb.2012.0843; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Spencer DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Wilder CN, 2009, INFECT IMMUN, V77, P5631, DOI 10.1128/IAI.00755-09; Yang L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-184; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108	55	50	51	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e83124	10.1371/journal.pone.0083124	http://dx.doi.org/10.1371/journal.pone.0083124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454693	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800007
J	Kim, J; Shapiro, MJ; Bamidele, AO; Gurel, P; Thapa, P; Higgs, HN; Hedin, KE; Shapiro, VS; Billadeau, DD				Kim, Joanna; Shapiro, Michael J.; Bamidele, Adebowale O.; Gurel, Pinar; Thapa, Puspa; Higgs, Henry N.; Hedin, Karen E.; Shapiro, Virginia S.; Billadeau, Daniel D.			Coactosin-Like 1 Antagonizes Cofilin to Promote Lamellipodial Protrusion at the Immune Synapse	PLOS ONE			English	Article							T-CELL-ACTIVATION; ACTIN-DEPOLYMERIZING FACTOR; ALDRICH-SYNDROME PROTEIN; IMMUNOLOGICAL SYNAPSE; BINDING-PROTEIN; TRANSCRIPTIONAL REPRESSOR; CRYSTAL-STRUCTURE; NONMUSCLE CELLS; ADAPTER PROTEIN; DYNAMICS	Actin depolymerizing factor-homology (ADF-H) family proteins regulate actin filament dynamics at multiple cellular locations. Herein, we have investigated the function of the ADF-H family member coactosin-like 1 (COTL1) in the regulation of actin dynamics at the T cell immune synapse (IS). We initially identified COTL1 in a genetic screen to identify novel regulators of T cell activation, and subsequently found that it associates with F-actin and localizes at the IS in response to TCR+CD28 stimulation. Live cell microscopy showed that depletion of COTL1 protein impaired T cell spreading in response to TCR ligation and abrogated lamellipodial protrusion at the T cell - B cell contact site, producing only a band of F-actin. Significantly, re-expression of wild type COTL1, but not a mutant deficient in F-actin binding could rescue these defects. In addition, COTL1 depletion reduced T cell migration. In vitro studies showed that COTL1 and cofilin compete with each other for binding to F-actin, and COTL1 protects F-actin from cofilin-mediated depolymerization. While depletion of cofilin enhanced F-actin assembly and lamellipodial protrusion at the IS, concurrent depletion of both COTL1 and cofilin restored lamellipodia formation. Taken together, our results suggest that COTL1 regulates lamellipodia dynamics in part by protecting F-actin from cofilin-mediated disassembly.	[Kim, Joanna; Billadeau, Daniel D.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA; [Shapiro, Michael J.; Thapa, Puspa; Hedin, Karen E.; Shapiro, Virginia S.; Billadeau, Daniel D.] Mayo Clin, Dept Immunol, Coll Med, Rochester, MN 55905 USA; [Bamidele, Adebowale O.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Coll Med, Rochester, MN USA; [Gurel, Pinar; Higgs, Henry N.] Dartmouth Coll, Dept Biochem, Geisel Sch Med Dartmouth, Hanover, NH 03755 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Dartmouth College	Shapiro, VS (corresponding author), Mayo Clin, Dept Immunol, Coll Med, Rochester, MN 55905 USA.	shapiro.virginia1@mayo.edu; billadeau.daniel@mayo.edu	Bamidele, Adebowale O./AAZ-2453-2020; Kim, Joanna/U-5556-2018	Bamidele, Adebowale O./0000-0002-9547-2195; Kim, Joanna/0000-0001-7877-9446; Higgs, Henry/0000-0002-2917-9644; Hedin, Karen/0000-0003-1010-923X	Mayo Foundation; National Institutes of Health [R01-AI065474, R21 AI104065]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065474, R21AI104065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062981, T34GM008078, T32GM008704, T32GM072474] Funding Source: NIH RePORTER	Mayo Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Mayo Foundation and National Institutes of Health grants R01-AI065474 (DDB) and R21 AI104065 (VSS and DDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Carrizosa E, 2009, J IMMUNOL, V183, P7352, DOI 10.4049/jimmunol.0900973; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; DEHOSTOS EL, 1993, CELL MOTIL CYTOSKEL, V26, P181, DOI 10.1002/cm.970260302; Doucet J, 2002, BIOCHEM BIOPH RES CO, V290, P783, DOI 10.1006/bbrc.2001.6236; Eibert SM, 2004, P NATL ACAD SCI USA, V101, P1957, DOI 10.1073/pnas.0308282100; Gomez TS, 2008, ADV IMMUNOL, V97, P1, DOI 10.1016/S0065-2776(08)00001-1; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Gorman JA, 2012, J IMMUNOL, V188, P6135, DOI 10.4049/jimmunol.1103487; Goroncy AK, 2009, PROTEIN SCI, V18, P2384, DOI 10.1002/pro.248; Greene TA, 2003, IMMUNOL RES, V27, P513, DOI 10.1385/IR:27:2-3:513; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Ham H, 2013, J IMMUNOL, V190, P3661, DOI 10.4049/jimmunol.1202792; Hellman M, 2004, FEBS LETT, V576, P91, DOI 10.1016/j.febslet.2004.08.068; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Hou X, 2013, DEV BIOL; Hsu FC, 2011, J EXP MED, V208, P1291, DOI 10.1084/jem.20101874; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; KARNITZ L, 1992, MOL CELL BIOL, V12, P4521, DOI 10.1128/MCB.12.10.4521; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Lappalainen P, 1998, MOL BIOL CELL, V9, P1951, DOI 10.1091/mbc.9.8.1951; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Li XM, 2004, PROTEIN SCI, V13, P2845, DOI 10.1110/ps.04937304; Liu L, 2004, J MOL BIOL, V344, P317, DOI 10.1016/j.jmb.2004.09.036; Nebl G, 2004, CELL SIGNAL, V16, P235, DOI 10.1016/S0898-6568(03)00133-5; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Nolz JC, 2007, J IMMUNOL, V179, P1104, DOI 10.4049/jimmunol.179.2.1104; Pajerowski AG, 2009, IMMUNITY, V30, P696, DOI 10.1016/j.immuni.2009.02.011; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Poukkula M, 2011, CYTOSKELETON, V68, P471, DOI 10.1002/cm.20530; Provost P, 1999, P NATL ACAD SCI USA, V96, P1881, DOI 10.1073/pnas.96.5.1881; Provost P, 2001, J BIOL CHEM, V276, P16520, DOI 10.1074/jbc.M011205200; Provost P, 2001, BIOCHEM J, V359, P255, DOI 10.1042/0264-6021:3590255; Ramabhadran V, 2012, J BIOL CHEM, V287, P34234, DOI 10.1074/jbc.M112.365122; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; ROHRIG U, 1995, FEBS LETT, V374, P284, DOI 10.1016/0014-5793(95)01130-7; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; Schluter K, 1997, BBA-MOL CELL RES, V1359, P97, DOI 10.1016/S0167-4889(97)00100-6; Shapiro VS, 1996, J EXP MED, V184, P1663, DOI 10.1084/jem.184.5.1663; Thapa P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2580; Wabnitz GH, 2006, J IMMUNOL, V176, P1668, DOI 10.4049/jimmunol.176.3.1668; Wilkinson Beverley, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010264; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388	51	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85090	10.1371/journal.pone.0085090	http://dx.doi.org/10.1371/journal.pone.0085090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454796	Green Submitted, Green Published, gold			2022-12-25	WOS:000329922500040
J	Maroteaux, M; Valjent, E; Longueville, S; Topilko, P; Girault, JA; Herve, D				Maroteaux, Matthieu; Valjent, Emmanuel; Longueville, Sophie; Topilko, Piotr; Girault, Jean-Antoine; Herve, Denis			Role of the Plasticity-Associated Transcription Factor Zif268 in the Early Phase of Instrumental Learning	PLOS ONE			English	Article							EARLY GENE ZIF268; NUCLEUS-ACCUMBENS; BASAL GANGLIA; SUBSTANTIA-NIGRA; PARS RETICULATA; DORSAL STRIATUM; DOPAMINE D-1; C-FOS; EXPRESSION; COCAINE	Gene transcription is essential for learning, but the precise role of transcription factors that control expression of many other genes in specific learning paradigms is yet poorly understood. Zif268 (Krox24/Egr-1) is a transcription factor and an immediate-early gene associated with memory consolidation and reconsolidation, and induced in the striatum after addictive drugs exposure. In contrast, very little is known about its physiological role at early stages of operant learning. We investigated the role of Zif268 in operant conditioning for food. Zif268 expression was increased in all regions of the dorsal striatum and nucleus accumbens in mice subjected to the first session of operant conditioning. In contrast, Zif268 increase in the dorsomedial caudate-putamen and nucleus accumbens core was not detected in yoked mice passively receiving the food reward. This indicates that Zif268 induction in these structures is linked to experiencing or learning contingency, but not to reward delivery. When the task was learned (5 sessions), Zif268 induction disappeared in the nucleus accumbens and decreased in the medial caudate-putamen, whereas it remained high in the lateral caudate-putamen, previously implicated in habit formation. In transgenic mice expressing green fluorescent protein (GFP) in the striatonigral neurons, Zif268 induction occured after the first training session in both GFP-positive and negative neurons indicating an enhanced Zif268 expression in both striatonigral and striatopallidal neurons. Mutant mice lacking Zif268 expression obtained less rewards, but displayed a normal discrimination between reinforced and non-reinforced targets, and an unaltered approach to food delivery box. In addition, their motivation to obtain food rewards, evaluated in a progressive ratio schedule, was blunted. In conclusion, Zif268 participates in the processes underlying performance and motivation to execute food-conditioned instrumental task.	[Maroteaux, Matthieu; Longueville, Sophie; Girault, Jean-Antoine; Herve, Denis] INSERM, UMR S 839, Paris, France; [Maroteaux, Matthieu; Longueville, Sophie; Girault, Jean-Antoine; Herve, Denis] Univ Paris 06, Paris, France; [Maroteaux, Matthieu; Longueville, Sophie; Girault, Jean-Antoine; Herve, Denis] Inst Fer Moulin, Paris, France; [Valjent, Emmanuel] INSERM, UMR S 661, Montpellier, France; [Valjent, Emmanuel] CNRS, UMR 5203, Montpellier, France; [Valjent, Emmanuel] Univ Montpellier I & II, Montpellier, France; [Topilko, Piotr] Ecole Normale Super, CNRS, UMR 8197, IBENS,Dev Biol Sect,Inserm,UMR S 1024, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Herve, D (corresponding author), INSERM, UMR S 839, Paris, France.	denis.herve@inserm.fr	Girault, Jean-Antoine/F-7518-2013; HERVE, Denis/E-2929-2017	Girault, Jean-Antoine/0000-0002-7900-1705; HERVE, Denis/0000-0003-1376-1522; Valjent, Emmanuel/0000-0002-1034-606X	Inserm; UPMC; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche [ANR-BLAN08-1_346422]; ERC	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission)	This work was supported by Inserm, UPMC, and grants from the Fondation pour la Recherche Medicale, the Agence Nationale de la Recherche (ANR-BLAN08-1_346422,) and ERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Belin D, 2009, BEHAV BRAIN RES, V199, P89, DOI 10.1016/j.bbr.2008.09.027; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Besnard A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072006; BHAT RV, 1992, J PHARMACOL EXP THER, V263, P343; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; Corbit LH, 2003, BEHAV BRAIN RES, V146, P145, DOI 10.1016/j.bbr.2003.09.023; Dalley JW, 2005, P NATL ACAD SCI USA, V102, P6189, DOI 10.1073/pnas.0502080102; Deniau JM, 2007, PROG BRAIN RES, V160, P151, DOI 10.1016/S0079-6123(06)60009-5; Deniau JM, 1996, NEUROSCIENCE, V73, P761, DOI 10.1016/0306-4522(96)00088-7; Durieux PF, 2012, EMBO J, V31, P640, DOI 10.1038/emboj.2011.400; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Flagel SB, 2011, NEUROSCIENCE, V196, P80, DOI 10.1016/j.neuroscience.2011.09.004; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gore BB, 2013, J NEUROSCI, V33, P8640, DOI 10.1523/JNEUROSCI.5532-12.2013; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hernandez PJ, 2006, LEARN MEMORY, V13, P599, DOI 10.1101/lm.335006; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kravitz AV, 2012, NAT NEUROSCI; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; MORATALLA R, 1992, J NEUROSCI, V12, P2609; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Segovia KN, 2012, EUR J NEUROSCI, V35, P1354, DOI 10.1111/j.1460-9568.2012.08036.x; Shiflett MW, 2011, PROG NEUROBIOL, V95, P1, DOI 10.1016/j.pneurobio.2011.05.007; Shiflett MW, 2011, BEHAV BRAIN RES, V218, P240, DOI 10.1016/j.bbr.2010.12.010; Shiflett MW, 2010, J NEUROSCI, V30, P2951, DOI 10.1523/JNEUROSCI.1778-09.2010; Smith-Roe SL, 2000, J NEUROSCI, V20, P7737; Soria G, 2005, NEUROPSYCHOPHARMACOL, V30, P1670, DOI 10.1038/sj.npp.1300707; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Thomas KL, 2003, EUR J NEUROSCI, V17, P1964, DOI 10.1046/j.1460-9568.2003.02617.x; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Valjent E, 2000, J NEUROSCI, V20, P8701; Valjent E, 2006, J NEUROSCI, V26, P4956, DOI 10.1523/JNEUROSCI.4601-05.2006; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	62	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e81868	10.1371/journal.pone.0081868	http://dx.doi.org/10.1371/journal.pone.0081868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465372	Green Published, gold, Green Submitted			2022-12-25	WOS:000330288000001
J	Nijhuis, LE; Olivier, BJ; Dhawan, S; Hilbers, FW; Boon, L; Wolkers, MC; Samsom, JN; de Jonge, WJ				Nijhuis, Laurens E.; Olivier, Brenda J.; Dhawan, Shobit; Hilbers, Francisca W.; Boon, Louis; Wolkers, Monika C.; Samsom, Janneke N.; de Jonge, Wouter J.			Adrenergic beta 2 Receptor Activation Stimulates Anti-Inflammatory Properties of Dendritic Cells In Vitro	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; VAGUS NERVE; T-CELLS; IMMUNE-RESPONSE; INFLAMMATION; SYSTEM; MODULATION	Vagal nerve efferent activation has been shown to ameliorate the course of many inflammatory disease states. This neuro-modulatory effect has been suggested to rest on acetylcholine receptor (AChR) activation on tissue macrophages or dendritic cells (DCs). In more recent studies, vagal anti-inflammatory activity was shown involve adrenergic, splenic, pathways. Here we provide evidence that the adrenergic, rather than cholinergic, receptor activation on bone marrow derived DCs results in enhanced endocytosis uptake, enhanced IL-10 production but a decreased IL-6, IL-12p70 and IL-23 production. In antigen specific T cell stimulation assays, adrenergic beta 2 receptor activation on bone marrow DCs led to an enhanced potential to induce Foxp3 positive suppressive Treg cells. These effects were independent of IL10-R activation, TGF beta release, or retinoic acid (RA) secretion. Hence, adrenergic receptor b2 activation modulates DC function resulting in skewing towards anti-inflammatory T cell phenotypes.	[Nijhuis, Laurens E.; Olivier, Brenda J.; Dhawan, Shobit; Hilbers, Francisca W.; de Jonge, Wouter J.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Gastrointestinal & Liver Res, NL-1105 AZ Amsterdam, Netherlands; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Samsom, Janneke N.] Erasmus MC, Lab Pediat Gastroenterol, Rotterdam, Netherlands; [Wolkers, Monika C.] Sanquin Res Landsteiner Lab, Dept Hematopoiesis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Bioceros B.V.; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam	de Jonge, WJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Gastrointestinal & Liver Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.j.dejonge@amc.nl	Boon, Laurence/HCI-3629-2022	Wolkers, Monika/0000-0003-3242-1363; Boon, Louis/0000-0002-0937-9171	Dutch Organization for Scientific Research (NWO-VIDI)	Dutch Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO))	SD, FWH and WdeJ were funded by a grant from the Dutch Organization for Scientific Research (NWO-VIDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrenergic modulation of dendritic cells function: relevance for the immune homeostasis, 2005, CURR NEUROVASC RES, V2, P169; Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cailotto C, 2011, NEUROGASTROENT MOTIL, V24, P191, DOI 10.1111/j.1365-2982.2011.01824.x; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Dhawan S, 2012, LIFE SCI, V91, P1038, DOI 10.1016/j.lfs.2012.04.042; FELTEN DL, 1985, J IMMUNOL, V135, pS755; Fujii T, 2012, LIFE SCI, V91, P981, DOI 10.1016/j.lfs.2012.04.031; Gaskill PJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-203; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kim BJ, 2010, BRAIN BEHAV IMMUN, V24, P1126, DOI 10.1016/j.bbi.2010.05.003; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; LIVNAT S, 1985, J NEUROIMMUNOL, V10, P5, DOI 10.1016/0165-5728(85)90031-1; Maestroni GJM, 2006, ANN NY ACAD SCI, V1069, P195, DOI 10.1196/annals.1351.017; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Manni M, 2011, CYTOKINE, V55, P380, DOI 10.1016/j.cyto.2011.05.013; Nijhuis LEJ, 2010, BIOCHEM PHARMACOL, V80, P2002, DOI 10.1016/j.bcp.2010.06.034; Olofsson PS, 2012, IMMUNOL REV, V248, P188, DOI 10.1111/j.1600-065X.2012.01138.x; PaninaBordignon P, 1997, J CLIN INVEST, V100, P1513, DOI 10.1172/JCI119674; Pena G, 2011, J IMMUNOL, V187, P718, DOI 10.4049/jimmunol.1100013; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; Salamone G, 2011, J NEUROIMMUNOL, V236, P47, DOI 10.1016/j.jneuroim.2011.05.007; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system, 2000, PHARM REV, V52, P595; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Weiner HL, 2001, IMMUNOL REV, V182, P207, DOI 10.1034/j.1600-065X.2001.1820117.x; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Yanagawa Y, 2010, J IMMUNOL, V185, P5762, DOI 10.4049/jimmunol.1001899	34	55	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85086	10.1371/journal.pone.0085086	http://dx.doi.org/10.1371/journal.pone.0085086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465481	Green Published, gold, Green Submitted			2022-12-25	WOS:000330283100022
J	Farnan, L; Ivanova, A; Peddada, SD				Farnan, Laura; Ivanova, Anastasia; Peddada, Shyamal D.			Linear Mixed Effects Models under Inequality Constraints with Applications	PLOS ONE			English	Article							ORDER-RESTRICTED INFERENCE; ZERO DOSE CONTROL; CELL-CYCLE; GENE-EXPRESSION; LONGITUDINAL DATA; FISSION YEAST; HEARING-LOSS; BRAIN; RATES; TIME	Constraints arise naturally in many scientific experiments/studies such as in, epidemiology, biology, toxicology, etc. and often researchers ignore such information when analyzing their data and use standard methods such as the analysis of variance (ANOVA). Such methods may not only result in a loss of power and efficiency in costs of experimentation but also may result poor interpretation of the data. In this paper we discuss constrained statistical inference in the context of linear mixed effects models that arise naturally in many applications, such as in repeated measurements designs, familial studies and others. We introduce a novel methodology that is broadly applicable for a variety of constraints on the parameters. Since in many applications sample sizes are small and/or the data are not necessarily normally distributed and furthermore error variances need not be homoscedastic (i.e. heterogeneity in the data) we use an empirical best linear unbiased predictor (EBLUP) type residual based bootstrap methodology for deriving critical values of the proposed test. Our simulation studies suggest that the proposed procedure maintains the desired nominal Type I error while competing well with other tests in terms of power. We illustrate the proposed methodology by re-analyzing a clinical trial data on blood mercury level. The methodology introduced in this paper can be easily extended to other settings such as nonlinear and generalized regression models.	[Farnan, Laura] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ivanova, Anastasia] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Peddada, Shyamal D.] NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Peddada, SD (corresponding author), NIEHS, Biostat Branch, POB 12233, Res Triangle Pk, NC 27709 USA.	peddada@niehs.nih.gov		Peddada, Shyamal/0000-0002-5014-6513	NIEHS, National Institutes of Health [Z01 ES102345-04]; National Institutes of Health [RO1 CA120082-01A1]; NATIONAL CANCER INSTITUTE [R01CA120082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102345, ZIAES101744] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research of SDP was supported by the Intramural Research Program of the NIEHS, National Institutes of Health (Z01 ES102345-04). LF and AI work was supported in part by National Institutes of Health grant RO1 CA120082-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Cao Y, 2011, J PEDIATR-US, V158, P480, DOI 10.1016/j.jpeds.2010.08.036; Davidov O, 2011, BIOSTATISTICS, V12, P327, DOI 10.1093/biostatistics/kxq051; Davis KA, 2012, CAN J STAT, V40, P243, DOI 10.1002/cjs.11126; DINSE GE, 1985, BIOMETRICS, V41, P751, DOI 10.2307/2531296; Fernandez MA, 2012, NUCLEIC ACIDS RES, V40, P2823, DOI 10.1093/nar/gkr1077; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; HWANG JTG, 1994, ANN STAT, V22, P67, DOI 10.1214/aos/1176325358; Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186; Khuri A. I., 1998, STAT TESTS MIXED LIN; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Lelandais G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000409; MUKERJEE H, 1988, BIOMETRIKA, V75, P616, DOI 10.1093/biomet/75.3.616; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Peddada S, 2005, BIOINFORMATICS, V21, P3933, DOI 10.1093/bioinformatics/bti637; Peddada SD, 2003, BIOINFORMATICS, V19, P834, DOI 10.1093/bioinformatics/btg093; Peddada SD, 2001, BIOMETRICS, V57, P1219, DOI 10.1111/j.0006-341X.2001.01219.x; Peddada SD, 2007, J AM STAT ASSOC, V102, P1212, DOI 10.1198/016214506000001356; Rao C. R., 1988, ESTIMATION VARIANCE; RAO CR, 1972, J AM STAT ASSOC, V67, P112, DOI 10.2307/2284708; Rogan WJ, 1998, PAEDIATR PERINAT EP, V12, P313; Rosen S, 2012, STAT MED, V31, P1761, DOI 10.1002/sim.5335; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Searle S. R., 1992, VARIANCE COMPONENTS; Silvapulle MJ, 1997, STAT PROBABIL LETT, V36, P23, DOI 10.1016/S0167-7152(97)00044-8; Silvapulle MJ, 2005, CONSTRAINED STAT INF; SINGH B, 1990, STAT PROBABIL LETT, V9, P195, DOI 10.1016/0167-7152(92)90016-X; WILLIAMS DA, 1977, BIOMETRIKA, V64, P9, DOI 10.2307/2335763; WILLIAMS DA, 1971, BIOMETRICS, V27, P103, DOI 10.2307/2528930; WILLIAMS DA, 1972, BIOMETRICS, V28, P519, DOI 10.2307/2556164	30	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84778	10.1371/journal.pone.0084778	http://dx.doi.org/10.1371/journal.pone.0084778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465432	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500015
J	Manshadi, SD; Ishiguro, L; Sohn, KJ; Medline, A; Renlund, R; Croxford, R; Kim, YI				Manshadi, Shaidah Deghan; Ishiguro, Lisa; Sohn, Kyoung-Jin; Medline, Alan; Renlund, Richard; Croxford, Ruth; Kim, Young-In			Folic Acid Supplementation Promotes Mammary Tumor Progression in a Rat Model	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; BREAST-CANCER RISK; DIETARY-FOLATE; COLORECTAL-CANCER; COLON-CANCER; DIHYDROFOLATE-REDUCTASE; PLASMA FOLATE; B-VITAMINS; CELL-DEATH; WOMEN	Folic acid supplementation may prevent the development of cancer in normal tissues but may promote the progression of established (pre) neoplastic lesions. However, whether or not folic acid supplementation can promote the progression of established (pre) neoplastic mammary lesions is unknown. This is a critically important issue because breast cancer patients and survivors in North America are likely exposed to high levels of folic acid owing to folic acid fortification and widespread supplemental use after cancer diagnosis. We investigated whether folic acid supplementation can promote the progression of established mammary tumors. Female Sprague-Dawley rats were placed on a control diet and mammary tumors were initiated with 7,12-dimethylbenza[a]anthracene at puberty. When the sentinel tumor reached a predefined size, rats were randomized to receive a diet containing the control, 2.5x, 4x, or 5x supplemental levels of folic acid for up to 12 weeks. The sentinel mammary tumor growth was monitored weekly. At necropsy, the sentinel and all other mammary tumors were analyzed histologically. The effect of folic acid supplementation on the expression of proteins involved in proliferation, apoptosis, and mammary tumorigenesis was determined in representative sentinel adenocarcinomas. Although no clear dose-response relationship was observed, folic acid supplementation significantly promoted the progression of the sentinel mammary tumors and was associated with significantly higher sentinel mammary tumor weight and volume compared with the control diet. Furthermore, folic acid supplementation was associated with significantly higher weight and volume of all mammary tumors. The most significant and consistent mammary tumor-promoting effect was observed with the 2.5x supplemental level of folic acid. Folic acid supplementation was also associated with an increased expression of BAX, PARP, and HER2. Our data suggest that folic acid supplementation may promote the progression of established mammary tumors. The potential tumor-promoting effect of folic acid supplementation in breast cancer patients and survivors needs further clarification.	[Manshadi, Shaidah Deghan; Ishiguro, Lisa] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Manshadi, Shaidah Deghan; Ishiguro, Lisa; Sohn, Kyoung-Jin; Kim, Young-In] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada; [Sohn, Kyoung-Jin] Univ Toronto, Dept Med, Toronto, ON, Canada; [Medline, Alan; Renlund, Richard] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Kim, Young-In] Univ Toronto, St Michaels Hosp, Dept Med, Div Gastroenterol, Toronto, ON M5B 1W8, Canada; [Kim, Young-In] Univ Toronto, St Michaels Hosp, Dept Nutr Sci, Div Gastroenterol, Toronto, ON, Canada; [Medline, Alan] Humber River Reg Hosp, Dept Pathol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Kim, YI (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, Div Gastroenterol, Toronto, ON M5B 1W8, Canada.	youngin.kim@utoronto.ca			Canadian Institutes of Health Research [14126]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (Grant # 14126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoglu B, 2001, NUTRITION, V17, P652, DOI 10.1016/S0899-9007(01)00594-9; Alamian A, 2006, NUTR CANCER, V54, P157, DOI 10.1207/s15327914nc5402_1; BAGGOTT JE, 1992, JNCI-J NATL CANCER I, V84, P1740, DOI 10.1093/jnci/84.22.1740; Bailey RL, 2010, AM J CLIN NUTR, V91, P231, DOI 10.3945/ajcn.2009.28427; Bailey SW, 2009, P NATL ACAD SCI USA, V106, P15424, DOI 10.1073/pnas.0902072106; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Bright-Gbebry M, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-30; Carrier J, 2003, CANCER EPIDEM BIOMAR, V12, P1262; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Colapinto CK, 2011, CAN MED ASSOC J, V183, pE100, DOI 10.1503/cmaj.100568; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; CRAVO ML, 1992, CANCER RES, V52, P5002; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ericson U, 2010, J NUTR, V140, P1661, DOI 10.3945/jn.110.124313; Figueiredo JC, 2011, INT J CANCER, V129, P192, DOI 10.1002/ijc.25872; Figueiredo JC, 2009, JNCI-J NATL CANCER I, V101, P432, DOI 10.1093/jnci/djp019; Giovannucci E, 2010, J CLIN ONCOL, V28, P4081, DOI 10.1200/JCO.2009.27.3219; Holmes RS, 2010, CANCER EPIDEM BIOMAR, V19, P2023, DOI 10.1158/1055-9965.EPI-09-1097; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Institute of Medicine, 1998, FOL DIET REF INT THI, P196; Jaszewski R, 1999, AM J PHYSIOL-CELL PH, V277, pC1142, DOI 10.1152/ajpcell.1999.277.6.C1142; Khosraviani K, 2002, GUT, V51, P195, DOI 10.1136/gut.51.2.195; Kim YI, 1996, GUT, V39, P732, DOI 10.1136/gut.39.5.732; Kim YI, 2008, CANCER EPIDEM BIOMAR, V17, P2220, DOI 10.1158/1055-9965.EPI-07-2557; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; Kim YI, 2006, NUTR REV, V64, P468, DOI 10.1301/nr.2006.oct.468-475; Kotsopoulos J, 2005, CARCINOGENESIS, V26, P1603, DOI 10.1093/carcin/bgi117; Kotsopoulos J, 2003, CARCINOGENESIS, V24, P937, DOI 10.1093/carcin/bgg036; Kotsopoulos J, 2012, CANCER CAUSE CONTROL, V23, P1405, DOI 10.1007/s10552-012-0022-y; Kwan ML, 2011, BREAST CANCER RES TR, V130, P195, DOI 10.1007/s10549-011-1557-4; Larsson SC, 2007, JNCI-J NATL CANCER I, V99, P64, DOI 10.1093/jnci/djk006; Lewis SJ, 2006, JNCI-J NATL CANCER I, V98, P1607, DOI 10.1093/jnci/djj440; Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734; Lindzon GM, 2009, CARCINOGENESIS, V30, P1536, DOI 10.1093/carcin/bgp152; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Ly A, 2012, ANTIOXID REDOX SIGN, V17, P302, DOI 10.1089/ars.2012.4554; Ly A, 2011, CANCER RES, V71, P988, DOI 10.1158/0008-5472.CAN-10-2379; Ma E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-122; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Miller JW, 2013, LANCET, V381, P974, DOI 10.1016/S0140-6736(13)60110-5; *NAT RES COUNC, 1995, NUTR REQ LAB AN, P11; Neuhouser ML, 2011, CANCER EPIDEM BIOMAR, V20, P1912, DOI 10.1158/1055-9965.EPI-10-1352; Nijhout HF, 2004, J BIOL CHEM, V279, P55008, DOI 10.1074/jbc.M410818200; NORTON L, 1988, CANCER RES, V48, P7067; Pfeiffer CM, 2007, AM J CLIN NUTR, V86, P718, DOI 10.1093/ajcn/86.3.718; Russo IH, 1996, ENVIRON HEALTH PERSP, V104, P938, DOI 10.2307/3433143; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Shane B., 2010, FOLATE HLTH DIS, V2nd, P1; Sie KKY, 2011, GUT, V60, P1687, DOI 10.1136/gut.2011.238782; Sohn KJ, 2004, JNCI-J NATL CANCER I, V96, P134, DOI 10.1093/jnci/djh015; Song J, 2000, CANCER RES, V60, P5434; Song J, 2000, CANCER RES, V60, P3191; Sowers R, 2003, MOL CANCER THER, V2, P535; Stevens VL, 2010, AM J CLIN NUTR, V91, P1708, DOI 10.3945/ajcn.2009.28553; Stolzenberg-Solomon RZ, 2006, AM J CLIN NUTR, V83, P895, DOI 10.1093/ajcn/83.4.895; Terada K, 2009, CARCINOGENESIS, V30, P466, DOI 10.1093/carcin/bgp021; Thompson HJ, 2000, J MAMMARY GLAND BIOL, V5, P409, DOI 10.1023/A:1009582012493; Ulrich CM, 2008, CANCER EPIDEM BIOMAR, V17, P2226, DOI 10.1158/1055-9965.EPI-07-2952; Velicer CM, 2008, J CLIN ONCOL, V26, P665, DOI 10.1200/JCO.2007.13.5905; Vollset SE, 2013, LANCET; Wien TN, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000653; Wilson RD, 2007, J OBSTET GYNAECOL CA, V29, P1003, DOI 10.1016/S1701-2163(16)32685-8; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Wright AJA, 2007, BRIT J NUTR, V98, P667, DOI 10.1017/S0007114507777140; Zhang SMM, 2008, JAMA-J AM MED ASSOC, V300, P2012, DOI 10.1001/jama.2008.555; Zhang SM, 2005, CANCER EPIDEM BIOMAR, V14, P2004, DOI 10.1158/1055-9965.EPI-05-0083	67	52	54	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84635	10.1371/journal.pone.0084635	http://dx.doi.org/10.1371/journal.pone.0084635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465421	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500009
J	Moretti, D; Thomas, L; Marques, T; Harwood, J; Dilley, A; Neales, B; Shaffer, J; McCarthy, E; New, L; Jarvis, S; Morrissey, R				Moretti, David; Thomas, Len; Marques, Tiago; Harwood, John; Dilley, Ashley; Neales, Bert; Shaffer, Jessica; McCarthy, Elena; New, Leslie; Jarvis, Susan; Morrissey, Ronald			A Risk Function for Behavioral Disruption of Blainville's Beaked Whales (Mesoplodon densirostris) from Mid-Frequency Active Sonar	PLOS ONE			English	Article								There is increasing concern about the potential effects of noise pollution on marine life in the world's oceans. For marine mammals, anthropogenic sounds may cause behavioral disruption, and this can be quantified using a risk function that relates sound exposure to a measured behavioral response. Beaked whales are a taxon of deep diving whales that may be particularly susceptible to naval sonar as the species has been associated with sonar-related mass stranding events. Here we derive the first empirical risk function for Blainville's beaked whales (Mesoplodon densirostris) by combining in situ data from passive acoustic monitoring of animal vocalizations and navy sonar operations with precise ship tracks and sound field modeling. The hydrophone array at the Atlantic Undersea Test and Evaluation Center, Bahamas, was used to locate vocalizing groups of Blainville's beaked whales and identify sonar transmissions before, during, and after Mid-Frequency Active (MFA) sonar operations. Sonar transmission times and source levels were combined with ship tracks using a sound propagation model to estimate the received level (RL) at each hydrophone. A generalized additive model was fitted to data to model the presence or absence of the start of foraging dives in 30-minute periods as a function of the corresponding sonar RL at the hydrophone closest to the center of each group. This model was then used to construct a risk function that can be used to estimate the probability of a behavioral change (cessation of foraging) the individual members of a Blainville's beaked whale population might experience as a function of sonar RL. The function predicts a 0.5 probability of disturbance at a RL of 150dBrms re mu Pa (CI: 144 to 155) This is 15dB lower than the level used historically by the US Navy in their risk assessments but 10 dB higher than the current 140 dB step-function.	[Moretti, David; Dilley, Ashley; Neales, Bert; Shaffer, Jessica; McCarthy, Elena; Jarvis, Susan; Morrissey, Ronald] Naval Undersea Warfare Ctr, Newport, RI 02841 USA; [Thomas, Len; Marques, Tiago; Harwood, John] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland; [New, Leslie] US Marine Mammal Commiss, Bethesda, MD USA	United States Department of Defense; United States Navy; US Navy Naval Sea Systems Command; University of St Andrews	Moretti, D (corresponding author), Naval Undersea Warfare Ctr, Newport, RI 02841 USA.	david.moretti@navy.mil	New, Leslie/C-8796-2018; Marques, Tiago A/A-5530-2010; Marques, Tiago A./M-3253-2019	Marques, Tiago A/0000-0002-2581-1972; Marques, Tiago A./0000-0002-2581-1972; Thomas, Len/0000-0002-7436-067X	U.S. Navy's Office of Naval Research (ONR); Living Marine Resources Program (LMR) [N0002512WX06703, N0001412WX20964]	U.S. Navy's Office of Naval Research (ONR); Living Marine Resources Program (LMR)	Funding was provided by the U.S. Navy's Office of Naval Research (ONR, http://www.onr.navy.mil/) and the Living Marine Resources Program (LMR, http://www.lmr.navy.mil/), award number: N0002512WX06703 and N0001412WX20964 respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird R. W., 2004, AB133F03SE0986 NAT M; Baird RW, 2006, CAN J ZOOL, V84, P1120, DOI 10.1139/Z06-095; Balcomb Kenneth C. III, 2001, Bahamas Journal of Science, V8, P2; Bowling SR, 2009, J IND ENG MANAG-JIEM, V2, P114, DOI 10.3926/jiem.2009.v2n1.p114-127; Bureau of Ocean Energy Management (Dec. 2011) Department of Navy (DON) National Oceanic and Atmospheric Administration (NOAA), 2011, MAR MAMM SOUND WORKS; CONNELL D.W., 2009, INTRO ECOTOXICOLOGY; D'Amico A, 2009, ACQUATIC MAMMALS, V35, P435; England G., 2001, JOINT INTERIM REPORT; Fetherston T, 2011, CURRENTS MAGAZINE; Filadelfo Ronald, 2009, Aquatic Mammals, V35, P435, DOI 10.1578/AM.35.4.2009.435; Finneran J, 2004, EDO DYNAMIC SYSTEMS; Finneran J. J., 2012, CRITERIA THRESHOLDS; Fromm D, 2004, ACOUSTIC MODELING RE; Jarvis SM, MTS J IN PRESS; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Marine Mammal Commission, 2007, MAR MAMM NOIS SOUND; Marques TA, 2009, J ACOUST SOC AM, V125, P1982, DOI 10.1121/1.3089590; McCarthy E, 2011, MAR MAMMAL SCI, V27, pE206, DOI 10.1111/j.1748-7692.2010.00457.x; Moore JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052770; Moretti D, 2010, APPL ACOUST, V71, P1036, DOI 10.1016/j.apacoust.2010.04.011; NAVOCEANO, 1998, OC ATM MAST LIB SUMM; Nowacek DP, 2004, P ROY SOC B-BIOL SCI, V271, P227, DOI 10.1098/rspb.2003.2570; R Core Team, 2012, R LANG ENV STAT COMP; Richardson W.J., 1998, MARINE MAMMALS NOISE, V1st ed.; Shaffer JW, 2013, J ACOUST SOC AM, V133, P1770, DOI 10.1121/1.4776177; Southall B. L., 2008, AQUAT MAMM, V17, P273, DOI [DOI 10.1578/AM.33.4.2007.411, 10.1578/AM, DOI 10.1578/AM]; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; U. S. EPA, 1998, GUID EC RISK ASS; Weilgart LS, 2007, CAN J ZOOL, V85, P1091, DOI 10.1139/Z07-101; Weinberg H, 1996, J ACOUST SOC AM, V100, P1421, DOI 10.1121/1.415989; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zimmer WMX, 2008, J ACOUST SOC AM, V124, P2823, DOI 10.1121/1.2988277	32	47	47	0	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85064	10.1371/journal.pone.0085064	http://dx.doi.org/10.1371/journal.pone.0085064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465477	gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500033
J	van Oeffelen, L; Peeters, E; Minh, PNL; Charlier, D				van Oeffelen, Liesbeth; Peeters, Eveline; Phu Nguyen Le Minh; Charlier, Daniel			The 'Densitometric Image Analysis Software' and Its Application to Determine Stepwise Equilibrium Constants from Electrophoretic Mobility Shift Assays	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; NUCLEIC ACID INTERACTIONS; SS-LRPB; COOPERATIVITY; SPECIFICITY; SULFOLOBUS	Current software applications for densitometric analysis, such as ImageJ, QuantityOne (BioRad) and the Intelligent or Advanced Quantifier (Bio Image) do not allow to take the non-linearity of autoradiographic films into account during calibration. As a consequence, quantification of autoradiographs is often regarded as problematic, and phosphorimaging is the preferred alternative. However, the non-linear behaviour of autoradiographs can be described mathematically, so it can be accounted for. Therefore, the 'Densitometric Image Analysis Software' has been developed, which allows to quantify electrophoretic bands in autoradiographs, as well as in gels and phosphorimages, while providing optimized band selection support to the user. Moreover, the program can determine protein-DNA binding constants from Electrophoretic Mobility Shift Assays (EMSAs). For this purpose, the software calculates a chosen stepwise equilibrium constant for each migration lane within the EMSA, and estimates the errors due to non-uniformity of the background noise, smear caused by complex dissociation or denaturation of double-stranded DNA, and technical errors such as pipetting inaccuracies. Thereby, the program helps the user to optimize experimental parameters and to choose the best lanes for estimating an average equilibrium constant. This process can reduce the inaccuracy of equilibrium constants from the usual factor of 2 to about 20%, which is particularly useful when determining position weight matrices and cooperative binding constants to predict genomic binding sites. The MATLAB source code, platform-dependent software and installation instructions are available via the website http://micr.vub.ac.be.	[van Oeffelen, Liesbeth; Peeters, Eveline; Phu Nguyen Le Minh; Charlier, Daniel] Vrije Univ Brussel, Microbiol Res Grp, Brussels, Belgium; [van Oeffelen, Liesbeth] IMEC, Louvain, Belgium	Vrije Universiteit Brussel; IMEC	van Oeffelen, L (corresponding author), Vrije Univ Brussel, Microbiol Res Grp, Brussels, Belgium.	Liesbeth.van.Oeffelen@vub.ac.be			Research Foundation - Flanders (FWO)	Research Foundation - Flanders (FWO)(FWO)	L. van Oeffelen has a Ph. D. fellowship of the Research Foundation - Flanders (FWO). E. Peeters and P. Nguyen Le Minh are postdoctoral fellows of the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerenza L, 1997, BBA-PROTEIN STRUCT M, V1339, P155, DOI 10.1016/S0167-4838(96)00228-2; CANN JR, 1989, J BIOL CHEM, V264, P17032; Fried MG, 1998, ELECTROPHORESIS, V19, P1247, DOI 10.1002/elps.1150190804; Garces J, 2008, J BIOL PHYS, V34, P213, DOI 10.1007/s10867-008-9116-x; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; LANE D, 1992, MICROBIOL REV, V56, P509, DOI 10.1128/MMBR.56.4.509-528.1992; Peeters E, 2007, NUCLEIC ACIDS RES, V35, P623, DOI 10.1093/nar/gkl1095; Peeters E, 2013, GENE, V524, P330, DOI 10.1016/j.gene.2013.03.118; SENEAR DF, 1991, J BIOL CHEM, V266, P13661; Song NN, 2013, NUCLEIC ACIDS RES, V41, P2932, DOI 10.1093/nar/gkt021; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Tkhun WM, 2006, INSTRUM EXP TECH+, V49, P703, DOI 10.1134/S0020441206050174; van Oeffelen L, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn140	13	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85146	10.1371/journal.pone.0085146	http://dx.doi.org/10.1371/journal.pone.0085146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465496	Green Submitted, Green Published, gold			2022-12-25	WOS:000330244500039
J	Kimura, T; Ohashi, M; Crailsheim, K; Schmickl, T; Okada, R; Radspieler, G; Ikeno, H				Kimura, Toshifumi; Ohashi, Mizue; Crailsheim, Karl; Schmickl, Thomas; Okada, Ryuichi; Radspieler, Gerald; Ikeno, Hidetoshi			Development of a New Method to Track Multiple Honey Bees with Complex Behaviors on a Flat Laboratory Arena	PLOS ONE			English	Article							SYSTEM	A computer program that tracks animal behavior, thereby revealing various features and mechanisms of social animals, is a powerful tool in ethological research. Because honeybee colonies are populated by thousands of bees, individuals co-exist in high physical densities and are difficult to track unless specifically tagged, which can affect behavior. In addition, honeybees react to light and recordings must be made under special red-light conditions, which the eyes of bees perceive as darkness. The resulting video images are scarcely distinguishable. We have developed a new algorithm, K-Track, for tracking numerous bees in a flat laboratory arena. Our program implements three main processes: (A) The object (bee's) region is detected by simple threshold processing on gray scale images, (B) Individuals are identified by size, shape and spatiotemporal positional changes, and (C) Centers of mass of identified individuals are connected through all movie frames to yield individual behavioral trajectories. The tracking performance of our software was evaluated on movies of mobile multi-artificial agents and of 16 bees walking around a circular arena. K-Track accurately traced the trajectories of both artificial agents and bees. In the latter case, K-track outperformed Ctrax, well-known software for tracking multiple animals. To investigate interaction events in detail, we manually identified five interaction categories; 'crossing', 'touching', 'passing', 'overlapping' and 'waiting', and examined the extent to which the models accurately identified these categories from bee's interactions. All 7 identified failures occurred near a wall at the outer edge of the arena. Finally, K-Track and Ctrax successfully tracked 77 and 60 of 84 recorded interactive events, respectively. K-Track identified multiple bees on a flat surface and tracked their speed changes and encounters with other bees, with good performance.	[Kimura, Toshifumi; Ohashi, Mizue; Ikeno, Hidetoshi] Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6712201, Japan; [Crailsheim, Karl; Schmickl, Thomas; Radspieler, Gerald] Karl Franzens Univ Graz, Dept Zool, Graz, Austria; [Okada, Ryuichi] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa, Japan	University of Hyogo; University of Graz; Tokushima Bunri University	Kimura, T (corresponding author), Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6712201, Japan.	kimura@shse.u-hyogo.ac.jp	; Ikeno, Hidetoshi/O-3034-2018	Schmickl, Thomas/0000-0001-8598-7462; Ikeno, Hidetoshi/0000-0002-5134-5485	KAKENHI [23650157, 24657019]; FWF [P19478-B16, P23943-N13]; EU [601074]; Austrian Science Fund (FWF) [P 23943] Funding Source: researchfish	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); FWF(Austrian Science Fund (FWF)); EU(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Kimura was supported by the Grant-in-Aid for Scientific Research (KAKENHI) (No. 23650157). Ohashi, Ikeno, Okada and Kimura were partly supported by the Grant-in-Aid for Scientific Research (KAKENHI) (No. 24657019). Schmickl was supported by the FWF-funded (Austrian Science Foundation) research grant Temperature-induced aggregation of young honey bees, no. P19478-B16, the FWF-funded project REBODIMENT (no. P23943-N13) and EU grant "ASSISI_bf", no. 601074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardekani R, 2013, INTERFACE, DOI [10.1098/rsif.2012.05475, DOI 10.1098/RSIF.2012.05475]; BALCH T, 2001, P 5 INT C AUT AG, V2001, P521; Barry MJ, 2012, CHEMOSPHERE, V86, P938, DOI 10.1016/j.chemosphere.2011.11.011; Bender JA, 2011, J EXP BIOL, V214, P2057, DOI 10.1242/jeb.056481; Benice TS, 2008, J NEUROSCI METH, V168, P422, DOI 10.1016/j.jneumeth.2007.11.002; Bodi M, 2012, MATH COMP MODEL DYN, V18, P87, DOI 10.1080/13873954.2011.601420; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008; Camazine S, 1998, APIDOLOGIE; DALTORIO KA, 2012, P 2012 IEEE INT C RO, P2261; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; Delcourt J, 2009, BEHAV RES METHODS, V41, P228, DOI 10.3758/BRM.41.1.228; Depickere S, 2004, J INSECT BEHAV, V17, P81, DOI 10.1023/B:JOIR.0000025134.06111.be; Drai D, 2001, BEHAV BRAIN RES, V125, P133, DOI 10.1016/S0166-4328(01)00290-X; Farina WM, 1991, ANIMAL BEHAV; Feldman A., 2003, P 2 INT WORKSH MATH P 2 INT WORKSH MATH, P53; Franklin EL, 2012, ANIM BEHAV, V84, P361, DOI 10.1016/j.anbehav.2012.05.002; Freund J, 2013, SCIENCE, V340, P756, DOI 10.1126/science.1235294; Fry SN, 2002, J COMP PHYSIOL A, V187, P1009, DOI 10.1007/s00359-001-0272-8; Hamann H, 2012, NEURAL COMPUT APPL, V21, P207, DOI 10.1007/s00521-010-0368-6; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Johnson BR, 2003, P ROY SOC B-BIOL SCI, V270, P147, DOI 10.1098/rspb.2002.2207; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/NMETH.2281, 10.1038/nmeth.2281]; Khan Z, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P254; Kimura T, 2005, IEEE PACIF, P149; KIMURA T, 2012, 2012 5 INT C EM TREN, P36; Kimura T, 2011, APIDOLOGIE, V42, P607, DOI 10.1007/s13592-011-0060-6; Korst P, 1982, NATURE TROPHALLAXIS; Mekdara NT, 2012, J EXP ZOOL PART A, V317A, P382, DOI 10.1002/jez.1731; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Morioka R, 2011, 6 AS PAC C CHEM EC, V120; Moritz RFA, 1990, ANIMAL BEHAV; Okada R, 2012, J EXP BIOL, V215, P1633, DOI 10.1242/jeb.068650; Patt JM, 2009, ENTOMOL EXP APPL, V132, P13, DOI 10.1111/j.1570-7458.2009.00865.x; Perera A. A., 2006, 2006 IEEE COMPUTER S, V1, P666; Ramdya P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048381; Reid CR, 2011, J EXP BIOL, V214, P50, DOI 10.1242/jeb.048173; Schmickl T, 2008, AUTON ROBOT, V25, P171, DOI 10.1007/s10514-007-9073-4; Schmickl T, 2011, BIO-INSPIRED COMPUTING AND NETWORKING, P95; Schneider J, 2012, P NATL ACAD SCI USA, V109, P17174, DOI 10.1073/pnas.1121252109; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Weissbrod A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3018; White KE, 2010, FRONT NEUROSCI, V4, P1; Willis MA, 2008, J EXP BIOL, V211, P2317, DOI 10.1242/jeb.016006	45	19	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84656	10.1371/journal.pone.0084656	http://dx.doi.org/10.1371/journal.pone.0084656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465422	Green Published, gold			2022-12-25	WOS:000330240500020
J	Zhang, H; Long, ZY; Ge, RY; Xu, LL; Jin, Z; Yao, L; Liu, YJ				Zhang, Hang; Long, Zhiying; Ge, Ruiyang; Xu, Lele; Jin, Zhen; Yao, Li; Liu, Yijun			Motor Imagery Learning Modulates Functional Connectivity of Multiple Brain Systems in Resting State	PLOS ONE			English	Article							NETWORKS; MRI; PLASTICITY; PRECUNEUS	Background: Learning motor skills involves subsequent modulation of resting-state functional connectivity in the sensory-motor system. This idea was mostly derived from the investigations on motor execution learning which mainly recruits the processing of sensory-motor information. Behavioral evidences demonstrated that motor skills in our daily lives could be learned through imagery procedures. However, it remains unclear whether the modulation of resting-state functional connectivity also exists in the sensory-motor system after motor imagery learning. Methodology/Principal Findings: We performed a fMRI investigation on motor imagery learning from resting state. Based on previous studies, we identified eight sensory and cognitive resting-state networks (RSNs) corresponding to the brain systems and further explored the functional connectivity of these RSNs through the assessments, connectivity and network strengths before and after the two-week consecutive learning. Two intriguing results were revealed: (1) The sensory RSNs, specifically sensory-motor and lateral visual networks exhibited greater connectivity strengths in precuneus and fusiform gyrus after learning; (2) Decreased network strength induced by learning was proved in the default mode network, a cognitive RSN. Conclusions/Significance: These results indicated that resting-state functional connectivity could be modulated by motor imagery learning in multiple brain systems, and such modulation displayed in the sensory-motor, visual and default brain systems may be associated with the establishment of motor schema and the regulation of introspective thought. These findings further revealed the neural substrates underlying motor skill learning and potentially provided new insights into the therapeutic benefits of motor imagery learning.	[Zhang, Hang; Ge, Ruiyang; Xu, Lele; Yao, Li] Beijing Normal Univ, Sch Informat Sci & Technol, Beijing 100875, Peoples R China; [Zhang, Hang; Liu, Yijun] Peking Univ, Dept Biomed Engn, Beijing 100871, Peoples R China; [Zhang, Hang] Chinese Acad Sci, C Lauterbur Res Ctr Biomed Imaging, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Long, Zhiying; Yao, Li] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Liu, Yijun] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA; [Jin, Zhen] PLA, Hosp 306, Lab Magnet Resonance Imaging, Beijing, Peoples R China	Beijing Normal University; Peking University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Beijing Normal University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Yao, L (corresponding author), Beijing Normal Univ, Sch Informat Sci & Technol, Beijing 100875, Peoples R China.	yaoli@bnu.edu.cn; yjliufl@gmail.com	Xu, Le/HDN-9623-2022		National Key Basic Research Program of China (973 Program) [2012CB720704]; Key Program of National Natural Science Foundation of China [60931003, 61131003]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Key Basic Research Program of China (973 Program) (2012CB720704); The Key Program of National Natural Science Foundation of China (60931003 and 61131003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Coynel D, 2010, NEUROIMAGE, V49, P759, DOI 10.1016/j.neuroimage.2009.08.048; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; de Lange FP, 2008, CORTEX, V44, P494, DOI 10.1016/j.cortex.2007.09.002; de Pasquale F, 2013, NEUROIMAGE, V69, P51, DOI 10.1016/j.neuroimage.2012.11.051; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Georgopoulos AP, 2000, CURR OPIN NEUROBIOL, V10, P238, DOI 10.1016/S0959-4388(00)00072-6; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Isaac A.R., 1986, J MENT IMAG, V10, P23, DOI DOI 10.1037/T07980-000; KARNI A, 1995, NATURE, V377, P155; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Li R, 2011, NEUROIMAGE, V56, P1035, DOI 10.1016/j.neuroimage.2011.03.010; Ma LS, 2011, NEUROIMAGE, V58, P226, DOI 10.1016/j.neuroimage.2011.06.014; Ma LS, 2010, BRAIN RES, V1318, P64, DOI 10.1016/j.brainres.2009.12.073; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Miall RC, 2006, CURR BIOL, V16, pR998, DOI 10.1016/j.cub.2006.10.041; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Nyberg L, 2006, NEUROPSYCHOLOGIA, V44, P711, DOI 10.1016/j.neuropsychologia.2005.08.006; Olsson CJ, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.005.2008; Ostby Y, 2012, P NATL ACAD SCI USA, V109, P16800, DOI 10.1073/pnas.1210627109; Pearson K, 2000, CURR OPIN NEUROBIOL, V10, P649, DOI 10.1016/S0959-4388(00)00130-6; Rabin E, 2004, EXP BRAIN RES, V155, P362, DOI 10.1007/s00221-003-1736-6; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Sommerville JA, 2006, PSYCHON B REV, V13, P179, DOI 10.3758/BF03193831; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Taylor JC, 2007, J NEUROPHYSIOL, V98, P1626, DOI 10.1152/jn.00012.2007; Taylor VA, 2013, SOC COGN AFFECT NEUR, V8, P4, DOI 10.1093/scan/nsr087; Vahdat S, 2011, J NEUROSCI, V31, P16907, DOI 10.1523/JNEUROSCI.2737-11.2011; Wallentin M, 2006, NEUROIMAGE, V32, P1850, DOI 10.1016/j.neuroimage.2006.05.002; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Xiong JH, 2009, NEUROIMAGE, V45, P75, DOI 10.1016/j.neuroimage.2008.11.016; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036052; Zhang H, 2011, BRAIN RES, V1407, P38, DOI 10.1016/j.brainres.2011.06.038	48	35	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85489	10.1371/journal.pone.0085489	http://dx.doi.org/10.1371/journal.pone.0085489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465577	Green Published, gold, Green Submitted			2022-12-25	WOS:000330237000039
J	Dikalova, A; Fagiana, A; Aschner, JL; Aschner, M; Summar, M; Fike, CD				Dikalova, Anna; Fagiana, Angela; Aschner, Judy L.; Aschner, Michael; Summar, Marshall; Fike, Candice D.			Sodium-Coupled Neutral Amino Acid Transporter 1 (SNAT1) Modulates L-Citrulline Transport and Nitric Oxide (NO) Signaling in Piglet Pulmonary Arterial Endothelial Cells	PLOS ONE			English	Article							L-ARGININE THERAPY; SYNTHASE; HYPERTENSION; SYSTEM; LYASE	Rationale: There is evidence that impairments in nitric oxide (NO) signaling contribute to chronic hypoxia-induced pulmonary hypertension. The L-arginine-NO precursor, L-citrulline, has been shown to ameliorate pulmonary hypertension. Sodium-coupled neutral amino acid transporters (SNATs) are involved in the transport of L-citrulline into pulmonary arterial endothelial cells (PAECs). The functional link between the SNATs, L-citrulline, and NO signaling has not yet been explored. Objective: We tested the hypothesis that changes in SNAT1 expression and transport function regulate NO production by modulating eNOS coupling in newborn piglet PAECs. Methods and Results: A silencing RNA (siRNA) technique was used to assess the contribution of SNAT1 to NO production and eNOS coupling (eNOS dimer-to-monomer ratios) in PAECs from newborn piglets cultured under normoxic and hypoxic conditions in the presence and absence of L-citrulline. SNAT1 siRNA reduced basal NO production in normoxic PAECs and prevented L-citrulline-induced elevations in NO production in both normoxic and hypoxic PAECs. SNAT1 siRNA reduced basal eNOS dimer-to-monomer ratios in normoxic PAECs and prevented L-citrulline-induced increases in eNOS dimer-to-monomer ratios in hypoxic PAECs. Conclusions: SNAT1 mediated L-citrulline transport modulates eNOS coupling and thus regulates NO production in hypoxic PAECs from newborn piglets. Strategies that increase SNAT1-mediated transport and supply of L-citrulline may serve as novel therapeutic approaches to enhance NO production in patients with pulmonary vascular disease.	[Dikalova, Anna; Fagiana, Angela; Aschner, Michael; Fike, Candice D.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Dikalova, Anna; Fagiana, Angela; Aschner, Michael; Fike, Candice D.] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA; [Aschner, Michael] Vanderbilt Ctr Mol Toxicol, Nashville, TN USA; [Summar, Marshall] Childrens Natl Med Ctr, Div Genet & Metab, Washington, DC 20010 USA; [Aschner, Judy L.] Albert Einstein Coll Med, Dept Pediat, New York, NY USA; [Aschner, Judy L.] Childrens Hosp Montefiore, New York, NY USA	Vanderbilt University; Vanderbilt University; Children's National Health System; Yeshiva University; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore	Fike, CD (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.	Candice.fike@vanderbilt.edu	Fike, Candice/HHN-1602-2022	Summar, Marshall/0000-0001-8920-0110	NIH [HL97566]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL097566, R01HL097566] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by HL97566 to CDF from NIH (www.NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan M, 2009, AM J PHYSIOL-LUNG C, V297, pL506, DOI 10.1152/ajplung.00017.2009; Bahri S, 2013, NUTRITION, V29, P479, DOI 10.1016/j.nut.2012.07.002; Boger RH, 2008, CURR OPIN CLIN NUTR, V11, P55, DOI 10.1097/MCO.0b013e3282f2b0c3; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Erez A, 2011, NAT MED, V17, P1619, DOI 10.1038/nm.2544; Fike CD, 2012, CARDIOVASC RES, V95, P375, DOI 10.1093/cvr/cvs186; Fike CD, 2004, AM J PHYSIOL-LUNG C, V286, pL1244, DOI 10.1152/ajplung.00345.2003; Flam BR, 2001, NITRIC OXIDE-BIOL CH, V5, P187, DOI 10.1006/niox.2001.0340; Gielis JF, 2011, FREE RADICAL BIO MED, V50, P765, DOI 10.1016/j.freeradbiomed.2010.12.018; Hoet PHM, 2000, AM J PHYSIOL-LUNG C, V278, pL417, DOI 10.1152/ajplung.2000.278.3.L417; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Mann GE, 2003, PHYSIOL REV, V83, P183, DOI 10.1152/physrev.00022.2002; Martasek P, 1998, J BIOL CHEM, V273, P34799, DOI 10.1074/jbc.273.52.34799; Mitani Y, 1997, CIRCULATION, V96, P689; Ou ZJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1131, DOI 10.1152/ajpendo.00107.2010; Sasaki S, 2004, RESP MED, V98, P205, DOI 10.1016/j.rmed.2003.09.013; Schulman SP, 2006, JAMA-J AM MED ASSOC, V295, P58, DOI 10.1001/jama.295.1.58; Solomonson LP, 2003, J EXP BIOL, V206, P2083, DOI 10.1242/jeb.00361; SU YC, 1995, AM J PHYSIOL-LUNG C, V269, pL581, DOI 10.1152/ajplung.1995.269.5.L581; Tonelli AR, 2013, PULM CIRC, V3, P20, DOI 10.4103/2045-8932.109911	20	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85730	10.1371/journal.pone.0085730	http://dx.doi.org/10.1371/journal.pone.0085730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454923	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100125
J	Lupon, J; de Antonio, M; Vila, J; Penafiel, J; Galan, A; Zamora, E; Urrutia, A; Bayes-Genis, A				Lupon, Josep; de Antonio, Marta; Vila, Joan; Penafiel, Judith; Galan, Amparo; Zamora, Elisabet; Urrutia, Agustin; Bayes-Genis, Antoni			Development of a Novel Heart Failure Risk Tool: The Barcelona Bio-Heart Failure Risk Calculator (BCN Bio-HF Calculator)	PLOS ONE			English	Article							PREDICTING MORTALITY; AMBULATORY PATIENTS; TROPONIN-T; SURVIVAL; VALIDATION; BIOMARKERS; DISCRIMINATION; PERFORMANCE; PROGNOSIS; SCORE	Background: A combination of clinical and routine laboratory data with biomarkers reflecting different pathophysiological pathways may help to refine risk stratification in heart failure (HF). A novel calculator (BCN Bio-HF calculator) incorporating N-terminal pro B-type natriuretic peptide (NT-proBNP, a marker of myocardial stretch), high-sensitivity cardiac troponin T (hs-cTnT, a marker of myocyte injury), and high-sensitivity soluble ST2 (ST2), (reflective of myocardial fibrosis and remodeling) was developed. Methods: Model performance was evaluated using discrimination, calibration, and reclassification tools for 1-, 2-, and 3-year mortality. Ten-fold cross-validation with 1000 bootstrapping was used. Results: The BCN Bio-HF calculator was derived from 864 consecutive outpatients (72% men) with mean age 68.2 +/- 12 years (73%/27% New York Heart Association (NYHA) class I-II/III-IV, LVEF 36%, ischemic etiology 52.2%) and followed for a median of 3.4 years (305 deaths). After an initial evaluation of 23 variables, eight independent models were developed. The variables included in these models were age, sex, NYHA functional class, left ventricular ejection fraction, serum sodium, estimated glomerular filtration rate, hemoglobin, loop diuretic dose, beta-blocker, Angiotensin converting enzyme inhibitor/Angiotensin-2 receptor blocker and statin treatments, and hs-cTnT, ST2, and NT-proBNP levels. The calculator may run with the availability of none, one, two, or the three biomarkers. The calculated risk of death was significantly changed by additive biomarker data. The average C-statistic in cross-validation analysis was 0.79. Conclusions: A new HF risk-calculator that incorporates available biomarkers reflecting different pathophysiological pathways better allowed individual prediction of death at 1, 2, and 3 years.	[Lupon, Josep; de Antonio, Marta; Zamora, Elisabet; Urrutia, Agustin; Bayes-Genis, Antoni] Hosp Badalona Germans Trias & Pujol, Heart Failure Unit, Badalona, Spain; [Lupon, Josep; de Antonio, Marta; Zamora, Elisabet; Urrutia, Agustin; Bayes-Genis, Antoni] Autonomous Univ Barcelona, Dept Med, Barcelona, Spain; [Vila, Joan; Penafiel, Judith] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain; [Vila, Joan; Penafiel, Judith] CIBER Epidemiol & Publ Hlth, Barcelona, Spain; [Galan, Amparo] Hosp Badalona Germans Trias & Pujol, Serv Biochem, Badalona, Spain	Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Germans Trias i Pujol	Bayes-Genis, A (corresponding author), Hosp Badalona Germans Trias & Pujol, Heart Failure Unit, Badalona, Spain.	abayesgenis@gmail.com	de A F, Marta/AAL-3341-2020; Bayes-Genis, Antoni/C-4002-2015; Bayes-Genis, Antonio/AAV-9422-2021	de A F, Marta/0000-0002-4319-797X; Bayes-Genis, Antoni/0000-0002-3044-197X; Bayes-Genis, Antonio/0000-0002-3044-197X; Vila-Domenech, Joan Salvador/0000-0002-0413-9291; Lupon, Josep/0000-0002-5601-9611; Lupon, Josep/0000-0002-3981-3020; Zamora, Elisabet/0000-0001-5317-7481	Roche Diagnostics; Catalan Society of Cardiology	Roche Diagnostics; Catalan Society of Cardiology	ST2 assays were performed by Critical Diagnostics; hs-cTnT and NT-proBNP assays were provided by Roche Diagnostics, which also provided a grant for statistical development and online application of the calculator. Dr. M. de Antonio received a competitive research grant from the Catalan Society of Cardiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; Abraham WT, 2008, J AM COLL CARDIOL, V52, P347, DOI 10.1016/j.jacc.2008.04.028; Bayes-Genis A, 2012, EUR J HEART FAIL, V14, P32, DOI 10.1093/eurjhf/hfr156; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Brophy JM, 2004, AM J MED, V116, P300, DOI 10.1016/j.amjmed.2003.09.035; Collet D, 1995, MODELLING SURVIVAL D, P107; D'Agostino RB, 2004, HANDB STAT, V23, P1; de Antonio M, 2012, AM HEART J, V163, P821, DOI 10.1016/j.ahj.2012.03.004; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Graf E, 1999, STAT MED, V18, P2529; Ketchum ES, 2011, PROG CARDIOVASC DIS, V54, P86, DOI 10.1016/j.pcad.2011.03.003; Ky B, 2012, CIRC-HEART FAIL, V5, P183, DOI 10.1161/CIRCHEARTFAILURE.111.965020; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Lupon J, 2013, MAYO CLIN PROC, V88, P234, DOI 10.1016/j.mayocp.2012.09.016; Newson R, 2006, STATA J, V6, P309, DOI 10.1177/1536867X0600600302; Pencina MJ, 2012, STAT MED, V31, P101, DOI 10.1002/sim.4348; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Pocock SJ, 2013, EUR HEART J, V34, P1404, DOI 10.1093/eurheartj/ehs337; Refaeilzadeh P., 2009, ENCYCL DATABASE SYST, P532, DOI [10.1007/978-0-387-39940-9, DOI 10.1007/978-0-387-39940-9_565]; Senni M, 2013, INT J CARDIOL, V163, P206, DOI 10.1016/j.ijcard.2011.10.071; Vazquez R, 2009, EUR HEART J, V30, P1088, DOI 10.1093/eurheartj/ehp032; Zamora E, 2012, J AM COLL CARDIOL, V59, P1709, DOI 10.1016/j.jacc.2011.11.066	23	74	77	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85466	10.1371/journal.pone.0085466	http://dx.doi.org/10.1371/journal.pone.0085466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454874	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100091
J	Musumari, PM; Wouters, E; Kayembe, PK; Nzita, MK; Mbikayi, SM; Suguimoto, SP; Techasrivichien, T; Lukhele, BW; El-Saaidi, C; Piot, P; Ono-Kihara, M; Kihara, M				Musumari, Patou Masika; Wouters, Edwin; Kayembe, Patrick Kalambayi; Nzita, Modeste Kiumbu; Mbikayi, Samclide Mutindu; Suguimoto, S. Pilar; Techasrivichien, Teeranee; Lukhele, Bhekumusa Wellington; El-Saaidi, Christina; Piot, Peter; Ono-Kihara, Masako; Kihara, Masahiro			Food Insecurity Is Associated with Increased Risk of Non-Adherence to Antiretroviral Therapy among HIV-Infected Adults in the Democratic Republic of Congo: A Cross-Sectional Study	PLOS ONE			English	Article							MEDICATION ADHERENCE; CARE UTILIZATION; MENTAL-HEALTH; INDIVIDUALS; HIV/AIDS; BARRIERS; ANXIETY; HAART; K6; INSUFFICIENCY	Background: Food insecurity is increasingly reported as an important barrier of patient adherence to antiretroviral therapy (ART) in both resource-poor and rich settings. However, unlike in resource rich-settings, very few quantitative studies to date have investigated the association of food insecurity with patient adherence to ART in Sub-Saharan Africa. The current study examines the association between food insecurity and adherence to ART among HIV-infected adults in the Democratic Republic of Congo (DRC). Methods and Findings: This is a cross-sectional quantitative study of patients receiving ART at three private and one public health facilities in Kinshasa, DRC. Participants were consecutively recruited into the study between April and November 2012. Adherence was measured using a combined method coupling pharmacy refill and self-reported adherence. Food insecurity was the primary predictor, and was assessed using the Household Food Insecurity Access Scale (HFIAS). Of the 898 participants recruited into the study, 512 (57%) were food insecure, and 188 (20.9%) were not adherent to ART. Food insecurity was significantly associated with non-adherence to ART (AOR, 2.06; CI, 1.38-3.09). We also found that perceived harmfulness of ART and psychological distress were associated respectively with increased (AOR, 1.95; CI, 1.15-3.32) and decreased (AOR, 0.31; CI, 0.11-0.83) odds of non-adherence to ART. Conclusion: Food insecurity is prevalent and a significant risk factor for non-adherence to ART among HIV-infected individuals in the DRC. Our findings highlight the urgent need for strategies to improve food access among HIV-infected on ART in order to ensure patient adherence to ART and ultimately the long-term success of HIV treatment in Sub-Saharan Africa.	[Musumari, Patou Masika; Suguimoto, S. Pilar; Techasrivichien, Teeranee; Lukhele, Bhekumusa Wellington; El-Saaidi, Christina; Ono-Kihara, Masako; Kihara, Masahiro] Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Wouters, Edwin] Univ Antwerp, Dept Sociol, Res Ctr Longitudinal & Life Course Studies, B-2020 Antwerp, Belgium; [Kayembe, Patrick Kalambayi; Nzita, Modeste Kiumbu] Univ Kinshasa, Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Mbikayi, Samclide Mutindu] Ctr Hosp Monkole, Kinshasa, DEM REP CONGO; [Piot, Peter] London Sch Hyg & Trop Med, London WC1, England	Kyoto University; University of Antwerp; Universite de Kinshasa; University of London; London School of Hygiene & Tropical Medicine	Musumari, PM (corresponding author), Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan.	patoumus@yahoo.fr	Mutindu, Samclide Mbikayi/AAZ-4056-2020; Wouters, Edwin/AAE-1649-2021	Wouters, Edwin/0000-0003-2268-3829; Kayembe Kalambayi, Patrick/0000-0002-5693-2144; Suguimoto, S. Pilar/0000-0002-8447-9172; Lukhele, Bhekumusa Wellington/0000-0001-6429-638X	Department of Global Health and Socio-epidemiology of the Kyoto University School of Public Health	Department of Global Health and Socio-epidemiology of the Kyoto University School of Public Health	This study was sponsored by the Department of Global Health and Socio-epidemiology of the Kyoto University School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LS, 2011, INT J METH PSYCH RES, V20, P215, DOI 10.1002/mpr.351; Anema A, 2011, AIDS CARE, V23, P221, DOI 10.1080/09540121.2010.498908; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Balcha Taye T, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P119, DOI 10.1177/1545109710387674; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Campos LN, 2010, AIDS BEHAV, V14, P289, DOI 10.1007/s10461-008-9435-8; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; Chi BH, 2009, INT J EPIDEMIOL, V38, P746, DOI 10.1093/ije/dyp004; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Curioso WH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-13; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Food and Agriculture Organization of the United Nations, 2012, STATE FOOD INS WORLD; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Godin G, 2005, AIDS CARE, V17, P493, DOI 10.1080/09540120412331291715; Godin G, 2003, AIDS PATIENT CARE ST, V17, P325, DOI 10.1089/108729103322231268; Goldman JD, 2008, AIDS RES HUM RETROV, V24, P1031, DOI 10.1089/aid.2008.0035; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Heaney C.A., 2008, HLTH BEHAV HLTH ED T, V4, P189, DOI DOI 10.1177/109019818501200106; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Institut National de la Statistique et Fonds des Nations Unies pour l'Enfance (National Institut of Statistics and United Nations Children's Fund), 2011, ENQ GRAPP IND MULT R; Jacquet A, 2009, 5 INT AIDS SOC IAS C; Johnston BE, 1998, 12 WORLD AIDS C GEN; *JOINT UN PROGR HI, 2009, AIDS EP UPD; Joint United Nations Programme on HIV/ AIDS, 2012, GLOB REP UNAIDS REP; Kalichman SC, 2011, PREV SCI, V12, P324, DOI 10.1007/s11121-011-0222-9; Kalichman SC, 2010, J URBAN HEALTH, V87, P631, DOI 10.1007/s11524-010-9446-4; Kalichman SC, 2009, AIDS CARE, V21, P87, DOI 10.1080/09540120802032627; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Molassiotis A, 2002, INT J STD AIDS, V13, P301, DOI 10.1258/0956462021925117; Musumari PM, 2013, AIDS CARE, V25, P1271, DOI 10.1080/09540121.2013.764391; Nel A, 2013, AIDS CARE, V25, P948, DOI 10.1080/09540121.2012.748867; Nemes MIB, 2004, AIDS, V18, pS15, DOI 10.1097/00002030-200406003-00004; Nguyen H, 2011, 6 INT C HIV TREATM P; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Peltzer K, 2011, AIDS CARE, V23, P60, DOI 10.1080/09540121.2010.498864; Peretti-Watel P, 2006, SOC SCI MED, V62, P2420, DOI 10.1016/j.socscimed.2005.10.020; Programme National Multisectoriel de lutte contre le VIH/SIDA (National Multi-sectoral Programme on HIV/AIDS), 2012, RAPP ACT RIP VIH SID; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tirivayi Nyasha, 2012, J AIDS Clin Res, V3, P171; Tiyou A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-51; Tsai AC, 2011, SOC SCI MED, V73, P1717, DOI 10.1016/j.socscimed.2011.09.026; Tsai AC, 2011, J GEN INTERN MED, V26, P1391, DOI 10.1007/s11606-011-1841-3; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; United Nations, 2001, SUBC NUTR 28 SESS NA; Wang EA, 2011, J GEN INTERN MED, V26, P1012, DOI 10.1007/s11606-011-1723-8; Wanyama J, 2007, AIDS, V21, P1486, DOI 10.1097/QAD.0b013e32823ecf7f; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; Weiser SD, 2013, AIDS, V27; Weiser SD, 2009, 5 INT AIDS SOC IAS C; Weiser SD, 2013, J GEN INTERN MED, V28, P91, DOI 10.1007/s11606-012-2176-4; Weiser SD, 2012, AIDS, V26, P67, DOI 10.1097/QAD.0b013e32834cad37; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; Weiser SD, 2009, JAIDS-J ACQ IMM DEF, V52, P342, DOI 10.1097/QAI.0b013e3181b627c2; Weiser SD, 2009, J GEN INTERN MED, V24, P14, DOI 10.1007/s11606-008-0824-5; *WORLD BANK, 2009, GLOB EC CRIS HIV PRE; World Food Programme, 2003, PROGR ERA AIDS WFPS; Wouters E, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-210; Young S, 2014, AIDS BEHAV, V18, pS505, DOI 10.1007/s10461-013-0547-4	68	57	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85327	10.1371/journal.pone.0085327	http://dx.doi.org/10.1371/journal.pone.0085327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DH	24454841	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000330235100071
J	Rochman, CM; Hentschel, BT; Teh, SJ				Rochman, Chelsea M.; Hentschel, Brian T.; Teh, Swee J.			Long-Term Sorption of Metals Is Similar among Plastic Types: Implications for Plastic Debris in Aquatic Environments	PLOS ONE			English	Article							SAN-DIEGO BAY; RESIN PELLETS; MARINE DEBRIS; TRACE-METALS; ADSORPTION; CONTAMINATION; ACCUMULATION; COMMUNITIES; POLLUTANTS; INGESTION	Concerns regarding plastic debris and its ability to accumulate large concentrations of priority pollutants in the aquatic environment led us to quantify relationships between different types of mass-produced plastic and metals in seawater. At three locations in San Diego Bay, we measured the accumulation of nine targeted metals (aluminum, chromium, manganese, iron, cobalt, nickel, zinc, cadmium and lead) sampling at 1, 3, 6, 9 and 12 months, to five plastic types: polyethylene terephthalate (PET), high-density polyethylene (HDPE), polyvinyl chloride (PVC), low-density polyethylene (LDPE), and polypropylene (PP). Accumulation patterns were not consistent over space and time, and in general all types of plastic tended to accumulate similar concentrations of metals. When we did observe significant differences among concentrations of metals at a single sampling period or location in San Diego Bay, we found that HDPE typically accumulated lesser concentrations of metals than the other four polymers. Furthermore, over the 12-month study period, concentrations of all metals increased over time, and chromium, manganese, cobalt, nickel, zinc and lead did not reach saturation on at least one plastic type during the entire 12-month exposure. This suggests that plastic debris may accumulate greater concentrations of metals the longer it remains at sea. Overall, our work shows that a complex mixture of metals, including those listed as priority pollutants by the US EPA (Cd, Ni, Zn and Pb), can be found on plastic debris composed of various plastic types.	[Rochman, Chelsea M.; Hentschel, Brian T.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Rochman, Chelsea M.; Hentschel, Brian T.] San Diego State Univ, Coastal Marine Inst, San Diego, CA 92182 USA; [Rochman, Chelsea M.; Teh, Swee J.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA	California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California Davis	Rochman, CM (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	cmrochman@ucdavis.edu			SoCal SETAC; PADI Foundation; SDSU Division of Research Affairs; EPA Superfund Region 9; Aquatic Health Program at the University of California, Davis; National Science Foundation [0548190, 2010101195]	SoCal SETAC; PADI Foundation; SDSU Division of Research Affairs; EPA Superfund Region 9; Aquatic Health Program at the University of California, Davis(University of California System); National Science Foundation(National Science Foundation (NSF))	This material is based on work supported by SoCal SETAC, PADI Foundation, SDSU Division of Research Affairs, EPA Superfund Region 9, The Aquatic Health Program at the University of California, Davis, National Science Foundation Grant No. 0548190, and a National Science Foundation Graduate Research Fellowship (Grant No. 2010101195). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artham T, 2009, INT BIODETER BIODEGR, V63, P884, DOI 10.1016/j.ibiod.2009.03.003; Ashton K, 2010, MAR POLLUT BULL, V60, P2050, DOI 10.1016/j.marpolbul.2010.07.014; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Davison P, 2011, MAR ECOL PROG SER, V432, P173, DOI 10.3354/meps09142; Decho AW, 2000, CONT SHELF RES, V20, P1257, DOI 10.1016/S0278-4343(00)00022-4; Deheyn DD, 2006, CHEMOSPHERE, V63, P818, DOI 10.1016/j.chemosphere.2005.07.066; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Donohue MJ, 2001, MAR POLLUT BULL, V42, P1301, DOI 10.1016/S0025-326X(01)00139-4; Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042; Fischer AC, 2007, MAR CHEM, V107, P533, DOI 10.1016/j.marchem.2007.08.004; Fotopoulou KN, 2012, MAR ENVIRON RES, V81, P70, DOI 10.1016/j.marenvres.2012.08.010; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Hirai H, 2011, MAR POLLUT BULL, V62, P1683, DOI 10.1016/j.marpolbul.2011.06.004; Holmes LA, 2012, ENVIRON POLLUT, V160, P42, DOI 10.1016/j.envpol.2011.08.052; HUTCHINSON TH, 1994, MAR ENVIRON RES, V38, P275, DOI 10.1016/0141-1136(94)90028-0; Johnston EL, 2009, ENVIRON POLLUT, V157, P1745, DOI 10.1016/j.envpol.2009.02.017; Karapanagioti HK, 2008, MAR ENVIRON RES, V65, P283, DOI 10.1016/j.marenvres.2007.11.005; Komoroske LM, 2012, SCI TOTAL ENVIRON, V417, P108, DOI 10.1016/j.scitotenv.2011.12.018; Lancellotti DA, 2004, MAR POLLUT BULL, V48, P303, DOI 10.1016/j.marpolbul.2003.08.005; Lazar B, 2011, MAR POLLUT BULL, V62, P43, DOI 10.1016/j.marpolbul.2010.09.013; Li WJ, 2001, J RADIOANAL NUCL CH, V250, P497; Lithner D, 2011, SCI TOTAL ENVIRON, V409, P3309, DOI 10.1016/j.scitotenv.2011.04.038; Luoma SN, 2005, ENVIRON SCI TECHNOL, V39, P1921, DOI 10.1021/es048947e; Lusher AL, 2013, MAR POLLUT BULL, V67, P94, DOI 10.1016/j.marpolbul.2012.11.028; Mato Y, 2001, ENVIRON SCI TECHNOL, V35, P318, DOI 10.1021/es0010498; McKinley AC, 2011, ENVIRON POLLUT, V159, P1499, DOI 10.1016/j.envpol.2011.03.008; Murray F, 2011, MAR POLLUT BULL, V62, P1207, DOI 10.1016/j.marpolbul.2011.03.032; Nakashima E, 2012, ENVIRON SCI TECHNOL, V46, P10099, DOI 10.1021/es301362g; Ogata Y, 2009, MAR POLLUT BULL, V58, P1437, DOI 10.1016/j.marpolbul.2009.06.014; Pascall MA, 2005, J AGR FOOD CHEM, V53, P164, DOI 10.1021/jf048978t; PlasticsEurope, 2010, PLAST FACTS 2010 AN; Quinn GP, 2002, EXPT DESGIN DATA ANA, P260; Rios LM, 2010, J ENVIRON MONITOR, V12, P2226, DOI 10.1039/c0em00239a; ROBERTSON DE, 1968, ANAL CHIM ACTA, V42, P533, DOI 10.1016/S0003-2670(01)80346-9; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P2439, DOI 10.1021/es400748b; Rochman CM, 2013, NATURE, V494, P169, DOI 10.1038/494169a; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P1646, DOI 10.1021/es303700s; Rusina TP, 2007, CHEMOSPHERE, V68, P1344, DOI 10.1016/j.chemosphere.2007.01.025; Secretariat of the Convention on Biological Diversity and the Scientific and Technical Advisory Panel-GEF, 2012, CBD TECHNICAL SERIES, V67; SPEAR LB, 1995, MAR ENVIRON RES, V40, P123, DOI 10.1016/0141-1136(94)00140-K; Tanaka K, 2013, MAR POLLUT BULL, V69, P219, DOI 10.1016/j.marpolbul.2012.12.010; Tarpley R. J., 1993, Aquatic Mammals, V19, P93; Teuten EL, 2007, ENVIRON SCI TECHNOL, V41, P7759, DOI 10.1021/es071737s; Tien CJ, 2013, ARCH ENVIRON CON TOX, V64, P605, DOI 10.1007/s00244-012-9856-2; Tien CJ, 2009, CHEMOSPHERE, V76, P1288, DOI 10.1016/j.chemosphere.2009.06.013; Uhrin AV, 2011, MAR POLLUT BULL, V62, P2605, DOI 10.1016/j.marpolbul.2011.10.006; Underwood AJ, 1997, EXPT ECOLOGY; Winer B.J., 1991, STAT PRINCIPLES EXPT; YE S, 1991, Marine Pollution Bulletin, V22, P608, DOI 10.1016/0025-326X(91)90249-R; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	51	294	310	20	235	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85433	10.1371/journal.pone.0085433	http://dx.doi.org/10.1371/journal.pone.0085433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454866	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100084
J	Fujikawa, A; Fujii, T; Mimura, S; Takahashi, R; Sakai, M; Suzuki, S; Kyoto, Y; Uwabe, Y; Maeda, S; Mori, T				Fujikawa, Akira; Fujii, Tatsuya; Mimura, Satoshi; Takahashi, Ryota; Sakai, Masao; Suzuki, Shinya; Kyoto, Yukishige; Uwabe, Yasuhide; Maeda, Shinji; Mori, Toru			Tuberculosis Contact Investigation Using Interferon-Gamma Release Assay with Chest X-Ray and Computed Tomography	PLOS ONE			English	Article							ACTIVE TUBERCULOSIS; PREDICTIVE-VALUE; SKIN-TEST; PULMONARY TUBERCULOSIS; INFECTION; DIAGNOSIS; CT; DISEASE; GOLD	Between September 2009 and January 2010, 6 members of the Japanese Eastern Army, who had completed the same training program, were diagnosed with active tuberculosis (TB) on different occasions. The Ministry of Defense conducted a contact investigation of all members who had come into contact with the infected members. The purpose of this study was to verify the efficacy of the TB screening protocol used in this investigation. A total of 884 subjects underwent interferon-gamma release assay (IGRA) and chest X-ray. The 132 subjects who were IGRA positive or with X-ray findings suggestive of TB subsequently underwent chest computer tomography (CT). Chest CT was performed for 132 subjects. Based on CT findings, 24 (2.7%) subjects were classified into the active TB group, 107 (12.1%) into the latent tuberculosis infection (LTBI) group, and 753 (85.2%) into the non-TB group. The first 2 groups underwent anti-TB therapy, and all 3 groups were followed for 2 years after treatment. Although one subject in the active TB group experienced relapse during the follow-up period, no patient in the LTBI or non-TB groups developed TB. IGRA and chest X-ray, followed by chest CT for those IGRA positive or with suspicious X-ray findings, appears to be an effective means of TB contact screening and infection prevention.	[Fujikawa, Akira; Suzuki, Shinya] Japan Self Def Forces Cent Hosp, Dept Med Educ & Res, Setagaya Ku, Tokyo, Japan; [Fujikawa, Akira; Kyoto, Yukishige] Japan Self Def Forces Cent Hosp, Dept Radiol, Tokyo, Japan; [Fujii, Tatsuya] Kawakita Gen Hosp, Dept Internal Med, Tokyo, Japan; [Mimura, Satoshi; Sakai, Masao; Suzuki, Shinya] Japan Self Def Forces Cent Hosp, Dept Internal Med, Div Resp Med, Tokyo, Japan; [Takahashi, Ryota] Japan Self Def Forces Cent Hosp, Div Infect Dis, Dept Internal Med, Tokyo, Japan; [Uwabe, Yasuhide] Japan Ground Self Def Force Fukuoka Hosp, Dept Internal Med, Kasuga, Fukuoka, Japan; [Maeda, Shinji] Res Inst TB Japan, Dept Mycobacterium Reference & Res, Mol Epidemiol Div, Tokyo, Japan; [Mori, Toru] Res Inst TB Japan, JATA, Tokyo, Japan		Fujikawa, A (corresponding author), Japan Self Def Forces Cent Hosp, Dept Med Educ & Res, Setagaya Ku, Tokyo, Japan.	fujikawa-sdf@umin.ac.jp; hujii@kawakita.or.jp						Chee CBE, 2009, EUR J CLIN MICROBIOL, V28, P667, DOI 10.1007/s10096-008-0670-8; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Diel R, 2009, CHEST, V135, P1010, DOI 10.1378/chest.08-2048; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; GREENBAUM M, 1980, AM REV RESPIR DIS, V121, P477, DOI 10.1164/arrd.1980.121.3.477; Higuchi K, 2007, RESPIROLOGY, V12, P88, DOI 10.1111/j.1440-1843.2006.01000.x; Horsburgh CR, 2011, NEW ENGL J MED, V364, P1441, DOI 10.1056/NEJMcp1005750; IM JG, 1993, RADIOLOGY, V186, P653, DOI 10.1148/radiology.186.3.8430169; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Kang YA, 2007, CHEST, V132, P959, DOI 10.1378/chest.06-2805; Kipfer B, 2008, SWISS MED WKLY, V138, P267, DOI 2008/17/smw-12051; Kowada A, 2013, EUR J RADIOL, V82, P1353, DOI 10.1016/j.ejrad.2013.02.017; Lee SW, 2010, CHEST, V137, P1057, DOI 10.1378/chest.09-1513; LEVY H, 1989, CHEST, V95, P1193, DOI 10.1378/chest.95.6.1193; McCollough CH, 2012, RADIOLOGY, V264, P567, DOI 10.1148/radiol.12112265; Mori T, 2007, INT J TUBERC LUNG D, V11, P1021; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Toyota M, 2001, Kekkaku, V76, P625; Wilkinson KA, 2006, J INFECT DIS, V193, P354, DOI 10.1086/499311; Yoshiyama Takashi, 2008, Kekkaku, V83, P411	21	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85612	10.1371/journal.pone.0085612	http://dx.doi.org/10.1371/journal.pone.0085612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454900	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800052
J	Unelius, CR; Schiebe, C; Bohman, B; Andersson, MN; Schlyter, F				Unelius, C. Rikard; Schiebe, Christian; Bohman, Bjorn; Andersson, Martin N.; Schlyter, Fredrik			Non-Host Volatile Blend Optimization for Forest Protection against the European Spruce Bark Beetle, Ips typographus	PLOS ONE			English	Article							DENDROCTONUS-VALENS COLEOPTERA; AGGREGATION PHEROMONE; PINE-BEETLE; NORWAY SPRUCE; SCOLYTIDAE; VERBENONE; ATTRACTION; PONDEROSAE; TREES; INTERRUPTION	Conifer feeding bark beetles (Coleoptera, Curculionidae, Scolytinae) pose a serious economic threat to forest production. Volatiles released by non-host angiosperm plants (so called non-host volatiles, NHV) have been shown to reduce the risk of attack by many bark beetle species, including the European spruce bark beetle, Ips typographus. However, the most active blend for I. typographus, containing three green leaf volatiles (GLVs) in addition to the key compounds trans-conophthorin (tC) and verbenone, has been considered too expensive for use in large-scale management. To lower the cost and improve the applicability of NHV, we aim to simplify the blend without compromising its anti-attractant potency. Since the key compound tC is expensive in pure form, we also tested a crude version: technical grade trans-conophthorin (T-tC). In another attempt to find a more cost effective substitute for tC, we evaluated a more readily synthesized analog: dehydroconophthorin (DHC). Our results showed that 1-hexanol alone could replace the three-component GLV blend containing 1-hexanol, (3Z)-hexen-1-ol, and (2E)-hexen-1-ol. Furthermore, the release rate of tC could be reduced from 5 mg/day to 0.5 mg/day in a blend with 1-hexanol and (-)-verbenone without compromising the anti-attractant activity. We further show that T-tC was comparable with tC, whereas DHC was a less effective anti-attractant. DHC also elicited weaker physiological responses in the tC-responding olfactory receptor neuron class, providing a likely mechanistic explanation for its weaker anti-attractive effect. Our results suggest a blend consisting of (-)-verbenone, 1-hexanol and technical trans-conophthorin as a cost-efficient anti-attractant for forest protection against I. typographus.	[Unelius, C. Rikard; Schiebe, Christian; Bohman, Bjorn] Linnaeus Univ, Dept Chem & Biomed Sci, Kalmar, Sweden; [Schiebe, Christian; Andersson, Martin N.; Schlyter, Fredrik] Swedish Univ Agr Sci, Dept Plant Protect Biol, Alnarp, Sweden	Linnaeus University; Swedish University of Agricultural Sciences	Unelius, CR (corresponding author), Linnaeus Univ, Dept Chem & Biomed Sci, Kalmar, Sweden.	rikard.unelius@lnu.se	Unelius, Carl Rikard/B-3183-2008; Unelius, Carl Rikard/O-7050-2019; Schlyter, Fredrik/F-8567-2015	Unelius, Carl Rikard/0000-0001-7158-6393; Unelius, Carl Rikard/0000-0001-7158-6393; Schlyter, Fredrik/0000-0002-1244-0308; Bohman, Bjorn/0000-0001-7097-5813; Andersson, Martin N/0000-0001-9807-8524	SJFR; Formas [24.0293/98, 2006-1064, 230-2005-1778]; foundation Oscar och Lilli Lamms Minne; Linnaeus University; Swedish University of Agricultural Sciences in Alnarp; Swedish Research Council (VR)	SJFR; Formas(Swedish Research Council Formas); foundation Oscar och Lilli Lamms Minne; Linnaeus University; Swedish University of Agricultural Sciences in Alnarp; Swedish Research Council (VR)(Swedish Research Council)	The studies in Asa were granted by SJFR and Formas (Nr 24.0293/98 and 2006-1064) and by the foundation Oscar och Lilli Lamms Minne. The University of Kalmar (now Linnaeus University) is acknowledged for financial support to RU and BB. The Swedish University of Agricultural Sciences in Alnarp is acknowledged for financial support to CS, FS. MNA was funded by FORMAS project #230-2005-1778 "Semiochemical diversity and insect dynamics'' and by the Swedish Research Council (VR) during manuscript preparation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Andersson MN, 2012, CHEM SENSES, V37, P403, DOI 10.1093/chemse/bjs009; Andersson MN, 2011, J CHEM ECOL, V37, P899, DOI 10.1007/s10886-011-9995-3; Andersson MN, 2010, J EXP BIOL, V213, P3332, DOI 10.1242/jeb.044396; Andersson MN, 2009, J INSECT PHYSIOL, V55, P556, DOI 10.1016/j.jinsphys.2009.01.018; ARMITAGE DMA, 1959, J AM CHEM SOC, V81, P2437, DOI 10.1021/ja01519a040; BAKKE A, 1981, Z ANGEW ENTOMOL, V92, P172; BIRGERSSON G, 1988, INSECT BIOCHEM, V18, P761, DOI 10.1016/0020-1790(88)90098-4; Byers JA, 1998, NATURWISSENSCHAFTEN, V85, P557, DOI 10.1007/s001140050551; Byers JA, 2000, NATURWISSENSCHAFTEN, V87, P503, DOI 10.1007/s001140050768; Enander G, 2006, 3206339HK3206339HK; Fettig CJ, 2005, J ECON ENTOMOL, V98, P2041, DOI 10.1603/0022-0493-98.6.2041; Gillette NE, 2009, FOREST ECOL MANAG, V257, P1405, DOI 10.1016/j.foreco.2008.12.017; Gillette NE, 2006, AGR FOREST ENTOMOL, V8, P243, DOI 10.1111/j.1461-9563.2006.00303.x; Gillette NE, 2012, AGR FOREST ENTOMOL, V14, P367, DOI 10.1111/j.1461-9563.2012.00577.x; Hedges L.V., 1985, STAT METHODS META AN; Huber DPW, 2001, AGR FOREST ENTOMOL, V3, P225, DOI 10.1046/j.1461-9555.2001.00111.x; HUNT DWA, 1990, J CHEM ECOL, V16, P1385, DOI 10.1007/BF01021034; IRELAND RE, 1980, TETRAHEDRON LETT, V21, P1389, DOI 10.1016/S0040-4039(00)92727-8; Jakus R, 2003, ANZ SCHADL-J PEST SC, V76, P89, DOI 10.1046/j.1439-0280.2003.03020.x; LEUFVEN A, 1987, CAN J BOT, V65, P1038, DOI 10.1139/b87-144; LEUFVEN A, 1984, J CHEM ECOL, V10, P1349, DOI 10.1007/BF00988116; Lindgren BS, 2002, ENVIRON ENTOMOL, V31, P759, DOI 10.1603/0046-225X-31.5.759; MUSTAPARTA H, 1984, J COMP PHYSIOL, V154, P591, DOI 10.1007/BF00610172; PAYNE TL, 1989, J ECON ENTOMOL, V82, P1702, DOI 10.1093/jee/82.6.1702; Rappaport NG, 2001, ENVIRON ENTOMOL, V30, P837, DOI 10.1603/0046-225X-30.5.837; RUDINSKY JA, 1974, ENVIRON ENTOMOL, V3, P90, DOI 10.1093/ee/3.1.90; Schiebe C, 2011, J APPL ENTOMOL, V135, P726, DOI 10.1111/j.1439-0418.2011.01624.x; Schiebe C, 2006, THESIS SWEDEN HOGSKO; Schiebe C, 2012, OECOLOGIA, V170, P183, DOI 10.1007/s00442-012-2298-8; SCHLYTER F, 1987, J CHEM ECOL, V13, P701, DOI 10.1007/BF01020153; SCHLYTER F, 1989, J CHEM ECOL, V15, P2263, DOI 10.1007/BF01014114; Schlyter F, 1999, PHEROMONES OF NON-LEPIDOPTERAN INSECTS ASSOCIATED WITH AGRICULTURAL PLANTS, P113; Schlyter Fredrik, 2012, Psyche (Cambridge), V2012, p10pp, DOI 10.1155/2012/268621; Seo SY, 2009, J AM CHEM SOC, V131, P263, DOI 10.1021/ja8072462; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Zhang QH, 2004, AGR FOREST ENTOMOL, V6, P1, DOI 10.1111/j.1461-9555.2004.00202.x; Zhang QH, 1999, J CHEM ECOL, V25, P2847, DOI 10.1023/A:1020816011131; Zhang QH, 2000, CHEMOECOLOGY, V10, P69, DOI 10.1007/s000490050010; Zhang QH, 2003, AGRIC FOR ENTOMOL, V5, P145, DOI 10.1046/j.1461-9563.2003.00173.x; Zhang QH, 2003, OIKOS, V101, P299, DOI 10.1034/j.1600-0706.2003.111595.x	42	20	20	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85381	10.1371/journal.pone.0085381	http://dx.doi.org/10.1371/journal.pone.0085381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454855	Green Published, gold, Green Submitted			2022-12-25	WOS:000329925800043
J	Li, KW; Yu, YP; Zhou, CY; Kim, DS; Lin, B; Sharp, K; Steward, O; Luo, ZD				Li, Kang-Wu; Yu, Yanhui Peter; Zhou, Chunyi; Kim, Doo-Sik; Lin, Bin; Sharp, Kelli; Steward, Oswald; Luo, Z. David			Calcium Channel alpha(2)delta(1) Proteins Mediate Trigeminal Neuropathic Pain States Associated with Aberrant Excitatory Synaptogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Molecular Pharmacology; Neuroscience; Pain; Synaptic Plasticity	SPINAL GLIAL ACTIVATION; CHRONIC CONSTRICTION INJURY; PERIPHERAL-NERVE INJURY; SUBUNIT UP-REGULATION; DORSAL-HORN; GABAPENTIN NEURONTIN; BEHAVIORAL HYPERSENSITIVITY; FUNCTIONAL EXPRESSION; ANTIEPILEPTIC DRUGS; INFRAORBITAL NERVE	Background: Factors mediating orofacial neuropathic pain are not well defined. Results: Trigeminal nerve injury-induced calcium channel (21) protein up-regulation in trigeminal ganglia and spinal complex correlated with enhanced spinal presynaptic neurotransmission, excitatory synaptogenesis, and orofacial pain states. Conclusion: This neuroplasticity may mediate orofacial neuropathic pain states by enhancing dorsal horn excitatory synaptic neurotransmission. Significance: This reveals a mechanism underlying orofacial neuropathic pain states. To investigate a potential mechanism underlying trigeminal nerve injury-induced orofacial hypersensitivity, we used a rat model of chronic constriction injury to the infraorbital nerve (CCI-ION) to study whether CCI-ION caused calcium channel (21) (Ca-v21) protein dysregulation in trigeminal ganglia and associated spinal subnucleus caudalis and C1/C2 cervical dorsal spinal cord (Vc/C2). Furthermore, we studied whether this neuroplasticity contributed to spinal neuron sensitization and neuropathic pain states. CCI-ION caused orofacial hypersensitivity that correlated with Ca-v21 up-regulation in trigeminal ganglion neurons and Vc/C2. Blocking Ca-v21 with gabapentin, a ligand for the Ca-v21 proteins, or Ca-v21 antisense oligodeoxynucleotides led to a reversal of orofacial hypersensitivity, supporting an important role of Ca-v21 in orofacial pain processing. Importantly, increased Ca-v21 in Vc/C2 superficial dorsal horn was associated with increased excitatory synaptogenesis and increased frequency, but not the amplitude, of miniature excitatory postsynaptic currents in dorsal horn neurons that could be blocked by gabapentin. Thus, CCI-ION-induced Ca-v21 up-regulation may contribute to orofacial neuropathic pain states through abnormal excitatory synapse formation and enhanced presynaptic excitatory neurotransmitter release in Vc/C2.	[Li, Kang-Wu; Kim, Doo-Sik; Lin, Bin; Luo, Z. David] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Sch Med, Irvine, CA 92697 USA; [Yu, Yanhui Peter; Zhou, Chunyi; Luo, Z. David] Univ Calif Irvine, Dept Pharmacol, Sch Med, Irvine, CA 92697 USA; [Sharp, Kelli; Steward, Oswald; Luo, Z. David] Univ Calif Irvine, Reeve Irvine Res Ctr, Sch Med, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Luo, ZD (corresponding author), Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Gillespie Bldg,Rm 3113,837 Hlth Sci Rd, Irvine, CA 92697 USA.	zluo@uci.edu		Steward, Oswald/0000-0001-7069-8756	National Institutes of Health [DE014545, DE019298, NS064341, DE021847]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019298, R21DE014545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DE014545, DE019298, NS064341, and DE021847 (to Z.D.L.).	Backonja M, 2003, CLIN THER, V25, P81, DOI 10.1016/S0149-2918(03)90011-7; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bauer CS, 2009, J NEUROSCI, V29, P4076, DOI 10.1523/JNEUROSCI.0356-09.2009; Boroujerdi A, 2011, PAIN, V152, P649, DOI 10.1016/j.pain.2010.12.014; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; BRUST PF, 1993, NEUROPHARMACOLOGY, V32, P1089, DOI 10.1016/0028-3908(93)90004-M; Cao H, 2008, NEUROSCI BIOBEHAV R, V32, P972, DOI 10.1016/j.neubiorev.2008.03.009; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Clark Glenn T, 2006, J Calif Dent Assoc, V34, P599; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Field MJ, 1999, PAIN, V80, P391, DOI 10.1016/S0304-3959(98)00239-5; Field MJ, 1997, BRIT J PHARMACOL, V121, P1513, DOI 10.1038/sj.bjp.0701320; Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768; Gordh TE, 2008, PAIN, V138, P255, DOI 10.1016/j.pain.2007.12.011; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; Hardt J, 2008, PAIN MED, V9, P803, DOI 10.1111/j.1526-4637.2008.00425.x; Hashizume H, 2000, SPINE, V25, P1206, DOI 10.1097/00007632-200005150-00003; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Hunter JC, 1997, EUR J PHARMACOL, V324, P153, DOI 10.1016/S0014-2999(97)00070-8; Hwang JH, 1997, REGION ANESTH, V22, P249, DOI 10.1016/S1098-7339(06)80010-6; Iwata K, 2011, INT REV NEUROBIOL, V97, P227, DOI 10.1016/B978-0-12-385198-7.00009-6; Kang MG, 2002, FEBS LETT, V528, P177, DOI 10.1016/S0014-5793(02)03295-7; Kernisant M, 2008, J NEUROSCI METH, V172, P43, DOI 10.1016/j.jneumeth.2008.04.013; Kim DS, 2012, J NEUROSCI, V32, P8977, DOI 10.1523/JNEUROSCI.6494-11.2012; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Klugbauer N, 1999, J NEUROSCI, V19, P684; Laird MA, 2000, ANN PHARMACOTHER, V34, P802; Leo S, 2009, EUR J PAIN, V13, P1008, DOI 10.1016/j.ejpain.2008.12.001; Li CY, 2006, PAIN, V125, P20, DOI 10.1016/j.pain.2006.04.022; Li CY, 2004, J NEUROSCI, V24, P8494, DOI 10.1523/JNEUROSCI.2982-04.2004; Li K.-W., 2013, EUR J PAIN, DOI 10.1002/j.1532-2149.2013.00396.x; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Marais E, 2001, MOL PHARMACOL, V59, P1243, DOI 10.1124/mol.59.5.1243; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Neumann S, 2008, J NEUROSCI, V28, P7936, DOI 10.1523/JNEUROSCI.1259-08.2008; Nguyen D, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-6; PEYRONNARD JM, 1989, CELL TISSUE RES, V257, P379, DOI 10.1007/BF00261840; Qin N, 2002, MOL PHARMACOL, V62, P485, DOI 10.1124/mol.62.3.485; Rogawski MA, 2004, NAT MED, V10, P685, DOI 10.1038/nm1074; Rogoz K, 2012, PAIN, V153, P1525, DOI 10.1016/j.pain.2012.04.017; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Shimoyama M, 2000, PAIN, V85, P405, DOI 10.1016/S0304-3959(99)00283-3; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; Singh L, 1996, PSYCHOPHARMACOLOGY, V127, P1, DOI 10.1007/BF02805968; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stanfa LC, 1997, NEUROREPORT, V8, P587, DOI 10.1097/00001756-199702100-00002; Sun S, 2008, BRAIN RES BULL, V75, P83, DOI 10.1016/j.brainresbull.2007.07.027; Sweitzer SM, 1999, BRAIN RES, V829, P209, DOI 10.1016/S0006-8993(99)01326-8; Valder CR, 2003, J NEUROCHEM, V87, P560, DOI 10.1046/j.1471-4159.2003.02016.x; Vickers E R, 2000, Aust Endod J, V26, P53; VOS BP, 1994, J NEUROSCI, V14, P2708; WAMIL AW, 1994, EPILEPSY RES, V17, P1, DOI 10.1016/0920-1211(94)90074-4; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Xiao W, 2007, NEUROSCIENCE, V144, P714, DOI 10.1016/j.neuroscience.2006.09.044	60	43	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7025	7037		10.1074/jbc.M114.548990	http://dx.doi.org/10.1074/jbc.M114.548990			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24459143	Green Published, hybrid			2022-12-25	WOS:000332389400062
J	Kher, SS; Struckhoff, AP; Alberts, AS; Worthylake, RA				Kher, Swapnil S.; Struckhoff, Amanda P.; Alberts, Arthur S.; Worthylake, Rebecca A.			A Novel Role for p115RhoGEF in Regulation of Epithelial Plasticity	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE FACTORS; CELL-CELL ADHESION; RHO FAMILY GTPASES; E-CADHERIN; MESENCHYMAL TRANSITION; ADHERENS JUNCTIONS; MORPHOGENESIS; MIGRATION; PROTEIN; ROCK	Epithelial plasticity plays a critical role during physiological processes, such as wound healing and tissue regeneration, and dysregulation of epithelial plasticity can lead to pathological conditions, such as cancer. Cell-cell junctions are a critical feature of epithelial cells and loss of junctions is associated with acquisition of mesenchymal features, such as enhanced protrusion and migration. Although Rho has been implicated in regulation of junctions in epithelial cells, the role of Rho signaling in the regulation of epithelial plasticity has not been understood. We show that members of the RGS RhoGEFs family play a critical role in regulation of epithelial cell-cell junctions in breast epithelial cells. We identify a novel role for p115RhoGEF in regulation of epithelial plasticity. Loss of p115RhoGEF leads to decreased junctional E-cadherin and enhanced protrusiveness and migration. Conversely, overexpression of p115RhoGEF enhanced junctional E-cadherin and inhibited cell protrusion and migration. siRNA screen of 23 Rho effectors showed that members of the Diaphanous-Related Formin (DRF) family are required for p115RhoGEF-mediated changes in epithelial plasticity. Thus, our data indicates a novel role for p115RhoGEF in regulation of epithelial plasticity, which is dependent on Rho-DRF signaling module.	[Kher, Swapnil S.] LSU Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA; [Struckhoff, Amanda P.] LSU Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA USA; [Alberts, Arthur S.] Van Andel Res Inst, Ctr Canc & Cell Biol, Grand Rapids, MI USA; [Worthylake, Rebecca A.] LSU Hlth Sci Ctr, Dept Oral Biol, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Van Andel Institute; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Worthylake, RA (corresponding author), LSU Hlth Sci Ctr, Dept Oral Biol, New Orleans, LA USA.	blakeworthy@gmail.com			Louisiana Cancer Research Consortium; NIH from the National Center for Research Resources [P20RR020160, P20RR021970]; NIH from the National Institute of Dental and Craniofacial Research [R03DE19166]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020160, P20RR021970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE019166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103501] Funding Source: NIH RePORTER	Louisiana Cancer Research Consortium; NIH from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH from the National Institute of Dental and Craniofacial Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank all of the members of the LSU Cell Migration Group for ongoing input and critique of this research. The authors also acknowledge funding from the Louisiana Cancer Research Consortium, and the following NIH grants: Grant Numbers P20RR020160 and P20RR021970 from the National Center for Research Resources, Grant Number R03DE19166 from the National Institute of Dental and Craniofacial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; Francis SA, 2006, BLOOD, V107, P1627, DOI 10.1182/blood-2005-03-1164; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Hart MJ, 1996, J BIOL CHEM, V271, P25452, DOI 10.1074/jbc.271.41.25452; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; Kher SS, 2012, NAT CELL BIOL, V14, P784, DOI 10.1038/ncb2553; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Levayer R, 2011, NAT CELL BIOL, V13, P529, DOI 10.1038/ncb2224; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mulinari S, 2008, MOL BIOL CELL, V19, P1883, DOI 10.1091/mbc.E07-12-1230; Mulinari Shai, 2010, Small GTPases, V1, P28; Nalbant P, 2009, MOL BIOL CELL, V20, P4070, DOI 10.1091/mbc.E09-01-0041; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Rana MK, 2012, J BIOL CHEM, V287, P21836, DOI 10.1074/jbc.M112.346114; Ratheesh A, 2012, NAT CELL BIOL; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; Struckhoff AP, 2013, J CELL SCI, V126, P4514, DOI 10.1242/jcs.132381; Struckhoff AP, 2010, J CELL SCI, V123, P401, DOI 10.1242/jcs.052167; Terry SJ, 2011, NAT CELL BIOL; Van Aelst L, 2002, GENE DEV, V16, P1032, DOI 10.1101/gad.978802; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wallace SW, 2011, MOL CELL BIOL, V31, P81, DOI 10.1128/MCB.01001-10; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Zheng R, 2006, ONCOGENE, V25, P5942, DOI 10.1038/sj.onc.1209586	41	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e85409	10.1371/journal.pone.0085409	http://dx.doi.org/10.1371/journal.pone.0085409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465552	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000013
J	Quach, TN; Tran, LSP; Valliyodan, B; Nguyen, HTM; Kumar, R; Neelakandan, AK; Guttikonda, SK; Sharp, RE; Nguyen, HT				Quach, Truyen N.; Lam-Son Phan Tran; Valliyodan, Babu; Nguyen, Hanh T. M.; Kumar, Rajesh; Neelakandan, Anjanasree K.; Guttikonda, Satish Kumar; Sharp, Robert E.; Nguyen, Henry T.			Functional Analysis of Water Stress-Responsive Soybean GmNAC003 and GmNAC004 Transcription Factors in Lateral Root Development in Arabidopsis	PLOS ONE			English	Article							ABSCISIC-ACID; DROUGHT RESISTANCE; SYSTEM ARCHITECTURE; EXPRESSION ANALYSIS; GENE NETWORKS; GLYCINE-MAX; GROWTH; AUXIN; THALIANA; ETHYLENE	In Arabidopsis, NAC (NAM, ATAF and CUC) transcription factors have been found to promote lateral root number through the auxin signaling pathway. In the present study, the role of water stress-inducible soybean GmNAC003 and GmNAC004 genes in the enhancement of lateral root development under water deficit conditions was investigated. Both genes were highly expressed in roots, leaves and flowers of soybean and were strongly induced by water stress and moderately induced by a treatment with abscisic acid (ABA). They showed a slight response to treatment with 2,4-dichlorophenoxyacetic acid (2,4-D). The transgenic Arabidopsis plants overexpressing GmNAC004 showed an increase in lateral root number and length under non-stress conditions and maintained higher lateral root number and length under mild water stress conditions compared to the wild-type (WT), while the transgenic plants overexpressing GmNAC003 did not show any response. However, LR development of GmNAC004 transgenic Arabidopsis plants was not enhanced in the water-stressed compared to the well-watered treatment. In the treatment with ABA, LR density of the GmNAC004 transgenic Arabidopsis was less suppressed than that of the WT, suggesting that GmNAC004 counteracts ABA-induced inhibition of lateral root development. In the treatment with 2,4-D, lateral root density was enhanced in both GmNAC004 transgenic Arabidopsis and WT plants but the promotion was higher in the transgenic plants. Conversely, in the treatment with naphthylphthalamic acid (NPA), lateral root density was inhibited and there was no difference in the phenotype of the GmNAC004 transgenic Arabidopsis and WT plants, indicating that auxin is required for the action of GmNAC004. Transcript analysis for a number of known auxin and ABA related genes showed that GmNAC004's role may suppress ABA signaling but promote auxin signaling to increase lateral root development in the Arabidopsis heterologous system.	[Nguyen, Henry T.] Univ Missouri, Div Plant Sci, Natl Ctr Soybean Biotechnol, Columbia, MO 65211 USA; Univ Missouri, Interdisciplinary Plant Grp, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Nguyen, HT (corresponding author), Univ Missouri, Div Plant Sci, Natl Ctr Soybean Biotechnol, Columbia, MO 65211 USA.	nguyenhenry@missouri.edu	Tran, Lam-Son P/A-1346-2009	Tran, Lam-Son P/0000-0001-9883-9768; Valliyodan, Babu/0000-0001-9457-9508	Missouri Soybean Merchandising Council	Missouri Soybean Merchandising Council	This work was funded by a grant from the Missouri Soybean Merchandising Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMARAS R R, 1975, Soil Science Society of America Proceedings, V39, P771; Bassel GW, 2008, PLANT PHYSIOL, V147, P143, DOI 10.1104/pp.107.110841; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Bolle Cordelia, 2009, V479, P35, DOI 10.1007/978-1-59745-289-2_3; BOYER JS, 1965, P NATL ACAD SCI USA, V54, P1044, DOI 10.1073/pnas.54.4.1044; Brady SM, 2003, PLANT J, V34, P67, DOI 10.1046/j.1365-313X.2003.01707.x; Brocard-Gifford I, 2004, PLANT CELL, V16, P406, DOI 10.1105/tpc.018077; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Smet I, 2006, TRENDS PLANT SCI, V11, P434, DOI 10.1016/j.tplants.2006.07.003; Deak KI, 2005, PLANT J, V43, P17, DOI 10.1111/j.1365-313X.2005.02425.x; DREW MC, 1979, PLANTA, V147, P83, DOI 10.1007/BF00384595; DREW MC, 1975, NEW PHYTOL, V75, P479, DOI 10.1111/j.1469-8137.1975.tb01409.x; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Guo DL, 2009, PLANT GROWTH REGUL, V58, P173, DOI 10.1007/s10725-009-9365-0; Gutierrez-Gonzalez JJ, 2010, PLANT CELL PHYSIOL, V51, P936, DOI 10.1093/pcp/pcq065; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; He Y, 2008, THESIS U MISSOURI; Himanen K, 2004, P NATL ACAD SCI USA, V101, P5146, DOI 10.1073/pnas.0308702101; HOOGENBOOM G, 1987, AGRON J, V79, P607, DOI 10.2134/agronj1987.00021962007900040004x; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; HUCK MG, 1983, PLANT PHYSIOL, V73, P422, DOI 10.1104/pp.73.2.422; Ivanchenko MG, 2008, PLANT J, V55, P335, DOI 10.1111/j.1365-313X.2008.03528.x; Jogaiah S, 2012, CRIT REV BIOTECHNOL, DOI [10.3109/07388551.2012.659174, DOI 10.3109/07388551.2012.659174]; Tran LSP, 2010, PLANT SIGNAL BEHAV, V5, P550, DOI 10.4161/psb.11088; Tran LSP, 2010, PLANT SIGNAL BEHAV, V5, P255, DOI 10.4161/psb.5.3.10550; Liao H, 2001, PLANT SOIL, V232, P69, DOI 10.1023/A:1010381919003; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; Mochida K, 2010, BIOINFORMATICS, V26, P290, DOI 10.1093/bioinformatics/btp645; Mochida K, 2009, DNA RES, V16, P353, DOI 10.1093/dnares/dsp023; Nakashima K, 2011, BIOCH BIOPHYS ACTA; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Narang RA, 2000, PLANT PHYSIOL, V124, P1786, DOI 10.1104/pp.124.4.1786; Thao NP, 2012, CRIT REV BIOTECHNOL, V32, P349, DOI 10.3109/07388551.2011.643463; Nishiyama R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032124; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Peret B, 2009, J EXP BOT, V60, P3637, DOI 10.1093/jxb/erp232; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Pinheiro GL, 2009, GENE, V444, P10, DOI 10.1016/j.gene.2009.05.012; Puranik S., 2012, TRENDS PLANT SCI; Rahman A, 2007, PLANT J, V50, P514, DOI 10.1111/j.1365-313X.2007.03068.x; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; READ DJ, 1972, J APPL ECOL, V9, P487, DOI 10.2307/2402447; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sharp RE, 2002, PLANT CELL ENVIRON, V25, P211, DOI 10.1046/j.1365-3040.2002.00798.x; Sharp RE, 2002, J EXP BOT, V53, P33, DOI 10.1093/jexbot/53.366.33; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Shkolnik-Inbar D, 2010, PLANT CELL, V22, P3560, DOI 10.1105/tpc.110.074641; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; SPONCHIADO BN, 1989, EXP AGR, V25, P249, DOI 10.1017/S0014479700016756; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; Tran Lam-Son Phan, 2010, GM Crops, V1, P32, DOI 10.4161/gmcr.1.1.10569; Tran LSP, 2010, FUNCT INTEGR GENOMIC, V10, P447, DOI 10.1007/s10142-010-0178-z; Tran LSP, 2009, MOL GENET GENOMICS, V281, P647, DOI 10.1007/s00438-009-0436-8; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Turner NC, 2001, ADV AGRON, V71, P193, DOI 10.1016/S0065-2113(01)71015-2; van der Weele CM, 2000, J EXP BOT, V51, P1555, DOI 10.1093/jexbot/51.350.1555; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Wang WQ, 2010, BMC PLANT BIOL, V10, DOI [10.1186/1471-2229-10-205, 10.1186/1471-2229-10-14]; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yamaguchi M, 2010, PLANT CELL ENVIRON, V33, P223, DOI 10.1111/j.1365-3040.2009.02073.x; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141	72	32	42	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e84886	10.1371/journal.pone.0084886	http://dx.doi.org/10.1371/journal.pone.0084886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465446	Green Published, Green Submitted, gold			2022-12-25	WOS:000330288000008
J	Gutierrez-Aguirre, MA; Cervantes-Martinez, A; Elias-Gutierrez, M				Angelica Gutierrez-Aguirre, Martha; Cervantes-Martinez, Adrian; Elias-Gutierrez, Manuel			An Example of How Barcodes Can Clarify Cryptic Species: The Case of the Calanoid Copepod Mastigodiaptomus albuquerquensis (Herrick)	PLOS ONE			English	Article							DNA; ZOOPLANKTON; TAXONOMY; DIAPTOMIDAE; DIVERSITY; MEXICO	Background: The freshwater calanoid Mastigodiaptomus is a genus with high richness in the Americas and is composed of nine species, seven recorded in Mexico and four that are apparently endemic to small areas. Mastigodiaptomus albuquerquensis is a common, widely distributed species ranging from the southern USA to Central America. This species can be easily identified by a notable butterfly-like sclerotization on the basis of the right fifth leg of males. Nevertheless, morphological differences observed among populations throughout this species distributional range have led to the description of several related species or subspecies, such as M. albuquerquensis patzcuarensis from Lake Patzcuaro in the Central Plateau of Mexico. Methods: Genetic results based on barcodes, morphology based on scanning electron and light microscopy images, and morphometric analyses were used to describe cryptic species within the M. albuquerquensis complex. Results: The morphological analyses coincided partially with the genetic markers, suggesting the existence of at least two sibling species: M. albuquerquensis s. str. and M. patzcuarensis. A third species was genetically separated but was morphologically indistinguishable from the M. patzcuarensis group. Conclusions: Hidden diversity has been a major problem in establishing real patterns of species distribution and genetic acquisition from megadiverse hotspots such as Mexico, where the Nearctic and the Neotropical regions of the Americas meet. Barcodes can help taxonomists to reveal and formally name these new species. Here, we describe two of three potential species highlighted by the use of barcodes: M. albuquerquensis s. str. in the northern semi-desert and M. patzcuarensis on the Central Plateau at more than 2000 m above sea level.	[Angelica Gutierrez-Aguirre, Martha; Cervantes-Martinez, Adrian] Univ Quintana Roo, Cozumel Quintana, Roo, Mexico; [Elias-Gutierrez, Manuel] Colegio Frontera Sur, Chetumal Quintana, Roo, Mexico	El Colegio de la Frontera Sur (ECOSUR)	Elias-Gutierrez, M (corresponding author), Colegio Frontera Sur, Chetumal Quintana, Roo, Mexico.	melias@ecosur.mx	Gutiérrez-Aguirre, Martha/CAG-4952-2022; Elias-Gutierrez, Manuel/A-8952-2013	Elias-Gutierrez, Manuel/0000-0003-2562-4584	National Council of Science and Technology (CONACYT) through the Mexican Barcode of Life (MEXBOL) [194045, 194025]; Comision Nacional Para el Conocimiento y Uso de la Biodiversidad [CONABIO HE009]; National Science Foundation [NSF DEB-0516032]; Genome Canada; Ontario Genomics Institute	National Council of Science and Technology (CONACYT) through the Mexican Barcode of Life (MEXBOL); Comision Nacional Para el Conocimiento y Uso de la Biodiversidad; National Science Foundation(National Science Foundation (NSF)); Genome Canada(Genome Canada); Ontario Genomics Institute	The authors received grants from the National Council of Science and Technology (CONACYT) through the Mexican Barcode of Life (MEXBOL)(Grants 194045, 194025), Comision Nacional Para el Conocimiento y Uso de la Biodiversidad (CONABIO HE009), National Science Foundation (NSF DEB-0516032), and Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life (iBOL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2007, SYST BIOL, V56, P531, DOI 10.1080/10635150701424546; ALLAN JD, 1984, EVOLUTION, V38, P280, DOI 10.1111/j.1558-5646.1984.tb00287.x; BAYS JS, 1983, CAN J FISH AQUAT SCI, V40, P1813, DOI 10.1139/f83-210; Birky CW, 2011, ZOOL J LINN SOC-LOND, V161, P723, DOI 10.1111/j.1096-3642.2010.00674.x; Bowman TE, 1986, SYLLOGEUS, V58, P237; Carrera-Parra Luis F., 2011, Zootaxa, V2880, P51; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Defaye D, 2000, J CRUSTACEAN BIOL, V20, P245, DOI 10.1651/0278-0372(2000)020[0245:GSASPI]2.0.CO;2; DosSantosSilva EN, 1996, HYDROBIOLOGIA, V328, P207, DOI 10.1007/BF00017631; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gutierrez-Aguirre MA, 2013, J NAT HIST, V47, P479, DOI 10.1080/00222933.2012.742587; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Herrick CL, 1895, SYNOPSIS ENTOMOSTRAC, P67; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kiefer F, 1938, ZOOL ANZ, V115, P274; MARSH CD, 1907, T WISC ACAD SCI, V15, P381; Miracle MR, 2013, J NAT HIST, V47, P863, DOI 10.1080/00222933.2012.744432; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Montiel-Martinez A, 2008, J PLANKTON RES, V30, P1079, DOI 10.1093/plankt/fbn067; Pearse AS, 1904, AM NAT, V38, P889, DOI 10.1086/278467; Plath K, 2001, ECOLOGY, V82, P1260, DOI 10.1890/0012-9658(2001)082[1260:MLOZSC]2.0.CO;2; Prosser S, 2013, MOL ECOLOGY IN PRESS; Quiroz-Vazquez P, 2009, ZOOTAXA, P50, DOI 10.11646/zootaxa.2236.1.4; Silva-Briano M, 1998, SCI NATURAE, V1, P37; Suarez-Morales E, 2000, J NAT HIST, V34, P693, DOI 10.1080/002229300299363; Suarez-Morales E, 1998, SOUTHWEST NAT, V43, P256; Sukhikh N, 2013, J NAT HIST, V47, P753, DOI 10.1080/00222933.2012.716865; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Williamson Craig E., 2001, P915, DOI 10.1016/B978-012690647-9/50023-5; Winder M, 2003, FRESHWATER BIOL, V48, P795, DOI 10.1046/j.1365-2427.2003.01054.x; [No title captured]	32	13	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85019	10.1371/journal.pone.0085019	http://dx.doi.org/10.1371/journal.pone.0085019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465470	Green Submitted, gold, Green Published			2022-12-25	WOS:000330244500029
J	Divashuk, MG; Alexandrov, OS; Razumova, OV; Kirov, IV; Karlov, GI				Divashuk, Mikhail G.; Alexandrov, Oleg S.; Razumova, Olga V.; Kirov, Ilya V.; Karlov, Gennady I.			Molecular Cytogenetic Characterization of the Dioecious Cannabis sativa with an XY Chromosome Sex Determination System	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; HUMULUS-JAPONICUS SIEBOLD; SILENE-LATIFOLIA; REPETITIVE DNA; EVOLUTIONARY STRATA; Y-CHROMOSOME; LUPULUS L.; PLANT; IDENTIFICATION; MARKERS	Hemp (Cannabis sativa L.) was karyotyped using by DAPI/C-banding staining to provide chromosome measurements, and by fluorescence in situ hybridization with probes for 45 rDNA (pTa71), 5S rDNA (pCT4.2), a subtelomeric repeat (CS-1) and the Arabidopsis telomere probes. The karyotype has 18 autosomes plus a sex chromosome pair (XX in female and XY in male plants). The autosomes are difficult to distinguish morphologically, but three pairs could be distinguished using the probes. The Y chromosome is larger than the autosomes, and carries a fully heterochromatic DAPI positive arm and CS-1 repeats only on the less intensely DAPI-stained, euchromatic arm. The X is the largest chromosome of all, and carries CS-1 subtelomeric repeats on both arms. The meiotic configuration of the sex bivalent locates a pseudoautosomal region of the Y chromosome at the end of the euchromatic CS-1-carrying arm. Our molecular cytogenetic study of the C. sativa sex chromosomes is a starting point for helping to make C. sativa a promising model to study sex chromosome evolution.	[Divashuk, Mikhail G.; Alexandrov, Oleg S.; Razumova, Olga V.; Kirov, Ilya V.; Karlov, Gennady I.] Russian State Agr Univ, Moscow Timiryazev Agr Acad, Ctr Mol Biotechnol, Moscow, Russia	Russian State Agrarian University - Moscow Timiryazev Agricultural Academy	Karlov, GI (corresponding author), Russian State Agr Univ, Moscow Timiryazev Agr Acad, Ctr Mol Biotechnol, Moscow, Russia.	karlovg@gmail.com	Razumova, Olga/N-1037-2016; Alexandrov, Oleg/L-8344-2016; Karlov, Gennady/F-7403-2013; Divashuk, Mikhail/T-7621-2019; Киров, Илья/G-2570-2019	Alexandrov, Oleg/0000-0002-7146-4094; Karlov, Gennady/0000-0002-9016-103X; Divashuk, Mikhail/0000-0001-6221-3659; Киров, Илья/0000-0003-3885-3837; Razumova, Olga/0000-0001-5157-0087	Russian Ministry of Science and Education [8588]; Russian Foundation of Basic Research [13-04-01804, 13-04-02116]	Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Ministry of Science and Education (No. 8588) and Russian Foundation of Basic Research No. 13-04-01804 and No. 13-04-02116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov OS, 2011, RUSS J GENET+, V47, P1016, DOI 10.1134/S1022795411080023; Alexandrov OS, 2012, COMP CYTOGENET, V6, P239, DOI 10.3897/CompCytogen.v6i3.3261; Armstrong SJ, 2008, CYTOGENET GENOME RES, V120, P241, DOI 10.1159/000121073; Bergero R, 2007, GENETICS, V175, P1945, DOI 10.1534/genetics.106.070110; Bergero R, 2011, CURR BIOL, V21, P1470, DOI 10.1016/j.cub.2011.07.032; CAMPELL BR, 1992, GENE, V112, P225, DOI 10.1016/0378-1119(92)90380-8; Cermak T, 2008, CHROMOSOME RES, V16, P961, DOI 10.1007/s10577-008-1254-2; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj.hdy.6800016; Charlesworth D, 2013, J EXP BOT, V64, P405, DOI 10.1093/jxb/ers322; Chattopadhyay D, 1991, FEDDES REPERT, V102, P29; Chibalina MV, 2011, CURR BIOL, V21, P1475, DOI 10.1016/j.cub.2011.07.045; Cunado N, 2007, CHROMOSOME RES, V15, P825, DOI 10.1007/s10577-007-1166-6; Danilova TV, 2006, EUPHYTICA, V151, P15, DOI 10.1007/s10681-005-9020-4; DELLAPORTA SL, 1993, PLANT CELL, V5, P1241, DOI 10.1105/tpc.5.10.1241; Divashuk MG, 2011, CYTOGENET GENOME RES, V134, P213, DOI 10.1159/000328831; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Filatov DA, 2001, MOL BIOL EVOL, V18, P1442, DOI 10.1093/oxfordjournals.molbev.a003930; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Grabowska-Joachimiak A, 2012, CYTOGENET GENOME RES, V137, P70, DOI 10.1159/000339383; Grabowska-Joachimiak A, 2011, CYTOGENET GENOME RES, V132, P203, DOI 10.1159/000321584; Grabowska-Joachimiak A, 2006, ACTA SOC BOT POL, V75, P207, DOI 10.5586/asbp.2006.024; Henegariu O, 2001, CYTOMETRY, V43, P101, DOI 10.1002/1097-0320(20010201)43:2<101::AID-CYTO1024>3.0.CO;2-8; Hobza R, 2006, CHROMOSOMA, V115, P376, DOI 10.1007/s00412-006-0065-5; Jamilena M, 2008, CYTOGENET GENOME RES, V120, P255, DOI 10.1159/000121075; Janousek B, 2010, BIOL J LINN SOC, V100, P737, DOI 10.1111/j.1095-8312.2010.01470.x; Karlov GI, 2003, EUPHYTICA, V132, P185, DOI 10.1023/A:1024646818324; Kato A, 2004, P NATL ACAD SCI USA, V101, P13554, DOI 10.1073/pnas.0403659101; Kejnovsky E, 2009, HEREDITY, V102, P533, DOI 10.1038/hdy.2009.17; Kejnovsky E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045519; Kim SY, 2008, GENES GENOM, V30, P157; Kubesova M, 2010, PRESLIA, V82, P81; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lengerova M, 2004, THEOR APPL GENET, V108, P1193, DOI 10.1007/s00122-003-1568-6; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Mandolino G, 1999, THEOR APPL GENET, V98, P86, DOI 10.1007/s001220051043; Mariotti B, 2006, GENOME, V49, P114, DOI 10.1139/G05-089; Mariotti B, 2009, MOL GENET GENOMICS, V281, P249, DOI 10.1007/s00438-008-0405-7; Matsunaga S, 2001, PLANT BIOLOGY, V3, P481, DOI 10.1055/s-2001-17735; Ming R, 2007, AM J BOT, V94, P141, DOI 10.3732/ajb.94.2.141; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Murakami A, 2006, HEREDITY, V97, P66, DOI 10.1038/sj.hdy.6800839; Murakami A, 2000, BREEDING SCI, V50, P155, DOI 10.1270/jsbbs.50.155; Muyle A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001308; Navajas-Perez R, 2009, GENETICA, V135, P87, DOI 10.1007/s10709-008-9261-y; Nicolas M, 2005, PLOS BIOL, V3, P47, DOI 10.1371/journal.pbio.0030004; Peil A, 2003, THEOR APPL GENET, V107, P102, DOI 10.1007/s00122-003-1212-5; Pillay M, 2006, PLANT SYST EVOL, V258, P97, DOI 10.1007/s00606-005-0396-3; Polley A, 1997, GENOME, V40, P357, DOI 10.1139/g97-048; Sakamoto K, 2000, PLANT MOL BIOL, V44, P723, DOI 10.1023/A:1026574405717; Sakamoto K, 2005, GENOME, V48, P931, DOI 10.1139/g05-056; Sakamoto Koichi, 1998, Cytologia (Tokyo), V63, P459, DOI 10.1508/cytologia.63.459; Shephard HL, 2000, NEW PHYTOL, V148, P397, DOI 10.1046/j.1469-8137.2000.00771.x; Sousa A, 2013, CYTOGENET GENOME RES, V139, P107, DOI 10.1159/000345370; Spigler RB, 2010, J HERED, V101, pS107, DOI 10.1093/jhered/esq001; Torjek O, 2002, EUPHYTICA, V127, P209, DOI 10.1023/A:1020204729122; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; Vyskot B, 2004, TRENDS GENET, V20, P432, DOI 10.1016/j.tig.2004.06.006; Wang JP, 2012, P NATL ACAD SCI USA, V109, P13710, DOI 10.1073/pnas.1207833109; Yang MQ, 2013, TAXON, V62, P473, DOI 10.12705/623.9; Yu QY, 2008, PLANT J, V53, P124, DOI 10.1111/j.1365-313X.2007.03329.x; Zerega NJC, 2005, MOL PHYLOGENET EVOL, V37, P402, DOI 10.1016/j.ympev.2005.07.004; Zonneveld BJM, 2005, ANN BOT-LONDON, V96, P229, DOI 10.1093/aob/mci170	62	57	61	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85118	10.1371/journal.pone.0085118	http://dx.doi.org/10.1371/journal.pone.0085118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465491	gold, Green Submitted, Green Published			2022-12-25	WOS:000330244500038
J	Kohlhase, S; Bogdanova, NV; Schurmann, P; Bermisheva, M; Khusnutdinova, E; Antonenkova, N; Park-Simon, TW; Hillemanns, P; Meyer, A; Christiansen, H; Schindler, D; Dork, T				Kohlhase, Sandra; Bogdanova, Natalia V.; Schuermann, Peter; Bermisheva, Marina; Khusnutdinova, Elza; Antonenkova, Natalia; Park-Simon, Tjoung-Won; Hillemanns, Peter; Meyer, Andreas; Christiansen, Hans; Schindler, Detlev; Doerk, Thilo			Mutation Analysis of the ERCC4/FANCQ Gene in Hereditary Breast Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ATM GENE; SUSCEPTIBILITY; RISK; ENDONUCLEASE; ERCC4; ERCC1-XPF; FREQUENCY; VARIANTS; LOCI	The ERCC4 protein forms a structure-specific endonuclease involved in the DNA damage response. Different cancer syndromes such as a subtype of Xeroderma pigmentosum, XPF, and recently a subtype of Fanconi Anemia, FA-Q, have been attributed to biallelic ERCC4 gene mutations. To investigate whether monoallelic ERCC4 gene defects play some role in the inherited component of breast cancer susceptibility, we sequenced the whole ERCC4 coding region and flanking untranslated portions in a series of 101 Byelorussian and German breast cancer patients selected for familial disease (set 1, n = 63) or for the presence of the rs1800067 risk haplotype (set 2, n = 38). This study confirmed six known and one novel exonic variants, including four missense substitutions but no truncating mutation. Missense substitution p.R415Q (rs1800067), a previously postulated breast cancer susceptibility allele, was subsequently screened for in a total of 3,698 breast cancer cases and 2,868 controls from Germany, Belarus or Russia. The Gln415 allele appeared protective against breast cancer in the German series, with the strongest effect for ductal histology (OR 0.67; 95%CI 0.49; 0.92; p = 0.003), but this association was not confirmed in the other two series, with the combined analysis yielding an overall Mantel-Haenszel OR of 0.94 (95% CI 0.81; 1.08). There was no significant effect of p.R415Q on breast cancer survival in the German patient series. The other three detected ERCC4 missense mutations included two known rare variants as well as a novel substitution, p.E17V, that we identified on a p.R415Q haplotype background. The p.E17V mutation is predicted to be probably damaging but was present in just one heterozygous patient. We conclude that the contribution of ERCC4/FANCQ coding mutations to hereditary breast cancer in Central and Eastern Europe is likely to be small.	[Kohlhase, Sandra; Bogdanova, Natalia V.; Schuermann, Peter; Bermisheva, Marina; Park-Simon, Tjoung-Won; Hillemanns, Peter; Doerk, Thilo] Hannover Med Sch, Clin Obstet, Hannover, Germany; [Kohlhase, Sandra; Bogdanova, Natalia V.; Schuermann, Peter; Bermisheva, Marina; Park-Simon, Tjoung-Won; Hillemanns, Peter; Doerk, Thilo] Hannover Med Sch, Clin Gynaecol, Hannover, Germany; [Bogdanova, Natalia V.; Meyer, Andreas; Christiansen, Hans] Hannover Med Sch, Clin Radiat Oncol, Hannover, Germany; [Bermisheva, Marina; Khusnutdinova, Elza] Inst Biochem & Genet, Ufa, Russia; [Antonenkova, Natalia] NN Alexandrov Res Inst Oncol & Med Radiol, Minsk, BELARUS; [Schindler, Detlev] Univ Wurzburg, Inst Human Genet, Bioctr, Wurzburg, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; University of Wurzburg	Dork, T (corresponding author), Hannover Med Sch, Clin Obstet, Hannover, Germany.	doerk.thilo@mh-hannover.de	Khusnutdinova, Elza Kamilevna/A-4810-2013; Dörk, Thilo/J-8620-2012; Bogdanova, Natalia V./Y-2205-2019	Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Dörk, Thilo/0000-0002-9458-0282; 				Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Backe J, 1999, GYNECOL ONCOL, V72, P402, DOI 10.1006/gyno.1998.5270; Bogdanova N, 2005, INT J CANCER, V116, P263, DOI 10.1002/ijc.21022; Bogdanova NV, 2010, CLIN GENET, V78, P364, DOI 10.1111/j.1399-0004.2010.01473.x; Bogdanova N, 2008, INT J CANCER, V122, P802, DOI 10.1002/ijc.23168; Bogdanova N, 2007, J CLIN ONCOL, V25, pE26, DOI 10.1200/JCO.2007.11.4223; Bogdanova N, 2013, HERED CANCER CLIN PR, V11, DOI 10.1186/1897-4287-11-12; Bogdanova N, 2009, BREAST CANCER RES TR, V118, P207, DOI 10.1007/s10549-008-0189-9; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Ding DP, 2011, BREAST CANCER RES TR, V129, P203, DOI 10.1007/s10549-011-1447-9; Dork T, 2001, CANCER RES, V61, P7608; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eng L, 2004, HUM MUTAT, V23, P67, DOI 10.1002/humu.10295; Fadda E, 2013, BIOPHYS J, V104, P2503, DOI 10.1016/j.bpj.2013.04.023; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Gaudet MM, 2009, CANCER EPIDEM BIOMAR, V18, P1610, DOI 10.1158/1055-9965.EPI-08-0745; Ghoussaini M, 2013, AM J PATHOL, V183, P1038, DOI 10.1016/j.ajpath.2013.07.003; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Jorgensen TJ, 2009, CANCER EPIDEM BIOMAR, V18, P346, DOI 10.1158/1055-9965.EPI-08-0659; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Landwehr R, 2011, BREAST CANCER RES TR, V130, P1021, DOI 10.1007/s10549-011-1681-1; McDaniel LD, 2008, ADV EXP MED BIOL, V637, P65; McNeil EM, 2012, NUCLEIC ACIDS RES, V40, P9990, DOI 10.1093/nar/gks818; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Milne RL, 2006, CANCER RES, V66, P9420, DOI 10.1158/0008-5472.CAN-06-1418; Motycka TA, 2004, J BIOL CHEM, V279, P13634, DOI 10.1074/jbc.M313779200; Osorio A, 2013, HUM MUTAT, V34, P1615, DOI 10.1002/humu.22438; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Prokofyeva D, 2013, BREAST CANCER RES TR, V137, P533, DOI 10.1007/s10549-012-2357-1; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7	34	12	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85334	10.1371/journal.pone.0085334	http://dx.doi.org/10.1371/journal.pone.0085334			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465539	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500056
J	Wang, XD; Huang, XF; Yan, QR; Bao, CD				Wang, Xiao-dong; Huang, Xin-fang; Yan, Qing-ran; Bao, Chun-de			Aberrant Activation of the WNT/beta-Catenin Signaling Pathway in Lupus Nephritis	PLOS ONE			English	Article							ERYTHEMATOSUS; CLASSIFICATION; CANCER	Objective: The canonical WNT pathway has been implicated as playing important roles in the pathogenesis of a variety of kidney diseases. Recently, WNT pathway activity was reported to be elevated in the renal tissue of a lupus mouse model. This study aimed to evaluate the potential role of the WNT pathway in the pathogenesis of human lupus nephritis. Methods: The expression of beta-catenin was evaluated in renal biopsy specimens from lupus nephritis patients and control kidney tissues by immunohistochemistry and western blotting. Real-time polymerase chain reaction (RT-PCR) was used to detect RNA expression of beta-catenin, Dkk-1 and Axin2. Plasma concentrations of Dkk-1 were measured by ELISA. Results: Immunohistochemistry and western blotting revealed increased expression of beta-catenin in the kidneys of patients with lupus nephritis compared with control kidney tissues (p<0.05), accompanied by an increase in mRNA expression of beta-catenin (p<0.01) and axin2 (p<0.05). beta-catenin was significantly greater in LN patients without renal interstitial fibrosis compared with those with renal interstitial fibrosis (p<0.01) at the mRNA expression level; the increase in beta-catenin mRNA positively correlated with the creatinine clearance rate (Ccr) and negatively correlated with chronicity indices of renal tissue injury. Greater plasma Dkk-1 concentrations were found in LN patients compared with controls (p<0.05). Plasma Dkk-1 concentrations also correlated negatively with anti-dsDNA antibody levels and positively with serum C3 levels. Conclusions: The canonical WNT/beta-catenin signaling pathway was activated in lupus nephritis patients, accompanied by an increase in plasma levels of Dkk-1. Altered WNT/beta-catenin signaling was related to the pathogenesis of lupus nephritis and might play a role in renal fibrosis.	[Wang, Xiao-dong; Huang, Xin-fang; Yan, Qing-ran; Bao, Chun-de] Shanghai Jiao Tong Univ, Shanghai Inst Rheumatol, Sch Med, Dept Rheumatol,Ren Ji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Huang, XF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Rheumatol, Sch Med, Dept Rheumatol,Ren Ji Hosp, Shanghai 200030, Peoples R China.	hxf343@126.com; baochunde_1678@126.com	Yan, Qingran/AAH-4402-2020		Ministry of Health [201202004]; National Natural Science Foundation of China [30801026]; Shanghai Jiao Tong University School of Medicine [BXJ201020]	Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University School of Medicine	This work was supported in part by the Special Fund for Public Benefit Research from Ministry of Health (201202004), the National Natural Science Foundation of China (No. 30801026), the Doctoral Innovation Fund of Shanghai Jiao Tong University School of Medicine (BXJ201020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; Benali SL, 2013, VET J; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tveita A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2532; Tveita AA, 2011, ARTHRITIS RHEUM-US, V63, P513, DOI 10.1002/art.30116; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007	15	37	41	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e84852	10.1371/journal.pone.0084852	http://dx.doi.org/10.1371/journal.pone.0084852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465439	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500018
J	Zhuang, ZH; Zhao, YL; Wu, QL; Li, M; Liu, HC; Sun, LM; Gao, W; Wang, DY				Zhuang, Ziheng; Zhao, Yunli; Wu, Qiuli; Li, Min; Liu, Haicui; Sun, Lingmei; Gao, Wei; Wang, Dayong			Adverse Effects from Clenbuterol and Ractopamine on Nematode Caenorhabditis elegans and the Underlying Mechanism	PLOS ONE			English	Article							ENVIRONMENTAL RELEVANT CONCENTRATIONS; MICROCYSTIN-LR EXPOSURE; SKELETAL-MUSCLE; LOCOMOTION BEHAVIORS; OXIDATIVE DAMAGE; INDUCED TOXICITY; C.-ELEGANS; LIFE-SPAN; NANOPARTICLES; LONGEVITY	In the present study, we used Caenorhabditis elegans assay system to investigate in vivo toxicity from clentuberol and ractopamine and the possible underlying mechanism. Both acute and prolonged exposures to clentuberol or ractopamine decreased brood size and locomotion behavior, and induced intestinal autofluorescence and reactive oxygen species (ROS) production. Although acute exposure to the examined concentrations of clentuberol or ractopamine did not induce lethality, prolonged exposure to 10 mu g/L of clentuberol and ractopamine reduced lifespan. At relatively high concentrations, ractopamine exhibited more severe toxicity than clentuberol on nematodes. Overexpression of sod-2 gene encoding a Mn-SOD to prevent induction of oxidative stress effectively inhibited toxicity from clentuberol or ractopamine. Besides oxidative stress, we found that clentuberol might reduce lifespan through influencing insulin/IGF signaling pathway; however, ractopamine might reduce lifespan through affecting both insulin/IGF signaling pathway and TOR signaling pathway. Ractopamine more severely decreased expression levels of daf-16, sgk-1, skn-1, and aak-2 genes than clentuberol, and increased expression levels of daf-2 and age-1 genes at the examined concentration. Therefore, the C. elegans assay system may be useful for assessing the possible toxicity from weight loss agents, and clentuberol and ractopamine may induce toxicity through different molecular mechanisms.	[Zhuang, Ziheng; Li, Min] Changzhou Univ, Sch Pharmaceut Engn & Life Sci, Changzhou, Peoples R China; [Zhao, Yunli; Wu, Qiuli; Li, Min; Sun, Lingmei; Wang, Dayong] Southeast Univ, Minist Educ, Sch Med, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China; [Gao, Wei] Jiangsu Prov Prod Qual Supervis & Inspect Inst, Nanjing, Jiangsu, Peoples R China; [Liu, Haicui] Xiuli Biol Technol Co Ltd, Changzhou, Peoples R China	Changzhou University; Southeast University - China	Gao, W (corresponding author), Jiangsu Prov Prod Qual Supervis & Inspect Inst, Nanjing, Jiangsu, Peoples R China.	jszjgaowei@126.com; dayongw@seu.edu.cn			Changzhou University [ZMF11020011]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120092120064]; National Natural Science Foundation of China [81172698, 81202233]	Changzhou University; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by scientific Starting Fund from Changzhou University (ZMF11020011), Specialized Research Fund for the Doctoral Program of Higher Education of China (20120092120064), and National Natural Science Foundation of China (81172698, 81202233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Avila D, 2012, HUM EXP TOXICOL, V31, P236, DOI 10.1177/0960327110392084; Badino P, 2008, FOOD CHEM TOXICOL, V46, P2239, DOI 10.1016/j.fct.2008.02.025; Benedetto A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001084; Bilkoo Pareena, 2007, Conn Med, V71, P89; Boyd WA, 2009, PLOS ONE, V4, pe7204; BRENNER S, 1974, GENETICS, V77, P71; Chai J, 2013, SPECTROCHIM ACTA A, V105, P200, DOI 10.1016/j.saa.2012.12.017; Chan TYK, 1999, J TOXICOL-CLIN TOXIC, V37, P517, DOI 10.1081/CLT-100102525; DONKIN SG, 1993, ARCH ENVIRON CON TOX, V25, P145, DOI 10.1007/BF00212125; Douillard A, 2012, CLIN EXP PHARMACOL P, V39, P364, DOI 10.1111/j.1440-1681.2012.05677.x; Douillard A, 2011, CAN J PHYSIOL PHARM, V89, P117, DOI [10.1139/Y10-114, 10.1139/y10-114]; Downie D, 2008, MOL REPROD DEV, V75, P785, DOI 10.1002/mrd.20795; Gojmerac T, 2002, VET HUM TOXICOL, V44, P269; He KW, 2009, NEUROSCI BULL, V25, P335, DOI 10.1007/s12264-009-6123-2; Hoffman RJ, 2001, J TOXICOL-CLIN TOXIC, V39, P339, DOI 10.1081/CLT-100105152; Hu YO, 2008, BIOMED ENVIRON SCI, V21, P467, DOI 10.1016/S0895-3988(09)60004-0; Jiang B, 2011, J BIOL INORG CHEM, V16, P267, DOI 10.1007/s00775-010-0723-1; Ju JJ, 2013, ENVIRON SCI POLLUT R, V20, P1823, DOI 10.1007/s11356-012-1151-2; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lapierre LR, 2012, TRENDS ENDOCRIN MET, V23, P637, DOI 10.1016/j.tem.2012.07.007; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Leung MCK, 2010, TOXICOL SCI, V118, P444, DOI 10.1093/toxsci/kfq295; Li YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044688; Li YX, 2013, NANOTOXICOLOGY, V7, P1004, DOI 10.3109/17435390.2012.689884; Li YX, 2012, J HAZARD MATER, V219, P221, DOI 10.1016/j.jhazmat.2012.03.083; Li YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071180; Li YH, 2009, J ENVIRON SCI, V21, P971, DOI 10.1016/S1001-0742(08)62370-0; Liu PD, 2012, ECOTOX ENVIRON SAFE, V79, P90, DOI 10.1016/j.ecoenv.2011.12.007; Lust EB, 2011, J EMERG MED, V40, P198, DOI 10.1016/j.jemermed.2009.09.026; Mazzanti G, 2007, FOOD CHEM TOXICOL, V45, P1694, DOI 10.1016/j.fct.2007.03.002; Mello C, 1995, METHOD CELL BIOL, V48, P451; Nouara A, 2013, NANOSCALE, V5, P6088, DOI 10.1039/c3nr00847a; Patiyal SN, 2005, JPN J PHYSIOL, V55, P165, DOI 10.2170/jjphysiol.R2118; Pluskota A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006622; Qu Y, 2011, NANO LETT, V11, P3174, DOI 10.1021/nl201391e; Roh JY, 2009, ENVIRON SCI TECHNOL, V43, P3933, DOI 10.1021/es803477u; Ruan QL, 2009, J TOXICOL ENV HEAL A, V72, P746, DOI 10.1080/15287390902841532; Rui Q, 2009, FRONT MED-PRC, V3, P76; Sangha JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043990; Shashikumar S, 2011, INDIAN J BIOCHEM BIO, V48, P191; Shen LL, 2010, NEUROSCI BULL, V26, P91, DOI 10.1007/s12264-010-0162-6; Shen LL, 2010, MECH AGEING DEV, V131, P732, DOI 10.1016/j.mad.2010.10.005; Sprando RL, 2009, FOOD CHEM TOXICOL, V47, P722, DOI 10.1016/j.fct.2009.01.007; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Wang Da-Yong, 2007, Environmental Bioindicators, V2, P89, DOI 10.1080/15555270701457695; Wang DY, 2013, METHODS MOL BIOL, V1048, P65, DOI 10.1007/978-1-62703-556-9_6; Wang DY, 2010, ECOTOX ENVIRON SAFE, V73, P1221, DOI 10.1016/j.ecoenv.2010.05.002; Wang DY, 2010, ENVIRON TOXICOL PHAR, V29, P213, DOI 10.1016/j.etap.2010.01.002; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Wu QL, 2013, NANOSCALE, V5, P9934, DOI 10.1039/c3nr02084c; Wu QL, 2013, CHEMOSPHERE, V90, P1123, DOI 10.1016/j.chemosphere.2012.09.019; Wu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043729; Wu QL, 2011, ENVIRON TOXICOL PHAR, V32, P175, DOI 10.1016/j.etap.2011.04.009; Wu QL, 2012, CHEMOSPHERE, V87, P1281, DOI 10.1016/j.chemosphere.2012.01.035; Xing X, 2009, B ENVIRON CONTAM TOX, V83, P530, DOI 10.1007/s00128-009-9816-3; Xing XJ, 2009, ENVIRON TOXICOL PHAR, V28, P104, DOI 10.1016/j.etap.2009.03.006; Yaeger MJ, 2012, VET PATHOL, V49, P569, DOI 10.1177/0300985811424752; Ye BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014052; Yen M, 2012, J MED TOXICOL, V8, P145, DOI 10.1007/s13181-012-0213-7; Yu SH, 2011, ENVIRON TOXICOL PHAR, V32, P233, DOI 10.1016/j.etap.2011.05.008; Yu ZY, 2012, CHEMOSPHERE, V87, P1361, DOI 10.1016/j.chemosphere.2012.02.029; Zhang YF, 2010, ARCH ENVIRON CON TOX, V59, P129, DOI 10.1007/s00244-009-9456-y; Zhao YL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/564093; Zhao YL, 2014, NANOMED-NANOTECHNOL, V10, P89, DOI 10.1016/j.nano.2013.07.004; Zhao YL, 2013, RSC ADV, V3, P5741, DOI 10.1039/c2ra22798c; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	67	33	35	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85482	10.1371/journal.pone.0085482	http://dx.doi.org/10.1371/journal.pone.0085482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465573	gold, Green Published, Green Submitted			2022-12-25	WOS:000330244500068
J	Devine, S; Markewitz, D; Hendrix, P; Coleman, D				Devine, Scott; Markewitz, Daniel; Hendrix, Paul; Coleman, David			Soil Aggregates and Associated Organic Matter under Conventional Tillage, No-Tillage, and Forest Succession after Three Decades	PLOS ONE			English	Article							MICROBIAL BIOMASS; CARBON; STABILIZATION; GRASSLAND; MECHANISMS; FRACTIONS; DYNAMICS; SEQUESTRATION; AGROECOSYSTEM; DECOMPOSITION	Impacts of land use on soil organic C (SOC) are of interest relative to SOC sequestration and soil sustainability. The role of aggregate stability in SOC storage under contrasting land uses has been of particular interest relative to conventional tillage (CT) and no-till (NT) agriculture. This study compares soil structure and SOC fractions at the 30-yr-old Horseshoe Bend Agroecosystem Experiment (HSB). This research is unique in comparing NT and CT with adjacent land concurrently undergoing forest succession (FS) and in sampling to depths (15-28 cm) previously not studied at HSB. A soil moving experiment (SME) was also undertaken to monitor 1-yr changes in SOC and aggregation. After 30 years, enhanced aggregate stability under NT compared to CT was limited to a depth of 5 cm, while enhanced aggregate stability under FS compared to CT occurred to a depth of 28 cm and FS exceeded NT from 5-28 cm. Increases in SOC concentrations generally followed the increases in stability, except that no differences in SOC concentration were observed from 15-28 cm despite greater aggregate stability. Land use differences in SOC were explained equally by differences in particulate organic carbon (POC) and in silt-clay associated fine C. Enhanced structural stability of the SME soil was observed under FS and was linked to an increase of 1 Mg SOC ha(-1) in 0-5 cm, of which 90% could be attributed to a POC increase. The crushing of macroaggregates in the SME soil also induced a 10% reduction in SOC over 1 yr that occurred under all three land uses from 5-15 cm. The majority of this loss was in the fine C fraction. NT and FS ecosystems had greater aggregation and carbon storage at the soil surface but only FS increased aggregation below the surface, although in the absence of increased carbon storage.	[Devine, Scott; Markewitz, Daniel] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Hendrix, Paul; Coleman, David] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Markewitz, D (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	dmarke@uga.edu	Devine, Scott/AAR-1265-2020	Devine, Scott/0000-0002-2306-8281; Markewitz, Daniel/0000-0002-2697-9865; Coleman, David/0000-0003-0390-1501				Arce Flores S, 2006, THESIS U GEORGIA ATH; BAKELAAR RG, 1978, ECOLOGY, V59, P660, DOI 10.2307/1938767; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; BARRETT GW, 1968, ECOLOGY, V49, P1019, DOI 10.2307/1934487; Barros E, 2001, GEODERMA, V100, P193, DOI 10.1016/S0016-7061(00)00086-0; BEARE MH, 1993, GEODERMA, V56, P87, DOI 10.1016/0016-7061(93)90102-Q; Beare MH, 1997, APPL SOIL ECOL, V5, P211, DOI 10.1016/S0929-1393(96)00142-4; BEARE MH, 1994, SOIL SCI SOC AM J, V58, P777, DOI 10.2136/sssaj1994.03615995005800030020x; BEARE MH, 1994, SOIL SCI SOC AM J, V58, P787, DOI 10.2136/sssaj1994.03615995005800030021x; Bossuyt H, 2002, SOIL SCI SOC AM J, V66, P1965, DOI 10.2136/sssaj2002.1965; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Causarano HJ, 2008, SOIL SCI SOC AM J, V72, P221, DOI 10.2136/sssaj2006.0274; Chan KY, 2001, SOIL USE MANAGE, V17, P217, DOI 10.1079/SUM200180; Coleman D, 2006, EUR J SOIL BIOL, V42, pS79, DOI 10.1016/j.ejsobi.2006.07.019; Coleman DC, 2009, AGROECOSYSTEM MANAGE; Devine S, 2011, FOREST SCI, V57, P36; ELLIOTT ET, 1991, AGR ECOSYST ENVIRON, V34, P443, DOI 10.1016/0167-8809(91)90127-J; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Feeney DS, 2006, MICROB ECOL, V52, P151, DOI 10.1007/s00248-006-9062-8; Franzluebbers AJ, 1997, SOIL SCI SOC AM J, V61, P1382, DOI 10.2136/sssaj1997.03615995006100050014x; Gale WJ, 2000, SOIL SCI SOC AM J, V64, P190, DOI 10.2136/sssaj2000.641190x; Gale WJ, 2000, SOIL SCI SOC AM J, V64, P201, DOI 10.2136/sssaj2000.641201x; Hendrix P. F., 1997, SOIL ORGANIC MATTER, P235; HORN R, 1994, SOIL TILL RES, V30, P187, DOI 10.1016/0167-1987(94)90005-1; HORN R, 1989, SOIL TILL RES, V13, P253, DOI 10.1016/0167-1987(89)90002-0; HU S, 1995, SOIL BIOL BIOCHEM, V27, P1127, DOI 10.1016/0038-0717(95)00041-C; INGHAM ER, 1991, SOIL BIOL BIOCHEM, V23, P465, DOI 10.1016/0038-0717(91)90011-8; JENKINSON DS, 1976, SOIL BIOL BIOCHEM, V8, P189, DOI 10.1016/0038-0717(76)90003-1; Kemper W. D., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P425; Kemper W.D., 1965, SIZE DISTRIBUTION 1, P499; Lachnicht SL, 2004, APPL SOIL ECOL, V27, P135, DOI 10.1016/j.apsoil.2004.05.001; Mack MC, 2003, ECOL APPL, V13, P154, DOI 10.1890/1051-0761(2003)013[0154:EGACOS]2.0.CO;2; Mikutta R, 2006, BIOGEOCHEMISTRY, V77, P25, DOI 10.1007/s10533-005-0712-6; NADELHOFFER KJ, 1992, ECOLOGY, V73, P1139, DOI 10.2307/1940664; NEILL C, 1992, ECOLOGY, V73, P1918, DOI 10.2307/1940044; OADES JM, 1991, AUST J SOIL RES, V29, P815, DOI 10.1071/SR9910815; OADES JM, 1984, PLANT SOIL, V76, P319, DOI 10.1007/BF02205590; Odum E. P., 1973, Proceedings. Annual Tall Timbers Fire Ecology Conference, P399; Six J, 2002, SOIL SCI SOC AM J, V66, P1981, DOI 10.2136/sssaj2002.1981; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Skjemstad JO, 2006, AUST J SOIL RES, V44, P255, DOI 10.1071/SR05124; Smucker AJM, 2007, VADOSE ZONE J, V6, P282, DOI 10.2136/vzj2007.0031; TIESSEN H, 1983, SOIL SCI SOC AM J, V47, P509, DOI 10.2136/sssaj1983.03615995004700030023x; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; WANDER MM, 1994, SOIL SCI SOC AM J, V58, P1130, DOI 10.2136/sssaj1994.03615995005800040018x; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Yoder LE., 1936, J AM SOC AGRON, V28, P337, DOI DOI 10.2134/AGRONJ1936.00021962002800050001X	53	87	98	5	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e84988	10.1371/journal.pone.0084988	http://dx.doi.org/10.1371/journal.pone.0084988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465460	gold, Green Published, Green Submitted			2022-12-25	WOS:000330240500027
J	Blednov, YA; Benavidez, JM; Black, M; Leiter, CR; Osterndorff-Kahanek, E; Johnson, D; Borghese, CM; Hanrahan, JR; Johnston, GAR; Chebib, M; Harris, RA				Blednov, Yuri A.; Benavidez, Jillian M.; Black, Mendy; Leiter, Courtney R.; Osterndorff-Kahanek, Elizabeth; Johnson, David; Borghese, Cecilia M.; Hanrahan, Jane R.; Johnston, Graham A. R.; Chebib, Mary; Harris, R. Adron			GABA(A) Receptors Containing rho 1 Subunits Contribute to In Vivo Effects of Ethanol in Mice	PLOS ONE			English	Article							CONDITIONED TASTE-AVERSION; ALCOHOL-INTOXICATION; BEHAVIORAL-RESPONSES; PERIODIC WITHDRAWAL; ALPHA-1 SUBUNIT; MOUSE RETINA; ION CHANNELS; KNOCKIN MICE; MUTANT MICE; NULL MUTANT	GABA(A) receptors consisting of rho 1, rho 2, or rho 3 subunits in homo-or hetero-pentamers have been studied mainly in retina but are detected in many brain regions. Receptors formed from rho 1 are inhibited by low ethanol concentrations, and family-based association analyses have linked rho subunit genes with alcohol dependence. We determined if genetic deletion of rho 1 in mice altered in vivo ethanol effects. Null mutant male mice showed reduced ethanol consumption and preference in a two-bottle choice test with no differences in preference for saccharin or quinine. Null mutant mice of both sexes demonstrated longer duration of ethanol-induced loss of righting reflex (LORR), and males were more sensitive to ethanol-induced motor sedation. In contrast, rho 1 null mice showed faster recovery from acute motor incoordination produced by ethanol. Null mutant females were less sensitive to ethanol-induced development of conditioned taste aversion. Measurement of mRNA levels in cerebellum showed that deletion of rho 1 did not change expression of rho 2, alpha 2, or alpha 6 GABA(A) receptor subunits. (S)-4-amino-cyclopent-1-enyl butylphosphinic acid ("rho 1" antagonist), when administered to wild type mice, mimicked the changes that ethanol induced in rho 1 null mice (LORR and rotarod tests), but the rho 1 antagonist did not produce these effects in rho 1 null mice. In contrast, (R)-4-amino-cyclopent-1-enyl butylphosphinic acid ("rho 2" antagonist) did not change ethanol actions in wild type but produced effects in mice lacking rho 1 that were opposite of the effects of deleting (or inhibiting) rho 1. These results suggest that rho 1 has a predominant role in two in vivo effects of ethanol, and a role for rho 2 may be revealed when rho 1 is deleted. We also found that ethanol produces similar inhibition of function of recombinant rho 1 and rho 2 receptors. These data indicate that ethanol action on GABA(A) receptors containing rho 1/rho 2 subunits may be important for specific effects of ethanol in vivo.	[Blednov, Yuri A.; Benavidez, Jillian M.; Black, Mendy; Leiter, Courtney R.; Osterndorff-Kahanek, Elizabeth; Johnson, David; Borghese, Cecilia M.; Harris, R. Adron] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Hanrahan, Jane R.; Chebib, Mary] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Johnston, Graham A. R.] Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia	University of Texas System; University of Texas Austin; University of Sydney; University of Sydney	Harris, RA (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA.	harris@austin.utexas.edu	Johnston, Graham/AAJ-9569-2021; Johnston, Graham AR/B-9827-2009; Hanrahan, Jane R/A-8155-2010	Johnston, Graham/0000-0001-8872-4078; Hanrahan, Jane R/0000-0001-8205-0260; Borghese, Cecilia/0000-0002-1028-8277	NIH [AA013520, AA06399]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA006399, U01AA013520, R01AA006399] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH grants AA013520 and AA06399. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk G., 2008, V182, P53, DOI 10.1007/978-3-540-74806-9_3; Blednov YA, 2008, GENES BRAIN BEHAV, V7, P1, DOI 10.1111/j.1601-183X.2007.00309.x; Blednov YA, 2013, NEUROPHARMACOLOGY, V67, P46, DOI 10.1016/j.neuropharm.2012.10.016; Blednov YA, 2011, J PHARMACOL EXP THER, V336, P145, DOI 10.1124/jpet.110.171645; Blednov YA, 2003, J PHARMACOL EXP THER, V305, P854, DOI 10.1124/jpet.103.049478; Blednov YA, 2001, PHYSIOL BEHAV, V74, P109, DOI 10.1016/S0031-9384(01)00555-8; Blednov YA, 2012, J PHARMACOL EXP THER, V340, P317, DOI 10.1124/jpet.111.185124; Boehm SL, 2004, BIOCHEM PHARMACOL, V68, P1581, DOI 10.1016/j.bcp.2004.07.023; Borghese CM, 2006, J PHARMACOL EXP THER, V319, P208, DOI 10.1124/jpet.106.104406; CALVO DJ, 1995, NEUROREPORT, V6, P1118, DOI 10.1097/00001756-199505300-00011; Carland JE, 2008, EUR J PHARMACOL, V580, P27, DOI 10.1016/j.ejphar.2007.10.036; Chebib M, 2004, CLIN EXP PHARMACOL P, V31, P800, DOI 10.1111/j.1440-1681.2004.04083.x; Chebib M, 2009, J PHARMACOL EXP THER, V328, P448, DOI 10.1124/jpet.108.146464; Crabbe JC, 2005, NEUROSCI BIOBEHAV R, V28, P785, DOI 10.1016/j.neubiorev.2004.08.002; CRABBE JC, 1991, J PHARMACOL EXP THER, V257, P663; Crabbe JC, 2006, ADDICT BIOL, V11, P195, DOI 10.1111/j.1369-1600.2006.00038.x; CUNNINGHAM CL, 1993, ALCOHOL, V10, P97, DOI 10.1016/0741-8329(93)90087-5; Eggers ED, 2007, J PHYSIOL-LONDON, V582, P569, DOI 10.1113/jphysiol.2007.131763; Findlay GS, 2003, J NEUROSCI, V23, P8051; Flood P, 2000, ANESTHESIOLOGY, V92, P1418, DOI 10.1097/00000542-200005000-00033; Flores-Gracia C, 2010, PSYCHOPHARMACOLOGY, V212, P475, DOI 10.1007/s00213-010-1973-x; Frazao R, 2007, CELL TISSUE RES, V330, P1, DOI 10.1007/s00441-007-0446-y; Fujimura J, 2005, MOL BRAIN RES, V138, P17, DOI 10.1016/j.molbrainres.2005.03.013; Green AS, 2008, ALCOHOL, V42, P1, DOI 10.1016/j.alcohol.2007.10.005; Greka A, 1998, NEUROREPORT, V9, P229, DOI 10.1097/00001756-199801260-00010; HARRISON NL, 1985, BRIT J PHARMACOL, V84, P381, DOI 10.1111/j.1476-5381.1985.tb12922.x; Harvey VL, 2006, J PHYSIOL-LONDON, V577, P127, DOI 10.1113/jphysiol.2006.112482; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hevers W, 2008, J NEUROSCI, V28, P5383, DOI 10.1523/JNEUROSCI.5443-07.2008; Johnston Graham A. R., 2002, Current Topics in Medicinal Chemistry, V2, P903, DOI 10.2174/1568026023393453; Kirischuk S, 2003, EUR J NEUROSCI, V18, P752, DOI 10.1046/j.1460-9568.2003.02805.x; Kumar RJ, 2008, J MED CHEM, V51, P3825, DOI 10.1021/jm7015842; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; Lobo IA, 2008, PHARMACOL BIOCHEM BE, V90, P90, DOI 10.1016/j.pbb.2008.03.006; LUNDQUIST F, 1959, METHOD BIOCHEM ANAL, V7, P217, DOI DOI 10.1002/9780470110232.CH7; Martinez-Delgado G, 2010, CURR NEUROPHARMACOL, V8, P422, DOI 10.2174/157015910793358141; McCall MA, 2002, J NEUROSCI, V22, P4163, DOI 10.1523/JNEUROSCI.22-10-04163.2002; Metten P, 1998, MAMM GENOME, V9, P983, DOI 10.1007/s003359900911; Mihalek RM, 2001, ALCOHOL CLIN EXP RES, V25, P1708, DOI 10.1111/j.1530-0277.2001.tb02179.x; Mihic SJ, 1996, J PHARMACOL EXP THER, V277, P411; Milligan CJ, 2004, J NEUROSCI, V24, P7241, DOI 10.1523/JNEUROSCI.1979-04.2004; Ochoa-de la Paz LD, 2008, NEUROSCI RES, V61, P302, DOI 10.1016/j.neures.2008.03.009; Ogurusu T, 1999, RECEPTOR CHANNEL, V6, P463; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Pan Y, 2005, NEUROSCI LETT, V376, P60, DOI 10.1016/j.neulet.2004.11.024; Pan ZH, 2000, EUR J NEUROSCI, V12, P3137, DOI 10.1046/j.1460-9568.2000.00198.x; PINEL JPJ, 1976, PHYSIOL BEHAV, V16, P693, DOI 10.1016/0031-9384(76)90238-9; Ponomarev I, 2006, J NEUROSCI, V26, P5673, DOI 10.1523/JNEUROSCI.0860-06.2006; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Rosas-Arellano A, 2012, J NEUROCHEM, V122, P900, DOI 10.1111/j.1471-4159.2011.07621.x; Rosas-Arellano A, 2011, NEUROSCI LETT, V500, P20, DOI 10.1016/j.neulet.2011.05.235; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; WAYNER MJ, 1972, PHYSIOL BEHAV, V9, P737, DOI 10.1016/0031-9384(72)90043-1; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Xuei XL, 2010, AM J MED GENET B, V153B, P418, DOI 10.1002/ajmg.b.30995; Zheng W, 2003, J BIOL CHEM, V278, P48321, DOI 10.1074/jbc.M307930200	57	42	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85525	10.1371/journal.pone.0085525	http://dx.doi.org/10.1371/journal.pone.0085525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DQ	24454882	gold, Green Published, Green Submitted			2022-12-25	WOS:000330236000011
J	Foster, GM; Ambrose, JC; Hue, S; Delpech, VC; Fearnhill, E; Abecasis, AB; Brown, AJL; Geretti, AM				Foster, Geraldine M.; Ambrose, John C.; Hue, Stephane; Delpech, Valerie C.; Fearnhill, Esther; Abecasis, Ana B.; Brown, Andrew J. Leigh; Geretti, Anna Maria		UK HIV Drug Resistance Database	Novel HIV-1 Recombinants Spreading across Multiple Risk Groups in the United Kingdom: The Identification and Phylogeography of Circulating Recombinant Form (CRF) 50_A1D	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SUBTYPE-A; DISEASE PROGRESSION; TRANSMISSION; INFECTIONS; EPIDEMIC; PROTEASE; PLASMA; COHORT; UGANDA	Background: An increase in non-B HIV-1 infections among men who have sex with men (MSM) in the United Kingdom (UK) has created opportunities for novel recombinants to arise and become established. We used molecular mapping to characterize the importance of such recombinants to the UK HIV epidemic, in order to gain insights into transmission dynamics that can inform control strategies. Methods and Results: A total of 55,556 pol (reverse transcriptase and protease) sequences in the UK HIV Drug Resistance Database were analyzed using Subtype Classification Using Evolutionary Algorithms (SCUEAL). Overall 72 patients shared the same A1/D recombination breakpoint in pol, comprising predominantly MSM but also heterosexuals and injecting drug users (IDUs). In six MSM, full-length single genome amplification of plasma HIV-1 RNA was performed in order to characterize the A1/D recombinant. Subtypes and recombination breakpoints were identified using sliding window and jumping profile hidden markov model approaches. Global maximum likelihood trees of gag, pol and env genes were drawn using FastTree version 2.1. Five of the six strains showed the same novel A1/D recombinant (8 breakpoints), which has been classified as CRF50_A1D. The sixth strain showed a complex CRF50_A1D/B/U structure. Divergence dates and phylogeographic inferences were determined using Bayesian Evolutionary Analysis using Sampling Trees (BEAST). This estimated that CRF50_A1D emerged in the UK around 1992 in MSM, with subsequent transmissions to heterosexuals and IDUs. Analysis of CRF50_A1D/B/U demonstrated that around the year 2000 CRF50_A1D underwent recombination with a subtype B strain. Conclusions: We report the identification of CRF50_A1D, a novel circulating recombinant that emerged in UK MSM around 1992, with subsequent onward transmission to heterosexuals and IDUs, and more recent recombination with subtype B. These findings highlight the changing dynamics of HIV transmission in the UK and the converging of the two previously distinct MSM and heterosexual epidemics.	[Foster, Geraldine M.; Ambrose, John C.; Geretti, Anna Maria] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Hue, Stephane] UCL, London, England; [Delpech, Valerie C.] Publ Hlth England, London, England; [Fearnhill, Esther] MRC Clin Trials Unit, London, England; [Abecasis, Ana B.] Univ Nova Lisboa, P-1200 Lisbon, Portugal; [Brown, Andrew J. Leigh] Univ Edinburgh, Edinburgh, Midlothian, Scotland	University of Liverpool; University of London; University College London; Public Health England; Medical Research Council Clinical Trials Unit; Universidade Nova de Lisboa; University of Edinburgh	Geretti, AM (corresponding author), Univ Liverpool, Liverpool L69 3BX, Merseyside, England.	geretti@liverpool.ac.uk	Abecasis, Ana/B-6295-2009; Abecasis, Ana/ABF-6657-2020; Leigh Brown, Andrew/F-3802-2010; Brown, Andrew Leigh/ABF-8269-2020	Abecasis, Ana/0000-0002-3903-5265; Abecasis, Ana/0000-0002-3903-5265; Leigh Brown, Andrew/0000-0002-5700-3128; Brown, Andrew Leigh/0000-0002-5700-3128; delpech, valerie/0000-0002-9952-8109; Kellam, Paul/0000-0003-3166-4734; Hue, Stephane/0000-0002-8580-6905; Geretti, Anna Maria/0000-0002-3670-6588	Medical Research Council; Department of Health; Janssen-Cilag Ltd; Bristol-Myers Squibb; Gilead; Pfizer; Roche; MRC [G0900274, MC_UU_12023/15] Funding Source: UKRI; Medical Research Council [MC_UU_12023/15, G0900274] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; Janssen-Cilag Ltd; Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Pfizer(Pfizer); Roche(Roche Holding); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Primary funding of the UK HIV Drug Resistance Database is provided by the Medical Research Council; the views expressed in the publication are those of the authors and not necessarily those of the Medical Research Council. The Database was originally established through funding from the Department of Health; additional support has been provided by Janssen-Cilag Ltd, Bristol-Myers Squibb, Gilead, Pfizer, and Roche. The authors declare that no commercial source had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Archer J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000178; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Balotta C, 2001, J ACQ IMMUN DEF SYND, V27, P499, DOI 10.1097/00126334-200108150-00012; Boni J, 1999, J ACQ IMMUN DEF SYND, V22, P174; BRODINE SK, 1995, LANCET, V346, P1198, DOI 10.1016/S0140-6736(95)92901-0; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Doherty IA, 2005, J INFECT DIS, V191, pS42, DOI 10.1086/425277; Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07; Health Protection Agency, SEX TRANSM INF MEN W; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Kaleebu P, 2007, JAIDS-J ACQ IMM DEF, V45, P28, DOI 10.1097/QAI.0b013e3180385aa0; Kiwanuka N, 2009, AIDS, V23, P2479, DOI 10.1097/QAD.0b013e328330cc08; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kuiken C, 0803719 LAUR LOS AL; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Nadai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001420; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Semaille C, 2007, J INFECT DIS, V196, P377, DOI 10.1086/519387; Van Laethem K, 2006, J VIROL METHODS, V132, P181, DOI 10.1016/j.jviromet.2005.10.008; Van Laethem K, 2005, J VIROL METHODS, V123, P25, DOI 10.1016/j.jviromet.2004.09.003	23	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83337	10.1371/journal.pone.0083337	http://dx.doi.org/10.1371/journal.pone.0083337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454702	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000330235100009
J	Giavi, S; Moretti, M; Bontadina, F; Zambelli, N; Schaub, M				Giavi, Simone; Moretti, Marco; Bontadina, Fabio; Zambelli, Nicola; Schaub, Michael			Seasonal Survival Probabilities Suggest Low Migration Mortality in Migrating Bats	PLOS ONE			English	Article							POPULATION-DYNAMICS; SITE FIDELITY; STOPOVER SITE; LASIONYCTERIS; SONGBIRD; WEATHER; WIND	Migration is adaptive if survival benefits are larger than costs of residency. Many aspects of bat migration ecology such as migratory costs, stopover site use and fidelity are largely unknown. Since many migrating bats are endangered, such information is urgently needed to promote conservation. We selected the migrating Leisler's bat (Nyctalus leisleri) as model species and collected capture-recapture data in southern Switzerland year round during 6 years. We estimated seasonal survival and site fidelity with Cormack-Jolly-Seber models that accounted for the presence of transients fitted with Bayesian methods and assessed differences between sexes and seasons. Activity peaked in autumn and spring, whereas very few individuals were caught during summer. We hypothesize that the study site is a migratory stopover site used during fall and spring migration for most individuals, but there is also evidence for wintering. Additionally, we found strong clues for mating during fall. Summer survival that included two major migratory journeys was identical to winter survival in males and slightly higher in females, suggesting that the migratory journeys did not bear significant costs in terms of survival. Transience probability was in both seasons higher in males than in females. Our results suggest that, similarly to birds, Leisler's bat also use stopover sites during migration with high site fidelity. In contrast to most birds, the stopover site was also used for mating and migratory costs in terms of survival seemed to be low. Transients' analyses highlighted strong individual variation in site use which makes particularly challenging the study and modelling of their populations as well as their conservation.	[Giavi, Simone; Moretti, Marco] Swiss Fed Res Inst WSL, Bellinzona, Ticino, Switzerland; [Bontadina, Fabio] SWILD, Zurich, Switzerland; [Bontadina, Fabio] Swiss Fed Res Inst WSL, Zurich, Switzerland; [Zambelli, Nicola] Museo Cantonale Storia Nat, Lugano, Ticino, Switzerland; [Schaub, Michael] Swiss Ornithol Inst, Sempach, Luzern, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Ornithological Institute	Giavi, S (corresponding author), Swiss Fed Res Inst WSL, Bellinzona, Ticino, Switzerland.	sgiavi@hotmail.com		Bontadina, Fabio/0000-0002-0163-2486; Moretti, Marco/0000-0002-5845-3198; Schaub, Michael/0000-0003-2745-0557; Giavi, Simone/0000-0001-8714-5912	Forest Department of the Canton of Ticino; Hochschulstiftung of University of Bern; Pro Natura	Forest Department of the Canton of Ticino; Hochschulstiftung of University of Bern; Pro Natura	This study is part of the SELPI (SELve & PIpistrelli) research program, supported by the Forest Department of the Canton of Ticino and by a grant from the Hochschulstiftung of University of Bern. Pro Natura supported the authors in the purchase of bat boxes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony E.L.P., 1988, P47; Bogdanowicz W, 2004, HDB SAUGETIERE EUROP, P717; Bontadina F, 2009, 1 INT S BAT MIGR BER; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Calvert AM, 2012, OECOLOGIA, V168, P849, DOI 10.1007/s00442-011-2119-5; CANTOS FJ, 1994, J AVIAN BIOL, V25, P131, DOI 10.2307/3677031; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Dondini G, 2009, HYSTRIX, V20, P147; Duriez O, 2012, OIKOS, V121, P862, DOI 10.1111/j.1600-0706.2012.20326.x; Dzal Y, 2009, ACTA CHIROPTEROL, V11, P307, DOI 10.3161/150811009X485549; Fleming TH, 2003, BAT ECOLOGY, P156; Hoch S, 2005, 2 WEITERE FERNFUNDE, P288; Ibanez C, 2009, J MAMMAL, V90, P235, DOI 10.1644/08-MAMM-A-037.1; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; McGuire LP, 2012, J ANIM ECOL, V81, P377, DOI 10.1111/j.1365-2656.2011.01912.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Papadatou E, 2012, ECOGRAPHY, V35, P153, DOI 10.1111/j.1600-0587.2011.07084.x; Papadatou E, 2009, BIOL CONSERV, V142, P280, DOI 10.1016/j.biocon.2008.10.023; Plummer M., 2003, P 3 INT WORKSH DISTR; Popa-Lisseanu AG, 2009, J MAMMAL, V90, P1283, DOI 10.1644/09-MAMM-S-130R2.1; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; R Core Team, 2012, LANG ENV STAT COMP; Racey P.A., 1988, P31; Reed ET, 1998, CONDOR, V100, P426, DOI 10.2307/1369708; Sanz-Aguilar A, 2012, J ANIM ECOL, V81, P1171, DOI 10.1111/j.1365-2656.2012.01997.x; Schaub M, 2004, ANIM BEHAV, V67, P229, DOI 10.1016/j.anbehav.2003.03.011; Schaub M, 2007, CONSERV BIOL, V21, P945, DOI 10.1111/j.1523-1739.2007.00743.x; SCHORCHT W, 2005, NYCTALUS, V10, P351; Schorcht Wigbert, 2002, Schriftenreihe fuer Landschaftspflege und Naturschutz, V71, P141; Schorcht W, 2009, J ANIM ECOL, V78, P1182, DOI 10.1111/j.1365-2656.2009.01577.x; Sendor T, 2003, J ANIM ECOL, V72, P308, DOI 10.1046/j.1365-2656.2003.00702.x; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; SPINEDI F, 2004, DATI STAT SOC, V6, P4; Steffens R, 2004, 40 JAHRE FLEDERMAUSM; Strandberg R, 2010, BIOL LETTERS, V6, P297, DOI 10.1098/rsbl.2009.0785; Su Y.-S., 2012, R2JAGS PACKAGE RUNNI; SWITZER PV, 1993, EVOL ECOL, V7, P533, DOI 10.1007/BF01237820; Szentkuti S, 2013, ENDANGER SPECIES RES, V21, P105, DOI 10.3354/esr00496; Taylor PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027054; Tidemann CR, 2004, J ZOOL, V263, P141, DOI 10.1017/S0952836904004960; Voigt CC, 2012, BIOL CONSERV, V153, P80, DOI 10.1016/j.biocon.2012.04.027; Zambelli N, 2008, PIPISTRELLI SELVE VA; Zambelli N, 2010, NAT TAG SCHWEIZ KOOR	49	13	13	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85628	10.1371/journal.pone.0085628	http://dx.doi.org/10.1371/journal.pone.0085628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454906	Green Submitted, gold, Green Published			2022-12-25	WOS:000330235100109
J	Pulskens, WP; Butter, LM; Teske, GJ; Claessen, N; Dessing, MC; Flavell, RA; Sutterwala, FS; Florquin, S; Leemans, JC				Pulskens, Wilco P.; Butter, Loes M.; Teske, Gwendoline J.; Claessen, Nike; Dessing, Mark C.; Flavell, Richard A.; Sutterwala, Fayyaz S.; Florquin, Sandrine; Leemans, Jaklien C.			Nlrp3 Prevents Early Renal Interstitial Edema and Vascular Permeability in Unilateral Ureteral Obstruction	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; TUBULAR DAMAGE; KIDNEY; FIBROSIS; INFLAMMASOME; NEPHROPATHY; APOPTOSIS; PROTEINS; CLAUDINS; INNATE	Progressive renal disease is characterized by tubulo-interstitial injury with ongoing inflammation and fibrosis. The Nlrp3 inflammasome contributes to these pathophysiological processes through its canonical effects in cytokine maturation. Nlrp3 may additionally exert inflammasome-independent effects following tissue injury. Hence, in this study we investigated potential non-canonical effects of Nlrp3 following progressive renal injury by subjecting WT and Nlrp3-deficient (-/-) mice to unilateral ureter obstruction (UUO). Our results revealed a progressive increase of renal Nlrp3 mRNA in WT mice following UUO. The absence of Nlrp3 resulted in enhanced tubular injury and dilatation and an elevated expression of injury biomarker NGAL after UUO. Moreover, interstitial edema was significantly elevated in Nlrp-/- mice. This could be explained by increased intratubular pressure and an enhanced tubular and vascular permeability. In accordance, renal vascular leakage was elevated in Nlrp-/- mice that associated with reduced mRNA expression of intercellular junction components. The decreased epithelial barrier function in Nlrp-/- mice was not associated with increased apoptosis and/or proliferation of renal epithelial cells. Nlrp3 deficiency did not affect renal fibrosis or inflammation. Together, our data reveal a novel non-canonical effect of Nlrp3 in preserving renal integrity and protection against early tubular injury and interstitial edema following progressive renal injury.	[Pulskens, Wilco P.; Butter, Loes M.; Teske, Gwendoline J.; Claessen, Nike; Dessing, Mark C.; Florquin, Sandrine; Leemans, Jaklien C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Flavell, Richard A.] Howard Hughes Med Inst, New Haven, CT 06510 USA; [Sutterwala, Fayyaz S.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Yale University; Howard Hughes Medical Institute; University of Iowa	Pulskens, WP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	w.pulskens@fysiol.umcn.nl	Cassel, Suzanne/AAI-3947-2021; Leemans, Jaklien/AAM-4958-2020; Pulskens, Wilco/P-6023-2015; Sutterwala, Fayyaz/AAH-5859-2021	Cassel, Suzanne/0000-0003-2492-1923; Pulskens, Wilco/0000-0001-9697-3189; Florquin, Sandrine/0000-0002-9676-1722	Dutch Kidney Foundation [IP10.20, C10-2350]; Netherlands Organization for Scientific Research [016.126.386-1]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	Dutch Kidney Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by a grant from the Dutch Kidney Foundation to W. P. (IP10.20) and L.M.B. (C10-2350), and the Netherlands Organization for Scientific Research to J.C.L. (016.126.386-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Ashworth SL, 2006, NEPHRON PHYSIOL, V103, P91, DOI 10.1159/000090626; Bakker PJ, 2013, KIDNEY INT IN PRESS; Balkovetz DF, 2009, BBA-BIOMEMBRANES, V1788, P858, DOI 10.1016/j.bbamem.2008.07.004; Bani-Hani AH, 2009, KIDNEY INT, V76, P500, DOI 10.1038/ki.2009.216; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Becker GJ, 2000, CURR OPIN NEPHROL HY, V9, P133, DOI 10.1097/00041552-200003000-00006; Cavanaugh KJ, 2001, AM J RESP CELL MOL, V25, P584, DOI 10.1165/ajrcmb.25.5.4486; Chevalier RL, 1999, PEDIATR NEPHROL, V13, P612, DOI 10.1007/s004670050756; Chevalier RL, 1996, J UROLOGY, V156, P1474, DOI 10.1016/S0022-5347(01)65633-7; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Cohen TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010385; Corada M, 2002, BLOOD, V100, P905, DOI 10.1182/blood.V100.3.905; Dunn KW, 2002, AM J PHYSIOL-CELL PH, V283, pC905, DOI 10.1152/ajpcell.00159.2002; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; GOBE GC, 1987, LAB INVEST, V56, P273; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jones LK, 2009, NEPHROL DIAL TRANSPL, V24, P3024, DOI 10.1093/ndt/gfp214; Kirk A, 2010, NEPHROL DIAL TRANSPL, V25, P2107, DOI 10.1093/ndt/gfq006; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Kuwabara T, 2009, KIDNEY INT, V75, P285, DOI 10.1038/ki.2008.499; Leemans JC, 2011, IMMUNOL REV, V243, P152, DOI 10.1111/j.1600-065X.2011.01043.x; Leemans JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005704; Lichtnekert J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026778; Lorenz G, 2013, NEPHROL DIAL TRANSPL; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Mulay SR, 2013, J CLIN INVEST, V123, P236, DOI 10.1172/JCI63679; Pulskens WP, 2010, J AM SOC NEPHROL, V21, P1299, DOI 10.1681/ASN.2009070722; Pulskens WP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003596; Rouschop KMA, 2006, J AM SOC NEPHROL, V17, P746, DOI 10.1681/ASN.2005080808; Rouschop KMA, 2004, J AM SOC NEPHROL, V15, P674, DOI 10.1097/01.ASN.0000115703.30835.96; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tanji N, 1998, Int J Urol, V5, P256, DOI 10.1111/j.1442-2042.1998.tb00600.x; Truong LD, 1998, SEMIN NEPHROL, V18, P641; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wang J, 2011, EURASIP J WIREL COMM, DOI 10.1155/2011/785437; Wang W, 2013, J IMMUNOL, V190, P1239, DOI 10.4049/jimmunol.1201959; Wasilewska A, 2011, PEDIATR NEPHROL, V26, P579, DOI 10.1007/s00467-011-1773-5; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10, DOI 10.1152/ajprenal.2001.280.1.F10; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yin Y, 2009, INT J IMMUNOPATH PH, V22, P311, DOI 10.1177/039463200902200208; Yu WM, 2007, AM J PHYSIOL-RENAL, V292, pF1873, DOI 10.1152/ajprenal.00218.2006	46	42	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85775	10.1371/journal.pone.0085775	http://dx.doi.org/10.1371/journal.pone.0085775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454932	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100133
J	Soraas, A; Sundsfjord, A; Jorgensen, SB; Liestol, K; Jenum, PA				Soraas, Arne; Sundsfjord, Arnfinn; Jorgensen, Silje Bakken; Liestol, Knut; Jenum, Pal A.			High Rate of Per Oral Mecillinam Treatment Failure in Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Escherichia coli	PLOS ONE			English	Article							PERORALLY ADMINISTERED PIVMECILLINAM; NITROFURANTOIN; ANTIBIOTICS; EFFICACY; THERAPY; WOMEN	A population-based study was performed to investigate the efficacy of mecillinam treatment of community-acquired urinary tract infections (CA-UTI) caused by extended-spectrum beta-lactamase (ESBL) producing Escherichia coli. The study was conducted in South-Eastern Norway. Data from patients with CA-UTI caused by ESBL-producing and non-producing (random controls) E. coli were collected through interviews, questionnaires, medical records and the Norwegian Prescription Database. Treatment failure was defined as a new antibiotic prescription appropriate for UTI prescribed within two weeks after the initial antimicrobial therapy. Multivariable logistic regression analysis was performed to identify treatment agents and patient-or bacterial traits associated with treatment failure. A total of 343 patients (mean age 59) were included, of which 158 (46%) were treated with mecillinam. Eighty-one patients (24%, mean age 54) had infections caused by ESBL producing E. coli, and 41 of these patients (51%) received mecillinam as the primary treatment. Mecillinam treatment failure was observed in 18 (44%) of patients infected by ESBL-producing strains and in 16 (14%) of patients with a CA-UTI caused by ESBL non-producing strains. Multivariable analysis showed that ESBL status (odds ratio (OR) 3.2, 95% confidence interval (CI) 1.3-7.8, p = 0.009) and increased MIC of mecillinam (OR 2.0 for each doubling value of MIC, CI 1.4-3.0, p< 0.001) were independently associated with mecillinam treatment failure. This study showed a high rate of mecillinam treatment failure in CA-UTIs caused by ESBL producing E. coli. The high failure rate could not be explained by the increased MIC of mecillinam alone. Further studies addressing the use of mecillinam against ESBL-producing E. coli, with emphasis on optimal dosing and combination therapy with b-lactamase inhibitors, are warranted.	[Soraas, Arne; Jorgensen, Silje Bakken; Jenum, Pal A.] Vestre Viken Hosp Trust, Dept Med Microbiol, Baerum, Norway; [Sundsfjord, Arnfinn] Univ Hosp North Norway, Dept Microbiol & Infect Control, Reference Ctr Detect Antimicrobial Resistance, Tromso, Norway; [Sundsfjord, Arnfinn] Univ Tromso, Dept Med Biol, Res Grp Host Microbe Interact, Fac Hlth Sci, Tromso, Norway; [Liestol, Knut] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Jenum, Pal A.] Univ Oslo, Fac Med, Dept Clin Med, Oslo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University of Oslo; University of Oslo	Soraas, A (corresponding author), Vestre Viken Hosp Trust, Dept Med Microbiol, Baerum, Norway.	arne@meg.no	Sundsfjord, Arnfinn/F-9668-2018	Sundsfjord, Arnfinn/0000-0002-3728-2270; Jorgensen, Silje/0000-0002-3135-1431	South Eastern Norway Health Authority	South Eastern Norway Health Authority	The study were funded by the South Eastern Norway Health Authority. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer S, 2010, ANTIMICROB AGENTS CH, V54, P4006, DOI 10.1128/AAC.01760-09; Berg C, 2011, NORWEGIAN PRESCRIPTI; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Bjerrum L, 2002, SCAND J PRIM HEALTH, V20, P97, DOI 10.1080/713796403; Bjerrum L, 2009, SCAND J PRIM HEALTH, V27, P6, DOI 10.1080/02813430802535312; Craig WA, 2003, INFECT DIS CLIN N AM, V17, P479, DOI 10.1016/S0891-5520(03)00065-5; Dewar S, 2014, J ANTIMICROB CHEMOTH, V69, P303, DOI 10.1093/jac/dkt368; *EUR COMM ANT SUSC, BREAKP TABL INT MICS; Ferry SA, 2007, SCAND J PRIM HEALTH, V25, P49, DOI 10.1080/02813430601183074; Frimodt-Moller N, 2002, INT J ANTIMICROB AG, V19, P546, DOI 10.1016/S0924-8579(02)00105-X; Garau J, 2008, CLIN MICROBIOL INFEC, V14, P198, DOI 10.1111/j.1469-0691.2007.01852.x; Goettsch WG, 2004, BRIT J CLIN PHARMACO, V58, P184, DOI 10.1111/j.1365-2125.2004.02106.x; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Hvidberg H, 2000, ANTIMICROB AGENTS CH, V44, P156, DOI 10.1128/AAC.44.1.156-163.2000; Jensen KS, 2008, 18 EUR C CLIN MICR I; Kahlmeter G, 2012, INT J ANTIMICROB AG, V39, P45, DOI 10.1016/j.ijantimicag.2011.09.013; Kerrn MB, 2004, CLIN MICROBIOL INFEC, V10, P54, DOI 10.1111/j.1469-0691.2004.00737.x; Lampri N, 2012, J ANTIMICROB CHEMOTH, V67, P2424, DOI 10.1093/jac/dks215; Lawrenson RA, 2001, J ANTIMICROB CHEMOTH, V48, P895, DOI 10.1093/jac/48.6.895; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Menday AP, 2000, INT J ANTIMICROB AG, V13, P183, DOI 10.1016/S0924-8579(99)00118-1; Naseer U, 2011, MICROB DRUG RESIST, V17, P83, DOI 10.1089/mdr.2010.0132; Nicolle LE, 2002, SCAND J INFECT DIS, V34, P487, DOI 10.1080/00365540110080728; Nicolle LE, 2007, SCAND J INFECT DIS, V39, P748, DOI 10.1080/00365540701367801; NORM/NORM-VET, 2010, US ANT AG OCC ANT RE; Raz R, 2000, CLIN INFECT DIS, V30, P152, DOI 10.1086/313596; Soraas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069581; Sougakoff W, 2000, J ANTIMICROB CHEMOTH, V46, P9, DOI 10.1093/jac/46.suppl_1.9; Sullivan A, 2005, ANTIMICROB AGENTS CH, V49, P170, DOI 10.1128/AAC.49.1.170-175.2005; Sullivan A, 2001, J CHEMOTHERAPY, V13, P299, DOI 10.1179/joc.2001.13.3.299; Tarnberg M, 2011, EUR J CLIN MICROBIOL, V30, P981, DOI 10.1007/s10096-011-1183-4; Thomas K, 2006, J ANTIMICROB CHEMOTH, V57, P367, DOI 10.1093/jac/dki451; Titelman E, 2012, MICROB DRUG RESIST, V18, P189, DOI 10.1089/mdr.2011.0161; Tofteland S, 2007, J CLIN MICROBIOL, V45, P199, DOI 10.1128/JCM.01319-06; Viera AJ, 2005, FAM MED, V37, P360; Wootton M, 2010, J ANTIMICROB CHEMOTH, V65, P79, DOI 10.1093/jac/dkp404	36	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85889	10.1371/journal.pone.0085889	http://dx.doi.org/10.1371/journal.pone.0085889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454943	Green Published, gold			2022-12-25	WOS:000330235100139
J	Xie, G; Lo, CC; Scholz, M; Chain, PSG				Xie, Gary; Lo, Chien-Chi; Scholz, Matthew; Chain, Patrick S. G.			Recruiting Human Microbiome Shotgun Data to Site-Specific Reference Genomes	PLOS ONE			English	Article							SKIN MICROBIOME; INTESTINAL MICROBIOTA; GUT MICROBIOME; DIVERSITY; COMMUNITY; ECOLOGY; CATALOG; TRACT; CORE	The human body consists of innumerable multifaceted environments that predispose colonization by a number of distinct microbial communities, which play fundamental roles in human health and disease. In addition to community surveys and shotgun metagenomes that seek to explore the composition and diversity of these microbiomes, there are significant efforts to sequence reference microbial genomes from many body sites of healthy adults. To illustrate the utility of reference genomes when studying more complex metagenomes, we present a reference-based analysis of sequence reads generated from 55 shotgun metagenomes, selected from 5 major body sites, including 16 sub-sites. Interestingly, between 13% and 92% (62.3% average) of these shotgun reads were aligned to a then-complete list of 2780 reference genomes, including 1583 references for the human microbiome. However, no reference genome was universally found in all body sites. For any given metagenome, the body site-specific reference genomes, derived from the same body site as the sample, accounted for an average of 58.8% of the mapped reads. While different body sites did differ in abundant genera, proximal or symmetrical body sites were found to be most similar to one another. The extent of variation observed, both between individuals sampled within the same microenvironment, or at the same site within the same individual over time, calls into question comparative studies across individuals even if sampled at the same body site. This study illustrates the high utility of reference genomes and the need for further site-specific reference microbial genome sequencing, even within the already well-sampled human microbiome.	[Xie, Gary; Lo, Chien-Chi; Scholz, Matthew; Chain, Patrick S. G.] Los Alamos Natl Lab, Genome Sci Grp, Los Alamos, NM 87545 USA; [Xie, Gary; Lo, Chien-Chi; Scholz, Matthew; Chain, Patrick S. G.] Joint Genome Inst, Microbial & Metagenome Program, Walnut Creek, CA USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Chain, PSG (corresponding author), Los Alamos Natl Lab, Genome Sci Grp, Los Alamos, NM 87545 USA.	pchain@lanl.gov	Chain, Patrick/O-4140-2019	Chain, Patrick/0000-0003-3949-3634; xie, gary/0000-0002-9176-924X; Scholz, Matthew/0000-0003-3686-1227; Lo, Chien-Chi/0000-0003-3470-1078	National Institutes of Health [Y1-DE-6006-02]; U.S. Department of Energy (Office of Science) Joint Genome Institute [DE-AC02-05CH11231]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy (Office of Science) Joint Genome Institute	This study was supported by grants from National Institutes of Health (Y1-DE-6006-02) and U.S. Department of Energy (Office of Science) Joint Genome Institute (DE-AC02-05CH11231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; BRISELDEN AM, 1990, J CLIN MICROBIOL, V28, P2761, DOI 10.1128/JCM.28.12.2761-2764.1990; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Erkel C, 2006, SCIENCE, V313, P370, DOI 10.1126/science.1127062; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gonzalez A, 2011, EMBO REP, V12, P775, DOI 10.1038/embor.2011.137; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kong HDH, 2011, TRENDS MOL MED, V17, P320, DOI 10.1016/j.molmed.2011.01.013; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Pelletier E, 2008, J BACTERIOL, V190, P2572, DOI 10.1128/JB.01248-07; Pflughoeft KJ, 2011, ANN REV PATHOLOGY; Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Xie G, 2010, MOL ORAL MICROBIOL, V25, P391, DOI 10.1111/j.2041-1014.2010.00587.x; Yang F, 2011, ISME J; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	34	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84963	10.1371/journal.pone.0084963	http://dx.doi.org/10.1371/journal.pone.0084963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454771	gold, Green Submitted, Green Published			2022-12-25	WOS:000330235100044
J	Kanemura, H; Go, MJ; Shikamura, M; Nishishita, N; Sakai, N; Kamao, H; Mandai, M; Morinaga, C; Takahashi, M; Kawamata, S				Kanemura, Hoshimi; Go, Masahiro J.; Shikamura, Masayuki; Nishishita, Naoki; Sakai, Noriko; Kamao, Hiroyuki; Mandai, Michiko; Morinaga, Chikako; Takahashi, Masayo; Kawamata, Shin			Tumorigenicity Studies of Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Pigment Epithelium (RPE) for the Treatment of Age-Related Macular Degeneration	PLOS ONE			English	Article							SUBRETINAL IMPLANTATION; GENERATION	Basic studies of human pluripotential stem cells have advanced rapidly and stem cell products are now seeing therapeutic applications. However, questions remain regarding the tumorigenic potential of such cells. Here, we report the tumorigenic potential of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of wet-type, age-related macular degeneration (AMD). First, immunodeficient mouse strains (nude, SCID, NOD-SCID and NOG) were tested for HeLa cells' tumor-forming capacity by transplanting various cell doses subcutaneously with or without Matrigel. The 50% Tumor Producing Dose (TPD50 value) is the minimal dose of transplanted cells that generated tumors in 50% of animals. For HeLa cells, the TPD50 was the lowest when cells were embedded in Matrigel and transplanted into NOG mice (TPD50= 10(1.1), n = 75). The TPD50 for undifferentiated iPSCs transplanted subcutaneously to NOG mice in Matrigel was 10(2.12); (n = 30). Based on these experiments, 1610 6 iPSC-derived RPE were transplanted subcutaneously with Matrigel, and no tumor was found during 15 months of monitoring (n = 65). Next, to model clinical application, we assessed the tumor-forming potential of HeLa cells and iPSC 201B7 cells following subretinal transplantation of nude rats. The TPD50 for iPSCs was 10(4.73) (n = 20) and for HeLa cells 10(1.32) (n = 37) respectively. Next, the tumorigenicity of iPSC-derived RPE was tested in the subretinal space of nude rats by transplanting 0.8-1.5x10(4) iPSC-derived RPE in a collagen-lined (1 mmx1 mm) sheet. No tumor was found with iPSC-derived RPE sheets during 6-12 months of monitoring (n = 26). Considering the number of rodents used, the monitoring period, the sensitivity of detecting tumors via subcutaneous and subretinal administration routes and the incidence of tumor formation from the iPSC-derived RPE, we conclude that the tumorigenic potential of the iPSC-derived RPE was negligible.	[Kanemura, Hoshimi; Go, Masahiro J.; Shikamura, Masayuki; Nishishita, Naoki; Kawamata, Shin] Fdn Biomed Res & Innovat, Div Cell Therapy, Kobe, Hyogo, Japan; [Kanemura, Hoshimi; Sakai, Noriko; Kamao, Hiroyuki; Mandai, Michiko; Morinaga, Chikako; Takahashi, Masayo; Kawamata, Shin] RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo, Japan; [Kamao, Hiroyuki] Kawasaki Med Sch, Dept Ophthalmol, Kurashiki, Okayama, Japan	Institute for Biomedical Research & Innovation (IBRI); RIKEN; Kawasaki Medical School	Kawamata, S (corresponding author), Fdn Biomed Res & Innovat, Div Cell Therapy, Kobe, Hyogo, Japan.	kawamata@fbri.org		Kamao, Hiroyuki/0000-0002-2194-7063; kawamata, shin/0000-0001-5148-1949	JST Japan	JST Japan(Japan Science & Technology Agency (JST))	This study was supported by funding from JST research grant "Safety Tests for Pluripotent Stem Cell (2010-2014)'' Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003685; Diniz B, 2013, INVEST OPHTH VIS SCI, V54, P5087, DOI 10.1167/iovs.12-11239; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Hu YT, 2012, OPHTHALMIC RES, V48, P186, DOI 10.1159/000338749; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Kanemura H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02334; Kuroda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037342; Lewis AM, 2005, REG IMPL NEOPL CELL; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Machida K, 2009, J TOXICOL SCI, V34, P123, DOI 10.2131/jts.34.123; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Muller FJ, 2010, CELL STEM CELL, V6, P412, DOI 10.1016/j.stem.2010.04.009; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okano Hideyuki, 2009, Genome Inform, V23, P217; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Prockop DJ, 2010, MOL THER, V18, P1249, DOI 10.1038/mt.2010.99; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; WHO, 2010, REC EV AN CELL CULT; World Health Organization, 2008, WHO TECHN REP SER, V878	21	119	125	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85336	10.1371/journal.pone.0085336	http://dx.doi.org/10.1371/journal.pone.0085336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454843	Green Published, Green Submitted, gold			2022-12-25	WOS:000329925800038
J	Nakajima, S; Lan, L; Wei, L; Hsieh, CL; Rapic-Otrin, V; Yasui, A; Levine, AS				Nakajima, Satoshi; Lan, Li; Wei, Leizhen; Hsieh, Ching-Lung; Rapic-Otrin, Vesna; Yasui, Akira; Levine, Arthur S.			Ubiquitin-Specific Protease 5 Is Required for the Efficient Repair of DNA Double-Strand Breaks	PLOS ONE			English	Article							HUMAN-CELLS; DEUBIQUITINATING ENZYMES; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; DAMAGE RESPONSE; PCNA MONOUBIQUITINATION; POLYUBIQUITIN CHAINS; EXCISION-REPAIR; ISOPEPTIDASE-T; GENOME-WIDE	During the DNA damage response (DDR), ubiquitination plays an important role in the recruitment and regulation of repair proteins. However, little is known about elimination of the ubiquitination signal after repair is completed. Here we show that the ubiquitin-specific protease 5 (USP5), a deubiquitinating enzyme, is involved in the elimination of the ubiquitin signal from damaged sites and is required for efficient DNA double-strand break (DSB) repair. Depletion of USP5 sensitizes cells to DNA damaging agents, produces DSBs, causes delayed disappearance of gamma H2AX foci after Bleocin treatment, and influences DSB repair efficiency in the homologous recombination pathway but not in the non-homologous end joining pathway. USP5 co-localizes to DSBs induced by laser micro-irradiation in a RAD18-dependent manner. Importantly, polyubiquitin chains at sites of DNA damage remained for longer periods in USP5-depleted cells. Our results show that disassembly of polyubiquitin chains by USP5 at sites of damage is important for efficient DSB repair.	[Nakajima, Satoshi; Lan, Li; Wei, Leizhen; Hsieh, Ching-Lung; Rapic-Otrin, Vesna; Levine, Arthur S.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Nakajima, Satoshi; Lan, Li; Wei, Leizhen; Hsieh, Ching-Lung; Rapic-Otrin, Vesna; Levine, Arthur S.] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA USA; [Yasui, Akira] Tohoku Univ, Inst Dev Aging & Canc, Div Dynam Proteome, Sendai, Miyagi 980, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tohoku University	Nakajima, S (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	san48@pitt.edu; lil64@pitt.edu			UPCI [P30CA047904]; National Institutes of Health [UL1 RR024153, UL1TR000005]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG045545] Funding Source: NIH RePORTER	UPCI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	UPCI shared resources that are supported in part by award P30CA047904 were used for this project. The project described was supported by the National Institutes of Health through Grant Numbers UL1 RR024153 and UL1TR000005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Amerik AY, 1997, EMBO J, V16, P4826; Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bish RA, 2007, J BIOL CHEM, V282, P23184, DOI 10.1074/jbc.M701042200; Butler LR, 2012, EMBO J, V31, P3918, DOI 10.1038/emboj.2012.232; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dayal S, 2009, J BIOL CHEM, V284, P5030, DOI 10.1074/jbc.M805871200; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Gabriel JM, 2002, BIOCHEMISTRY-US, V41, P13755, DOI 10.1021/bi026096m; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; HADARI T, 1992, J BIOL CHEM, V267, P719; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Inagaki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023155; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Katsumi S, 2001, J INVEST DERMATOL, V117, P1156, DOI 10.1046/j.0022-202x.2001.01540.x; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lan L, 2005, J CELL SCI, V118, P4153, DOI 10.1242/jcs.02544; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Lan L, 2010, MOL CELL, V40, P976, DOI 10.1016/j.molcel.2010.12.003; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Levy-Barda A, 2011, CELL CYCLE, V10, P4300, DOI 10.4161/cc.10.24.18642; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Liu T, 2010, DNA REPAIR, V9, P1241, DOI 10.1016/j.dnarep.2010.09.016; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Murai J, 2011, MOL CELL BIOL, V31, P2462, DOI 10.1128/MCB.05058-11; Nakajima S, 2006, J BIOL CHEM, V281, P34687, DOI 10.1074/jbc.M605545200; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rossetto D, 2010, CLIN CANCER RES, V16, P4543, DOI 10.1158/1078-0432.CCR-10-0513; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Shiomi N, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl979; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Tsuji Y, 2008, GENES CELLS, V13, P343, DOI 10.1111/j.1365-2443.2008.01176.x; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032	57	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e84899	10.1371/journal.pone.0084899	http://dx.doi.org/10.1371/journal.pone.0084899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454762	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000329925800018
J	Yu, Y; Zhu, R; Zeng, ZL; Jia, YW; Wu, ZR; Ren, YL; Chen, B; Ding, ZQ; Cheng, LM				Yu, Yan; Zhu, Rui; Zeng, Zhi-Li; Jia, Yong-Wei; Wu, Zhou-Rui; Ren, Yi-Long; Chen, Bo; Ding, Zu-Quan; Cheng, Li-Ming			The Strain at Bone-Implant Interface Determines the Effect of Spinopelvic Reconstruction following Total Sacrectomy: A Strain Gauge Analysis in Various Spinopelvic Constructs	PLOS ONE			English	Article							PELVIC FIXATION; LUMBOPELVIC RECONSTRUCTION; 4-ROD TECHNIQUE; FINITE-ELEMENT; INSTRUMENTATION; NEOPLASMS; SCREWS; ROD	Purpose: There is still some controversy regarding the optimal biomechanical concept for spinopelvic stabilization following total sacrectomy for malignancy. Strains at specific anatomical sites at pelvis/sacrum and implants interfaces have been poorly investigated. Herein, we compared and analyzed the strains applied at key points at the bone-implant interface in four different spinopelvic constructs following total sacrectomy; consequently, we defined a balanced architecture for spinopelvic fusion in that situation. Methods: Six human cadaveric specimens, from second lumbar vertebra to proximal femur, were used to compare the partial strains at specific sites in a total sacrectomy model. Test constructs included: (1) intact pelvis (control), (2) sacral-rod reconstruction (SRR), (3) bilateral fibular flap reconstruction (BFFR), (4) four-rods reconstruction (FRR), and (5) improved compound reconstruction (ICR). Strains were measured by bonded strain gauges onto the surface of three specific sites (pubic rami, arcuate lines, and posterior spinal rods) under a 500 N axial load. Results: ICR caused lower strains at specific sites and, moreover, on stress distribution and symmetry, compared to the other three constructs. Strains at pubic rami and arcuate lines following BFFR were lower than those following SRR, but higher at the posterior spinal rod construct. The different modes of strain distribution reflected different patient's parameter-related conditions. FRR model showed the highest strains at all sites because of the lack of an anterior bracing frame. Conclusions: The findings of this investigation suggest that both anterior bracing frame and the four-rods load dispersion provide significant load sharing. Additionally, these two constructs decrease the peak strains at bone-implant interface, thus determining the theoretical surgical technique to achieve optimal stress dispersion and balance for spinopelvic reconstruction in early postoperative period following total sacrectomy.	[Yu, Yan; Zhu, Rui; Zeng, Zhi-Li; Jia, Yong-Wei; Wu, Zhou-Rui; Ren, Yi-Long; Cheng, Li-Ming] Tongji Univ, Sch Med, Dept Spine Surg, Tongji Hosp, Shanghai 200092, Peoples R China; [Zhu, Rui] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Chen, Bo; Ding, Zu-Quan] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Chen, Bo] Inst Orthopaed & Traumatol, Shanghai, Peoples R China	Tongji University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Tongji University	Cheng, LM (corresponding author), Tongji Univ, Sch Med, Dept Spine Surg, Tongji Hosp, Shanghai 200092, Peoples R China.	chlm.d@163.com	cheng, liming/GMX-4116-2022; Xiao, Hu/GMX-0258-2022	Yu, Yan/0000-0003-1120-7552; Zhu, Rui/0000-0002-9008-9875	Program for New Century Excellent Talents at the University of China [NCET-06-0375]; Program of Shanghai Subject Chief Scientist [12XD1404400]; Youth Foundation of Shanghai Health Bureau [20124Y158]	Program for New Century Excellent Talents at the University of China(Program for New Century Excellent Talents in University (NCET)); Program of Shanghai Subject Chief Scientist; Youth Foundation of Shanghai Health Bureau	This study was supported by the Program for New Century Excellent Talents at the University of China (NCET-06-0375), the Program of Shanghai Subject Chief Scientist (12XD1404400) and the Youth Foundation of Shanghai Health Bureau (20124Y158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng LM, 2011, CLIN BIOMECH, V26, P977, DOI 10.1016/j.clinbiomech.2011.06.003; Dickey ID, 2005, CLIN ORTHOP RELAT R, P42, DOI 10.1097/01.blo.0000180054.76969.41; Ghosh R, 2013, P I MECH ENG H, V227, P162, DOI 10.1177/0954411912461238; Gokaslan ZL, 1997, J NEUROSURG, V87, P781, DOI 10.3171/jns.1997.87.5.0781; Hugate RR, 2006, CLIN ORTHOP RELAT R, P82, DOI 10.1097/01.blo.0000229331.14029.44; Jackson RJ, 2000, J NEUROSURG, V92, P61, DOI 10.3171/spi.2000.92.1.0061; Kawahara N, 2003, SPINE, V28, P1567, DOI 10.1097/00007632-200307150-00017; Kelly BP, 2008, SPINE, V33, pE400, DOI 10.1097/BRS.0b013e31817615c5; King AG, 2000, J PEDIATR ORTHOPED, V20, P667, DOI 10.1097/01241398-200009000-00023; Mindea SA, 2012, SPINE, V37, pE1622, DOI 10.1097/BRS.0b013e31827619d3; Moshirfar A, 2005, J BONE JOINT SURG AM, V87A, P89, DOI 10.2106/JBJS.E.00453; Murakami Hideki, 2002, J Orthop Sci, V7, P658, DOI 10.1007/s007760200117; Nachemson A, 1970, Scand J Rehabil Med Suppl, V1, P1; Peelle MW, 2006, SPINE, V31, P2392, DOI 10.1097/01.brs.0000238973.13294.16; Shen FH, 2006, SPINE, V31, P1395, DOI 10.1097/01.brs.0000219527.64180.95; Spiegel DA, 1999, J BONE JOINT SURG AM, V81A, P848, DOI 10.2106/00004623-199906000-00012; Wood KB, 1996, SPINE, V21, P1185, DOI 10.1097/00007632-199605150-00010; Yu BS, 2010, CLIN BIOMECH, V25, P867, DOI 10.1016/j.clinbiomech.2010.06.012; Yu BS, 2010, EUR SPINE J, V19, P1121, DOI 10.1007/s00586-010-1343-8; Zhou Y, 2013, INT ORTHOP, V37, P653, DOI 10.1007/s00264-012-1756-6; Zhu R, 2012, CLIN BIOMECH, V27, P771, DOI 10.1016/j.clinbiomech.2012.05.008	21	5	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85298	10.1371/journal.pone.0085298	http://dx.doi.org/10.1371/journal.pone.0085298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454839	Green Submitted, Green Published, gold			2022-12-25	WOS:000329925800036
J	Chiba, T; Suzuki, E; Yuki, K; Zen, Y; Oshima, M; Miyagi, S; Saraya, A; Koide, S; Motoyama, T; Ogasawara, S; Ooka, Y; Tawada, A; Nakatsura, T; Hayashi, T; Yamashita, T; Kaneko, S; Miyazaki, M; Iwama, A; Yokosuka, O				Chiba, Tetsuhiro; Suzuki, Eiichiro; Yuki, Kaori; Zen, Yoh; Oshima, Motohiko; Miyagi, Satoru; Saraya, Atsunori; Koide, Shuhei; Motoyama, Tenyu; Ogasawara, Sadahisa; Ooka, Yoshihiko; Tawada, Akinobu; Nakatsura, Tetsuya; Hayashi, Takehiro; Yamashita, Taro; Kaneko, Syuichi; Miyazaki, Masaru; Iwama, Atsushi; Yokosuka, Osamu			Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners	PLOS ONE			English	Article							BREAST-CANCER CELLS; STEM-CELLS; SELF-RENEWAL; EXPRESSION; INHIBITION; GLYPICAN-3; APOPTOSIS; MARKER	Tumor-initiating cells (TICs) play a central role in tumor development, metastasis, and recurrence. In the present study, we investigated the effect of disulfiram (DSF), an inhibitor of aldehyde dehydrogenase, toward tumor-initiating hepatocellular carcinoma (HCC) cells. DSF treatment suppressed the anchorage-independent sphere formation of both HCC cells. Flow cytometric analyses showed that DSF but not 5-fluorouracil (5-FU) drastically reduces the number of tumor-initiating HCC cells. The sphere formation assays of epithelial cell adhesion molecule (EpCAM)(+) HCC cells co-treated with p38-specific inhibitor revealed that DSF suppresses self-renewal capability mainly through the activation of reactive oxygen species (ROS)-p38 MAPK pathway. Microarray experiments also revealed the enrichment of the gene set involved in p38 MAPK signaling in EpCAM(+) cells treated with DSF but not 5-FU. In addition, DSF appeared to downregulate Glypican 3 (GPC3) in a manner independent of ROS-p38 MAPK pathway. GPC3 was co-expressed with EpCAM in HCC cell lines and primary HCC cells and GPC3-knockdown reduced the number of EpCAM(+) cells by compromising their self-renewal capability and inducing the apoptosis. These results indicate that DSF impaired the tumorigenicity of tumor-initiating HCC cells through activation of ROS-p38 pathway and in part through the downregulation of GPC3. DSF might be a promising therapeutic agent for the eradication of tumor-initiating HCC cells.	[Chiba, Tetsuhiro; Suzuki, Eiichiro; Yuki, Kaori; Motoyama, Tenyu; Ogasawara, Sadahisa; Ooka, Yoshihiko; Tawada, Akinobu; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; [Chiba, Tetsuhiro; Suzuki, Eiichiro; Yuki, Kaori; Oshima, Motohiko; Miyagi, Satoru; Saraya, Atsunori; Koide, Shuhei; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan; [Zen, Yoh] Kings Coll Hosp London, Inst Liver Studies, London SE5 8RX, England; [Nakatsura, Tetsuya] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Canc Immunotherapy, Kashiwa, Chiba, Japan; [Hayashi, Takehiro; Yamashita, Taro; Kaneko, Syuichi] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Miyazaki, Masaru] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chiba, Japan	Chiba University; Chiba University; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; National Cancer Center - Japan; Kanazawa University; Chiba University	Chiba, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	techiba@faculty.chiba-u.jp	Ogasawara, Sadahisa/GRF-7061-2022	Ogasawara, Sadahisa/0000-0002-6540-9064; Koide, Shuhei/0000-0001-8599-6115	Global COE program (Global Center for Education and Research in Immune System Regulation and Treatment) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST); Foundation for the Promotion of Cancer Research; Grants-in-Aid for Scientific Research [25460977] Funding Source: KAKEN	Global COE program (Global Center for Education and Research in Immune System Regulation and Treatment) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Foundation for the Promotion of Cancer Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants for the Global COE program (Global Center for Education and Research in Immune System Regulation and Treatment) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.jsps.go.jp/j-globalcoe/); grants from Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST)(http://www.jst.go.jp/kisoken/crest/); and the Foundation for the Promotion of Cancer Research (http://www.fpcr.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Cen DZ, 2002, MOL CANCER THER, V1, P197; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dolle L, 2012, HEPATOLOGY, V55, P540, DOI 10.1002/hep.24693; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grozdanov PN, 2006, LAB INVEST, V86, P1272, DOI 10.1038/labinvest.3700479; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Ji JF, 2012, SEMIN ONCOL, V39, P461, DOI 10.1053/j.seminoncol.2012.05.011; JOHANSSON B, 1992, ACTA PSYCHIAT SCAND, V86, P15, DOI 10.1111/j.1600-0447.1992.tb03310.x; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Liu P, 2012, BRIT J CANCER, V107, P1488, DOI 10.1038/bjc.2012.442; Liu SY, 2012, BIOCHEM BIOPH RES CO, V419, P656, DOI 10.1016/j.bbrc.2012.02.069; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Midorikawa Y, 2003, INT J CANCER, V103, P455, DOI 10.1002/ijc.10856; Moreb JS, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-87; Rountree CB, 2012, HEPATOLOGY, V55, P298, DOI 10.1002/hep.24762; Sawada Y, 2012, CLIN CANCER RES, V18, P3686, DOI 10.1158/1078-0432.CCR-11-3044; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki E, 2012, HEPATOL RES, V42, P1100, DOI 10.1111/j.1872-034X.2012.01028.x; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang WG, 2003, INT J CANCER, V104, P504, DOI 10.1002/ijc.10972; Wong DJ, 2008, CANCER RES, V68, P369, DOI 10.1158/0008-5472.CAN-07-0382; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yip NC, 2011, BRIT J CANCER, V104, P1564, DOI 10.1038/bjc.2011.126; Zhang HJ, 2010, CANCER RES, V70, P3996, DOI 10.1158/0008-5472.CAN-09-3752	32	54	56	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84807	10.1371/journal.pone.0084807	http://dx.doi.org/10.1371/journal.pone.0084807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454751	Green Published, gold, Green Submitted			2022-12-25	WOS:000329922500022
J	Mendoza, Y; Bello, G; Mewa, JC; Martinez, AA; Gonzalez, C; Garcia-Morales, C; Avila-Rios, S; Reyes-Teran, G; Pascale, JM				Mendoza, Yaxelis; Bello, Gonzalo; Castillo Mewa, Juan; Martinez, Alexander A.; Gonzalez, Claudia; Garcia-Morales, Claudia; Avila-Rios, Santiago; Reyes-Teran, Gustavo; Pascale, Juan M.			Molecular Epidemiology of HIV-1 in Panama: Origin of Non-B Subtypes in Samples Collected from 2007 to 2013	PLOS ONE			English	Article							ANTIRETROVIRAL DRUG-RESISTANCE; CIRCULATING RECOMBINANT FORMS; GENOTYPING SYSTEM; GENETIC DIVERSITY; IDENTIFICATION; SURVEILLANCE; PERFORMANCE; PREVALENCE; INFECTION; SEQUENCES	Phylogenetic studies have suggested that the HIV-1 epidemic in the Americas is mainly dominated by HIV subtype B. However, countries of South America and the Caribbean have recently reported changes in their circulating HIV-1 genetic profiles. The aim of this study was to characterize the molecular profile of the HIV-1 epidemic in Panama by the analysis of 655 polymerase gene (pol) sequences that were obtained from HIV-infected Panamanians diagnosed between 1987 and 2013. Blood samples were collected from recently infected, antiretroviral drug-naive and treatment-experienced subjects since mid-2007 to 2013. Viral RNA from plasma was extracted and sequences of HIV protease and reverse transcriptase genes were obtained. Bootscanning and phylogenetic methods were used for HIV subtyping and to trace the putative origin of non-B subtype strains. Our results showed that HIV-1 infections in Panama are dominated by subtype B (98.9%). The remaining 1.1% is represented by a diverse collection of recombinant variants including: three URFs_BC, one CRF20_BG, and one CRF28/29_BF, in addition to one subtype F1 and one subtype C, none of which were previously reported in Panama. The non-B subtype variants detected in Panama were probably introduced from Brazil (subtype F1 and CRF28/29_BF), Cuba (CRF20_BG), Dominican Republic (URFs_BC) and India (subtype C). Panama is the geographical vertex that connects the North with South America and the Caribbean through trade and cultural relations, which may explain the observed introductions of non-B subtype HIV-1 variants from both the Caribbean and South America into this Central American country.	[Mendoza, Yaxelis; Castillo Mewa, Juan; Martinez, Alexander A.; Gonzalez, Claudia; Pascale, Juan M.] Gorgas Mem Inst Hlth Studies, Dept Genom & Prote, Panama City, Panama; [Mendoza, Yaxelis; Martinez, Alexander A.] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur City, Andhra Pradesh, India; [Mendoza, Yaxelis] Univ Panama, Dept Genet & Mol Biol, Panama City, Panama; [Mendoza, Yaxelis; Martinez, Alexander A.] INDICASAT AIP, Panama City, Panama; [Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil; [Garcia-Morales, Claudia; Avila-Rios, Santiago; Reyes-Teran, Gustavo] Inst Nacl Enfermedades Resp, Ctr Invest Enfermedades Infecciosas, Mexico City, DF, Mexico	Instituto Conmemorativo Gorgas de Estudios de la Salud; Acharya Nagarjuna University; Universidad de Panama; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Fundacao Oswaldo Cruz	Mendoza, Y (corresponding author), Gorgas Mem Inst Hlth Studies, Dept Genom & Prote, Panama City, Panama.	yaxelis_mendoza@yahoo.com	Avila-Rios, Santiago/AAB-4383-2020; Bentancor, Gonzalo Jose Bello/N-7377-2019; Martínez, Alexander/HHC-2101-2022; Martinez, Alexander A/F-9601-2012; Bello, Gonzalo/E-6842-2013	Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Martinez, Alexander A/0000-0002-7816-3040; Reyes-Teran, Gustavo/0000-0002-4115-4888; Gonzalez, Claudia/0000-0002-0055-9758	Department of Genomics and Proteomics (ICGES); Ministry of Health (Panama); International Atomic Energy Agency (IAEA) [PAN-6011]; Secretaria Nacional de Ciencia y Tecnologia (SENACYT); Instituto para la Formacion de Recursos Humanos (IFARHU)	Department of Genomics and Proteomics (ICGES); Ministry of Health (Panama); International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Secretaria Nacional de Ciencia y Tecnologia (SENACYT); Instituto para la Formacion de Recursos Humanos (IFARHU)	The project was supported in part by Department of Genomics and Proteomics (ICGES) and the Ministry of Health (Panama) and Project PAN-6011 from the International Atomic Energy Agency (IAEA). YM was funded by a fellowship from Secretaria Nacional de Ciencia y Tecnologia (SENACYT) and Instituto para la Formacion de Recursos Humanos (IFARHU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada-Ruiz S, 2008, AIDS RES HUM RETROV, V24, P1461, DOI 10.1089/aid.2008.0153; Ahumada-Ruiz S, 2009, INFECT GENET EVOL, V9, P933, DOI 10.1016/j.meegid.2009.06.013; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2011, B EST 2010 MIN SAL, P113; [Anonymous], 2012, MOV INT PAS EST PAN; [Anonymous], 2012, B EST 2002 2011 RES; [Anonymous], 2000, GACETA OFICIAL, V23, P964; [Anonymous], 2010, EST PROYECC POBL TOT; Bello G, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/154945; Bongertz V, 2000, J ACQ IMMUN DEF SYND, V23, P184; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Carr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002; CARR JK, 1998, REFERENCE SEQUENCES; Castillero JR, 2011, DIAGNOSTICO REDES RE; Castillo J, 2011, REV PANAM SALUD PUBL, V30, P649, DOI 10.1590/S1020-49892011001200025; De Mendoza C, 2009, AIDS RES HUM RETROV, V25, P967, DOI 10.1089/aid.2008.0166; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1; de Sa DJ, 2008, AIDS RES HUM RETROV, V24, P347, DOI 10.1089/aid.2007.0203; Geretti AM, 2006, CURR OPIN INFECT DIS, V19, P1, DOI 10.1097/01.qco.0000200293.45532.68; Gonzalez-Alba JM, 2011, J VIROL, V85, P10755, DOI 10.1128/JVI.00454-11; Guerrero Delgado G A, 1994, Rev Med Panama, V19, P186; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hakre S, 2013, SEX TRANSM INFECT, V89, P156, DOI 10.1136/sextrans-2012-050557; Hemelaar J, 2012, TRENDS MOL MED, V18, P182, DOI 10.1016/j.molmed.2011.12.001; Holguin A, 2008, J CLIN MICROBIOL, V46, P2918, DOI 10.1128/JCM.02414-07; Kouri V, 2012, J CLIN VIROL, V55, P348, DOI 10.1016/j.jcv.2012.08.019; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Machado LY, 2012, AIDS RES HUM RETROV, V28, P956, DOI [10.1089/aid.2011.0295, 10.1089/AID.2011.0295]; Manak M, 2012, AIDS RES HUM RETROV, V28, P594, DOI [10.1089/aid.2011.0271, 10.1089/AID.2011.0271]; Martinez H, 2012, INFORM NACL PROGRESO; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Ministry of Education and Culture, 2009, PRACT GUID MEAS ENH; Nadai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004814; Neogi U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039819; NOWAK MA, 1990, AIDS, V4, P1095, DOI 10.1097/00002030-199011000-00007; Perez L, 2013, INFECT GENET EVOL, V16, P144, DOI 10.1016/j.meegid.2013.02.002; Ratha D, 2011, MIGRATION REMITTANCE; REEVES WC, 1988, AM J TROP MED HYG, V39, P398; Salustiano Cavalcanti AM, 2007, MEM I OSWALDO CRUZ, V102, P785, DOI 10.1590/S0074-02762007005000109; Cavalcanti AMS, 2012, MEM I OSWALDO CRUZ, V107, P450, DOI 10.1590/S0074-02762012000400002; Shen CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025956; Sierra M, 2007, JAIDS-J ACQ IMM DEF, V45, P151, DOI 10.1097/QAI.0b013e318046ea47; Sierra Maria, 2005, Infection Genetics and Evolution, V5, P209, DOI 10.1016/j.meegid.2004.07.010; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; Smyth RP, 2012, VIRUS RES, V169, P415, DOI 10.1016/j.virusres.2012.06.015; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor-Castillo L, 2010, REV PANAM SALUD PUBL, V27, P23, DOI 10.1590/S1020-49892010000100004; Teixeira SLM, 2004, J CLIN VIROL, V31, P221, DOI 10.1016/j.jcv.2004.03.016; Teva I, 2012, REV MED CHILE, V140, P50, DOI /S0034-98872012000100007; Thiam M, 2013, J VIROL METHODS, V188, P97, DOI 10.1016/j.jviromet.2012.11.044; Thomson MM, 2005, AIDS REV, V7, P210; Tupinambas U, 2013, MEM I OSWALDO CRUZ, V108, P470, DOI 10.1590/S0074-0276108042013012; United Nations Programme on HIV/AIDS (UNAIDS), 2012, GLOB REP REP GLOB AI	54	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85153	10.1371/journal.pone.0085153	http://dx.doi.org/10.1371/journal.pone.0085153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454808	Green Submitted, gold, Green Published			2022-12-25	WOS:000329922500045
J	McKay, PF; Cope, AV; Mann, JFS; Joseph, S; Esteban, M; Tatoud, R; Carter, D; Reed, SG; Weber, J; Shattock, RJ				McKay, Paul F.; Cope, Alethea V.; Mann, Jamie F. S.; Joseph, Sarah; Esteban, Mariano; Tatoud, Roger; Carter, Darrick; Reed, Steven G.; Weber, Jonathan; Shattock, Robin J.			Glucopyranosyl Lipid A Adjuvant Significantly Enhances HIV Specific T and B Cell Responses Elicited by a DNA-MVA-Protein Vaccine Regimen	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN DENDRITIC CELLS; IMMUNE-RESPONSES; CLADE-C; NEUTRALIZING ANTIBODIES; LYMPHOCYTE RESPONSES; GENETIC-VARIATION; RHESUS-MONKEYS; GAG; IMMUNOGENICITY	Using a unique vaccine antigen matched and single HIV Clade C approach we have assessed the immunogenicity of a DNA-poxvirus-protein strategy in mice and rabbits, administering MVA and protein immunizations either sequentially or simultaneously and in the presence of a novel TLR4 adjuvant, GLA-AF. Mice were vaccinated with combinations of HIV env/gag-pol-nef plasmid DNA followed by MVA-C (HIV env/gag-pol-nef) with HIV CN54gp140 protein (+/2GLA-AF adjuvant) and either co-administered in different muscles of the same animal with MVA-C or given sequentially at 3-week intervals. The DNA prime established a population of B cells that were able to mount a statistically significant anamnestic response to the boost vaccines. The greatest antigen-specific antibody response was observed in animals that received all vaccine components. Moreover, a high proportion of the total mucosal IgG (20 - 50%) present in the vaginal vault of these vaccinated animals was vaccine antigen-specific. The potent elicitation of antigen-specific immune responses to this vaccine modality was also confirmed in rabbits. Importantly, co-administration of MVA-C with the GLA-AF adjuvanted HIV CN54gp140 protein significantly augmented the antigen-specific T cell responses to the Gag antigen, a transgene product expressed by the MVA-C vector in a separate quadriceps muscle. We have demonstrated that co-administration of MVA and GLA-AF adjuvanted HIV CN54gp140 protein was equally effective in the generation of humoral responses as a sequential vaccination modality thus shortening and simplifying the immunization schedule. In addition, a significant further benefit of the condensed vaccination regime was that T cell responses to proteins expressed by the MVA-C were potently enhanced, an effect that was likely due to enhanced immunostimulation in the presence of systemic GLA-AF.	[McKay, Paul F.; Cope, Alethea V.; Mann, Jamie F. S.; Tatoud, Roger; Weber, Jonathan; Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, Div Med, London, England; [Joseph, Sarah] MRC, Clin Trials Unit, London, England; [Esteban, Mariano] CSIC, Dept Mol & Cellular Biol, Ctr Nacl Biotecnol, Madrid, Spain; [Carter, Darrick; Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA	Imperial College London; Medical Research Council Clinical Trials Unit; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	McKay, PF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, Div Med, Norfolk Pl, London, England.	p.mckay@imperial.ac.uk	Esteban, Mariano/ABG-5375-2020; Carter, Darrick/N-3304-2016	Esteban, Mariano/0000-0003-0846-2827; TATOUD, Roger/0000-0002-3999-8264; McKay, Paul/0000-0001-5195-6254; Tatoud, Roger/0000-0002-2394-6435; Mann, Jamie/0000-0001-7037-1286; Carter, Darrick/0000-0001-5901-3402	Wellcome Trust; Dormeur Investment Service Ltd; Sir Joseph Hotung Trust Fellowship; Medical Research Council [MC_U122861400, G1001784] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10313] Funding Source: researchfish; MRC [MC_U122861400, G1001784] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Dormeur Investment Service Ltd; Sir Joseph Hotung Trust Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was funded by a grant to the UK HIV Vaccine Consortium (UK HVC) by the Wellcome Trust. The authors gratefully acknowledge Dormeur Investment Service Ltd for providing funds to purchase equipment used in these studies. PMK was supported by a Sir Joseph Hotung Trust Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alving CR, 2012, CURR OPIN IMMUNOL, V24, P310, DOI 10.1016/j.coi.2012.03.008; Amara RR, 2002, J VIROL, V76, P6138, DOI 10.1128/JVI.76.12.6138-6146.2002; Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; Arias MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041144; Asmuth DM, 2010, J INFECT DIS, V201, P132, DOI 10.1086/648591; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005; Barouch DH, 2003, J VIROL, V77, P8729, DOI 10.1128/JVI.77.16.8729-8735.2003; Barouch DH, 2001, J VIROL, V75, P2462, DOI 10.1128/JVI.75.5.2462-2467.2001; Bielinska AU, 2008, AIDS RES HUM RETROV, V24, P271, DOI 10.1089/aid.2007.0148; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Brave A, 2007, VACCINE, V25, P6882, DOI 10.1016/j.vaccine.2007.07.012; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Chahroudi A, 2006, J VIROL, V80, P8469, DOI 10.1128/JVI.02749-05; Chen H, 2008, J GEN VIROL, V89, P2597, DOI 10.1099/vir.0.2008/003491-0; Cox KS, 2008, J VIROL, V82, P8161, DOI 10.1128/JVI.00620-08; Cranage MP, 2010, MUCOSAL IMMUNOL, V3, P57, DOI 10.1038/mi.2009.110; DA'Dara AA, 2003, PARASITE IMMUNOL, V25, P429, DOI 10.1111/j.1365-3024.2003.00651.x; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Gomez CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035485; Falivene J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032220; Ferraro B, 2011, HUM VACCINES, V7, P120, DOI 10.4161/hv.7.0.14574; Fox CB, 2012, CLIN VACCINE IMMUNOL, V19, P1633, DOI 10.1128/CVI.00235-12; Gomes R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001610; HAHN BH, 1986, SCIENCE, V232, P1548, DOI 10.1126/science.3012778; Hallengard D, 2012, VIRAL IMMUNOL, V25, P423, DOI 10.1089/vim.2012.0046; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Hurwitz Julia L, 2007, J Pediatr Pharmacol Ther, V12, P68, DOI 10.5863/1551-6776-12.2.68; Jalah R, 2012, HUM VACCIN IMMUNOTHE, V8; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Kastenmuller W, 2006, VIROLOGY, V350, P276, DOI 10.1016/j.virol.2006.02.039; Khawaja G, 2012, VIROLOGY, V425, P61, DOI 10.1016/j.virol.2012.01.001; Krashias G, 2010, VACCINE, V28, P2482, DOI 10.1016/j.vaccine.2010.01.046; Lambert SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051618; Lu S, 2008, EXPERT REV VACCINES, V7, P175, DOI 10.1586/14760584.7.2.175; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Mann JFS, 2012, J CONTROL RELEASE, V158, P240, DOI 10.1016/j.jconrel.2011.11.009; Mann JFS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067412; Mansky LM, 1998, J GEN VIROL, V79, P1337, DOI 10.1099/0022-1317-79-6-1337; McKay PF, 2004, EUR J IMMUNOL, V34, P1011, DOI 10.1002/eji.200324840; Montefiori DC, 2001, J VIROL, V75, P5879, DOI 10.1128/JVI.75.13.5879-5890.2001; Otero M, 2004, VACCINE, V22, P1782, DOI 10.1016/j.vaccine.2004.01.037; Park Su-Hyung, 2010, Immune Netw, V10, P198, DOI 10.4110/in.2010.10.6.198; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Santra S, 2002, J VIROL, V76, P6376, DOI 10.1128/JVI.76.12.6376-6381.2002; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Thorner AR, 2006, J VIROL, V80, P12009, DOI 10.1128/JVI.01749-06; Wu L, 2005, J VIROL, V79, P8024, DOI 10.1128/JVI.79.13.8024-8031.2005; Xiao L, 2012, VACCINE, V30, P2570, DOI 10.1016/j.vaccine.2012.01.074; Yang ZY, 2003, J VIROL, V77, P799, DOI 10.1128/JVI.77.1.799-803.2003; Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109	55	31	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e84707	10.1371/journal.pone.0084707	http://dx.doi.org/10.1371/journal.pone.0084707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24465426	gold, Green Published, Green Submitted			2022-12-25	WOS:000330288000005
J	Bassett, IV; Govindasamy, D; Erlwanger, AS; Hyle, EP; Kranzer, K; van Schaik, N; Noubary, F; Paltiel, AD; Wood, R; Walensky, RP; Losina, E; Bekker, LG; Freedberg, KA				Bassett, Ingrid V.; Govindasamy, Darshini; Erlwanger, Alison S.; Hyle, Emily P.; Kranzer, Katharina; van Schaik, Nienke; Noubary, Farzad; Paltiel, A. David; Wood, Robin; Walensky, Rochelle P.; Losina, Elena; Bekker, Linda-Gail; Freedberg, Kenneth A.			Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY PROGRAMS; RESOURCE-POOR SETTINGS; CARE; METAANALYSIS; PROPHYLAXIS; PREVENTION; MORTALITY; COUNTRIES; EFFICACY; ROUTINE	Background: Mobile HIV screening may facilitate early HIV diagnosis. Our objective was to examine the cost-effectiveness of adding a mobile screening unit to current medical facility-based HIV testing in Cape Town, South Africa. Methods and Findings: We used the Cost Effectiveness of Preventing AIDS Complications International (CEPAC-I) computer simulation model to evaluate two HIV screening strategies in Cape Town: 1) medical facility-based testing (the current standard of care) and 2) addition of a mobile HIV-testing unit intervention in the same community. Baseline input parameters were derived from a Cape Town-based mobile unit that tested 18,870 individuals over 2 years: prevalence of previously undiagnosed HIV (6.6%), mean CD4 count at diagnosis (males 423/mL, females 516/mL), CD4 count-dependent linkage to care rates (males 31%-58%, females 49%-58%), mobile unit intervention cost (includes acquisition, operation and HIV test costs, $29.30 per negative result and $31.30 per positive result). We conducted extensive sensitivity analyses to evaluate input uncertainty. Model outcomes included site of HIV diagnosis, life expectancy, medical costs, and the incremental cost-effectiveness ratio (ICER) of the intervention compared to medical facility-based testing. We considered the intervention to be "very cost-effective" when the ICER was less than South Africa's annual per capita Gross Domestic Product (GDP) ($8,200 in 2012). We projected that, with medical facility-based testing, the discounted (undiscounted) HIV-infected population life expectancy was 132.2 (197.7) months; this increased to 140.7 (211.7) months with the addition of the mobile unit. The ICER for the mobile unit was $2,400/year of life saved (YLS). Results were most sensitive to the previously undiagnosed HIV prevalence, linkage to care rates, and frequency of HIV testing at medical facilities. Conclusion: The addition of mobile HIV screening to current testing programs can improve survival and be very cost-effective in South Africa and other resource-limited settings, and should be a priority.	[Bassett, Ingrid V.; Hyle, Emily P.; Walensky, Rochelle P.; Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Bassett, Ingrid V.; Erlwanger, Alison S.; Hyle, Emily P.; Walensky, Rochelle P.; Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Bassett, Ingrid V.; Erlwanger, Alison S.; Hyle, Emily P.; Walensky, Rochelle P.; Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Bassett, Ingrid V.; Walensky, Rochelle P.; Losina, Elena; Freedberg, Kenneth A.] Harvard Univ, Ctr AIDS Res CFAR, Boston, MA 02115 USA; [Govindasamy, Darshini; van Schaik, Nienke; Wood, Robin; Bekker, Linda-Gail] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Kranzer, Katharina] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Noubary, Farzad] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Noubary, Farzad] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Paltiel, A. David] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Wood, Robin] Univ Cape Town, Dept Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Losina, Elena; Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Losina, Elena; Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; Tufts Medical Center; Tufts University; Yale University; University of Cape Town; Harvard University; Brigham & Women's Hospital; Boston University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Bassett, IV (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	ibassett@partners.org	Kranzer, Katharina/O-8845-2014; Bekker, Linda-Gail/AAZ-8929-2020; Bassett, Ingrid V./ABI-7674-2020	Kranzer, Katharina/0000-0001-5691-7270; Bassett, Ingrid V./0000-0001-6920-6080; Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Paltiel, A. David/0000-0002-4861-3290	National Institute of Allergy and Infectious Disease [R01 AI058736, T32 AI007433]; Harvard University Center for AIDS Research [P30 AI060354]; National Institute of Mental Health [R01 MH090326, R01 MH073445]; President's Emergency Plan for AIDS Relief (PEPFAR); Claflin Distinguished Scholar Award; PEPFAR through the Anova Health Institute; United States Agency for International Development program; Agence Francaise de Developpement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093269, T32AI007433, U01AI069519, R01AI058736, P30AI060354, UM1AI069519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294, R01MH090326, R01MH073445] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard University Center for AIDS Research; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Claflin Distinguished Scholar Award; PEPFAR through the Anova Health Institute; United States Agency for International Development program(United States Agency for International Development (USAID)); Agence Francaise de Developpement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by: the National Institute of Allergy and Infectious Disease: R01 AI058736, T32 AI007433; the Harvard University Center for AIDS Research P30 AI060354; the National Institute of Mental Health: R01 MH090326, R01 MH073445; the President's Emergency Plan for AIDS Relief (PEPFAR); and the Claflin Distinguished Scholar Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The mobile testing unit was partially funded by PEPFAR through the Anova Health Institute and the United States Agency for International Development program and received further funding through the Agence Francaise de Developpement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2013, AIDS CARE, V25, P85, DOI 10.1080/09540121.2012.686597; [Anonymous], 2012, NATL TREASURY REPUBL; [Anonymous], 2012, REPUBLIC S AFRICA GL; [Anonymous], 2012, W CAPE BUDGET OVERVI; Babigumira JB, 2009, PHARMACOECONOMICS, V27, P963, DOI 10.2165/11318230-000000000-00000; Bassett IV, 2007, JAIDS-J ACQ IMM DEF, V46, P181, DOI 10.1097/QAI.0b013e31814277c8; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Ciaranello AL, 2011, AIDS, V25, P479, DOI 10.1097/QAD.0b013e3283428cbe; CLEARY S, 2004, COST EFFECTIVENESS A; Cleary S, 2005, S AFRICAN HLTH REV; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Freedberg KA, 2007, AIDS, V21, pS117, DOI 10.1097/01.aids.0000279714.60935.a2; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Govindasamy D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080017; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hammond R, 2008, INT J STD AIDS, V19, P291, DOI 10.1258/ijsa.2007.007248; Hoerger TJ, 2004, ANN INTERN MED, V140, P689, DOI 10.7326/0003-4819-140-9-200405040-00008; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; IMF, 2012, INT MON FUND WORLD E; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Johnson M, 2005, AIDS, V19, P685, DOI 10.1097/01.aids.0000166091.39317.99; Larson BA, 2010, B WORLD HEALTH ORGAN, V88, P675, DOI 10.2471/BLT.09.068981; Lyamuya EF, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-19; Maheswaran H, 2012, JAIDS-J ACQ IMM DEF, V59, pE43, DOI 10.1097/QAI.0b013e3182414ed7; Matsoso MP, 2012, LETT REACCELERATING; Mauskopf JA, 2007, VALUE HEALTH, V10, P336, DOI 10.1111/j.1524-4733.2007.00187.x; Medecins Sans Frontieres, 2004, MED SANS FRONTIERS K; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; Ostermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016488; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; *SANAC, 2010, S AFR ANT TREATM GUI; SANAC, 2010, S AFR NAT DEP HLTH C; SANAC National Strategic Plan on HIV, STIS TB 2012 2016; Seyler C, 2003, ANTIVIR THER, V8, P385; Shisana O, 2009, S AFRICAN NATL HIV P; Statistics South Africa, 2011, MID POP EST 2011; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; The Clinton Foundation HIV/AIDS Initiative, 2012, ANT PRIC LIST; Tuboi SH, 2007, JAIDS-J ACQ IMM DEF, V45, P52, DOI 10.1097/QAI.0b013e318042e1c3; UNAIDS HIV and AIDS Estimates, 2009, UNAIDS HIV AIDS ESTI; van Rooyen H, 2012, AIDS BEHAV, V11; van Schaik N, 2010, SAMJ S AFR MED J, V100, P671, DOI 10.7196/SAMJ.4162; Venkatesh KK, 2010, FUTURE VIROL, V5, P405, DOI 10.2217/FVL.10.38; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Walensky RP, 2011, JAIDS-J ACQ IMM DEF, V56, P26, DOI 10.1097/QAI.0b013e3181fb8f24; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; World Health Organization, 2012, CHOOSING INT AR COST; Wright JC, 1998, NEW ENGL J MED, V339, P380, DOI 10.1056/NEJM199808063390606; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6	58	41	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85197	10.1371/journal.pone.0085197	http://dx.doi.org/10.1371/journal.pone.0085197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465503	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000330283100025
J	Carbonero, F; Oakley, BB; Purdy, KJ				Carbonero, Franck; Oakley, Brian B.; Purdy, Kevin J.			Metabolic Flexibility as a Major Predictor of Spatial Distribution in Microbial Communities	PLOS ONE			English	Article							ESTUARINE GRADIENT; ECOLOGICAL SPECIALIZATION; GENOTYPIC DISTRIBUTION; BACTERIAL COMMUNITIES; MODEL MICROORGANISM; SULFATE REDUCTION; ORGANIC-MATTER; RIBOSOMAL-RNA; UK ESTUARY; DIVERSITY	A better understand the ecology of microbes and their role in the global ecosystem could be achieved if traditional ecological theories can be applied to microbes. In ecology organisms are defined as specialists or generalists according to the breadth of their niche. Spatial distribution is often used as a proxy measure of niche breadth; generalists have broad niches and a wide spatial distribution and specialists a narrow niche and spatial distribution. Previous studies suggest that microbial distribution patterns are contrary to this idea; a microbial generalist genus (Desulfobulbus) has a limited spatial distribution while a specialist genus (Methanosaeta) has a cosmopolitan distribution. Therefore, we hypothesise that this counter-intuitive distribution within generalist and specialist microbial genera is a common microbial characteristic. Using molecular fingerprinting the distribution of four microbial genera, two generalists, Desulfobulbus and the methanogenic archaea Methanosarcina, and two specialists, Methanosaeta and the sulfate-reducing bacteria Desulfobacter were analysed in sediment samples from along a UK estuary. Detected genotypes of both generalist genera showed a distinct spatial distribution, significantly correlated with geographic distance between sites. Genotypes of both specialist genera showed no significant differential spatial distribution. These data support the hypothesis that the spatial distribution of specialist and generalist microbes does not match that seen with specialist and generalist large organisms. It may be that generalist microbes, while having a wider potential niche, are constrained, possibly by intrageneric competition, to exploit only a small part of that potential niche while specialists, with far fewer constraints to their niche, are more capable of filling their potential niche more effectively, perhaps by avoiding intrageneric competition. We suggest that these counter-intuitive distribution patterns may be a common feature of microbes in general and represent a distinct microbial principle in ecology, which is a real challenge if we are to develop a truly inclusive ecology.	[Carbonero, Franck; Oakley, Brian B.; Purdy, Kevin J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Carbonero, Franck] Univ Arkansas, Dept Food Sci, Fayetteville, AR 72703 USA; [Oakley, Brian B.] ARS, USDA, Richard B Russell Res Ctr, Athens, GA USA	University of Warwick; University of Arkansas System; University of Arkansas Fayetteville; United States Department of Agriculture (USDA)	Purdy, KJ (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	k.purdy@warwick.ac.uk	Carbonero, Franck/L-2292-2019; Oakley, Brian Oakley B/AAG-4015-2019; Carbonero, Franck/AAF-9523-2019; Purdy, Kevin/A-1900-2009	Carbonero, Franck/0000-0003-3389-3725; Purdy, Kevin/0000-0002-2997-9342; Oakley, Brian/0000-0003-2098-6439	EU Commission [MEXT-CT-2005-024112]; NERC [NE/J024503/1] Funding Source: UKRI; Natural Environment Research Council [NE/J024503/1] Funding Source: researchfish	EU Commission(European CommissionEuropean Commission Joint Research Centre); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was performed as part of an EU Commission funded Marie Curie Excellence Grant for Teams, MicroComXT (MEXT-CT-2005-024112) to KJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Begon M., 1996, ECOLOGY; Boone DR, 2001, BERGEYS MANUAL SYSTE, P269; Brenner D. J., 2005, BERGEYS MANUAL SYSTE, Vtwo, P961; Carbonero F, 2012, MICROB ECOL, V63, P856, DOI 10.1007/s00248-011-9993-6; Cermeno P, 2009, SCIENCE, V325, P1539, DOI 10.1126/science.1174159; Cohan FM, 2006, PHILOS T R SOC B, V361, P1985, DOI 10.1098/rstb.2006.1918; Colles A, 2009, ECOL LETT, V12, P849, DOI 10.1111/j.1461-0248.2009.01336.x; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Curtis TP, 2004, CURR OPIN MICROBIOL, V7, P221, DOI 10.1016/j.mib.2004.04.010; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fitzsimons MF, 2001, ENVIRON EXP BOT, V46, P225, DOI 10.1016/S0098-8472(01)00102-2; Flynn AM, 2008, J COASTAL RES, P76, DOI 10.2112/SI55-010.1; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gaston KJ, 2001, GLOBAL ECOL BIOGEOGR, V10, P179, DOI 10.1046/j.1466-822x.2001.00225.x; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Hawkins RJ, 2007, FEMS MICROBIOL ECOL, V62, P187, DOI 10.1111/j.1574-6941.2007.00376.x; JORGENSEN BB, 1977, MAR BIOL, V41, P7, DOI 10.1007/BF00390576; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kuever J, 2005, BERGEYS MANUAL SYSTE, V2, P988; LAANBROEK HJ, 1982, ARCH MICROBIOL, V133, P178, DOI 10.1007/BF00414998; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; MANTEL N, 1980, AM J EPIDEMIOL, V112, P129, DOI 10.1093/oxfordjournals.aje.a112962; Nedwell DB, 2004, AQUAT MICROB ECOL, V37, P209, DOI 10.3354/ame037209; Oakley BB, 2012, ISME J, V6, P905, DOI 10.1038/ismej.2011.165; Oakley BB, 2011, FEMS MICROBIOL ECOL, V77, P17, DOI 10.1111/j.1574-6941.2011.01079.x; Oakley BB, 2010, ISME J, V4, P488, DOI 10.1038/ismej.2009.146; Patel GB, 2001, BERGEYS MANUAL SYSTE, P289; Philippot L, 2010, NAT REV MICROBIOL, V8, P523, DOI 10.1038/nrmicro2367; Poisot T, 2011, ECOL LETT, V14, P841, DOI 10.1111/j.1461-0248.2011.01645.x; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Purdy KJ, 2005, METHOD ENZYMOL, V397, P271, DOI 10.1016/S0076-6879(05)97016-X; Purdy KJ, 1996, APPL ENVIRON MICROB, V62, P3905, DOI 10.1128/AEM.62.10.3905-3907.1996; Purdy KJ, 2003, FEMS MICROBIOL ECOL, V44, P361, DOI 10.1016/S0168-6496(03)00078-3; Purdy KJ, 2002, FEMS MICROBIOL ECOL, V39, P17, DOI 10.1111/j.1574-6941.2002.tb00902.x; Purdy KJ, 2011, ADV ECOLOG RES, V43, P88; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Silva S, 2004, ACTIVITY DIVERSITY S; SPOONER GM, 1947, J MAR BIOL ASSOC UK, V27, P1, DOI 10.1017/S0025315400014107; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x	46	34	34	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85105	10.1371/journal.pone.0085105	http://dx.doi.org/10.1371/journal.pone.0085105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465487	Green Published, Green Submitted, gold			2022-12-25	WOS:000330244500037
J	Hagmann, H; Bossung, V; Belaidi, AA; Fridman, A; Karumanchi, SA; Thadhani, R; Schermer, B; Mallmann, P; Schwarz, G; Benzing, T; Brinkkoetter, PT				Hagmann, Henning; Bossung, Verena; Belaidi, Abdel Ali; Fridman, Alexander; Karumanchi, S. Ananth; Thadhani, Ravi; Schermer, Bernhard; Mallmann, Peter; Schwarz, Guenter; Benzing, Thomas; Brinkkoetter, Paul T.			Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination	PLOS ONE			English	Article							PLACENTAL GROWTH-FACTOR; TYROSINE KINASE 1; ANGIOGENIC FACTORS; SOLUBLE ENDOGLIN; EARLY-PREGNANCY; WOMEN; RISK; PREECLAMPSIA; PERMSELECTIVITY; MACROMOLECULES	Rationale: Preeclampsia is a devastating medical complication of pregnancy which leads to maternal and fetal morbidity and mortality. While the etiology of preeclampsia is unclear, human and animal studies suggest that excessive circulating levels of soluble fms-like tyrosine-kinase-1 (sFlt-1), an alternatively spliced variant of VEGF-receptor1, contribute to the signs and symptoms of preeclampsia. Since sFlt-1 binds to heparin and heparan sulfate proteoglycans, we hypothesized that the anticoagulant heparin, which is often used in pregnancy, may interfere with the levels, distribution and elimination of sFlt-1 in vivo. Objective: We systematically determined serum and urine levels of angiogenic factors in preeclamptic women before and after administration of low molecular weight heparin and further characterized the interaction with heparin in biochemical studies. Methods and Results: Serum and urine samples were used to measure sFlt-1 levels before and after heparin administration. Serum levels of sFlt-1 increased by 25% after heparin administration in pregnant women. The magnitude of the increase in circulating sFlt-1 correlated with initial sFlt-1 serum levels. Urinary sFlt-1 levels were also elevated following heparin administration and levels of elimination were dependent on the underlying integrity of the glomerular filtration barrier. Biochemical binding studies employing cation exchange chromatography revealed that heparin bound sFlt-1 had decreased affinity to negatively charged surfaces when compared to sFlt-1 alone. Conclusion: Low molecular weight heparin administration increased circulating sFlt1 levels and enhanced renal elimination. We provide evidence that both effects may be due to heparin binding to sFlt1 and masking the positive charges on sFlt1 protein.	[Hagmann, Henning; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul T.] Univ Cologne, Div Nephrol, Dept Internal Med, D-50931 Cologne, Germany; [Hagmann, Henning; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul T.] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; [Bossung, Verena; Fridman, Alexander; Mallmann, Peter] Univ Cologne, Dept Obstet & Gynecol, D-50931 Cologne, Germany; [Belaidi, Abdel Ali; Schwarz, Guenter] Univ Cologne, Dept Biochem, D-50931 Cologne, Germany; [Karumanchi, S. Ananth] Howard Hughes Med Inst, Boston, MA 02115 USA; [Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Karumanchi, S. Ananth] Harvard Univ, Sch Med, Boston, MA USA; [Thadhani, Ravi] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Nephrol,Dept Med, Boston, MA USA	University of Cologne; University of Cologne; University of Cologne; University of Cologne; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Hagmann, H (corresponding author), Univ Cologne, Div Nephrol, Dept Internal Med, D-50931 Cologne, Germany.	henning.hagmann@uk-koeln.de	Karumanchi, Subbian Ananth/AAI-1694-2021; Schwarz, Guenter/ABE-9643-2021; Belaidi, Abdel Ali/T-7593-2017; Bossung, Verena/GOV-6766-2022; Schermer, Bernhard/E-9972-2014; Benzing, Thomas/X-5476-2019	Schwarz, Guenter/0000-0002-2118-9338; Belaidi, Abdel Ali/0000-0003-0792-8728; Bossung, Verena/0000-0001-5561-1827; Schermer, Bernhard/0000-0002-5194-9000; 	Forschungspool "Klinische Studien", Faculty of Medicine, University of Cologne; DFG [SFB 635, BR2955]	Forschungspool "Klinische Studien", Faculty of Medicine, University of Cologne; DFG(German Research Foundation (DFG))	This work was supported by Forschungspool "Klinische Studien", Faculty of Medicine, University of Cologne and by the DFG (SFB 635 to T. B. and BR2955 to P. T. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOHRER MP, 1979, J GEN PHYSIOL, V74, P583, DOI 10.1085/jgp.74.5.583; BRENNER BM, 1977, KIDNEY INT, V12, P229, DOI 10.1038/ki.1977.107; Buhimschi CS, 2005, AM J OBSTET GYNECOL, V192, P734, DOI 10.1016/j.ajog.2004.12.052; CHANG RLS, 1975, BIOPHYS J, V15, P887, DOI 10.1016/S0006-3495(75)85863-2; Conserva V, 2012, J MATERN-FETAL NEO M, V25, P1467, DOI 10.3109/14767058.2011.643326; DEEN WM, 1979, KIDNEY INT, V16, P353, DOI 10.1038/ki.1979.138; Diab AE, 2008, INT J GYNECOL OBSTET, V102, P146, DOI 10.1016/j.ijgo.2008.02.016; Dodd JM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006780.pub2; Drewlo S, 2011, J THROMB HAEMOST, V9, P2486, DOI 10.1111/j.1538-7836.2011.04526.x; Espinoza J, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.002; Hagmann H, 2012, CLIN CHEM, V58, P837, DOI 10.1373/clinchem.2011.169094; Hertig A, 2004, CLIN CHEM, V50, P1702, DOI 10.1373/clinchem.2004.036715; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kupferminc M, 2011, BLOOD COAGUL FIBRIN, V22, P123, DOI 10.1097/MBC.0b013e328343315c; Kupferminc MJ, 2011, J MATERN-FETAL NEO M, V24, P1042, DOI 10.3109/14767058.2010.545911; Kupferminc MJ, 2001, HYPERTENS PREGNANCY, V20, P35, DOI 10.1081/PRG-100104170; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2005, JAMA-J AM MED ASSOC, V293, P77, DOI 10.1001/jama.293.1.77; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Martinelli I, 2012, BLOOD, V119, P3269, DOI 10.1182/blood-2011-11-391383; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mello G, 2005, HYPERTENSION, V45, P86, DOI 10.1161/01.HYP.0000149950.05182.a3; Park M, 1999, BIOCHEM BIOPH RES CO, V264, P730, DOI 10.1006/bbrc.1999.1580; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Roberts J, 1998, LANCET, P19; Rosenberg VA, 2011, CIRCULATION, V124, P2543, DOI 10.1161/CIRCULATIONAHA.111.046821; Salahuddin S, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.010; Schiettecatte J, 2010, CLIN BIOCHEM, V43, P768, DOI 10.1016/j.clinbiochem.2010.02.010; Searle J, 2011, ARTERIOSCL THROM VAS, V31, P2972, DOI 10.1161/ATVBAHA.111.237784; Sela S, 2011, CIRC RES, V108, P1063, DOI 10.1161/CIRCRESAHA.110.239665; SIBAI BM, 1993, AM J OBSTET GYNECOL, V169, P1000, DOI 10.1016/0002-9378(93)90043-I; Simas TAM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.030; Smith GCS, 2007, OBSTET GYNECOL, V109, P1316, DOI 10.1097/01.AOG.0000265804.09161.0d; Stepan H, 2007, HYPERTENSION, V49, P818, DOI 10.1161/01.HYP.0000258404.21552.a3; Stepan H, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.052; Sunderji S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.025; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Thadhani R, 2011, CIRCULATION, V124, P940, DOI 10.1161/CIRCULATIONAHA.111.034793; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Verlohren S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.016	41	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85258	10.1371/journal.pone.0085258	http://dx.doi.org/10.1371/journal.pone.0085258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465515	Green Published, gold, Green Submitted			2022-12-25	WOS:000330244500046
J	Meng, L; Kramer, MA; Middleton, SJ; Whittington, MA; Eden, UT				Meng, Liang; Kramer, Mark A.; Middleton, Steven J.; Whittington, Miles A.; Eden, Uri T.			A Unified Approach to Linking Experimental, Statistical and Computational Analysis of Spike Train Data	PLOS ONE			English	Article							SINGLE-NEURON MODELS; SPECTRUM; CONSTRUCTION; EXCITABILITY; CONDUCTANCE; CURRENTS	A fundamental issue in neuroscience is how to identify the multiple biophysical mechanisms through which neurons generate observed patterns of spiking activity. In previous work, we proposed a method for linking observed patterns of spiking activity to specific biophysical mechanisms based on a state space modeling framework and a sequential Monte Carlo, or particle filter, estimation algorithm. We have shown, in simulation, that this approach is able to identify a space of simple biophysical models that were consistent with observed spiking data (and included the model that generated the data), but have yet to demonstrate the application of the method to identify realistic currents from real spike train data. Here, we apply the particle filter to spiking data recorded from rat layer V cortical neurons, and correctly identify the dynamics of an slow, intrinsic current. The underlying intrinsic current is successfully identified in four distinct neurons, even though the cells exhibit two distinct classes of spiking activity: regular spiking and bursting. This approach - linking statistical, computational, and experimental neuroscience - provides an effective technique to constrain detailed biophysical models to specific mechanisms consistent with observed spike train data.	[Meng, Liang; Kramer, Mark A.; Eden, Uri T.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Middleton, Steven J.; Whittington, Miles A.] York Univ, Hull York Med Sch, York, N Yorkshire, England	Boston University; University of Hull; University of York - UK	Eden, UT (corresponding author), Boston Univ, Dept Math & Stat, Boston, MA 02215 USA.	tzvi@bu.edu	Kramer, Mark/A-1291-2014	Whittington, Miles Adrian/0000-0002-0247-1362; Kramer, Mark/0000-0002-9979-7202; Middleton, Steven/0000-0001-8875-8956	National Science Foundation [IIS-06439952]; National Institute of Neurological Disorders and Stroke [R01 NS073118, R01 NS072023]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073118, R01NS072023] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Science Foundation (IIS-06439952) and from the National Institute of Neurological Disorders and Stroke (R01 NS073118) to UTE, and from the National Institute of Neurological Disorders and Stroke (R01 NS072023) to UTE and MAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHALLA US, 1993, J NEUROPHYSIOL, V69, P1948, DOI 10.1152/jn.1993.69.6.1948; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Catmull E, 1974, COMPUT AIDED GEOM D, V74, P317; Daley D. J., 2007, INTRO THEORY POINT P, V2; Doucet A, 2001, SEQUENTIAL MONTE CAR, V1; Druckmann S, 2007, FRONT NEUROSCI-SWITZ, V1, P7, DOI 10.3389/neuro.01.1.1.001.2007; Ergun A, 2007, IEEE T BIO-MED ENG, V54, P419, DOI 10.1109/TBME.2006.888821; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huys QJM, 2006, J NEUROPHYSIOL, V96, P872, DOI 10.1152/jn.00079.2006; Huys QJM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000379; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Kramer MA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000169; Lansky P, 2008, BIOL CYBERN, V99, P253, DOI 10.1007/s00422-008-0237-x; Liu J., 1999, COMBINED PARAMETER S; MCCORMICK DA, 1993, CEREB CORTEX, V3, P387, DOI 10.1093/cercor/3.5.387; Meng L, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065006; Mitra P., 2007, OBSERVED BRAIN DYNAM; Mullowney P, 2008, J COMPUT NEUROSCI, V24, P179, DOI 10.1007/s10827-007-0047-5; NADIM F, 1995, J COMPUT NEUROSCI, V2, P215, DOI 10.1007/BF00961435; Paninski L, 2004, NEURAL COMPUT, V16, P2533, DOI 10.1162/0899766042321797; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Pawitan Y, 2001, ALL LIKELIHOOD STAT; PERCIVAL DB, 1993, SPECTRAL ANAL PHYS A, P583; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; Robinson PA, 2004, HUM BRAIN MAPP, V23, P53, DOI 10.1002/hbm.20032; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Schiff SJ, 2008, J NEURAL ENG, V5, P1, DOI 10.1088/1741-2560/5/1/001; Shepherd G.M., 2003, SYNAPTIC ORG BRAIN, DOI [10.1093/acprof:oso/9780195159561.001.1, DOI 10.1093/ACPROF:OSO/9780195159561.001.1]; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Thomson DJ, 2007, IEEE SIGNAL PROC MAG, V24, P20, DOI 10.1109/MSP.2007.4286561; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Traub RD, 2003, J NEUROPHYSIOL, V89, P909, DOI 10.1152/jn.00573.2002; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Ullah G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000776; Vanier MC, 1999, J COMPUT NEUROSCI, V7, P149, DOI 10.1023/A:1008972005316; Vervaeke K, 2006, J PHYSIOL-LONDON, V576, P235, DOI 10.1113/jphysiol.2006.111336; WONNACOTT TH, 1990, INTRO STAT	40	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85269	10.1371/journal.pone.0085269	http://dx.doi.org/10.1371/journal.pone.0085269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24465520	Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000029
J	Higginbotham, S; Wong, WR; Linington, RG; Spadafora, C; Iturrado, L; Arnold, AE				Higginbotham, Sarah; Wong, Weng Ruh; Linington, Roger G.; Spadafora, Carmenza; Iturrado, Liliana; Arnold, A. Elizabeth			Sloth Hair as a Novel Source of Fungi with Potent Anti-Parasitic, Anti-Cancer and Anti-Bacterial Bioactivity	PLOS ONE			English	Article							NATURAL-PRODUCTS; ENDOPHYTES; DIVERSITY; HOST; MICROORGANISMS; BIODIVERSITY; COMMUNITIES; INFECTIONS; ALIGNMENT; ACCURACY	The extraordinary biological diversity of tropical forests harbors a rich chemical diversity with enormous potential as a source of novel bioactive compounds. Of particular interest are new environments for microbial discovery. Sloths - arboreal mammals commonly found in the lowland forests of Panama - carry a wide variety of micro-and macro-organisms on their coarse outer hair. Here we report for the first time the isolation of diverse and bioactive strains of fungi from sloth hair, and their taxonomic placement. Eighty-four isolates of fungi were obtained in culture from the surface of hair that was collected from living three-toed sloths (Bradypus variegatus, Bradypodidae) in Soberania National Park, Republic of Panama. Phylogenetic analyses revealed a diverse group of Ascomycota belonging to 28 distinct operational taxonomic units (OTUs), several of which are divergent from previously known taxa. Seventy-four isolates were cultivated in liquid broth and crude extracts were tested for bioactivity in vitro. We found a broad range of activities against strains of the parasites that cause malaria (Plasmodium falciparum) and Chagas disease (Trypanosoma cruzi), and against the human breast cancer cell line MCF-7. Fifty fungal extracts were tested for antibacterial activity in a new antibiotic profile screen called BioMAP; of these, 20 were active against at least one bacterial strain, and one had an unusual pattern of bioactivity against Gram-negative bacteria that suggests a potentially new mode of action. Together our results reveal the importance of exploring novel environments for bioactive fungi, and demonstrate for the first time the taxonomic composition and bioactivity of fungi from sloth hair.	[Higginbotham, Sarah; Iturrado, Liliana] Smithsonian Trop Res Inst, Panama City, Panama; [Wong, Weng Ruh; Linington, Roger G.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Spadafora, Carmenza] Inst Invest Cient & Serv Alta Tecnol, Panama City, Panama; [Arnold, A. Elizabeth] Univ Arizona, Sch Plant Sci, Tucson, AZ USA	Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Santa Cruz; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); University of Arizona	Higginbotham, S (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	higginbothams@si.edu	Spadafora, Carmenza/ABE-8973-2020; Linington, Roger/ABD-5582-2021	Spadafora, Carmenza/0000-0002-3002-9467; Linington, Roger/0000-0003-1818-4971	International Cooperative Biodiversity Groups program (ICBG-Panama) [2 U01 TW006634-06]; College of Agriculture and Life Sciences at the University of Arizona; FOGARTY INTERNATIONAL CENTER [U01TW006634] Funding Source: NIH RePORTER	International Cooperative Biodiversity Groups program (ICBG-Panama); College of Agriculture and Life Sciences at the University of Arizona; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the International Cooperative Biodiversity Groups program (ICBG-Panama http://www.icbg.org/, grant number 2 U01 TW006634-06) and the College of Agriculture and Life Sciences at the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aly AH, 2011, APPL MICROBIOL BIOT, V90, P1829, DOI 10.1007/s00253-011-3270-y; [Anonymous], NEGL TROP DIS; Arabi MIE, 2007, J PLANT PATHOL, V89, P79; Xavier GAA, 2008, BRAZ J MICROBIOL, V39, P508, DOI 10.1590/S1517-838220080003000018; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold AE, 2009, SYST BIOL, V58, P283, DOI 10.1093/sysbio/syp001; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Arnold AE, 2003, MYCOLOGIA, V95, P388, DOI 10.2307/3761880; Ayers S, 2012, J PEPT SCI, V18, P500, DOI 10.1002/psc.2425; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Bukovska P, 2010, J MICROBIOL METH, V82, P223, DOI 10.1016/j.mimet.2010.06.007; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Castro JA, 2006, HUM EXP TOXICOL, V25, P471, DOI 10.1191/0960327106het653oa; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dye C, 2013, LANCET, V381, P413, DOI 10.1016/S0140-6736(12)61812-1; ECDC/EMEA, 2009, BACT CHALL TIM REACT; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elewski BE, 2005, J INVEST DERM SYMP P, V10, P190, DOI 10.1111/j.1087-0024.2005.10103.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P630, DOI 10.1016/j.ijantimicag.2006.12.012; Figueroa M, 2012, J ANTIBIOT, V65, P559, DOI 10.1038/ja.2012.69; Frisvad JC, 2013, FEMS MICROBIOL LETT, V339, P77, DOI 10.1111/1574-6968.12054; Gilmore DP, 2001, BRAZ J MED BIOL RES, V34, P9, DOI 10.1590/S0100-879X2001000100002; Glenn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032980; GLOER JB, 1995, CAN J BOT, V73, pS1265, DOI 10.1139/b95-387; Goyette JL, 2011, J FIELD ORNITHOL, V82, P279, DOI 10.1111/j.1557-9263.2011.00331.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunatilaka AAL, 2006, J NAT PROD, V69, P509, DOI 10.1021/np058128n; Hawksworth DL, 1997, PHYTOPATHOLOGY, V87, P888, DOI 10.1094/PHYTO.1997.87.9.888; Higginbotham SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073192; Higgins KL, 2011, MYCOLOGIA, V103, P247, DOI 10.3852/09-158; Hoffman MT, 2010, APPL ENVIRON MICROB, V76, P4063, DOI 10.1128/AEM.02928-09; Hoyos-Carvajal L, 2009, FUNGAL GENET BIOL, V46, P615, DOI 10.1016/j.fgb.2009.04.006; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Iwatsuki M, 2011, J ANTIBIOT, V64, P183, DOI 10.1038/ja.2010.124; Kluger CG, 2008, J TROP ECOL, V24, P351, DOI 10.1017/S0266467408005026; Kunz AN, 2010, CHEMOTHERAPY, V56, P492, DOI 10.1159/000321018; Lee HB, 2005, LETT APPL MICROBIOL, V40, P497, DOI 10.1111/j.1472-765X.2005.01719.x; Liu L, 2009, ORG LETT, V11, P2836, DOI 10.1021/ol901039m; Maddison WP, 2011, MESQUITE MODULAR SYS; McGuire KL, 2010, OECOLOGIA, V164, P785, DOI 10.1007/s00442-010-1686-1; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Mohamed Hala F., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P863, DOI 10.1016/S2221-1691(12)60244-5; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; O'Donnell K, 2009, J CLIN MICROBIOL, V47, P3851, DOI 10.1128/JCM.01616-09; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Perez-Garcia A, 2006, J PHYTOPATHOL, V154, P190, DOI 10.1111/j.1439-0434.2006.01086.x; Ramsamy Y, 2013, SAMJ S AFR MED J, V103, P371, DOI [10.7196/SAMJ.6459, 10.7196/samj.6459]; Rodrigues A, 2011, FEMS MICROBIOL ECOL, V78, P244, DOI 10.1111/j.1574-6941.2011.01152.x; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Singh MP, 2007, MAR DRUGS, V5, P71, DOI 10.3390/md20070007; Singh SB, 1996, TETRAHEDRON LETT, V37, P8077, DOI 10.1016/0040-4039(96)01844-8; Smith SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003052; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Suutari M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-86; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; U'ren JM, 2009, MYCOL RES, V113, P432, DOI 10.1016/j.mycres.2008.11.015; Waldrop MP, 2006, ECOL LETT, V9, P1127, DOI 10.1111/j.1461-0248.2006.00965.x; Wang P, 2011, INT J BIOL SCI, V7, P209, DOI 10.7150/ijbs.7.209; Wong WR, 2012, CHEM BIOL, V19, P1483, DOI 10.1016/j.chembiol.2012.09.014; You JL, 2010, J IND MICROBIOL BIOT, V37, P245, DOI 10.1007/s10295-009-0667-z; Zwickl D., 2006, GARLI GENETIC ALGORI	65	20	20	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e84549	10.1371/journal.pone.0084549	http://dx.doi.org/10.1371/journal.pone.0084549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454729	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100024
J	Nifong, JC; Nifong, RL; Silliman, BR; Lowers, RH; Guillette, LJ; Ferguson, JM; Welsh, M; Abernathy, K; Marshall, G				Nifong, James C.; Nifong, Rachel L.; Silliman, Brian R.; Lowers, Russell H.; Guillette, Louis J., Jr.; Ferguson, Jake M.; Welsh, Matthew; Abernathy, Kyler; Marshall, Greg			Animal-Borne Imaging Reveals Novel Insights into the Foraging Behaviors and Diel Activity of a Large-Bodied Apex Predator, the American Alligator (Alligator mississippiensis)	PLOS ONE			English	Article							CAIMAN-CROCODILUS; FOOD-HABITS; CROCODYLUS-NILOTICUS; PARAGUAYAN CAIMAN; FISHING BEHAVIOR; SALT-MARSH; WATER; FLORIDA; THERMOREGULATION; COMMUNITIES	Large-bodied, top- and apex predators (e.g., crocodilians, sharks, wolves, killer whales) can exert strong top-down effects within ecological communities through their interactions with prey. Due to inherent difficulties while studying the behavior of these often dangerous predatory species, relatively little is known regarding their feeding behaviors and activity patterns, information that is essential to understanding their role in regulating food web dynamics and ecological processes. Here we use animal-borne imaging systems (Crittercam) to study the foraging behavior and activity patterns of a cryptic, large-bodied predator, the American alligator (Alligator mississippiensis) in two estuaries of coastal Florida, USA. Using retrieved video data we examine the variation in foraging behaviors and activity patterns due to abiotic factors. We found the frequency of prey-attacks (mean = 0.49 prey attacks/hour) as well as the probability of prey-capture success (mean = 0.52 per attack) were significantly affected by time of day. Alligators attempted to capture prey most frequently during the night. Probability of prey-capture success per attack was highest during morning hours and sequentially lower during day, night, and sunset, respectively. Position in the water column also significantly affected prey-capture success, as individuals' experienced two-fold greater success when attacking prey while submerged. These estimates are the first for wild adult American alligators and one of the few examples for any crocodilian species worldwide. More broadly, these results reveal that our understandings of crocodilian foraging behaviors are biased due to previous studies containing limited observations of cryptic and nocturnal foraging interactions. Our results can be used to inform greater understanding regarding the top-down effects of American alligators in estuarine food webs. Additionally, our results highlight the importance and power of using animal-borne imaging when studying the behavior of elusive large-bodied, apex predators, as it provides critical insights into their trophic and behavioral interactions.	[Nifong, James C.; Silliman, Brian R.; Ferguson, Jake M.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Nifong, Rachel L.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL USA; [Lowers, Russell H.] InoMed Hlth Applicat, Merritt Isl, FL USA; [Guillette, Louis J., Jr.] Med Univ Charleston South Carolina, Dept Obstet & Gynecol, Charleston, SC USA; [Guillette, Louis J., Jr.] Med Univ Charleston South Carolina, Hollings Marine Lab, Charleston, SC USA; [Welsh, Matthew] Guana Tolomato Matanzas Natl Estuarine Res Reserv, Marineland, FL USA; [Abernathy, Kyler; Marshall, Greg] Natl Geog Remote Imaging, Washington, DC USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Geographic Society	Nifong, JC (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	ncboy@ufl.edu	Nifong, James C/D-4137-2015	Nifong, James C/0000-0003-3607-0441; Ferguson, Jake/0000-0002-5034-9089; Silliman, Brian/0000-0001-6360-650X; Nifong, Rachel/0000-0001-8940-3583	Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration [NA10NOS4200022]; University of Florida Foundation Inc. [016501]; University of Florida Singer Biology Fund; National Science Foundation [OCE-1030822, 10021501]; Division Of Ocean Sciences [1237140] Funding Source: National Science Foundation	Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Florida Foundation Inc.(University of Florida); University of Florida Singer Biology Fund; National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was conducted under an award from the Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration, Award No. NA10NOS4200022 (url: http://www.nerrs.noaa.gov/). This work was supported in-part by the University of Florida Foundation Inc. Alligator Research Fund (016501) (Donors: Delecker Family) (url: https://www.uff.ufl.edu/OnlineGiving/FundDetail.asp?FundCode=016501), University of Florida Singer Biology Fund, and the National Science Foundation, OCE-1030822 (Award No. 10021501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Bondavalli C, 1999, ECOSYSTEMS, V2, P49, DOI 10.1007/s100219900057; Brazaitis P., 1987, P373; Bugbee C.D, 2008, THESIS U FLORIDA; CLEUREN J, 1992, J MORPHOL, V212, P141, DOI 10.1002/jmor.1052120205; Coulson R., 1964, BIOCH ALLIGATOR STUD; Craighead F, 1968, FLORIDA NATURALIST, V21; DELANY MF, 1986, J WILDLIFE MANAGE, V50, P348, DOI 10.2307/3801926; DIEFENBACH COD, 1988, COMP BIOCHEM PHYS A, V89, P149; DIEFENBACH CODC, 1975, COMP BIOCHEM PHYS A, V51, P259; DUNSON WA, 1982, COPEIA, P374, DOI 10.2307/1444618; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FISH FE, 1987, COPEIA, P804, DOI 10.2307/1445682; Frazel T.D, 2009, RHETORIC CICEROS VER; Gabrey SW, 2010, HERPETOL CONSERV BIO, V5, P241; GANS C, 1969, COPEIA, P855, DOI 10.2307/1441816; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Jackson J.F., 1974, Journal Herpet, V8, P378, DOI 10.2307/1562912; Keddy PA, 2009, SOUTHEAST NAT, V8, P213, DOI 10.1656/058.008.0202; KUSHLAN JA, 1974, COPEIA, P993; KUSHLAN JA, 1980, COPEIA, P930, DOI 10.2307/1444493; LANG JW, 1979, COPEIA, P48, DOI 10.2307/1443728; Lazzaro X, 2009, J ANIM ECOL, V78, P1307, DOI 10.1111/j.1365-2656.2009.01588.x; Leitch DB, 2012, J EXP BIOL, V215, P4217, DOI 10.1242/jeb.076836; LEWIS LY, 1985, COMP BIOCHEM PHYS A, V80, P441, DOI 10.1016/0300-9629(85)90065-9; Magnusson W. E., 1982, CROCODILES, P389; Marshall GJ, 1998, MAR TECHNOL SOC J, V32, P11; Martin S, 2008, HYDROBIOLOGIA, V595, P587, DOI 10.1007/s10750-007-9030-4; MAZZOTTI FJ, 1984, COMP BIOCHEM PHYS A, V79, P641, DOI 10.1016/0300-9629(84)90462-6; Mazzotti FJ, 2009, ECOL INDIC, V9, pS137, DOI 10.1016/j.ecolind.2008.06.008; MCILHENNY EA, 1935, ALLIGATORS LIFE HIST; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Nifong James C., 2013, Herpetological Review, V44, P243; Nifong JC, 2013, J EXP MAR BIOL ECOL, V440, P185, DOI 10.1016/j.jembe.2013.01.002; Nifong JC, 2012, COPEIA, P419, DOI 10.1643/CE-11-177; OLMOS F, 1990, COPEIA, P875, DOI 10.2307/1446458; Palmer ML, 2004, WETLANDS, V24, P115, DOI 10.1672/0277-5212(2004)024[0115:SOEAH]2.0.CO;2; Pauly D, 2000, ICES J MAR SCI, V57, P697, DOI 10.1006/jmsc.2000.0726; Platt SG, 2006, HERPETOL J, V16, P281; Pooley A.C., 1989, P76; R Core Development Team, 2011, R LANG ENV STAT COMP; Rosenblatt AE, 2013, OCEANOGRAPHY, V26, P156, DOI 10.5670/oceanog.2013.59; Rosenblatt AE, 2011, J ANIM ECOL, V80, P786, DOI 10.1111/j.1365-2656.2011.01830.x; Rozas LP, 1998, B MAR SCI, V63, P481; SCHALLER GB, 1982, COPEIA, P66; SMITH EN, 1979, AM ZOOL, V19, P239; Soares D, 2002, NATURE, V417, P241, DOI 10.1038/417241a; Subalusky AL, 2009, BIOL CONSERV, V142, P1507, DOI 10.1016/j.biocon.2009.02.019; TAPLIN LE, 1982, J COMP PHYSIOL, V149, P43, DOI 10.1007/BF00735713; Terborgh J., 2010, TROPHIC CASCADES PRE; Thorbjarnarson J, 1990, J HERPETOL, P17; THORBJARNARSON JB, 1993, COPEIA, P1166; U. S. Fish and Wildlife Service, 2013, MERR ISL NAT WILDL R; Wallace KM, 2008, J HERPETOL, V42, P361, DOI 10.1670/07-1071.1; Watanabe YY, 2013, AQUAT BIOL, V18, P1, DOI 10.3354/ab00489; WHITFIELD AK, 1979, COPEIA, P266; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; WOLFE J L, 1987, Northeast Gulf Science, V9, P1; Woodward AR, 1996, PROCEEDINGS OF THE FIFTIETH ANNUAL CONFERENCE - SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P509; [No title captured]	63	19	23	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e83953	10.1371/journal.pone.0083953	http://dx.doi.org/10.1371/journal.pone.0083953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454711	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100013
J	Tang, WM; Pan, JC; Jiang, N; Hu, HY; Mahapatra, T; Yin, YP; Mahapatra, S; Wang, XL; Chen, XS; Lin, N; Zhang, X; Huan, XP; Yang, HT; Fu, GF				Tang, Weiming; Pan, Jicheng; Jiang, Ning; Hu, Hai-Yang; Mahapatra, Tanmay; Yin, Yue-Ping; Mahapatra, Sanchita; Wang, Xiao-Liang; Chen, Xiang-Sheng; Lin, Nan; Zhang, Xun; Huan, Xi-Ping; Yang, Hai-Tao; Fu, Geng-Feng			Correlates of Chlamydia and Gonorrhea Infection among Female Sex Workers: The Untold Story of Jiangsu, China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; RISK BEHAVIORS; COMMERCIAL SEX; HIV-INFECTIONS; PREVALENCE; SYPHILIS; MEN; INTERVENTIONS; SURVEILLANCE; TRANSMISSION	Objective(s): To estimate the prevalence of sexually transmitted infections (STIs) among female sex workers (FSWs) in the Jiangsu Province, China and measure the association of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections with their potential correlates. Design: A cross-sectional study on a representative sample of FSWs in Yangzhou and Changzhou cities of Jiangsu was conducted. Methods: 185 sex-work venues in Yangzhou and 174 in Changzhou were selected by stratified random sampling. 2972 FSWs (1108 in Yangzhou and 1864 in Changzhou), aged 15 years or more, who agreed to participate and provided blood sample for HIV and syphilis testing were interviewed in these venues. Cervical specimens from 849 randomly chosen participants were then tested for CT and NG. Results: Proportions of young, school-educated, currently married FSWs who were living alone, migrated from other provinces and engaged in unprotected vaginal intercourse in past 3 months (UVI) were relatively high. Prevalence of HIV, syphilis, CT and NG were 0.20%, 4.88%, 14.61% and 5.42% respectively. Younger age, living alone or with persons other than partners/family members, engaging in UVI and having other STIs seemed to be associated with higher risk of CT or NG infection. Being divorced/widowed and working in middle/low-level venues were identified as additional risk factors for NG. Conclusions: Based on a representative sample, this initial effort to identify the correlates of CT/NG infections among FSWs of Jiangsu revealed that focused interventions targeting high-risk FSWs are urgently required for controlling STI epidemics in Yangzhou and Changzhou where substantial number of STI cases were identified.	[Tang, Weiming; Mahapatra, Tanmay; Mahapatra, Sanchita] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Tang, Weiming; Hu, Hai-Yang; Wang, Xiao-Liang; Yang, Hai-Tao; Fu, Geng-Feng] Jiangsu Prov Cent Dis Prevent & Control, Nanjing, Jiangsu, Peoples R China; [Pan, Jicheng] Jiangsu Prov Geriatr Inst, Nanjing, Jiangsu, Peoples R China; [Jiang, Ning; Yin, Yue-Ping; Chen, Xiang-Sheng; Huan, Xi-Ping] China CDC, Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China; [Lin, Nan] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China; [Zhang, Xun] Univ S Florida, MCM, Dept Mol Pharmacol & Physiol, Tampa, FL USA	University of California System; University of California Los Angeles; Xiamen University; State University System of Florida; University of South Florida	Fu, GF (corresponding author), Jiangsu Prov Cent Dis Prevent & Control, Nanjing, Jiangsu, Peoples R China.	fugf@jscdc.cn	wang, xl/Y-8251-2019; wang, xiao/HGB-7081-2022; Wang, Xin/AAN-8435-2021	wang, xiao/0000-0002-4088-3341; Wang, Xin/0000-0002-4457-7376; Tang, Weiming/0000-0002-9026-707X	National Natural Science Foundation [81373125]; "Mega Project" of China National Science Research for the 11th Five-Year Plan [2008ZX10001 -005]; Ministry of Health and the Ministry of Sciences and Technology in China, Jiangsu Provincial Technologies Research Program [BE2009685]; Jiangsu Province's Outstanding Medical Academic Leader Program [RC2011086, 2011087]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); "Mega Project" of China National Science Research for the 11th Five-Year Plan; Ministry of Health and the Ministry of Sciences and Technology in China, Jiangsu Provincial Technologies Research Program; Jiangsu Province's Outstanding Medical Academic Leader Program	This work was supported by the National Natural Science Foundation (81373125), "Mega Project" of China National Science Research for the 11th Five-Year Plan (2008ZX10001 -005) from the Ministry of Health and the Ministry of Sciences and Technology in China, Jiangsu Provincial Technologies Research Program (BE2009685) and Jiangsu Province's Outstanding Medical Academic Leader Program (RC2011086, 2011087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker M, 2000, WHO REPORT GLOBAL SU, P11; [Anonymous], 2011, 2011 EST HIV AIDS EP; Bruus M., 2003, EPIDATA VERSION 3 CO; Burns FM, 2009, SEX TRANSM INFECT, V85, P75, DOI 10.1136/sti.2007.029546; Chen XS, 2006, SEX TRANSM INFECT, V82, P283, DOI 10.1136/sti.2006.019711; Chen XS, 2013, LANCET INFECT DIS, V13, P13, DOI 10.1016/S1473-3099(12)70298-0; Chen XS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-84; Das A, 2011, INFECT DIS OBSTET GY; Duckett M, 2000, DEV B, V18; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549; Furstenberg F., 1999, MANAGING MAKE IT URB; Hampton MC, 2012, AIDS BEHAV, P1; Hao C, 2011, SEX TRANSM INFECT, V87, P199, DOI 10.1136/sti.2010.042903; Hong Y, 2011, AIDS CARE, V23, P54, DOI 10.1080/09540121.2011.554526; Huang YY, 2004, SEX TRANSM DIS, V31, P695, DOI 10.1097/01.olq.0000143107.06988.ea; Institute S, 1996, SAS SYSTEM WINDOWS; Jin X, 2011, INT J STD AIDS, V22, P80, DOI 10.1258/ijsa.2010.010289; Pando MA, 2006, AM J TROP MED HYG, V74, P233, DOI 10.4269/ajtmh.2006.74.233; Peng ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052731; Pepin J, 2005, SEX TRANSM INFECT, V81, P67, DOI 10.1136/sti.2003.009100; Poon AN, 2011, AIDS CARE, V23, P5, DOI 10.1080/09540121.2011.554519; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Ruan YH, 2006, SEX TRANSM DIS, V33, P719, DOI 10.1097/01.olq.0000218881.01437.99; Safika I, 2011, INT J DRUG POLICY, V22, P49, DOI 10.1016/j.drugpo.2010.09.003; Strathdee SA, 1998, J ACQ IMMUN DEF SYND, V19, P61, DOI 10.1097/00042560-199809010-00010; Thuong NV, 2005, SEX TRANSM INFECT, V81, P477, DOI 10.1136/sti.2005.016097; Tucker JD, 2010, NEW ENGL J MED, V362, P1658, DOI 10.1056/NEJMp0911149; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Wang B, 2007, SEX TRANSM DIS, V34, P1, DOI 10.1097/01.olq.0000222668.95038.03; Wang H, 2009, SEX TRANSM INFECT, V85, P290, DOI 10.1136/sti.2008.033100; Weiming Tang HY, 2009, CHIN J EPIDEMIOL, V30, P448; Xu JJ, 2008, SEX TRANSM DIS, V35, P558, DOI 10.1097/OLQ.0b013e318165926b; Yang C, 2010, SEX TRANSM INFECT, V86, P559, DOI 10.1136/sti.2009.041731; Yang H, 2004, PREVENTION SEXUAL ST, P471; YANG H-t, 2009, ACTA U MED NANJING N, V8; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yang X, 2007, AIDS CARE, V19, P282, DOI 10.1080/09540120600909414; Zermiani Monica, 2012, Open AIDS J, V6, P60, DOI 10.2174/1874613601206010060; ZHANG Q-q, 2012, ACTA U MED NANJING N, V4	40	12	12	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85985	10.1371/journal.pone.0085985	http://dx.doi.org/10.1371/journal.pone.0085985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454950	gold, Green Published, Green Submitted			2022-12-25	WOS:000330235100142
J	Rahman, MM; Khan, SB; Asiri, AM				Rahman, Mohammed M.; Khan, Sher Bahadar; Asiri, Abdullah M.			Fabrication of Smart Chemical Sensors Based on Transition-Doped-Semiconductor Nanostructure Materials with mu-Chips	PLOS ONE			English	Article							THIN-FILM; SENSING PROPERTIES; PHOTO-CATALYST; ZINC-OXIDE; GAS SENSOR; ZNO; NANOPARTICLES; ZNFE2O4; SB2O3; GROWTH	Transition metal doped semiconductor nanostructure materials (Sb2O3 doped ZnO microflowers, MFs) are deposited onto tiny mu-chip (surface area, -0.02217 cm(2)) to fabricate a smart chemical sensor for toxic ethanol in phosphate buffer solution (0.1 M PBS). The fabricated chemi-sensor is also exhibited higher sensitivity, large-dynamic concentration ranges, long-term stability, and improved electrochemical performances towards ethanol. The calibration plot is linear (r(2) = 0.9989) over the large ethanol concentration ranges (0.17 mM to 0.85 M). The sensitivity and detection limit is similar to 5.845 mu Acm(-2)mM(-1) and similar to 0.11 +/- 0.02 mM (signal-to-noise ratio, at a SNR of 3) respectively. Here, doped MFs are prepared by a wet-chemical process using reducing agents in alkaline medium, which characterized by UV/vis., FT-IR, Raman, X-ray photoelectron spectroscopy (XPS), powder X-ray diffraction (XRD), and field-emission scanning electron microscopy (FE-SEM) etc. The fabricated ethanol chemical sensor using Sb2O3-ZnO MFs is simple, reliable, low-sample volume (<70.0 mu L), easy of integration, high sensitivity, and excellent stability for the fabrication of efficient I-V sensors on mu-chips.	[Rahman, Mohammed M.; Khan, Sher Bahadar; Asiri, Abdullah M.] King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah 21413, Saudi Arabia; [Rahman, Mohammed M.; Khan, Sher Bahadar; Asiri, Abdullah M.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Rahman, MM (corresponding author), King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah 21413, Saudi Arabia.	mmrahman@kau.edu.sa	Khan, Prof. Sher Bahadar/M-7968-2019; Asiri, Abdullah M./C-3458-2009; Khan, Sher Bahadar/H-5833-2012; Rahman, Mohammed M./H-5823-2012	Khan, Prof. Sher Bahadar/0000-0001-9635-7175; Asiri, Abdullah M./0000-0001-7905-3209; Khan, Sher Bahadar/0000-0001-9635-7175; Rahman, Mohammed M./0000-0003-2773-1244	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [130-019-D1433]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. 130-019-D1433. The authors, therefore, acknowledge with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah M., 2011, SENSORS TRANSDUCERS, V134, P32; Aguilar-Leyva J, 2007, MATER CHARACT, V58, P740, DOI 10.1016/j.matchar.2006.11.016; Bundesmann C, 2003, APPL PHYS LETT, V83, P1974, DOI 10.1063/1.1609251; Cebriano T, 2012, MATER CHEM PHYS, V135, P1096, DOI 10.1016/j.matchemphys.2012.06.024; Choi KI, 2010, SENSOR ACTUAT B-CHEM, V146, P183, DOI 10.1016/j.snb.2010.02.050; Dale L., 2009, SMALL, V1, P482; DAMEN TC, 1966, PHYS REV, V142, P570, DOI 10.1103/PhysRev.142.570; Das S, 2011, MATER RES BULL, V46, P609, DOI 10.1016/j.materresbull.2010.12.034; De Vicente FS, 2003, J NON-CRYST SOLIDS, V330, P168, DOI 10.1016/j.jnoncrysol.2003.08.047; Di Francesco F, 2005, MICROCHEM J, V79, P405, DOI 10.1016/j.microc.2004.10.008; Faisal M, 2012, APPL SURF SCI, V258, P7515, DOI 10.1016/j.apsusc.2012.04.075; Faisal M, 2011, CHEM ENG J, V173, P178, DOI 10.1016/j.cej.2011.07.067; Faisal M, 2011, MATER LETT, V65, P1400, DOI 10.1016/j.matlet.2011.02.013; Friedrichs S, 2001, CHEM COMMUN, P929, DOI 10.1039/b102348a; Fujii T, 1999, PHYS REV B, V59, P3195, DOI 10.1103/PhysRevB.59.3195; Gibert JP, 2000, POLYM DEGRAD STABIL, V67, P437, DOI 10.1016/S0141-3910(99)00142-1; Gong H, 2006, SENSOR ACTUAT B-CHEM, V115, P247, DOI 10.1016/j.snb.2005.09.008; Guo L, 2000, CHEM PHYS LETT, V318, P49, DOI 10.1016/S0009-2614(99)01461-X; Hagen J, 1999, HETEROGENEOUS CATALY, P83; Han N, 2010, SENSOR ACTUAT B-CHEM, V147, P525, DOI 10.1016/j.snb.2010.03.082; Holmes JD, 2000, SCIENCE, V287, P1471, DOI 10.1126/science.287.5457.1471; Hsueh TJ, 2007, SENSOR ACTUAT B-CHEM, V126, P473, DOI 10.1016/j.snb.2007.03.034; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Ingler WB, 2004, J AM CHEM SOC, V126, P10238, DOI 10.1021/ja048461y; Jamal A, 2011, MAT SCI APPL, V2, P676; Khan SB, 2011, TALANTA, V85, P943, DOI 10.1016/j.talanta.2011.05.003; Khan SB, 2011, SCI TOTAL ENVIRON, V409, P2987, DOI 10.1016/j.scitotenv.2011.04.019; Khan SB, 2011, TALANTA, V84, P1005, DOI 10.1016/j.talanta.2011.02.036; Kim GW, 2012, J KOREAN PHYS SOC, V60, P1548, DOI 10.3938/jkps.60.1548; Kumar A, 2007, NANOTECHNOL, V18; Lao YW, 2007, J ELECTROCERAM, V19, P187, DOI 10.1007/s10832-007-9187-2; Lee SR, 2009, BIOSENS BIOELECTRON, V24, P1877, DOI 10.1016/j.bios.2008.09.008; Lee SR, 2009, TRAC-TREND ANAL CHEM, V28, P196, DOI 10.1016/j.trac.2008.11.009; Li YB, 2009, SOLID STATE SCI, V11, P1319, DOI 10.1016/j.solidstatesciences.2009.04.014; Majumder S, 2009, MATER SCI-POLAND, V27, P123; Montenegro A, 2007, J EUR CERAM SOC, V27, P4143, DOI 10.1016/j.jeurceramsoc.2007.02.106; Mori H, 1996, MATER CHEM PHYS, V45, P211, DOI 10.1016/0254-0584(95)01729-1; Ng HT, 2004, NANO LETT, V4, P1247, DOI 10.1021/nl049461z; Nicoletti S, 2003, IEEE SENS J, V3, P454, DOI 10.1109/JSEN.2003.815797; Nomura K, 2003, SCIENCE, V300, P1269, DOI 10.1126/science.1083212; Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120; Pearton SJ, 2004, SEMICOND SCI TECH, V19, pR59, DOI 10.1088/0268-1242/19/10/R01; Pokhrel S, 2008, SENSOR ACTUAT B-CHEM, V133, P78, DOI 10.1016/j.snb.2008.01.054; Rahman MM, 2011, J BIOMED NANOTECHNOL, V7, P351, DOI 10.1166/jbn.2011.1299; Rahman MM, 2009, SENSOR ACTUAT B-CHEM, V137, P327, DOI 10.1016/j.snb.2008.10.060; Rahman MM, 2012, SENSOR ACTUAT B-CHEM, V171, P932, DOI 10.1016/j.snb.2012.06.006; Rahman MM, 2012, TALANTA, V99, P924, DOI 10.1016/j.talanta.2012.07.060; Rahman MM, 2012, ELECTROCHIM ACTA, V75, P164, DOI 10.1016/j.electacta.2012.04.093; Rahman MM, 2012, CHEM ENG J, V192, P122, DOI 10.1016/j.cej.2012.03.045; Rahman MM, 2012, MICROCHIM ACTA, V178, P99, DOI 10.1007/s00604-012-0817-2; Rahman MM, 2011, SUPERLATTICE MICROST, V50, P369, DOI 10.1016/j.spmi.2011.07.016; Rahman MM, 2011, BIOSENS BIOELECTRON, V28, P127, DOI 10.1016/j.bios.2011.07.024; Rahman MM, 2011, J PHYS CHEM C, V115, P9503, DOI 10.1021/jp202252j; Rahman MM, 2011, ACS APPL MATER INTER, V3, P1346, DOI 10.1021/am200151f; Rahman MM, 2011, J NANOPART RES, V13, P3789, DOI 10.1007/s11051-011-0301-7; Sahner K, 2005, SENSOR ACTUAT B-CHEM, V108, P102, DOI 10.1016/j.snb.2004.12.104; Shaalan NM, 2011, SENSOR ACTUAT B-CHEM, V153, P11, DOI 10.1016/j.snb.2010.09.070; Soci C, 2007, NANO LETT, V7, P1003, DOI 10.1021/nl070111x; Song P, 2005, SENSOR ACTUAT B-CHEM, V104, P312, DOI 10.1016/j.snb.2004.05.023; Suchea M, 2007, THIN SOLID FILMS, V515, P6562, DOI 10.1016/j.tsf.2006.11.151; Tao BR, 2009, SENSOR ACTUAT B-CHEM, V142, P298, DOI 10.1016/j.snb.2009.08.004; Umar A, 2008, J NANOSCI NANOTECHNO, V8, P3216, DOI 10.1166/jnn.2008.116; Umar A, 2008, CHEM COMMUN, P166, DOI 10.1039/b711215g; Umar A, 2009, ELECTROCHEM COMMUN, V11, P118, DOI 10.1016/j.elecom.2008.10.046; Wang C, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/14/145506; Wang N, 1998, PHYS REV B, V58, P16024, DOI 10.1103/PhysRevB.58.R16024; Wang XD, 2007, SCIENCE, V316, P102, DOI 10.1126/science.1139366; Wang ZL, 2004, J PHYS-CONDENS MAT, V16, pR829, DOI 10.1088/0953-8984/16/25/R01; Weng YC, 2004, BIOSENS BIOELECTRON, V20, P41, DOI 10.1016/j.bios.2004.01.027; Weng YC, 2002, SENSOR ACTUAT B-CHEM, V85, P246, DOI 10.1016/S0925-4005(02)00125-9; Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899; Wongrat E, 2009, APPL SURF SCI, V256, P968, DOI 10.1016/j.apsusc.2009.02.046; Yang ZX, 2009, SENSOR ACTUAT B-CHEM, V140, P549, DOI 10.1016/j.snb.2009.04.052; Yao CW, 2007, J PHYS CHEM C, V111, P12274, DOI 10.1021/jp0732763; Ye CH, 2002, CHEM PHYS LETT, V363, P34, DOI 10.1016/S0009-2614(02)01018-7; Zhang CC, 2002, J EUR CERAM SOC, V22, P61, DOI 10.1016/S0955-2219(01)00232-1	76	30	30	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85036	10.1371/journal.pone.0085036	http://dx.doi.org/10.1371/journal.pone.0085036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454785	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500033
J	Chen, JQ; Shi, Y; Regan, J; Karuppaiah, K; Ornitz, DM; Long, FX				Chen, Jianquan; Shi, Yu; Regan, Jenna; Karuppaiah, Kannan; Ornitz, David M.; Long, Fanxin			Osx-Cre Targets Multiple Cell Types besides Osteoblast Lineage in Postnatal Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-FORMATION; OSTERIX; MOUSE; DIFFERENTIATION; MAINTENANCE; ACTIVATION; HEDGEHOG; ROLES	Osterix (Osx or Sp7) is a zinc-finger-family transcriptional factor essential for osteoblast differentiation in mammals. The Osx-Cre mouse line (also known as Osx1-GFP:: Cre) expresses GFP:: Cre fusion protein from a BAC transgene containing the Osx regulatory sequence. The mouse strain was initially characterized during embryogenesis, and found to target mainly osteoblast-lineage cells. Because the strain has been increasingly used in postnatal studies, it is important to evaluate its targeting specificity in mice after birth. By crossing the Osx-Cre mouse with the R26-mT/mG reporter line and analyzing the progenies at two months of age, we find that Osx-Cre targets not only osteoblasts, osteocytes and hypertrophic chondrocytes as expected, but also stromal cells, adipocytes and perivascular cells in the bone marrow. The targeting of adipocytes and perivascular cells appears to be specific to those residing within the bone marrow, as the same cell types elsewhere are not targeted. Beyond the skeleton, Osx-Cre also targets the olfactory glomerular cells, and a subset of the gastric and intestinal epithelium. Thus, potential contributions from the non-osteoblast-lineage cells should be considered when Osx-Cre is used to study gene functions in postnatal mice.	[Chen, Jianquan; Shi, Yu; Regan, Jenna; Long, Fanxin] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA; [Karuppaiah, Kannan; Ornitz, David M.; Long, Fanxin] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Long, Fanxin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Long, FX (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA.	longf@wudosis.wustl.edu	Shi, Yu/J-5370-2018	Regan, Jenna/0000-0002-6698-3340; Chen, Jianping/0000-0001-5685-8581; Ornitz, David/0000-0003-1592-7629	National Institutes of Health [DK065789, AR055923]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work is funded by National Institutes of Health grants DK065789 and AR055923 to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Fazeli PK, 2013, J CLIN ENDOCR METAB, V98, P935, DOI 10.1210/jc.2012-3634; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Joeng KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055134; Liu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071318; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Maes C, DEV CELL, V19, P329; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Park JS, 2011, BIOCHEM BIOPH RES CO, V407, P842, DOI 10.1016/j.bbrc.2011.03.129; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	26	255	264	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85161	10.1371/journal.pone.0085161	http://dx.doi.org/10.1371/journal.pone.0085161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24971451	gold, Green Submitted, Green Published			2022-12-25	WOS:000330235100058
J	Wang, HJ; Wang, RZ; Xu, SH; Lakshmana, MK				Wang, Hongjie; Wang, Ruizhi; Xu, Shaohua; Lakshmana, Madepalli K.			RanBP9 Overexpression Accelerates Loss of Pre and Postsynaptic Proteins in the AP Delta E9 Transgenic Mouse Brain	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; ALZHEIMERS-DISEASE; SCAFFOLDING PROTEIN; TEMPORAL CORTEX; SYNAPTIC LOSS; HIPPOCAMPUS; SYNAPTOPHYSIN; ABNORMALITIES; DEPOSITION; DENDRITE	There is now compelling evidence that the neurodegenerative process in Alzheimer's disease (AD) begins in synapses. Loss of synaptic proteins and functional synapses in the amyloid precursor protein (APP) transgenic mouse models of AD is well established. However, what is the earliest age at which such loss of synapses occurs, and whether known markers of AD progression accelerate functional deficits is completely unknown. We previously showed that RanBP9 overexpression leads to robustly increased amyloid beta peptide (A beta) generation leading to enhanced amyloid plaque burden in a mouse model of AD. In this study we compared synaptic protein levels among four genotypes of mice, i.e., RanBP9 single transgenic (Ran), AP Delta E9 double transgenic (Dbl), AP Delta E9/RanBP9 triple transgenic (Tpl) and wild-type (WT) controls. We found significant reductions in the levels of synaptic proteins in both cortex and hippocampus of 5-and 6-months-old but not 3-or 4-months- old mice. Specifically, at 5-months of age, rab3A was reduced in the triple transgenic mice only in the cortex by 25% (p<0.05) and gap43 levels were reduced only in the hippocampus by 44% (p<0.01) compared to wild-type (WT) controls. Interestingly, RanBP9 overexpression in the Tpl mice reduced gap43 levels by a further 31% (p<0.05) compared to AP Delta E9 mice. RanBP9 also further decreased the levels of drebrin in the hippocampus by 32% (p<0.01) and chromogranin in the cortex by 24% (p<0.05) compared to APDE9 mice. At 6-months of age, RanBP9 expression in the cortex led to further reduction of rab3A by 30% (p<0.05) and drebrin by 38% (p<0.01) compared to APDE9 mice. RanBP9 also increased Ab oligomers in the cortex at 6 months. Similarly, in the hippocampus, RanBP9 expression further reduced rab3A levels by 36% (p<0.01) and drebrin levels by 33% (p<0.01). Taken together these data suggest that RanBP9 overexpression accelerates loss of synaptic proteins in the mouse brain.	[Wang, Hongjie; Wang, Ruizhi; Lakshmana, Madepalli K.] Torrey Pines Inst Mol Studies, Neurobiol Sect, Port Saint Lucie, FL USA; [Xu, Shaohua] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	Torrey Pines Institute for Molecular Studies, Florida; Florida Institute of Technology	Lakshmana, MK (corresponding author), Torrey Pines Inst Mol Studies, Neurobiol Sect, Port Saint Lucie, FL USA.	mlakshmana@tpims.org		Xu, Shaohua/0000-0003-1221-6354; Tang, Yamei/0000-0002-6353-6107	National Institutes of Health [1R03AG032064-01, 1R01AG036859-01]; NATIONAL INSTITUTE ON AGING [R03AG032064, R01AG036859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health grant numbers: 1R03AG032064-01, M. K. Lakshmana; 1R01AG036859-01, M. K. Lakshmana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefin AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045535; Bowman AL, 2008, MOL BIOL CELL, V19, P3782, DOI 10.1091/mbc.E08-03-0237; Brasnjevic I, 2013, TRANSL NEUROSCI, V4, P8, DOI 10.2478/s13380-013-0111-8; Cheng L, 2005, J NEUROCHEM, V94, P1102, DOI 10.1111/j.1471-4159.2005.03254.x; Davidsson P, 1998, Int Psychogeriatr, V10, P11, DOI 10.1017/S1041610298005110; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Gakhar-Koppole N, 2008, EUR J NEUROSCI, V28, P871, DOI 10.1111/j.1460-9568.2008.06398.x; Heffernan JM, 1998, EXP NEUROL, V150, P235, DOI 10.1006/exnr.1997.6772; Honer WG, 2003, NEUROBIOL AGING, V24, P1047, DOI 10.1016/j.neurobiolaging.2003.04.005; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Lakshmana MK, 2012, FASEB J, V26, P2072, DOI 10.1096/fj.11-196709; Lakshmana MK, 2010, FASEB J, V24, P119, DOI 10.1096/fj.09-136457; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Murrin LC, 2007, J NEUROIMMUNE PHARM, V2, P290, DOI 10.1007/s11481-007-9079-x; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Nistico R, 2012, EUR J NEURODEG DIS, V1, P21; Palavicini JP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.183; Palavicini JP, 2013, J ALZHEIMER IN PRESS; Provoda CJ, 2000, J BIOL CHEM, V275, P7004, DOI 10.1074/jbc.275.10.7004; Quast T, 2003, FASEB J, V17, P1739, DOI 10.1096/fj.02-1059fje; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; Roh S-E, 2013, FASEB J; Rutten BPF, 2005, AM J PATHOL, V167, P161, DOI 10.1016/S0002-9440(10)62963-X; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Suresh B, 2012, DRUG DISCOV TODAY, V17, P379, DOI 10.1016/j.drudis.2011.10.030; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Sze CI, 2000, J NEUROL SCI, V175, P81, DOI 10.1016/S0022-510X(00)00285-9; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Wang H, 2013, J BIOL CHEM, V7; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; Woo JA, 2012, CELL DEATH DIFFER, V19, P1413, DOI 10.1038/cdd.2012.14; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200	43	59	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e85484	10.1371/journal.pone.0085484	http://dx.doi.org/10.1371/journal.pone.0085484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24454876	Green Submitted, Green Published, gold			2022-12-25	WOS:000329925800047
J	Sun, YY; Chen, LN; Xu, RD; Kong, RQ				Sun, Yuanyuan; Chen, Lina; Xu, Rudan; Kong, Ruiqing			An Image Encryption Algorithm Utilizing Julia Sets and Hilbert Curves	PLOS ONE			English	Article							CRYPTANALYSIS	Image encryption is an important and effective technique to protect image security. In this paper, a novel image encryption algorithm combining Julia sets and Hilbert curves is proposed. The algorithm utilizes Julia sets' parameters to generate a random sequence as the initial keys and gets the final encryption keys by scrambling the initial keys through the Hilbert curve. The final cipher image is obtained by modulo arithmetic and diffuse operation. In this method, it needs only a few parameters for the key generation, which greatly reduces the storage space. Moreover, because of the Julia sets' properties, such as infiniteness and chaotic characteristics, the keys have high sensitivity even to a tiny perturbation. The experimental results indicate that the algorithm has large key space, good statistical property, high sensitivity for the keys, and effective resistance to the chosen-plaintext attack.	[Sun, Yuanyuan; Xu, Rudan; Kong, Ruiqing] Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Peoples R China; [Chen, Lina] Chinese Acad Sci, Natl Astron Observ, Beijing, Peoples R China	Dalian University of Technology; Chinese Academy of Sciences; National Astronomical Observatory, CAS	Sun, YY (corresponding author), Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Peoples R China.	syuan@dlut.edu.cn			National Natural Science Foundation of China [61103147, 61075018, 61070098]; National Key Project of Science and Technology of China [2011ZX05039-003-4]; Fundamental Research Funds for the Central Universities [DUT12JB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project of Science and Technology of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the National Natural Science Foundation of China (No. 61103147, 61075018, 61070098, http://www.nsfc.gov.cn), the National Key Project of Science and Technology of China (No. 2011ZX05039-003-4, http://www.most.gov.cn) and the Fundamental Research Funds for the Central Universities (No. DUT12JB06, http://www.dlut.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen GR, 2004, CHAOS SOLITON FRACT, V21, P749, DOI 10.1016/j.chaos.2003.12.022; Falconer KJ, 2003, FRACTAL MATH FDN APP; Hermassi H, 2010, COMMUN NONLINEAR SCI, V15, P2987, DOI 10.1016/j.cnsns.2009.11.022; Kumar S, 2006, MILCOM 2006, P1, DOI [10.1109/MILCOM.2006.302396, DOI 10.1109/MILCOM.2006.302396]; Li CQ, 2012, NONLINEAR DYNAM, V70, P2383, DOI 10.1007/s11071-012-0626-5; Li CQ, 2011, SIGNAL PROCESS, V91, P949, DOI 10.1016/j.sigpro.2010.09.014; Lin KT, 2012, OPT COMMUN, V285, P2335, DOI 10.1016/j.optcom.2012.01.028; Liu Wen-tao, 2008, Journal of China Academy of Electronics and Information Technology, V3, P580; Lock Abraham Jun Jiang, 2010, Proceedings Second International Conference on Computer Research and Development (ICCRD 2010), P213, DOI 10.1109/ICCRD.2010.40; Rozouvan V, 2009, OPT LASER ENG, V47, P1, DOI 10.1016/j.optlaseng.2008.09.001; Shyu SH, 2007, PATTERN RECOGN, V40, P1014, DOI 10.1016/j.patcog.2006.02.025; Tong XJ, 2009, SIGNAL PROCESS, V89, P480, DOI 10.1016/j.sigpro.2008.09.011; Yuan-yuan Sun, 2010, 2010 International Workshop on Chaos-Fractals Theories and Applications (IWCFTA 2010), P170, DOI 10.1109/IWCFTA.2010.70; Yuen CH, 2012, FRACTALS, V20, P41, DOI 10.1142/S0218348X12500041; Yuen CH, 2011, APPL SOFT COMPUT, V11, P5092, DOI 10.1016/j.asoc.2011.05.050	15	95	96	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84655	10.1371/journal.pone.0084655	http://dx.doi.org/10.1371/journal.pone.0084655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	24404181	Green Published, gold			2022-12-25	WOS:000329460800060
J	Martin-Serra, A; Figueirido, B; Palmqvist, P				Martin-Serra, Alberto; Figueirido, Borja; Palmqvist, Paul			A Three-Dimensional Analysis of Morphological Evolution and Locomotor Performance of the Carnivoran Forelimb	PLOS ONE			English	Article							FUNCTIONAL TRADE-OFFS; GEOMETRIC MORPHOMETRICS; BODY-SIZE; PREDATORY BEHAVIOR; LIMB MUSCLES; LATE MIOCENE; SKULL SHAPE; MAMMALIA; EXTANT; EXTINCT	In this study, three-dimensional landmark-based methods of geometric morphometrics are used for estimating the influence of phylogeny, allometry and locomotor performance on forelimb shape in living and extinct carnivorans (Mammalia, Carnivora). The main objective is to investigate morphological convergences towards similar locomotor strategies in the shape of the major forelimb bones. Results indicate that both size and phylogeny have strong effects on the anatomy of all forelimb bones. In contrast, bone shape does not correlate in the living taxa with maximum running speed or daily movement distance, two proxies closely related to locomotor performance. A phylomorphospace approach showed that shape variation in forelimb bones mainly relates to changes in bone robustness. This indicates the presence of biomechanical constraints resulting from opposite demands for energetic efficiency in locomotion -which would require a slender forelimb-and resistance to stress -which would be satisfied by a robust forelimb-. Thus, we interpret that the need of maintaining a trade-off between both functional demands would limit shape variability in forelimb bones. Given that different situations can lead to one or another morphological solution, depending on the specific ecology of taxa, the evolution of forelimb morphology represents a remarkable "one-to-many mapping'' case between anatomy and ecology.	[Martin-Serra, Alberto; Figueirido, Borja; Palmqvist, Paul] Univ Malaga, Fac Ciencias, Dept Ecol & Geol, E-29071 Malaga, Spain	Universidad de Malaga	Martin-Serra, A (corresponding author), Univ Malaga, Fac Ciencias, Dept Ecol & Geol, E-29071 Malaga, Spain.	almarse@uma.es	Figueirido, Borja/AAV-7882-2020; Martín-Serra, Alberto/C-3460-2015; Figueirido, Borja/G-9665-2015; Palmqvist, Paul/B-5378-2013; Simoes, Nuno/D-9974-2011	Figueirido, Borja/0000-0003-2542-3977; Martín-Serra, Alberto/0000-0003-0221-1103; Figueirido, Borja/0000-0003-2542-3977; Palmqvist, Paul/0000-0002-6630-6956; Martinez, Ana/0000-0002-0515-1946; Simoes, Nuno/0000-0001-7490-3147; Castillo Hernandez, Tania/0000-0002-9492-855X; Mascaro, Maite/0000-0003-3614-4383; Lopez-Rull, Isabel/0000-0002-3255-0459	Spanish Ministry of Education PhD Research Fellowship (FPU); Spanish Ministry of Science and Innovation [CGL2008-04896, CGL2011-30334, CGL2012-37866]; Junta de Andalucia [Hum-7248]	Spanish Ministry of Education PhD Research Fellowship (FPU)(German Research Foundation (DFG)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia)	This study was supported by the Spanish Ministry of Education PhD Research Fellowship (FPU) to AMS, projects CGL2008-04896, CGL2011-30334 and CGL2012-37866 from the Spanish Ministry of Science and Innovation, and project Hum-7248 from Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; ALBERCH P, 1980, AM ZOOL, V20, P653; Alexander RM, 2005, J EXP BIOL, V208, P1645, DOI 10.1242/jeb.01484; Alexander RM., 2003, PRINCIPLES ANIMAL LO; Andersson K, 2005, PALEOBIOLOGY, V31, P56, DOI 10.1666/0094-8373(2005)031<0056:WTPCIT>2.0.CO;2; Andersson K, 2003, P ROY SOC B-BIOL SCI, V270, pS163, DOI 10.1098/rsbl.2003.0070; Andersson K, 2003, THESIS U UPPSALA SWE; Anton M, 2004, J VERTEBR PALEONTOL, V24, P957, DOI 10.1671/0272-4634(2004)024[0957:FKCSOT]2.0.CO;2; Anton M, 2004, ZOOL J LINN SOC-LOND, V140, P207, DOI 10.1111/j.1096-3642.2003.00093.x; Anyonge W, 1996, J ZOOL, V238, P395, DOI 10.1111/j.1469-7998.1996.tb05402.x; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Barone R, 1986, ANATOMIE COMP MAMMIF, V1; Beisiegel Beatriz de Mello, 2005, Mammalian Species, P1, DOI 10.1644/783.1; BERTRAM JEA, 1990, J MORPHOL, V204, P157, DOI 10.1002/jmor.1052040205; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; BIEWENER AA, 1983, J EXP BIOL, V105, P147; BIEWENER AA, 1983, J EXP BIOL, V103, P131; Biewener AA., 2003, ANIMAL LOCOMOTION; Christiansen P, 2002, ZOOL J LINN SOC-LOND, V136, P685, DOI 10.1046/j.1096-3642.2002.00041.x; Ercoli MD, 2012, ZOOL J LINN SOC-LOND, V165, P224, DOI 10.1111/j.1096-3642.2011.00793.x; Day LM, 2007, J EXP BIOL, V210, P642, DOI 10.1242/jeb.02703; Diaz-Uriarte R, 1998, SYST BIOL, V47, P654, DOI 10.1080/106351598260653; Doube M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004742; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; Dryden IL, 1998, STAT ANAL SHAPE; Ewer, 1998, CARNIVORES; Fabre AC, 2013, J EVOLUTION BIOL, V26, P1521, DOI 10.1111/jeb.12161; Fabre AC, 2013, BIOL J LINN SOC, V110, P91, DOI 10.1111/bij.12103; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Figueirido B, 2010, J EVOLUTION BIOL, V23, P2579, DOI 10.1111/j.1420-9101.2010.02117.x; Figueirido B, 2013, EVOLUTION, V67, P1975, DOI 10.1111/evo.12059; Figueirido B, 2011, BIOL LETTERS, V7, P937, DOI 10.1098/rsbl.2011.0364; Figueirido B, 2011, PALEOBIOLOGY, V37, P490, DOI 10.1666/09062.1; Finarelli JA, 2006, SYST BIOL, V55, P301, DOI 10.1080/10635150500541698; GARLAND T, 1993, J ZOOL, V229, P133, DOI 10.1111/j.1469-7998.1993.tb02626.x; GARLAND T, 1983, AM NAT, V121, P571, DOI 10.1086/284084; Gidaszewski NA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-110; GONYEA WJ, 1978, ACTA ANAT, V102, P111, DOI 10.1159/000145627; GOSLOW GE, 1981, J EXP BIOL, V94, P15; GUNNELL GF, 1998, EVOLUTION TERTIARY M, V1, P91; Halenar LB, 2011, ANAT REC, V294, P2048, DOI 10.1002/ar.21499; Hanna JB, 2006, AM J PHYS ANTHROPOL, V130, P529, DOI 10.1002/ajpa.20385; Harris MA, 1997, J ZOOL, V241, P381, DOI 10.1111/j.1469-7998.1997.tb01966.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hildebrand M., 1985, P38; Homberger DG, 2004, VERTEBRATE DISSECTIO; Hunt Robert M. Jr, 1998, P196; Iriarte-Diaz J, 2002, J EXP BIOL, V205, P2897; Iwaniuk AN, 1999, BEHAV BRAIN RES, V99, P35, DOI 10.1016/S0166-4328(98)00067-9; Janis CM, 2012, J VERTEBR PALEONTOL, V32, P433, DOI 10.1080/02724634.2012.635737; Janis Christine M., 1993, Journal of Mammalian Evolution, V1, P103, DOI 10.1007/BF01041590; Janis CM, 2008, EVOLUTION OF TERTIARY MAMMALS OF NORTH AMERICA, VOL 2, P1, DOI 10.1017/CBO9780511541438; Kardong K., 2006, VERTEBRATES COMP ANA; Kemp TJ, 2005, J EXP BIOL, V208, P3475, DOI 10.1242/jeb.01814; Klingenberg CP, 2012, J EVOLUTION BIOL, V25, P115, DOI 10.1111/j.1420-9101.2011.02410.x; Klingenberg CP, 2013, HYSTRIX, V24, P15, DOI 10.4404/hystrix-24.1-7691; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; Klingenberg CP, 1996, BIOL J LINN SOC, V59, P143; Klingenberg CP, 2011, MORPHOJ; Koepfli KP, 2007, MOL PHYLOGENET EVOL, V43, P1076, DOI 10.1016/j.ympev.2006.10.003; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Krausman Paul R., 2005, Mammalian Species, P1; Laurin M, 2004, SYST BIOL, V53, P594, DOI 10.1080/10635150490445706; Lee DV, 1999, J EXP BIOL, V202, P3565; MacLeod N, 2001, PALEOBIOLOGY, V27, P226, DOI 10.1666/0094-8373(2001)027<0226:TROPIQ>2.0.CO;2; MACLEOD N, 1993, AM J SCI, V293A, P300, DOI 10.2475/ajs.293.A.300; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Maddison WP, 2011, MESQUITE MODULAR SYS; Martin LD, 1998, EVOLUTION TERTIARY M, P228; McLellan B, 1994, BEARS THEIR BIOL MAN, P85; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; Meachen-Samuels J, 2009, J MORPHOL, V270, P729, DOI 10.1002/jmor.10712; Meachen-Samuels JA, 2012, PALEOBIOLOGY, V38, P1, DOI 10.1666/10036.1; Meachen-Samuels JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011412; Meloro C, 2013, PALEOBIOLOGY, V39, P323, DOI 10.1666/12001; Midford P.E., 2008, PDAP PACKAGE MESQUIT; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; Morlo M, 2004, ZOOL J LINN SOC-LOND, V140, P43, DOI 10.1111/j.1096-3642.2004.00087.x; Nyakatura K, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-12; Osborn HF, 1900, B AM MUS NAT HIST, V13, P269; Pasi BM, 2003, J EVOLUTION BIOL, V16, P324, DOI 10.1046/j.1420-9101.2003.00512.x; Peigne S, 2003, ZOOL SCR, V32, P199, DOI 10.1046/j.1463-6409.2003.00116.x; Polly P. David, 2008, P167, DOI 10.1007/978-1-4020-6997-0_9; Polly PD, 2001, AM NAT, V157, P596, DOI 10.1086/320622; Raichlen DA, 2009, AM J PHYS ANTHROPOL, V138, P395, DOI 10.1002/ajpa.20952; REYNOLDS TR, 1985, AM J PHYS ANTHROPOL, V67, P335, DOI 10.1002/ajpa.1330670406; Rohlf F. James, 2002, VVolume 64, P175; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rothwell T, 2003, AM MUS NOV, V3403; Salesa MJ, 2011, RED PANDA: BIOLOGY AND CONSERVATION OF THE FIRST PANDA, P27, DOI 10.1016/B978-1-4377-7813-7.00003-3; Salesa MJ, 2010, J ANAT, V216, P381, DOI 10.1111/j.1469-7580.2009.01178.x; Samuels JX, 2008, J MORPHOL, V269, P1387, DOI 10.1002/jmor.10662; Samuels JX, 2013, J MORPHOL, V274, P121, DOI 10.1002/jmor.20077; Sanger TJ, 2012, EVOLUTION, V66, P1525, DOI 10.1111/j.1558-5646.2011.01519.x; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Schmitt D, 2002, AM J PHYS ANTHROPOL, V118, P231, DOI 10.1002/ajpa.10048; Schoenebeck JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002849; Schutz H, 2007, ZOOL J LINN SOC-LOND, V150, P895, DOI 10.1111/j.1096-3642.2007.00303.x; Schwenk K, 2003, KEYWORDS CONCEPTS EV, P52; Singleton M, 2012, EVOL BIOL, V39, P499, DOI 10.1007/s11692-011-9153-4; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Sorkin B, 2008, LETHAIA, V41, P333, DOI 10.1111/j.1502-3931.2007.00091.x; SPOOR CF, 1986, ANAT ANZEIGER, V161, P375; Stein BR, 1997, J ZOOL, V242, P185, DOI 10.1111/j.1469-7998.1997.tb02939.x; STEUDEL K, 1993, J MORPHOL, V217, P55, DOI 10.1002/jmor.1052170105; STRANG KT, 1990, J ZOOL, V221, P343, DOI 10.1111/j.1469-7998.1990.tb04006.x; Taylor M.E., 1989, P382; Turner A., 1997, BIG CATS THEIR FOSSI; van Valkenburgh B., 1987, Journal of Vertebrate Paleontology, V7, P162; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; VANVALKENBURGH B, 1985, PALEOBIOLOGY, V11, P406, DOI 10.1017/S0094837300011702; Wallace SC, 2011, RED PANDA: BIOLOGY AND CONSERVATION OF THE FIRST PANDA, P43, DOI 10.1016/B978-1-4377-7813-7.00004-5; Walmsley A, 2012, J MORPHOL, V273, P1424, DOI 10.1002/jmor.20084; Walter RM, 2007, J EXP BIOL, V210, P208, DOI 10.1242/jeb.02645; Wang XM, 1999, B AM MUS NAT HIST, P1; Wiley DF, 2005, IEEE VISUALIZATION 2005, PROCEEDINGS, P431; Wilson DE, 2009, HDB MAMMALS WORLD, V1; Wortman, 1894, B AM MUS NAT HIST, V6, P129; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Wroe S, 2007, EVOLUTION, V61, P1251, DOI 10.1111/j.1558-5646.2007.00101.x	126	64	64	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85574	10.1371/journal.pone.0085574	http://dx.doi.org/10.1371/journal.pone.0085574			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	25229639	Green Published, gold, Green Submitted			2022-12-25	WOS:000330235100101
J	Adams, J; Light, R				Adams, Jimi; Light, Ryan			Mapping Interdisciplinary Fields: Efficiencies, Gaps and Redundancies in HIV/AIDS Research	PLOS ONE			English	Article								While interdisciplinarity continues to increase in popularity among funders and other scientific organizations, its potential to promote scientific advances remains under-examined. For HIV/AIDS research, we examine the dynamics of disciplinary integration (or lack thereof) providing insight into a field's knowledge base and those questions that remain unresolved. Drawing on the complete histories of two interdisciplinary journals, we construct bibliographic coupling networks based on overlapping citations to identify segregation into research clusters and estimate topic models of research content. We then compare how readily those bibliographic coupling clusters account for the structuring of topics covered within the field as it evolves over two decades. These comparisons challenge one-dimensional and/or cross-sectional approaches to interdisciplinarity. Some topics are increasingly coordinated across disciplinary boundaries (e. g., vaccine development); others remain relatively segmented into disconnected disciplinary domains for the full period (e. g., drug resistance). This divergence indicates heterogeneity in interdisciplinarity and emphasizes the need for critical approaches to studying the organization of science.	[Adams, Jimi] Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA; [Light, Ryan] Univ Oregon, Dept Sociol, Eugene, OR 97403 USA	University of Colorado System; University of Colorado Denver; University of Oregon	Adams, J (corresponding author), Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA.	jimi.adams@ucdenver.edu	Adams, Jean/G-2402-2010; Light, Ryan/AAA-1684-2019; adams, jimi/H-5997-2016	Adams, Jean/0000-0002-5733-7830; adams, jimi/0000-0001-5043-1149; Nettle, Daniel/0000-0001-9089-2599; Light, Ryan/0000-0002-1508-154X	Robert Wood Johnson Foundation's Health and Society Scholars Program at Columbia University; Medical Research Council [MR/K02325X/1] Funding Source: researchfish	Robert Wood Johnson Foundation's Health and Society Scholars Program at Columbia University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Robert Wood Johnson Foundation's Health and Society Scholars Program at Columbia University provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured], DOI DOI 10.1103/PhysRevE.69.066133; [Anonymous], 1992, ASA P STAT GRAPH SEC; [Anonymous], PREP FUT HIV AIDS AF; [Anonymous], CULTURAL BOUNDARIES; [Anonymous], 2012, AIDS 30 HIST; [Anonymous], SCI SCI SCI2 TOOL; Bettencourt LMA, 2008, SCIENTOMETRICS, V75, P495, DOI 10.1007/s11192-007-1888-4; Bettencourt LMA, 2011, P NATL ACAD SCI USA, V108, P19540, DOI 10.1073/pnas.1102712108; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borner K, 2003, ANNU REV INFORM SCI, V37, P179, DOI 10.1002/aris.1440370106; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Crane D., 1972, INVISIBLE COLL DIFFU; Csardi N., 2006, INT J COMP SYST, V1695, P1; Garfield E, 2001, BIBLIOGRAPHIC COUPLI; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Jacobs J., 2013, DEFENSE DISCIPLINES; Jacobs JA, 2009, ANNU REV SOCIOL, V35, P43, DOI 10.1146/annurev-soc-070308-115954; Klavans R, 2006, J AM SOC INF SCI TEC, V57, P251, DOI 10.1002/asi.20274; Knorr-Cetina Karin, 1999, EPISTEMIC CULTURES S; Leydesdorff L, 2006, J AM SOC INF SCI TEC, V57, P1616, DOI 10.1002/asi.20335; Manton KG, 2009, P NATL ACAD SCI USA, V106, P10981, DOI 10.1073/pnas.0905104106; Moody James, 2006, AM SOCIOL, V37, P67; National Academy of Sciences, 2005, FAC INT RES; National Institutes of Health, 2007, NIH NEWS; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Porter AL, 2007, SCIENTOMETRICS, V72, P117, DOI 10.1007/s11192-007-1700-5; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; SENGUPTA IN, 1991, SCIENTOMETRICS, V20, P297, DOI 10.1007/BF02018160; Shwed U, 2010, AM SOCIOL REV, V75, P817, DOI 10.1177/0003122410388488; Small H, 2010, SCIENTOMETRICS, V83, P835, DOI 10.1007/s11192-009-0121-z; Steyvers M, 2007, HDB LATENT SEMANTIC; Wilbur W John, 2002, Pac Symp Biocomput, P386; Yan EJ, 2012, J AM SOC INF SCI TEC, V63, P1313, DOI 10.1002/asi.22680	38	22	23	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115092	10.1371/journal.pone.0115092	http://dx.doi.org/10.1371/journal.pone.0115092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9WY	25506703	Green Published, Green Submitted, gold			2022-12-25	WOS:000346607100048
J	Tang, Y; He, H; Cheng, N; Song, YL; Ding, WJ; Zhang, YF; Zhang, WH; Zhang, J; Peng, H; Jiang, H				Tang, Yi; He, Hua; Cheng, Ning; Song, Yanling; Ding, Weijin; Zhang, Yingfan; Zhang, Wenhao; Zhang, Jie; Peng, Heng; Jiang, Hua			PDGF, NT-3 and IGF-2 in Combination Induced Transdifferentiation of Muscle-Derived Stem Cells into Schwann Cell-Like Cells	PLOS ONE			English	Article							DIFFERENTIATION; REGENERATION	Muscle-derived stem cells (MDSCs) are multipotent stem cells with a remarkable long-term self-renewal and regeneration capacity. Here, we show that postnatal MDSCs could be transdifferentiated into Schwann cell-like cells upon the combined treatment of three neurotrophic factors (PDGF, NT-3 and IGF-2). The transdifferentiation of MDSCs was initially induced by Schwann cell (SC) conditioned medium. MDSCs adopted a spindle-like morphology similar to SCs after the transdifferentiation. Immunocytochemistry and immunoblot showed clearly that the SC markers S100, GFAP and p75 were expressed highly only after the transdifferentiation. Flow cytometry assay showed that the portion of S100 expressed cells was more than 60 percent and over one fourth of the transdifferentiated cells expressed all the three SC markers, indicating an efficient transdifferentiation. We then tested neurotrophic factors in the conditioned medium and found it was PDGF, NT-3 and IGF-2 in combination that conducted the transdifferentiation. Our findings demonstrate that it is possible to use specific neurotrophic factors to transdifferentiate MDSCs into Schwann cell-like cells, which might be therapeutically useful for clinical applications.	[Tang, Yi; Song, Yanling; Ding, Weijin; Zhang, Yingfan; Zhang, Jie; Jiang, Hua] Second Mil Med Univ, Changzheng Hosp, Dept Plast Surg, Shanghai, Peoples R China; [Tang, Yi] 411 Hosp CPLA, Dept Plast Surg, Shanghai, Peoples R China; [He, Hua] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Cheng, Ning] Second Mil Med Univ, Changhai Hosp, Dept Transfus, Shanghai, Peoples R China; [Zhang, Wenhao] Shanghai Jiao Tong Univ, XinHua Hosp, Dept Hematol, Sch Med, Shanghai 200030, Peoples R China; [Peng, Heng] Hong Kong Baptist Univ, Dept Math, Kowloon, Hong Kong, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Shanghai Jiao Tong University; Hong Kong Baptist University	Jiang, H (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Plast Surg, Shanghai, Peoples R China.	lmiao.simm@gmail.com	Peng, Heng/B-7152-2009; Johnson, William/N-1972-2017	Peng, Heng/0000-0001-7807-8527; Johnson, William/0000-0002-3823-4094	National Natural Science Foundation of China [81100950]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 81100950. Website http://www.nsfc.gov.cn no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; BUNGE RP, 1994, J NEUROL, V242, pS19, DOI 10.1007/BF00939235; Cheng HL, 1999, ENDOCRINOLOGY, V140, P4478, DOI 10.1210/en.140.10.4478; Cohen RI, 1999, J EXP BIOL, V202, P461; Deasy BM, 2001, BLOOD CELL MOL DIS, V27, P924, DOI 10.1006/bcmd.2001.0463; Deasy BM, 2005, MOL BIOL CELL, V16, P3323, DOI 10.1091/mbc.E05-02-0169; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Grompe M, 2012, CELL STEM CELL, V10, P685, DOI 10.1016/j.stem.2012.04.006; GUENARD V, 1992, J NEUROSCI, V12, P3310; Ide C, 1996, NEUROSCI RES, V25, P101; Keilhoff G, 2006, EUR J CELL BIOL, V85, P11, DOI 10.1016/j.ejcb.2005.09.021; Keilhoff G, 2000, NEUROREPORT, V11, P3805, DOI 10.1097/00001756-200011270-00042; Keilhoff G, 1999, J NEUROSCI METH, V89, P17, DOI 10.1016/S0165-0270(99)00034-5; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Li QF, 2006, MICROSURG, V26, P116, DOI 10.1002/micr.20192; Mosahebi A, 2001, GLIA, V34, P8, DOI 10.1002/glia.1035; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Usas A, 2007, BIOMATERIALS, V28, P5401, DOI 10.1016/j.biomaterials.2007.09.008; Zhao JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041506	22	62	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2014	9	1							e73402	10.1371/journal.pone.0073402	http://dx.doi.org/10.1371/journal.pone.0073402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292TQ	24637790	Green Submitted, Green Published, gold			2022-12-25	WOS:000329925800001
J	Kim, JA; Choi, HJ; Kwon, YK; Ryu, DH; Kwon, TH; Hwang, GS				Kim, Ju-Ae; Choi, Hyo-Jung; Kwon, Yong-Kook; Ryu, Do Hyun; Kwon, Tae-Hwan; Hwang, Geum-Sook			H-1 NMR-Based Metabolite Profiling of Plasma in a Rat Model of Chronic Kidney Disease	PLOS ONE			English	Article							EXPERIMENTAL CHRONIC UREMIA; AMINO-ACID-METABOLISM; SKELETAL-MUSCLE; GLUTAMINE FORMATION; SERUM METABOLITES; PROXIMAL TUBULE; PROTEIN; ALANINE; CITRATE; COTRANSPORTER	Chronic kidney disease (CKD) is characterized by the gradual loss of the kidney function to excrete wastes and fluids from the blood. H-1 NMR-based metabolomics was exploited to investigate the altered metabolic pattern in rats with CKD induced by surgical reduction of the renal mass (i.e., 5/6 nephrectomy (5/6 Nx)), particularly for identifying specific metabolic biomarkers associated with early of CKD. Plasma metabolite profiling was performed in CKD rats (at 4- or 8-weeks after 5/6 Nx) compared to sham-operated rats. Principle components analysis (PCA), partial least squares-discriminant analysis (PLS-DA) and orthogonal partial least squares-discriminant analysis (OPLS-DA) score plots showed a significant separation between the groups. The resulting metabolic profiles demonstrated significantly increased plasma levels of organic anions, including citrate, beta-hydroxybutyrate, lactate, acetate, acetoacetate, and formate in CKD. Moreover, levels of alanine, glutamine, and glutamate were significantly higher. These changes were likely to be associated with complicated metabolic acidosis in CKD for counteracting systemic metabolic acidosis or increased protein catabolism from muscle. In contrast, levels of VLDL/LDL (CH2)(n) and N-acetylglycoproteins were decreased. Taken together, the observed changes of plasma metabolite profiles in CKD rats provide insights into the disturbed metabolism in early phase of CKD, in particular for the altered metabolism of acid-base and/or amino acids.	[Kim, Ju-Ae; Kwon, Yong-Kook; Hwang, Geum-Sook] Korea Basic Sci Inst, Integrated Metabol Res Grp, Seoul Ctr, Seoul, South Korea; [Kim, Ju-Ae; Ryu, Do Hyun] Sungkyunkwan Univ, Dept Chem, Suwon, South Korea; [Choi, Hyo-Jung; Kwon, Tae-Hwan] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu 702701, South Korea; [Kwon, Yong-Kook; Hwang, Geum-Sook] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon, South Korea	Korea Basic Science Institute (KBSI); Sungkyunkwan University (SKKU); Kyungpook National University; Chungnam National University	Kwon, TH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu 702701, South Korea.	thkwon@knu.ac.kr; gshwang@kbsi.re.kr	Ryu, Do Hyun/ADI-9819-2022; Kwon, Tae-Hwan/ABA-1981-2020		National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning, Korea [2010-0019393, 2010-0019394, 2013R1A1A2007266, 2013M3A9B6046418]; Korea Healthcare Technology R&D Project, Ministry of Health Welfare, Korea [A111345]; Korea Basic Science Institute [T33409]; Creative Allied Project (CAP); Kyungpook National University Research Fund	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning, Korea; Korea Healthcare Technology R&D Project, Ministry of Health Welfare, Korea; Korea Basic Science Institute; Creative Allied Project (CAP); Kyungpook National University Research Fund	This study was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning, Korea (2010-0019393, 2010-0019394, 2013R1A1A2007266, and 2013M3A9B6046418); the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Korea (A111345), Korea Basic Science Institute (T33409), the Creative Allied Project (CAP), and Kyungpook National University Research Fund, 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A RJ, 2000, KIDNEY, P455; Adeva MM, 2011, CLIN NUTR, V30, P416, DOI 10.1016/j.clnu.2011.03.008; ALPERN RJ, 1990, PHYSIOL REV, V70, P79, DOI 10.1152/physrev.1990.70.1.79; ALPERN RJ, 1995, KIDNEY INT, V47, P1205, DOI 10.1038/ki.1995.171; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; BORON WF, 1983, J GEN PHYSIOL, V81, P53, DOI 10.1085/jgp.81.1.53; BOUBY N, 1993, KIDNEY INT, V44, P676, DOI 10.1038/ki.1993.300; BRENNAN S, 1988, AM J PHYSIOL, V255, pF301, DOI 10.1152/ajprenal.1988.255.2.F301; CHARLES J.C., 2005, HOSP PHYS, V1, P37; Choi HJ, 2012, J PROTEOME RES, V11, P3816, DOI 10.1021/pr300309d; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Choi JY, 2011, NEPHROL DIAL TRANSPL, V26, P1304, DOI 10.1093/ndt/gfq554; CONDON JR, 1971, CLIN CHIM ACTA, V32, P333, DOI 10.1016/0009-8981(71)90433-5; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; FARBER MO, 1976, CLIN SCI MOL MED, V50, P165, DOI 10.1042/cs0500165; GARBER AJ, 1976, J BIOL CHEM, V251, P826; GARBER AJ, 1978, J CLIN INVEST, V62, P633, DOI 10.1172/JCI109170; GARBER AJ, 1978, J CLIN INVEST, V62, P623, DOI 10.1172/JCI109169; HAMM LL, 1990, KIDNEY INT, V38, P728, DOI 10.1038/ki.1990.265; Hong YS, 2010, ARCH PHARM RES, V33, P1091, DOI 10.1007/s12272-010-0716-1; Hwang GS, 2010, AM J PHYSIOL-RENAL, V298, pF461, DOI 10.1152/ajprenal.00389.2009; Jang ZH, 2012, MOL BIOSYST, V8, P2001, DOI 10.1039/c2mb25073j; JENKINS AD, 1985, AM J PHYSIOL, V249, pF590, DOI 10.1152/ajprenal.1985.249.4.F590; Jung JY, 2011, STROKE, V42, P1282, DOI 10.1161/STROKEAHA.110.598789; Kim CD, 2010, TRANSPLANTATION, V90, P748, DOI 10.1097/TP.0b013e3181edd69a; Kirschenlohr HL, 2006, NAT MED, V12, P705, DOI 10.1038/nm1432; Kovesdy CP, 2009, NEPHROL DIAL TRANSPL, V24, P1232, DOI 10.1093/ndt/gfn633; Kraut JA, 2005, AM J KIDNEY DIS, V45, P978, DOI 10.1053/j.ajkd.2005.03.003; Kwon TH, 2002, AM J PHYSIOL-RENAL, V282, pF341, DOI 10.1152/ajprenal.00104.2001; Kwon TH, 1998, AM J PHYSIOL-RENAL, V275, pF724, DOI 10.1152/ajprenal.1998.275.5.F724; Kwon TH, 1999, AM J PHYSIOL-RENAL, V277, pF257, DOI 10.1152/ajprenal.1999.277.2.F257; Laing CM, 2005, INT J BIOCHEM CELL B, V37, P1151, DOI 10.1016/j.biocel.2005.01.002; MADDOX DA, 1986, J CLIN INVEST, V77, P1639, DOI 10.1172/JCI112481; MAY RC, 1987, J CLIN INVEST, V79, P1099, DOI 10.1172/JCI112924; MAY RC, 1986, J CLIN INVEST, V77, P614, DOI 10.1172/JCI112344; Roderick PJ, 2007, COCHRANE DB SYST REV, V1; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Schicho R, 2012, J PROTEOME RES, V11, P3344, DOI 10.1021/pr300139q; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Somashekar BS, 2012, J PROTEOME RES, V11, P4873, DOI 10.1021/pr300345x; Tanner GA, 2000, KIDNEY INT, V58, P1859, DOI 10.1046/j.1523-1755.2000.00357.x; Vorum H, 2000, AM J PHYSIOL-RENAL, V279, pF901, DOI 10.1152/ajprenal.2000.279.5.F901; Weiner ID, 2011, CORE CONCEPTS DISORD, P203; Zhao YY, 2012, CLIN CHIM ACTA, V413, P642, DOI 10.1016/j.cca.2011.12.014	46	89	100	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85445	10.1371/journal.pone.0085445	http://dx.doi.org/10.1371/journal.pone.0085445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24647444	Green Submitted, Green Published, gold			2022-12-25	WOS:000330240500046
J	Zhao, JP; Levy, E; Fraser, WD; Julien, P; Delvin, E; Montoudis, A; Spahis, S; Garofalo, C; Nuyt, AM; Luo, ZC				Zhao, Jin-Ping; Levy, Emile; Fraser, William D.; Julien, Pierre; Delvin, Edgard; Montoudis, Alain; Spahis, Schohraya; Garofalo, Carole; Nuyt, Anne Monique; Luo, Zhong-Cheng			Circulating Docosahexaenoic Acid Levels Are Associated with Fetal Insulin Sensitivity	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; GESTATIONAL DIABETES-MELLITUS; ALPHA-LINOLENIC ACID; PHOSPHOLIPID-COMPOSITION; DESATURASE ACTIVITIES; ARACHIDONIC-ACID; PREGNANCY; GLUCOSE; SECRETION; OBESITY	Background: Arachidonic acid (AA; C20: 4 n-6) and docosahexaenoic acid (DHA; C22: 6 n-3) are important long-chain polyunsaturated fatty acids (LC-PUFA) in maintaining pancreatic beta-cell structure and function. Newborns of gestational diabetic mothers are more susceptible to the development of type 2 diabetes in adulthood. It is not known whether low circulating AA or DHA is involved in perinatally "programming'' this susceptibility. This study aimed to assess whether circulating concentrations of AA, DHA and other fatty acids are associated with fetal insulin sensitivity or beta-cell function, and whether low circulating concentrations of AA or DHA are involved in compromised fetal insulin sensitivity in gestational diabetic pregnancies. Methods and Principal Findings: In a prospective singleton pregnancy cohort, maternal (32-35 weeks gestation) and cord plasma fatty acids were assessed in relation to surrogate indicators of fetal insulin sensitivity (cord plasma glucose-to-insulin ratio, proinsulin concentration) and beta-cell function (proinsulin-to-insulin ratio) in 108 mother-newborn pairs. Cord plasma DHA levels (in percentage of total fatty acids) were lower comparing newborns of gestational diabetic (n = 24) vs. nondiabetic pregnancies (2.9% vs. 3.5%, P = 0.01). Adjusting for gestational age at blood sampling, lower cord plasma DHA levels were associated with lower fetal insulin sensitivity (lower glucose-to-insulin ratio, r = 0.20, P = 0.036; higher proinsulin concentration, r = 20.37, P<0.0001). The associations remained after adjustment for maternal and newborn characteristics. Cord plasma saturated fatty acids C18:0 and C20:0 were negatively correlated with fetal insulin sensitivity, but their levels were not different between gestational diabetic and non-diabetic pregnancies. Cord plasma AA levels were not correlated with fetal insulin sensitivity. Conclusion: Low circulating DHA levels are associated with compromised fetal insulin sensitivity, and may be involved in perinatally "programming'' the susceptibility to type 2 diabetes in the offspring of gestational diabetic mothers.	[Zhao, Jin-Ping; Fraser, William D.; Luo, Zhong-Cheng] Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ, Canada; [Levy, Emile; Montoudis, Alain; Spahis, Schohraya; Garofalo, Carole] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Julien, Pierre] Laval Univ Hosp Res Ctr, Quebec City, PQ, Canada; [Julien, Pierre] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Delvin, Edgard] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Nuyt, Anne Monique] Univ Montreal, Dept Pediat, St Justine Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada; [Luo, Zhong-Cheng] Shanghai Jiao Tong Univ, Minist Educ, Shanghai Key Lab Childrens Environm Hlth, Xinhua Hosp,Sch Med, Shanghai 200030, Peoples R China	Universite de Montreal; Universite de Montreal; Laval University; Laval University; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Shanghai Jiao Tong University	Luo, ZC (corresponding author), Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ, Canada.	zc_luo@yahoo.com	Julien, Pierre/AGO-7542-2022; Luo, Zhong-Cheng/T-3882-2017	Julien, Pierre/0000-0002-9247-6676; Luo, Zhong-Cheng/0000-0002-1794-1312	Canadian Institutes of Health Research (CIHR) [79896, 78879]; Quebec Training Network in Perinatal Research (QTNPR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Quebec Training Network in Perinatal Research (QTNPR)	This work was supported by the Canadian Institutes of Health Research (CIHR grant no. 79896 and 78879). J-P Zhao is the recipient of a Postdoctoral Scholarship from Quebec Training Network in Perinatal Research (QTNPR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardenheier BH, 2013, DIABETES CARE, V36, P1209, DOI 10.2337/dc12-0901; Baur LA, 1998, METABOLISM, V47, P106, DOI 10.1016/S0026-0495(98)90202-5; Bergeron K, 2007, J LIPID RES, V48, P2396, DOI 10.1194/jlr.M700166-JLR200; Bitsanis D, 2006, LIPIDS, V41, P341, DOI 10.1007/s11745-006-5104-8; Brenner RR, 2003, PROSTAG LEUKOTR ESS, V68, P151, DOI 10.1016/S0952-3278(02)00265-X; Burdge GC, 2008, PROSTAG LEUKOTR ESS, V78, P73, DOI 10.1016/j.plefa.2007.10.028; Burdge GC, 2002, BRIT J NUTR, V88, P411, DOI 10.1079/BJN2002689; Burdge GC, 2006, NUTR RES REV, V19, P26, DOI 10.1079/NRR2005113; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Dabelea D, 2008, DIABETES CARE, V31, P1422, DOI 10.2337/dc07-2417; Decsi T, 2000, LIPIDS, V35, P1179, DOI 10.1007/s11745-000-0634-7; Dixon G, 2004, CLIN SCI, V106, P191, DOI 10.1042/CS20030261; FAAS FH, 1983, LIPIDS, V18, P339, DOI 10.1007/BF02534712; FIELD CJ, 1990, J BIOL CHEM, V265, P11143; Gibson RA, 2011, MATERN CHILD NUTR, V7, P17, DOI 10.1111/j.1740-8709.2011.00299.x; Innis SM, 2003, AM J CLIN NUTR, V77, P473, DOI 10.1093/ajcn/77.2.473; Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424; Konrad RJ, 1996, PANCREAS, V13, P253, DOI 10.1097/00006676-199610000-00007; KONRAD RJ, 1994, BIOCHEMISTRY-US, V33, P13284, DOI 10.1021/bi00249a015; Korotkova M, 2005, AM J PHYSIOL-REG I, V288, pR575, DOI 10.1152/ajpregu.00342.2004; Lambert M, 2004, INT J OBESITY, V28, P833, DOI 10.1038/sj.ijo.0802694; LEPAGE G, 1989, J LIPID RES, V30, P1483; Luo ZC, 2010, DIABETES CARE, V33, P2055, DOI 10.2337/dc10-0819; Luoto R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001036; Makrides M, 2000, AM J CLIN NUTR, V71, p307S, DOI 10.1093/ajcn/71.1.307S; Miller MR, 2012, J CLIN ENDOCR METAB, V97, P3285, DOI 10.1210/jc.2012-1318; Min Y, 2005, DIABETIC MED, V22, P914, DOI 10.1111/j.1464-5491.2005.01556.x; Min Y, 2004, DIABETOLOGIA, V47, P75, DOI 10.1007/s00125-003-1275-5; MONTELONGO A, 1992, DIABETES, V41, P1651, DOI 10.2337/diabetes.41.12.1651; Ortega-Senovilla H, 2009, DIABETES CARE, V32, P120, DOI 10.2337/dc08-0679; Resnick HE, 2000, DIABETES CARE, V23, P176, DOI 10.2337/diacare.23.2.176; Setia S, 2006, PATHOLOGY, V38, P236, DOI 10.1080/00313020600696256; Spahis S, 2008, PROSTAG LEUKOTR ESS, V79, P47, DOI 10.1016/j.plefa.2008.07.005; Steffen LM, 2008, INT J OBESITY, V32, P1297, DOI 10.1038/ijo.2008.89; Thomas BA, 2005, PROSTAG LEUKOTR ESS, V72, P335, DOI 10.1016/j.plefa.2005.01.001; Wang QW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059845; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37; Welch AA, 2010, AM J CLIN NUTR, V92, P1040, DOI 10.3945/ajcn.2010.29457; Whelan J, 2009, PROSTAG LEUKOTR ESS, V81, P133, DOI 10.1016/j.plefa.2009.05.008; Wijendran V, 2000, LIPIDS, V35, P927, DOI 10.1007/S11745-000-0602-2; Zhang G, 2012, J CLIN ENDOCR METAB, V97, pE973, DOI 10.1210/jc.2011-2997	42	252	260	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e85054	10.1371/journal.pone.0085054	http://dx.doi.org/10.1371/journal.pone.0085054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	25303175	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500037
J	Clutterbuck, S; Adams, J; Nettle, D				Clutterbuck, Stephanie; Adams, Jean; Nettle, Daniel			Childhood Adversity Accelerates Intended Reproductive Timing in Adolescent Girls without Increasing Interest in Infants	PLOS ONE			English	Article							SEX-DIFFERENCES; FATHER ABSENCE; EVOLUTIONARY-THEORY; LIFE-HISTORY; BABY SCHEMA; AGE; RESPONSIVENESS; YOUNG; MENARCHE; BABIES	Women experiencing greater childhood adversity exhibit faster reproductive trajectories. One possible psychological mechanism underlying this phenomenon is an increased interest in infants. Interest in infants is thought to be an adaptation important for successful rearing as it motivates the acquisition of caretaking skills. We investigated the relationships between childhood adversity, intended reproductive timing and interest in infants in a sample of English adolescent girls. Specifically we sought to investigate the relationship between 1) childhood adversity and intended reproductive timing; 2) childhood adversity and interest in infants; and 3) intended reproductive timing and interest in infants. Additionally we explored different methods of measuring interest in infants using self-reported fondness for babies, a forced choice adult versus infant paper-based preference task and a novel computer based attention task using adult and infant stimuli. In total 357 girls aged nine to 14 years participated in the study, which took place in schools. Participants completed the two interest in infants tasks before moving on to a childhood adversity questionnaire. Girls with more childhood adversity reported earlier ideal ages at parenthood. We found some evidence that, contrary to our predictions, girls with less childhood adversity were more interested in infants. There was no relationship between intended reproductive timing and interest in infants. The different measurements for interest in infants were only weakly related, if at all, highlighting the complexity of measuring this construct. Our findings suggest that rather than interest in infants being a mechanism for the effect of childhood adversity on early reproductive timing it might instead be an indicator of future reproductive strategies.	[Clutterbuck, Stephanie; Nettle, Daniel] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Adams, Jean] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Clutterbuck, S (corresponding author), Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	p.clutterbuck@ncl.ac.uk	Adams, Jean/G-2402-2010; Light, Ryan/AAA-1684-2019; adams, jimi/H-5997-2016	Adams, Jean/0000-0002-5733-7830; adams, jimi/0000-0001-5043-1149; Nettle, Daniel/0000-0001-9089-2599; Light, Ryan/0000-0002-1508-154X	North Tyneside Council [001]; Birtch Control Trust of the Galton Institute [001]; Medical Research Council [MR/K02325X/1] Funding Source: researchfish	North Tyneside Council; Birtch Control Trust of the Galton Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was partly funded from two sources: 1. The North Tyneside Council. Grant Number: 001 URL: http://www.northtyneside.gov.uk/, and 2. The Birtch Control Trust of the Galton Institute. Grant Number: 001 URL: http://www.galtoninstitute.org.uk/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber N, 2001, CROSS-CULT RES, V35, P263, DOI 10.1177/106939710103500301; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; BERMAN PW, 1975, SEX ROLES, V1, P311; BERMAN PW, 1978, CHILD DEV, V49, P917, DOI 10.2307/1128272; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; BLAKEMORE JEO, 1981, CHILD DEV, V52, P386; BLAKEMORE JEO, 1985, SEX ROLES, V13, P405, DOI 10.1007/BF00287951; Blell M, 2008, J BIOSOC SCI, V40, P563, DOI 10.1017/S0021932007002696; Bottino MN, 2012, J AFFECT DISORDERS, V142, P219, DOI 10.1016/j.jad.2012.04.030; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; DRAPER P, 1982, J ANTHROPOL RES, V38, P255, DOI 10.1086/jar.38.3.3629848; Duchowski A, 2007, EYE TRACKING METHODO, V373; Elliott D. S., 1985, EXPLAINING DELINQUEN; Ellis BJ, 2003, CHILD DEV, V74, P801, DOI 10.1111/1467-8624.00569; Ellis BJ, 2000, CHILD DEV, V71, P485, DOI 10.1111/1467-8624.00159; Ellis BJ, 2009, HUM NATURE-INT BIOS, V20, P204, DOI 10.1007/s12110-009-9063-7; FAIRBANKS LA, 1990, ANIM BEHAV, V40, P553, DOI 10.1016/S0003-3472(05)80536-6; FELDMAN SS, 1979, CHILD DEV, V50, P942, DOI 10.2307/1129318; FELDMAN SS, 1978, CHILD DEV, V49, P617, DOI 10.1111/j.1467-8624.1978.tb02361.x; FELDMAN SS, 1977, DEV PSYCHOL, V13, P675, DOI 10.1037/0012-1649.13.6.675; FRODI AM, 1984, SEX ROLES, V10, P639; FRODI AM, 1978, CHILD DEV, V49, P1182, DOI 10.2307/1128758; FULLARD W, 1976, CHILD DEV, V47, P1191, DOI 10.2307/1128462; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Harden A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4254; Johns SE, 2011, HEALTH PLACE, V17, P122, DOI 10.1016/j.healthplace.2010.09.006; Kiernan KE, 1997, BRIT J SOCIOL, V48, P406, DOI 10.2307/591138; Kim K, 1998, J ADOLESCENCE, V21, P231, DOI 10.1006/jado.1998.0149; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Lobmaier JS, 2010, EVOL HUM BEHAV, V31, P16, DOI 10.1016/j.evolhumbehav.2009.05.004; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Maestripieri D, 2004, DEVELOPMENTAL SCI, V7, P560, DOI 10.1111/j.1467-7687.2004.00380.x; Maestripieri D, 2002, HUM NATURE-INT BIOS, V13, P327, DOI 10.1007/s12110-002-1018-1; Maestripieri D, 2006, DEV REV, V26, P120, DOI 10.1016/j.dr.2006.02.006; McCulloch A, 2001, J EPIDEMIOL COMMUN H, V55, P16, DOI 10.1136/jech.55.1.16; McLennan D., 2011, ENGLISH INDICES DEPR; Mikach SM, 1999, EVOL HUM BEHAV, V20, P141, DOI 10.1016/S1090-5138(98)00045-2; Nettle D., 2010, P R SOC B, V278, P1721, DOI DOI 10.1098/RSPB.2010.1726.PMID:21068037; Nettle D, 2011, PHILOS T R SOC B, V366, P357, DOI 10.1098/rstb.2010.0073; Nettle D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012690; Nettle D, 2010, AM J HUM BIOL, V22, P172, DOI 10.1002/ajhb.20970; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; Nishitani S, 2011, NEUROSCI RES, V70, P183, DOI 10.1016/j.neures.2011.02.007; Parsons CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020632; Quinlan RJ, 2003, EVOL HUM BEHAV, V24, P376, DOI 10.1016/S1090-5138(03)00039-4; Romans SE, 2003, PSYCHOL MED, V33, P933, DOI 10.1017/S0033291703007530; Russell ST, 2002, J RES ADOLESCENCE, V12, P305, DOI 10.1111/1532-7795.00035; Schmukle SC, 2005, EUR J PERSONALITY, V19, P595, DOI 10.1002/per.554; Seamark CJ, 1997, BRIT J GEN PRACT, V47, P175; Sprengelmeyer R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065844; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Thompson-Booth C, 2014, DEVELOPMENTAL SCI, V17, P35, DOI 10.1111/desc.12090; Wellings K, 1999, REV REPROD, V4, P184, DOI 10.1530/revreprod/4.3.184; Wilson M, 1997, BRIT MED J, V314, P1271, DOI 10.1136/bmj.314.7089.1271; Yamamoto R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006042	58	22	23	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85013	10.1371/journal.pone.0085013	http://dx.doi.org/10.1371/journal.pone.0085013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DQ	25506703	Green Submitted, Green Published, gold			2022-12-25	WOS:000330236000007
J	Liu, YQ; Luo, BW; Han, FY; Li, XM; Xiong, J; Jiang, M; Yang, XF; Wu, YZ; Zhang, ZR				Liu, Yuqi; Luo, Bangwei; Han, Fuyu; Li, Xiaoming; Xiong, Jian; Jiang, Man; Yang, Xioafeng; Wu, Yuzhang; Zhang, Zhiren			Erythropoietin-Derived Nonerythropoietic Peptide Ameliorates Experimental Autoimmune Neuritis by Inflammation Suppression and Tissue Protection	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC NEURITIS; PERIPHERAL NERVOUS-SYSTEM; TERTIARY STRUCTURE; CANCER-PATIENTS; CELLS; NEUROPATHIES; RECEPTOR; ANEMIA; ARA290; TRIAL	Experimental autoimmune neuritis (EAN) is an autoantigen-specific T-cell-mediated disease model for human demyelinating inflammatory disease of the peripheral nervous system. Erythropoietin (EPO) has been known to promote EAN recovery but its haematopoiesis stimulating effects may limit its clinic application. Here we investigated the effects and potential mechanisms of an EPO-derived nonerythropoietic peptide, ARA 290, in EAN. Exogenous ARA 290 intervention greatly improved EAN recovery, improved nerve regeneration and remyelination, and suppressed nerve inflammation. Furthermore, haematopoiesis was not induced by ARA 290 during EAN treatment. ARA 290 intervention suppressed lymphocyte proliferation and altered helper T cell differentiation by inducing increase of Foxp3(+)/CD4(+) regulatory T cells and IL-4(+)/CD4(+) Th2 cells and decrease of IFN-gamma(+)/CD4(+) Th1 cells in EAN. In addition, ARA 290 inhibited inflammatory macrophage activation and promoted its phagocytic activity. In vitro, ARA 290 was shown to promote Schwann cell proliferation and inhibit its inflammatory activation. In summary, our data demonstrated that ARA 290 could effectively suppress EAN by attenuating inflammation and exerting direct cell protection, indicating that ARA 290 could be a potent candidate for treatment of autoimmune neuropathies.	[Liu, Yuqi; Luo, Bangwei; Han, Fuyu; Li, Xiaoming; Xiong, Jian; Jiang, Man; Yang, Xioafeng; Wu, Yuzhang; Zhang, Zhiren] Third Mil Med Univ, Peoples Liberat Army, Inst Immunol, Chongqing, Peoples R China	Army Medical University	Wu, YZ (corresponding author), Third Mil Med Univ, Peoples Liberat Army, Inst Immunol, Chongqing, Peoples R China.	yuzhangwu@yahoo.com.cn; zhangzhiren@yahoo.com	Zhang, Zhiren/O-1012-2019; zhang, zhiren/I-1046-2014	Zhang, Zhiren/0000-0002-5238-2835; zhang, zhiren/0000-0002-5238-2835; Wu, Yuzhang/0000-0002-4049-0214	National Nature Science Foundation of China [31170851]; National Science and Technology Major Projects of New Drugs [2012ZX09103301-035]; SRF for ROCS, SEM	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects of New Drugs; SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This investigation was supported by National Nature Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default166.htm), No: 31170851, the National Science and Technology Major Projects of New Drugs (2012ZX09103301-035) and the SRF for ROCS, SEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bohlius J, 2006, NAT CLIN PRACT ONCOL, V3, P152, DOI 10.1038/ncponc0451; Bohr S, 2013, P NATL ACAD SCI USA, V110, P3513, DOI 10.1073/pnas.1214099110; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; CRAGGS RI, 1984, ACTA NEUROPATHOL, V62, P316, DOI 10.1007/BF00687614; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Enders U, 1998, BRAIN, V121, P1257, DOI 10.1093/brain/121.7.1257; Farrell F, 2004, ONCOLOGIST, V9, P18, DOI 10.1634/theoncologist.9-90005-18; Glaspy JA, 2009, ANNU REV MED, V60, P181, DOI 10.1146/annurev.med.60.050307.110718; Heij L, 2012, MOL MED, V18, P1430, DOI 10.2119/molmed.2012.00332; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Horste GMZ, 2008, MUSCLE NERVE, V37, P3, DOI 10.1002/mus.20893; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 2002, J ANAT, V200, P331, DOI 10.1046/j.1469-7580.2002.00041.x; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kieseier BC, 2004, MUSCLE NERVE, V30, P131, DOI 10.1002/mus.20076; Maiese K, 2008, PROG NEUROBIOL, V85, P194, DOI 10.1016/j.pneurobio.2008.02.002; Maurer M, 2002, REV NEUROL-FRANCE, V158, pS7; Mausberg AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026280; Nairz M, 2012, MICROBES INFECT, V14, P238, DOI 10.1016/j.micinf.2011.10.005; Rosenzweig MQ, 2004, J PAIN SYMPTOM MANAG, V27, P185, DOI 10.1016/j.jpainsymman.2003.06.010; SCHABET M, 1991, J NEUROIMMUNOL, V31, P265, DOI 10.1016/0165-5728(91)90048-C; Shin T, 2012, ANAT CELL BIOL, V45, P215, DOI 10.5115/acb.2012.45.4.215; Soliven B, 2012, J PERIPHER NERV SYST, V17, P28, DOI 10.1111/j.1529-8027.2012.00392.x; Swartjes M, 2011, ANESTHESIOLOGY, V115, P1084, DOI 10.1097/ALN.0b013e31822fcefd; van Rijt WG, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-9; Winer JB, 2001, J CLIN PATHOL-MOL PA, V54, P381; Xanthos T, 2011, CURR PHARM DESIGN, V17, P1517, DOI 10.2174/138161211796197115; Zhang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027067; Zhang Z, 2009, EXP NEUROL, V216, P75, DOI 10.1016/j.expneurol.2008.11.014; ZHANG ZY, 2009, NEUROPATHOL APPL NEU	34	45	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90942	10.1371/journal.pone.0090942	http://dx.doi.org/10.1371/journal.pone.0090942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603865	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600112
J	Machado, L; Magnusson, M; Paul, NA; de Nys, R; Tomkins, N				Machado, Lorenna; Magnusson, Marie; Paul, Nicholas A.; de Nys, Rocky; Tomkins, Nigel			Effects of Marine and Freshwater Macroalgae on In Vitro Total Gas and Methane Production	PLOS ONE			English	Article							RED ALGA ASPARAGOPSIS; VOLATILE FATTY-ACIDS; RUMINAL FERMENTATION; ASCOPHYLLUM-NODOSUM; REGRESSION TREES; MITIGATION; EMISSIONS; FORAGE; METHANOGENESIS; DIGESTION	This study aimed to evaluate the effects of twenty species of tropical macroalgae on in vitro fermentation parameters, total gas production (TGP) and methane (CH4) production when incubated in rumen fluid from cattle fed a low quality roughage diet. Primary biochemical parameters of macroalgae were characterized and included proximate, elemental, and fatty acid (FAME) analysis. Macroalgae and the control, decorticated cottonseed meal (DCS), were incubated in vitro for 72 h, where gas production was continuously monitored. Post-fermentation parameters, including CH4 production, pH, ammonia, apparent organic matter degradability (OMd), and volatile fatty acid (VFA) concentrations were measured. All species of macroalgae had lower TGP and CH4 production than DCS. Dictyota and Asparagopsis had the strongest effects, inhibiting TGP by 53.2% and 61.8%, and CH4 production by 92.2% and 98.9% after 72 h, respectively. Both species also resulted in the lowest total VFA concentration, and the highest molar concentration of propionate among all species analysed, indicating that anaerobic fermentation was affected. Overall, there were no strong relationships between TGP or CH4 production and the >70 biochemical parameters analysed. However, zinc concentrations >0.10 g.kg(-1) may potentially interact with other biochemical components to influence TGP and CH4 production. The lack of relationship between the primary biochemistry of species and gas parameters suggests that significant decreases in TGP and CH4 production are associated with secondary metabolites produced by effective macroalgae. The most effective species, Asparagopsis, offers the most promising alternative for mitigation of enteric CH4 emissions.	[Machado, Lorenna; Magnusson, Marie; Paul, Nicholas A.; de Nys, Rocky] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Machado, Lorenna; Magnusson, Marie; Paul, Nicholas A.; de Nys, Rocky] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Tomkins, Nigel] James Cook Univ, CSIRO Anim Food & Hlth Sci, Townsville, Qld 4811, Australia	James Cook University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University	Machado, L (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	lorenna.machado@my.jcu.edu.au	Paul, Nicholas/B-6496-2009; de Nys, Rocky/D-6741-2012; Machado, Lorenna/I-1434-2015; Pavan, Fernando/F-6046-2010; Magnusson, Marie/D-8996-2012; Cardoso, Rosilene Fressatti/J-4796-2015	de Nys, Rocky/0000-0003-3869-4928; Machado, Lorenna/0000-0002-1554-6108; Pavan, Fernando/0000-0002-6969-3963; Magnusson, Marie/0000-0002-3141-8544; Paul, Nicholas/0000-0002-9275-1535; Cardoso, Rosilene Fressatti/0000-0001-6228-4780	Australian Government Department of Agriculture, Fisheries and Forestry as part of its Carbon Farming Futures Filling the Research Gap Program; Australian Government through the Australian Renewable Energy Agency; Advanced Manufacturing Cooperative Research Centre (AMCRC); Australian Government's Cooperative Research Centre Scheme	Australian Government Department of Agriculture, Fisheries and Forestry as part of its Carbon Farming Futures Filling the Research Gap Program(Australian GovernmentDepartment of Agriculture and Water Resources); Australian Government through the Australian Renewable Energy Agency(Australian Renewable Energy Agency (ARENA)); Advanced Manufacturing Cooperative Research Centre (AMCRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This project is supported by funding from the Australian Government Department of Agriculture, Fisheries and Forestry as part of its Carbon Farming Futures Filling the Research Gap Program. The project is also supported by the Australian Government through the Australian Renewable Energy Agency, and the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla AL, 2012, TROP ANIM HEALTH PRO, V44, P953, DOI 10.1007/s11250-011-9992-0; [Anonymous], 1970, AGR HDB; Arelovich HM, 2000, J ANIM SCI, V78, P2972; Bach SJ, 2008, ANIM FEED SCI TECH, V142, P17, DOI 10.1016/j.anifeedsci.2007.05.033; Beauchemin KA, 2008, AUST J EXP AGR, V48, P21, DOI 10.1071/EA07199; BIDLACK JE, 1992, CAN J PLANT SCI, V72, P809, DOI 10.4141/cjps92-097; Blunt JW, 2013, NAT PROD REP, V30, P237, DOI [10.1039/c2np20112g, 10.1039/d0np00089b]; Boyd RS, 2012, PLANT SCI, V195, P88, DOI 10.1016/j.plantsci.2012.06.012; Bozic AK, 2009, BIORESOURCE TECHNOL, V100, P4017, DOI 10.1016/j.biortech.2008.12.061; BREIMAN L., 1984, CRC PRESS; Bueno ICS, 2005, ANIM FEED SCI TECH, V123, P95, DOI 10.1016/j.anifeedsci.2005.05.003; Channiwala SA, 2002, FUEL, V81, P1051, DOI 10.1016/S0016-2361(01)00131-4; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Chojnacka K, 2012, HANDBOOK OF MARINE MACROALGAE: BIOTECHNOLOGY AND APPLIED PHYCOLOGY, P478; CHOPIN T, 2009, SEAWEEDS THEIR MARIC, V3, P4477; Chowdhury S, 1995, AGR SCI BIOD SUST WO, P3; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Cottle DJ, 2011, ANIM PROD SCI, V51, P491, DOI 10.1071/AN10163; COTTYN BG, 1968, J AGR FOOD CHEM, V16, P105, DOI 10.1021/jf60155a002; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; del Val Antonio Gonzalez, 2001, International Microbiology, V4, P35; FOLCH J, 1957, J BIOL CHEM, V226, P497; Genovese G, 2009, MAR DRUGS, V7, P361, DOI 10.3390/md7030361; Getachew G, 1998, ANIM FEED SCI TECH, V72, P261, DOI 10.1016/S0377-8401(97)00189-2; Goel G, 2012, TROP ANIM HEALTH PRO, V44, P729, DOI 10.1007/s11250-011-9966-2; Gosch BJ, 2012, GCB BIOENERGY, V4, P919, DOI 10.1111/j.1757-1707.2012.01175.x; Grainger C, 2008, AUST J EXP AGR, V48, P73, DOI 10.1071/EA07224; Grainger C, 2011, ANIM FEED SCI TECH, V166-67, P308, DOI 10.1016/j.anifeedsci.2011.04.021; Henry B, 2012, CROP PASTURE SCI, V63, P191, DOI 10.1071/CP11169; Jayanegara A, 2011, ANIM FEED SCI TECH, V163, P231, DOI 10.1016/j.anifeedsci.2010.11.009; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Ktita SR, 2010, SMALL RUMINANT RES, V91, P116, DOI 10.1016/j.smallrumres.2010.01.012; Lee HJ, 2003, ASIAN AUSTRAL J ANIM, V16, P1143, DOI 10.5713/ajas.2003.1143; Lourenco Sergio O., 2002, Phycological Research, V50, P233; MacArtain P, 2007, NUTR REV, V65, P535, DOI [10.1301/nr.2007.dec.535-543, 10.1111/j.1753-4887.2007.tb00278.x]; Marin A, 2009, REV BIOL TROP, V57, P1271; McGinn SM, 2004, J ANIM SCI, V82, P3346; Meale SJ, 2012, ASIAN AUSTRAL J ANIM, V25, P86, DOI 10.5713/ajas.2011.11249; MOORE RE, 1977, ACCOUNTS CHEM RES, V10, P40, DOI 10.1021/ar50110a002; Morgavi DP, 2010, ANIMAL, V4, P1024, DOI 10.1017/S1751731110000546; Nagadi S, 2000, ANIM FEED SCI TECH, V87, P231, DOI 10.1016/S0377-8401(00)00197-8; O'Sullivan L, 2010, MAR DRUGS, V8, P2038, DOI 10.3390/md8072038; OTTENSTEIN DM, 1971, J CHROMATOGR SCI, V9, P673, DOI 10.1093/chromsci/9.11.673; Patra AK, 2006, ANIM FEED SCI TECH, V128, P276, DOI 10.1016/j.anifeedsci.2005.11.001; Patra AK, 2010, PHYTOCHEMISTRY, V71, P1198, DOI 10.1016/j.phytochem.2010.05.010; Patra AK, 2012, ENVIRON MONIT ASSESS, V184, P1929, DOI 10.1007/s10661-011-2090-y; Paul NA, 2006, MAR ECOL PROG SER, V306, P87, DOI 10.3354/meps306087; Paul VJ, 2004, NAT PROD REP, V21, P189, DOI 10.1039/b302334f; PLAYNE MJ, 1985, J SCI FOOD AGR, V36, P638, DOI 10.1002/jsfa.2740360803; Reay D., 2010, METHANE CLIMATE CHAN, P1; Saunders RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036470; Sawidis T, 2001, ENVIRON INT, V27, P43, DOI 10.1016/S0160-4120(01)00052-6; Singh S, 2012, ANIM FEED SCI TECH, V178, P2, DOI 10.1016/j.anifeedsci.2012.08.019; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Tavendale MH, 2005, ANIM FEED SCI TECH, V123, P403, DOI 10.1016/j.anifeedsci.2005.04.037; VanNevel CJ, 1996, ENVIRON MONIT ASSESS, V42, P73, DOI 10.1007/BF00394043; Wang Y, 2008, ANIM FEED SCI TECH, V145, P375, DOI 10.1016/j.anifeedsci.2007.03.013; Wuebbles DJ, 2002, EARTH-SCI REV, V57, P177, DOI 10.1016/S0012-8252(01)00062-9	59	97	104	10	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85289	10.1371/journal.pone.0085289	http://dx.doi.org/10.1371/journal.pone.0085289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465524	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000330283100035
J	Zhang, BB; Shimada, Y; Kuroyanagi, J; Umemoto, N; Nishimura, Y; Tanaka, T				Zhang, Beibei; Shimada, Yasuhito; Kuroyanagi, Junya; Umemoto, Noriko; Nishimura, Yuhei; Tanaka, Toshio			Quantitative wPhenotyping-Based In Vivo Chemical Screening in a Zebrafish Model of Leukemia Stem Cell Xenotransplantation	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; KAPPA-B PATHWAY; APOPTOSIS; MECHANISMS; QUIESCENT; CML; PROLIFERATION; XENOGRAFTS; DISCOVERY; IMATINIB	Zebrafish-based chemical screening has recently emerged as a rapid and efficient method to identify important compounds that modulate specific biological processes and to test the therapeutic efficacy in disease models, including cancer. In leukemia, the ablation of leukemia stem cells (LSCs) is necessary to permanently eradicate the leukemia cell population. However, because of the very small number of LSCs in leukemia cell populations, their use in xenotransplantation studies (in vivo) and the difficulties in functionally and pathophysiologically replicating clinical conditions in cell culture experiments (in vitro), the progress of drug discovery for LSC inhibitors has been painfully slow. In this study, we developed a novel phenotype-based in vivo screening method using LSCs xenotransplanted into zebrafish. Aldehyde dehydrogenase-positive (ALDH+) cells were purified from chronic myelogenous leukemia K562 cells tagged with a fluorescent protein (Kusabira-orange) and then implanted in young zebrafish at 48 hours post-fertilization. Twenty-four hours after transplantation, the animals were treated with one of eight different therapeutic agents (imatinib, dasatinib, parthenolide, TDZD-8, arsenic trioxide, niclosamide, salinomycin, and thioridazine). Cancer cell proliferation, and cell migration were determined by high-content imaging. Of the eight compounds that were tested, all except imatinib and dasatinib selectively inhibited ALDH+ cell proliferation in zebrafish. In addition, these anti-LSC agents suppressed tumor cell migration in LSC-xenotransplants. Our approach offers a simple, rapid, and reliable in vivo screening system that facilitates the phenotype-driven discovery of drugs effective in suppressing LSCs.	[Zhang, Beibei; Shimada, Yasuhito; Kuroyanagi, Junya; Umemoto, Noriko; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Med Zebrafish Res Ctr, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Life Sci Res Ctr, Dept Bioinformat, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ Ind Technol Innovat, Dept Om Med, Tsu, Mie, Japan; [Shimada, Yasuhito; Umemoto, Noriko; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Syst Pharmacol, Tsu, Mie 514, Japan	Mie University; Mie University; Mie University; Mie University	Tanaka, T (corresponding author), Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan.	tanaka@doc.medic.mie-u.ac.jp	Shimada, Yasuhito/H-2916-2019	Shimada, Yasuhito/0000-0002-4111-8262; Zhang, Bin/0000-0002-7347-0367; Ichino, Noriko/0000-0002-7009-8299; Nishimura, Yuhei/0000-0003-1901-8799	Japan Science and Technology Agency; New Energy and Industrial Technology Development Organization	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the Japan Science and Technology Agency, KAKENHI of Grants-in-Aid for Scientific Research, and the New Energy and Industrial Technology Development Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2010, J EXP MED, V207, P677, DOI 10.1084/jem.20100523; Angstreich GR, 2005, BRIT J HAEMATOL, V130, P373, DOI 10.1111/j.1365-2141.2005.05606.x; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Corkery DP, 2011, BRIT J HAEMATOL, V153, P786, DOI 10.1111/j.1365-2141.2011.08661.x; Davison K, 2002, SEMIN HEMATOL, V39, P3, DOI 10.1053/shem.2002.33610; Delvecchio C, 2011, ASSAY DRUG DEV TECHN, V9, P354, DOI 10.1089/adt.2010.0346; Fleischman AG, 2012, BLOOD, V119, P3376, DOI 10.1182/blood-2012-02-406751; Fuchs Ota, 2010, Curr Mol Pharmacol, V3, P98; Gerber JM, 2011, AM J HEMATOL, V86, P31, DOI 10.1002/ajh.21915; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2007, BLOOD, V110, P4436, DOI 10.1182/blood-2007-05-088815; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; Heaney NCB, 2007, HEMATOL ONCOL, V25, P66, DOI 10.1002/hon.813; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Jing LL, 2011, DIS MODEL MECH, V4, P433, DOI 10.1242/dmm.006791; Jordan CT, 2007, BEST PRACT RES CL HA, V20, P13, DOI 10.1016/j.beha.2006.10.005; Ketola K, 2012, BRIT J CANCER, V106, P99, DOI 10.1038/bjc.2011.530; Konantz M, 2012, ANN NY ACAD SCI, V1266, P124, DOI 10.1111/j.1749-6632.2012.06575.x; Koyama-Nasu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053710; Liu L, 2011, MED ONCOL, V28, P835, DOI 10.1007/s12032-010-9529-9; Liu ZB, 2012, BIOCHEM BIOPH RES CO, V427, P223, DOI 10.1016/j.bbrc.2012.09.064; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; Miller WH, 2002, CANCER RES, V62, P3893; Moreb JS, 2012, CHEM-BIOL INTERACT, V195, P52, DOI 10.1016/j.cbi.2011.10.007; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nakamura S, 2012, INT J CANCER, V130, P1046, DOI 10.1002/ijc.26065; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Peal DS, 2010, J CARDIOVASC TRANSL, V3, P454, DOI 10.1007/s12265-010-9212-8; Pei SS, 2012, BEST PRACT RES CL HA, V25, P415, DOI 10.1016/j.beha.2012.10.003; Pichler FB, 2003, NAT BIOTECHNOL, V21, P879, DOI 10.1038/nbt852; Pruvot B, 2011, HAEMATOL-HEMATOL J, V96, P612, DOI 10.3324/haematol.2010.031401; Rice KN, 2010, INT J HEMATOL, V91, P748, DOI 10.1007/s12185-010-0615-8; Rodrigues T, 2002, BRIT J PHARMACOL, V136, P136, DOI 10.1038/sj.bjp.0704672; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Savona M, 2008, NAT REV CANCER, V8, P341, DOI 10.1038/nrc2368; Smithen DA, 2013, ORG BIOMOL CHEM, V11, P62, DOI 10.1039/c2ob26535d; Snaar-Jagalska BE, 2009, ZEBRAFISH, V6, P441, DOI 10.1089/zeb.2009.0614; Stuart SA, 2009, CELL CYCLE, V8, P1338, DOI 10.4161/cc.8.9.8209; Szabo AZ, 2013, STEM CELLS, V31, P786, DOI 10.1002/stem.1329; Takeuchi Y, 2004, J NEUROCHEM, V88, P41, DOI 10.1046/j.1471-4159.2003.02129.x; Thomas Xavier, 2012, World J Stem Cells, V4, P44; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Yang IH, 2008, IEEE ENG MED BIO, P1837, DOI 10.1109/IEMBS.2008.4649537; Yong ASM, 2008, LEUKEMIA, V22, P1721, DOI 10.1038/leu.2008.161; Yuan Lin-Bo, 2007, Zhejiang Da Xue Xue Bao Yi Xue Ban, V36, P191; Zhelev Z, 2004, CANCER CHEMOTH PHARM, V53, P267, DOI 10.1007/s00280-003-0738-1; Zhen XC, 2001, MOL PHARMACOL, V60, P857; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	54	71	73	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85439	10.1371/journal.pone.0085439	http://dx.doi.org/10.1371/journal.pone.0085439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	25036550	gold, Green Submitted, Green Published			2022-12-25	WOS:000330235100085
J	Wang, MC; Chien, HF; Tsai, YL; Liu, MC; Liaw, SJ				Wang, Min-Cheng; Chien, Hsiung-Fei; Tsai, Yi-Lin; Liu, Ming-Che; Liaw, Shwu-Jen			The RNA Chaperone Hfq Is Involved in Stress Tolerance and Virulence in Uropathogenic Proteus mirabilis	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; POLYMYXIN-B RESISTANCE; ESCHERICHIA-COLI; OUTER-MEMBRANE; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; EPITHELIAL-CELLS; MOUSE MODEL; BACTERIA; MACROPHAGES	Hfq is a bacterial RNA chaperone involved in the riboregulation of diverse genes via small noncoding RNAs. Here, we show that Hfq is critical for the uropathogenic Proteus mirabilis to effectively colonize the bladder and kidneys in a murine urinary tract infection (UTI) model and to establish burned wound infection of the rats. In this regard, we found the hfq mutant induced higher IL-8 and MIF levels of uroepithelial cells and displayed reduced intra-macrophage survival. The loss of hfq affected bacterial abilities to handle H2O2 and osmotic pressures and to grow at 50 degrees C. Relative to wild-type, the hfq mutant had reduced motility, fewer flagella and less hemolysin expression and was less prone to form biofilm and to adhere to and invade uroepithelial cells. The MR/P fimbrial operon was almost switched to the off phase in the hfq mutant. In addition, we found the hfq mutant exhibited an altered outer membrane profile and had higher RpoE expression, which indicates the hfq mutant may encounter increased envelope stress. With the notion of envelope disturbance in the hfq mutant, we found increased membrane permeability and antibiotic susceptibilities in the hfq mutant. Finally, we showed that Hfq positively regulated the RpoS level and tolerance to H2O2 in the stationary phase seemed largely mediated through the Hfq-dependent RpoS expression. Together, our data indicate that Hfq plays a critical role in P. mirabilis to establish UTIs by modulating stress responses, surface structures and virulence factors. This study suggests Hfq may serve as a scaffold molecule for development of novel anti-P. mirabilis drugs and P. mirabilis hfq mutant is a vaccine candidate for preventing UTIs.	[Wang, Min-Cheng; Tsai, Yi-Lin; Liu, Ming-Che; Liaw, Shwu-Jen] Natl Taiwan Univ, Coll Med, Dept & Grad Inst Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Chien, Hsiung-Fei] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Liaw, Shwu-Jen] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Liaw, SJ (corresponding author), Natl Taiwan Univ, Coll Med, Dept & Grad Inst Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	sjliaw@ntu.edu.tw		LIAW, SHWU-JEN/0000-0002-2666-5284	National Science Council [NSC101-2320-B-002-028]; National Taiwan University Hospital, Taipei, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Taipei, Taiwan	This work was supported by grants from National Science Council (NSC101-2320-B-002-028) and National Taiwan University Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 1996, EUR RESPIR J, V9, P1713, DOI 10.1183/09031936.96.09081713; Alamuri P, 2010, INFECT IMMUN, V78, P4882, DOI 10.1128/IAI.00718-10; Asakawa R, 2003, MOL MICROBIOL, V50, P1125, DOI 10.1046/j.1365-2958.2003.03748.x; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Caiola MG, 2004, ANN MICROBIOL, V54, P365; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Chiang MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022248; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; De Lay N, 2013, J BIOL CHEM, V288, P7996, DOI 10.1074/jbc.R112.441386; De Lay N, 2012, MOL MICROBIOL, V86, P524, DOI 10.1111/j.1365-2958.2012.08209.x; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FUKUOKA T, 1991, ANTIMICROB AGENTS CH, V35, P529, DOI 10.1128/AAC.35.3.529; Geng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006213; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Guillier M, 2006, GENE DEV, V20, P2338, DOI 10.1101/gad.1457506; Hamrick TS, 2000, INFECT IMMUN, V68, P125, DOI 10.1128/IAI.68.1.125-132.2000; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Jansen AM, 2004, INFECT IMMUN, V72, P7294, DOI 10.1128/IAI.72.12.7294-7305.2004; Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P2000, DOI 10.1128/AAC.01384-09; Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P1564, DOI 10.1128/AAC.01219-09; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Li X, 2002, MOL MICROBIOL, V45, P865, DOI 10.1046/j.1365-2958.2002.03067.x; LISSNER CR, 1985, J IMMUNOL, V135, P544; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; Mobley HLT, 1996, INFECT IMMUN, V64, P5332, DOI 10.1128/IAI.64.12.5332-5340.1996; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Nishino K, 2011, J ANTIMICROB CHEMOTH, V66, P291, DOI 10.1093/jac/dkq420; Odenbreit S, 2009, INFECT IMMUN, V77, P3782, DOI 10.1128/IAI.00364-09; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Pearson MM, 2007, J MED MICROBIOL, V56, P1277, DOI 10.1099/jmm.0.47314-0; Richards GR, 2011, BBA-GENE REGUL MECH, V1809, P525, DOI 10.1016/j.bbagrm.2011.07.013; Rocha SPD, 2007, FEMS IMMUNOL MED MIC, V51, P319, DOI 10.1111/j.1574-695X.2007.00308.x; Roger T, 2013, J INFECT DIS, V207, P331, DOI 10.1093/infdis/jis673; Roscetto E, 2012, J BACTERIOL, V194, P5864, DOI 10.1128/JB.00746-12; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Schiano CA, 2010, INFECT IMMUN, V78, P2034, DOI 10.1128/IAI.01046-09; Simonsen KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016387; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Thompson KM, 2007, J BACTERIOL, V189, P4243, DOI 10.1128/JB.00020-07; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Van Puyvelde S, 2013, RNA BIOL, V10, P185, DOI 10.4161/rna.23341; Vogel J, 2009, MOL MICROBIOL, V73, P737, DOI 10.1111/j.1365-2958.2009.06806.x; Xiao B, 2009, CURR MICROBIOL, V58, P258, DOI 10.1007/s00284-008-9318-2; Yamada J, 2010, J ANTIMICROB CHEMOTH, V65, P853, DOI 10.1093/jac/dkq067; Zhong M, 2013, J BACTERIOL, V195, P1061, DOI 10.1128/JB.01143-12	52	49	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85626	10.1371/journal.pone.0085626	http://dx.doi.org/10.1371/journal.pone.0085626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24454905	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100108
J	Zhang, XJ; Bowles, AC; Semon, JA; Scruggs, BA; Zhang, SJ; Strong, AL; Gimble, JM; Bunnell, BA				Zhang, Xiujuan; Bowles, Annie C.; Semon, Julie A.; Scruggs, Brittni A.; Zhang, Shijia; Strong, Amy L.; Gimble, Jeffrey M.; Bunnell, Bruce A.			Transplantation of Autologous Adipose Stem Cells Lacks Therapeutic Efficacy in the Experimental Autoimmune Encephalomyelitis Model	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MULTIPLE-SCLEROSIS; BONE-MARROW; STROMAL CELLS; IMMUNE-RESPONSE; TISSUE; EXPRESSION; MCP-1; CCL2; METALLOPROTEINASES	Multiple sclerosis (MS), characterized by chronic inflammation, demyelination, and axonal damage, is a complicated neurological disease of the human central nervous system. Recent interest in adipose stromal/stem cell (ASCs) for the treatment of CNS diseases has promoted further investigation in order to identify the most suitable ASCs. To investigate whether MS affects the biologic properties of ASCs and whether autologous ASCs from MS-affected sources could serve as an effective source for stem cell therapy, cells were isolated from subcutaneous inguinal fat pads of mice with established experimental autoimmune encephalomyelitis (EAE), a murine model of MS. ASCs from EAE mice and their syngeneic wildtype mice were cultured, expanded, and characterized for their cell morphology, surface antigen expression, osteogenic and adipogenic differentiation, colony forming units, and inflammatory cytokine and chemokine levels in vitro. Furthermore, the therapeutic efficacy of the cells was assessed in vivo by transplantation into EAE mice. The results indicated that the ASCs from EAE mice displayed a normal phenotype, typical MSC surface antigen expression, and in vitro osteogenic and adipogenic differentiation capacity, while their osteogenic differentiation capacity was reduced in comparison with their unafflicted control mice. The ASCs from EAE mice also demonstrated increased expression of pro-inflammatory cytokines and chemokines, specifically an elevation in the expression of monocyte chemoattractant protein-1 and keratin chemoattractant. In vivo, infusion of wild type ASCs significantly ameliorate the disease course, autoimmune mediated demyelination and cell infiltration through the regulation of the inflammatory responses, however, mice treated with autologous ASCs showed no therapeutic improvement on the disease progression.	[Zhang, Xiujuan] Dalian Univ Technol, Sch Petr & Chem Engn, Panjin, Liaoning Provin, Peoples R China; [Zhang, Xiujuan; Bowles, Annie C.; Semon, Julie A.; Scruggs, Brittni A.; Zhang, Shijia; Strong, Amy L.; Bunnell, Bruce A.] Tulane Univ, Sch Med, Ctr Stem Cell Res & Regenerat Med, New Orleans, LA 70112 USA; [Bowles, Annie C.; Bunnell, Bruce A.] Tulane Univ, Dept Cell & Mol Biol, Sch Sci & Engn, New Orleans, LA 70118 USA; [Scruggs, Brittni A.; Zhang, Shijia] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA; [Gimble, Jeffrey M.] Pennington Biomed Res Ctr, Stem Cell Biol Lab, Baton Rouge, LA 70808 USA; [Bunnell, Bruce A.] Tulane Natl Primate Res Ctr, Div Regenerat Med, Covington, LA USA	Dalian University of Technology; Tulane University; Tulane University; Tulane University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Tulane University	Bunnell, BA (corresponding author), Tulane Univ, Sch Med, Ctr Stem Cell Res & Regenerat Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.	bbunnell@tulane.edu		Bunnell, Bruce/0000-0001-6196-3722; Strong, Amy/0000-0002-2581-2481	Tulane University; Pennington Biomedical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	Tulane University; Pennington Biomedical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this study was provided by Tulane University and the Pennington Biomedical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Baker D, 2007, ADV CLIN NEUROSCI RE, V6, P10; BONAB MM, 2007, IRAN J IMMUNOL, V4, P50; Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2; Constantin G, 2009, STEM CELLS, V27, P2624, DOI 10.1002/stem.194; Dawson J, 2003, EXPERT OPIN THER TAR, V7, P35; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Fisher-Shoval Y, 2012, J MOL NEUROSCI; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Freedman SM, 2010, MULT SCLER, V16, P7; FUENTES ME, 1995, J IMMUNOL, V155, P5769; Ge SJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-171; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; GODISKA R, 1995, J NEUROIMMUNOL, V58, P167, DOI 10.1016/0165-5728(95)00008-P; Gordon D, 2010, J NEUROPATH EXP NEUR, V69, P1087, DOI 10.1097/NEN.0b013e3181f97392; Hemmer B, 2006, NAT CLIN PRACT NEURO, V2, P201, DOI 10.1038/ncpneuro0154; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kieseier BC, 2007, CURR OPIN NEUROL, V20, P286, DOI 10.1097/WCO.0b013e3281568b80; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Lanz TV, 2010, STEM CELLS DEV, V19, P657, DOI 10.1089/scd.2009.0385; Liang J, 2009, MULT SCLER, V15, P2; Liu YL, 2011, STEM CELLS, V29, P1804, DOI 10.1002/stem.728; Luo Y, 2000, J IMMUNOL, V165, P4015, DOI 10.4049/jimmunol.165.7.4015; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; Mallam E, 2010, MULT SCLER J, V16, P909, DOI 10.1177/1352458510371959; Miller David H, 2004, NeuroRx, V1, P284, DOI 10.1602/neurorx.1.2.284; Niimi N, 2013, NEUROPATHOLOGY, V33, P612, DOI 10.1111/neup.12039; Payne N, 2012, CELL ADH MIGR, V6; Rafei M, 2009, MOL THER, V17, P1799, DOI 10.1038/mt.2009.157; Rafei M, 2009, J IMMUNOL, V182, P5994, DOI 10.4049/jimmunol.0803962; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SELA J, 1986, BIOMATER ARTIF CELL, V14, P227, DOI 10.3109/10731198609117544; Semon JA, 2013, STEM CELL TRANSL MED, V2, P789, DOI 10.5966/sctm.2013-0032; Song L, 2004, MICROVASC RES, V67, P78, DOI 10.1016/j.mvr.2003.07.001; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Toft-Hansen H, 2006, J IMMUNOL, V177, P7242, DOI 10.4049/jimmunol.177.10.7242; Uccelli A, 2012, MULT SCLER J, P1; Yamout B, 2010, J NEUROIMMUNOL, V227, P185, DOI 10.1016/j.jneuroim.2010.07.013; Yao Y, 2011, J CELL SCI, V124, P1486, DOI 10.1242/jcs.082834; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	49	199	202	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85007	10.1371/journal.pone.0085007	http://dx.doi.org/10.1371/journal.pone.0085007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24465465	Green Published, gold			2022-12-25	WOS:000330244500026
J	Zhou, JH; Wang, YF; Wang, Y; Yin, X; He, YF; Chen, LL; Wang, WW; Liu, T; Di, W				Zhou, Jinhua; Wang, Yunfei; Wang, You; Yin, Xia; He, Yifeng; Chen, Lilan; Wang, Wenwen; Liu, Ting; Di, Wen			FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; BREAST-CANCER; REPAIR; RESISTANCE; CELLS; CONTRIBUTES; EXPRESSION	Cisplatin is commonly used in ovarian cancer chemotherapy, however, chemoresistance to cisplatin remains a great clinical challenge. Oncogenic transcriptional factor FOXM1 has been reported to be overexpressed in ovarian cancer. In this study, we aimed to investigate the potential role of FOXM1 in ovarian cancers with chemoresistance to cisplatin. Our results indicate that FOXM1 is upregulated in chemoresistant ovarian cancer samples, and defends ovarian cancer cells against cytotoxicity of cisplatin. FOXM1 facilitates DNA repair through regulating direct transcriptional target EXO1 to protect ovarian cancer cells from cisplatin-mediated apoptosis. Attenuating FOXM1 and EXO1 expression by small interfering RNA, augments the chemotherapy efficacy against ovarian cancer. Our findings indicate that targeting FOXM1 and its target gene EXO1 could improve cisplatin effect in ovarian cancer, confirming their role in modulating cisplatin sensitivity.	[Zhou, Jinhua; Wang, Yunfei; Wang, You; Yin, Xia; He, Yifeng; Chen, Lilan; Wang, Wenwen; Liu, Ting; Di, Wen] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Zhou, Jinhua; Wang, Yunfei; Wang, You; Yin, Xia; He, Yifeng; Chen, Lilan; Wang, Wenwen; Liu, Ting; Di, Wen] Shanghai Key Lab Gynecol Oncol, Shanghai, Peoples R China; [Zhou, Jinhua; Wang, Yunfei; Di, Wen] Focus Construct Subject Shanghai Educ Dept, Shanghai, Peoples R China; [Zhou, Jinhua; Wang, Yunfei; Di, Wen] Shanghai Hlth Bur Key Disciplines & Specialties F, Shanghai, Peoples R China; [Zhou, Jinhua] Soochow Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Suzhou, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Di, W (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China.	diwen163@163.com	Xia, Kai/GYU-7618-2022; Singh, Brijesh Kumar/C-1093-2009	Yen, Paul/0000-0002-3790-8114; Singh, Brijesh Kumar/0000-0003-4615-3988; Wu, Yajun/0000-0001-9598-4433	National Natural Science Foundation of China [81272882, 81302275, 81072137]; Shanghai Committee of Science and Technology [12411950200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	In accomplish of this manuscript, the authors have received the support of the National Natural Science Foundation of China (Grant No. 81272882, 81302275, 81072137) and Shanghai Committee of Science and Technology (Grant No. 12411950200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Carozzi VA, 2010, CURR CANCER DRUG TAR, V10, P670; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Chang IY, 2005, BIOCHEM BIOPH RES CO, V327, P225, DOI 10.1016/j.bbrc.2004.12.008; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Eccleston J, 2011, J IMMUNOL, V186, P2336, DOI 10.4049/jimmunol.1003104; Furuta T, 2002, CANCER RES, V62, P4899; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7; Halasi M, 2013, MOL CANCER THER, V12, P245, DOI 10.1158/1535-7163.MCT-12-0712; Halasi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031761; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Lok GTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023790; Miller DS, 2009, J CLIN ONCOL, V27, P2686, DOI 10.1200/JCO.2008.19.2963; Myatt SS, 2008, NAT REV CANCER, V8, P244, DOI 10.1038/nrc2223-c2; Olive PL, 2011, RADIOTHER ONCOL, V101, P18, DOI 10.1016/j.radonc.2011.05.055; Park YY, 2012, CARCINOGENESIS, V33, P1843, DOI 10.1093/carcin/bgs167; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Ruggiero A, 2013, ANTI-CANCER DRUG, V24, P1007, DOI 10.1097/CAD.0b013e3283650bda; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; Zhang N, 2012, CLIN CANCER RES, V18, P5961, DOI 10.1158/1078-0432.CCR-12-0039; Zhao R, 2014, MOL CANCER RES, V12, P370, DOI 10.1158/1541-7786.MCR-13-0281; Zhu HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031431; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Ziebarth AJ, 2013, CLIN CANCER RES, V19, P170, DOI 10.1158/1078-0432.CCR-12-1045	40	158	163	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96989	10.1371/journal.pone.0096989	http://dx.doi.org/10.1371/journal.pone.0096989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24454741	Green Submitted, Green Published, gold			2022-12-25	WOS:000336369200045
J	Zhou, J; Xiao, KF; Wei, BY; Wang, Z; Tian, Y; Tian, YX; Song, QS				Zhou, Ji; Xiao, Kaifu; Wei, Baoyang; Wang, Zhi; Tian, Yun; Tian, Yixing; Song, Qisheng			Bioaccumulation of Cry1Ab Protein from an Herbivore Reduces Anti-Oxidant Enzyme Activities in Two Spider Species	PLOS ONE			English	Article							BT RICE; SUPEROXIDE-DISMUTASE; BROWN PLANTHOPPER; FIELD-EVALUATION; TRANSGENIC RICE; GENES; RESISTANCE; DIVERSITY; LINES	Cry proteins are expressed in rice lines for lepidopteran pest control. These proteins can be transferred from transgenic rice plants to non-target arthropods, including planthoppers and then to a predatory spider. Movement of Cry proteins through food webs may reduce fitness of non-target arthropods, although recent publications indicated no serious changes in nontarget populations. Nonetheless, Cry protein intoxication influences gene expression in Cry-sensitive insects. We posed the hypothesis that Cry protein intoxication influences enzyme activities in spiders acting in tri-trophic food webs. Here we report on the outcomes of experiments designed to test our hypothesis with two spider species. We demonstrated that the movement of CryAb protein from Drosophila culture medium into fruit flies maintained on the CryAb containing medium and from the flies to the spiders Ummeliata insecticeps and Pardosa pseudoannulata. We also show that the activities of three key metabolic enzymes, acetylcholine esterase (AchE), glutathione peroxidase (GSH-Px), and superoxide dismutase (SOD) were significantly influenced in the spiders after feeding on Cry1Ab-containing fruit flies. We infer from these data that Cry proteins originating in transgenic crops impacts non-target arthropods at the physiological and biochemical levels, which may be one mechanism of Cry protein-related reductions in fitness of non-target beneficial predators.	[Zhou, Ji; Xiao, Kaifu; Wei, Baoyang; Wang, Zhi; Tian, Yun; Tian, Yixing; Song, Qisheng] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Song, Qisheng] Univ Missouri, Div Plant Sci, Columbia, MO USA	Hunan Agricultural University; University of Missouri System; University of Missouri Columbia	Wang, Z (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China.	wangzhispider@hotmail.com; SongQ@missouri.edu	Xia, Kai/GYU-7618-2022; Singh, Brijesh Kumar/C-1093-2009	Yen, Paul/0000-0002-3790-8114; Singh, Brijesh Kumar/0000-0003-4615-3988; Wu, Yajun/0000-0001-9598-4433	Natural Science Foundation of P. R. China [31071943, 31272339]; Scientific Research Fund of Hunan Provincial Education Department [10A054]	Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department)	This work was in part supported by the Natural Science Foundation of P. R. China (No. 31071943). The additional part of the funding of the study has come from Natural Science Foundation of P. R. China (No. 31272339) and Scientific Research Fund of Hunan Provincial Education Department(No. 10A054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir K, 2004, MOL BREEDING, V13, P301, DOI 10.1023/B:MOLB.0000034078.54872.25; Bernal CC, 2002, ENTOMOL EXP APPL, V102, P21, DOI 10.1023/A:1015278618586; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitler JC, 2004, PLANT BIOTECHNOL J, V2, P417, DOI 10.1111/j.1467-7652.2004.00086.x; Chen H, 2008, J ECON ENTOMOL, V101, P182, DOI 10.1603/0022-0493(2008)101[182:EOTBTR]2.0.CO;2; Chen Mao, 2003, Acta Phytophylacica Sinica, V30, P365; Chen Mao, 2003, Journal of Zhejiang University (Agriculture and Life Sciences), V29, P29; Chen Mao, 2005, Acta Entomologica Sinica, V48, P208; Chen M, 2007, BIOL CONTROL, V42, P242, DOI 10.1016/j.biocontrol.2007.05.005; Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; GORUN V, 1978, ANAL BIOCHEM, V86, P324, DOI 10.1016/0003-2697(78)90350-0; Hoefler CD, 2006, J ECON ENTOMOL, V99, P432, DOI 10.1603/0022-0493-99.2.432; Jones AK, 2010, ADV EXP MED BIOL, V683, P25; Li FF, 2007, ENVIRON ENTOMOL, V36, P646, DOI 10.1603/0046-225X(2007)36[646:AAADIB]2.0.CO;2; Liu Li-Jun, 2010, Acta Arachnologica Sinica, V19, P47; Ministry of Agriculture of the People's Republic of China (MAPRC), 2009, 2 LIST APPR AGR GEN; Missirlis F, 2003, PROCEEDINGS OF THE MEETING OF THE SOCIETY FOR FREE RADICAL RESEARCH, EUROPEAN SECTION, P147; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Oppert B, 2012, PLOS ONE, V4; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Riaz N, 2006, S AFR J BOT, V72, P217, DOI 10.1016/j.sajb.2005.07.005; Rogina B, 2000, BIOGERONTOLOGY, V1, P163, DOI 10.1023/A:1010039813107; Sigsgaard L, 2007, B ENTOMOL RES, V97, P533, DOI 10.1017/S0007485307005196; Sogawa K, 2003, CHINESE J RICE SCI, V17, P47; Tian JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035164; Ye GY, 2001, J ECON ENTOMOL, V94, P271, DOI 10.1603/0022-0493-94.1.271; Ye RJ, 2009, PEST MANAG SCI, V65, P1015, DOI 10.1002/ps.1788; Zaidi MA, 2009, MOL BIOTECHNOL, V43, P232, DOI 10.1007/s12033-009-9201-9	28	158	163	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84724	10.1371/journal.pone.0084724	http://dx.doi.org/10.1371/journal.pone.0084724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24454741	Green Published, Green Submitted, gold			2022-12-25	WOS:000329922500016
J	Martin-Murphy, BV; You, Q; Wang, H; De La Houssaye, BA; Reilly, TP; Friedman, JE; Ju, C				Martin-Murphy, Brittany V.; You, Qiang; Wang, Hong; De La Houssaye, Becky A.; Reilly, Timothy P.; Friedman, Jacob E.; Ju, Cynthia			Mice Lacking Natural Killer T Cells Are More Susceptible to Metabolic Alterations following High Fat Diet Feeding	PLOS ONE			English	Article							INDUCED LIVER-INJURY; ADIPOSE-TISSUE; INSULIN-RESISTANCE; NKT CELLS; DEFICIENT MICE; NONALCOHOLIC STEATOHEPATITIS; MACROPHAGE POLARIZATION; GLUCOSE-INTOLERANCE; INDUCED OBESITY; BALB/C MICE	Current estimates suggest that over one-third of the adult population has metabolic syndrome and three-fourths of the obese population has non-alcoholic fatty liver disease (NAFLD). Inflammation in metabolic tissues has emerged as a universal feature of obesity and its co-morbidities, including NAFLD. Natural Killer T (NKT) cells are a subset of innate immune cells that abundantly reside within the liver and are readily activated by lipid antigens. There is general consensus that NKT cells are pivotal regulators of inflammation; however, disagreement exists as to whether NKT cells exert pathogenic or suppressive functions in obesity. Here we demonstrate that CD1d(-/-) mice, which lack NKT cells, were more susceptible to weight gain and fatty liver following high fat diet (HFD) feeding. Compared with their WT counterparts, CD1d(-/-) mice displayed increased adiposity and greater induction of inflammatory genes in the liver suggestive of the precursors of NAFLD. Calorimetry studies revealed a significant increase in food intake and trends toward decreased metabolic rate and activity in CD1d(-/-) mice compared with WT mice. Based on these findings, our results suggest that NKT cells play a regulatory role that helps to prevent diet-induced obesity and metabolic dysfunction and may play an important role in mechanisms governing cross-talk between metabolism and the immune system to regulate energy balance and liver health.	[You, Qiang] Nanjing Med Univ, Affiliated Hosp 2, Dept Biotherapy, Nanjing, Jiangsu, Peoples R China; [You, Qiang; Ju, Cynthia] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA; [Martin-Murphy, Brittany V.] Univ Colorado, Barbara Davis Ctr Diabet, Aurora, CO USA; [Wang, Hong] Univ Colorado, Div Endocrinol Diabet & Metab, Aurora, CO USA; [De La Houssaye, Becky A.; Friedman, Jacob E.] Univ Colorado, Dept Pediat, Aurora, CO USA; [Reilly, Timothy P.] Bristol Myers Squibb Co, Drug Safety Evaluat Res & Dev, Princeton, NJ USA	Nanjing Medical University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Bristol-Myers Squibb	Ju, C (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA.	Cynthia.ju@ucdenver.edu	Wang, Huaqing/A-9179-2017	Wang, Huaqing/0000-0001-5333-0829; Marteinsdottir, Bryndis/0000-0003-3779-7327	National Institute of Health [F31DK082269, RO1ES012914, R01-DK059767, P30DK048520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059767, P30DK048520, F31DK082269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012914] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Health grants F31DK082269 (BVM), RO1ES012914 (CJ), R01-DK059767 (JEF) and P30DK048520 to the Colorado Nutrition and Obesity Research Center (NORC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Bourdi M, 2007, CHEM RES TOXICOL, V20, P208, DOI 10.1021/tx060228l; BRENNER GJ, 1994, CELL IMMUNOL, V157, P510, DOI 10.1006/cimm.1994.1246; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Durante-Mangoni E, 2004, J IMMUNOL, V173, P2159, DOI 10.4049/jimmunol.173.3.2159; Elinav E, 2006, J PATHOL, V209, P121, DOI 10.1002/path.1950; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Exley MA, 2004, HEPATOLOGY, V40, P1033, DOI 10.1002/hep.20433; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Gaupp S, 2003, AM J PATHOL, V162, P139, DOI 10.1016/S0002-9440(10)63805-9; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Guebre-Xabier M, 2000, HEPATOLOGY, V31, P633, DOI 10.1002/hep.510310313; GUIDA JD, 1995, J VIROL, V69, P7674, DOI 10.1128/JVI.69.12.7674-7681.1995; Hammond KJL, 1998, J EXP MED, V187, P1047, DOI 10.1084/jem.187.7.1047; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Jensen DR, 2001, J APPL PHYSIOL, V90, P912, DOI 10.1152/jappl.2001.90.3.912; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Kotas ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025478; Lai DZ, 2011, J EXP MED, V208, P1093, DOI 10.1084/jem.20101527; Li ZP, 2004, HEPATOLOGY, V40, P434, DOI 10.1002/hep.20320; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J IMMUNOL, V187, P6208, DOI 10.4049/jimmunol.1102188; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Maachi M, 2004, INT J OBESITY, V28, P993, DOI 10.1038/sj.ijo.0802718; Madhur MS, 2011, ARTERIOSCL THROM VAS, V31, P1565, DOI 10.1161/ATVBAHA.111.227629; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; Margalit M, 2006, J PHARMACOL EXP THER, V319, P105, DOI 10.1124/jpet.106.104950; Miyagi T, 2010, J GASTROENTEROL, V45, P1247, DOI 10.1007/s00535-010-0272-y; Monroy-Ostria A, 1994, Arch Med Res, V25, P401; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; NIEWIESK S, 1993, J VIROL, V67, P75, DOI 10.1128/JVI.67.1.75-81.1993; NONOGAKI K, 1995, ENDOCRINOLOGY, V136, P2143, DOI 10.1210/en.136.5.2143; Novak J, 2007, INT REV IMMUNOL, V26, P49, DOI 10.1080/08830180601070229; Omar B, 2012, NUTRIENTS, V4, P1367, DOI 10.3390/nu4101367; Park O, 2009, HEPATOLOGY, V49, P1683, DOI 10.1002/hep.22813; Poulton LD, 2001, INT IMMUNOL, V13, P887, DOI 10.1093/intimm/13.7.887; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Satoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030568; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675; Sell H, 2012, NAT REV ENDOCRINOL, DOI [10.1038/nrendo.2012.114, DOI 10.1038/NRENDO.2012.114.]; Tajiri K, 2009, EUR J GASTROEN HEPAT, V21, P673, DOI 10.1097/MEG.0b013e32831bc3d6; Tsigos C, 1997, J CLIN ENDOCR METAB, V82, P4167, DOI 10.1210/jc.82.12.4167; Umetsu DT, 2012, CELL RES, V22, P1210, DOI 10.1038/cr.2012.65; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Werner JM, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-26; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu L, 2012, P NATL ACAD SCI USA, V109, pE1143, DOI 10.1073/pnas.1200498109; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang L, 2007, LAB INVEST, V87, P927, DOI 10.1038/labinvest.3700603; You Q, 2006, HEPATOLOGY, V44, P1421, DOI 10.1002/hep.21425	61	86	89	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e80949	10.1371/journal.pone.0080949	http://dx.doi.org/10.1371/journal.pone.0080949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	25057815	Green Published, Green Submitted, gold			2022-12-25	WOS:000330240500002
J	Chen, H; Luo, R; Gong, SZ; Matta, SG; Sharp, BM				Chen, Hao; Luo, Rui; Gong, Suzhen; Matta, Shannon G.; Sharp, Burt M.			Protection Genes in Nucleus Accumbens Shell Affect Vulnerability to Nicotine Self-Administration across Isogenic Strains of Adolescent Rat	PLOS ONE			English	Article							CUE-INDUCED REINSTATEMENT; AFRICAN-AMERICAN SMOKERS; GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMAS; CA2+ SENSOR VILIP-1; HIPPOCAMPAL-NEURONS; NEOSTRIATAL NEURONS; MOLECULAR-GENETICS; SMOKING-CESSATION; EUROPEAN-AMERICAN	Classical genetic studies show the heritability of cigarette smoking is 0.4-0.6, and that multiple genes confer susceptibility and resistance to smoking. Despite recent advances in identifying genes associated with smoking behaviors, the major source of this heritability and its impact on susceptibility and resistance are largely unknown. Operant self-administration (SA) of intravenous nicotine is an established model for smoking behavior. We recently confirmed that genetic factors exert strong control over nicotine intake in isogenic rat strains. Because the processing of afferent dopaminergic signals by nucleus accumbens shell (AcbS) is critical for acquisition and maintenance of motivated behaviors reinforced by nicotine, we hypothesized that differential basal gene expression in AcbS accounts for much of the strain-to-strain variation in nicotine SA. We therefore sequenced the transcriptome of AcbS samples obtained by laser capture microdissection from 10 isogenic adolescent rat strains and compared all RNA transcript levels with behavior. Weighted gene co-expression network analysis, a systems biology method, found 12 modules (i.e., unique sets of genes that covary across all samples) that correlated (p<0.05) with amount of self-administered nicotine; 9 of 12 correlated negatively, implying a protective role. PCR confirmed selected genes from these modules. Chilibot, a literature mining tool, identified 15 genes within 1 module that were nominally associated with cigarette smoking, thereby providing strong support for the analytical approach. This is the first report demonstrating that nicotine intake by adolescent rodents is associated with the expression of specific genes in AcbS of the mesolimbic system, which controls motivated behaviors. These findings provide new insights into genetic mechanisms that predispose or protect against tobacco addiction.	[Chen, Hao; Gong, Suzhen; Matta, Shannon G.; Sharp, Burt M.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Luo, Rui] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chen, H (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA.	hchen@uthsc.edu; bsharp@uthsc.edu	Sharp, Burt/X-6200-2019; Chen, Hao/AAX-5849-2020; Norenburg, Jon L/K-3481-2015	Sharp, Burt/0000-0002-3765-8848; Chen, Hao/0000-0002-2680-6921; Norenburg, Jon L/0000-0001-7776-1527; Zhou, Tan/0000-0002-9193-5113; Yu, Rongjie/0000-0001-9285-5783	NIH [RC2 DA 028962]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by NIH grant RC2 DA 028962. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anney RJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-46; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Beuten J, 2007, AM J MED GENET B, V144B, P285, DOI 10.1002/ajmg.b.30399; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bierut LJ, 2011, NEURON, V69, P618, DOI 10.1016/j.neuron.2011.02.015; Brower VG, 2002, BRAIN RES, V930, P12, DOI 10.1016/S0006-8993(01)03375-3; Brunzell DH, 2010, NEUROPSYCHOPHARMACOL, V35, P665, DOI 10.1038/npp.2009.171; Buczek Y, 1999, PSYCHOPHARMACOLOGY, V144, P183, DOI 10.1007/s002130050992; Cadoni C, 2009, NEUROPHARMACOLOGY, V57, P496, DOI 10.1016/j.neuropharm.2009.07.033; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Chen H, 2007, NEUROPSYCHOPHARMACOL, V32, P700, DOI 10.1038/sj.npp.1301135; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044234; Chen H, 2011, NEUROPSYCHOPHARMACOL, V36, P2629, DOI 10.1038/npp.2011.149; Chen H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00098; Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; Dao JM, 2011, NEUROPSYCHOPHARMACOL, V36, P1319, DOI 10.1038/npp.2011.8; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Donny EC, 1998, PSYCHOPHARMACOLOGY, V136, P83, DOI 10.1007/s002130050542; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gold AB, 2012, NEUROPSYCHOPHARMACOL, V37, P1683, DOI 10.1038/npp.2012.13; Hafkamp HC, 2009, MODERN PATHOL, V22, P686, DOI 10.1038/modpathol.2009.23; Hamada M, 2005, J PHARMACOL EXP THER, V315, P872, DOI 10.1124/jpet.105.090852; Hamada M, 2004, J NEUROCHEM, V90, P1094, DOI 10.1111/j.1471-4159.2004.02574.x; Han SZ, 2010, BIOL PSYCHIAT, V67, P12, DOI 10.1016/j.biopsych.2009.08.028; Iancu OD, 2013, ALCOHOL CLIN EXP RES, V37, P1295, DOI 10.1111/acer.12100; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; JOSEPH R, 1994, BIOCHEM BIOPH RES CO, V201, P1227, DOI 10.1006/bbrc.1994.1836; Kalomenidis L, 2001, LUNG, V179, P265, DOI 10.1007/s0040800000067; Kendler KS, 2012, NAT NEUROSCI, V15, P181, DOI 10.1038/nn.3018; Keskitalo-Vuokko K, 2012, NICOTINE TOB RES, V14, P153, DOI 10.1093/ntr/ntr153; Konu O, 2001, BRAIN RES, V909, P194, DOI 10.1016/S0006-8993(01)02685-3; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Le Foll B, 2012, INT J NEUROPSYCHOPH, V15, P1265, DOI 10.1017/S1461145711001398; Lecca D, 2006, PSYCHOPHARMACOLOGY, V184, P435, DOI 10.1007/s00213-005-0280-4; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li MD, 2003, AM J MED SCI, V326, P168, DOI 10.1097/00000441-200310000-00003; Liechti ME, 2007, J NEUROSCI, V27, P9077, DOI 10.1523/JNEUROSCI.1766-07.2007; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Liu X, 2007, NEUROPSYCHOPHARMACOL, V32, P710, DOI 10.1038/sj.npp.1301129; Ma JZ, 2010, HUM GENET, V127, P503, DOI 10.1007/s00439-010-0787-6; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; Nussbaum J, 2008, HUM MOL GENET, V17, P1569, DOI 10.1093/hmg/ddn044; O'Dell LE, 2007, J PHARMACOL EXP THER, V320, P180, DOI 10.1124/jpet.106.105270; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-63; Oyang EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024879; Paterson NE, 2005, NEUROPSYCHOPHARMACOL, V30, P119, DOI 10.1038/sj.npp.1300524; Rose JE, 1999, DRUG ALCOHOL DEPEN, V56, P99, DOI 10.1016/S0376-8716(99)00025-3; Rose JE, 1997, PSYCHOPHARMACOLOGY, V130, P28, DOI 10.1007/s002130050209; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Sasaki H, 2012, MOL MED REP, V5, P725, DOI 10.3892/mmr.2011.715; Sato N, 2010, PSYCHIAT GENET, V20, P135, DOI 10.1097/YPG.0b013e32833a21f9; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sharp BM, 2011, GENES BRAIN BEHAV, V10, P778, DOI 10.1111/j.1601-183X.2011.00716.x; Shoaib M, 1997, PSYCHOPHARMACOLOGY, V129, P35, DOI 10.1007/s002130050159; Shoaib M, 1999, PSYCHOPHARMACOLOGY, V143, P318, DOI 10.1007/s002130050954; Slotkin TA, 2007, NEUROPSYCHOPHARMACOL, V32, P1082, DOI 10.1038/sj.npp.1301231; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; Sullivan P F, 1999, Nicotine Tob Res, V1 Suppl 2, pS51; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Valentine JD, 1997, PSYCHOPHARMACOLOGY, V133, P300, DOI 10.1007/s002130050405; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Wei JX, 2012, ADDICT BEHAV, V37, P622, DOI 10.1016/j.addbeh.2012.01.009; Winden KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020763; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Young RJ, 2013, ORAL ONCOL, V49, P576, DOI 10.1016/j.oraloncology.2013.01.006; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001; Zhao CJ, 2009, CELL MOL NEUROBIOL, V29, P273, DOI 10.1007/s10571-008-9320-z; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	82	136	143	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86214	10.1371/journal.pone.0086214	http://dx.doi.org/10.1371/journal.pone.0086214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465966	Green Published, Green Submitted, gold			2022-12-25	WOS:000330283100127
J	Chen, HX; Sun, SC; Norenburg, JL; Sundberg, P				Chen, Haixia; Sun, Shichun; Norenburg, Jon L.; Sundberg, Per			Mutation and Selection Cause Codon Usage and Bias in Mitochondrial Genomes of Ribbon Worms (Nemertea)	PLOS ONE			English	Article							AMINO-ACID USAGE; TRANSFER-RNAS; TRANSLATIONAL SELECTION; EFFECTIVE NUMBER; GENE-EXPRESSION; EVOLUTION; PATTERNS; FREQUENCIES; NUCLEOTIDE; ABUNDANCE	The phenomenon of codon usage bias is known to exist in many genomes and it is mainly determined by mutation and selection. To understand the patterns of codon usage in nemertean mitochondrial genomes, we use bioinformatic approaches to analyze the protein-coding sequences of eight nemertean species. Neutrality analysis did not find a significant correlation between GC12 and GC3. ENc-plot showed a few genes on or close to the expected curve, but the majority of points with low-ENc values are below it. ENc-plot suggested that mutational bias plays a major role in shaping codon usage. The Parity Rule 2 plot (PR2) analysis showed that GC and AT were not used proportionally and we propose that codons containing A or U at third position are used preferentially in nemertean species, regardless of whether corresponding tRNAs are encoded in the mitochondrial DNA. Context-dependent analysis indicated that the nucleotide at the second codon position slightly affects synonymous codon choices. These results suggested that mutational and selection forces are probably acting to codon usage bias in nemertean mitochondrial genomes.	[Chen, Haixia; Sundberg, Per] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Sun, Shichun] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China; [Norenburg, Jon L.] Smithsonians Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC USA	University of Gothenburg; Ocean University of China; Smithsonian Institution; Smithsonian National Museum of Natural History	Chen, HX (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	chen_hai_xia@126.com; per.sundberg@bioenv.gu.se	Sharp, Burt/X-6200-2019; Chen, Hao/AAX-5849-2020; Norenburg, Jon L/K-3481-2015	Sharp, Burt/0000-0002-3765-8848; Chen, Hao/0000-0002-2680-6921; Norenburg, Jon L/0000-0001-7776-1527; Zhou, Tan/0000-0002-9193-5113; Yu, Rongjie/0000-0001-9285-5783	Swedish Research Council; National Natural Science Foundation of China [30970333]	Swedish Research Council(Swedish Research CouncilEuropean Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported (to PS) by the Swedish Research Council, and National Natural Science Foundation of China (to SCS, grant no. 30970333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Akashi H, 1998, CURR OPIN GENET DEV, V8, P688, DOI 10.1016/S0959-437X(98)80038-5; Angellotti MC, 2007, NUCLEIC ACIDS RES, V35, pW132, DOI 10.1093/nar/gkm392; BULMER M, 1988, J EVOLUTION BIOL, V1, P15, DOI 10.1046/j.1420-9101.1988.1010015.x; Carullo M, 2008, J MOL EVOL, V66, P484, DOI 10.1007/s00239-008-9102-8; Chen HX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-139; Chen HX, 2011, MOL BIOL REP, V38, P4509, DOI 10.1007/s11033-010-0582-4; Chen HX, 2009, GENE, V442, P8, DOI 10.1016/j.gene.2009.04.015; Chiapello H, 1998, GENE, V209, pGC1, DOI 10.1016/S0378-1119(97)00671-9; Cutter AD, 2006, MOL BIOL EVOL, V23, P2303, DOI 10.1093/molbev/msl097; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Francino HP, 1999, NATURE, V400, P30, DOI 10.1038/21804; Fuglsang A, 2008, GENE, V410, P82, DOI 10.1016/j.gene.2007.12.001; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, P1893, DOI 10.1093/nar/8.9.1893; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ingvarsson PK, 2007, MOL BIOL EVOL, V24, P836, DOI 10.1093/molbev/msl212; Ingvarsson PK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-307; Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259; Kamatani T, 2007, BIOSYSTEMS, V90, P362, DOI 10.1016/j.biosystems.2006.09.039; Le Thanh Hoa, 2004, Korean Journal of Parasitology, V42, P159, DOI 10.3347/kjp.2004.42.4.159; LOBRY JR, 1995, J MOL EVOL, V40, P326, DOI 10.1007/BF00163237; Mitreva M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r75; Oliveira MT, 2008, MOL PHYLOGENET EVOL, V48, P850, DOI 10.1016/j.ympev.2008.05.022; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Podsiadlowski L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-364; Powell JR, 1997, P NATL ACAD SCI USA, V94, P7784, DOI 10.1073/pnas.94.15.7784; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; SHARP PM, 1993, BIOCHEM SOC T, V21, P835, DOI 10.1042/bst0210835; Shioiri C, 2001, J MOL EVOL, V53, P364, DOI 10.1007/s002390010226; STENICO M, 1994, NUCLEIC ACIDS RES, V22, P2437, DOI 10.1093/nar/22.13.2437; Subramanian S, 2008, GENETICS, V178, P2429, DOI 10.1534/genetics.107.086405; Sueoka N, 1999, GENE, V238, P53, DOI 10.1016/S0378-1119(99)00320-0; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; SUEOKA N, 1995, J MOL EVOL, V40, P318, DOI 10.1007/BF00163236; Swire J, 2005, J MOL EVOL, V60, P128, DOI 10.1007/s00239-004-0077-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turbeville JM, 2007, MOL PHYLOGENET EVOL, V43, P1056, DOI 10.1016/j.ympev.2006.10.025; Vicario S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-226; Wang B, 2010, J INTEGR PLANT BIOL, V52, P1100, DOI 10.1111/j.1744-7909.2010.00998.x; Wang X, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-14; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Xia XH, 2005, GENE, V345, P13, DOI 10.1016/j.gene.2004.11.019; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Yu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016147	48	136	143	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85631	10.1371/journal.pone.0085631	http://dx.doi.org/10.1371/journal.pone.0085631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24465966	Green Submitted, Green Published, gold			2022-12-25	WOS:000330235100110
J	Wang, Y; Jin, S; Sonobe, Y; Cheng, Y; Horiuchi, H; Parajuli, B; Kawanokuchi, J; Mizuno, T; Takeuchi, H; Suzumura, A				Wang, Yue; Jin, Shijie; Sonobe, Yoshifumi; Cheng, Yi; Horiuchi, Hiroshi; Parajuli, Bijay; Kawanokuchi, Jun; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio			Interleukin-1 beta Induces Blood-Brain Barrier Disruption by Downregulating Sonic Hedgehog in Astrocytes	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS; NEUROLOGICAL DISEASES; MOLECULAR-MECHANISMS; MAGNETIC-RESONANCE; ALZHEIMERS-DISEASE; CNS	The blood-brain barrier (BBB) is composed of capillary endothelial cells, pericytes, and perivascular astrocytes, which regulate central nervous system homeostasis. Sonic hedgehog (SHH) released from astrocytes plays an important role in the maintenance of BBB integrity. BBB disruption and microglial activation are common pathological features of various neurologic diseases such as multiple sclerosis, Parkinson's disease, amyotrophic lateral sclerosis, and Alzheimer's disease. Interleukin-1 beta (IL-1 beta), a major pro-inflammatory cytokine released from activated microglia, increases BBB permeability. Here we show that IL-1 beta abolishes the protective effect of astrocytes on BBB integrity by suppressing astrocytic SHH production. Astrocyte conditioned media, SHH, or SHH signal agonist strengthened BBB integrity by upregulating tight junction proteins, whereas SHH signal inhibitor abrogated these effects. Moreover, IL-1 beta increased astrocytic production of pro-inflammatory chemokines such as CCL2, CCL20, and CXCL2, which induce immune cell migration and exacerbate BBB disruption and neuroinflammation. Our findings suggest that astrocytic SHH is a potential therapeutic target that could be used to restore disrupted BBB in patients with neurologic diseases.	[Wang, Yue; Jin, Shijie; Sonobe, Yoshifumi; Cheng, Yi; Horiuchi, Hiroshi; Parajuli, Bijay; Kawanokuchi, Jun; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Nagoya, Aichi 464, Japan	Nagoya University	Takeuchi, H (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Nagoya, Aichi 464, Japan.	htake@riem.nagoya-u.ac.jp	Antaki, James/S-3051-2016; Vandenberghe, Stijn/T-9364-2019; Antaki, James Francis/AAC-5331-2020; Vandenberghe, Stijn/G-9038-2016; Bijay, Parajuli/AAT-5590-2021; Parajuli, Bijay/G-2961-2015	Antaki, James/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Antaki, James Francis/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Parajuli, Bijay/0000-0003-3813-113X; Horiuchi, Hiroshi/0000-0001-9008-2027; Takeuchi, Hideyuki/0000-0001-5912-7581	Ministry of Education, Culture, Sports, Science and Technology of Japan; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant from the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO) of Japan; and grants from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Araujo GLL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00077; Argaw AT, 2006, J IMMUNOL, V177, P5574, DOI 10.4049/jimmunol.177.8.5574; Aronica E, 2012, GLIA, V60, P1258, DOI 10.1002/glia.22312; Blamire AM, 2000, J NEUROSCI, V20, P8153; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Carvey PM, 2009, J NEUROCHEM, V111, P291, DOI 10.1111/j.1471-4159.2009.06319.x; Chakraborty S, 2010, J NEUROSCI RES, V88, P1615, DOI 10.1002/jnr.22343; Cheng Y, 2014, J NEUROIMMUNOL, V269, P38, DOI 10.1016/j.jneuroim.2014.02.001; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Doi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061988; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; FREQUIN STFM, 1992, J NEUROIMMUNOL, V40, P265, DOI 10.1016/0165-5728(92)90142-8; Friedman WJ, 1996, J BIOL CHEM, V271, P31115, DOI 10.1074/jbc.271.49.31115; Glazner GW, 2000, J NEUROCHEM, V75, P101, DOI 10.1046/j.1471-4159.2000.0750101.x; Grammas P, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001918; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; Herx LM, 2001, J NEUROPATH EXP NEUR, V60, P961, DOI 10.1093/jnen/60.10.961; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kraus J, 2006, DRUG DISCOV TODAY, V11, P755, DOI 10.1016/j.drudis.2006.06.008; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Laflamme N, 1999, J NEUROSCI, V19, P10923, DOI 10.1523/JNEUROSCI.19-24-10923.1999; Liang JF, 2008, BRAIN RES, V1210, P11, DOI 10.1016/j.brainres.2008.03.012; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; MARTINEY JA, 1990, AM J PATHOL, V137, P1411; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Mastronardi FG, 2004, J IMMUNOL, V172, P6418, DOI 10.4049/jimmunol.172.10.6418; Mastronardi FG, 2003, MULT SCLER, V9, P362, DOI 10.1191/1352458503ms924oa; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Osterlund T, 2006, TRENDS CELL BIOL, V16, P176, DOI 10.1016/j.tcb.2006.02.004; Parajuli B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.503; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Sonobe Y, 2009, J BIOL CHEM, V284, P31834, DOI 10.1074/jbc.M109.025940; SUZUMURA A, 1986, SCIENCE, V232, P991, DOI 10.1126/science.3010460; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Traiffort E, 2010, J NEUROCHEM, V113, P576, DOI 10.1111/j.1471-4159.2010.06642.x; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Wang JY, 2008, P NATL ACAD SCI USA, V105, P3915, DOI 10.1073/pnas.0709592105; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	47	247	256	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2014	9	10							e110024	10.1371/journal.pone.0110024	http://dx.doi.org/10.1371/journal.pone.0110024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR5ZW	25313834	Green Submitted, Green Published, gold			2022-12-25	WOS:000343662500094
J	Wang, YJ; Loghmanpour, N; Vandenberghe, S; Ferreira, A; Keller, B; Gorcsan, J; Antaki, J				Wang, Yajuan; Loghmanpour, Natasha; Vandenberghe, Stijn; Ferreira, Antonio; Keller, Bradley; Gorcsan, John; Antaki, James			Simulation of Dilated Heart Failure with Continuous Flow Circulatory Support	PLOS ONE			English	Article							VENTRICULAR ASSIST DEVICE; PRESSURE-VOLUME RELATIONS; TURBODYNAMIC BLOOD PUMPS; MYOCARDIAL RECOVERY; FILLING PRESSURES; RISK SCORE; IN-VIVO; EXERCISE; MODEL; REST	Lumped parameter models have been employed for decades to simulate important hemodynamic couplings between a left ventricular assist device (LVAD) and the native circulation. However, these studies seldom consider the pathological descending limb of the Frank-Starling response of the overloaded ventricle. This study introduces a dilated heart failure model featuring a unimodal end systolic pressure-volume relationship (ESPVR) to address this critical shortcoming. The resulting hemodynamic response to mechanical circulatory support are illustrated through numerical simulations of a rotodynamic, continuous flow ventricular assist device (cfVAD) coupled to systemic and pulmonary circulations with baroreflex control. The model further incorporated septal interaction to capture the influence of left ventricular (LV) unloading on right ventricular function. Four heart failure conditions were simulated (LV and bi-ventricular failure with/without pulmonary hypertension) in addition to normal baseline. Several metrics of LV function, including cardiac output and stroke work, exhibited a unimodal response whereby initial unloading improved function, and further unloading depleted preload reserve thereby reducing ventricular output. The concept of extremal loading was introduced to reflect the loading condition in which the intrinsic LV stroke work is maximized. Simulation of bi-ventricular failure with pulmonary hypertension revealed inadequacy of LV support alone. These simulations	[Wang, Yajuan; Loghmanpour, Natasha; Ferreira, Antonio; Antaki, James] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Vandenberghe, Stijn] Univ Bern, Bern, Switzerland; [Ferreira, Antonio] Univ Fed Maranhao, Maranhao, Brazil; [Keller, Bradley] Univ Louisville, Cardiovasc Innovat Inst, Louisville, KY 40292 USA; [Gorcsan, John] Univ Pittsburgh, Med Ctr, Inst Heart & Vasc, Pittsburgh, PA USA	Carnegie Mellon University; University of Bern; Universidade Federal do Maranhao; University of Louisville; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Antaki, J (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.	antaki@cmu.edu	Antaki, James/S-3051-2016; Vandenberghe, Stijn/T-9364-2019; Antaki, James Francis/AAC-5331-2020; Vandenberghe, Stijn/G-9038-2016; Bijay, Parajuli/AAT-5590-2021; Parajuli, Bijay/G-2961-2015	Antaki, James/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Antaki, James Francis/0000-0002-5430-7353; Vandenberghe, Stijn/0000-0003-1464-0597; Parajuli, Bijay/0000-0003-3813-113X; Horiuchi, Hiroshi/0000-0001-9008-2027; Takeuchi, Hideyuki/0000-0001-5912-7581	NIH [1R01HL086918]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research was supported by NIH grant 1R01HL086918. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURKHOFF D, 1987, AM J PHYSIOL, V252, pH1218, DOI 10.1152/ajpheart.1987.252.6.H1218; CAREY CF, 1998, WASHINGTON MANUAL ME; Choi S., 1998, THESIS U PITTSBURGH; Chung DC, 1997, AM J PHYSIOL-HEART C, V272, pH2942, DOI 10.1152/ajpheart.1997.272.6.H2942; Dang NC, 2006, J HEART LUNG TRANSPL, V25, P1, DOI 10.1016/j.healun.2005.07.008; EHRSAM RE, 1983, CLIN SCI, V65, P653, DOI 10.1042/cs0650653; FARRAR DJ, 1985, WORLD J SURG, V9, P89, DOI 10.1007/BF01656260; Ferreira A, 2007, P ANN INT IEEE EMBS, P3978, DOI 10.1109/IEMBS.2007.4353205; Ferreira A, 2009, IEEE T BIO-MED ENG, V56, P656, DOI 10.1109/TBME.2008.2005960; Fitzpatrick JR, 2009, J THORAC CARDIOV SUR, V137, P971, DOI 10.1016/j.jtcvs.2008.09.021; Fitzpatrick JR, 2008, J HEART LUNG TRANSPL, V27, P1286, DOI 10.1016/j.healun.2008.09.006; Gorcsan J, 2003, J HEART LUNG TRANSPL, V22, P1304, DOI 10.1016/S1053-2498(03)00056-1; Gwak KW, 2004, IEEE DECIS CONTR P, P1069, DOI 10.1109/CDC.2004.1428833; Gwak KW, 2007, ASAIO J, V53, P403, DOI 10.1097/MAT.0b013e31806ada0a; Gwak KW, 2011, ARTIF ORGANS, V35, P725, DOI 10.1111/j.1525-1594.2011.01230.x; Hall JE, 2010, GUYTON HALL TXB MED, P110; KASS DA, 1989, CIRCULATION, V79, P167, DOI 10.1161/01.CIR.79.1.167; Katz AM, 2008, CIRC-HEART FAIL, V1, P63, DOI 10.1161/CIRCHEARTFAILURE.108.772756; Kinoshita M, 1988, ASAIO Trans, V34, P208; KORMOS RL, 1990, ANN THORAC SURG, V49, P261, DOI 10.1016/0003-4975(90)90148-Y; Kormos RL, 2010, J THORAC CARDIOV SUR, V139, P1316, DOI 10.1016/j.jtcvs.2009.11.020; Kovacs G, 2009, EUR RESPIR J, V34, P888, DOI 10.1183/09031936.00145608; Lisy O, 2000, CIRCULATION, V102, P338; LITTLE WC, 1988, CIRCULATION, V78, P736, DOI 10.1161/01.CIR.78.3.736; Matthews JC, 2008, J AM COLL CARDIOL, V51, P2163, DOI 10.1016/j.jacc.2008.03.009; Maybaum S, 2011, CIRCULATION, V123, P355, DOI 10.1161/CIRCULATIONAHA.110.005199; Morley D, 2007, J THORAC CARDIOV SUR, V133, P21, DOI 10.1016/j.jtcvs.2006.07.037; Moscato F, 2010, ARTIF ORGANS, V34, P736, DOI 10.1111/j.1525-1594.2010.01066.x; Nair PK, 2010, J HEART LUNG TRANSPL, V29, P201, DOI 10.1016/j.healun.2009.09.013; Nakatani S, 1996, J AM COLL CARDIOL, V27, P894, DOI 10.1016/0735-1097(95)00555-2; NORDENFELT I, 1985, CLIN PHYSIOL, V5, P161, DOI 10.1111/j.1475-097X.1985.tb00592.x; Palardy M, 2009, CIRC-HEART FAIL, V2, P181, DOI 10.1161/CIRCHEARTFAILURE.108.822999; Rose AG, 2000, ANN THORAC SURG, V70, P1270, DOI 10.1016/S0003-4975(00)01929-9; ROSS J, 1964, CIRCULATION, V29, P739, DOI 10.1161/01.CIR.29.5.739; SARNOFF SJ, 1954, CIRCULATION, V9, P706, DOI 10.1161/01.CIR.9.5.706; Schima H, 2004, J THORAC CARDIOV SUR, V127, P1743, DOI 10.1016/j.jtcvs.2003.09.029; Shi YB, 2006, ARTIF ORGANS, V30, P929, DOI 10.1111/j.1525-1594.2006.00326.x; SHROFF SG, 1985, AM J PHYSIOL, V249, pH358, DOI 10.1152/ajpheart.1985.249.2.H358; Simon MA, 2010, J CARD FAIL, V16, P99, DOI 10.1016/j.cardfail.2009.10.018; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Soloff LA, 1999, CIRCULATION, V100, P1012, DOI 10.1161/circ.100.9.1011/-b; Starling E. H., 1918, LINACRE LECT LAW HEA; STEVENSON LW, 1986, CIRCULATION, V74, P1303, DOI 10.1161/01.CIR.74.6.1303; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; THADANI U, 1978, AM J CARDIOL, V41, P52, DOI 10.1016/0002-9149(78)90131-5; Ursino M, 1998, AM J PHYSIOL-HEART C, V275, pH1733, DOI 10.1152/ajpheart.1998.275.5.H1733; Vandenberghe S, 2003, ARTIF ORGANS, V27, P1094, DOI 10.1111/j.1525-1594.2003.07198.x; Vollkron M, 2002, ARTIF ORGANS, V26, P349, DOI 10.1046/j.1525-1594.2002.06870.x; ZARET BL, 1984, EUR HEART J, V5, P850, DOI 10.1093/oxfordjournals.eurheartj.a061576	49	247	256	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e85234	10.1371/journal.pone.0085234	http://dx.doi.org/10.1371/journal.pone.0085234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	25313834	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000330237000027
